Admission	O
Date	O
:	O

2012-10-31	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-11-07	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1941-03-23	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Nsaids/Anti-Inflammatory	B-treatment
Classifier	I-treatment
/	O
Vancomycin	B-treatment

Attending	O
:	O

Kristie	O
R.	O
Hamby	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

CC	O
:	O
Antonio	O
M.	O
Z.	O
Eddings	O
,	O
M.D.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Mesenteric	B-test
angiograpm	I-test
w/	O
coil	B-treatment
embolization	I-treatment
of	O
bleeding	B-problem
vessel	I-problem
.	O

Sigmoidoscopy	B-test
.	O

Colonoscopy	B-test
.	O

History	O
of	O
Present	O
Illness	O
:	O

HPI:	O
Pt	O
is	O
a	O
71	O
y/o	O
male	O
with	O
h/o	O
dm2	B-problem
,	O
cad	B-problem
s/p	O
cabg	B-treatment
,	O
DVT/PE	B-problem
on	O
long	B-treatment
term	I-treatment
anti-coagulation	I-treatment
,	O
ulcerative	B-problem
colitis	I-problem
on	O
Asacol	B-treatment
presents	O
with	O
brbpr	B-problem
starting	O
at	O
9am	O
of	O
the	O
morning	O
of	O
admission	O
.	O

He	O
'd	O
been	O
having	O
lower	B-problem
abdominal	I-problem
pain	I-problem
for	O
approximately	O
the	O
past	O
week	O
,	O
a	B-problem
symptom	I-problem
for	O
which	O
he	O
's	O
been	O
admitted	O
in	O
the	O
past	O
.	O

His	O
PCP	O
had	O
recently	O
started	O
ciprofloxacin	B-treatment
for	O
a	B-problem
UTI	I-problem
.	O

At	O
9am	O
the	O
morning	O
of	O
admission	O
he	O
passed	O
a	B-problem
large	I-problem
,	I-problem
bloody	I-problem
bowel	I-problem
movement	I-problem
and	O
came	O
to	O
the	O
Michael	O
.	O
There	O
,	O
his	B-test
vitals	I-test
were	O
intially	O
stable	O
with	O
a	B-test
hct	I-test
of	O
36.7	O
,	O
though	O
he	O
was	O
felt	O
to	O
be	O
hypovolemic	B-problem
and	O
this	O
hemoconcentrated	B-problem
;	O
his	B-test
previous	I-test
hct	I-test
was	O
39	O
about	O
five	O
months	O
ago	O
.	O

He	O
refused	O
an	B-treatment
NG	I-treatment
lavage	I-treatment
.	O

Although	O
an	B-test
initial	I-test
DRE	I-test
showed	O
only	O
clot	B-problem
,	O
he	O
later	O
passed	O
a	B-problem
large	I-problem
,	I-problem
bloody	I-problem
bowel	I-problem
movement	I-problem
,	O
and	O
his	B-test
bp	I-test
nadired	O
to	O
the	O
low	O
90's	O
but	O
rested	O
there	O
only	O
transiently	O
and	O
easily	O
rebounded	O
to	O
the	O
130's-140's	O
with	O
fluid	B-treatment
;	O
he	O
then	O
went	O
to	O
angiography	O
for	O
a	B-test
tagged	I-test
RBC	I-test
scan	I-test
where	O
they	O
found	O
and	O
embolized	O
two	O
vessels	O
to	O
the	O
sigmoid	O
colon	O
.	O

His	B-test
HCT	I-test
had	O
dropped	O
from	O
36.7	O
to	O
30.8	O
despite	O
2U	B-treatment
PRBC	I-treatment
and	O
3	B-treatment
U	I-treatment
FFP	I-treatment
.	O

Is	O
called	O
out	O
of	O
the	O
FICU	O
as	O
has	O
been	O
been	O
HD	O
and	O
stable	O
HCT	B-test
.	O

Currently	O
denies	O
CP	B-problem
,	O
SOB	B-problem
,	O
abd	B-problem
pain	I-problem
or	O
continued	B-problem
BRBPR	I-problem
.	O

Past	O
Medical	O
History	O
:	O

PMH	O
:	O

1.)	O
DM-2	B-problem

2.)	O
CAD	B-problem
s/p	O
3v-CABG	B-treatment
2003	O
and	O
subsequent	O
stenting	B-treatment
of	O
SVG	B-treatment
and	O
LIMA	O

3.)	O
CHF	B-problem
with	O
EF	B-test
30-35%	O
on	O
07-10	O
echo	B-test

4.)	O
Right	B-problem
parietal	I-problem
intracranial	I-problem
bleeding	I-problem
following	O
1996	O
cardiac	B-test
cath	I-test

5.)	O
LBBB	B-problem

6.)	O
Sinus	B-problem
node	I-problem
dysfunction	I-problem
s/p	O
pacemaker	B-treatment

7.)	O
H/O	O
DVT	B-problem
(	O
right	O
sided	O
)	O
and	O
subsequent	O
PE	B-problem
,	O
put	O
onto	O
lifetime	O
warfarin	B-treatment

8.)	O
Ulcerative	B-problem
colitis	I-problem

PSH	O
:	O

1.)	O
C4-7	B-treatment
anterior	I-treatment
discectomies	I-treatment

2.)	O
CABG	B-treatment
2003	O

3.)	O
R	B-treatment
intracerebral	I-treatment
hemorrhage	I-treatment
drainage	I-treatment

Social	O
History	O
:	O

SocHx	O
:	O
Mr	O
Peres	O
generally	O
lives	O
with	O
his	O
wife	O
but	O
has	O
spent	O
a	O
great	O
deal	O
of	O
time	O
recently	O
at	O
rehab	B-treatment
.	O

He	O
has	O
no	O
h/o	O
ETOH/IVDA	O
but	O
quit	O
tob	O
15	O
years	O
ago	O
.	O

Family	O
History	O
:	O

Noncontributory	O
.	O

Physical	O
Exam	O
:	O

VS	B-test
98.4	O
,	O
62	O
,	O
103/37	O
,	O
15	O
97%2L	O

gen	O
-	O
lying	O
in	O
bed	O
,	O
NAD	B-problem

heent	O
-	O
anicteric	B-problem
sclera	I-problem
,	O
op	O
clear	O
with	O
mmm	O

neck	O
-	O
jvd	B-problem
flat	O

cv	O
-	O
rrr	O
,	O
s1s2	O
,	O
no	O
m/r/g	B-problem

pul	O
-	O
CTAB	O
without	O
rales	B-problem

abd	O
-	O
soft	O
,	O
minimally	B-problem
distended	I-problem
,	O
nt	B-problem
,	O
no	O
rebound/guarding	B-problem
,	O
nabs	O

extrm	O
-	O
trace	B-problem
edema	I-problem
at	I-problem
ankles	I-problem
,	O
no	O
cyanosis	B-problem
,	O
warm/dry	O

Pertinent	O
Results	O
:	O

2012-10-31	O
05:47PM	O
URINE	O

COLOR	B-test
-	O
Straw	O
APPEAR	B-test
-	O
Clear	O
SP	O
Marquez	O
-	O
1.021	O

2012-10-31	O
05:47PM	O
URINE	O

BLOOD	O
-	O
LG	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
NEG	O

GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
7.0	O
LEUK	B-test
-	O
NEG	O

2012-10-31	O
05:47PM	O
URINE	O

RBC-21-50*	B-test
WBC-0-2	B-test
BACTERIA	B-test
-	O
FEW	O

YEAST	B-test
-	O
NONE	O
EPI	B-test
-	O
<1	O

2012-10-31	O
02:32PM	O

LACTATE	B-test
-	O
1.8	O

2012-10-31	O
12:20PM	O

GLUCOSE	B-test
-	O
197*	O
UREA	B-test
N-25*	I-test
CREAT	B-test
-	O
0.8	O
SODIUM	B-test
-	O
141	O

POTASSIUM	B-test
-	O
3.7	O
CHLORIDE	B-test
-	O
105	O
TOTAL	B-test
CO2	I-test
-	O
22	O
ANION	B-test
GAP	I-test
-	O
18	O

2012-10-31	O
12:20PM	O

WBC	B-test
-	O
5.6	O
RBC	B-test
-	O
4.35*	O
HGB	B-test
-	O
12.6*	O
HCT	B-test
-	O
36.7*	O
MCV	B-test
-	O
84	O

MCH	B-test
-	O
28.9	O
MCHC	B-test
-	O
34.3	O
RDW	B-test
-	O
15.7*	O

2012-10-31	O
12:20PM	O

NEUTS	B-test
-	O
80.5*	O
LYMPHS	B-test
-	O
13.1*	O
MONOS	B-test
-	O
3.5	O
EOS	B-test
-	O
2.5	O

BASOS	B-test
-	O
0.4	O

2012-10-31	O
12:20PM	O

POIKILOCY	B-test
-	O
1+	O
MICROCYT	B-test
-	O
1+	O

2012-10-31	O
12:20PM	O

PLT	B-test
COUNT	I-test
-	O
102*	O

2012-10-31	O
12:20PM	O

PT	B-test
-	O
20.5*	O
PTT	B-test
-	O
29.4	O
INR(PT)	B-test
-	O
3.0	O

GI	B-test
BLEEDING	I-test
STUDY	I-test

2012-10-31	O
PAD-WORD	O

IMPRESSION	O
:	O
Increased	B-problem
tracer	I-problem
activity	I-problem
demonstrated	O
within	O
the	O
left	O
lower	O
quadrant	O
,	O
most	O
likely	O
sigmoid	O
colonic	O
loops	O
of	O
bowel	O
,	O
consistent	O
with	O
active	B-problem
bleeding	I-problem
.	O

CT	B-test
ABDOMEN	I-test
W/CONTRAST	I-test

2012-10-31	O
3:27	O
PM	O

IMPRESSION	O
:	O

1.	O
No	O
evidence	O
of	O
colitis	B-problem
or	O
other	B-problem
bowel	I-problem
pathology	I-problem
present	O
to	O
explain	O
the	B-problem
patient	I-problem
's	I-problem
bright	I-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
.	O

2.	O
Stable	O
appearance	O
of	O
left	B-problem
adrenal	I-problem
fat-containing	I-problem
lesion	I-problem
consistent	O
with	O
a	B-problem
myelolipoma	I-problem
.	O

3.	O
Stable	O
appearance	O
of	O
hypodense	B-problem
lesion	I-problem
within	I-problem
the	I-problem
caudate	I-problem
lobe	I-problem
of	O
the	O
liver	O
,	O
too	O
small	O
to	O
fully	O
characterize	O
.	O

4.	O
Subcentimeter	B-problem
attenuation	I-problem
lesion	I-problem
within	I-problem
the	I-problem
lower	I-problem
pole	I-problem
of	O
the	O
right	O
kidney	O
,	O
too	O
small	O
to	O
characterize	O
.	O

5.	O
3-mm	B-problem
noncalcified	I-problem
pulmonary	I-problem
nodule	I-problem
within	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
.	O

If	O
the	O
patient	O
does	O
not	O
have	O
a	O
history	O
of	O
a	B-problem
primary	I-problem
malignancy	I-problem
,	O
followup	B-test
CT	I-test
of	I-test
the	I-test
chest	I-test
in	O
1	O
year	O
is	O
recommended	O
to	O
evaluate	O
for	O
stability	O
of	O
this	O
finding	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Initial	O
A/P	O
:	O

71	O
y/o	O
male	O
with	O
dm2	B-problem
,	O
cad	B-problem
,	O
chf	B-problem
,	O
uc	B-problem
presents	O
with	O
one	O
week	O
of	O
lower	B-problem
abdominal	I-problem
pain	I-problem
and	O
2	O
episodes	O
of	O
brpbr	B-problem
on	O
the	O
day	O
of	O
admission	O
.	O

#	O
BRBPR	B-problem
--	O
The	O
patient	O
was	O
in	O
the	O
intensive	O
care	O
unit	O
given	O
his	B-problem
lower	I-problem
GI	I-problem
bleed	I-problem
.	O

An	B-test
angiography	I-test
showed	O
bleeding	B-problem
in	I-problem
two	I-problem
vessels	I-problem
off	O
of	O
the	O
Minnie	O
supplying	O
the	O
sigmoid	O
that	O
were	O
succesfully	O
embolized	O
.	O

The	O
patient	O
was	O
transfused	O
from	O
a	B-test
Hct	I-test
29	O
to	O
34	O
on	O
the	O
day	O
of	O
discharge	O
.	O

His	B-treatment
coumadin	I-treatment
was	O
held	O
during	O
his	O
stay	O
given	O
his	B-problem
acute	I-problem
bleed	I-problem
but	O
restarted	O
per	O
his	O
PCP	O
with	O
the	O
guidance	O
of	O
GI	O
on	O
the	O
day	O
of	O
discharge	O
.	O

-	O
The	O
patient	O
underwent	O
a	B-test
flex	I-test
sigmoidoscopy	I-test
on	O
Friday	O
,	O
11-02	O
,	O
which	O
showed	O
old	B-problem
blood	I-problem
in	I-problem
the	I-problem
rectal	I-problem
vault	I-problem
but	O
no	O
active	B-problem
source	I-problem
of	I-problem
bleeding	I-problem
.	O

Given	O
this	O
,	O
it	O
was	O
advised	O
that	O
the	O
patient	O
have	O
a	B-test
colonoscopy	I-test
to	O
rule	O
out	O
further	O
bleeding	B-problem
.	O

-	O
The	O
patient	O
had	O
a	B-test
colonoscopy	I-test
on	O
Monday	O
11-05	O
but	O
unfortunately	O
,	O
was	O
unable	O
to	O
complete	O
the	O
study	O
as	O
his	O
bowel	O

prep	O
was	O
inadequate	O
.	O

Therefore	O
,	O
he	O
had	O
a	B-test
repeat	I-test
colonoscopy	I-test
on	O
11-06	O
which	O
showed	O
expected	O
mucosal	B-problem
signs	I-problem
of	O
moderate	B-problem
ulcerative	I-problem
colitis	I-problem
,	O
no	O
polyps	B-problem
,	O
w/	O
8	B-problem
mm	I-problem
ulcer	I-problem
at	I-problem
junction	I-problem
of	I-problem
distal	I-problem
descending	I-problem
colon	I-problem
and	I-problem
sigmoid	I-problem
colon	I-problem
.	O

-	O
Biopsies	B-test
were	O
obtained	O
during	O
his	B-test
colonoscopy	I-test
and	O
he	O
should	O
follow	O
up	O
with	O
gastroenterology	O
for	O
the	O
results	O
.	O

#	O
Ulcerative	B-problem
colitis	I-problem
--	O
The	B-treatment
patient	I-treatment
's	I-treatment
Asacol	I-treatment
was	O
originally	O
held	O
but	O
restarted	O
the	O
day	O
prior	O
to	O
discharge	O
per	O
GI	O
.	O

#	O
CAD/CHF	B-problem
-	O
The	O
patient	O
was	O
restarted	O
on	O
his	B-treatment
home	I-treatment
regimen	I-treatment
prior	O
to	O
discharge	O
as	O
it	O
was	O
held	O
temporarily	O
given	O
his	B-problem
acute	I-problem
GI	I-problem
bleed	I-problem
.	O

The	O
exception	O
is	O
that	O
per	O
his	O
PCP	O
,	O
Jason	O
aspirin	B-treatment
will	O
be	O
held	O
for	O
2	O
weeks	O
given	O
that	O
he	O
was	O
restarted	O
on	O
coumadin	B-treatment
with	O

his	B-problem
risk	I-problem
of	I-problem
bleeding	I-problem
.	O

#	O
DM-2	B-problem
--	O
The	O
patient	O
was	O
maintained	O
on	O
his	B-treatment
home	I-treatment
insulin	I-treatment
regimen	I-treatment
.	O

#	O
h/o	O
DVT/PE	B-problem
:	O

Coumadin	B-treatment
was	O
initially	O
held	O
.	O

It	O
was	O
unclear	O
at	O
first	O
as	O
to	O
why	O
the	O
patient	O
required	O
life-long	B-treatment
anticoagulation	I-treatment
.	O

After	O
discussing	O
this	O
with	O
his	O
PCP	O
,	O
Leon	O
was	O
clear	O
that	O
the	O
patient	O
had	O
had	O
recurrent	B-problem
DVTs	I-problem
and	O
ultimately	O
a	B-problem
PE	I-problem
and	O
his	O
PCP	O
felt	O
strongly	O
that	O
he	O
required	O
long-term	B-treatment
anticoagulation	I-treatment
.	O

His	B-test
goal	I-test
INR	I-test
should	O
be	O
1.6-2.0	O
.	O
If	O
bleeding	B-problem
continues	O
to	O
occur	O
,	O
consider	O
V.	B-treatment
Winchester	I-treatment
filter	I-treatment
.	O

#	O
Access	O
--	O
2	B-treatment
large	I-treatment
bore	I-treatment
PIV's	I-treatment

#	O
Code	O
--	O
full	O

Medications	O
on	O
Admission	O
:	O

Meds	O
on	O
Admission	O
:	O

1.)	O
Spironolactone/hctz	B-treatment
25/25	O
daily	O

2.)	O
Atenolol	B-treatment
12.5mg	O
daily	O

3.)	O
Insulin	B-treatment
45N/8R	O
qAM	O
and	O
33N	O
qPM	O

4.)	O
Furosemide	B-treatment
10	O
mg	O
every	O
other	O
day	O

5.)	O
Aspirin	B-treatment
81	O
mg	O
daily	O

6.)	O
Zoloft	B-treatment
40	O
mg	O
qAM	O

7.)	O
Flomax	B-treatment

8.)	O
Atorvastatin	B-treatment
40	O
mg	O
daily	O

9.)	O
Ritalin	B-treatment
20	O
mg	O
daily	O

10.)	O
Ramipril	B-treatment
2.5	O
mg	O
daily	O

11.)	O
Asacol	B-treatment
400	O
mg	O
3	O
,	O
TID	O

12.)	O
Carafate	B-treatment
1	O
gm	O
bid	O

13.)	O
Actos	B-treatment
15	O
mg	O
daily	O

14.)	O
Folate	B-treatment
1	O
mg	O
daily	O

15.)	O
Warfarin	B-treatment
2	O
mg	O
daily	O

Discharge	O
Medications	O
:	O

1.	O
Tamsulosin	B-treatment
0.4	O
mg	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24HR	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

2.	O
Atorvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Methylphenidate	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

5.	O
Folic	B-treatment
Acid	I-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Atenolol	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Spironolactone	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

8.	O
Ramipril	B-treatment
1.25	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

9.	O
Hydrochlorothiazide	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

10.	O
Pioglitazone	B-treatment
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
DM	B-problem
.	O

11.	O
Mesalamine	B-treatment
400	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
ulcerative	B-problem
colitis	I-problem
w/o	O
recent	O
severe	B-problem
flares	I-problem
.	O

12.	O
Insulin	B-treatment
45	O
NPH	B-treatment
in	O
am	O
with	O
33	O
NPH	B-treatment
at	O
bedtime	O

Continue	O
Sliding	B-treatment
scale	I-treatment
insulin	I-treatment
as	O
needed	O
.	O

13.	O
Sertraline	B-treatment
20	O
mg/mL	O
Concentrate	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
PO	O
at	O
bedtime	O
.	O

14.	O
Coumadin	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Oak	O
Bluffs	O
Of	O
Greenfield	O

Discharge	O
Diagnosis	O
:	O

Rectal	B-problem
bleeding	I-problem
from	I-problem
inferior	I-problem
mesenteric	I-problem
artery	I-problem
tributaries	I-problem
supplying	O
sigmoid	O
colon	O
.	O

Discharge	O
Condition	O
:	O
Good	O
.	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
physician	O
if	O
you	O
develop	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
weakness	B-problem
in	I-problem
your	I-problem
legs	I-problem
or	I-problem
arms	I-problem
,	O
sudden	B-problem
blurry	I-problem
vision	I-problem
or	O
slurred	B-problem
speech	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
faintness	B-problem
,	O
or	O
significant	B-problem
unexplained	I-problem
weight	I-problem
loss	I-problem
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Lucio	O
Y.	O
Matthews	O
,	O
M.D.	O
Phone	O
:	O
(	O
967	O
)	O
675	O
1641	O
Date/Time	O
:	O
2012-12-28	O
2:30	O

Provider	O
:	O
Greg	O
CLINIC	O
Phone	O
:	O
(	O
212	O
)	O
442	O
0438	O
Date/Time	O
:	O
2013-01-11	O
1:30	O

Provider	O
:	O
Lucio	O
F.	O
R.	O
Matthews	O
,	O
M.D.	O
Phone	O
:	O
(	O
967	O
)	O
675	O
1641	O
Date/Time	O
:	O
2013-01-11	O
2:00	O

Please	O
call	O
White	O
,	O
Leslie	O
L.	O
at	O
(	O
602	O
)	O
743	O
8709	O
to	O
schedule	O
an	O
appointment	O
with	O
him	O
in	O
1	O
week	O
.	O

Please	O
call	O
your	O
gastroenterologist	O
to	O
schedule	O
a	O
follow	O
up	O
appointment	O
in	O
2	O
weeks	O
.	O

Alan	O
John	O
MD	O
54-745	O

Completed	O
by	O
:	O
Bertha	O
Janice	O
Motta	O
MD	O
52-860	O
2012-11-07	O
@	O
1207	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Melody	O
PARKS	O
on:	O
WED	O
2012-11-21	O
6:22	O
PM	O

(	O
End	O
of	O
Report	O
)	O

004668411	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

68299235	O
PAD-WORD	O

763052	O
PAD-WORD	O

9/29/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

09/29/1993	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

10/04/1993	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
28-year-old	O
woman	O
who	O
is	O
HIV	B-problem
positive	I-problem
for	O
two	O
years	O
.	O

She	O
presented	O
with	O
left	B-problem
upper	I-problem
quadrant	I-problem
pain	I-problem
as	O
well	O
as	O
nausea	B-problem
and	O
vomiting	B-problem
which	O
is	O
a	B-problem
long-standing	I-problem
complaint	I-problem
.	O

She	O
was	O
diagnosed	O
in	O
1991	O
during	O
the	O
birth	O
of	O
her	O
child	O
.	O

She	O
claims	O
she	O
does	O
not	O
know	O
why	O
she	O
is	O
HIV	B-problem
positive	I-problem
.	O

She	O
is	O
from	O
Maryland	O
,	O
apparently	O
had	O
no	O
blood	B-treatment
transfusions	I-treatment
before	O
the	O
birth	O
of	O
her	O
children	O
so	O
it	O
is	O
presumed	O
heterosexual	B-problem
transmission	I-problem
.	O

At	O
that	O
time	O
,	O
she	O
also	O
had	O
cat	B-problem
scratch	I-problem
fever	I-problem
and	O
she	O
had	O
resection	B-treatment
of	O
an	B-problem
abscess	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
extremity	I-problem
.	O

She	O
has	O
not	O
used	O
any	B-treatment
anti	I-treatment
retroviral	I-treatment
therapy	I-treatment
since	O
then	O
,	O
because	O
of	O
pancytopenia	B-problem
and	O
vomiting	B-problem
on	O
DDI	B-treatment
.	O

She	O
has	O
complaints	O
of	O
nausea	B-problem
and	O
vomiting	B-problem
as	O
well	O
as	O
left	B-problem
upper	I-problem
quadrant	I-problem
pain	I-problem
on	O
and	O
off	O
getting	O
progressively	O
worse	O
over	O
the	O
past	O
month	O
.	O

She	O
has	O
had	O
similar	B-problem
pain	I-problem
intermittently	O
for	O
last	O
year	O
.	O

She	O
described	O
the	B-problem
pain	I-problem
as	O
a	B-problem
burning	I-problem
pain	I-problem
which	O
is	O
positional	O
,	O
worse	O
when	O
she	O
walks	O
or	O
does	O
any	O
type	O
of	O
exercise	O
.	O

She	O
has	O
no	O
relief	O
from	O
antacids	B-treatment
or	O
H2	B-treatment
blockers	I-treatment
.	O

In	O
10/92	O
,	O
she	O
had	O
a	B-test
CT	I-test
scan	I-test
which	O
showed	O
fatty	B-problem
infiltration	I-problem
of	I-problem
her	I-problem
liver	I-problem
diffusely	I-problem
with	O
a	B-problem
1	I-problem
cm	I-problem
cyst	I-problem
in	I-problem
the	I-problem
right	I-problem
lobe	I-problem
of	I-problem
the	I-problem
liver	I-problem
.	O

She	O
had	O
a	O
normal	O
pancreas	O
at	O
that	O
time	O
,	O
however	O
,	O
hyperdense	B-problem
kidneys	I-problem
.	O

Her	B-test
alkaline	I-test
phosphatase	I-test
was	O
slightly	B-problem
elevated	I-problem
but	O
otherwise	O
relatively	O
normal	O
.	O

Her	B-test
amylase	I-test
was	O
mildly	B-problem
elevated	I-problem
but	O
has	O
been	O
down	O
since	O
then	O
.	O

The	O
patient	O
has	O
had	O
progressive	B-problem
failure	I-problem
to	I-problem
thrive	I-problem
and	O
steady	B-problem
weight	I-problem
loss	I-problem
.	O

She	O
was	O
brought	O
in	O
for	O
an	B-test
esophagogastroduodenoscopy	I-test
on	O
9/26	O
but	O
she	O
basically	O
was	O
not	O
sufficiently	O
sedated	B-treatment
and	O
readmitted	O
at	O
this	O
time	O
for	O
a	B-test
GI	I-test
work-up	I-test
as	O
well	O
as	O
an	B-test
evaluation	I-test
of	O
new	B-problem
abscess	I-problem
in	I-problem
her	I-problem
left	I-problem
lower	I-problem
calf	I-problem
and	O
right	O
medial	O
lower	O
extremity	O
quadriceps	O
muscle	O
.	O

She	O
was	O
also	O
admitted	O
to	O
be	O
connected	O
up	O
with	O
social	O
services	O
for	O
HIV	B-problem
patients	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

ALLERGIES	O
:	O

BACTRIM	B-treatment
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Percocet	B-treatment
,	O
Prinovil	B-treatment
,	O
Dapsone	B-treatment
,	O
Mycelex	B-treatment
troches	I-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
was	O
recently	O
separated	O
from	O
her	O
husband	O
.	O

She	O
lives	O
with	O
her	O
daughter	O
.	O

She	O
does	O
not	O
drink	O
,	O
use	O
IV	O
drugs	O
or	O
smoke	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
revealed	O
a	O
cachetic	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
with	O
stable	O
vital	O
signs	O
.	O

She	O
was	O
afebrile	B-problem
.	O

She	O
was	O
not	O
orthostatic	B-problem
.	O

Blood	B-test
pressure	I-test
110/80	O
.	O

HEENT	B-test
exam	I-test
was	O
within	O
normal	O
limits	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
bilaterally	O
.	O

Cardiovascular	B-test
exam	I-test
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-problem
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
with	O
positive	O
bowel	O
sounds	O
.	O

There	O
was	O
no	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
revealed	O
a	B-problem
2	I-problem
x	I-problem
3	I-problem
cm	I-problem
tender	I-problem
mass	I-problem
in	I-problem
the	I-problem
lateral	I-problem
left	I-problem
calf	I-problem
,	O
medial	B-problem
1	I-problem
cm	I-problem
mass	I-problem
above	I-problem
her	I-problem
knee	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
edema	B-problem
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
included	O
BUN	B-test
/	O
creatinine	B-test
of	O
33/2.1	O
.	O

Sodium	B-test
141	O
.	O

Potassium	B-test
4.2	O
.	O

Hematocrit	B-test
23	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
2.1	O
with	O
56	B-test
polys	I-test
and	O
1	B-test
band	I-test
.	O

Platelet	B-test
count	I-test
411,000	O
.	O

Amylase	B-test
143	O
.	O

Lipase	B-test
was	O
elevated	B-problem
to	O
600	O
.	O

ESR	B-test
was	O
greater	O
than	O
140	O
.	O

Alkaline	B-test
phosphatase	I-test
190	O
.	O

ALT	B-test
52	O
.	O

AST	B-test
65	O
.	O

Beta	B-test
hCG	I-test
was	O
negative	O
.	O

Urinalysis	B-test
was	O
positive	B-problem
for	I-problem
protein	I-problem
.	O

Bilirubin	B-test
0.4	O
.	O

Chest	B-test
x-ray	I-test
revealed	O
clear	O
lung	O
fields	O
.	O

There	O
was	O
no	O
evidence	O
of	O
rib	B-problem
fracture	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
many	B-test
cultures	I-test
were	O
sent	O
which	O
were	O
all	O
negative	O
.	O

She	O
did	O
not	O
have	O
any	O
of	O
her	B-problem
pain	I-problem
in	O
the	O
hospital	O
.	O

On	O
the	O
third	O
hospital	O
day	O
,	O
she	O
did	O
have	O
some	B-problem
pain	I-problem
and	O
was	O
treated	O
with	O
Percocet	B-treatment
.	O

She	O
went	O
for	O
a	B-treatment
debridement	I-treatment
of	O
her	B-problem
left	I-problem
calf	I-problem
lesion	I-problem
on	O
10/2/93	O
and	O
was	O
started	O
empirically	O
on	O
IV	B-treatment
ceftriaxone	I-treatment
which	O
was	O
changed	O
to	O
po	B-treatment
doxycycline	I-treatment
on	O
the	O
day	O
of	O
discharge	O
.	O

A	B-test
follow-up	I-test
CT	I-test
scan	I-test
was	O
done	O
which	O
did	O
not	O
show	O
any	O
evidence	O
for	O
splenomegaly	B-problem
or	O
hepatomegaly	B-problem
.	O

The	B-problem
1	I-problem
cm	I-problem
cyst	I-problem
which	O
was	O
seen	O
in	O
10/92	O
was	O
still	O
present	O
.	O

There	O
was	O
a	O
question	O
of	O
a	B-problem
cyst	I-problem
in	I-problem
her	I-problem
kidney	I-problem
with	O
a	B-problem
stone	I-problem
right	O
below	O
the	B-problem
cyst	I-problem
,	O
although	O
this	O
did	O
not	O
seem	O
to	O
be	O
clinically	O
significant	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
.	O

Cultures	B-test
were	O
pending	O
on	O
her	B-test
aspirate	I-test
and	O
will	O
be	O
treated	O
with	O
po	B-treatment
doxycycline	I-treatment
.	O

Dictated	O
By	O
:	O

JIMCHARL	O
B.	O
BUN	O
,	O
M.D.	O
OC33	O

Attending	O
:	O

I	O
BUN	O
,	O
M.D.	O
GR67	O
EF283/9675	O

Batch	O
:	O

2027	O
PAD-WORD	O

Index	O
No.	O
BOKMII88JZ	O

D	O
:	O

10/03/93	O
PAD-WORD	O

T	O
:	O

10/07/93	O
PAD-WORD	O

﻿Admission	O
Date	O
:	O

2016-12-24	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-12-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1936-01-11	O
PAD-WORD	O

Sex:	O
PAD-WORD	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CSRU	O

CHIEF	O
COMPLAINT	O
:	O

Cough	B-problem
,	O
rhinorrhea	B-problem
,	O
dehydration	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
80	O
year	O
old	O
female	O
with	O
breast	B-problem
cancer	I-problem
,	O
status	O
post	O
lumpectomy	B-treatment
/	O
radiation	B-treatment
therapy	I-treatment
/	O
Tamoxifen	B-treatment
(	O
2000	O
)	O
,	O
hypertension	B-problem
,	O
hyperlipidemia	B-problem
,	O
multiple	B-problem
urinary	I-problem
tract	I-problem
infections	I-problem
who	O
presents	O
with	O
a	O
four	O
day	O
prodrome	O
of	O
dry	B-problem
cough	I-problem
,	O
rhinorrhea	B-problem
,	O
coryza	B-problem
,	O
malaise	B-problem
,	O
chills	B-problem
,	O
headache	B-problem
,	O
decreased	B-problem
p.o.	I-problem
intake	I-problem
,	O
loose	B-problem
bowel	I-problem
movements	I-problem
with	O
diarrhea	B-problem
and	O
no	O
blood	B-problem
,	O
decreased	B-problem
urine	I-problem
output	I-problem
,	O
no	O
sick	O
contacts	O
,	O
had	O
flu	B-treatment
shot	I-treatment
this	O
year	O
.	O

In	O
the	O
Emergency	O
Department	O
,	O
she	O
had	O
labile	B-problem
blood	I-problem
pressure	I-problem
with	O
systolic	B-test
blood	I-test
pressure	I-test
in	O
the	O
80	O
s	O
.	O

Her	O
usual	O
is	O
systolic	B-test
blood	I-test
pressure	I-test
in	O
the	O
120	O
s	O
,	O
this	O
was	O
despite	O
two	B-treatment
liters	I-treatment
of	I-treatment
intravenous	I-treatment
fluids	I-treatment
and	O
she	O
was	O
transferred	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
closer	O
monitoring	O
for	O
possible	O
early	B-problem
sepsis	I-problem
.	O

The	O
Intensive	O
Care	O
Unit	O
course	O
was	O
notable	O
for	O
initially	O
receiving	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
as	O
well	O
as	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
11.0	O
with	O
15	O
bands	B-test
.	O

She	O
was	O
ultimately	O
changed	O
to	O
Levaquin	B-treatment
for	O
a	O
possible	O
early	B-problem
pneumonia	I-problem
pending	B-test
cultures	I-test
.	O

The	O
Intensive	O
Care	O
Unit	O
course	O
was	O
also	O
notable	O
for	O
negative	O
chest	O
x-ray	O
,	O
two	B-treatment
units	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
for	O
a	B-test
hematocrit	I-test
of	O
24.0	O
with	O
appropriate	O
bump	O
in	O
her	B-test
hematocrit	I-test
and	O
no	O
evidence	B-problem
of	I-problem
bleeding	I-problem
,	O
stable	O
blood	B-test
pressure	I-test
despite	O
a	B-test
net	I-test
fluid	I-test
balance	I-test
of	O
negative	O
2.5	O
liters	O
.	O

No	O
central	B-treatment
access	I-treatment
was	O
needed	O
.	O

The	B-treatment
sepsis	I-treatment
protocol	I-treatment
was	O
aborted	O
.	O

Also	O
of	O
note	O
,	O
her	B-test
liver	I-test
function	I-test
tests	I-test
had	O
been	O
normal	O
.	O

Random	B-test
cortisol	I-test
was	O
17	O
and	O
her	B-test
DFA	I-test
was	O
positive	O
for	O
influenzae	B-problem
A	I-problem
with	O
a	B-test
viral	I-test
culture	I-test
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Blood	B-test
and	I-test
urine	I-test
cultures	I-test
were	O
no	O
growth	O
at	O
the	O
time	O
of	O
discharge	O
as	O
well	O
.	O

She	O
also	O
had	O
a	B-test
right	I-test
lower	I-test
extremity	I-test
noninvasive	I-test
ultrasound	I-test
that	O
was	O
negative	O
for	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
Breast	B-problem
cancer	I-problem
diagnosed	O
in	O
2010	O
,	O
Stage	O
I	O
,	O
status	B-treatment
post	I-treatment
left	I-treatment
lumpectomy	I-treatment
,	O
on	O
2012-05-08	O
,	O
and	O
repeat	B-treatment
surgery	I-treatment
with	O
sentinel	B-treatment
node	I-treatment
dissection	I-treatment
on	O
2012-06-05	O
.	O

Invasive	B-problem
mucinous	I-problem
carcinoma	I-problem
with	O
estrogen	B-problem
receptor	I-problem
positivity	I-problem
and	O
HER2/NEU	B-problem
negative	O
.	O

Left	B-treatment
chest	I-treatment
radiation	I-treatment
,	O
on	O
Tamoxifen	B-treatment
therapy	I-treatment
.	O

She	O
is	O
followed	O
by	O
Dr.	O
Alonso	O
Naugle	O
.	O

Question	O
of	O
vertebral	B-problem
basilar	I-problem
cerebrovascular	I-problem
accident	I-problem
in	O
2016-08-17	O
,	O
with	O
associated	O
limb	B-problem
ataxia	I-problem
.	O

Magnetic	B-test
resonance	I-test
imaging	I-test
was	O
negative	O
except	O
for	O
some	B-problem
microvascular	I-problem
cerebral	I-problem
white	I-problem
matter	I-problem
changes	I-problem
.	O

Question	O
peripheral	B-problem
vertigo	I-problem
,	O
takes	O
Meclizine	B-treatment
p.r.n.	O

Hypothyroidism	B-problem
.	O

Hypertension	B-problem
.	O

Hypercholesterolemia	B-problem
.	O

Glaucoma	B-problem
.	O

Cataract	B-problem
.	O

Osteopenia	B-problem
.	O

Left	B-problem
hip	I-problem
arthritis	I-problem
.	O

History	O
of	O
urinary	B-problem
tract	I-problem
infections	I-problem
.	O

Anemia	B-problem
,	O
with	O
a	B-test
baseline	I-test
hematocrit	I-test
of	O
31.0	O
,	O
with	O
a	B-test
TIBC	I-test
that	O
was	O
low	B-problem
and	O
a	B-problem
high	I-problem
ferritin	I-problem
.	O

Echocardiogram	B-test
in	O
2016-09-16	O
,	O
with	O
preserved	O
ejection	B-test
fraction	I-test
of	O
60	O
percent	O
with	O
trivial	B-problem
mitral	I-problem
regurgitation	I-problem
and	O
mild	B-problem
left	I-problem
atrial	I-problem
enlargement	I-problem
.	O

Cardiac	B-test
stress	I-test
test	I-test
in	O
2016-03-17	O
,	O
that	O
was	O
negative	O
for	O
inducible	B-problem
ischemia	I-problem
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Evista	B-treatment
60	O
mg	O
p.o.	O
daily	O
.	O

2.	O
Tamoxifen	B-treatment
20	O
mg	O
p.o.	O
daily	O
.	O

3.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
daily	O
.	O

4.	O
Triamterene/Hydrochlorothiazide	B-treatment
37.5/25	O
mg	O
p.o.	O
daily	O
.	O

5.	O
Enteric	B-treatment
Coated	I-treatment
Aspirin	I-treatment
325	O
mg	O
p.o.	O
daily	O
.	O

6.	O
Meclizine	B-treatment
25	O
mg	O
q8hours	O
p.r.n.	O

7.	O
Aggrenox	B-treatment
twice	O
a	O
day	O
,	O
the	O
dose	O
was	O
not	O
known	O
.	O

8.	O
Synthroid	B-treatment
125	O
mcg	O
daily	O
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
denies	O
tobacco	O
and	O
alcohol	O
abuse	O
.	O

She	O
is	O
a	O
professional	O
bowler	O
.	O

She	O
lives	O
alone	O
though	O
her	O
family	O
is	O
in	O
the	O
area	O
.	O

FAMILY	O
HISTORY	O
:	O

Breast	B-problem
cancer	I-problem
in	O
multiple	O
female	O
relatives	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

At	O
the	O
time	O
of	O
presentation	O
,	O
temperature	B-test
100.8	O
,	O
heart	B-test
rate	I-test
89	O
,	O
blood	B-test
pressure	I-test
106	O
systolic	B-test
,	O
respiratory	B-test
rate	I-test
18	O
,	O
oxygen	B-test
saturation	I-test
97	O
percent	O
in	O
room	O
air	O
.	O

Physical	B-test
examination	I-test
is	O
read	O
off	O
the	O
admitting	O
note	O
from	O
the	O
Intensive	O
Care	O
Unit	O
team	O
and	O
is	O
not	O
reflective	O
of	O
the	B-test
examination	I-test
by	O
this	O
dictator	O
.	O

General	O
-	O
The	O
patient	O
appears	O
stated	O
age	O
,	O
found	O
lying	O
flat	O
in	O
bed	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
-	O
Sclera	B-problem
anicteric	I-problem
,	O
conjunctiva	B-problem
injected	I-problem
,	O
the	O
pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
the	O
mucous	O
membranes	O
are	O
dry	B-problem
,	O
oropharynx	O
clear	O
.	O

Neck	O
-	O
No	O
jugular	B-problem
venous	I-problem
distention	I-problem
,	O
no	O
lymphadenopathy	B-problem
.	O

Cardiac	O
regular	O
rate	B-test
and	O
rhythm	B-test
,	O
normal	O
S1	O
and	O
S2	O
,	O
I/VI	B-problem
holosystolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
apex	I-problem
.	O

Chest	O
clear	O
to	O
percussion	B-test
and	O
auscultation	B-test
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
no	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
-	O
No	O
calf	B-problem
tenderness	I-problem
,	O
no	O
edema	B-problem
.	O

Neurologically	O
,	O
mental	B-test
status	I-test
examination	I-test
is	O
normal	O
.	O

Cranial	B-test
nerves	I-test
II	I-test
through	I-test
XII	I-test
are	O
intact	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
chest	B-test
x-ray	I-test
with	O
no	O
acute	B-problem
cardiopulmonary	I-problem
process	I-problem
.	O

Electrocardiogram	B-test
notable	O
for	O
sinus	B-problem
tachycardia	I-problem
with	O
a	B-test
rate	I-test
of	O
104	O
beats	O
per	O
minute	O
,	O
normal	O
axis	O
,	O
normal	O
intervals	O
,	O
new	B-problem
T	I-problem
wave	I-problem
inversion	I-problem
in	I-problem
III	I-problem
and	O
old	B-problem
T	I-problem
wave	I-problem
inversions	I-problem
in	I-problem
aVL	I-problem
and	I-problem
V1	I-problem
.	O

This	O
was	O
not	O
significantly	O
changed	O
from	O
comparison	O
with	O
2016-03-17	O
.	O

On	O
admission	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
7.3	O
,	O
73	O
percent	O
neutrophils	B-test
,	O
15	O
percent	O
bands	B-test
,	O
6	O
percent	O
lymphocytes	B-test
,	O
hematocrit	B-test
30.4	O
,	O
platelet	B-test
count	I-test
228,000	O
.	O

Sodium	B-test
136	O
,	O
potassium	B-test
3.5	O
,	O
chloride	B-test
98	O
,	O
bicarbonate	B-test
23	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
16	O
,	O
creatinine	B-test
0.8	O
,	O
glucose	B-test
142	O
.	O

HOSPITAL	O
COURSE	O
:	O

This	O
is	O
an	O
80	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
Stage	B-problem
I	I-problem
breast	I-problem
cancer	I-problem
,	O
hypertension	B-problem
,	O
hyperlipidemia	B-problem
,	O
who	O
presents	O
with	O
a	B-problem
leukocytosis/bandemia	I-problem
,	O
hypotension	B-problem
in	O
the	O
setting	O
of	O
dehydration	B-problem
and	O
influenza	B-problem
.	O

After	O
a	O
short	O
Medical	O
Intensive	O
Care	O
Unit	O
course	O
where	O
she	O
remained	O
hemodynamically	O
stable	O
,	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
.	O

Gerardi	O
problem	O
list	O
is	O
as	O
follows	O
:	O

Hypotension	B-problem
-	O
This	O
was	O
likely	O
secondary	O
to	O
volume	B-problem
depletion	I-problem
in	O
the	O
setting	O
of	O
a	B-problem
diarrheal	I-problem
and	I-problem
viral	I-problem
respiratory	I-problem
syndrome	I-problem
.	O

Her	B-test
blood	I-test
pressure	I-test
was	O
stable	O
after	O
three	B-treatment
liters	I-treatment
of	I-treatment
normal	I-treatment
saline	I-treatment
.	O

She	O
was	O
clinically	O
euvolemic	O
after	O
that	O
.	O

She	O
did	O
receive	O
two	B-treatment
units	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

There	O
is	O
no	O
evidence	O
of	O
gastrointestinal	B-problem
bleed	I-problem
or	O
adrenal	B-problem
insufficiency	I-problem
during	O
the	O
course	O
of	O
her	B-test
evaluation	I-test
.	O

Her	B-treatment
antihypertensives	I-treatment
were	O
initially	O
held	O
and	O
reinstated	O
upon	O
discharge	O
.	O

Influenza	B-problem
A	I-problem
-	O
DFA	B-test
confirmed	O
,	O
the	B-test
viral	I-test
cultures	I-test
were	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

The	B-problem
initial	I-problem
bandemia	I-problem
would	O
not	O
have	O
been	O
consistent	O
with	O
a	B-problem
typical	I-problem
influenza	I-problem
presentation	I-problem
,	O
so	O
she	O
was	O
continued	O
on	O
a	O
fourteen	O
day	O
course	O
of	O
Levaquin	B-treatment
to	O
eliminate	O
any	O
possibility	O
of	O
a	B-problem
bacterial	I-problem
superinfection	I-problem
or	O
early	B-problem
pneumonia	I-problem
.	O

Loose	B-problem
bowel	I-problem
movements	I-problem
-	O
This	O
problem	O
was	O
resolved	O
and	O
had	O
been	O
a	B-problem
viral	I-problem
syndrome	I-problem
on	O
presentation	O
.	O

There	O
was	O
no	O
evidence	O
of	O
diarrhea	B-problem
during	O
medical	O
Lawrence	O
Memorial	O
Hospital	O
stay	O
.	O

Anemia	B-problem
-	O
This	O
is	O
a	B-problem
chronic	I-problem
problem	I-problem
.	O

She	O
has	O
known	B-problem
iron	I-problem
deficiency	I-problem
.	O

There	O
was	O
no	O
evidence	B-problem
of	I-problem
bleeding	I-problem
.	O

She	O
was	O
guaiac	B-test
negative	O
and	O
the	B-test
Hemophilus	I-test
panel	I-test
was	O
negative	O
.	O

She	O
was	O
reinstated	O
on	O
iron	B-treatment
at	O
discharge	O
and	O
her	B-test
hematocrit	I-test
was	O
stable	O
.	O

Hypothyroid	B-problem
-	O
She	O
was	O
continued	O
on	O
her	B-treatment
Synthroid	I-treatment
.	O

Osteopenia	B-problem
-	O
She	O
was	O
continued	O
on	O
Evista	B-treatment
.	O

Fluids	B-treatment
,	O
electrolytes	B-treatment
and	O
nutrition	B-treatment
-	O
She	O
was	O
tolerating	O
a	O
house	O
diet	O
upon	O
discharge	O
.	O

FOLLOW	O
UP	O
:	O

She	O
is	O
a	O
patient	O
of	O
Dr.	O
James	O
Deighan	O
and	O
will	O
follow-up	O
with	O
her	O
in	O
one	O
to	O
two	O
weeks	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Evista	B-treatment
60	O
mg	O
p.o.	O
daily	O
.	O

2.	O
Tamoxifen	B-treatment
20	O
mg	O
p.o.	O
daily	O
.	O

3.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
daily	O
.	O

4.	O
Triamterene/Hydrochlorothiazide	B-treatment
37.5/25	O
mg	O
p.o.	O
daily	O
.	O

5.	O
Enteric	B-treatment
Coated	I-treatment
Aspirin	I-treatment
325	O
mg	O
p.o.	O
daily	O
.	O

6.	O
Meclizine	B-treatment
25	O
mg	O
q8hours	O
p.r.n.	O

7.	O
Aggrenox	B-treatment
twice	O
a	O
day	O
,	O
the	O
dose	O
was	O
not	O
known	O
.	O

8.	O
Synthroid	B-treatment
125	O
mcg	O
daily	O
.	O

9.	O
Levofloxacin	B-treatment
250	O
mg	O
p.o.	O
daily	O
to	O
complete	O
a	O
fourteen	O
day	O
course	O
.	O

She	O
was	O
given	O
a	O
prescription	O
for	O
ten	O
more	O
days	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Influenza	B-problem
A	I-problem
.	O

Hypotension	B-problem
secondary	O
to	O
volume	B-problem
depletion	I-problem
.	O

Anemia	B-problem
.	O

Hypothyroidism	B-problem
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
breathing	O
comfortably	O
in	O
room	O
air	O
.	O

She	O
was	O
normotensive	O
and	O
her	B-test
hematocrit	I-test
was	O
stable	O
at	O
her	O
baseline	O
upon	O
discharge	O
.	O

Linette	O
Randall	O
,	O
Mississippi	O
82499	O

Dictated	O
By	O
:	O
Jason	O
L	O
Parra	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2016-12-28	O
16:25:42	O

T	O
:	O

2016-12-28	O
20:11:26	O

Job	O
#	O
:	O

74466	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Wanda	O
PARKS	O
on	O
:	O
Yesenia	O
2017-01-10	O
6:50	O
PM	O

(	O
End	O
of	O
Report	O
)	O

006544894	O
PAD-WORD	O

NVH	O
PAD-WORD	O

65104826	O
PAD-WORD	O

1/2/2004	O
12:00:00	O
AM	O

VT	B-problem
s/p	O
cardiac	B-test
cath	I-test
,	O
stent	B-treatment
and	O
amp	O
;	O
amio	B-treatment
loading	I-treatment

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/02/2004	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/07/2004	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

NERSLET	O
,	O
BERISS	O
665-07-74-6Q06	O

Room	O
:	O

89H-593	O
PAD-WORD	O

Service	O
:	O

CAR	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/07/04	O
AT	O
02:00	O
PM	O

CONTINGENT	O
UPON	O
Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

MOST	O
,	O
ANNETIFF	O
SIAYUDE	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

AMIODARONE	B-treatment
400	O
MG	O
PO	O
BID	O
Starting	O
Today	O
(	O
01/06	O
)	O

Instructions	O
:	O

For	O
7	O
days	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
01/03/04	O
by	O
TIKNEAV	O
,	O
JEFFCI	O
SUOT	O
A.	O
,	O
M.D.	O

SERIOUS	B-problem
INTERACTION	I-problem
:	O

DIGOXIN	B-treatment
and	O
AMIODARONE	B-treatment
HCL	I-treatment

Reason	O
for	O
override	O
:	O

ok	O
ENTERIC	B-treatment
COATED	I-treatment
ASA	I-treatment
(	I-treatment
ASPIRIN	I-treatment
ENTERIC	I-treatment
COATED	I-treatment
)	I-treatment
325	O
MG	O
PO	O
QD	O
DIGOXIN	B-treatment
0.0625	O
MG	O
PO	O
QD	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
01/03/04	O
by	O
TIKNEAV	O
,	O
JEFFCI	O
SUOT	O
A.	O
,	O
M.D.	O
on	O
order	O
for	O
AMIODARONE	B-treatment
PO	I-treatment
(	O
ref	O
#	O
23731718	O
)	O

SERIOUS	B-problem
INTERACTION	I-problem
:	O

DIGOXIN	B-treatment
and	O
AMIODARONE	B-treatment
HCL	I-treatment

Reason	O
for	O
override	O
:	O

ok	O
PAD-WORD	O

Previous	O
override	O
information	O
:	O

Override	O
added	O
on	O
01/02/04	O
by	O
KOTESLENT	O
,	O
ANT	O
ODEWYJU	O
,	O
M.D.	O
on	O
order	O
for	O
AMIODARONE	B-treatment
IV	I-treatment
1	O
(	O
ref	O
#	O
45803793	O
)	O

SERIOUS	B-problem
INTERACTION	I-problem
:	O

DIGOXIN	B-treatment
and	O
AMIODARONE	B-treatment
HCL	I-treatment

Reason	O
for	O
override	O
:	O

will	O
follow	O

Previous	O
override	O
information	O
:	O

Override	O
added	O
on	O
01/02/04	O
by	O
KOTESLENT	O
,	O
ANT	O
ODEWYJU	O
,	O
M.D.	O

SERIOUS	B-problem
INTERACTION	I-problem
:	O

AMIODARONE	B-treatment
HCL	I-treatment
and	O
DIGOXIN	B-treatment

Reason	O
for	O
override	O
:	O

will	O
follow	O

MVI	B-treatment
THERAPEUTIC	I-treatment
W	I-treatment
/	I-treatment
MINERALS	I-treatment
(	I-treatment
THERAP	I-treatment
VITS	I-treatment
/	I-treatment
MINERALS	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
01/02/04	O
by	O
KOTESLENT	O
,	O
ANT	O
ODEWYJU	O
,	O
M.D.	O
on	O
order	O
for	O
ZOCOR	B-treatment
PO	I-treatment
(	O
ref	O
#	O
71920299	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	B-treatment
,	O
VIT	O
.	O

B-3	O
and	O
SIMVASTATIN	B-treatment

Reason	O
for	O
override	O
:	O

wil	O
follow	O

ZOCOR	B-treatment
(	I-treatment
SIMVASTATIN	I-treatment
)	I-treatment
40	O
MG	O
PO	O
QHS	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Avoid	O
grapefruit	O
unless	O
MD	O
instructs	O
otherwise	O
.	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
01/02/04	O
by	O
KOTESLENT	O
,	O
ANT	O
ODEWYJU	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

NIACIN	B-treatment
,	O
VIT	O
.	O

B-3	O
and	O
SIMVASTATIN	B-treatment

Reason	O
for	O
override	O
:	O

wil	O
follow	O

TOPROL	B-treatment
XL	I-treatment
(	I-treatment
METOPROLOL	I-treatment
(	I-treatment
SUST.	I-treatment
REL.	I-treatment
)	I-treatment
)	I-treatment
100	O
MG	O
PO	O
QD	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

5	B-treatment
PLAVIX	I-treatment
(	I-treatment
CLOPIDOGREL	I-treatment
)	I-treatment
75	O
MG	O
PO	O
QD	O
Starting	O
Today	O
(	O
01/06	O
)	O
KEFLEX	B-treatment
(	I-treatment
CEPHALEXIN	I-treatment
)	I-treatment
500	O
MG	O
PO	O
QID	O
X	O
40	O
doses	O
AMIODARONE	B-treatment
400	O
MG	O
PO	O
QD	O

Instructions	O
:	O

After	O
7	O
days	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
01/07/04	O
by:	O

SERIOUS	B-problem
INTERACTION	I-problem
:	O

DIGOXIN	B-treatment
and	O
AMIODARONE	B-treatment
HCL	I-treatment

Reason	O
for	O
override	O
:	O

ok	O
PAD-WORD	O

DIET	O
:	O

House	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O
FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Levels	O
(	O
Electrophysiology	O
)	O
4	O
weeks	O
,	O
PCP	O
1-2	O
weeks	O
,	O

ALLERGY	O
:	O

NKA	B-problem
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
VT	B-problem
s	O
/	O
p	O
cardiac	B-test
cath	I-test
,	O
stent	B-treatment
and	O
amio	B-treatment
loading	I-treatment

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
VT	B-problem
,	O
CAD	B-problem
s	O
/	O
p	O
MI	B-problem
ischemic	B-problem
cardiomyopathy	I-problem
bilateral	B-treatment
knee	I-treatment
replacement	I-treatment

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Cardiac	B-test
Cath	I-test
1/6/0004	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

78	O
M	O
w/	O
longstanding	B-problem
CAD	I-problem
s	O
/	O
p	O
CABG	B-treatment
'97	O
,	O
had	O
PPM	B-treatment
and	O
AICD	B-treatment
placed	O
in	O
'02	O
after	O
admitted	O
for	O
presyncope	B-problem
and	O
found	O
to	O
have	O
inducible	B-problem
VT	I-problem
.	O

in	O
USOH	O
until	O
this	O
am	O
when	O
felt	O
LH	B-problem
and	O
then	O
ICD	B-treatment
discharge	I-treatment
.	O

Subsequent	O
4	B-treatment
ICD	I-treatment
discharges	I-treatment
at	O
rest	O
.	O

Denies	O
change	B-problem
in	I-problem
ET	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
SOB	B-problem
.	O

Went	O
to	O
OSH	O
c	O
further	B-treatment
ICD	I-treatment
shocks	I-treatment
,	O
VT	B-problem
on	O
monitor	B-test
but	O
stable	O
VS	O
.	O

Given	O
amio	B-treatment
bolu	I-treatment
,	O
started	O
on	O
gtt	B-treatment
and	O
transferred	O
to	O
NVH	O
for	O
further	B-test
evaluation	I-test
.	O

Exam	B-test
remarkable	O
for	O
b	B-problem
/	I-problem
l	I-problem
carotid	I-problem
bruits	I-problem
,	O
soft	B-problem
murmur	I-problem
at	I-problem
L	I-problem
sternal	I-problem
border	I-problem
,	O
clear	O
chest	O
,	O
1+	B-problem
b	I-problem
/	I-problem
l	I-problem
edema	I-problem
.	O

Labs	B-test
at	O
OSH	O
c	O
Cr	B-test
:	O

1.9	O
,	O

Hct	B-test
:	O

39.1	O
,	O

gluc	B-test
:	O

214	O
,	O

CK	B-test
:	O

130	O
,	O

MB	B-test
:	O

2.6.	O
PAD-WORD	O

ECG	B-test
is	O
AV	O
paced	O
but	O
prior	O
shower	B-problem
R	I-problem
on	I-problem
T	I-problem
VPB	I-problem
c	O
monomorphic	B-problem
VT	I-problem
then	O
overdrive	O
paced	O
.	O

****	O
Course	O

1)	O
CV	O
(	O
R	O
)	O
finished	O
amio	B-treatment
IV	I-treatment
load	I-treatment
then	O
started	O
on	O
po	O
,	O
agressive	B-treatment
lytes	I-treatment
;	O
although	O
interrogation	B-test
showed	O
>100	O
episodes	O
of	O
VT	B-problem
(	O
as	O
/	O
x	O
)	O
,	O
pt	O
prefers	O
med	B-treatment
therapy	I-treatment
as	O
opposed	O
to	O
ablation	B-treatment
(	O
I	O
)	O
enzymes	B-test
mildly	B-problem
elevated	I-problem
but	O
not	O
actively	B-problem
ischemic	I-problem
;	O
lipids	B-test
,	O
ASA	B-treatment
,	O
statin	B-treatment
,	O
BB	B-treatment
;	O
Adenosine	B-test
thal	I-test
1/4	O
and	O
echo	B-test
1/4	O
to	O
look	O
for	O
signs	O
of	O
ischemia	B-problem
as	O
active	O
cause	O
for	O
VT	B-problem
(	O
P	O
)	O
JVP	B-test
at	O
angle	O
of	O
jaw	O
1/4	O
-->	O
giving	O
20	B-treatment
Lasix	I-treatment
;	O
dig	B-test
level	I-test
1/4	O
1.3	O
-->	O
1/2	O
dose	O
as	O
on	O
Amio	B-treatment

2)	O
Endo	O
:	O

elevated	B-problem
glu	I-problem
on	O
admit	O
BMP	B-test
and	O
FSG	B-test
also	O
concurring	O
-->	O
follow	O
and	O
Lispro	B-treatment
;	O
will	O
probably	O
need	O
w	B-test
/	I-test
u	I-test
as	O
outpt	O

3)	O
Pulm	O
:	O

baseline	B-test
PFTs	I-test
as	O
staring	O
amio	B-treatment

4)	O
GI	O
:	O

baseline	B-test
LFTs	I-test
wnl	O
;	O
taking	O
cardiac	B-treatment
/	I-treatment
ADA	I-treatment
diet	I-treatment
as	O
glu	B-test
remains	O
elevated	B-problem

5)	O
Renal	O
:	O

baseline	B-test
CRI	I-test
(	O
1.2-1.6	O
)	O
with	O
elevation	B-problem
at	O
admission	O
probably	O
prerenal	O
;	O
will	O
monitor	O
BUN	B-test
/	O
Cr	B-test
after	O
giving	O
Lasix	B-treatment

6)	O
Proph	O
:	O

PPI	B-treatment
and	O
pneumoboots	B-treatment

HOSPITAL	O
COURSE	O
and	O
OUTCOME	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
cardiology	O
service	O
and	O
commenced	O
amiodarone	B-treatment
loading	I-treatment
.	O

Adenosine	B-test
stress	I-test
MIBI	I-test
revealed	O
a	B-problem
small	I-problem
reversible	I-problem
defect	I-problem
in	I-problem
the	I-problem
PDA	I-problem
territory	I-problem
and	O
the	O
patient	O
underwent	O
coronary	B-test
catheterisation	I-test
on	O
1/6/0004	O
which	O
revealed	O
a	B-problem
70%	I-problem
lesion	I-problem
in	I-problem
the	I-problem
SVG	I-problem
to	I-problem
PDA	I-problem
->	O
cypher	B-treatment
stented	I-treatment
successfully	O
.	O

He	O
had	O
occasional	B-problem
ventricular	I-problem
extopyon	I-problem
telemetry	B-test
but	O
no	O
further	B-problem
recurrence	I-problem
of	O
ventricular	B-problem
tachycardia	I-problem
.	O

During	O
his	O
admission	O
,	O
his	B-test
am	I-test
fasting	I-test
glucose	I-test
levels	I-test
were	O
intermittently	B-problem
elevated	I-problem
and	O
his	B-test
HbA1C	I-test
was	O
greater	O
than	O
7	O
.	O

I	O
have	O
explained	O
to	O
him	O
that	O
he	O
may	O
have	O
developed	O
some	B-problem
glucose	I-problem
intolerance	I-problem
and	O
that	O
,	O
in	O
the	O
first	O
instance	O
,	O
he	O
should	O
see	O
his	O
Primary	O
Care	O
Physician	O
and	O
attempt	O
dietary	B-treatment
control	I-treatment
.	O

On	O
the	O
day	O
prior	O
to	O
discharge	O
he	O
noticed	O
a	O
small	O
area	O
of	O
erythema	B-problem
surrounding	O
his	B-treatment
R	I-treatment
antecubital	I-treatment
venous	I-treatment
access	I-treatment
site	I-treatment
.	O

This	O
will	O
be	O
treated	O
empirically	O
with	O
a	O
10	O
day	O
course	O
of	O
Keflex	B-treatment
.	O

I	O
have	O
instructed	O
him	O
to	O
see	O
his	O
PCP	O
if	O
it	O
does	O
not	O
improve	O
in	O
a	O
few	O
days	O
or	O
if	O
he	O
develops	O
fevers	B-problem
.	O

In	O
terms	O
of	O
his	B-treatment
amiodarone	I-treatment
,	O
he	O
will	O
be	O
discharged	O
on	O
400mg	O
po	O
bid	O
for	O
a	O
further	O
7	O
days	O
followed	O
by	O
400mg	O
qd	O
thereafter	O
.	O

He	O
will	O
followup	O
with	O
Dr.	O
Levels	O
in	O
device	O
clinic	O
in	O
4	O
weeks	O
.	O

I	O
have	O
advised	O
him	O
that	O
he	O
must	O
not	O
drive	O
until	O
he	O
is	O
seena	O
gain	O
in	O
clinic	O
and	O
his	B-treatment
device	I-treatment
interrogated	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

STENVERS	O
,	O
IMARL	O
,	O
M.D.	O
(	O
AW45	O
)	O
01/07/04	O
02:14	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

﻿Admission	O
Date	O
:	O

2015-10-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-10-21	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1953-07-19	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
CSRU	O

Allergies	O
:	O

Coumadin	B-treatment
PAD-WORD	O

Attending	O
:	O
James	O
I	O
Schultz,	O
M.D.	O

Chief	O
Complaint	O
:	O

fever	B-problem
,	O
left	B-problem
lower	I-problem
extremity	I-problem
redness	I-problem
,	O
dysuria	B-problem
,	O
inability	B-problem
to	I-problem
urinate	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Transesophageal	B-test
Echocardiogram	I-test

History	O
of	O
Present	O
Illness	O
:	O

62	O
year-old	O
status-post	O
gastric	B-treatment
bypass	I-treatment
and	O
laprascopic	B-treatment
cholecystectomy	I-treatment
7	O
weeks	O
prior	O
to	O
admission	O
who	O
presented	O
with	O
fever	B-problem
,	O
chills	B-problem
,	O
and	O
left	B-problem
lower	I-problem
extemity	I-problem
redness	I-problem
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
multiple	O
hospitalizations	O
for	O
lower	B-problem
extremity	I-problem
cellulitis	I-problem
and	O
noted	O
that	O
his	B-problem
symptoms	I-problem
and	O
the	O
appearance	O
of	O
his	O
left	O
leg	O
mirrored	O
previous	B-problem
episodes	I-problem
.	O

He	O
denied	O
recent	B-problem
trauma	I-problem
to	I-problem
the	I-problem
area	I-problem
or	O
travel	O
.	O

Review	B-test
of	I-test
systems	I-test
was	O
significant	O
only	O
for	O
painful	B-problem
urination	I-problem
over	O
the	O
past	O
few	O
days	O
and	O
a	B-problem
reduction	I-problem
in	I-problem
urine	I-problem
output	I-problem
.	O

He	O
denied	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
palpitations	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
N/V	B-problem
,	O
penile	B-problem
discharge	I-problem
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Morbid	B-problem
obesity	I-problem

2.	O
Frequent	B-problem
cellulitis	I-problem

3.	O
Lymphedema	B-problem
.	O

4.	O
CAD	B-problem
s/p	O
velocity	B-treatment
stenting	I-treatment
proximal	I-treatment
LAD	I-treatment
2002	O

5.	O
Osteoarthritis	B-problem
of	I-problem
the	I-problem
knees	I-problem

6.	O
Hypertension	B-problem

7.	O
Hypercholesterolemia	B-problem

8.	O
Obstructive	B-problem
sleep	I-problem
apnea	I-problem

9.	O
CVA	B-problem
x2	O
with	O
left-sided	B-problem
weakness	I-problem

10.	O
Gastric	B-treatment
bypass	I-treatment
surgery	I-treatment
7	O
weeks	O
PTA	O

11.	O
Lap	B-treatment
cholecystectomy	I-treatment
7	O
weeks	O
PTA	O

Physical	O
Exam	O
:	O

VS	B-test
T	O
101.4	O
BP	B-test
85/50	O
HR	B-test
130	O

RR	B-test
20	O
O2	B-test
Sat	I-test
:	O
98%	O
RA	O

GEN	O
:	O
Obese	B-problem
male	O
,	O
AAOx3	O

HEENT	O
:	O
MM	B-problem
dry	I-problem
,	O
JVD	B-problem
cannot	O
be	O
assessed	O

CV	O
:	O
Irregularly	B-problem
irregular	I-problem
rhytmm	I-problem
,	O
no	O
m/r/g	B-problem

Chest	O
:	O
CTAB	O

ABD	O
:	O
Obese	B-problem
,	O
NT/ND	B-problem
,	O
no	O
rebound/guarding	B-problem

EXT	O
:	O
3+	B-problem
bilateral	I-problem
edema	I-problem
,	O
LLE	B-problem
edema	I-problem
and	O
erythema	B-problem
,	O
no	O
chords	B-problem
,	O
+	O
warmth	B-problem
,	O
+	O
chronic	B-problem
venous	I-problem
changes	I-problem
,	O
negative	O
Homens	O

Pertinent	O
Results	O
:	O

2015-10-10	O
02:16PM	O

WBC	B-test
-	O
6.3	O
RBC	B-test
-	O
4.90	O
HGB	B-test
-	O
14.1	O
HCT	B-test
-	O
41.0	O
MCV	B-test
-	O
84	O
MCH	B-test
-	O
28.7	O
MCHC	B-test
-	O
34.4	O
RDW	B-test
-	O
15.0	O

2015-10-10	O
02:16PM	O

NEUTS	B-test
-	O
92	O
*	O
BANDS	B-test
-	O
4	O
LYMPHS	B-test
-	O
2	O
*	O
MONOS	B-test
-	O
2	O
EOS	B-test
-	O
0	O
BASOS	B-test
-	O
0	O
ATYPS	B-test
-	O
0	O
METAS	B-test
-	O
0	O
MYELOS	B-test
-	O
0	O

2015-10-10	O
02:16PM	O

PLT	B-test
SMR	I-test
-	O
NORMAL	O
PLT	B-test
COUNT	I-test
-	O
143	O
*#	O

2015-10-10	O
02:16PM	O
URINE	B-test

BLOOD	B-test
-	O
NEG	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
NEG	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
5.0	O
LEUK	B-test
-	O
SM	O

2015-10-10	O
02:16PM	O

CALCIUM	B-test
-	O
9.6	O
PHOSPHATE	B-test
-	O
0.8	O
*#	O
MAGNESIUM	B-test
-	O
1.4	O
*	O

2015-10-10	O
02:16PM	O

CK-MB	B-test
-	O
2	O
cTropnT	B-test
-<	O
0.01	O

2015-10-10	O
02:16PM	O

CK(CPK)	B-test
-	O
109	O

2015-10-10	O
02:34PM	O

LACTATE	B-test
-	O
2.4	O
*	O

2015-10-10	O
07:42PM	O

PT	B-test
-	O
16.6	O
*	O
PTT	B-test
-	O
32.2	O
INR(PT)	B-test
-	O
1.7	O

2015-10-10	O
07:42PM	O

ALBUMIN	B-test
-	O
3.0	O
*	O
CALCIUM	B-test
-	O
7.6	O
*	O
PHOSPHATE	B-test
-	O
1.6	O
*	O
MAGNESIUM	B-test
-	O
1.1	O
*	O

2015-10-10	O
07:42PM	O

ALT(SGPT)	B-test
-	O
28	O
AST(SGOT)	B-test
-	O
27	O
LD(LDH)	B-test
-	O
191	O
CK(CPK)	B-test
-	O
58	O
ALK	B-test
PHOS	I-test
-	O
63	O
AMYLASE	B-test
-	O
27	O
TOT	B-test
BILI	I-test
-	O
0.9	O

2015-10-10	O
08:19PM	O

LACTATE	B-test
-	O
1.9	O

Brief	O
Hospital	O
Course	O
:	O

This	O
62	O
year-old	O
obese	O
male	O
was	O
admitted	O
with	O
cellulitis	B-problem
and	O
presumed	O
bacteremia	B-problem
.	O

In	O
the	O
John	O
,	O
he	O
was	O
found	O
to	O
be	O
in	O
hypotensive	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Medical	O
ICU	O
where	O
his	B-problem
hypotension	I-problem
was	O
managed	O
with	O
IVF	B-treatment
hydration	I-treatment
and	O
he	O
was	O
maintained	O
on	O
a	B-treatment
diltiazam	I-treatment
drip	I-treatment
for	O
atrial	B-problem
fibrillation	I-problem
.	O

After	O
his	B-test
heart	I-test
rate	I-test
was	O
controlled	O
,	O
he	O
was	O
transitioned	O
to	O
oral	B-treatment
medications	I-treatment
and	O
transferred	O
to	O
the	O
medicine	O
service	O
.	O

1.	O
Cellulitis	B-problem
/	O
Bacteremia	B-problem

Review	O
of	O
the	O
medical	O
record	O
revealed	O
several	O
previous	O
admissions	O
for	O
cellulitis	B-problem
and	O
bacteremia	B-problem
.	O

Blood	B-test
cultures	I-test
on	O
this	O
admission	O
and	O
were	O
positive	O
for	O
Beta	B-problem
streptococcus	I-problem
Group	I-problem
B	I-problem
.	O

The	O
patient	O
had	O
previous	O
episodes	O
of	O
the	B-problem
same	I-problem
infection	I-problem
,	O
with	O
lower	B-problem
extremity	I-problem
cellulitis	I-problem
the	O
likely	O
source	O
.	O

A	B-test
left	I-test
lower	I-test
extremity	I-test
ultrasound	I-test
was	O
negative	O
for	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
.	O

The	O
patient	O
was	O
too	B-problem
large	I-problem
to	O
have	O
a	B-test
CTA	I-test
.	O

He	O
was	O
initially	O
treated	O
with	O
vancomycin	B-treatment
and	O
zosyn	B-treatment
while	O
awaiting	O
culture	B-test
results	O
.	O

Once	O
the	B-problem
organism	I-problem
was	O
identified	O
,	O
he	O
was	O
transitioned	O
to	O
a	O
regimen	O
of	O
intravenous	B-treatment
penicillin	I-treatment
and	O
oral	B-treatment
levofloxacin	I-treatment
,	O
which	O
had	O
successfully	O
treated	O
the	B-problem
infection	I-problem
during	O
his	O
most	O
recent	O
admission	O
1	O
year	O
prior	O
.	O

He	O
completed	O
7	O
days	O
of	O
levofloxacin	B-treatment
and	O
had	O
a	B-treatment
PICC	I-treatment
line	I-treatment
placed	O
to	O
facilitate	O
a	O
2	O
week	O
course	O
of	O
IV	B-treatment
Penicillin	I-treatment
.	O

2.	O
Atrial	B-problem
fibrillation	I-problem

The	O
patient	O
's	O
development	O
of	O
atrial	B-problem
fibrillation	I-problem
was	O
believed	O
to	O
be	O
secondary	O
to	O
infection	B-problem
and	O
structural	B-problem
heart	I-problem
disease	I-problem
.	O

It	O
was	O
initially	O
managed	O
with	O
intravenous	B-treatment
diltiazam	I-treatment
,	O
and	O
it	O
was	O
later	O
managed	O
with	O
metoprolol	B-treatment
and	O
anticoagulation	B-treatment
.	O

A	B-test
transthoracic	I-test
echocardiogram	I-test
showed	O
a	B-problem
mildly	I-problem
dilated	I-problem
and	I-problem
elongated	I-problem
left	I-problem
atrium	I-problem
,	O
with	O
a	B-problem
markedly	I-problem
dilated	I-problem
right	I-problem
atrium	I-problem
.	O

He	O
had	O
occasional	O
episodes	O
of	O
rapid	B-problem
atrial	I-problem
fibrillation	I-problem
that	O
were	O
controlled	O
with	O
responded	O
to	O
IV	B-treatment
metoprolol	I-treatment
.	O

However	O
,	O
his	B-test
rate	I-test
proved	O
difficult	O
to	O
control	O
despite	O
metoprolol	B-treatment
and	O
diltiazam	B-treatment
.	O

The	O
EP	O
service	O
was	O
consulted	O
and	O
recommended	O
transesophageal	B-test
echocardiogram	I-test
and	O
cardioversion	B-treatment
.	O

The	B-test
TEE	I-test
was	O
negative	O
for	O
thrombus	B-problem
and	O
the	O
patient	O
was	O
successfully	O
cardioverted	O
to	O
normal	O
sinus	O
rhythm	O
with	O
ibutilide	B-treatment
.	O

He	O
was	O
subsequently	O
started	O
on	O
amiodarone	B-treatment
and	O
is	O
scheduled	O
to	O
complete	O
a	O
10	O
week	O
course	O
.	O

EKG	B-test
before	O
discharge	O
showed	O
mild	B-problem
QT	I-problem
prolongation	I-problem
and	O
no	O
effect	O
from	O
amiodarone	B-treatment
.	O

EKG	B-test
and	O
LFTs	B-test
should	O
be	O
monitored	O
by	O
his	O
PCP	O
,	O
William	O
given	O
the	O
high	O
dose	O
of	O
amiodarone	B-treatment
he	O
will	O
receive	O
.	O

3.	O
FEN	O

He	O
was	O
followed	O
by	O
the	O
nutrition	O
team	O
throughout	O
his	O
admission	O
and	O
their	O
recommendations	O
were	O
followed	O
.	O

He	O
demonstrated	O
several	B-problem
asymptomatic	I-problem
electrolyte	I-problem
deficiecies	I-problem
;	O
these	O
were	O
likely	O
due	O
to	O
inadequate	B-problem
absorption	I-problem
following	O
his	B-treatment
surgery	I-treatment
and	O
he	O
responded	O
well	O
to	O
repletion	B-treatment
.	O

Vitamin	B-test
D	I-test
and	O
parathyroid	B-test
tests	I-test
were	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
Kindred	O
Park	O
View	O
Specialty	O
Hospital	O
of	O
Springfield	O
Rehabilitation	O
Hospital	O
in	O
good	O
condition	O
.	O

He	O
was	O
sent	O
with	O
a	B-test
King	I-test
of	I-test
Hearts	I-test
monitor	I-test
and	O
scheduled	O
for	O
follow-up	O
with	O
cardiology	O
and	O
his	O
primary	O
care	O
physician	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Amiodarone	B-treatment
HCl	I-treatment
400	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
one	O
tid	O
for	O
2	O
weeks	O
,	O
then	O
1	O
qd	O
for	O
2	O
months	O
for	O
2	O
months	O
:	O
Please	O
take	O
1	O
tablet	O
3	O
times	O
per	O
day	O
for	O
2	O
weeks	O
,	O
then	O
take	O
1	O
tablet	O
per	O
day	O
for	O
2	O
months	O
.	O

Disp	O
:*	O
105	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Atorvastatin	B-treatment
Calcium	I-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QD	O
(	O
once	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
1	O
*	O

3.	O
Zolpidem	B-treatment
Tartrate	I-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Potassium	B-treatment
&	I-treatment
Sodium	I-treatment
Phosphates	I-treatment
(	O
875	O
)	O
623	O
9797	O
mg	O
Packet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Packet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Packet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

5.	O
Warfarin	B-treatment
Sodium	I-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Penicillin	B-treatment
G	I-treatment
Pot	I-treatment
in	I-treatment
Dextrose	I-treatment
2,000,000	O
unit	O
/	O
50	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
Q4H	O
(	O
every	O
4	O
hours	O
).	O

Disp	O
:*	O
30	O
bags	O
*	O
Refills	O
:*	O
0	O
*	O

7.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QD	O
(	O
once	O
a	O
day	O
).	O

8.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

9.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

10.	O
Calcium	B-treatment
Carbonate	I-treatment
500	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
,	O
Chewable	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

McLean	O
Hospital	O
&	O
Rehab	O
Center	O
-	O
Tewksbury	O
State	O
Hospital	O

Discharge	O
Diagnosis	O
:	O

Atrial	B-problem
fibrillation	I-problem
,	O
Cellulitis	B-problem
,	O
Bacteremia	B-problem

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
take	O
all	O
over	O
your	B-treatment
medications	I-treatment
.	O

Please	O
make	O
a	O
follow-up	O
appointments	O
with	O
Dr.	O
Robinson	O
Dr.	O
Sturtevant	O
.	O

Return	O
to	O
the	O
Emergency	O
Department	O
if	O
you	O
develop	O
fevers	B-problem
,	O
chills	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
palpitations	B-problem
,	O
or	O
lightheadedness	B-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
keep	O
your	O
appointment	O
with	O
Dr.	O
Ryan	O
on	O
Monday	O
,	O
12-07	O
at	O
11	O
AM	O
.	O

Please	O
call	O
Dr.	O
Pytel	O
(	O
760	O
)	O
496-3627	O
and	O
make	O
a	O
follow-up	O
appointment	O
for	O
1	O
week	O
,	O
and	O
discuss	O
resuming	O
your	B-treatment
other	I-treatment
outpatient	I-treatment
medications	I-treatment
at	O
that	O
time	O
.	O

Janine	O
Karina	O
MD	O
98-439	O

Completed	O
by	O
:	O
Opal	O
Anne	O
MD	O
40-158	O
2015-10-22	O
@	O
1759	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Stephen	O
Williams	O
on	O
:	O
SAT	O
2015-10-24	O
9:46	O
AM	O

(	O
End	O
of	O
Report	O
)	O

013496896	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4925669	O
PAD-WORD	O

21983/7jk2	O
PAD-WORD	O

129165	O
PAD-WORD	O

02/22/1992	O
12:00:00	O
AM	O

LEFT	B-problem
CORONARY	I-problem
ARTERY	I-problem
STENOSIS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

02/22/92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

03/08/92	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

left	B-problem
coronary	I-problem
artery	I-problem
stenosis	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

diabetes	B-problem
mellitus	I-problem
with	O
diabetic	B-problem
renopathy	I-problem
,	O
renovascular	B-problem
occlusive	I-problem
disease	I-problem
,	O
with	O
thrombosis	B-problem
of	I-problem
the	I-problem
right	I-problem
renal	I-problem
artery	I-problem
,	O
hypertension	B-problem
,	O
probably	O
renal	O
vascular	O
,	O
hypertensive	B-problem
cardiac	I-problem
disease	I-problem
with	O
history	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

03/03/92	O
-	O
left	B-treatment
carotid	I-treatment
endarterectomy	I-treatment
with	O
continuous	B-test
interoperative	I-test
electroencephalogram	I-test
monitoring	I-test
and	O
saphenous	B-treatment
vein	I-treatment
patch	I-treatment
closure	I-treatment
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

Sep/24/05	O
cardiac	B-test
catheterization	I-test
and	O
coronary	B-test
angiography	I-test
,	O
02/23/92	O
-	O
transfemoral	B-test
aortogram	I-test
,	O
bilateral	B-test
carotid	I-test
arteriogram	I-test
,	O
abdominal	B-test
aortogram	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
72	O
year	O
old	O
female	O
with	O
known	B-problem
carotid	I-problem
stenosis	I-problem
,	O
and	O
recent	B-test
carotid	I-test
noninvasives	I-test
at	O
an	O
outside	O
hospital	O
,	O
which	O
showed	O
90%	B-problem
left	I-problem
sided	I-problem
stenosis	I-problem
.	O

She	O
has	O
not	O
had	O
a	B-problem
stroke	I-problem
,	O
or	O
transient	B-problem
ischemic	I-problem
attack	I-problem
.	O

She	O
was	O
recently	O
discharged	O
from	O
the	O
Per	O
Naplesspecrycet	O
Hospital	O
after	O
an	O
admission	O
for	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
noted	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Significant	O
for	O
having	O
had	O
a	B-treatment
cholecystectomy	I-treatment
and	O
hysterectomy	B-treatment
,	O
tonsillectomy	B-treatment
and	O
adenoidectomy	B-treatment
,	O
and	O
mastoidectomy	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Insulin	B-treatment
44	O
units	O
NPH	B-treatment
qam	O
;	O
8	O
units	O
qpm	O
;	O
Vasotec	B-treatment
2.5	O
qd	O
;	O
Lasix	B-treatment
40	O
qd	O
;	O
Mevacor	B-treatment
40	O
qd	O
;	O
Cardizem	B-treatment
CD	I-treatment
180	O
qd	O
;	O
Ciprofloxacin	B-treatment
for	O
urinary	B-problem
tract	I-problem
infection	I-problem
;	O
aspirin	B-treatment
.	O

ALLERGIES	O
:	O

Seldane	B-treatment
causes	O
gastrointestinal	B-problem
distress	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Clear	O
chest	O
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
.	O

Extremities	O
:	O

revealed	O
2+	B-test
carotid	I-test
pulses	I-test
with	O
bruits	B-problem
bilaterally	I-problem
,	O
2+	B-test
radial	I-test
,	O
2+	B-test
femoral	I-test
,	O
1+	B-test
dorsalis	I-test
pedis	I-test
bilaterally	I-test
.	O

LABORATORY	O
DATA	O
ON	O
ADMISSION	O
:	O

Significant	O
for	O
BUN	B-test
and	O
creatinine	B-test
33/2.4	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Tau	O
Memorial	O
Hospital	O
.	O

She	O
was	O
seen	O
by	O
Dr.	O
Freiermthalskush	O
of	O
the	O
renal	O
service	O
for	O
management	B-treatment
of	O
her	B-problem
chronic	I-problem
renal	I-problem
insufficiency	I-problem
.	O

On	O
02/22	O
,	O
she	O
underwent	O
angiography	B-test
,	O
which	O
revealed	O
minimal	B-problem
right	I-problem
internal	I-problem
carotid	I-problem
artery	I-problem
disease	I-problem
,	O
and	O
proximal	B-problem
left	I-problem
internal	I-problem
carotid	I-problem
artery	I-problem
stenosis	I-problem
,	O
2	O
cm	O
in	O
length	O
for	O
the	O
1	O
mm	O
residual	O
lumen	O
.	O

The	O
left	O
anterior	O
communicating	O
artery	O
fell	O
from	O
the	O
right	O
.	O

She	O
was	O
also	O
seen	O
by	O
Cardiology	O
,	O
and	O
she	O
underwent	O
cardiac	B-test
catheterization	I-test
,	O
as	O
part	O
of	O
her	B-test
preop	I-test
evaluation	I-test
,	O
which	O
revealed	O
normal	O
resting	O
hemodynamics	O
,	O
and	O
a	O
moderate	O
posterior	O
descending	O
artery	O
,	O
and	O
obtuse	B-problem
marginal	I-problem
stenoses	I-problem
.	O

She	O
was	O
,	O
therefore	O
,	O
cleared	O
for	O
the	O
operating	O
room	O
,	O
and	O
on	O
3/3/92	O
,	O
she	O
underwent	O
a	B-treatment
left	I-treatment
carotid	I-treatment
endarterectomy	I-treatment
,	O
with	O
continuous	B-test
electroencephalogram	I-test
monitoring	I-test
and	O
vein	B-treatment
patch	I-treatment
angioplasty	I-treatment
,	O
which	O
was	O
uneventful	O
.	O

Her	O
postoperative	O
course	O
was	O
marked	O
only	O
by	O
prolonged	B-problem
ileus	I-problem
,	O
perhaps	O
secondary	O
to	O
constipation	B-problem
,	O
with	O
persistent	B-problem
vomiting	I-problem
,	O
requiring	O
intravenous	B-treatment
fluids	I-treatment
,	O
however	O
,	O
on	O
03/07/92	O
,	O
she	O
had	O
a	O
large	O
bowel	O
movement	O
,	O
after	O
aggressive	B-treatment
bowel	I-treatment
regime	I-treatment
,	O
felt	O
significantly	O
better	O
,	O
was	O
able	O
to	O
tolerate	O
PO	O
&apos;s	O
.	O

She	O
is	O
now	O
able	O
to	O
be	O
discharged	O
home	O
on	O
her	B-treatment
admission	I-treatment
medications	I-treatment
,	O
with	O
the	O
exception	O
of	O
the	O
fact	O
that	O
Vasotec	B-treatment
was	O
increased	O
to	O
10	O
mg	O
PO	O
bid	O
.	O

SHERMENE	O
JESCSELC	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O
.	O

TR	O
:	O

pv	O
/	O
bmot	O

DD	O
:	O

03/08/92	O
PAD-WORD	O

TD	O
:	O

03/10/92	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Person	O

Admission	O
Date	O
:	O

2016-05-05	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-06-15	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2016-05-05	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

NEONATOLOGY	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
30	O
and	O
08-01	O
week	O
gestation	O
female	O
,	O
triplet	O
number	O
two	O
,	O
delivered	O
by	O
cesarean	B-treatment
section	I-treatment
due	O
to	O
progressive	B-problem
preterm	I-problem
labor	I-problem
and	O
triplet	B-problem
gestation	I-problem
.	O

PERINATAL	O
HISTORY	O
:	O

Mother	O
is	O
a	O
29	O
year-old	O
gravida	O
4	O
,	O
para	O
1	O
mother	O
,	O
Marian	O
Jane	O
conception	O
,	O
EDC	O
2016-07-08	O
.	O

Prenatal	B-test
screen	I-test
,	O
O	O
positive	O
,	O
antibody	B-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
reportedly	O
GBS	B-test
negative	O
,	O
Rubella	B-test
immune	O
.	O

Pregnancy	O
complicated	O
by	O
gestational	B-problem
diabetes	I-problem
mellitus	I-problem
,	O
then	O
possible	O
preterm	B-problem
labor	I-problem
.	O

Mother	O
presented	O
with	O
abdominal	B-problem
discomfort	I-problem
and	O
vaginal	B-problem
pressure	I-problem
at	O
23	O
and	O
1/7	O
weeks	O
.	O

At	O
that	O
time	O
she	O
was	O
admitted	O
and	O
received	O
a	B-treatment
full	I-treatment
course	I-treatment
of	I-treatment
betamethasone	I-treatment
at	O
24	O
weeks	O
and	O
remained	O
in	O
house	O
until	O
delivery	B-treatment
.	O

Mother	O
presented	O
on	O
day	O
of	O
delivery	B-treatment
with	O
preterm	B-problem
labor	I-problem
,	O
cervical	B-problem
dilation	I-problem
,	O
therefore	O
delivered	O
by	O
repeat	B-treatment
cesarean	I-treatment
section	I-treatment
.	O

This	O
triplet	O
required	O
only	O
blow	B-treatment
by	I-treatment
oxygen	I-treatment
and	O
routine	B-treatment
care	I-treatment
in	O
delivery	O
room	O
.	O

Apgars	B-test
were	O
8	O
at	O
one	O
minute	O
and	O
9	O
at	O
five	O
minutes	O
.	O

Infant	O
demonstrated	O
mild	B-problem
increased	I-problem
work	I-problem
of	I-problem
breathing	I-problem
in	O
the	O
delivery	O
room	O
.	O

Infant	O
transported	O
to	O
Neonatal	O
Intensive	O
Care	O
Unit	O
on	O
facial	B-treatment
CPAP	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Birth	B-test
weight	I-test
1455	O
grams	O
(	O
50th	O
percentile	O
),	O
head	B-test
circumference	I-test
29.25	O
cm	O
(	O
50th	O
percentile	O
),	O
length	B-test
41.5	O
cm	O
(	O
50th	O
percentile	O
).	O

Nondysmorphic	B-problem
with	O
overall	O
appearance	O
consistent	O
with	O
gestational	O
age	O
.	O

Anterior	O
fontanel	O
soft	O
,	O
open	O
,	O
flat	O
,	O
red	B-test
reflex	I-test
present	O
bilaterally	O
,	O
palate	O
intact	O
.	O

Intermittent	B-problem
grunting	I-problem
,	O
moderate	B-problem
intercostal	I-problem
retractions	I-problem
,	O
diminished	B-problem
air	I-problem
entry	I-problem
,	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-problem
,	O
2+	O
femoral	B-test
pulses	I-test
.	O

Abdomen	O
benign	O
with	O
no	O
hepatosplenomegaly	B-problem
or	O
masses	B-problem
.	O

No	O
external	O
female	O
genitalia	O
.	O

Normal	O
back	O
and	O
extremities	O
with	O
stable	O
hips	O
,	O
appropriate	O
tone	O
,	O
skin	O
pink	O
with	O
fair	O
perfusion	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Pulmonary	O
:	O

On	O
admission	O
the	O
infant	O
required	O
CPAP	B-treatment
6	O
cm	O
of	O
water	O
,	O
30%	B-treatment
oxygen	I-treatment
.	O

Initial	B-test
capillary	I-test
blood	I-test
gas	I-test
was	O
pH	B-test
7.29	O
,	O
CO2	B-test
47	O
.	O

Infant	O
was	O
intubated	B-treatment
on	O
day	O
of	O
life	O
two	O
for	O
increased	B-problem
respiratory	I-problem
distress	I-problem
and	O
received	O
one	O
dose	O
of	O
surfactant	B-treatment
.	O

Infant	O
was	O
extubated	B-treatment
on	O
day	O
of	O
life	O
four	O
to	O
CPAP	B-treatment
and	O
transitioned	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
six	O
.	O

The	O
infant	O
has	O
remained	O
in	O
room	O
air	O
throughout	O
the	O
hospitalization	O
.	O

Caffeine	B-treatment
citrate	I-treatment
was	O
started	O
on	O
day	O
of	O
life	O
six	O
and	O
was	O
discontinued	O
on	O
05-23	O
(	O
day	O
of	O
life	O
18	O
).	O

The	B-problem
last	I-problem
apnea	I-problem
and	O
bradycardia	B-problem
was	O
on	O
06-10	O
.	O

2.	O
Cardiovascular	O
:	O

The	O
infant	O
has	O
remained	O
hemodynamically	O
stable	O
throughout	O
this	O
hospitalization	O
,	O
no	O
murmur	B-problem
.	O

Heart	B-test
rate	I-test
150	O
to	O
160	O
,	O
mean	B-test
blood	I-test
pressure	I-test
40	O
to	O
54	O
.	O

3.	O
Fluid	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

Infant	O
was	O
initially	O
nothing	B-treatment
by	I-treatment
mouth	I-treatment
receiving	O
80	O
cc	O
per	O
kilogram	O
per	O
day	O
of	O
D10W	B-treatment
intravenously	I-treatment
.	O

Infant	O
was	O
started	O
on	O
enteral	B-treatment
feedings	I-treatment
on	O
day	O
of	O
life	O
four	O
and	O
advanced	O
to	O
full	O
volume	O
feedings	O
of	O
150	O
cc	O
per	O
kilogram	O
per	O
day	O
by	O
day	O
of	O
life	O
seven	O
.	O

During	O
feeding	B-treatment
advancement	I-treatment
infant	O
was	O
given	O
parenteral	B-treatment
nutrition	I-treatment
and	O
intralipids	B-treatment
.	O

The	O
infant	O
tolerated	O
feeding	B-treatment
advancement	I-treatment
without	O
difficulty	B-problem
.	O

Infant	O
was	O
advanced	O
to	O
maximum	O
caloric	O
density	O
of	O
breast	O
milk	O
or	O
premature	B-treatment
Enfamil	I-treatment
26	O
calories	O
per	O
ounce	O
with	O
ProMod	B-treatment
by	O
day	O
of	O
life	O
11	O
.	O

Infant	O
is	O
currently	O
on	O
breast	O
milk	O
or	O
Enfamil	B-treatment
24	O
calories	O
per	O
ounce	O
po	O
minimum	O
140	O
cc	O
per	O
kilogram	O
per	O
day	O
.	O

The	B-test
most	I-test
recent	I-test
weight	I-test
is	O
2525	O
g.	O

Head	B-test
circumference	I-test
24.5	O
cm	O
,	O
length	B-test
45.5	O
cm	O
.	O

The	B-test
most	I-test
recent	I-test
electrolytes	I-test
on	O
day	O
of	O
life	O
five	O
were	O
sodium	B-test
145	O
,	O
chloride	B-test
115	O
,	O
potassium	B-test
4	O
,	O
TCO2	B-test
of	O
21	O
.	O

On	O
day	O
of	O
life	O
25	O
,	O
calcium	B-test
10.1	O
,	O
phosphorus	B-test
6.9	O
,	O
alkaline	B-test
phosphatase	I-test
341	O
.	O

4.	O
Gastrointestinal	O
:	O

Infant	O
was	O
started	O
on	O
double	B-treatment
phototherapy	I-treatment
on	O
day	O
of	O
life	O
two	O
for	O
a	B-test
maximum	I-test
bilirubin	I-test
level	I-test
of	O
8.1	O
with	O
a	B-test
direct	I-test
of	O
0.3	O
.	O

Infant	O
decreased	O
to	O
single	B-treatment
phototherapy	I-treatment
and	O
phototherapy	B-treatment
was	O
discontinued	O
on	O
day	O
of	O
life	O
six	O
.	O

Rebound	B-test
bilirubin	I-test
level	I-test
on	O
day	O
of	O
life	O
seven	O
was	O
5.3	O
with	O
a	B-test
direct	I-test
of	O
0.3	O
.	O

5.	O
Hematology	O
:	O

The	O
infant	O
did	O
not	O
receive	O
any	B-treatment
blood	I-treatment
transfusions	I-treatment
this	B-treatment
hospitalization	I-treatment
.	O

The	B-test
most	I-test
recent	I-test
hematocrit	I-test
on	O
day	O
of	O
life	O
two	O
was	O
47%	O
.	O

CBC	B-test
on	O
admission	O
white	B-test
blood	I-test
cell	I-test
count	I-test
8.9	O
,	O
hematocrit	B-test
47%	O
,	O
platelets	B-test
243,000	O
,	O
6%	O
neutrophils	B-test
,	O
0	O
bands	B-test
.	O

Repeat	B-test
CBC	I-test
on	O
day	O
of	O
life	O
two	O
showed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
8.4	O
,	O
platelets	B-test
95	O
,	O
41%	O
neutrophils	B-test
,	O
0	O
bands	B-test
.	O

Repeat	B-test
platelet	I-test
count	I-test
on	O
day	O
of	O
life	O
three	O
was	O
229	O
.	O

6.	O
Infectious	O
disease	O
:	O

The	O
infant	O
received	O
48	O
hours	O
of	O
ampicillin	B-treatment
and	O
gentamicin	B-treatment
for	O
rule	O
out	O
sepsis	B-problem
.	O

Blood	B-test
cultures	I-test
remained	O
negative	O
to	O
date	O
.	O

Infant	O
has	O
not	O
had	O
any	B-problem
issues	I-problem
with	I-problem
sepsis	I-problem
this	B-treatment
hospitalization	I-treatment
.	O

7.	O
Neurology	O
:	O

Head	B-test
ultrasound	I-test
on	O
day	O
of	O
life	O
seven	O
showed	O
no	O
intraventricular	B-problem
hemorrhage	I-problem
.	O

A	B-test
repeat	I-test
head	I-test
ultrasound	I-test
on	O
day	O
of	O
life	O
33	O
06-07	O
showed	O
a	B-problem
slight	I-problem
increase	I-problem
of	I-problem
echogenicity	I-problem
in	I-problem
the	I-problem
caudothalamic	I-problem
groove	I-problem
,	O
which	O
may	O
represent	O
tiny	B-problem
bilateral	I-problem
germinal	I-problem
matrix	I-problem
hemorrhages	I-problem
,	O
no	O
periventricular	B-problem
leukomalacia	I-problem
.	O

A	B-test
repeat	I-test
head	I-test
ultrasound	I-test
is	O
recommended	O
in	O
one	O
month	O
.	O

Normal	O
neurological	O
examination	O
.	O

Sensory	B-test
,	I-test
hearing	I-test
screening	I-test
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Infant	O
passed	O
both	O
ears	O
.	O

Ophthalmology	O
,	O
eyes	O
examined	O
most	O
recently	O
on	O
05-30	O
revealing	O
immaturity	B-problem
of	I-problem
the	I-problem
retinal	I-problem
vessels	I-problem
,	O
but	O
no	O
ROP	B-problem
as	O
of	O
yet	O
.	O

A	B-test
follow	I-test
up	I-test
examination	I-test
should	O
be	O
scheduled	O
for	O
the	O
week	O
of	O
06-20	O
.	O

Ophthalmologist	O
is	O
Dr.	O
Cruea	O
Franklin	O
.	O

8.	O
Psycho	O
/	O
social	O
:	O

Parents	O
involved	O
.	O

Triplet	O
number	O
one	O
is	O
still	O
in	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
and	O
triplet	O
number	O
three	O
is	O
home	O
with	O
family	O
and	O
there	O
is	O
also	O
a	O
2	O
year-old	O
sibling	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
on	O
room	O
air	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Home	O
with	O
parents	O
.	O

NAME	O
OF	O
PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Janetta	O
Burmaster	O
,	O
phone	O
number	O
(	O
262	O
)	O
892	O
0330	O
,	O
fax	O
491-6171	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Feedings	O
breast	O
milk	O
or	O
Enfamil	B-treatment
24	O
calories	O
per	O
ounce	O
,	O
breast	O
milk	O
mixed	O
with	O
4	O
calories	O
per	O
ounce	O
of	O
Enfamil	B-treatment
powder	I-treatment
,	O
minimum	O
of	O
140	O
cc	O
per	O
kilogram	O
per	O
day	O
po	O
.	O

MEDICATIONS	O
:	O

Ferrous	B-treatment
sulfate	I-treatment
25	O
mg	O
per	O
ml	O
,	O
2	O
mg	O
per	O
kilogram	O
per	O
day	O
.	O

Car	B-test
seat	I-test
position	I-test
screening	I-test
passed	O
on	O
06-07	O
.	O

Hearing	B-test
screen	I-test
passed	O
on	O
2016-06-07	O
.	O

State	B-test
newborn	I-test
screens	I-test
were	O
sent	O
on	O
05-08	O
and	O
05-19	O
.	O

No	O
abnormal	B-problem
results	I-problem
have	O
been	O
reported	O
.	O

Immunizations	B-treatment
,	O
the	O
infant	O
received	O
hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
on	O
2016-06-02	O
.	O

Immunizations	B-treatment
recommended	O
,	O
Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
,	O
born	O
at	O
less	O
then	O
32	O
weeks	O
,	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
two	O
of	O
three	O
of	O
the	O
following	O
,	O
day	O
care	O
during	O
RSV	O
season	O
,	O
smoker	O
on	O
the	O
household	O
,	O
neuromuscular	B-problem
disease	I-problem
,	O
airway	B-problem
abnormalities	I-problem
or	O
school	O
age	O
siblings	O
or	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

FOLLOW	O
UP	O
APPOINTMENTS	O
:	O

1.	O
Primary	O
pediatrician	O
.	O

2.	O
Ophthalmology	O
Dr.	O
Wilson	O
.	O

3.	O
Visiting	O
Nurse	O
Association	O
early	O
intervention	O
program	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
triplet	O
number	O
two	O
.	O

2.	O
Status	O
post	O
respiratory	B-problem
distress	I-problem
.	O

3.	O
Status	O
post	O
rule	O
out	O
sepsis	B-problem
,	O
ruled	O
out	O
.	O

4.	O
Status	O
post	O
apnea	B-problem
of	I-problem
prematurity	I-problem
.	O

5.	O
Status	O
post	O
indirect	B-problem
hyperbilirubinemia	I-problem
.	O

Richard	O
Hartney	O
,	O
M.D.	O
02-219	O

Dictated	O
By	O
:	O
Leonard	O
J.	O
Pellegrino	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2016-06-14	O
11:22	O

T	O
:	O
2016-06-15	O
07:09	O

JOB	O
#:	O
47623	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Thomas	O
M.	O
Muth	O
on	O
:	O
WED	O
2016-06-15	O
9:49	O
AM	O

(	O
End	O
of	O
Report	O
)	O

014894512	O
PAD-WORD	O

FIH	O
PAD-WORD	O

0589930	O
PAD-WORD	O

86515/6878	O
PAD-WORD	O

801232	O
PAD-WORD	O

10/27/1993	O
12:00:00	O
AM	O

OSTEOCHONDROMATOSIS	B-problem
,	I-problem
RIGHT	I-problem
KNEE	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10-27-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

11-1-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Osteochondromatosis	B-problem
,	I-problem
right	I-problem
knee	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
68	O
year	O
old	O
white	O
male	O
who	O
had	O
a	O
seven	O
to	O
eight	O
year	O
history	O
of	O
knee	B-problem
pain	I-problem
.	O

In	O
1984	O
,	O
he	O
had	O
the	O
right	O
knee	O
aspirated	O
and	O
was	O
noted	O
to	O
have	O
some	O
uric	B-problem
acid	I-problem
crystals	I-problem
,	O
although	O
serum	B-test
uric	I-test
acid	I-test
was	O
normal	O
and	O
erythrocyte	B-test
sedimentation	I-test
rate	I-test
.	O

He	O
continued	O
to	O
have	O
intermittent	B-problem
symptoms	I-problem
and	O
was	O
noted	O
to	O
have	O
some	B-problem
fullness	I-problem
in	I-problem
the	I-problem
suprapatellar	I-problem
pouch	I-problem
.	O

Plain	B-test
films	I-test
taken	O
by	O
his	O
orthopedist	O
in	O
Mongcana	O
Ster	O
Staarv	O
revealed	O
some	B-problem
soft	I-problem
tissue	I-problem
calcification	I-problem
within	O
the	O
medial	O
and	O
lateral	O
compartments	O
of	O
the	O
joint	O
.	O

an	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
demonstrated	O
calcification	B-problem
densities	I-problem
in	I-problem
the	I-problem
suprapatellar	I-problem
bursa	I-problem
region	I-problem
,	O
also	O
with	O
hypertrophia	B-problem
of	I-problem
the	I-problem
synovium	I-problem
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
had	O
synovial	B-problem
chondromatosis	I-problem
and	O
would	O
benefit	O
from	O
an	B-treatment
open	I-treatment
synovectomy	I-treatment
and	O
debridement	B-treatment
.	O

He	O
was	O
admitted	O
for	O
that	B-treatment
procedure	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

He	O
had	O
tonsillectomy	B-treatment
at	O
the	O
age	O
of	O
five	O
,	O
and	O
appendectomy	B-treatment
in	O
1940	O
.	O

He	O
had	O
right	B-treatment
knee	I-treatment
aspirations	I-treatment
done	O
in	O
1986	O
,	O
otherwise	O
,	O
he	O
does	O
not	O
suffer	O
from	O
any	B-problem
other	I-problem
medical	I-problem
problems	I-problem
.	O

ALLERGIES	O
:	O

He	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

He	O
is	O
on	O
______________	O
2	O
tabs	O
PO	O
qd	O
.	O

SOCIAL	O
HISTORY	O
:	O

Married	O
and	O
lives	O
with	O
his	O
wife	O
in	O
Forda	O
Minsas	O
Ve	O
,	O
Wyoming	O
.	O

He	O
is	O
a	O
retired	O
school	O
teacher	O
by	O
profession	O
.	O

He	O
has	O
a	O
son	O
who	O
is	O
an	O
orthopedic	O
surgeon	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
has	O
been	O
a	O
smoker	O
for	O
the	O
last	O
50	O
years	O
and	O
he	O
drinks	O
alcohol	O
occasionally	O
,	O
but	O
stopped	O
in	O
1987	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
is	O
healthy	O
looking	O
.	O

The	B-test
general	I-test
physical	I-test
examination	I-test
did	O
not	O
reveal	O
any	B-problem
abnormality	I-problem
.	O

Heart	B-test
,	I-test
chest	I-test
,	I-test
and	I-test
abdominal	I-test
examinations	I-test
were	O
normal	O
.	O

The	B-test
right	I-test
knee	I-test
examination	I-test
showed	O
some	B-problem
effusion	I-problem
.	O

The	O
range	O
of	O
motion	O
was	O
15	O
to	O
120	O
degree	O
on	O
the	O
right	O
side	O
;	O
and	O
on	O
the	O
left	O
side	O
,	O
it	O
was	O
zero	O
to	O
135	O
.	O

There	O
was	O
normal	O
muscle	O
power	O
.	O

The	B-test
peripheral	I-test
pulses	I-test
were	O
palpable	O
.	O

LABORATORY	O
DATA	O
:	O

His	B-test
hematocrit	I-test
was	O
44.4	O
,	O
with	O
white	B-test
blood	I-test
count	I-test
of	O
11.9	O
,	O
and	O
platelet	B-test
count	I-test
of	O
410	O
.	O

His	B-test
MCV	I-test
was	O
92	O
,	O
MCH	B-test
32.1	O
,	O
and	O
MCHE	B-test
34.8	O
.	O

His	B-test
chest	I-test
X-ray	I-test
did	O
not	O
reveal	O
any	B-problem
abnormality	I-problem
.	O

A	B-test
electrocardiogram	I-test
showed	O
nonspecific	B-problem
T-wave	I-problem
abnormalities	I-problem
,	O
otherwise	O
,	O
it	O
was	O
normal	O
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
underwent	O
right	B-treatment
knee	I-treatment
open	I-treatment
synovectomy	I-treatment
and	O
debridement	B-treatment
of	O
synovial	B-problem
chondromatosis	I-problem
on	O
10-28-93	O
.	O

Postoperatively	O
,	O
he	O
has	O
done	O
well	O
.	O

He	O
is	O
mobilized	O
with	O
the	O
help	O
of	O
physical	B-treatment
therapy	I-treatment
,	O
on	O
a	B-treatment
continuous	I-treatment
passive	I-treatment
motion	I-treatment
machine	I-treatment
.	O

His	O
discharge	O
range	O
of	O
motion	O
is	O
from	O
zero	O
to	O
40	O
degrees	O
.	O

He	O
was	O
on	O
pain	B-treatment
medication	I-treatment
and	O
he	O
was	O
also	O
on	O
Percocet	B-treatment
,	O
but	O
now	O
he	O
can	O
manage	O
without	O
the	O
Percocet	B-treatment
.	O

He	O
is	O
on	O
Coumadin	B-treatment
which	O
is	O
to	O
be	O
continued	O
for	O
six	O
weeks	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Percocet	B-treatment
1-2	O
PO	O
q4h	O
prn	O
.	O

FOLLOW	O
UP	O
:	O

He	O
will	O
be	O
followed	O
up	O
in	O
Cesa	O
,	O
New	O
York	O
.	O

DISPOSITION	O
:	O

On	O
discharge	O
,	O
he	O
is	O
mobilized	O
,	O
partial	O
weight	O
bearing	O
with	O
the	O
help	O
of	O
a	B-treatment
walker	I-treatment
.	O

The	O
condition	O
on	O
discharge	O
is	O
good	O
.	O

STA	O
AGE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

SHAA	O
STONGE	O
,	O
M.D.	O

TR	O
:	O

fu	O
/	O
bmot	O

DD	O
:	O

11-1-93	O
PAD-WORD	O

TD	O
:	O

11/01/93	O
PAD-WORD	O

CC	O
:	O

139391631	O
PAD-WORD	O

GH	O
PAD-WORD	O

97368061	O
PAD-WORD	O

7/20/1999	O
12:00:00	O
AM	O

NEUROPATHIC	B-problem
PAIN	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

07/20/1999	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
Discharge	O

Date	O
:	O

07/26/1999	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Post	B-problem
thoracotomy	I-problem
syndrome	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

The	O
patient	O
had	O
a	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
trial	I-treatment
on	O
07/21/99	O
,	O
the	O
patient	O
had	O
an	B-treatment
epidural	I-treatment
trial	I-treatment
on	O
07/24/99	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65	O
year	O
old	O
female	O
with	O
post	B-problem
thoracotomy	I-problem
syndrome	I-problem
that	O
occurred	O
on	O
the	O
site	O
of	O
her	B-problem
thoracotomy	I-problem
incision	I-problem
.	O

She	O
had	O
a	B-problem
thoracic	I-problem
aortic	I-problem
aneurysm	I-problem
repaired	O
in	O
the	O
past	O
and	O
subsequently	O
developed	O
neuropathic	B-problem
pain	I-problem
at	O
the	B-problem
incision	I-problem
site	I-problem
.	O

She	O
is	O
currently	O
on	O
Vicodin	B-treatment
,	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
p.r.n.	O
,	O
Fentanyl	B-treatment
patch	I-treatment
25	O
mcg	O
an	O
hour	O
,	O
change	O
of	O
patch	O
every	O
72	O
hours	O
,	O
Elavil	B-treatment
50	O
mgq	O
.h.s.	O
,	O
Neurontin	B-treatment
600	O
mg	O
p.o.	O
t.i.d.	O
with	O
still	O
what	O
she	O
reports	O
as	O
stabbing	B-problem
left-sided	I-problem
chest	I-problem
pain	I-problem
that	O
can	O
be	O
as	O
severe	O
as	O
a	O
7/10.	O

She	O
has	O
failed	O
conservative	B-treatment
therapy	I-treatment
and	O
is	O
admitted	O
for	O
a	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
trial	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
.	O

2.	O
Hypothyroidism	B-problem
.	O

3.	O
Paraplegia	B-problem
status	O
post	O
thoracic	B-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

4.	O
Left	B-problem
hemidiaphragmatic	I-problem
paralysis	I-problem
,	O
history	O
of	O
recurrent	B-problem
lung	I-problem
infections	I-problem
.	O

5.	O
Sacral	B-problem
decubitus	I-problem
ulcer	I-problem
.	O

6.	O
Home	B-treatment
oxygen	I-treatment
at	O
two	O
liters	O
a	O
minute	O
when	O
she	O
is	O
at	O
home	O
;	O
she	O
does	O
not	O
use	O
the	B-treatment
oxygen	I-treatment
when	O
she	O
is	O
in	O
a	B-treatment
wheelchair	I-treatment
or	O
is	O
out	O
of	O
the	O
house	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Atrovent	B-treatment
nebulizers	I-treatment
0.5	O
mg	O
mixed	O
with	O
albuterol	B-treatment
,	O
nebulizer	B-treatment
is	O
given	O
every	O
six	O
hours	O
.	O

2.	O
Norvasc	B-treatment
2.5	O
mg	O
p.o.	O
q	O
day	O
.	O

3.	O
Colistin	B-treatment
30	O
mg	O
nebulizer	O
twice	O
a	O
day	O
,	O
give	O
30	O
minutes	O
post	O
albuterol	B-treatment
and	O
Atrovent	B-treatment
.	O

4.	O
Pressure	B-treatment
,	I-treatment
dermal	I-treatment
ulcer	I-treatment
care	I-treatment
b.i.d.	O
dressing	B-treatment
change	I-treatment
with	O
antibiotic	B-treatment
solution	I-treatment
.	O

5.	O
Neurontin	B-treatment
600	O
mg	O
p.o.	O
t.i.d.	O

6.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

7.	O
Albuterol	B-treatment
neb	I-treatment
2.5	O
mg	O
every	O
six	O
hours	O
,	O
30	O
minutes	O
before	O
Colistin	B-treatment
.	O

8.	O
Amitriptyline	B-treatment
50	O
mg	O
q.h.s.	O

9.	O
Vitamin	B-treatment
C	I-treatment
500	O
mg	O
p.o.	O
b.i.d.	O

10.	O
Calcium	B-treatment
carbonate	I-treatment
125.0	O
mg	O
t.i.d.	O

11.	O
Fentanyl	B-treatment
patch	I-treatment
25	O
mcg	O
an	O
hour	O
,	O
change	O
patch	B-treatment
every	O
72	O
hours	O
.	O

12.	O
Folate	B-treatment
1	O
mg	O
p.o.	O
q	O
day	O
.	O

13.	O
Synthroid	B-treatment
50	O
mcg	O
p.o.	O
q	O
day	O
.	O

14.	O
Zinc	B-treatment
sulfate	I-treatment
220	O
mg	O
p.o.	O
q	O
day	O
.	O

15.	O
Multivitamin	B-treatment
,	O
one	O
tablet	O
p.o.	O
q	O
day	O
.	O

16.	O
Hydrocodone	B-treatment
5	O
mg	O
with	O
Tylenol	B-treatment
,	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
p.r.n.	O
pain	B-problem
.	O

17.	O
Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
30	O
cc	O
p.o.	O
q	O
day	O
constipation	B-problem
.	O

ALLERGIES	O
:	O

PENICILLIN	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
in	O
Napro	O
with	O
her	O
husband	O
who	O
is	O
her	O
primary	O
caregiver	O
.	O

She	O
is	O
not	O
a	O
smoker	O
.	O

She	O
has	O
approximately	O
one	O
glass	O
of	O
wine	O
every	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
well-appearing	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Blood	B-test
pressure	I-test
is	O
150/90	O
,	O
heart	B-test
rate	I-test
of	O
90	O
,	O
respiratory	B-test
rate	I-test
20	O
with	O
saturation	B-test
of	O
98%	O
.	O

HEENT	O
:	O

Pupils	O
are	O
equal	O
and	O
reactive	O
to	O
light	O
.	O

The	O
patient	O
wears	O
dentures	B-treatment
.	O

Neck	O
:	O

Full	O
range	O
of	O
motion	O
with	O
no	O
lymphadenopathy	B-problem
.	O

Chest	O
:	O

Clear	O
to	O
auscultation	O
on	O
the	O
right	O
.	O

Decreased	B-problem
breath	I-problem
sounds	I-problem
on	I-problem
the	I-problem
left	I-problem
base	I-problem
with	O
coarse	B-problem
rales	I-problem
on	I-problem
the	I-problem
left	I-problem
base	I-problem
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
.	O

Abdomen	O
:	O

Soft	O
,	O
nondistended	B-problem
,	O
nontender	B-problem
.	O

Positive	O
bowel	O
sounds	O
.	O

Back	O
:	O

Clear	O
.	O

Epidural	O
site	O
is	O
without	O
erythema	B-problem
,	O
drainage	B-problem
or	O
tenderness	B-problem
.	O

Left	O
buttock	O
area	O
has	O
a	B-treatment
dressing	I-treatment
over	O
the	B-problem
sacral	I-problem
decubitus	I-problem
ulcer	I-problem
.	O

Extremities	O
:	O

Well-profused	O
.	O

4/5	O
motor	O
strength	O
in	O
the	O
upper	O
extremities	O
bilaterally	O
.	O

Flaccid	B-problem
paralysis	I-problem
of	I-problem
bilateral	I-problem
lower	I-problem
extremities	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
07/20/99	O
for	O
a	O
history	O
of	O
left	B-problem
chest	I-problem
wall	I-problem
pain	I-problem
from	O
postthoracotomy	B-problem
syndrome	I-problem
.	O

The	O
patient	O
developed	O
the	B-problem
syndrome	I-problem
after	O
her	B-treatment
thoracic	I-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

The	O
patient	O
failed	O
the	B-treatment
conservative	I-treatment
therapy	I-treatment
and	O
is	O
admitted	O
for	O
a	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
trial	I-treatment
.	O

The	O
patient	O
had	O
a	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
placed	O
on	O
07/21/99	O
.	O

She	O
underwent	O
the	B-treatment
procedure	I-treatment
and	O
tolerated	O
the	B-treatment
procedure	I-treatment
very	O
well	O
.	O

The	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
was	O
programmed	O
with	O
setting	O
of	O
a	O
rate	O
of	O
80	O
,	O
power	O
450	O
and	O
4.0	O
amps	O
.	O

Channel	O
1	O
was	O
negative	O
,	O
2	O
was	O
neutral	O
,	O
3	O
was	O
neutral	O
,	O
4	O
was	O
positive	O
.	O

The	O
patient	O
the	O
next	O
two	O
days	O
did	O
not	O
notice	O
any	O
significant	O
change	O
in	O
her	B-problem
pain	I-problem
pattern	I-problem
.	O

The	O
patient	O
was	O
also	O
noted	O
to	O
have	O
a	O
lot	O
of	O
musculoskeletal	B-problem
component	I-problem
of	I-problem
her	I-problem
pain	I-problem
.	O

So	O
,	O
an	B-treatment
epidural	I-treatment
catheter	I-treatment
was	O
placed	O
on	O
07/23/99	O
.	O

The	B-treatment
epidural	I-treatment
was	O
placed	O
in	O
the	O
L1-2	O
region	O
and	O
the	B-treatment
catheter	I-treatment
was	O
placed	O
in	O
the	O
T7	O
region	O
using	O
fluoroscope	B-test
to	O
guide	O
the	B-treatment
catheter	I-treatment
.	O

Within	O
the	O
next	O
couple	O
of	O
days	O
,	O
the	O
patient	O
noticed	O
a	O
significant	O
improvement	O
in	O
her	B-problem
pain	I-problem
pattern	I-problem
.	O

The	B-problem
stabbing	I-problem
,	I-problem
sharp	I-problem
pain	I-problem
that	O
she	O
occasionally	O
has	O
on	O
the	O
left	O
chest	O
wall	O
was	O
significantly	O
diminished	O
and	O
she	O
also	O
noticed	O
periods	O
of	O
time	O
when	O
she	O
did	O
not	O
have	O
any	O
of	O
that	B-problem
pain	I-problem
.	O

The	B-treatment
epidural	I-treatment
catheter	I-treatment
had	O
a	B-treatment
morphine	I-treatment
infusion	I-treatment
initially	O
started	O
at	O
1	O
mg	O
a	O
day	O
and	O
increased	O
to	O
3	O
mg	O
a	O
day	O
in	O
a	O
period	O
of	O
three	O
days	O
.	O

The	B-treatment
epidural	I-treatment
was	O
discontinued	O
on	O
07/26/99	O
and	O
was	O
considered	O
a	B-treatment
successful	I-treatment
trial	I-treatment
.	O

The	O
patient	O
will	O
schedule	O
with	O
the	O
Pain	O
Clinic	O
regarding	O
upcoming	B-treatment
epidural	I-treatment
pump	I-treatment
placement	I-treatment
.	O

During	O
her	O
hospitalization	O
,	O
the	O
patient	O
was	O
also	O
seen	O
by	O
the	O
Plastic	O
Service	O
.	O

Dr.	O
Falccouette	O
would	O
like	O
to	O
perform	O
an	B-treatment
excision	I-treatment
and	O
closure	B-treatment
flap	I-treatment
of	O
her	B-problem
left	I-problem
ischial	I-problem
decubitusin	I-problem
the	O
near	O
future	O
.	O

The	O
patient	O
was	O
discharged	O
in	O
stable	O
conditionand	O
will	O
follow	O
up	O
for	O
(	O
1	O
)	O
sacral	B-treatment
decubitus	I-treatment
closure	I-treatment
,	O
and	O
(	O
2	O
)	O
placement	B-treatment
of	I-treatment
epidural	I-treatment
pump	I-treatment
in	O
the	O
future	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
will	O
have	O
SMH	O
Service	O
that	O
comes	O
to	O
her	O
home	O
once	O
a	O
day	O
for	O
adressing	B-treatment
change	I-treatment
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Kayschird	O
to	O
schedule	O
for	O
the	B-treatment
epidural	I-treatment
pump	I-treatment
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Falccouette	O
to	O
schedule	O
for	O
excision	B-treatment
and	O
closure	B-treatment
of	O
her	B-problem
left	I-problem
ischial	I-problem
sacral	I-problem
decubitus	I-problem
.	O

Dictated	O
By	O
:	O

ECI	O
JESCSLAND	O
,	O
M.D.	O
OO63	O

Attending	O
:	O

FOMAIRE	O
KOTEKOTEJESCDREWE	O
,	O
M.D.	O
RY93	O
KE526/9219	O

Batch	O
:	O

37707	O
PAD-WORD	O

Index	O
No.	O

RWRF75BSI	O
PAD-WORD	O

D	O
:	O

07/26/99	O
PAD-WORD	O

T	O
:	O

07/26/99	O
PAD-WORD	O

CC	O
:	O

JOFREDD	O
N.	O
FALCCOUETTE	O
,	O
M.D.	O
SV7	O

[	O
report_end	O
]	O

017480654	O
PAD-WORD	O

FIH	O
PAD-WORD	O

6160323	O
PAD-WORD	O

59147/s876	O
PAD-WORD	O

971818	O
PAD-WORD	O

2/15/1994	O
12:00:00	O
AM	O

CHRONIC	B-problem
MYELOMONOCYTIC	I-problem
LEUKEMIA	I-problem
,	O
WITHOUT	O
REMISSION	O
,	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

2/15/94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

2/28/94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Chronic	B-problem
myelomonocytic	I-problem
leukemia	I-problem
,	O
without	O
remission	O
,	O
atrial	B-problem
fibrillation	I-problem
,	O
chronic	B-problem
airway	I-problem
obstruction	I-problem
,	O
hypopotassemia	B-problem
,	O
cellulitis	B-problem
,	O
orbital	B-problem
hemorrhage	I-problem
,	O
protein	B-problem
calorie	I-problem
malnutrition	I-problem
,	O
gastrointestinal	B-problem
hemorrhage	I-problem
,	O
pulmonary	B-problem
hemorrhage	I-problem
/	O
pneumonia	B-problem
,	O
hyperglycemia	B-problem
,	O
renal	B-problem
insufficiency	I-problem
,	O
hyperuricemia	B-problem
,	O
hypophosphatemia	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
75	O
year	O
old	O
male	O
had	O
been	O
noted	O
to	O
be	O
anemic	B-problem
with	O
an	B-problem
abnormal	I-problem
white	I-problem
blood	I-problem
count	I-problem
since	O
at	O
least	O
November	O
1993	O
,	O
while	O
he	O
was	O
living	O
in	O
Aersing	O
Rocuch	O
Sun	O
and	O
his	O
physicians	O
there	O
had	O
begun	O
to	O
manage	O
him	O
with	O
transfusions	B-treatment
,	O
and	O
low	B-treatment
dose	I-treatment
hydroxyurea	I-treatment
.	O

Apparently	O
,	O
a	B-test
bone	I-test
marrow	I-test
biopsy	I-test
at	O
the	O
time	O
confirmed	O
the	O
diagnosis	O
of	O
chronic	B-problem
myelomonocytic	I-problem
leukemia	I-problem
.	O

He	O
came	O
to	O
this	O
country	O
in	O
late	O
December	O
1994	O
to	O
live	O
with	O
his	O
son	O
for	O
a	O
few	O
months	O
and	O
was	O
referred	O
to	O
me	O
for	O
follow	O
up	O
.	O

He	O
had	O
been	O
noting	O
night	B-problem
sweats	I-problem
,	O
increasing	B-problem
fatigue	I-problem
,	O
anorexia	B-problem
,	O
and	O
dyspnea	B-problem
,	O
which	O
were	O
not	O
particularly	O
improved	O
by	O
increased	B-treatment
transfusions	I-treatment
or	O
alterations	O
of	O
hydroxy	B-treatment
urea	I-treatment
.	O

He	O
became	O
profoundly	B-problem
thrombocytopenic	I-problem
,	O
and	O
ultimately	O
was	O
admitted	O
to	O
the	O
hospital	O
on	O
2/15	O
with	O
headache	B-problem
and	O
weakness	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
,	O
managed	O
with	O
an	O
Italian	O
variation	O
of	O
Digoxin	B-treatment
,	O
and	O
Amioadrone	B-treatment
,	O
hypertension	B-problem
managed	O
with	O
an	B-treatment
ACE	I-treatment
inhibitor	I-treatment
,	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
managed	O
with	O
a	B-treatment
zanthine	I-treatment
preparation	I-treatment
and	O
low	B-treatment
dose	I-treatment
steroids	I-treatment
,	O
as	O
well	O
as	O
an	B-treatment
occasional	I-treatment
inhaler	I-treatment
.	O

Other	B-problem
medical	I-problem
problems	I-problem
included	O
chronic	B-problem
liver	I-problem
disease	I-problem
of	O
uncertain	O
etiology	O
,	O
for	O
which	O
he	O
had	O
been	O
advised	O
not	O
to	O
drink	O
any	O
alcohol	O
.	O

He	O
also	O
had	O
a	B-problem
penetrating	I-problem
injury	I-problem
to	I-problem
the	I-problem
right	I-problem
eye	I-problem
,	O
which	O
had	O
rendered	O
him	O
blind	B-problem
10	O
years	O
previously	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
a	O
chronically	O
ill	O
appearing	O
elderly	O
man	O
,	O
with	O
a	B-test
respiratory	I-test
rate	I-test
of	O
30	O
,	O
temperature	B-test
99.6	O
,	O
pulse	B-test
100	O
,	O
and	O
irregularly	B-problem
irregular	I-problem
,	O
blood	B-test
pressure	I-test
148/71	O
.	O

He	O
had	O
some	B-problem
petechiae	I-problem
on	I-problem
his	I-problem
extremities	I-problem
,	O
as	O
well	O
as	O
in	O
his	O
mucosal	O
membranes	O
with	O
some	B-problem
hemorrhagic	I-problem
bullae	I-problem
.	O

There	O
were	O
bibasilar	B-problem
rales	I-problem
with	O
some	B-problem
wheezing	I-problem
.	O

He	O
had	O
no	O
cardiac	B-problem
murmur	I-problem
.	O

His	O
abdomen	O
was	O
distended	B-problem
with	O
massive	B-problem
hepatosplenomegaly	I-problem
,	O
which	O
was	O
somewhat	B-problem
tender	I-problem
.	O

The	B-test
neurological	I-test
examination	I-test
aside	O
from	O
the	B-problem
blind	I-problem
right	I-problem
eye	I-problem
was	O
unremarkable	O
.	O

LABORATORY	O
DATA	O
:	O

Included	O
a	B-test
white	I-test
blood	I-test
count	I-test
of	O
140,000	O
,	O
7%	B-test
polys	I-test
,	O
1%	B-test
bands	I-test
,	O
3%	B-test
lymphs	I-test
,	O
1%	B-test
monos	I-test
,	O
2	B-test
basos	I-test
,	O
4	B-test
blasts	I-test
,	O
76%	B-test
pearl	I-test
monocytes	I-test
,	O
6%	B-test
meta	I-test
&apos;s	I-test
,	O
3	B-test
nucleated	I-test
red	I-test
blood	I-test
cells	I-test
.	O

There	O
were	O
some	O
oval	B-problem
tear	I-problem
drop	I-problem
cells	I-problem
and	O
target	B-problem
cells	I-problem
with	O
a	B-problem
few	I-problem
schistocytes	I-problem
.	O

The	B-test
platelet	I-test
count	I-test
was	O
9,000	O
,	O
hematocrit	B-test
was	O
26.5	O
,	O
with	O
an	B-test
mean	I-test
corpuscular	I-test
volume	I-test
of	O
about	O
73	O
.	O

His	B-test
prothrombin	I-test
time	I-test
and	O
partial	B-test
thromboplastin	I-test
time	I-test
were	O
normal	O
.	O

His	B-test
uric	I-test
acid	I-test
was	O
up	O
at	O
97	O
,	O
his	B-test
total	I-test
bilirubin	I-test
was	O
up	O
at	O
1.8	O
,	O
his	B-test
LDH	I-test
was	O
428	O
,	O
his	B-test
phosphorus	I-test
was	O
1.2	O
,	O
calcium	B-test
8.6	O
,	O
Digoxin	B-test
level	I-test
was	O
1.0	O
,	O
potassium	B-test
on	O
admission	O
was	O
2.9	O
,	O
sodium	B-test
135	O
,	O
BUN	B-test
and	O
creatinine	B-test
13/1.6	O
,	O
and	O
sugar	B-test
of	O
267	O
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
of	O
his	O
head	O
showed	O
no	O
signs	O
of	O
an	B-problem
acute	I-problem
bleed	I-problem
,	O
a	B-test
chest	I-test
X-ray	I-test
showed	O
no	O
new	B-problem
infiltrates	I-problem
or	O
masses	B-problem
.	O

There	O
was	O
cardiomegaly	B-problem
with	O
prominent	B-problem
vascularity	I-problem
,	O
but	O
no	O
effusions	B-problem
.	O

An	B-test
electrocardiogram	I-test
was	O
consistent	O
with	O
atrial	B-problem
fibrillation	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
and	O
begun	O
on	O
high	B-treatment
dose	I-treatment
Hydroxyurea	I-treatment
,	O
with	O
a	O
gradual	O
improvement	O
in	O
his	B-test
white	I-test
blood	I-test
count	I-test
over	O
the	O
next	O
few	O
days	O
.	O

He	O
did	O
spike	O
a	B-problem
fever	I-problem
and	O
began	O
Ancef	B-treatment
and	O
Gentamicin	B-treatment
,	O
although	O
cultures	B-test
never	O
revealed	O
a	O
source	O
for	O
this	O
.	O

He	O
also	O
tried	O
Amicar	B-treatment
and	O
continued	O
on	O
low	B-treatment
dose	I-treatment
Prednisone	I-treatment
.	O

His	B-problem
headache	I-problem
improved	O
,	O
but	O
her	O
remained	O
profoundly	B-problem
weak	I-problem
and	O
intermittently	B-problem
febrile	I-problem
with	O
dyspnea	B-problem
.	O

There	O
was	O
hemoptysis	B-problem
and	O
intermittent	B-problem
gastrointestinal	I-problem
bleeding	I-problem
,	O
while	O
he	O
remained	O
profoundly	B-problem
thrombocytopenia	I-problem
.	O

Transfusions	B-treatment
of	I-treatment
platelets	I-treatment
did	O
not	O
change	O
his	B-test
platelet	I-test
count	I-test
,	O
presumably	O
because	O
of	O
sequestration	B-problem
and	O
a	B-problem
massive	I-problem
spleen	I-problem
.	O

Amicar	B-treatment
was	O
of	O
uncertain	O
value	O
,	O
but	O
used	O
intermittently	O
.	O

A	B-test
bone	I-test
marrow	I-test
biopsy	I-test
revealed	O
the	O
transformation	O
of	O
his	B-problem
CMML	I-problem
to	O
acute	B-problem
myelogenous	I-problem
leukemia	I-problem
,	O
and	O
given	O
his	B-problem
other	I-problem
underlying	I-problem
medical	I-problem
problems	I-problem
,	O
we	O
chose	O
chemotherapy	B-treatment
with	O
subcutaneous	B-treatment
Cystosine	I-treatment
Arabinoside	I-treatment
and	O
6-Thioguanine	B-treatment
,	O
which	O
he	O
tolerated	O
without	O
incident	O
and	O
this	O
brought	O
his	B-test
white	I-test
blood	I-test
count	I-test
down	O
to	O
below	O
1,000	O
,	O
and	O
his	O
spleen	O
shrank	O
noticeably	O
,	O
but	O
he	O
still	O
could	O
not	O
maintain	O
a	O
bump	O
in	O
platelet	B-test
count	I-test
with	O
platelet	B-treatment
transfusions	I-treatment
.	O

He	O
was	O
intermittently	B-problem
congested	I-problem
limiting	O
our	O
ability	O
to	O
give	O
intravenous	B-treatment
fluid	I-treatment
,	O
for	O
his	B-treatment
hydrea	I-treatment
,	O
although	O
we	O
kept	O
him	O
on	O
Allopurinol	B-treatment
.	O

The	O
renal	O
function	O
deteriorated	O
somewhat	O
,	O
hampering	O
our	O
ability	O
to	O
give	O
him	O
his	B-treatment
Gentamicin	I-treatment
.	O

The	O
family	O
maintained	O
an	O
extraordinary	O
vigil	O
over	O
the	O
days	O
of	O
his	O
hospitalization	O
,	O
providing	O
him	O
with	O
some	O
food	O
and	O
constant	O
attention	O
,	O
while	O
we	O
awaited	O
the	O
results	O
of	O
his	B-treatment
chemotherapy	I-treatment
and	O
treatment	B-treatment
of	O
his	B-problem
infection	I-problem
.	O

He	O
was	O
intermittently	B-problem
restless	I-problem
and	O
somewhat	B-problem
confused	I-problem
,	O
and	O
as	O
his	O
respiratory	O
status	O
deteriorated	O
,	O
the	O
family	O
agreed	O
to	O
a	B-treatment
low	I-treatment
dose	I-treatment
Morphine	I-treatment
drip	I-treatment
which	O
made	O
him	O
much	O
more	O
comfortable	O
.	O

They	O
agreed	O
with	O
a	O
do	O
not	O
resuscitate	O
status	O
early	O
on	O
in	O
the	O
hospitalization	O
and	O
in	O
the	O
course	O
of	O
being	O
maintain	O
on	O
low	B-treatment
dose	I-treatment
Morphine	I-treatment
,	O
he	O
ultimately	O
expired	O
on	O
2/28/94	O
with	O
the	O
family	O
present	O
.	O

No	O
autopsy	B-test
was	O
obtained	O
.	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O

TR	O
:	O

lj	O
/	O
bmot	O

DD	O
:	O

3/12/94	O
PAD-WORD	O

TD	O
:	O

03/13/94	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Ca	O
Shuff	O
,	O
FIH	O
Oregon	O
Dr.	O
Ille	O
Kote	O

Admission	O
Date	O
:	O

2010-08-30	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-09-06	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1946-01-08	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Cardiothoracic	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
64-year-old	O
man	O
with	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
endocarditis	B-problem
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
and	O
mitral	B-treatment
valve	I-treatment
replacement	I-treatment
on	O
2010-08-13	O
.	O

He	O
was	O
transferred	O
to	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
from	O
the	O
rehabilitation	O
center	O
where	O
he	O
had	O
been	O
discharged	O
to	O
on	O
2010-08-25	O
following	O
his	B-treatment
CABG/MVR	I-treatment
.	O

At	O
the	O
rehabilitation	O
center	O
the	O
patient	O
developed	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

A	B-test
chest	I-test
x-ray	I-test
done	O
at	O
that	O
time	O
revealed	O
a	B-problem
left-sided	I-problem
infiltrate	I-problem
versus	O
effusion	B-problem
.	O

He	O
was	O
transferred	O
to	O
Mass.	O
Eye	O
&	O
Ear	O
Infirmary	O
for	O
treatment	B-treatment
.	O

At	O
the	O
time	O
he	O
complained	O
of	O
no	O
chest	B-problem
pain	I-problem
,	O
weakness	B-problem
or	O
cough	B-problem
,	O
although	O
he	O
is	O
intermittently	B-problem
short	I-problem
of	I-problem
breath	I-problem
.	O

He	O
had	O
been	O
anticoagulated	B-treatment
during	O
his	O
stay	O
at	O
rehabilitation	O
for	O
atrial	B-problem
fibrillation	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Significant	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
CABG/MVR	B-treatment
.	O

2.	O
Endocarditis	B-problem
.	O

3.	O
Rectal	B-problem
cancer	I-problem
.	O

4.	O
Atrial	B-problem
fibrillation	I-problem
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Amiodarone	B-treatment
200	O
mg	O
q.d.	O

2.	O
Lasix	B-treatment
20	O
mg	O
b.i.d.	O

3.	O
Potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
b.i.d.	O

4.	O
Ampicillin	B-treatment
2	O
grams	O
q.	O
4	O
hours	O
.	O

5.	O
Albuterol	B-treatment
and	O
Atrovent	B-treatment
p.r.n.	O

6.	O
Aspirin	B-treatment
325	O
q.d.	O

7.	O
Coumadin	B-treatment
5	O
q.d.	O

8.	O
Nystatin	B-treatment
swish	O
and	O
swallow	O
5	O
cc	O
t.i.d.	O

9.	O
Colace	B-treatment
100	O
b.i.d.	O

10.	O
Percocet	B-treatment
5/325	O
,	O
1-2	O
tablets	O
q.	O
4	O
hours	O
p.r.n.	O

LABORATORY	O
DATA	O
:	O

White	B-test
count	I-test
12.6	O
,	O
hematocrit	B-test
28.9	O
,	O
platelet	B-test
count	I-test
259	O
,	O
PT	B-test
21.4	O
,	O
PTT	B-test
40.2	O
,	O
INR	B-test
3.0	O
,	O
sodium	B-test
137	O
,	O
potassium	B-test
4.2	O
,	O
chloride	B-test
100	O
,	O
CO2	B-test
27	O
,	O
BUN	B-test
26	O
,	O
creatinine	B-test
1.3	O
,	O
glucose	B-test
120	O
.	O

Chest	B-test
x-ray	I-test
shows	O
a	B-problem
large	I-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
vital	B-test
signs	I-test
were	O
temperature	B-test
100.1	O
,	O
heart	B-test
rate	I-test
83	O
and	O
sinus	O
rhythm	O
,	O
blood	B-test
pressure	I-test
108/50	O
,	O
respiratory	B-test
rate	I-test
25	O
,	O
oxygen	B-test
saturation	I-test
97%	O
on	O
three	B-treatment
liters	I-treatment
.	O

Generally	O
he	O
was	O
a	O
pleasant	O
man	O
with	O
mild	B-problem
respiratory	I-problem
distress	I-problem
.	O

Lungs	O
had	O
decreased	B-problem
breath	I-problem
sounds	I-problem
on	O
the	O
left	O
.	O

Cardiac	B-test
examination	I-test
showed	O
regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
and	O
S2	O
.	O

Chest	B-problem
incision	I-problem
was	O
with	O
Steri-Strips	B-treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

Abdomen	O
was	O
soft	O
and	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
with	O
positive	O
bowel	O
sounds	O
.	O

Extremities	O
had	O
bilateral	B-problem
pedal	I-problem
edema	I-problem
.	O

Right	B-problem
leg	I-problem
wound	I-problem
had	O
Steri-Strips	B-treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Vencor	O
Hospital	O
.	O

He	O
was	O
given	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
to	O
correct	O
his	B-test
INR	I-test
and	O
a	B-treatment
left	I-treatment
chest	I-treatment
tube	I-treatment
was	O
placed	O
.	O

Over	O
the	O
first	O
12	O
hours	O
the	B-treatment
chest	I-treatment
tube	I-treatment
drained	O
2,500	O
cc	O
.	O

On	O
hospital	O
day	O
two	O
the	O
patient	O
was	O
transferred	O
from	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
to	O
07-02	O
for	O
continuing	O
care	O
.	O

He	O
remained	O
hemodynamically	O
stable	O
.	O

His	B-problem
chest	I-problem
tube	I-problem
drainage	I-problem
reduced	O
significantly	O
after	O
the	O
first	O
24	O
hours	O
and	O
on	O
hospital	O
day	O
three	O
his	B-treatment
chest	I-treatment
tube	I-treatment
was	O
discontinued	O
.	O

Over	O
the	O
next	O
several	O
days	O
the	O
patient	O
remained	O
in	O
the	O
hospital	O
to	O
reassess	O
for	O
recurrent	B-problem
pleural	I-problem
effusion	I-problem
.	O

On	O
09-02	O
it	O
was	O
decided	O
that	O
the	O
patient	O
was	O
stable	O
and	O
ready	O
to	O
be	O
transferred	O
back	O
to	O
rehabilitation	O
,	O
however	O
case	O
management	O
was	O
unable	O
to	O
get	O
authorization	O
from	O
the	O
patient	O
's	O
insurance	O
company	O
and	O
he	O
remained	O
in	O
the	O
hospital	O
throughout	O
the	O
holiday	O
weekend	O
awaiting	O
insurance	O
authorization	O
for	O
transfer	O
back	O
to	O
rehabilitation	O
.	O

At	O
this	O
time	O
the	B-test
patient	I-test
's	I-test
physical	I-test
examination	I-test
is	O
as	O
follows	O
:	O

Vital	B-test
signs	I-test
were	O
temperature	B-test
97.8	O
,	O
heart	B-test
rate	I-test
80	O
and	O
sinus	O
rhythm	O
,	O
blood	B-test
pressure	I-test
140/82	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O

O2	B-test
saturation	I-test
96%	O
on	O
room	O
air	O
.	O

Weight	B-test
on	I-test
admission	I-test
was	O
64	O
kg	O
,	O
at	O
discharge	O
was	O
51.6	O
kg	O
.	O

Laboratory	O
data	O
showed	O
an	B-test
hematocrit	I-test
of	O
31.6	O
,	O
PT	B-test
13	O
,	O
INR	B-test
1.2	O
,	O
potassium	B-test
4.5	O
,	O
BUN	B-test
18	O
,	O
creatinine	B-test
0.9	O
.	O

He	O
was	O
alert	O
and	O
oriented	O
x	O
3	O
,	O
moved	O
all	O
extremities	O
,	O
followed	O
commands	O
.	O

Respiratory	B-test
examination	I-test
was	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Cardiac	O
showed	O
a	O
regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
and	O
S2	O
.	O

Sternum	O
was	O
stable	O
.	O

Incisions	B-problem
had	O
Steri-Strips	B-treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
with	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
were	O
warm	O
and	O
well	O
perfused	O
with	O
no	O
edema	B-problem
.	O

Right	B-problem
lower	I-problem
extremity	I-problem
incision	I-problem
with	O
Steri-Strips	B-treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

3.	O
Nystatin	B-treatment
swish	O
and	O
swallow	O
,	O
5	O
cc	O
q.	O
8	O
hours	O
.	O

4.	O
Ampicillin	B-treatment
2	O
grams	O
IV	O
q.	O
6	O
through	O
09-08	O
.	O

5.	O
Amiodarone	B-treatment
200	O
mg	O
q.d.	O

6.	O
Percocet	B-treatment
5/325	O
,	O
1-2	O
tablets	O
q.	O
6	O
hours	O
p.r.n.	O

7.	O
Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
30	O
cc	O
q.h.s.	O
p.r.n.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISPOSITION	O
:	O

He	O
is	O
to	O
be	O
discharged	O
to	O
rehabilitation	O
.	O

FOHintonP	O
:	O

He	O
is	O
to	O
see	O
Dr.	O
les	O
Dina	O
in	O
one	O
month	O
,	O
Dr.	O
Bennett	O
in	O
one	O
month	O
and	O
Dr.	O
Duval	O
in	O
one	O
month	O
.	O

Russell	O
von	O
der	O
Hassler	O
,	O
M.D.	O

47-736	O
PAD-WORD	O

Dictated	O
By	O
:	O

Leonard	O
S.	O
Perdue	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2010-09-06	O
PAD-WORD	O

08:54	O
PAD-WORD	O

T	O
:	O

2010-09-06	O
PAD-WORD	O

09:17	O
PAD-WORD	O

JOB#	O
:	O

92751	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Gene	O
au	O
Holden	O
on	O
:	O

FRI	O
2010-10-01	O
3:26	O
PM	O

(	O
End	O
of	O
Report	O
)	O

025897906	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

81515170	O
PAD-WORD	O

481064	O
PAD-WORD	O

06/11/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

06/11/1991	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

06/22/1991	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSIS	O
:	O

METASTATIC	B-problem
CERVICAL	I-problem
CARCINOMA	I-problem
.	O

SECONDARY	O
DIAGNOSES	O
INCLUDE	O
PERICARDIAL	B-problem
EFFUSION	I-problem
,	O
PULMONARY	B-problem
LYMPHANGITIC	I-problem
SPREAD	I-problem
,	O
AND	O
LIVER	B-problem
AND	I-problem
SPLEEN	I-problem
METASTASES	I-problem
.	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Echocardiogram	B-test
times	O
two	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
28	O
year	O
old	O
gravida	O
IV	O
,	O
para	O
2	O
with	O
metastatic	B-problem
cervical	I-problem
cancer	I-problem
admitted	O
with	O
a	O
question	O
of	O
malignant	B-problem
pericardial	I-problem
effusion	I-problem
.	O

Patient	O
underwent	O
a	B-treatment
total	I-treatment
abdominal	I-treatment
hysterectomy	I-treatment
in	O
02/90	O
for	O
a	B-problem
4x3.6x2	I-problem
cm	I-problem
cervical	I-problem
mass	I-problem
felt	O
to	O
be	O
a	B-problem
fibroid	I-problem
at	O
Vanor	O
.	O

Pathology	B-test
revealed	O
poorly	B-problem
differentiated	I-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
cervix	I-problem
with	O
spots	O
of	O
vaginal	O
margins	O
and	O
metastatic	B-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
in	I-problem
the	I-problem
cardinal	I-problem
ligaments	I-problem
with	O
extensive	B-problem
lymphatic	I-problem
invasion	I-problem
.	O

Patient	O
was	O
felt	O
to	O
have	O
stage	B-problem
2B	I-problem
disease	I-problem
and	O
post-operatively	O
,	O
she	O
was	O
treated	O
with	O
intracavitary	B-treatment
and	I-treatment
external	I-treatment
beam	I-treatment
radiation	I-treatment
therapy	I-treatment
and	O
low	B-treatment
dose	I-treatment
Cisplatin	I-treatment
.	O

On	O
ultrasound	B-test
in	O
02/91	O
,	O
the	O
patient	O
was	O
found	O
to	O
have	O
bilateral	B-problem
cystic	I-problem
adnexal	I-problem
masses	I-problem
confirmed	O
on	O
physical	B-test
examination	I-test
.	O

She	O
underwent	O
exploratory	B-test
laparotomy	I-test
and	O
had	O
a	B-treatment
bilateral	I-treatment
salpingo-oophorectomy	I-treatment
and	O
appendectomy	B-treatment
.	O

Pathology	B-test
was	O
negative	O
for	O
tumor	B-problem
and	O
showed	O
peritubal	B-problem
and	I-problem
periovarian	I-problem
adhesions	I-problem
.	O

The	O
patient	O
now	O
presents	O
with	O
a	O
three	O
to	O
four	O
week	O
history	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
a	B-problem
dry	I-problem
non-productive	I-problem
cough	I-problem
.	O

She	O
was	O
evaluated	O
by	O
Dr.	O
Mielke	O
,	O
a	O
Pulmonologist	O
,	O
who	O
found	O
her	O
to	O
be	O
wheezing	B-problem
and	O
performed	O
pulmonary	B-test
function	I-test
tests	I-test
which	O
showed	O
an	B-test
FEV1	I-test
of	O
1.1	O
and	O
an	B-test
FVC	I-test
of	O
1.8	O
.	O

She	O
was	O
admitted	O
to	O
Weekscook	O
University	O
Medical	O
Center	O
with	O
a	O
diagnosis	O
of	O
possible	O
asthma	B-problem
.	O

Room	B-test
air	I-test
arterial	I-test
blood	I-test
gas	I-test
showed	O
a	B-test
pO2	I-test
of	O
56	O
,	O
a	B-test
pCO2	I-test
of	O
35	O
,	O
and	O
a	B-test
pH	I-test
of	O
7.52	O
.	O

EKG	B-test
showed	O
sinus	B-problem
tachycardia	I-problem
at	O
100	O
and	O
echo	B-test
revealed	O
pericardial	B-problem
effusion	I-problem
,	O
a	B-problem
10	I-problem
mm	I-problem
pulsus	I-problem
paradoxus	I-problem
was	O
noted	O
,	O
and	O
no	O
evidence	O
of	O
tamponade	B-problem
.	O

Given	O
the	O
patient	O
&apos;s	O
history	O
of	O
cervical	B-problem
cancer	I-problem
,	O
the	B-problem
pericardial	I-problem
effusion	I-problem
was	O
felt	O
most	O
likely	O
to	O
be	O
malignant	B-problem
.	O

She	O
was	O
therefore	O
transferred	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
further	B-treatment
care	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

02/90	O
,	O
total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
complicated	O
by	O
ureteral	B-treatment
transection	I-treatment
with	O
right	B-treatment
ureteral	I-treatment
tube	I-treatment
placed	O
for	O
six	O
weeks	O
,	O
stent	B-treatment
tube	I-treatment
placed	O
in	O
left	O
ureter	O
six	O
weeks	O
prior	O
to	O
admission	O
for	O
a	B-problem
hydronephrosis	I-problem
post	O
,	O
in	O
03/91	O
,	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
and	O
appendectomy	B-treatment
.	O

CURRENT	O
MEDICATIONS	O
:	O

Prednisone	B-treatment
20	O
mg	O
p.o.	O
q.a.m.	O
with	O
10	O
mg	O
p.o.	O
q.p.m.	O
,	O
Uniphyl	B-treatment
400	O
mg	O
p.o.	O
q.d.	O
,	O
Augmentin	B-treatment
250	O
p.o.	O
t.i.d.	O
,	O
Estrase	B-treatment
2	O
mg	O
p.o.	O
q.d.	O
,	O
MS	B-treatment
Contin	I-treatment
30	O
mg	O
q.12h.	O
,	O
and	O
Morphine	B-treatment
p.r.n.	O

PHYSICAL	O
EXAMINATION	O
:	O

Emaciated	O
white	O
female	O
in	O
mild	B-problem
respiratory	I-problem
distress	I-problem
.	O

Temperature	B-test
was	O
98.1	O
,	O
heart	B-test
rate	I-test
116	O
,	O
blood	B-test
pressure	I-test
120/68	O
,	O
and	O
room	B-test
air	I-test
O2	I-test
saturation	I-test
was	O
93%	O
.	O

HEENT	O
:	O

Dry	B-problem
mucous	I-problem
membranes	I-problem
and	O
myotic	B-problem
pupils	I-problem
.	O

NECK	O
:	O

No	O
lymphadenopathy	B-problem
.	O

CHEST	O
:	O

Few	B-problem
inspiratory	I-problem
wheezes	I-problem
and	O
no	O
rhonchi	B-problem
.	O

HEART	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
tachycardia	B-problem
and	O
no	O
rubs	B-problem
or	O
murmur	B-problem
.	O

ABDOMEN	O
:	O

Well	B-problem
healed	I-problem
Pfannenstiel	I-problem
scars	I-problem
and	O
no	O
masses	B-problem
.	O

PELVIC	O
:	O

No	O
masses	B-problem
.	O

RECTAL	O
:	O

No	O
masses	B-problem
and	O
guaiac	B-test
negative	O
.	O

EXTREMITIES	O
:	O

No	O
edema	B-problem
or	O
cyanosis	B-problem
.	O

LABORATORY	O
EXAMINATION	O
:	O

Hematocrit	B-test
was	O
40	O
,	O
white	B-test
count	I-test
was	O
21	O
,	O
and	O
platelet	B-test
count	I-test
of	O
723,000	O
.	O

PT	B-test
and	O
PTT	B-test
were	O
12	O
and	O
26	O
.	O

Electrolytes	B-test
were	O
within	O
normal	O
limits	O
,	O
liver	B-test
function	I-test
tests	I-test
within	O
normal	O
limits	O
,	O
and	O
EKG	B-test
showed	O
a	B-test
heart	I-test
rate	I-test
of	O
128	O
,	O
axis	B-test
73	O
,	O
and	O
possible	O
ectopic	B-problem
P	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
a	B-problem
new	I-problem
pericardial	I-problem
effusion	I-problem
which	O
was	O
felt	O
most	O
likely	O
to	O
be	O
secondary	O
to	O
metastatic	B-problem
cervical	I-problem
cancer	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
tamponade	B-problem
.	O

An	B-test
echocardiogram	I-test
was	O
scheduled	O
and	O
Cardiology	O
was	O
consulted	O
.	O

Echocardiogram	B-test
showed	O
moderate	B-problem
anterior	I-problem
pericardial	I-problem
effusion	I-problem
of	O
approximately	O
600	O
cc	O
with	O
diastolic	B-problem
indications	I-problem
of	I-problem
the	I-problem
right	I-problem
ventricle	I-problem
and	O
low	B-problem
velocity	I-problem
paradox	I-problem
.	O

Cardiology	O
did	O
not	O
feel	O
that	O
tamponade	B-problem
at	O
this	O
time	O
was	O
a	O
concern	O
and	O
that	O
a	B-treatment
tap	I-treatment
need	O
not	O
be	O
performed	O
.	O

She	O
continued	O
to	O
have	O
pulmonary	B-problem
wheezing	I-problem
,	O
unknown	O
origin	O
,	O
without	O
history	O
of	O
asthma	B-problem
.	O

Her	B-treatment
steroids	I-treatment
were	O
tapered	O
and	O
Pulmonary	O
was	O
consulted	O
who	O
recommended	O
a	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
chest	I-test
to	O
evaluate	O
the	O
lung	O
parenchyma	O
,	O
induce	O
sputum	O
for	O
CBC	B-test
,	O
arterial	B-test
blood	I-test
gas	I-test
,	O
continuing	O
of	O
the	B-treatment
beta	I-treatment
agonist	I-treatment
inhalers	I-treatment
,	O
and	O
trial	O
of	O
steroid	B-treatment
inhalers	I-treatment
.	O

They	O
felt	O
it	O
was	O
most	O
likely	O
a	B-problem
malignant	I-problem
lymphangitic	I-problem
spread	I-problem
with	O
pericardial	B-problem
involvement	I-problem
versus	O
infectious	B-problem
,	O
other	B-problem
cardiovascular	I-problem
causes	I-problem
,	O
or	O
viral	B-problem
bronchiolitis	I-problem
.	O

She	O
had	O
pulmonary	B-test
function	I-test
tests	I-test
repeated	O
which	O
showed	O
an	B-test
FEV1	I-test
of	O
36%	O
of	O
predicted	O
and	O
FVC	B-test
of	O
56%	O
of	O
predicted	O
.	O

Room	B-test
air	I-test
arterial	I-test
blood	I-test
gas	I-test
showed	O
a	B-test
pH	I-test
of	O
7.45	O
,	O
pO2	B-test
of	O
63	O
,	O
a	B-test
pCO2	I-test
of	O
41	O
,	O
and	O
fairly	B-problem
significant	I-problem
AA	I-problem
gradient	I-problem
.	O

She	O
was	O
continued	O
on	O
two	O
liters	O
of	O
oxygen	B-treatment
awaiting	O
her	B-test
CT	I-test
scan	I-test
on	O
06/14	O
and	O
she	O
developed	O
a	B-problem
new	I-problem
junctional	I-problem
rhythm	I-problem
with	O
a	O
question	O
of	O
a	B-problem
new	I-problem
rub	I-problem
versus	O
murmur	B-problem
on	O
examination	B-test
.	O

Cardiology	O
felt	O
she	O
had	O
a	B-problem
rub	I-problem
and	O
her	B-test
pulsus	I-test
was	O
still	O
10	O
.	O

EKG	B-test
showed	O
an	B-problem
ectopic	I-problem
low	I-problem
atrial	I-problem
P	I-problem
and	O
they	O
thought	O
she	O
was	O
still	O
stable	O
without	O
evidence	O
of	O
tamponade	B-problem
.	O

She	O
should	O
have	O
a	B-test
follow-up	I-test
echocardiogram	I-test
.	O

Echocardiogram	B-test
showed	O
left	O
ventricle	O
at	O
the	O
upper	O
limits	O
of	O
normal	O
for	O
size	O
,	O
low	B-problem
normal	I-problem
function	I-problem
,	O
moderate	B-problem
to	I-problem
mild	I-problem
effusion	I-problem
with	O
pericardial	B-test
pressures	I-test
exceeding	O
right	B-test
atrial	I-test
pressures	I-test
,	O
and	O
right	B-test
ventricular	I-test
pressures	I-test
at	O
various	O
points	O
of	O
patient	O
&apos;s	O
cycle	O
without	O
any	O
change	O
in	O
the	B-problem
effusion	I-problem
from	O
06/11	O
.	O

Thoracic	O
Surgery	O
was	O
also	O
consulted	O
and	O
they	O
felt	O
that	O
there	O
was	O
no	O
need	O
for	O
a	B-treatment
pericardial	I-treatment
window	I-treatment
at	O
the	O
time	O
.	O

She	O
should	O
be	O
continued	O
with	O
pulmonary	B-test
oximetry	I-test
testing	I-test
.	O

She	O
underwent	O
her	B-test
CT	I-test
scan	I-test
.	O

This	O
showed	O
lymphangitic	B-problem
spread	I-problem
of	O
cancer	B-problem
in	I-problem
the	I-problem
chest	I-problem
,	O
question	O
of	O
pulmonary	B-problem
nodules	I-problem
in	I-problem
the	I-problem
chest	I-problem
,	O
pericardial	B-problem
effusion	I-problem
,	O
multiple	B-problem
liver	I-problem
metastases	I-problem
,	O
decreased	B-problem
function	I-problem
of	I-problem
the	I-problem
left	I-problem
kidney	I-problem
,	O
dilated	B-problem
left	I-problem
intrarenal	I-problem
collecting	I-problem
system	I-problem
and	I-problem
proximal	I-problem
ureter	I-problem
,	O
and	O
periaortic	B-problem
lymphadenopathy	I-problem
.	O

Pulmonary	O
felt	O
this	O
was	O
consistent	O
also	O
with	O
lymphangitic	B-problem
spread	I-problem
and	O
they	O
did	O
not	O
feel	O
that	O
a	B-test
bronchoscopy	I-test
would	O
be	O
of	O
any	O
assistance	O
at	O
this	O
time	O
.	O

Chemotherapy	B-treatment
for	O
metastatic	B-problem
cervical	I-problem
cancer	I-problem
was	O
discussed	O
with	O
the	O
patient	O
and	O
she	O
was	O
started	O
on	O
5-FU	B-treatment
800	O
mg	O
per	O
meter	O
squared	O
days	O
06/18	O
,	O
06/19	O
,	O
and	O
06/20	O
.	O

She	O
also	O
received	O
Cisplatin	B-treatment
35	O
per	O
meter	O
squared	O
on	O
06/19	O
and	O
Ifex	B-treatment
and	O
Mesna	B-treatment
on	O
06/18	O
.	O

She	O
was	O
noted	O
,	O
on	O
06/16	O
,	O
to	O
have	O
numerous	B-problem
erythematous	I-problem
maculopapules	I-problem
on	I-problem
her	I-problem
back	I-problem
and	O
chest	O
.	O

Dermatology	O
was	O
consulted	O
and	O
they	O
felt	O
that	O
this	O
was	O
most	O
likely	O
steroid	B-problem
acne	I-problem
.	O

They	O
therefore	O
felt	O
a	B-treatment
rapid	I-treatment
steroid	I-treatment
taper	I-treatment
was	O
indicated	O
and	O
topical	B-treatment
Erythromycin	I-treatment
if	O
desired	O
by	O
the	O
patient	O
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
wheezing	B-problem
continued	O
but	O
without	O
change	O
.	O

Her	B-test
cardiac	I-test
examination	I-test
remained	O
the	O
same	O
and	O
there	O
continued	O
to	O
be	O
no	O
evidence	O
of	O
tamponade	B-problem
.	O

Cardiology	O
felt	O
that	O
follow-up	B-test
echo	I-test
was	O
indicated	O
on	O
06/18	O
as	O
she	O
had	O
another	B-test
echocardiogram	I-test
which	O
showed	O
no	O
change	O
or	O
evidence	O
of	O
tamponade	B-problem
.	O

They	O
therefore	O
felt	O
that	O
she	O
could	O
be	O
continued	O
to	O
be	O
followed	O
by	O
examination	B-test
.	O

She	O
had	O
some	B-problem
mental	I-problem
status	I-problem
changes	I-problem
with	O
confusion	B-problem
and	O
hallucinations	B-problem
on	O
06/18	O
originating	O
from	O
narcotics	B-treatment
versus	O
decreased	B-problem
pO2	I-problem
.	O

The	B-treatment
Ifex	I-treatment
was	O
held	O
as	O
it	O
was	O
felt	O
that	O
it	O
could	O
have	O
precipitated	O
the	B-problem
mental	I-problem
status	I-problem
changes	I-problem
and	O
that	O
she	O
was	O
to	O
receive	O
no	O
further	B-treatment
Ifex	I-treatment
.	O

She	O
had	O
no	O
further	B-problem
hallucinations	I-problem
since	O
stopping	O
the	O
Ifex	B-treatment
.	O

Psychiatry	O
was	O
also	O
consulted	O
to	O
help	O
her	O
with	O
the	O
changes	O
she	O
was	O
feeling	O
since	O
her	O
new	O
diagnosis	O
.	O

She	O
was	O
hooked	O
up	O
with	O
support	O
services	O
in	O
Collot	O
Ln	O
,	O
Dugo	O
,	O
Indiana	O
68961	O
for	O
further	B-treatment
counselling	I-treatment
and	O
given	O
Xanax	B-treatment
for	O
symptoms	B-problem
of	O
anxiety	B-problem
.	O

She	O
continued	O
to	O
have	O
no	O
change	O
in	O
her	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
or	O
cardiac	B-test
examination	I-test
and	O
was	O
discharged	O
home	O
on	O
06/22/91	O
after	O
completing	O
her	B-treatment
5-FU	I-treatment
and	O
Cisplatin	B-treatment
chemotherapy	I-treatment
.	O

DISPOSITION	O
:	O

She	O
will	O
be	O
followed	O
by	O
Dr.	O
Mielke	O
and	O
home	O
care	O
services	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Premarin	B-treatment
0.625	O
q.d.	O
,	O
Proventil	B-treatment
Inhaler	I-treatment
two	O
puffs	O
q.i.d.	O
,	O
Beclovent	B-treatment
four	O
puffs	O
b.i.d.	O
,	O
Colace	B-treatment
100	O
mg	O
p.o.	O
t.i.d.	O
,	O
MS	B-treatment
Contin	I-treatment
30	O
mg	O
p.o.	O
t.i.d.	O
,	O
Elavil	B-treatment
25	O
mg	O
p.o.	O
q.h.s.	O
,	O
Trilisate	B-treatment
750	O
mg	O
p.o.	O
b.i.d.	O
,	O
MS	B-treatment
Elixir	I-treatment
100	O
mg	O
p.o.	O
q.2h.	O
p.r.n.	O
,	O
Robitussin	B-treatment
with	O
Codeine	B-treatment
5	O
cc	O
p.o.	O
q.2h.	O
,	O
and	O
home	B-treatment
O2	I-treatment
two	I-treatment
liters	I-treatment
via	O
nasal	B-treatment
prong	I-treatment
with	O
increase	O
to	O
four	O
liters	O
as	O
needed	O
for	O
symptoms	B-problem
p.r.n.	O

ZQ233/5272	O
EARLLAMARG	O
S.	O
MIELKE	O
,	O
M.D.	O
RP75	O

D	O
:	O

07/17/91	O
PAD-WORD	O

Batch	O
:	O

8600	O
PAD-WORD	O

Report	O
:	O

J4678A87	O
PAD-WORD	O

T	O
:	O

07/21/91	O
PAD-WORD	O

Dicatated	O
By	O
:	O

SONRELLE	O
LOUELLPASCGACH	O
,	O
M.D.	O
EH41	O

Admission	O
Date	O
:	O

2014-04-14	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-04-19	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2014-04-14	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Baby	O
boy	O
Liles	O
is	O
the	O
2.985	O
kg	O
product	O
of	O
a	O
34	O
week	O
gestation	O
born	O
to	O
a	O
30-year-old	O
G3	O
,	O
P0	O
,	O
now	O
1	O
mother	O
.	O

Prenatal	B-test
screens	I-test
-	O
A	O
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
rubella	B-test
immune	O
,	O
GBS	B-test
unknown	O
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

Remarkable	O
for	O
an	B-problem
intrauterine	I-problem
fetal	I-problem
demise	I-problem
at	O
30	O
weeks	O
gestation	O
.	O

This	O
pregnancy	O
complicated	O
by	O
hydramnios	B-problem
also	O
.	O

The	B-test
baby	I-test
's	I-test
autopsy	I-test
was	O
reported	O
to	O
be	O
normal	O
.	O

Dates	O
are	O
by	O
first	B-test
trimester	I-test
ultrasound	I-test
.	O

Pregnancy	O
was	O
complicated	O
by	O
severe	B-problem
polyhydramnios	I-problem
with	O
an	B-test
AFI	I-test
of	O
45	O
just	O
prior	O
to	O
delivery	O
.	O

Mother	O
has	O
had	O
multiple	B-test
ultrasounds	I-test
and	O
fetal	B-test
surveys	I-test
at	O
17	O
and	O
21	O
weeks	O
that	O
had	O
been	O
unremarkable	O
.	O

Mother	O
was	O
transferred	O
to	O
the	O
Debbie-Monaco	O
from	O
Western	O
Mass.	O
Hospital	O
Hospital	O
in	O
the	O
middle	O
of	O
January	O
with	O
increasing	B-problem
polyhydramnios	I-problem
and	O
preterm	B-problem
labor	I-problem
.	O

She	O
received	O
a	B-treatment
full	I-treatment
course	I-treatment
of	I-treatment
betamethasone	I-treatment
on	O
03-28	O
and	O
was	O
treated	O
with	O
magnesium	B-treatment
sulfate	I-treatment
until	O
04-12	O
.	O

She	O
was	O
given	O
1	O
dose	O
of	O
nifedipine	B-treatment
2	O
days	O
ago	O
as	O
a	B-treatment
tocolytic	I-treatment
without	O
effect	O
.	O

Delivery	O
by	O
cesarean	B-treatment
section	I-treatment
was	O
prompted	O
by	O
ongoing	B-problem
labor	I-problem
.	O

Preterm	B-problem
labor	I-problem
with	O
new	O
onset	O
of	O
late	B-problem
decelerations	I-problem
and	O
breech	B-problem
presentation	I-problem
.	O

Nuchal	B-problem
cord	I-problem
was	O
noted	O
at	O
delivery	O
.	O

The	O
infant	O
cried	O
after	O
bulb	B-treatment
suctioning	I-treatment
and	O
stimulation	B-treatment
.	O

Apgars	B-test
were	O
8	O
and	O
8	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Weight	B-test
2.985	O
kg	O
,	O
95th	O
percentile;	O
length	B-test
48	O
cm	O
,	O
85th	O
percentile;	O
head	B-test
circumference	I-test
35	O
cm	O
,	O
greater	O
than	O
95th	O
percentile	O
.	O

Anterior	O
fontanel	O
soft	O
and	O
flat.	O
Head	O
shape	O
normal	O
with	O
mildly	B-problem
flattened	I-problem
on	I-problem
top	I-problem
consistent	O
with	O
breech	B-problem
positioning	I-problem
in	I-problem
utero	I-problem
.	O

Facies	O
nondysmorphic	B-problem
,	O
palate	O
intact	O
.	O

Mild	B-problem
intermittent	I-problem
grunting	I-problem
noted	O
with	O
mild	B-problem
subcostal	I-problem
retractions	I-problem
.	O

Good	O
air	O
entry	O
bilaterally	O
.	O

S1	O
and	O
S2	O
normal	O
intensity	O
.	O

No	O
murmur	B-problem
noted	O
.	O

Perfusion	O
good	O
.	O

Abdomen	O
soft	O
with	O
no	O
masses	B-problem
.	O

Three	O
vessel	O
cord	O
.	O

Normal	O
male	O
with	O
testes	O
palpable	O
bilaterally	O
.	O

Tone	B-problem
initially	I-problem
low	I-problem
normal	I-problem
but	O
improved	O
within	O
normal	O
limits	O
on	O
admission	O
.	O

Hips	O
increased	B-problem
lax	I-problem
knee	I-problem
but	O
no	O
obvious	B-problem
dislocation	I-problem
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

RESPIRATORY	O
:	O

Jacqueline	O
has	O
been	O
admitted	O
to	O
the	O
newborn	O
intensive	O
care	O
unit	O
and	O
has	O
been	O
stable	O
in	O
room	O
air	O
since	O
admission	O
.	O

CARDIOVASCULAR	O
:	O

Infant	O
has	O
an	B-problem
audible	I-problem
murmur	I-problem
.	O

Cardiology	O
consult	O
of	O
the	O
infant	O
on	O
04-18	O
.	O

Echocardiogram	B-test
results	I-test
were	O
within	O
normal	O
limits	O
revealing	O
a	B-problem
PPS	I-problem
murmur	I-problem
.	O

FLUIDS	O
,	O
ELECTROLYTES	O
AND	O
NUTRITION	O
:	O

Birth	B-test
weight	I-test
was	O
2.985	O
kg	O
.	O

Discharge	B-test
weight	I-test
..	O

The	O
infant	O
was	O
initially	O
started	O
on	O
60	O
cc	O
per	O
kg	O
per	O
day	O
of	O
D10W	B-treatment
.	O

Enteral	B-treatment
feedings	I-treatment
were	O
initiated	O
on	O
day	O
of	O
life	O
No.1	O
.	O

The	O
infant	O
is	O
currently	O
on	O
a	O
120	O
cc	O
per	O
kg	O
per	O
day	O
of	O
premature	B-treatment
Enfamil	I-treatment
20	O
calorie	O
or	O
breast	O
milk	O
,	O
tolerating	O
feeds	O
well	O
.	O

Electrolytes	B-test
on	O
day	O
of	O
life	O
1	O
showed	O
a	B-test
sodium	I-test
of	O
142	O
,	O
potassium	B-test
of	O
5.1	O
,	O
chloride	B-test
of	O
108	O
,	O
and	O
total	B-test
CO2	I-test
of	O
23	O
.	O

GASTROINTESTINAL	O
:	O

Bilirubin	B-test
on	O
04-17	O
was	O
8.2/0.3	O
.	O

Surgery	O
was	O
consulted	O
to	O
rule	O
out	O
a	B-problem
TE	I-problem
fistula	I-problem
as	O
the	O
infant	O
had	O
an	B-problem
incidental	I-problem
pass	I-problem
of	O
a	B-treatment
gavage	I-treatment
tube	I-treatment
into	O
his	O
right	O
bronchus	O
.	O

TEF	B-problem
was	O
primarily	O
ruled	O
out	O
as	O
Baker	O
was	O
passed	O
easily	O
to	O
stomach	O
and	O
x-ray	B-test
revealed	O
good	O
position	O
.	O

HEMATOLOGY	O
:	O

Hematocrit	B-test
on	I-test
admission	I-test
was	O
38.2	O
.	O

The	O
infant	O
has	O
not	O
required	O
any	B-treatment
blood	I-treatment
transfusions	I-treatment
.	O

INFECTIOUS	O
DISEASE	O
:	O

CBC	B-test
and	O
blood	B-test
cultures	I-test
were	O
obtained	O
on	O
admission	O
.	O

CBC	B-test
was	O
benign	O
and	O
blood	B-test
cultures	I-test
remained	O
negative	O
at	O
48	O
hours	O
at	O
which	O
time	O
ampicillin	B-treatment
and	O
gentamicin	B-treatment
were	O
discontinued	O
.	O

Initial	B-test
CBC	I-test
had	O
a	B-test
white	I-test
count	I-test
of	O
16	O
,	O
platelet	B-test
count	I-test
of	O
204	O
,	O
53	O
polys	B-test
and	O
0	O
bands	B-test
.	O

NEUROLOGY	O
:	O

Appropriate	O
for	O
gestational	O
age	O
.	O

MUSCULOSKELETAL	O
:	O

Of	O
note	O
incidental	O
finding	O
on	O
x-ray	B-test
,	O
the	O
infant	O
has	O
a	B-problem
hemivertebra	I-problem
at	I-problem
T11	I-problem
.	O

AUDIOLOGY	O
:	O

Hearing	B-test
screen	I-test
has	O
not	O
been	O
done	O
but	O
should	O
be	O
done	O
prior	O
to	O
discharge	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
Western	O
Mass.	O
Hospital	O
Hospital	O
.	O

NAME	O
OF	O
PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Joseph.	O

Telephone	O
No	O
.	O

208	O
1429	O
.	O

CARE	O
RECOMMENDATIONS:	O

1.	O
Continue	O
advancing	O
fluid	O
volume	O
to	O
support	O
infant	O
's	O
weight	O
gain	O
needs	O
.	O

2.	O
Medications	B-treatment
:	O
Not	O
applicable	O
.	O

3.	O
Car	B-test
Seat	I-test
Position	I-test
Screening	I-test
has	O
not	O
been	O
performed	O
.	O

4.	O
State	B-test
Newborn	I-test
Screen	I-test
was	O
sent	O
on	O
day	O
of	O
life	O
3	O
.	O

5.	O
Immunizations	B-treatment
received:	O
The	O
infant	O
has	O
not	O
received	O
any	B-treatment
immunizations	I-treatment
at	O
this	O
time	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Premature	O
infant	O
born	O
at	O
34	O
weeks	O
.	O

Rule	O
out	O
sepsis	B-problem
with	O
antibiotics	B-treatment
.	O

Robert	O
Mincer	O
,	O
M.D.	O
50AHB	O

Dictated	O
By:Penny	O
K.	O
Mcbride	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2014-04-18	O
21:56:45	O

T	O
:	O

2014-04-18	O
22:38:39	O

Job#	O
:	O

44791	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Kenneth	O
RHEIN	O
on	O
:	O

SAT	O
2014-04-19	O
10:03	O
AM	O

(	O
End	O
of	O
Report	O
)	O

032890433	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

75066875	O
PAD-WORD	O

828710	O
PAD-WORD	O

02/21/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/21/1991	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

Discharge	O
Date	O
:	O

02/26/1991	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSIS	O
:	O

LEFT	B-problem
RENAL	I-problem
MASS	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
a	O
63	O
year	O
old	O
female	O
with	O
long-standing	O
history	O
of	O
polycythemia	B-problem
vera	I-problem
,	O
managed	O
medically	O
,	O
who	O
on	O
a	B-test
routine	I-test
follow-up	I-test
examination	I-test
complained	O
of	O
left	B-problem
side	I-problem
pain	I-problem
and	O
had	O
an	B-test
ultrasound	I-test
that	O
demonstrated	O
a	B-problem
complex	I-problem
left	I-problem
renal	I-problem
mass	I-problem
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
demonstrated	O
a	B-problem
contrast	I-problem
enhancing	I-problem
complex	I-problem
left	I-problem
renal	I-problem
mass	I-problem
.	O

Metastatic	B-test
work-up	I-test
was	O
negative	O
.	O

The	O
patient	O
presented	O
for	O
nephrectomy	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
included	O
polycythemia	B-problem
vera	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
included	O
appendectomy	B-treatment
and	O
bunionectomy	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
were	O
Hydrea	B-treatment
.	O

REVIEW	B-test
OF	I-test
SYSTEMS	I-test
was	O
negative	O
in	O
detail	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
a	O
robust	O
white	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
afebrile	B-problem
,	O
blood	B-test
pressure	I-test
165/80	O
.	O

Head	O
and	O
neck	O
were	O
unremarkable	O
.	O

Lungs	O
were	O
clear	O
.	O

Heart	O
had	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdomen	O
was	O
benign	O
.	O

Rectal	B-test
examination	I-test
was	O
guaiac	B-test
negative	O
.	O

Extremities	B-test
and	I-test
neurological	I-test
examinations	I-test
were	O
unremarkable	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
by	O
Dr.	O
Suot	O
N.	O
Dragtente	O
on	O
02-21-91	O
,	O
where	O
a	B-treatment
left	I-treatment
radical	I-treatment
nephrectomy	I-treatment
was	O
performed	O
.	O

At	O
operation	B-treatment
,	O
there	O
was	O
no	O
gross	B-problem
adenopathy	I-problem
or	O
renal	B-problem
vein	I-problem
involvement	I-problem
,	O
and	O
it	O
was	O
felt	O
that	O
the	B-problem
tumor	I-problem
was	O
completely	O
excised	O
.	O

The	O
patient	O
thereafter	O
had	O
a	O
benign	O
convalescence	O
,	O
and	O
was	O
discharged	O
on	O
the	O
5th	O
postoperative	O
day	O
.	O

The	O
oncology	O
fellows	O
from	O
Venbonlea	O
Health	O
followed	O
her	O
course	O
and	O
recommended	O
holding	O
off	O
on	O
her	B-treatment
Hydrea	I-treatment
while	O
she	O
is	O
hospitalized	O
,	O
and	O
they	O
will	O
follow	O
her	O
as	O
an	O
outpatient	O
and	O
restart	O
her	B-treatment
Hydrea	I-treatment
when	O
her	B-test
hematocrit	I-test
is	O
over	O
40%	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

The	O
patient	O
was	O
discharged	O
on	O
a	O
regular	O
diet	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
was	O
stable	O
.	O

FOLLOW-UP	O
will	O
be	O
with	O
Dr.	O
Suot	O
N.	O
Dragtente	O
and	O
with	O
her	O
Venbonlea	O
Health	O
oncology	O
fellows	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
included	O
Percocet	B-treatment
1	O
to	O
2	O
tablets	O
by	O
mouth	O
every	O
4	O
hours	O
as	O
needed	O
for	O
pain	B-problem
,	O
Colace	B-treatment
100	O
milligrams	O
by	O
mouth	O
twice	O
a	O
day	O
.	O

PL926/1533	O
SUOT	O
N.	O
DRAGTENTE	O
,	O
M.D.	O
GJ7	O

D	O
:	O

02/26/91	O
PAD-WORD	O

Batch	O
:	O

8776	O
PAD-WORD	O

Report	O
:	O

P9055V6	O
PAD-WORD	O

T	O
:	O

03/02/91	O
PAD-WORD	O

Dicatated	O
By	O
:	O

ESPEXIINE	O
BRIZ	O
,	O
M.D.	O
XT67	O

cc	O
:	O

1.	O
VENBONLEA	O
HEALTH	O

Admission	O
Date	O
:	O

2015-09-14	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-09-19	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2015-09-14	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEONATOLOGY	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
3285	O
gm	O
infant	O
born	O
at	O
37	O
5/7	O
weeks	O
to	O
a	O
21	O
year	O
old	O
G3	O
P1	O
now	O
2	O
mother	O
with	O
prenatal	B-test
screens	I-test
as	O
follows	O
:	O

O	O
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
GBS	B-test
negative	O
.	O

Unremarkable	O
pregnancy	O
except	O
for	O
minor	B-problem
fullness	I-problem
of	I-problem
the	I-problem
left	I-problem
renal	I-problem
pelvis	I-problem
reported	O
during	O
the	O
week	O
prior	O
to	O
delivery	B-treatment
.	O

Past	O
OB	O
history	O
remarkable	O
for	O
postpartum	B-problem
depression	I-problem
.	O

Mother	O
was	O
admitted	O
in	O
labor	B-problem
.	O

Baby	O
was	O
delivered	O
by	O
repeat	B-treatment
C-section	I-treatment
with	O
rupture	B-treatment
of	I-treatment
membranes	I-treatment
at	O
delivery	B-treatment
.	O

Apgars	B-test
were	O
8	O
and	O
9	O
.	O

CMED	O
CSRU	O
staff	O
was	O
called	O
about	O
30	O
minutes	O
of	O
age	O
for	O
grunting	B-problem
,	O
flaring	B-problem
and	O
retractions	B-problem
and	O
the	O
baby	O
was	O
admitted	O
to	O
the	O
CMED	O
CSRU	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Exam	B-test
was	O
notable	O
for	O
a	O
term	O
infant	O
with	O
flat	O
anterior	O
fontanelle	O
,	O
pink	O
color	O
,	O
normal	O
facies	O
,	O
intact	O
palate	O
,	O
mild	B-problem
retractions	I-problem
,	O
good	O
air	O
entry	O
,	O
no	O
murmurs	B-problem
.	O

Femoral	B-test
pulses	I-test
present	O
.	O

Flat	O
,	O
soft	O
and	O
nontender	B-problem
abdomen	I-problem
without	O
hepatosplenomegaly	B-problem
.	O

Stable	O
hips	O
.	O

Normal	O
male	O
genitalia	O
.	O

Testes	O
scrotum	O
.	O

Normal	O
perfusion	O
.	O

Normal	O
tone	O
and	O
activity	O
.	O

LABORATORY	O
DATA	O
:	O

Initial	B-test
white	I-test
count	I-test
19.4	O
thousand	O
,	O
64	O
polys	B-test
,	O
3	O
bands	B-test
,	O
hematocrit	B-test
35.8	O
,	O
platelets	B-test
281,000	O
.	O

Chest	B-test
x-ray	I-test
revealed	O
streaky	B-problem
lung	I-problem
fields	I-problem
of	O
normal	O
situs	O
,	O
no	O
consolidation	B-problem
,	O
consistent	O
with	O
retained	B-problem
fetal	I-problem
lung	I-problem
fluid	I-problem
.	O

HOSPITAL	O
COURSE:	O

1.	O
Respiratory	O
.	O

The	O
Athol	O
Memorial	O
Hospital	O
hospital	O
course	O
was	O
initially	O
consistent	O
with	O
transient	B-problem
tachypnea	I-problem
of	I-problem
the	I-problem
newborn	I-problem
.	O

Chest	B-test
x-ray	I-test
revealed	O
mild	B-problem
streakiness	I-problem
of	I-problem
the	I-problem
lung	I-problem
fields	I-problem
.	O

He	O
was	O
initially	O
placed	O
on	O
nasal	B-treatment
cannula	I-treatment
with	O
subsequent	O
resolution	O
of	O
respiratory	B-problem
distress	I-problem
.	O

Nasal	B-treatment
cannula	I-treatment
was	O
weaned	O
off	O
on	O
day	O
of	O
life	O
3	O
and	O
he	O
initially	O
was	O
maintaining	O
O2	B-test
sat	I-test
above	O
94%	O
and	O
breathing	O
comfortably	O
.	O

He	O
was	O
subsequently	O
placed	O
back	O
on	O
nasal	B-treatment
cannula	I-treatment
for	O
mild	B-problem
oxygen	I-problem
desaturation	I-problem
and	O
was	O
requiring	O
25	O
c/min	O
flow	O
at	O
the	O
time	O
of	O
discharge	O
.	O

No	O
apneic	B-problem
or	I-problem
brady	I-problem
episodes	I-problem
.	O

2.	O
Cardiovascular	O
.	O

The	O
patient	O
's	O
cardiovascular	O
status	O
has	O
been	O
stable	O
throughout	O
his	O
CMED	O
CSRU	O
stay	O
.	O

No	O
murmur	B-problem
on	O
exam	B-test
.	O

3.	O
FEN	O
.	O

The	O
patient	O
had	O
been	O
tolerating	O
oral	O
feeding	O
as	O
of	O
day	O
of	O
life	O
2	O
and	O
is	O
currently	O
taking	O
Enfamil	B-treatment
20	O
p.o.	O
ad	O
lib	O
.	O

He	O
has	O
been	O
weaned	O
off	O
IV	B-treatment
fluids	I-treatment
and	O
has	O
been	O
maintaining	O
good	O
blood	O
glucose	O
.	O

His	B-test
birth	I-test
weight	I-test
was	O
3285	O
gm	O
.	O

His	B-test
weight	I-test
is	O
3015	O
gm	O
on	O
day	O
of	O
life	O
5	O
.	O

4.	O
GI	O
.	O

The	B-test
patient	I-test
's	I-test
bilirubin	I-test
level	I-test
at	O
24	O
hours	O
of	O
life	O
was	O
4.6.	O

No	O
phototherapy	B-treatment
was	O
started	O
.	O

5.	O
ID	O
.	O

The	O
patient	O
was	O
not	O
started	O
on	O
antibiotics	B-treatment
,	O
given	O
lack	O
of	O
sepsis	B-problem
risk	I-problem
factors	I-problem
.	O

His	B-test
initial	I-test
CBC	I-test
showed	O
no	O
left	B-problem
shift	I-problem
.	O

Blood	B-test
culture	I-test
had	O
remained	O
no	O
growth	B-problem
to	O
date	O
.	O

6.	O
Heme	O
.	O

The	B-test
patient	I-test
's	I-test
initial	I-test
hematocrit	I-test
was	O
35.8	O
.	O

No	O
transfusion	B-treatment
during	O
this	B-treatment
admission	I-treatment
.	O

CONDITION	O
ON	O
TRANSFER	O
:	O

The	O
patient	O
has	O
been	O
doing	O
well	O
on	O
low	B-treatment
flow	I-treatment
nasal	I-treatment
cannula.	I-treatment
He	O
has	O
been	O
tolerating	O
p.o.	O
ad	O
lib	O
feeds	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

The	O
patient	O
is	O
to	O
be	O
transferred	O
to	O
the	O
Cambridge	O
Hospital	O
Hospital	O
Special	O
Care	O
Nursery	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Amanda	O
Hilton	O
of	O
Crown	O
Colony	O

Pediatrics	O
,	O
phone	O
number	O
353-5927	O
,	O
fax	O
number	O

(	O
853	O
)	O
390	O
1387	O
.	O

CARE	O
AND	O
RECOMMENDATIONS:	O

1.	O
Feeds	O
at	O
discharge	O
:	O
Enfamil	B-treatment
20	O
p.o.	O
ad	O
lib	O
.	O

2.	O
Medications	B-treatment
:	O
none	O
.	O

3.	O
Car	O
seat	O
positioning	O
:	O
not	O
yet	O
done	O
.	O

4.	O
State	B-test
newborn	I-test
screening	I-test
sent	O
.	O

5.	O
Immunizations	B-treatment
:	O
received	O
hepatitis	B-treatment
B	I-treatment
on	O
09-16	O
.	O

DISCHARGE	O
DIAGNOSES:	O

1.	O
Prolonged	B-problem
Respiratory	I-problem
Transition	I-problem
.	O

1.	O
Hyaline	B-problem
Membrane	I-problem
Disease	I-problem
.	O

2.	O
Rule	O
out	O
sepsis	B-problem
without	O
antibiotics	B-treatment
.	O

Kevin	O
F	O
Juliusson	O
,	O
M.D.	O

04-834	O
PAD-WORD	O

Dictated	O
By:Anita	O
X.	O
Duffy	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2015-09-17	O
PAD-WORD	O

13:45	O
PAD-WORD	O

T	O
:	O

2015-09-17	O
PAD-WORD	O

14:15	O
PAD-WORD	O

JOB#	O
:	O

24313	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Vanessa	O
Riker	O
on	O
:	O

SAT	O
2015-09-19	O
2:01	O
PM	O

(	O
End	O
of	O
Report	O
)	O

040076444	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

2267360	O
PAD-WORD	O

95601/1m70	O
PAD-WORD	O

602566	O
PAD-WORD	O

10/17/1995	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10/17/95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

10/20/95	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
73-year-old	O
man	O
with	O
squamous	B-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
lung	I-problem
,	O
status	O
post	O
lobectomy	B-treatment
and	O
resection	B-treatment
of	O
left	B-problem
cervical	I-problem
recurrence	I-problem
,	O
admitted	O
here	O
with	O
fever	B-problem
and	O
neutropenia	B-problem
.	O

Recently	O
he	O
had	O
been	O
receiving	O
a	O
combination	O
of	O
outpatient	B-treatment
chemotherapy	I-treatment
with	O
the	O
CAMP	O
Program	O
.	O

Other	B-problem
medical	I-problem
problems	I-problem
include	O
hypothyroidism	B-problem
,	O
hypercholesterolemia	B-problem
,	O
hypertension	B-problem
and	O
neuropathy	B-problem
from	O
Taxol	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
a	O
well-developed	O
,	O
well-nourished	O
man	O
who	O
was	O
breathing	O
comfortably	O
.	O

Temperature	B-test
was	O
101.3	O
.	O

HEENT	O
were	O
normal	O
.	O

Neck	O
was	O
supple	O
.	O

Lungs	O
were	O
clear	O
to	O
percussion	B-test
and	O
auscultation	B-test
with	O
a	B-problem
few	I-problem
scattered	I-problem
rales	I-problem
,	O
left	O
greater	O
than	O
right	O
.	O

Abdominal	B-test
examination	I-test
was	O
normal	O
.	O

Extremities	O
were	O
normal	O
.	O

Neurological	B-test
examination	I-test
was	O
nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

The	B-test
WBC	I-test
was	O
0.9	O
,	O
the	B-test
ANC	I-test
was	O
540	O
,	O
platelets	B-test
were	O
156,000	O
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
started	O
on	O
Neupogen	B-treatment
,	O
400	O
mcg.	O
subq.	O
q.d.	O

He	O
was	O
initially	O
treated	O
with	O
antibiotic	B-treatment
therapy	I-treatment
.	O

Chest	B-test
x-ray	I-test
showed	O
questionable	O
nodule	B-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
,	O
reasonably	O
stable	O
.	O

Calcium	B-test
8.7	O
,	O
bilirubin	B-test
0.3/1.3	O
,	O
creatinine	B-test
1.1	O
,	O
glucose	B-test
128	O
.	O

Hematocrit	B-test
24.6	O
.	O

WBC	B-test
rose	O
to	O
1.7	O
on	O
10/19	O
.	O

The	O
patient	O
had	O
some	B-problem
diarrhea	I-problem
.	O

There	O
was	O
no	O
diarrhea	B-problem
on	O
10/20	O
.	O

He	O
was	O
feeling	O
well	O
and	O
afebrile	B-problem
.	O

The	B-problem
neutropenia	I-problem
resolved	O
and	O
he	O
was	O
felt	O
to	O
be	O
in	O
satisfactory	O
condition	O
on	O
discharge	O
on	O
10/20/95	O
.	O

He	O
was	O
discharged	O
home	O
on	O
Neupogen	B-treatment
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Fever	B-problem
neutropenia	I-problem
,	O
metastatic	B-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
lung	I-problem
,	O
hypertension	B-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Include	O
Neupogen	B-treatment
,	O
480	O
mcg.	O
subq.	O
q.d.	O
and	O
usual	B-treatment
medications	I-treatment
.	O

GUABENFRANDA	O
D.	O
PATCH	O
,	O
M.D.	O

TR	O
:	O

wl	O
/	O
bmot	O

DD	O
:	O

11/01/95	O
PAD-WORD	O

TD	O
:	O

11/02/95	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2019-06-25	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-07-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1950-04-19	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Penicillins	B-treatment
/	O
Norvasc	B-treatment
/	O
Verapamil	B-treatment

Attending	O
:	O
Christopher	O
Q	O
Thompson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

preop	B-test
w/	I-test
for	O
knee	B-treatment
surgery	I-treatment
revealed	O
cardiac	B-problem
dz	I-problem
,	O
asymptomatic	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

CABGx4	B-treatment
(	O
06-26	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

69yoM	O
with	O
OA	B-problem
having	O
workup	B-test
for	O
knee	B-treatment
replacements	I-treatment
found	O
to	O
be	O
in	O
Afib	B-problem
,	O
had	O
stress	B-test
test	I-test
that	O
was	O
positive	O
followed	O
by	O
cardiac	B-test
catheterization	I-test
which	O
revealed	O
severe	B-problem
3VD	I-problem
.	O

Then	O
referred	O
for	O
CABG	B-treatment

Past	O
Medical	O
History	O
:	O

HTN	B-problem
PAD-WORD	O

chol	B-problem
PAD-WORD	O

AFib	B-problem
PAD-WORD	O

OA	B-problem
needs	O
bilat	B-treatment
arthroplasty	I-treatment

CRI	B-problem
PAD-WORD	O

Social	O
History	O
:	O

Lives	O
with	O
wife	O
.	O

Remote	O
Timothy	O
,	O
quit	O
1990	O
.	O
+	O
ETOH	O
(	O
1-2	O
drinks	O
/	O
Rivero	O
)	O

Family	O
History	O
:	O

Brother	O
died	O
64	O
/	O
MI	B-problem

Physical	O
Exam	O
:	O

Admission	O
PAD-WORD	O

VS	B-test
T	B-test
98	O
HR	B-test
74	O
BP	B-test
136/88	O
RR	B-test
18	O

Gen	O
NAD	B-problem

Neuro	O
A&Ox3	O
,	O
nonfocal	O

Chest	O
CTA	O
bilat	O

CV	O
irreg-irreg	B-problem
,	O
no	O
M/R	B-problem

Abdn	O
soft	O
,	O
NT/ND/+BS	B-problem

Ext	O
warm	O
no	O
edema	B-problem

Discharge	O
PAD-WORD	O

T99.9	B-test
HR	B-test
70AF	O
BP	B-test
120/69	O
RR	B-test
20	O
O2sat	B-test
94%RA	O

Neuro	O
A&Ox3	O
MAE	O
,	O
non	B-test
focal	I-test
exam	I-test

Pulm	O
CTAB	O

CV	O
irreg	B-problem
irreg	I-problem
,	O
sternum	B-problem
stable	I-problem
incision	I-problem
CDI	O

Abdm	O
soft	O
,	O
NT/ND/+BS	B-problem

Ext	O
warm	O
2+	B-problem
edema	I-problem

Pertinent	O
Results	O
:	O

2019-06-25	O
04:10	O
PM	O

GLUCOSE	B-test
-	O
97	O
UREA	B-test
N	O
-	O
44	O
*	O
CREAT	B-test
-	O
2.0	O
*	O
SODIUM	B-test
-	O
143	O
POTASSIUM	B-test
-	O
4.1	O
CHLORIDE	B-test
-	O
107	O
TOTAL	B-test
CO2	I-test
-	O
27	O
ANION	B-test
GAP	I-test
-	O
13	O

2019-06-25	O
04:10	O
PM	O

ALT(SGPT)	B-test
-	O
19	O
AST(SGOT)	B-test
-	O
19	O
LD(LDH)	B-test
-	O
153	O
ALK	B-test
PHOS	I-test
-	O
58	O
TOT	B-test
BILI	I-test
-	O
0.4	O

2019-06-25	O
04:10	O
PM	O

ALBUMIN	B-test
-	O
4.3	O

2019-06-25	O
04:10	O
PM	O

%HbA1c	B-test
-	O
5.7	O

2019-06-25	O
04:10	O
PM	O

TSH	B-test
-	O
1.2	O

2019-06-25	O
04:10	O
PM	O

WBC	B-test
-	O
7.0	O
RBC	B-test
-	O
3.92	O
*	O
HGB	B-test
-	O
12.6	O
*	O
HCT	B-test
-	O
36.4	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
32.1	O
*	O
MCHC	B-test
-	O
34.6	O
RDW	B-test
-	O
13.6	O

2019-06-25	O
04:10	O
PM	O

PLT	B-test
COUNT	I-test
-	O
207	O

2019-06-25	O
04:10	O
PM	O

PT	B-test
-	O
11.8	O
PTT	B-test
-	O
22.4	O
INR(PT)	B-test
-	O
1.0	O

2019-07-01	O
07:30	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
8.7	O
RBC	B-test
-	O
3.18	O
*	O
Hgb	B-test
-	O
10.4	O
*	O
Hct	B-test
-	O
30.4	O
*	O
MCV	B-test
-	O
96	O
MCH	B-test
-	O
32.7	O
*	O
MCHC	B-test
-	O
34.3	O
RDW	B-test
-	O
13.5	O
Plt	B-test
Ct	I-test
-	O
303	O

2019-07-01	O
07:30	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
303	O

2019-07-01	O
07:30	O
AM	O
BLOOD	B-test
PT	B-test
-	O
14.4	O
*	O
PTT	B-test
-	O
24.2	O
INR(PT)-	B-test
1.3	O
*	O

2019-06-30	O
06:45	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
99	O
UreaN	B-test
-	O
40	O
*	O
Creat	B-test
-	O
1.9	O
*	O
Na	B-test
-	O
137	O
K	O
-	O
4.1	O
Cl	B-test
-	O
99	O
HCO3	B-test
-	O
28	O
AnGap	B-test
-	O
14	O

CHEST	B-test
(	I-test
PORTABLE	I-test
A	I-test
P)	I-test

2019-06-30	O
11:26	O
AM	O

CHEST	B-test
(	I-test
PORTABLE	I-test
AP	I-test
)	I-test

Reason	O
:	O
Effusion	B-problem
?	O
Pntx	B-problem
?	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

69	O
year	O
old	O
man	O
with	O
s/p	O
Off	B-treatment
Pump	I-treatment
CABG	I-treatment

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Effusion	B-problem
?	O
Pntx	B-problem
?	O

PORTABLE	B-test
CHEST	I-test
ON	O
2019-06-30	O
AT	O
11:39	O

INDICATION	O
:	O
CABG	B-treatment
with	O
chest	B-treatment
tube	I-treatment
in	O
place	O
.	O

COMPARISON	O
:	O
2019-06-29	O
.	O

FINDINGS	O
:	O
Left	B-treatment
chest	I-treatment
tube	I-treatment
remains	O
in	O
place	O
with	O
some	B-problem
density	I-problem
adjacent	I-problem
to	I-problem
the	I-problem
tip	I-problem
,	O
but	O
there	O
is	O
no	O
significant	B-problem
interval	I-problem
change	I-problem
vs	O
.	O
prior	O
.	O

Specifically	O
,	O
there	O
is	O
no	O
pneumothorax	B-problem
and	O
no	O
interval	B-problem
development	I-problem
of	I-problem
effusion	I-problem
.	O

Cardiac	O
silhouette	O
and	O
mediastinal	O
contours	O
are	O
stable	O
.	O

IMPRESSION	O
:	O
No	O
change	O
vs	O
.	O
prior	O
.	O

DR.	O
James	O
A	O
Roberts	O

Brief	O
Hospital	O
Course	O
:	O

69	O
yo	O
M	O
with	O
known	B-problem
Atrial	I-problem
fibrillation	I-problem
and	O
coronary	B-problem
artery	I-problem
disease	I-problem
admitted	O
preop	O
for	O
transition	O
fro	O
Coumadin	B-treatment
to	O
Heparin	B-treatment
.	O

Brought	O
to	O
the	O
OR	O
on	O
06-26	O
for	O
CABG	B-treatment
,	O
please	O
see	O
OR	O
report	O
for	O
details	O
.	O

In	O
summary	O
pt	O
had	O
off	B-treatment
pump	I-treatment
CABGx4	I-treatment
with	O
LIMA-LAD	B-treatment
,	O
SVG	B-treatment
OM-Y	I-treatment
graft	I-treatment
-	I-treatment
Diag	I-treatment
,	O
SVG-PDA	B-treatment
.	O

Pt	O
tolerated	O
surgery	B-treatment
well	O
and	O
was	O
transferred	O
to	O
CT	O
CMED	O
ICU	O
.	O

He	O
did	O
well	O
in	O
immediate	O
post-op	O
period	O
was	O
extubated	B-treatment
and	O
on	O
POD1	O
he	O
was	O
transferred	O
to	O
the	O
step	O
down	O
floor	O
.	O

On	O
POD2	O
his	B-treatment
chest	I-treatment
tubes	I-treatment
and	O
epicardial	B-treatment
pacing	I-treatment
wires	I-treatment
were	O
removed	O
and	O
his	B-treatment
Coumadin	I-treatment
was	O
restarted	O
.	O

Over	O
the	O
next	O
several	O
days	O
his	O
activity	O
was	O
advanced	O
on	O
POD5	O
it	O
was	O
decided	O
he	O
was	O
stable	O
and	O
ready	O
to	O
be	O
discharged	O
home	O
with	O
visiting	O
nurses	O
.	O

Medications	O
on	O
Admission	O
:	O

Atenolol	B-treatment
200	O
'	O

HCTZ	B-treatment
25	O
'	O

Lisinopril	B-treatment
20	O
'	O

Ultram	B-treatment
50	O
'	O

Prilosec	B-treatment
20	O
'	O

Zocor	B-treatment
40	O
'	O

Levitra	B-treatment
/	O
prn	O

Warfarin	B-treatment
4	O
'	O

Discharge	O
Medications	O
:	O

1.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
Ellis	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
Leukhardt	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
once	O
a	O
Sine	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
28	O
Tablet	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
Costa	O
).	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
2	O
*	O

5.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O

6.	O
Warfarin	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
once	O
a	O
Avrett	O
:	O
target	B-test
INR	I-test
1.5-2	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

7.	O
Oxycodone	B-treatment
-	I-treatment
Acetaminophen	I-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Prilosec	B-treatment
20	O
mg	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
once	O
a	O
Gray	O
.	O

10.	O
Ultram	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6	O
hrs	O
/	O
PRN	O
.	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

s/p	O
off	B-treatment
pump	I-treatment
CABGx4	I-treatment
LIMA-LAD	B-treatment
,Y	B-treatment
SVG-OM-Diag,	I-treatment
SVG-PDA	B-treatment
(	O
06-26	O
)	O
PMH	O
:	O
HTN	B-problem
,	O
chol	B-problem
,	O
AF	B-problem
,	O
OA	B-problem
,	O
CRI	B-problem
,	O
s/p	O
bilat	B-treatment
knee	I-treatment
surgery	I-treatment

Discharge	O
Condition	O
:	O

good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Keep	O
wounds	B-problem
clean	O
and	O
dry	O
.	O

OK	O
to	O
shower	O
,	O
no	O
bathing	O
or	O
swimming	O
.	O

Take	O
all	B-treatment
medications	I-treatment
as	O
prescribed	O

Call	O
for	O
any	O
fever	B-problem
,	O
redness	B-problem
or	O
drainage	B-problem
from	O
wounds	B-problem
.	O

Followup	O
Instructions	O
:	O

Wound	O
clinic	O
in	O
2	O
weeks	O

Dr	O
Anderson	O
in	O
2-3	O
weeks	O

Dr	O
Brown	O
in	O
4	O
weeks	O

Ada	O
Jordan	O
MD	O
62-102	O

Completed	O
by	O
:	O
MARK	O
Eugene	O
NP	O
80-AUO	O
2019-07-01	O
@	O
1417	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Elizabeth	O
P.	O
Fernandez	O
on	O
:	O
TUE	O
2019-07-30	O
8:03	O
AM	O

(	O
End	O
of	O
Report	O
)	O

054478430	O
ELMVH	O

79660638	O
PAD-WORD	O

1835979	O
PAD-WORD	O

12/11/2005	O
12:00:00	O
AM	O

Right	B-problem
LE	I-problem
pain	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

12/11/2005	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/13/2005	O
PAD-WORD	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

HIBBSKOTE	O
,	O
SIALIND	O
071-43-95-1	O
W78	O

Room	O
:	O

65Q-505	O
PAD-WORD	O

Service	O
:	O

ORT	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/13/05	O
AT	O
12:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

HEAD	O
,	O
SANTDEL	O
L.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	B-treatment
(	I-treatment
ACETAMINOPHEN	I-treatment
)	I-treatment
325-650	O
MG	O
PO	O
Q4H	O
PRN	O
Pain	B-problem
,	O
Headache	B-problem
,	O
Temperature	B-test
greater	O
than	O
:	O

101	O
COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
BID	O
OXYCODONE	B-treatment
10-25	O
MG	O
PO	O
Q3H	O
PRN	O
Pain	B-problem

HOLD	O
IF	O
:	O

excesive	B-problem
sedation	I-problem
RR	B-test
&lt;	O
6	O
FLEXERIL	B-treatment
(	I-treatment
CYCLOBENZAPRINE	I-treatment
HCL	I-treatment
)	I-treatment
10	O
MG	O
PO	O
TID	O
PRN	O
Pain	B-problem

DIET	O
:	O

House	O
/	O
ADA	O
2100	O
cals	O
/	O
day	O
/	O
Low	O
saturated	O
fat	O
low	O
cholesterol	O
&lt;	O
FDI	O
&gt;	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Maa	O
Bloch	O
(	O
WAMA	O
HEALTH	O
)	O
Call	O
ASAP	O
to	O
schedule	O
in	O
1-2	O
days	O

Phoen	O
:	O

381-389-5852	O
,	O

Dr.	O
Santdel	O
Head	O
Call	O
ASAP	O
to	O
schedule	O
in	O
2	O
weeks	O
.	O

449-059-6882	O
,	O

ALLERGY	O
:	O

NKA	B-problem
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

R	B-problem
leg	I-problem
pain	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Right	B-problem
LE	I-problem
pain	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

DM	B-problem
PAD-WORD	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

None	O
PAD-WORD	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

PT	B-test
Spien	I-test
MRI	I-test
Pelvis	B-test
XR	I-test
R	B-test
hip	I-test
Xray	I-test

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

HPI	O
:	O

Hibbskote	O
has	O
severe	B-problem
low	I-problem
back	I-problem
pain	I-problem
radiating	O
down	O
the	O
right	O
leg	O
.	O

She	O
has	O
been	O
suffering	O
from	O
this	B-problem
problem	I-problem
for	O
the	O
last	O
few	O
weeks	O
.	O

A	O
week	O
and	O
half	O
ago	O
,	O
she	O
had	O
a	B-treatment
steroid	I-treatment
injection	I-treatment
in	O
an	O
efforts	O
to	O
ameliorate	O
the	B-problem
pain	I-problem
.	O

She	O
presents	O
now	O
with	O
worsening	B-problem
low	I-problem
back	I-problem
pain	I-problem
radiating	O
down	O
the	O
right	O
leg	O
.	O

She	O
denies	O
numbness	B-problem
or	O
weakness	B-problem
in	O
any	O
part	O
of	O
the	O
body	O
.	O

She	O
denies	O
fever	B-problem
.	O

She	O
denies	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
and	O
diarrhea	B-problem
.	O

She	O
denies	O
chest	B-problem
pain	I-problem
.	O

She	O
says	O
the	B-problem
pain	I-problem
is	O
sharp	O
in	O
character	O
,	O
and	O
radiates	O
with	O
a	B-problem
shock	I-problem
like	I-problem
intensity	I-problem
down	I-problem
the	I-problem
right	I-problem
leg	I-problem
.	O

She	O
says	O
that	O
oral	B-treatment
analgesics	I-treatment
have	O
been	O
of	O
little	O
help	O
.	O

On	O
detailed	B-test
review	I-test
of	I-test
systems	I-test
,	O
she	O
admitted	O
to	O
one	O
episode	O
of	O
urinary	B-problem
incontinence	I-problem
.	O

She	O
denied	O
any	B-problem
changes	I-problem
in	I-problem
bowel	I-problem
habits	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Non-insulin-requiring	B-problem
diabetes	I-problem
mellitus	I-problem
,	O
and	O
hypercholesterolemia	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

As	O
given	O
above	O
.	O

SOCIAL	O
HISTORY	O
:	O

Negative	O
for	O
tobacco	O
,	O
drugs	O
,	O
or	O
domestic	O
violence	O
.	O

FAMILY	O
HISTORY	O
:	O

Negative	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

All	O
systems	O
were	O
reviewed	O
and	O
were	O
negative	O
except	O
as	O
given	O
above	O
.	O

MEDICATIONS	O
:	O

Metformin	B-treatment
,	O
Zocor	B-treatment
,	O
and	O
analgesics	B-treatment
.	O

ALLERGIES	O
:	O

None	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Awake	O
,	O
alert	O
,	O
spontaneous	O
and	O
appropriate	O
,	O
and	O
somewhat	B-problem
uncomfortable	I-problem
due	O
to	O
pain	B-problem
but	O
looked	O
well	O
.	O

She	O
was	O
afebrile	B-problem
and	O
had	O
normal	O
vital	O
signs	O
.	O

The	B-test
oxygen	I-test
saturation	I-test
was	O
normal	O
at	O
98%	O
on	O
room	O
air	O
.	O

There	O
was	O
no	O
evidence	O
of	O
head	B-problem
trauma	I-problem
.	O

There	O
was	O
no	O
scleral	B-problem
icterus	I-problem
.	O

The	O
oropharynx	O
was	O
clear	O
.	O

The	O
neck	O
was	O
supple	O
with	O
no	O
lymphadenopathy	B-problem
.	O

The	O
chest	O
was	O
clear	O
with	O
normal	O
excursion	O
.	O

Heart	O
was	O
regular	O
with	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	B-problem
with	O
no	O
masses	B-problem
,	O
no	O
organomegaly	B-problem
.	O

The	O
skin	O
and	O
extremities	O
were	O
normal	O
with	O
no	O
cyanosis	B-problem
,	O
clubbing	B-problem
,	O
edema	B-problem
,	O
lesions	B-problem
,	O
or	O
rashes	B-problem
.	O

Neurologic	B-test
examination	I-test
was	O
normal	O
.	O

Strength	O
,	O
sensation	O
,	O
coordination	O
and	O
cranial	O
nerve	O
function	O
were	O
all	O
normal	O
.	O

Straight	B-test
leg	I-test
raise	I-test
test	I-test
was	O
difficult	O
to	O
perform	O
due	O
to	O
pain	B-problem
but	O
seemed	O
to	O
be	O
positive	B-problem
on	O
the	O
right	O
.	O

Psychiatric	B-test
examination	I-test
was	O
normal	O
.	O

Examination	B-test
of	I-test
the	I-test
back	I-test
revealed	O
lumbar	B-problem
tenderness	I-problem
with	O
no	O
point	B-problem
tenderness	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Patient	O
was	O
evaluated	O
by	O
the	O
orthopedic	O
service	O
.	O

An	B-test
MRI	I-test
of	I-test
the	I-test
spine	I-test
showed	O
L4/5	B-problem
facet	I-problem
enhancement	I-problem
.	O

It	O
was	O
evaluated	O
by	O
the	O
IR	O
radiology	O
.	O

Thad	B-problem
lesion	I-problem
was	O
read	O
as	O
a	B-problem
facet	I-problem
hypertrophy	I-problem
and	O
not	O
an	B-problem
infectious	I-problem
process	I-problem
.	O

Patient	O
remained	O
afebrile	B-problem
.	O

ESR	B-test
was	O
within	O
normal	O
limits	O
and	O
CPR	B-test
was	O
mildly	B-problem
elevated	I-problem
.	O

An	B-test
AP	I-test
of	I-test
pelvis	I-test
and	O
R	B-test
hip	I-test
films	I-test
were	O
unremarkable	O
.	O

Physical	B-test
examination	I-test
of	I-test
the	I-test
RLE	I-test
showed	O
mild	B-problem
pain	I-problem
in	I-problem
right	I-problem
hip	I-problem
with	O
some	O
movements	O
.	O

When	O
patient	O
was	O
distracted	O
,	O
some	O
maneuvers	O
were	O
not	O
painful	B-problem
.	O

Patient	O
remained	O
cardiovascularly	O
stable	O
.	O

Patient	O
was	O
weaned	O
from	O
supplemental	B-treatment
oxygen	I-treatment
and	O
tolerated	O
a	O
regular	O
diet	O
prior	O
to	O
discharge	O
.	O

The	O
patient	O
received	O
pneumoboots	B-treatment
and	O
lovenox	B-treatment
for	O
DVT	B-treatment
prophylaxis	I-treatment
.	O
.	O

Patient	O
was	O
instructed	O
by	O
PT	O
on	O
the	O
correct	O
way	O
to	O
ambulate	O
,	O
weight	O
bearing	O
as	O
tolerated	O
in	O
the	O
RLE	O
.	O
.	O

Patient	O
was	O
able	O
to	O
void	O
and	O
ambulated	O
without	O
assistance	O
as	O
directed	O
by	O
P.T.	O

The	O
team	O
decided	O
that	O
the	O
patient	O
was	O
ready	O
for	O
discharge	O
.	O

Patient	O
should	O
follow	O
up	O
with	O
her	O
pain	O
doctor	O
,	O
Dr.	O
Maa	O
Bloch	O
381-389-5852	O
,	O
for	O
her	B-treatment
chronic	I-treatment
pain	I-treatment
management	I-treatment

ADDITIONAL	O
COMMENTS	O
:	O

Do	O
not	O
drive	O
or	O
drink	O
alcohol	O
while	O
taking	O
narcotics	B-treatment
.	O

Resume	O
all	O
of	O
your	B-treatment
home	I-treatment
medications	I-treatment
,	O
but	O
please	O
avoid	O
motrin	B-treatment
/	I-treatment
advil	I-treatment
for	O
1	O
week	O
.	O

Call	O
449-059-6882	O
if	O
you	O
have	O
any	O
questions	O
.	O

If	O
you	O
have	O
fevers	B-problem
&gt;	O
101.5	O
F	O
,	O
vomiting	B-problem
,	O
or	O
increased	B-problem
redness	I-problem
,	O
swelling	B-problem
,	O
or	O
discharge	B-problem
from	O
your	B-problem
incision	I-problem
,	O
call	O
your	O
MD	O
or	O
go	O
to	O
the	O
nearest	O
ER	O
.	O

You	O
may	O
bear	O
weight	O
on	O
your	O
both	O
legs	O
.	O

Call	O
381-389-5852	O
to	O
schedule	O
an	O
apointment	O
with	O
your	O
pain	O
doctor	O
(	O
Dr.	O
Maa	O
Bloch	O
)	O
ASAP	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

FLOMKOTEWIERST	O
,	O
NEENIE	O
LAURE	O
,	O
M.D.	O
(	O
DK739	O
)	O
12/13/05	O
01:01	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2018-04-23	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2018-05-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1818-04-23	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Penicillins	B-treatment
PAD-WORD	O

Attending	O
:	O

Crystal	O
GQ	O
Divers	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

respiratory	B-problem
distress	I-problem
,	O
hemoptysis	B-problem
transferred	O
from	O
OSH	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

debridement	B-treatment
of	O
mass	B-problem
from	O
tracheal	O
lumen	O
by	O
interventional	O
pulmonary	O

History	O
of	O
Present	O
Illness	O
:	O

95	O
yo	O
male	O
with	O
PMH	O
large	B-problem
right	I-problem
thyroid	I-problem
cystic	I-problem
mass	I-problem
eroding	I-problem
into	O
trachea	O
,	O
who	O
presented	O
to	O
St.	O
Anne	O
's	O
Hospital	O
2018-04-22	O
with	O
hemoptysis	B-problem
and	O
respiratory	B-problem
distress	I-problem
,	O
now	O
diagnosed	O
with	O
anaplastic	B-problem
thyroid	I-problem
carcinoma	I-problem
.	O

.	O
PAD-WORD	O

Pt	O
reports	O
that	O
he	O
noticed	O
a	B-problem
right	I-problem
neck	I-problem
mass	I-problem
last	O
October	O
.	O

The	B-problem
mass	I-problem
grew	O
larger	O
,	O
to	O
the	O
size	O
of	O
a	O
baseball	O
.	O

It	O
appears	O
that	O
FNA	B-test
was	O
performed	O
but	O
was	O
non-diagnostic	O
(	O
probably	O
because	O
anaplastic	B-problem
tumors	I-problem
tend	O
to	O
be	O
necrotic	O
)	O
.	O

The	B-problem
mass	I-problem
appears	O
to	O
be	O
cystic	B-problem
in	O
nature	O
and	O
has	O
been	O
aspirated	O
at	O
least	O
3	O
times	O
,	O
which	O
decrease	O
in	O
size	O
each	O
time	O
.	O

Now	O
size	O
is	O
6.5cm*6.5cm	O
.	O

Plan	O
for	O
surgery	B-treatment
in	O
Oct	O
was	O
deferred	O
04-05	O
syncope	B-problem
and	O
pacer	B-treatment
placement	I-treatment
for	O
SSS;	B-problem
again	O
deferred	O
2	O
weeks	O
ago	O
04-05	O
URI;	B-problem
was	O
planned	O
for	O
surgery	B-treatment
this	O
Thurday	O
.	O

.	O
PAD-WORD	O

Pt	O
was	O
o/w	O
in	O
his	O
USOH	O
until	O
2-3	O
weeks	O
ago	O
when	O
he	O
developed	O
a	B-problem
URI	I-problem
with	O
symptoms	B-problem
of	O
dry	B-problem
cough;	I-problem
no	O
fever	B-problem
,	O
chills	B-problem
,	O
sore	B-problem
throat	I-problem
,	O
myalgias	B-problem
.	O

Pt	O
was	O
treated	O
with	O
3	O
days	O
of	O
an	B-treatment
antibiotics	I-treatment
,	O
followed	O
by	O
a	O
10	O
day	O
course	O
of	O
levaquin	B-treatment
(	O
completed	O
2	O
days	O
PTA	O
)	O
.	O

Per	O
pt	O
and	O
son	O
,	O
no	O
James	B-problem
pna	I-problem
.	O

2	O
days	O
prior	O
to	O
admission	O
,	O
pt	O
developed	O
hemoptysis;	B-problem
states	O
he	O
coughed	O
up	O
4	O
tsp	O
of	O
blood	B-problem
.	O

1	O
day	O
PTA	O
,	O
pt	O
developed	O
stridorous	B-problem
breathing	I-problem
and	O
respiratory	B-problem
distress	I-problem
.	O

Pt	O
was	O
initially	O
seen	O
at	O
Lahey	O
North	O
,	O
where	O
he	O
was	O
given	O
steroids	B-treatment
,	O
with	O
improvement	O
in	O
respiratory	O
status	O
.	O

Pt	O
was	O
transferred	O
to	O
New	O
England	O
Baptist	O
Hospital	O
,	O
where	O
his	O
surgeon	O
is	O
located	O
.	O

There	O
he	O
was	O
admitted	O
to	O
the	O
CMED	O
.	O

Thyroid	B-problem
cyst	I-problem
was	O
aspirated	O
with	O
removal	O
of	O
300cc	O
of	O
fluid	O
.	O

Pt	O
was	O
given	O
racemic	B-treatment
epinephrine	I-treatment
and	O
Decadron	B-treatment
10mg	O
IV	O
x1.	O
CT	B-test
neck	I-test
showed	O
tracheal	B-problem
mass	I-problem
per	O
nursing	O
s/o	O
(	O
pt	O
brought	O
CT	B-test
)	O
.	O

.	O
PAD-WORD	O

Pt	O
now	O
breathing	O
more	O
comfortably	O
.	O

He	O
has	O
not	O
had	O
fever	B-problem
and	O
night	B-problem
sweats	I-problem
but	O
reports	O
weakness	B-problem
and	O
weight	B-problem
loss	I-problem
for	O
several	O
months	O
recently	O
.	O

Past	O
Medical	O
History	O
:	O

R	B-problem
thyroid	I-problem
cyst	I-problem
(	O
as	O
above	O
)	O

Goiter	B-problem
PAD-WORD	O

CRI	B-problem
PAD-WORD	O

HTN	B-problem
PAD-WORD	O

SSS	B-problem
(	O
s/p	O
pacer	B-treatment
Michelle	O
Matthew	O
Mccaulley	O
)	O
prostate	B-problem
cancer	I-problem
-dx	O
10	O
years	O
ago;	O
received	O
monthly	B-treatment
shots	I-treatment
which	O
were	O
discontinued	O
recently	O
.	O

anemia	B-problem
Afib	I-problem
(	O
19	O
episodes	O
since	O
2017-12-02	O
,	O
as	O
documented	O
on	O
pacer	B-test
interogation	I-test
2018-04-04	O
)	O

Social	O
History	O
:	O

Was	O
living	O
alone	O
in	O
ALF	O
.	O

Walks	O
with	O
walker	O
.	O

Able	O
to	O
take	O
care	O
of	O
himself;	O
home	O
health	O
aide	O
visits	O
once	O
a	O
week	O
.	O

Denies	O
history	O
of	O
tobacco	O
,	O
etoh	O
,	O
drugs	O
.	O

Used	O
to	O
work	O
as	O
hat	O
manufacturer	O
.	O

Family	O
History:	O

No	O
history	O
of	O
thyroid	B-problem
disease	I-problem
.	O

Sister	O
with	O
lung	B-problem
ca	I-problem
.	O

Brother	O
with	O
gastric	B-problem
ca	I-problem
.	O

sister	O
with	O
unknown	B-problem
ca	I-problem
.	O

Father	O
with	O
stroke	B-problem
.	O

Physical	O
Exam:	O

VS	B-test
:	O

T	B-test
99.4	O
,	O
BP	B-test
119/59	O
,	O
HR	B-test
76	O
,	O
RR	B-test
18	O
,	O
99%	O
RA	O

Gen	O
:	O

NAD	B-problem
PAD-WORD	O

HEENT	O
:	O

PERRL	O
,	O
EOMI	O
,	O
clear	O
OP	O
,	O
MMM	O

Neck	O
:	O

Large	B-problem
~6	I-problem
x	I-problem
6	I-problem
cm	I-problem
sized	I-problem
right	I-problem
thyroid	I-problem
mass	I-problem
,	O
soft	O
,	O
possibly	O
cystic	B-problem
,	O
non-tender.	B-problem

L	O
lobe	O
of	O
the	O
thyroid	O
gland	O
also	O
prominent	B-problem
.	O

CVS	O
:	O

RRR	O
,	O
nl	O
s1	O
s2	O
,	O
no	O
m/g/r	B-problem

Lungs	O
:	O
transmitted	B-problem
upper	I-problem
airway	I-problem
stridor;	I-problem
otherwise	O
clear	O

Abd	O
:	O
soft	O
,	O
NT	B-problem
,	O
ND	B-problem
,	O
+BS	O

Ext	O
:	O
no	O
edema	B-problem

Neuro	O
:	O

CN	B-test
04-15	O
intact	O
,	O
07-06	O
bilateral	O
upper	O
and	O
lower	O
extremity	O
strength	O
.	O

Pertinent	O
Results	O
:	O

CT	B-test
Neck	I-test
-	O
IMPRESSION	O
:	O

1.	O
7-cm	B-problem
diameter	I-problem
right	I-problem
neck	I-problem
mass	I-problem
,	O
with	O
direct	B-problem
invasion	I-problem
of	I-problem
the	I-problem
subglottic	I-problem
,	I-problem
cervical	I-problem
and	I-problem
proximal	I-problem
thoracic	I-problem
trachea	I-problem
.	O

The	B-problem
mass	I-problem
is	O
reportedly	O
thyroid	O
in	O
origin	O
.	O

Differential	O
diagnosis	O
includes	O
primary	B-problem
head/neck	I-problem
cancer	I-problem
and	O
lymphoma	B-problem
.	O

2.	O
Left	B-problem
lobe	I-problem
thyroid	I-problem
enlargement	I-problem
with	O
heterogeneous	O
appearance	O
.	O

3.	O
Right	B-problem
upper	I-problem
paratracheal	I-problem
and	I-problem
prevascular	I-problem
lymphadenopathy	I-problem
as	O
well	O
as	O
additional	B-problem
nodes	I-problem
in	I-problem
the	I-problem
right	I-problem
side	I-problem
of	I-problem
the	I-problem
neck	I-problem
.	O

Dedicated	B-test
MR	I-test
of	I-test
the	I-test
neck	I-test
may	O
be	O
helpful	O
for	O
more	B-test
complete	I-test
assessment	I-test
of	O
the	B-problem
neck	I-problem
mass	I-problem
and	O
lymphadenopathy	B-problem
if	O
warranted	O
clinically	O
.	O

.	O
PAD-WORD	O

Pathology	O
:	O

The	B-problem
tumor	I-problem
is	O
composed	O
of	O
a	B-problem
relatively	I-problem
monotonous	I-problem
proliferation	I-problem
of	I-problem
spindle	I-problem
cells	I-problem
which	O
grow	O
in	O
sheets	O
with	O
a	O
prominent	O
vascular	O
pattern	O
.	O

Immunostains	B-test
for	O
cytokeratin	B-test
AE1/3	I-test
and	O
CAM	B-test
5.2	I-test
,	O
CD-68	B-test
,	O
CD-79a	B-test
,	O
CD-138	B-test
,	O
S-100	B-test
,	O
LCA	B-test
absorbed	I-test
CEA	I-test
,	O
EMA	B-test
,	O
CD34	B-test
,	O
CD31	B-test
,	O
TTF-1	B-test
,	O
actin	B-test
,	O
desmin	B-test
,	O
MNF-116	B-test
,	O
calcitonin	B-test
,	O
and	O
thyroglobulin	B-test
are	O
negative	O
.	O

These	O
results	O
exclude	O
both	O
melanoma	B-problem
and	O
hematopoietic	B-problem
neoplasms	I-problem
.	O

The	O
differential	O
diagnosis	O
includes	O
,	O
but	O
is	O
not	O
limited	O
to	O
,	O
sarcoma	B-problem
,	O
spindle	B-problem
cell	I-problem
carcinomas	I-problem
(	O
sarcomatoid	B-problem
carcinoma	I-problem
of	I-problem
the	I-problem
upper	I-problem
aerodigestive	I-problem
tract	I-problem
and	O
anaplastic	B-problem
thyroid	I-problem
carcinoma	I-problem
)	O
,	O
and	O
malignant	B-problem
salivary	I-problem
gland	I-problem
neoplasms	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

Pt	O
was	O
transferred	O
here	O
for	O
further	B-treatment
mgmt	I-treatment
of	I-treatment
airway	I-treatment
and	O
large	B-problem
thyroid	I-problem
mass	I-problem
by	O
our	O
IP	O
team	O
.	O

IP	O
found	O
endotracheal	B-problem
obstructing	I-problem
tumor	I-problem
and	O
extrinsic	B-problem
compression	I-problem
of	I-problem
the	I-problem
high	I-problem
trachea	I-problem
by	O
thyroid	B-problem
mass	I-problem
.	O

After	O
rigid	B-test
bronchoscopy	I-test
with	O
removal	B-treatment
of	O
the	B-problem
intratracheal	I-problem
tumor	I-problem
component	I-problem
on	O
2018-04-24	O
,	O
stat	B-test
pathology	I-test
showed	O
anaplastic	B-problem
tumor	I-problem
.	O

He	O
was	O
tranferred	O
to	O
the	O
CMED	O
.	O

Subsequently	O
extubated	O
and	O
his	O
respiratory	B-problem
Sx	I-problem
are	O
now	O
improved	O
.	O

Pt	O
was	O
seen	O
by	O
Rad	O
Onc	O
,	O
who	O
recommended	O
transfer	O
to	O
the	O
East	O
Campus	O
for	O
XRT	B-treatment
.	O

On	O
the	O
morning	O
of	O
possible	B-treatment
radiation	I-treatment
,	O
patient	O
and	O
family	O
met	O
with	O
interventional	O
pulmonary	O
team	O
who	O
explained	O
that	O
the	B-test
most	I-test
recent	I-test
CT	I-test
showed	O
further	B-problem
invasion	I-problem
of	I-problem
the	I-problem
tumor	I-problem
into	O
the	O
trachea	O
.	O

After	O
a	O
long	O
discussion	O
,	O
patient	O
and	O
family	O
asked	O
to	O
be	O
made	O
CMO	B-treatment
.	O

Patient	O
was	O
started	O
on	O
morphine	B-treatment
drip	I-treatment
and	O
palliative	O
care	O
team	O
was	O
consulted	O
with	O
recommendations	O
to	O
ensure	O
comfort	O
.	O

Mr	O
.	O
Davison	O
died	O
approximately	O
24	O
hours	O
after	O
decision	O
to	O
be	O
CMO	O
,	O
on	O
2018-05-01	O
.	O

Discharge	O
Disposition	O
:	O

Expired	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

NC	O
PAD-WORD	O

Discharge	O
Condition	O
:	O

NC	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

NC	O
PAD-WORD	O

Followup	O
Instructions	O
:	O

NC	O
PAD-WORD	O

John	O
Iris	O
MD	O
70-363	O

Completed	O
by	O
:	O

Patricia	O
Rojas	O
MD	O
73-701	O
2018-05-06	O
@	O
1434	O

Signed	O
electronically	O
by	O
:	O

DR.	O
John	O
J.	O
Booker	O
on	O
:	O

WED	O
2018-05-30	O
5:50	O
PM	O

(	O
End	O
of	O
Report	O
)	O

060514276	O
SC	O

52175844	O
PAD-WORD	O

023928	O
PAD-WORD	O

2/17/2000	O
12:00:00	O
AM	O

ACUTE	B-problem
PANCREATITIS	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/17/2000	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

02/29/2000	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

ACUTE	B-problem
PANCREATITIS	I-problem
.	O

SECONDARY	O
DIAGNOSIS	O
:	O

GASTROESOPHAGEAL	B-problem
REFLUX	I-problem
DISEASE	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ri	O
Strength	O
is	O
a	O
40	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
GERD	B-problem
,	O
who	O
presents	O
with	O
abdominal	B-problem
pain	I-problem
of	O
seven	O
days	O
duration	O
.	O

The	O
patient	O
was	O
in	O
general	O
good	O
health	O
until	O
seven	O
days	O
ago	O
(	O
2/11/00	O
)	O
,	O
when	O
he	O
had	O
a	O
sudden	O
onset	O
of	O
sharp	B-problem
left	I-problem
flank	I-problem
pain	I-problem
with	O
radiation	B-problem
to	I-problem
the	I-problem
lower	I-problem
abdomen	I-problem
and	O
then	O
to	O
the	O
epigastrium	O
.	O

The	O
patient	O
described	O
the	B-problem
pain	I-problem
as	O
&quot;	O
knife-like	B-problem
&quot;	O
with	O
a	O
severity	O
of	O
1/25	O
at	O
its	O
worse	O
.	O

The	O
patient	O
was	O
exacerbated	O
when	O
eating	O
and	O
when	O
lying	O
flat	O
.	O

The	O
patient	O
also	O
reports	O
blood-streaked	B-problem
diarrhea	I-problem
for	O
two	O
days	O
.	O

He	O
denies	O
nausea	B-problem
and	O
vomiting	B-problem
.	O

He	O
has	O
had	O
no	O
fevers	B-problem
or	O
chills	B-problem
.	O

He	O
has	O
had	O
no	O
recent	B-problem
weight	I-problem
loss	I-problem
,	O
no	O
light-headedness	B-problem
or	O
dizziness	B-problem
.	O

He	O
denies	O
increased	B-problem
urinary	I-problem
frequent	I-problem
or	O
urgency	B-problem
.	O

The	O
patient	O
presented	O
to	O
the	O
Sloan-	O
Center	O
Emergency	O
Department	O
,	O
where	O
he	O
was	O
resuscitated	O
with	O
normal	B-treatment
saline	I-treatment
and	O
received	O
morphine	B-treatment
for	O
pain	B-problem
.	O

He	O
was	O
then	O
transferred	O
to	O
the	O
general	O
medicine	O
service	O
for	O
further	B-treatment
management	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

(1)	O
GERD	B-problem
;	O
(2)	O
Pneumonia	B-problem
with	O
partially	B-problem
collapsed	I-problem
lung	I-problem
in	O
1999	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

Prilosec	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

GERD	B-problem
and	O
PUD	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
currently	O
lives	O
in	O
Son	O
Wooda	O
with	O
his	O
wife	O
.	O

He	O
has	O
been	O
a	O
construction	O
worker	O
for	O
the	O
past	O
20	O
years	O
.	O

The	O
patient	O
admits	O
to	O
smoking	O
one	O
pack	O
of	O
cigarettes	O
per	O
day	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
excessive	O
alcohol	O
use	O
.	O

He	O
currently	O
drinks	O
10	O
beers	O
every	O
other	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

VITAL	O
SIGNS	O
:	O

Temp	B-test
98.5	O
,	O
heart	B-test
rate	I-test
74	O
,	O
BP	B-test
140/90	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
O2	B-test
sat	I-test
98%	O
.	O

GENERAL	O
:	O

The	O
patient	O
was	O
alert	O
but	O
in	O
mild	B-problem
discomfort	I-problem
.	O

HEENT	O
:	O

PERRL	O
,	O
EOMI	O
,	O
oropharynx	O
clear	O
,	O
moist	O
buccal	O
mucosa	O
.	O

NECK	O
:	O

No	O
lymphadenopathy	B-problem
,	O
no	O
JVD	B-problem
.	O

LUNGS	O
:	O

Bibasilar	B-problem
crackles	I-problem
.	O

Breath	O
sounds	O
were	O
of	O
good	O
intensity	O
.	O

HEART	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
S1	O
,	O
S2	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

ABDOMEN	O
:	O

Soft	O
,	O
non-distended	B-problem
.	O

Tender	B-problem
to	O
palpation	B-test
at	I-test
the	I-test
left	I-test
lower	I-test
quadrant	I-test
and	O
especially	O
at	O
the	O
epigastrium	O
.	O

There	O
was	O
no	O
splenomegaly	B-problem
or	O
hepatosplenomegaly	B-problem
.	O

Bowel	O
sounds	O
were	O
present	O
.	O

BACK	O
:	O

Point	B-problem
tenderness	I-problem
at	I-problem
the	I-problem
left	I-problem
costovertebral	I-problem
angle	I-problem
.	O

EXTREMITIES	O
:	O

Warm	O
to	O
touch	O
,	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
,	O
or	O
edema	B-problem
.	O

NEURO	O
:	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
x3	O
.	O

Deep	B-test
tendon	I-test
reflexes	I-test
were	O
equal	O
and	O
adequate	O
in	O
upper	O
and	O
lower	O
extremities	O
.	O

Cerebellar	O
function	O
was	O
intact	O
.	O

Sensation	O
was	O
intact	O
to	O
pain	B-problem
and	O
light	B-test
touch	I-test
.	O

LABORATORY	O
DATA	O
:	O

Chem-7	B-test
-	O
Na	B-test
139	O
,	O
K	B-test
3.7	O
,	O
Cl	B-test
99	O
,	O
bicarb	B-test
28	O
,	O
BUN	B-test
15	O
,	O
creatinine	B-test
0.9	O
,	O
glucose	B-test
89	O
.	O

Liver	B-test
function	I-test
tests	I-test
were	O
significant	O
for	O
an	B-test
ALT	I-test
41	O
,	O
AST	B-test
31	O
,	O
alk	B-test
phos	I-test
76	O
,	O
T.	B-test
bili	I-test
0.7	O
,	O
D.	B-test
bili	I-test
0.2	O
,	O
amylase	B-test
345	O
,	O
lipase	B-test
2510	O
,	O
T.	B-test
protein	I-test
8.1	O
,	O
albumin	B-test
4.9	O
,	O
globulin	B-test
3.2	O
,	O
Ca	B-test
9.9	O
.	O

CBC	B-test
-	O
White	B-test
blood	I-test
cell	I-test
count	I-test
8.82	O
,	O
hemoglobin	B-test
15.2	O
,	O
hematocrit	B-test
43	O
,	O
and	O
platelets	B-test
322	O
.	O

Imaging	B-test
studies	I-test
:	O

Abdominal	B-test
CT	I-test
scan	I-test
on	O
2/21/00	O
-	O
Study	B-test
revealed	O
a	B-problem
prominent	I-problem
pancreas	I-problem
with	O
associated	B-problem
mesenteric	I-problem
stranding	I-problem
.	O

No	O
abscess	B-problem
or	O
pseudocyst	B-problem
.	O

A	B-problem
small	I-problem
gallstone	I-problem
was	O
noted	O
in	O
the	O
gallbladder	O
neck	O
.	O

Bilateral	B-problem
pleural	I-problem
effusion	I-problem
were	O
seen	O
with	O
associated	B-problem
compression	I-problem
atelectasis	I-problem
.	O

Abdominal	B-test
ultrasound	I-test
on	O
2/23/00	O
-	O
This	B-test
study	I-test
revealed	O
gallbladder	B-problem
sludge	I-problem
but	O
no	O
cholelithiasis	B-problem
.	O

There	O
was	O
swelling	B-problem
of	I-problem
the	I-problem
body	I-problem
and	O
tail	O
of	O
the	O
pancreas	O
.	O

Portable	B-test
chest	I-test
on	O
2/23/00	O
-	O
Lungs	O
were	O
clear	O
.	O

Heart	O
was	O
normal	O
.	O

There	O
was	O
no	O
pleural	B-problem
effusion	I-problem
.	O

Chest	B-test
(	I-test
PA	I-test
and	I-test
lateral	I-test
)	I-test
on	O
2/25/00	O
-	O
Lungs	O
were	O
clear	O
.	O

There	O
was	O
no	O
infiltrates	B-problem
or	O
consolidation	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
diagnosed	O
with	O
acute	B-problem
pancreatitis	I-problem
.	O

He	O
was	O
made	O
NPO	B-treatment
and	O
was	O
resuscitated	O
with	O
IV	B-treatment
fluids	I-treatment
.	O

Pain	B-treatment
control	I-treatment
was	O
initiated	O
with	O
morphine	B-treatment
but	O
was	O
then	O
changed	O
to	O
Demerol	B-treatment
,	O
which	O
gave	O
the	O
patient	O
better	O
relief	O
of	O
his	B-problem
epigastric	I-problem
pain	I-problem
.	O

From	O
2/17/00	O
to	O
2/21/00	O
,	O
the	O
patient	O
complained	O
of	O
persistent	B-problem
and	I-problem
occasionally	I-problem
severe	I-problem
epigastric	I-problem
pain	I-problem
.	O

His	B-treatment
pain	I-treatment
medication	I-treatment
was	O
then	O
changed	O
to	O
Dilaudid	B-treatment
IV	I-treatment
in	O
an	O
attempt	O
to	O
better	O
alleviate	O
his	B-problem
symptoms	I-problem
.	O

Dilaudid	B-treatment
IV	I-treatment
was	O
continued	O
for	O
the	O
remainder	O
of	O
the	O
patient	O
&apos;s	O
hospitalization	O
.	O

The	O
does	O
was	O
titrated	O
to	O
the	O
patient	O
&apos;s	O
need	O
for	O
comfort	O
and	O
was	O
eventually	O
tapered	O
.	O

The	O
severity	O
and	O
persistent	O
of	O
the	B-problem
patient	I-problem
&apos;s	I-problem
epigastric	I-problem
pain	I-problem
was	O
concerning	O
for	O
a	B-problem
pancreatic	I-problem
complication	I-problem
such	O
as	O
necrosis	B-problem
or	O
abscess	B-problem
.	O

The	O
patient	O
had	O
a	B-test
CT	I-test
scan	I-test
,	O
which	O
revealed	O
a	B-problem
mass	I-problem
in	I-problem
the	I-problem
gallbladder	I-problem
neck	I-problem
,	O
but	O
no	O
biliary	B-problem
dilatation	I-problem
.	O

There	O
was	O
stranding	B-problem
along	I-problem
the	I-problem
pancreas	I-problem
,	O
but	O
no	O
necrosis	B-problem
,	O
abscess	B-problem
,	O
or	O
pseudocyst	B-problem
.	O

On	O
2/22/00	O
,	O
the	O
patient	O
had	O
fevers	B-problem
to	O
103.5	O
.	O

Blood	B-test
and	I-test
urine	I-test
cultures	I-test
were	O
sent	O
.	O

A	B-test
chest	I-test
x-ray	I-test
was	O
done	O
,	O
which	O
revealed	O
no	O
infiltrate	B-problem
or	O
effusion	B-problem
.	O

The	O
patient	O
was	O
started	O
on	O
cefotaxime	B-treatment
1	O
gm	O
IV	O
for	O
empiric	B-treatment
antibiotic	I-treatment
treatment	I-treatment
.	O

All	B-test
cultures	I-test
were	O
negative	O
.	O

On	O
2/23/00	O
,	O
the	B-problem
high	I-problem
grade	I-problem
fever	I-problem
persisted	O
.	O

An	B-test
ultrasound	I-test
was	O
done	O
to	O
R	O
/	O
O	O
cholestasis	B-problem
or	O
cholangitis	B-problem
.	O

The	B-test
ultrasound	I-test
showed	O
biliary	B-problem
sludge	I-problem
and	O
swelling	B-problem
of	I-problem
the	I-problem
body	I-problem
and	O
tail	O
of	O
the	O
pancreas	O
.	O

No	O
other	B-problem
abnormalities	I-problem
were	O
noted	O
.	O

On	O
2/24/00	O
,	O
the	O
patient	O
had	O
an	O
episode	O
of	O
exacerbation	O
of	O
epigastric	B-problem
pain	I-problem
with	O
radiation	B-problem
to	I-problem
the	I-problem
left	I-problem
upper	I-problem
quadrant	I-problem
.	O

The	B-problem
pain	I-problem
was	O
subsequently	O
relieved	O
with	O
high	B-treatment
dose	I-treatment
Dilaudid	I-treatment
.	O

The	O
patient	O
had	O
a	B-test
follow-up	I-test
chest	I-test
x-ray	I-test
,	O
which	O
was	O
essentially	O
unchanged	O
from	O
previously	O
,	O
showing	O
a	O
normal	O
heart	O
and	O
lungs	O
without	O
infiltrate	B-problem
.	O

From	O
2/25	O
-	O
2/27/00	O
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
fever	I-problem
defervesced	O
and	O
his	B-problem
abdominal	I-problem
pain	I-problem
gradually	O
subsided	O
.	O

The	B-treatment
cefotaxime	I-treatment
was	O
discontinued	O
since	O
no	O
infection	B-problem
was	O
identified	O
.	O

On	O
2/28/00	O
,	O
the	O
patient	O
&apos;s	O
diet	O
was	O
advanced	O
to	O
a	B-treatment
low	I-treatment
fat	I-treatment
solids	I-treatment
(	O
per	O
pancreatitis	B-test
study	I-test
)	O
,	O
which	O
the	O
patient	O
tolerated	O
well	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
on	O
2/29/00	O
,	O
with	O
much	O
improvement	O
of	O
his	B-problem
symptoms	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Prilosec	B-treatment
20	O
mg	O
p.o.	O
q.d.	O
;	O
Percocet	B-treatment
1-2	O
tabs	O
p.o.	O
q.6-8h.	O
x5	O
days	O
;	O
MVI	B-treatment
1	O
tab	O
p.o.	O
q.d.	O

DISCHARGE	O
FOLLOW-UP	O
:	O

The	O
patient	O
was	O
advised	O
to	O
follow-up	O
with	O
Dr.	O
Edwards	O
in	O
clinic	O
in	O
one	O
week	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
condition	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

Dictated	O
By	O
:	O

SON	O
RHALT	O
,	O
SUBINTERN	O
.	O

Attending	O
:	O

MOPAIGEIT	O
S.	O
SOLID	O
,	O
M.D.	O
KP91	O
KX681/6848	O

Batch	O
:	O

52108	O
PAD-WORD	O

Index	O
No.	O
GAEHS07465	O

D	O
:	O

03/01/00	O
PAD-WORD	O

T	O
:	O

03/01/00	O
PAD-WORD	O

CC	O
:	O

1.	O
MOPAIGEIT	O
S.	O
SOLID	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2012-11-21	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-11-28	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1975-05-29	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

Transplant	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
37-year-old	O
female	O
who	O
presents	O
on	O
an	O
elective	O
basis	O
for	O
a	B-treatment
living-related	I-treatment
kidney	I-treatment
transplant	I-treatment
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
end-stage	B-problem
renal	I-problem
failure	I-problem
secondary	O
to	O
type	B-problem
1	I-problem
diabetes	I-problem
with	O
a	B-test
baseline	I-test
creatinine	I-test
of	O
around	O
5	O
.	O

She	O
is	O
receiving	O
a	B-treatment
kidney	I-treatment
from	O
her	O
sister	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
hypertension	B-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
and	O
insulin-dependent	B-problem
diabetes	I-problem
for	O
32	O
years	O
.	O

She	O
is	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
April	O
of	O
this	O
year	O
and	O
subsequently	O
underwent	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
surgery	I-treatment
.	O

She	O
present	O
electively	O
on	O
the	O
morning	O
of	O
her	B-treatment
surgery	I-treatment
with	O
no	O
recent	O
changes	O
in	O
her	B-problem
medical	I-problem
problems	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Sarcoidosis	B-problem
since	O
2001	O
.	O

2.	O
She	O
is	O
status	O
post	O
cholecystectomy	B-treatment
.	O

3.	O
Status	O
post	O
tubal	B-treatment
ligation	I-treatment
.	O

4.	O
Status	O
post	O
left	B-treatment
arteriovenous	I-treatment
graft	I-treatment
placement	I-treatment
for	O
hemodialysis	B-treatment
.	O

5.	O
Insulin-dependent	B-problem
diabetes	I-problem
mellitus	I-problem
times	O
32	O
years	O
.	O

6.	O
Hypertension	B-problem
.	O

7.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
2012-05-06	O
.	O

8.	O
End-stage	B-problem
renal	I-problem
disease	I-problem
,	O
on	O
hemodialysis	B-treatment
for	O
1.5	O
years	O
.	O

ALLERGIES	O
:	O

Allergies	B-problem
include	O
AMOXICILLIN	B-treatment
and	O
CODEINE	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION:	O

1.	O
Insulin	B-treatment
by	O
sliding-scale	O
,	O
NPH	B-treatment
insulin	I-treatment
16	O
units	O
in	O
the	O
morning	O
and	O
6	O
units	O
in	O
the	O
evening	O
.	O

2.	O
Lipitor	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

3.	O
Zoloft	B-treatment
50	O
mg	O
p.o.	O
t.i.d.	O

4.	O
Reglan	B-treatment
10	O
mg	O
p.o.	O
t.i.d.	O

5.	O
Lopressor	B-treatment
50	O
mg	O
p.o.	O
b.i.d.	O

6.	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.d.	O

7.	O
Multivitamin	B-treatment
1	O
p.o.	O
q.d.	O

8.	O
Remeron	B-treatment
p.o.	O
q.d.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
a	O
half	O
to	O
one	O
pack	O
per	O
day	O
smoker	O
for	O
10	O
years	O
who	O
quit	O
approximately	O
one	O
week	O
prior	O
to	O
her	O
admission	O
.	O

She	O
denies	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Physical	B-test
examination	I-test
at	O
the	O
time	O
of	O
admission	O
revealed	O
she	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Blood	B-test
pressure	I-test
was	O
150/79	O
,	O
a	B-test
pulse	I-test
of	O
81	O
.	O

She	O
is	O
legally	B-problem
blind	I-problem
.	O

She	O
was	O
without	O
any	B-problem
adenopathy	I-problem
.	O

Her	O
chest	O
was	O
clear	O
to	O
auscultation	B-test
.	O

Heart	O
had	O
a	O
normal	O
S1	O
and	O
S2	O
,	O
with	O
no	O
murmurs	B-problem
,	O
gallops	B-problem
or	O
rubs	B-problem
.	O

Her	O
abdomen	O
was	O
soft	O
with	O
well-healed	B-problem
incisions	I-problem
.	O

There	O
was	O
no	O
organomegaly	B-problem
.	O

Extremities	O
were	O
without	O
edema	B-problem
.	O

She	O
had	O
a	B-problem
functioning	I-problem
arteriovenous	I-problem
fistula	I-problem
with	O
a	B-problem
thrill	I-problem
and	O
a	B-problem
bruit	I-problem
in	O
her	O
left	O
arm	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
preoperative	O
holding	O
area	O
and	O
taken	O
electively	O
to	O
the	O
operating	O
room	O
.	O

She	O
underwent	O
a	B-treatment
living-related	I-treatment
renal	I-treatment
transplant	I-treatment
in	I-treatment
the	I-treatment
right	I-treatment
iliac	I-treatment
fossa	I-treatment
.	O

The	B-treatment
operation	I-treatment
was	O
somewhat	O
technically	O
difficult	O
secondary	O
to	O
a	B-problem
short	I-problem
segment	I-problem
of	I-problem
ureter	I-problem
which	O
was	O
anastomosed	O
over	O
a	B-treatment
stent	I-treatment
to	O
the	O
bladder	O
.	O

Otherwise	O
,	O
there	O
were	O
difficulties	B-problem
,	O
and	O
estimated	B-problem
blood	I-problem
loss	I-problem
was	O
minimal	O
.	O

She	O
was	O
taken	O
postoperatively	O
to	O
the	O
recovery	O
room	O
already	O
making	O
a	O
large	O
amount	O
of	O
urine	O
.	O

Intraoperatively	O
,	O
for	O
immunosuppression	B-treatment
she	O
received	O
thymoglobulin	B-treatment
and	O
Solu-Medrol	B-treatment
.	O

She	O
was	O
started	O
on	O
Prograf	B-treatment
and	O
CellCept	B-treatment
in	O
the	O
postoperative	O
period	O
.	O

She	O
was	O
also	O
maintained	O
on	O
Bactrim	B-treatment
postoperatively	O
and	O
did	O
not	O
require	O
ganciclovir	B-treatment
,	O
as	O
she	O
and	O
her	O
sister	O
were	O
cytomegalovirus	B-problem
negative	O
.	O

The	O
patient	O
's	O
initial	O
postoperative	O
course	O
was	O
relatively	O
uneventful	O
.	O

Her	B-test
creatinine	I-test
,	O
which	O
was	O
5	O
initially	O
postoperatively	O
,	O
slowly	O
dropped	O
over	O
the	O
next	O
few	O
days	O
until	O
eventually	O
reaching	O
a	O
low	O
of	O
1	O
.	O

She	O
did	O
receive	O
pamidronate	B-treatment
on	O
postoperative	O
day	O
one	O
and	O
received	O
a	O
total	O
of	O
four	O
doses	O
thymoglobulin	B-treatment
.	O

Her	B-treatment
steroid	I-treatment
doses	I-treatment
were	O
slowly	O
tapered	O
over	O
her	O
hospital	O
course	O
,	O
and	O
her	B-test
Prograf	I-test
level	I-test
was	O
adjusted	O
to	O
maintain	O
therapeutic	O
values	O
between	O
10	O
and	O
15	O
.	O

She	O
continued	O
to	O
make	O
good	O
urine	O
over	O
the	O
first	O
few	O
days	O
and	O
had	O
her	O
urine	O
losses	O
replaced	O
with	O
intravenous	B-treatment
fluids	I-treatment
.	O

On	O
postoperative	O
day	O
three	O
,	O
the	O
patient	O
had	O
an	B-problem
episode	I-problem
of	I-problem
shortness	I-problem
of	I-problem
breath	I-problem
that	O
was	O
evaluated	O
by	O
both	O
the	O
Renal	O
and	O
surgical	O
residents	O
.	O

It	O
was	O
found	O
that	O
she	O
was	O
in	O
acute	B-problem
pulmonary	I-problem
edema	I-problem
and	O
required	O
transfer	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
.	O

Her	B-test
blood	I-test
pressure	I-test
at	O
the	O
time	O
of	O
this	O
incident	O
was	O
in	O
the	O
range	O
of	O
200/120	O
.	O

Her	B-test
electrocardiogram	I-test
showed	O
no	O
specific	B-problem
ST	I-problem
changes	I-problem
,	O
but	O
there	O
was	O
some	B-problem
loss	I-problem
of	I-problem
her	I-problem
R	I-problem
wave	I-problem
progression	I-problem
laterally	I-problem
.	O

Serial	B-test
enzymes	I-test
were	O
drawn	O
,	O
and	O
Cardiology	O
was	O
consulted	O
.	O

With	O
blood	B-treatment
pressure	I-treatment
control	I-treatment
via	O
a	B-treatment
nitroglycerin	I-treatment
drip	I-treatment
and	O
fluid	B-treatment
restriction	I-treatment
,	O
the	O
patient	O
quickly	O
improved	O
and	O
a	O
had	O
a	O
relatively	O
short	O
stay	O
in	O
the	O
Intensive	O
Care	O
Unit	O
.	O

Throughout	O
this	O
time	O
,	O
her	B-test
creatinine	I-test
continued	O
to	O
drop	O
,	O
and	O
there	O
was	O
no	O
apparent	B-problem
deleterious	I-problem
effect	I-problem
on	O
her	B-treatment
transplant	I-treatment
from	O
this	O
episode	O
.	O

Her	B-treatment
beta	I-treatment
blocker	I-treatment
was	O
progressively	O
increased	O
,	O
and	O
her	B-treatment
nitroglycerin	I-treatment
drip	I-treatment
was	O
weaned	O
down	O
.	O

Two	O
days	O
after	O
this	O
event	O
,	O
she	O
underwent	O
an	B-test
echocardiogram	I-test
which	O
was	O
significant	O
for	O
slightly	B-problem
depressed	I-problem
left	I-problem
ventricular	I-problem
systolic	I-problem
function	I-problem
with	O
severe	B-problem
posterior	I-problem
wall	I-problem
hypokinesis	I-problem
.	O

This	O
was	O
a	O
change	O
from	O
her	B-test
prior	I-test
echocardiogram	I-test
and	O
demonstrated	O
evidence	O
of	O
a	B-problem
small	I-problem
myocardial	I-problem
infarction	I-problem
.	O

Clinically	O
,	O
she	O
did	O
much	O
better	O
and	O
her	B-test
blood	I-test
pressure	I-test
was	O
optimized	O
prior	O
to	O
discharge	O
.	O

She	O
was	O
transferred	O
out	O
of	O
the	O
Intensive	O
Care	O
Unit	O
on	O
postoperative	O
day	O
five	O
and	O
was	O
stable	O
on	O
the	O
floor	O
for	O
the	O
next	O
two	O
days	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

She	O
was	O
set	O
to	O
be	O
discharged	O
to	O
home	O
on	O
11-28	O
,	O
on	O
postoperative	O
day	O
seven	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE:	O

1.	O
Prograf	B-treatment
4	O
mg	O
p.o.	O
b.i.d.	O
(	O
this	O
may	O
change	O
depending	O
on	O
her	B-test
most	I-test
recent	I-test
Prograf	I-test
level	I-test
which	O
will	O
be	O
drawn	O
on	O
the	O
morning	O
of	O
11-28	O
)	O
.	O

2.	O
Prednisone	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

3.	O
CellCept	B-treatment
1	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Bactrim	B-treatment
1	O
single-strength	O
tablet	O
p.o.	O
q.d.	O

5.	O
Zantac	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O

6.	O
NPH	B-treatment
insulin	I-treatment
16	O
units	O
q.a.m.	O
and	O
6	O
units	O
q.p.m.	O

7.	O
Zoloft	B-treatment
175	O
mg	O
p.o.	O
q.d.	O

8.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

9.	O
Reglan	B-treatment
10	O
mg	O
p.o.	O
t.i.d.	O

10.	O
Percocet	B-treatment
one	O
to	O
two	O
tablets	O
p.o.	O
q.4-6h.	O
p.r.n.	O

11.	O
Lopressor	B-treatment
125	O
mg	O
p.o.	O
b.i.d.	O

12.	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.d.	O

13.	O
Cardizem-CD	B-treatment
180	O
mg	O
p.o.	O
q.d.	O

DISCHARGE	O
FOLLOWUP	O
:	O

Follow-up	O
appointments	O
should	O
be	O
with	O
Dr.	O
Jones	O
and	O
Dr.	O
Yost	O
in	O
the	O
Transplant	O
Clinic	O
.	O

Furthermore	O
,	O
she	O
needs	O
a	O
follow-up	O
appointment	O
with	O
Dr.	O
Miller	O
of	O
Cardiology	O
within	O
the	O
next	O
two	O
weeks	O
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Condition	O
was	O
good	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Status	O
post	O
living-related	B-treatment
renal	I-treatment
transplant	I-treatment
with	O
perioperative	B-problem
small	I-problem
myocardial	I-problem
infarction	I-problem
.	O

Christina	O
Kinde	O
,	O
MD	O

46-131	O
PAD-WORD	O

Dictated	O
By:Lillian	O
U	O
Walley	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2012-11-27	O
PAD-WORD	O

18:32	O
PAD-WORD	O

T	O
:	O

2012-11-28	O
PAD-WORD	O

12:49	O
PAD-WORD	O

JOB#	O
:	O

09180	O
PAD-WORD	O

(	O
cclist	O
)	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Thomas	O
Rosier	O
on	O
:	O

FRI	O
2012-12-07	O
3:33	O
PM	O

(	O
End	O
of	O
Report	O
)	O

060972300	O
PAD-WORD	O

NVH	O
PAD-WORD	O

58893318	O
PAD-WORD	O

2/1/2002	O
12:00:00	O
AM	O

CONGESTIVE	B-problem
HEART	I-problem
FAILURE	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/01/2002	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

02/08/2002	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Saujule	O
Study	O
is	O
a	O
77-year-old	O
woman	O
with	O
a	O
history	O
of	O
obesity	B-problem
and	O
hypertension	B-problem
who	O
presents	O
with	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
x	O
5	O
days	O
.	O

Her	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
has	O
been	O
progressive	O
over	O
the	O
last	O
2-3	O
years	O
.	O

She	O
has	O
an	B-problem
associated	I-problem
dry	I-problem
cough	I-problem
but	O
no	O
fevers	B-problem
,	O
chills	B-problem
,	O
or	O
leg	B-problem
pain	I-problem
.	O

She	O
has	O
dyspnea	B-problem
on	O
exertion	O
.	O

She	O
ambulates	O
with	O
walker	B-treatment
and	O
a	B-treatment
cane	I-treatment
secondary	O
to	O
osteoarthritis	B-problem
.	O

She	O
becomes	O
short	B-problem
of	I-problem
breath	I-problem
just	O
by	O
getting	O
up	O
from	O
her	O
chair	O
and	O
can	O
only	O
walk	O
2-3	O
steps	O
on	O
a	O
flat	O
surface	O
.	O

She	O
feels	O
light	B-problem
headed	I-problem
when	O
getting	O
up	O
.	O

Her	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
dyspnea	B-problem
on	O
exertion	O
has	O
been	O
progressive	O
for	O
the	O
past	O
several	O
years	O
.	O

It	O
has	O
not	O
been	O
sudden	O
or	O
acute	O
.	O

She	O
sleeps	O
in	O
a	O
chair	O
up	O
right	O
for	O
the	O
last	O
2	O
1/2	O
years	O
secondary	O
to	O
osteoarthritis	B-problem
.	O

She	O
has	O
orthopnea	B-problem
as	O
well	O
but	O
noparoxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

She	O
occasionally	O
feels	O
chest	B-problem
twinges	I-problem
which	O
are	O
nonradiating	B-problem
but	O
are	O
sharp	B-problem
.	O

They	O
last	O
a	O
few	O
seconds	O
on	O
the	O
left	O
side	O
and	O
are	O
not	O
associated	O
with	O
sweating	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
or	O
syncope	B-problem
.	O

She	O
has	O
had	O
lower	B-problem
extremity	I-problem
edema	I-problem
for	O
thelast	O
several	O
years	O
with	O
multiple	O
episodes	O
of	O
cellulitis	B-problem
.	O

Her	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
has	O
increased	O
for	O
the	O
several	O
weeks	O
prior	O
to	O
admission	O
secondary	O
to	O
an	O
inability	O
to	O
elevate	O
her	O
legs	O
due	O
to	O
a	O
broken	O
chair	O
at	O
home	O
.	O

She	O
denies	O
any	B-problem
pleural	I-problem
chest	I-problem
pain	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Negative	O
for	O
headaches	B-problem
,	O
vision	B-problem
changes	I-problem
,	O
numbness	B-problem
,	O
tingling	B-problem
,	O
dyspnea	B-problem
,	O
hematuria	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
diarrhea	B-problem
,	O
melena	B-problem
or	O
hematochezia	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Obesity	B-problem
,	O
hypertension	B-problem
,	O
lower	B-problem
extremity	I-problem
cellulitis	I-problem
and	O
edema	B-problem
,	O
breast	B-problem
cancer	I-problem
in	O
1988	O
treated	O
with	O
right	B-treatment
lumpectomy	I-treatment
and	O
XRT	B-treatment
,	O
partial	B-treatment
thyroidectomy	I-treatment
in	O
1963	O
,	O
osteoarthritis	B-problem
with	O
right	B-problem
leg	I-problem
deformities	I-problem
,	O
hernia	B-treatment
repair	I-treatment
50	O
years	O
ago	O
,	O
bilateral	B-treatment
cataract	I-treatment
surgery	I-treatment
.	O

ALLERGIES	O
:	O

Codeine	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Hydrochlorothiazide	B-treatment
50	O
mg	O
p.o.	O
q	O
day	O
,	O
atenolol	B-treatment
50	O
mg	O
p.o.	O
q	O
day	O
,	O
dicloxacillin	B-treatment
started	O
on	O
December	O
29	O
,	O
2002	O
,	O
Naproxen	B-treatment
500	O
mg	O
p.o.	O
t.i.d.	O
,	O
aspirin	B-treatment
81	O
mg	O
p.o.	O
q	O
day	O
,	O
Tylenol	B-treatment
p.r.n.	O

SOCIAL	O
HISTORY	O
:	O

Widowed	O
since	O
1972	O
,	O
no	O
tobacco	O
,	O
no	O
alcohol	O
,	O
lives	O
alone	O
.	O

Smoked	O
3	O
packs	O
per	O
day	O
x	O
17	O
years	O
.	O

FAMILY	O
HISTORY	O
:	O

Son	O
died	O
at	O
50	O
of	O
diabetes	B-problem
and	O
myocardial	B-problem
infarction	I-problem
.	O

PHYSICAL	O
EXAM	O
:	O

In	O
the	O
emergency	O
room	O
,	O
vitals	B-test
were	O
temperature	B-test
96.4	O
,	O
pulse	B-test
40-50	O
,	O
blood	B-test
pressure	I-test
154-58	O
,	O
satting	O
86%	O
on	O
room	O
air	O
,	O
99%	O
on	O
3	O
liters	O
of	O
3	B-treatment
liters	I-treatment
cannula	I-treatment
.	O

Rate	B-test
28	O
.	O

HEENT	O
:	O

Anicteric	B-problem
.	O

Extraocular	O
movements	O
intact	O
.	O

2	B-test
plus	I-test
carotids	I-test
.	O

No	O
delayed	B-problem
upstroke	I-problem
.	O

Oropharynx	O
is	O
clear	O
without	O
lymphadenopathyin	B-problem
the	I-problem
neck	I-problem
.	O

Jugular	B-problem
venous	I-problem
distention	I-problem
to	O
the	O
jaw	O
.	O

Positive	O
hepatojugular	O
reflexes	O
.	O

LUNGS	O
:	O

Crackles	B-problem
1/3	I-problem
up	I-problem
bilaterally	I-problem
.	O

CARDIAC	O
:	O

Regular	O
,	O
rate	O
and	O
rhythm	O
.	O

Normal	O
S1	O
and	O
S2	O
.	O

3/6	B-problem
crescendo	I-problem
decrescendo	I-problem
murmur	I-problem
at	I-problem
the	I-problem
right	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
with	O
radiation	B-problem
to	I-problem
the	I-problem
carotids	I-problem
.	O

No	O
rubs	B-problem
or	O
gallops	B-problem
.	O

ABDOMEN	O
:	O

Soft	O
,	O
obese	B-problem
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

No	O
hepatosplenomegaly	B-problem
.	O

EXTREMITIES	O
:	O

3	B-problem
plus	I-problem
pitting	I-problem
edema	I-problem
to	I-problem
the	I-problem
knee	I-problem
bilaterally	I-problem
with	O
areas	O
of	O
darkened	B-problem
erythema	I-problem
which	O
is	O
crusted	B-problem
,	O
indented	B-problem
.	O

A	B-problem
shallow	I-problem
chronic	I-problem
ulcer	I-problem
in	I-problem
the	I-problem
right	I-problem
shin	I-problem
with	O
desquamation	B-problem
bilaterally	I-problem
around	I-problem
the	I-problem
ankle	I-problem
and	O
half	O
way	O
up	O
the	O
shin	O
.	O

1	B-problem
x	I-problem
2	I-problem
cm	I-problem
ulcer	I-problem
with	O
clean	O
sharp	O
borders	O
to	O
the	O
dermatome	O
on	O
the	O
left	O
posterior	O
thigh	O
.	O

NEUROLOGICAL	O
:	O

Alert	O
and	O
oriented	O
x	O
3	O
.	O

Cranial	O
nerves	O
II-XII	O
intact	O
.	O

4/5	O
lower	O
extremity	O
bilaterally	O
.	O

5/5	O
strength	O
upper	O
extremities	O
bilaterally	O
.	O

Unable	O
to	O
assess	O
reflexes	B-test
due	O
to	O
the	B-problem
knee	I-problem
deformities	I-problem
.	O

2	B-test
plus	I-test
reflexes	I-test
in	O
the	O
upper	O
extremities	O
symmetrically	O
bilaterally	O
.	O

Toes	O
downgoing	O
.	O

LABORATORY	O
DATA	O
ON	O
ADMISSION	O
:	O

Sodium	B-test
134	O
,	O
potassium	B-test
4.0	O
,	O
chloride	B-test
91	O
,	O
bicarbonate	B-test
33	O
,	O
BUN	B-test
21	O
,	O
creatinine	B-test
1.1	O
,	O
glucose	B-test
99	O
,	O
CK	B-test
22	O
,	O
troponin	B-test
0	O
.	O

Calcium	B-test
8.8	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
10.6	O
,	O
hematocrit	B-test
37.1	O
,	O
platelets	B-test
289	O
.	O

INR	B-test
1.1	O
,	O
PTT	B-test
30.3.Chest	B-test
x-ray	I-test
shows	O
cardiomegaly	B-problem
.	O

Small	B-problem
left	I-problem
effusion	I-problem
.	O

Lobular	B-problem
density	I-problem
at	I-problem
the	I-problem
right	I-problem
hilum	I-problem
.	O

No	O
pneumonia	B-problem
.	O

Electrocardiogram	B-test
shows	O
normal	O
sinus	O
rhythm	O
at	O
50	O
.	O

Normal	O
axis	O
.	O

primary	B-problem
AV	I-problem
block	I-problem
.	O

Left	B-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
acute	B-problem
and	I-problem
chronic	I-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

1.	O
Cardiovascular	O
:	O

The	O
patient	O
was	O
found	O
to	O
be	O
in	O
congestive	B-problem
heart	I-problem
failure	I-problem
and	O
thought	O
likely	O
secondary	O
to	O
diastolic	B-problem
dysfunction	I-problem
secondary	O
to	O
hypertension	B-problem
.	O

The	O
patient	O
was	O
also	O
found	O
to	O
have	O
pulmonary	B-problem
hypertension	I-problem
.	O

She	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
with	O
3	O
negative	O
enzymes	O
.	O

On	O
admission	O
,	O
she	O
was	O
diuresed	O
with	O
Lasix	B-treatment
and	O
was	O
negative	O
1-2	O
liters	O
per	O
day	O
for	O
several	O
days	O
.	O

The	B-treatment
diuresis	I-treatment
was	O
backed	O
off	O
when	O
her	B-test
bicarbonate	I-test
increased	O
from	O
36	O
to	O
39	O
.	O

She	O
was	O
restarted	O
on	O
20	O
mg	O
p.o.	O
q	O
day	O
prior	O
to	O
discharge	O
.	O

Her	B-test
lipids	I-test
were	O
checked	O
with	O
a	B-test
total	I-test
cholesterol	I-test
of	O
110	O
,	O
triglycerides	B-test
59	O
,	O
HDL32	B-test
,	O
LDL	B-test
64	O
.	O

The	O
patient	O
had	O
a	B-test
D-dimer	I-test
greater	O
than	O
1000	O
with	O
lower	B-test
extremity	I-test
non-invasive	I-test
studies	I-test
which	O
were	O
positive	O
for	O
a	B-problem
small	I-problem
right	I-problem
common	I-problem
femoral	I-problem
clot	I-problem
.	O

It	O
was	O
unclear	O
whether	O
this	O
was	O
old	O
or	O
new	O
.	O

A	B-test
TTE	I-test
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
60%	O
,	O
mild	B-problem
mitral	I-problem
regurgitation	I-problem
,	O
left	B-problem
atrial	I-problem
enlargement	I-problem
,	O
mild	B-problem
tricuspid	I-problem
regurgitation	I-problem
,	O
pulmonary	B-test
artery	I-test
pressures	I-test
of	O
44	B-test
plus	I-test
right	I-test
atrial	I-test
pressure	I-test
.	O

There	O
was	O
an	B-problem
intra-atrial	I-problem
shunt	I-problem
from	O
the	O
right	O
to	O
the	O
left	O
through	O
a	B-problem
patent	I-problem
foramen	I-problem
ovale	I-problem
.	O

Chest	B-test
CT	I-test
was	O
a	B-test
poor	I-test
study	I-test
but	O
did	O
not	O
show	O
a	B-problem
pulmonary	I-problem
embolus	I-problem
.	O

The	O
patient	O
had	O
subsequent	B-test
dobutamine	I-test
MIBI	I-test
which	O
was	O
positive	O
for	O
inducible	B-problem
ischemia	I-problem
in	O
the	O
distribution	O
of	O
posterior	O
descending	O
coronary	O
artery	O
and	O
posterolateral	O
coronary	O
artery	O
with	O
a	B-problem
small	I-problem
to	I-problem
medium	I-problem
perfusion	I-problem
defect	I-problem
in	O
the	O
inferolateral	O
wall	O
and	O
basal	O
inferior	O
wall	O
which	O
was	O
partially	O
reversible	O
.	O

The	O
cardiology	O
service	O
saw	O
the	O
patient	O
and	O
recommended	O
medical	O
management	O
only	O
without	O
catheterization	B-test
.	O

Her	B-test
blood	I-test
pressure	I-test
was	O
high	B-problem
so	O
Captopril	B-treatment
was	O
titrated	O
up	O
to	O
50	O
mg	O
p.o.	O
t.i.d.	O
.	O

She	O
will	O
be	O
discharged	O
on	O
Lisinopril	B-treatment
with	O
further	O
titration	O
as	O
an	O
outpatient	O
.	O

She	O
is	O
on	O
hydrochlorothiazide	B-treatment
50	O
mg	O
p.o.	O
q	O
day	O
.	O

Her	B-treatment
atenolol	I-treatment
was	O
stopped	O
due	O
to	O
bradycardia	B-problem
on	O
admission	O
but	O
this	O
may	O
be	O
restarted	O
as	O
an	O
outpatient	O
in	O
gentle	B-treatment
doses	I-treatment
with	O
careful	O
monitoring	O
of	O
heart	B-test
rate	I-test
.	O

She	O
is	O
on	O
an	B-treatment
aspirin	I-treatment
.	O

She	O
will	O
be	O
discharged	O
on	O
Lasix	B-treatment
20	O
mg	O
for	O
continued	O
control	O
of	O
her	B-problem
edema	I-problem
.	O

2.	O
Pulmonary	O
;	O

Pulmonary	B-problem
hypertension	I-problem
as	O
seen	O
on	O
echocardiogram	B-test
.	O

Unclear	O
whether	O
there	O
are	O
chronic	B-problem
pulmonary	I-problem
embolus	I-problem
but	O
did	O
have	O
positive	O
test	O
for	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
and	O
will	O
be	O
treated	O
with	O
Coumadin	B-treatment
.	O

An	B-test
ABG	I-test
was	O
done	O
which	O
showed	O
pH	B-test
7.34	O
,	O
pCO2	B-test
78	O
,	O
pO2	B-test
92	O
on	O
2	O
liters	O
.	O

Her	B-test
bicarbonate	I-test
peaked	O
at	O
39	O
and	O
generally	O
is	O
in	O
the	O
36-38	O
range	O
.	O

She	O
has	O
severe	B-problem
sleep	I-problem
apnea	I-problem
and	O
falls	O
asleep	O
midsentence	O
.	O

She	O
has	O
episodes	O
of	O
not	B-problem
breathing	I-problem
.	O

BIPAP	B-treatment
was	O
attempted	O
for	O
3	O
nights	O
in	O
a	O
row	O
and	O
the	O
patient	O
did	O
not	O
tolerate	O
this	O
.	O

She	O
will	O
need	O
pulmonary	B-test
function	I-test
studies	I-test
as	O
an	O
outpatient	O
as	O
these	O
were	O
not	O
done	O
in	O
the	O
hospital	O
.	O

The	O
pulmonary	O
team	O
saw	O
the	O
patient	O
and	O
only	O
recommended	O
the	B-test
above	I-test
testing	I-test
.	O

She	O
needs	O
home	B-treatment
oxygen	I-treatment
and	O
is	O
currently	O
at	O
2	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
oxygen	I-treatment
.	O

3.	O
Infectious	B-problem
disease	I-problem
:	O

Evidence	O
for	O
cellulitis	B-problem
on	I-problem
her	I-problem
legs	I-problem
,	O
likely	O
due	O
to	O
distention	B-problem
from	O
edema	B-problem
and	O
poor	B-problem
perfusion	I-problem
.	O

She	O
was	O
originally	O
started	O
on	O
cefazolin	B-treatment
which	O
was	O
then	O
changed	O
to	O
Keflex	B-treatment
with	O
good	O
improvement	O
.	O

She	O
will	O
need	O
to	O
continue	O
for	O
at	O
least	O
10	O
more	O
days	O
or	O
as	O
clinically	O
indicated	O
by	O
the	O
course	O
of	O
her	B-problem
cellulitis	I-problem
.	O

4.	O
Hematology	O
:	O

D-dimer	B-test
in	O
the	O
emergency	O
room	O
was	O
greater	O
than	O
1000	O
and	O
a	B-problem
right	I-problem
common	I-problem
femoral	I-problem
clot	I-problem
was	O
seen	O
.	O

This	B-problem
clot	I-problem
was	O
small	O
and	O
it	O
was	O
questionable	O
as	O
to	O
whether	O
it	O
was	O
old	O
or	O
new	O
.	O

She	O
was	O
started	O
on	O
anticoagulation	B-treatment
given	O
the	B-problem
positive	I-problem
D-dimer	I-problem
.	O

Chest	B-test
CT	I-test
was	O
nondiagnostic	O
but	O
did	O
not	O
show	O
pulmonary	B-problem
embolus	I-problem
.	O

It	O
was	O
a	B-test
poor	I-test
study	I-test
.	O

Heparin	B-treatment
was	O
maintained	O
during	O
her	O
hospital	O
course	O
and	O
then	O
Lovenox	B-treatment
was	O
started	O
.	O

Her	B-treatment
dose	I-treatment
was	O
increased	O
to	O
7.5	O
mg	O
q	O
day	O
the	O
day	O
prior	O
to	O
discharge	O
.	O

She	O
will	O
be	O
discharged	O
on	O
this	O
dose	O
in	O
addition	O
to	O
1	O
day	O
of	O
Lovenox	B-treatment
.	O

Discharge	B-test
INR	I-test
1.8	O
.	O

Goal	B-test
INR	I-test
is	O
2.0-3.0	O
.	O

5.	O
Fluids	O
/	O
electrolytes	O
/	O
nutrition	O
:	O

Low	B-treatment
salt	I-treatment
diet	I-treatment
.	O

Low	B-treatment
cholesterol	I-treatment
,	I-treatment
low	I-treatment
fat	I-treatment
diet	I-treatment
.	O

DISPOSITION	O
ON	O
DISCHARGE	O
:	O

To	O
rehabilitation	B-treatment
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

House	O
diet	O
.	O

No	O
added	O
salt	O
.	O

Low	O
saturated	O
fat	O
.	O

Low	O
cholesterol	O
.	O

ACTIVITY	O
:	O

As	O
tolerated	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

The	O
patient	O
needs	O
physical	B-treatment
therapy	I-treatment
to	O
increase	O
stability	O
in	O
mobilization	O
.	O

Need	O
to	O
try	O
to	O
control	O
blood	B-test
pressure	I-test
.	O

Can	O
increase	O
her	B-treatment
Ace	I-treatment
inhibitor	I-treatment
as	O
tolerated	O
.	O

May	O
start	O
beta-blocker	B-treatment
at	O
a	O
low	O
dose	O
given	O
mild	B-problem
bradycardia	I-problem
at	O
atenolol	B-treatment
50	O
mg	O
p.o.	O
q	O
day	O
.	O

Need	O
to	O
continue	O
oxygen	B-treatment
2	O
liters	O
via	O
nasal	B-treatment
cannula	I-treatment
.	O

Needs	O
anticoagulation	B-treatment
for	O
6	O
months	O
for	O
right	B-problem
common	I-problem
femoral	I-problem
artery	I-problem
deep	I-problem
venous	I-problem
thrombosis	I-problem
.	O

Goal	B-test
INR	I-test
is	O
2.0-3.0	O
.	O

Should	O
continue	O
Keflex	B-treatment
for	O
10	O
more	O
days	O
or	O
as	O
clinically	O
indicated	O
.	O

Need	O
to	O
follow	O
INR	B-test
after	O
Keflex	B-treatment
is	O
discontinued	O
as	O
expect	O
it	O
will	O
change	O
.	O

The	O
patient	O
has	O
severe	B-problem
sleep	I-problem
apnea	I-problem
and	O
stops	O
breathing	O
during	O
sleep	O
.	O

This	O
is	O
her	O
baseline	O
status	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Satisfactory	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Tylenol	B-treatment
650	O
mg	O
p.o.	O
q	O
4-6	O
hours	O
p.r.n.	O
headache	B-problem
,	O
enteric	B-treatment
coated	I-treatment
aspirin	I-treatment
325	O
mg	O
p.o.	O
q	O
day	O
,	O
calcium	B-treatment
gluconate	I-treatment
1000	O
mg	O
p.o.	O
b.i.d.	O
,	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O
,	O
enema	B-treatment
of	I-treatment
choice	I-treatment
and	O
laxative	B-treatment
of	I-treatment
choice	I-treatment
p.o.	O
q	O
day	O
p.r.n.	O
constipation	B-problem
,	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q	O
day	O
,	O
Coumadin	B-treatment
7.5	O
mg	O
p.o.q.h.s.	O
for	O
goal	B-test
INR	I-test
of	O
2.0-3.0	O
.	O

Keflex	B-treatment
500	O
mg	O
p.o.	O
q.i.d.	O
x	O
10	O
more	O
days	O
,	O
Miconazole	B-treatment
2%	O
powder	O
topically	O
b.i.d.	O
apply	O
to	O
affected	O
areas	O
of	O
breasts	O
and	O
groins	O
b.i.d.	O
,	O
Lisinopril	B-treatment
20	O
mg	O
p.o.	O
q	O
day	O
hold	O
of	O
systolic	B-test
blood	I-test
pressure	I-test
less	O
than	O
110	O
,	O
Lovenox	B-treatment
100	O
mg	O
subcutaneously	O
q	O
12	O
hours	O
x	O
2	O
doses	O
and	O
then	O
discontinued	O
,	O
atenolol	B-treatment
12.5	O
mg	O
p.o.	O
q	O
day	O
hold	O
for	O
a	B-test
systolic	I-test
blood	I-test
pressure	I-test
of	O
less	O
than	O
110	O
,	O
heart	B-test
rate	I-test
less	O
than	O
55	O
.	O

Dictated	O
By	O
:	O

MONAHA	O
SCREEN	O
,	O
M.D.	O
YR61	O

Attending	O
:	O

CAR	O
APRUESS	O
,	O
M.D.	O
FS15	O
TX837/072487	O

Batch	O
:	O

3205	O
PAD-WORD	O

V2ZAS8884	O
J	O

D	O
:	O

02/08/02	O
PAD-WORD	O

T	O
:	O

02/08/02	O
PAD-WORD	O

Admission	O
Date	O
:	O

2018-12-04	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2018-12-12	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1984-02-13	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

OBSTETRICS/GYNECOLOGY	O
PAD-WORD	O

Allergies	O
:	O

Ciprofloxacin	B-treatment
/	O
Flagyl	B-treatment

Attending	O
:	O

Ana	O
K	O
Warren	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Pelvic	B-problem
organ	I-problem
prolapse	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

total	B-treatment
vaginal	I-treatment
hysterectomy;	I-treatment
combined	O
anterior-posterior	B-treatment
colporrhaphy	I-treatment
with	O
posterior	B-treatment
mesh;	I-treatment
subpubic	B-treatment
urethral	I-treatment
sling;	I-treatment
sacrospinous	B-test
colpopexy	I-test
exploratory	I-test
laparotomy	I-test

Reexploration	B-test
of	I-test
vaginal	I-test
surgical	I-test
area	I-test
pelvic	I-test
angiography	I-test

History	O
of	O
Present	O
Illness	O
:	O

34	O
yo	O
G3P3	O
with	O
pelvic	B-problem
organ	I-problem
prolapse	I-problem
after	O
her	O
second	O
delivery;	O
after	O
her	O
third	O
delivery	O
it	O
became	O
much	B-problem
worse	I-problem
.	O

She	O
feels	O
like	O
"everything	O
is	O
falling	O
out."	O

She	O
urinates	O
frequently	O
,	O
but	O
occasionally	O
the	O
urine	O
is	O
very	B-problem
slow	I-problem
to	I-problem
start	I-problem
.	O

She	O
is	O
unable	O
to	O
run	O
without	O
losing	O
urine	O
.	O

The	B-problem
prolapse	I-problem
is	O
especailly	O
large	B-problem
and	I-problem
uncomfotable	I-problem
when	O
she	O
tries	O
to	O
move	O
her	O
bowels	O
and	O
it	O
is	O
easier	O
for	O
her	O
to	O
do	O
sowhile	O
standing	O
rather	O
than	O
sitting	O
.	O

She	O
has	O
deep	B-problem
pain	I-problem
in	O
intercourse	O
.	O

Past	O
Medical	O
History	O
:	O

Medical	O
PAD-WORD	O

Chronic	B-problem
back	I-problem
pain	I-problem
:	O
several	B-problem
discs	I-problem
and	O
spondylolisthesis	B-problem

Surgical	O
PAD-WORD	O

Left	B-treatment
salpingo	I-treatment
oophorectomy	I-treatment
2002	O
for	O
torsion;	B-problem
coloposcopy	B-test
and	O
cryotherapy	B-treatment
2001;	O
appendectomy;	B-treatment
T	B-treatment
+	I-treatment
A	I-treatment

Ob	O
PAD-WORD	O

3	O
FTNDs	O

Social	O
History	O
:	O

Occasional	O
EtOH	O

1ppd	O
tobacco	O

Family	O
History	O
:	O

Mother	O
had	O
breast	B-problem
cancer	I-problem

Physical	O
Exam	O
:	O

112	O
#	O

138/94	O
PAD-WORD	O

Gen	O
:	O

NAD	B-problem
PAD-WORD	O

Heart	O
:	O

RRR	O
,	O
no	O
murmurs	B-problem

Lungs	O
:	O

Clear	O
to	O
percussion	B-test
and	O
auscultation	B-test

Breast	O
:	O

Negative	O
PAD-WORD	O

Abdomen	O
:	O

Negative	O
PAD-WORD	O

Pelvic	O
PAD-WORD	O

Ext	O
gen	O
:	O

negative	O
PAD-WORD	O

Support	O
:	O

Anterior	B-problem
wall	I-problem
prolapses	I-problem
3	O
cm	O
past	O
the	O
hymen	O
with	O
loss	B-problem
of	I-problem
urine	I-problem
on	I-problem
valsalva;	I-problem
cervix	O
1cm	O
above	O
the	O
hymen;	O
posterior	B-problem
prolapse	I-problem
only	O
to	O
the	O
hymen	O
but	O
3.4	O
cm	O
of	O
perineal	B-problem
descent	I-problem
.	O

Vagina	O
:	O

Negative	O
PAD-WORD	O

Cervix	O
:	O

Negative	O
PAD-WORD	O

Uterus	O
:	O

Anterior	O
,	O
tender	B-problem
on	O
motion	O

Adnexa	O
:	O

Right	O
not	O
palpable	O
,	O
left	O
absent	O

Rectal	O
:	O

Neg	O
PAD-WORD	O

Pertinent	O
Results	O
:	O

RADIOLABLED	B-test
RED	I-test
CELL	I-test
STUDY	I-test
12-05	O

IMPRESSION	O
:	O

No	O
evidence	O
of	O
acute	B-problem
bleed	I-problem
in	I-problem
the	I-problem
abdomen	I-problem
or	I-problem
pelvis	I-problem
.	O

PELVIC	B-test
ARTEROGRAM	I-test
12-05	O

FINDINGS	O
:	O

Images	O
demonstrate	O
diffusely	B-problem
small	I-problem
caliber	I-problem
vasculature	I-problem
consistent	O
with	O
shock	B-problem
.	O

There	O
is	O
luminal	B-problem
irregularity	I-problem
seen	O
in	O
segments	O
of	O
both	O
the	O
left	O
and	O
right	O
external	O
iliac	O
arteries	O
consistent	O
with	O
spasm	B-problem
.	O

Specifically	O
,	O
no	O
extravasation	B-problem
of	I-problem
contrast	I-problem
,	O
obstruction	B-problem
of	I-problem
blood	I-problem
flow	I-problem
,	O
AV	B-problem
fistulization	I-problem
or	O
intimal	B-problem
injury	I-problem
was	O
observed	O
.	O

Thus	O
,	O
no	O
embolotherapy	B-treatment
was	O
embarked	O
upon	O
.	O

IMPRESSION	O
:	O

No	O
active	B-problem
bleeding	I-problem
was	O
observed	O
.	O

PATHOLOGY	O
uterus	O
,	O
tubes	O
,	O
ovaries	O
12-04	O

1.	O
Uterus	O
and	O
cervix	O
,	O
hysterectomy	B-treatment
(	O
A-E	O
):	O

A.	O
Secretory	B-problem
endometrium	I-problem
.	O

B.	O
Cervix	O
with	O
squamous	B-problem
metaplasia	I-problem
.	O

C.	O
Unremarkable	O
myometrium	O
.	O

D.	O
One	B-treatment
intrauterine	I-treatment
device	I-treatment
,	O
gross	O
description	O
.	O

2.	O
Vaginal	O
epithelium	O
(	O
F	O
):	O

Squamous	B-problem
mucosa	I-problem
and	O
skin	O
with	O
no	O
significant	B-problem
pathologic	I-problem
change	I-problem
.	O

2018-12-04	O
06:37PM	O
BLOOD	O

WBC	B-test
-	O
20.0*	O
RBC	B-test
-	O
3.31*	O
Hgb	B-test
-	O
10.2*#	O
Hct	B-test
-	O
31.2*	O

MCV	B-test
-	O
95	O
MCH	B-test
-	O
30.9	O
MCHC	B-test
-	O
32.7	O
RDW	B-test
-	O
13.6	O
Plt	B-test
Ct	I-test
-	O
297	O

2018-12-04	O
08:48PM	O
BLOOD	O

Hct	B-test
-	O
19.5*#	O

2018-12-05	O
01:46AM	O
BLOOD	O

WBC	B-test
-	O
20.0*	O
RBC	B-test
-	O
3.96*	O
Hgb	B-test
-	O
12.5	O
Hct	B-test
-	O
34.4*#	O

MCV	B-test
-	O
87#	O
MCH	B-test
-	O
31.5	O
MCHC	B-test
-	O
36.4*#	O
RDW	B-test
-	O
13.6	O
Plt	B-test
Ct	I-test
-	O
89*#	O

2018-12-05	O
09:45AM	O
BLOOD	O

WBC	B-test
-	O
12.7*	O
RBC	B-test
-	O
3.17*	O
Hgb	B-test
-	O
9.9*	O
Hct	B-test
-	O
27.6*	O

MCV	B-test
-	O
87	O
MCH	B-test
-	O
31.3	O
MCHC	B-test
-	O
35.9*	O
RDW	B-test
-	O
14.2	O
Plt	B-test
Ct	I-test
-	O
104*	O

2018-12-06	O
04:09AM	O
BLOOD	O

WBC	B-test
-	O
12.1*	O
RBC	B-test
-	O
3.73*	O
Hgb	B-test
-	O
11.3*	O
Hct	B-test
-	O
31.5*	O

MCV	B-test
-	O
84	O
MCH	B-test
-	O
30.2	O
MCHC	B-test
-	O
35.8*	O
RDW	B-test
-	O
15.4	O
Plt	B-test
Ct	I-test
-	O
91*	O

2018-12-07	O
12:15AM	O
BLOOD	O

Hct	B-test
-	O
28.7*	O

2018-12-08	O
06:30AM	O
BLOOD	O

Hct	B-test
-	O
27.9*	O

2018-12-10	O
04:45AM	O
BLOOD	O

WBC	B-test
-	O
12.6*	O
RBC	B-test
-	O
3.53*	O
Hgb	B-test
-	O
10.5*	O
Hct	B-test
-	O
30.1*	O

MCV	B-test
-	O
85	O
MCH	B-test
-	O
29.8	O
MCHC	B-test
-	O
35.0	O
RDW	B-test
-	O
14.6	O
Plt	B-test
Ct	I-test
-	O
308#	O

2018-12-04	O
06:37PM	O
BLOOD	O

PT	B-test
-	O
13.0	O
PTT	B-test
-	O
26.1	O
INR	B-test
(	O
PT	B-test
)	O
-	O
1.1	O

2018-12-05	O
02:03PM	O
BLOOD	O

PT	B-test
-	O
13.2*	O
PTT	B-test
-	O
24.2	O
INR	B-test
(	O
PT	B-test
)	O
-	O
1.1	O

2018-12-06	O
04:09AM	O
BLOOD	O

PT	B-test
-	O
11.6	O
PTT	B-test
-	O
23.8	O
INR	B-test
(	O
PT	B-test
)	O
-	O
1.0	O

2018-12-04	O
06:37PM	O
BLOOD	O

Glucose	B-test
-	O
146*	O
UreaN	B-test
-	O
12	O
Creat	B-test
-	O
0.6	O
Na	B-test
-	O
140	O

K	B-test
-	O
4.1	O
Cl	B-test
-	O
108	O
HCO3	B-test
-	O
21*	O
AnGap	B-test
-	O
15	O

2018-12-06	O
04:09AM	O
BLOOD	O

Glucose	B-test
-	O
96	O
UreaN	B-test
-	O
5*	O
Creat	B-test
-	O
0.4	O
Na	B-test
-	O
139	O

K	B-test
-	O
3.1*	O
Cl	B-test
-	O
108	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
8	O

2018-12-08	O
09:20PM	O
BLOOD	O

UreaN	B-test
-	O
4*	O
Creat	B-test
-	O
0.3*	O
Na	B-test
-	O
140	O
K	B-test
-	O
4.0	O
Cl	B-test
-	O
108	O

HCO3	B-test
-	O
27	O
AnGap	B-test
-	O
9	O

2018-12-04	O
06:37PM	O
BLOOD	O

Calcium	B-test
-	O
7.9*	O
Phos	B-test
-	O
4.5	O
Mg	B-test
-	O
1.5*	O

2018-12-06	O
01:03PM	O
BLOOD	O

Calcium	B-test
-	O
7.3*	O
Phos	B-test
-	O
2.3*	O
Mg	B-test
-	O
1.7	O

2018-12-07	O
06:30AM	O
BLOOD	O

Calcium	B-test
-	O
7.5*	O
Mg	B-test
-	O
1.6	O

2018-12-08	O
09:20PM	O
BLOOD	O

Calcium	B-test
-	O
7.5*	O
Phos	B-test
-	O
2.7	O
Mg	B-test
-	O
1.9	O

2018-12-04	O
10:53PM	O
BLOOD	O

Type	O
-	O
ART	O
pO2	B-test
-	O
229*	O
pCO2	B-test
-	O
44	O
pH	B-test
-	O
7.26*	O
calTCO2	B-test
-	O
21	O
Base	B-test
XS	I-test
-	O
-6	O
Intubat	O
-	O
INTUBATED	O
Vent	O
-	O
CONTROLLED	O

2018-12-05	O
09:09AM	O
BLOOD	O

Type	O
-	O
ART	O
Temp	B-test
-	O
37.2	O
Rates	B-test
-	O
/12	O
Tidal	B-test
V	I-test
-	O
560	O

PEEP	B-test
-	O
5	O
FiO2	B-test
-	O
50	O
pO2	B-test
-	O
176*	O
pCO2	B-test
-	O
42	O
pH	B-test
-	O
7.35	O
calTCO2	B-test
-	O
24	O
Base	B-test
XS	I-test
-	O
-2	O

Intubat	O
-	O
INTUBATED	O
Vent	O
-	O
SPONTANEOU	O

Brief	O
Hospital	O
Course	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2018-12-04	O
for	O
TVH	B-treatment
,	O
sacrospinous	B-treatment
fixation	I-treatment
,	O
SPARC	B-treatment
,	O
anterior	B-treatment
and	I-treatment
posterior	I-treatment
repair	I-treatment
with	I-treatment
mesh	I-treatment
,	O
cystoscopy;	B-test
for	O
pelvic	B-problem
organ	I-problem
prolapse	I-problem
.	O

There	O
were	O
no	O
intraoperative	B-problem
complications	I-problem
and	O
the	O
surgical	O
field	O
was	O
hemostatic	O
at	O
the	O
conclusion	O
of	O
the	O
case	O
(	O
see	O
operative	O
report	O
for	O
full	O
description	O
)	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
stable	O
in	O
the	O
PACU	O
and	O
admitted	O
to	O
the	O
CMED	O
CCU	O
floor	O
for	O
routine	B-treatment
care	I-treatment
.	O

At	O
1645	O
12-04	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
hypotensive	B-problem
to	O
70/40	O

HR	B-test
84	O
with	O
symptoms	B-problem
of	I-problem
lightheadedness	I-problem
while	O
lying	O
supine	O
.	O

There	O
was	O
no	O
active	B-problem
bleeding	I-problem
noted	O
at	O
the	O
surgical	O
site	O
on	O
examination	B-test
.	O

A	B-test
STAT	I-test
HCT	I-test
drawn	O
at	O
this	O
time	O
was	O
31.2	O
.	O

The	O
patient	O
was	O
re-evalutated	O
at	O
2000	O
and	O
was	O
found	O
to	O
be	O
tacchycardic	B-problem
to	O
115	O
with	O
BP	B-test
104/50	O
using	O
a	O
manual	O
cuff	O
.	O

Urine	B-test
output	I-test
during	O
the	O
prior	O
two	O
hours	O
had	O
been	O
50cc	O
and	O
24cc	O
.	O

A	B-test
STAT	I-test
HCT	I-test
drawn	O
at	O
this	O
time	O
was	O
19.5	O
.	O

The	O
clinical	O
picture	O
was	O
concerning	O
for	O
a	B-problem
post-operative	I-problem
hematoma	I-problem
.	O

The	O
ICU	O
was	O
alerted	O
to	O
the	O
patient	O
's	O
disposition	O
and	O
the	O
operating	O
room	O
was	O
activated	O
for	O
urgent	B-test
re-exploration	I-test
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
OR	O
on	O
POD#0	O
for	O
re-exploration	B-test
with	I-test
incision	I-test
at	O
2243	O
.	O

Exploratory	B-test
laparotomy	I-test
revealed	O
hemoperitonium	B-problem
and	O
approximately	O
1	O
L	O
of	O
blood	B-problem
was	O
evacuated	O
.	O

There	O
was	O
approximately	O
500cc	O
of	O
retroperitoneal	B-problem
clot	I-problem
.	O

Despite	O
laparotomy	B-test
and	O
re-exploration	B-test
through	I-test
the	I-test
vaginal	I-test
cuff	I-test
,	O
no	O
source	O
for	O
the	B-problem
bleeding	I-problem
could	O
be	O
found	O
.	O

At	O
the	O
conclusion	O
of	O
the	O
case	O
,	O
the	O
patient	O
continued	O
to	O
bleed	O
,	O
allbeit	O
at	O
a	O
less	O
brisk	O
pace	O
.	O

The	B-treatment
endotracheal	I-treatment
tube	I-treatment
was	O
left	O
in	O
place	O
.	O

Intraoperatively	O
,	O
the	O
patient	O
recieved	O
5u	O
PRBC	B-treatment
.	O

IR	O
was	O
consulted	O
to	O
identify	O
the	B-problem
bleeding	I-problem
vessel	I-problem
with	O
angiography	B-test
,	O
then	O
perform	O
embolization	B-treatment
.	O

Tagged	B-test
cell	I-test
and	I-test
angiographic	I-test
studies	I-test
performed	O
immediately	O
after	O
re-exploration	B-test
on	O
12-05	O
did	O
not	O
indetify	O
active	B-problem
bleeding	I-problem
and	O
no	O
emobolization	B-treatment
was	O
indicated	O
.	O

THe	O
patient	O
was	O
stable	O
and	O
remained	O
intubated	B-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
ICU	O
for	O
further	B-treatment
care	I-treatment
.	O

The	O
patient	O
's	O
ICU	O
course	O
was	O
uneventful	O
.	O

There	O
was	O
no	O
evidence	O
of	O
continued	O
bleeding	B-problem
and	O
her	B-test
HCT	I-test
remained	O
stable	O
around	O
30	O
.	O

The	O
pt	O
self-extubated	O
on	O
POD	O
#1	O
.	O

The	O
patient	O
developed	O
a	B-problem
low	I-problem
grade	I-problem
fever	I-problem
to	O
100.1	O
on	O
POD#1	O
which	O
persisted	O
to	O
POD#2	O
and	O
imperic	B-treatment
treatment	I-treatment
with	O
gent/clinda	B-treatment
was	O
started	O
.	O

The	O
patient	O
was	O
stable	O
for	O
transfer	O
to	O
the	O
CMED	O
floor	O
on	O
POD#3	O
.	O

Antibiotics	B-treatment
were	O
discontinued	O
on	O
POD#8	O
and	O
pt	O
remained	O
afebrile	B-problem
thereafter	O
.	O

On	O
POD#9	O
,	O
the	O
patient	O
was	O
afebrile	B-problem
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
ambultating	O
without	O
difficulty	B-problem
and	O
voiding	O
spontaneously	O
.	O

She	O
was	O
discharged	O
home	O
with	O
follow-up	O
in	O
two	O
weeks	O
.	O

Medications	O
on	O
Admission	O
:	O

Zoloft	B-treatment
100mg	O
QD	O

Ritalin	B-treatment
0.5mg	O
BID	O

Loraze3pam	B-treatment
0.5mg	O
BID	O

Percocet	B-treatment
5/325	O
QHS	O

Allergies	O
:	O

Cipro	B-treatment
,	O
Flagyl	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Ibuprofen	B-treatment
600	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:	O
*60	O
Tablets*	O

Refills	O
:	O
*1*	O

2.	O
Oxycodone-Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Capsule(	O
s	O
)*	O

Refills	O
:	O
*2*	O

Continue	O
home	B-treatment
meds	I-treatment
.	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

pelvic	B-problem
organ	I-problem
prolapse	I-problem
stress	B-problem
urinary	I-problem
incontinence	I-problem
retroperitoneal	B-problem
bleed	I-problem
hemoperitoneum	I-problem

Discharge	O
Condition	O
:	O

stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

No	O
heavy	O
lifting	O
for	O
6	O
weeks	O

No	O
abdominal	O
exercises	O
for	O
6	O
weeks	O

Nothing	O
in	O
the	O
vagina	O
for	O
6	O
weeks	O

Keep	O
stools	O
soft	O

Followup	O
Instructions	O
:	O

Please	O
call	O
Dr.	O
Lewis	O
office	O
for	O
an	O
appointment	O
in	O
2	O
weeks	O
.	O

Adam	O
Saundra	O
MD	O
46-863	O

Completed	O
by	O
:	O

Michael	O
KNIGHT	O
MD	O
21-317	O
2018-12-16	O
@	O
1245	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Wanda	O
Detz	O
on	O
:	O

TUE	O
2018-12-18	O
8:13	O
AM	O

(	O
End	O
of	O
Report	O
)	O

061486522	O
PAD-WORD	O

TGCHO	O
PAD-WORD	O

8946835	O
PAD-WORD	O

850116	O
PAD-WORD	O

12/19/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

KOTEFOOKS	O
,	O
DASHA	O

MRN	O
:	O

8946835	O
PAD-WORD	O

Age	O
:	O

89y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

12/19/2001	O
01:44	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
KOTEFOOKS	O
,	O
DASHA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Tecal	O
Galecounxopt	O
Community	O
Hospital	O
on	O
12/19/2001	O
01:44	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
S	O
/	O
P	O
FALL	O
/	O
WEAK	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
TECAL	O
GALENCOUNXOPT	O
COMMUNITY	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
SHUFFCUCH	O
,	O
SEYSHARMSE	O
N	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
HYPERGLYCEMIA	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
418-196-2156	O
.	O

PCP	O
Name	O
:	O

LETTE	O
,	O
VITA	O
N	O

Provider	O
Number	O
:	O

32325	O
PAD-WORD	O

Admission	O
Date	O
:	O

2011-03-06	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-03-21	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1945-09-15	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service:	O
PAD-WORD	O

ADDENDUM	O
:	O

Addendum	O
to	O
hospital	O
course	O
.	O

The	O
patient	O
's	O
actual	O
date	O
of	O
discharge	O
was	O
2011-03-21	O
.	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
rehabilitation	B-treatment
in	O
Brain	O
Tree	O
Maryland	O
.	O

Service	O
is	O
actually	O
Medicine	O
,	O
Newburyport	O
Firm	O
not	O
C-CMED	O
.	O

The	O
Jewish	O
Memorial	O
Hospital	O
hospital	O
course	O
over	O
the	O
1-day	O
addendum	O
is	O
improving	O
.	O

The	O
patient	O
is	O
diuresing	O
well	O
,	O
negative	O
2	O
liters	O
again	O
per	O
day	O
.	O

The	O
patient	O
will	O
be	O
continued	O
on	O
medications	B-treatment
per	O
Discharge	O
Summary	O
with	O
the	O
addition	O
of	O
captopril	B-treatment
ACE	I-treatment
inhibitor	I-treatment
since	O
the	B-test
patient	I-test
's	I-test
blood	I-test
pressure	I-test
is	O
stable	O
.	O

The	O
patient	O
with	O
no	O
new	B-problem
events	I-problem
.	O

The	O
patient	O
's	O
condition	O
on	O
discharge	O
was	O
stable	O
and	O
improved	O
.	O

The	O
patient	O
continues	O
to	O
improve	O
with	O
regard	O
to	O
his	B-problem
scrotal	I-problem
and	I-problem
lower	I-problem
extremity	I-problem
edema	I-problem
.	O

The	O
patient	O
has	O
no	O
lower	B-problem
extremity	I-problem
ulcers	I-problem
,	O
and	O
all	B-problem
former	I-problem
leg	I-problem
excoriations	I-problem
are	O
healing	O
well	O
.	O

The	O
patient	O
ambulating	O
three	O
to	O
four	O
times	O
per	O
day	O
and	O
able	O
to	O
get	O
out	O
of	O
bed	O
using	O
a	B-treatment
walker	I-treatment
.	O

The	O
patient	O
will	O
get	O
rehabilitation	B-treatment
and	O
continue	O
to	O
get	O
care	O
for	O
his	B-problem
fluid	I-problem
status	I-problem
.	O

Shirley	O
H.Q.	O
Neller	O
,	O
M.D.	O

56-333	O
PAD-WORD	O

Dictated	O
By:Caroline	O
D	O
Dempsey	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2011-03-21	O
PAD-WORD	O

14:42	O
PAD-WORD	O

T	O
:	O

2011-03-23	O
PAD-WORD	O

13:01	O
PAD-WORD	O

JOB#	O
:	O

42266	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Shirley	O
X	O
Schaack	O
on	O
:	O

Russell	O
2011-03-24	O
7:54	O
AM	O

(	O
End	O
of	O
Report	O
)	O

062287942	O
PAD-WORD	O

PRGH	O
PAD-WORD	O

14021094	O
PAD-WORD	O

430901	O
PAD-WORD	O

12/22/2000	O
12:00:00	O
AM	O

SYNCOPE	B-problem
PAD-WORD	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

12/22/2000	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/01/2001	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSES	O
:	O

1	O
)	O
PRESYNCOPE	B-problem
.	O

2	O
)	O
DIZZINESS	B-problem
.	O

SECONDARY	O
DIAGNOSES	O
:	O

1	O
)	O
IRON	B-problem
DEFICIENCY	I-problem
ANEMIA	I-problem
,	O
COLONOSCOPY	B-test
IN	O
1990	O
FOLLOWED	O
BY	O
HEMATOLOGY	O
ONCOLOGY	O
THROUGH	O
LYMPNANIER	O
HEALTH	O
SERVICES	O
,	O
DR.	O
NUMBER	O
.	O

2	O
)	O
HISTORY	O
OF	O
DIASTOLIC	B-problem
DYSFUNCTION	I-problem
WITH	O
AN	B-test
ECHOCARDIOGRAM	I-test
IN	O
February	O
OF	O
1998	O
DEMONSTRATING	O
A	O
NORMAL	O
EJECTION	O
FRACTION	O
WITH	O
LEFT	B-problem
VENTRICULAR	I-problem
HYPERTROPHY	I-problem
,	O
STATUS	O
POST	O
ADMISSION	O
AT	O
LYMPNANIER	O
HEALTH	O
SERVICES	O
IN	O
January	O
OF	O
1999	O
FOR	O
DIASTOLIC	B-problem
CONGESTIVE	I-problem
HEART	I-problem
FAILURE	I-problem
REQUIRING	O
AN	O
ADMISSION	O
TO	O
THE	O
CORONARY	O
CARE	O
UNIT	O
.	O

3	O
)	O
HYPOTHYROIDISM	B-problem
.	O

4	O
)	O
RHEUMATOID	B-problem
ARTHRITIS	I-problem
/	O
CUTANEOUS	B-problem
LUPUS	I-problem
(	I-problem
MIXED	I-problem
CONNECTIVE	I-problem
TISSUE	I-problem
DISEASE	I-problem
)	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
80	O
female	O
with	O
a	O
history	O
of	O
diastolic	B-problem
function	I-problem
and	O
heart	B-problem
failure	I-problem
,	O
hypertension	B-problem
and	O
rheumatoid	B-problem
arthritis	I-problem
who	O
presents	O
from	O
an	O
outside	O
hospital	O
with	O
presyncope	B-problem
.	O

The	O
patient	O
reports	O
dizziness	B-problem
intermittently	I-problem
times	O
several	O
months	O
now	O
increasing	O
in	O
frequency	O
described	O
as	O
episodes	O
where	O
she	O
feels	O
faint	B-problem
.	O

The	O
room	O
spins	O
with	O
no	O
visual	B-problem
changes	I-problem
,	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
no	O
palpitations	B-problem
or	O
chest	B-problem
pain	I-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
diaphoresis	B-problem
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
was	O
with	O
some	O
friends	O
,	O
rose	O
from	O
a	O
chair	O
to	O
leave	O
and	O
felt	O
dizzy	B-problem
while	O
ambulating	O
,	O
fell	O
and	O
hit	O
elbow	O
with	O
minor	B-problem
head	I-problem
trauma	I-problem
.	O

The	O
patient	O
denied	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
no	O
bowel	B-problem
or	I-problem
bladder	I-problem
incontinence	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
an	O
outside	O
hospital	O
where	O
she	O
was	O
noted	O
to	O
have	O
a	B-problem
50	I-problem
point	I-problem
discrepancy	I-problem
in	O
her	B-test
upper	I-test
extremity	I-test
blood	I-test
pressures	I-test
,	O
right	O
greater	O
than	O
left	O
.	O

This	O
had	O
been	O
noted	O
in	O
the	O
outpatient	O
setting	O
approximately	O
one	O
to	O
two	O
years	O
prior	O
to	O
admission	O
.	O

The	O
patient	O
had	O
no	O
mediastinal	B-problem
widening	I-problem
on	O
chest	B-test
x-ray	I-test
,	O
but	O
was	O
transferred	O
to	O
Verg	O
Medical	O
Center	O
for	O
further	B-test
evaluation	I-test
.	O

In	O
the	O
emergency	O
room	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
temperature	I-test
was	O
98.8	O
degrees	O
,	O
heart	B-test
rate	I-test
73	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
oxygen	B-test
saturation	I-test
98%	O
on	O
room	O
air	O
.	O

Blood	B-test
pressure	I-test
in	I-test
the	I-test
left	I-test
arm	I-test
demonstrated	O
125/89	O
,	O
blood	B-test
pressure	I-test
in	I-test
the	I-test
right	I-test
arm	I-test
was	O
177/119	O
.	O

The	O
patient	O
had	O
a	B-problem
systolic	I-problem
murmur	I-problem
3/6	O
that	O
radiated	O
to	O
the	O
carotids	O
with	O
a	B-problem
decreased	I-problem
left	I-problem
radial	I-problem
pulse	I-problem
per	O
the	O
emergency	O
room	O
.	O

The	O
patient	O
had	O
a	B-test
chest	I-test
CT	I-test
scan	I-test
demonstrating	O
no	O
dissection	B-problem
or	O
evidence	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

She	O
received	O
Nitropaste	B-treatment
,	O
aspirin	B-treatment
,	O
laboratory	B-test
studies	I-test
and	O
was	O
taken	O
to	O
the	O
floor	O
for	O
further	O
management	O
.	O

The	O
patient	O
denies	O
melena	B-problem
,	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
,	O
no	O
emesis	B-problem
,	O
or	O
fevers	B-problem
or	O
chills	B-problem
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
anemia	B-problem
as	O
per	O
past	O
medical	O
history	O
above	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Otherwise	O
negative	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Heart	B-test
rate	I-test
62	O
,	O
respiratory	B-test
rate	I-test
16	O
,	O
blood	B-test
pressure	I-test
right	I-test
arm	I-test
205/84	O
,	O
oxygen	B-test
saturation	I-test
97%	O
on	O
two	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
.	O

General	O
:	O

She	O
was	O
in	O
no	O
apparent	B-problem
distress	I-problem
,	O
tired	B-problem
,	O
easily	O
arousable	O
older	O
female	O
.	O

HEENT	B-test
examination	I-test
demonstrated	O
that	O
the	O
pupils	O
were	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Extraocular	O
movements	O
were	O
intact	O
.	O

There	O
was	O
a	B-problem
left	I-problem
cataract	I-problem
on	O
the	B-test
fundoscopic	I-test
examination	I-test
.	O

Neck	O
was	O
supple	O
,	O
bilateral	B-problem
bruits	I-problem
,	O
although	O
possibly	O
radiating	O
from	O
cardiac	O
base	O
.	O

There	O
was	O
no	O
jugular	B-problem
venous	I-problem
distension	I-problem
.	O

Chest	O
demonstrated	O
bilateral	B-problem
holosystolic	I-problem
bruits	I-problem
over	I-problem
the	I-problem
subclavians	I-problem
,	O
left	O
greater	O
than	O
right	O
with	O
few	B-problem
bibasilar	I-problem
crackles	I-problem
.	O

Cardiovascular	B-test
examination	I-test
demonstrated	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
2/6	B-problem
cresendo	I-problem
/	I-problem
descrecendo	I-problem
murmur	I-problem
heard	O
best	O
at	O
the	O
apex	O
with	O
preservation	O
of	O
the	O
second	O
heart	O
sound	O
,	O
no	O
S3	B-problem
or	O
S4	B-problem
.	O

Abdominal	B-test
examination	I-test
was	O
soft	O
,	O
non-tender	B-problem
,	O
non-distended	B-problem
,	O
positive	O
bowel	O
sounds	O
,	O
no	O
hepatosplenomegaly	B-problem
,	O
no	O
abdominal	B-problem
tenderness	I-problem
.	O

However	O
,	O
there	O
were	O
bilateral	B-problem
bilateral	I-problem
renal	I-problem
bruits	I-problem
and	O
femoral	B-problem
bruits	I-problem
.	O

The	O
patient	O
was	O
guaiac	B-test
negative	O
per	O
the	O
emergency	O
room	O
.	O

Extremities	O
demonstrated	O
no	O
edema	B-problem
.	O

Extremity	B-test
pulses	I-test
revealed	O
a	B-test
right	I-test
radial	I-test
of	O
2+	O
,	O
left	B-test
radial	I-test
of	O
1+	O
,	O
2+	B-test
distal	I-test
pulses	I-test
in	I-test
the	I-test
lower	I-test
extremities	I-test
bilaterally	I-test
.	O

Lower	B-test
extremity	I-test
blood	I-test
pressures	I-test
demonstrated	O
systolics	B-test
of	O
205-210	O
.	O

LABORATORY	O
:	O

Laboratory	O
values	O
on	O
admission	O
included	O
a	B-test
sodium	I-test
of	O
142	O
,	O
potassium	B-test
4.8	O
,	O
chloride	B-test
106	O
,	O
bicarbonate	B-test
27	O
,	O
BUN	B-test
and	O
creatinine	B-test
of	O
39	O
and	O
1.6	O
respectively	O
,	O
glucose	B-test
113	O
.	O

Calcium	B-test
was	O
9.6	O
.	O

CK	B-test
was	O
62	O
.	O

Troponin	B-test
was	O
0.2	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
11.5	O
,	O
85	B-test
polys	I-test
,	O
5	B-test
bands	I-test
,	O
hematocrit	B-test
37.6	O
,	O
platelet	B-test
count	I-test
328	O
.	O

Coagulation	B-test
studies	I-test
were	O
11.3/25.5/0.9	O
.	O

Urinalysis	B-test
demonstrated	O
trace	B-problem
leukocyte	I-problem
esterase	I-problem
,	O
5-10	B-problem
white	I-problem
blood	I-problem
cells	I-problem
and	O
1+	B-problem
squamous	I-problem
epithelial	I-problem
cells	I-problem
.	O

EKG	B-test
demonstrated	O
normal	O
sinus	O
rhythm	O
,	O
rate	B-test
of	O
73	O
,	O
borderline	B-problem
left	I-problem
atrial	I-problem
enlargement	I-problem
,	O
axis	B-test
of-28	O
,	O
T-wave	B-problem
inversions	I-problem
in	I-problem
V4	I-problem
through	O
V6	O
,	O
I	O
and	O
aVL	O
,	O
borderline	B-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
with	O
strain	B-problem
compared	O
to	O
earlier	O
this	O
AM	O
.	O

There	O
appeared	O
to	O
be	O
a	B-problem
new	I-problem
T-wave	I-problem
inversion	I-problem
in	O
V4	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1	O
)	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

2	O
)	O
Os-Cal	B-treatment
1250	O
mg	O
p.o.	O
three	O
times	O
a	O
day	O
.	O

3	O
)	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
q.o.d.	O

4	O
)	O
Plaquenil	B-treatment
200	O
mg	O
p.o.	O
q.	O
day	O
.	O

5	O
)	O
Ibuprofen	B-treatment
400	O
mg	O
p.o.	O
t.i.d.	O

6	O
)	O
Levoxyl	B-treatment
100	O
mg	O
p.o.	O
q.	O
day	O
.	O

7	O
)	O
Arava	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

8	O
)	O
Zantac	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O

9	O
)	O
Isosorbide	B-treatment
dinitrate	I-treatment
unclear	O
dose	O
.	O

10	O
)	O
Diltiazem	B-treatment
240	O
mg	O
p.o.	O
q.	O
day	O
.	O

11	O
)	O
Epogen	B-treatment
q.	O
two	O
weeks	O
.	O

SOCIAL	O
HISTORY	O
:	O

Negative	O
for	O
tobacco	O
,	O
negative	O
for	O
alcohol	O
.	O

The	O
patient	O
lives	O
alone	O
,	O
but	O
in	O
a	O
senior	O
living	O
facility	O
adjacent	O
to	O
friends	O
.	O

HOSPITAL	O
COURSE	O
:	O

1	O
)	O
Cardiovascular	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
rule	O
out	O
myocardial	B-problem
infarction	I-problem
.	O

She	O
remained	O
on	O
telemetry	B-test
for	O
greater	O
than	O
48	O
hours	O
which	O
demonstrated	O
no	O
dysrhythmia	B-problem
during	O
this	O
time	O
.	O

The	O
patient	O
underwent	O
an	B-test
echocardiogram	I-test
which	O
demonstrated	O
a	O
preserved	O
ejection	O
fraction	O
with	O
left	B-problem
ventricular	I-problem
hypertrophy	I-problem
and	O
no	O
significant	B-problem
valvular	I-problem
abnormalities	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
her	B-treatment
aspirin	I-treatment
and	O
Lasix	B-treatment
.	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
Diltiazem	I-treatment
was	O
stopped	O
due	O
to	O
her	B-problem
increased	I-problem
blood	I-problem
pressure	I-problem
and	O
was	O
started	O
on	O
Labetalol	B-treatment
which	O
was	O
gradually	O
titrated	O
up	O
to	O
a	B-test
target	I-test
blood	I-test
pressure	I-test
of	O
160-170	B-test
systolic	I-test
in	O
her	O
right	O
arm	O
.	O

The	O
patient	O
also	O
underwent	O
an	B-test
Adenosine	I-test
MIBI	I-test
stress	I-test
test	I-test
which	O
showed	O
only	O
mild	B-problem
lateral	I-problem
ischemia	I-problem
.	O

At	O
this	O
time	O
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
presyncopal	I-problem
symptoms	I-problem
were	O
not	O
felt	O
to	O
be	O
secondary	O
to	O
a	O
cardiovascular	O
etiology	O
.	O

2	O
)	O
Neurological	O
/	O
vascular	O
:	O

The	B-problem
discrepancy	I-problem
in	O
the	B-test
patient	I-test
&apos;s	I-test
pulses	I-test
and	O
blood	B-test
pressure	I-test
was	O
felt	O
to	O
be	O
consistent	O
with	O
a	B-problem
subclavian	I-problem
artery	I-problem
stenosis	I-problem
.	O

The	O
patient	O
underwent	O
MRI	B-test
/	I-test
MRA	I-test
of	I-test
the	I-test
head	I-test
,	I-test
neck	I-test
and	I-test
upper	I-test
chest	I-test
which	O
demonstrated	O
a	B-problem
proximal	I-problem
left	I-problem
subclavian	I-problem
artery	I-problem
stenosis	I-problem
,	O
proximal	O
to	O
the	O
take	O
off	O
of	O
the	O
left	O
vertebral	O
artery	O
.	O

The	O
left	O
vertebral	O
artery	O
had	O
a	B-problem
decreased	I-problem
flow	I-problem
consistent	O
with	O
either	O
native	B-problem
vessel	I-problem
disease	I-problem
or	O
some	B-problem
degree	I-problem
of	I-problem
retrograde	I-problem
flow	I-problem
with	O
subclavian	B-problem
steal	I-problem
phenomenon	I-problem
.	O

The	O
patient	O
had	O
patent	O
carotids	O
bilaterally	O
on	O
her	B-test
neck	I-test
MRA	I-test
.	O

MRI	B-test
of	I-test
the	I-test
head	I-test
demonstrated	O
a	B-problem
small	I-problem
vessel	I-problem
disease	I-problem
and	O
was	O
likely	O
an	B-problem
old	I-problem
right	I-problem
cerebellar	I-problem
infarct	I-problem
.	O

The	O
patient	O
underwent	O
non-invasive	B-test
carotid	I-test
ultrasounds	I-test
which	O
demonstrated	O
no	O
significant	B-problem
carotid	I-problem
disease	I-problem
.	O

The	O
patient	O
was	O
also	O
noted	O
to	O
have	O
antegrade	B-problem
flow	I-problem
in	O
both	O
of	O
her	O
vertebral	O
arteries	O
bilaterally	O
.	O

The	O
results	O
of	O
these	B-test
studies	I-test
suggested	O
that	O
the	B-problem
patient	I-problem
&apos;s	I-problem
symptoms	I-problem
were	O
not	O
due	O
to	O
subclavian	B-problem
steal	I-problem
phenomenon	I-problem
,	O
and	O
therefore	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
would	O
not	O
go	O
further	O
to	O
angio	B-treatment
and	O
/	O
or	O
surgical	B-treatment
or	I-treatment
percutaneous	I-treatment
intervention	I-treatment
.	O

A	O
Neurology	O
consult	O
was	O
obtained	O
and	O
it	O
was	O
felt	O
that	O
the	B-treatment
most	I-treatment
valuable	I-treatment
intervention	I-treatment
that	O
could	O
be	O
done	O
for	O
the	B-problem
patient	I-problem
&apos;s	I-problem
intervascular	I-problem
disease	I-problem
would	O
be	O
adequate	O
control	O
of	O
her	B-test
blood	I-test
pressure	I-test
.	O

3	O
)	O
Orthopedic	O
:	O

The	O
patient	O
suffered	O
a	O
fall	O
at	O
home	O
with	O
her	O
initial	O
event	O
.	O

Outside	B-test
hip	I-test
films	I-test
were	O
obtained	O
,	O
but	O
were	O
not	O
available	O
for	O
view	O
.	O

Repeat	B-test
hip	I-test
films	I-test
demonstrated	O
a	B-problem
right	I-problem
sided	I-problem
pubic	I-problem
rami	I-problem
fracture	I-problem
,	O
likely	O
new	O
.	O

An	O
Orthopedics	O
consult	O
was	O
obtained	O
and	O
the	O
patient	O
was	O
encouraged	O
to	O
weight	O
bear	O
as	O
tolerated	O
with	O
Physical	B-treatment
Therapy	I-treatment
assistance	I-treatment
.	O

A	B-test
bone	I-test
scan	I-test
was	O
also	O
obtained	O
to	O
rule	O
out	O
an	B-problem
occult	I-problem
hip	I-problem
fracture	I-problem
which	O
was	O
negative	O
.	O

At	O
the	O
time	O
of	O
this	O
dictation	O
,	O
the	O
patient	O
was	O
able	O
to	O
bear	O
weight	O
with	O
the	O
assistance	O
of	O
Physical	O
Therapy	O
and	O
a	B-treatment
walker	I-treatment
.	O

Plans	O
were	O
made	O
for	O
the	O
patient	O
to	O
be	O
discharged	O
to	O
Dwardmegriff	O
Rehabilitation	O
for	O
rehabilitation	B-treatment
of	O
her	B-problem
rami	I-problem
fracture	I-problem
.	O

4	O
)	O
Gastrointestinal	O
:	O

The	O
patient	O
had	O
an	O
episode	O
of	O
her	B-problem
described	I-problem
vertigo	I-problem
while	O
lying	O
in	O
bed	O
and	O
on	O
the	B-test
monitor	I-test
during	O
which	O
no	O
dysrhythmia	B-problem
was	O
noted	O
.	O

The	O
patient	O
also	O
complained	O
of	O
frequent	B-problem
vomiting	I-problem
at	O
least	O
once	O
a	O
day	O
,	O
occasionally	O
associated	O
with	O
ingestion	O
of	O
her	B-treatment
medications	I-treatment
,	O
but	O
sometimes	O
associated	O
with	O
ambulation	O
.	O

The	O
patient	O
has	O
a	O
long-standing	O
history	O
of	O
spontaneous	B-problem
emesis	I-problem
due	O
to	O
overwhelming	O
stress	O
or	O
excitement	O
.	O

However	O
,	O
the	O
patient	O
reports	O
emesis	B-problem
in	O
the	O
hospital	O
more	O
frequently	O
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
emesis	I-problem
was	O
noted	O
to	O
be	O
bilious	B-problem
without	O
evidence	O
of	O
new	B-problem
or	I-problem
old	I-problem
blood	I-problem
.	O

The	O
etiology	O
of	O
the	B-problem
patient	I-problem
&apos;s	I-problem
nausea	I-problem
remained	O
unclear	O
as	O
she	O
demonstrated	O
ability	O
to	O
keep	O
down	O
many	O
of	O
her	O
meals	O
which	O
did	O
not	O
suggest	O
an	B-problem
anatomical	I-problem
lesion	I-problem
of	I-problem
her	I-problem
gastrointestinal	I-problem
tract	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
Meclizine	B-treatment
on	O
December	O
31	O
,	O
2000	O
for	O
her	B-problem
nausea	I-problem
and	O
vertigo	B-problem
.	O

An	O
attempt	O
was	O
also	O
made	O
to	O
reduce	O
the	O
patient	O
&apos;s	O
large	O
number	O
of	O
medications	B-treatment
and	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
Os-Cal	I-treatment
,	O
multivitamin	B-treatment
,	O
Lasix	B-treatment
and	O
Colace	B-treatment
were	O
discontinued	O
.	O

5	O
)	O
Infectious	O
disease	O
:	O

The	O
patient	O
complained	O
of	O
some	B-problem
urinary	I-problem
incontinence	I-problem
and	O
difficulty	O
initiating	O
urine	O
on	O
December	O
30	O
,	O
2000	O
.	O

Urinalysis	B-test
demonstrated	O
a	B-problem
likely	I-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
Levofloxacin	B-treatment
250	O
mg	O
p.o.	O
q.	O
day	O
times	O
seven	O
days	O
for	O
a	O
possible	O
nosocomial	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

The	B-test
urine	I-test
culture	I-test
was	O
pending	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

6	O
)	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	O
patient	O
had	O
a	B-problem
mild	I-problem
increase	I-problem
in	O
her	B-test
BUN	I-test
and	O
creatinine	B-test
during	O
her	O
hospitalization	O
which	O
promptly	O
returned	O
to	O
her	O
baseline	O
levels	O
with	O
intravenous	B-treatment
fluids	I-treatment
.	O

The	O
patient	O
was	O
encouraged	O
to	O
increase	O
her	O
p.o.	O
intake	O
.	O

Dictated	O
By	O
:	O

BONE	O
A	O
,	O
M.D.	O
IQ35	O

Attending	O
:	O

LANAY	O
I.	O
IRON	O
,	O
M.D.	O
TJ93	O
YB914/4843	O

Batch	O
:	O

9056	O
PAD-WORD	O

Index	O
No.	O
FPOF6TO0Q7	O

D	O
:	O

New	O
Years	O
Eve	O

T	O
:	O

New	O
Years	O
Day	O

Admission	O
Date	O
:	O

2014-05-08	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-05-19	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1946-01-06	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O

Jana	O
V	O
Pennington	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

lightheadedness	B-problem
,	O
slight	B-problem
DOE	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2014-05-11	O
PAD-WORD	O

Redo	B-treatment
AVR	I-treatment
with	O
aortic	B-treatment
root	I-treatment
enlargement	I-treatment
(	O
21	O
mm	O
CE	O
Magna	O
pericardial	O
valve	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

68	O
yo	O
female	O
trasnferred	O
in	O
from	O
Catholic	O
CMED	O
CSRU.	O
Ctr.	O
with	O
periprosthetic	B-problem
aortic	I-problem
valve	I-problem
stenosis	I-problem
and	O
aortic	B-problem
valve	I-problem
thrombus	I-problem
.	O

No	O
cath	B-test
done	O
,	O
but	O
echo	B-test
05-07	O
showed	O
EF	B-test
60-65%	O
,	O
stenotic	B-problem
mech.	I-problem
valve	I-problem
,	O
mean	B-test
gradient	I-test
33	O
mm	O
,	O
decreased	B-problem
disc	I-problem
motion	I-problem
,	O
mobile	B-problem
mass	I-problem
in	I-problem
LVOT	I-problem
,	O
mild	B-problem
AI	I-problem
,	O
mild	B-problem
to	I-problem
moderate	I-problem
MR	I-problem
,	O
trace	B-problem
TR.	I-problem
Referred	O
for	O
surgical	B-test
evaluation	I-test
.	O

Past	O
Medical	O
History	O
:	O

HTN	B-problem
elev.	B-problem
lipids	I-problem
hypothyroidism	B-problem
back	B-problem
pain	I-problem

GERD	B-problem
PAD-WORD	O

PSH	O
:	O

s/p	O
AVR	B-treatment
2000	O
remote	B-treatment
tonsillectomy/adenoidectomy	I-treatment
partial	B-treatment
thyroidectomy	I-treatment
rem.	B-treatment
right	I-treatment
wrist	I-treatment
ganglion	I-treatment
cyst	I-treatment
left	B-treatment
foot	I-treatment
bunionectomy	I-treatment
breast	B-test
biopsies	I-test

Social	O
History	O
:	O

retired	O
,	O
lives	O
alone	O
,	O
widowed	O
quit	O
smoking	O
20+	O
years	O
ago	O
no	O
ETOH	O
use	O

Family	O
History	O
:	O

father	O
died	O
at	O
57	O
of	O
heart	B-problem
problems	I-problem
brother	O
died	O
at	O
age	O
7	O
of	O
"leaky	B-problem
valve"	I-problem
sister	O
with	O
CAD/CABG	B-problem

Physical	O
Exam:	O

180/88	O
PAD-WORD	O

HR	B-test
68	O

RR	B-test
18	O

95%	O
sat	B-test

65.5"	O
PAD-WORD	O

87	O
kg	O

NAD	B-problem
skin/HEENT	O
unremarkable	O
neck	O
supple	O
,	O
murmur	B-problem
radiates	O
bilat.	O
to	O
carotids	O

CTAB	O
PAD-WORD	O

RRR	O
with	O
holosystolic	B-problem
murmur	I-problem
soft	O
,	O
NT	B-problem
,	O
ND	B-problem
,	O
+	O
BS	O
warm	O
,	O
well-perfused	O
,	O
no	O
edema	B-problem
,	O
superficial	B-problem
varicosities	I-problem
neuro	O
grossly	O
intact	O

2+	O
bil.	O
fem/	O
radials	O

1+	O
bil.	O
DP/PTs	O

Pertinent	O
Results	O
:	O

Cardiology	O
Report	O
ECHO	B-test
Study	I-test
Date	O
of	O
2014-05-11	O

POST-BYPASS	O
:	O

Pt	O
is	O
being	O
AV	O
paced	O
,	O
on	O
an	B-treatment
infusion	I-treatment
of	I-treatment
phenylephrine	I-treatment

1.	O
A	B-treatment
bioprosthesis	I-treatment
is	O
well	O
seated	O
in	O
the	O
aortic	O
position	O
,	O
leaflets	O
open	O
well	O
,	O
trace	B-problem
central	I-problem
AI	I-problem
is	O
seen	O
.	O

Trace	B-problem
AI	I-problem
is	O
also	O
noted	O
between	O
the	O
left	O
and	O
right	O
coronary	O
cusps	O
.	O

There	O
is	O
a	B-problem
small	I-problem
paravavluar	I-problem
leak	I-problem
in	O
the	O
area	O
adjacent	O
to	O
the	O
anterior	O
mitral	O
leaflet	O
,	O
resulting	O
in	O
some	B-problem
trace	I-problem
insuffiency	I-problem
outside	O
the	O
sewing	O
ring	O
.	O

2.	O
Mitral	B-problem
regurgitation	I-problem
is	O
unchanged	O
from	O
before	O
.	O

3.	O
Biventricular	O
systolic	O
function	O
is	O
unchanged	O
.	O

4.	O
Aorta	O
is	O
intact	O
post	O
decannulation	B-treatment

5.	O
Other	O
findings	O
are	O
unchanged	O

6.	O
All	O
findings	O
discussed	O
with	O
surgeon	O
at	O
the	O
time	O
of	O
the	B-test
exam	I-test
.	O

2014-05-18	O
05:45AM	O
BLOOD	O

Hct	B-test
-	O
29.2*	O

2014-05-17	O
04:40AM	O
BLOOD	O

WBC	B-test
-	O
12.4*	O
RBC	B-test
-	O
2.89*	O
Hgb	B-test
-	O
9.0*	O
Hct	B-test
-	O
26.0*	O

MCV	B-test
-	O
90	O
MCH	B-test
-	O
31.3	O
MCHC	B-test
-	O
34.9	O
RDW	B-test
-	O
13.5	O
Plt	B-test
Ct	I-test
-	O
262	O

2014-05-18	O
05:45AM	O
BLOOD	O

PT	B-test
-	O
16.8*	O
PTT	B-test
-	O
65.3*	O
INR	B-test
(	O
PT	B-test
)	O
-	O
1.5*	O

2014-05-19	O
07:10AM	O
BLOOD	O

Glucose	B-test
-	O
115*	O
UreaN	B-test
-	O
20	O
Creat	B-test
-	O
1.3*	O
Na	B-test
-	O
137	O

K	B-test
-	O
4.8	O
Cl	B-test
-	O
96	O
HCO3	B-test
-	O
34*	O
AnGap	B-test
-	O
12	O

Brief	O
Hospital	O
Course	O
:	O

Admitted	O
05-08	O
to	O
cardiology	O
service	O
for	O
surgical	B-test
work-up	I-test
.	O

INR	B-test
2.7	O
and	O
echo	B-test
repeated	O
,	O
coumadin	B-treatment
held	O
,	O
and	O
heparin	B-treatment
drips	I-treatment
started	O
.	O

Review	O
of	O
OSH	B-test
echo	I-test
revealed	O
peak	B-test
gradient	I-test
of	O
64mm	O
(	O
not	O
30	O
's	O
)	O
.	O

New	B-test
echo	I-test
showed	O
pannus	B-problem
involving	O
the	O
valve	O
and	O
?	O
thrombus	B-problem
.	O

Seen	O
by	O
Dr.	O
Laura	O
of	O
cardiac	O
surgery	O
and	O
underwent	O
redo	B-treatment
AVR	I-treatment
with	O
aortic	B-treatment
root	I-treatment
enlargement	I-treatment
on	O
05-11	O
.	O

Transferred	O
to	O
the	O
CSRU	O
in	O
stable	O
condition	O
on	O
phenylephrine	B-treatment
and	O
propofol	B-treatment
drips	I-treatment
.	O

Weaned	O
to	O
extubation	O
on	O
POD	O
#2	O
and	O
off	O
all	B-treatment
drips	I-treatment
.	O

Episode	B-problem
of	I-problem
AFib	I-problem
that	O
evening	O
treated	O
with	O
amiodarone	B-treatment
and	O
converted	O
to	O
SR	O
.	O

Transferred	O
to	O
the	O
floor	O
on	O
POD	O
#3	O
to	O
begin	O
increasing	O
her	O
activity	O
level	O
.	O

Chest	B-treatment
tubes	I-treatment
and	O
wires	B-treatment
removed	O
without	O
incident	B-problem
.	O

Cleared	O
for	O
discharge	O
to	O
home	O
with	O
services	O
.	O

Pt.	O
to	O
make	O
all	O
follow-up	O
appts.	O
per	O
discharge	O
instructions	O
.	O

Medications	O
on	O
Admission	O
:	O

synthroid	B-treatment
75	O
mcg	O
daily	O

HCTZ	B-treatment
37.5	O
mg	O
daily	O

MVI	B-treatment
daily	O

Vit.C	B-treatment
500	O
mg	O
daily	O
prevacid	B-treatment
15	O
mg	O
daily	O
coumadin	B-treatment
(	O
held	O
)	O
toprol	B-treatment
XL	I-treatment
100	O
mg	O
daily	O
zocor	B-treatment
40	O
mg	O
daily	O

KCl	B-treatment
12-27	O
mEq	O
daily	O
cozaar	B-treatment
25	O
mg	O
daily	O

Discharge	O
Medications	O
:	O

1.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*180	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

2.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
1	O
months	O
.	O

Disp	O
:	O
*60	O
Capsule(	O
s	O
)*	O

Refills	O
:	O
*0*	O

3.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O

Refills	O
:	O
*2*	O

4.	O
Oxycodone-Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:	O
*40	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

5.	O
Levothyroxine	B-treatment
75	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

6.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

7.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O

Refills	O
:	O
*2*	O

8.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
2	O
days	O
:	O
for	O
2	O
days	O
,	O
then	O
start	O
200	O
mg	O
daily	O
ongoing	O
on	O
05-20	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*1*	O

9.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
once	O
a	O
day	O
for	O
7	O
days	O
.	O

Disp	O
:	O
*14	O
Capsule	O
,	O
Sustained	O
Release(	O
s	O
)*	O

Refills	O
:	O
*0*	O

10.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
twice	O
a	O
day	O
for	O
7	O
days	O
.	O

Disp	O
:	O
*14	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

prosthetic	B-problem
aortic	I-problem
valve	I-problem
stenosis	I-problem

HTN	B-problem
elev.	B-problem
lipds	I-problem
hypothyroidism	B-problem
back	B-problem
pain	I-problem

GERD	B-problem
PAD-WORD	O

A	B-problem
Fib	I-problem
s/p	O
AVR	B-treatment
2000	O

Discharge	O
Condition	O
:	O

stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

no	O
driving	O
for	O
one	O
month	O
no	O
lifting	O
greater	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
no	O
lotions	O
,	O
creams	O
or	O
powders	O
on	O
any	O
incision	B-problem
may	O
shower	O
over	O
incisions	B-problem
and	O
pat	O
dry	O
call	O
for	O
fever	B-problem
greater	O
than	O
100.5	O
,	O
redness	B-problem
or	O
drainage	B-problem

Followup	O
Instructions	O
:	O

see	O
Dr.	O
Rodriguez	O
in	O
1-2	O
weeks	O
see	O
Dr.	O
Laura	O
in	O
4	O
weeks	O

(	O
944	O
)	O
596	O
7247	O

Anthony	O
Louis	O
MD	O
43-293	O

Completed	O
by	O
:	O

Jerry	O
Pamela	O
NP	O
80-BXH	O
2014-05-19	O
@	O
1424	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Andre	O
D.	O
Bruner	O
on	O
:	O

WED	O
2014-05-21	O
5:55	O
PM	O

(	O
End	O
of	O
Report	O
)	O

082738817	O
PAD-WORD	O

CMC	O
PAD-WORD	O

19153629	O
PAD-WORD	O

6/3/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

06/03/1993	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

06/06/1993	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSIS	O
:	O

UTERINE	B-problem
PROLAPSE	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
70	O
year	O
old	O
gravida	O
IV	O
,	O
para	O
4	O
who	O
presented	O
for	O
a	B-treatment
vaginal	I-treatment
hysterectomy	I-treatment
secondary	O
to	O
uterine	B-problem
prolapse	I-problem
and	O
also	O
presented	O
for	O
evaluation	B-test
of	O
a	B-problem
suspicious	I-problem
lesion	I-problem
seen	O
on	O
a	B-test
mammogram	I-test
.	O

Patient	B-problem
&apos;s	I-problem
problem	I-problem
started	O
four	O
years	O
ago	O
when	O
she	O
first	O
experienced	O
a	B-problem
pushing	I-problem
forward	I-problem
of	I-problem
her	I-problem
uterus	I-problem
.	O

The	O
patient	O
described	O
this	O
sensation	O
as	O
uncomfortable	B-problem
and	O
becoming	O
more	O
prominent	O
over	O
the	O
following	O
three	O
years	O
with	O
increasing	B-problem
pressure	I-problem
and	O
pain	B-problem
.	O

Two	O
months	O
ago	O
,	O
the	O
patient	O
slipped	O
and	O
fell	O
with	O
valsalva	O
that	O
precipitated	O
an	O
exacerbation	O
of	O
her	B-problem
prolapse	I-problem
.	O

She	O
subsequently	O
could	O
not	O
urinate	O
and	O
was	O
in	O
pain	B-problem
secondary	O
to	O
her	B-problem
problem	I-problem
.	O

At	O
this	O
time	O
,	O
she	O
decided	O
that	O
she	O
needed	O
the	B-problem
prolapse	I-problem
fixed	O
and	O
actually	O
wrote	O
to	O
the	O
Norri	O
Hospital	O
to	O
try	O
and	O
find	O
a	O
Gynecologist	O
.	O

Her	O
letter	O
was	O
referred	O
to	O
Dr.	O
Earllamarg	O
Para	O
who	O
saw	O
her	O
in	O
the	O
office	O
and	O
recommended	O
vaginal	B-treatment
hysterectomy	I-treatment
.	O

Patient	O
has	O
never	O
had	O
a	B-treatment
pessary	I-treatment
and	O
refused	O
one	O
and	O
denies	O
nausea	B-problem
,	O
fever	B-problem
,	O
chills	B-problem
,	O
dysuria	B-problem
,	O
or	O
stress	B-problem
incontinence	I-problem
on	O
her	O
current	O
admission	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
a	B-problem
lower	I-problem
left	I-problem
saphenous	I-problem
vein	I-problem
thrombosis	I-problem
diagnosed	O
with	O
lower	B-test
extremity	I-test
non-invasives	I-test
and	O
on	O
May	O
2	O
,	O
1993	O
with	O
no	O
evidence	O
of	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
and	O
clearance	O
by	O
Dr.	O
Ribreefcheampner	O
for	O
further	B-treatment
intervention	I-treatment
.	O

She	O
also	O
has	O
a	B-problem
heart	I-problem
murmur	I-problem
since	O
childhood	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Negative	O
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

Significant	O
for	O
vaginal	O
deliveries	O
times	O
four	O
.	O

PAST	O
GYNECOLOGICAL	O
HISTORY	O
:	O

Last	O
menstrual	O
period	O
was	O
at	O
age	O
fifty	O
,	O
the	O
patient	O
is	O
not	O
on	O
hormonal	B-treatment
replacement	I-treatment
and	O
she	O
has	O
a	O
four	O
history	O
of	O
uterine	B-problem
prolapse	I-problem
.	O

CURRENT	O
MEDICATIONS	O
:	O

Aspirin	B-treatment
one	O
per	O
day	O
which	O
the	O
patient	O
quit	O
taking	O
two	O
weeks	O
prior	O
to	O
admission	O
.	O

ALLERGIES	O
:	O

None	O
.	O

SOCIAL	O
HISTORY	O
:	O

Patient	O
lives	O
on	O
Sauxdo	O
Lo	O
with	O
her	O
husband	O
and	O
denies	O
alcohol	O
and	O
denies	O
drug	O
abuse	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

GENERAL	O
:	O

This	O
was	O
a	O
well-developed	O
,	O
well-nourished	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Patient	O
had	O
a	B-test
blood	I-test
pressure	I-test
of	O
128/72	O
,	O
a	B-test
pulse	I-test
of	O
84	O
that	O
was	O
regular	O
,	O
and	O
she	O
was	O
afebrile	B-problem
at	O
98.4	O
.	O

SKIN	O
:	O

Examination	B-test
showed	O
right	B-problem
axillary	I-problem
and	I-problem
right	I-problem
posterior	I-problem
axillary	I-problem
skin	I-problem
tags	I-problem
and	O
crusted	B-problem
lesions	I-problem
.	O

HEENT	O
:	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
,	O
extraocular	O
muscles	O
were	O
intact	O
,	O
and	O
no	O
lymphadenopathy	B-problem
.	O

CARDIAC	O
:	O

Examination	B-test
showed	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
S3	B-problem
or	O
S4	B-problem
heard	O
and	O
a	B-problem
grade	I-problem
II/VI	I-problem
holosystolic	I-problem
murmur	I-problem
loudest	O
at	O
the	O
left	O
sternal	O
border	O
.	O

LUNGS	O
:	O

Examination	B-test
was	O
clear	O
to	O
auscultation	B-test
.	I-test

BREASTS	O
:	O

Examination	B-test
showed	O
a	B-problem
right	I-problem
upper	I-problem
mid	I-problem
small	I-problem
breast	I-problem
mass	I-problem
which	O
was	O
detected	O
actually	O
by	O
Dr.	O
Para	O
.	O

ABDOMEN	O
:	O

Soft	O
and	O
non-tender	B-problem
.	O

PELVIC	O
:	O

Deferred	O
until	O
the	O
Operating	O
Room	O
.	O

EXTREMITIES	O
:	O

She	O
had	O
left	B-problem
lower	I-problem
leg	I-problem
varicose	I-problem
veins	I-problem
,	O
no	O
venous	B-problem
cords	I-problem
,	O
and	O
bilateral	B-test
2+	I-test
pedal	I-test
pulses	I-test
.	O

LABORATORY	O
EXAMINATION	O
:	O

The	O
patient	O
had	O
a	B-test
BUN	I-test
and	O
creatinine	B-test
of	O
12	O
and	O
1.2	O
,	O
a	B-test
white	I-test
count	I-test
of	O
6.7	O
,	O
a	B-test
hematocrit	I-test
of	O
39.4	O
,	O
negative	O
urinalysis	O
,	O
and	O
a	B-test
potassium	I-test
of	O
4.6	O
.	O

Her	O
CA-125	B-test
was	O
20	O
and	O
she	O
had	O
a	B-test
chest	I-test
X-Ray	I-test
that	O
showed	O
no	O
infiltrates	B-problem
and	O
a	B-test
mammogram	I-test
that	O
showed	O
a	B-problem
left	I-problem
upper	I-problem
quadrant	I-problem
large	I-problem
calcified	I-problem
fibroadenoma	I-problem
and	O
right	B-problem
upper	I-problem
mid	I-problem
area	I-problem
of	I-problem
calcification	I-problem
.	O

She	O
had	O
an	B-test
EKG	I-test
that	O
showed	O
a	O
question	O
of	O
an	B-problem
old	I-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Cardiology	O
was	O
consulted	O
to	O
evaluate	O
this	O
and	O
felt	O
that	O
the	B-problem
changes	I-problem
seen	O
on	O
the	B-test
EKG	I-test
were	O
not	O
significant	O
.	O

The	O
patient	O
was	O
also	O
seen	O
by	O
Dr.	O
Nusc	O
from	O
General	O
Surgery	O
for	O
evaluation	B-test
of	O
micro	B-problem
calcifications	I-problem
in	I-problem
the	I-problem
right	I-problem
breast	I-problem
.	O

The	O
patient	O
refused	O
a	B-test
biopsy	I-test
for	O
this	O
admission	O
and	O
desires	O
follow-up	B-test
mammograms	I-test
.	O

She	O
is	O
to	O
be	O
followed	O
up	O
by	O
General	O
Surgery	O
.	O

The	O
patient	O
underwent	O
a	B-treatment
total	I-treatment
vaginal	I-treatment
hysterectomy	I-treatment
on	O
June	O
4	O
,	O
1993	O
which	O
she	O
tolerated	O
without	O
complications	B-problem
.	O

Her	O
post-operative	O
course	O
has	O
been	O
uncomplicated	O
.	O

She	O
remained	O
afebrile	B-problem
throughout	O
her	O
admission	O
tolerating	O
a	O
regular	O
diet	O
by	O
post-operative	O
day	O
two	O
and	O
was	O
discharged	O
on	O
June	O
6	O
,	O
1993	O
with	O
Percocet	B-treatment
for	O
pain	B-problem
.	O

The	B-treatment
Foley	I-treatment
was	O
discontinued	O
and	O
the	O
patient	O
was	O
urinating	O
on	O
her	O
own	O
.	O

DISPOSITION	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

Percocet	B-treatment
one	O
to	O
two	O
tablets	O
p.o.	O
q.4-6h.	O
p.r.n.	O
,	O
Iron	B-treatment
Sulfate	I-treatment
325	O
mg	O
p.o.	O
b.i.d.	O
,	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O
,	O
and	O
one	O
Aspirin	B-treatment
q.d.	O

She	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Para	O
for	O
follow-up	O
.	O

Dictated	O
By	O
:	O

RIMARVNAA	O
D.	O
KUSHDREPS	O
,	O
M.D.	O
AV94	O

Attending	O
:	O

EARLLAMARG	O
S.	O
PARA	O
,	O
M.D.	O
FT99	O
OH475/4059	O

Batch	O
:	O

2446	O
PAD-WORD	O

Index	O
No.	O
LXAIB23C4	O
L	O

D	O
:	O

06/07/93	O
PAD-WORD	O

T	O
:	O

06/11/93	O
PAD-WORD	O

Admission	O
Date	O
:	O

2014-04-21	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-04-24	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1960-10-27	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O

Mary	O
X	O
Baxter	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

TIA/Palpitations	B-problem
PAD-WORD	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2014-04-21	O
-	O
PFO	B-treatment
closure	I-treatment
via	O
Right	B-treatment
mini	I-treatment
thoracotomy	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

This	O
53-year-old	O
with	O
a	O
history	O
of	O
multiple	B-problem
transient	I-problem
ischemic	I-problem
attacks	I-problem
in	O
the	O
past	O
was	O
investigated	O
and	O
was	O
found	O
to	O
have	O
a	B-problem
small	I-problem
patent	I-problem
foramen	I-problem
ovale	I-problem
,	O
and	O
he	O
was	O
electively	O
admitted	O
for	O
closure	B-treatment
of	O
the	O
same	O
.	O

His	B-test
preoperative	I-test
investigations	I-test
with	O
coronary	B-test
angiogram	I-test
showed	O
normal	O
coronary	O
arteries	O
.	O

His	O
left	O
ventricular	O
function	O
was	O
well	O
preserved	O
.	O

He	O
had	O
no	O
valvular	B-problem
disease	I-problem
.	O

Past	O
Medical	O
History	O
:	O

Right	B-problem
Upper	I-problem
lobe	I-problem
nodule	I-problem

TIA	B-problem
's	I-problem

Childhood	B-problem
skull	I-problem
fracture	I-problem

PFO	B-problem
PAD-WORD	O

Social	O
History	O
:	O

Lives	O
with	O
wife	O
.	O

1	O
ETO	O
drink	O
daily	O
.	O

Quit	O
smoking	O
30	O
years	O
ago	O
after	O
smoking	O
1ppd	O
.	O

Retired	O
.	O

Family	O
History	O
:	O

Brother	O
with	O
MI	B-problem
at	O
age	O
35	O

Father	O
with	O
MI/CABG	B-problem
died	O
at	O
age	O
60	O
.	O

Physical	O
Exam	O
:	O

Vitals	O
:	O

BP	B-test
144/90	O
,	O
HR	B-test
64	O
,	O
RR	B-test
14	O

General	O
:	O

well	O
developed	O
male	O
in	O
no	O
acute	B-problem
distress	I-problem

HEENT	O
:	O

oropharynx	O
benign	O
,	O
poor	B-problem
dental	I-problem
health	I-problem

Neck	O
:	O

supple	O
,	O
no	O
JVD	B-problem

Heart	O
:	O

regular	O
rate	O
,	O
normal	O
s1s2	O
,	O
no	O
murmur	B-problem

Lungs	O
:	O

clear	O
bilaterally	O

Abdomen	O
:	O

soft	O
,	O
nontender	B-problem
,	O
normoactive	O
bowel	O
sounds	O

Ext	O
:	O

warm	O
,	O
no	O
edema	B-problem
,	O
no	O
varicosities	B-problem

Pulses	O
:	O

2+	O
distally	O

Neuro	O
:	O

nonfocal	O
PAD-WORD	O

Pertinent	O
Results:	O

2014-04-24	O
07:30AM	O
BLOOD	B-test

Hct	B-test
-	O
25.9*	O

2014-04-23	O
07:05AM	O
BLOOD	B-test

WBC	B-test
-	O
5.9	O
RBC	B-test
-	O
2.72*	O
Hgb	B-test
-	O
8.6*	O
Hct	B-test
-	O
25.2*	O

MCV	B-test
-	O
93	O
MCH	B-test
-	O
31.5	O
MCHC	B-test
-	O
34.0	O
RDW	B-test
-	O
13.0	O
Plt	B-test
Ct	I-test
-	O
150	O

2014-04-23	O
07:05AM	O
BLOOD	B-test

Plt	B-test
Ct	I-test
-	O
150	O

2014-04-24	O
07:30AM	O
BLOOD	B-test

UreaN	B-test
-	O
11	O
Creat	B-test
-	O
0.8	O
K	O
-	O
4.4	O

2014-04-21	O
ECHO	B-test

No	O
spontaneous	B-problem
echo	I-problem
contrast	I-problem
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium	O
.	O

No	O
mass/thrombus	B-problem
is	O
seen	O
in	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

No	O
spontaneous	B-problem
echo	I-problem
contrast	I-problem
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
right	O
atrium	O
.	O

A	B-problem
patent	I-problem
foramen	I-problem
ovale/secundum	I-problem
ASD	I-problem
is	O
present	O
.	O

A	B-problem
left-to-right	I-problem
shunt	I-problem
across	I-problem
the	I-problem
interatrial	I-problem
septum	I-problem
is	O
seen	O
at	O
rest	O
.	O

A	B-problem
right-to-left	I-problem
shunt	I-problem
across	I-problem
the	I-problem
interatrial	I-problem
septum	I-problem
is	O
seen	O
at	O
rest	O
with	O
injection	B-test
of	I-test
agitated	I-test
saline	I-test
contrast	I-test
.	O

The	O
inferior	O
vena	O
cava	O
is	O
dilated	B-problem
(	O
>2.5	O
cm	O
)	O
.	O

Left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
LVEF	B-test
>55%	I-test
)	O
.	O

Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

Regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
normal	O
(	O
LVEF>55%	B-test
)	O
.	O

Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

The	O
ascending	O
,	O
transverse	O
and	O
descending	O
thoracic	O
aorta	O
are	O
normal	O
in	O
diameter	O
and	O
free	O
of	O
atherosclerotic	B-problem
plaque	I-problem
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-problem
regurgitation	I-problem
.	O

No	O
aortic	B-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

POST	O
BYPASS	B-treatment

Flow	O
across	O
the	O
interatrial	O
septum	O
is	O
no	O
longer	O
visualized	O
with	O
color	B-test
flow	I-test
doppler	I-test
or	O
with	O
injection	B-test
of	I-test
agitatated	I-test
saline	I-test
at	O
rest	O
or	O
with	O
valsalva	O
.	O

The	B-test
study	I-test
is	O
otherwise	O
unchanged	O
from	O
pre-bypass	B-test
.	O

2014-04-22	O
CXR	B-test

Previous	B-problem
right	I-problem
pneumothorax	I-problem
has	O
resolved	O
except	O
for	O
what	O
is	O
either	O
a	B-problem
small	I-problem
fissural	I-problem
component	I-problem
or	O
a	B-problem
bulla	I-problem
adjacent	O
to	O
the	O
minor	O
fissure	O
.	O

May	O
be	O
a	B-problem
small	I-problem
right	I-problem
pleural	I-problem
effusion	I-problem
.	O

Right	B-treatment
apical	I-treatment
pleural	I-treatment
tube	I-treatment
in	O
place	O
.	O

Left	O
lung	O
clear	O
from	O
basal	B-problem
atelectasis	I-problem
.	O

Paratracheal	B-problem
mediastinal	I-problem
hematoma	I-problem
is	O
resolving	O
.	O

Heart	O
size	O
is	O
normal	O
.	O

Tip	O
of	O
the	O
left	O
internal	O
jugular	O
line	O
projects	O
over	O
the	O
SVC	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Freeman	O
was	O
admitted	O
to	O
the	O
Nantucket	O
Cottage	O
Hospital	O
on	O
2014-04-21	O
for	O
surgical	B-treatment
management	I-treatment
of	O
his	B-problem
PFO	I-problem
.	O

He	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	B-treatment
mini-thoracotomy	I-treatment
with	O
closure	B-treatment
of	O
his	B-problem
patent	I-problem
foramen	I-problem
ovale	I-problem
(	I-problem
PFO	I-problem
)	I-problem
.	O

Postoperatively	O
he	O
was	O
taken	O
to	O
the	O
cardiac	O
surgical	O
intensive	O
care	O
unit	O
for	O
monitoring	O
.	O

Within	O
a	O
few	O
hours	O
,	O
he	O
woke	O
neurologically	O
intact	O
and	O
was	O
extubated	B-treatment
.	O

Aspirin	B-treatment
was	O
resumed.	O
On	O
postoperative	O
day	O
one	O
,	O
he	O
was	O
transferred	O
to	O
the	O
cardiac	O
surgical	O
step	O
down	O
unit	O
.	O

He	O
was	O
gently	O
diuresed	O
towards	O
his	O
preoperative	O
weight	O
.	O

The	O
physical	O
therapy	O
service	O
was	O
consulted	O
for	O
assistance	O
with	O
his	O
postoperative	O
strength	O
and	O
mobility	O
.	O

Iron	B-treatment
and	O
vitamin	B-treatment
C	I-treatment
were	O
started	O
for	O
postoperative	B-problem
anemia	I-problem
.	O

Mr.	O
Freeman	O
maintained	O
stable	O
hemodynamics	O
with	O
a	O
normal	O
sinus	O
rhythm	O
throughout	O
his	O
postoperative	O
course	O
.	O

He	O
continued	O
to	O
make	O
steady	O
progress	O
and	O
was	O
discharged	O
home	O
on	O
postoperative	O
day	O
three	O
.	O

He	O
will	O
follow-up	O
with	O
Dr.	O
de	O
la	O
Cisneros	O
,	O
Dr.	O
Belt	O
,	O
his	O
cardiologist	O
and	O
his	O
primary	O
care	O
physician	O
as	O
an	O
outpatient	O
.	O

Medications	O
on	O
Admission	O
:	O

Plavix	B-treatment
75mg	O
daily	O
aspirin	B-treatment
81mg	O
daily	O

Discharge	O
Medications	O
:	O

1.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
5	O
days	O
.	O

Disp	O
:	O
*10	O
Capsule	O
,	O
Sustained	O
Release(	O
s	O
)*	O

Refills	O
:	O
*0*	O

2.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Capsule(	O
s	O
)*	O

Refills	O
:	O
*0*	O

3.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O

Refills	O
:	O
*2*	O

4.	O
Oxycodone-Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:	O
*50	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

5.	O
Ferrous	B-treatment
Sulfate	I-treatment
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
:	O
Take	O
for	O
one	O
month	O
then	O
stop	O
.	O

Disp	O
:	O
*30	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

6.	O
Camphor-Menthol	B-treatment
0.5-0.5	O
%	O
Lotion	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

Disp	O
:	O
*qs	O
qs*	O

Refills	O
:	O
*0*	O

7.	O
Ascorbic	B-treatment
Acid	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
:	O
Take	O
for	O
one	O
month	O
then	O
stop	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

8.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
5	O
days	O
.	O

Disp	O
:	O
*10	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

PFO	B-problem
PAD-WORD	O

TIA	B-problem
lung	I-problem
nodule	I-problem
(	O
followed	O
by	O
Dr.	O
Belt	O
)	O
s/p	O
fissurectomy/skull	B-problem
Fx	I-problem

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

1)	O
Shower	O
,	O
wash	O
incisions	B-problem
with	O
mild	O
soap	O
and	O
water	O
and	O
pat	O
dry	O
.	O

No	O
lotions	B-treatment
,	O
creams	B-treatment
or	O
powders	B-treatment
to	O
incisions	B-problem
.	O

2)	O
Call	O
with	O
fever	B-problem
>101	I-problem
,	O
redness	B-problem
or	O
drainage	B-problem
from	I-problem
incision	I-problem
,	O
or	O
weight	B-problem
gain	I-problem
more	I-problem
than	I-problem
2	I-problem
pounds	I-problem
in	O
one	O
day	O
or	O
five	O
pounds	O
in	O
one	O
week	O
.	O

3)	O
No	O
driving	O
while	O
on	O
narcotics	B-treatment
.	O

4)	O
Take	O
lasix	B-treatment
twice	O
daily	O
with	O
potassium	B-treatment
for	O
five	O
days	O
then	O
stop	O
.	O

5)	O
Take	O
Vitamin	B-treatment
C	I-treatment
with	O
iron	B-treatment
for	O
one	O
month	O
then	O
stop	O
.	O

6)	O
Call	O
with	O
any	O
questions	O
or	O
concerns	O
.	O

Followup	O
Instructions:	O

Follow	O
up	O
with	O
Dr.	O
Heird	O
in	O
four	O
weeks	O
,	O
671	O
745	O
2553	O

Follow	O
up	O
with	O
Dr.	O
Knowlton	O
in	O
1-2	O
weeks	O
,	O
(246)	O
828-4417	O

Follow	O
up	O
with	O
Dr.	O
Eckman	O
in	O
2-3	O
weeks	O
,	O
(506)	O
946-4576	O

Call	O
all	O
providers	O
for	O
appointments	O
.	O

CAT	O
SCAN	O
Phone	O
:	O

(476)	O
713	O
6117	O

Date/Time	O
:	O
2014-10-16	O
9:15	O

Edna	O
Arnold	O
,	O
MD	O

Phone	O
:	O
(300)	O
922-6590	O

Date/Time	O
:	O
2014-10-16	O
2:30	O

Melonson	O
de	O
la	O
Donnelly	O
MD	O
08-301	O

Completed	O
by	O
:	O

Jeremy	O
N.	O
P.	O
Moschella	O
PA	O
80-BYE	O
2014-04-24	O
@	O
1103	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Dorothy	O
au	O
Pratt	O
on	O
:	O

FRI	O
2014-06-06	O
10:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

086326823	O
PAD-WORD	O

FIH	O
PAD-WORD	O

6708320	O
PAD-WORD	O

235967	O
PAD-WORD	O

594818	O
PAD-WORD	O

8/24/1998	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

RIEFF	O
,	O
ALB	O
P	O

UNIT	O
NUMBER	O
:	O

185-64-30	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

08/24/1998	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

09/14/1998	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Sternal	B-problem
wound	I-problem
infection	I-problem
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Infected	B-problem
aortic	I-problem
graft	I-problem
.	O

Hypertension	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

08/31/98	O
ascending	B-treatment
aortic	I-treatment
root	I-treatment
replacement	I-treatment
with	O
homograft	B-treatment
with	O
omentopexy	B-treatment
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

09/02/98	O
sternal	B-treatment
debridement	I-treatment
.	O

Bilateral	B-treatment
pectoralis	I-treatment
major	I-treatment
myocutaneous	I-treatment
advancement	I-treatment
flap	I-treatment
.	O

Right	B-treatment
superiorly	I-treatment
based	I-treatment
rectus	I-treatment
abdominis	I-treatment
flap	I-treatment
.	O

Primary	B-treatment
closure	I-treatment
of	O
wound	B-problem
.	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

The	O
patient	O
is	O
a	O
79	O
year	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
an	B-treatment
ascending	I-treatment
aortic	I-treatment
graft	I-treatment
replacement	I-treatment
in	O
1991	O
for	O
aortic	B-problem
dissection	I-problem
.	O

At	O
that	O
time	O
the	O
patient	O
's	O
hospital	O
course	O
was	O
complicated	O
by	O
a	B-problem
sternal	I-problem
wound	I-problem
infection	I-problem
requiring	O
a	B-treatment
sternal	I-treatment
debridement	I-treatment
and	O
subsequent	B-treatment
abdominal	I-treatment
flap	I-treatment
.	O

The	O
patient	O
was	O
then	O
continued	O
by	O
report	O
on	O
Dicloxacillin	B-treatment
for	O
approximately	O
one	O
year	O
following	O
that	B-treatment
reconstructive	I-treatment
operation	I-treatment
.	O

The	O
patient	O
apparently	O
did	O
well	O
until	O
June	O
1998	O
when	O
he	O
noted	O
a	B-problem
bulge	I-problem
in	I-problem
his	I-problem
sternal	I-problem
area	I-problem
.	O

A	B-problem
ruptured	I-problem
aneurysm	I-problem
or	O
pseudoaneurysm	B-problem
at	O
the	O
junction	O
of	O
the	B-treatment
graft	I-treatment
and	O
arch	O
was	O
diagnosed	O
and	O
this	O
was	O
subsequently	O
repaired	O
.	O

The	O
patient	O
then	O
had	O
recurrent	B-problem
bleeding	I-problem
two	O
weeks	O
later	O
which	O
was	O
once	O
again	O
repaired	O
.	O

However	O
the	B-problem
same	I-problem
problem	I-problem
recurred	O
for	O
a	O
third	O
time	O
and	O
a	B-test
computer	I-test
tomogram	I-test
scan	I-test
at	O
an	O
outside	O
hospital	O
showed	O
an	B-problem
anterior	I-problem
hematoma	I-problem
.	O

By	O
report	O
the	O
patient	O
was	O
at	O
that	O
time	O
told	O
that	O
there	O
was	O
no	O
more	O
that	O
could	O
be	O
done	O
for	O
him	O
and	O
was	O
then	O
apparently	O
placed	O
on	O
comfort	B-treatment
measures	I-treatment
and	O
pain	B-treatment
control	I-treatment
at	O
the	O
outside	O
hospital	O
.	O

However	O
the	O
patient	O
was	O
then	O
subsequently	O
transferred	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
upon	O
request	O
of	O
the	O
family	O
on	O
8/24/98	O
for	O
further	B-test
evaluation	I-test
and	O
possible	O
intervention	B-treatment
.	O

The	O
patient	O
was	O
evaluated	O
by	O
Dr.	O
Rhalt	O
of	O
Dentvailr.	O
Medical	O
Center	O
.	O

As	O
the	B-test
patient	I-test
's	I-test
early	I-test
evaluation	I-test
the	O
patient	O
underwent	O
an	B-test
aortogram	I-test
which	O
showed	O
an	B-treatment
ascending	I-treatment
aortic	I-treatment
graft	I-treatment
with	O
bulging	B-problem
flaps	I-problem
and	O
a	B-problem
pseudoaneurysm	I-problem
at	O
the	O
anastomosis	O
of	O
the	B-treatment
graft	I-treatment
and	O
arch	O
just	O
below	O
the	O
great	O
vessels	O
.	O

There	O
was	O
no	O
evidence	O
for	O
a	B-problem
definite	I-problem
leak	I-problem
but	O
there	O
was	O
evidence	O
for	O
gas	B-problem
bubbles	I-problem
in	O
the	O
anterior	O
posterior	O
distal	O
ends	O
of	O
the	B-treatment
grafts	I-treatment
consistent	O
with	O
an	B-problem
infectious	I-problem
process	I-problem
.	O

At	O
the	O
same	O
time	O
the	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Infectious	O
Disease	O
Service	O
who	O
upon	O
culturing	O
the	B-problem
patient	I-problem
's	I-problem
sternal	I-problem
drainage	I-problem
switched	O
the	O
patient	O
from	O
intravenous	B-treatment
Unasyn	I-treatment
to	O
Levofloxacin	B-treatment
for	O
what	O
appeared	O
to	O
be	O
Citrobacter	B-problem
and	O
Diphtheroids	B-problem
in	O
the	B-test
wound	I-test
cultures	I-test
.	O

Subsequent	O
to	O
starting	O
this	B-treatment
antibiotic	I-treatment
regimen	I-treatment
the	B-problem
patient	I-problem
's	I-problem
wound	I-problem
drainage	I-problem
appeared	O
to	O
subside	O
.	O

Given	O
all	O
the	O
findings	O
on	O
the	B-test
aortogram	I-test
and	O
the	B-test
subsequent	I-test
chest	I-test
computer	I-test
tomogram	I-test
scan	I-test
it	O
was	O
discovered	O
that	O
the	O
patient	O
's	O
only	O
real	O
surgical	O
option	O
for	O
cure	O
was	O
a	B-treatment
risky	I-treatment
operation	I-treatment
that	O
involved	O
removal	B-treatment
and	I-treatment
replacement	I-treatment
of	I-treatment
the	I-treatment
aortic	I-treatment
graft	I-treatment
probably	O
with	O
homograft	B-treatment
and	O
long	B-treatment
term	I-treatment
antibiotic	I-treatment
coverage	I-treatment
as	O
well	O
as	O
a	B-treatment
plastic	I-treatment
surgical	I-treatment
reconstructive	I-treatment
procedure	I-treatment
.	O

The	O
patient	O
understood	O
the	O
risks	O
and	O
potential	O
benefits	O
of	O
the	B-treatment
procedure	I-treatment
and	O
was	O
willing	O
to	O
proceed	O
.	O

The	O
patient	O
otherwise	O
complained	O
of	O
no	O
angina	B-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
no	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
,	O
no	O
edema	B-problem
,	O
no	O
palpitations	B-problem
or	O
symptoms	O
of	O
syncope	B-problem
.	O

He	O
did	O
report	O
a	B-problem
20	I-problem
lbs	I-problem
weight	I-problem
loss	I-problem
over	O
the	O
last	O
several	O
months	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Thoracic	B-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Status	O
post	O
hernia	B-treatment
repair	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Lopressor	B-treatment
100	O
mg	O
po	O
three	O
times	O
a	O
day	O
.	O

2.	O
Captopril	B-treatment
75	O
mg	O
po	O
three	O
times	O
a	O
day	O
.	O

3.	O
Prilosec	B-treatment
20	O
mg	O
po	O
per	O
day	O
.	O

4.	O
Hydralazine	B-treatment
12.5	O
mg	O
four	O
times	O
per	O
day	O
.	O

5.	O
Reglan	B-treatment
10	O
mg	O
po	O
three	O
times	O
a	O
day	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
was	O
married	O
and	O
denied	O
any	O
tobacco	O
or	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
afebrile	B-problem
,	O
vital	B-test
signs	I-test
were	O
stable	O
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
exam	I-test
:	O

negative	O
.	O

Neck	O
was	O
supple	O
.	O

There	O
was	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

2+	B-test
carotids	I-test
without	O
bruits	B-problem
.	O

Cardiovascular	B-test
exam	I-test
:	O

regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
2/6	I-problem
diastolic	I-problem
___	O
and	O
a	B-problem
1/6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
without	O
any	O
evidence	O
for	O
crackles	B-problem
.	O

Extremities	O
:	O

the	O
patient	O
had	O
2+	B-test
femoral	I-test
pulses	I-test
and	O
1+	B-test
pedal	I-test
pulses	I-test
.	O

LABORATORY	O
AND	O
RADIOLOGIC	O
DATA	O
:	O

Sodium	B-test
137	O
,	O
potassium	B-test
4.0	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
16	O
,	O
creatinine	B-test
.9	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
4.9	O
,	O
hematocrit	B-test
29.7	O
,	O
platelet	B-test
count	I-test
207	O
.	O

The	B-test
patient	I-test
's	I-test
preoperative	I-test
chest	I-test
x-ray	I-test
showed	O
bilateral	B-problem
effusions	I-problem
and	O
bibasilar	B-problem
atelectasis	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-problem
patient	I-problem
's	I-problem
sternal	I-problem
incision	I-problem
had	O
a	O
superior	O
edge	O
that	O
was	O
dehisced	B-problem
with	O
evidence	O
for	O
stay	B-treatment
sutures	I-treatment
and	O
some	O
superficial	B-treatment
closure	I-treatment
sutures	I-treatment
exposed	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
initially	O
admitted	O
to	O
the	O
Cardiac	O
Surgical	O
Service	O
under	O
Dr.	O
Rhalt	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Cardiac	O
Surgical	O
Intensive	O
Care	O
Unit	O
given	O
the	O
patient	O
's	O
precarious	O
condition	O
.	O

Over	O
the	O
next	O
several	O
hospital	O
days	O
the	O
patient	O
underwent	O
aortogram	B-test
as	O
well	O
as	O
chest	B-test
computer	I-test
tomogram	I-test
as	O
outlined	O
earlier	O
.	O

The	O
patient	O
was	O
also	O
seen	O
in	O
consultation	O
by	O
the	O
Infectious	O
Disease	O
Service	O
as	O
well	O
as	O
the	O
Cardiology	O
Service	O
who	O
assisted	O
in	O
managing	O
the	B-problem
patient	I-problem
's	I-problem
intermittent	I-problem
hypertension	I-problem
.	O

The	O
patient	O
was	O
also	O
seen	O
preoperatively	O
in	O
consultation	O
by	O
the	O
Plastic	O
Surgical	O
Service	O
for	O
potential	B-treatment
sternal	I-treatment
reconstruction	I-treatment
.	O

After	O
lengthy	O
discussions	O
with	O
the	O
patient	O
and	O
the	O
patient	O
's	O
family	O
as	O
well	O
as	O
the	O
various	O
consultant	O
services	O
it	O
was	O
decided	O
that	O
the	O
patient	O
was	O
a	O
viable	O
candidate	O
for	O
aortic	B-treatment
root	I-treatment
replacement	I-treatment
procedure	I-treatment
using	O
homograft	B-treatment
.	O

This	O
was	O
obtained	O
on	O
08/30/98	O
by	O
Dr.	O
Niste	O
Rhalt	O
of	O
the	O
Cardiac	O
Surgical	O
Service	O
.	O

The	O
patient	O
was	O
then	O
subsequently	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
08/31/98	O
with	O
the	O
preoperative	O
diagnosis	O
of	O
ascending	B-problem
aortic	I-problem
graft	I-problem
infection	I-problem
.	O

The	B-treatment
procedure	I-treatment
performed	O
was	O
homograft	B-treatment
replacement	I-treatment
of	I-treatment
the	I-treatment
ascending	I-treatment
aorta	I-treatment
with	O
omentopexy	B-treatment
and	O
an	B-problem
open	I-problem
chest	I-problem
.	O

The	O
aortic	O
perfusions	O
were	O
via	O
the	O
femoral	O
artery	O
with	O
venous	O
return	O
by	O
the	O
femoral	O
vein	O
.	O

The	O
cardiopulmonary	O
bypass	O
time	O
was	O
one	O
hour	O
and	O
49	O
minutes	O
.	O

The	B-treatment
graft	I-treatment
used	O
was	O
a	B-treatment
homograft	I-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
fairly	O
well	O
and	O
was	O
transferred	O
intubated	B-treatment
to	O
the	O
Cardiac	O
Surgical	O
Intensive	O
Care	O
Unit	O
with	O
his	B-problem
chest	I-problem
open	I-problem
.	O

The	O
immediate	O
postoperative	O
plans	O
were	O
for	O
a	O
short	O
Intensive	O
Care	O
Unit	O
stay	O
and	O
subsequent	B-treatment
plastic	I-treatment
surgical	I-treatment
reconstruction	I-treatment
of	I-treatment
the	I-treatment
patient	I-treatment
's	I-treatment
sternum	I-treatment
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Cardiac	O
Surgical	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
.	O

There	O
he	O
continued	O
to	O
be	O
hemodynamically	O
stable	O
.	O

Of	O
note	O
,	O
intraoperatively	B-test
multiple	I-test
tissue	I-test
cultures	I-test
had	O
been	O
sent	O
.	O

In	O
the	O
Intensive	O
Care	O
Unit	O
the	O
patient	O
was	O
kept	O
intubated	B-treatment
and	O
sedated	B-treatment
until	O
09/02/98	O
which	O
was	O
postoperative	O
day	O
no.	O
1	O
following	O
the	B-treatment
homograft	I-treatment
replacement	I-treatment
.	O

On	O
that	O
day	O
the	O
Plastic	O
Surgical	O
Service	O
performed	O
further	B-treatment
sternal	I-treatment
debridement	I-treatment
and	O
subsequent	B-treatment
reconstruction	I-treatment
using	O
bilateral	B-treatment
pectoralis	I-treatment
major	I-treatment
myocutaneous	I-treatment
advancement	I-treatment
flaps	I-treatment
and	O
right	B-treatment
superiorly	I-treatment
rectus	I-treatment
abdominis	I-treatment
flap	I-treatment
to	O
cover	O
the	B-problem
patient	I-problem
's	I-problem
sternal	I-problem
wound	I-problem
with	O
subsequent	B-treatment
primary	I-treatment
closure	I-treatment
of	O
that	B-problem
wound	I-problem
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
there	O
were	O
no	O
complications	B-problem
.	O

A	O
number	O
of	O
indwelling	B-treatment
closed	I-treatment
suction	I-treatment
drains	I-treatment
were	O
left	O
in	O
place	O
so	O
as	O
to	O
drain	O
the	O
bed	O
underneath	O
the	O
muscle	O
flaps	O
.	O

The	O
patient	O
was	O
then	O
transferred	O
back	O
to	O
the	O
Cardiac	O
Surgical	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
.	O

At	O
this	O
point	O
the	O
patient	O
continued	O
to	O
followed	O
by	O
Infectious	O
Disease	O
Service	O
and	O
continued	O
to	O
be	O
on	O
intravenous	B-treatment
antibiotics	I-treatment
which	O
included	O
Vancomycin	B-treatment
and	O
Levofloxacin	B-treatment
.	O

The	B-test
Operating	I-test
Room	I-test
cultures	I-test
at	O
that	O
point	O
were	O
positive	O
for	O
Crinobactermium	B-problem
with	O
sputum	B-test
cultures	I-test
being	O
sensitive	O
for	O
yeast	B-problem
and	O
gram	B-problem
positive	I-problem
cocci	I-problem
in	I-problem
clusters	I-problem
.	O

Over	O
the	O
next	O
postoperative	O
day	O
the	O
patient	O
was	O
awakened	O
and	O
weaned	O
to	O
extubate	O
without	O
significant	B-problem
difficulties	I-problem
.	O

The	O
patient	O
's	O
subsequent	O
postoperative	O
course	O
was	O
characterized	O
by	O
persistent	B-problem
hypertension	I-problem
which	O
required	O
a	O
significant	O
amount	O
of	O
antihypertensives	B-treatment
including	O
Lopressor	B-treatment
100	O
mg	O
po	O
three	O
times	O
a	O
day	O
,	O
Captopril	B-treatment
100	O
mg	O
po	O
three	O
times	O
a	O
day	O
,	O
as	O
well	O
as	O
Procardia	B-treatment
.	O

The	O
patient	O
otherwise	O
continued	O
to	O
do	O
well	O
and	O
was	O
becoming	O
more	O
oriented	O
as	O
time	O
went	O
on	O
and	O
as	O
his	B-test
blood	I-test
pressure	I-test
was	O
brought	O
under	O
control	O
.	O

Subsequently	O
on	O
postoperative	O
day	O
no.	O
8	O
in	O
the	O
Intensive	O
Care	O
Unit	O
the	O
patient	O
was	O
felt	O
to	O
be	O
ready	O
for	O
transfer	O
to	O
the	O
Cardiac	O
Surgical	O
Inpatient	O
Service	O
.	O

The	O
patient	O
continued	O
to	O
be	O
followed	O
by	O
the	O
Infectious	O
Disease	O
Service	O
who	O
felt	O
that	O
the	B-treatment
patient	I-treatment
's	I-treatment
Jackson	I-treatment
Pratt	I-treatment
drains	I-treatment
needed	O
to	O
stay	O
in	O
as	O
there	O
was	O
still	O
some	B-problem
significant	I-problem
drainage	I-problem
from	O
them	O
.	O

As	O
per	O
the	O
Infectious	O
Disease	O
Service	O
the	O
patient	O
was	O
continued	O
on	O
Levofloxacin	B-treatment
,	O
Vancomycin	B-treatment
as	O
antibiotic	B-treatment
coverage	I-treatment
.	O

However	O
on	O
09/08/98	O
the	O
Infectious	O
Disease	O
Service	O
was	O
made	O
aware	O
that	O
the	B-test
patient	I-test
's	I-test
intraoperative	I-test
cultures	I-test
had	O
also	O
grown	O
out	O
Mycoplasma	B-problem
humilius	I-problem
.	O

Given	O
this	O
finding	O
it	O
was	O
felt	O
that	O
the	O
patient	O
would	O
certainly	O
need	O
long	B-treatment
term	I-treatment
intravenous	I-treatment
antibiotics	I-treatment
to	O
include	O
at	O
least	O
six	O
weeks	O
of	O
Vancomycin	B-treatment
and	O
then	O
subsequent	B-treatment
Levofloxacin	I-treatment
for	O
the	B-problem
Citrobacter	I-problem
and	O
Mycoplasma	B-problem
as	O
well	O
.	O

The	O
patient	O
was	O
scheduled	O
for	O
peripherally	B-treatment
inserted	I-treatment
central	I-treatment
catheter	I-treatment
line	I-treatment
placement	I-treatment
knowing	O
that	O
he	O
was	O
going	O
to	O
need	O
long	B-treatment
term	I-treatment
intravenous	I-treatment
antibiotics	I-treatment
.	O

This	O
was	O
placed	O
on	O
postoperative	O
day	O
no.	O
9	O
without	O
any	B-problem
difficulty	I-problem
.	O

At	O
the	O
same	O
time	O
the	O
patient	O
continued	O
to	O
be	O
stable	O
on	O
his	B-treatment
antihypertensive	I-treatment
regimen	I-treatment
.	O

He	O
was	O
becoming	O
more	O
mobile	O
and	O
was	O
taking	O
a	B-treatment
high	I-treatment
protein	I-treatment
high	I-treatment
calories	I-treatment
diet	I-treatment
which	O
he	O
tolerated	O
well	O
.	O

He	O
continued	O
to	O
be	O
afebrile	B-problem
and	O
otherwise	O
very	O
stable	O
.	O

On	O
postoperative	O
day	O
no.	O
12	O
the	O
patient	O
was	O
noted	O
to	O
have	O
fallen	O
and	O
subsequently	O
dislocating	O
the	O
PIP	O
joint	O
of	O
his	O
left	O
middle	O
finger	O
.	O

Subsequent	B-test
hand	I-test
x-rays	I-test
obtained	O
showed	O
no	O
evidence	O
of	O
fracture	B-problem
but	O
the	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Plastic	O
Surgery	O
Hand	O
Service	O
.	O

The	O
patient	O
will	O
benefit	O
from	O
splinting	B-treatment
of	I-treatment
his	I-treatment
finger	I-treatment
while	O
the	B-problem
swelling	I-problem
subsided	O
and	O
subsequent	B-treatment
early	I-treatment
mobilization	I-treatment
to	O
prevent	O
any	B-problem
rigidity	I-problem
in	I-problem
that	I-problem
joint	I-problem
.	O

The	O
patient	O
was	O
also	O
seen	O
subsequently	O
in	O
consultation	O
by	O
the	O
Plastic	O
Surgical	O
Service	O
who	O
discontinued	O
a	O
number	O
of	O
the	B-treatment
patient	I-treatment
's	I-treatment
indwelling	I-treatment
drains	I-treatment
but	O
they	O
felt	O
that	O
others	O
needed	O
to	O
stay	O
while	O
the	O
patient	O
was	O
sent	O
to	O
rehabilitation	O
.	O

These	B-treatment
drains	I-treatment
will	O
then	O
be	O
subsequently	O
taken	O
out	O
by	O
Dr.	O
General	O
upon	O
his	O
followup	O
with	O
the	O
patient	O
.	O

Prior	O
to	O
discharge	O
the	O
patient	O
also	O
underwent	O
an	B-test
audiogram	I-test
as	O
a	B-test
baseline	I-test
hearing	I-test
test	I-test
while	O
the	O
patient	O
was	O
to	O
stay	O
on	O
long	B-treatment
term	I-treatment
intravenous	I-treatment
antibiotics	I-treatment
.	O

The	O
patient	O
otherwise	O
continued	O
to	O
be	O
hemodynamically	O
stable	O
making	O
good	O
progress	O
.	O

As	O
a	O
matter	O
of	O
fact	O
the	O
patient	O
made	O
remarkable	O
progress	O
given	O
the	O
severity	O
of	O
his	B-problem
disease	I-problem
condition	I-problem
prior	O
to	O
the	B-treatment
operation	I-treatment
.	O

The	O
patient	O
's	O
condition	O
continued	O
to	O
be	O
improved	O
.	O

Given	O
this	O
finding	O
the	O
patient	O
was	O
therefore	O
felt	O
to	O
be	O
ready	O
for	O
discharge	O
to	O
a	O
rehabilitation	O
facility	O
on	O
09/13/1998	O
.	O

In	O
consultation	O
with	O
the	O
Infectious	O
Disease	O
Service	O
the	O
patient	O
was	O
to	O
stay	O
on	O
long	B-treatment
term	I-treatment
intravenous	I-treatment
antibiotics	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Diet	O
:	O

High	B-treatment
calorie	I-treatment
,	I-treatment
high	I-treatment
protein	I-treatment
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
treatment	I-treatment
will	O
include	O
typical	B-treatment
peripherally	I-treatment
inserted	I-treatment
central	I-treatment
catheter	I-treatment
line	I-treatment
care	I-treatment
with	O
frequent	B-test
wound	I-test
checks	I-test
.	O

The	O
patient	O
prior	O
to	O
discharge	O
was	O
fitted	O
with	O
an	B-treatment
orthoplast	I-treatment
finger	I-treatment
splint	I-treatment
as	O
manufactured	O
by	O
Occupational	O
Therapy	O
Services	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

The	O
patient	O
was	O
also	O
instructed	O
in	O
range	B-treatment
of	I-treatment
motion	I-treatment
exercises	I-treatment
for	O
the	O
left	O
middle	O
finger	O
.	O

The	O
patient	O
on	O
discharge	O
is	O
to	O
have	O
twice	O
weekly	O
Vancomycin	B-test
peak	I-test
and	I-test
trough	I-test
levels	I-test
while	O
he	O
continues	O
on	O
long	B-treatment
term	I-treatment
Vancomycin	I-treatment
therapy	I-treatment
.	O

The	O
patient	O
was	O
instructed	O
to	O
return	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
if	O
he	O
developed	O
any	O
signs	O
of	O
wound	B-problem
infection	I-problem
such	O
a	B-problem
erythema	I-problem
,	O
drainage	B-problem
,	O
or	O
increasing	B-problem
incisional	I-problem
pain	I-problem
.	O

The	O
patient	O
was	O
instructed	O
to	O
be	O
vigilant	O
for	O
any	B-problem
fevers	I-problem
or	O
chills	B-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Vancomycin	B-treatment
750	O
mg	O
intravenous	O
q	O
18h.	O

2.	O
Levofloxacin	B-treatment
500	O
mg	O
po	O
per	O
day	O
.	O

3.	O
Prilosec	B-treatment
20	O
mg	O
po	O
per	O
day	O
.	O

4.	O
Captopril	B-treatment
100	O
mg	O
po	O
three	O
times	O
a	O
day	O
.	O

5.	O
Lopressor	B-treatment
100	O
mg	O
po	O
three	O
times	O
a	O
day	O
.	O

6.	O
Albuterol	B-treatment
nebulizers	I-treatment
q6h	O
as	O
needed	O
.	O

7.	O
Atrovent	B-treatment
nebulizers	I-treatment
q6h	O
as	O
needed	O
.	O

8.	O
Lasix	B-treatment
20	O
mg	O
po	O
per	O
day	O
.	O

9.	O
Kay-Ciel	B-treatment
20	O
mEq	O
po	O
per	O
day	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
was	O
instructed	O
that	O
he	O
needed	O
to	O
followup	O
with	O
Dr.	O
Rhalt	O
by	O
calling	O
his	O
office	O
for	O
appointment	O
at	O
763-6361	O
subsequent	O
to	O
his	O
discharge	O
to	O
his	O
rehabilitation	O
facility	O
in	O
Oaksale	O
Lavalle	O
.	O

The	O
patient	O
was	O
also	O
instructed	O
to	O
followup	O
with	O
Dr.	O
Both	O
of	O
the	O
Cardiology	O
Service	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
following	O
his	O
discharge	O
so	O
that	O
his	B-treatment
antihypertension	I-treatment
medications	I-treatment
could	O
be	O
appropriately	O
adjusted	O
.	O

The	O
patient	O
will	O
also	O
be	O
seen	O
in	O
followup	O
by	O
Dr.	O
Chpo	O
E.	O
Enla	O
General	O
of	O
the	O
Plastic	O
Surgery	O
Service	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
so	O
that	O
his	B-treatment
indwelling	I-treatment
Jackson	I-treatment
Pratt	I-treatment
drains	I-treatment
be	O
appropriately	O
management	O
and	O
if	O
needed	O
be	O
discontinued	O
by	O
him	O
.	O

The	O
patient	O
will	O
also	O
be	O
followed	O
by	O
the	O
Infectious	O
Disease	O
Service	O
so	O
as	O
to	O
ascertain	O
the	O
exact	O
length	O
and	O
course	O
of	O
his	B-treatment
antibiotic	I-treatment
therapy	I-treatment
.	O

The	O
patient	O
was	O
instructed	O
to	O
followup	O
with	O
Dr.	O
Naco	O
Mesprhalt	O
of	O
the	O
Infectious	O
Disease	O
Service	O
by	O
calling	O
her	O
office	O
for	O
an	O
appointment	O
at	O
094-902-2879	O
to	O
be	O
seen	O
in	O
approximately	O
four	O
weeks	O
following	O
the	O
patient	O
's	O
discharge	O
.	O

Dr.	O
Dau	O
's	O
recommendation	O
is	O
that	O
the	O
patient	O
is	O
to	O
stay	O
on	O
Vancomycin	B-treatment
and	O
Levofloxacin	B-treatment
for	O
approximately	O
six	O
weeks	O
following	O
discharge	O
and	O
then	O
subsequently	O
on	O
antibiotic	B-treatment
regimen	I-treatment
for	O
chronic	B-treatment
suppression	I-treatment
.	O

RYNA	O
DAU	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

NISTE	O
MA	O
RHALT	O
,	O
M.D.	O

TR	O
:	O

oq	O
PAD-WORD	O

DD	O
:	O

09/13/1998	O
PAD-WORD	O

TD	O
:	O

09/13/1998	O
7:18	O
A	O

cc	O
:	O

KEND	O
N	O
BOTH	O
,	O
M.D.	O
CARDIAC	O
FELLOWS	O
ROOM	O
LOLI	O
MEMORIAL	O
MEDICAL	O
CENTER	O
NACO	O
MESPRHALT	O
,	O
M.D.	O
INFECTIOUS	O
DISEASE	O
UNIT	O
CIL	O
HOSPITAL	O
RYNA	O
R	O
DAU	O
,	O
M.D.	O
SURGICAL	O
RESIDENT	O
SURG	O
AG	O
NISTE	O
MA	O
RHALT	O
,	O
M.D.	O
SURGERY	O
BROTROJEUNECOCK	O
HEALTH	O
CHPO	O
E	O
ENLA	O
GENERAL	O
,	O
M.D.	O
SURGERY	O
ON	O
HOSPITAL	O
STAT	O
EDITED	O
09/15/1998	O
RJ	O

Admission	O
Date	O
:	O

2016-05-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-05-16	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1985-06-12	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	B-treatment
PAD-WORD	O

Allergies	O
:	O

Zosyn	B-treatment
PAD-WORD	O

Attending	O
:	O

Gayle	O
M	O
Whitener	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Transfer	O
from	O
Tewksbury	O
State	O
Hospital	O
Hospital	O
CMED	O
CCU	O
for	O
neurologic	B-problem
compromise	I-problem
,	O
at	O
request	O
of	O
family	O
for	O
second	O
opinion	O
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

30-year-old	O
woman	O
with	O
metastatic	B-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
of	O
unknown	O
primary	O
.	O

At	O
ChelseaWomens	O
'	O
,	O
about	O
04-25	O
,	O
she	O
developed	O
pseudomonal	B-problem
urosepsis	I-problem
and	O
vaginal	B-problem
bleeding	I-problem
from	O
tumor	B-problem
extension/anti-coagulation	I-problem
.	O

She	O
was	O
transfered	O
to	O
AttleboroHospital	O
after	O
an	O
arrest	O
.	O

Her	O
course	O
was	O
complicated	O
by	O
post-hypotensive	B-problem
coma	I-problem
as	O
well	O
as	O
subarachnoid	B-problem
hemorrhages	I-problem
and	O
intraparenchymal	B-problem
bleeds	I-problem
.	O

Neurologists	O
at	O
RIH	O
felt	O
she	O
had	O
a	O
poor	O
prognosis	O
,	O
but	O
communication	O
between	O
the	O
medical	O
team	O
and	O
family	O
was	O
strained	O
and	O
transfer	O
was	O
arranged	O
to	O
Mediplex	O
Rehab	O
Hospital	O
for	O
a	O
second	O
opinion	O
.	O

Her	O
outside	O
course	O
in	O
more	O
detail:	O

Patient	O
transferred	O
from	O
Women	O
and	O
Infants	O
Hospital	O
to	O
RI	O
Hospital	O
2016-04-25	O
with	O
weaknes	B-problem
,	O
vag	B-problem
bleeding	I-problem
x	O
several	O
days	O
,	O
fever	B-problem
102.5	O
,	O
hypotension	B-problem
,	O
hypoxic	B-problem
84%	O
on	O
4L	B-treatment
NC	I-treatment
,	O
tachypnic	B-problem
to	O
30	O
,	O
with	O
labs	B-test
significant	O
for	O
lactate	B-test
6.3	O
,	O
wbc	B-test
<1.0	O
,	O
plt	B-test
9	O
,	O
hgb	B-test
8.9	O
,	O
and	O
INR	B-test
greater	O
than	O
lab	O
threshold	O
.	O

Intubated	B-treatment
for	O
airway	B-treatment
protection	I-treatment
(	O
ABG	B-test
7.39/26.5/73.6	O
)	O
and	O
placed	O
on	O
levophed	B-treatment
.	O

.	O
PAD-WORD	O

Placed	O
on	O
Reynolds/vanc/fluc/gentamicin	B-treatment
for	O
neutropenic	B-problem
fever	I-problem
and	O
thrush	B-problem
initially	O
.	O

IVC	B-treatment
filter	I-treatment
placed	O
04-26	O
.	O

CT	B-test
abdomen	I-test
consistent	O
with	O
large	B-problem
necrotic	I-problem
pelvic	I-problem
mass	I-problem
-	O
not	O
sampled	O
02-12	O
coagulopathy	B-problem
.	O

04-27	O
results	O
from	O
Blood	B-test
Cx	I-test
from	O
W+I	O
:	O

04-24	O
PICC	B-test
Bld	I-test
Cx	I-test
:	O
pseudomonas	B-problem
Diaz	O
to	O
zosyn	B-treatment
,	O
cipro	B-treatment
,	O
cefepime	B-treatment
,	O
Tardugno	O
--	O
staph	B-problem
epi-	I-problem
Gray	O
to	O
vanc	B-treatment

04-24	O
Peripheral	B-test
Bld	I-test
Cx	I-test
:	O
pseudomonas	B-problem
as	O
above	O

04-24	O
Urine	B-test
Cx	I-test
:	O
pseudomonas	B-problem
as	O
above	O

Abx	B-treatment
changed	O
to	O
vanc	B-treatment
,	O
zosyn	B-treatment
,	O
cipro	B-treatment
,	O
fluc	B-treatment
,	O
azith	B-treatment
.	O

Pressors	B-treatment
weaned	O
off	O
by	O
04-27	O
.	O

Completed	O
7	O
days	O
of	O
vanc/fluc	B-treatment
,	O
13/14	O
days	O
of	O
cipro/zosyn	B-treatment
.	O

Continued	O
to	O
have	O
recurrent	B-problem
fevers	I-problem
.	O

.	O
PAD-WORD	O

Seen	O
by	O
Urology	O
who	O
did	O
not	O
change	O
stents	B-treatment
given	O
severe	B-problem
coagulopathy	I-problem
and	O
worsening	B-problem
renal	I-problem
function	I-problem
.	O

Found	O
to	O
be	O
in	O
DIC	B-problem
and	O
supported	O
with	O
daily	B-treatment
blood	I-treatment
products	I-treatment
.	O

Seen	O
by	O
heme	O
and	O
GCSF	B-treatment
started	O
.	O

Despite	O
aggressive	B-treatment
blood	I-treatment
product	I-treatment
repletion	I-treatment
patient	O
poorly	B-problem
responsive	I-problem
02-12	O
alloimmunization	B-problem
.	O

Plt	B-test
count	I-test
1	O
on	O
2016-04-29	O
.	O

Supported	O
on	O
TPN	B-treatment
for	O
nutrition	O
then	O
switched	O
to	O
tube	B-treatment
feeds	I-treatment
.	O

Developed	O
renal	B-problem
failure	I-problem
with	O
Cr	B-test
peak	I-test
of	O
2.9.	O

Seen	O
by	O
renal	O
who	O
felt	O
was	O
c/w	O
ATN	B-problem
.	O

.	O
PAD-WORD	O

Head	B-test
CT	I-test
done	O
05-04	O
with	O
bilateral	B-problem
SAH	I-problem
and	O
L	B-problem
temporal	I-problem
parenchymal	I-problem
hematoma	I-problem
.	O

Also	O
with	O
multiple	B-problem
masses	I-problem
consistent	O
with	O
metastasis	B-problem
.	O

Placed	O
on	O
Dilantin	B-treatment
.	O

Neurosurgery	O
consulted	O
.	O

Felt	O
secondary	O
to	O
low	B-problem
platelets	I-problem
with	O
no	O
surgical	B-treatment
intervention	I-treatment
indicated	O
.	O

.	O
PAD-WORD	O

Mult	O
family	O
meetings	O
given	O
poor	O
prognosis	O
.	O

Initially	O
decided	O
not	O
to	O
escilate	O
care	O
and	O
make	O
DNR	O
05-05	O
.	O

Then	O
progressed	O
to	O
withdrawal	O
of	O
care	O
05-06	O
with	O
plan	O
to	O
extubate	B-treatment
05-07	O
.	O

However	O
there	O
was	O
dissent	O
among	O
neurologists	O
about	O
patient	O
's	O
ability	O
to	O
recover	O
from	O
the	B-problem
SAH	I-problem
while	O
awaiting	O
family	O
members	O
and	O
the	O
patient	O
was	O
changed	O
to	O
full	O
code	O
.	O

Given	O
48	O
hours	O
off	O
sedation	B-treatment
with	O
out	O
change	B-problem
in	I-problem
mental	I-problem
status	I-problem
(	O
last	O
morphine	B-treatment
was	O
2016-05-07	O
)	O
.	O

Transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
for	O
further	O
work	O
up	O
.	O

.	O
PAD-WORD	O

On	O
arrival	O
to	O
the	O
FICU	O
the	O
patient	O
was	O
intubated	B-treatment
and	O
non-sedated	O
.	O

Past	O
Medical	O
History	O
:	O

-	O
Retroperitoneal	B-problem
Squamous	I-problem
Cell	I-problem
Carcinoma	I-problem
of	O
unknown	O
primary	O
,	O
dx	O

12-15	O
,	O
s/p	O
XRT	B-treatment
(	O
last	O
tx	O
2015-04-20	O
)	O
,	O
s/p	O
cisplatin	B-treatment
(	O
last	O
dose	O
3/22	O
)	O

-	O
L	B-problem
hydroureter	I-problem
obstruction	I-problem
,	O
s/p	O
R	B-treatment
ureteral	I-treatment
stent	I-treatment
2016-03-24	O

-	O
h/o	O
LLE	B-problem
DVT	I-problem
on	O
coumadin	B-treatment

-	O
laser	B-treatment
conization	I-treatment
of	I-treatment
cervix	I-treatment
2004	O

Social	O
History	O
:	O

Lives	O
with	O
husband	O
and	O
4	O
y.o.	O
son	O
.	O

Family	O
History	O
:	O

Non-contributory	O
PAD-WORD	O

Physical	O
Exam	O
:	O

VS	B-test
-	O
Tm	B-test
101.7	O

Tc	B-test
99.7	O
P	B-test
123	O
BP	B-test
137/75	O

Resp	O
-	O
PCV	B-test
Pinsp	I-test
26	O
R	B-test
16	O
FiO2	B-test
50%	O
Rate	B-test
8	O
,	O
breathing	B-test
20	O
,	O
Sat	B-test
100%	O

Gen	O
-	O
lying	O
in	O
bed	O
unresponsive	B-problem

HEENT	O
-	O
OP	O
clear	O
,	O
PERRL	O

Neck	O
-	O
supple	O

Cor	O
-	O
RRR	O

Chest	O
-	O
diffuse	B-problem
ronchi	I-problem

Abd	O
-	O
Mass	B-problem
in	I-problem
LLQ	I-problem
,	O
nephrostomy	B-treatment
with	O
yellow	O
clear	O
output	O

Ext	O
-	O
diffuse	B-problem
anasarca	I-problem
x	O
4	O
ext	O

Neuro	O
-	O
PERRL	O
,	O
corneal	O
reflex	O
,	O
gag	O
reflex	O
,	O
Dolls	B-problem
eyes	I-problem
,	O
spont	O
mvt	O
of	O
head	O
with	O
out	O
purpose	O
side	O
to	O
side	O

Pertinent	O
Results	O
:	O

2016-05-10	O
11:02PM	O

PT	B-test
-	O
14.6*	O
PTT	B-test
-	O
29.1	O
INR	B-test
(	I-test
PT	I-test
)	I-test
-	O
1.3*	O

2016-05-10	O
11:02PM	O

PLT	B-test
SMR	I-test
-	O
LOW	B-problem
PLT	I-problem
COUNT	I-problem
-	O
86*	O

2016-05-10	O
11:02PM	O

WBC	B-test
-	O
3.7*	O
RBC	B-test
-	O
2.78*	O
HGB	B-test
-	O
8.6	O
*	O
HCT	B-test
-	O
25.8*	O
MCV	B-test
-	O
93	O

MCH	B-test
-	O
31.1	O
MCHC	B-test
-	O
33.5	O
RDW	B-test
-	O
14.9	O

2016-05-10	O
11:02PM	O

CALCIUM	B-test
-	O
7.1*	O
PHOSPHATE	B-test
-	O
5.1*	O
MAGNESIUM	B-test
-	O
1.7	O

2016-05-10	O
11:02PM	O

ALT	B-test
(	I-test
SGPT	I-test
)	I-test
-	O
23	O
AST	B-test
(	I-test
SGOT	I-test
)	I-test
-	O
19	O
ALK	B-test
PHOS	I-test
-	O
101	O

2016-05-10	O
11:02PM	O

estGFR	B-test
-	O
Using	O
this	O

2016-05-10	O
11:02PM	O

GLUCOSE	B-test
-	O
96	O
UREA	B-test
N	I-test
-	O
113*	O
CREAT	B-test
-	O
2.3*	O
SODIUM	B-test
-	O
150*	O

POTASSIUM	B-test
-	O
3.9	O
CHLORIDE	B-test
-	O
110*	O
TOTAL	B-test
CO2	I-test
-	O
28	O
ANION	B-test
GAP	I-test
-	O
16	O

2016-05-15	O
06:02AM	O
BLOOD	B-test

WBC	B-test
-	O
9.5	O
RBC	B-test
-	O
2.78*	O
Hgb	B-test
-	O
8.8*	O
Hct	B-test
-	O
25.7*	O

MCV	B-test
-	O
93	O
MCH	B-test
-	O
31.7	O
MCHC	B-test
-	O
34.2	O
RDW	B-test
-	O
14.6	O
Plt	B-test
Ct	I-test
-	O
26*	O

2016-05-11	O
04:30AM	O
BLOOD	B-test

Neuts	B-test
-	O
80.4*	O
Bands	B-test
-	O
9.3*	O
Lymphs	B-test
-	O
4.1*	O

Monos	B-test
-	O
3.1	O
Eos	B-test
-	O
1.0	O
Baso	B-test
-	O
0	O
Atyps	B-test
-	O
1.0*	O
Metas	B-test
-	O
1.0*	O

2016-05-15	O
06:02AM	O
BLOOD	B-test

Fibrino	B-test
-	O
406*	O

2016-05-15	O
06:02AM	O
BLOOD	B-test

Glucose	B-test
-	O
120*	O
UreaN	B-test
-	O
79*	O
Creat	B-test
-	O
1.8*	O
Na	B-test
-	O
144	O

K	B-test
-	O
3.6	O
Cl	B-test
-	O
110*	O
HCO3	B-test
-	O
23	O
AnGap	B-test
-	O
15	O

2016-05-11	O
04:30AM	O
BLOOD	B-test

ALT	B-test
-	O
19	O
AST	B-test
-	O
18	O
LD	B-test
(	I-test
LDH	I-test
)	I-test
-	O
313*	O
AlkPhos	B-test
-	O
104	O

Amylase	B-test
-	O
37	O
TotBili	B-test
-	O
0.8	O

2016-05-15	O
06:02AM	O
BLOOD	O

Calcium	B-test
-	O
7.4*	O
Phos	B-test
-	O
3.6	O
Mg	B-test
-	O
2.2	O

2016-05-11	O
04:30AM	O
BLOOD	B-test

Albumin	B-test
-	O
2.3	O

2016-05-13	O
08:32AM	O
BLOOD	B-test

Type	O
-	O
ART	B-test
Temp	I-test
-	O
38.2	O
Tidal	B-test
V	I-test
-	O
500	O
PEEP	B-test
-	O
5	O

FiO2	B-test
-	O
40	O
pO2	B-test
-	O
104	O
pCO2	B-test
-	O
50*	O
pH	B-test
-	O
7.36	O
calTCO2	B-test
-	O
29	O
Base	B-test
XS	I-test
-	O
1	O

-ASSIST/CON	O
Intubat	O
-	O
INTUBATED	B-treatment

2016-05-11	O
02:08AM	O
BLOOD	B-test

Lactate	B-test
-	O
1.6	O

.	O
PAD-WORD	O

2016-05-11	O
MRI	B-test
head:	I-test

FINDINGS	O
:	O

The	B-test
sagittal	I-test
T1	I-test
images	I-test
demonstrate	O
several	O
areas	O
of	O
high	B-problem
signal	I-problem
along	I-problem
the	I-problem
sulci	I-problem
bilaterally	I-problem
which	O
could	O
be	O
secondary	O
to	O
subarachnoid	B-problem
hemorrhages	I-problem
.	O

There	O
are	O
several	O
areas	O
of	O
hyperintensities	B-problem
at	I-problem
the	I-problem
convexity	I-problem
which	O
could	O
be	O
intraaxial	O
and	O
could	O
be	O
related	O
to	O
hemorrhage	B-problem
within	I-problem
the	I-problem
metastatic	I-problem
lesions	I-problem
but	O
in	O
absence	O
of	O
gradient	B-test
echo	I-test
images	I-test
,	O
this	O
could	O
not	O
be	O
further	O
confirmed	O
.	O

A	B-test
CT	I-test
would	O
help	O
for	O
further	O
assessment	O
if	O
indicated	O
.	O

There	O
is	O
increased	B-problem
signal	I-problem
seen	O
in	O
both	O
basal	O
ganglia	O
region	O
as	O
well	O
as	O
along	O
the	O
rolandic	O
region	O
bilaterally	O
which	O
is	O
suggestive	O
of	O
global	B-problem
hypoxic	I-problem
injury	I-problem
to	I-problem
the	I-problem
brain	I-problem
.	O

There	O
are	O
several	O
areas	O
of	O
brain	B-problem
edema	I-problem
identified	O
in	O
the	O
left	O
frontal	O
and	O
parietal	O
lobe	O
and	O
both	O
temporal	O
lobes	O
,	O
which	O
are	O
suspicious	O
for	O
areas	B-problem
of	I-problem
metastatic	I-problem
disease	I-problem
with	O
surrounding	B-problem
edema	I-problem
.	O

There	O
is	O
no	O
hydrocephalus	B-problem
or	O
midline	B-problem
shift	I-problem
seen	O
.	O

No	O
herniation	B-problem
is	O
identified	O
.	O

Images	B-test
through	I-test
the	I-test
skull	I-test
base	I-test
demonstrate	O
soft	B-problem
tissue	I-problem
changes	I-problem
in	I-problem
the	I-problem
sphenoid	I-problem
sinus	I-problem
which	O
could	O
be	O
due	O
to	O
retained	B-problem
secretions	I-problem
from	O
intubation	B-treatment
.	O

There	O
is	O
increased	B-problem
signal	I-problem
seen	O
along	O
the	O
sulci	O
on	O
FLAIR	B-test
images	I-test
at	O
the	O
convexity	O
which	O
could	O
be	O
secondary	O
to	O
subarachnoid	B-problem
hemorrhage	I-problem
.	O

A	B-test
CT	I-test
would	O
help	O
for	O
further	O
assessment	O
and	O
exclude	O
proteinaceous	B-problem
material	I-problem
within	I-problem
the	I-problem
sulci	I-problem
.	O

Gadolinium-enhanced	B-test
MRI	I-test
would	O
also	O
help	O
for	O
further	O
assessment	O
.	O

.	O
PAD-WORD	O

pCXR	B-test
2016-05-11	O
5:01am:	O

FINDINGS	O
:	O

No	O
prior	O
comparisons	O
.	O

Tip	O
of	O
the	B-treatment
ETT	I-treatment
projects	O
roughly	O
5	O
cm	O
above	O
the	O
carina	O
.	O

A	B-treatment
right	I-treatment
IJ	I-treatment
central	I-treatment
venous	I-treatment
line	I-treatment
is	O
at	O
the	O
level	O
of	O
the	O
mid	O
SVC	O
.	O

Tip	O
of	O
the	B-treatment
NGT	I-treatment
is	O
below	O
the	O
edge	O
of	O
the	O
image	O
.	O

IVC	B-treatment
filter	I-treatment
and	O
probable	O
NU	B-treatment
stent	I-treatment
catheter	I-treatment
on	I-treatment
the	I-treatment
left	I-treatment
also	O
noted	O
.	O

Heart	O
and	O
mediastinum	O
are	O
unremarkable	O
allowing	O
for	O
technique	O
,	O
no	O
sizeable	B-problem
pneumothorax	I-problem
.	O

There	O
is	O
a	B-problem
somewhat	I-problem
wedge-shaped	I-problem
opacity	I-problem
at	I-problem
the	I-problem
right	I-problem
lung	I-problem
base	I-problem
which	O
could	O
represent	O
aspiration	B-problem
or	O
pneumonia	B-problem
.	O

No	O
other	B-problem
confluent	I-problem
infiltrates	I-problem
are	O
appreciated	O

.	O
PAD-WORD	O

pCXR	B-test
2016-05-11.	O
1:46pm:	O

1.	O
Mild	B-problem
pulmonary	I-problem
edema	I-problem
.	O

2.	O
Vague	B-problem
right	I-problem
lower	I-problem
lobe	I-problem
opacity	I-problem
most	O
likely	O
represents	O
pulmonary	B-problem
edema	I-problem
though	O
if	O
opacity	B-problem
persistent	O
after	O
diuresis	B-treatment
,	O
aspiration	B-problem
and	O
pneumonia	B-problem
will	O
become	O
considerations	O
.	O

3.	O
ETT	B-treatment
4	O
cm	O
above	O
the	O
carina	O
with	O
NG	B-treatment
tube	I-treatment
advancement	O
into	O
the	O
stomach	O
.	O

.	O
PAD-WORD	O

EEG	B-test
2016-05-12:	O

Abnormal	B-problem
portable	I-problem
EEG	I-problem
due	O
to	O
the	B-problem
slow	I-problem
and	I-problem
disorganized	I-problem
background	I-problem
and	O
bursts	B-problem
of	I-problem
generalized	I-problem
slowing	I-problem
.	O

These	O
findings	O
indicate	O
a	B-problem
widespread	I-problem
encephalopathy	I-problem
.	O

Medications	B-treatment
,	O
metabolic	B-problem
disturbances	I-problem
,	O
and	O
infection	B-problem
are	O
among	O
the	O
most	O
common	O
causes	O
.	O

Subarachnoid	B-problem
hemorrhage	I-problem
is	O
another	O
possible	O
explanation	O
.	O

There	O
were	O
no	O
areas	O
of	O
prominent	B-problem
focal	I-problem
slowing	I-problem
,	O
and	O
there	O
were	O
no	O
epileptiform	B-problem
features	I-problem

.	O
PAD-WORD	O

Trans-thoracic	B-test
echocardiogram	I-test
2016-05-12	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

Left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
LVEF>55%	B-test
)	O
.	O

Regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal	O
.	O

Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-problem
regurgitation	I-problem
.	O

The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

There	O
is	O
no	O
mitral	B-problem
valve	I-problem
prolapse	I-problem
.	O

The	B-test
pulmonary	I-test
artery	I-test
systolic	I-test
pressure	I-test
could	O
not	O
be	O
determined	O
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

IMPRESSION	O
:	O

Normal	O
global	O
and	O
regional	O
biventricular	O
systolic	O
function	O
.	O

No	O
pericardial	B-problem
effusion	I-problem
.	O

.	O
PAD-WORD	O

pCXR	B-test
2016-05-13	O
:	O

Mild	B-problem
left	I-problem
lower	I-problem
perihilar	I-problem
opacification	I-problem
has	O
improved	O
,	O
probably	O
resolving	B-problem
edema	I-problem
.	O

There	O
is	O
more	B-problem
rightward	I-problem
mediastinal	I-problem
shift	I-problem
,	O
suggesting	O
new	B-problem
atelectasis	I-problem
in	I-problem
the	I-problem
right	I-problem
lung	I-problem
.	O

Enlargement	B-problem
of	I-problem
the	I-problem
right	I-problem
hilus	I-problem
could	O
represent	O
adenopathy	B-problem
.	O

Whether	O
to	O
pursue	O
this	O
would	O
depend	O
upon	O
clinical	O
circumstances	O
.	O

Heart	O
size	O
normal	O
.	O

ET	B-treatment
tube	I-treatment
in	O
standard	O
placement	O
.	O

Nasogastric	B-treatment
tube	I-treatment
passes	O
below	O
the	O
diaphragm	O
and	O
out	O
of	O
view	O
.	O

No	O
appreciable	B-problem
pneumothorax	I-problem
or	O
pleural	B-problem
effusions	I-problem

.	O
PAD-WORD	O

pCXR	B-test
2016-05-14	O
:	O

Increasing	B-problem
opacification	I-problem
of	I-problem
the	I-problem
lungs	I-problem
could	O
be	O
due	O
to	O
mild	B-problem
pulmonary	I-problem
edema	I-problem
and	O
multiple	B-problem
micrometastases	I-problem
,	O
worsened	O
slightly	O
since	O
05-13	O
at	O
10:57	O
p.m.	O

Heart	O
size	O
is	O
normal	O
.	O

There	O
is	O
no	O
pleural	B-problem
effusion	I-problem
.	O

The	B-treatment
ET	I-treatment
tube	I-treatment
and	O
right	B-treatment
PICC	I-treatment
line	I-treatment
in	O
standard	O
placements	O
.	O

Nasogastric	B-treatment
tube	I-treatment
passes	O
below	O
the	O
diaphragm	O
and	O
out	O
of	O
view	O
.	O

No	O
pneumothorax	B-problem
.	O

.	O
PAD-WORD	O

Microbiology	O
:	O

05-11-	O
Blood	B-test
cultures	I-test
:	O
no	O
growth	B-problem
to	O
date	O
on	O
2/2	O
bottles	O

05-12-	O
Blood	B-test
cultures	I-test
:	O
no	O
growth	B-problem
to	O
date	O
on	O
6/6	O
bottles	O

05-14-	O
Blood	B-test
cultures	I-test
:	O
no	O
growth	B-problem
to	O
date	O
on	O
4/4	O
bottles	O

.	O
PAD-WORD	O

05-11-	O
Urine	B-test
culture	I-test
:	O
no	O
growth	B-problem
(	O
final	O
)	O

05-12-	O
Urine	B-test
culture	I-test
:	O
no	O
growth	B-problem
(	O
final	O
)	O

05-14-	O
Urine	B-test
culture	I-test
:	O
no	O
growth	B-problem
to	O
date	O

.	O
PAD-WORD	O

05-11-	O
Stool	B-test
:	O
negative	O
for	O
Cdiff	B-problem
toxin	I-problem

05-12-	O
Stool	B-test
:	O
negative	O
for	O
Cdiff	B-problem
toxin	I-problem

.	O
PAD-WORD	O

05-12-	O
Swab	B-test
from	O
Nephrostomy	B-treatment
:	O

GRAM	B-test
STAIN	I-test
(	O
Final	O
2016-05-12	O
)	O
:	O

NO	O
POLYMORPHONUCLEAR	B-problem
LEUKOCYTES	I-problem
SEEN	O
.	O

NO	O
MICROORGANISMS	B-problem
SEEN	O
.	O

WOUND	B-test
CULTURE	I-test
(	O
Preliminary	O
)	O
:	O

Due	O
to	O
mixed	B-problem
bacterial	I-problem
types	I-problem
(	O
>=	O
3	O
colony	O
types	O
)	O
an	B-test
abbreviated	I-test
workup	I-test
is	O
performed	O
appropriate	O
to	O
the	O
isolates	O
recovered	O
from	O
the	O
site	O
(	O
including	O
a	B-test
screen	I-test
for	O
Pseudomonas	B-problem
aeruginosa	I-problem
,	O
Staphylococcus	B-problem
aureus	I-problem
and	O
beta	B-problem
streptococcus	I-problem
)	O
.	O

STAPHYLOCOCCUS	B-problem
,	I-problem
COAGULASE	I-problem
NEGATIVE	O
.	O

RARE	B-problem
GROWTH	I-problem
.	O

CORYNEBACTERIUM	B-problem
SPECIES	I-problem
(	I-problem
DIPHTHEROIDS	I-problem
)	I-problem
.	O

SPARSE	B-problem
GROWTH	I-problem
.	O

PSEUDOMONAS	B-problem
AERUGINOSA	I-problem
.	O

RARE	B-problem
GROWTH	I-problem
.	O

SENSITIVITIES	O
:	O

MIC	O
expressed	O
in	O

MCG/ML	O
PAD-WORD	O

_________________________________________________________	O
PAD-WORD	O

PSEUDOMONAS	B-problem
AERUGINOSA	I-problem

|	O
PAD-WORD	O

.	O
PAD-WORD	O

05-12-	O
Sputum	O
:	O

Source	O
:	O

Endotracheal	O
.	O

GRAM	B-test
STAIN	I-test
(	O
Final	O
2016-05-12	O
)	O
:	O

11-03	O
PMNs	B-test
and	O
<10	O
epithelial	O
cells/100X	O
field	O
.	O

NO	O
MICROORGANISMS	B-problem
SEEN	O
.	O

RESPIRATORY	B-test
CULTURE	I-test
(	O
Final	O
2016-05-14	O
)	O
:	O

NO	O
GROWTH	B-problem
.	O

FUNGAL	B-test
CULTURE	I-test
(	O
Preliminary	O
)	O
:	O

NO	O
FUNGUS	B-problem
ISOLATED	O
.	O

NOCARDIA	B-test
CULTURE	I-test
(	O
Preliminary	O
)	O
:	O

NO	O
NOCARDIA	B-problem
ISOLATED	O
.	O

.	O
PAD-WORD	O

05-14-	O
Sputum	O
:	O

Source	O
Endotracheal	O
.	O

GRAM	B-test
STAIN	I-test
(	O
Final	O
2016-05-14	O
)	O
:	O

>25	O
PMNs	B-test
and	O
<10	O
epithelial	O
cells/100X	O
field	O
.	O

1+	O
(	O
<1	O
per	O
1000X	O
FIELD	O
)	O
:	O

GRAM	B-problem
POSITIVE	I-problem
COCCI	I-problem
.	O

IN	O
PAIRS	O
AND	O
CLUSTERS	O
.	O

1+	O
(	O
<1	O
per	O
1000X	O
FIELD	O
)	O
:	O

YEAST(	B-problem
S	I-problem
)	I-problem
.	O

.	O
PAD-WORD	O

05-14-	O
Catheter	B-treatment
tip	I-treatment
(	I-treatment
IV	I-treatment
):	I-treatment

WOUND	B-test
CULTURE	I-test
(	O
Final	O
2016-05-15	O
)	O
:	O

No	O
significant	B-problem
growth	I-problem

Brief	O
Hospital	O
Course	O
:	O

30	O
yo	O
F	O
with	O
metastatic	B-problem
squamous	I-problem
cell	I-problem
carcinoma	I-problem
of	O
unknown	O
primary	O
who	O
presented	O
to	O
OSH	O
04-25	O
with	O
pseudomonal	B-problem
urosepsis	I-problem
,	O
vaginal	B-problem
bleeding	I-problem
from	O
tumor	B-problem
extension/anti-coagulation	I-problem
.	O

Course	O
complicated	O
by	O
sub	B-problem
arachnoid	I-problem
hemorrhages	I-problem
and	O
intraparenchymal	B-problem
bleeds	I-problem
as	O
well	O
as	O
potential	O
hypotensive	B-problem
brain	I-problem
injury	I-problem
with	O
poor	O
prognosis	O
per	O
neurology	O
.	O

Transferred	O
here	O
for	O
second	O
opinion	O
on	O
poor	O
prognosis	O
.	O

.	O
PAD-WORD	O

#	O
Neurologic	O
-	O
The	O
patient	O
was	O
seen	O
by	O
the	O
Neurology	O
consult	O
service	O
and	O
underwent	O
MRI	B-test
head	I-test
which	O
revealed	O
lesions	B-problem
suspicious	O
for	O
metastases	B-problem
,	O
possible	O
hemorrhages	B-problem
,	O
and	O
findings	O
consistent	O
with	O
hypoxic	B-problem
brain	I-problem
injury	I-problem
.	O

EEG	B-test
was	O
performed	O
and	O
revealed	O
encephalopathy	B-problem
.	O

The	B-test
patient	I-test
's	I-test
neurologic	I-test
exam	I-test
(	O
performed	O
after	O
sedation	B-treatment
removed	O
>48	O
hours	O
)	O
revealed	O
intact	O
brainstem	O
function	O
without	O
evidence	O
of	O
higher	O
cortical	O
activity	O
.	O

She	O
had	O
some	B-problem
metabolic	I-problem
abnormalities	I-problem
which	O
were	O
corrected	O
(	O
hypernatremia	B-problem
,	O
hyperphosphatemia	B-problem
)	O
,	O
but	O
neurologic	B-test
exam	I-test
was	O
unchanged	O
.	O

A	O
family	O
meeting	O
on	O
2016-05-13	O
was	O
held	O
and	O
these	O
findings	O
communicated	O
with	O
the	O
patient	O
's	O
family	O
.	O

Final	B-test
neurologic	I-test
assessment	I-test
was	O
that	O
the	O
patient	O
was	O
unlikely	O
to	O
regain	O
meaningful	O
neurologic	O
functioning	O
.	O

At	O
the	O
request	O
of	O
her	O
family	O
,	O
she	O
will	O
be	O
transferred	O
closer	O
to	O
her	O
home	O
in	O
Wyoming	O
,	O
to	O
Women	O
and	O

Infants	O
hospital	O
.	O

.	O
PAD-WORD	O

#	O
Respiratory	B-problem
Failure	I-problem
-	O
Pt	O
arrived	O
on	O
pressure	B-treatment
support	I-treatment
ventilation	I-treatment
,	O
which	O
was	O
changed	O
to	O
Assist	B-treatment
control	I-treatment
to	O
make	O
patient	O
more	O
comfortable	O
.	O

She	O
was	O
originally	O
intubated	B-treatment
for	O
airway	B-treatment
protection	I-treatment
,	O
and	O
it	O
is	O
felt	O
she	O
could	O
likely	O
be	O
weaned	O
from	O
the	B-treatment
ventilator	I-treatment
although	O
she	O
would	O
be	O
extremely	O
high	O
risk	O
for	O
aspiration	B-problem
.	O

Due	O
to	O
family	O
request	O
to	O
move	O
patient	O
to	O
a	O
hospital	O
closer	O
to	O
home	O
,	O
she	O
will	O
remain	O
intubated	B-treatment
until	O
transfer	O
,	O
with	O
plan	O
to	O
extubate	B-treatment
upon	O
arrival	O
to	O
Women	O
and	O
Infants	O
hospital	O
with	O
initiation	O
of	O
full	B-treatment
palliative	I-treatment
care	I-treatment
and	O
compliance	O
of	O
DNI	O
status	O
.	O

.	O
PAD-WORD	O

#	O
Fevers/Infection	B-problem
-	O
Per	O
outside	O
hospital	O
records	O
,	O
the	O
patient	O
grew	O
pseudomonas	B-problem
from	O
blood	O
and	O
urine	O
.	O

At	O
OSH	O
,	O
she	O
was	O
treated	O
with	O
7	O
days	O
of	O
vancomycin	B-treatment
,	O
as	O
well	O
as	O
13	O
days	O
(	O
of	O
14-day	O
planned	O
course	O
)	O
of	O
Ciprofloxacin	B-treatment
and	O
Zosyn	B-treatment
.	O

She	O
was	O
intially	O
continued	O
on	O
Cipro/Zosyn	B-treatment
.	O

CXR	B-test
05-11	O
revealed	O
?	O
pneumonia	B-problem
vs	O
atelectasis	B-problem
at	I-problem
the	I-problem
R	I-problem
lung	I-problem
base	I-problem
.	O

Continues	O
to	O
spike	O
fever	B-problem
.	O

Could	O
have	O
still	O
seeding	O
of	O
nephrostomy	B-treatment
tube	I-treatment
.	O

Urology	O
at	O
OSH	O
against	O
pulling	O
tube	B-treatment
because	O
coagulopathy	B-problem
and	O
may	O
not	O
be	O
able	O
to	O
replace	O
.	O

Fevers	B-problem
also	O
may	O
be	O
from	O
head	B-problem
bleed	I-problem
,	O
cancer	B-problem
,	O
or	O
drug	B-treatment
.	O

She	O
was	O
continued	O
on	O
zosyn	B-treatment
and	O
vancomycin	B-treatment
to	O
complete	O
a	O
>14	O
day	O
course	O
.	O

She	O
continued	O
to	O
have	O
fevers	B-problem
.	O

Antibiotics	B-treatment
were	O
discontinued	O
on	O
05-15	O
.	O

No	O
further	B-problem
infectious	I-problem
course	I-problem
was	O
identified	O
and	O
the	B-problem
fevers	I-problem
may	O
have	O
been	O
due	O
to	O
underlying	B-problem
malignant	I-problem
process	I-problem
.	O

.	O
PAD-WORD	O

#	O
Squamous	B-problem
Cell	I-problem
Cancer	I-problem
-	O
unknown	O
primary	O
.	O

The	O
patient	O
was	O
seen	O
by	O
the	O
oncology	O
consult	O
service	O
who	O
contacted	O
her	O
outside	O
hematologist	O
Dr.	O
Pauling	O
.	O

Upon	O
discussion	O
with	O
him	O
it	O
was	O
noted	O
that	O
the	O
patient	O
had	O
progression	O
of	O
her	B-problem
disease	I-problem
after	O
systemic	B-treatment
therapy	I-treatment
with	O
topotecan	B-treatment
and	O
cisplatin	B-treatment
.	O

She	O
then	O
proceed	O
to	O
XRT	B-treatment
with	O
cisplatin	B-treatment
which	O
she	O
was	O
unable	O
to	O
tolerate	O
this	O
secondary	O
to	O
thrombocytopenia	B-problem
(	O
40-50K	O
)	O
.	O

Given	O
this	O
we	O
were	O
unable	O
to	O
offer	O
her	O
additional	B-treatment
therapy.	I-treatment
Hematology/Oncology	O
service	O
at	O
Mediplex	O
Rehab	O
Hospital	O
confirmed	O
her	O
grim	O
prognosis	O
and	O
expective	O
survival	O
in	O
terms	O
of	O
weeks	O
to	O
months	O
with	O
no	O
further	B-treatment
available	I-treatment
treatment	I-treatment
.	O

.	O
PAD-WORD	O

#	O
h/o	O
DVT	B-problem
-	O
patient	O
with	O
head	B-problem
bleed	I-problem
which	O
is	O
contraindication	O
to	O
anti-coagulation	B-treatment
.	O

IVC	B-treatment
filter	I-treatment
in	O
place	O
.	O

Patient	O
was	O
on	O
pneumoboots	B-treatment
while	O
in	O
hospital	O
.	O

.	O
PAD-WORD	O

#	O
Hypernatremia	B-problem
-	O
Improved	O
from	O
OSH	O
.	O

Total	B-problem
body	I-problem
volume	I-problem
overloaded	I-problem
.	O

Water	O
Deficit	O
2.5	O
L	O
.	O

She	O
was	O
continued	O
on	O
free	B-treatment
H20	I-treatment
boluses	I-treatment
and	O
D5	B-treatment
1/2	I-treatment
NS	I-treatment
and	O
corrected	O
.	O

.	O
PAD-WORD	O

#	O
Acute	B-problem
Renal	I-problem
Failure	I-problem
-	O
stable	O
,	O
likely	O
02-12	O
hypotension	B-problem
leading	O
to	O
ATN	B-problem
that	O
is	O
slowly	O
improving	O
.	O

.	O
PAD-WORD	O

#	O
Access	O
-	O
R	B-treatment
IJ	I-treatment
changed	O
sterilly	O
over	O
wire	B-treatment
05-01	O

.	O
PAD-WORD	O

#	O
FEN	O
-	O
tube	B-treatment
feeds	I-treatment
are	O
held	O
in	O
route	O
in	O
anticipation	O
of	O
extubation	O
.	O

.	O
PAD-WORD	O

.	O
PAD-WORD	O

#	O
Code	O
Status	O
:	O

After	O
multiple	O
discussion	O
with	O
family	O
and	O
the	O
doctor	O
accepting	O
the	O
patient	O
at	O
Women	O
and	O
Infants	O
Hospital(	O
Dr	O
.	O
Pauling	O
)	O
at	O
RI	O
.	O

She	O
was	O
made	O
DNR/DNI	O
and	O
the	O
plan	O
is	O
that	O
she	O
will	O
be	O
transferred	O
to	O
WIH	O
and	O
extubated	B-treatment
there	O
upon	O
arrival	O
with	O
initiation	O
of	O
full	B-treatment
palliative	I-treatment
care	I-treatment
.	O

The	O
family	O
understood	O
this;	O
all	O
questions	O
were	O
answered	O
and	O
they	O
wished	O
to	O
proceed	O
.	O

They	O
understand	O
that	O
there	O
is	O
no	O
ICU	O
at	O
WIH	O
and	O
no	O
further	O
advanced	B-treatment
pulmonary	I-treatment
support	I-treatment
can	O
be	O
offered	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B-problem
or	O
pain	B-problem
.	O

2.	O
Albuterol-Ipratropium	B-treatment
103-18	O
mcg/Actuation	O
Aerosol	O
Sig	O
:	O
06-17	O
Puffs	O
Inhalation	O
Q2-4H	O
(	O
every	O
2	O
to	O
4	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Calcium	B-treatment
Acetate	I-treatment
667	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
TID	O
W/MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
)	O
.	O

4.	O
Fentanyl	B-treatment
Citrate	I-treatment
(	O
PF	O
)	O
0.05	O
mg/mL	O
Solution	O
Sig	O
:	O
25-100	O
mcg	O
Injection	O
Q2H	O
(	O
every	O
2	O
hours	O
)	O
as	O
needed	O
for	O
comfort	O
.	O

5.	O
Insulin	B-treatment
Regular	I-treatment
Human	I-treatment
100	O
unit/mL	O
Solution	O
Sig	O
:	O
2-10	O
units	O
Injection	O
ASDIR	O
(	O
AS	O
DIRECTED	O
)	O
:	O
per	O
sliding	B-treatment
scale	I-treatment
for	O
blood	B-test
sugars	I-test
>	O
150mg/dl	O
.	O

6.	O
Midazolam	B-treatment
1	O
mg/mL	O
Solution	O
Sig	O
:	O
1-2	O
mg	O
Injection	O
Q2H	O
(	O
every	O
2	O
hours	O
)	O
as	O
needed	O
for	O
comfort	O
.	O

7.	O
Phenytoin	B-treatment
Sodium	I-treatment
50	O
mg/mL	O
Solution	O
Sig	O
:	O
One	O
95y	O
(	O
150	O
)	O
mg	O
Intravenous	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
.	O

8.	O
Ranitidine	B-treatment
HCl	O
15	O
mg/mL	O
Syrup	O
Sig	O
:	O
One	O
95y	O
(	O
150	O
)	O
mg	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

9.	O
Polyvinyl	B-treatment
Alcohol-Povidone	I-treatment
1.4-0.6	O
%	O
Dropperette	O
Sig	O
:	O
01-12	O
Drops	O
Ophthalmic	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

1.	O
Hypoxic	B-problem
brain	I-problem
injury	I-problem

2.	O
Cranial	B-problem
hemorrages	I-problem
(	I-problem
sub	I-problem
arachnoid	I-problem
and	I-problem
parenchemal	I-problem
)	I-problem

3.	O
Pseudomonal	B-problem
sepsis	I-problem
,	O
completed	O
antibiotic	B-treatment
course	I-treatment

4.	O
Metastatic	B-problem
Squamous	I-problem
cell	I-problem
carcinoma	I-problem
of	O
unknown	O
primary	O
.	O

5.	O
Thrombocytopenia	B-problem

6.	O
Blood	B-problem
loss	I-problem
anemia	I-problem

Discharge	O
Condition	O
:	O

Intubated	B-treatment
,	O
stable	O

Discharge	O
Instructions	O
:	O

You	O
are	O
being	O
transferred	O
to	O
another	O
hospital	O
,	O
intubated	B-treatment
,	O
with	O
the	O
plan	O
to	O
extubate	B-treatment
upon	O
arrival	O
to	O
Women	O
's	O
and	O
Infants	O
hosptial	O
and	O
initiation	O
of	O
palliative	B-treatment
care	I-treatment
.	O

.	O
PAD-WORD	O

Your	B-treatment
antibiotics	I-treatment
were	O
stopped	O
2016-05-15	O
(	O
Vancomycin	B-treatment
1000mg	O
q24	O
and	O
Aztreonam	B-treatment
1000mg	O
q8	O
)	O
as	O
your	O
micorbiology	B-test
data	I-test
has	O
been	O
negative	O
and	O
your	O
course	O
for	O
pseudomonal	B-problem
sepsis	I-problem
has	O
been	O
completed	O
.	O

If	O
you	O
continue	O
to	O
have	O
fevers	B-problem
,	O
blood	B-test
cultures	I-test
should	O
be	O
repeated	O
.	O

Followup	O
Instructions	O
:	O

As	O
directed	O
.	O

Jacque	O
John	O
MD	O
40-836	O

Completed	O
by	O
:	O

Marcy	O
Caroline	O
Latham	O
MD	O
51-251	O
2016-05-31	O
@	O
1628	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Richard	O
Ronald	O
Lockett	O
on	O
:	O

MON	O
2016-08-01	O
3:08	O
PM	O

(	O
End	O
of	O
Report	O
)	O

099147779	O
WGH	O

2346613	O
PAD-WORD	O

367017	O
PAD-WORD	O

2170984	O
PAD-WORD	O

11/17/2004	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

BRENOCE	O
,	O
T	O
N	O

UNIT	O
NUMBER	O
:	O

254-05-39	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

11/17/2004	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

11/26/2004	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pneumonia	B-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Pill	B-problem
esophagitis	I-problem
.	O

2.	O
Right	B-problem
ventricular	I-problem
hypokinesis	I-problem
.	O

OPERATIONS	O
/	O
PROCEDURES	O
:	O

Dobutamine	B-test
stress	I-test
test	I-test
,	O
cardiac	B-test
ultrasound	I-test
,	O
EGD	B-test
,	O
chest	B-test
x-ray	I-test
,	O
PICC	B-treatment
placement	I-treatment
.	O

The	O
patient	O
is	O
a	O
62-year-old	O
female	O
with	O
a	O
history	O
of	O
diabetes	B-problem
mellitus	I-problem
,	O
hypertension	B-problem
,	O
COPD	B-problem
,	O
hypercholesterolemia	B-problem
,	O
depression	B-problem
and	O
CHF	B-problem
who	O
was	O
lying	O
in	O
bed	O
on	O
the	O
night	O
prior	O
to	O
admission	O
when	O
she	O
developed	O
left-sided	B-problem
chest	I-problem
pain	I-problem
located	O
in	O
the	O
mid-breast	O
region	O
with	O
some	B-problem
fluttering	I-problem
her	I-problem
chest	I-problem
.	O

The	O
patient	O
radiated	O
down	O
her	O
left	O
arm	O
associated	O
with	O
some	B-problem
nausea	I-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
cough	B-problem
,	O
vomiting	B-problem
,	O
diarrhea	B-problem
.	O

She	O
slept	O
through	O
the	O
night	O
,	O
woke	O
with	O
persistent	B-problem
pain	I-problem
.	O

She	O
went	O
with	O
her	O
sister	O
&apos;s	O
husband	O
to	O
La	O
Community	O
Hospital	O
where	O
she	O
was	O
given	O
sublingual	B-treatment
nitroglycerin	I-treatment
with	O
complete	O
relief	O
of	O
pain	B-problem
.	O

She	O
refused	O
ambulance	O
to	O
the	O
Emergency	O
Room	O
and	O
was	O
driven	O
to	O
Well	O
General	O
Hospital	O
Emergency	O
Room	O
by	O
her	O
sister	O
.	O

She	O
arrived	O
pain	B-problem
free	O
.	O

She	O
was	O
given	O
Aspirin	B-treatment
,	O
Lopressor	B-treatment
and	O
Insulin	B-treatment
for	O
hyperglycemia	B-problem
.	O

EKG	B-test
was	O
unchanged	O
compared	O
to	O
the	B-test
prior	I-test
EKG	I-test
several	O
months	O
ago	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Insulin-dependent	B-problem
diabetes	I-problem
mellitus	I-problem
,	O
hypertension	B-problem
,	O
depression	B-problem
,	O
back	B-problem
pain	I-problem
,	O
COPD	B-problem
,	O
allergic	B-problem
rhinitis	I-problem
,	O
GERD	B-problem
,	O
obesity	B-problem
,	O
hyperlipidemia	B-problem
.	O

ALLERGIES	O
:	O

Codeine	B-treatment
,	O
reaction	O
unknown	O
.	O

MEDICATIONS	O
:	O

Atrovent	B-treatment
.	O

Aspirin	B-treatment
.	O

Flonase	B-treatment
.	O

Quinine	B-treatment
Celebrex	B-treatment
.	O

Compazine	B-treatment
.	O

Oxybutynin	B-treatment
Amitriptyline	B-treatment
.	O

Zyrtec	B-treatment
.	O

Prozac	B-treatment
.	O

Trazodone	B-treatment
.	O

Humulin	B-treatment
70	O
units	O
bid	O
.	O

Albuterol	B-treatment
.	O

Lasix	B-treatment
40	O
PO	O
bid	O
.	O

Triamcinolone	B-treatment
cream	I-treatment
.	O

Miconazole	B-treatment
cream	I-treatment
Flovent	B-treatment
.	O

Nifedipine	B-treatment
ER	I-treatment
60	O
daily	O
.	O

Lisinopril	B-treatment
,	O
30	O
daily	O
.	O

KCl	B-treatment
10	O
mEq	O
q	O
day	O
.	O

Protonix	B-treatment
,	O
40	O
daily	O
.	O

Lipitor	B-treatment
,	O
20	O
daily	O
.	O

Methadone	B-treatment
10	O
bid	O
.	O

FAMILY	O
HISTORY	O
:	O

Non-contributory	O
.	O

HABITS	O
:	O

Tobacco	O
:	O

Quit	O
20	O
years	O
ago	O
.	O

Alcohol	O
:	O

Rare	O
drinks	O
per	O
week	O
.	O

SOCIAL	O
HISTORY	O
:	O

Lives	O
along	O
,	O
takes	O
care	O
of	O
herself	O
.	O

Retired	O
.	O

Used	O
to	O
work	O
in	O
fast	O
food	O
.	O

VITAL	O
SIGNS	O
:	O

On	O
admission	O
blood	B-test
pressure	I-test
165/70	O
.	O

temperature	B-test
99.8	O
,	O
pulse	B-test
86	O
,	O
respiratory	B-test
rate	I-test
18	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Obese	B-problem
,	O
no	O
acute	B-problem
distress	I-problem
.	O

Multiple	O
tattoos	O
.	O

Skin	O
normal	O
.	O

HEENT	O
,	O
ears	O
poor	B-problem
hearing	I-problem
.	O

Extraocular	O
movements	O
intact	O
.	O

Moist	O
mucous	O
membranes	O
.	O

No	O
lymphadenopathy	B-problem
.	O

Chest	O
,	O
lungs	O
clear	O
to	O
auscultation	B-test
with	O
faint	B-problem
wheezes	I-problem
,	O
no	O
rales	B-problem
.	O

Cardiac	O
,	O
normal	O
S1	O
,	O
S2	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Positive	O
bowel	O
sounds	O
.	O

Neurologic	O
:	O

Alert	O
and	O
oriented	O
x3	O
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
intact	O
.	O

Motor	O
and	O
sensory	O
intact	O
.	O

Extremities	O
:	O

Feet	O
no	O
edema	B-problem
.	O

Pulses	O
2+	B-test
PT	I-test
and	O
DP	B-test
.	O

LABORATORY	O
:	O

Unremarkable	O
with	O
normal	O
electrolytes	O
except	O
for	O
glucose	B-test
of	O
328	O
.	O

CBC	B-test
,	O
white	B-test
count	I-test
6.7	O
,	O
hematocrit	B-test
37.4	O
,	O
platelets	B-test
280	O
.	O

Chest	B-test
x-ray	I-test
was	O
low	B-problem
lung	I-problem
volumes	I-problem
,	O
no	O
consolidation	B-problem
.	O

EKG	B-test
showed	O
sinus	B-problem
brady	I-problem
at	O
16	O
,	O
normal	O
axis	O
,	O
normal	O
intervals	O
,	O
no	O
STT	B-problem
wave	I-problem
abnormalities	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Team	O
Four	O
for	O
cardiac	O
monitoring	O
and	O
ruling	O
out	O
for	O
MI	B-problem
.	O

Hospital	O
course	O
by	O
system	O
:	O

1.	O
Cardiovascular	O
:	O

The	O
patient	O
ruled	O
out	O
for	O
MI	B-problem
by	O
cardiac	B-test
markers	I-test
.	O

The	O
patient	O
was	O
set	O
to	O
go	O
for	O
a	B-test
dobutamine	I-test
stress	I-test
test	I-test
on	O
11/16/04	O
given	O
her	O
history	O
of	O
COPD	B-problem
,	O
but	O
the	B-test
stress	I-test
portion	I-test
was	O
canceled	O
when	O
she	O
was	O
down	O
there	O
due	O
to	O
fever	B-problem
and	O
hypotension	B-problem
.	O

The	O
next	O
day	O
,	O
she	O
underwent	O
a	B-test
cardiac	I-test
echo	I-test
(	I-test
transthoracic	I-test
echocardiogram	I-test
)	I-test
.	O

This	B-test
echo	I-test
showed	O
LV	B-test
ejection	I-test
fraction	I-test
of	O
50%	O
with	O
no	O
wall	B-problem
motion	I-problem
abnormality	I-problem
.	O

However	O
,	O
the	O
right	O
ventricular	O
was	O
diffusely	B-problem
hypokinetic	I-problem
.	O

It	O
was	O
suboptimally	O
imaged	O
,	O
so	O
there	O
was	O
no	O
RVSP	B-test
given	O
.	O

The	O
patient	O
also	O
suffered	O
a	B-problem
hypotensive	I-problem
episode	I-problem
while	O
in	O
the	O
endoscopy	O
suite	O
for	O
her	B-test
EGD	I-test
on	O
11/17/04	O
.	O

This	O
responded	O
to	O
fluid	B-treatment
bolus	I-treatment
.	O

The	O
patient	O
was	O
then	O
transferred	O
to	O
Medicine	O
Team	O
D	O
given	O
her	B-problem
tenuous	I-problem
hemodynamic	I-problem
status	I-problem
.	O

The	O
patient	O
,	O
several	O
days	O
later	O
11/23	O
,	O
underwent	O
another	B-test
dobutamine	I-test
stress	I-test
test	I-test
.	O

This	B-test
stress	I-test
test	I-test
,	O
although	O
complicated	O
by	O
hypotension	B-problem
again	O
,	O
to	O
the	O
60	O
&apos;s	O
or	O
70	O
&apos;s	O
was	O
completed	O
and	O
there	O
was	O
some	B-problem
mild	I-problem
anterior	I-problem
septal	I-problem
thinning	I-problem
,	O
but	O
no	O
evidence	O
of	O
ischemia	B-problem
and	O
an	B-test
EF	I-test
from	O
this	B-test
test	I-test
was	O
76%	O
.	O

Clearly	O
,	O
the	O
patient	O
&apos;s	O
hemodynamic	O
vascular	O
status	O
was	O
very	O
sensitive	O
to	O
dobutamine	B-treatment
.	O

2.	O
Infectious	O
Disease	O
:	O

On	O
hospital	O
day	O
#2	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
increased	B-problem
dyspnea	I-problem
on	O
exertion	O
.	O

The	O
next	O
day	O
she	O
developed	O
a	B-problem
fever	I-problem
and	O
she	O
was	O
started	O
on	O
levofloxacin	B-treatment
for	O
a	O
potential	O
UTI	B-problem
.	O

She	O
continued	O
to	O
have	O
low-grade	B-problem
fevers	I-problem
and	O
on	O
the	O
next	O
day	O
,	O
11/17/04	O
,	O
her	B-test
chest	I-test
x-ray	I-test
showed	O
possible	O
new	B-problem
right	I-problem
upper	I-problem
lobe	I-problem
infiltrates	I-problem
.	O

She	O
was	O
then	O
started	O
on	O
ceftriaxone	B-treatment
and	O
azithromycin	B-treatment
.	O

Her	B-test
urine	I-test
legionella	I-test
antigen	I-test
was	O
negative	O
.	O

On	O
11/22/04	O
,	O
she	O
was	O
noted	O
to	O
have	O
gram-positive	B-problem
cocci	I-problem
in	O
her	O
sputum	O
.	O

She	O
was	O
started	O
on	O
vancomycin	B-treatment
for	O
this	O
.	O

These	B-problem
bacteria	I-problem
turned	O
out	O
to	O
be	O
MRSA	B-problem
and	O
she	O
was	O
continued	O
on	O
her	B-treatment
vancomycin	I-treatment
.	O

She	O
had	O
PICC	B-treatment
line	I-treatment
placed	O
on	O
the	O
day	O
prior	O
to	O
discharge	O
for	O
home	B-treatment
vancomycin	I-treatment
administration	I-treatment
.	O

3.	O
GI	O
:	O

The	O
patient	O
had	O
an	O
episode	O
of	O
nausea	B-problem
on	O
the	O
morning	O
of	O
11/16/04	O
associated	O
with	O
some	B-problem
cough	I-problem
,	O
apparent	B-problem
emesis	I-problem
.	O

GI	O
was	O
consulted	O
for	O
an	B-test
EGD	I-test
,	O
however	O
,	O
while	O
she	O
was	O
in	O
the	O
Endoscopy	O
Suite	O
,	O
as	O
mentioned	O
above	O
,	O
she	O
had	O
a	B-problem
hypotensive	I-problem
episode	I-problem
,	O
which	O
responded	O
to	O
some	B-treatment
fluid	I-treatment
boluses	I-treatment
.	O

Finally	O
,	O
on	O
the	O
day	O
prior	O
to	O
discharge	O
,	O
she	O
was	O
stabilized	O
to	O
the	O
point	O
that	O
she	O
could	O
have	O
her	B-test
EGD	I-test
.	O

The	B-test
EGD	I-test
did	O
show	O
three	B-problem
esophageal	I-problem
ulcers	I-problem
that	O
were	O
localized	O
and	O
apparent	O
suggestion	O
of	O
pill	B-problem
esophagitis	I-problem
.	O

Her	O
stomach	O
and	O
duodenum	O
were	O
normal	O
and	O
it	O
was	O
suggested	O
that	O
she	O
change	O
her	B-treatment
Nexium	I-treatment
doses	I-treatment
to	O
daily	O
and	O
that	O
she	O
also	O
drink	O
plenty	O
of	O
fluids	O
and	O
water	O
with	O
meals	O
,	O
sit	O
upright	O
when	O
she	O
would	O
eat	O
her	O
meals	O
to	O
decrease	O
the	O
chance	O
of	O
pills	B-treatment
eroding	O
her	O
esophagus	O
.	O

4.	O
Shortness	B-problem
of	I-problem
breath	I-problem
:	O

As	O
mentioned	O
above	O
,	O
the	O
patient	O
did	O
develop	O
MRSA	B-problem
pneumonia	I-problem
that	O
was	O
started	O
to	O
be	O
treated	O
with	O
vancomycin	B-treatment
and	O
she	O
did	O
also	O
develop	O
an	B-problem
oxygen	I-problem
requirement	I-problem
the	O
day	O
prior	O
to	O
discharge	O
.	O

At	O
most	O
,	O
her	B-problem
oxygen	I-problem
requirement	I-problem
was	O
4-5	O
liters	O
and	O
on	O
the	O
day	O
prior	O
to	O
discharge	O
,	O
she	O
was	O
satting	O
well	O
on	O
two	O
liters	O
of	O
nasal	B-treatment
cannula	I-treatment
.	O

This	O
was	O
thought	O
to	O
be	O
due	O
to	O
her	B-problem
pneumonia	I-problem
;	O
however	O
,	O
with	O
her	B-problem
right	I-problem
ventricular	I-problem
hypokinesis	I-problem
,	O
it	O
is	O
also	O
possible	O
that	O
she	O
may	O
have	O
an	O
element	O
of	O
pulmonary	B-problem
hypertension	I-problem
and	O
may	O
warrant	O
further	O
investigation	O
as	O
an	O
outpatient	O
,	O
for	O
example	O
,	O
with	O
chest	B-test
CT	I-test
.	O

5.	O
Derm	O
:	O

Several	O
days	O
prior	O
to	O
discharge	O
,	O
the	O
patient	O
developed	O
some	B-problem
erythematous	I-problem
rash	I-problem
under	O
her	O
left	O
breast	O
and	O
left	O
side	O
that	O
was	O
thought	O
to	O
be	O
due	O
to	O
yeast	B-problem
.	O

She	O
was	O
started	O
on	O
some	B-treatment
Miconazole	I-treatment
Cream	I-treatment
.	O

The	B-problem
rash	I-problem
was	O
always	O
localized	O
to	O
her	O
left	O
side	O
,	O
sometimes	O
extending	O
down	O
to	O
her	O
leg	O
,	O
but	O
never	O
on	O
the	O
right	O
side	O
.	O

The	B-problem
rash	I-problem
appeared	O
to	O
be	O
resolving	O
by	O
the	O
time	O
of	O
discharge	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Tums	B-treatment
,	O
500-1250	O
mg	O
PO	O
tid	O
.	O

Albuterol	B-treatment
inhaler	I-treatment
.	O

Lipitor	B-treatment
,	O
20	O
daily	O
.	O

Prozac	B-treatment
,	O
60	O
daily	O
.	O

Flovent	B-treatment
inhaler	I-treatment
,	O
220	O
mcg	O
bid	O
.	O

Atrovent	B-treatment
,	O
two	O
puffs	O
qid	O
.	O

Ditropan	B-treatment
,	O
5	O
mg	O
tid	O
.	O

Colace	B-treatment
,	O
100	O
mg	O
tid	O
.	O

Aspirin	B-treatment
,	O
325	O
mg	O
daily	O
.	O

Insulin	B-treatment
NPH	I-treatment
,	O
36	O
subcu	O
q	O
AM	O
,	O
30	O
subcu	O
q	O
PM	O
.	O

Nystatin	B-treatment
Mouthwash	I-treatment
Swish	O
and	O
Swallow	O
.	O

Nexium	B-treatment
,	O
20	O
mg	O
PO	O
daily	O
.	O

Vancomycin	B-treatment
1	O
gm	O
IV	O
q12h	O
.	O

The	O
patient	O
will	O
follow-up	O
with	O
her	O
primary	O
care	O
provider	O
,	O
Dr.	O
Na	O
Fongbain	O
at	O
the	O
Cord	O
Memorial	O
Hospital	O
.	O

IEVE	O
MANUAL	O
,	O
MD	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
IEVE	O
MANUAL	O
,	O
MD	O
12/23/2004	O
11:19	O

_____________________________	O
IEVE	O
MANUAL	O
,	O
MD	O

TR	O
:	O

mm	O
PAD-WORD	O

DD	O
:	O

11/25/2004	O
PAD-WORD	O

TD	O
:	O

11/25/2004	O
8:49	O
P	O
367017	O

cc	O
:	O

IEVE	O
MANUAL	O
,	O
MD	O

Admission	O
Date	O
:	O

2011-06-14	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-06-18	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1939-11-27	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

FICU	O
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

Shortness	B-problem
of	I-problem
breath	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
71-year-old-female	O
with	O
asthma	B-problem
and	O
a	O
history	O
of	O
recent	B-problem
exacerbation	I-problem
of	O
lower	B-problem
extremity	I-problem
edema	I-problem
who	O
,	O
at	O
her	O
baseline	O
,	O
gets	O
short	B-problem
of	I-problem
breath	I-problem
walking	O
across	O
the	O
room	O
and	O
sleeps	O
on	O
four	O
pillows	O
times	O
several	O
years	O
.	O

She	O
has	O
reported	O
that	O
she	O
has	O
had	O
upper	B-problem
respiratory	I-problem
symptoms	I-problem
times	O
several	O
days	O
with	O
increasing	B-problem
dyspnea	I-problem
on	O
exertion	O
and	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
eventually	O
at	O
rest	O
with	O
marked	B-problem
wheezing	I-problem
.	O

She	O
also	O
has	O
a	B-problem
cough	I-problem
with	O
a	O
small	O
amount	O
of	O
white	B-problem
sputum	I-problem
.	O

At	O
3	O
a.m.	O
on	O
the	O
day	O
of	O
admission	O
,	O
she	O
became	O
much	O
worse	O
and	O
after	O
several	O
days	O
of	O
increasing	O
her	B-treatment
meter-dosed	I-treatment
inhaler	I-treatment
use	O
,	O
she	O
call	O
Emergency	O
Medical	O
Services	O
which	O
assessed	O
her	O
as	O
having	O
heart	B-problem
failure	I-problem
with	O
elevated	B-problem
jugular	I-problem
venous	I-problem
distention	I-problem
and	O
rales	B-problem
.	O

She	O
received	O
aspirin	B-treatment
,	O
Lasix	B-treatment
40	O
mg	O
intravenously	O
times	O
two	O
,	O
0.8	O
mg	O
of	O
nitroglycerin	B-treatment
times	O
four	O
,	O
plus	O
morphine	B-treatment
sulfate	I-treatment
.	O

Her	B-test
blood	I-test
pressure	I-test
was	O
noted	O
to	O
be	O
up	O
to	O
220/110	O
.	O

She	O
was	O
taken	O
to	O
the	O
The	O
Hospital	O
for	O
Orthopedics	O
Emergency	O
Room	O
where	O
she	O
was	O
assessed	O
as	O
having	O
asthma	B-problem
.	O

She	O
then	O
received	O
continuous	B-treatment
nebulizer	I-treatment
treatments	I-treatment
for	O
approximately	O
eight	O
hours	O
with	O
minimal	O
improvement	O
.	O

She	O
did	O
receive	O
intravenous	B-treatment
nitroglycerin	I-treatment
in	O
the	O
Emergency	O
Room	O
for	O
blood	O
pressure	O
controlled	O
to	O
the	O
170s	O
.	O

She	O
initially	O
received	O
a	O
treatment	O
of	O
BiPAP	B-treatment
on	O
arrival	O
as	O
she	O
was	O
barely	O
able	O
to	O
speak	O
.	O

She	O
also	O
received	O
80	B-treatment
mg	I-treatment
of	I-treatment
Solu-Medrol	I-treatment
in	O
the	O
Emergency	O
Department	O
.	O

She	O
was	O
never	O
hypoxic	B-problem
but	O
initially	O
her	B-test
arterial	I-test
blood	I-test
gas	I-test
showed	O
a	B-problem
respiratory	I-problem
acidosis	I-problem
with	O
a	B-test
PCO2	I-test
of	O
71	O
.	O

The	O
patient	O
does	O
have	O
a	O
vague	O
history	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
but	O
this	O
is	O
felt	O
to	O
be	O
inaccurate	O
.	O

She	O
also	O
received	O
captopril	B-treatment
12.5	O
mg	O
times	O
one	O
.	O

Recently	O
,	O
the	O
patient	O
has	O
been	O
treated	O
with	O
several	B-treatment
steroid	I-treatment
tapers	I-treatment
.	O

Depending	O
on	O
the	O
family	O
,	O
patient	O
,	O
and	O
the	O
OMR	O
records	O
,	O
the	O
exact	O
duration	O
of	O
the	O
most	O
recent	O
one	O
was	O
unclear	O
.	O

It	O
either	O
ended	O
in	O
2011-04-11	O
or	O
continued	O
through	O
2011-05-11	O
with	O
use	O
of	O
Augmentin	B-treatment
;	O
and	O
,	O
by	O
report	O
,	O
lasted	O
until	O
06-07	O
.	O

However	O
,	O
the	O
family	O
said	O
the	O
patient	O
has	O
been	O
on	O
steroids	B-treatment
for	O
several	O
weeks	O
.	O

The	O
patient	O
denies	O
any	O
exposure	O
to	O
smoke	O
,	O
animals	O
,	O
unusual	O
dust	O
or	O
vapors	O
,	O
or	O
other	O
asthma	O
triggers	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Asthma	B-problem
as	O
a	O
child	O
which	O
recurred	O
in	O
2001	O
.	O

She	O
takes	O
an	B-treatment
albuterol	I-treatment
and	O
Atrovent	B-treatment
inhalers	I-treatment
as	O
well	O
as	O
Serevent	B-treatment
and	O
Flovent	B-treatment
.	O

She	O
has	O
had	O
multiple	O
hospitalizations	O
and	O
has	O
never	O
been	O
intubated	B-treatment
.	O

She	O
has	O
had	O
multiple	B-treatment
prednisone	I-treatment
tapers	I-treatment
(	O
see	O
History	O
of	O
Present	O
Illness	O
)	O
.	O

On	O
prednisone	B-treatment
or	O
sometime	O
after	O
it	O
was	O
discontinued	O
,	O
depending	O
on	O
the	O
version	O
,	O
the	O
patient	O
developed	O
worsening	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
which	O
has	O
been	O
a	B-problem
Vega	I-problem
problem	I-problem
for	O
her	O
and	O
was	O
started	O
on	O
dyazide	B-treatment
as	O
an	O
outpatient	O
.	O

Pulmonary	B-test
function	I-test
tests	I-test
most	O
recently	O
in	O
2009-01-10	O
were	O
not	O
obstructive	O
.	O

They	O
showed	O
an	B-test
FVC	I-test
of	O
91%	O
of	O
predicted	O
,	O
and	O
a	B-test
FEV1	I-test
of	O
104%	O
of	O
predicted	O
,	O
with	O
a	B-test
ratio	I-test
of	O
114%	O
.	O

In	O
2003	O
,	O
there	O
was	O
19%	O
change	O
of	O
the	O
FEV1	O
and	O
an	O
11%	O
change	O
in	O
the	O
FVC	O
with	O
bronchodilators	B-treatment
.	O

2.	O
Mild	B-problem
hypertension	I-problem
,	O
especially	O
on	O
prednisone	B-treatment
.	O

3.	O
Hypoplastic	B-problem
left	I-problem
lower	I-problem
extremity	I-problem
and	O
hip	B-treatment
repair	I-treatment
at	O
the	O
age	O
of	O
five	O
.	O

4.	O
Polio	B-problem
.	O

5.	O
Status	O
post	O
cesarean	B-treatment
section	I-treatment
.	O

6.	O
History	O
of	O
zoster	B-problem
.	O

7.	O
Past	O
Discharge	O
Summary	O
mention	O
a	O
history	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
but	O
the	O
patient	O
has	O
never	O
smoked	O
.	O

8.	O
Incontinent	B-problem
of	I-problem
both	I-problem
stool	I-problem
and	I-problem
urine	I-problem
.	O

9.	O
Allergic	B-problem
rhinitis	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Brother	O
and	O
sister	O
both	O
have	O
asthma	B-problem
.	O

Brother	O
has	O
diabetes	B-problem
mellitus	I-problem
.	O

There	O
is	O
no	O
family	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
on	O
the	O
first	O
floor	O
of	O
her	O
home	O
with	O
her	O
daughter	O
living	O
upstairs	O
.	O

There	O
are	O
several	O
foster	O
children	O
also	O
in	O
the	O
home	O
that	O
take	O
care	O
of	O
her	O
at	O
times	O
.	O

She	O
has	O
never	O
smoked	O
and	O
does	O
not	O
drink	O
.	O

She	O
does	O
not	O
use	O
drugs	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Dyazide	B-treatment
25/37.5	O
p.o.	O
q.d.	O
,	O
as	O
well	O
as	O
Atrovent	B-treatment
,	O
albuterol	B-treatment
,	O
and	O
Flovent	B-treatment
inhalers	I-treatment
,	O
and	O
Swanson	B-treatment
60	O
mg	O
p.o.	O
b.i.d.	O
,	O
and	O
Serevent	B-treatment
2	O
puffs	O
q.12h.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

On	O
transfer	O
,	O
she	O
also	O
arrived	O
on	O
200	O
mcg	O
of	O
nitroglycerin	B-treatment
and	O
reports	O
p.r.n.	O
Alka-Seltzer	B-treatment
,	O
sinus	B-treatment
and	O
NyQuil	B-treatment
use	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	B-test
of	I-test
systems	I-test
were	O
notable	O
for	O
lower	B-problem
extremity	I-problem
edema	I-problem
which	O
worsened	O
in	O
May	O
.	O

She	O
says	O
she	O
has	O
had	O
this	O
intermittently	O
with	O
hot	O
summers	O
in	O
the	O
past	O
.	O

She	O
denies	O
chest	B-problem
pain	I-problem
.	O

She	O
does	O
have	O
chest	B-problem
tightness	I-problem
since	O
two	O
days	O
ago	O
,	O
coinciding	O
with	O
her	B-problem
wheezing	I-problem
.	O

She	O
had	O
paroxysms	B-problem
of	I-problem
cough	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
which	O
resolves	O
with	O
water	O
and	O
sitting	O
up	O
.	O

This	O
is	O
worse	O
when	O
she	O
has	O
asthma	B-problem
flares	I-problem
.	O

She	O
denies	O
a	B-problem
rash	I-problem
and	O
any	B-problem
genitourinary	I-problem
symptoms	I-problem
.	O

She	O
has	O
had	O
a	B-problem
constant	I-problem
runny	I-problem
nose	I-problem
and	O
has	O
had	O
no	O
sick	O
contacts	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Physical	B-test
examination	I-test
revealed	O
afebrile	B-problem
,	O
respiratory	B-test
rate	I-test
of	O
23	O
,	O
heart	B-test
rate	I-test
of	O
113	O
,	O
blood	B-test
pressure	I-test
130s/90s	O
.	O

In	O
general	O
,	O
this	O
was	O
a	O
female	O
in	O
moderate	B-problem
distress	I-problem
secondary	O
to	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
spoke	O
in	O
short	O
phrases	O
and	O
then	O
in	O
complete	O
sentences	O
as	O
the	O
night	O
went	O
on	O
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
revealed	O
oropharynx	O
was	O
moist	O
.	O

There	O
was	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

There	O
was	O
no	O
HDR	B-problem
.	O

Sclerae	O
were	O
anicteric	B-problem
.	O

Cardiovascular	O
revealed	O
she	O
was	O
tachycardic	B-problem
with	O
a	O
regular	O
first	O
heart	O
sound	O
and	O
second	O
heart	O
sound	O
.	O

Pulmonary	O
revealed	O
she	O
had	O
diffuse	B-problem
wheezes	I-problem
.	O

There	O
were	O
no	O
rales	B-problem
.	O

She	O
had	O
reduced	B-problem
but	I-problem
adequate	I-problem
air	I-problem
movement	I-problem
.	O

The	O
abdomen	O
revealed	O
normal	O
active	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-problem
,	O
obese	B-problem
,	O
and	O
nondistended	B-problem
.	O

Extremities	O
revealed	O
left	O
lower	O
extremity	O
was	O
hypoplastic	B-problem
.	O

There	O
was	O
pitting	B-problem
edema	I-problem
on	I-problem
both	I-problem
sides	I-problem
of	O
the	O
lower	O
extremities	O
.	O

The	O
right	O
ankle	O
was	O
somewhat	B-problem
tender	I-problem
from	O
this	B-problem
edema	I-problem
.	O

Neurologically	O
,	O
the	O
patient	O
was	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
;	O
however	O
,	O
she	O
was	O
somewhat	B-problem
drowsy	I-problem
and	O
at	O
times	O
was	O
difficult	O
to	O
keep	O
awake	O
during	O
conversations	O
.	O

PERTINENT	O
LABORATORY	O
DATA	O
ON	O
PRESENTATION	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
10.2	O
,	O
hematocrit	B-test
of	O
37.5	O
,	O
platelets	B-test
of	O
236	O
.	O

INR	B-test
of	O
1.3	O
,	O
PTT	B-test
of	O
30.3	O
.	O

Urinalysis	B-test
revealed	O
6	O
to	O
10	O
red	B-test
blood	I-test
cells	I-test
,	O
0	O
to	O
2	O
white	B-test
blood	I-test
cells	I-test
,	O
4	O
epithelial	B-test
cells	I-test
with	O
Foley	B-treatment
in	O
place	O
.	O

Urine	B-test
culture	I-test
later	O
grew	O
out	O
contaminated	O
specimen	O
.	O

Differential	B-test
with	O
72	O
polys	B-test
,	O
16	O
lymphocytes	B-test
,	O
4.6	O
monocytes	B-test
,	O
6.3	O
eosinophils	B-test
.	O

Chem-7	B-test
was	O
notable	O
for	O
a	B-test
bicarbonate	I-test
of	O
31	O
and	O
a	B-test
glucose	I-test
of	O
156	O
.	O

Arterial	B-test
blood	I-test
gas	I-test
was	O
7.24/71/227	O
.	O

Creatine	B-test
kinase	I-test
was	O
243	O
,	O
with	O
a	B-test
MB	I-test
of	O
9	O
,	O
and	O
a	B-test
troponin	I-test
of	O
less	O
than	O
0.3.	O

RADIOLOGY/IMAGING	O
:	O

Chest	B-test
x-ray	I-test
showed	O
low	B-problem
lung	I-problem
volumes	I-problem
but	O
no	O
evidence	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Electrocardiogram	B-test
showed	O
sinus	B-problem
tachycardia	I-problem
at	O
115	O
with	O
a	O
normal	O
axis	O
,	O
intermittent	B-problem
Q	I-problem
wave	I-problem
in	I-problem
III;	I-problem
a	B-problem
wavy	I-problem
baseline	I-problem
.	O

The	O
patient	O
had	O
a	B-test
stress	I-test
echocardiogram	I-test
with	O
a	O
normal	O
ejection	O
fraction	O
in	O
2007	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM:	O

1.	O
PULMONARY	O
:	O

She	O
was	O
treated	O
with	O
albuterol	B-treatment
and	O
Atrovent	B-treatment
continuous	I-treatment
nebulizers	I-treatment
and	O
was	O
weaned	O
then	O
to	O
intermittent	B-treatment
nebulizer	I-treatment
treatments	I-treatment
and	O
then	O
to	O
her	B-treatment
meter-dosed	I-treatment
inhalers	I-treatment
taking	O
them	O
q.4h.	O
at	O
the	O
time	O
of	O
discharge	O
.	O

She	O
was	O
continued	O
on	O
salmeterol	B-treatment
and	O
Flovent	B-treatment
.	O

She	O
was	O
continued	O
on	O
Solu-Medrol	B-treatment
80	O
mg	O
q.8h.	O
then	O
converted	O
to	O
prednisone	B-treatment
at	O
60	O
mg	O
p.o.	O
q.d.	O

She	O
was	O
started	O
on	O
Singulair	B-treatment
10	O
mg	O
p.o.	O
q.d.	O

Serial	B-test
arterial	I-test
blood	I-test
gases	I-test
were	O
followed	O
after	O
an	B-treatment
arterial	I-treatment
line	I-treatment
was	O
placed	O
.	O

Her	B-test
PCO2	I-test
gradually	O
declined	O
to	O
the	O
48	O
range	O
.	O

Despite	O
episodes	O
of	O
somnolence	B-problem
the	O
first	O
night	O
which	O
were	O
presumably	O
due	O
to	O
having	O
spent	O
the	O
entire	O
night	O
in	O
the	O
Emergency	O
Department	O
,	O
she	O
never	O
became	O
more	B-problem
hypercarbic	I-problem
,	O
and	O
her	B-test
PCO2	I-test
trended	O
to	O
48	O
by	O
the	O
time	O
the	B-treatment
arterial	I-treatment
line	I-treatment
was	O
discontinued	O
.	O

On	O
the	O
night	O
of	O
admission	O
and	O
thereafter	O
,	O
she	O
was	O
noted	O
to	O
have	O
a	B-problem
very	I-problem
stridorous	I-problem
sounding	I-problem
breathing	I-problem
when	O
the	O
patient	O
was	O
asleep	O
.	O

This	O
would	O
disappear	O
whenever	O
she	O
was	O
awake	O
.	O

Her	O
case	O
was	O
discussed	O
with	O
Ear/Nose/Throat	O
and	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
attending	O
.	O

She	O
was	O
given	O
a	B-treatment
trial	I-treatment
of	I-treatment
80/20	I-treatment
mixed	I-treatment
helium/oxygen	I-treatment
to	O
decrease	O
the	B-problem
stridor	I-problem
but	O
had	O
minimal	O
effect	O
.	O

Ear/Nose/Throat	O
recommended	O
not	O
considering	O
this	O
an	B-problem
airway	I-problem
problem	I-problem
unless	O
she	O
was	O
stridorous	B-problem
while	I-problem
awake	I-problem
.	O

The	O
patient	O
was	O
to	O
arrange	O
for	O
Pulmonary	O
and	O
Medicine	O
followup	O
through	O
her	O
primary	O
care	O
physician	O
upon	O
discharge	O
as	O
she	O
has	O
not	O
been	O
seen	O
in	O
the	O
Pulmonary	O
Clinic	O
in	O
two	O
years	O
.	O

2.	O
CARDIOVASCULAR	O
:	O

The	O
patient	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
with	O
serial	B-test
creatine	I-test
kinases	I-test
,	O
although	O
these	O
did	O
rise	O
to	O
816	O
.	O

MB	B-test
was	O
negative	O
.	O

She	O
was	O
treated	O
with	O
captopril	B-treatment
for	O
hypertension	B-problem
,	O
and	O
this	O
was	O
switched	O
to	O
Norvasc	B-treatment
7.5	O
mg	O
p.o.	O
q.d.	O
on	O
discharge	O
.	O

She	O
had	O
an	B-test
echocardiogram	I-test
which	O
showed	O
a	B-problem
hyperdynamic	I-problem
left	I-problem
ventricular	I-problem
of	O
normal	O
thickness	O
and	O
size	O
,	O
and	O
no	O
significant	B-problem
valvular	I-problem
disease	I-problem
.	O

She	O
apparently	O
did	O
not	O
have	O
a	O
cardiovascular	O
component	O
to	O
her	B-problem
wheezing	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
;	O
however	O
,	O
she	O
was	O
to	O
go	O
home	O
on	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q.d.	O
to	O
help	O
with	O
lower	B-problem
extremity	I-problem
edema	I-problem
,	O
as	O
she	O
experiences	O
discomfort	B-problem
with	O
this	O
,	O
and	O
the	O
team	O
felt	O
this	O
may	O
be	O
a	O
limiting	O
factor	O
with	O
her	B-treatment
prednisone	I-treatment
compliance	I-treatment
.	O

3.	O
ENDOCRINE	O
:	O

She	O
was	O
treated	O
with	O
a	B-treatment
sliding-scale	I-treatment
of	I-treatment
regular	I-treatment
insulin	I-treatment
while	O
she	O
was	O
in	O
house	O
.	O

She	O
was	O
given	O
500	O
mg	O
p.o.	O
q.d.	O
of	O
metformin	B-treatment
to	O
treat	O
her	B-problem
steroid-induced	I-problem
diabetes	I-problem
on	O
discharge	O
.	O

This	O
should	O
be	O
followed	O
up	O
by	O
her	O
primary	O
care	O
physician	O
.	O

4.	O
INFECTIOUS	O
DISEASE	O
:	O

She	O
was	O
treated	O
briefly	O
with	O
levofloxacin	B-treatment
because	O
of	O
the	B-problem
gram-positive	I-problem
cocci	I-problem
in	O
her	B-test
sputum	I-test
culture	I-test
;	O
however	O
,	O
her	B-problem
symptoms	I-problem
were	O
felt	O
to	O
be	O
consistent	O
with	O
a	B-problem
viral	I-problem
upper	I-problem
respiratory	I-problem
infection	I-problem
,	O
and	O
levofloxacin	B-treatment
was	O
continued	O
at	O
the	O
time	O
of	O
discharge	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE:	O

1.	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

2.	O
Combivent	B-treatment
meter-dosed	I-treatment
inhaler	I-treatment
2	O
puffs	O
q.4h.	O
weaning	O
to	O
albuterol	B-treatment
meter-dosed	I-treatment
inhaler	I-treatment
2	O
puffs	O
q.4h.	O

3.	O
Salmeterol	B-treatment
2	O
puffs	O
q.12h.	O

4.	O
Flovent	B-treatment
220	O
mcg	O
2	O
puffs	O
q.12h.	O

5.	O
Prednisone	B-treatment
40	O
mg	O
p.o.	O
q.d.	O
with	O
taper	O
.	O

6.	O
Fentress	B-treatment
60	O
mg	O
p.o.	O
b.i.d.	O

7.	O
Singulair	B-treatment
10	O
mg	O
p.o.	O
q.d.	O

8.	O
Univasc	B-treatment
7.5	O
mg	O
p.o.	O
q.d.	O

9.	O
Metformin	B-treatment
500	O
mg	O
p.o.	O
q.d.	O

Dyazide	B-treatment
was	O
discontinued	O
.	O

DISCHARGE	O
STATUS	O
:	O

Discharge	O
services	O
included	O
visiting	O
nursing	O
which	O
was	O
to	O
assess	O
in	O
her	O
inhaler	O
technique	O
,	O
monitor	O
her	B-test
fasting	I-test
blood	I-test
sugars	I-test
,	O
as	O
well	O
as	O
her	B-test
blood	I-test
pressure	I-test
,	O
monitor	O
her	B-test
peak	I-test
flows	I-test
,	O
and	O
assess	O
her	O
mobility	O
and	O
activities	O
of	O
daily	O
living	O
at	O
home	O
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

She	O
was	O
also	O
to	O
seek	O
the	O
next	O
available	O
appointment	O
with	O
Dr.	O
Jeanette	O
Barr	O
or	O
to	O
see	O
another	O
resident	O
in	O
the	O
Saint	O
Vincent	O
Hospital	O
Clinic	O
if	O
she	O
cannot	O
get	O
an	O
appointment	O
within	O
one	O
week	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Condition	O
on	O
discharge	O
was	O
good	O
..	O

CODE	O
STATUS	O
:	O

Full	O
code	O
.	O

DISCHARGE	O
DIAGNOSES:	O

1.	O
Asthma	B-problem
flare	I-problem
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Steroid-induced	B-problem
diabetes	I-problem
.	O

James	O
Z	O
Berg	O
,	O
M.D.	O

19-421	O
PAD-WORD	O

Dictated	O
By	O
:	O

Melanie	O
L.W.	O
Palevic	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2011-06-18	O
PAD-WORD	O

16:33	O
PAD-WORD	O

T	O
:	O

2011-06-21	O
PAD-WORD	O

15:34	O
PAD-WORD	O

JOB#	O
:	O

92012	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Andrea	O
Trotter	O
on	O
:	O

Jose	O
2011-06-23	O
12:09	O
PM	O

(	O
End	O
of	O
Report	O
)	O

100007275	O
PAD-WORD	O

OMH	O
PAD-WORD	O

4153022	O
PAD-WORD	O

539937	O
PAD-WORD	O

1/4/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

RHALTDEALBBREUTZ	O
,	O
STA	O

MRN	O
:	O

4153022	O
PAD-WORD	O

Age	O
:	O

94y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

01/04/2001	O
07:21	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
RHALTDEALBBREUTZ	O
,	O
STA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Oaksgekesser/	O
Memorial	O
Hospital	O
on	O
01/04/2001	O
07:21	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
PNEUMONIA	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
OAKSGEKESSER/	O
MEMORIAL	O
HOSPITAL	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
TUBBOLM	O
,	O
LISSWHITI	O
N	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
PNEUMONIA	B-problem
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
598-754-5083	O
.	O

PCP	O
Name	O
:	O

AJESC	O
,	O
DARLMA	O
MARGEA	O
L	O

Provider	O
Number	O
:	O

63669	O
PAD-WORD	O

Admission	O
Date	O
:	O

2017-06-28	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-07-02	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1977-06-19	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

A	O
40-year-old	O
female	O
with	O
history	O
of	O
non-ST-elevation	B-problem
myocardial	I-problem
infarction	I-problem
in	O
2016-09-30	O
with	O
stent	B-treatment
to	I-treatment
the	I-treatment
LAD	I-treatment
and	O
50%	O
to	O
the	O
mid	O
LAD	O
,	O
had	O
instent	B-problem
restenosis	I-problem
in	O
2017-04-02	O
and	O
then	O
underwent	O
brachytherapy	B-treatment
to	I-treatment
the	I-treatment
RCA	I-treatment
,	O
who	O
presented	O
to	O
Baldpate	O
Hospital	O
with	O
several	O
weeks	O
of	O
chest	B-problem
pain	I-problem
similar	O
to	O
her	B-problem
anginal	I-problem
equivalent	I-problem
and	O
MI	B-problem
in	O
the	O
past	O
.	O

It	O
started	O
at	O
rest	O
.	O

No	O
relief	O
with	O
nitroglycerin	B-treatment
x3	O
.	O

Radiates	O
to	O
the	O
left	O
arm	O
.	O

Positive	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Troponins	B-test
have	O
been	O
less	O
than	O
0.01.	O

With	O
history	O
,	O
will	O
go	O
for	O
cardiac	B-test
catheterization	I-test
evaluation	I-test
.	O

Still	O
getting	O
chest	B-problem
pain	I-problem
intermittently	O
,	O
but	O
relieved	O
by	O
morphine	B-treatment
sulfate	I-treatment
.	O

Was	O
on	O
a	B-treatment
Heparin	I-treatment
and	O
nitroglycerin	B-treatment
drip	I-treatment
with	O
only	O
intermittent	O
relief	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypercholesterolemia	B-problem
.	O

2.	O
Obesity	B-problem
.	O

3.	O
Hypertension	B-problem
.	O

4.	O
Tobacco	O
history	O
.	O

5.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
:	O

2016-09-30	O
non-ST-elevation	B-problem
myocardial	I-problem
infarction	I-problem
,	O
100%	O
RCA	O
,	O
three	B-treatment
stents	I-treatment
,	O
50%	O
mid	O
LAD	O
.	O

2017-04-02	O
instent	B-problem
restenosis	I-problem
status	O
post	O
brachytherapy	B-treatment
.	O

6.	O
GERD	B-problem
.	O

7.	O
Asthma	B-problem
.	O

8.	O
Sciatica	B-problem
.	O

9.	O
Degenerative	B-problem
joint	I-problem
disease	I-problem
.	O

10.	O
Glomerulosclerosis	B-problem
.	O

FAMILY	O
HISTORY	O
:	O

Brothers	O
with	O
William	B-problem
cancer	I-problem
and	O
a	B-problem
MI	I-problem
.	O

Father	O
with	O
emphysema	B-problem
.	O

Mother	O
with	O
lung	B-problem
cancer	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Quit	O
tobacco	O
in	O
2016-09-30	O
.	O

Occasional	O
alcohol	O
.	O

Lives	O
with	O
her	O
6-year-old	O
daughter	O
.	O

ALLERGIES	O
:	O

Aspirin	B-treatment
under	O
which	O
she	O
develops	O
worsening	O
of	O
her	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
asthma	B-problem
flare	I-problem
,	O
tetracycline	B-treatment
,	O
sulfa	B-treatment
,	O

Demerol	B-treatment
.	O

MEDICATIONS:	O
PAD-WORD	O

1.	O
Diovan	B-treatment
106	O
mg	O
q.d.	O

2.	O
Advair	B-treatment
500/50	O
two	O
puffs	O
b.i.d.	O

3.	O
Plavix	B-treatment
75	O
mg	O
q.d.	O

4.	O
Crestor	B-treatment
20	O
mg	O
q.d.	O

5.	O
Neurontin	B-treatment
300	O
mg	O
t.i.d.	O

6.	O
Prilosec	B-treatment
20	O
mg	O
b.i.d.	O

7.	O
Vicodin	B-treatment
as	O
needed	O
.	O

8.	O
Trazodone	B-treatment
50	O
mg	O
q.d.	O

9.	O
Singulair	B-treatment
10	O
mg	O
q.d.	O

10.	O
Flexeril	B-treatment
10	O
mg	O
t.i.d.	O

11.	O
Lopressor	B-treatment
75	O
mg	O
b.i.d.	O

12.	O
Humibid	B-treatment
3600	O
b.i.d.	O

13.	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O

14.	O
Zetia	B-treatment
10	O
mg	O
q.d.	O

15.	O
Benadryl	B-treatment
as	O
needed	O
.	O

16.	O
Tricor	B-treatment
106	O
mg	O
q.d.	O

17.	O
Premarin	B-treatment
0.3	O
mg	O
q.d.	O

18.	O
Prozac	B-treatment
40	O
mg	O
q.d.	O

19.	O
Omega-3	B-treatment
fatty	I-treatment
acids	I-treatment
t.i.d.	O

PHYSICAL	O
EXAM	O
:	O

82	O
,	O
119/60	O
,	O
22	O
,	O
and	O
99%	O
on	O
room	O
air	O
.	O

Well	O
appearing	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

Pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Moist	O
mucous	O
membranes	O
.	O

No	O
JVD	B-problem
.	O

Regular	O
rate	O
and	O
rhythm	O
.	O

Positive	O
tenderness	B-problem
to	I-problem
sternum	I-problem
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Abdomen	O
:	O

Obese	B-problem
,	O
soft	O
.	O

Extremities	O
show	O
no	O
edema	B-problem
,	O
2+	B-test
dorsalis	I-test
pedis	I-test
,	O

1+	B-test
femoral	I-test
pulses	I-test
.	O

LABORATORIES	O
:	O

Troponin-T	B-test
less	O
than	O
0.01.	O

EKG	B-test
:	O

Sinus	B-test
,	O
84	O
,	O
normal	O
axis	O
,	O
QTc	B-test
430	O
,	O
Q	B-problem
's	I-problem
in	I-problem
III	I-problem
and	I-problem
aVF	I-problem
,	O
no	O

ST	B-problem
changes	I-problem
as	O
compared	O
to	O
2017-05-01	O
EKG	B-test
.	O

HOSPITAL	O
COURSE:	O

1.	O
Chest	B-problem
pain	I-problem
:	O

The	O
patient	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
.	O

However	O
,	O
with	O
her	O
history	O
of	O
disease	B-problem
,	O
patient	O
underwent	O
a	B-test
cardiac	I-test
catheterization	I-test
.	O

The	O
patient	O
was	O
found	O
at	O
cardiac	B-test
catheterization	I-test
to	O
have	O
mild	B-problem
diffuse	I-problem
instent	I-problem
restenosis	I-problem
in	I-problem
the	I-problem
mid	I-problem
stent	I-problem
,	O
otherwise	O
hemodynamically	O
normal	O
and	O
the	O
coronary	O
arteries	O
otherwise	O
were	O
without	O
flow-limiting	B-problem
stenoses	I-problem
.	O

The	O
patient	O
was	O
then	O
continued	O
on	O
her	B-treatment
cardiac	I-treatment
medications	I-treatment
.	O

It	O
was	O
felt	O
that	O
if	O
we	O
attempted	O
aspirin	B-treatment
desensitize	O
her	O
while	O
an	O
inpatient	O
,	O
then	O
she	O
would	O
benefit	O
from	O
the	O
use	O
of	O
aspirin	B-treatment
and	O
Plavix	B-treatment
.	O

The	O
patient	O
was	O
sent	O
to	O
the	O
CCU	O
and	O
underwent	O
aspirin	B-treatment
desensitization	I-treatment
protocol	I-treatment
,	O
which	O
she	O
tolerated	O
well	O
.	O

She	O
had	O
mild	O
worsening	O
of	O
her	B-problem
asthma	I-problem
attacks	I-problem
,	O
which	O
was	O
relieved	O
by	O
Benadryl	B-treatment
and	O
occasionally	O
albuterol	B-treatment
.	O

The	O
patient	O
found	O
that	O
if	O
she	O
took	O
the	B-treatment
aspirin	I-treatment
in	O
the	O
evening	O
with	O
her	B-treatment
Benadryl	I-treatment
that	O
she	O
takes	O
for	O
sleep	O
,	O
that	O
the	B-problem
asthma	I-problem
exacerbation	I-problem
did	O
not	O
occur	O
.	O

Aspirin	B-treatment
no	O
longer	O
should	O
be	O
considered	O
an	B-problem
allergy	I-problem
for	O
this	O
patient	O
,	O
and	O
she	O
is	O
going	O
to	O
take	O
this	O
as	O
an	O
outpatient	O
.	O

2.	O
Hyperlipidemia	B-problem
:	O

The	B-treatment
patient	I-treatment
's	I-treatment
Lipitor	I-treatment
was	O
increased	O
to	O
80	O
mg	O
q.d.	O

3.	O
Back	B-problem
pain	I-problem
:	O

This	O
is	O
a	B-problem
chronic	I-problem
issue	I-problem
and	O
was	O
controlled	O
with	O
Flexeril	B-treatment
and	O
Vicodin	B-treatment
.	O

DISPOSITION	O
:	O

To	O
home	O
.	O

DISCHARGE	O
STATUS	O
:	O

Patient	O
is	O
able	O
to	O
ambulate	O
without	O
any	B-problem
chest	I-problem
pain	I-problem
or	O
discomfort	B-problem
.	O

Can	O
carry	O
out	O
all	O
activities	O
of	O
daily	O
living	O
.	O

DISCHARGE	O
MEDICATIONS:	O

1.	O
Metoprolol	B-treatment
100	O
mg	O
b.i.d.	O

2.	O
Plavix	B-treatment
75	O
mg	O
q.d.	O

3.	O
Advair	B-treatment
550	O
mcg	O
two	O
puffs	O
b.i.d.	O

4.	O
Neurontin	B-treatment
300	O
mg	O
t.i.d.	O

5.	O
Protonix	B-treatment
40	O
mg	O
q.d.	O

6.	O
Montelukast	B-treatment
10	O
mg	O
q.d.	O

7.	O
Bethanechol	B-treatment
25	O
mg	O
b.i.d.	O

8.	O
Docusate	B-treatment
sodium	I-treatment
100	O
mg	O
b.i.d.	O

9.	O
Zetia	B-treatment
10	O
mg	O
q.d.	O

10.	O
Estrogen	B-treatment
0.3	O
mg	O
q.d.	O

11.	O
Fluoxetine	B-treatment
40	O
mg	O
q.d.	O

12.	O
Vicodin	B-treatment
5-500	O
mg	O
tablets	O
q.4-6h.	O
as	O
needed	O
for	O
pain	B-problem
.	O

13.	O
Cyclobenzaprine	B-treatment
10	O
mg	O
tablet	O
one	O
tablet	O
orally	O
t.i.d.	O

14.	O
Atorvastatin	B-treatment
80	O
mg	O
q.d.	O

15.	O
Valsartan	B-treatment
320	O
mg	O
q.d.	O

16.	O
Aspirin	B-treatment
one	O
q.d.	O

17.	O
Benadryl	B-treatment
as	O
needed	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
will	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Benson	O
,	O
(	O
845	O
)	O
253	O
6629	O
in	O
two	O
weeks	O
by	O
calling	O
to	O
schedule	O
an	O
appointment	O
.	O

DR.	O
Luedeman,Melissa	O
69-853	O

Dictated	O
By	O
:	O

Andrew	O
C	O
Hoffman	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2017-07-02	O
PAD-WORD	O

11:35	O
PAD-WORD	O

T	O
:	O

2017-07-04	O
PAD-WORD	O

05:14	O
PAD-WORD	O

JOB#	O
:	O

19444	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Andrew	O
X..	O
Dale	O
on	O
:	O

FRI	O
2017-09-22	O
9:13	O
AM	O

(	O
End	O
of	O
Report	O
)	O

100469881	O
EH	O

00989464	O
PAD-WORD	O

822862	O
PAD-WORD	O

06/09/1998	O
12:00:00	O
AM	O

OCCIPITAL	B-problem
CEREBROVASCULAR	I-problem
ACCIDENT	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

06/09/1998	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

06/12/1998	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSES	O
:	O

1)	O
EXTENSIVE	B-problem
POSTERIOR	I-problem
CIRCULATION	I-problem
INFARCTION	I-problem
.	O

2)	O
ASPIRATION	B-problem
PNEUMONIA	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
82	O
year-old	O
right	O
handed	O
gentleman	O
who	O
has	O
a	O
past	O
medical	O
history	O
of	O
hypertension	B-problem
and	O
tobacco	O
use	O
presented	O
to	O
the	O
emergency	O
room	O
with	O
acute	B-problem
change	I-problem
in	I-problem
mental	I-problem
status	I-problem
.	O

He	O
was	O
well	O
until	O
the	O
evening	O
prior	O
to	O
presentation	O
to	O
the	O
emergency	O
room	O
when	O
he	O
complained	O
of	O
headache	B-problem
across	I-problem
the	I-problem
forehead	I-problem
.	O

On	O
the	O
day	O
of	O
presentation	O
,	O
he	O
was	O
then	O
found	O
by	O
his	O
daughter	O
lying	O
on	O
his	O
bed	O
groaning	O
,	O
being	O
relatively	B-problem
unresponsive	I-problem
and	O
unable	O
to	O
speak	O
.	O

The	O
family	O
reported	O
one	O
episode	O
of	O
vomiting	B-problem
at	O
home	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
afebrile	B-problem
,	O
heart	B-test
rate	I-test
73	O
,	O
blood	B-test
pressure	I-test
158/53	O
,	O
respiratory	B-test
rate	I-test
16-20	O
,	O
oxygen	B-test
saturation	I-test
97%	O
on	O
three	B-treatment
liters	I-treatment
.	O

General	O
:	O

The	O
patient	O
was	O
somnolent	B-problem
,	O
breathing	O
comfortably	O
,	O
occasionally	B-problem
coughing	I-problem
.	O

Neck	O
was	O
supple	O
with	O
full	O
range	O
of	O
motion	O
.	O

No	O
bruits	B-problem
were	O
heard	O
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
but	O
with	O
poor	B-problem
air	I-problem
entry	I-problem
.	O

Heart	O
sounds	O
were	O
regular	O
with	O
one	B-problem
out	I-problem
of	I-problem
six	I-problem
holosystolic	I-problem
murmur	I-problem
at	O
the	O
left	O
lower	O
sternal	O
border	O
.	O

Abdomen	O
was	O
soft	O
,	O
non-tender	B-problem
,	O
bowel	O
sounds	O
present	O
.	O

Extremities	O
were	O
without	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

Neurological	B-test
examination	I-test
revealed	O
a	O
patient	O
who	O
was	O
intermittently	B-problem
alert	I-problem
,	O
opening	O
eyes	O
to	O
voice	O
,	O
following	O
simple	O
commands	O
,	O
but	O
without	B-problem
any	I-problem
speech	I-problem
.	O

Pupils	O
were	O
4	O
mm	O
reactive	O
to	O
2	O
mm	O
bilaterally	O
.	O

There	O
was	O
no	O
pupillary	B-problem
defect	I-problem
.	O

Dolls	B-test
eye	I-test
was	O
negative	O
.	O

There	O
was	O
a	O
possible	O
right	B-problem
gaze	I-problem
preference	I-problem
and	O
the	O
patient	O
did	O
not	O
move	O
his	O
eyes	O
.	O

Corneals	B-test
were	O
present	O
bilaterally	O
.	O

Gag	B-test
was	O
present	O
weakly	O
.	O

Face	O
was	O
symmetrical	O
.	O

Tongue	O
was	O
midline	O
.	O

The	O
patient	O
was	O
moving	O
the	O
right	O
side	O
spontaneously	O
,	O
but	O
could	O
not	O
hold	O
arm	O
or	O
leg	O
up	O
for	O
any	O
length	O
of	O
time	O
.	O

There	O
was	O
only	O
minimal	B-problem
movement	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
.	O

On	O
sensory	B-test
testing	I-test
,	O
the	O
patient	O
withdrew	O
all	O
extremities	O
to	O
pain	B-problem
.	O

Reflexes	B-test
were	O
2+	O
and	O
symmetrical	O
all	O
over	O
.	O

The	O
left	O
toe	O
was	O
upgoing	B-problem
,	O
the	O
right	O
toe	O
was	O
downgoing	O
.	O

LABORATORY	O
:	O

Laboratory	O
data	O
revealed	O
a	B-test
sodium	I-test
of	O
139	O
,	O
potassium	B-test
3.4	O
,	O
chloride	B-test
101	O
,	O
bicarbonate	B-test
28	O
,	O
BUN	B-test
11	O
,	O
creatinine	B-test
1.2	O
,	O
glucose	B-test
151	O
.	O

AST	B-test
was	O
20	O
,	O
ALT	B-test
12	O
,	O
alkaline	B-test
phosphatase	I-test
80	O
,	O
bilirubin	B-test
0.5.	O
CK	B-test
was	O
113	O
.	O

Thyroid	B-test
function	I-test
tests	I-test
were	O
normal	O
.	O

Troponin	B-test
I	I-test
was	O
0.05	O
.	O

Total	B-test
protein	I-test
was	O
8	O
,	O
albumin	B-test
4.3	O
,	O
globulin	B-test
3.7	O
,	O
calcium	B-test
9.9	O
,	O
phosphate	B-test
2.7	O
,	O
magnesium	B-test
2.0.	O
White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
7	O
,	O
hemoglobin	B-test
14.1	O
,	O
hematocrit	B-test
43.6	O
,	O
platelet	B-test
count	I-test
241	O
.	O

Erythrocyte	B-test
sedimentation	I-test
rate	I-test
was	O
41	O
.	O

PT	B-test
was	O
12.3	O
,	O
PTT	B-test
27.1.	O
An	B-test
EKG	I-test
showed	O
sinus	B-problem
bradycardia	I-problem
at	O
53	O
with	O
a	O
normal	O
axis	O
,	O
first	B-problem
degree	I-problem
atrioventricular	I-problem
block	I-problem
,	O
biphasic	B-problem
T-waves	I-problem
in	O
V1	O
to	O
V3	O
without	O
any	B-problem
acute	I-problem
changes	I-problem
.	O

A	B-test
chest	I-test
x-ray	I-test
shows	O
left	B-problem
lower	I-problem
lobe	I-problem
consolidation	I-problem
.	O

The	B-test
head	I-test
CT	I-test
scan	I-test
revealed	O
a	B-problem
large	I-problem
right	I-problem
occipital	I-problem
infarct	I-problem
without	O
midline	B-problem
shift	I-problem
,	O
but	O
positive	B-problem
mass	I-problem
effect	I-problem
on	I-problem
the	I-problem
temporal	I-problem
horn	I-problem
,	O
on	O
the	O
right	O
ventricle	O
and	O
some	B-problem
effacement	I-problem
of	I-problem
the	I-problem
sulci	I-problem
in	O
the	O
right	O
parietal	O
area	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
a	O
telemetry	O
bed	O
and	O
started	O
on	O
heparin	B-treatment
.	O

Around	O
4:00	O
AM	O
the	O
next	O
day	O
,	O
an	B-problem
acute	I-problem
decompensation	I-problem
in	I-problem
respiratory	I-problem
status	I-problem
was	O
noted	O
.	O

Lung	B-test
examination	I-test
at	O
that	O
point	O
showed	O
good	O
air	O
entry	O
,	O
no	O
wheezing	B-problem
,	O
coarse	B-problem
breath	I-problem
sounds	I-problem
throughout	I-problem
.	O

Neurologically	O
,	O
the	O
patient	O
was	O
not	O
following	O
commands	O
.	O

Eyes	O
were	O
closed	O
.	O

He	O
was	O
moving	O
the	O
right	O
arm	O
and	O
leg	O
spontaneously	O
,	O
though	O
less	O
than	O
before	O
.	O

Withdrawal	O
to	O
pain	B-test
was	O
still	O
present	O
.	O

Both	O
plantars	O
were	O
upgoing	B-problem
.	O

A	B-test
blood	I-test
gas	I-test
at	O
this	O
point	O
showed	O
a	B-test
pH	I-test
of	O
7.49	O
,	O
pO2	B-test
61	O
,	O
pCO2	B-test
of	O
33	O
on	O
100%	B-treatment
non-rebreather	I-treatment
mask	I-treatment
.	O

EKG	B-test
showed	O
sinus	B-problem
tachycardia	I-problem
.	O

The	B-test
patient	I-test
&apos;s	I-test
temperature	I-test
was	O
102	O
degrees	O
.	O

A	B-test
repeat	I-test
CAT	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
was	O
performed	O
.	O

This	O
showed	O
continued	O
evolution	O
of	O
the	B-problem
right	I-problem
posterior	I-problem
cerebral	I-problem
artery	I-problem
infarction	I-problem
now	O
extending	O
into	O
the	O
right	O
cerebellar	O
hemisphere	O
.	O

There	O
was	O
also	O
a	B-problem
high	I-problem
density	I-problem
adjacent	O
to	O
the	B-problem
right	I-problem
cerebellar	I-problem
infarction	I-problem
suggesting	O
the	O
presence	O
of	O
hemorrhage	B-problem
.	O

At	O
this	O
point	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
.	O

An	B-test
MRI	I-test
and	O
MRA	B-test
of	I-test
the	I-test
head	I-test
was	O
arranged	O
to	O
evaluate	O
the	O
extent	O
of	O
his	B-problem
stroke	I-problem
and	O
the	B-problem
posterior	I-problem
circulation	I-problem
.	O

The	B-test
MRI	I-test
showed	O
infarct	B-problem
of	I-problem
the	I-problem
cerebellar	I-problem
hemispheres	I-problem
bilaterally	I-problem
,	O
the	O
right	O
occipital	O
lobe	O
,	O
the	O
right	O
thalamus	O
and	O
bilateral	O
pons	O
.	O

The	B-test
MRA	I-test
of	I-test
the	I-test
intracranial	I-test
circulation	I-test
demonstrated	O
gross	B-problem
patency	I-problem
of	I-problem
the	I-problem
internal	I-problem
carotid	I-problem
arteries	I-problem
bilaterally	I-problem
and	I-problem
the	I-problem
basilar	I-problem
arteries	I-problem
.	O

The	O
left	O
vertebral	O
artery	O
was	O
not	O
visualized	O
.	O

There	O
was	O
a	O
dominant	O
right	O
vertebral	O
artery	O
.	O

There	O
was	O
mildly	B-problem
reduced	I-problem
flow	I-problem
in	O
the	O
branches	O
of	O
the	O
right	O
middle	O
cerebral	O
artery	O
compared	O
to	O
the	O
left	O
.	O

There	O
was	O
visualization	O
of	O
flow	O
within	O
both	O
posterior	O
cerebral	O
arteries	O
.	O

Clinically	O
,	O
the	O
patient	O
continued	O
to	O
deteriorate	O
.	O

Neurosurgery	O
was	O
consulted	O
,	O
however	O
the	O
neurosurgeons	O
felt	O
that	O
there	O
was	O
no	O
surgical	O
option	O
,	O
since	O
even	O
in	O
the	O
case	O
of	O
cerebellar	B-problem
swelling	I-problem
,	O
there	O
would	O
be	O
no	O
improvement	O
from	O
decompensation	B-problem
.	O

The	O
patient	O
was	O
therefore	O
treated	O
conservatively	O
with	O
fluid	B-treatment
restriction	I-treatment
and	O
blood	B-treatment
pressure	I-treatment
management	I-treatment
.	O

Heparin	B-treatment
was	O
discontinued	O
because	O
of	O
the	O
risk	O
of	O
intercerebral	B-problem
hemorrhage	I-problem
.	O

The	B-problem
aspiration	I-problem
pneumonia	I-problem
was	O
treated	O
with	O
Cefotaxime	B-treatment
and	O
Metronidazole	B-treatment
.	O

The	O
patient	O
&apos;s	O
family	O
was	O
involved	O
and	O
they	O
decided	O
to	O
opt	O
for	O
DNR	O
/	O
DNI	O
in	O
view	O
of	O
the	O
poor	O
prognosis	O
.	O

The	O
patient	O
passed	O
away	O
at	O
6:45	O
AM	O
on	O
June	O
12	O
,	O
1998	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Deceased	O
.	O

DISCHARGE	O
ORDERS	O
:	O

None	O
.	O

Dictated	O
By	O
:	O

GREGSIS	O
STREETS	O
,	O
M.D.	O
SQ51	O

Attending	O
:	O

CHLINO	O
B.	O
SHAM	O
,	O
M.D.	O
NI76	O
LN647/8356	O

Batch	O
:	O

57390	O
PAD-WORD	O

Index	O
No.	O
TCVBBUJ1Y	O

D	O
:	O

07/09/98	O
PAD-WORD	O

T	O
:	O

07/10/98	O
PAD-WORD	O

CC	O
:	O

1.	O
NATA	O
NELMI	O
PAIN	O
,	O
M.D.	O
,	O
Sonsantna	O
.	O

Admission	O
Date	O
:	O

2015-03-17	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-03-23	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1992-12-06	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service:	O
PAD-WORD	O

ADDENDUM	O
:	O

The	O
initial	O
part	O
to	O
this	O
Discharge	O
Summary	O
confirmation	O
number	O
was	O
276836	O
(	O
I	O
believe	O
)	O
.	O

Please	O
add	O
this	O
dictation	O
to	O
initial	O
dictation	O
done	O
on	O
2015-03-26	O
.	O

After	O
quoting	O
vital	O
signs	O
,	O
please	O
include	O
:	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
with	O
N.	B-test
Ramirez	I-test
Coma	I-test
Scale	I-test
of	O
15	O
on	O
arrival	O
.	O

He	O
was	O
following	O
all	O
commands	O
and	O
moving	O
all	O
extremities	O
.	O

The	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

The	O
tympanic	O
membranes	O
were	O
clear	O
.	O

The	O
oropharynx	O
was	O
clear	O
.	O

The	O
extraocular	O
muscles	O
were	O
intact	O
.	O

Cardiovascular	B-test
examination	I-test
revealed	O
regular	O
rate	O
and	O
rhythm	O
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Good	O
breath	O
sounds	O
.	O

No	O
crepitus	B-problem
.	O

Positive	O
tenderness	B-problem
over	O
the	O
distal	O
half	O
of	O
the	O
left	O
rib	O
cage	O
.	O

The	O
abdomen	O
was	O
tender	B-problem
in	I-problem
the	I-problem
left	I-problem
upper	I-problem
quadrant	I-problem
.	O

Positive	O
guarding	B-problem
.	O

The	O
pelvis	O
was	O
stable	O
.	O

No	O
deformities	B-problem
.	O

No	O
costovertebral	B-problem
angle	I-problem
tenderness	I-problem
bilaterally	I-problem
.	O

No	O
deformities	B-problem
,	O
stepoff	B-problem
,	O
or	O
tenderness	B-problem
of	I-problem
the	I-problem
cervical	I-problem
spine	I-problem
.	O

Rectal	B-test
examination	I-test
was	O
guaiac-negative	O
.	O

Good	O
tone	O
.	O

The	O
right	O
upper	O
extremity	O
was	O
positive	O
for	O
abrasions	B-problem
.	O

The	O
right	O
lower	O
extremity	O
was	O
positive	O
for	O
abrasions	B-problem
.	O

Left	O
upper	O
and	O
lower	O
extremities	O
revealed	O
no	O
deformities	B-problem
.	O

Strength	O
was	O
5/5	O
times	O
four	O
extremities	O
.	O

Good	O
pulses	O
throughout	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
for	O
resuscitation	B-treatment
.	O

The	O
patient	O
responded	O
to	O
aggressive	B-treatment
resuscitation	I-treatment
and	O
was	O
hemodynamically	O
stable	O
.	O

At	O
this	O
time	O
,	O
the	O
decision	O
to	O
treat	O
the	O
patient	O
nonoperatively	O
was	O
made	O
,	O
and	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Intensive	O
Care	O
Unit	O
for	O
close	O
monitoring	O
.	O

The	O
patient	O
was	O
kept	O
nothing	O
by	O
mouth	O
with	O
intravenous	B-treatment
fluids	I-treatment
,	O
bed	B-treatment
rest	I-treatment
,	O
every	B-test
4-hour	I-test
hematocrit	I-test
checks	I-test
,	O
and	O
serial	B-test
abdominal	I-test
examinations	I-test
.	O

The	O
Athol	O
Memorial	O
Hospital	O
hospital	O
course	O
was	O
unremarkable	O
.	O

The	O
patient	O
remained	O
hemodynamically	O
stable	O
throughout	O
the	O
course	O
of	O
his	O
hospital	O
stay	O
,	O
and	O
his	B-test
hematocrit	I-test
was	O
relatively	O
stable	O
with	O
a	B-problem
gradual	I-problem
drop	I-problem
due	O
to	O
dilutional	B-problem
changes	I-problem
.	O

On	O
post	O
trauma	O
day	O
four	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
with	O
a	O
stable	O
hematocrit	O
and	O
a	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
abdomen	I-problem
.	O

The	O
patient	O
's	O
bed	O
rest	O
status	O
was	O
changed	O
to	O
out	O
of	O
bed	O
,	O
and	O
oral	O
intake	O
was	O
started	O
.	O

The	O
patient	O
tolerated	O
the	O
advancement	O
of	O
his	O
diet	O
without	O
problems	O
.	O

The	O
patient	O
ambulated	O
with	O
pain	B-problem
on	I-problem
the	I-problem
left	I-problem
lower	I-problem
extremity	I-problem
secondary	O
to	O
the	B-problem
left	I-problem
pubic	I-problem
rami	I-problem
fractures	I-problem
.	O

Physical	O
Therapy	O
was	O
consulted	O
,	O
and	O
crutches	B-treatment
were	O
given	O
to	O
the	O
patient	O
.	O

Pain	B-problem
was	O
managed	O
with	O
a	B-treatment
Fentanyl	I-treatment
patch	I-treatment
and	O
by	B-treatment
mouth	I-treatment
Dilaudid	I-treatment
with	O
adequate	O
pain	B-treatment
control	I-treatment
on	O
discharge	O
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
DIAGNOSES:	O

1.	O
Grade	B-problem
3	I-problem
splenic	I-problem
laceration	I-problem
.	O

2.	O
Left	B-problem
rib	I-problem
8	I-problem
through	I-problem
12	I-problem
fractures	I-problem
.	O

3.	O
Left	B-problem
superior/inferior	I-problem
pubic	I-problem
rami	I-problem
fractures	I-problem
.	O

4.	O
Comorbidities	O
of	O
anxiety	B-problem
disorder/depression	I-problem
.	O

DISCHARGE	O
INSTRUCTIONS/FOLLOWUP:	O

1.	O
The	O
patient	O
was	O
asked	O
to	O
call	O
his	O
physician	O
if	O
he	O
experienced	O
any	B-problem
lightheadedness	I-problem
,	O
dizziness	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
fevers	B-problem
,	O
or	O
chills	B-problem
.	O

2.	O
The	O
patient	O
was	O
instructed	O
to	O
not	O
participate	O
in	O
contact	O
sports	O
for	O
six	O
weeks	O
.	O

3.	O
The	O
patient	O
was	O
instructed	O
to	O
follow	O
up	O
in	O
the	O
Trauma	O

Clinic	O
in	O
three	O
to	O
four	O
weeks	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

The	O
patient	O
's	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Fentanyl	B-treatment
75-mcg	O
per	O
hour	O
patch	O
q.72h.	O

2.	O
Zoloft	B-treatment
50	O
mg	O
by	O
mouth	O
once	O
per	O
day	O
.	O

3.	O
Wellbutrin	B-treatment
200	O
mg	O
by	O
mouth	O
twice	O
per	O
day	O
.	O

4.	O
Dilaudid	B-treatment
one	O
to	O
two	O
tablets	O
by	O
mouth	O
q.4-6h.	O
as	O
needed	O
(	O
for	O
pain	B-problem
)	O
.	O

Ernest	O
K.	O
Gardner	O
,	O
M.D.	O

09-697	O
PAD-WORD	O

Dictated	O
By	O
:	O

Sarah	O
Z	O
Stephens	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2015-03-26	O
PAD-WORD	O

18:08	O
PAD-WORD	O

T	O
:	O

2015-03-26	O
PAD-WORD	O

21:53	O
PAD-WORD	O

JOB#	O
:	O

81804	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Billie	O
SCHNEIDER	O
on	O
:	O

FRI	O
2015-03-27	O
11:01	O
AM	O

(	O
End	O
of	O
Report	O
)	O

116752045	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

20515082	O
PAD-WORD	O

422603	O
PAD-WORD	O

12/23/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

12/23/1991	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/02/1992	O
PAD-WORD	O

ADMISSION	O
DIAGNOSIS	O
:	O

ABDOMINAL	B-problem
AORTIC	I-problem
ANEURYSM	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
64	O
year	O
old	O
white	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
smoking	O
,	O
coronary	B-problem
artery	I-problem
disese	I-problem
,	O
hypertension	B-problem
,	O
and	O
hypercholesterolemia	B-problem
with	O
a	B-problem
l0	I-problem
cm	I-problem
abdominal	I-problem
aortic	I-problem
aneurysm	I-problem
.	O

Patient	O
presented	O
to	O
his	O
private	O
medical	O
doctor	O
in	O
Gewestster	O
with	O
transient	B-problem
calf	I-problem
pain	I-problem
on	O
walking	O
less	O
than	O
fifty	O
yards	O
.	O

Abdominal	B-problem
aortic	I-problem
aneurysm	I-problem
was	O
discovered	O
on	O
examination	B-test
and	O
patient	O
was	O
referred	O
to	O
Retelk	O
County	O
Medical	O
Center	O
.	O

He	O
was	O
admitted	O
on	O
10/17/06	O
and	O
echocardiogram	B-test
done	O
on	O
11/13/09	O
revealed	O
poor	B-problem
left	I-problem
ventricular	I-problem
function	I-problem
and	O
cardiac	B-test
catheterization	I-test
was	O
done	O
on	O
admission	O
which	O
showed	O
three	B-problem
vessel	I-problem
disease	I-problem
.	O

Patient	O
was	O
referred	O
to	O
Cardiology	O
and	O
underwent	O
a	B-treatment
three	I-treatment
vessel	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
on	O
11/25/09	O
.	O

His	O
post-operative	O
course	O
was	O
complicated	O
by	O
an	B-problem
E.	I-problem
coli	I-problem
urinary	I-problem
tract	I-problem
infection	I-problem
and	O
transient	B-problem
acute	I-problem
renal	I-problem
failure	I-problem
with	O
increasing	B-problem
creatinine	I-problem
.	O

Patient	B-test
&apos;s	I-test
renal	I-test
function	I-test
returned	O
to	O
normal	O
over	O
several	O
days	O
,	O
however	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
last	I-test
ultrasound	I-test
of	I-test
his	I-test
aorta	I-test
revealed	O
a	B-problem
l0	I-problem
cm	I-problem
aneurysm	I-problem
and	O
he	O
presented	O
at	O
the	O
time	O
of	O
admission	O
for	O
an	B-treatment
abdominal	I-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

Myocardial	B-problem
infarction	I-problem
also	O
in	O
l983	O
and	O
l988	O
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
in	O
l989	O
,	O
diverticulitis	B-problem
in	O
l978	O
,	O
and	O
spontaneous	B-problem
pneumothorax	I-problem
in	O
l956	O
.	O

He	O
had	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	I-treatment
three	I-treatment
as	O
mentioned	O
above	O
.	O

CURRENT	O
MEDICATIONS	O
:	O

He	O
came	O
in	O
on	O
Carafate	B-treatment
,	O
Enteric	B-treatment
Coated	I-treatment
Aspirin	I-treatment
,	O
Albuterol	B-treatment
Inhaler	I-treatment
,	O
Atrovent	B-treatment
Inhaler	I-treatment
,	O
Procan	B-treatment
SR	I-treatment
,	O
Mevacor	B-treatment
,	O
and	O
Digoxin	B-treatment
.	O

ALLERGIES	O
:	O

He	O
is	O
allergic	B-problem
to	O
Penicillin	B-treatment
,	O
Inderal	B-treatment
,	O
and	O
also	O
to	O
Procan	B-treatment
.	O

Patient	O
has	O
a	O
seventy	O
pack	O
year	O
history	O
of	O
smoking	O
which	O
he	O
quit	O
ten	O
years	O
ago	O
and	O
he	O
has	O
previously	O
had	O
problems	O
with	O
alcohol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
was	O
remarkable	O
for	O
an	O
abdomen	O
which	O
was	O
soft	O
and	O
non-tender	B-problem
.	O

There	O
was	O
a	B-problem
pulsatile	I-problem
mass	I-problem
felt	O
in	O
the	O
right	O
upper	O
quadrant	O
near	O
the	O
midline	O
.	O

He	O
had	O
dopplerable	B-problem
lower	I-problem
extremity	I-problem
pulses	I-problem
on	I-problem
the	I-problem
left	I-problem
and	O
on	O
the	O
right	O
,	O
they	O
were	O
palpable	O
.	O

HOSPITAL	O
COURSE	O
:	O

Patient	O
was	O
admitted	O
and	O
taken	O
to	O
the	O
Operating	O
Room	O
the	O
next	O
day	O
on	O
12/24/09	O
where	O
patient	O
underwent	O
an	B-treatment
abdominal	I-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

In	O
his	O
post-operative	O
course	O
,	O
patient	O
was	O
sent	O
to	O
the	O
unit	O
and	O
was	O
put	O
on	O
perioperative	B-treatment
Vancomycin	I-treatment
.	O

Post-operatively	O
,	O
patient	O
was	O
found	O
to	O
have	O
frequent	B-problem
aberrant	I-problem
atrial	I-problem
premature	I-problem
beats	I-problem
and	O
some	B-problem
rare	I-problem
ventricular	I-problem
premature	I-problem
beats	I-problem
.	O

His	O
lungs	O
were	O
found	O
to	O
have	O
decreased	B-problem
breath	I-problem
sounds	I-problem
with	O
a	O
question	O
of	O
fluid	B-problem
overload	I-problem
.	O

There	O
was	O
a	O
question	O
of	O
whether	O
to	O
start	O
him	O
on	O
Quinidine	B-treatment
versus	O
beta	B-treatment
blockers	I-treatment
.	O

An	B-test
echocardiogram	I-test
was	O
obtained	O
which	O
showed	O
moderate	B-problem
left	I-problem
ventricular	I-problem
dysfunction	I-problem
with	O
hypokinetic	B-problem
and	I-problem
akinetic	I-problem
areas	I-problem
throughout	I-problem
the	I-problem
left	I-problem
and	I-problem
right	I-problem
ventricle	I-problem
.	O

Patient	O
was	O
loaded	O
with	O
Quinidine	B-treatment
and	O
then	O
started	O
on	O
a	B-treatment
maintenance	I-treatment
dose	I-treatment
.	O

Patient	O
converted	O
to	O
normal	O
sinus	O
rhythm	O
once	O
on	O
Quinidine	B-treatment
.	O

Patient	O
was	O
discharged	O
from	O
the	O
unit	O
on	O
12/30/09	O
and	O
was	O
sent	O
to	O
the	O
floor	O
.	O

His	B-treatment
digoxin	I-treatment
was	O
found	O
to	O
be	O
elevated	B-problem
so	O
his	B-treatment
Digoxin	I-treatment
was	O
held	O
for	O
four	O
days	O
while	O
levels	B-test
slowly	O
came	O
down	O
.	O

Patient	O
was	O
restarted	O
on	O
Digoxin	B-treatment
just	O
prior	O
to	O
discharge	O
.	O

Patient	O
also	O
was	O
found	O
to	O
have	O
elevated	B-problem
LDH	I-problem
,	I-problem
alkaline	I-problem
phosphatase	I-problem
,	I-problem
and	I-problem
amylase	I-problem
prior	O
to	O
admission	O
.	O

Lipase	B-test
was	O
within	O
normal	O
limits	O
.	O

Ultrasound	B-test
was	O
obtained	O
of	O
the	O
biliary	O
tree	O
which	O
demonstrated	O
no	O
abnormalities	B-problem
.	O

Patient	O
was	O
also	O
found	O
to	O
have	O
several	O
complaints	O
of	O
awaking	O
in	O
the	O
middle	O
of	O
the	O
night	O
with	O
tachypnea	B-problem
and	O
some	B-problem
bilateral	I-problem
chest	I-problem
pain	I-problem
associated	O
with	O
breathing	O
.	O

Serial	B-test
EKG	I-test
and	I-test
CK	I-test
were	O
obtained	O
which	O
were	O
negative	O
.	O

A	B-test
chest	I-test
X-Ray	I-test
demonstrated	O
some	B-problem
pulmonary	I-problem
edema	I-problem
.	O

An	B-test
arterial	I-test
blood	I-test
gas	I-test
at	O
that	O
time	O
showed	O
pO2	B-test
of	O
68	O
,	O
saturation	B-test
of	O
95%	O
,	O
a	B-test
pH	I-test
of	O
7.5l	O
,	O
pCO2	B-test
of	O
37	O
,	O
a	B-test
bicarbonate	I-test
of	O
37	O
,	O
and	O
a	B-test
pCO2	I-test
of	O
3l	O
with	O
a	B-test
+7	I-test
base	I-test
.	O

Patient	B-test
&apos;s	I-test
chest	I-test
X-Ray	I-test
,	O
as	O
mentioned	O
above	O
,	O
showed	O
pulmonary	B-problem
edema	I-problem
.	O

Patient	O
was	O
aggressively	O
diuresed	O
with	O
resolution	O
of	O
symptoms	B-problem
.	O

DISPOSITION	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

Patient	O
is	O
being	O
sent	O
home	O
on	O
Ecotrin	B-treatment
one	O
q.d.	O
,	O
Digoxin	B-treatment
0.l25	O
mg	O
every	O
three	O
days	O
,	O
Quinidine	B-treatment
648	O
mg	O
q.a.m.	O
and	O
324	O
mg	O
q.p.m.	O
and	O
q.h.s.	O
,	O
Mevacor	B-treatment
20	O
mg	O
p.o.	O
q.d.	O
,	O
Carafate	B-treatment
one	O
gram	O
p.o.	O
q.i.d.	O
,	O
Colace	B-treatment
l00	O
mg	O
p.o.	O
t.i.d.	O
,	O
Lasix	B-treatment
80	O
mg	O
p.o.	O
q.d.	O
,	O
Potassium	B-treatment
20	O
mEq	O
p.o.	O
q.d.	O
,	O
and	O
iron	B-treatment
supplements	I-treatment
.	O

Patient	O
has	O
follow-up	O
with	O
Dr.	O
Merkel	O
and	O
with	O
his	O
private	O
medical	O
doctor	O
.	O

EV956/4659	O
RISHAN	O
M.	O
MERKEL	O
,	O
M.D.	O
BS9	O

D	O
:	O

01/02/92	O
PAD-WORD	O

Batch	O
:	O

3669	O
PAD-WORD	O

Report	O
:	O

F6644X53	O
PAD-WORD	O

T	O
:	O

01/02/92	O
PAD-WORD	O

Dicatated	O
By	O
:	O

RAMA	O
R.	O
KOTEOBE	O
,	O
M.D.	O

cc	O
:	O

1.	O
DWAINCO	O
L.	O
MERKEL	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2012-03-23	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-03-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1972-06-27	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
George	O
XL	O
Patrick	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

mental	B-problem
status	I-problem
change	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

intubation	B-treatment
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

39	O
year	O
old	O
male	O
w/	O
h/o	O
low	B-problem
back	I-problem
pain	I-problem
on	O
chronic	B-treatment
narcotics	I-treatment
presents	O
after	O
being	O
found	O
unresponsive	B-problem
at	O
home	O
.	O

His	O
daughter	O
awoke	O
him	O
at	O
7	O
a.m.	O
,	O
reports	O
he	O
said	O
he	O
felt	O
"	O
cold	B-problem
and	O
shivery	B-problem
,"	O
vomited	O
several	O
times	O
,	O
then	O
drove	O
her	O
to	O
school	O
.	O

According	O
to	O
his	O
wife	O
,	O
he	O
came	O
home	O
and	O
went	O
to	O
sleep	O
.	O

When	O
she	O
tried	O
to	O
awaken	O
him	O
at	O
11	O
a.m.	O
,	O
she	O
was	O
unable	O
to	O
do	O
so	O
and	O
called	O
EMS	O
.	O

She	O
did	O
not	O
notice	O
any	B-problem
blood	I-problem
/	I-problem
urine	I-problem
/	I-problem
emesis	I-problem
/	I-problem
stool	I-problem
in	I-problem
the	I-problem
bed	I-problem
.	O

EMS	O
found	O
him	O
with	O
agonal	B-problem
respirations	I-problem
and	O
pinpoint	B-problem
pupils	I-problem
.	O

FS	B-test
420	O
.	O

He	O
received	O
1	O
mg	O
IV	B-treatment
Narcan	I-treatment
(	O
numerous	O
bottles	O
of	O
oxycontin	B-treatment
,	O
percocet	B-treatment
were	O
found	O
in	O
room	O
);	O
his	O
pupils	O
dilated	O
to	O
~	O
8	O
mm	O
and	O
he	O
became	O
combative	B-problem
/	O
agitated	B-problem
.	O

He	O
was	O
then	O
intubated	O
for	O
airway	B-treatment
protection	I-treatment
(	O
etomidate	B-treatment
/	O
succinate	B-treatment
);	O
it	O
was	O
a	B-treatment
traumatic	I-treatment
intubation	I-treatment

and	O
one	O
of	O
his	O
teeth	O
was	O
chipped	O
.	O

He	O
was	O
transported	O
to	O
Hallmark	O
Health	O
System	O
Monica	O
,	O
where	O
ABG	B-test
7.14/82/44	O
while	O
bagging	O
on	O
100%	B-treatment
FiO2	I-treatment
.	O

Wife	O
reports	O
that	O
he	O
drank	O
a	O
large	O
amt	O
of	O
alcohol	O
(	O
12	O
bottles	O
of	O
beer	O
)	O
night	O
PTA	O
.	O

For	O
2	O
days	O
PTA	O
,	O
he	O
has	O
expressed	O
a	O
wish	O
to	O
kill	O
himself	O
(	O
no	O
clear	O
plan	O
,	O
but	O
fixing	O
things	O
around	O
the	O
house	O
"	O
so	O
things	O
will	O
be	O
ready	O
when	O
I	O
'm	O
gone	O
").	O

In	O
Monica	O
,	O
pt	O
received	O
charcoal	B-treatment
,	O
500	O
mg	O
IV	B-treatment
levofloxacin	I-treatment
,	O
500	O
mg	O
IV	B-treatment
metronidazole	I-treatment
for	O
presumed	O
aspiration	B-problem
pna	I-problem
.	O

Past	O
Medical	O
History	O
:	O

chronic	B-problem
LBP	I-problem
,	O
HTN	B-problem
,	O
anxiety	B-problem
,	O
depression	B-problem
,	O
L	B-treatment
arm	I-treatment
surgeries	I-treatment
(	O
hardware	B-treatment
in	O
place	O
)	O

Social	O
History	O
:	O

lives	O
with	O
wife	O
and	O
daughters	O
.	O

On	O
disability	O
secondary	O
to	O
work-related	B-problem
back	I-problem
injury	I-problem
.	O

Heavy	O
EtOH	O
(	O
12	O
beers	O
several	O
times	O
a	O
week	O
).	O

Smokes	O
~	O
1	O
pk	O
/	O
week	O
.	O

No	O
other	O
known	O
drug	O
use	O
other	O
than	O
Oxycontin	B-treatment
/	O
percocet	B-treatment
.	O

Family	O
History	O
:	O

No	O
family	O
history	O
of	O
heart	B-problem
disease	I-problem
or	O
cancer	B-problem

Physical	O
Exam	O
:	O

PE	O
:	O
Tc	B-test
98.7	O
,	O
pc	B-test
88	O
,	O
bpc	B-test
120/60	O
,	O
AC	B-test
600/20	O
,	O
FiO2	B-test
100%	O
,	O
PEEP	B-test
10	O

Gen	O
:	O
young	O
male	O
,	O
intubated	B-treatment
,	O
sedated	B-treatment
,	O
in	O
hard	B-treatment
collar	I-treatment
.	O

HEENT	O
:	O
Pupils	B-problem
pinpoint	I-problem
,	O
equal	O
,	O
anicteric	B-problem
,	O
normal	O
conjunctiva	O
,	O
intubated	B-treatment
,	O
OGT	B-treatment
in	O
place	O
,	O
OMMM	O
,	O
normocephalic	O
,	O
atraumatic	B-problem

Cardiac	O
:	O
RRR	O
,	O
I/VI	B-problem
SM	I-problem
at	I-problem
apex	I-problem
,	O
no	O
R/G	B-problem
appreciated	O

Pulm	O
:	O
coarse	B-problem
breath	I-problem
sounds	I-problem
throughout	I-problem

Abd	O
:	O
mildly	B-problem
distended	I-problem
,	O
hypoactive	B-problem
BS	I-problem
,	O
soft	O
,	O
no	O
HSM	B-problem

Ext	O
:	O
trace	B-problem
LE	I-problem
edema	I-problem
at	I-problem
ankles	I-problem
,	O
extremities	B-problem
cool	I-problem
w/	O
2+	O
radial	B-test
,	O
1+	O
DP/PT	B-test
pulses	I-test
.	O

Well-healed	B-problem
scars	I-problem
over	I-problem
dorsal	I-problem
/	I-problem
lateral	I-problem
distal	I-problem
LUE	I-problem

Neuro	O
:	O
DTR	B-test
3+	O
upper	O
and	O
lower	O
extremities	O
,	O
symmetric	O
bilaterally	O
.	O

Toes	O
equivocal	O
bilaterally	O
.	O

(+)	O
gag	O

Pertinent	O
Results	O
:	O

EKG	B-test
NSR	O
@	O
92	O
bpm	O
,	O
nl	O
axis	O
,	O
borderline	B-problem
QT	I-problem
(	O
QTc	B-test
0.442	O
),	O
J	B-problem
Pt	I-problem
elevtation	I-problem
V3	B-test
,	O
TWF	B-test
II	I-test
,	O
III	B-test
,	O
avF	B-test
,	O
I	B-test
,	O
avL	B-test
(	O
no	O
prior	B-test
EKG	I-test
for	O
comparison	O
)	O

2012-03-23	O
03:39	O
PM	O

TYPE	O
-	O
ART	B-test
PO2	I-test
-	O
122	O
*	O
PCO2	B-test
-	O
38	O
PH	B-test
-	O
7.43	O
TOTAL	B-test
CO2	I-test
-	O
26	O
BASE	B-test
XS	I-test
-	O
1	O

2012-03-23	O
03:39	O
PM	O

LACTATE	B-test
-	O
2.0	O

2012-03-23	O
01:30	O
PM	O
URINE	B-test

HOURS	O
-	O
RANDOM	O

2012-03-23	O
01:30	O
PM	O
URINE	B-test

bnzodzpn	B-test
-	O
POS	B-problem
barbitrt	B-test
-	O
NEG	O
opiates	B-test
-	O
NEG	O
cocaine	B-test
-	O
NEG	O
amphetmn	B-test
-	O
NEG	O
mthdone	B-test
-	O
NEG	O

2012-03-23	O
01:30	O
PM	O
URINE	B-test

COLOR	O
-	O
Straw	O
APPEAR	O
-	O
Clear	O
SP	B-test
Barajas	I-test
-	O
1.015	O

2012-03-23	O
01:30	O
PM	O
URINE	B-test

BLOOD	B-test
-	O
SM	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
30	O
GLUCOSE	B-test
-	O
1000	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
6.0	O
LEUK	B-test
-	O
NEG	O

2012-03-23	O
01:30	O
PM	O
URINE	B-test

RBC	B-test
-	O
03-10	O
*	O
WBC	B-test
-	O
0-2	O
BACTERIA	B-test
-	O
FEW	B-problem
YEAST	B-test
-	O
NONE	O
EPI	B-test
-	O
0	O

2012-03-23	O
01:30	O
PM	O
URINE	B-test

MUCOUS	B-test
-	O
FEW	O

2012-03-23	O
12:22	O
PM	O

PO2	B-test
-	O
44	O
*	O
PCO2	B-test
-	O
82	O
*	O
PH	B-test
-	O
7.14	O
*	O
TOTAL	B-test
CO2	I-test
-	O
30	O
BASE	B-test
XS	I-test
--	O
4	O

2012-03-23	O
12:22	O
PM	O

GLUCOSE	B-test
-	O
296	O
*	O
LACTATE	B-test
-	O
4.8	O
*	O
NA+	B-test
-	O
140	O
K+	B-test
-	O
5.2	O
CL	B-test
--	O
101	O

2012-03-23	O
12:20	O
PM	O

UREA	B-test
N	O
-	O
20	O
CREAT	B-test
-	O
1.1	O

2012-03-23	O
12:20	O
PM	O

ALT(SGPT)	B-test
-	O
30	O
AST(SGOT)	B-test
-	O
38	O
LD(LDH)	B-test
-	O
217	O
CK(CPK)	B-test
-	O
1152	O
*	O
ALK	B-test
PHOS	I-test
-	O
52	O
AMYLASE	B-test
-	O
426	O
*	O
TOT	B-test
BILI	I-test
-	O
0.4	O

2012-03-23	O
12:20	O
PM	O

LIPASE	B-test
-	O
22	O

2012-03-23	O
12:20	O
PM	O

CK-MB	B-test
-	O
45	O
*	O
MB	B-test
INDX	I-test
-	O
3.9	O
cTropnT	B-test
-<	O
0.01	O

2012-03-23	O
12:20	O
PM	O

ALBUMIN	B-test
-	O
4.4	O

2012-03-23	O
12:20	O
PM	O

ASA	B-test
-	O
NEG	O
ETHANOL	B-test
-	O
NEG	O
ACETMNPHN	B-test
-	O
NEG	O
bnzodzpn	B-test
-	O
NEG	O
barbitrt	B-test
-	O
NEG	O
tricyclic	B-test
-	O
NEG	O

2012-03-23	O
12:20	O
PM	O

WBC	B-test
-	O
8.9	O
RBC	B-test
-	O
3.93	O
*	O
HGB	B-test
-	O
12.1	O
*	O
HCT	B-test
-	O
36.7	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
30.8	O
MCHC	B-test
-	O
33.0	O
RDW	B-test
-	O
13.0	O

2012-03-23	O
12:20	O
PM	O

NEUTS	B-test
-	O
84.7	O
*	O
LYMPHS	B-test
-	O
13.1	O
*	O
MONOS	B-test
-	O
1.5	O
*	O
EOS	B-test
-	O
0.3	O
BASOS	B-test
-	O
0.4	O

2012-03-23	O
12:20	O
PM	O

PLT	B-test
COUNT	I-test
-	O
227	O

2012-03-23	O
12:20	O
PM	O

PT	B-test
-	O
14.1	O
*	O
PTT	B-test
-	O
21.0	O
*	O
INR(PT)	B-test
-	O
1.2	O

2012-03-23	O
12:20	O
PM	O

FIBRINOGE	B-test
-	O
375	O

2012-03-26	O
04:30	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
6.9	O
RBC	B-test
-	O
3.28	O
*	O
Hgb	B-test
-	O
9.8	O
*	O
Hct	B-test
-	O
29.0	O
*	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
29.7	O
MCHC	B-test
-	O
33.6	O
RDW	B-test
-	O
13.1	O
Plt	B-test
Ct	I-test
-	O
206	O

2012-03-26	O
04:30	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
206	O

2012-03-26	O
04:30	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
88	O
UreaN	B-test
-	O
10	O
Creat	B-test
-	O
0.7	O
Na	B-test
-	O
143	O
K-3.6	B-test
Cl	B-test
-	O
108	O
HCO3	B-test
-	O
28	O
AnGap	B-test
-	O
11	O

2012-03-26	O
04:30	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
8.5	O
Phos	B-test
-	O
3.1	O
Mg	B-test
-	O
1.9	O

2012-03-25	O
04:00	O
AM	O
BLOOD	B-test
calTIBC	B-test
-	O
237	O
*	O
Ferritn	B-test
-	O
534	O
*	O
TRF	B-test
-	O
182	O
*	O

Brief	O
Hospital	O
Course	O
:	O

A	O
:	O
39	O
year	O
old	O
male	O
w/	O
HTN	B-problem
,	O
chronic	B-problem
LBP	I-problem
on	O
narcotics	B-treatment
presents	O
after	O
being	O
found	O
unresponsive	B-problem
at	O
home	O
.	O

P	O
:	O

1)	O
Unresponsiveness	B-problem
:	O
This	O
is	O
likely	O
due	O
todrug	B-problem
overdose	I-problem
(	O
known	O
oxycontin	B-treatment
use	O
,	O
(+)	B-problem
BNZ	I-problem
on	O
tox	B-test
screen	I-test
).	O

Ddx	O
:	O
cardiac	B-problem
ischemia	I-problem
(	O
no	O
ischemic	B-problem
EKG	I-problem
changes	I-problem
noted	O
),	O
seizure	B-problem
w/	O
post-ictal	B-problem
state	I-problem
,	O
CVA	B-problem
(	O
head	B-test
CT	I-test
neg	O
).	O

His	B-test
cardiac	I-test
enzymes	I-test
include	O
only	O
elevated	B-problem
CK	I-problem
,	O
but	O
not	O
Shaffer	O
,	O
Juan	O
he	O
ruled	O
out	O
for	O
MI	B-problem
.	O

His	O
mental	O
status	O
gradually	O
improved	O
from	O
03-23	O
to	O
03-24	O
.	O

He	O
was	O
able	O
to	O
communicate	O
appropriately	O
as	O
his	B-test
level	I-test
of	O
narcotic	B-treatment
medications	I-treatment
waned	O
in	O
his	B-test
blood	I-test
.	O

He	O
was	O
able	O
to	O
maintain	O
a	O
stable	O
mental	O
level	O
for	O
extubation	B-treatment
on	O
03-24	O
.	O

As	O
of	O
3/21	O
,	O
he	O
was	O
alert	O
,	O
appropriate	O
and	O
answers	O
questions	O
and	O
follows	O
command	O
on	O
exam	B-test
.	O

2)	O
Pulmonary	B-problem
infiltrates	I-problem
:	O
THere	O
was	O
initially	O
concern	O
that	O
he	O
was	O
developing	O
ARDS	B-problem
from	O
aspiration	B-problem
pneumonia	I-problem
in	O
the	O
setting	O
of	O
being	O
found	O
unconscious	B-problem
.	O

He	O
was	O
intubated	O
and	O
was	O
on	O
mechanical	B-treatment
ventilation	I-treatment
from	O
9/13-10/11	O
,	O
but	O
he	O
was	O
started	O
on	O
levofloxacin	B-treatment

and	O
flagyl	B-treatment
for	O
total	O
of	O
4	O
days	O
.	O

ON	O
03-26	O
,	O
his	B-treatment
antibiotics	I-treatment
were	O
started	O
as	O
this	O
most	O
likely	O
represent	O
a	B-problem
transiet	I-problem
aspiration	I-problem
episode	I-problem
and	O
not	O
ARDS	B-problem
.	O

3)	O
Airway	B-treatment
protection	I-treatment
:	O
He	O
was	O
intubated	B-treatment
in	O
the	O
field	O
for	O
airway	B-treatment
protection	I-treatment

He	O
was	O
extubated	B-treatment
on	O
03-24	O
and	O
was	O
weaned	O
off	O
oxygen	B-treatment
slowly	O
from	O
03-24	O
to	O
03-26	O
without	O
significant	O
event	O
.	O

4)	O
Hypertension	B-problem
:	O
He	O
was	O
restarted	O
on	O
his	B-treatment
atenolol	I-treatment
and	O
verapamil	B-treatment
once	O
his	B-test
blood	I-test
pressure	I-test
stabilized	O
on	O
03-25	O
.	O

5)	O
Depression	B-problem
:	O
He	O
was	O
restarted	O
on	O
his	B-treatment
paxil	I-treatment
on	O
03-25	O
and	O
was	O
given	B-treatment
1:1	I-treatment
sitter	I-treatment
for	O
suicidal	B-problem
ideation	I-problem
leading	O
up	O
to	O
his	O
suicide	O
leading	O
up	O
to	O
this	O
admission	O
.	O

He	O
has	O
not	O
had	O
further	B-problem
episodes	I-problem
while	O
he	O
was	O
in	O
the	O
hospital	O
.	O

-	O
plan	O
to	O
restart	O
Paxil	B-treatment
when	O
taking	O
PO	O

6)	O
Hyperglycemia	B-problem
:	O
Although	O
he	O
has	O
no	O
known	O
history	O
of	O
diabetes	B-problem
,	O
his	B-problem
elevated	I-problem
FS	I-problem
noted	O
in	O
field	O
with	O
glycosuria	B-problem
prompted	O
fingerstick	B-test
check	I-test
but	O
he	O
has	O
not	O
required	O
insulin	B-treatment
coverage	I-treatment
.	O

7)	O
High	B-problem
amylase	I-problem
:	O
He	O
was	O
admitted	O
on	O
03-23	O
with	O
elevated	B-problem
amylase	I-problem
but	O
non-elevated	B-problem
lipase	I-problem
.	O

This	O
likely	O
is	O
not	O
concerning	O
of	O
pancreatic	O
process	O
.	O

His	B-test
amylase	I-test
trended	O
down	O
.	O

He	O
was	O
restarted	O
on	O
regular	O
diet	O
on	O
4/14-4/17	O
after	O
his	B-treatment
extubation	I-treatment

8)	O
Anemia	B-problem
-	O
He	O
was	O
admitted	O
with	O
borderline	B-problem
anemia	I-problem
with	O
Fe	B-test
studies	I-test
suggestive	O
of	O
anemia	B-problem
of	I-problem
chronic	I-problem
disease	I-problem
and	O
his	B-test
hct	I-test
decreased	O
in	O
the	O
setting	O
fluid	B-treatment
resucitation	I-treatment
.	O

His	B-test
hct	I-test
has	O
stabilized	O
and	O
improved	O
to	O
close	O
to	O
30	O
at	O
the	O
time	O
of	O
3/21	O
.	O

He	O
reports	O
that	O
his	O
primary	O
physician	O
is	O
aware	O
of	O
his	B-problem
anemia	I-problem
and	O
was	O
in	O
the	O
process	O
of	O
followup	O
.	O

Medications	O
on	O
Admission	O
:	O

Oxycontin	B-treatment
PAD-WORD	O

Percocet	B-treatment
PAD-WORD	O

Paxil	B-treatment
PAD-WORD	O

Gabapentin	B-treatment
PAD-WORD	O

Atenolol	B-treatment
PAD-WORD	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

benzodiazipine	B-problem
overdose	I-problem

Discharge	O
Condition	O
:	O

stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

please	O
take	O
your	B-treatment
medications	I-treatment
and	O
call	O
your	O
doctor	O
if	O
you	O
experience	O
chest	B-problem
pain	I-problem
,	O
abdominal	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
any	B-problem
thoughts	I-problem
of	I-problem
hurting	I-problem
yourself	I-problem
or	I-problem
anyone	I-problem
else	I-problem
.	O

Followup	O
Instructions	O
:	O

please	O
call	O
your	O
primary	O
doctor	O
Edmund	O
Starke	O
once	O
your	O
are	O
discharge	O
from	O
the	O
hospital	O

Clemmie	O
Shawn	O
MD	O
65-948	O

Completed	O
by	O
:	O
Michael	O
Melvin	O
Kinzer	O
MD	O
51-991	O
2012-03-26	O
@	O
1709	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Justin	O
Pappas	O
on:	O
MON	O
2012-05-07	O
4:52	O
PM	O

(	O
End	O
of	O
Report	O
)	O

125667950	O
PAD-WORD	O

PRGH	O
PAD-WORD	O

10805085	O
PAD-WORD	O

360731	O
PAD-WORD	O

10/22/2000	O
12:00:00	O
AM	O

CHRONIC	B-problem
LYMPHOCYTIC	I-problem
LEUKEMIA	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

10/22/2000	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

11/17/2000	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

CHRONIC	B-problem
LYMPHOCYTIC	I-problem
LEUKEMIA	I-problem
.	O

OTHER	O
PROBLEMS	O
:	O

1.	O
FREQUENT	B-problem
HEADACHES	I-problem
.	O

2.	O
CHOLECYSTITIS	B-problem
.	O

3.	O
SPASTIC	B-problem
COLON	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47-year-old	O
man	O
with	O
advanced	B-problem
stage	I-problem
chronic	I-problem
lymphocytic	I-problem
leukemia	I-problem
who	O
was	O
admitted	O
for	O
autologous	B-treatment
bone	I-treatment
marrow	I-treatment
transplant	I-treatment
as	O
per	O
protocol	O
94-055	O
of	O
the	O
Santusli	O
Hospital	O
.	O

The	O
patient	O
was	O
originally	O
diagnosed	O
in	O
06/98	O
during	O
a	B-test
routine	I-test
physical	I-test
when	O
he	O
was	O
noted	O
to	O
have	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
20,000	O
,	O
weight	B-problem
loss	I-problem
,	O
and	O
swelling	B-problem
in	I-problem
his	I-problem
neck	I-problem
and	I-problem
groin	I-problem
.	O

He	O
was	O
watched	O
after	O
his	B-problem
initial	I-problem
diagnosis	I-problem
,	O
but	O
six	O
months	O
later	O
he	O
developed	O
rapidly	B-problem
increasing	I-problem
leukocytosis	I-problem
and	O
he	O
became	O
more	B-problem
symptomatic	I-problem
.	O

After	O
treatment	B-treatment
with	I-treatment
three	I-treatment
cycles	I-treatment
of	I-treatment
fludarabine	I-treatment
he	O
had	O
90%	B-problem
involvement	I-problem
of	I-problem
his	I-problem
intratrabecular	I-problem
space	I-problem
.	O

He	O
was	O
therefore	O
treated	O
with	O
three	B-treatment
cycles	I-treatment
of	I-treatment
fludarabine	I-treatment
in	O
combination	O
with	O
cytoxan	B-treatment
.	O

After	O
this	B-treatment
therapy	I-treatment
he	O
achieved	O
a	B-problem
protocol	I-problem
eligible	I-problem
minimal	I-problem
disease	I-problem
state	I-problem
.	O

However	O
,	O
he	O
did	O
have	O
relative	B-problem
pancytopenia	I-problem
following	O
this	B-treatment
therapy	I-treatment
.	O

He	O
was	O
taken	O
to	O
bone	B-treatment
marrow	I-treatment
harvest	I-treatment
in	O
08/22	O
at	O
which	O
time	O
insufficient	B-problem
cells	I-problem
were	O
obtained	O
to	O
proceed	O
.	O

He	O
was	O
returned	O
previous	O
to	O
this	O
admission	O
for	O
repeat	B-treatment
bone	I-treatment
marrow	I-treatment
harvest	I-treatment
and	O
at	O
that	O
time	O
he	O
was	O
given	O
Neupogen	B-treatment
prior	O
to	O
his	B-treatment
harvest	I-treatment
,	O
and	O
sufficient	O
cells	O
were	O
not	O
obtained	O
to	O
proceed	O
with	O
autologous	B-treatment
bone	I-treatment
marrow	I-treatment
transplantation	I-treatment
.	O

His	B-test
most	I-test
recent	I-test
bone	I-test
marrow	I-test
biopsy	I-test
revealed	O
less	B-problem
than	I-problem
5%	I-problem
of	I-problem
intratrabecular	I-problem
space	I-problem
involvement	I-problem
.	O

Recent	B-test
CT	I-test
scan	I-test
showed	O
no	O
significant	B-problem
lymphadenopathy	I-problem
.	O

The	O
spleen	O
was	O
within	O
normal	O
limits	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Episode	O
of	O
pneumonia	B-problem
in	O
1996	O
.	O

2.	O
At	O
the	O
age	O
of	O
40	O
he	O
had	O
problems	O
with	O
frequent	B-problem
headaches	I-problem
.	O

3.	O
Episodes	O
of	O
cholecystitis	B-problem
and	O
spastic	B-problem
colon	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

No	O
medications	B-treatment
upon	O
admission	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
works	O
as	O
an	O
airline	O
pilot	O
for	O
Vent	O

He	O
is	O
currently	O
flying	O
on	O
Hwy	O
routes	O
.	O

He	O
was	O
married	O
for	O
many	O
years	O
.	O

He	O
has	O
three	O
children	O
.	O

He	O
is	O
separated	O
and	O
has	O
a	O
very	O
supportive	O
new	O
partner	O
.	O

FAMILY	O
HISTORY	O
:	O

His	O
father	O
had	O
prostate	B-problem
cancer	I-problem
.	O

Mother	O
had	O
breast	B-problem
cancer	I-problem
.	O

Has	O
a	O
cousin	O
with	O
a	B-problem
brain	I-problem
tumor	I-problem
.	O

No	O
family	O
history	O
of	O
leukemia	B-problem
or	O
lymphoma	B-problem
.	O

He	O
has	O
one	O
sister	O
and	O
one	O
brother	O
who	O
are	O
alive	O
and	O
well	O
.	O

They	O
are	O
not	O
HLA	O
matched	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

On	O
admission	O
he	O
had	O
no	O
upper	B-problem
respiratory	I-problem
tract	I-problem
symptoms	I-problem
,	O
recent	B-problem
infections	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
nausea	B-problem
or	O
vomiting	B-problem
,	O
change	B-problem
in	I-problem
bowel	I-problem
habits	I-problem
or	O
abdomen	B-problem
pain	I-problem
.	O

He	O
did	O
complain	O
of	O
frequent	B-problem
headaches	I-problem
.	O

Following	O
his	B-treatment
recent	I-treatment
bone	I-treatment
marrow	I-treatment
harvest	I-treatment
he	O
had	O
protracted	O
episodes	O
of	O
nausea	B-problem
and	O
vomiting	B-problem
.	O

All	O
other	O
systems	O
were	O
negative	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
.	O

GENERAL	O
:	O

He	O
was	O
well-appearing	O
and	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

Performance	O
status	O
was	O
0	O
.	O

VITAL	O
SIGNS	O
:	O

Weight	B-test
70.4	O
kilograms	O
,	O
temperature	B-test
96.5	O
,	O
respiratory	B-test
rate	I-test
20	O
,	O
blood	B-test
pressure	I-test
105/60	O
,	O
pulse	B-test
76	O
.	O

SKIN	O
:	O

Unremarkable	O
without	O
rashes	B-problem
or	O
lesions	B-problem
.	O

HEENT	O
:	O

Sclerae	B-problem
anicteric	I-problem
.	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Oropharynx	O
,	O
lips	O
,	O
teeth	O
and	O
gums	O
were	O
without	O
lesions	B-problem
and	O
without	O
evidence	O
of	O
mucositis	B-problem
.	O

NECK	O
:	O

Supple	O
with	O
a	O
normal	O
thyroid	O
gland	O
.	O

No	O
cervical	B-problem
,	I-problem
supraclavicular	I-problem
or	I-problem
axillary	I-problem
adenopathy	I-problem
.	O

CHEST	O
:	O

Clear	O
.	O

HEART	O
:	O

Heart	B-test
sounds	I-test
normal	O
.	O

ABDOMEN	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
without	O
any	B-problem
masses	I-problem
and	O
without	O
any	B-problem
hepatosplenomegaly	I-problem
.	O

GU	O
:	O

Normal	O
testes	O
and	O
penis	O
.	O

EXTREMITIES	O
:	O

Without	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

NEURO	O
:	O

Normal	O
with	O
intact	O
cranial	O
nerves	O
,	O
deep	O
tendon	O
reflexes	O
and	O
normal	O
motor	O
/	O
sensory	O
exam	O
.	O

LABORATORY	O
DATA	O
:	O

Electrolytes	B-test
were	O
within	O
normal	O
limits	O
.	O

Liver	B-test
function	I-test
tests	I-test
were	O
within	O
normal	O
limits	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
10.4	O
,	O
hemoglobin	B-test
11.9	O
,	O
platelets	B-test
124	O
,	O
PT	B-test
and	O
PTT	B-test
were	O
within	O
normal	O
limits	O
.	O

HOSPITAL	O
COURSE	O
:	O

1	O
)	O
Oncology	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
10/22/00	O
and	O
received	O
cytoxan	B-treatment
and	O
total	B-treatment
body	I-treatment
irradiation	I-treatment
per	O
protocol	O
.	O

Autologous	B-treatment
bone	I-treatment
marrow	I-treatment
infusion	I-treatment
occurred	O
on	O
10/29/00	O
and	O
was	O
uneventful	O
.	O

His	O
post-transplant	O
course	O
was	O
complicated	O
by	O
pain	B-problem
from	O
mucositis	B-problem
and	O
recalcitrant	B-problem
nausea	I-problem
and	I-problem
vomiting	I-problem
.	O

The	O
patient	O
did	O
not	O
tolerate	O
antiemetics	B-treatment
well	O
and	O
it	O
was	O
subsequently	O
decided	O
to	O
avoid	O
phenothiazides	B-treatment
secondary	O
to	O
jitteryness	B-problem
and	O
restless	B-problem
legs	I-problem
.	O

2	O
)	O
Infectious	O
Disease	O
:	O

The	O
patient	O
remained	O
afebrile	B-problem
until	O
day	O
+11	O
when	O
he	O
spiked	O
and	O
was	O
started	O
on	O
ceftazidime	B-treatment
.	O

Blood	B-test
cultures	I-test
and	O
urine	B-test
cultures	I-test
were	O
all	O
negative	O
.	O

3	O
)	O
Heme	O
:	O

The	O
patient	O
acquired	O
intermittent	B-treatment
transfusions	I-treatment
for	O
pancytopenia	B-problem
.	O

4	O
)	O
FEN	O
:	O

The	O
patient	O
was	O
unable	O
to	O
tolerate	O
adequate	O
p.o.&apos;s	O
in	O
the	O
last	O
several	O
days	O
.	O

He	O
was	O
well	O
nourished	O
so	O
TPN	B-treatment
was	O
not	O
started	O
.	O

I	B-test
&apos;s	I-test
and	I-test
O	I-test
&apos;s	I-test
were	O
balanced	O
and	O
maintained	O
with	O
IV	B-treatment
fluids	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Tylenol	B-treatment
650	O
mg	O
p.o.	O
q.	O
4-6h	O
p.r.n.	O
headache	B-problem
or	O
pain	B-problem
;	O
acyclovir	B-treatment
400	O
mg	O
p.o.	O
t.i.d.;	O
acyclovir	B-treatment
topical	I-treatment
t.i.d.	O
to	O
be	O
applied	O
to	O
lesion	B-problem
on	I-problem
corner	I-problem
of	I-problem
mouth	I-problem
;	O
Peridex	B-treatment
15	O
ml	O
p.o.	O
b.i.d.;	O
Mycelex	B-treatment
1	O
troche	O
p.o.	O
t.i.d.;	O
g-csf	O
404	O
mcg	O
subcu	O
q.d.;	O
folic	B-treatment
acid	I-treatment
1	O
mg	O
p.o.	O
q.d.;	O
lorazepam	B-treatment
1-2	O
mg	O
p.o.	O
q.	O
4-6h	O
p.r.n.	O
nausea	B-problem
and	O
vomiting	B-problem
;	O
Miracle	B-treatment
Cream	I-treatment
topical	O
q.d.	O
p.r.n.	O
perianal	B-problem
irritation	I-problem
;	O
Eucerin	B-treatment
Cream	I-treatment
topical	O
b.i.d.;	O
Zantac	B-treatment
150	O
mg	O
p.o.	O
b.i.d.;	O
Restoril	B-treatment
15-30	O
mg	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O
insomnia	B-problem
;	O
multivitamin	B-treatment
1	O
tablet	O
p.o.	O
q.d.;	O
viscous	B-treatment
lidocaine	I-treatment
15	O
ml	O
p.o.	O
q.	O
3h	O
can	O
be	O
applied	O
to	O
corner	O
of	O
mouth	O
or	O
lips	O
p.r.n.	O
pain	B-treatment
control	I-treatment
.	O

CONDITION	O
UPON	O
DISCHARGE	O
:	O

Stable	O
.	O

FOLLOWUP	O
:	O

Follow	O
up	O
appointment	O
with	O
Die	O
Anoort	O
and	O
Tomedankell	O
Care	O
on	O
11/18/00	O
at	O
9:30	O
a.m.	O
(	O
one	O
day	O
after	O
discharge	O
)	O
.	O

The	O
patient	O
knows	O
to	O
go	O
to	O
Sper	O
Medical	O
Center	O
every	O
day	O
for	O
line	B-treatment
care	I-treatment
,	O
blood	B-test
draws	I-test
,	O
and	O
monitoring	B-test
.	O

Dictated	O
By	O
:	O

CONRELLIE	O
KOTERUDES	O
,	O
M.D.	O
VJ31	O

Attending	O
:	O

SUOT	O
CARE	O
,	O
M.D.	O
OB89	O
RL958/5760	O

Batch	O
:	O

24769	O
PAD-WORD	O

Index	O
No.	O
GFNC2Z5N8Q	O

D	O
:	O

11/22/00	O
PAD-WORD	O

T	O
:	O

11/22/00	O
PAD-WORD	O

CC	O
:	O

1.	O
TOMEDANKELL	O
CARE	O
,	O
M.D.	O
RE04	O

Admission	O
Date	O
:	O

2014-11-29	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-12-05	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1967-08-29	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Penicillins	B-treatment
/	O
Estrogens	B-treatment
/	O
Ancef	B-treatment
/	O
Tegretol	B-treatment
/	O
Keflex	B-treatment

Attending	O
:	O

Mary	O
S.	O
Corral	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

hypotension	B-problem
PAD-WORD	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O

Nephrostomy	B-treatment
tube	I-treatment
placement	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

47	O
yo	O
F	O
w/	O
h/o	O
steroid-induced	B-problem
hyperglycemia	I-problem
,	O
SLE	B-problem
w/	O
h/o	O
pericarditis	B-problem
,	O
transverse	B-problem
myelitis	I-problem
w/	O
paraplegia	B-problem
and	O
neurogenic	B-problem
bladder	I-problem
s/p	B-treatment
urostomy	I-treatment
w/	O
ileal	B-treatment
conduit	I-treatment
,	O
h/o	O
ureteropelvic	B-problem
stone	I-problem
and	O
urosepsis	B-problem
,	O
and	O
h/o	O
RLE	B-problem
DVT	I-problem
a/w	O
F	O
2014-11-29	O
transferred	O
to	O
CMED	O
2014-11-30	O
for	O
hypotn	B-problem
resistant	O
to	O
IVFs	B-treatment
and	O
stress	B-treatment
steroids	I-treatment
.	O

Patient	O
initially	O
p/w	O
c/o	O
sudden	B-problem
onset	I-problem
N/abd	I-problem
pain/chills	I-problem
w/	O
T	B-test
103	O
at	O
NH	O
.	O

Rigors	B-problem
progressed	O
so	O
she	O
was	O
brought	O
to	O
Robert	O
.	O

She	O
reported	O
h/o	O
fatigue	B-problem
and	O
anorexia	B-problem
for	O
the	O
past	O
few	O
days	O
and	O
had	O
noticed	O
foul	B-problem
smelling	I-problem
urine	I-problem
and	O
some	O
abdominal	B-problem
distension	I-problem
,	O
similar	O
to	O
prior	O
episodes	O
of	O
pyelo	B-problem
.	O

She	O
also	O
c/o	O
LLQ	B-problem
and	I-problem
groin	I-problem
pain	I-problem
which	O
responded	O
to	O
tylenol	B-treatment
.	O

She	O
denies	O
V	B-problem
or	O
D	B-problem
.	O

No	O
AMS	B-problem
.	O

No	O
c/o	O
CP	B-problem
.	O

On	O
arrival	O
to	O
Shirley	O
,	O
temperature	B-test
was	O
101.2	O
.	O

CT	B-test
abd	I-test
showed	O
an	B-problem
8	I-problem
mm	I-problem
right	I-problem
proximal	I-problem
ureteral	I-problem
stone	I-problem
with	O
right-sided	B-problem
hydronephrosis	I-problem
and	O
inflammatory	B-problem
stranding	I-problem
,	O
in	O
addition	O
to	O
pyelonephritis	B-problem
of	I-problem
the	I-problem
left	I-problem
kidney	I-problem
without	O
left	B-problem
sided	I-problem
hydronephrosis	I-problem
.	O

Labs	B-test
were	O
remarkable	O
for	O
wbc	B-test
23.5	O
w/	O
1%	O
bands	B-test
which	O
decreased	O
to	O
14	O
today	O
but	O
now	O
w/	O
15%	O
bands	B-test
on	O
vanc	B-treatment
(	O
h/o	O
MRSA	B-problem
urosepsis	I-problem
)	O
and	O
gent	B-treatment
(	O
mult	B-problem
drug	I-problem
allergies	I-problem
)	O
.	O

AG	B-test
on	O
admission	O
18	O
(	O
bicarb	B-test
17	O
,	O
down	O
from	O
23	O
on	O
a	O
previous	O
admission	O
)	O
,	O
down	O
to	O
AG	B-test
15	O
this	O
AM	O
.	O

ABG	B-test
prior	O
to	O
transfer	O
(	O
on	O
room	O
air	O
)	O
:	O

7.43/24/69	O
w/	O
lactate	B-test
1.3	O
(	O
down	O
from	O
1.4	O
on	O
the	O
prior	O
day	O
)	O
.	O

Currently	O
,	O
03-14	O
blood	B-test
cx	I-test
are	O
growing	O
GNR	B-problem
in	O
both	O
anaerobic	O
bottles	O
.	O

Urine	B-test
cx	I-test
is	O
pending	O
.	O

Prior	O
to	O
transfer	O
,	O
patient	O
dropped	O
bp	B-test
to	O
68/40s	O
.	O

BP	B-test
did	O
not	O
improve	O
despite	O
2	O
L	O
NS	B-treatment
and	O
100	O
mg	O
IV	B-treatment
hydrocortisone	I-treatment
.	O

A	B-treatment
central	I-treatment
line	I-treatment
was	O
placed	O
and	O
she	O
was	O
sent	O
to	O
IR	O
for	O
a	B-treatment
right	I-treatment
nephrostomy	I-treatment
tube	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

##	O
h/o	O
nephrolithiasis	B-problem
s/p	O
lithotripsy	B-treatment
and	O
h/o	O
left	B-problem
ureteropelvic	I-problem
junction	I-problem
stone	I-problem
'03	O
spontaneously	O
passing	O
by	O
U/S	B-test
,	O
no	O
evidence	O
of	O
right	B-problem
stone	I-problem
on	O
most	B-test
recent	I-test
u/s	I-test
5	O
months	O
ago	O

##	O
h/o	O
pyelo	B-problem
,	O
last	O
episode	O
in	O
'03	O
(	O
MRSA	B-problem
in	I-problem
blood	I-problem
and	I-problem
urine	I-problem
)	O

##	O
SLE	B-problem
w/	O
h/o	O
pericarditis	B-problem
,	O
last	O
flare	O
couple	O
years	O
ago	O
,	O
didn	O
't	O
flare	O
w/	O
urosepsis	B-problem

##	O
Devic	B-problem
's	I-problem
disease	I-problem
:	O

Recurrent	B-problem
transverse	I-problem
myelitis	I-problem
with	O
sequelae	O
of	O
paraplegia-exacerbation	B-problem
in	O
93	O
Recurrent	B-problem
bilateral	I-problem
optic	I-problem
neuritis	I-problem
with	O
legal	O

(	O
neurologist	O
:	O
Dr.	O
Heaton	O
,	O
UMass	O
Memorial	O
Medical	O
Center	O
)	O
-	O
(	O
steroids	B-treatment
increased	O
to	O
40	O
qd	O
in	O
Renee	O
for	O
concern	O
for	O
recurrent	B-problem
optic	I-problem
neuritis	I-problem
which	O
turned	O
out	O
to	O
be	O
capsular	B-problem
ossification	I-problem
)	O

##	O
blindness	B-problem
in	I-problem
right	I-problem
CMED	O
CSRU	O
.	O

##	O
Bilateral	B-problem
knee	I-problem
arthritis	I-problem

##	O
Suspected	O
glaucoma	B-problem
in	I-problem
left	I-problem
CMED	O
CSRU	O
,	O
turned	O
out	O
to	O
be	O
capsular	B-problem
ossification	I-problem
or	O
a	B-problem
secondary	I-problem
cataract	I-problem
,	O
corrected	O
w/	O
laser	B-treatment
surgery	I-treatment

2014-11-03	O
PAD-WORD	O

##	O
Urostomy	B-treatment
s/p	O
ileal	B-treatment
loop	I-treatment
conduit	I-treatment
in	O
2007	O
for	O
neurogenic	B-problem
bladder	I-problem
w/	O
persistent	B-problem
leak	I-problem

##	O
Steroid-induced	B-problem
hyperglycemia	I-problem

##	O
Hypothyroid	B-problem

##	O
Osteoporosis	B-problem

##	O
Hx	O
of	O
DVT	B-problem
in	I-problem
RLE	I-problem
'93	O
-	O
on	O
coumadin	B-treatment
for	O
a	O
couple	O
years	O
and	O
then	O
ASA	B-treatment
until	O
a	O
couple	O
months	O
ago	O

Social	O
History	O
:	O

Retired	O
ICU	O
nurse	O
.	O

Thomas	O
Haas	O
x	O
15	O
yrs	O
but	O
maintains	O
her	O
certification	O
.	O

Lives	O
at	O
Lowell	O
Home	O
NH	O
x	O
11	O
yrs	O
due	O
to	O
chronic	B-problem
CMED	I-problem
issues	I-problem
.	O

Her	O
doctor	O
there	O
is	O
Dr.	O
Gerald	O
Jones	O
.	O

No	O
h/o	O
tobacco	O
,	O
alcohol	O
,	O
or	O
IVDA	O
.	O

Wheelchair	B-problem
dependent	I-problem
+	O
requires	O
Hoyer	B-treatment
lift	I-treatment
.	O

UE	B-test
strength	I-test
intact	O
but	O
poor	B-problem
motor	I-problem
movements	I-problem
due	O
to	O
loss	B-problem
of	I-problem
sensation	I-problem
.	O

Family	O
History	O
:	O

Mother	O
died	O
at	O
51	O
metastatic	B-problem
BCA	I-problem

Father	O
died	O
at	O
36	O
aplastic	B-problem
anemia	I-problem
only	O
child	O

Physical	O
Exam	O
:	O

T	B-test
100.0	O
bp	B-test
109/56	O

CVP	B-test
11	O
hr	B-test
113	O
rr	B-test
16	O

O2	B-test
95%	O
on	O
3L	B-treatment
NC	I-treatment
mixed	O
Quinn	O
82%	O
genrl	O
:	O
in	O
nad	B-problem
,	O
resting	O
comfortably	O
heent	O
:	O
perrla	O
(	O
4->3	O
mm	O
)	O
bilaterally	O
,	O
blind	B-problem
in	I-problem
right	I-problem
visual	I-problem
field	I-problem
,	O
eomi	O
,	O
dry	B-problem
mm	I-problem
,	O
?	O
thrush	B-problem
neck	O
:	O
no	O
bruits	B-problem
cv	O
:	O
rrr	O
,	O
no	O
m/r/g	B-problem
,	O
faint	B-problem
s1/s2	I-problem
pulm	O
:	O
cta	O
bilaterally	O
abd	O
:	O
midline	B-problem
scar	I-problem
(	O
from	O
urostomy	B-treatment
)	O
,	O
nabs	O
,	O
soft	O
,	O
appears	O
distended	B-problem
but	O
patient	O
denies	O
,	O
ostomy	B-treatment
RLQ	O
c/d/i	O
,	O
NT	B-problem
to	O
palpation	B-test
back	O
:	O
right	B-treatment
flank	I-treatment
urostomy	I-treatment
tube	I-treatment
,	O
c/d/i	O
,	O
nt	B-problem
to	O
palpation	B-test
extr	O
:	O
no	O
Gardner	B-test
neuro	O
:	O
a	O
,	O
ox3	O
,	O
wiggles	O
toes	O
bilaterally	O
,	O
unable	B-problem
to	I-problem
lift	I-problem
LE	I-problem
,	O
06-12	O
grip	O
bilaterally	O
w/	O
UE	O
,	O
decrease	B-problem
sensation	I-problem
to	O
soft	O
touch	O
in	O
left	O

UE	O
and	O
LE	O

Pertinent	O
Results	O
:	O

2014-11-29	O
05:11PM	O

WBC	B-test
-	O
23.5*#	O
RBC	B-test
-	O
3.81*	O
HGB	B-test
-	O
9.4*	O
HCT	B-test
-	O
29.2*	O

MCV	B-test
-	O
77*#	O
MCH	B-test
-	O
24.6*#	O
MCHC	B-test
-	O
32.1	O
RDW	B-test
-	O
18.1*	O

2014-11-29	O
05:11PM	O

NEUTS	B-test
-	O
93*	O
BANDS	B-test
-	O
1	O
LYMPHS	B-test
-	O
0	O
MONOS	B-test
-	O
6	O
EOS	B-test
-	O
0	O

BASOS	B-test
-	O
0	O
ATYPS	B-test
-	O
0	O
METAS	B-test
-	O
0	O
MYELOS	B-test
-	O
0	O

2014-11-29	O
05:11PM	O

GLUCOSE	B-test
-	O
229*	O
UREA	B-test
N	O
-	O
25*	O
CREAT	B-test
-	O
0.8	O
SODIUM	B-test
-	O
136	O

POTASSIUM	B-test
-	O
5.3*	O
CHLORIDE	B-test
-	O
101	O
TOTAL	B-test
CO2	I-test
-	O
17*	O
ANION	B-test
GAP	I-test
-	O
23*	O

2014-11-29	O
05:11PM	O

LD	B-test
(	I-test
LDH	I-test
)	I-test
-	O
214	O

2014-11-29	O
06:41PM	O

LACTATE	B-test
-	O
1.4	O

2014-11-29	O
05:11PM	O
URINE	B-test

COLOR	B-test
-	O
Straw	O
APPEAR	B-test
-	O
Hazy	O
SP	O
Thibodeaux	B-test
-	O
1.008	O

2014-11-29	O
05:11PM	O
URINE	B-test

BLOOD	B-test
-	O
LG	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
TR	O

GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
9.0*	O

LEUK	B-test
-	O
SM	O

2014-11-29	O
05:11PM	O
URINE	B-test

RBC	B-test
-	O
21-50*	O
WBC	B-test
-	O
04-12	O
BACTERIA	B-test
-	O
MANY	O

YEAST	B-test
-	O
NONE	O
EPI	B-test
-	O
0-2	O

2014-11-29	O
05:11PM	O
URINE	B-test

3PHOSPHAT	B-test
-	O
OCC	O

2014-11-29	O
CT	B-test
CAP	I-test
:	O

1.	O
An	B-problem
8	I-problem
x	I-problem
7	I-problem
x	I-problem
7	I-problem
mm	I-problem
stone	I-problem
in	I-problem
the	I-problem
proximal	I-problem
right	I-problem
ureter	I-problem
with	O
associated	O
right	B-problem
hydronephrosis	I-problem
and	O
inflammatory	B-problem
perinephric	I-problem
stranding	I-problem
.	O

Additional	B-problem
smaller	I-problem
non-obstructing	I-problem
right	I-problem
renal	I-problem
stones	I-problem
.	O

2.	O
Left	B-problem
renal	I-problem
stones	I-problem
without	O
evidence	O
of	O
hydronephrosis	B-problem
.	O

Ileal	B-treatment
conduit	I-treatment
is	O
not	O
well	O
evaluated	O
.	O

3.	O
Right	B-problem
breast	I-problem
calcification	I-problem
.	O

Correlation	O
with	O
mammography	B-test
is	O
suggested	O
.	O

.	O
PAD-WORD	O

2014-11-29	O
CXR	B-test
:	O

No	O
evidence	O
of	O
pneumonia	B-problem
.	O

.	O
PAD-WORD	O

2014-11-29	O
CT	B-test
AP	I-test
#2	I-test
(	I-test
with	I-test
contrast	I-test
)	I-test
:	O

1.	O
Eight	B-problem
mm	I-problem
right	I-problem
proximal	I-problem
ureteral	I-problem
stone	I-problem
with	O
right-sided	B-problem
hydronephrosis	I-problem
and	O
inflammatory	B-problem
stranding	I-problem
.	O

Pyelonephritis	B-problem
of	I-problem
the	I-problem
left	I-problem
kidney	I-problem
without	O
left	B-problem
sided	I-problem
hydronephrosis	I-problem
.	O

2.	O
No	O
evidence	O
of	O
intraabdominal	B-problem
abscess	I-problem
or	O
of	O
diverticulitis	B-problem
.	O

3.	O
Bilateral	B-problem
round	I-problem
,	I-problem
hypodense	I-problem
renal	I-problem
lesions	I-problem
,	O
too	O
small	O
to	O
accurately	O
characterize	O
but	O
likely	O
representing	O
cysts	B-problem
.	O

4.	O
1.4	B-problem
cm	I-problem
hypodense	I-problem
lesion	I-problem
in	I-problem
right	I-problem
lobe	I-problem
of	I-problem
the	I-problem
liver	I-problem
is	O
incompletely	O
characterized	O
.	O

.	O
PAD-WORD	O

2014-11-30	O
CT	B-test
CAP	I-test
:	O

1.	O
Nephrostomy	B-treatment
tube	I-treatment
in	I-treatment
the	I-treatment
right	I-treatment
kidney	I-treatment
with	O
an	B-problem
8	I-problem
mm	I-problem
right	I-problem
ureteric	I-problem
stone	I-problem
.	O

2.	O
6	B-problem
mm	I-problem
nonobstructing	I-problem
calculus	I-problem
in	I-problem
the	I-problem
left	I-problem
kidney	I-problem
.	O

3.	O
Calcified	B-problem
focus	I-problem
and	O
a	B-problem
small	I-problem
hypodense	I-problem
lesion	I-problem
in	I-problem
the	I-problem
right	I-problem
lobe	I-problem
of	I-problem
the	I-problem
liver	I-problem
,	O
incompletely	O
characterized	O
.	O

4.	O
Bibasilar	B-problem
and	I-problem
dependent	I-problem
atelectasis	I-problem
.	O

.	O
PAD-WORD	O

2014-11-29	O
5:10	O
pm	O
BLOOD	B-test
CULTURE	I-test

2.	O
PAD-WORD	O

**FINAL	O
REPORT	O
2014-12-04**	O

AEROBIC	B-test
BOTTLE	I-test
(	O
Final	O
2014-12-04	O
)	O
:	O

KLEBSIELLA	B-problem
PNEUMONIAE	I-problem
.	O

IDENTIFICATION	B-test
AND	O
SENSITIVITIES	B-test
PERFORMED	O
FROM	O

ANAEROBIC	B-test
BOTTLE	I-test
.	O

OF	O
TWO	B-problem
COLONIAL	I-problem
MORPHOLOGIES	I-problem
.	O

ANAEROBIC	B-test
BOTTLE	I-test
(	O
Final	O
2014-12-04	O
)	O
:	O

REPORTED	O
BY	O
PHONE	O
TO	O
Robert	O
BURGER	O
2014-11-30	O
10:35A	O
.	O

KLEBSIELLA	B-problem
PNEUMONIAE	I-problem
.	O

FINAL	B-test
SENSITIVITIES	I-test
.	O

Trimethoprim/Sulfa	B-test
sensitivity	I-test
testing	I-test
available	O
on	O
request	O
.	O

KLEBSIELLA	B-problem
PNEUMONIAE	I-problem
.	O

FINAL	B-test
SENSITIVITIES	I-test
.	O

Trimethoprim/Sulfa	B-test
sensitivity	I-test
testing	I-test
available	O
on	O
request	O
.	O

2ND	O
STRAIN	O
.	O

SENSITIVITIES	B-test
:	O

MIC	B-test
expressed	O
in	O
MCG/ML	O

_________________________________________________________	O
PAD-WORD	O

KLEBSIELLA	B-problem
PNEUMONIAE	I-problem

|	O
PAD-WORD	O

KLEBSIELLA	B-problem
PNEUMONIAE	I-problem

|	O
PAD-WORD	O

|	O
PAD-WORD	O

AMPICILLIN/SULBACTAM--	B-treatment
PAD-WORD	O

=>32	O
R	O

=>32	O
R	O

CEFAZOLIN-------------	B-treatment
PAD-WORD	O

<=4	O
S	O

<=4	O
S	O

CEFEPIME--------------	B-treatment
PAD-WORD	O

<=1	O
S	O

<=1	O
S	O

CEFTAZIDIME-----------	B-treatment
PAD-WORD	O

<=1	O
S	O

<=1	O
S	O

CEFTRIAXONE-----------	B-treatment
PAD-WORD	O

<=1	O
S	O

<=1	O
S	O

CEFUROXIME------------	B-treatment
PAD-WORD	O

4	O
S	O

4	O
S	O

CIPROFLOXACIN---------	B-treatment
PAD-WORD	O

=>4	O
R	O

=>4	O
R	O

GENTAMICIN------------	B-treatment
PAD-WORD	O

8	O
I	O

8	O
I	O

IMIPENEM--------------	B-treatment
PAD-WORD	O

<=1	O
S	O

<=1	O
S	O

LEVOFLOXACIN----------	B-treatment
PAD-WORD	O

=>8	O
R	O

=>8	O
R	O

MEROPENEM-------------	B-treatment
PAD-WORD	O

<=0.25	O
S	O

<=0.25	O
S	O

PIPERACILLIN/TAZO-----	B-treatment
PAD-WORD	O

<=4	O
S	O

<=4	O
S	O

TOBRAMYCIN------------	B-treatment
PAD-WORD	O

4	O
S	O

8	O
I	O

.	O
PAD-WORD	O

2014-11-30	O
1:50	O
pm	O
URINE,KIDNEY	O

PERC.	O
NEPH.	O
.	O

**FINAL	O
REPORT	O
2014-12-03**	O

FLUID	B-test
CULTURE	I-test
(	O
Final	O
2014-12-03	O
)	O
:	O

Due	O
to	O
mixed	B-problem
bacterial	I-problem
types	I-problem
(	O
>=	O
3	B-problem
colony	I-problem
types	I-problem
)	O
an	B-test
abbreviated	I-test
workup	I-test
is	O
performed	O
appropriate	O
to	O
the	O
isolates	O
recovered	O
from	O
the	O
site	O
(	O
including	O
a	B-test
screen	I-test
for	O
Pseudomonas	B-problem
aeruginosa	I-problem
,	O
Staphylococcus	B-problem
aureus	I-problem
and	O
beta	B-problem
streptococcus	I-problem
)	O
.	O

STAPH	B-problem
AUREUS	I-problem
COAG	I-problem
+	I-problem
.	O

>100,000	O
ORGANISMS/ML.	B-test
.	O

OF	O
TWO	B-problem
COLONIAL	I-problem
MORPHOLOGIES	I-problem
.	O

Oxacillin	B-problem
RESISTANT	I-problem
Staphylococci	I-problem
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins	B-treatment
,	O
cephalosporins	B-treatment
,	O
carbacephems	B-treatment
,	O
carbapenems	B-treatment
,	O
and	O
beta-lactamase	B-treatment
inhibitor	I-treatment
combinations	I-treatment
.	O

Rifampin	B-treatment
should	O
not	O
be	O
used	O
alone	O
for	O
therapy	B-treatment
.	O

GRAM	O
NEGATIVE	O
ROD(	O
S	O
)	O
.	O

>100,000	O
ORGANISMS/ML.	B-test
.	O

OF	O
TWO	B-problem
COLONIAL	I-problem
MORPHOLOGIES	I-problem
.	O

SENSITIVITIES	B-test
:	O

MIC	B-test
expressed	O
in	O

MCG/ML	O
PAD-WORD	O

_________________________________________________________	O
PAD-WORD	O

STAPH	B-problem
AUREUS	I-problem
COAG	I-problem
+	O

|	O
PAD-WORD	O

GENTAMICIN------------	B-treatment
PAD-WORD	O

=>16	O
R	O

LEVOFLOXACIN----------	B-treatment
PAD-WORD	O

=>8	O
R	O

NITROFURANTOIN--------	B-treatment
PAD-WORD	O

<=16	O
S	O

OXACILLIN-------------	B-treatment
PAD-WORD	O

=>4	O
R	O

PENICILLIN------------	B-treatment
PAD-WORD	O

=>0.5	O
R	O

TETRACYCLINE----------	B-treatment
PAD-WORD	O

=>16	O
R	O

VANCOMYCIN------------	B-treatment
PAD-WORD	O

<=1	O
S	O

.	O
PAD-WORD	O

2014-12-03	O
BLOOD	B-test
CULTURE	I-test

AEROBIC	B-test
BOTTLE	I-test
-	O
PENDING	O
;	O
ANAEROBIC	B-test
BOTTLE	I-test
-	O
PENDING	O

2014-12-03	O
BLOOD	B-test
CULTURE	I-test

AEROBIC	B-test
BOTTLE	I-test
-	O
PENDING	O
;	O
ANAEROBIC	B-test
BOTTLE	I-test
-	O
PENDING	O

2014-12-02	O
URINE	B-test

URINE	B-test
CULTURE	I-test
-	O
FINAL	O
No	O
Growth	O

2014-12-02	O
CATHETER	B-treatment
TIP	I-treatment
-	I-treatment
IV	I-treatment

WOUND	B-test
CULTURE	I-test
-	O
FINAL	O
No	O
Growth	O

2014-12-02	O
BLOOD	B-test
CULTURE	I-test

AEROBIC	B-test
BOTTLE	I-test
-	O
PENDING	O
;	O
ANAEROBIC	B-test
BOTTLE	I-test
-	O
PENDING	O

Brief	O
Hospital	O
Course	O
:	O

47	O
yo	O
F	O
w/	O
h/o	O
steroid-induced	B-problem
hyperglycemia	I-problem
,	O
SLE	B-problem
w/	O
h/o	O
pericarditis	B-problem
,	O
transverse	B-problem
myelitis	I-problem
w/	O
paraplegia	B-problem
and	O
neurogenic	B-problem
bladder	I-problem
s/p	O
urostomy	B-treatment
w/	O
ileal	B-treatment
conduit	I-treatment
,	O
h/o	O
ureteropelvic	B-problem
stone	I-problem
and	O
urosepsis	B-problem
,	O
and	O
h/o	O
RLE	B-problem
DVT	I-problem
admitted	O
11-29	O
w/	O
left	B-problem
pyelo	I-problem
and	O
right	B-problem
8	I-problem
mm	I-problem
proximal	I-problem
ureteral	I-problem
stone	I-problem
w/	O
right	B-problem
hydro	I-problem
s/p	O
perc	B-treatment
urostomy	I-treatment
tube	I-treatment
to	O
relieve	O
right	B-problem
hydro	I-problem
.	O

.	O
PAD-WORD	O

##	O
GNR	B-problem
sepsis:	I-problem

Upon	O
admission	O
,	O
pt	O
was	O
febrile	B-problem
to	O
101.2	O
with	O
U/A	B-test
consistent	O
with	O
UTI	B-problem
.	O

A	B-test
CT	I-test
abd	I-test
showed	O
8mm	B-problem
obstructing	I-problem
stone	I-problem
,	O
hydro	B-problem
with	O
stranding	B-problem
consistent	O
with	O
pylonephritis	B-problem
.	O

Her	O
presentation	O
was	O
thought	O
likely	O
due	O
to	O
urosepsis	B-problem
given	O
h/o	O
foul	B-problem
smelling	I-problem
urine	I-problem
and	O
in	O
setting	O
of	O
stone	B-problem
w/	O
hydro	B-problem
+	O
pyelo	B-problem
by	O
CT.	B-test
The	O
patient	O
went	O
to	O
IR	O
on	O
2014-11-30	O
given	O
evidence	O
of	O
right	B-problem
hydronephrosis	I-problem
on	O
imaging	B-test
for	O
decompression	B-treatment
and	O
drainage.	B-treatment
Upon	O
admission	O
,	O
she	O
was	O
treated	O
with	O
Vancomycin	B-treatment
and	O
Gentamycin	B-treatment
and	O
Flagyl	B-treatment
.	O

She	O
was	O
started	O
on	O
the	B-treatment
MUST	I-treatment
protocol	I-treatment
with	O
high	B-treatment
dose	I-treatment
steroids	I-treatment
as	O
well	O
and	O
a	O
goal	O
SVO2	B-test
>70%	O
.	O

She	O
was	O
hypoxic	B-problem
requiring	O
3L	B-treatment
nasal	I-treatment
cannula	I-treatment
O2	I-treatment
.	O

She	O
subsequently	O
developed	O
hypotension	B-problem
with	O
SBP	B-test
in	O
the	O
70s	O
.	O

She	O
was	O
transferred	O
to	O
the	O
CMED	O
where	O
the	O
patient	O
was	O
continued	O
on	O
the	B-treatment
MUST	I-treatment
protocol	I-treatment
with	O
goais	O
of	O
CVP	B-test
10-12	O
,	O
SVO2	B-test
greater	O
than	O
70%	O
.	O

The	O
patient	O
was	O
bolused	O
with	O
NS	B-treatment
and	O
did	O
not	O
required	O
pressors	B-treatment
.	O

On	O
the	O
day	O
after	O
admission	O
to	O
the	O
CMED	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
small	B-problem
oxygen	I-problem
requirement	I-problem
with	O
2L	B-treatment
NC	I-treatment
.	O

Repeat	B-test
imaging	I-test
revealed	O
evidence	O
of	O
mild	B-problem
pulmonary	I-problem
congestion	I-problem
which	O
was	O
thought	O
to	O
account	O
for	O
the	B-problem
patient	I-problem
's	I-problem
mild	I-problem
hypoxia	I-problem
.	O

Given	O
that	O
the	O
patient	O
had	O
been	O
maintaining	O
a	B-test
MAP	I-test
of	O
60	O
without	O
fluids	B-treatment
or	O
pressors	B-treatment
,	O
her	O
goal	O
CVP	B-test
was	O
decreased	O
to	O
>8	O
to	O
avoid	O
fluid	B-problem
overload	I-problem
.	O

The	O
patient	O
was	O
continued	O
on	O
Vancomycin	B-treatment
and	O
Gentamycin	B-treatment
while	O
speciation	B-test
and	O
sensitivities	B-test
were	O
pending	O
.	O

Ciprofloxacin	B-treatment
was	O
added	O
on	O
2014-12-01	O
for	O
synergy	O
when	O
surveillance	B-test
cultures	I-test
were	O
found	O
to	O
be	O
growing	O
again	O
GNR	B-problem
.	O

Gent	B-treatment
and	O
Cipro	B-treatment
were	O
then	O
discontinued	O
and	O
changed	O
to	O
meropenem	B-treatment
when	O
blood	B-test
culture	I-test
sensitivities	I-test
became	O
available	O
revealing	O
GNR	B-problem
sensitive	O
to	O
Jacoby	B-treatment
but	O
resistant	O
to	O
both	O
Gent	B-treatment
and	O
Cipro	B-treatment
.	O

Additionaly	O
surveillance	B-test
cultures	I-test
were	O
drawn	O
daily	O
and	O
the	O
patient	O
was	O
transferred	O
back	O
to	O
the	O
floor	O
with	O
no	O
subsequent	B-problem
pressor	I-problem
requirement	I-problem
.	O

Blood	B-test
cltures	I-test
from	O
11-30	O
grew	O
KLEBSIELLA	B-problem
PNEUMONIAE	I-problem
and	O
12-01	O
grew	O
KLEBSIELLA	B-problem
PNEUMONIAE	I-problem
and	O
PROTEUS	B-problem
MIRABILIS	I-problem
both	O
sensitive	O
to	O
the	B-treatment
Meropenam	I-treatment
which	O
she	O
had	O
already	O
been	O
receiving	O
.	O

Urine	B-test
cultures	I-test
from	O
11-30	O
grew	O
STAPH	B-problem
AUREUS	I-problem
COAG	I-problem
+	O
,	O
and	O
GRAM	B-problem
NEGATIVE	I-problem
RODS	I-problem
of	O
two	O
morphologies	O
(	O
not	O
further	O
speciated	O
)	O
.	O

She	O
defervesed	O
by	O
12-02	O
and	O
remained	O
clinically	O
stable	O
with	O
normal	O
blood	O
pressures	O
until	O
the	O
day	O
of	O
discharge	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
blood	B-test
cultures	I-test
from	O
12-02	O
and	O
12-03	O
have	O
no	O
growth	B-problem
to	O
date	O
.	O

She	O
received	O
a	B-treatment
midline	I-treatment
on	O
12-04	O
with	O
a	O
goal	O
of	O
16	O
days	O
of	O
further	B-treatment
antibiotic	I-treatment
treatment	I-treatment
with	O
Meropenam	B-treatment
(	O
for	O
a	O
total	O
of	O
3	O
weeks	O
)	O
upon	O
discharge	O
back	O
to	O
the	O
nursing	O
home	O
where	O
she	O
lives	O
.	O

.	O
PAD-WORD	O

##	O
Right	B-problem
hydronephrosis	I-problem
:	O

Given	O
right	B-problem
sided	I-problem
hydronephrosis	I-problem
and	O
GNR	B-problem
bactermeia	I-problem
,	O
a	B-treatment
percutaneous	I-treatment
nephrostomy	I-treatment
tube	I-treatment
was	O
placed	O
by	O
IR	O
2014-11-30	O
.	O

The	O
patient	O
put	O
out	O
1385	O
cc	O
urine	O
the	O
day	O
after	O
placement	O
,	O
950	O
cc	O
of	O
which	O
came	O
from	O
nephrostomy	B-treatment
tube	I-treatment
.	O

The	B-treatment
tube	I-treatment
appeared	O
to	O
be	O
functioning	O
well	O
,	O
draining	O
urine	O
with	O
occasional	B-problem
clot	I-problem
passage	I-problem
.	O

Urology	O
was	O
notified	O
about	O
the	B-problem
clots	I-problem
and	O
occasional	B-problem
blood	I-problem
tinged	I-problem
urine	I-problem
but	O
they	O
did	O
not	O
make	O
any	O
further	O
recommendations	O
.	O

Cultures	B-test
from	I-test
urine	I-test
drawn	O
from	O
the	B-treatment
nephrostomy	I-treatment
tube	I-treatment
are	O
currently	O
growing	O
>	O
100K	O
GNR	B-problem
,	O
possibly	O
of	O
two	B-problem
colony	I-problem
morphologies	I-problem
,	O
speciation	B-test
and	O
sensitivity	B-test
pending	O
.	O

.	O
PAD-WORD	O

##	O
Hct	B-problem
drop	I-problem
:	O

On	O
admission	O
to	O
hospital	O
patient	O
had	O
Hct	B-test
of	O
29.2	O
.	O

In	O
the	O
setting	O
of	O
Right	B-treatment
sublavian	I-treatment
line	I-treatment
placement	I-treatment
as	O
well	O
as	O
nephrostomy	B-treatment
tube	I-treatment
placement	I-treatment
the	O
patient	O
was	O
noted	O
to	O
have	O
a	B-problem
drifting	I-problem
Hct	I-problem
,	O
concerning	O
for	O
bleed	B-problem
,	O
with	O
nadir	B-test
of	O
22.8	O
on	O
2014-12-01	O
.	O

A	B-test
CT	I-test
abdomen	I-test
was	O
performed	O
which	O
did	O
not	O
demonstrate	O
any	B-problem
retroperitoneal	I-problem
bleed	I-problem
.	O

Hct	B-test
stabilized	O
to	O
24	O
for	O
three	O
days	O
prior	O
to	O
discharge	O
.	O

This	O
can	O
be	O
followed	O
as	O
an	O
outpatient	O
.	O

Anemia	B-test
workup	I-test
revealed	O
a	O
picture	O
of	O
anemia	B-problem
of	I-problem
chronic	I-problem
disease	I-problem
(	O
TIBC	B-test
225	O
,	O
B12	B-test
and	O
Folate	B-test
normal	O
,	O
Hapto	B-test
397	O
,	O
Ferritin	B-test
51	O
,	O
TRF	B-test
173	O
,	O
Iron	B-test
35	O
)	O
.	O

.	O
PAD-WORD	O

##	O
Hypoxia:	B-problem

The	O
patient	O
on	O
admission	O
was	O
requiring	O
3	B-treatment
L	I-treatment
NC	I-treatment
in	O
the	O
setting	O
of	O
receiving	O
2L	B-treatment
NS	I-treatment
and	O
chest	B-test
film	I-test
which	O
demonstrated	O
pulmonary	B-problem
congestion	I-problem
.	O

The	O
patient	O
was	O
not	O
diuresed	O
but	O
allowed	O
to	O
auto-diurese	O
any	O
additional	O
fluids	O
and	O
is	O
currently	O
with	O
O2	B-test
sats	I-test
97-98%	O
on	O
room	O
air	O
.	O

As	O
her	B-test
BP	I-test
remained	O
stable	O
she	O
did	O
not	O
receiving	O
any	B-treatment
standing	I-treatment
fluids	I-treatment
but	O
was	O
be	O
bolused	B-treatment
as	O
appropriate	O
for	O
a	B-test
MAP	I-test
<	O
60	O
or	O
CVP	B-test
<	O
8	O
with	O
careful	O
monitoring	O
of	O
pulmonary	O
status	O
.	O

Patient	O
had	O
an	B-test
echocardiogram	I-test
in	O
2012	O
which	O
demonstrated	O
an	B-test
EF	I-test
of	O
60-65%	O
.	O

her	B-problem
O2	I-problem
requirement	I-problem
by	O
discharge	O
was	O
96%	O
on	O
room	O
air	O
with	O
no	O
SOB	B-problem
.	O

.	O
PAD-WORD	O

##	O
Steroid-induced	B-problem
hyperglycemia	I-problem
:	O

At	O
home	O
,	O
the	O
patient	O
received	O
metformin	B-treatment
and	O
SSI	B-treatment
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
metformin	I-treatment
was	O
held	O
and	O
she	O
has	O
been	O
maintained	O
on	O
SSI	B-treatment
qid	O
while	O
in	O
the	O
CMED	O
.	O

As	O
the	O
patient	O
appeared	O
to	O
be	O
clinically	O
stable	O
,	O
her	B-treatment
stress	I-treatment
dose	I-treatment
steroids	I-treatment
were	O
discontinued	O
and	O
the	O
patient	O
was	O
changed	O
back	O
to	O
her	O
home	O
dose	O
of	O
Prednisone	B-treatment
40mg	O
PO	O
qd	O
for	O
maintenance	O
with	O
anticipated	O
decrease	O
in	O
her	B-test
blood	I-test
sugars	I-test
.	O

Her	B-treatment
Metformin	I-treatment
was	O
re-added	O
2	O
days	O
prior	O
to	O
discharge	O
as	O
well	O
and	O
fingerstick	B-test
glucoses	I-test
on	O
the	O
day	O
of	O
discharge	O
were	O
93	O
and	O
156	O
,	O
respectively	O
.	O

.	O
PAD-WORD	O

##	O
Hypothyroidism	B-problem
:	O

Repeat	B-test
TSH	I-test
and	O
Free	B-test
T4	I-test
were	O
appropriate	O
on	O
current	B-treatment
outpatient	I-treatment
regimen.	I-treatment
Patient	O
was	O
continued	O
on	O
Levothyroxine	B-treatment
75mcg	O
po	O
qd	O
.	O

.	O
PAD-WORD	O

##	O
H/o	O
transverse	B-problem
myelitis/optic	I-problem
neuritis	I-problem
:	O

On	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
originally	O
given	O
MUST	B-treatment
protocol	I-treatment
and	O
sepsis	B-problem
,	O
as	O
patient	O
clinically	O
stabilized	O
,	O
she	O
was	O
changed	O
back	O
to	O
home	O
dose	O
of	O
Prednisone	B-treatment
40mg	O
pO	O
qd	O
.	O

.	O
PAD-WORD	O

##	O
SLE	B-problem
:	O

Currently	O
no	O
sx	B-problem
of	I-problem
active	I-problem
disease	I-problem
.	O

No	O
manifestations	O
of	O
SLE	B-problem
during	O
this	O
admission	O
.	O

.	O
PAD-WORD	O

#	O
Osteoporosis	B-problem
-	O
We	O
continued	O
actonel/vit	B-treatment
D	I-treatment
,	O
Tums	B-treatment

.	O
PAD-WORD	O

##	O
Capsular	B-problem
ossification	I-problem
:	O

We	O
continued	O
CMED	B-treatment
CSRU	I-treatment
gtt	I-treatment
.	O

.	O
PAD-WORD	O

##	O
FEN:	O

She	O
had	O
a	B-problem
low	I-problem
bicarb	I-problem
likely	O
due	O
to	O
renal	B-problem
wasting	I-problem
but	O
there	O
is	O
an	B-problem
anion	I-problem
gap	I-problem
present	O
.	O

Serum	B-test
acetone	I-test
was	O
normal	O
.	O

We	O
followed	O
lactate	B-test
while	O
she	O
was	O
in	O
the	O
CMED	O
which	O
was	O
normal	O
.	O

She	O
was	O
NPO	B-treatment
periodically	O
but	O
maintained	O
a	O
normal	O
diet	O
prior	O
to	O
discharge	O
.	O

.	O
PAD-WORD	O

#	O
PPX	O
-	O
SQ	B-treatment
Heparin	I-treatment
during	O
this	O
admission	O
,	O
PPI	B-treatment

.	O
PAD-WORD	O

##	O
Communication	O
:	O
patient	O

.	O
PAD-WORD	O

##	O
Dispo	O
:	O

To	O
nursing	O
home	O
for	O
follow	O
up	O
with	O
Dr.	O
Hipp	O
(	O
urology	O
)	O
this	O
coming	O
Monday	O
,	O
12-08	O
at	O
1:30pm	O
and	O
with	O
her	O
PCP	O
at	O
the	O
nursing	O
home	O

Medications	O
on	O
Admission	O
:	O

Home	B-treatment
Meds	I-treatment
:	O

Ascorbic	B-treatment
Acid	I-treatment
500	O
TID	O

Cranberry	B-treatment
Extract	I-treatment
425	O
BID	O

Bisacodyl	B-treatment
10mg	O

Senna	B-treatment
PAD-WORD	O

Dephenhydramine	B-treatment
50mg	O
prn	O
loperamide	B-treatment
prn	O
famotidine	B-treatment
20mg	O

KCL	B-treatment
20mg	O
QD	O

Metformin	B-treatment
1000	O
qd	O
tums	B-treatment
1500	O
bid	O

MVI	B-treatment
PAD-WORD	O

Timolol	B-treatment
1	O
Drop	O
BID	O
0.5%	O
L	O
CMED	O
CSRU	O

Synthroid	B-treatment
75	O
QD	O

Compro	B-treatment
25mg	O
pr	O

Citrucel	B-treatment
PAD-WORD	O

Vitamin	B-treatment
D	I-treatment
50k	O
Qmondays	O

Oxazepam	B-treatment
15mg	O
qhs	O
tizamidine	B-treatment
8mg	O
qhs	O
actonel	B-treatment
35	O
qwed	O

Diovan	B-treatment
80	O
qd	O
prednisone	B-treatment
40	O
qd	O
bactrim	B-treatment
ds	I-treatment
qmwf	O
baclofen	B-treatment
pump	I-treatment
2-3yrs	O

Insulin	B-treatment
SS	I-treatment

.	O
PAD-WORD	O

Meds	O
on	O
transfer	O
:	O

Actonel	B-treatment
35	O
mg	O
Oral	O
qwednesdays	O

Ascorbic	B-treatment
Acid	I-treatment
500	O
mg	O
PO	O
TID	O

Sodium	B-treatment
Polystyrene	I-treatment
Sulfonate	I-treatment
15	O
gm	O
PO	O
ONCE	O
11-29	O
@	O
2201	O

Famotidine	B-treatment
20	O
mg	O
PO	O
DAILY	O

Sulfameth/Trimethoprim	B-treatment
DS	O
1	O
TAB	O
PO	O
QMOWEFR	O

Gentamicin	B-treatment
80	O
mg	O
IV	O
Q8H	O

Timolol	B-treatment
Maleate	I-treatment
0.5%	O
1	O
DROP	O
OS	O
BID	O

Heparin	B-treatment
5000	O
UNIT	O
SC	O
TID	O

Tizanidine	B-treatment
HCl	I-treatment
8	O
mg	O
PO	O
QHS	O

Hydrocortisone	B-treatment
Na	I-treatment
Succ.	I-treatment
100	O
mg	O
IV	O
Q8H	O

11-30	O
@	O
0906	O

Valsartan	B-treatment
80	O
mg	O
PO	O
DAILY	O

Insulin	B-treatment
SC	I-treatment
(	O
per	O
Insulin	O
Flowsheet	O
)	O

Vancomycin	B-treatment
HCl	I-treatment
1000	O
mg	O
IV	O
Q	O
12H	O

Levothyroxine	B-treatment
Sodium	I-treatment
75	O
mcg	O
PO	O
DAILY	O

Vitamin	B-treatment
D	I-treatment
50,000	O
UNIT	O
PO	O
QWEDNESDAYS	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

GNR	B-problem
Sepsis	I-problem
;	O
Steroid	B-problem
induced	I-problem
hyperglycemia	I-problem
;	O
Hydronephrosis	B-problem
;	O
SLE	B-problem

Discharge	O
Condition	O
:	O

Stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Pls	O
take	O
all	B-treatment
meds	I-treatment
as	O
prescribed	O
.	O

Call	O
your	O
doctor	O
immediately	O
if	O
any	B-problem
new	I-problem
symptoms	I-problem
develop	O
including	O
fevers	B-problem
,	O
rash	B-problem
,	O
increase	B-problem
in	I-problem
bloody	I-problem
urine	I-problem
in	O
nephrostomy	B-treatment
or	O
urostomy	B-treatment
bags	I-treatment
,	O
etc	O
.	O

Follow	O
up	O
appointments	O
listed	O
below	O
.	O

Followup	O
Instructions	O
:	O

With	O
Dr.	O
Vivian	O
Hansen	O
,	O
UMass	O
Memorial	O
Medical	O
Center	O
,	O
3rd	O
floor	O
Morris	O
on	O
Monday	O
12-08	O
at	O
@	O
1:30pm	O
(	O
you	O
also	O
have	O
an	O
appointment	O
scheduled	O
with	O
Dr.	O
Hipp	O
for	O
01-14	O
)	O
.	O

.	O
PAD-WORD	O

Provider	O
:	O

Sheena	O
PAD-WORD	O

Phone	O
:	O

361-438-6334	O
PAD-WORD	O

Date/Time	O
:	O
2015-01-07	O
8:30	O

Colleen	O
Thomas	O
MD	O
80-548	O

Completed	O
by	O
:	O

Edward	O
James	O
MD	O
50-497	O
2014-12-05	O
@	O
1042	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Ronald	O
Z.	O
Thome	O
on	O
:	O

Robert	O
2015-01-15	O
5:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

125721767	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

34028893	O
PAD-WORD	O

597337	O
PAD-WORD	O

3/31/2001	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

03/31/2001	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

MYASTHENIA	B-problem
GRAVIS	I-problem
.	O

SECONDARY	O
DIAGNOSES	O
:	O

1.	O
HYPOTHYROIDISM	B-problem
.	O

2.	O
HISTORY	O
OF	O
THYMOMA	B-problem
,	O
STATUS	O
POST	O
RESECTION	B-treatment
.	O

3.	O
HYPERTENSION	B-problem
.	O

4.	O
HISTORY	O
OF	O
COLON	B-problem
CANCER	I-problem
,	O
STATUS	O
POST	O
RESECTION	B-treatment
.	O

5.	O
BENIGN	B-problem
PROSTATIC	I-problem
HYPERTROPHY	I-problem
.	O

6.	O
HYDROCELE	B-problem
.	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

ECHOCARDIOGRAM	B-test
,	O
CARDIAC	B-test
CATHETERIZATION	I-test
,	O
EMG	B-test
,	O
CT	B-test
SCAN	I-test
OF	I-test
THE	I-test
CHEST	I-test
.	O

MEDICATIONS	O
:	O

Aspirin	B-treatment
325	O
q.d.	O
;	O
albuterol	B-treatment
nebs	I-treatment
2.5	O
mg	O
q.	O
4h	O
;	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O
;	O
heparin	B-treatment
5,000	O
units	O
subcu	O
b.i.d.	O
;	O
Synthroid	B-treatment
200	O
mcg	O
q.d.	O
;	O
Ocean	B-treatment
Spray	I-treatment
2	O
sprays	O
q.	O
i.d.	O
;	O
simvastatin	B-treatment
10	O
mg	O
q.	O
h.s.	O
;	O
Flovent	B-treatment
220	O
mcg	O
2	O
puffs	O
b.i.d.	O
;	O
Zantac	B-treatment
150	O
b.i.d.	O
;	O
nystatin	B-treatment
ointment	I-treatment
to	O
the	O
gluteal	O
fold	O
b.i.d.	O
;	O
Lisinopril	B-treatment
20	O
mg	O
q.d.	O
;	O
Mestinon	B-treatment
controlled	I-treatment
release	I-treatment
180	O
q.	O
h.s.	O
;	O
Mestinon	B-treatment
30	O
mg	O
q.	O
4h	O
while	O
awake	O
;	O
prednisone	B-treatment
60	O
mg	O
p.o.	O
q.	O
IM	O
;	O
Atrovent	B-treatment
nebs	I-treatment
0.5	O
mg	O
q.	O
i.d.	O

DIET	O
:	O

No	O
restrictions	O
.	O

ACTIVITY	O
:	O

As	O
tolerated	O
.	O

HOSPITAL	O
COURSE	O
:	O

This	O
is	O
a	O
72-year-old	O
male	O
with	O
a	O
history	O
of	O
thymoma	B-problem
resected	O
in	O
1996	O
,	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
hypothyroidism	B-problem
who	O
was	O
transferred	O
from	O
Gobay	O
Hos	O
Memorial	O
Hospital	O
for	O
an	B-problem
myocardial	I-problem
infarction	I-problem
and	O
cardiac	B-test
catheterization	I-test
.	O

The	O
patient	O
developed	O
shortness	B-problem
of	I-problem
breath	I-problem
at	O
home	O
and	O
the	O
EMTs	O
were	O
called	O
and	O
the	O
patient	O
was	O
found	O
to	O
be	O
in	O
respiratory	B-problem
distress	I-problem
.	O

He	O
was	O
transferred	O
to	O
Gobay	O
Hos	O
Memorial	O
Hospital	O
where	O
chest	B-test
x-ray	I-test
showed	O
left	B-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
and	O
cardiac	B-test
enzymes	I-test
were	O
elevated	B-problem
with	O
a	B-test
CK	I-test
of	O
297	O
,	O
MB	B-test
fraction	I-test
of	O
38	O
and	O
troponin	B-test
of	O
12	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
medicine	O
service	O
at	O
the	O
Retelk	O
County	O
Medical	O
Center	O
and	O
underwent	O
cardiac	B-test
catheterization	I-test
which	O
was	O
negative	O
for	O
disease	B-problem
.	O

He	O
continued	O
to	O
complain	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
with	O
an	O
episode	O
of	O
respiratory	B-problem
failure	I-problem
in	O
the	O
hospital	O
requiring	O
100%	B-treatment
nonrebreather	I-treatment
.	O

Neurology	O
was	O
consulted	O
for	O
difficulty	B-problem
lifting	I-problem
his	I-problem
arms	I-problem
.	O

On	O
consultation	O
the	O
patient	O
admitted	O
to	O
dysphasia	B-problem
and	O
periods	O
of	O
diplopia	B-problem
in	O
the	O
past	O
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
weakness	B-problem
in	I-problem
the	I-problem
proximal	I-problem
muscles	I-problem
as	O
well	O
as	O
the	O
capability	O
of	O
the	O
muscles	O
.	O

He	O
was	O
started	O
on	O
IV	B-treatment
ig	I-treatment
and	O
IV	B-treatment
Solu-Medrol	I-treatment
for	O
a	O
diagnosis	O
of	O
myasthenia	B-problem
gravis	I-problem
given	O
his	O
past	O
history	O
of	O
thymoma	B-problem
.	O

He	O
markedly	O
improved	O
after	O
a	O
dose	O
of	O
Mestinon	B-treatment
.	O

He	O
completed	O
a	O
five-day	O
course	O
of	O
IV	B-treatment
ig	I-treatment
.	O

His	B-test
work	I-test
up	I-test
included	O
acetylcholine	B-test
esterase	I-test
,	O
receptor	B-test
antibodies	I-test
,	O
thyroglobulin	B-test
antibody	I-test
is	O
pending	O
.	O

An	B-test
ANA	I-test
and	O
rheumatoid	B-test
factor	I-test
were	O
negative	O
.	O

Sed	B-test
rate	I-test
was	O
58	O
and	O
repeat	O
75	O
.	O

EMG	B-test
studies	I-test
were	O
performed	O
,	O
the	O
result	O
is	O
pending	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

He	O
also	O
had	O
a	B-test
repeat	I-test
chest	I-test
CT	I-test
which	O
showed	O
a	O
question	O
of	O
recurrence	O
of	O
the	B-problem
thymoma	I-problem
.	O

Thoracic	O
Surgery	O
was	O
consulted	O
and	O
recommended	O
repeating	O
the	B-test
CT	I-test
scan	I-test
in	O
six	O
weeks	O
as	O
an	O
outpatient	O
.	O

This	O
could	O
represent	O
either	O
recurrence	O
of	O
scar	B-problem
tissue	I-problem
.	O

The	O
patient	O
was	O
tapered	O
to	O
p.o.	B-treatment
prednisone	I-treatment
and	O
tolerated	O
Mestinon	B-treatment
30	O
mg	O
q.	O
4h	O
with	O
180	O
mg	O
longacting	O
at	O
bedtime	O
.	O

Dictated	O
By	O
:	O

THYRNCINDE	O
BOTH	O
,	O
M.D.	O
VZ84	O

Attending	O
:	O

LENNI	O
E.	O
STENT	O
,	O
M.D.	O
UQ5	O
MX420/8849	O

Batch	O
:	O

85467	O
PAD-WORD	O

Index	O
No.	O
EJDFG7458J	O

D	O
:	O

04/07/01	O
PAD-WORD	O

T	O
:	O

04/10/01	O
PAD-WORD	O

Admission	O
Date	O
:	O

2010-09-06	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-09-17	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1968-04-26	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

ADDENDUM	O
:	O

The	O
patient	O
was	O
extubated	O
overnight	O
without	O
incident	B-problem
.	O

He	O
had	O
a	O
good	O
cardiac	O
index	O
off	O
all	B-treatment
inotropic	I-treatment
medications	I-treatment
and	O
his	B-treatment
Swan-Ganz	I-treatment
catheter	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
underwent	O
an	B-treatment
exchange	I-treatment
peritoneal	I-treatment
dialysis	I-treatment
.	O

The	O
Parrack	O
Diabetes	O
Center	O
was	O
consulted	O
to	O
help	O
manage	O
the	B-problem
patient	I-problem
's	I-problem
hyperglycemia	I-problem
.	O

By	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
had	O
remained	O
in	O
sinus	O
rhythm	O
and	O
his	B-treatment
Lopressor	I-treatment
was	O
increased	O
.	O

He	O
was	O
having	O
a	O
bit	O
of	O
a	B-problem
respiratory	I-problem
acidosis	I-problem
,	O
therefore	O
,	O
bicarbonate	B-treatment
was	O
added	O
to	O
the	B-treatment
dialysate	I-treatment
.	O

His	B-treatment
mediastinal	I-treatment
chest	I-treatment
tubes	I-treatment
were	O
removed	O
,	O
however	O
,	O
his	B-treatment
pleural	I-treatment
chest	I-treatment
tubes	I-treatment
remained	O
in	O
place	O
.	O

On	O
postoperative	O
day	O
three	O
,	O
it	O
was	O
apparent	O
that	O
,	O
despite	O
an	B-test
oxygen	I-test
saturation	I-test
of	O
99%	O
on	O
three	O
liters	O
,	O
that	O
the	O
patient	O
was	O
still	O
in	O
a	B-problem
respiratory	I-problem
acidosis	I-problem
,	O
and	O
he	O
received	O
aggressive	B-treatment
pulmonary	I-treatment
toilette	I-treatment
.	O

His	B-treatment
pleural	I-treatment
chest	I-treatment
tubes	I-treatment
were	O
removed	O
.	O

On	O
postoperative	O
day	O
four	O
,	O
the	B-treatment
patient	I-treatment
Cordis	I-treatment
was	O
removed	O
.	O

His	B-treatment
Lopressor	I-treatment
was	O
increased	O
another	O
increment	O
.	O

The	O
patient	O
was	O
subsequently	O
transferred	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
five	O
in	O
stable	O
and	O
good	O
condition	O
.	O

Once	O
on	O
the	O
floor	O
,	O
the	O
patient	O
had	O
an	O
uneventful	O
hospital	O
course	O
,	O
remaining	O
afebrile	B-problem
for	O
the	O
remainder	O
of	O
his	O
hospital	O
stay	O
.	O

The	O
patient	O
's	O
only	O
issue	O
was	O
his	B-problem
hypertension	I-problem
.	O

On	O
postoperative	O
day	O
seven	O
,	O
the	O
patient	O
had	O
a	B-test
peak	I-test
blood	I-test
pressure	I-test
of	O
210/100	O
.	O

The	O
decision	O
was	O
made	O
to	O
start	O
the	O
patient	O
on	O
lisinopril	B-treatment
,	O
and	O
the	O
initial	O
dose	O
of	O
7.5	O
mg	O
was	O
increased	O
to	O
10	O
mg	O
daily	O
by	O
the	O
day	O
of	O
discharge	O
in	O
order	O
to	O
control	O
his	B-test
pressure	I-test
more	O
tightly	O
.	O

On	O
postoperative	O
day	O
seven	O
,	O
the	O
patient	O
was	O
refusing	O
to	O
be	O
discharged	O
to	O
a	O
rehabilitation	O
facility	O
despite	O
his	O
doctor	O
's	O
insistence	O
that	O
he	O
would	O
do	O
much	O
better	O
in	O
an	O
assisted	O
environment	O
.	O

Nevertheless	O
,	O
the	O
patient	O
was	O
adamant	O
about	O
going	O
home	O
.	O

The	O
patient	O
was	O
discharged	O
on	O
postoperative	O
day	O
seven	O
and	O
arrangements	O
were	O
made	O
to	O
have	O
physical	O
therapy	O
perform	O
a	B-test
home	I-test
safety	I-test
evaluation	I-test
for	O
the	O
patient	O
,	O
to	O
which	O
he	O
agreed	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
times	O
three	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Lopressor	B-treatment
100	O
mg	O
p.o.b.i.d.	O

Lisinopril	B-treatment
10	O
mg	O
p.o.q.d.	O

Lipitor	B-treatment
10	O
mg	O
p.o.q.d.	O

Aspirin	B-treatment
81	O
mg	O
p.o.q.d.	O

Percocet	B-treatment
one	O
to	O
two	O
tablets	O
p.o.q.	O
3-4	O
h.	O
p.r.n.	O
pain	B-problem
.	O

Colace	B-treatment
100	O
mg	O
p.o.b.i.d.	O

DISCHARGE	O
PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
had	O
a	B-test
temperature	I-test
of	O
98.4	O
,	O
heart	B-test
rate	I-test
72	O
,	O
blood	B-test
pressure	I-test
154/89	O
,	O
respiratory	B-test
rate	I-test
18	O
and	O
oxygen	B-test
saturation	I-test
90%	O
in	O
room	O
air	O
.	O

He	O
was	O
alert	O
and	O
oriented	O
.	O

His	O
neck	O
was	O
supple	O
without	O
lymphadenopathy	B-problem
.	O

He	O
had	O
faint	B-problem
bibasilar	I-problem
crackles	I-problem
on	O
lung	B-test
examination	I-test
.	O

His	O
heart	O
had	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
.	O

His	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
and	O
nondistended	B-problem
with	O
a	B-problem
nonerythematous	I-problem
peritoneal	I-problem
dialysis	I-problem
insertion	I-problem
site	I-problem
.	O

Extremities	O
were	O
warm	O
and	O
well	O
perfused	O
.	O

DR	O
.	O
Kemp	O
,	O
Julie	O
R.	O
02-358	O

Dictated	O
By	O
:	O
Judy	O
Y	O
Carnevale	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2010-09-18	O
19:42	O

T	O
:	O
2010-09-22	O
11:10	O

JOB	O
#	O
:	O
34822	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dalila	O
Talbot	O
on	O
:	O
Robert	O
2010-09-23	O
4:07	O
PM	O

(	O
End	O
of	O
Report	O
)	O

126304158	O
PAD-WORD	O

PRGH	O
PAD-WORD	O

30872450	O
PAD-WORD	O

619542	O
PAD-WORD	O

2/10/1998	O
12:00:00	O
AM	O

CORONARY	B-problem
ARTERY	I-problem
DISEASE	I-problem

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/10/1998	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

Discharge	O
Date	O
:	O

02/26/1998	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
69	O
year-old	O
white	O
gentleman	O
who	O
is	O
status	O
post	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
in	O
1985	O
with	O
a	B-problem
large	I-problem
anterior	I-problem
septal	I-problem
myocardial	I-problem
infarction	I-problem
intraoperatively	O
.	O

Two	O
years	O
after	O
this	B-treatment
operation	I-treatment
,	O
he	O
required	O
a	B-treatment
pacer	I-treatment
implantation	I-treatment
for	O
sick	B-problem
sinus	I-problem
syndrome	I-problem
.	O

The	O
patient	O
presents	O
now	O
with	O
progressive	B-problem
dyspnea	I-problem
,	O
but	O
no	O
anginal	B-problem
pain	I-problem
.	O

Ejection	B-test
fraction	I-test
was	O
noted	O
to	O
be	O
20%	O
.	O

He	O
is	O
status	O
post	O
multiple	B-treatment
angioplasty	I-treatment
stents	I-treatment
.	O

He	O
presents	O
now	O
for	O
possible	O
reoperative	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1	O
)	O
Non-insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

2	O
)	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
,	O
status	O
post	O
anterior	B-problem
myocardial	I-problem
infarction	I-problem
,	O
sick	B-problem
sinus	I-problem
syndrome	I-problem
,	O
status	O
post	O
a	B-treatment
VVI	I-treatment
pacer	I-treatment
placement	I-treatment
.	O

Cardiac	B-test
catheterization	I-test
demonstrates	O
severe	B-problem
triple	I-problem
vessel	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
,	O
RCA	B-problem
100%	I-problem
occluded	I-problem
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	O
OM1	B-treatment
graft	I-treatment
was	O
100%	B-problem
occluded	I-problem
and	O
a	O
patent	O
LIMA	O
,	O
but	O
severely	B-problem
diseased	I-problem
LAD	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1	O
)	O
Enteric	B-treatment
coated	I-treatment
aspirin	I-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

2	O
)	O
Capoten	B-treatment
25	O
mg	O
p.o.	O
t.i.d.	O

3	O
)	O
Lanoxin	B-treatment
0.25	O
mg	O
p.o.	O
q.	O
day	O
.	O

4	O
)	O
Cardizem	B-treatment
125	O
mg	O
p.o.	O
q.	O
day	O
.	O

5	O
)	O
Glucotrol	B-treatment
XL	I-treatment
10	O
mg	O
p.o.	O
b.i.d.	O

6	O
)	O
Glucophage	B-treatment
500	O
mg	O
p.o.	O
q.	O
day	O
.	O

7	O
)	O
Amaryl	B-treatment
2	O
mg	O
p.o.	O
q.h.s.	O

PHYSICAL	O
EXAMINATION	O
:	O

Physical	B-test
examination	I-test
revealed	O
that	O
the	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
was	O
irregular	B-problem
with	O
no	O
murmurs	B-problem
palpated	O
.	O

Abdomen	O
was	O
benign	O
.	O

Pulses	B-test
were	O
2+	O
throughout	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Verg	O
Medical	O
Center	O
.	O

Subsequent	B-test
exercise	I-test
treadmill	I-test
test	I-test
demonstrated	O
no	O
evidence	O
of	O
ischemia	B-problem
by	O
EKG	B-test
.	O

The	O
patient	O
was	O
subsequently	O
taken	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	B-treatment
reoperative	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	I-treatment
three	I-treatment
with	O
a	B-treatment
subaortic	I-treatment
proximal	I-treatment
graft	I-treatment
from	O
the	O
aorta	O
to	O
the	O
OM1	O
and	O
then	O
OM2	O
and	O
aorta	O
to	O
the	O
LAD	O
with	O
a	B-treatment
wide	I-treatment
graft	I-treatment
per	O
Dr.	O
Lumar	O
Jongguild	O
.	O

Postoperatively	O
,	O
the	O
patient	O
was	O
ventilated	O
.	O

The	O
patient	O
was	O
weaned	O
off	O
an	B-treatment
Epinephrine	I-treatment
drip	I-treatment
.	O

Rhythm	B-test
became	O
more	O
stable	O
.	O

Balloon	B-treatment
was	O
weaned	O
and	O
finally	O
discontinued	O
.	O

The	O
patient	O
was	O
extubated	O
.	O

His	B-treatment
Melranon	I-treatment
was	O
weaned	O
off	O
and	O
his	B-treatment
ACE	I-treatment
inhibitor	I-treatment
began	O
.	O

The	O
patient	O
was	O
started	O
on	O
Amiodarone	B-treatment
and	O
diuresed	O
.	O

The	O
patient	O
&apos;s	O
lower	O
extremities	O
began	O
to	O
swell	O
and	O
the	O
patient	O
was	O
begun	O
on	O
Hirudin	B-treatment
for	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
heparin	I-problem
induced	I-problem
thrombocytopenia	I-problem
became	O
positive	O
and	O
so	O
he	O
is	O
allergic	B-problem
to	O
heparin	B-treatment
.	O

The	O
patient	O
was	O
begun	O
on	O
Coumadin	B-treatment
and	O
he	O
stayed	O
several	O
days	O
for	O
Coumadinization	B-treatment
and	O
was	O
finally	O
discharged	O
on	O
therapeutic	B-treatment
Coumadin	I-treatment
.	O

The	O
patient	O
tolerated	O
a	O
regular	O
diet	O
on	O
postoperative	O
day	O
number	O
thirteen	O
from	O
his	B-treatment
reoperative	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1	O
)	O
Amiodarone	B-treatment
400	O
mg	O
p.o.	O
q.	O
day	O
.	O

2	O
)	O
Captopril	B-treatment
50	O
mg	O
p.o.	O
t.i.d.	O

3	O
)	O
Digoxin	B-treatment
0.125	O
mg	O
p.o.	O
q.	O
day	O
.	O

4	O
)	O
Colace	B-treatment
100	O
mg	O
p.o.	O
t.i.d.	O

5	O
)	O
Lasix	B-treatment
80	O
mg	O
p.o.	O
b.i.d.	O

6	O
)	O
Potassium	B-treatment
chloride	I-treatment
40	O
mEq	O
p.o.	O
b.i.d.	O

7	O
)	O
Glucophage	B-treatment
500	O
mg	O
p.o.	O
q.	O
day	O
.	O

8	O
)	O
Glucotrol	B-treatment
XL	I-treatment
10	O
mg	O
p.o.	O
b.i.d.	O

9	O
)	O
Coumadin	B-treatment
5	O
mg	O
p.o.	O
q.	O
day	O
.	O

FOLLOW-UP	O
:	O

The	O
patient	O
was	O
instructed	O
to	O
follow-up	O
with	O
Dr.	O
Lumar	O
Jongguild	O
.	O

Dictated	O
By	O
:	O

RAMAG	O
TROISQUARCKAYS	O
,	O
M.D.	O
JB48	O

Attending	O
:	O

LUMAR	O
R.	O
JONGGUILD	O
,	O
M.D.	O
NJ48	O
RO267/6080	O

Batch	O
:	O

5076	O
PAD-WORD	O

Index	O
No.	O
KHQTW3FS3	O

D	O
:	O

04/26/98	O
PAD-WORD	O

T	O
:	O

04/27/98	O
PAD-WORD	O

Admission	O
Date	O
:	O

2016-03-31	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-04-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1965-10-09	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Vicodin	B-treatment
PAD-WORD	O

Attending	O
:	O
Richard	O
S.	O
Humphries	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
chest	B-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Cardiac	B-test
Catheterization	I-test

History	O
of	O
Present	O
Illness	O
:	O

50	O
yo	O
male	O
,	O
h/o	O
CAD	B-problem
s/p	O
stent	B-treatment
to	I-treatment
LAD	I-treatment
in	O
2011	O
,	O
Hypercholesterolemia	B-problem
,	O
DM	B-problem
,	O
cocaine	O
abuse	O
,	O
presenting	O
with	O
chest	B-problem
pain	I-problem
.	O

He	O
states	O
he	O
had	O
onset	O
of	O
this	B-problem
pain	I-problem
today	O
;	O
described	O
as	O
anterior	B-problem
chest	I-problem
pain	I-problem
with	O
radiation	B-problem
to	I-problem
right	I-problem
shoulder	I-problem
,	O
09-26	O
,	O
was	O
increasing	O
over	O
the	O
course	O
of	O
45	O
minutes	O
to	O
1	O
hour	O
(	O
occurred	O
after	O
arrested	O
).	O

He	O
states	O
that	O
he	O
also	O
felt	O
SOB	B-problem
and	O
diaphoretic	B-problem
but	O
denies	O
n/v/palpitations	B-problem
.	O

He	O
reports	O
that	O
the	B-problem
pain	I-problem
was	O
increasing	O
in	O
intensity	O
.	O

He	O
was	O
brought	O
to	O
Providence	O
Behavioral	O
Health	O
Hospital	O
where	O
he	O
was	O
found	O
to	O
have	O
positive	O
urine	O
cocaine	O
,	O
EKG	B-test
with	O
new	O
2-7392	O
W.	O
Second	O
Cr.	O
elevations	B-problem
in	I-problem
the	I-problem
anterior	I-problem
leads	I-problem
(	I-problem
v2-5	I-problem
)	I-problem
and	O
some	B-problem
ST	I-problem
depressions	I-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
AvF	I-problem
.	O

He	O
was	O
given	O
lopressor	B-treatment
5	O
mg	O
x	O
2	O
(	O
3rd	O
dose	O
given	O
by	O
medflight	O
,	O
5	O
mg	O
morphine	B-treatment
,	O
ativan	B-treatment
,	O
nitro	B-treatment
gtt	I-treatment
,	O
heparin	B-treatment
,	O
and	O
integrillin	B-treatment
.	O

Pain	B-problem
was	O
12-28	O
at	O
time	O
of	O
transfer	O
.	O

In	O
the	O
cath	O
lab	O
,	O
he	O
was	O
found	O
to	O
have	O
hazy	B-problem
plaque	I-problem
in	I-problem
LAD	I-problem
(	O
prior	B-treatment
stent	I-treatment
)	O
,	O
80%	B-problem
hazy	I-problem
plaque	I-problem
in	I-problem
circumflex	I-problem
,	O
and	O
a	B-problem
totally	I-problem
occluded	I-problem
PLB	I-problem
(	I-problem
with	I-problem
collaterals	I-problem
)	I-problem
.	O

1	B-treatment
cypher	I-treatment
stent	I-treatment
was	O
place	O
in	O
the	O
LAD	O
while	O
2	O
were	O
placed	O
in	O
Lcx	O
.	O

Right	O
system	O
was	O
not	O
intervened	O
upon	O
,	O
for	O
the	O
PLB	O
was	O
unable	O
to	O
be	O
crossed	O
by	O
wire	B-treatment
.	O

He	O
was	O
transferred	O
to	O
the	O
CCU	O
for	O
observation	B-test
.	O

Past	O
Medical	O
History	O
:	O

1.	O
CAD	B-problem
,	O
s/p	O
MI	B-problem
in	O
2011	O
with	O
stenting	B-treatment
of	I-treatment
LAD	I-treatment

2.	O
Hypercholesterolemia	B-problem

3.	O
DM	B-problem

Social	O
History	O
:	O

Lives	O
with	O
friend	O

History	O
of	O
cocaine	O
use	O
,	O
most	O
recent	O
use	O
day	O
of	O
admission	O

Etoh	O
use	O
,	O
01-21	O
drinks	O
/	O
day	O
,	O
most	O
recently	O
on	O
day	O
of	O
admission	O

Former	O
smoker	O
,	O
quit	O
4	O
yrs	O
ago	O
,	O
30	O
pack	O
year	O
history	O

Arrested	O
on	O
day	O
of	O
admission	O
for	O
soliciting	O
prostitute	O
(	O
undercover	O
police	O
officer	O
)	O
,	O
currently	O
in	O
police	O
custody	O

Family	O
History	O
:	O

No	O
CAD	B-problem
in	O
1st	O
degree	O
relatives	O
.	O

Robert	O
sudden	B-problem
death	I-problem

Physical	O
Exam	O
:	O

VS	B-test
:	O
94.1	O
130/81	O
71	O
21	O
99%	O
4L	B-treatment
NC	I-treatment

Gen	O
:	O
somnolent	B-problem
,	O
pleasant	O
male	O
,	O
lying	O
in	O
bed	O

HEENT	O
:	O
PERRL	O
,	O
some	B-problem
dried	I-problem
blood	I-problem
on	I-problem
lips	I-problem
,	I-problem
tongue	I-problem

Neck	O
:	O
no	O
LAD	B-problem
,	O
?	O
enlarged	B-problem
parotid	I-problem
glands	I-problem
bilaterally	I-problem

CV	O
:	O
RRR	O
,	O
nl	O
s1/s2	O
,	O
with	O
S4	B-problem
,	O
no	O
m/r	B-problem

Lungs	O
:	O
CTA	O
bilaterally	O
,	O
no	O
w/r/r	B-problem

Abdomen	O
:	O
protuberant	B-problem
,	O
nt/nd	B-problem
,	O
nabs	O

Right	O
groin	O
:	O
with	O
sheath	B-treatment
in	O
place	O

Extr	O
:	O
DP/PT	B-test
2+	O
bilaterally	O
,	O
no	O
c/c/e	B-problem

Pertinent	O
Results	O
:	O

Catheterization	B-test
on	O
2016-03-31	O
:	O

HEMODYNAMICS	O
RESULTS	O
BODY	O
SURFACE	O
AREA	O
:	O

1.87	O
m2	O

HEMOGLOBIN	B-test
:	O

14	O
gms	O
%	O

FICK	B-test
PAD-WORD	O

**	O
PRESSURES	O

RIGHT	B-test
ATRIUM	I-test
{	O
a/v/m	O
}	O
18/17/13	O

RIGHT	B-test
VENTRICLE	I-test
{	O
s/Ruben	O
}	O
45/18	O

PULMONARY	B-test
ARTERY	I-test
{	O
s/d/m	O
}	O
45/22	O

PULMONARY	B-test
WEDGE	I-test
{	O
a/v/m	O
}	O
21/22/20	O

AORTA	B-test
{	O
s/d/m	O
}	O
97/66/81	O

**	O
CARDIAC	O
OUTPUT	O

HEART	B-test
RATE	I-test
{	O
beats/min	O
}	O
88	O

RHYTHM	O
SINUS	O

O2	B-test
CONS.	I-test
IND	I-test
{	O
ml/min/m2	O
}	O
125	O

A-V	B-test
O2	I-test
DIFFERENCE	I-test
{	O
ml/ltr	O
}	O
32	O

CARD.	B-test
OP/IND	I-test
FICK	I-test
{	O
l/mn/m2	O
}	O
7.3/3.9	O

**	O
RESISTANCES	O

SYSTEMIC	B-test
VASC.	I-test
RESISTANCE	I-test
745	O

**%	O
SATURATION	O
DATA	O
(	O
NL	O
)	O

SVC	B-test
LOW	I-test
81	O

PA	B-test
MAIN	I-test
81	O

AO	B-test
98	O

OTHER	O
HEMODYNAMIC	O
DATA	O
:	O

The	B-test
oxygen	I-test
consumption	I-test
was	O
assumed	O
.	O

**	O
ARTERIOGRAPHY	O
RESULTS	O
MORPHOLOGY	O
%	O
STENOSIS	O
COLLAT.	O
FROM	O

**	O
RIGHT	O
CORONARY	O

1)	O
PROXIMAL	B-test
RCA	I-test
:	O
NORMAL	O

2)	O
MID	B-test
RCA	I-test
:	O
NORMAL	O

2A)	O
ACUTE	B-test
MARGINAL	I-test
:	O
NORMAL	O

3)	O
DISTAL	B-test
RCA	I-test
:	O
NORMAL	O

4)	O
R-PDA	B-test
:	O
NORMAL	O

4A)	O
R-POST-LAT	B-test
:	O
DISCRETE	O
100	O

4B)	O
R-LV	B-test
:	O
NORMAL	O

**	O
ARTERIOGRAPHY	O
RESULTS	O
MORPHOLOGY	O
%	O
STENOSIS	O
COLLAT.	O
FROM	O

**	O
LEFT	O
CORONARY	O

5)	O
LEFT	B-test
MAIN	I-test
:	O
NORMAL	O

6)	O
PROXIMAL	B-test
LAD	I-test
:	O
ULCERATED	B-problem

6A)	O
SEPTAL-1	B-test
:	O
NORMAL	O

7)	O
MID-LAD	B-test
:	O
NORMAL	O

8)	O
DISTAL	B-test
LAD	I-test
:	O
NORMAL	O

9)	O
DIAGONAL-1	B-test
:	O
NORMAL	O

10)	O
DIAGONAL-2	B-test
:	O
NORMAL	O

12)	O
PROXIMAL	B-test
CX	I-test
:	O
DISCRETE	O
80	O

13)	O
MID	B-test
CX	I-test
:	O
NORMAL	O

13A)	O
DISTAL	B-test
CX	I-test
:NORMAL	O

14)	O
OBTUSE	B-test
MARGINAL	I-test
-	I-test
1	I-test
:	O
NORMAL	O

15)	O
OBTUSE	B-test
MARGINAL	I-test
-	I-test
2	I-test
:	O
NORMAL	O

16)	O
OBTUSE	B-test
MARGINAL	I-test
-	I-test
3	I-test
:	O
NORMAL	O

Proximal	O
LAD	O
with	O
hazy	B-problem
ulceration	I-problem
,	O
proximal	O
circumflex	O
with	O
80%	B-problem
hazy	I-problem
,	O
totally	B-problem
occluded	I-problem
PLB	I-problem
with	I-problem
collaterals	I-problem

1	B-treatment
cypher	I-treatment
stent	I-treatment
placed	O
in	O
LAD	O
,	O
2	B-treatment
cypher	I-treatment
stents	I-treatment
placed	O
in	O
Left	O

Circ	O
PAD-WORD	O

Echo	B-test
:	O

2016-03-31	O
:	O

"	O
Conclusions	O
:	O

1.	O
The	O
left	O
ventricular	O
cavity	O
is	O
moderately	B-problem
dilated	I-problem
.	O

There	O
is	O
severe	B-problem
global	I-problem
left	I-problem
ventricular	I-problem
hypokinesis	I-problem
to	O
akinesis	B-problem
with	O
some	O
sparing	O
of	O
basal	O
wall	O
motion	O
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
severely	B-problem
depressed	I-problem
.	O

2.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

Trivial	B-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
."	O

2016-03-31	O
10:40	O
PM	O

GLUCOSE	B-test
-	O
180	O
*	O
UREA	B-test
N	I-test
-	O
10	O
CREAT	B-test
-	O
0.8	O
SODIUM	B-test
-	O
142	O
POTASSIUM	B-test
-	O
3.7	O
CHLORIDE	B-test
-	O
104	O
TOTAL	B-test
CO2	I-test
-	O
30	O
*	O
ANION	B-test
GAP	I-test
-	O
12	O

2016-03-31	O
10:40	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
137	O

2016-03-31	O
10:40	O
PM	O

CK-MB	B-test
-	O
4	O
cTropnT	B-test
-<	O
0.01	O

2016-03-31	O
10:40	O
PM	O

CALCIUM	B-test
-	O
8.6	O
PHOSPHATE	B-test
-	O
3.4	O
MAGNESIUM	B-test
-	O
1.7	O

2016-03-31	O
10:40	O
PM	O

WBC	B-test
-	O
9.1	O
RBC	B-test
-	O
4.08	O
*	O
HGB	B-test
-	O
12.7	O
*	O
HCT	B-test
-	O
35.7	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
31.0	O
MCHC	B-test
-	O
35.4	O
*	O
RDW	B-test
-	O
12.7	O

2016-03-31	O
10:40	O
PM	O

PLT	B-test
COUNT	I-test
-	O
253	O

Brief	O
Hospital	O
Course	O
:	O

1.	O
CAD	B-problem
:	O
presented	O
with	O
anginal	B-problem
symptoms	I-problem
and	O
EKG	B-problem
changes	I-problem
(	O
STEMI	B-problem
)	O
,	O
with	O
cardiac	B-test
catheterization	I-test
revealing	O
lesions	B-problem
in	I-problem
LAD	I-problem
,	I-problem
LcX	I-problem
,	I-problem
and	I-problem
PLB	I-problem
.	O

Unclear	O
if	O
hazy	B-problem
lesions	I-problem
significant	O
or	O
if	O
this	O
was	O
cocaine	O
induced	O
vasospasm	O
.	O

LAD	O
and	O
LCX	O
were	O
stented	B-treatment
,	O
but	O
PLB	O
could	O
not	O
be	O
crossed	O
by	O
guidewire	B-treatment
(	O
were	O
collaterals	O
)	O
.	O

-	O
continue	O
ASA	B-treatment
,	O
statin	B-treatment
,	O
Plavix	B-treatment
;	O
will	O
hold	O
BB	B-treatment
given	O
recent	O
cocaine	O
use	O
(	O
?	O
can	O
consider	O
labetalol	B-treatment
if	O
necessary	O
)	O
,	O
Integrillin	B-treatment
for	O
18	O
hours	O

-	O
CK	B-test
negative	O
.	O

TN	B-test
WNL	O
.	O

-	O
post	B-test
cath	I-test
check	I-test
normal	O

2.	O
CHF	B-problem
:	O
EF	B-test
25%	O
on	O
Echo	B-test
,	O
states	O
he	O
takes	O
lasix	B-treatment
at	O
home	O

-	O
Started	O
lisinopril	B-treatment
.	O

-	O
Consider	O
repeat	B-test
Echo	I-test
in	O
1	O
month	O
and	O
Quincy	O
Medical	O
Center	O
-	O
V/ICD	B-treatment
per	O
discretion	O
of	O
primary	O
cardiologist	O
.	O

-	O
kept	O
euvolemic	O
and	O
monitored	O
for	O
signs	O
of	O
overload	B-problem

-	O
Low	B-treatment
Na	I-treatment
diet	I-treatment
with	O
1	B-treatment
liter	I-treatment
fluid	I-treatment
restriction	I-treatment

-	O
may	O
need	O
to	O
diurese	O
based	O
on	O
clinical	O
status	O
,	O
swan	B-test
numbers	I-test

3.	O
Rhythm	B-test
:	O
No	O
ectopy	B-problem
post	I-problem
cath/MI	I-problem

4.	O
DM	B-problem
:	O
on	O
metformin	B-treatment
at	O
home	O
,	O
will	O
hold	O
given	O
cath	B-treatment
/	I-treatment
dye	I-treatment
adn	O
cover	O
with	O
SSI	B-treatment

5.	O
Cocaine	O
use	O
:	O
last	O
use	O
this	O
morning	O
,	O
no	O
BB	B-treatment
given	O
this	O
;	O
considered	O
using	O
CCB	B-treatment
/	O
phentolamine	B-treatment
if	O
chest	B-problem
pain	I-problem
recurs	O
.	O

--	O
Will	O
discuss	O
beta-blocker	B-treatment
risks	O
and	O
benefits	O
with	O
primary	O
cardiologist	O

--	O
Pt	O
advised	O
of	O
medical	O
risks	O
of	O
using	O
cocaine	O

6.	O
EtOH	O
use	O
:	O
unclear	O
how	O
much	O
,	O
monitor	O
on	O
CIWA	B-test
for	O
signs	O
of	O
withdrawal	B-problem
,	O
ativan	B-treatment
prn	O

--	O
CIWAs	B-test
were	O
0	O
throughout	O
admission	O

7.	O
Hyperlipidemia	B-problem
:	O
on	O
lipitor	B-treatment
80	O
.	O

LDL	B-test
79	O
,	O
HDL	B-test
51	O

8.	O
Social	O
:	O
in	O
police	O
custody	O
,	O
with	O
24	O
hr	O
guard	O
,	O
handcuffed	O
to	O
bed	O

9.	O
FEN	O
:	O
cardiac	B-treatment
diet	I-treatment
,	O
watch	O
for	O
aspiration	B-problem
given	O
somnolent	B-problem
status	I-problem
at	O
this	O
time	O
,	O
ck	B-test
and	O
replete	O
Mg/K/Ca	B-treatment
aggressively	O

10.	O
Code	O
:	O
FULL	O

11.	O
Dispo	O
:	O
back	O
to	O
prison;	O
?	O
extradition	O
to	O
Hawaii	O

Medications	O
on	O
Admission	O
:	O

Lipitor	B-treatment
80	O

Coreg	B-treatment
PAD-WORD	O

ASA	B-treatment
81	O
mg	O

Lasix	B-treatment
PAD-WORD	O

Glucophage	B-treatment
PAD-WORD	O

ALL	O
:	O
Vicodin	B-treatment
-?	O
rash	B-problem

Discharge	O
Medications	O
:	O

1.	O
Please	O
continue	O
your	B-treatment
previous	I-treatment
diabetes	I-treatment
medications	I-treatment

2.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Clopidogrel	B-treatment
Bisulfate	I-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

6.	O
Atorvastatin	B-treatment
Calcium	I-treatment
80	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Lisinopril	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Oak	O
BluffsCorrectional	O
Facility	O

Discharge	O
Diagnosis	O
:	O

Cocaine	O
Abuse	O

ST	B-problem
Elevation	I-problem
Myocardial	I-problem
Infarction	I-problem

Discharge	O
Condition	O
:	O

stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
notify	O
nurses	O
,	O
doctors	O
Marilyn	O
Kristen	O
Layne	O
workers	O
of	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
palpitations	B-problem
or	O
lightheadedness	B-problem
.	O

Cocaine	O
use	O
has	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
heart	B-problem
attacks	I-problem
,	O
stroke	B-problem
and	O
death	B-problem
.	O

You	O
must	O
continue	O
to	O
take	O
plavix	B-treatment
.	O

Please	O
discuss	O
the	O
use	O
of	O
beta-blockers	B-treatment
with	O
your	O
cardiologist	O
.	O

Beta-blockers	B-treatment
should	O
not	O
be	O
used	O
while	O
using	O
cocaine	O
.	O

Followup	O
Instructions	O
:	O

Please	O
follow-up	O
with	O
your	O
cardiologist	O
within	O
2	O
weeks	O
of	O
leaving	O
the	O
hospital	O
.	O

Please	O
follow-up	O
with	O
your	O
primary	O
doctor	O
within	O
2	O
weeks	O
of	O
leaving	O
the	O
hospital	O
.	O

Robert	O
Melissa	O
MD	O
41-790	O

Completed	O
by	O
:	O
William	O
Bennett	O
MD	O
47-894	O
2016-04-01	O
@	O
1501	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Evelyn	O
Paulk	O
on	O
:	O
Flora	O
2016-06-16	O
2:06	O
PM	O

(	O
End	O
of	O
Report	O
)	O

129714460	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

30735304	O
PAD-WORD	O

279659	O
PAD-WORD	O

8/31/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

08/31/1992	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

09/07/1992	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
37-year-old	O
white	O
male	O
with	O
AIDS	B-problem
complicated	O
by	O
recurrent	B-problem
pseudomonas	I-problem
infections	I-problem
presently	O
on	O
Ceftazidime	B-treatment
and	O
Aztrenam	B-treatment
complicated	O
by	O
MAI	B-problem
who	O
comes	O
in	O
with	O
fever	B-problem
,	O
chills	B-problem
and	O
blood	B-test
cultures	I-test
positive	O
for	O
candida	B-problem
species	I-problem
.	O

The	O
patient	O
has	O
multiple	B-problem
AIDS	I-problem
illnesses	I-problem
including	O
MAI	B-problem
who	O
has	O
multiple	O
admissions	O
for	O
pseudomonas	B-problem
pneumonia	I-problem
.	O

His	O
most	O
recent	O
admission	O
was	O
on	O
08/23/92	O
to	O
08/25/92	O
with	O
fever	B-problem
and	O
chills	B-problem
.	O

He	O
was	O
again	O
treated	O
with	O
IV	B-treatment
Ceftazidime	I-treatment
for	O
presumed	O
pseudomonal	B-problem
pneumonia	I-problem
and	O
discharged	O
home	O
on	O
IV	B-treatment
antibiotics	I-treatment
which	O
he	O
is	O
presently	O
on	O
.	O

The	O
patient	O
did	O
well	O
at	O
home	O
with	O
decreasing	O
fever	O
and	O
good	O
appetite	O
until	O
the	O
night	O
prior	O
to	O
admission	O
when	O
he	O
developed	O
fever	B-problem
and	O
chills	B-problem
.	O

Concurrent	B-test
blood	I-test
cultures	I-test
grew	O
out	O
candida	B-problem
species	I-problem
at	O
HCHP	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
baseline	I-test
O2	I-test
saturation	I-test
is	O
92%	O
on	O
three	B-treatment
liters	I-treatment
.	O

He	O
has	O
a	B-treatment
left	I-treatment
arm	I-treatment
graft	I-treatment
placed	O
for	O
access	O
three	O
weeks	O
ago	O
which	O
is	O
used	O
for	O
blood	B-treatment
drawing	I-treatment
and	O
IV	B-treatment
medications	I-treatment
.	O

He	O
notes	O
no	O
tenderness	B-problem
,	O
erythema	B-problem
,	O
warmth	B-problem
or	O
exudate	B-problem
from	O
the	B-treatment
passport	I-treatment
site	I-treatment
.	O

Medications	O
at	O
the	O
time	O
of	O
admission	O
include	O
Dapsone	B-treatment
50	O
mg	O
p.o.	O
on	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
,	O
Ceftazidime	B-treatment
1	O
gram	O
IV	O
q.	O
8	O
hours	O
,	O
Cipro	B-treatment
750	O
mg	O
p.o.	O
b.i.d.	O
,	O
Acyclovir	B-treatment
400	O
mg	O
p.o.	O
q.	O
day	O
,	O
Megastrol	B-treatment
80	O
mg	O
p.o.	O
t.i.d.	O
and	O
G-CSF	B-treatment
150	O
micrograms	O
subcu	O
b.i.d.	O

PHYSICAL	O
EXAMINATION	O
:	O

At	O
the	O
time	O
of	O
admission	O
,	O
his	B-test
temperature	I-test
was	O
101	O
,	O
blood	B-test
pressure	I-test
110/60	O
,	O
pulse	B-test
96	O
,	O
respirations	B-test
16	O
.	O

O2	B-test
saturation	I-test
on	O
three	B-treatment
liters	I-treatment
was	O
96%	O
.	O

HEENT	B-test
exam	I-test
was	O
unremarkable	O
.	O

The	O
neck	O
was	O
supple	O
.	O

No	O
lymphadenopathy	B-problem
or	O
thyromegaly	B-problem
.	O

Chest	O
revealed	O
bilateral	B-problem
basilar	I-problem
rales	I-problem
.	O

Cardiovascular	B-test
exam	I-test
has	O
a	O
normal	O
S1	O
and	O
S2	O
without	O
murmurs	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

The	O
liver	O
was	O
approximately	O
8.0	O
cm	O
.	O

The	O
extremities	O
had	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

Neurological	B-test
exam	I-test
was	O
alert	O
and	O
oriented	O
x	O
three	O
.	O

Nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

Notable	O
on	O
admission	O
were	O
BUN	B-test
and	O
creatinine	B-test
of	O
8.0	O
and	O
0.7	O
.	O

Sodium	B-test
134	O
,	O
ALT	B-test
18	O
,	O
AST	B-test
27	O
,	O
LDH	B-test
221	O
,	O
white	B-test
count	I-test
2.05	O
,	O
hematocrit	B-test
23	O
,	O
platelet	B-test
count	I-test
137,000	O
.	O

The	B-test
differential	I-test
showed	O
45	B-test
polys	I-test
,	O
6	B-test
bands	I-test
,	O
8	B-test
lymphs	I-test
,	O
32	B-test
monos	I-test
.	O

Urinalysis	B-test
was	O
negative	O
.	O

Sputum	B-test
gram	I-test
stain	I-test
showed	O
no	O
polys	B-problem
and	O
no	O
bacteria	B-problem
.	O

AFB	B-test
stain	I-test
was	O
negative	O
.	O

Chest	B-test
X-ray	I-test
was	O
consistent	O
with	O
an	B-test
old	I-test
chest	I-test
X-ray	I-test
on	O
08/08/92	O
showing	O
a	B-problem
resolving	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
and	I-problem
lingular	I-problem
infiltrate	I-problem
and	O
resolution	O
of	O
the	B-problem
right	I-problem
mid	I-problem
lung	I-problem
infiltrate	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
problems	O
:	O

1.	O
Infectious	B-problem
Disease	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
Amphotericine	B-treatment
at	O
.6	O
mg	O
/	O
kg	O
for	O
a	O
total	O
of	O
250	O
mg	O
for	O
positive	B-problem
blood	I-problem
cultures	I-problem
for	O
candida	B-problem
.	O

The	B-treatment
passport	I-treatment
in	I-treatment
his	I-treatment
left	I-treatment
arm	I-treatment
was	O
pulled	O
and	O
will	O
be	O
replaced	O
if	O
needed	O
after	O
the	B-treatment
Amphotericine	I-treatment
is	O
completed	O
.	O

The	O
patient	O
will	O
continue	O
on	O
his	B-treatment
antibiotics	I-treatment
for	O
pseudomonas	B-problem
pneumonia	I-problem
to	O
complete	O
the	O
fourteen	O
day	O
course	O
which	O
was	O
completed	O
on	O
09/06/92	O
.	O

The	O
patient	O
was	O
continued	O
on	O
his	B-treatment
admission	I-treatment
medications	I-treatment
.	O

2.	O
Hematology	O
.	O

The	O
patient	O
was	O
continued	O
on	O
his	B-treatment
G-CSF	I-treatment
with	O
an	O
increase	O
in	O
his	B-test
white	I-test
count	I-test
to	O
8	O
from	O
1.8	O
.	O

The	O
patient	O
required	O
multiple	B-treatment
blood	I-treatment
transfusions	I-treatment
for	O
a	B-problem
low	I-problem
hematocrit	I-problem
.	O

DISPOSITION	O
:	O

MEDICATIONS	B-treatment
at	O
the	O
time	O
of	O
discharge	O
are	O
G-CSF	B-treatment
300	O
micrograms	O
subcu	O
q.	O
day	O
,	O
Acyclovir	B-treatment
200	O
mg	O
p.o.	O
b.i.d.	O
,	O
Erythromycin	B-treatment
500	O
mg	O
p.o.	O
b.i.d.	O
,	O
Dapsone	B-treatment
50	O
mg	O
p.o.	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
,	O
Imodium	B-treatment
1-2	O
tablets	O
p.o.	O
q.	O
6	O
hours	O
p.r.n.	O
,	O
Nystatin	B-treatment
5	O
cc	O
swish	O
and	O
swallow	O
q.i.d.	O
,	O
Serax	B-treatment
50	O
mg	O
p.o.	O
q.	O
6	O
hours	O
p.r.n.	O
and	O
Kay-Ceil	B-treatment
40	O
mEq	O
p.o.	O
b.i.d.	O

The	O
patient	O
needs	O
to	O
have	O
his	B-test
blood	I-test
drawn	I-test
the	O
day	O
after	O
discharge	O
to	O
check	O
a	B-test
potassium	I-test
and	O
magnesium	B-test
which	O
he	O
has	O
been	O
wasting	O
secondary	O
to	O
Amphotericine	B-treatment
.	O

He	O
will	O
probably	O
need	O
potassium	B-treatment
and	O
magnesium	B-treatment
replacement	I-treatment
.	O

He	O
will	O
need	O
follow	B-test
up	I-test
lytes	I-test
drawn	O
throughout	O
the	O
week	O
.	O

CR887/2594	O
TRANGCA	O
FERCI	O
CHIRDSTEN	O
,	O
M.D.	O
UO2	O

D	O
:	O

09/07/92	O
PAD-WORD	O

Batch	O
:	O

5346	O
PAD-WORD	O

Report	O
:	O

P4722W3	O
PAD-WORD	O

T	O
:	O

09/09/92	O
PAD-WORD	O

Dicatated	O
By	O
:	O

LANETTE	O
SC	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2017-01-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-01-16	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1963-12-23	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

Medical	O
ICU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
53	O
-	O
year-old	O
female	O
found	O
down	O
in	O
hotel	O
room	O
by	O
EMS	O
with	O
change	B-problem
in	I-problem
mental	I-problem
status	I-problem
and	O
lethargy	B-problem
.	O

A	O
suicide	O
note	O
found	O
at	O
the	O
scene	O
referenced	O
multiple	B-problem
medical	I-problem
problems	I-problem
as	O
well	O
as	O
suggested	O
ingestion	O
of	O
beta	B-treatment
blocker	I-treatment
,	O
muscle	B-treatment
relaxant	I-treatment
,	O
and	O
Neurontin	B-treatment
.	O

Vital	B-test
signs	I-test
were	O
stable	O
on	O
arrival	O
in	O
the	O
David	O
,	O
but	O
the	O
patient	O
was	O
minimally	B-problem
responsive	I-problem
and	O
subsequently	O
intubated	O
for	O
airway	B-treatment
protection	I-treatment
.	O

Patient	O
initially	O
given	O
2	O
mg	O
of	O
Narcan	B-treatment
,	O
4	O
amps	O
of	O
sodium	B-treatment
bicarb	I-treatment
,	O
and	O
5	O
grams	O
of	O
activated	B-treatment
charcoal	I-treatment
.	O

Patient	B-test
's	I-test
blood	I-test
pressures	I-test
were	O
noted	O
to	O
decrease	B-problem
systolics	I-problem
to	O
the	O
80s	O
,	O
which	O
responded	O
to	O
IV	B-treatment
fluids	I-treatment
and	O
insulin	B-treatment
/	O
glucose	B-treatment
drips	I-treatment
.	O

Also	O
noted	O
to	O
be	O
bradycardic	B-problem
to	O
the	O
50s	O
,	O
which	O
responded	O
to	O
atropine	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hepatitis	B-problem
C	I-problem
.	O

2.	O
Hypertrophic	B-problem
cardiomyopathy	I-problem
.	O

3.	O
Lumbar	B-problem
and	I-problem
cervical	I-problem
degenerative	I-problem
disk	I-problem
disease	I-problem
.	O

4.	O
Sarcoid	B-problem
.	O

5.	O
Depression	B-problem
.	O

6.	O
Headaches	B-problem
.	O

MEDICATIONS	O
:	O

1.	O
Neurontin	B-treatment
.	O

2.	O
Propanolol	B-treatment
.	O

3.	O
Tylenol	B-treatment
#3	I-treatment
.	O

4.	O
Butalbital	B-treatment
.	O

5.	O
Morphine	B-treatment
.	O

6.	O
Protonix	B-treatment
.	O

7.	O
Doxepin	B-treatment
.	O

8.	O
Dilaudid	B-treatment
.	O

9.	O
Inderal	B-treatment
.	O

10.	O
Skelaxin	B-treatment
.	O

11.	O
Zantac	B-treatment
.	O

12.	O
Flexeril	B-treatment
.	O

13.	O
MS	B-treatment
Contin	I-treatment
.	O

PHYSICAL	O
EXAM	O
:	O

Temperature	B-test
96.8	O
,	O
heart	B-test
rate	I-test
81	O
,	O
blood	B-test
pressure	I-test
92/47	O
,	O
and	O
saturating	O
100%	O
on	O
40%	O
FIO2	B-treatment
.	O

General	O
:	O

Patient	O
is	O
intubated	O
and	O
sedated	O
.	O

HEENT	O
:	O

Pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B-problem
.	O

Pulmonary	O
is	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
.	O

Extremities	O
:	O

No	O
edema	B-problem
.	O

LABORATORIES	O
:	O

White	B-test
count	I-test
20.0	O
,	O
hematocrit	B-test
52	O
,	O
platelets	B-test
439	O
.	O

Chem-7	B-test
:	O

141	O
/	O
5.6	O
/	O
104	O
/	O
24	O
/	O
23	O
/	O
0.8	O
/	O
118	O
.	O

Urinalysis	B-test
negative	O
except	O
for	O
large	B-problem
blood	I-problem
.	O

EKG	B-test
:	O

Sinus	B-problem
bradycardia	I-problem
,	O
left	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
,	O
prolonged	B-problem
QRS	I-problem
.	O

Urine	B-test
tox	I-test
positive	B-problem
for	I-problem
barbiturates	I-problem
,	I-problem
opiates	I-problem
,	I-problem
and	I-problem
methadone	I-problem
.	O

Serum	B-test
Tylenol	I-test
level	I-test
is	O
8.3	O
.	O

Positive	B-problem
for	I-problem
serum	I-problem
barbiturates	I-problem
.	O

CK	B-test
15,000	O
.	O

ALT	B-test
77	O
,	O
AST	B-test
159	O
,	O
amylase	B-test
153	O
,	O
alkaline	B-test
phosphatase	I-test
216	O
,	O
total	B-test
bilirubin	I-test
0.6	O
.	O

INR	B-test
1.1	O
.	O

HOSPITAL	O
COURSE	O
:	O

In	O
summary	O
,	O
patient	O
is	O
a	O
53	O
-	O
year-old	O
female	O
with	O
multiple	B-problem
medical	I-problem
problems	I-problem
and	O
history	O
of	O
depression	B-problem
with	O
intentional	O
overdose	O
of	O
barbiturates	B-treatment
,	O
opiates	B-treatment
,	O
Tylenol	B-treatment
,	O
and	O
beta	B-treatment
blocker	I-treatment
.	O

CMED	O
:	O

Patient	O
was	O
maintained	O
on	O
insulin	B-treatment
,	O
D10	B-treatment
and	O
glucagon	B-treatment
drips	I-treatment
to	O
maintain	O
her	O
hemodynamics	O
.	O

This	O
was	O
achieved	O
with	O
good	O
effect	O
,	O
and	O
they	O
were	O
subsequently	O
weaned	O
off	O
.	O

Patient	O
was	O
able	O
to	O
be	O
extubated	O
on	O
hospital	O
day	O
three	O
.	O

Psychiatry	O
was	O
consulted	O
after	O
the	O
patient	O
was	O
extubated	O
,	O
and	O
felt	O
that	O
patient	O
had	O
a	B-problem
high	I-problem
suicide	I-problem
risk	I-problem
,	O
and	O
plan	O
was	O
for	O
her	O
to	O
be	O
admitted	O
to	O
the	O
Psychiatry	O
service	O
once	O
medically	O
stable	O
.	O

Patient	O
's	O
renal	O
function	O
remained	O
stable	O
and	O
her	B-test
CKs	I-test
trended	O
down	O
gradually	O
.	O

Patient	O
remained	O
on	O
suicide	B-treatment
precautions	I-treatment
,	O
but	O
was	O
deemed	O
not	O
to	O
need	O
ICU	B-test
level	I-test
monitoring	I-test
,	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
01-11	O
.	O

In	O
the	O
a.m.	O
of	O
01/08	O
,	O
the	O
patient	O
experienced	O
episode	O
of	O
tongue	B-problem
biting	I-problem
,	O
unresponsiveness	B-problem
,	O
disorientation	B-problem
.	O

Was	O
loaded	O
on	O
Dilantin	B-treatment
.	O

Became	O
progressively	O
hypoxic	B-problem
and	O
tachypneic	B-problem
throughout	O
the	O
day	O
with	O
respiratory	B-test
rates	I-test
of	O
30-40	O
with	O
a	B-test
max	I-test
respiratory	I-test
rate	I-test
of	O
116	O
,	O
tachycardia	B-problem
to	O
120s	O
.	O

Patient	O
subsequently	O
was	O
transferred	O
back	O
to	O
the	O
CMED	O
CCU	O
on	O
2017-01-13	O
for	O
further	B-test
monitoring	I-test
.	O

Patient	B-problem
's	I-problem
hypoxia	I-problem
was	O
felt	O
most	O
likely	O
to	O
be	O
caused	O
by	O
pneumonia	B-problem
.	O

She	O
was	O
started	O
on	O
appropriate	B-treatment
antibiotics	I-treatment
.	O

Etiology	O
of	O
patient	B-problem
's	I-problem
tachypnea	I-problem
was	O
unclear	O
.	O

Initially	O
,	O
the	O
patient	O
's	O
etiology	O
of	O
seizure	B-problem
was	O
not	O
quite	O
clear	O
,	O
but	O
thought	O
possibly	O
secondary	O
to	O
alcohol	B-problem
and	I-problem
benzodiazepine	I-problem
withdrawal	I-problem
.	O

She	O
received	O
EEG	B-test
,	O
MRI	B-test
,	O
LP	B-test
.	O

Subsequently	O
EEG	B-test
was	O
noted	O
to	O
have	O
no	O
seizure	B-problem
activity	I-problem
.	O

MRI	B-test
was	O
suboptimal	O
due	O
to	O
motion	O
artifact	O
and	O
LP	B-test
was	O
unremarkable	O
.	O

Despite	O
absence	O
of	O
seizure	B-problem
activity	I-problem
on	O
EEG	B-test
,	O
patient	O
was	O
continued	O
on	O
Dilantin	B-treatment
.	O

Her	B-problem
delirium	I-problem
was	O
felt	O
possibly	O
secondary	O
to	O
withdrawal	B-problem
versus	O
toxic	B-problem
metabolic	I-problem
,	O
but	O
gradually	O
improved	O
slowly	O
,	O
and	O
therefore	O
patient	O
did	O
not	O
receive	O
treatment	B-treatment
for	O
barbiturate	B-problem
withdrawal	I-problem
.	O

Her	O
mental	O
status	O
,	O
tachypnea	B-problem
,	O
and	O
hypoxia	B-problem
all	O
improved	O
,	O
and	O
patient	O
was	O
subsequently	O
transferred	O
back	O
to	O
the	O
floor	O
medical	O
team	O
on	O
2017-01-15	O
.	O

While	O
on	O
the	O
floor	O
,	O
the	O
patient	O
's	O
mental	O
status	O
was	O
noted	O
to	O
be	O
improved	O
back	O
at	O
baseline	O
compared	O
to	O
that	O
back	O
to	O
the	O
CMED	O
CCU	O
,	O
and	O
she	O
exhibited	O
no	O
evidence	O
of	O
barbiturate	B-problem
withdrawal	I-problem
.	O

She	O
was	O
continued	O
on	O
suicide	B-treatment
precautions	I-treatment
with	O
a	B-treatment
one-to-one	I-treatment
sitter	I-treatment
,	O
and	O
plan	O
was	O
for	O
psychiatric	O
admission	O
when	O
medical	B-problem
issues	I-problem
had	O
resolved	O
.	O

On	O
2017-01-16	O
,	O
the	O
night	O
float	O
intern	O
was	O
called	O
to	O
see	O
the	O
patient	O
as	O
she	O
was	O
unresponsive	B-problem
.	O

Patient	O
unresponsive	B-problem
to	O
verbal	B-test
command	I-test
,	O
sternal	B-test
rub	I-test
.	O

Pupils	O
were	O
fixed	B-problem
and	O
dilated	B-problem
.	O

Patient	O
noted	O
to	O
be	O
without	B-problem
corneal	I-problem
reflexes	I-problem
,	I-problem
spontaneous	I-problem
breathing	I-problem
,	I-problem
heart	I-problem
sounds	I-problem
,	I-problem
or	I-problem
palpable	I-problem
pulses	I-problem
.	O

Patient	O
was	O
pronounced	O
dead	O
at	O
6:15	O
a.m.	O
on	O
2017-01-16	O
.	O

Patient	O
's	O
family	O
was	O
notified	O
and	O
declined	O
autopsy	B-test
.	O

Given	O
the	O
sudden	O
unexpected	O
nature	O
of	O
patient	O
's	O
death	O
,	O
the	O
medical	O
examiner	O
was	O
contacted	O
and	O
the	O
case	O
was	O
accepted	O
.	O

Of	O
note	O
at	O
time	O
of	O
death	O
,	O
patient	O
was	O
DNR	B-treatment
/	O
DNI	B-treatment
.	O

This	O
was	O
initiated	O
after	O
several	O
conversations	O
with	O
the	O
patient	O
's	O
mother	O
,	O
who	O
stated	O
that	O
the	O
patient	O
had	O
desired	O
to	O
be	O
DNR	B-treatment
/	O
DNI	B-treatment
for	O
many	O
years	O
,	O
not	O
just	O
in	O
the	O
recent	O
past	O
.	O

These	O
facts	O
were	O
confirmed	O
via	O
separate	O
conversations	O
with	O
both	O
the	O
patient	O
's	O
lawyer	O
and	O
her	O
primary	O
care	O
physician	O
.	O

Michael	O
N	O
Sawyer	O
,	O
M.D.	O

86-331	O
PAD-WORD	O

Dictated	O
By	O
:	O
Rebecca	O
S	O
Jefcoat	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2017-03-08	O
10:57	O

T	O
:	O
2017-03-10	O
07:01	O

JOB	O
#	O
:	O
53408	O

(	O
cclist	O
)	O

***************************	O
PAD-WORD	O

Please	O
note	O
that	O
all	O
of	O
the	O
conversations	O
regarding	O
code	O
status	O
took	O
place	O
during	O
we	O
icu	O
admit	O
;	O
and	O
that	O
this	O
patient	O
passed	O
away	O
in	O
early	O
am	O
hours	O
of	O
night	O
she	O
was	O
called	O
back	O
out	O
to	O
the	O
medicine	O
floor	O
,	O
therefore	O
she	O
had	O
not	O
yet	O
been	O
re-evaluated	O
by	O
the	O
floor	O
medicine	O
attending	O
,	O
but	O
had	O
been	O
earlier	O
that	O
day	O
by	O
the	O
icu	O
attending	O
.	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dorothy	O
Desalvo	O
on	O
:	O
WED	O
2017-04-26	O
7:22	O
AM	O

(	O
End	O
of	O
Report	O
)	O

139391631	O
PAD-WORD	O

GH	O
PAD-WORD	O

97368061	O
PAD-WORD	O

7/20/1999	O
12:00:00	O
AM	O

NEUROPATHIC	B-problem
PAIN	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

07/20/1999	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
Discharge	O

Date	O
:	O

07/26/1999	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Post	B-problem
thoracotomy	I-problem
syndrome	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

The	O
patient	O
had	O
a	B-test
spinal	I-test
cord	I-test
stimulator	I-test
trial	I-test
on	O
07/21/99	O
,	O
the	O
patient	O
had	O
an	B-test
epidural	I-test
trial	I-test
on	O
07/24/99	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65	O
year	O
old	O
female	O
with	O
post	B-problem
thoracotomy	I-problem
syndrome	I-problem
that	O
occurred	O
on	O
the	O
site	O
of	O
her	B-problem
thoracotomy	I-problem
incision	I-problem
.	O

She	O
had	O
a	B-problem
thoracic	I-problem
aortic	I-problem
aneurysm	I-problem
repaired	O
in	O
the	O
past	O
and	O
subsequently	O
developed	O
neuropathic	B-problem
pain	I-problem
at	O
the	B-problem
incision	I-problem
site	I-problem
.	O

She	O
is	O
currently	O
on	O
Vicodin	B-treatment
,	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
p.r.n.	O
,	O
Fentanyl	B-treatment
patch	I-treatment
25	O
mcg	O
an	O
hour	O
,	O
change	O
of	O
patch	O
every	O
72	O
hours	O
,	O
Elavil	B-treatment
50	O
mgq	O
.h.s.	O
,	O
Neurontin	B-treatment
600	O
mg	O
p.o.	O
t.i.d.	O
with	O
still	O
what	O
she	O
reports	O
as	O
stabbing	B-problem
left-sided	I-problem
chest	I-problem
pain	I-problem
that	O
can	O
be	O
as	O
severe	O
as	O
a	O
7/10.	O

She	O
has	O
failed	O
conservative	B-treatment
therapy	I-treatment
and	O
is	O
admitted	O
for	O
a	B-test
spinal	I-test
cord	I-test
stimulator	I-test
trial	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
.	O

2.	O
Hypothyroidism	B-problem
.	O

3.	O
Paraplegia	B-problem
status	O
post	O
thoracic	B-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

4.	O
Left	B-problem
hemidiaphragmatic	I-problem
paralysis	I-problem
,	O
history	O
of	O
recurrent	B-problem
lung	I-problem
infections	I-problem
.	O

5.	O
Sacral	B-problem
decubitus	I-problem
ulcer	I-problem
.	O

6.	O
Home	B-treatment
oxygen	I-treatment
at	O
two	O
liters	O
a	O
minute	O
when	O
she	O
is	O
at	O
home	O
;	O
she	O
does	O
not	O
use	O
the	B-treatment
oxygen	I-treatment
when	O
she	O
is	O
in	O
a	B-treatment
wheelchair	I-treatment
or	O
is	O
out	O
of	O
the	O
house	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Atrovent	B-treatment
nebulizers	I-treatment
0.5	O
mg	O
mixed	O
with	O
albuterol	B-treatment
,	O
nebulizer	B-treatment
is	O
given	O
every	O
six	O
hours	O
.	O

2.	O
Norvasc	B-treatment
2.5	O
mg	O
p.o.	O
q	O
day	O
.	O

3.	O
Colistin	B-treatment
30	O
mg	O
nebulizer	O
twice	O
a	O
day	O
,	O
give	O
30	O
minutes	O
post	O
albuterol	B-treatment
and	O
Atrovent	B-treatment
.	O

4.	O
Pressure	B-treatment
,	I-treatment
dermal	I-treatment
ulcer	I-treatment
care	I-treatment
b.i.d.	O
dressing	B-treatment
change	I-treatment
with	O
antibiotic	B-treatment
solution	I-treatment
.	O

5.	O
Neurontin	B-treatment
600	O
mg	O
p.o.	O
t.i.d.	O

6.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

7.	O
Albuterol	B-treatment
neb	I-treatment
2.5	O
mg	O
every	O
six	O
hours	O
,	O
30	O
minutes	O
before	O
Colistin	B-treatment
.	O

8.	O
Amitriptyline	B-treatment
50	O
mg	O
q.h.s.	O

9.	O
Vitamin	B-treatment
C	I-treatment
500	O
mg	O
p.o.	O
b.i.d.	O

10.	O
Calcium	B-treatment
carbonate	I-treatment
125.0	O
mg	O
t.i.d.	O

11.	O
Fentanyl	B-treatment
patch	I-treatment
25	O
mcg	O
an	O
hour	O
,	O
change	O
patch	O
every	O
72	O
hours	O
.	O

12.	O
Folate	B-treatment
1	O
mg	O
p.o.	O
q	O
day	O
.	O

13.	O
Synthroid	B-treatment
50	O
mcg	O
p.o.	O
q	O
day	O
.	O

14.	O
Zinc	B-treatment
sulfate	I-treatment
220	O
mg	O
p.o.	O
q	O
day	O
.	O

15.	O
Multivitamin	B-treatment
,	O
one	O
tablet	O
p.o.	O
q	O
day	O
.	O

16.	O
Hydrocodone	B-treatment
5	I-treatment
mg	I-treatment
with	I-treatment
Tylenol	I-treatment
,	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
p.r.n.	O
pain	B-problem
.	O

17.	O
Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
30	O
cc	O
p.o.	O
q	O
day	O
constipation	B-problem
.	O

ALLERGIES	O
:	O

PENICILLIN	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
in	O
Napro	O
with	O
her	O
husband	O
who	O
is	O
her	O
primary	O
caregiver	O
.	O

She	O
is	O
not	O
a	O
smoker	O
.	O

She	O
has	O
approximately	O
one	O
glass	O
of	O
wine	O
every	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
well-appearing	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Blood	B-test
pressure	I-test
is	O
150/90	O
,	O
heart	B-test
rate	I-test
of	O
90	O
,	O
respiratory	B-test
rate	I-test
20	O
with	O
saturation	B-test
of	O
98%	O
.	O

HEENT	O
:	O

Pupils	O
are	O
equal	O
and	O
reactive	O
to	O
light	O
.	O

The	O
patient	O
wears	O
dentures	B-treatment
.	O

Neck	O
:	O

Full	O
range	O
of	O
motion	O
with	O
no	O
lymphadenopathy	B-problem
.	O

Chest	O
:	O

Clear	O
to	O
auscultation	B-test
on	O
the	O
right	O
.	O

Decreased	B-problem
breath	I-problem
sounds	I-problem
on	I-problem
the	I-problem
left	I-problem
base	I-problem
with	O
coarse	B-problem
rales	I-problem
on	I-problem
the	I-problem
left	I-problem
base	I-problem
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
.	O

Abdomen	O
:	O

Soft	O
,	O
nondistended	B-problem
,	O
nontender	B-problem
.	O

Positive	O
bowel	O
sounds	O
.	O

Back	O
:	O

Clear	O
.	O

Epidural	B-treatment
site	I-treatment
is	O
without	O
erythema	B-problem
,	O
drainage	B-problem
or	O
tenderness	B-problem
.	O

Left	O
buttock	O
area	O
has	O
a	B-treatment
dressing	I-treatment
over	O
the	B-problem
sacral	I-problem
decubitus	I-problem
ulcer	I-problem
.	O

Extremities	O
:	O

Well-profused	O
.	O

4/5	O
motor	O
strength	O
in	O
the	O
upper	O
extremities	O
bilaterally	O
.	O

Flaccid	B-problem
paralysis	I-problem
of	I-problem
bilateral	I-problem
lower	I-problem
extremities	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
07/20/99	O
for	O
a	O
history	O
of	O
left	B-problem
chest	I-problem
wall	I-problem
pain	I-problem
from	O
postthoracotomy	B-problem
syndrome	I-problem
.	O

The	O
patient	O
developed	O
the	B-problem
syndrome	I-problem
after	O
her	B-treatment
thoracic	I-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
.	O

The	O
patient	O
failed	O
the	B-treatment
conservative	I-treatment
therapy	I-treatment
and	O
is	O
admitted	O
for	O
a	B-test
spinal	I-test
cord	I-test
stimulator	I-test
trial	I-test
.	O

The	O
patient	O
had	O
a	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
placed	O
on	O
07/21/99	O
.	O

She	O
underwent	O
the	B-treatment
procedure	I-treatment
and	O
tolerated	O
the	B-treatment
procedure	I-treatment
very	O
well	O
.	O

The	B-treatment
spinal	I-treatment
cord	I-treatment
stimulator	I-treatment
was	O
programmed	O
with	O
setting	O
of	O
a	O
rate	O
of	O
80	O
,	O
power	O
450	O
and	O
4.0	O
amps	O
.	O

Channel	O
1	O
was	O
negative	O
,	O
2	O
was	O
neutral	O
,	O
3	O
was	O
neutral	O
,	O
4	O
was	O
positive	O
.	O

The	O
patient	O
the	O
next	O
two	O
days	O
did	O
not	O
notice	O
any	O
significant	O
change	O
in	O
her	B-problem
pain	I-problem
pattern	I-problem
.	O

The	O
patient	O
was	O
also	O
noted	O
to	O
have	O
a	O
lot	O
of	O
musculoskeletal	B-problem
component	I-problem
of	O
her	B-problem
pain	I-problem
.	O

So	O
,	O
an	B-treatment
epidural	I-treatment
catheter	I-treatment
was	O
placed	O
on	O
07/23/99	O
.	O

The	B-treatment
epidural	I-treatment
was	O
placed	O
in	O
the	O
L1-2	O
region	O
and	O
the	B-treatment
catheter	I-treatment
was	O
placed	O
in	O
the	O
T7	O
region	O
using	O
fluoroscope	B-treatment
to	O
guide	O
the	B-treatment
catheter	I-treatment
.	O

Within	O
the	O
next	O
couple	O
of	O
days	O
,	O
the	O
patient	O
noticed	O
a	O
significant	O
improvement	O
in	O
her	B-problem
pain	I-problem
pattern	I-problem
.	O

The	B-problem
stabbing	I-problem
,	I-problem
sharp	I-problem
pain	I-problem
that	O
she	O
occasionally	O
has	O
on	O
the	O
left	O
chest	O
wall	O
was	O
significantly	O
diminished	O
and	O
she	O
also	O
noticed	O
periods	O
of	O
time	O
when	O
she	O
did	O
not	O
have	O
any	O
of	O
that	B-problem
pain	I-problem
.	O

The	B-treatment
epidural	I-treatment
catheter	I-treatment
had	O
a	B-treatment
morphine	I-treatment
infusion	I-treatment
initially	O
started	O
at	O
1	O
mg	O
a	O
day	O
and	O
increased	O
to	O
3	O
mg	O
a	O
day	O
in	O
a	O
period	O
of	O
three	O
days	O
.	O

The	B-treatment
epidural	I-treatment
was	O
discontinued	O
on	O
07/26/99	O
and	O
was	O
considered	O
a	O
successful	O
trial	O
.	O

The	O
patient	O
will	O
schedule	O
with	O
the	O
Pain	O
Clinic	O
regarding	O
upcoming	O
epidural	B-treatment
pump	I-treatment
placement	I-treatment
.	O

During	O
her	O
hospitalization	O
,	O
the	O
patient	O
was	O
also	O
seen	O
by	O
the	O
Plastic	O
Service	O
.	O

Dr.	O
Falccouette	O
would	O
like	O
to	O
perform	O
an	B-treatment
excision	I-treatment
and	O
closure	B-treatment
flap	I-treatment
of	O
her	B-problem
left	I-problem
ischial	I-problem
decubitusin	I-problem
the	O
near	O
future	O
.	O

The	O
patient	O
was	O
discharged	O
in	O
stable	O
conditionand	O
will	O
follow	O
up	O
for	O
(	O
1	O
)	O
sacral	B-treatment
decubitus	I-treatment
closure	I-treatment
,	O
and	O
(	O
2	O
)	O
placement	B-treatment
of	I-treatment
epidural	I-treatment
pump	I-treatment
in	O
the	O
future	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
will	O
have	O
SMH	O
Service	O
that	O
comes	O
to	O
her	O
home	O
once	O
a	O
day	O
for	O
adressing	B-treatment
change	I-treatment
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Kayschird	O
to	O
schedule	O
for	O
the	B-treatment
epidural	I-treatment
pump	I-treatment
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Falccouette	O
to	O
schedule	O
for	O
excision	B-treatment
and	O
closure	B-treatment
of	O
her	B-problem
left	I-problem
ischial	I-problem
sacral	I-problem
decubitus	I-problem
.	O

Dictated	O
By	O
:	O

ECI	O
JESCSLAND	O
,	O
M.D.	O
OO63	O

Attending	O
:	O

FOMAIRE	O
KOTEKOTEJESCDREWE	O
,	O
M.D.	O
RY93	O
KE526/9219	O

Batch	O
:	O

37707	O
PAD-WORD	O

Index	O
No.	O

RWRF75BSI	O
PAD-WORD	O

D	O
:	O

07/26/99	O
PAD-WORD	O

T	O
:	O

07/26/99	O
PAD-WORD	O

CC	O
:	O

JOFREDD	O
N.	O
FALCCOUETTE	O
,	O
M.D.	O
SV7	O

Admission	O
Date	O
:	O

2011-01-21	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-02-23	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1988-10-20	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

TRAUMA	O
SER	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
20	O
year	O
old	O
driver	O
was	O
in	O
a	O
major	O
motor	O
vehicle	O
accident	O
and	O
brought	O
to	O
the	O
Emergency	O
Saints	O
Medical	O
Center	O
following	O
this	O
,	O
with	O
multiple	B-problem
trauma	I-problem
.	O

The	O
patient	O
was	O
an	O
unrestrained	O
driver	O
in	O
a	O
car	O
versus	O
tree	O
.	O

He	O
was	O
involved	O
in	O
a	O
long	O
extrication	O
with	O
a	B-test
blood	I-test
pressure	I-test
of	O
88	O
at	O
the	O
scene	O
.	O

Upon	O
extrication	O
from	O
the	O
vehicle	O
,	O
he	O
was	O
intubated	O
and	O
transported	O
to	O
the	O
Emergency	O
Room	O
.	O

He	O
was	O
tachycardic	B-problem
with	O
an	B-test
initial	I-test
blood	I-test
pressure	I-test
of	O
120	O
/	O
palpable	O
.	O

A	B-treatment
groin	I-treatment
line	I-treatment
was	O
placed	O
and	O
the	O
patient	O
was	O
sedated	O
and	O
paralyzed	O
.	O

He	O
was	O
resuscitated	O
with	O
Crystalloid	B-treatment
and	O
remained	O
hemodynamically	O
stable	O
.	O

He	O
had	O
a	B-problem
grossly	I-problem
deformed	I-problem
left	I-problem
lower	I-problem
extremity	I-problem
.	O

On	O
examination	B-test
,	O
Belmont	B-test
Coma	I-test
Scale	I-test
was	O
6T	O
;	O
blood	B-test
pressure	I-test
was	O
120	O
/	O
palpable	O
with	O
a	B-test
heart	I-test
rate	I-test
of	O
122	O
.	O

The	O
trachea	O
was	O
midline	O
.	O

The	O
abdomen	O
was	O
soft	O
.	O

Rectal	O
was	O
heme	B-problem
positive	I-problem
with	O
normal	O
prostate	O
.	O

There	O
were	O
no	O
meatal	B-problem
blood	I-problem
.	O

The	O
left	O
femur	O
was	O
grossly	B-problem
deformed	I-problem
with	O
a	B-problem
pinhole	I-problem
opening	I-problem
in	I-problem
the	I-problem
lateral	I-problem
thigh	I-problem
.	O

His	O
left	O
forearm	O
was	O
also	O
grossly	B-problem
deformed	I-problem
.	O

There	O
is	O
no	O
step-off	B-problem
at	I-problem
the	I-problem
back	I-problem
.	O

Admission	B-test
laboratories	I-test
included	O
a	B-test
hematocrit	I-test
of	O
43.3	O
and	O
white	B-test
blood	I-test
cell	I-test
count	I-test
of	O
25.2	O
,	O
normal	O
electrolytes	O
and	O
amylase	B-test
of	O
98	O
.	O

Arterial	B-test
blood	I-test
gas	I-test
showed	O
a	B-problem
mild	I-problem
metabolic	I-problem
acidosis	I-problem
.	O

Additional	B-test
assay	I-test
shows	O
slight	B-problem
widening	I-problem
of	I-problem
the	I-problem
mediastinum	I-problem
on	O
chest	B-test
x-ray	I-test
.	O

The	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
and	I-test
chest	I-test
were	O
negative	O
.	O

There	O
was	O
a	B-problem
small	I-problem
liver	I-problem
laceration	I-problem
seen	O
on	O
the	B-test
A/P	I-test
pelvis	I-test
.	O

There	O
was	O
a	B-problem
distal	I-problem
ulnar	I-problem
and	I-problem
radial	I-problem
fracture	I-problem
as	O
well	O
as	O
a	B-problem
left	I-problem
mid-shaft	I-problem
comminuted	I-problem
fracture	I-problem
of	I-problem
the	I-problem
femur	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Intensive	O
Care	O
Unit	O
.	O

He	O
was	O
also	O
seen	O
by	O
the	O
Orthopedics	O
Service	O
and	O
Neurosurgical	O
Service	O
.	O

He	O
went	O
to	O
the	O
Operating	O
Room	O
quickly	O
and	O
had	O
an	B-treatment
intramedullary	I-treatment
rodding	I-treatment
of	I-treatment
the	I-treatment
femur	I-treatment
and	O
open	B-treatment
reduction	I-treatment
and	O
internal	B-treatment
fixation	I-treatment
of	I-treatment
the	I-treatment
radius	I-treatment
and	I-treatment
ulna	I-treatment
.	O

He	O
was	O
evaluated	O
by	O
Neurosurgery	O
for	O
his	B-problem
head	I-problem
injury	I-problem
which	O
showed	O
multiple	B-problem
contusions	I-problem
in	I-problem
the	I-problem
frontal	I-problem
lobe	I-problem
.	O

He	O
was	O
extubated	O
on	O
postoperative	O
day	O
two	O
.	O

He	O
did	O
have	O
some	B-problem
blood	I-problem
loss	I-problem
anemia	I-problem
with	O
a	B-test
hematocrit	I-test
of	O
20.9	O
.	O

A	B-test
repeat	I-test
CT	I-test
scan	I-test
showed	O
no	O
change	O
.	O

He	O
was	O
begun	O
on	O
Physical	B-treatment
Therapy	I-treatment
but	O
remained	O
agitated	B-problem
.	O

He	O
was	O
discharged	O
to	O
the	O
Floor	O
.	O

His	B-test
hematocrit	I-test
remained	O
stable	O
.	O

His	O
cervical	O
spine	O
was	O
cleared	O
.	O

The	O
patient	O
was	O
seen	O
by	O
Psychiatry	O
due	O
to	O
some	B-problem
delirium	I-problem
and	O
question	O
of	O
suicidal	B-problem
ideation	I-problem
.	O

He	O
was	O
also	O
evaluated	O
by	O
the	O
Neuro-Rehabilitation	O
Service	O
who	O
thought	O
that	O
he	O
had	O
a	B-problem
post-head	I-problem
injury	I-problem
syndrome	I-problem
with	O
diffuse	B-problem
cognitive	I-problem
deficits	I-problem
.	O

He	O
continued	O
to	O
have	O
some	O
episodes	O
of	O
agitation	B-problem
which	O
were	O
treated	O
with	O
medication	B-treatment
.	O

He	O
required	O
some	B-treatment
sedation	I-treatment
and	O
restraint	B-treatment
and	O
was	O
begun	O
on	O
whatever	O
Physical	B-treatment
Therapy	I-treatment
he	O
could	O
have	O
given	O
his	B-problem
head	I-problem
injury	I-problem
.	O

He	O
was	O
continued	O
to	O
be	O
followed	O
by	O
Psychiatry	O
and	O
then	O
was	O
casted	O
by	O
Orthopedics	O
.	O

He	O
continued	O
to	O
have	O
episodes	O
of	O
confusion	B-problem
.	O

He	O
removed	O
the	B-treatment
cast	I-treatment
that	O
had	O
been	O
placed	O
and	O
then	O
a	B-treatment
long-leg	I-treatment
cast	I-treatment
was	O
then	O
placed	O
so	O
it	O
would	O
be	O
difficult	O
for	O
him	O
to	O
remove	O
or	O
to	O
ambulate	O
on	O
his	O
leg	O
,	O
which	O
might	O
jeopardize	O
his	O
closure	O
.	O

It	O
continued	O
to	O
be	O
somewhat	O
difficult	O
to	O
control	O
his	O
activity	O
and	O
Rehabilitation	O
Screen	O
was	O
in	O
place	O
but	O
there	O
was	O
difficulty	O
finding	O
the	O
appropriate	O
facility	O
.	O

His	O
family	O
was	O
also	O
involved	O
in	O
his	O
care	O
and	O
orientation	O
.	O

He	O
does	O
of	O
BuSpar	B-treatment
,	O
Trazodone	B-treatment
and	O
Haldol	B-treatment
were	O
continued	O
and	O
were	O
adjusted	O
by	O
Psychiatry	O
.	O

He	O
was	O
continued	O
on	O
observation	B-test
and	O
sitters	O
and	O
finally	O
became	O
more	O
docile	O
and	O
cooperative	O
.	O

He	O
was	O
continued	O
on	O
Physical	B-treatment
Therapy	I-treatment
and	O
with	O
his	O
mother	O
present	O
,	O
he	O
began	O
to	O
follow	O
commands	O
much	O
more	O
appropriately	O
and	O
was	O
able	O
to	O
be	O
rehabilitated	B-treatment
.	O

He	O
was	O
finally	O
sent	O
home	O
for	O
home	B-treatment
rehabilitation	I-treatment
on	O
2011-02-23	O
.	O

FINAL	O
DIAGNOSES	O
:	O

1.	O
Multiple	B-problem
trauma	I-problem
with	O
severe	B-problem
frontal	I-problem
head	I-problem
injury	I-problem
.	O

2.	O
Open	B-problem
fracture	I-problem
of	I-problem
the	I-problem
femur	I-problem
.	O

3.	O
Radial	B-problem
and	I-problem
ulnar	I-problem
fractures	I-problem
.	O

4.	O
Liver	B-problem
laceration	I-problem
.	O

SURGICAL	O
PROCEDURES	O
:	O

1.	O
Open	B-treatment
reduction	I-treatment
and	O
internal	B-treatment
fixation	I-treatment
of	I-treatment
femur	I-treatment
2011-01-21	O
.	O

2.	O
Open	B-treatment
reduction	I-treatment
and	O
internal	B-treatment
fixation	I-treatment
of	I-treatment
radius	I-treatment
and	I-treatment
ulna	I-treatment
2011-01-21	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Percocet	B-treatment
,	O
one	O
p.o.	O
q.	O
four	O
hours	O
p.r.n.	O
pain	B-problem
.	O

2.	O
Haldol	B-treatment
1	O
mg	O
p.o.	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O
agitation	B-problem
.	O

3.	O
Trazodone	B-treatment
50	O
mg	O
p.o.	O
q.	O
h.s.	O

4.	O
Droperidol	B-treatment
1.5	O
to	O
2.5	O
mg	O
p.r.n.	O
agitation	B-problem
.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
discharged	O
home	O
with	O
home	B-treatment
rehabilitation	I-treatment
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
The	O
patient	O
will	O
be	O
followed	O
by	O
Orthopedics	O
,	O
Dr.	O
Johnson	O
.	O

2.	O
To	O
be	O
followed	O
by	O
William	O
Scheidel	O
of	O
Neurological	O
Rehabilitation	O
.	O

Maria	O
L.	O
Bell	O
,	O
M.D.	O
05-084	O

Dictated	O
By	O
:	O
Michael	O
X.	O
Fisher	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2011-04-08	O
14:01	O

T	O
:	O
2011-04-10	O
08:09	O

JOB	O
#	O
:	O
48774	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Fredrick	O
Rossi	O
on	O
:	O
WED	O
2011-04-13	O
1:45	O
PM	O

(	O
End	O
of	O
Report	O
)	O

139964603	O
PAD-WORD	O

NVH	O
PAD-WORD	O

40876531	O
PAD-WORD	O

11/17/2003	O
12:00:00	O
AM	O

PELVIC	B-problem
MASS	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

11/17/2003	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

12/22/2003	O
PAD-WORD	O

ATTENDING	O
:	O

DAY	O
SECOND	O
MD	O

This	O
dictation	O
goes	O
through	O
12/21/03	O
.	O

The	O
patient	O
received	O
care	O
on	O
the	O
Baydell	O
Medical	O
Center	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pelvic	B-problem
mass	I-problem
.	O

PROBLEMS	O
:	O

Include	O
hypertension	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
57-year-old	O
female	O
status	O
post	O
ERT	B-treatment
with	O
recurrence	O
of	O
a	B-problem
pelvic	I-problem
mass	I-problem
and	O
resection	B-treatment
at	O
an	O
outside	O
hospital	O
in	O
06/22	O
.	O

Per	O
the	O
patient	O
,	O
the	B-problem
mass	I-problem
was	O
benign	O
.	O

The	O
patient	O
developed	O
severe	B-problem
left	I-problem
lower	I-problem
quadrant	I-problem
pain	I-problem
in	O
07/24	O
.	O

An	B-test
MRI	I-test
was	O
done	O
on	O
08/27/03	O
that	O
showed	O
an	B-problem
8	I-problem
cm	I-problem
left	I-problem
lower	I-problem
quadrant	I-problem
mass	I-problem
with	O
both	B-problem
cystic	I-problem
and	I-problem
solid	I-problem
components	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
Lupron	B-treatment
on	O
10/18/03	O
,	O
but	O
pain	B-problem
was	O
not	O
affected	O
.	O

She	O
was	O
put	O
on	O
Vicodin	B-treatment
ES	I-treatment
and	O
Ultram	B-treatment
with	O
minimal	O
relief	O
.	O

On	O
11/16/03	O
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
pain	I-problem
increased	O
and	O
she	O
presented	O
to	O
an	O
outside	O
hospital	O
with	O
nausea	B-problem
and	O
vomiting	B-problem
and	O
an	B-problem
inability	I-problem
to	I-problem
tolerate	I-problem
p.o.	I-problem
intake	I-problem
.	O

The	B-problem
left	I-problem
lower	I-problem
quadrant	I-problem
pain	I-problem
in	I-problem
the	I-problem
groin	I-problem
radiated	O
to	O
the	O
left	O
knee	O
.	O

No	O
fevers	B-problem
or	O
chills	B-problem
,	O
no	O
vaginal	B-problem
discharge	I-problem
or	O
bleeding	B-problem
.	O

Potassium	B-test
at	O
the	O
outside	O
hospital	O
was	O
3.1	O
.	O

White	B-test
count	I-test
was	O
27.3	O
with	O
16%	B-test
bands	I-test
.	O

Hematocrit	B-test
was	O
28.7	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
NVH	O
after	O
receiving	O
intravenous	B-treatment
fluid	I-treatment
with	O
potassium	B-treatment
,	O
Demerol	B-treatment
for	O
pain	B-treatment
control	I-treatment
and	O
clindamycin	B-treatment
,	O
Valium	B-treatment
and	O
droperidol	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypothyroidism	B-problem
,	O
arthritis	B-problem
,	O
hypertension	B-problem
,	O
hypercholesterolemia	B-problem
,	O
anemia	B-problem
and	O
asthma	B-problem
.	O

SURGICAL	O
HISTORY	O
:	O

A	B-treatment
TAH-BSO	I-treatment
in	O
1980	O
and	O
an	B-test
exploratory	I-test
laparotomy	I-test
with	O
resection	B-treatment
of	O
a	B-problem
pelvic	I-problem
mass	I-problem
in	O
06/22	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Vicodin	B-treatment
75/750	O
p.r.n.	O

2.	O
Ultram	B-treatment
.	O

3.	O
Verapamil	B-treatment
240	O
mg	O
b.i.d.	O

4.	O
Synthroid	B-treatment
100	O
mcg	O
q.d.	O

5.	O
HCTZ	B-treatment
25	O
mg	O
q.d.	O

6.	O
Arthrotec	B-treatment
0.2	O
mg	O
b.i.d.	O

7.	O
Advair	B-treatment
250/50	O
mcg	O
one	O
puff	O
q.a.m.	O

8.	O
Tofranil	B-treatment
.	O

9.	O
Ambien	B-treatment
10	O
mg	O
q.h.s.	O

10.	O
Trazadone	B-treatment
150	O
mg	O
q.h.s.	O

11.	O
Ferrous	B-treatment
sulfate	I-treatment
325	O
mg	O
t.i.d.	O

12.	O
Colace	B-treatment
.	O

ALLERGIES	O
:	O

Her	B-problem
allergies	I-problem
are	O
penicillin	B-treatment
,	O
which	O
cause	O
throat	B-problem
edema	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
tobacco	O
,	O
alcohol	O
or	O
drug	O
use	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
NVH	O
and	O
started	O
on	O
vancomycin	B-treatment
,	O
levofloxacin	B-treatment
and	O
Flagyl	B-treatment
.	O

Cultures	B-test
were	O
taken	O
.	O

Blood	B-test
cultures	I-test
were	O
done	O
for	O
a	O
possible	O
rectosigmoid	B-problem
mass	I-problem
or	O
fistula	B-problem
and	O
a	B-test
CT	I-test
showed	I-test
questionable	O
abscess	B-problem
versus	O
tumor	B-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
quadrant	I-problem
.	O

Blood	B-test
cultures	I-test
done	O
on	O
11/17/03	O
grew	O
C.	B-problem
perfringens	I-problem
.	O

Other	B-test
blood	I-test
culture	I-test
was	O
negative	O
.	O

On	O
11/20/03	O
,	O
a	B-test
PE	I-test
protocol	I-test
CT	I-test
was	O
negative	O
for	O
both	O
DVT	B-problem
and	O
PE	B-problem
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
bilateral	B-treatment
stent	I-treatment
placement	I-treatment
,	O
resection	B-treatment
of	O
the	B-problem
pelvic	I-problem
mass	I-problem
,	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
left	B-treatment
ureterolysis	I-treatment
,	O
rectosigmoid	B-treatment
resection	I-treatment
,	O
SBR	B-treatment
,	O
removal	B-treatment
of	O
a	B-problem
vaginal	I-problem
tumor	I-problem
,	O
omentectomy	B-treatment
complicated	O
by	O
an	B-problem
enterotomy	I-problem
and	O
was	O
admitted	O
to	O
the	O
ICU	O
postoperatively	O
on	O
11/21/03	O
.	O

Postoperative	O
course	O
by	O
systems	O
is	O
as	O
follows	O
:	O

1.	O
Neuro	O
:	O

She	O
had	O
a	B-treatment
PCEA	I-treatment
for	O
pain	B-problem
,	O
then	O
a	B-treatment
Dilaudid	I-treatment
PCA	I-treatment
.	O

The	O
patient	O
was	O
anxious	B-problem
with	O
depression	B-problem
poorly	I-problem
controlled	I-problem
until	O
12/14/03	O
.	O

The	O
patient	O
was	O
seen	O
by	O
Onc	O
Psychiatry	O
consult	O
,	O
who	O
recommended	O
imipramine	B-treatment
75	O
mg	O
;	O
that	O
was	O
subsequently	O
increased	O
to	O
150	O
mg	O
p.o.	O
q.h.s.	O
,	O
trazadone	B-treatment
100	O
mg	O
q.h.s.	O
and	O
Ambien	B-treatment
10	O
mg	O
q.h.s.	O

2.	O
Cardiovascular	O
:	O

The	O
patient	O
has	O
baseline	B-problem
hypertension	I-problem
that	O
was	O
difficult	O
to	O
control	O
.	O

In	O
the	O
ICU	O
,	O
the	O
patient	O
was	O
on	O
enalapril	B-treatment
,	O
hydralazine	B-treatment
and	O
labetalol	B-treatment
.	O

After	O
a	O
Cardiology	O
consulton	O
12/13/03	O
,	O
the	O
patient	O
was	O
started	O
on	O
metoprolol	B-treatment
100	O
mg	O
p.o.	O
q.i.d.	O
,	O
lisinopril	B-treatment
10	O
mg	O
q.d.	O
,	O
hydrochlorothiazide	B-treatment
25	O
mg	O
q.d.	O
.	O

Hydralazine	B-treatment
was	O
stopped	O
.	O

Blood	B-test
pressure	I-test
stayed	O
high	B-problem
with	O
an	B-test
SBP	I-test
in	O
the	O
170s	O
,	O
so	O
amlodipine	B-treatment
10	O
mg	O
q.d.	O
was	O
added	O
and	O
that	B-test
blood	I-test
pressure	I-test
was	O
still	B-problem
elevated	I-problem
.	O

At	O
the	O
time	O
of	O
transfer	O
to	O
the	O
________	O
Onc	O
Service	O
,	O
blood	B-test
pressure	I-test
was	O
within	O
the	O
normal	O
range	O
.	O

3.	O
Pulmonary	O
:	O

The	O
patient	O
was	O
extubated	O
on	O
11/22/03	O
.	O

Once	O
the	O
patient	O
was	O
extubated	O
,	O
after	O
the	B-treatment
third	I-treatment
surgery	I-treatment
,	O
the	O
patient	O
could	O
not	O
be	O
weaned	O
off	O
2	B-treatment
liters	I-treatment
of	I-treatment
nasal	I-treatment
cannula	I-treatment
and	O
was	O
to	O
______	O
to	O
20	O
breaths	O
per	O
minute	O
despite	O
nebulizer	B-treatment
treatment	I-treatment
.	O

The	O
patient	O
was	O
restarted	O
on	O
Advair	B-treatment
and	O
by	O
12/15/03	O
,	O
was	O
weaned	O
to	O
room	O
air	O
likely	O
an	O
effective	O
Advair	B-treatment
and	O
control	O
of	O
anxiety	B-problem
and	O
psychiatric	B-problem
issues	I-problem
.	O

4.	O
GI	O
:	O

On	O
postoperative	O
day	O
4	O
,	O
after	O
the	B-treatment
initial	I-treatment
surgery	I-treatment
,	O
the	O
patient	O
had	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
tachycardia	B-problem
with	O
abdominal	B-problem
pain	I-problem
.	O

A	B-test
chest	I-test
x-ray	I-test
revealed	O
increased	B-problem
free	I-problem
air	I-problem
under	I-problem
the	I-problem
diaphragm	I-problem
.	O

A	B-test
CT	I-test
revealed	O
a	O
large	O
amount	O
of	O
free	B-problem
air	I-problem
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
OR	O
on	O
postop	O
day	O
5	O
for	O
emergent	B-test
exploratory	I-test
laparotomy	I-test
that	O
disclosed	O
a	B-problem
small	I-problem
bowel	I-problem
enterotomy	I-problem
with	O
2	O
liters	O
of	O
bilious	B-problem
fluid	I-problem
within	I-problem
the	I-problem
peritoneum	I-problem
.	O

On	O
postop	O
day	O
9	O
,	O
the	O
patient	O
had	O
a	B-problem
similar	I-problem
increased	I-problem
abdominal	I-problem
pain	I-problem
episode	I-problem
and	O
was	O
taken	O
back	O
to	O
the	O
operating	O
room	O
for	O
another	B-test
emergent	I-test
exploratory	I-test
laparotomy	I-test
revealing	O
another	B-problem
peroration	I-problem
at	O
the	B-problem
site	I-problem
of	I-problem
previous	I-problem
repair	I-problem
.	O

Intraoperatively	B-treatment
,	O
the	O
patient	O
suffered	O
hypotension	B-problem
with	O
induction	O
and	O
respiratory	B-problem
insufficiency	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
ICU	O
intubated	B-treatment
with	O
stable	O
.	O

The	O
patient	O
was	O
kept	O
NPO	B-treatment
with	O
an	B-treatment
NG	I-treatment
tube	I-treatment
until	O
postop	O
day	O
14	O
and_____	O
started	O
on	O
clear	B-treatment
sips	I-treatment
with	O
TPN	B-treatment
for	O
nutritional	B-treatment
supplementation	I-treatment
.	O

The	O
patient	O
intermittently	O
tolerated	O
diet	B-treatment
advancement	I-treatment
,	O
but	O
then	O
would	O
vomit	O
and	O
would	O
have	O
the	B-treatment
NG	I-treatment
tube	I-treatment
replaced	O
.	O

The	O
patient	O
,	O
at	O
the	O
time	O
of	O
transfer	O
,	O
was	O
tolerating	O
clears	B-treatment
with	O
low	B-problem
stoma	I-problem
output	I-problem
,	O
likely	O
to	O
tolerate	O
slow	O
advancement	O
.	O

The	O
patient	O
still	O
had	O
a	B-treatment
PICC	I-treatment
line	I-treatment
at	O
the	O
time	O
,	O
although	O
TPN	B-treatment
was	O
being	O
held	O
and	O
calorie	B-treatment
counts	I-treatment
were	O
done	O
to	O
evaluate	O
the	O
benefit	O
of	O
p.o.	O
nutrition	O
.	O

5.	O
GU	O
:	O

No	O
issues	O
.	O

The	O
patient	O
generally	O
had	O
good	O
urine	O
output	O
.	O

Presumably	O
,	O
should	O
follow	O
up	O
with	O
the	O
Urology	O
Clinic	O
for	O
removal	B-treatment
of	I-treatment
the	I-treatment
ureteral	I-treatment
stents	I-treatment
at	O
some	O
point	O
.	O

6.	O
Infectious	B-problem
Disease	I-problem
:	O

Blood	B-test
cultures	I-test
mentioned	O
previously	O
were	O
positive	O
for	O
C.	B-problem
perfringens	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
empiricvancomycin	B-treatment
,	O
levofloxacin	B-treatment
and	O
Flagyl	B-treatment
after	O
the	B-test
second	I-test
exploratory	I-test
laparotomy	I-test
.	O

She	O
was	O
started	O
on	O
vancomycin	B-treatment
,	O
levofloxacin	B-treatment
,	O
Flagyl	B-treatment
,	O
doxycycline	B-treatment
and	O
fluconazole	B-treatment
.	O

Blood	B-test
cultures	I-test
drawn	O
on	O
12/01/03	O
were	O
negative	O
.	O

JP	B-treatment
drain	I-treatment
was	O
cultured	B-test
on	O
12/11/03	O
along	O
with	O
aurine	B-test
culture	I-test
.	O

TLC	B-test
,	O
TIB	B-test
and	O
blood	B-test
culture	I-test
were	O
all	O
negative	O
.	O

These	O
were	O
cultured	O
because	O
the	B-test
patient	I-test
&apos;s	I-test
white	I-test
blood	I-test
count	I-test
was	O
increasing	O
to	O
the	O
mid	O
20s	O
without	O
fever	B-problem
or	O
other	B-problem
symptoms	I-problem
for	O
explanation	O
.	O

The	O
patient	O
,	O
at	O
the	O
time	O
of	O
transfer	O
,	O
to	O
the	O
Gyn	O
/	O
Onc	O
Service	O
was	O
not	O
antibiotics	B-treatment
and	O
the	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
trending	O
down	O
.	O

7.	O
Heme	O
:	O

The	O
patient	O
was	O
stable	O
.	O

She	O
was	O
receiving	O
sub	B-treatment
.q.	I-treatment
heparin	I-treatment
for	O
DVT	B-treatment
prophylaxis	I-treatment
postoperatively	O
.	O

On	O
postop	O
day	O
6	O
,	O
an	O
ID	O
consult	O
noted	O
erythema	B-problem
at	O
the	B-treatment
right	I-treatment
IJ	I-treatment
line	I-treatment
site	I-treatment
.	O

On	O
postop	O
day	O
8	O
,	O
the	B-treatment
right	I-treatment
IJ	I-treatment
line	I-treatment
was	O
pulled	O
.	O

The	O
tip	O
was	O
cultured	O
with	O
no	O
growth	B-problem
.	O

On	O
postop	O
day	O
9	O
,	O
bilateral	B-test
upper	I-test
extremity	I-test
Dopplers	I-test
revealed	O
a	B-problem
right	I-problem
IJ	I-problem
clot	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
heparin	B-treatment
.	O

The	O
patient	O
transitioned	O
to	O
Lovenox	B-treatment
on	O
12/09/03	O
after	O
a	O
Cardiology	O
consult	O
indicated	O
increased	O
survival	O
with	O
Lovenox	B-treatment
therapy	I-treatment
.	O

8.	O
Endocrine	O
:	O

Has	O
a	O
history	O
of	O
hypothyroidism	B-problem
.	O

The	O
patient	O
was	O
on	O
home	B-treatment
Synthroid	I-treatment
dose	I-treatment
during	O
her	O
hospitalization	O
,	O
insulin	B-treatment
sliding	I-treatment
scale	I-treatment
with	O
q.6h.	O
fingersticks	B-test
while	O
she	O
was	O
on	O
TPN	B-treatment
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Gynecologic	O
Oncology	O
Service	O
on	O
12/21/03	O
.	O

The	O
rest	O
of	O
the	O
dictation	O
is	O
to	O
follow	O
.	O

eScription	O
document	O
:	O

2-9396725	O
JFDDaua	O
Tel	O

Dictated	O
By	O
:	O

FOORDRIG	O
,	O
LA	O
BOMA	O

Attending	O
:	O

SECOND	O
,	O
CA	O
Dictation	O
ID	O
0750210	O

D	O
:	O

12/24/03	O
PAD-WORD	O

T	O
:	O

12/24/03	O
PAD-WORD	O

Admission	O
Date	O
:	O

2015-05-13	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-05-20	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1813-05-16	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CME	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
104	O
year	O
old	O
female	O
patient	O
with	O
a	O
history	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
hypertension	B-problem
and	O
cerebrovascular	B-problem
accident	I-problem
who	O
presents	O
with	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
cough	B-problem
.	O

The	O
patient	O
states	O
that	O
she	O
has	O
no	O
idea	O
why	O
she	O
was	O
brought	O
to	O
the	O
Emergency	O
Department	O
and	O
denies	O
any	B-problem
symptoms	I-problem
.	O

She	O
reports	O
an	B-problem
occasional	I-problem
nonproductive	I-problem
cough	I-problem
that	O
she	O
has	O
had	O
"for	O
years"	O
and	O
feels	O
that	O
she	O
has	O
been	O
experiencing	O
alternating	B-problem
chills	I-problem
and	I-problem
feeling	I-problem
hot	I-problem
.	O

A	O
progress	O
note	O
in	O
the	O
patient	O
's	O
chart	O
from	O
her	O
assisted	O
living	O
facility	O
indicates	O
that	O
the	O
patient	O
has	O
had	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
cough	B-problem
for	O
one	O
day	O
with	O
chills	B-problem
but	O
no	O
fever	B-problem
.	O

She	O
has	O
been	O
recently	O
evaluated	O
as	O
an	O
outpatient	O
for	O
bradycardia	B-problem
.	O

She	O
was	O
seen	O
by	O
her	O
cardiologist	O
,	O
Dr.	O
Clements	O
and	O
had	O
a	B-test
Holter	I-test
monitor	I-test
on	O
2015-05-01	O
,	O
that	O
showed	O
first	B-problem
degree	I-problem
AV	I-problem
block	I-problem
with	O
a	B-test
rate	I-test
that	O
ranged	O
between	O
35	O
to	O
53	O
beats	O
per	O
minute	O
.	O

In	O
the	O
Emergency	O
Department	O
,	O
the	O
patient	O
was	O
given	O
nebulizer	B-treatment
treatment	I-treatment
,	O
started	O
on	O
antibiotics	B-treatment
for	O
presumed	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
exacerbation	I-problem
.	O

She	O
was	O
noted	O
to	O
have	O
lateral	B-problem
ST	I-problem
depressions	I-problem
and	O
given	O
Aspirin	B-treatment
.	O

She	O
continues	O
to	O
deny	O
chest	B-problem
pain	I-problem
,	O
palpitations	B-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
fevers	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
,	O
melena	B-problem
,	O
dysuria	B-problem
,	O
urinary	B-problem
frequency	I-problem
and	I-problem
urgency	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
with	O
asthmatic	B-problem
component	I-problem
.	O

Hypothyroidism	B-problem
.	O

Gastroenteritis	B-problem
.	O

Anxiety	B-problem
.	O

Insomnia	B-problem
.	O

Hypertension	B-problem
.	O

Osteoporosis	B-problem
.	O

History	O
of	O
cerebrovascular	B-problem
accident	I-problem
with	O
residual	B-problem
right	I-problem
sided	I-problem
weakness	I-problem
.	O

Scoliosis	B-problem
.	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

History	O
of	O
kidney	B-problem
mass	I-problem
.	O

History	O
of	O
lower	B-problem
gastrointestinal	I-problem
bleed	I-problem
.	O

Status	O
post	O
total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingo-	I-treatment
oophorectomy	I-treatment
.	O

Left	B-problem
cataract	I-problem
.	O

Bradycardia	B-problem
followed	O
by	O
outpatient	O
cardiologist	O
with	O
a	B-test
Holter	I-test
monitor	I-test
on	O
2015-05-01	O
,	O
with	O
first	B-problem
degree	I-problem
AV	I-problem
block	I-problem
and	O
a	B-test
heart	I-test
rate	I-test
ranging	O
between	O
35	O
to	O
53	O
beats	O
per	O
minute	O
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
,	O
Erythromycin	B-treatment
,	O
Valium	B-treatment
,	O
Compazine	B-treatment
,	O

Demerol	B-treatment
,	O
Percodan	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION:	O

1.	O
Levothyroxine	B-treatment
50	O
mcg	O
p.o.	O
once	O
daily	O
.	O

2.	O
Combivent	B-treatment
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

3.	O
Flovent	B-treatment
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

4.	O
Protonix	B-treatment
40	O
mg	O
once	O
daily	O
.	O

5.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
once	O
daily	O
.	O

6.	O
Norvasc	B-treatment
5	O
mg	O
twice	O
a	O
day	O
.	O

7.	O
Lasix	B-treatment
40	O
mg	O
once	O
daily	O
.	O

8.	O
Senna	B-treatment
one	O
once	O
daily	O
.	O

9.	O
Dulcolax	B-treatment
10	O
mg	O
once	O
daily	O
p.r.n.	O

10	O
.	O

TUMS	B-treatment
500	O
mg	O
twice	O
a	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
at	O
Norwood	O
in	O
assisted	O
living	O
section	O
.	O

She	O
has	O
a	O
24	O
hour	O
caregiver	O
.	O

The	O
patient	O
quit	O
smoking	O
fifty	O
years	O
ago	O
but	O
previously	O
was	O
a	O
heavy	O
smoker	O
,	O
though	O
states	O
that	O
she	O
never	O
inhaled	O
.	O

The	O
patient	O
denies	O
use	O
of	O
alcohol	O
or	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
98.1	O
,	O
blood	B-test
pressure	I-test

144/38	O
,	O
heart	B-test
rate	I-test
41	O
,	O
respiratory	B-test
rate	I-test
20	O
,	O
oxygen	B-test
saturation	I-test

94	O
percent	O
in	O
room	O
air	O
and	O
96	O
percent	O
on	O
three	O
liters	O
.	O

In	O
general	O
,	O
a	O
well	O
appearing	O
elderly	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Skin	O
is	O
warm	O
and	O
dry	O
with	O
decreased	B-problem
skin	I-problem
turgor	I-problem
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
-	O
The	O
pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Extraocular	O
movements	O
are	O
intact	O
.	O

Dry	B-problem
mucous	I-problem
membranes	I-problem
.	O

The	O
oropharynx	O
is	O
clear	O
.	O

Neck	O
is	O
supple	O
,	O
full	O
range	O
of	O
motion	O
,	O
no	O
jugular	B-problem
venous	I-problem
distension	I-problem
or	O
lymphadenopathy	B-problem
.	O

The	O
heart	O
was	O
bradycardic	B-problem
with	O
regular	O
rhythm	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Lungs	O
-	O
diffuse	B-problem
expiratory	I-problem
wheezes	I-problem
with	O
bibasilar	B-problem
rales	I-problem
,	O
left	O
over	O
right	O
.	O

The	O
abdomen	O
revealed	O
normoactive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Rectal	O
is	O
guaiac	B-problem
positive	I-problem
per	O
Emergency	O
Department	O
.	O

Extremities	O
-	O
no	O
cyanosis	B-problem
or	O
clubbing	B-problem
,	O
one	B-problem
plus	I-problem
bilateral	I-problem
lower	I-problem
extremity	I-problem
edema	I-problem
with	O
right	O
worse	O
than	O
left	O
.	O

Neurologically	O
,	O
the	O
patient	O
is	O
awake	O
,	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
8.5	O
(	O
80	O
percent	O
neutrophils	B-test
,	O
13	O
percent	O
lymphocytes	B-test
)	O
,	O
hematocrit	B-test
27.4	O
,	O
platelet	B-test
count	I-test
277,000	O
.	O

Sodium	B-test
133	O
,	O
potassium	B-test
4.8	O
,	O
chloride	B-test

94	O
,	O
bicarbonate	B-test
24	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
39	O
,	O
creatinine	B-test
2.0	O
,	O
glucose	B-test
111	O
.	O

CK	B-test
152	O
,	O
CK	B-test
MB	I-test
3.0	O
,	O
troponin	B-test
0.04.	O

INR	B-test
1.1.	O

Chest	B-test
x-ray	I-test
showed	O
equivocal	B-problem
retrocardiac	I-problem
opacity	I-problem
.	O

Electrocardiogram	B-test
showed	O
sinus	B-problem
bradycardia	I-problem
at	O
40	O
beats	O
per	O
minute	O
.	O

First	B-problem
degree	I-problem
AV	I-problem
block	I-problem
with	O
PR	B-test
interval	I-test
220	O
,	O
left	B-problem
axis	I-problem
deviation	I-problem
,	O
right	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
with	O
a	B-problem
left	I-problem
anterior	I-problem
fascicular	I-problem
block	I-problem
,	O
0.1103	O
N.	O
Fifth	O
Cir.	O
depressions	O
in	O

V4	O
through	O
V6	O
.	O

HOSPITAL	O
COURSE	O
:	O

Shortness	B-problem
of	I-problem
breath	I-problem
-	O
Though	O
the	O
patient	O
denied	O
shortness	B-problem
of	I-problem
breath	I-problem
on	O
admission	O
,	O
a	O
progress	O
note	O
from	O

Norwood	O
nursing	O
facility	O
suggested	O
that	O
the	O
patient	O
had	O
been	O
having	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
cough	B-problem
for	O
approximately	O
one	O
day	O
with	O
difficulty	B-problem
ambulating	I-problem
,	O
needing	O
to	O
travel	O
in	O
a	B-treatment
wheelchair	I-treatment
.	O

The	O
patient	O
was	O
afebrile	B-problem
on	O
admission	O
with	O
a	O
normal	O
white	O
blood	O
cell	O
count	O
but	O
had	O
significant	B-problem
wheezing	I-problem
and	O
rales	B-problem
on	O
physical	B-test
examination	I-test
with	O
a	O
possible	O
left	B-problem
lower	I-problem
lobe	I-problem
opacity	I-problem
seen	O
on	O
chest	B-test
x-ray	I-test
.	O

The	O
etiology	O
of	O
the	B-problem
patient	I-problem
's	I-problem
shortness	I-problem
of	I-problem
breath	I-problem
was	O
considered	O
a	O
likely	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
exacerbation	I-problem
and	O
the	O
patient	O
was	O
started	O
on	O
Albuterol	B-treatment
and	O
Atrovent	B-treatment
nebulizers	I-treatment
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
Doxycycline	B-treatment
given	O
the	O
concern	O
for	O
pneumonia	B-problem
on	O
chest	B-test
x-ray	I-test
.	O

She	O
was	O
also	O
continued	O
on	O
steroids	B-treatment
given	O
evidence	O
of	O
severe	B-problem
airway	I-problem
obstruction	I-problem
.	O

The	B-problem
patient	I-problem
's	I-problem
shortness	I-problem
of	I-problem
breath	I-problem
was	O
also	O
considered	O
possibly	O
related	O
to	O
a	B-problem
coronary	I-problem
event	I-problem
and	O
she	O
was	O
admitted	O
for	O
rule	O
out	O
myocardial	B-problem
infarction	I-problem
.	O

The	B-test
patient	I-test
's	I-test
enzymes	I-test
were	O
cycled	O
and	O
were	O
negative	O
.	O

The	B-test
patient	I-test
's	I-test
electrocardiogram	I-test
performed	O
on	O
hospital	O
day	O
number	O
two	O
was	O
concerning	O
for	O
2:1	B-problem
heart	I-problem
block	I-problem
and	O
the	O
cardiology	O
consult	O
service	O
was	O
contacted	O
for	O
evaluation	B-test
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Coronary	O
Care	O
Unit	O
late	O
on	O
hospital	O
day	O
number	O
two	O
and	O
received	O
a	B-treatment
temporary	I-treatment
wire	I-treatment
.	O

The	O
following	O
day	O
the	O
patient	O
received	O
a	B-treatment
permanent	I-treatment
dual	I-treatment
chamber	I-treatment
rate	I-treatment
responsive	I-treatment
pacemaker	I-treatment
.	O

The	O
patient	O
was	O
transferred	O
back	O
to	O
the	O
general	O
medicine	O
service	O
where	O
she	O
continued	O
to	O
exhibit	O
signs	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
exacerbation	I-problem
and	O
nebulizers	B-treatment
,	O
steroids	B-treatment
and	O
antibiotics	B-treatment
were	O
continued	O
.	O

The	O
patient	O
's	O
respiratory	O
status	O
improved	O
throughout	O
the	O
remainder	O
of	O
her	O
hospitalization	O
and	O
oxygen	B-treatment
was	O
eventually	O
weaned	O
.	O

Once	O
the	O
patient	O
was	O
transferred	O
out	O
of	O
the	O
Coronary	O
Care	O
Unit	O
,	O
she	O
appeared	O
to	O
have	O
an	B-problem
element	I-problem
of	I-problem
heart	I-problem
failure	I-problem
in	O
addition	O
to	O
her	B-problem
chronic	I-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

She	O
was	O
given	O
20	O
mg	O
of	O
intravenous	B-treatment
Lasix	I-treatment
with	O
impressive	O
urine	O
output	O
and	O
improvement	O
in	O
her	B-test
overall	I-test
fluid	I-test
status	I-test
.	O

The	O
patient	O
was	O
eventually	O
restarted	O
on	O
her	O
outpatient	O
dose	O
of	O
Lasix	B-treatment
once	O
her	B-test
renal	I-test
function	I-test
improved	O
to	O
baseline	O
and	O
remained	O
hemodynamically	O
stable	O
throughout	O
the	O
remainder	O
of	O
her	B-treatment
hospitalization	I-treatment
.	O

Heart	B-problem
block	I-problem
-	O
As	O
noted	O
previously	O
,	O
the	B-test
patient	I-test
's	I-test
electrocardiogram	I-test
was	O
significant	O
for	O
a	B-problem
2:1	I-problem
heart	I-problem
block	I-problem
and	O
cardiology	O
consult	O
service	O
was	O
contacted	O
for	O
evaluation	B-test
.	O

The	O
patient	O
received	O
a	B-treatment
temporary	I-treatment
pacing	I-treatment
wire	I-treatment
on	O
the	O
evening	O
of	O
hospital	O
day	O
number	O
two	O
and	O
on	O
hospital	O
day	O
number	O
three	O
received	O
a	B-treatment
dual	I-treatment
chamber	I-treatment
pacemaker	I-treatment
.	O

Renal	O
-	O
The	O
patient	O
was	O
admitted	O
with	O
a	B-test
creatinine	I-test
of	O
1.8	O
,	O
considered	O
likely	O
secondary	O
to	O
hypovolemia	B-problem
.	O

Her	B-test
calculated	I-test
fractional	I-test
excretion	I-test
of	I-test
sodium	I-test
was	O
0.13	O
percent	O
suggesting	O
a	B-problem
prerenal	I-problem
cause	I-problem
.	O

The	B-test
patient	I-test
's	I-test
creatinine	I-test
improved	O
to	O
1.1	O
with	O
hydration	B-treatment
.	O

Once	O
the	B-test
patient	I-test
's	I-test
creatinine	I-test
had	O
improved	O
to	O
baseline	O
,	O
her	B-treatment
Lasix	I-treatment
and	O
ace	B-treatment
inhibitor	I-treatment
were	O
restarted	O
and	O
the	B-test
patient	I-test
's	I-test
creatinine	I-test
was	O
noted	O
to	O
be	O
stable	O
.	O

Gastrointestinal	O
-	O
The	O
patient	O
was	O
admitted	O
with	O
a	O
history	O
of	O
gastrointestinal	B-problem
bleed	I-problem
with	O
guaiac	B-problem
positive	I-problem
stools	I-problem
on	O
admission	O
.	O

Her	B-test
hematocrit	I-test
was	O
noted	O
to	O
trend	O
down	O
after	O
transfusion	B-treatment
of	O
one	O
unit	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
on	O
admission	O
.	O

Given	O
guaiac	B-problem
positive	I-problem
stools	I-problem
and	O
her	O
history	O
of	O
gastrointestinal	B-problem
bleed	I-problem
in	O
addition	O
to	O
use	O
of	O
steroids	B-treatment
for	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
exacerbation	I-problem
,	O
the	O
gastroenterology	O
consult	O
service	O
was	O
contacted	O
.	O

The	O
results	O
of	O
that	O
consultation	O
and	O
potential	O
esophagogastroduodenoscopy	B-test
are	O
pending	O
at	O
the	O
time	O
of	O
dictation	O
.	O

Hypertension	B-problem
-	O
The	O
patient	O
had	O
moderate	O
control	O
of	O
her	B-test
blood	I-test
pressure	I-test
throughout	O
her	O
admission	O
.	O

Her	B-treatment
calcium	I-treatment
channel	I-treatment
blocker	I-treatment
and	O
ace	B-treatment
inhibitor	I-treatment
were	O
continued	O
.	O

Hematology	O
-	O
As	O
noted	O
previously	O
,	O
the	B-test
patient	I-test
's	I-test
hematocrit	I-test
was	O
noted	O
to	O
drop	O
after	O
transfusion	B-treatment
with	O
one	O
unit	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
on	O
admission	O
.	O

Given	O
guaiac	B-problem
positive	I-problem
stools	I-problem
and	O
the	O
patient	O
's	O
history	O
of	O
gastrointestinal	B-problem
bleed	I-problem
,	O
gastroenterology	O
consult	O
service	O
was	O
contacted	O
for	O
possible	O
esophagogastroduodenoscopy	B-test
and/or	O
colonoscopy	B-test
.	O

The	O
results	O
of	O
this	O
consultation	O
are	O
pending	O
at	O
the	O
time	O
of	O
dictation	O
.	O

The	O
remainder	O
of	O
the	O
Hubbard	O
Regional	O
Hospital	O
hospital	O
course	O
,	O
discharge	O
diagnoses	O
,	O
medications	B-treatment
and	O
follow-up	O
will	O
be	O
dictated	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Justin	O
Q.	O
Yagi	O
,	O
M.D.	O
12AKK	O

Dictated	O
By:Miriam	O
H	O
Hines	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2015-05-18	O
11:24:17	O

T	O
:	O

2015-05-18	O
14:58:16	O

Job#	O
:	O

21080	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Jose	O
M.	O
Rosales	O
on	O
:	O

MON	O
2015-07-27	O
9:58	O
AM	O

(	O
End	O
of	O
Report	O
)	O

142995994	O
SC	O

54818584	O
PAD-WORD	O

976113	O
PAD-WORD	O

1/23/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/23/1992	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/26/1992	O
PAD-WORD	O

DIAGNOSIS	O
ON	O
DISCHARGE	O
:	O

1.	O
STATUS	O
POST	O
MOTORVEHICLE	O
ACCIDENT	O
WITH	O
TRANSIENT	B-problem
PARAPLEGIA	I-problem
.	O

2.	O
RIGHT	B-problem
HYDRONEPHROSIS	I-problem
ON	O
CT	B-test
SCAN	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
20	O
year	O
old	O
black	O
female	O
who	O
was	O
a	O
pedestrian	O
when	O
struck	O
by	O
a	O
car	O
at	O
apparent	O
high	O
speed	O
.	O

There	O
was	O
apparent	B-problem
loss	I-problem
of	I-problem
consciousness	I-problem
at	O
the	O
scene	O
and	O
significant	O
deformity	O
of	O
the	O
anterior	O
portion	O
of	O
the	O
motorvehicle	O
with	O
positive	O
starring	O
of	O
the	O
windshield	O
.	O

The	O
patient	O
was	O
conscious	O
on	O
the	O
scene	O
when	O
evaluated	O
by	O
EMT	O
&apos;s	O
but	O
at	O
the	O
scene	O
,	O
the	O
patient	O
was	O
apparently	B-problem
paraplegic	I-problem
below	I-problem
the	I-problem
umbilicus	I-problem
with	O
absence	B-problem
of	I-problem
movement	I-problem
and	I-problem
sensation	I-problem
below	I-problem
the	I-problem
umbilicus	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Status	O
post	O
laparotomy	B-treatment
for	O
an	B-problem
ovarian	I-problem
cyst	I-problem
in	O
1988	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

None	O
.	O

ALLERGIES	O
:	O

None	O
.	O

She	O
denies	O
cigarette	O
use	O
and	O
ethanol	O
use	O
as	O
well	O
as	O
a	O
recreational	O
drug	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
initial	B-test
exam	I-test
,	O
her	O
left	O
shoulder	O
was	O
tender	B-problem
to	O
palpation	B-test
over	O
the	O
proximal	O
humerus	O
with	O
decreased	B-problem
range	I-problem
of	I-problem
motion	I-problem
.	O

She	O
was	O
without	O
the	O
ability	O
to	O
move	O
her	O
left	O
lower	O
extremity	O
with	O
decreased	B-problem
sensation	I-problem
in	I-problem
the	I-problem
left	I-problem
leg	I-problem
.	O

The	O
right	O
leg	O
was	O
with	O
decreased	B-problem
range	I-problem
of	I-problem
motion	I-problem
of	O
thigh	O
flexion	O
and	O
extension	O
.	O

The	O
back	O
was	O
notable	O
for	O
tenderness	B-problem
at	O
the	O
level	O
of	O
L3-L5	O
.	O

LABORATORY	O
EXAMINATION	O
:	O

Initial	B-test
radiologic	I-test
evaluation	I-test
showed	O
negative	O
C-spine	O
,	O
thoracic	O
spine	O
,	O
and	O
lumbosacral	O
spine	O
films	O
.	O

Abdominal	B-test
CT	I-test
was	O
negative	O
except	O
for	O
right	B-problem
hydronephrosis	I-problem
with	O
mild	B-problem
right	I-problem
hydroureter	I-problem
.	O

Back	B-test
MRI	I-test
was	O
negative	O
.	O

Film	B-test
of	I-test
the	I-test
left	I-test
humerus	I-test
was	O
also	O
negative	O
.	O

HOSPITAL	O
COURSE	O
:	O

A	O
Neurosurgery	O
consultation	O
was	O
obtained	O
,	O
and	O
it	O
was	O
their	O
impression	O
that	O
the	B-problem
patient	I-problem
&apos;s	I-problem
paraplegia	I-problem
might	O
possibly	O
represent	O
a	B-problem
cord	I-problem
concussion	I-problem
,	O
and	O
recommended	O
treatment	B-treatment
with	I-treatment
intravenous	I-treatment
steroids	I-treatment
for	O
24	O
hours	O
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
paraplegia	I-problem
resolved	O
by	O
the	O
morning	O
of	O
her	O
second	O
hospital	O
day	O
,	O
and	O
she	O
maintained	O
5/5	O
motor	O
strength	O
in	O
all	O
groups	O
.	O

A	O
Urology	O
consultation	O
was	O
obtained	O
,	O
and	O
it	O
was	O
recommended	O
that	O
an	B-test
IVP	I-test
be	O
obtained	O
.	O

This	O
was	O
obtained	O
on	O
the	O
day	O
of	O
discharge	O
,	O
however	O
,	O
due	O
to	O
residual	B-problem
contrast	I-problem
in	I-problem
the	I-problem
colon	I-problem
from	O
the	B-test
patient	I-test
&apos;s	I-test
prior	I-test
abdominal	I-test
CT	I-test
scan	I-test
,	O
the	B-test
exam	I-test
was	O
postponed	O
after	O
a	B-test
scout	I-test
film	I-test
was	O
obtained	O
.	O

The	O
patient	O
fell	O
well	O
on	O
the	O
day	O
of	O
discharge	O
.	O

She	O
remained	O
afebrile	B-problem
throughout	O
her	O
hospital	O
course	O
.	O

Additionally	O
on	O
the	O
night	O
before	O
discharge	O
,	O
flexion	B-test
and	I-test
extension	I-test
views	I-test
of	I-test
the	I-test
lumbosacral	I-test
spine	I-test
were	O
obtained	O
,	O
and	O
showed	O
no	O
fracture	B-problem
or	O
instability	B-problem
.	O

DISPOSITION	O
:	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Tylenol	B-treatment
650	O
mg	O
p.o.	O
q4	O
hours	O
p.r.n.	O
pain	B-problem
.	O

She	O
will	O
followup	O
in	O
the	O
Wardca	O
Presiew	O
Hospital	O
in	O
one	O
week	O
.	O

She	O
will	O
have	O
an	B-test
IVP	I-test
repeated	O
in	O
one	O
week	O
at	O
which	O
time	O
she	O
should	O
have	O
cleared	O
the	B-problem
residual	I-problem
contrast	I-problem
in	I-problem
her	I-problem
colon	I-problem
.	O

She	O
will	O
have	O
urology	O
followup	O
after	O
her	B-test
IVP	I-test
.	O

OP303/0134	O
NARI	O
BLACK	O
,	O
M.D.	O
SU1	O

D	O
:	O

01/26/92	O
PAD-WORD	O

Batch	O
:	O

7505	O
PAD-WORD	O

Report	O
:	O

K7798E74	O
PAD-WORD	O

T	O
:	O

01/27/92	O
PAD-WORD	O

Dictated	O
By	O
:	O

SHAZA	O
C.	O
SCHAUMANN	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2013-11-01	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-12-10	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2013-11-01	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

Neonatology	O
PAD-WORD	O

HISTORY	O
:	O

Mychelia	O
Boyd	O
was	O
born	O
at	O
28-2/7	O
weeks	O
gestation	O
and	O
delivered	O
due	O
to	O
unstoppable	B-problem
premature	I-problem
labor	I-problem
.	O

Mother	O
is	O
an	O
18-year-old	O
prima	O
gravida	O
,	O
estimated	O
date	O
of	O
delivery	O
2014-01-22	O
.	O

Prenatal	B-test
screens	I-test
include	O
blood	B-test
type	I-test
O	O
negative	O
.	O

Other	B-test
prenatal	I-test
screens	I-test
were	O
unknown	O
at	O
time	O
of	O
delivery	B-treatment
.	O

Pregnancy	O
was	O
uncomplicated	O
until	O
the	O
day	O
of	O
delivery	B-treatment
when	O
mother	O
presented	O
to	O
HealthSouth	O
New	O
England	O
Rehab	O
Hospital	O
Hospital	O
with	O
bleeding	B-problem
and	O
was	O
sent	O
home	O
.	O

She	O
then	O
presented	O
to	O
Jordan	O
Hospital	O
Hospital	O
where	O
she	O
was	O
noted	O
to	O
be	O
5	B-problem
cm	I-problem
dilated	I-problem
with	O
a	B-problem
transverse	I-problem
lie	I-problem
presentation	I-problem
.	O

She	O
was	O
given	O
betamethasone	B-treatment
times	O
one	O
and	O
transferred	O
to	O
the	O
Nantucket	O
Cottage	O
Hospital	O
where	O
she	O
was	O
delivered	O
by	O
cesarean	B-treatment
section	I-treatment
with	O
rupture	B-problem
of	I-problem
membranes	I-problem
at	O
time	O
of	O
delivery	B-treatment
notable	O
for	O
slight	B-problem
meconium	I-problem
stained	I-problem
amniotic	I-problem
fluid	I-problem
.	O

The	O
baby	O
emerged	O
with	O
spontaneous	O
cry	O
,	O
received	O
routine	B-treatment
care	I-treatment
and	O
then	O
was	O
intubated	O
in	O
the	O
Delivery	O
Room	O
due	O
to	O
inconsistent	B-problem
respiratory	I-problem
effort	I-problem
and	O
increased	B-problem
work	I-problem
of	I-problem
breathing	I-problem
.	O

Apgars	B-test
were	O
6	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

She	O
was	O
transferred	O
to	O
the	O
newborn	O
Intensive	O
Care	O
Unit	O
for	O
further	B-treatment
management	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Her	B-test
admission	I-test
physical	I-test
revealed	O
a	B-test
birth	I-test
weight	I-test
of	O
901	O
gm	O
,	O
20th	O
percentile	O
;	O
length	B-test
34	O
cm	O
,	O
25th	O
percentile	O
;	O
head	B-test
circumference	I-test
25	O
cm	O
,	O
25th	O
percentile	O
.	O

Anterior	O
fontanelle	O
open	O
,	O
soft	O
and	O
flat	O
.	O

Red	B-test
reflex	I-test
was	O
difficult	O
to	O
appreciate	O
bilaterally	O
.	O

Pupils	O
were	O
large	O
but	O
equal	O
and	O
reactive	O
.	O

Palate	O
deferred	O
due	O
to	O
oral	B-treatment
intubation	I-treatment
.	O

No	O
defect	B-problem
noted	O
during	O
procedure	B-treatment
.	O

Increased	B-problem
work	I-problem
of	I-problem
breathing	I-problem
prior	O
to	O
intubation	B-treatment
,	O
but	O
presently	O
comfortable	O
.	O

Breath	O
sounds	O
slightly	B-problem
crackly	I-problem
,	O
symmetric	O
equal	O
air	O
entry	O
.	O

Cardiovascular	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-problem
.	O

Peripheral	B-test
pulses	I-test
plus	O
2	O
and	O
symmetric	O
.	O

Abdomen	O
soft	O
without	O
hepatosplenomegaly	B-problem
.	O

Three-vessel	O
cord	O
,	O
clamped	O
.	O

Normal	O
female	O
external	O
genitalia	O
.	O

Normal	O
back	O
and	O
hips	O
.	O

Skin	O
was	O
pink	O
and	O
well-perfused	O
.	O

Appropriate	O
tone	O
and	O
activity	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

Respiratory	O
:	O

The	O
baby	O
was	O
intubated	O
in	O
the	O
Delivery	O
Room	O
,	O
received	O
two	O
doses	O
of	O
surfactant	B-treatment
.	O

Radiograph	B-test
revealed	O
bilateral	B-problem
diffuse	I-problem
granular	I-problem
pattern	I-problem
consistent	O
with	O
surfactant	B-problem
deficiency	I-problem
.	O

Maximum	B-treatment
mechanical	I-treatment
ventilation	I-treatment
PIP	B-treatment
26	O
,	O
PEEP	B-treatment
6	O
,	O
rate	B-treatment
of	O
25	O
,	O
maximum	B-treatment
FIO2	I-treatment
35	O
percent	O
.	O

Mychelia	O
was	O
extubated	O
to	O
a	B-treatment
CPAP	I-treatment
of	O
6	O
cm	O
on	O
day	O
of	O
life	O
two	O
where	O
she	O
remained	O
until	O
day	O
of	O
life	O
20	O
.	O

On	O
day	O
of	O
life	O
two	O
,	O
she	O
was	O
also	O
loaded	O
with	O
caffeine	B-treatment
and	O
continues	O
on	O
caffeine	B-treatment
at	O
time	O
of	O
transfer	O
.	O

She	O
was	O
transitioned	O
to	O
a	B-treatment
nasal	I-treatment
cannula	I-treatment
on	O
day	O
of	O
life	O
20	O
and	O
remains	O
on	O
nasal	B-treatment
cannula	I-treatment
O2	I-treatment
100	O
percent	O
at	O
13	O
cc	O
flow	O
.	O

She	O
averaged	O
2-3	O
apnea	B-problem
episodes	I-problem
a	O
day	O
with	O
bradycardia	B-problem
and	O
desaturations	B-problem
.	O

She	O
has	O
a	O
comfortable	O
respiratory	B-test
rate	I-test
and	O
good	O
air	O
exchange	O
.	O

Cardiovascular	O
:	O

She	O
received	O
a	B-treatment
normal	I-treatment
saline	I-treatment
bolus	I-treatment
times	O
one	O
initially	O
for	O
poor	B-problem
perfusion	I-problem
and	O
was	O
started	O
on	O
dopamine	B-treatment
with	O
a	O
maximum	O
infusion	O
rate	O
of	O
6	O
mcg	O
per	O
kg	O
per	O
hour	O
.	O

This	O
was	O
discontinued	O
on	O
day	O
of	O
life	O
two	O
to	O
maintain	O
a	B-test
mean	I-test
arterial	I-test
pressure	I-test
of	O
greater	O
than	O
33	O
.	O

She	O
has	O
remained	O
hemodynamically	O
stable	O
during	O
the	O
remainder	O
of	O
her	O
hospitalization	O
here	O
.	O

Fluids	O
,	O
electrolytes	O
,	O
nutrition	O
:	O

Initially	O
maintained	O
NPO	B-treatment
.	O

UAC	B-treatment
and	I-treatment
UVC	I-treatment
lines	I-treatment
were	O
placed	O
upon	O
admission	O
to	O
the	O
CMED	O
.	O

The	B-treatment
UAC	I-treatment
was	O
left	O
in	O
place	O
until	O
day	O
of	O
life	O
two	O
and	O
was	O
removed	O
after	O
wean	O
from	O
dopamine	B-treatment
.	O

UVC	B-treatment
remained	O
in	O
place	O
through	O
day	O
of	O
life	O
six	O
and	O
was	O
utilized	O
to	O
administer	O
parenteral	B-treatment
nutrition	I-treatment
.	O

Electrolytes	B-test
and	O
glucose	B-test
remained	O
in	O
the	O
normal	O
range	O
throughout	O
the	O
first	O
week	O
.	O

She	O
was	O
started	O
on	O
enteral	B-treatment
feeds	I-treatment
on	O
day	O
of	O
life	O
six	O
with	O
a	O
slow	O
advance	O
secondary	O
to	O
increased	B-problem
abdominal	I-problem
girth	I-problem
which	O
was	O
felt	O
to	O
be	O
due	O
to	O
CPAP	B-treatment
.	O

She	O
passed	O
meconium	O
.	O

She	O
achieved	O
full	O
feeds	O
on	O
day	O
of	O
life	O
13	O
.	O

Calories	O
were	O
gradually	O
increased	O
to	O
breast	O
milk	O
30	O
calories	O
with	O
ProMod	B-treatment
consisting	O
of	O
four	O
of	O
human	O
milk	O
fortifier	O
,	O
four	O
of	O
MCT	B-treatment
and	O
two	O
of	O
Polycose	B-treatment
with	O
a	O
12-28	O
teaspoon	O
of	O
ProMod	B-treatment
per	O
50	O
ml	O
of	O
breast	O
milk	O
or	O
60	O
ml	O
of	O
formula	O
.	O

On	O
day	O
of	O
life	O
six	O
due	O
to	O
concerns	O
for	O
hyperglycemia	B-problem
and	O
abdominal	B-problem
distention	I-problem
,	O
sepsis	B-test
evaluation	I-test
was	O
obtained	O
.	O

She	O
was	O
noted	O
at	O
this	O
time	O
to	O
have	O
hyperglycemia	B-problem
requiring	O
two	O
subcutaneous	O
doses	O
of	O
insulin	B-treatment
and	O
a	B-treatment
decreased	I-treatment
glucose	I-treatment
infusion	I-treatment
rate	I-treatment
to	O
achieve	O
euglycemia	O
.	O

This	O
resolved	O
that	O
same	O
day	O
.	O

Urine	B-test
output	I-test
was	O
always	O
noted	O
to	O
be	O
of	O
sufficient	O
quantity	O
.	O

Gastrointestinal	O
:	O

Mychelia	O
demonstrated	O
slow	B-problem
gastrointestinal	I-problem
motility	I-problem
and	O
abdominal	B-problem
distention	I-problem
felt	O
to	O
be	O
due	O
to	O
CPAP	B-treatment
.	O

She	O
was	O
slow	O
to	O
advance	O
on	O
enteral	O
feeds	O
and	O
gradually	O
attained	O
full	O
enteral	O
volume	O
on	O
day	O
of	O
life	O
13	O
.	O

On	O
day	O
of	O
life	O
15	O
,	O
she	O
was	O
made	O
NPO	B-treatment
for	O
a	B-problem
distended	I-problem
abdomen	I-problem
and	O
a	B-problem
bilious	I-problem
spit	I-problem
.	O

Serial	B-test
KUBs	I-test
revealed	O
nonspecific	B-problem
changes	I-problem
with	O
dilated	B-problem
loops	I-problem
.	O

No	O
pneumatosis	B-problem
or	O
free	B-problem
air	I-problem
was	O
seen	O
.	O

She	O
was	O
noted	O
to	O
have	O
bluish	B-problem
discoloration	I-problem
thought	O
to	O
perhaps	O
be	O
a	B-problem
bruise	I-problem
on	I-problem
her	I-problem
left	I-problem
lower	I-problem
quadrant	I-problem
.	O

There	O
was	O
no	O
radiographic	O
correlation	O
with	O
this	O
.	O

Feeds	O
were	O
restarted	O
.	O

Again	O
,	O
she	O
was	O
advanced	O
to	O
full	O
volume	O
but	O
was	O
made	O
NPO	B-treatment
on	O
day	O
of	O
life	O
20	O
for	O
abdominal	B-problem
distention	I-problem
.	O

This	B-treatment
NPO	I-treatment
was	O
temporary	O
for	O
that	O
day	O
and	O
she	O
then	O
resumed	O
feedings	O
and	O
has	O
been	O
tolerating	O
full	B-treatment
enteral	I-treatment
feeds	I-treatment
well	O
,	O
improved	O
since	O
off	O
of	O
CPAP	B-treatment
,	O
passing	O
normal	O
stools	O
,	O
guaiac	B-test
negative	O
.	O

Mychelia	O
was	O
also	O
treated	O
for	O
physiologic	B-problem
jaundice	I-problem
.	O

She	O
was	O
started	O
under	O
phototherapy	B-treatment
on	O
day	O
of	O
life	O
one	O
through	O
day	O
of	O
life	O
three	O
with	O
a	B-test
peak	I-test
serum	I-test
bilirubin	I-test
of	O
4.7/0.3	O
.	O

This	O
issue	O
resolved	O
.	O

Hematologic	O
and	O
Infectious	O
Disease	O
:	O

Initial	B-test
CBC	I-test
was	O
notable	O
for	O
a	B-test
white	I-test
count	I-test
of	O
5.5	O
with	O
49	B-test
polys	I-test
,	O
1	B-test
band	I-test
and	O
47	B-test
lymphs	I-test
.	O

Initial	B-test
hematocrit	I-test
was	O
46.3	O
percent	O
and	O
platelets	B-test
320,000	O
.	O

Her	B-test
initial	I-test
blood	I-test
culture	I-test
remained	O
negative	O
and	O
she	O
received	O
48	O
hours	O
of	O
ampicillin	B-treatment
and	O
gentamicin	B-treatment
.	O

As	O
previously	O
noted	O
on	O
day	O
of	O
life	O
six	O
with	O
hyperglycemia	B-problem
,	O
abdominal	B-problem
distention	I-problem
,	O
a	B-test
CBC	I-test
and	O
blood	B-test
culture	I-test
were	O
again	O
obtained	O
revealing	O
a	B-test
white	I-test
count	I-test
of	O
9.1	O
with	O
30	B-test
polys	I-test
,	O
0	B-test
bands	I-test
and	O
58	B-test
lymphs	I-test
.	O

Hematocrit	B-test
at	O
that	O
time	O
was	O
noted	O
to	O
be	O
31	O
and	O
platelets	B-test
370,000	O
.	O

Blood	B-test
culture	I-test
grew	O
staph	B-problem
coagulase	I-problem
negative	I-problem
and	O
the	O
baby	O
received	O
seven	O
days	O
of	O
vancomycin	B-treatment
and	O
gentamicin	B-treatment
.	O

A	B-test
lumbar	I-test
puncture	I-test
was	O
also	O
performed	O
to	O
rule	O
out	O
meningitis	B-problem
.	O

This	B-test
culture	I-test
remained	O
negative	O
with	O
normal	O
cell	O
counts	O
and	O
chemistries	O
.	O

Antibiotic	B-test
levels	I-test
were	O
monitored	O
and	O
doses	O
adjusted	O
accordingly	O
.	O

Mychelia	O
required	O
two	B-treatment
transfusions	I-treatment
during	O
her	O
hospital	O
stay	O
.	O

On	O
day	O
of	O
life	O
15	O
for	O
a	B-test
hematocrit	I-test
of	O
29	O
,	O
she	O
received	O
20	O
cc	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

She	O
started	O
on	O
iron	B-treatment
and	O
vitamin	B-treatment
E	I-treatment
supplements	I-treatment
on	O
day	O
of	O
life	O
25	O
and	O
continues	O
on	O
that	O
at	O
this	O
time	O
of	O
transfer	O
.	O

However	O
,	O
on	O
day	O
of	O
life	O
34	O
,	O
12-04	O
,	O
she	O
was	O
noted	O
to	O
be	O
pale	B-problem
and	O
less	B-problem
stress	I-problem
tolerant	I-problem
,	O
mottling	O
easily	O
with	O
care	O
.	O

A	B-test
hematocrit	I-test
and	O
reticulocyte	B-test
count	I-test
showed	O
a	B-test
hematocrit	I-test
of	O
23	O
percent	O
and	O
a	B-test
reticulocyte	I-test
count	I-test
of	O
1.9	O
percent	O
.	O

Therefore	O
,	O
with	O
blood	B-treatment
available	O
from	O
the	O
first	O
aliquot	O
,	O
a	O
second	O
20	O
cc	O
per	O
kg	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
were	O
infused	O
without	O
incident	O
.	O

Neurological	O
:	O

Initial	B-test
head	I-test
ultrasound	I-test
on	O
day	O
of	O
life	O
seven	O
was	O
normal	O
.	O

At	O
one	O
month	O
of	O
age	O
,	O
on	O
12-03	O
,	O
she	O
was	O
noted	O
to	O
have	O
an	B-problem
absent	I-problem
septum	I-problem
pellucidum	I-problem
.	O

An	B-test
MRI	I-test
obtained	O
and	O
reviewed	O
by	O
the	O
Hallmark	O
Health	O
System	O
Radiology	O
Department	O
revealed	O
focal	B-problem
gyral	I-problem
morphology	I-problem
consistent	O
with	O
prematurity	B-problem
,	O
normal	O
midline	O
structures	O
,	O
normal	O
myelination	O
,	O
no	O
lesions	B-problem
,	O
no	O
signal	B-problem
abnormalities	I-problem
or	O
extracerebral	B-problem
collections	I-problem
.	O

The	O
cortical	O
ribbon	O
is	O
intact	O
.	O

The	O
major	O
vascular	O
structures	O
at	O
the	O
skull	O
base	O
are	O
normal	O
.	O

The	O
septal	O
leaflets	O
may	O
be	O
partially	B-problem
absent	I-problem
,	O
but	O
there	O
are	O
no	O
coronal	B-test
images	I-test
provided	O
for	O
confirmation	O
and	O
the	O
pituitary	O
stalk	O
is	O
present	O
.	O

An	O
Ophthalmology	O
consult	O
was	O
obtained	O
to	O
determine	O
the	O
presence	O
of	O
optic	O
nerves	O
.	O

These	O
were	O
both	O
determined	O
to	O
be	O
present	O
and	O
intact	O
.	O

Endocrine	O
was	O
also	O
consulted	O
.	O

Several	B-test
labs	I-test
were	O
ordered	O
.	O

Electrolytes	B-test
and	O
thyroid	B-test
studies	I-test
were	O
noted	O
to	O
be	O
in	O
the	O
normal	O
range	O
with	O
serum	B-test
sodium	I-test
of	O
136	O
,	O
potassium	B-test
4.7	O
,	O
chloride	B-test
98	O
and	O
CO2	B-test
34	O
.	O

She	O
had	O
a	B-test
calcium	I-test
of	O
10.3	O
,	O
a	B-test
phosphorus	I-test
of	O
4.8	O
and	O
alkaline	B-test
phosphatase	I-test
of	O
440	O
.	O

Thyroid	B-test
function	I-test
studies	I-test
revealed	O
a	B-test
TSH	I-test
of	O
2.2	O
,	O
T4	B-test
of	O
5.7	O
,	O
T3	B-test
of	O
101	O
and	O
a	B-test
cortisol	I-test
level	I-test
of	O
43	O
,	O
all	O
within	O
the	O
normal	O
range	O
.	O

A	B-test
growth	I-test
hormone	I-test
was	O
sent	O
and	O
the	O
results	O
were	O
pending	O
at	O
time	O
of	O
transfer	O
.	O

In	O
addition	O
,	O
an	B-test
FSH	I-test
and	O
LH	B-test
were	O
obtained	O
on	O
12-10	O
and	O
results	O
are	O
pending	O
at	O
time	O
of	O
transfer	O
.	O

Please	O
contact	O
lab	O
control	O
at	O
Mattapan	O
Community	O
Health	O
Center	O
for	O
results	O
:	O
(	O
409	O
)	O
238-8236	O
.	O

The	B-test
baby	I-test
's	I-test
neurologic	I-test
examination	I-test
is	O
appropriate	O
for	O
corrected	O
gestational	O
age	O
which	O
is	O
33	O
and	O
6/7	O
weeks	O
on	O
day	O
of	O
transfer	O
.	O

By	O
mother	O
's	O
report	O
,	O
a	O
maternal	O
cousin	O
also	O
has	O
an	B-problem
absent	I-problem
septum	I-problem
pellucidum	I-problem
.	O

Given	O
normal	O
pituitary	O
tests	O
thus	O
far	O
and	O
normal	O
optic	O
nerve	O
,	O
no	O
evidence	O
of	O
septic	B-problem
optic	I-problem
dysplasia	I-problem
.	O

Pediatrician	O
should	O
have	O
low	O
threshold	O
for	O
endocrinology	O
reconsult	O
if	O
any	B-problem
signs	I-problem
of	I-problem
pituitary	I-problem
problems	I-problem
.	O

Sensory	O
:	O

Audiology	O
hearing	O
has	O
not	O
yet	O
been	O
obtained	O
.	O

This	O
is	O
recommended	O
prior	O
to	O
discharge	O
from	O
hospital	O
to	O
home	O
.	O

Ophthalmology	O
:	O

Initial	B-test
ROP	I-test
screen	I-test
was	O
done	O
on	O
12-02	O
and	O
revealed	O
immature	B-problem
retinas	I-problem
to	I-problem
zone	I-problem
2	I-problem
bilaterally	I-problem
.	O

They	O
recommended	O
follow-up	B-test
examination	I-test
due	O
on	O
the	O
week	O
of	O
12/20	O
.	O

Psychosocial	O
:	O

Gardner	O
State	O
Hospital	O
social	O
worker	O
has	O
assisted	O
in	O
working	O
with	O
this	O
family	O
.	O

The	O
contact	O
may	O
be	O
reached	O
at	O
(	O
754	O
)	O
791	O
7976	O
.	O

Parents	O
have	O
been	O
very	O
involved	O
and	O
appropriate	O
with	O
infant	O
and	O
have	O
eagerly	O
learned	O
to	O
care	O
for	O
their	O
baby	O
.	O

Condition	O
at	O
time	O
of	O
transfer	O
is	O
good	O
.	O

Discharge	O
disposition	O
is	O
to	O
level	O
2	O
nursery	O
at	O
Jordan	O
Hospital	O
Hospital	O
.	O

Name	O
of	O
primary	O
pediatrician	O
is	O
Ashley	O
Daley	O
of	O
Village	O
Pediatrics	O
in	O
Stockbridge	O
.	O

Feedings	O
at	O
the	O
time	O
of	O
transfer	O
include	O
breast	O
milk	O
30	O
with	O
ProMod	B-treatment
at	O
150	O
cc	O
per	O
kg	O
per	O
day	O
,	O
all	O
gavage	B-treatment
given	O
over	O
one	O
hour	O
.	O

Medications	B-treatment
include	O
Fer-In-Norman	B-treatment
,	O
vitamin	B-treatment
E	I-treatment
5	O
international	O
units	O
each	O
day	O
and	O
caffeine	B-treatment
citrate	I-treatment
once	O
a	O
day	O
.	O

Car	B-test
seat	I-test
positioning	I-test
screening	I-test
has	O
not	O
been	O
obtained	O
.	O

Newborn	B-test
state	I-test
screens	I-test
have	O
been	O
sent	O
per	O
protocol	O
.	O

Results	O
have	O
been	O
in	O
the	O
normal	O
range	O
.	O

IMMUNIZATIONS	O
RECEIVED	O
:	O

Mychelia	O
received	O
hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
on	O
11-02	O
due	O
to	O
unknown	O
maternal	O
hepatitis	O
B	O
surface	O
antigen	O
status	O
.	O

She	O
also	O
received	O
hepatitis	B-treatment
B	I-treatment
immune	I-treatment
globulin	I-treatment
on	O
11-02	O
.	O

On	O
12-06	O
,	O
she	O
received	O
her	B-treatment
second	I-treatment
hepatitis	I-treatment
B	I-treatment
vaccine	I-treatment
.	O

Her	B-treatment
two	I-treatment
month	I-treatment
immunizations	I-treatment
have	O
not	O
yet	O
been	O
given	O
.	O

IMMUNIZATIONS	O
RECOMMENDED	O
:	O

Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
November	O
through	O
March	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

1)	O
born	O
at	O
less	O
than	O
32	O
weeks	O
,	O

2)	O
born	O
at	O
between	O
32	O
and	O
35	O
weeks	O
with	O
two	O
of	O
the	O
following	O
:	O

Daycare	O
during	O
RSV	O
season	O
,	O
a	O
smoker	O
in	O
the	O
household	O
,	O
neuromuscular	B-problem
disease	I-problem
,	O
airway	B-problem
abnormalities	I-problem
or	O
school	O
age	O
siblings	O
or	O

3)	O
infants	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
infant	O
's	O
life	O
,	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

Follow-up	O
appointments	O
recommended	O
with	O
the	O
primary	O
pediatrician	O
,	O
Dr.	O
Marilyn	O
Daley	O
of	O
Stockbridge	O
,	O
Village	O
Pediatrics	O
,	O
Dr.	O
Lynn	O
Warren	O
of	O
Neurology	O
from	O
Emerson	O
Hospital	O
and	O
Ophthalmology	O
to	O
follow	O
her	O
ophthalmology	O
status	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
at	O
28-2/7	O
weeks	O
.	O

2.	O
Surfactant	B-problem
deficiency	I-problem
.	O

3.	O
Hypotension	B-problem
.	O

4.	O
Sepsis	B-problem
suspect	O
.	O

5.	O
Physiologic	B-problem
jaundice	I-problem
.	O

6.	O
Coagulase	B-problem
negative	I-problem
bacteremia	I-problem
.	O

7.	O
Anemia	B-problem
of	O
prematurity	B-problem
.	O

8.	O
Apnea	B-problem
of	O
prematurity	B-problem
.	O

9.	O
Absent	B-problem
septum	I-problem
pellucidum	I-problem
.	O

Rosalie	O
Gloria	O
,	O
North	O
Dakota	O
67177	O

Dictated	O
By	O
:	O
George	O
D	O
Gregory	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-12-10	O
12:41:22	O

T	O
:	O
2013-12-10	O
14:03:32	O

Job	O
#	O
:	O
48183	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Yolanda	O
Corona	O
on	O
:	O
WED	O
2013-12-11	O
11:46	O
AM	O

(	O
End	O
of	O
Report	O
)	O

143484920	O
PAD-WORD	O

GH	O
PAD-WORD	O

57104201	O
PAD-WORD	O

7/10/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

07/10/1991	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

Discharge	O
Date	O
:	O

07/18/1991	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

C.	B-problem
difficile	I-problem
colitis	I-problem
.	O

SECONDARY	O
DIAGNOSIS	O
:	O

1.	O
Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

2.	O
Chronic	B-problem
pleural	I-problem
effusion	I-problem
.	O

3.	O
History	O
of	O
ischemic	B-problem
bowel	I-problem
.	O

4.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
azotemia	B-problem
.	O

PROCEDURES	O
:	O

Thoracentesis	B-treatment
was	O
performed	O
on	O
7-12-91	O
.	O

REASON	O
FOR	O
ADMISSION	O
:	O

The	O
patient	O
is	O
an	O
85-year-old	O
white	O
male	O
with	O
a	O
history	O
of	O
ischemic	B-problem
bowel	I-problem
status	O
post	O
recent	O
admission	O
for	O
urosepsis	B-problem
and	O
C.	B-problem
difficile	I-problem
colitis	I-problem
.	O

He	O
returns	O
from	O
the	O
nursing	O
home	O
with	O
fever	B-problem
,	O
leukocytosis	B-problem
,	O
and	O
azotemia	B-problem
.	O

PRESENT	O
ILLNESS	O
:	O

Briefly	O
,	O
the	O
patient	O
has	O
a	O
history	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
ethanol	O
abuse	O
,	O
chronic	B-problem
pleural	I-problem
effusions	I-problem
,	O
and	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

He	O
presented	O
to	O
Gaanvantsir	O
on	O
04-17-92	O
with	O
abdominal	B-problem
pain	I-problem
and	O
bloody	B-problem
diarrhea	I-problem
.	O

Workup	B-test
revealed	O
ischemic	B-problem
bowel	I-problem
secondary	O
to	O
Celiac	B-problem
and	O
SMA	B-problem
stenoses	I-problem
.	O

The	O
patient	O
underwent	O
an	B-treatment
angioplasty	I-treatment
of	O
his	B-problem
SMA	I-problem
from	O
90-20%	O
residual	O
.	O

The	O
patient	O
was	O
also	O
found	O
to	O
have	O
gram	B-problem
negative	I-problem
rod	I-problem
sepsis	I-problem
with	O
blood	B-test
cultures	I-test
times	O
two	O
growing	O
E.	B-problem
coli	I-problem
and	O
B.	B-problem
fragilis	I-problem
.	O

The	O
patient	O
was	O
treated	O
with	O
ampicillin	B-treatment
,	O
gentamicin	B-treatment
,	O
and	O
Flagyl	B-treatment
.	O

The	O
patient	O
was	O
readmitted	O
on	O
5-21-91	O
with	O
a	B-problem
falling	I-problem
hematocrit	I-problem
from	O
36	O
to	O
22	O
,	O
mild	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
,	O
and	O
guaiac	B-problem
positive	I-problem
stool	I-problem
.	O

The	B-test
colonoscopy	I-test
and	O
upper	B-test
gastrointestinal	I-test
series	I-test
were	O
negative	O
.	O

The	O
patient	O
was	O
given	O
two	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
and	O
H2	B-treatment
blockers	I-treatment
.	O

His	B-test
hematocrit	I-test
was	O
31	O
on	O
discharge	O
.	O

His	B-test
hematocrit	I-test
was	O
31	O
on	O
discharge	O
.	O

On	O
6-12-91	O
the	O
patient	O
was	O
admitted	O
to	O
Ingtermst.gay	O
Health	O
Center	O
with	O
fever	B-problem
,	O
hypertension	B-problem
,	O
and	O
diarrhea	B-problem
.	O

The	B-test
BUN	I-test
and	O
creatinine	B-test
equalled	O
128/8.6	O
,	O
CO2	B-test
equaled	O
12	O
.	O

The	O
patient	O
was	O
treated	O
with	O
intravenous	B-treatment
fluids	I-treatment
,	O
Kefzol	B-treatment
,	O
gentamicin	B-treatment
,	O
Vancomycin	B-treatment
,	O
and	O
he	O
was	O
transferred	O
to	O
Gaanvantsir	O
.	O

He	O
was	O
hospitalized	O
from	O
6-12-91	O
to	O
7-9-91	O
with	O
a	O
prolonged	O
course	O
notable	O
for	O
:	O

1)	O
Serratia	B-problem
urosepsis	I-problem
treated	O
with	O
ceftizoxime	B-treatment
.	O

2)	O
Azotemia	B-problem
presumed	O
secondary	O
to	O
sepsis	B-problem
and	O
dehydration	B-problem
,	O
creatinine	B-test
decreased	O
to	O
2.1	O
with	O
intravenous	B-treatment
fluids	I-treatment
and	O
antibiotics	B-treatment
.	O

Renal	B-test
ultrasound	I-test
was	O
negative	O
for	O
abscess	B-problem
orhydronephrosis	I-problem
.	O

3)	O
Loculated	B-problem
pleural	I-problem
effusions	I-problem
.	O

Thoracentesis	B-test
revealed	O
a	B-test
pH	I-test
of	O
7.18	O
,	O
glucose	B-test
52	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
200	O
;	O
evaluated	O
by	O
thoracic	O
surgery	O
,	O
no	O
chest	B-treatment
tube	I-treatment
placed	O
.	O

4)	O
C.	B-problem
difficile	I-problem
colitis	I-problem
with	O
white	B-test
blood	I-test
cell	I-test
count	I-test
rising	O
to	O
51,000	O
,	O
treated	O
with	O
intravenous	B-treatment
and	I-treatment
p.o.	I-treatment
Flagyl	I-treatment
.	O

C.	B-test
difficile	I-test
was	O
negative	O
times	O
three	O
prior	O
to	O
discharge	O
.	O

The	O
patient	O
went	O
to	O
his	O
nursing	O
home	O
on	O
7-9-91	O
but	O
the	O
next	O
day	O
he	O
developed	O
a	B-problem
temperature	I-problem
to	O
102.4	O
degrees	O
,	O
diarrhea	B-problem
,	O
and	O
orthostasis	B-problem
and	O
he	O
was	O
transferred	O
back	O
to	O
Gaanvantsir	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
medical	O
intensive	O
care	O
unit	O
with	O
question	O
of	O
sepsis	B-problem
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
40,000	O
with	O
left	B-problem
shift	I-problem
.	O

The	B-test
BUN	I-test
was	O
35	O
,	O
creatinine	B-test
4.3	O
.	O

Urinalysis	B-test
had	O
5-10	B-test
white	I-test
blood	I-test
cells	I-test
and	O
2+	B-test
bacteria	I-test
.	O

The	O
patient	O
underwent	O
thoracentesis	B-test
without	O
evidence	O
of	O
empyema	B-problem
.	O

He	O
was	O
treated	O
with	O
intravenous	B-treatment
fluids	I-treatment
and	O
intravenous	B-treatment
antibiotics	I-treatment
with	O
ceftizoxime	B-treatment
,	O
gentamicin	B-treatment
,	O
and	O
Flagyl	B-treatment
.	O

He	O
was	O
also	O
started	O
on	O
p.o.	B-treatment
Vancomycin	I-treatment
for	O
question	O
C.	B-problem
difficile	I-problem
colitis	I-problem
.	O

He	O
is	O
now	O
transferred	O
to	O
the	O
medicine	O
service	O
for	O
further	B-treatment
care	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Alcohol	O
abuse	O
in	O
the	O
past	O
.	O

2)	O
Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

3)	O
Chronic	B-problem
pleural	I-problem
effusions	I-problem
.	O

4)	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
baseline	B-test
creatinine	I-test
1.8-2	O
.	O

5)	O
Ischemic	B-problem
bowel	I-problem
status	O
post	O
SMA	B-treatment
Percutaneous	I-treatment
Transluminal	I-treatment
Coronary	I-treatment
Angioplasty	I-treatment
.	O

6)	O
Serratiaurosepsis	B-problem
.	O

7)	O
Positive	B-problem
PPD	I-problem
.	O

8)	O
Status	O
post	O
total	B-treatment
hip	I-treatment
replacement	I-treatment
.	O

9)	O
Right	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
with	O
left	B-problem
anterior	I-problem
hemiblock	I-problem
on	O
electrocardiogram	B-test
.	O

Allergies	B-problem
to	O
penicillin	B-treatment
,	O
sulfa	B-treatment
,	O
codeine	B-treatment
,	O
morphine	B-treatment
sulfate	I-treatment
.Medications	B-treatment
on	I-treatment
transfer	I-treatment
included	O
thiamine	B-treatment
;	O
multivitamin	B-treatment
;	O
Pepcid	B-treatment
;	O
ceftizoxime	B-treatment
1	O
gm	O
intravenously	O
q.	O
eight	O
hours	O
;	O
Flagyl	B-treatment
500	O
mg	O
intravenously	O
q.	O
eight	O
hours	O
;	O
gentamicin	B-treatment
80	O
mg	O
IV	O
q.	O
24	O
hours	O
;	O
Ventolin	B-treatment
inhaler	I-treatment
;	O
Lotrimin	B-treatment
cream	I-treatment
;	O
sliding	B-treatment
scale	I-treatment
nitro	I-treatment
paste	I-treatment
;	O
pyridium	B-treatment
;	O
Vancomycin	B-treatment
125	O
mg	O
p.o.	O
q.i.d.	O
;	O
and	O
calcium	B-treatment
carbonate	I-treatment
.	O

Habits	O
:	O

Positive	O
for	O
cigarettes	O
of	O
40	O
pack	O
/	O
years	O
quit	O
in	O
1990.	O

Positive	O
alcohol	O
abuse	O
in	O
the	O
distant	O
past	O
.	O

Family	O
history	O
is	O
positive	O
for	O
tuberculosis	B-problem
,	O
hypertension	B-problem
,	O
and	O
alcoholism	O
.	O

Social	O
history	O
:	O

Former	O
Vermont	O
blacksmith	O
.	O

He	O
has	O
one	O
son	O
and	O
lives	O
in	O
a	O
nursing	O
home	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

GENERAL	O
:	O

He	O
is	O
a	O
drowsy	O
,	O
elderly	O
white	O
male	O
lying	O
with	O
O2	B-treatment
on	O
,	O
asking	O
to	O
be	O
scratched	O
.	O

Blood	B-test
pressure	I-test
110/50	O
,	O
pulse	B-test
rate	I-test
94	O
,	O
respiratory	B-test
rate	I-test
22	O
,	O
temperature	B-test
maximum	I-test
101	O
degrees	O
,	O
decreasing	O
to	O
99	O
degrees	O
.	O

SKIN	O
:	O

Without	O
rash	B-problem
or	O
petechiae	B-problem
.	O

HEENT	O
:	O

Dry	B-problem
mucous	I-problem
membranes	I-problem
.	O

NECK	O
:	O

Supple	O
.	O

LUNGS	O
:	O

Bibasilar	B-problem
crackles	I-problem
,	O
right	O
greater	O
than	O
left	O
,	O
no	O
wheezes	B-problem
.	O

CARDIAC	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
I	B-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

ABDOMEN	O
:	O

Distended	B-problem
,	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
mild	B-problem
tenderness	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
quadrant	I-problem
,	O
no	O
rebound	B-problem
.	O

RECTAL	O
:	O

Tender	B-problem
,	O
external	B-problem
hemorrhoids	I-problem
,	O
guaiac	B-test
negative	O
.	O

EXTREMITIES	O
:	O

Without	O
edema	B-problem
.	O

NEUROLOGIC	O
:	O

Alert	O
and	O
oriented	O
to	O
person	O
and	O
place	O
,	O
no	O
asterixis	B-problem
or	O
tremor	B-problem
.	O

LABORATORY	O
DATA	O
:	O

Significant	O
for	O
sodium	B-test
140	O
,	O
potassium	B-test
3	O
,	O
BUN	B-test
35	O
,	O
creatinine	B-test
3.6	O
,	O
liver	B-test
function	I-test
tests	I-test
within	O
normal	O
limits	O
,	O
calcium	B-test
6.6	O
,	O
albumin	B-test
2	O
,	O
magnesium1.4	B-test
,	O
PT	B-test
14	O
,	O
white	B-test
count	I-test
30.1	O
with	O
77	O
polys	B-test
,	O
13	O
bands	B-test
,	O
5	O
lymphs	B-test
,	O
and	O
5	O
monos	B-test
.	O

Urine	B-test
sodium	I-test
is	O
75	O
,	O
urine	B-test
creatinine	I-test
143	O
,	O
urine	B-test
osmose	I-test
392	O
.	O

Pleural	B-test
fluid	I-test
pH	I-test
is	O
7.29	O
,	O
glucose	B-test
91	O
,	O
total	B-test
protein3.1	I-test
,	O
LDH	B-test
296	O
,	O
70	B-test
white	I-test
blood	I-test
cells	I-test
,	O
50	B-test
red	I-test
blood	I-test
cells	I-test
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Colitis	B-problem
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
ischemic	B-problem
bowel	I-problem
status	O
post	O
SMA	B-treatment
Percutaneous	I-treatment
Transluminal	I-treatment
Coronary	I-treatment
Angioplasty	I-treatment
with	O
recent	O
admission	O
for	O
gram	B-problem
negative	I-problem
rod	I-problem
urosepsis	I-problem
complicated	O
by	O
C.	B-problem
difficile	I-problem
colitis	I-problem
.	O

The	O
patient	O
received	O
a	B-treatment
full	I-treatment
course	I-treatment
of	I-treatment
Flagyl	I-treatment
and	O
was	O
C.	B-test
difficile	I-test
toxin	I-test
negative	O
times	O
three	O
prior	O
to	O
transfer	O
.	O

He	O
now	O
returns	O
with	O
fever	B-problem
,	O
rising	B-problem
white	I-problem
count	I-problem
,	O
diarrhea	B-problem
,	O
and	O
dehydration	B-problem
.	O

Initially	O
treated	O
with	O
intravenous	B-treatment
ceftizoxime	I-treatment
,	O
gentamicin	B-treatment
,	O
and	O
Flagyl	B-treatment
for	O
presumed	O
sepsis	B-problem
,	O
either	O
with	O
urine	O
or	O
bowel	O
source	O
.	O

He	O
was	O
also	O
started	O
on	O
p.o.	B-treatment
Vancomycin	I-treatment
.	O

Blood	B-test
cultures	I-test
and	O
urine	B-test
cultures	I-test
came	O
back	O
negative	O
.	O

Stool	B-test
for	I-test
C.	I-test
difficile	I-test
returned	O
positive	B-problem
.	O

The	O
diagnosis	O
,	O
therefore	O
,	O
was	O
relapsed	B-problem
C.	I-problem
difficile	I-problem
colitis	I-problem
.	O

Intravenous	B-treatment
antibiotics	I-treatment
were	O
discontinued	O
and	O
the	O
patient	O
was	O
continued	O
on	O
p.o.	B-treatment
Vancomycin	I-treatment
.	O

He	O
improved	O
clinically	O
with	O
defervescence	O
,	O
decreased	O
white	B-test
blood	I-test
cell	I-test
count	I-test
to	O
10,000	O
with	O
resolution	O
of	O
left	B-problem
shift	I-problem
,	O
and	O
some	O
decrease	O
in	O
abdominal	B-problem
distention	I-problem
on	O
exam	B-test
.	O

An	B-test
abdominal	I-test
CAT	I-test
scan	I-test
revealed	O
thickened	B-problem
bowel	I-problem
wall	I-problem
and	O
thumb	B-problem
printing	I-problem
,	O
primarily	O
involving	O
the	O
cecum	O
and	O
right	O
colon	O
greater	O
than	O
the	O
left	O
,	O
consistent	O
with	O
C.	B-problem
difficile	I-problem
colitis	I-problem
.	O

The	O
diagnosis	O
of	O
recurrent	B-problem
bowel	I-problem
ischemia	I-problem
,	O
however	O
,	O
was	O
not	O
ruled	O
out	O
and	O
this	O
will	O
continue	O
to	O
be	O
a	O
concern	O
in	O
the	O
future	O
.	O

The	O
patient	O
was	O
initially	O
n.p.o.	B-treatment
and	O
was	O
then	O
advanced	O
to	O
clear	B-treatment
liquids	I-treatment
which	O
he	O
tolerated	O
.	O

He	O
will	O
be	O
advanced	O
to	O
soft	B-treatment
solids	I-treatment
prior	O
to	O
discharge	O
.	O

2.	O
Azotemia	B-problem
.	O

The	O
patient	O
has	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
baseline	B-test
creatinine	I-test
1.8-2	O
.	O

Creatinine	B-test
had	O
risen	O
to	O
4.3	O
on	O
admission	O
presumed	O
secondary	O
to	O
sepsis	B-problem
and	O
dehydration	B-problem
.	O

With	O
intravenous	B-treatment
hydration	I-treatment
the	B-test
BUN	I-test
and	O
creatinine	B-test
fell	O
to	O
12/1.9	O
which	O
is	O
within	O
normal	O
limits	O
for	O
this	O
patient	O
.	O

The	B-test
abdominal	I-test
CAT	I-test
scan	I-test
showed	O
no	O
evidence	O
of	O
hydronephrosis	B-problem
orrenal	B-problem
abscess	I-problem
.	O

3.	O
Mental	O
status	O
.	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
throughout	O
the	O
admission	O
;	O
however	O
,	O
by	O
personality	O
,	O
he	O
is	O
somewhat	O
cantankerous	O
and	O
demanding	O
of	O
the	O
nurses	O
.	O

He	O
was	O
written	O
for	O
Haldol	B-treatment
1	O
mg	O
p.o.b.i.d.	O
p.r.n.	O
to	O
help	O
with	O
this	B-problem
problem	I-problem
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Medications	B-treatment
on	I-treatment
transfer	I-treatment
include	O
multivitamin	B-treatment
1	O
tablet	O
p.o.	O
q.d.	O
;	O
Pepcid	B-treatment
20	O
mg	O
p.o.	O
b.i.d.	O
;	O
Ventolin	B-treatment
inhaler	I-treatment
two	O
puffs	O
q.i.d.	O
;	O
Vancomycin	B-treatment
125	O
mg	O
p.o.	O
q.i.d.	O
times	O
seven	O
days	O
;	O
calcium	B-treatment
carbonate	I-treatment
1250	O
mg	O
p.o.	O
b.i.d.	O
;	O
Lotrimin	B-treatment
cream	I-treatment
to	O
groin	O
b.i.d.	O
p.r.n.	O
;	O
O2	B-treatment
at	O
four	O
liters	O
per	O
minute	O
;	O
and	O
Haldol	B-treatment
1	O
mg	O
p.o.	O
b.i.d.	O
p.r.n.	O

Dictated	O
By	O
:	O

CA	O
NA	O
SHUFF	O
,	O
M.D.	O
SO92	O
VX072/9578	O

TRANGCA	O
CHIRDSTEN	O
,	O
M.D.	O
ZO84	O

D	O
:	O

07/17/91	O
PAD-WORD	O

T	O
:	O

07/17/91	O
PAD-WORD	O

Batch	O
:	O

T099	O
PAD-WORD	O

Report	O
:	O

XM487M32	O
PAD-WORD	O

Admission	O
Date	O
:	O

2018-08-04	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2018-08-16	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1986-03-06	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

SURGERY	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
William	O
I.	O
Sundquist	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Abdominal	B-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
pheresis	B-test
renal	I-test
biopsy	I-test

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
a	O
32	O
year	O
old	O
male	O
who	O
was	O
recently	O
discharged	O
from	O
Mediplex	O
Rehab	O
Hospital	O
and	O
presents	O
again	O
to	O
us	O
with	O
chief	O
complaint	O
of	O
abdominal	B-problem
pain	I-problem
(	O
sudden	B-problem
onset	I-problem
left-sided	I-problem
abdominal	I-problem
pain	I-problem
).	O

Of	O
note	O
,	O
he	O
had	O
a	B-test
recent	I-test
kidney	I-test
biopsy	I-test
on	O
2018-07-30	O
and	O
his	B-test
Cr	I-test
bumped	O
from	O
4.7	O
to	O
5.7	O
.	O

Also	O
,	O
HCT	B-test
on	O
admission	O
21	O
from	O
25	O
.	O

Past	O
Medical	O
History	O
:	O

ESRD	B-problem
on	O
HD	B-treatment
(	O
M,W,F	O
)	O
(	O
03-30	O
glomerulonephritis	B-problem
)	O

HTN	B-problem
PAD-WORD	O

Hypercholesterolemia	B-problem
PAD-WORD	O

PSH	O
:	O

AVF	B-treatment
-	I-treatment
R	I-treatment
radial	I-treatment
-	I-treatment
cephalic	I-treatment

AVF	B-treatment
-	I-treatment
L	I-treatment
aneurysm	I-treatment
resection	I-treatment

Tunneled	B-treatment
L	I-treatment
subclavian	I-treatment
catheter	I-treatment

Social	O
History	O
:	O
denies	O
tobacco	O
,	O
ETOH	O
,	O
drugs	O

Family	O
History	O
:	O
sister	O
who	O
is	O
26	O
also	O
has	O
ESRD	B-problem
on	O
HD	B-treatment
(	O
?	O
etiology	O
)	O

Physical	O
Exam	O
:	O

VS	B-test
:	O
Afebrile	B-problem
,	O
HR	B-test
:	O
70-80	O
,	O
99/70	O

Lungs	O
:	O
CTA	O
bilaterally	O

CV	O
:	O
RRR	O

Abd	O
:	O
Non-distended	B-problem
,	O
tender	B-problem
to	O
palpation	B-test
LLQ	I-test

Pertinent	O
Results	O
:	O

ADMISSION	O
LABS	O
-->	O
2018-08-04	O

WBC	B-test
-	O
6.8	O
RBC	B-test
-	O
2.50	O
*	O
Hgb	B-test
-	O
6.8	O
*	O
Hct	B-test
-	O
21.2	O
*	O
MCV	B-test
-	O
85	O
MCH	B-test
-	O
27.2	O
MCHC	B-test
-	O
32.1	O
RDW	B-test
-	O
18.0	O
*	O
Plt	B-test
Ct	I-test
-	O
149	O
*	O
PT	B-test
-	O
11.9	O
PTT	B-test
-	O
31.1	O
INR	B-test
(	I-test
PT	I-test
)	I-test
-	O
1.0	O
Fibrinogen	B-test
-	O
148	O
*	O
Glucose	B-test
-	O
144	O
*	O
UreaN	B-test
-	O
52	O
*	O
Creat	B-test
-	O
5.7	O
*	O
Na	B-test
-	O
138	O
K	B-test
-	O
4.1	O
Cl	B-test
-	O
107	O
HCO3	B-test
-	O
17	O
*	O
AnGap	B-test
-	O
18	O

2018-08-04	O
06:09	O
PM	O
BLOOD	B-test
Calcium	B-test
-	O
8.3	O
*	O
Phos	B-test
-	O
5.0	O
*	O
Mg	B-test
-	O
2.2	O

Discharge	O
Labs	O
:	O

2018-08-16	O
PAD-WORD	O

WBC	B-test
-	O
5.7	O
RBC	B-test
-	O
3.10	O
*	O
Hgb	B-test
-	O
8.9	O
*	O
Hct	B-test
-	O
26.2	O
*	O
MCV	B-test
-	O
85	O
MCH	B-test
-	O
28.7	O
MCHC	B-test
-	O
33.9	O
RDW	B-test
-	O
15.4	O
Plt	B-test
Ct	I-test
-	O
186	O
PT	B-test
-	O
11.5	O
PTT	B-test
-	O
25.6	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.0	O
Fibrinogen	B-test
-	O
443	O
*	O
Glucose	B-test
-	O
104	O
UreaN	B-test
-	O
60	O
*	O
Creat	B-test
-	O
4.8	O
*	O
Na	B-test
-	O
139	O
K	B-test
-	O
4.3	O
Cl	B-test
-	O
105	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
12	O
Calcium	B-test
-	O
8.8	O
Phos	B-test
-	O
5.0	O
*	O
Mg	B-test
-	O
2.2	O

DISCHARGE	O
LABS	O
--->	O

2018-08-16	O
05:47	O
AM	O

BLOOD	B-test
WBC	B-test
-	O
5.7	O
RBC	B-test
-	O
3.10	O
*	O
Hgb	B-test
-	O
8.9	O
*	O
Hct	B-test
-	O
26.2	O
*	O
MCV	B-test
-	O
85	O
MCH	B-test
-	O
28.7	O
MCHC	B-test
-	O
33.9	O
RDW	B-test
-	O
15.4	O
Plt	B-test
Ct	I-test
-	O
186	O

2018-08-16	O
05:47	O
AM	O

BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
186	O

2018-08-16	O
05:47	O
AM	O

BLOOD	B-test
PT	B-test
-	O
11.5	O
PTT	B-test
-	O
25.6	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.0	O

2018-08-16	O
05:47	O
AM	O

BLOOD	B-test
Fibrino	B-test
-	O
443	O
*	O

2018-08-16	O
05:47	O
AM	O

BLOOD	B-test
Glucose	B-test
-	O
104	O
UreaN	B-test
-	O
60	O
*	O
Creat	B-test
-	O
4.8	O
*	O
Na	B-test
-	O
139	O
K	B-test
-	O
4.3	O
Cl	B-test
-	O
105	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
12	O

2018-08-16	O
05:47	O
AM	O

BLOOD	B-test
Calcium	B-test
-	O
8.8	O
Phos	B-test
-	O
5.0	O
*	O
Mg	B-test
-	O
2.2	O

Brief	O
Hospital	O
Course	O
:	O

This	O
patient	O
was	O
admitted	O
on	O
08-04	O
after	O
a	O
recent	O
discharge	O
from	O
the	O
hospital	O
for	O
sudden	O
onset	O
of	O
left	B-problem
sided	I-problem
abdominal	I-problem
pain	I-problem
.	O

In	O
the	O
emergency	O
room	O
,	O
his	B-test
ultrasound	I-test
showed	O
mild	B-problem
hydronephrosis	I-problem
with	O
new	B-problem
perinephric	I-problem
fluid	I-problem
surrounding	O
the	O
transplant	O
kidney	O
and	O
hence	O
,	O
underwent	O
a	B-test
CT	I-test
scan	I-test
of	I-test
his	I-test
abdomen	I-test
/	I-test
pelvis	I-test
which	O
showed	O
a	O
large	O
left-sided	O
of	O
retroperitoneal	B-problem
hemorrhage	I-problem
extending	O
down	O
to	O
the	O
level	O
of	O
the	B-treatment
renal	I-treatment
transplant	I-treatment
possibly	O
related	O
to	O
recent	B-test
transplant	I-test
biopsy	I-test
.	O

Renal	O
transplant	O
medicine	O
and	O
transplant	O
surgery	O
were	O
made	O
aware	O
and	O
the	O
pt	O
was	O
admitted	O
to	O
transplant	O

CMED	O
and	O
to	O
the	O
ICU	O
.	O

Serial	B-test
hematocrits	I-test
and	O
abdominal	B-test
exams	I-test
were	O
performed	O
.	O

He	O
was	O
not	O
taken	O
to	O
the	O
OR	O
.	O

On	O
08-06	O
,	O
he	O
received	O
2	O
units	O
of	O
pRBC	B-treatment
and	O
underwent	O
plasmaphersis	B-treatment
,	O
followed	O
by	O
10mg	O
of	O
IVIG	B-treatment
.	O

He	O
received	O
another	B-treatment
unit	I-treatment
pRBC	I-treatment
on	O
08-07	O
.	O

By	O
08-07	O
,	O
it	O
was	O
thought	O
there	O
was	O
improvement	O
of	O
his	B-test
labs	I-test
.	O

In	O
the	O
am	O
of	O
6/13	O
,	O
he	O
was	O
given	O
1	B-treatment
unit	I-treatment
pRBC	I-treatment
for	O
a	B-test
Hct	I-test
of	O
21.8	O
.	O

His	B-test
Hct	I-test
was	O
stable	O
on	O
08-09	O
at	O
24.4	O
;	O
he	O
had	O
plasmapheresis	B-treatment
on	O
08-09	O
(	O
followed	O
by	O
10	O
mg	O
IVIG	B-treatment
).	O

He	O
was	O
transfered	O
to	O
the	O
floor	O
on	O
08-09	O
.	O

On	O
08-10	O
,	O
his	B-test
am	I-test
Hct	I-test
was	O
21.9	O
,	O
hence	O
,	O
he	O
received	O
1	B-treatment
unit	I-treatment
pRBC	I-treatment
.	O

On	O
08-10	O
class	B-test
I	I-test
and	I-test
II	I-test
antibody	I-test
levels	I-test
were	O
sent	O
.	O

He	O
had	O
plasmapheresis	B-treatment
on	O
08-11	O
,	O
followed	O
by	O
10	B-treatment
mg	I-treatment
IVIG	I-treatment
.	O

This	O
was	O
repeated	O
on	O
08-13	O
.	O

Hct	B-test
remained	O
stable	O
.	O

On	O
08-15	O
,	O
he	O
went	O
for	O
pheresis	B-treatment
/	O
IVIG	B-treatment
.	O

No	O
new	B-problem
issues	I-problem
.	O

LLQ	B-problem
pain	I-problem
has	O
improved	O
over	O
the	O
course	O
of	O
this	O
hospitalization	O
.	O

He	O
is	O
eating	O
and	O
ambulating	O
w/o	O
difficulties	B-problem
.	O

Pheresis	B-treatment
to	O
continue	O
as	O
an	O
outpatient	O
with	O
supervision	O
of	O
transplant	O
nephrology	O
on	O
08-17	O
,	O
08-20	O
and	O
08-22	O
.	O

Prograf	B-treatment
was	O
increased	O
to	O
12	O
mg	O
bid	O
on	O
08-16	O
for	O
a	B-test
trough	I-test
level	I-test
of	O
7.1	O
.	O

He	O
was	O
instructed	O
to	O
have	O
labs	B-test
drawn	O
on	O
08-17	O
to	O
check	O
trough	B-test
level	I-test
of	I-test
prograf	I-test
as	O
well	O
as	O
cbc	B-test
,	O
chem	B-test
10	I-test
,	O
coags	B-test
.	O

Medications	O
on	O
Admission	O
:	O

Bactrim	B-treatment
,	O
Valcyte	B-treatment
,	O
MMF	B-treatment
,	O
Prednisone	B-treatment
,	O
FK	B-treatment
,	O
Nifedipine	B-treatment
,	O
Protonix	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Mycophenolate	B-treatment
Mofetil	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3.	O
Valganciclovir	B-treatment
450	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q48H	O
(	O
every	O
48	O
hours	O
)	O
.	O

4.	O
Trimethoprim	B-treatment
-	O
Sulfamethoxazole	B-treatment
80-400	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Nifedipine	B-treatment
60	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
Sustained	O
Release	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

6.	O
Labetalol	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
360	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

7.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Oxycodone	B-treatment
-	O
Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Sevelamer	B-treatment
800	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

10.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
.	O

11.	O
Minoxidil	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

12.	O
Nystatin	B-treatment
100,000	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
ML	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

13.	O
Prednisone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

14.	O
Epogen	B-treatment
40,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
ml	O
Injection	O
once	O
a	O
week	O
.	O

Disp	O
:*	O
8	O
*	O
Refills	O
:*	O
2	O
*	O

15.	O
syringes	B-treatment
for	O
epogen	B-treatment
q	O
week	O

1	O
box	O

refill	O
:	O
none	O

16.	O
Tacrolimus	B-treatment
5	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
.	O

17.	O
Tacrolimus	B-treatment
1	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
twice	O
a	O
day	O
.	O

18.	O
Outpatient	B-test
Lab	I-test
Work	I-test

Friday	O
08-17	O
and	O
Monday	O
08-20	O
cbc	B-test
,	O
chem10	B-test
,	O
pt/ptt/inr	B-test
and	O
trough	B-test
prograf	I-test
level	I-test
.	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O
humoral	B-problem
rejection	I-problem
of	I-problem
renal	I-problem
transplant	I-problem
perinephric	B-problem
transplant	I-problem
hemorrhage	I-problem

Discharge	O
Condition	O
:	O
good	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
transplant	O
office	O
(	O
789	O
)	O
583	O
5023	O
if	O
fevers	B-problem
,	O
chills	B-problem
,	O
nausea	B-problem
/	O
vomiting	B-problem
,	O
bleeding	B-problem
,	O
decreased	B-problem
urine	I-problem
output	I-problem
,	O
weight	B-problem
gain	I-problem
of	O
3	O
pounds	O
in	O
a	O
day	O
,	O
abdominal	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem

Pheresis	B-treatment
Friday	O
08-17	O
then	O
Monday	O
08-20	O

Labwork	B-test
every	O
Monday	O
and	O
Thursday	O
per	O
Transplant	O
clinic	O
:	O
CBC	B-test
,	O
Chem	B-test
7	I-test
,	O
Ca	B-test
,	O
Phos	B-test
,	O
AST	B-test
,	O
T	B-test
Bili	I-test
,	O
U/A	B-test
and	O
Trough	B-test
Prograf	I-test
level	I-test
.	O

Fax	O
results	O
to	O
326-955-2529	O

Followup	O
Instructions	O
:	O

PHERESIS	B-treatment
,	O
BED	O
FIVE	O
PHERESIS	O
ROOMS	O
Date	O
/	O
Time	O
:	O
2018-08-17	O
9:15	O

PHERESIS	B-treatment
,	O
BED	O
SIX	O
PHERESIS	O
ROOMS	O
Date	O
/	O
Time	O
:	O
2018-08-20	O
2:00	O

Vanessa	O
John	O
,	O
MD	O
Phone	O
:(	O
789	O
)	O
583	O
5023	O
Date	O
/	O
Time	O
:	O
2018-08-21	O
9:50	O

Michael	O
Douglas	O
MD	O
87-106	O

Completed	O
by	O
:	O
Edwin	O
Marilyn	O
MD	O
50-613	O
2018-08-16	O
@	O
1456	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brian	O
B.	O
B.	O
Chatterjee	O
on	O
:	O
MON	O
2018-09-10	O
1:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

158656269	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

02692537	O
PAD-WORD	O

322365	O
PAD-WORD	O

7/8/2000	O
12:00:00	O
AM	O

chest	B-problem
pain	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

07/08/2000	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

07/09/2000	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

CLOZLUIN	O
,	O
NOSHIN	O
699-77-12-2	O
K97	O

Room	O
:	O

18J-512	O
PAD-WORD	O

Service	O
:	O

MED	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

07/09/00	O
AT	O
04:00	O
PM	O
CONTINGENT	O
UPON	O
Attending	B-test
evaluation	I-test

WILL	O
D/C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D/C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	B-treatment
#3	I-treatment
(	I-treatment
ACETAMINOPHEN	I-treatment
W	I-treatment
/	I-treatment
CODEINE	I-treatment
30MG	O
)	O
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
pain	B-problem
ALLOPURINOL	B-treatment
300	O
MG	O
PO	O
QD	O
COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
BID	O
HYDROCHLOROTHIAZIDE	B-treatment
25	O
MG	O
PO	O
QD	O
LEVOFLOXACIN	B-treatment
500	O
MG	O
PO	O
QD	O
Starting	O
Today	O
(	O
07/09	O
)	O

Instructions	O
:	O

continue	O
through	O
7/16/00	O

FLAGYL	B-treatment
(	I-treatment
METRONIDAZOLE	I-treatment
)	I-treatment
500	O
MG	O
PO	O
TID	O

Instructions	O
:	O

through	O
7/16/00	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
with	O
meals	O

DIET	O
:	O

No	O
Restrictions	O
Activity	O
-	O
As	O
tolerated	O

RETURN	O
TO	O
WORK	O
:	O

Not	O
Applicable	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

dr.	O
mandessquarc	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

chest	B-problem
pain	I-problem
unclear	I-problem
etiology	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
chest	B-problem
pain	I-problem

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

***	O
07/09/00	O
***	O

80	O
yo	O
woman	O
recently	O
diagnosed	O
with	O
metastatic	B-problem
squamous	I-problem
cell	I-problem
lung	I-problem
CA	I-problem
.	O

Mets	B-problem
to	I-problem
spine	I-problem
,	I-problem
femur	I-problem
.	O

On	O
XRT	B-treatment
.	O

Tumor	B-problem
invasive	I-problem
of	I-problem
pleura	I-problem
and	I-problem
rib	I-problem
.	O

Admitted	O
after	O
acute	B-problem
onset	I-problem
left	I-problem
chest	I-problem
pain	I-problem
.	O

Transferred	O
today	O
from	O
Ez	O
Ephtro	O
Health	O
Center	O
on	O
LMWH	O
for	O
R	O
/	O
O	O
PE	B-problem
vs	O
pneumonia	B-problem
vs	O
tumor	B-problem
invasion	I-problem
.	O

Following	O
enzymes	B-test
to	O
rule	O
out	O
unstable	B-problem
angina	I-problem
(	O
no	O
EKG	B-problem
changes	I-problem
)	O
.	O

v	B-test
/	I-test
q	I-test
at	O
outside	O
hospital	O
read	O
as	O
low	O
prob.	O
leni	O
&apos;s	O
here	O
neg.	O
d/c&apos;ed	O
on	O
levo	B-treatment
/	O
flagyl	B-treatment
for	O
presumed	O
post-obstructive	B-problem
pneumonia	I-problem
.	O

ADDITIONAL	O
COMMENTS	O
:	O

1.	O
Continue	O
with	O
medications	B-treatment
as	O
prescribed	O
,	O
including	O
antibiotics	B-treatment
(	O
levofloxacin	B-treatment
/	O
flagyl	B-treatment
)	O
through	O
7/16/00	O
.	O

2.	O
If	O
you	O
have	O
further	B-problem
chest	I-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
fevers	B-problem
,	O
or	O
other	B-problem
symptoms	I-problem
which	O
concern	O
you	O
,	O
call	O
your	O
doctor	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

ENTERED	O
BY	O
:	O

ISNIFF	O
,	O
DALA	O
TAN	O
,	O
M.D.	O
(	O
EP01	O
)	O

07/09/00	O
02:54	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2013-09-22	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-09-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1934-05-15	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

SURGERY	O
PAD-WORD	O

Allergies	O
:	O

Iodine	B-treatment
PAD-WORD	O

Attending	O
:	O
Ronald	O
B	O
Tekautz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
sp	O
cardiac	B-problem
arrest	I-problem
/	O
colitis	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

sp	O
Left	B-treatment
subclavian	I-treatment
CVL	I-treatment
placement	I-treatment

sp	O
Right	B-treatment
femoral	I-treatment
CVL	I-treatment
placement	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

79F	O
Pmhx	O
CHF,COPD	B-problem
,	O
found	O
down	O
at	O
home	O
,	O
pulseless	B-problem
-	O
CPR	B-treatment
initiated	O
w/	O
conciousness	O
regained	O
on	O
scene	O
.	O

At	O
OSH	O
ABG	B-test
7.19/94/110	O
,	O
BiPAP	B-treatment
started	O
.	O

Pt	O
found	O
to	O
be	O
hypothermic	B-problem
w/	O
WBC	B-test
17	O
(	O
pt	O
on	O
steroids	B-treatment
)	O
pnuemobilia	B-problem
and	O
thickening	B-problem
of	I-problem
sigmoid	I-problem
.	O

Currently	O
on	O
Nasal	B-treatment
cannula	I-treatment
02	I-treatment
+	O
hemodymamically	O
stable	O
.	O

Past	O
Medical	O
History	O
:	O

CHF	B-problem
(	O
EF	B-test
25%	O
,	O
mod	B-problem
AS,AR	I-problem
,	O
mod	B-problem
MR	I-problem
,	O
CAD,PAF	B-problem
,	O
angina	B-problem
,	O
COPD	B-problem
(	O
O2	B-problem
dependent	I-problem
-	O
2	O
L	O
)	O
PVD	B-problem
,	O
recurrent	B-problem
UTI	I-problem
's	I-problem
,	O
Chronic	B-problem
bronchitis	I-problem
,	O
?	O
h/o	O

DM	B-problem
,	O
sp	O
L	B-treatment
ax-bifem	I-treatment
,	O
L	B-treatment
fem-CMED	I-treatment
,	O
ERCP	B-treatment
'04	O
,	O
T+A	B-treatment
,	O
Appy	B-treatment
,	O
CEA	B-treatment
,	O
L4-L5	B-treatment
laminectomy	I-treatment
.	O

Social	O
History	O
:	O
ex	O
tobacco	O
denies	O
ETOH	O
nursing	O
home	O
resident	O

Family	O
History	O
:	O

NC	O
PAD-WORD	O

Physical	O
Exam	O
:	O
thin	O
,	O
A&O	O
X	O
1	O

IRRR	B-problem
PAD-WORD	O

Decreased	B-problem
BS	I-problem
bilaterally	I-problem

soft	O
,	O
mild	B-problem
tenderness	I-problem
R	I-problem
and	I-problem
L	I-problem
lower	I-problem
quadrants	I-problem
-	O
not	O
reproducible	O

visible	B-treatment
fem-fem	I-treatment
graft	I-treatment

ext	O
warm	O
,	O
+	B-problem
1	I-problem
edema	I-problem

Pertinent	O
Results	O
:	O

2013-09-22	O
04:20	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
13.8	O
*	O
RBC	B-test
-	O
3.17	O
*	O
Hgb	B-test
-	O
8.9	O
*	O
Hct	B-test
-	O
28.4	O
*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
28.2	O
MCHC	B-test
-	O
31.4	O
RDW	B-test
-	O
15.0	O
Plt	B-test
Ct	I-test
-	O
185	O

2013-09-24	O
03:15	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
6.8	O
RBC	B-test
-	O
2.86	O
*	O
Hgb	B-test
-	O
7.7	O
*	O
Hct	B-test
-	O
25.9	O
*	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
27.0	O
MCHC	B-test
-	O
29.9	O
*	O
RDW	B-test
-	O
15.1	O
Plt	B-test
Ct	I-test
-	O
178	O

2013-09-25	O
02:41	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
5.3	O
RBC	B-test
-	O
2.94	O
*	O
Hgb	B-test
-	O
8.2	O
*	O
Hct	B-test
-	O
27.4	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
27.9	O
MCHC	B-test
-	O
29.9	O
*	O
RDW	B-test
-	O
15.0	O
Plt	B-test
Ct	I-test
-	O
194	O

2013-09-23	O
03:07	O
AM	O
BLOOD	B-test
PT	B-test
-	O
14.0	O
*	O
PTT	B-test
-	O
30.1	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.2	O
*	O

2013-09-22	O
04:20	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
86	O
UreaN	B-test
-	O
18	O
Creat	B-test
-	O
0.8	O
Na	B-test
-	O
144	O
K	B-test
-	O
3.7	O
Cl	B-test
-	O
101	O
HCO3	B-test
-	O
40	O
*	O
AnGap	B-test
-	O
7	O
*	O

2013-09-24	O
09:36	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
202	O
*	O
UreaN	B-test
-	O
25	O
*	O
Creat	B-test
-	O
1.1	O
Na	B-test
-	O
139	O
K	B-test
-	O
3.9	O
Cl	B-test
-	O
100	O
HCO3	B-test
-	O
37	O
*	O
AnGap	B-test
-	O
6	O
*	O

2013-09-25	O
02:41	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
122	O
*	O
UreaN	B-test
-	O
31	O
*	O
Creat	B-test
-	O
1.3	O
*	O
Na	B-test
-	O
139	O
K	B-test
-	O
4.1	O
Cl	B-test
-	O
99	O
HCO3	B-test
-	O
35	O
*	O
AnGap	B-test
-	O
9	O

2013-09-22	O
04:20	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
51	O
*	O
AST	B-test
-	O
86	O
*	O
CK	B-test
(	I-test
CPK	I-test
)-	I-test
638	O
*	O
AlkPhos	B-test
-	O
65	O
Amylase	B-test
-	O
120	O
*	O
TotBili	B-test
-	O
0.4	O

2013-09-22	O
12:38	O
PM	O
BLOOD	B-test
CK	B-test
(	I-test
CPK	I-test
)-	I-test
1086	O
*	O

2013-09-22	O
09:45	O
PM	O
BLOOD	B-test
CK	B-test
(	I-test
CPK	I-test
)-	I-test
972	O
*	O

2013-09-25	O
02:41	O
AM	O
BLOOD	B-test
CK	B-test
(	I-test
CPK	I-test
)-	I-test
218	O
*	O

2013-09-22	O
04:20	O
AM	O
BLOOD	B-test
cTropnT	B-test
-	O
0.18	O
*	O

2013-09-22	O
12:38	O
PM	O
BLOOD	B-test
CK-MB	B-test
-	O
18	O
*	O
MB	B-test
Indx	I-test
-	O
1.7	O
cTropnT	B-test
-	O
0.17	O
*	O

2013-09-22	O
09:45	O
PM	O
BLOOD	B-test
CK-MB	B-test
-14	O
*	O
MB	B-test
Indx	I-test
-	O
1.4	O

2013-09-23	O
04:26	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
10	O
MB	B-test
Indx	I-test
-	O
1.4	O
cTropnT	B-test
-	O
0.12	O
*	O

2013-09-25	O
02:41	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
5	O
cTropnT	B-test
-	O
0.10	O
*	O

2013-09-22	O
04:20	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
8.1	O
*	O
Phos	B-test
-	O
3.2	O
Mg	B-test
-	O
2.0	O

2013-09-25	O
02:41	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
8.2	O
*	O
Phos	B-test
-	O
5.3	O
*	O
Mg	B-test
-	O
1.9	O

2013-09-23	O
07:36	O
AM	O
BLOOD	B-test
Vanco	B-test
-	O
16.2	O
*	O

2013-09-24	O
10:26	O
AM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
pO2	B-test
-	O
105	O
pCO2	B-test
-	O
95	O
*	O
pH	B-test
-	O
7.19	O
*	O
calTCO2	B-test
-	O
38	O
*	O
Base	B-test
XS	I-test
-	O
4	O

2013-09-24	O
11:05	O
AM	O
BLOOD	B-test
Type	I-test
-	O
May	O
pO2	B-test
-	O
35	O
*	O
pCO2	B-test
-	O
107	O
*	O
pH	B-test
-	O
7.17	O
*	O
calTCO2	B-test
-	O
41	O
*	O
Base	B-test
XS	I-test
-	O
5	O

2013-09-24	O
11:31	O
AM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
pO2	B-test
-	O
144	O
*	O
pCO2	B-test
-	O
80	O
*	O
pH	B-test
-	O
7.23	O
*	O
calTCO2	B-test
-	O
35	O
*	O
Base	B-test
XS	I-test
-	O
3	O

2013-09-24	O
07:42	O
PM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
pO2	B-test
-	O
127	O
*	O
pCO2	B-test
-	O
105	O
*	O
pH	B-test
-	O
7.16	O
*	O
calTCO2	B-test
-	O
40	O
*	O
Base	B-test
XS	I-test
-	O
4	O

2013-09-24	O
09:19	O
PM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
pO2	B-test
-	O
76	O
*	O
pCO2	B-test
-	O
85	O
*	O
pH	B-test
-	O
7.26	O
*	O
calTCO2	B-test
-	O
40	O
*	O
Base	B-test
XS	I-test
-	O
7	O

2013-09-25	O
01:50	O
AM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
pO2	B-test
-	O
47	O
*	O
pCO2	B-test
-	O
105	O
*	O
pH	B-test
-	O
7.15	O
*	O
calTCO2	B-test
-	O
39	O
*	O
Base	B-test
XS	I-test
-	O
3	O

2013-09-25	O
02:54	O
AM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
pO2	B-test
-	O
64	O
*	O
pCO2	B-test
-	O
91	O
*	O
pH	B-test
-	O
7.23	O
*	O
calTCO2	B-test
-	O
40	O
*	O
Base	B-test
XS	I-test
-	O
6	O

CT	B-test
CSpine	I-test
:	O

No	O
evidence	O
of	O
cervical	B-problem
spine	I-problem
fracture	I-problem
.	O

Cervical	B-problem
spondylosis	I-problem
as	O
described	O
above	O
.	O

CXR	B-test
post	O
CVL	B-treatment
placement	I-treatment
09-23	O
:	O

A	B-treatment
left	I-treatment
subclavian	I-treatment
vascular	I-treatment
catheter	I-treatment
terminates	O
in	O
the	O
superior	O
vena	O
cava	O
.	O

Several	O
skin	O
folds	O
are	O
present	O
in	O
the	O
left	O
hemithorax	O
but	O
there	O
is	O
no	O
pneumothorax	B-problem
.	O

There	O
are	O
bilateral	B-problem
moderate	I-problem
pleural	I-problem
effusions	I-problem
,	O
both	O
of	O
which	O
have	O
increased	O
in	O
size	O
since	O
the	B-test
previous	I-test
study	I-test
.	O

New	B-problem
perihilar	I-problem
and	I-problem
basilar	I-problem
opacities	I-problem
may	O
reflect	O
pulmonary	B-problem
edema	I-problem
sparing	O
the	O
upper	O
lobes	O
in	O
the	O
setting	O
of	O
emphysema	B-problem
,	O
but	O
it	O
is	O
difficult	O
to	O
exclude	O
underlying	B-problem
aspiration	I-problem
or	O
infectious	B-problem
pneumonia	I-problem
in	I-problem
the	I-problem
lung	I-problem
bases	I-problem
.	O

Surgical	B-treatment
clips	I-treatment
are	O
present	O
in	O
the	O
left	O
axilla	O
.	O

09-25	O
CXR	B-test
:	O

Interval	O
development	O
of	O
large	B-problem
left	I-problem
pneumothorax	I-problem
with	O
almost	B-problem
complete	I-problem
collapse	I-problem
of	I-problem
the	I-problem
left	I-problem
lung	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

79F	O
w/	O
a	O
multiple	B-problem
medical	I-problem
problems	I-problem
including	O
Sylvia	O
(	O
EF20%	B-test
)	O
,	O
COPD	B-problem
(	O
on	O
home	B-treatment
O2	I-treatment
)	O
,	O
found	O
down	O
at	O
home	O
,	O
pulseless	B-problem
-	O
CPR	B-treatment
initiated	O
w/conciousness	O
regained	O
on	O
scene	O
.	O

At	O
OSH	O
ABG	B-test
7.19/94/110	O
,	O
BiPAP	B-treatment
started	O
.	O

Pt	O
found	O
to	O
be	O
hypothermic	B-problem
w/	O
WBC	B-test
17	O
(	O
pt	O
on	O
steroids	B-treatment
)	O
pnuemobilia	B-problem
and	O
thickening	B-problem
of	I-problem
sigmoid	I-problem
.	O

Pt	O
was	O
transferred	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
for	O
further	B-treatment
management	I-treatment
with	O
wishes	O
from	O
the	O
pt	O
and	O
family	O
to	O
reverse	O
DNR/DNI	O
status	O
if	O
surgery	B-treatment
was	O
indicated	O
.	O

On	O
transfer	O
,	O
the	O
pt	O
had	O
VSS	O
with	O
a	B-problem
mildly	I-problem
tender	I-problem
abdomen	I-problem
without	O
peritoneal	O
signs	O
.	O

It	O
was	O
decided	O
to	O
treat	O
her	O
conservatively	O
with	O
bowel	B-treatment
and	I-treatment
IV	I-treatment
antibiotics	I-treatment
.	O

She	O
improved	O
and	O
was	O
tolerating	O
PO	O
's	O
without	O
difficulty	O
after	O
passing	O
a	B-test
swallow	I-test
study	I-test
.	O

Her	O
Cpine	O
was	O
clearly	O
with	O
both	O
a	O
negative	O
CT	O
Cspine	O
and	O
clinical	B-test
exam	I-test
.	O

Her	B-treatment
groin	I-treatment
CVL	I-treatment
was	O
DC	O
'd	O
after	O
a	B-treatment
L	I-treatment
SC	I-treatment
SVL	I-treatment
was	O
palced	O
.	O

CXR	B-test
confirmed	O
good	O
position	O
and	O
no	O
PTx	B-problem
.	O

Overnight	O
on	O
HD	O
3	O
,	O
pt	O
became	O
mildly	B-problem
agitated	I-problem
and	O
an	B-test
ABG	I-test
was	O
drawn	O
which	O
showed	O
a	B-problem
severe	I-problem
resp	I-problem
acidosis	I-problem
and	O
BiPAP	B-treatment
was	O
initiated	O
.	O

The	O
pt	O
subsequently	O
developed	O
severe	B-problem
hypoxia	I-problem
with	O
hypotension	B-problem
.	O

A	B-test
CXR	I-test
was	O
obtained	O
which	O
showed	O
complete	B-problem
collapse	I-problem
of	I-problem
the	I-problem
L	I-problem
lung	I-problem
thought	O
to	O
be	O
a	O
result	O
of	O
bursting	O
a	B-problem
bleb	I-problem
associated	O
with	O
her	B-problem
severe	I-problem
COPD	I-problem
.	O

Family	O
did	O
not	O
want	O
a	B-treatment
chest	I-treatment
tube	I-treatment
placed	O
and	O
decided	O
to	O
make	O
the	O
pt	O
CMO	B-treatment
measures	I-treatment
.	O

On	O
HD	O
4	O
pt	O
continued	O
to	O
show	O
a	B-problem
severe	I-problem
respiratory	I-problem
acidosis	I-problem
,	O
was	O
continued	O
on	O
a	B-treatment
morphine	I-treatment
drip	I-treatment
,	O
and	O
was	O
difficult	O
to	O
arouse	O
.	O

At	O
6pm	O
pt	O
's	O
respiratory	O
status	O
worsened	O
and	O
she	O
died	O
.	O

Medications	O
on	O
Admission	O
:	O

coreg	B-treatment
6.25	O
"	O
,	O
captopril	B-treatment
12.5	O
"	O
,	O
effexor	B-treatment
150	O
'	O
,	O
colace	B-treatment
100	O
"	O
prn	O
,	O
calcium	B-treatment
"	O
,	O
lasix	B-treatment
40	O
'	O
,	O
KCL	B-treatment
20	O
'	O
,	O
Pred	B-treatment
5	O
'	O
,	O
opscal	B-treatment
'	O
,	O
protonix	B-treatment
40	O
'	O
,	O
diamoxx	B-treatment
250	O
'	O
,	O
albuterol	B-treatment
prn	O
,	O
darvocet	B-treatment
prn	O
,	O
senekot	B-treatment
,	O
trazadone	B-treatment
25	O
'	O

Discharge	O
Medications	O
:	O

NA	O
PAD-WORD	O

Discharge	O
Disposition	O
:	O

Expired	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O
respiratory	B-problem
failure	I-problem

Discharge	O
Condition	O
:	O

NA	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

NA	O
PAD-WORD	O

Followup	O
Instructions	O
:	O

NA	O
PAD-WORD	O

Keith	O
Clint	O
MD	O
44-982	O

Completed	O
by	O
:	O
Christine	O
Mary	O
MD	O
00-155	O
2013-09-27	O
@	O
0902	O

Signed	O
electronically	O
by	O
:	O
DR.	O
William	O
Lawson	O
on	O
:	O
MON	O
2013-10-14	O
8:51	O
PM	O

(	O
End	O
of	O
Report	O
)	O

164312247	O
PAD-WORD	O

NVH	O
PAD-WORD	O

47624330	O
PAD-WORD	O

1/19/2002	O
12:00:00	O
AM	O

Sepsis	B-problem
,	O
myocardial	B-problem
infarction	I-problem
,	O
ARDS	B-problem
,	O
pneumonia	B-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/19/2002	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/20/2002	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O

TROSPROB	O
,	O
STYEES	O

650-29-95-3E45	O
PAD-WORD	O

Room	O
:	O

9V-851	O
PAD-WORD	O

Service	O
:	O

PUL	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/20/02	O
AT	O
03:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

GLOMOBESAP	O
,	O
BAMJET	O
ELLDAN	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Other-Expired	O
.	O

DISPOSITION	O
:	O

Expired	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

RETURN	O
TO	O
WORK	O
:	O

Not	O
Applicable	O

ALLERGY	O
:	O

Penicillins	B-treatment
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

Sepsis	B-problem
,	O
ARDS	B-problem
,	O
Pneumonia	B-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Sepsis	B-problem
,	O
myocardial	B-problem
infarction	I-problem
,	O
ARDS	B-problem
,	O
pneumonia	B-problem

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
DM2	B-problem
,	O
s	O
/	O
p	O
splenectomy	B-treatment
,	O
depression	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

None	O
.	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O
None	O
.	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

Patient	O
received	O
as	O
transfer	O
from	O
outside	O
hospital	O
.	O

Patient	O
on	O
vent	B-treatment
,	O
febrile	B-problem
,	O
hypotensive	B-problem
.	O

Developed	O
requirement	B-problem
for	O
multiple	B-treatment
pressors	I-treatment
,	O
then	O
arrhythmias	B-problem
.	O

Full	B-treatment
code	I-treatment
carried	O
out	O
.	O

Despite	O
extraordinary	B-treatment
measures	I-treatment
,	O
stable	O
sinus	O
rhythm	O
could	O
not	O
be	O
restored	O
.	O

Please	O
see	O
written	O
medical	O
record	O
for	O
complete	O
report	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Expired	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

NELLFYFE	O
,	O
SHATAYE	O
I	O
,	O
M.D.	O
,	O
PH.D.	O
(	O
IY150	O
)	O

01/20/02	O
03:35	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2011-09-24	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-09-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1932-02-28	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

ADMISSION	O
DIAGNOSIS	O
:	O

Subarachnoid	B-problem
hemorrhage	I-problem
,	I-problem
posttraumatic	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
a	O
79	O
-	O
year-old	O
gentleman	O
found	O
down	O
at	O
home	O
unresponsive	B-problem
by	O
his	O
wife	O
after	O
lunch	O
.	O

He	O
had	O
an	O
unwitnessed	O
fall	O
.	O

He	O
had	O
no	O
history	O
of	O
headaches	B-problem
or	O
recent	B-problem
illness	I-problem
.	O

He	O
remained	O
unresponsive	B-problem
when	O
the	O
ambulance	O
arrived	O
.	O

Systolic	B-test
blood	I-test
pressure	I-test
was	O
reported	O
250	O
on	O
arrival	O
to	O
the	O
Mass.	O
Eye	O
&	O
Ear	O
Infirmary	O
Emergency	O
Department	O
.	O

He	O
was	O
intubated	O
and	O
given	O
Versed	B-treatment
and	O
Fentanyl	B-treatment
.	O

His	B-test
GCS	I-test
was	O
reported	O
as	O
3	O
on	O
arrival	O
to	O
the	O
Emergency	O
Department	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
.	O

Status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

Pacemaker	B-treatment
implantation	I-treatment
.	O

Atrial	B-problem
fibrillation	I-problem
.	O

Cerebrovascular	B-problem
accident	I-problem
.	O

Previous	B-problem
intracranial	I-problem
hemorrhage	I-problem
.	O

MEDICATIONS	O
:	O

Aspirin	B-treatment
,	O
Folate	B-treatment
,	O
Multivitamin	B-treatment
,	O
Amiodarone	B-treatment
,	O
Lasix	B-treatment
,	O
Imdur	B-treatment
,	O
Celexa	B-treatment
,	O
Lipitor	B-treatment
,	O
Potassium	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

He	O
was	O
afebrile	B-problem
,	O
blood	B-test
pressure	I-test
154/75	O
,	O
on	O
Nipride	B-treatment
drip	I-treatment
,	O
heart	B-test
rate	I-test
81	O
,	O
oxygen	B-test
saturation	I-test
97%	O
.	O

General	O
:	O

He	O
was	O
intubated	B-treatment
and	O
sedated	B-treatment
at	O
the	O
time	O
.	O

Neurological	O
:	O

Pinpoint	B-problem
pupils	I-problem
,	O
intact	O
corneal	O
reflexes	O
bilaterally	O
.	O

Doll	B-problem
's	I-problem
eyes	I-problem
.	O

He	O
withdrew	O
both	O
lower	O
extremities	O
to	O
peripheral	B-test
stimulation	I-test
,	O
as	O
well	O
as	O
his	O
upper	O
extremities	O
to	O
peripheral	B-test
stimulation	I-test
.	O

He	O
also	O
withdrew	O
his	O
left	O
upper	O
extremity	O
to	O
peripheral	B-test
stimulation	I-test
but	O
not	O
his	O
right	O
upper	O
extremity	O
.	O

His	B-test
reflexes	I-test
were	O
brisk	O
in	O
his	O
patellas	O
bilaterally	O
,	O
and	O
he	O
had	O
upgoing	B-problem
toes	I-problem
bilaterally	I-problem
.	O

IMAGING	O
:	O

Head	B-test
CT	I-test
showed	O
diffuse	B-problem
subarachnoid	I-problem
hemorrhage	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
admitted	O
to	O
the	O
Neuro	O
Surgical	O
Intensive	O
Care	O
Unit	O
for	O
close	O
monitoring	O
and	O
Neuro-checks	B-test
.	O

A	B-treatment
Vent	I-treatment
drain	I-treatment
was	O
placed	O
to	O
monitor	O
and	O
CP	O
and	O
relieved	O
fluid	O
.	O

He	O
received	O
12	O
U	O
of	O
platelets	B-treatment
.	O

His	O
Intensive	O
Care	O
Unit	O
stay	O
was	O
unremarkable	O
.	O

His	B-test
neurologic	I-test
exam	I-test
did	O
not	O
change	O
significantly	O
.	O

His	B-test
ICPs	I-test
were	O
in	O
the	O
range	O
of	O
11-22	O
,	O
and	O
he	O
was	O
weaned	O
off	O
the	B-treatment
Nipride	I-treatment
drip	I-treatment
.	O

He	O
developed	O
extensive	B-problem
posturing	I-problem
.	O

A	B-test
CTA	I-test
showed	O
diffuse	B-problem
subarachnoid	I-problem
hemorrhage	I-problem
and	O
intraventricular	B-problem
blood	I-problem
but	O
no	O
evidence	O
of	O
an	B-problem
aneurysm	I-problem
.	O

A	B-test
repeat	I-test
CT	I-test
on	O
09-26	O
showed	O
worsening	O
of	O
the	B-problem
diffuse	I-problem
subarachnoid	I-problem
hemorrhage	I-problem
and	O
a	B-problem
new	I-problem
cerebellar	I-problem
hemorrhage	I-problem
.	O

The	O
family	O
was	O
informed	O
of	O
the	O
patient	O
's	O
condition	O
and	O
repeat	B-test
scan	I-test
.	O

A	O
family	O
discussion	O
resulted	O
in	O
the	O
decision	O
to	O
make	O
the	O
patient	O
comfort	B-treatment
measures	I-treatment
only	I-treatment
.	O

The	O
patient	O
was	O
placed	O
on	O
a	B-treatment
Morphine	I-treatment
drip	I-treatment
and	O
extubated	O
and	O
passed	O
away	O
at	O
10:55	O
a.m.	O
on	O
2011-09-27	O
.	O

The	O
family	O
was	O
notified	O
of	O
the	O
patient	O
's	O
passing	O
.	O

The	O
medical	O
examiner	O
has	O
also	O
been	O
notified	O
of	O
the	O
passing	O
of	O
the	O
patient	O
.	O

Shawn	O
B	O
Crawford	O
,	O
M.D.	O

46-411	O
PAD-WORD	O

Dictated	O
By	O
:	O
Linda	O
P.F.	O
Clark	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2011-09-27	O
11:53	O

T	O
:	O
2011-09-27	O
12:41	O

JOB	O
#	O
:	O
63722	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Carlos	O
Warner	O
on	O
:	O
TUE	O
2011-09-27	O
3:42	O
PM	O

(	O
End	O
of	O
Report	O
)	O

165342718	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

79284819	O
PAD-WORD	O

181252	O
PAD-WORD	O

11/30/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

11/30/1993	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

Discharge	O
Date	O
:	O

12/07/1993	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
40	O
year	O
old	O
woman	O
with	O
end	B-problem
stage	I-problem
renal	I-problem
disease	I-problem
,	O
on	O
hemodialysis	B-treatment
since	O
12/91	O
.	O

This	O
was	O
secondary	O
to	O
polycystic	B-problem
kidneydisease	I-problem
,	O
which	O
was	O
noted	O
since	O
age	O
12	O
.	O

She	O
is	O
status	O
post	O
cadaveric	B-treatment
renal	I-treatment
allograft	I-treatment
in	O
03/93	O
,	O
and	O
she	O
subsequently	O
underwent	O
an	B-treatment
early	I-treatment
postoperative	I-treatment
transplant	I-treatment
nephrectomy	I-treatment
secondary	O
to	O
rupture	B-problem
.	O

He	O
has	O
been	O
having	O
difficult	B-problem
access	I-problem
problems	I-problem
and	O
now	O
has	O
a	B-treatment
left	I-treatment
upper	I-treatment
arm	I-treatment
PTFE	I-treatment
.	O

She	O
had	O
been	O
placed	O
on	O
emergency	B-treatment
transplant	I-treatment
for	O
this	B-problem
difficult	I-problem
access	I-problem
problem	I-problem
.	O

Otherwise	O
,	O
she	O
has	O
been	O
healthy	O
and	O
her	B-treatment
last	I-treatment
hemodialysis	I-treatment
was	O
the	O
day	O
prior	O
to	O
transplant	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
hypertension	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Multiple	B-treatment
angio	I-treatment
accesses	I-treatment
,	O
TAH	B-treatment
at	O
age	O
18	O
,	O
cadaveric	B-treatment
renal	I-treatment
allograft	I-treatment
in	O
03/93	O
,	O
reoperation	B-treatment
for	O
bleed	B-problem
followed	O
by	O
transplant	B-treatment
nephrectomy	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMIT	O
:	O

Iron	B-treatment
,	O
Nephro-Caps	B-treatment
,	O
calcium	B-treatment
carbonate	I-treatment
and	O
Valium	B-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
11/30/93	O
where	O
Dr.	O
Tiveloydherdes	O
performed	O
a	B-treatment
cadaveric	I-treatment
renal	I-treatment
allograft	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
iliac	I-treatment
fossa	I-treatment
which	O
she	O
tolerated	O
well	O
.	O

Postoperative	O
course	O
was	O
unremarkable	O
.	O

She	O
was	O
started	O
on	O
her	B-treatment
immunosuppressive	I-treatment
agents	I-treatment
as	O
per	O
protocol	O
.	O

Her	B-test
creatinine	I-test
fell	O
to	O
the	O
normal	O
range	O
early	O
.	O

Over	O
several	O
days	O
she	O
continued	O
to	O
make	O
good	O
amounts	O
or	O
urine	O
.	O

She	O
was	O
gradually	O
advanced	O
to	O
a	O
regular	O
diet	O
.	O

Her	B-treatment
prednisone	I-treatment
was	O
tapered	O
to	O
a	B-treatment
stable	I-treatment
dose	I-treatment
.	O

DISPOSITION	O
:	O

Discharge	B-treatment
medications	I-treatment
were	O
prednisone	B-treatment
30	O
q.d.	O
,	O
Imuran	B-treatment
120	O
q.d.	O
,	O
cyclosporin	B-treatment
400	O
b.i.d.	O
and	O
Pepcid	B-treatment
20	O
b.i.d.	O
and	O
Colace	B-treatment
100	O
b.i.d.	O

Dicatated	O
By	O
:	O

IA	O
A	O
,	O
M.D.	O
AX37	O

Attending	O
:	O

AE	O
Z.	O
TIVELOYDHERDES	O
,	O
M.D.	O
ZC5	O
GI592/4-03	O

Batch	O
:	O

6066	O
PAD-WORD	O

Index	O
No.	O
VQCUHL4S7Y	O

D	O
:	O

12/07/93	O
PAD-WORD	O

T	O
:	O

12/08/93	O
PAD-WORD	O

Admission	O
Date	O
:	O

2013-11-11	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-11-13	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1938-06-09	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
PAD-WORD	O

Allergies	O
:	O

No	O
Drug	B-problem
Allergy	I-problem
Information	O
on	O
File	O

Attending	O
:	O
Leroy	O
F	O
Stalnaker	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Left	B-problem
sided	I-problem
weakness	I-problem
,	O
slurred	B-problem
speech	I-problem
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
and	O
mechanical	B-treatment
ventilation	I-treatment
.	O

History	O
of	O
Present	O
Illness	O
:	O

Patient	O
is	O
a	O
75	O
year	O
old	O
right	O
handed	O
male	O
with	O
past	O
medical	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
s/p	O
NQWMI	B-problem
02-25	O
,	O
s/p	O
LAD	B-treatment
angioplasty	I-treatment
and	O
stent	B-treatment
05-26	O
,	O
dementia	B-problem
,	O
hyperlipidemia	B-problem
,	O
aortic	B-problem
stenosis	I-problem
,	O
atrial	B-problem
fibrillation	I-problem
on	O
coumadin	B-treatment
who	O
presented	O
from	O
his	O
CMED	O
CSRU	O
doctor	O
's	O
office	O
wtih	O
acute	B-problem
onset	I-problem
left	I-problem
sided	I-problem
weakness	I-problem
and	O
dysarthria	B-problem
.	O

Patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
around	O
12:15	O
on	O
day	O
of	O
admission	O
.	O

Was	O
at	O
this	O
doctor	O
's	O
office	O
and	O
complained	O
of	O
severe	B-problem
headache	I-problem
.	O

Thereafter	O
,	O
wife	O
noted	O
development	O
of	O
left	B-problem
sided	I-problem
weakness	I-problem
,	O
facial	B-problem
droop	I-problem
,	O
slurring	B-problem
of	I-problem
speech	I-problem
.	O

Sent	O
to	O
Hahnemann	O
General	O
Hospital	O
for	O
evaluation	B-test
emergently	O
.	O

Tom	O
course	O
:	O

Arrived	O
at	O
Hahnemann	O
General	O
Hospital	O
at	O
12:30	O
.	O

Finger	B-test
stick	I-test
blood	I-test
glucose	I-test
120	O
.	O

Rest	O
of	O
vitals	B-test
BP	B-test
112/70	O
,	O
HR	B-test
60	O
.	O

Blood	B-test
pressure	I-test
up	O
to	O
230	O
s	O
systolic	O
.	O

Seen	O
emergently	O
by	O
stroke	O
team	O
.	O

Initial	B-test
NIH	I-test
stroke	I-test
scale	I-test
of	O
33	O
.	O

Head	B-test
CT	I-test
showed	O
large	B-problem
right	I-problem
intracerebral	I-problem
hemorrhage	I-problem
.	O

Intubated	O
for	O
airway	B-treatment
protection	I-treatment
at	O
13:35	O
after	O
Fentanyl	B-treatment
,	O
Etomidate	B-treatment
,	O
Vecuronium	B-treatment
and	O
Succhinylcholine	B-treatment
given	O
.	O

Started	O
on	O
Labetalol	B-treatment
and	O
then	O
Nipride	B-treatment
drip	I-treatment
for	O
BP	B-treatment
control	I-treatment
;	O
discontinued	O
as	O
goal	B-test
BP	I-test
in	O
130-160	O
s.	O

Received	O
10	B-treatment
mg	I-treatment
SC	I-treatment
Vitamin	I-treatment
K	I-treatment
and	O
2	B-treatment
units	I-treatment
FFP	I-treatment
while	O
in	O
Gary	O
.	O

Pupils	O
noted	O
to	O
be	O
fixed	B-problem
and	O
dilated	B-problem
at	O
14:10	O
.	O

Loaded	O
with	O
Dilantin	B-treatment
and	O
50	B-treatment
grams	I-treatment
Mannitol	I-treatment
.	O

Transferred	O
to	O
intensive	O
care	O
unit	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Atrial	B-problem
fibrillation	I-problem
,	O
on	O
coumadin	B-treatment

2.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
NQWMI	B-problem
02-25	O
,	O
s/p	O
LAD	B-treatment
angioplasty	I-treatment
and	O
stent	B-treatment
05-26	O
.	O
Known	B-problem
non-dominant	I-problem
90%	I-problem
RCA	I-problem
lesion	I-problem
not	O
intervened	O
upon	O
.	O

3.	O
Dementia	B-problem

4.	O
Mild-moderate	B-problem
aortic	I-problem
stenosis	I-problem

5.	O
Hyperlipidemia	B-problem

6.	O
Colon	B-problem
cancer	I-problem

7.	O
Obstructive	B-problem
sleep	I-problem
apnea	I-problem

8.	O
Anxiety	B-problem

9.	O
Diabetes	B-problem
mellitus	I-problem
,	O
on	O
oral	B-treatment
medications	I-treatment

Social	O
History	O
:	O

Married	O
.	O

Lives	O
with	O
wife	O
.	O

One	O
son	O
,	O
in	O
area	O
.	O

Social	O
alcohol	O
.	O

No	O
tobacco	O
,	O
drug	O
use	O
.	O

Family	O
History	O
:	O

Non-contributory	O
.	O

Physical	O
Exam	O
:	O

PHYSICAL	B-test
EXAM	I-test
(	O
Examined	O
off	O
of	O
Propofol	B-treatment
):	O

Tc	B-test
:	O
96.7	O

BP	B-test
:	O
120/48	O

HR	B-test
:	O
61	O

RR	B-test
:	O
14	O

O2Sat.	B-test
:	O
100%	O
,	O
ventilated	B-treatment
.	O

Gen	O
:	O
WD/WN	O
male	O
,	O
comfortable	O
appearing	O
,	O
intubated	B-treatment
,	O
not	O
sedated	B-treatment
.	O

HEENT	O
:	O
NC/AT	B-problem
.	O

Anicteric	B-problem
.	O

MMM	O
.	O

+Endotracheal	B-treatment
tube	I-treatment
.	O

Neck	O
:	O
Supple	O
.	O

No	O
masses	B-problem
or	O
LAD	B-problem
.	O

No	O
JVD	B-problem
.	O

No	O
thyromegaly	B-problem
.	O

No	O
carotid	B-problem
bruits	I-problem
.	O

Lungs	O
:	O
Coarse	B-problem
breath	I-problem
sounds	I-problem
anterolaterally	I-problem
.	O

Cardiac	O
:	O
Irregularly	B-problem
irregular	I-problem
.	O

S1/S2	O
.	O

No	O
M/R/G	B-problem
.	O

Abd	O
:	O
Soft	O
,	O
NT	B-problem
,	O
ND	B-problem
,	O
+NABS	O
.	O

No	O
rebound	B-problem
or	O
guarding	B-problem
.	O

No	O
HSM	B-problem
.	O

Extrem	O
:	O
Warm	O
and	O
well-perfused	O
.	O

No	O
C/C/E	B-problem
.	O

Neuro	O
:	O

Mental	O
status	O
:	O

No	B-problem
response	I-problem
to	I-problem
voice	I-problem
,	O
sternal	B-test
rub	I-test
.	O

Grimaces	O
to	O
nasal	B-test
tickle	I-test
.	O

Cranial	O
Nerves	O
:	O

Pupils	B-problem
fixed	I-problem
at	O
7	O
mm	O
bilaterally	O
.	O

Very	O
weak	O
flicker	O
of	O
inner	O
canthus	O
on	O
left	O
with	O
corneal	B-test
stimulation	I-test
.	O

No	B-problem
oculocephalic	I-problem
reflex	I-problem
.	O

Left	B-problem
facial	I-problem
droop	I-problem
.	O

No	B-problem
gag	I-problem
provoked	O
,	O
but	O
biting	O
ETT	B-treatment
at	O
times	O
.	O

Tongue	O
midline	O
.	O

Motor	O
:	O

Normal	O
bulk	O
.	O

Increased	O
tone	O
x4	O
with	O
LEs	O
>	O
UEs	O
.	O

No	B-problem
withdrawal	I-problem
to	O
noxious	B-test
stimuli	I-test
.	O

Bilateral	O
feet	O
externally	O
rotated	O
.	O

Sensation	O
:	O

No	B-problem
withdrawal	I-problem
to	O
noxious	B-test
stimuli	I-test
.	O

Reflexes	B-test
:	O

Absent	O
in	O
LUE	O
,	O
left	O
ankle	O
.	O

Striking	O
left	O
patellar	O
tendon	O
results	O
in	O
sustained	B-problem
clonus	I-problem
of	I-problem
left	I-problem
leg	I-problem
.	O

Toes	B-problem
upgoing	I-problem
bilaterally	I-problem
.	O

02-27	O
RUE	O
,	O
absent	O
right	O
ankle	O
.	O

Coordination	O
:	O

Unable	O
to	O
assess	O
.	O

Gait	O
:	O

Unable	O
to	O
assess	O
.	O

Pertinent	O
Results	O
:	O

2013-11-11	O
12:39	O
PM	O

WBC	B-test
-	O
9.1	O
RBC	B-test
-	O
4.29	O
*	O
HGB	B-test
-	O
14.1	O
HCT	B-test
-	O
38.7	O
*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
32.8	O
*	O
MCHC	B-test
-	O
36.4	O
*	O
RDW	B-test
-	O
14.7	O

2013-11-11	O
12:39	O
PM	O

PLT	B-test
COUNT	I-test
-	O
147	O
*	O

2013-11-11	O
12:39	O
PM	O

PT	B-test
-	O
20.0	O
*	O
PTT	B-test
-	O
32.4	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
2.5	O

2013-11-11	O
12:39	O
PM	O

GLUCOSE	B-test
-	O
101	O
UREA	B-test
N	I-test
-	O
25	O
*	O
CREAT	B-test
-	O
1.0	O
SODIUM	B-test
-	O
142	O
POTASSIUM	B-test
-	O
4.2	O
CHLORIDE	B-test
-	O
106	O
TOTAL	B-test
CO2	I-test
-	O
27	O
ANION	B-test
GAP	I-test
-	O
13	O

2013-11-11	O
12:39	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
200	O
*	O

2013-11-11	O
12:39	O
PM	O
cTropnT	B-test
-<	O
0.01	O

2013-11-11	O
12:39	O
PM	O

CK-MB	B-test
-	O
7	O

2013-11-11	O
09:45	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
196	O
*	O

2013-11-11	O
09:45	O
PM	O

CK-MB	B-test
-	O
3	O
cTropnT	B-test
-<	O
0.01	O

2013-11-12	O
03:30	O
AM	O
BLOOD	B-test
CK	B-test
(	I-test
CPK	I-test
)-	I-test
312	O
*	O

2013-11-12	O
03:30	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
5	O
cTropnT	B-test
-<	O
0.01	O

2013-11-11	O
01:55	O
PM	O
URINE	B-test
BLOOD	B-test
-	O
SM	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
100	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
6.5	O
LEUK	B-test
-	O
NEG	O

2013-11-12	O
11:16	O
AM	O
BLOOD	B-test
ASA	B-test
-	O
NEG	O
Ethanol	B-test
-	O
NEG	O
Acetmnp	B-test
-	O
NEG	O
Bnzodzp	B-test
-	O
NEG	O
Barbitr	B-test
-	O
NEG	O
Tricycl	B-test
-	O
NEG	O

2013-11-12	O
10:17	O
AM	O
URINE	B-test
bnzodzp	B-test
-	O
NEG	O
barbitr	B-test
-	O
NEG	O
opiates	B-test
-	O
NEG	O
cocaine	B-test
-	O
NEG	O
amphetm	B-test
-	O
NEG	O
mthdone	B-test
-	O
NEG	O

CT	B-test
head	I-test
without	I-test
contrast	I-test
2013-11-11	O
:	O

FINDINGS	O
:	O

There	O
is	O
a	O
large	O
region	O
of	O
high	B-problem
attenuation	I-problem
within	I-problem
the	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
and	O
the	O
region	O
of	O
the	O
right	O
basal	O
ganglia	O
.	O

This	O
is	O
consistent	O
with	O
intraparenchymal	B-problem
hemorrhage	I-problem
,	O
more	O
likely	O
hypertensive	B-problem
in	O
etiology	O
.	O

No	O
significant	B-problem
subarachnoid	I-problem
or	O
intraventricular	B-problem
hemorrhage	I-problem
is	O
appreciated	O
.	O

There	O
is	O
mass	B-problem
effect	I-problem
present	O
with	O
shift	B-problem
of	I-problem
the	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
towards	O
the	O
left	O
.	O

There	O
is	O
also	O
left	B-problem
sided	I-problem
subfalcine	I-problem
herniation	I-problem
.	O

There	O
is	O
no	O
hydrocephalus	B-problem
.	O

The	O
visualized	O
osseous	O
structures	O
and	O
paranasal	O
sinuses	O
are	O
unremarkable	O
.	O

IMPRESSION	O
:	O

Large	B-problem
intraparenchymal	I-problem
hemorrhage	I-problem
within	I-problem
the	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
.	O

This	O
most	O
likely	O
relates	O
to	O
hypertensive	B-problem
hemorrhage	I-problem
,	O
as	O
opposed	O
to	O
a	B-problem
ruptured	I-problem
right	I-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
aneurysm	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

Patient	O
was	O
a	O
75	O
year	O
old	O
right	O
handed	O
male	O
with	O
past	O
medical	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
on	O
coumadin	B-treatment
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
hyperlipidemia	B-problem
,	O
dementia	B-problem
with	O
sudden	B-problem
onset	I-problem
left	I-problem
sided	I-problem
weakness	I-problem
,	O
dysarthria	B-problem
.	O

Head	B-test
CT	I-test
demonstrated	O
a	B-problem
large	I-problem
right	I-problem
intracerebral	I-problem
hemorrhage	I-problem
,	O
centered	O
around	O
basal	O
ganglia	O
and	O
putamen	O
.	O

We	O
felt	O
this	O
was	O
likely	O
secondary	O
to	O
hypertension	B-problem
.	O

While	O
still	O
in	O
the	O
emergency	O
department	O
,	O
he	O
had	O
rapid	B-problem
decompensation	I-problem
necessitating	O
intubation	B-treatment
for	O
airway	B-treatment
protection	I-treatment
.	O

Examination	B-test
post	O
intubation	B-treatment
but	O
off	O
intubations	B-treatment
showed	O
clinical	O
evidence	O
of	O
elevated	B-problem
intracranial	I-problem
pressure	I-problem
and	O
brainstem	B-problem
compression	I-problem
.	O

The	O
overall	O
prognosis	O
was	O
guarded	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Neurology	O
/	O
Neurosurgery	O
ICU	O
.	O

He	O
was	O
loaded	O
with	O
Mannitol	B-treatment
and	O
Dilantin	B-treatment
in	O
the	O
emergency	O
room	O
.	O

He	O
was	O
evaluated	O
by	O
the	O
Neurosurgery	O
service	O
and	O
they	O
did	O
not	O
feel	O
a	B-treatment
surgical	I-treatment
intervention	I-treatment
or	O
ventriculary	B-treatment
drain	I-treatment
was	O
warranted	O
.	O

After	O
arrival	O
in	O
the	O
ICU	O
,	O
patient	O
was	O
followed	O
with	O
neuro	B-test
checks	I-test
every	O
1	O
hour	O
.	O

Sedation	B-treatment
was	O
held	O
to	O
allow	O
for	O
frequent	B-test
exams	I-test
.	O

Head	O
of	O
bed	O
was	O
kept	O
at	O
30	O
degrees	O
.	O

Labetalol	B-treatment
continuous	I-treatment
infusion	I-treatment
was	O
titrated	O
for	O
systolic	B-test
blood	I-test
pressure	I-test
of	O
130-160	O
.	O

Mannitol	B-treatment
and	O
Dilantin	B-treatment
were	O
continued	O
.	O

After	O
lengthy	O
discussion	O
,	O
the	O
patient	O
's	O
wife	O
opted	O
to	O
make	O
him	O
DNR	O
on	O
afternoon	O
of	O
2013-11-11	O
.	O

Overnight	O
,	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
was	O
given	O
for	O
goal	B-test
INR	I-test
of	O
<	O
1.4	O
.	O

On	O
serial	B-test
exams	I-test
by	O
neurology	O
and	O
ICU	O
attendings	O
in	O
the	O
morning	O
on	O
2013-11-12	O
,	O
patient	O
had	O
no	B-problem
clinical	I-problem
signs	I-problem
of	I-problem
brainstem	I-problem
activity	I-problem
.	O

Namely	O
,	O
he	O
was	O
unresponsive	B-problem
.	O

Pupils	O
were	O
fixed	B-problem
and	O
dilated	B-problem
.	O

No	O
corneal	B-test
,	I-test
gag	I-test
,	I-test
oculocephalic	I-test
,	I-test
and	I-test
oculovestibular	I-test
reflexes	I-test
were	O
elicited	O
.	O

He	O
was	O
not	O
overbreathing	O
his	B-treatment
ventilator	I-treatment
.	O

At	O
this	O
point	O
,	O
patient	O
was	O
felt	O
to	O
have	O
clinical	O
signs	O
consistent	O
with	O
brain	B-problem
death	I-problem
.	O

Plans	O
were	O
made	O
to	O
proceed	O
with	O
apnea	B-test
testing	I-test
.	O

However	O
,	O
after	O
discussion	O
with	O
patient	O
's	O
wife	O
,	O
this	O
was	O
postponed	O
with	O
test	B-test
planned	O
on	O
2013-11-13	O
.	O

Full	B-treatment
medical	I-treatment
care	I-treatment
and	O
managment	B-treatment
continued	O
overnight	O
11/9-11/20/2002	O
.	O

At	O
approximately	O
06:00	O
on	O
2013-11-13	O
,	O
the	O
patient	O
became	O
bradycardic	B-problem
.	O

He	O
lapsed	O
first	O
into	O
a	B-problem
junctional	I-problem
rhythm	I-problem
and	O
then	O
had	O
very	B-problem
infrequent	I-problem
ventricular	I-problem
escape	I-problem
beats	I-problem
on	O
telemetry	B-test
.	O

Finally	O
,	O
he	O
went	O
asystolic	B-problem
.	O

He	O
was	O
not	O
resuscitated	O
as	O
per	O
previous	O
conversations	O
with	O
his	O
wife	O
.	O

Ronald	O
was	O
pronounced	O
dead	B-problem
at	O
06:59	O
am	O
.	O

The	O
patient	O
's	O
wife	O
was	O
notified	O
.	O

The	O
attending	O
was	O
notified	O
as	O
well	O
.	O

Medications	O
on	O
Admission	O
:	O

1.	O
Coumadin	B-treatment

2.	O
Lipitor	B-treatment

3.	O
Toprol	B-treatment
XL	I-treatment

4.	O
ASA	B-treatment

5.	O
Zoloft	B-treatment

6.	O
Glucophage	B-treatment

7.	O
Aricept	B-treatment

8.	O
Namenda	B-treatment

9.	O
Artificial	B-treatment
Tears	I-treatment

Discharge	O
Medications	O
:	O

Not	O
applicable	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Patient	O
deceased	O
.	O

Discharge	O
Diagnosis	O
:	O

Not	O
applicable;	O
patient	O
deceased	O
.	O

Discharge	O
Condition	O
:	O

Not	O
applicable	O
.	O

Discharge	O
Instructions	O
:	O

Not	O
applicable	O
.	O

Followup	O
Instructions	O
:	O

Not	O
applicable	O
.	O

William	O
William	O
MD	O
,	O
PHD	O
13-279	O

Completed	O
by	O
:	O
Barbara	O
Josephine	O
MD	O
21-547	O
2013-11-15	O
@	O
1413	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Exie	O
Culbreath	O
on	O
:	O
MON	O
2013-11-18	O
10:06	O
AM	O

(	O
End	O
of	O
Report	O
)	O

166394283	O
PUMC	O

1991524	O
PAD-WORD	O

328713	O
PAD-WORD	O

0095918	O
PAD-WORD	O

12/02/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

KOTENORT	O
,	O
OAN	O
R	O

UNIT	O
NUMBER	O
:	O

105-24-06	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12/02/2002	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

12/04/2002	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Probably	O
sigmoid	B-problem
volvulus	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
81	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
cerebrovascular	B-problem
accident	I-problem
,	O
atrial	B-problem
fibrillation	I-problem
,	O
hypothyroidism	B-problem
and	O
dementia	B-problem
who	O
is	O
status	O
post	O
laparoscopic	B-treatment
cholecystectomy	I-treatment
one	O
week	O
ago	O
who	O
currently	O
presents	O
with	O
a	O
4	O
day	O
history	O
of	O
no	B-problem
bowel	I-problem
movement	I-problem
.	O

She	O
has	O
complaints	O
of	O
abdominal	B-problem
distention	I-problem
,	O
emesis	B-problem
,	O
and	O
constipation	B-problem
.	O

She	O
has	O
no	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
fever	B-problem
.	O

She	O
has	O
no	O
nausea	B-problem
or	O
vomiting	B-problem
,	O
chills	B-problem
,	O
dysuria	B-problem
,	O
hematochezia	B-problem
,	O
or	O
melena	B-problem
.	O

She	O
was	O
discharged	O
from	O
the	O
hospital	O
on	O
11/28/02	O
to	O
a	O
short	O
term	O
rehabilitation	O
facility	O
.	O

She	O
was	O
found	O
to	O
have	O
normal	O
bowel	O
sounds	O
.	O

She	O
presented	O
to	O
the	O
Ponta,itri-	O
University	O
Medical	O
Center	O
Emergency	O
Department	O
on	O
12/01/02	O
for	O
evaluation	B-test
of	O
this	B-problem
constipation	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Cerebrovascular	B-problem
accident	I-problem
.	O

2.	O
Atrial	B-problem
fibrillation	I-problem
on	O
Coumadin	B-treatment
.	O

3.	O
Diabetes	B-problem
mellitus	I-problem
type	I-problem
2	I-problem
.	O

4.	O
Hypothyroidism	B-problem
.	O

5.	O
Mild	B-problem
dementia	I-problem
.	O

6.	O
Proteinuria	B-problem
.	O

7.	O
Nephropathy	B-problem
.	O

8.	O
Anemia	B-problem
.	O

9.	O
Hearing	B-problem
impaired	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

1.	O
Laparoscopic	B-treatment
cholecystectomy	I-treatment
as	O
above	O
.	O

2.	O
Total	B-treatment
hip	I-treatment
replacement	I-treatment
in	O
2002	O
.	O

3.	O
Appendectomy	B-treatment
.	O

4.	O
Diskectomy	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Digoxin	B-treatment
.125	O
mg	O
qod	O
,	O
.25	O
mg	O
qod	O
.	O

2.	O
Colace	B-treatment
100	O
mg	O
po	O
tid	O
.	O

3.	O
Levoxyl	B-treatment
100	O
ugm	O
po	O
qd	O
.	O

4.	O
Prinivil	B-treatment
20	O
mg	O
po	O
qd	O
.	O

5.	O
Zantac	B-treatment
150	O
mg	O
po	O
bid	O
.	O

6.	O
Aspirin	B-treatment
325	O
mg	O
qd	O
.	O

7.	O
Aricept	B-treatment
5	O
mg	O
po	O
qd	O
.	O

8.	O
Glyburide	B-treatment
1.25	O
mg	O
po	O
qam	O
.	O

9.	O
Oxybutynin	B-treatment
5	O
mg	O
po	O
bid	O
.	O

10.	O
Coumadin	B-treatment
7.5	O
mg	O
on	O
Sun	O
,	O
Tues	O
,	O
Wed	O
,	O
Fri	O
and	O
Sat	O
.	O

5	O
mg	O
on	O
Mon	O
and	O
Thurs	O
.	O

ALLERGIES	O
:	O

Fluoroquinolones	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
tobacco	O
,	O
alcohol	O
or	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
96.7F	O
,	O
pulse	B-test
63	O
,	O
respiratory	B-test
rate	I-test
20	O
,	O
blood	B-test
pressure	I-test
167/68	O
,	O
02	O
sat	O
99%	O
on	O
room	O
air	O
.	O

In	O
general	O
the	O
patient	O
is	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
exam	I-test
is	O
within	O
normal	O
limits	O
.	O

Chest	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Heart	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdomen	B-problem
grossly	I-problem
distended	I-problem
,	O
tympanitic	B-problem
,	O
plus	O
right	B-problem
upper	I-problem
quadrant	I-problem
tenderness	I-problem
and	O
no	O
rebound	B-problem
.	O

Rectal	O
had	O
normal	O
tone	O
,	O
empty	B-problem
rectal	I-problem
vault	I-problem
,	O
and	O
guaiac	B-test
negative	O
.	O

Extremities	O
were	O
warm	O
and	O
well	O
perfused	O
.	O

LABORATORY	O
AND	O
RADIOLOGIC	O
DATA	O
:	O

On	O
admission	O
Digoxin	B-treatment
7.3	O
,	O
sodium	B-treatment
142	O
,	O
potassium	B-treatment
2.8	O
(	O
was	O
supplemented	O
)	O
,	O
blood	B-treatment
urea	I-treatment
nitrogen	I-treatment
15	O
,	O
creatinine	B-treatment
.9	O
,	O
calcium	B-treatment
9.3	O
,	O
phosphorus	B-treatment
1.9	O
,	O
magnesium	B-treatment
1.8	O
.	O

Liver	B-test
function	I-test
tests	I-test
were	O
within	O
normal	O
limits	O
.	O

Hematocrit	B-test
36	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
8.3	O
,	O
platelets	B-test
342	O
.	O

Electrocardiogram	B-test
shows	O
sinus	B-problem
bradycardia	I-problem
with	O
Digitalis	B-problem
effect	I-problem
.	O

Urinalysis	B-test
is	O
pending	O
.	O

Abdominal	B-test
series	I-test
showed	O
non-specific	B-problem
dilatation	I-problem
of	I-problem
the	I-problem
large	I-problem
bowel	I-problem
with	O
no	O
evidence	O
of	O
ileus	B-problem
.	O

CT	B-test
of	I-test
the	I-test
abdomen	I-test
and	I-test
pelvis	I-test
showed	O
dilated	B-problem
colon	I-problem
with	O
a	B-problem
large	I-problem
amount	I-problem
of	I-problem
fluid	I-problem
.	O

There	O
was	O
no	O
free	B-problem
air	I-problem
and	O
no	O
bowel	B-problem
wall	I-problem
thickening	I-problem
.	O

There	O
was	O
no	O
obstruction	B-problem
.	O

Normal	O
appearing	O
small	O
bowel	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
presented	O
to	O
the	O
operating	O
room	O
late	O
at	O
night	O
on	O
12/01/02	O
and	O
was	O
admitted	O
to	O
the	O
floor	O
early	O
on	O
the	O
morning	O
on	O
12/02/02	O
.	O

She	O
was	O
placed	O
on	O
a	B-treatment
bowel	I-treatment
regimen	I-treatment
of	O
Dulcolax	B-treatment
,	O
Fleet	B-treatment
enema	I-treatment
,	O
and	O
Colace	B-treatment
.	O

On	O
12/03/02	O
the	O
patient	O
underwent	O
a	B-test
repeat	I-test
KUB	I-test
which	O
was	O
suggestive	O
of	O
volvulus	B-problem
.	O

She	O
then	O
underwent	O
a	B-test
CT	I-test
scan	I-test
which	O
showed	O
no	O
evidence	O
of	O
volvulus	B-problem
.	O

Rigid	B-test
sigmoidoscopy	I-test
revealed	O
no	O
obvious	B-problem
mucosal	I-problem
abnormalities	I-problem
but	O
during	O
the	O
time	O
of	O
the	O
procedure	O
22cc	O
of	O
mucous	B-problem
like	I-problem
stool	I-problem
was	O
evacuated	O
with	O
a	B-problem
large	I-problem
amount	I-problem
of	I-problem
gas	I-problem
.	O

Subsequent	O
to	O
that	O
the	O
patients	O
abdomen	O
was	O
significantly	B-problem
less	I-problem
distended	I-problem
and	O
her	B-problem
pain	I-problem
decreased	O
as	O
well	O
.	O

On	O
the	O
following	O
day	O
,	O
hospital	O
day	O
number	O
3	O
,	O
the	O
patient	O
was	O
doing	O
well	O
.	O

The	O
abdomen	O
was	O
again	O
far	B-problem
less	I-problem
distended	I-problem
.	O

She	O
was	O
tolerating	O
clear	B-treatment
liquids	I-treatment
ad	O
lib	O
.	O

She	O
was	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
.	O

A	B-test
repeat	I-test
KUB	I-test
was	O
performed	O
which	O
showed	O
no	O
evidence	O
of	O
volvulus	B-problem
.	O

She	O
was	O
discharged	O
back	O
to	O
a	O
rehabilitation	O
facility	O
in	O
good	O
condition	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Digoxin	B-treatment
.125	O
mg	O
qod	O
,	O
.25	O
mg	O
qod	O
.	O

2.	O
Colace	B-treatment
100	O
mg	O
po	O
tid	O
.	O

3.	O
Levoxyl	B-treatment
100	O
ugm	O
po	O
qd	O
.	O

4.	O
Prinivil	B-treatment
20	O
mg	O
po	O
qd	O
.	O

5.	O
Zantac	B-treatment
150	O
mg	O
po	O
bid	O
.	O

6.	O
Aspirin	B-treatment
325	O
mg	O
qd	O
.	O

7.	O
Aricept	B-treatment
5	O
mg	O
po	O
qd	O
.	O

8.	O
Glyburide	B-treatment
1.25	O
mg	O
po	O
qam	O
.	O

9.	O
Oxybutynin	B-treatment
5	O
mg	O
po	O
bid	O
.	O

10.	O
Coumadin	B-treatment
7.5	O
mg	O
on	O
Sun	O
,	O
Tues	O
,	O
Wed	O
,	O
Fri	O
and	O
Sat	O
.	O

5	O
mg	O
on	O
Mon	O
and	O
Thurs	O
.	O

ERIN	O
KENGEKOTE	O
,	O
MD	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
MAENZET	O
HEAD	O
,	O
M.D.	O

12/25/2002	O
12:48	O

_____________________________	O
MAENZET	O
HEAD	O
,	O
M.D.	O

TR	O
:	O

su	O
PAD-WORD	O

DD	O
:	O

12/04/2002	O
PAD-WORD	O

TD	O
:	O

12/04/2002	O
2:34	O
P	O
328713	O

cc	O
:	O

ERIN	O
KENGEKOTE	O
,	O
MD	O
Surg	O
Obrh	O
ALBI	O
OSHASON	O
HEAD	O
,	O
M.D.	O
SURGERY	O
NIME	O
ETHILLBRID	O
HEALTHCARE	O
MAENZET	O
HEAD	O
,	O
M.D.	O
Ston	O
Community	O
Hospital	O
5223	O
Cannola	O
Creek	O
Rd	O
Granger	O
CO	O
78438	O
STAT	O

Admission	O
Date	O
:	O

2011-12-17	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-01-14	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1932-12-18	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEUROLOGY	O
PAD-WORD	O

Allergies	O
:	O

Bactrim	B-treatment
PAD-WORD	O

Attending	O
:	O
Patricia	O
Q	O
Pendergrass	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
altered	B-problem
metnal	I-problem
status	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
bronchoscopy	B-test

History	O
of	O
Present	O
Illness	O
:	O

79	O
-	O
year-old	O
M	O
recently	O
diagnosed	O
by	O
biopsy	B-test
with	O
gliomatosis	B-problem
cerebri	I-problem
(	I-problem
grade	I-problem
II	I-problem
astrocytoma	I-problem
)	I-problem
in	O
8/04	O
,	O
being	O
treated	O
with	O
XRT	B-treatment
,	O
timidar	B-treatment
.	O

She	O
is	O
currently	O
on	O
a	B-treatment
decadron	I-treatment
taper	I-treatment
after	O
it	O
was	O
increased	O
several	O
months	O
ago	O
secondary	O
to	O
increasing	B-problem
ocular	I-problem
symptoms	I-problem
.	O

Seen	O
by	O
PMD	O
on	O
12-14	O
w/	O
symptoms	O
of	O
cough	B-problem
productive	O
of	O
yellow	B-problem
sputum	I-problem
,	O
which	O
wife	O
also	O
had	O
,	O
prescribed	O
zpak	B-treatment
w/o	O
improvement	O
.	O

Pt	O
was	O
brought	O
to	O
the	O
Victor	O
for	O
increasing	B-problem
somnolence	I-problem
over	O
past	O
several	O
days-weeks	O
.	O

Over	O
the	O
past	O
two	O
weeks	O
,	O
pt	O
has	O
declined	O
in	O
status	O
.	O

He	O
is	O
confused	B-problem
,	O
has	O
had	O
hallucinations	B-problem
.	O

Family	O
believed	O
pt	O
was	O
becoming	O
dehydrated	B-problem
.	O

Also	O
,	O
pt	O
's	O
strength	O
has	O
been	O
declining	O
over	O
the	O
past	O
2	O
weeks	O
.	O

He	O
used	O
to	O
be	O
able	O
to	O
walk	O
with	O
a	B-treatment
walker	I-treatment
,	O
and	O
the	O
past	O
few	O
days	O
has	O
required	O
a	B-treatment
wheelchair	I-treatment
.	O

+	O
incontinence	B-problem
over	O
the	O
past	O
2	O
weeks	O
.	O

+	O
non-bloody	B-problem
diarrhea	I-problem
x	O
1	O
on	O
DOA	O
.	O

In	O
the	O
Deborah	O
VS	B-test
on	O
arrival	O
were	O
T	B-test
:	O
97.5	O
;	O
BP	B-test
:	O
90/65	O
;	O
HR	B-test
:	O
82	O
;	O
RR	B-test
:	O
16	O
;	O
94	O
on	O
RA	O
.	O

CXR	B-test
shows	O
diffuse	B-problem
b/l	I-problem
infiltrates	I-problem
R	I-problem
>	I-problem
L	I-problem
and	O
pt	O
was	O
found	O
to	O
have	O
a	B-problem
bandemia	I-problem
.	O

LDH	B-test
was	O
511	O
.	O

Pt	O
received	O
bactrim	B-treatment
500	O
mg	O
x	O
1	O
for	O
possible	O
PCP	B-problem
.	O

Lillian	O
R.	O
/	O
hypoxic	B-problem
respiratory	I-problem
distress	I-problem
.	O

During	O
admission	O
,	O
became	O
steadily	B-problem
more	I-problem
SOB	I-problem
,	O
increasing	B-problem
lethargy	I-problem
.	O

12-20	O
satting	O
initially	O
~	O
90%	O
on	O
40%	O
face	B-treatment
mask	I-treatment
.	O

ABG	B-test
7.45/33/57	O
.	O

He	O
was	O
switched	O
to	O
a	B-treatment
100%	I-treatment
NRB	I-treatment
mask	I-treatment
and	O
ABG	B-test
was	O
7.47/31/80	O
.	O

On	O
floor	O
on	O
day	O
of	O
transfer	O
7.25/50/70	O
on	O
100%	B-treatment
NRB	I-treatment
.	O

During	O
evaluation	B-test
pt	O
responsive	O
to	O
sternal	B-test
rub	I-test
but	O
could	O
not	O
follow	O
commands	O
.	O

Intubated	O
for	O
failure	B-problem
to	I-problem
protect	I-problem
airway	I-problem
,	O
transferred	O
to	O
ICU	O
.	O

Past	O
Medical	O
History	O
:	O

PMHx	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
s/p	O
MI	B-problem
20	O
years	O
ago	O

2.	O
Hypertension	B-problem

3.	O
Hyperlipidemia	B-problem

4.	O
DJD	B-problem
in	I-problem
the	I-problem
C-spine	I-problem

5.	O
depression	B-problem

6.	O
h/o	O
DVT	B-problem

7.	O
Shingles	B-problem
recently	O
finished	O
treatment	B-treatment

Social	O
History	O
:	O

Landfill	O
worker	O
-	O
retired	O

15-20	O
pky	O
h/o	O
smoking	O
,	O
quit	O
15	O
yrs	O
ago	O

Denies	O
etoh	O
/	O
drugs	O

Family	O
History	O
:	O
non-contributory	O
.	O

Physical	B-test
Exam	I-test
:	O
t	B-test
98.9	O
,	O
bp	B-test
63/28	O
on	O
neo	B-treatment
,	O
p	B-test
114	O
,	O
AC	B-treatment
fi02	B-treatment
1/	O
vt	B-treatment
550/	O
peep	B-treatment
5/	O
breathing	O
at	O
16/22	O
,	O
w/	O
volumes	B-test
of	O
500	O
s	O
.	O

Intubated	O
,	O
minimally	B-problem
responsive	I-problem
,	O
localized	O
pain	O
.	O

PERRL	O
.	O

OP	O
clear	O
.	O

MMM	O
.	O

JVD	B-problem
not	O
appreciated	O
03-07	O
to	O
deep	O
inspiratory	O
breaths	O
.	O

+	O
bs	O
.	O

Distended	B-problem
.	O

Soft	O
.	O

NT	B-problem
>	O

No	O
le	B-problem
edema	I-problem
.	O

Pertinent	O
Results	O
:	O

2011-12-23	O
07:54	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
9.7	O
RBC	B-test
-	O
3.02	O
*	O
Hgb	B-test
-	O
10.0	O
*	O
Hct	B-test
-	O
29.0	O
*	O
MCV	B-test
-	O
96	O
MCH	B-test
-	O
33.1	O
*	O
MCHC	B-test
-	O
34.4	O
RDW	B-test
-	O
17.7	O
*	O
Plt	B-test
Ct	I-test
-	O
307	O

2011-12-23	O
07:54	O
PM	O
BLOOD	B-test
Neuts	B-test
-	O
88	O
*	O
Bands	B-test
-	O
0	O
Lymphs	B-test
-	O
7	O
*	O
Monos	B-test
-	O
3	O
Eos	B-test
-	O
0	O
Baso	B-test
-	O
0	O
Atyps	B-test
-	O
0	O
Metas	B-test
-	O
1	O
*	O
Myelos	B-test
-	O
1	O
*	O

2011-12-23	O
07:54	O
PM	O
BLOOD	B-test
PT	B-test
-	O
16.0	O
*	O
PTT	B-test
-	O
35.7	O
*	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.6	O

Chem	B-test
7	I-test
:	O

2011-12-23	O
07:54	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
108	O
*	O
UreaN	B-test
-	O
27	O
*	O
Creat	B-test
-	O
1.9	O
*	O
Na	B-test
-	O
132	O
*	O
K	B-test
-	O
4.6	O
Cl	B-test
-	O
102	O
HCO3	B-test
-	O
20	O
*	O
AnGap	B-test
-	O
15	O

2011-12-18	O
06:15	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
29	O
AST	B-test
-	O
25	O
LD	B-test
(	I-test
LDH	I-test
)-	I-test
400	O
*	O
AlkPhos	B-test
-	O
52	O
TotBili	B-test
-	O
0.3	O

2011-12-23	O
11:16	O
PM	O
BLOOD	B-test
Type	B-test
-	O
ART	O
pO2	B-test
-	O
202	O
*	O
pCO2	B-test
-	O
40	O
pH	B-test
-	O
7.29	O
*	O
calHCO3	B-test
-	O
20	O
*	O
Base	B-test
XS	I-test
--	O
6	O

2011-12-20	O
07:53	O
AM	O
BLOOD	B-test
Lactate	B-test
-	O
1.1	O

Brief	O
Hospital	O
Course	O
:	O

Impression	O
:	O

71	O
yo	O
m	O
w/	O
astrocytoma	B-problem
on	O
xrt	B-treatment
and	O
chemotx	B-treatment
,	O
who	O
p/w	O
1	O
wk	O
h/o	O
productive	B-problem
cough	I-problem
,	O
sick	O
contact	O
,	O
hypoxic	B-problem
,	O
now	O
intubated	O
,	O
w/	O
increasing	B-problem
infiltrates	I-problem
b/l	I-problem
.	O

1)	O
Resp	B-problem
failure	I-problem
-	O
pt	O
admitted	O
w/	O
primarily	B-problem
hypoxic	I-problem
respiratory	I-problem
failure	I-problem
.	O

Following	O
admission	O
to	O
the	O
floor	O
the	O
pt	O
developed	O
increasing	B-problem
hypoxia	I-problem
and	O
somnolence	B-problem
,	O
requiring	O
intubation	B-treatment
on	O
HD	O
5	O
.	O

Pulm	O
had	O
previously	O
been	O
consulted	O
and	O
felt	O
that	O
presentation	O
was	O
c/w	O
PCP	B-problem
,	O
Joann	O
started	O
on	O
Bactrim	B-treatment
.	O

Previously	O
treated	O
for	O
CAP	B-problem
as	O
outpt	O
but	O
hypoxia	B-problem
continued	O
to	O
progress	O
.	O

Similar	O
lack	O
of	O
improvement	O
w/	O
additional	B-treatment
broad	I-treatment
spectrum	I-treatment
coverage	I-treatment
following	O
admission	O
.	O

Pt	O
underwent	O
bronchoscopy	B-test
on	O
11-22	O
following	O
transfer	O
to	O
the	O
ICU	O
for	O
hypoxic	B-problem
respiratory	I-problem
failure	I-problem
and	O
intubation	B-treatment
(	O
7.25/52/70	O
on	O
100%	B-treatment
NRB	I-treatment
)	O
.	O

On	O
admission	O
to	O
the	O
ICU	O
the	B-treatment
pt	I-treatment
'	I-treatment
steroid	I-treatment
dose	I-treatment
was	O
increased	O
to	O
8	O
mg	O
bid	O
03-07	O
to	O
a	B-test
dead	I-test
space	I-test
measurement	I-test
of	O
50%	O
.	O

Pt	O
did	O
well	O
in	O
the	O
ICU	O
,	O
w/	O
his	O
respiratory	O
status	O
steadily	O
improving	O
and	O
was	O
extubated	O
on	O

01-03	O
.	O

He	O
was	O
subsequently	O
tranferred	O
to	O
the	O
floor	O
,	O
where	O
he	O
continued	O
to	O
have	O
a	B-problem
stable	I-problem
oxygen	I-problem
requirement	I-problem
.	O

Repeat	B-test
CXR	I-test
was	O
unchanged	O
from	O
previously	O
in	O
the	O
ICU	O
(	O
official	O
read	O
noted	O
mild	B-problem
CHF	I-problem
,	O
but	O
pt	O
was	O
continuing	O
to	O
autodiurese	O
and	O
has	O
remained	O
net	O
negative	O
everyday	O
while	O
on	O
the	O
floor	O
.	O

On	O
discharge	O
the	O
patient	O
has	O
stable	B-problem
O2	I-problem
req	I-problem
,	O
90%	O
on	O
RA	O
.	O

2)	O
astrocytoma	B-problem
-	I-problem
grade	I-problem
II	I-problem
,	O
as	O
per	O
d/w	O
PMD	O
,	O
Dr.	O
Holscher	O
,	O
pt	O
has	O
poor	O
prognosis	O
,	O
but	O
reasonable	O
for	O
ongoing	B-treatment
treatment	I-treatment
.	O

Pt	O
has	O
had	O
two	O
recent	O
neg	O
head	O
CT	O
s	O
,	O
so	O
unlikely	O
the	O
etiology	O
of	O
the	B-problem
patient	I-problem
's	I-problem
MS	I-problem
change	I-problem
.	O

Pt	O
was	O
continued	O
on	O
keppra	B-treatment
during	O
admission	O
for	O
sz	B-problem
px	I-problem
.	O

Initially	O
he	O
had	O
been	O
on	O
lamotrigine	B-treatment
but	O
the	O
was	O
stopped	O
in	O
10/12	O
when	O
the	O
pt	O
was	O
noted	O
to	O
be	O
developing	O
a	B-problem
new	I-problem
rash	I-problem
.	O

Decadron	B-treatment
has	O
been	O
steadily	O
tapered	O
since	O
arrival	O
on	O
the	O
floor	O
.	O

Now	O
continued	O
on	O
1	O
mg	O
BID	O
,	O
to	O
complete	O
a	O
7	O
day	O
course	O
,	O
which	O
will	O
be	O
tapered	O
to	O
1	O
mg	O
qday	O
on	O
01-15	O
,	O
and	O
subsequently	O
to	O
0.5	O
mg	O
qday	O
x	O
7	O
days	O
then	O
to	O
be	O
discontinued	O
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
keppra	I-treatment
should	O
be	O
continued	O
for	O
sz	B-treatment
prophylaxis	I-treatment
.	O

3)	O
MS	B-problem
change	I-problem
-	O
on	O
admission	O
pt	O
was	O
agitated	B-problem
,	O
requiring	O
restraints	B-treatment
and	O
antipsychotics	B-treatment
,	O
however	O
as	O
he	O
became	O
increasingly	B-problem
hypoxic	I-problem
he	O
became	O
somnolent	B-problem
.	O

In	O
the	O
ICU	O
the	O
pt	O
remained	O
stuporous	B-problem
,	O
responsive	O
to	O
painful	B-test
stimuli	I-test
.	O

On	O
the	O
floor	O
the	O
patient	O
intially	O
was	O
imporved	O
,	O
but	O
has	O
plateaued	O
,	O
responding	O
to	O
simple	O
commands	O
and	O
verbalizing	O
groans	O
but	O
no	B-problem
real	I-problem
speech	I-problem
.	O

Improvement	O
has	O
correlated	O
w/	O
tapering	O
of	O
steroids	B-treatment
,	O
one	O
of	O
the	O
causes	O
in	O
the	B-test
differential	I-test
.	O

Pt	O
had	O
multiple	B-test
head	I-test
CT	I-test
s	I-test
which	O
ruled	O
out	O
progression	O
of	O
astrocytoma	B-problem
.	O

MRI	B-test
has	O
been	O
deferred	O
given	O
that	O
the	O
pt	O
currently	O
would	O
not	O
tolerate	O
the	B-test
procedure	I-test
.	O

EEG	B-test
was	O
w/o	O
evidence	O
of	O
epileptiform	B-problem
activity	I-problem
and	O
c/w	O
toxic	B-problem
encephalopathy	I-problem
.	O

Plan	O
to	O
continue	O
to	O
follow	O
MS	B-problem
,	O
expect	O
improvement	O
as	O
steroids	B-treatment
are	O
continued	O
to	O
be	O
tapered	O
.	O

4)	O
h/o	O
DVT	B-problem
-	O
cont	O
heparin	B-treatment
,	O
previously	O
on	O
enoxaparin	B-treatment
x10	O
days	O
at	O
treatment	O
dose	O
,	O
followed	O
by	O
prophylactic	B-treatment
dose	I-treatment
.	O

On	O
admission	O
,	O
the	O
pt	O
was	O
started	O
on	O
treatment	O
doses	O
of	O
enoxaparin	B-treatment
.	O

Upon	O
transfer	O
to	O
the	O
Intensive	O
Care	O
Unit	O
the	O
pt	O
was	O
started	O
on	O
heparin	B-treatment
gtt	I-treatment
.	O

Course	O
was	O
c/b	O
one	O
episode	O
of	O
gross	B-problem
hematochezia	I-problem
on	O
12-28	O
,	O
w/	O
concomitant	B-problem
hct	I-problem
drop	I-problem
of	O
~	O
3	O
pts	O
.	O

B/L	B-test
lower	I-test
ext	I-test
duplex	I-test
us	I-test
and	O
a	B-test
cta	I-test
were	O
performed	O
,	O
both	O
of	O
which	O
were	O
negative	O
.	O

Given	O
that	O
the	O
pt	O
was	O
w/o	O
evidence	O
of	O
DVT	B-problem
it	O
was	O
felt	O
that	O
the	O
risks	O
of	O
anticoagulation	B-treatment
in	O
the	O
setting	O
of	O
gross	B-problem
GIB	I-problem
,	O
outweigh	O
the	O
risks	O
of	O
undetected	B-problem
deep	I-problem
vv	I-problem
thrombosis/pe	I-problem
.	O

Pt	O
was	O
continued	O
on	O
prophylactic	B-treatment
heparin	I-treatment
.	O

4)	O
hypersensitivity	B-problem
reaction	I-problem
-	O
on	O
11-24	O
pt	O
was	O
noted	O
to	O
have	O
developing	O
rash	B-problem
of	I-problem
abdomen	I-problem
and	I-problem
anterior	I-problem
thighs	I-problem
.	O

Derm	O
initially	O
reviewed	O
and	O
thought	O
that	O
it	O
was	O
not	O
c/w	O
hypersensitivity	B-problem
rxn	I-problem
.	O

Over	O
the	O
next	O
the	B-problem
rash	I-problem
progressed	O
,	O
and	O
the	O
patient	O
subsequently	O
began	O
spiking	O
fevers	B-problem
to	O
approx	O
103	O
F	O
,	O
c/b	O
hypotension	B-problem
requiring	O
aggressive	B-treatment
fluid	I-treatment
repletion	I-treatment
and	O
pressors	B-treatment
,	O
and	O
tachycardia	B-problem
to	O
the	O

130s	O
.	O

The	O
patient	O
also	O
developed	O
elevated	B-problem
transaminases	I-problem
and	I-problem
pancreatic	I-problem
enzymes	I-problem
during	O
this	O
time	O
.	O

On	O
the	O
second	O
day	O
that	O
the	B-problem
rash	I-problem
had	O
been	O
noted	O
,	O
Derm	O
was	O
asked	O
to	O
see	O
again	O
,	O
felt	O
c/w	O
hypersensitivity	B-problem
,	O
bactrim	B-treatment
was	O
switched	O
to	O
pentamidine	B-treatment
,	O
and	O
lamictal	B-treatment
was	O
held	O
.	O

Pt	O
continued	O
to	O
have	O
elev	B-problem
pancreatic	I-problem
enzymes	I-problem
and	O
pentamidine	B-treatment
was	O
switched	O
to	O
clinda/primaquine	B-treatment
.	O

Following	O
discontinuation	O
of	O
the	B-treatment
bactrim	I-treatment
the	O
patient	O
defervesced	O
,	O
and	O
remained	O
normotensive	O
.	O

He	O
received	O
one	O
dose	O
of	O
furosemide	B-treatment
in	O
the	O
ICU	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
the	O
next	O
day	O
.	O

On	O
arrival	O
to	O
the	O
floor	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	B-problem
lacy	I-problem
reticular	I-problem
rash	I-problem
of	I-problem
upper	I-problem
arms	I-problem
,	O
which	O
resolved	O
over	O
the	O
next	O
48h	O
.	O

Felt	O
likely	O
03-07	O
the	B-treatment
sulfa	I-treatment
moiety	O
of	O
the	B-treatment
furosemide	I-treatment
.	O

Plan	O
for	O
pt	O
to	O
complete	O
total	O
of	O
28	O
day	O
course	O
of	O
therapy	B-treatment
for	O
PCP	B-problem
,	O
James	O
will	O
be	O
completed	O
on	O
01-16	O
.	O

5)	O
Anemia	B-problem
-	O
previous	B-test
w/u	I-test
c/w	O
ACD	B-problem
(	O
elev	B-problem
ferritin	I-problem
,	O
low	B-problem
transferrin	I-problem
saturation	I-problem
)	O
.	O

-	O
transfuse	B-test
threshold	I-test
<	O
24	O

6)	O
ARF	B-problem
-	O
Cr	B-test
mildly	B-problem
elevated	I-problem
on	O
tx	O
to	O
ICU	O
,	O
u	B-test
lytes	I-test
c/w	O
prerenal	B-problem
azotemia	I-problem
,	O
which	O
resolved	O
w/	O
IVF	B-treatment
.	O

7)	O
hyponatremia	B-problem
-	O
also	O
hyponatremic	B-problem
on	O
transfer	O
,	O
resolved	O
w/	O
ivf	B-treatment
.	O

8)	O
CAD	B-problem
-	O
w/	O
abnl	B-problem
EF	I-problem
,	O
however	O
pt	O
tolerated	O
aggressive	B-treatment
fluid	I-treatment
resusciation	I-treatment
w/o	O
significant	B-problem
hypoxia	I-problem
.	O

Continued	O
on	O
valsartan	B-treatment
,	O
BB	B-treatment
continued	O
,	O
statin	B-treatment

9)	O
Nutrition	O
-	O
pt	O
was	O
maintained	O
on	O
TFs	B-treatment
via	O
post-pyloric	B-treatment

10)	O
Px	O
:	O
Heparin	B-treatment
(	O
full	O
dose	O
)	O
,	O
IV	B-treatment
PPI	I-treatment

11)	O
Comm	O
:	O
Family	O
very	O
involved	O
at	O
bedside	O
,	O
evaluating	O
rehab	B-treatment
today	O

17)	O
DNR	O
,	O
but	O
may	O
intubate	O
for	O
reversible	O
causes	O

18)	O
Restraint	B-treatment

Medications	O
on	O
Admission	O
:	O

Meds	O
on	O
Transfer	O
:	O

Acyclovir	B-treatment
PAD-WORD	O

Bactrim	B-treatment
PAD-WORD	O

Zoloft	B-treatment
PAD-WORD	O

Valsartan	B-treatment
PAD-WORD	O

Metoprolol	B-treatment
PAD-WORD	O

Keppra	B-treatment
PAD-WORD	O

Lovenox	B-treatment
PAD-WORD	O

Levofloxacin	B-treatment
PAD-WORD	O

Ambisone	B-treatment
PAD-WORD	O

Atrovent	B-treatment
nebs	I-treatment

Albuterol	B-treatment
nebs	I-treatment

Lasix	B-treatment
10	O
mg	O
qd	O

Lipitor	B-treatment
PAD-WORD	O

Haldol	B-treatment
prn	O

Discharge	O
Medications	O
:	O

1.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

2.	O
Sertraline	B-treatment
HCl	I-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Albuterol	B-treatment
Sulfate	I-treatment
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
.	O

4.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
.	O

5.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

6.	O
Bisacodyl	B-treatment
10	O
mg	O
Suppository	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Suppository	O
Rectal	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

7.	O
Levetiracetam	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

8.	O
Nystatin	B-treatment
100,000	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
ML	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

9.	O
Heparin	B-treatment
Sodium	I-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

10.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

11.	O
Primaquine	B-treatment
Phosphate	I-treatment
26.3	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
3	O
days	O
.	O

12.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

13.	O
Dexamethasone	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
:	O
Take	O
2	O
tablet	O
po	O
bid	O
for	O
four	O
days	O
,	O
then	O
2	O
tablet	O
po	O
qday	O
for	O
7	O
days	O
,	O
then	O
take	O
one	O
tablet	O
qday	O
for	O
7	O
days	O
.	O

Then	O
stop	O
taking	O
the	B-treatment
medication	I-treatment
.	O

14.	O
Acyclovir	B-treatment
Sodium	I-treatment
500	O
mg	O
Recon	O
Soln	O
Sig	O
:	O
200mg	O
Recon	O
Solns	O
Intravenous	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
.	O

15.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Recon	O
Soln	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Recon	O
Soln	O
Intravenous	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
.	O

16.	O
Clindamycin	B-treatment
Phosphate	I-treatment
in	O
D5W	B-treatment
600	O
mg	O
/	O
50	O
mL	O
Piggyback	O
Sig	O
:	O
600	O
mg	O
Intravenous	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
for	O
3	O
days	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Danvers	O
State	O
Hospital	O
&	O
Rehab	O
Center	O
-	O
Sterling	O
Medical	O
Center	O

Discharge	O
Diagnosis	O
:	O

1)	O
PCP	B-problem
pna	I-problem

2)	O
Astrocytoma	B-problem

3)	O
Hypersensitivity	B-problem
to	O
Bactrim	B-treatment

4)	O
Hematochezia	B-problem

5)	O
h/o	O
DVT	B-problem

Discharge	O
Condition	O
:	O

Good	O
,	O
still	O
w/	O
altered	B-problem
mental	I-problem
status	I-problem
but	O
improving	O
.	O

Discharge	O
Instructions	O
:	O

1)	O
Take	O
your	O
medications	B-treatment

2)	O
Attend	O
follow	O
up	O
appointments	O

Followup	O
Instructions	O
:	O

Provider	O
:	O

Irene	O
FIELD	O
SCREENING	O
Where	O
:	O
Pembroke	O
Hospital	O

Winchester	O
Hospital	O
Phone	O
:(	O
217	O
)	O
275	O
6206	O
Date	O
/	O
Time	O
:	O
2012-02-13	O
1:30	O

Provider	O
:	O
Annie	O
A.	O
Payne	O
,	O
M.D.	O
Where	O
:	O
Pembroke	O
Hospital	O

Winchester	O
Hospital	O
Phone	O
:(	O
217	O
)	O
275	O
6206	O
Date	O
/	O
Time	O
:	O
2012-02-13	O
2:30	O

Alfonso	O
Daniel	O
MD	O
13-431	O

Completed	O
by	O
:	O
Bernadette	O
Sanders	O
MD	O
04-142	O
2012-01-14	O
@	O
0914	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Earnestine	O
Marsden	O
on	O
:	O
WED	O
2012-03-21	O
1:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

169333047	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4852999	O
PAD-WORD	O

72670/2ol1	O
PAD-WORD	O

131444	O
PAD-WORD	O

9/7/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

09-07-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

09-08-93	O
PATIENT	O
DIED	O
ON	O
9/8/93	O
.	O

ADMISSION	O
DIAGNOSIS	O
:	O

Renal	B-problem
tubular	I-problem
acidosis	I-problem
distal	I-problem
type	I-problem
I	I-problem
;	O
shock	B-problem
;	O
seizure	B-problem
disorder	I-problem
;	O
severe	B-problem
acidosis	I-problem
and	O
severe	B-problem
electrolyte	I-problem
imbalance	I-problem
;	O
rule	O
out	O
sepsis	B-problem
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Renal	B-problem
tubular	I-problem
acidosis	I-problem
distal	I-problem
type	I-problem
I	I-problem
;	O
shock	B-problem
;	O
severe	B-problem
acidosis	I-problem
and	O
severe	B-problem
electrolyte	I-problem
imbalance	I-problem
;	O
seizure	B-problem
disorder	I-problem
;	O
rule	O
out	O
sepsis	B-problem
,	O
varicella	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Date	O
of	O
birth	O
:	O

10/4/88	O
.	O

This	O
patient	O
is	O
a	O
5	O
year	O
old	O
white	O
female	O
with	O
a	O
history	O
of	O
type	B-problem
I	I-problem
renal	I-problem
tubular	I-problem
acidosis	I-problem
on	O
nephrocalcinosis	B-problem
who	O
was	O
admitted	O
to	O
Noughwell	O
Entanbon	O
Health	O
of	O
Washington	O
on	O
9/5/93	O
at	O
21:16	O
hours	O
with	O
a	O
2-3	O
day	O
history	O
of	O
chills	B-problem
,	O
fevers	B-problem
,	O
cough	B-problem
,	O
vomiting	B-problem
and	O
weakness	B-problem
(	O
unable	O
to	O
walk	O
)	O
.	O

At	O
Noughwell	O
Entanbon	O
Health	O
,	O
her	B-test
temperature	I-test
was	O
101	O
,	O
pulse	B-test
135	O
,	O
blood	B-test
pressure	I-test
94/74	O
,	O
respiratory	B-test
rate	I-test
20	O
.	O

Positive	O
findings	O
of	O
physical	B-test
examination	I-test
include	O
chicken	B-problem
pox	I-problem
lesions	I-problem
on	I-problem
thorax	I-problem
,	O
sunken	B-problem
eyes	I-problem
,	O
thick	B-problem
nasal	I-problem
discharge	I-problem
,	O
dry	B-problem
lips	I-problem
,	I-problem
tongue	I-problem
and	I-problem
mucous	I-problem
membranes	I-problem
,	O
red	B-problem
tonsils	I-problem
.	O

The	O
remainder	O
of	O
the	B-test
physical	I-test
examination	I-test
was	O
considered	O
within	O
normal	O
limits	O
.	O

Admission	O
diagnosis	O
at	O
Ni	O
Hospital	O
&apos;s	O
:	O

vomiting	B-problem
and	O
dehydration	B-problem
,	O
hypokalemia	B-problem
,	O
hyponatremia	B-problem
,	O
tonsillitis	B-problem
.	O

A	B-treatment
peripheral	I-treatment
intravenous	I-treatment
line	I-treatment
was	O
started	O
on	O
Labor	O
Day	O
in	O
the	O
a.m.	O
No	O
respiratory	B-problem
distress	I-problem
was	O
noted	O
.	O

Oral	B-problem
cyanosis	I-problem
and	O
shallow	B-problem
respirations	I-problem
were	O
noted	O
on	O
9/7/93	O
at	O
2:45	O
a.m.	O

Therefore	O
the	O
patient	O
was	O
intubated	O
at	O
3:45	O
a.m.	O
on	O
9/7/93	O
.	O

Chest	B-test
x-ray	I-test
was	O
unremarkable	O
.	O

Cardiovascular	O
stable	O
,	O
significant	B-problem
hypertension	I-problem
was	O
noted	O
on	O
9/7/93	O
at	O
5:10	O
a.m.	O
and	O
therefore	O
10	B-treatment
cc&apos;s	I-treatment
per	I-treatment
kilo	I-treatment
albumin	I-treatment
was	O
given	O
.	O

The	O
patient	O
was	O
admitted	O
was	O
started	O
on	O
clear	B-treatment
fluids	I-treatment
,	O
tolerated	O
,	O
with	O
D5	B-treatment
normal	I-treatment
saline	I-treatment
plus	O
40	O
mEq	O
per	O
liter	O
of	O
KCL	B-treatment
at	O
a	O
rate	O
of	O
50	O
cc	O
&apos;s	O
per	O
hour	O
for	O
9	O
hours	O
.	O
(	O
100	O
cc&apos;s	O
per	O
kilo	O
)	O
.	O

Sodium	B-test
and	O
potassium	B-test
at	O
this	O
time	O
were	O
128/1.5	O
.	O

At	O
Labor	O
Day	O
,	O
9:30	O
a.m.	O
,	O
the	B-treatment
fluids	I-treatment
were	O
increased	O
to	O
100	O
cc&apos;s	O
per	O
hour	O
(	O
200	O
cc&apos;s	O
per	O
kilo	O
for	O
5	O
hours	O
)	O
.	O

Electrolytes	B-test
at	O
this	O
point	O
were	O
sodium	B-test
132	O
,	O
potassium	B-test
1.8	O
.	O

At	O
9/6/93	O
,	O
2:30	O
p.m.	O
,	O
fluids	B-treatment
were	O
decreased	O
to	O
75	O
cc&apos;s	O
per	O
hour	O
,	O
150	O
cc&apos;s	O
per	O
kilo	O
,	O
40	O
mEq	O
of	O
K	B-treatment
phosphate	I-treatment
added	O
to	O
the	B-treatment
intravenous	I-treatment
fluids	I-treatment
.	O

Electrolytes	B-test
at	O
this	O
point	O
were	O
a	B-test
sodium	I-test
of	O
143	O
and	O
potassium	B-test
1.7	O
.	O

On	O
9/6/93	O
,	O
22:00	O
,	O
fluids	B-treatment
were	O
changed	O
to	O
D5	B-treatment
normal	I-treatment
saline	I-treatment
plus	O
40	O
KCL	B-treatment
and	O
40	O
K	B-treatment
phosphate	I-treatment
at	O
75	O
cc	O
&apos;s	O
per	O
hour	O
.	O

This	O
rate	O
was	O
maintained	O
for	O
11	O
hours	O
.	O

Electrolytes	B-test
at	O
this	O
time	O
were	O
a	B-test
sodium	I-test
of	O
148	O
,	O
potassium	B-test
1.7	O
.	O

At	O
9/7/93	O
,	O
1:00	O
a.m.	O
,	O
intravenous	B-treatment
fluids	I-treatment
rate	O
was	O
decreased	O
to	O
50	O
cc&apos;s	O
per	O
hour	O
,	O
total	B-treatment
fluids	I-treatment
given	O
during	O
the	O
first	O
24	O
hours	O
were	O
140	O
to	O
150	O
cc&apos;s	O
per	O
kilo	O
per	O
day	O
.	O

At	O
this	O
time	O
,	O
sodium	B-test
was	O
147	O
,	O
potassium	B-test
2.6	O
,	O
total	B-treatment
sodium	I-treatment
given	O
during	O
the	O
first	O
24	O
hours	O
20	O
mEq	O
per	O
kilo	O
per	O
day	O
.	O

On	O
9/7/93	O
at	O
4:00	O
a.m.	O
,	O
albumin	B-treatment
bolus	I-treatment
5%	O
10	O
cc&apos;s	O
per	O
kilo	O
was	O
given	O
,	O
a	O
total	O
of	O
120	O
cc&apos;s	O
,	O
electrolytes	B-test
were	O
sodium	B-test
155	O
,	O
potassium	B-test
3.1	O
.	O

At	O
9/7/93	O
at	O
5:00	O
a.m.	O
,	O
sodium	B-treatment
bicarbonate	I-treatment
given	O
60	O
mEq	O
,	O
calcium	B-treatment
bolus	I-treatment
10	O
cc&apos;s	O
given	O
.	O

On	O
9/7	O
,	O
5:30	O
a.m.	O
,	O
D5	B-treatment
quarter	I-treatment
normal	I-treatment
saline	I-treatment
,	O
and	O
40	O
of	O
K	B-treatment
phosphate	I-treatment
at	O
100	O
cc&apos;s	O
per	O
hour	O
was	O
given	O
.	O

The	O
patient	O
was	O
taking	O
PO	O
initially	O
until	O
9/6/93	O
at	O
17:45	O
.	O

There	O
were	O
no	O
abnormal	B-problem
findings	I-problem
in	O
abdominal	B-test
exam	I-test
.	O

On	O
9/5/93	O
,	O
hematocrit	B-test
48	O
,	O
white	B-test
blood	I-test
count	I-test
11.2	O
,	O
neutrophiles	B-test
67	O
,	O
bands	B-test
14	O
,	O
lymphs	B-test
11	O
,	O
monos	B-test
6%	O
,	O
meta	B-test
2%	O
,	O
platelets	B-test
220,000	O
.	O

Copious	B-problem
urine	I-problem
output	I-problem
,	O
BUN	B-test
1.0	O
,	O
creatinine	B-test
.8	O
.	O

Normal	O
neurologic	O
exam	O
on	O
admission	O
,	O
then	O
lethargic	B-problem
on	O
9/6/93	O
at	O
17:45	O
,	O
then	O
patient	O
became	O
unresponsive	B-problem
,	O
areflexic	B-problem
and	O
limp	B-problem
at	O
9/6/93	O
,	O
at	O
17:45	O
to	O
22:00	O
.	O

Patient	O
was	O
having	O
seizures	B-problem
,	O
twitching	B-problem
of	I-problem
face	I-problem
and	O
rapid	B-problem
movements	I-problem
of	I-problem
eyes	I-problem
.	O

Pupils	B-problem
dilated	I-problem
and	I-problem
sluggish	I-problem
.	O

Valium	B-treatment
was	O
given	O
at	O
9/7/93	O
,	O
00:02	O
.	O

IV	B-treatment
ampicillin	I-treatment
,	O
chloramphenicol	B-treatment
,	O
ceftriaxone	B-treatment
,	O
and	O
culture	B-test
were	O
sent	O
.	O

Finally	O
,	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
transport	O
team	O
was	O
called	O
and	O
transport	O
team	O
arrived	O
on	O
9/7/93	O
,	O
6:30	O
a.m.	O
,	O
and	O
on	O
arrival	O
patient	O
was	O
seizing	O
with	O
rhythmic	B-problem
eye	I-problem
movement	I-problem
to	I-problem
left	I-problem
.	O

The	O
patient	O
was	O
unresponsive	B-problem
,	O
poor	B-problem
perfusion	I-problem
.	O

Temperature	B-test
was	O
101.8	O
.	O

A	B-treatment
second	I-treatment
intravenous	I-treatment
was	O
started	O
and	O
given	O
normal	B-treatment
saline	I-treatment
bolus	I-treatment
,	O
change	O
in	O
intravenous	B-treatment
fluids	I-treatment
to	O
D5	B-treatment
water	I-treatment
with	O
80	O
mEq	O
of	O
bicarbonate	B-treatment
,	O
plus	O
40	O
mEq	O
of	O
KCL	B-treatment
at	O
45	O
cc&apos;s	O
per	O
hour	O
,	O
bicarbonate	B-treatment
given	O
2	O
mEq	O
per	O
kilo	O
,	O
attempted	O
to	O
start	O
dopa	B-treatment
for	O
poor	B-problem
perfusion	I-problem
but	O
worsening	B-problem
perfusion	I-problem
.	O

Therefore	O
,	O
dopa	B-treatment
was	O
stopped	O
.	O

Total	O
volume	O
given	O
as	O
bolus	B-treatment
50	O
cc&apos;s	O
per	O
kilo	O
,	O
sodium	B-treatment
bicarbonate	I-treatment
at	O
2	O
mEq	O
per	O
kilo	O
was	O
given	O
.	O

Last	O
ABG	B-test
there	O
was	O
6.98	O
,	O
31	O
,	O
171	O
,	O
bicarbonate	B-test
of	O
7	O
.	O

Phenobarbital	B-treatment
and	O
Dilantin	B-treatment
given	O
for	O
seizure	B-treatment
control	I-treatment
.	O

Electrolytes	B-test
before	O
departure	O
for	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
was	O
a	B-test
sodium	I-test
of	O
176	O
,	O
potassium	B-test
2.5	O
,	O
chloride	B-test
140	O
,	O
bicarbonate	B-test
14	O
,	O
calcium	B-test
7.2	O
,	O
magnesium	B-test
2.7	O
.	O

Admission	O
to	O
the	O
Pediatric	O
Intensive	O
Care	O
Unit	O
at	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
was	O
9/7/93	O
,	O
11:15	O
a.m.	O

Lines	B-treatment
placed	O
were	O
a	B-treatment
right	I-treatment
femoral	I-treatment
triple	I-treatment
lumen	I-treatment
,	O
endotracheal	B-treatment
tube	I-treatment
4.0	O
,	O
arterial	B-treatment
line	I-treatment
,	O
right	B-treatment
radial	I-treatment
line	I-treatment
,	O
Foley	B-treatment
placed	O
,	O
peripheral	B-treatment
intravenous	I-treatment
line	I-treatment
,	O
nasogastric	B-treatment
tube	I-treatment
.	O

On	O
admission	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
temperature	B-test
100.2	O
,	O
pulse	B-test
149	O
,	O
respiratory	B-test
rate	I-test
50	O
,	O
blood	B-test
pressure	I-test
98/66	O
,	O
mean	B-test
arterial	I-test
pressure	I-test
of	O
73	O
,	O
weight	B-test
12	O
kilos	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

RTA	B-problem
diagnosed	O
at	O
14	O
months	O
of	O
age	O
,	O
she	O
had	O
a	O
history	O
of	O
scarlet	B-problem
fever	I-problem
at	O
14	O
months	O
of	O
age	O
.	O

She	O
also	O
had	O
a	O
recent	O
exposure	O
to	O
varicella	B-problem
.	O

Her	O
brother	O
had	O
developed	O
the	B-problem
typical	I-problem
rash	I-problem
on	O
9/3/93	O
.	O

ALLERGIES	O
:	O

None	O
known	O
.	O

SOCIAL	O
HISTORY	O
:	O

Mom	O
on	O
Medicaid	O
,	O
recovered	O
alcoholic	O
.	O

11	O
year	O
old	O
brother,6	O
year	O
old	O
sister	O
,	O
healthy	O
.	O

Mom	O
separated	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
admission	O
,	O
FI02	B-treatment
was	O
50-60%	O
,	O
PID	B-treatment
30-32/PEEP	B-treatment
of	O
5.7	O
,	O
total	B-test
volume	I-test
was	O
between	O
140	O
to	O
210	O
during	O
Intensive	O
Care	O
Unit	O
stay	O
.	O

Chest	B-test
x-ray	I-test
showed	O
right	B-problem
upper	I-problem
lobe	I-problem
pneumonia	I-problem
.	O

Cardiovascular	O
:	O

CVP	B-test
on	O
admission	O
was	O
1	O
cm	O
of	O
water	O
.	O

Then	O
during	O
the	O
Intensive	O
Care	O
Unit	O
stay	O
,	O
the	O
CVP	B-test
remained	O
between	O
7	O
to	O
8	O
after	O
volume	B-treatment
resuscitation	I-treatment
.	O

Dopamine	B-treatment
and	O
epinephrine	B-treatment
given	O
for	O
cardiovascular	B-treatment
support	I-treatment
.	O

Her	B-test
electrocardiogram	I-test
findings	O
were	O
compatible	O
with	O
hypokalemia	B-problem
(	O
flattening	B-problem
T	I-problem
waves	I-problem
and	O
ST	B-problem
changes	I-problem
)	O
.	O

Fluids	O
/	O
electrolytes/nutrition	O
:	O

On	O
admission	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
hypernatremia	B-problem
and	O
hypovolemic	B-problem
shock	I-problem
.	O

Fluids	B-treatment
of	I-treatment
D5	I-treatment
water	I-treatment
with	O
30	O
mEq	O
of	O
sodium	B-treatment
acetate	I-treatment
per	O
liter	O
,	O
30	O
ml	O
per	O
liter	O
of	O
phosphate	B-treatment
,	O
and	O
30	O
mEq	O
of	O
K	B-treatment
acetate	I-treatment
per	O
liter	O
at	O
90	O
cc&apos;s	O
per	O
hour	O
was	O
given	O
.	O

Free	B-treatment
water	I-treatment
deficit	I-treatment
over	O
48	O
hours	O
was	O
given	O
,	O
plus	O
maintenance	O
,	O
plus	O
adjusting	O
the	O
ongoing	O
losses	O
.	O

Pediatric	O
Nephrology	O
recommended	O
on	O
9/7/93	O
,	O
5:50	O
p.m.	O
,	O
10	O
cc	O
&apos;s	O
per	O
kilo	O
of	O
150	O
mEq	O
of	O
sodium	B-treatment
bicarbonate	I-treatment
per	O
liter	O
,	O
(	O
1.5	O
mEq	O
per	O
kilo	O
bicarbonate	B-treatment
,	O
one	O
dose	O
of	O
Lasix	B-treatment
and	O
volume	B-treatment
as	O
needed	O
)	O
.	O

The	O
patient	O
required	O
multiple	B-treatment
boluses	I-treatment
of	I-treatment
albumin	I-treatment
for	O
hypotension	B-problem
,	O
patient	O
also	O
required	O
multiple	B-treatment
boluses	I-treatment
of	I-treatment
calcium	I-treatment
because	O
of	O
hypocalcemia	B-problem
and	O
hypotension	B-problem
.	O

Magnesium	B-treatment
2.0	O
mEq	O
per	O
liter	O
,	O
phosphate	B-treatment
8	O
mg	O
/	O
dl	O
.	O

Gastrointestinal	O
:	O

Normal	O
.	O

NPO	B-treatment
.	O

Albumin	B-test
was	O
4.9	O
.	O

Globulin	B-test
was	O
1.6	O
,	O
uric	B-test
acid	I-test
was	O
6.5	O
,	O
alkaline	B-test
phosphatase	I-test
150	O
,	O
SGPT	B-test
11	O
,	O
SGOT	B-test
85	O
,	O
LDH	B-test
524	O
,	O
CK	B-test
152	O
,	O
NH3	B-test
81	O
.	O

Hematologic	O
:	O

White	B-test
cell	I-test
count	I-test
9.4	O
,	O
hematocrit	B-test
42	O
,	O
platelets	B-test
151,000	O
.	O

Differential	B-test
was	O
polys	B-test
59	O
,	O
bands	B-test
3	O
,	O
lymphs	B-test
25	O
.	O

Repeat	B-test
white	I-test
cell	I-test
count	I-test
6.4	O
,	O
hematocrit	B-test
34	O
,	O
platelets	B-test
103	O
.	O

PT	B-test
11.6/10.1	O
,	O
repeat	B-test
PT	I-test
12.8/10.5	O
.	O

PTT	B-test
36.4	O
,	O
repeat	B-test
PTT	I-test
50.9	O
.	O

Fibrinogen	B-test
211	O
.	O

Renal	O
:	O

Urine	B-test
output	I-test
was	O
about	O
5	O
to	O
8	O
cc&apos;s	O
per	O
kilo	O
per	O
hour	O
.	O

Renal	B-test
ultrasound	I-test
was	O
scheduled	O
during	O
the	O
Intensive	O
Care	O
Unit	O
stay	O
.	O

Urinalysis	B-test
showed	O
specific	B-test
gravity	I-test
1.005	O
,	O
pH	B-test
8.0	O
,	O
positive	B-problem
proteins	I-problem
,	O
positive	B-problem
red	I-problem
blood	I-problem
cells	I-problem
,	O
negative	O
white	O
cell	O
count	O
,	O
positive	B-problem
glucose	I-problem
.	O

Neurologic	O
:	O

Patient	O
did	O
not	O
receive	O
sedation	B-treatment
or	O
muscle	B-treatment
relaxant	I-treatment
since	O
admission	O
to	O
the	O
Pediatric	O
Intensive	O
Care	O
Unit	O
.	O

Phenobarbital	B-test
levels	I-test
were	O
31.4	O
,	O
30.2	O
,	O
and	O
50	O
.	O

Dilantin	B-test
level	I-test
was	O
22.6	O
,	O
20.2	O
,	O
20	O
.	O

Neurology	O
consultation	O
on	O
the	O
evening	O
of	O
9/7/93	O
revealed	O
supple	O
neck	O
,	O
no	B-problem
response	I-problem
to	O
external	B-test
rub	I-test
.	O

Pupils	O
were	O
3.5	O
OD	O
,	O
and	O
3.0	O
OS	O
,	O
irregular	B-problem
and	O
non	B-problem
reactive	I-problem
.	O

Corneal	B-test
reflexes	I-test
and	O
oculocephalic	B-test
reflexes	I-test
were	O
absent	B-problem
.	O

There	O
was	O
no	B-problem
gag	I-problem
.	O

Muscle	B-test
tone	I-test
was	O
increased	B-problem
throughout	I-problem
,	O
and	O
the	O
legs	O
were	O
both	B-problem
extended	I-problem
and	I-problem
internally	I-problem
rotated	I-problem
.	O

Deep	B-test
tendon	I-test
reflexes	I-test
could	O
not	O
be	O
elicited	O
and	O
plantar	B-test
responses	I-test
were	O
silent	B-problem
.	O

Repeat	B-test
neurological	I-test
examination	I-test
revealed	O
no	B-problem
spontaneous	I-problem
movement	I-problem
and	O
no	B-problem
response	I-problem
to	O
voice	B-test
or	I-test
noxious	I-test
stimulation	I-test
.	O

Pupils	O
were	O
dilated	B-problem
and	O
non	B-problem
reactive	I-problem
.	O

Disc	O
margins	O
appeared	O
blurred	B-problem
on	O
funduscopic	B-test
exam	I-test
.	O

A	B-test
non	I-test
contrast	I-test
head	I-test
CT	I-test
scan	I-test
was	O
obtained	O
and	O
CT	B-test
revealed	O
severe	B-problem
cerebral	I-problem
edema	I-problem
with	O
thalamic	B-problem
mid	I-problem
brain	I-problem
,	I-problem
pons	I-problem
,	I-problem
medullar	I-problem
low	I-problem
attenuation	I-problem
,	O
diffuse	B-problem
cerebral	I-problem
edema	I-problem
,	O
loss	B-problem
of	I-problem
gray	I-problem
white	I-problem
matter	I-problem
differentiation	I-problem
.	O

Cerebral	B-test
blood	I-test
flow	I-test
was	O
done	O
on	O
9/7/93	O
at	O
2:30	O
p.m.	O
,	O
revealed	O
complete	B-problem
absence	I-problem
of	I-problem
blood	I-problem
flow	I-problem
to	I-problem
brain	I-problem
.	O

There	O
was	O
a	B-problem
tiny	I-problem
region	I-problem
of	I-problem
activity	I-problem
in	O
what	O
appears	O
to	O
be	O
anterior	O
scalp	O
.	O

Infectious	O
Disease	O
:	O

Ampicillin	B-treatment
and	O
chloramphenicol	B-treatment
were	O
given	O
at	O
Noughwell	O
Entanbon	O
Health	O
,	O
and	O
ceftriaxone	B-treatment
was	O
given	O
at	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

Acyclovir	B-treatment
was	O
started	O
,	O
also	O
considering	O
the	B-problem
varicella	I-problem
at	O
120	O
mg	O
intravenously	O
every	O
8	O
hours	O
.	O

Urine	B-test
cultures	I-test
,	O
blood	B-test
cultures	I-test
and	O
sputum	B-test
cultures	I-test
were	O
sent	O
.	O

The	O
patient	O
finally	O
died	O
.	O

The	O
situation	O
of	O
the	O
patient	O
was	O
extensively	O
discussed	O
with	O
the	O
parents	O
,	O
and	O
the	O
attending	O
physician	O
from	O
Neurology	O
,	O
Dr.	O
Breunkote	O
,	O
and	O
the	O
attending	O
physician	O
from	O
Pediatric	O
Intensive	O
Care	O
Unit	O
,	O
Dr.	O
Boormcose	O
,	O
and	O
the	O
decision	O
was	O
finally	O
made	O
with	O
the	O
family	O
and	O
attendings	O
to	O
disconnect	O
the	O
patient	O
from	O
the	B-treatment
mechanical	I-treatment
ventilation	I-treatment
due	O
to	O
severe	B-problem
neurological	I-problem
injury	I-problem
and	O
poor	B-problem
prognosis	I-problem
.	O

ZAKAY	O
COUGH	O
,	O
M.D.	O

TR	O
:	O

jx	O
/	O
bmot	O

DD	O
:	O

10-20-93	O
PAD-WORD	O

TD	O
:	O

10/21/93	O
PAD-WORD	O

CC	O
:	O

edited	O
10/24/93	O
rc	O

Admission	O
Date	O
:	O

2018-08-02	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2018-08-08	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1941-03-03	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Penicillins	B-treatment
/	O
Codeine	B-treatment
/	O
Heparin	B-treatment
Agents	I-treatment
/	O
Levofloxacin	B-treatment

Attending	O
:	O
Faye	O
B.	O
Jones	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
rectal	B-problem
bleeding	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
colonoscopy	B-test
egd	B-test

GI	B-test
bleeding	I-test
study	I-test

History	O
of	O
Present	O
Illness	O
:	O

Patient	O
is	O
a	O
77	O
year	O
old	O
female	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
GI	B-problem
bleeding	I-problem
secondary	O
to	O
arteriovenous	B-problem
malformations	I-problem
,	O
who	O
presents	O
with	O
maroon	B-problem
stool	I-problem
and	O
a	B-problem
hematocrit	I-problem
drop	I-problem
.	O

Three	O
days	O
ago	O
began	O
to	O
develop	O
black	B-problem
stools	I-problem
.	O

There	O
was	O
no	O
clear	B-problem
blood	I-problem
in	O
the	O
toilet	O
bowl	O
.	O

In	O
addition	O
,	O
she	O
developed	O
nausea	B-problem
and	O
decreased	B-problem
PO	I-problem
intake	I-problem
.	O

She	O
had	O
a	B-problem
cough	I-problem
productive	O
of	O
white	B-problem
sputum	I-problem
and	O
felt	O
warm	O
,	O
although	O
she	O
did	O
not	O
record	O
her	B-test
temperature	I-test
.	O

At	O
dialysis	O
on	O
day	O
of	O
admission	O
,	O
she	O
related	O
these	O
symptoms	O
for	O
the	O
first	O
time	O
and	O
had	O
a	B-problem
bloody	I-problem
bowel	I-problem
movement	I-problem
.	O

Concerned	O
,	O
the	O
staff	O
sent	O
her	O
directly	O
to	O
the	O
Nantucket	O
Cottage	O
Hospital	O
.	O

In	O
the	O
Deanna	O
,	O
her	B-test
temperature	I-test
was	O
96.5	O
,	O
HR	B-test
51	O
,	O
BP	B-test
112/60	O
,	O
RR	B-test
18	O
,	O
and	O
oxygen	B-test
saturation	I-test
was	O
98%	O
on	O
ambient	O
air	O
.	O

Her	B-test
hematocrit	I-test
was	O
measured	O
at	O
23.5	O
,	O
while	O
her	B-test
baseline	I-test
hematocrit	I-test
is	O
in	O
the	O
low	O
30	O
s.	O

An	B-test
NG	I-test
lavage	I-test
was	O
performed	O
and	O
there	O
was	O
bilious	B-problem
return	I-problem
.	O

Rectal	B-test
examination	I-test
was	O
notable	O
for	O
guiaiac	B-problem
positive	I-problem
maroon	I-problem
stool	I-problem
.	O

She	O
was	O
type	O
and	O
crossed	O
and	O
transfused	O
two	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

IV	B-treatment
PPI	I-treatment
was	O
given	O
and	O
the	O
GI	O
team	O
was	O
consulted	O
and	O
she	O
was	O
scheduled	O
for	O
colonoscopy	B-test
and	O
EGD	B-test
on	O
the	O
morning	O
of	O
6/8	O
.	O

She	O
was	O
transferred	O
to	O
the	O
CMED	O
CCU	O
for	O
observation	B-test
.	O

Past	O
Medical	O
History	O
:	O

DM2	B-problem
on	O
insulin	B-treatment

CRI	B-problem
03-30	O
HTN	B-problem
and	O
DM	B-problem
nephropathy	I-problem
,	O
with	O
baseline	B-test
creatinine	I-test
4-4.5	O

Chronic	B-problem
GI	I-problem
bleeding	I-problem
:	O
documented	B-problem
AVMs	I-problem

Anemia	B-problem
w/	O
baseline	B-test
hct	I-test
27-30	O

Thrombocytopenia	B-problem
PAD-WORD	O

Coagulopathy	B-problem
,	O
HIT	B-problem
in	O
2014	O

Cardiomyopathy	B-problem
PAD-WORD	O

MRSA	B-problem
endocardiitis	I-problem
(	O
01-28	O
)	O

CAD	B-problem
;	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
two	O
and	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
2001	O
and	O
2000	O
.	O

Asthma	B-problem
PAD-WORD	O

Hypothyroidism	B-problem
PAD-WORD	O

Osteoarthritis	B-problem
PAD-WORD	O

Paroxysmal	B-problem
atrial	I-problem
fibrillation	I-problem

PUD	B-problem
,	O
Barrett	B-problem
's	I-problem
Esophagus	I-problem

CHF	B-problem
EF	B-test
50%	O

Social	O
History	O
:	O

Primarily	O
Togolese	O
speaking	O
,	O
wheelchair	B-problem
bound	I-problem
and	O
lives	O
alone	O
but	O
cared	O
for	O
entirely	O
by	O
her	O
daughter	O
.	O

She	O
denies	O
EtOH	O
,	O
tobacco	O
,	O
and	O
drugs	O
.	O

Patient	O
has	O
8	O
children	O
,	O
40	O
grandchildren	O
and	O
one	O
great-grandaughter	O
.	O

Family	O
History	O
:	O

CAD	B-problem
and	O
DM	B-problem

Physical	O
Exam	O
:	O

T	B-test
:	O
97.2	O
BP	B-test
:	O
127/57	O
HR	B-test
:	O
68	O
RR	B-test
:	O
11	O
O2saturation	B-test
:	O
97%	O
on	O
ambient	O
air	O

Gen	O
:	O

Pleasant	O
,	O
well	O
appearing	O
heavy	O
set	O
woman	O
laying	O
in	O
bed	O
.	O

HEENT	O
:	O

Slight	B-problem
conjunctival	I-problem
pallor	I-problem
.	O

No	O
scleral	B-problem
icterus	I-problem
.	O

Slightly	B-problem
dry	I-problem
mucous	I-problem
membranes	I-problem
.	O

NECK	O
:	O

Supple	O
.	O

No	O
JVD	B-problem
.	O

CV	O
:	O

RRR	O
.	O

Systolic	B-problem
murmur	I-problem
in	I-problem
right	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
.	O

Normal	O
S1	O
and	O
S2	O
.	O

No	O
rubs	B-problem
or	O
Andringa	B-problem
appreciated	O
.	O

LUNGS	O
:	O

Crackles	B-problem
in	I-problem
lower	I-problem
lung	I-problem
fields	I-problem
.	O

No	O
wheezes	B-problem
or	O
rhonci	B-problem
appreciated	O
.	O

ABD	O
:	O

Slightly	B-problem
hyperactive	I-problem
bowel	I-problem
sounds	I-problem
throughout	I-problem
.	O

Soft	O
.	O

Nontender	B-problem
and	O
nondistended	B-problem
.	O

No	O
guarding	B-problem
or	O
rebound	B-problem
.	O

Liver	O
edge	O
not	O
palpated	O
.	O

No	O
splenomegaly	B-problem
appreciated	O
.	O

Guaiac	B-problem
positive	I-problem
maroon	I-problem
stool	I-problem
in	O
Deanna	O
.	O

EXT	O
:	O

Warm	O
and	O
well	O
perfused	O
.	O

No	O
clubbing	B-problem
or	O
cyanosis	B-problem
.	O

No	O
lower	B-problem
extremity	I-problem
edema	I-problem
,	I-problem
bilaterally	I-problem
.	O

2+	B-test
dorsalis	I-test
pedis	I-test
and	I-test
radial	I-test
pulse	I-test
on	I-test
left	I-test
.	O

No	B-problem
radial	I-problem
pulse	I-problem
on	I-problem
right	I-problem
.	O

AV	B-treatment
fistula	I-treatment
on	O
right	O
.	O

Pertinent	O
Results	O
:	O

2018-08-07	O
12:56	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
4.0	O
RBC	B-test
-	O
3.54	O
*	O
Hgb	B-test
-	O
11.6	O
*	O
Hct	B-test
-	O
32.9	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
32.8	O
*	O
MCHC	B-test
-	O
35.2	O
*	O
RDW	B-test
-	O
18.5	O
*	O
Plt	B-test
Ct	I-test
-	O
65	O
*	O

2018-08-02	O
12:29	O
PM	O
BLOOD	B-test
Hct	B-test
-	O
23.5	O
*#	O

2018-08-02	O
04:40	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
3.2	O
*	O
RBC	B-test
-	O
2.49	O
*#	O
Hgb	B-test
-	O
8.4	O
*#	O
Hct	B-test
-	O
24.5	O
*#	O
MCV	B-test
-	O
98	O
MCH	B-test
-	O
33.7	O
*	O
MCHC	B-test
-	O
34.3	O
RDW	B-test
-	O
18.5	O
*	O
Plt	B-test
Ct	I-test
-	O
69	O
*	O

2018-08-06	O
04:52	O
AM	O
BLOOD	B-test
PT	B-test
-	O
14.7	O
*	O
PTT	B-test
-	O
28.9	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.3	O
*	O

2018-08-07	O
12:56	O
AM	O
BLOOD	B-test
UreaN	B-test
-	O
27	O
*	O
Creat	B-test
-	O
4.1	O
*	O
Na	B-test
-	O
130	O
*	O
K	B-test
-	O
3.7	O
Cl	B-test
-	O
94	O
*	O
HCO3	B-test
-	O
27	O
AnGap	B-test
-	O
13	O

2018-08-06	O
04:52	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
129	O
*	O
UreaN	B-test
-	O
24	O
*	O
Creat	B-test
-	O
3.4	O
*	O
Na	B-test
-	O
134	O
K	B-test
-	O
3.2	O
*	O
Cl	B-test
-	O
96	O
HCO3	B-test
-	O
29	O
AnGap	B-test
-	O
12	O

2018-08-02	O
04:40	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
187	O
*	O
UreaN	B-test
-	O
21	O
*	O
Creat	B-test
-	O
2.0	O
*#	O
Na	B-test
-	O
139	O
K	B-test
-	O
3.2	O
*	O
Cl	B-test
-	O
96	O
HCO3	B-test
-	O
35	O
*	O
AnGap	B-test
-	O
11	O

2018-08-07	O
12:56	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
8.0	O
*	O
Phos	B-test
-	O
3.5	O
Mg	B-test
-	O
1.8	O

Cardiology	O
Report	O
ECG	B-test
Study	I-test
Date	O
of	O
2018-08-02	O
5:40:48	O
PM	O

Sinus	B-problem
bradycardia	I-problem
with	O
markedly	B-problem
prolonged	I-problem
P-R	I-problem
interval	I-problem
and	O
Wenckebach	B-problem
type	I-problem

atrio-ventricular	B-problem
conduction	I-problem
delay	I-problem
.	O

Right	B-problem
bundle-branch	I-problem
block	I-problem
.	O

Indeterminate	B-problem
frontal	I-problem
plane	I-problem
QRS	I-problem
axis	I-problem
.	O

Compared	O
to	O
the	B-test
previous	I-test
tracing	I-test
of	O
2017-10-12	O
multiple	B-problem
abnormalities	I-problem
as	O
previously	O
noted	O
persist	O
without	O
major	B-problem
change	I-problem
.	O

Read	O
by	O
:	O
Dunn	O
,	O
Rachel	O
Finch	O

Intervals	B-test
Axes	I-test

Rate	B-test
PR	B-test
QRS	B-test
QT/QTc	B-test
P	B-test
QRS	B-test
T	B-test

57	O
0	O
154	O
670-32166	O
-37	O

2018-08-03	O
5:40	O
pm	O
SEROLOGY/BLOOD	B-test

Source	O
:	O

Line-central	B-treatment
.	O

**	O
FINAL	O
REPORT	O
2018-08-06	O
**	O

HELICOBACTER	B-test
PYLORI	I-test
ANTIBODY	I-test
TEST	I-test
(	O
Final	O
2018-08-06	O
)	O
:	O

NEGATIVE	O
BY	O
EIA	O
.	O

(	O
Reference	O
Range-Negative	O
)	O
.	O

GI	B-test
bleed	I-test
study	I-test
-	O
IMPRESSION	O
:	O

Active	B-problem
radiotracer	I-problem
activity	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
quadrant	I-problem
in	O
a	O
serpingneous	O
f	O
fashion	O
suggestive	O
of	O
distal	O
small	O
bowel	O
.	O

EGD	B-test
-	O
Impression	O
:	O

Angioectasias	B-problem
in	I-problem
the	I-problem
fundus	I-problem

Angioectasias	B-problem
in	I-problem
the	I-problem
antrum	I-problem

Angioectasias	B-problem
in	I-problem
the	I-problem
proximal	I-problem
jejunum	I-problem
and	I-problem
mid	I-problem
jejunum	I-problem

Angioectasia	B-problem
in	I-problem
the	I-problem
duodenum	I-problem

Otherwise	O
normal	O
small	O
bowel	O
enteroscopy	O
to	O
mid	O
jejunum	O

Recommendations	O
:	O

No	O
site	O
of	O
active	B-problem
bleeding	I-problem
was	O
seen	O
.	O

The	B-problem
fundal	I-problem
AVMs	I-problem
are	O
a	O
potential	O
site	O
of	O
bleeding	B-problem
although	O
do	O
not	O
explain	O
the	O
extent	O
of	O
bleeding	B-problem
.	O

Consider	O
endoscopic	B-treatment
argon	I-treatment
plasma	I-treatment
therapy	I-treatment

Proceed	O
with	O
colonoscopy	B-test
.	O

Colonoscopy	B-test
-	O

Impression	O
:	O

Blood	B-problem
in	I-problem
the	I-problem
colon	I-problem

Grade	B-problem
1	I-problem
external	I-problem
hemorrhoids	I-problem

Angioectasia	B-problem
in	I-problem
the	I-problem
colon	I-problem

Diverticulosis	B-problem
of	I-problem
the	I-problem
colon	I-problem

Otherwise	O
normal	O
colonoscopy	O
to	O
cecum	O

Brief	O
Hospital	O
Course	O
:	O

Blood	B-problem
loss	I-problem
anemia	I-problem
from	O
GI	B-problem
bleeding	I-problem
-	O
the	B-problem
bleeding	I-problem
was	O
likely	O
from	O
an	B-problem
AVM	I-problem
.	O

EGD	B-test
,	O
colonoscopy	B-test
and	O
tagged	B-test
scan	I-test
results	O
as	O
above	O
.	O

eventhough	O
uptake	O
was	O
noted	O
in	O
the	O
rt	O
LQ	O
,	O
no	O
clear	O
site	O
of	O
bleeding	B-problem
was	O
noticed	O
on	O
colonoscopy	B-test
.	O

hence	O
,	O
no	O
intervention	B-treatment
was	O
performed	O
.	O

she	O
was	O
transfused	O
with	O
5	O
units	O
of	O
PRBC	B-treatment
in	O
the	O
ICU	O
andsent	O
to	O
the	O
Lahey	O
Clinic	O
-	O
North	O
Shore	O
.	O

Her	B-test
hematocrit	I-test
remained	O
stable	O
for	O
4	O
days	O
prior	O
to	O
discharge	O
.	O

No	O
further	B-problem
bleeding	I-problem
noted	O
.	O

GI	O
consult	O
team	O
followed	O
pt	O
in	O
hospital	O
.	O

On	O
discussion	O
with	O
Dr	O
Leigh	O
and	O
Dr	O
White	O
from	O
GI	O
-	O
they	O
recommended	O
that	O
she	O
follow	O
with	O
Dr.	O
Taylor	O
for	O
consideration	O
of	O
argon	B-treatment
photocoagulation	I-treatment
as	O
out-patient	O
.	O

Given	O
the	O
innumerable	O
number	O
of	O
AVM	B-problem
's	I-problem
,	O
it	O
is	O
diffcult	O
to	O
assess	O
which	O
the	B-problem
culprit	I-problem
lesion	I-problem
is	O
and	O
GI	O
may	O
start	O
APL	B-treatment
from	I-treatment
the	I-treatment
fundus	I-treatment
of	O
stomach	O
.	O

Patient	O
to	O
get	O
CBC	B-test
checked	O
with	O
PCP	O
this	O
week	O
as	O
below	O
.	O

ASA	B-treatment
was	O
held	O
and	O
may	O
be	O
restarted	O
if	O
Hct	B-test
stable	O
in	O
clinic	O
at	O
the	O
PCP	O
's	O
discretion	O
.	O

Chronic	B-problem
thrombocytopenia	I-problem
was	O
noted	O
,	O
however	O
the	O
patient	O
did	O
not	O
require	O
platelet	B-treatment
transfusions	I-treatment
.	O

Has	O
a	O
h/o	O
HIT	B-problem
.	O

The	B-treatment
metoprolol	I-treatment
was	O
held	O
during	O
acute	B-problem
bleeding	I-problem
phase	I-problem
and	O
restarted	O
prior	O
to	O
discharge	O
as	O
her	B-test
BP	I-test
stabilized	O
.	O

Other	B-problem
medical	I-problem
problems	I-problem
stable	O
.	O

Dialysis	B-treatment
was	O
continued	O
3	O
/	O
week	O
.	O

I	O
personally	O
talked	O
with	O
Dr	O
Pannell	O
at	O
the	O
time	O
of	O
discharge	O
to	O
update	O
him	O
with	O
the	O
hospital	O
events	O
.	O

Medications	O
on	O
Admission	O
:	O

-	O
Atorvastatin	B-treatment
80	O
mg	O
QD	O

-	O
Hydroxyzine	B-treatment
HCl	I-treatment
25	O
mg	O
Tablet	O
PO	O
Q4-6H	O
PRN	O
for	O
itching	B-problem

-	O
Levothyroxine	B-treatment
175	O
mcg	O
PO	O
qd	O

-	O
Albuterol	B-treatment
90	O
mcg	O
1-2	O
Puffs	O
INH	O
q6hr	O
PRN	O

-	O
Nitroglycerin	B-treatment
0.3	O
mg	O
Tablet	O
PRN	O

-	O
Metoprolol	B-treatment
Tartrate	I-treatment
12.5	O
mg	O
BID	O

-	O
B	B-treatment
Complex	I-treatment
-	O
Vitamin	B-treatment
C	I-treatment
-	O
Folic	B-treatment
Acid	I-treatment
1	O
mg	O
Capsule	O
QD	O

-	O
Insulin	B-treatment
NPH	I-treatment
75-25	O
20units	O
qAM	O
and	O
humalog	B-treatment
sliding	I-treatment
scale	I-treatment

Discharge	O
Medications	O
:	O

1.	O
Atorvastatin	B-treatment
80	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Albuterol	B-treatment
90	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
1-2	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Levothyroxine	B-treatment
175	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Hydroxyzine	B-treatment
HCl	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

5.	O
B-Complex	B-treatment
with	O
Vitamin	B-treatment
C	I-treatment
Tablet	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Menthol	B-treatment
-	I-treatment
Cetylpyridinium	I-treatment
Cl	I-treatment
2	O
mg	O
Lozenge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Lozenge	O
Mucous	O
membrane	O
PRN	O
(	O
as	O
needed	O
)	O
.	O

7.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
.	O

8.	O
Nitroglycerin	B-treatment
0.3	O
mg	O
Tablet	O
,	O
Sublingual	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Sublingual	O
as	O
needed	O
as	O
needed	O
for	O
chest	B-problem
pain	I-problem
.	O

9.	O
Insulin	B-treatment

Continue	O
to	O
take	O
the	B-treatment
insulin	I-treatment
as	O
you	O
were	O
taking	O
prior	O
to	O
the	O
hospital	O
visit	O

10.	O
Outpatient	B-test
Lab	I-test
Work	I-test

CBC	B-test
(	O
to	O
be	O
checked	O
by	O
Dr	O
Pannell	O
444-1034	O
on	O
2018-08-10	O
)	O

11.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Acute	B-problem
blood	I-problem
loss	I-problem
anemia	I-problem
from	O
rectal	B-problem
bleeding	I-problem

Thrombocytopenia	B-problem
-	I-problem
chronic	I-problem

Secondary	O
diagnosis	O
-	O

HTN	B-problem
PAD-WORD	O

DM	B-problem
type	I-problem
1	I-problem

CKD	B-problem
stage	I-problem
5	I-problem

Hypothyroidism	B-problem
PAD-WORD	O

Asthma	B-problem
PAD-WORD	O

Coronary	B-problem
artery	I-problem
disease	I-problem

Discharge	O
Condition:	O
stable	O
.	O

Discharge	O
Instructions	O
:	O

Weigh	O
yourself	O
every	O
morning	O
,	O
call	O
MD	O
if	O
weight	B-problem
>	I-problem
3	I-problem
lbs	I-problem
.	O

Adhere	O
to	O
2	B-treatment
gm	I-treatment
sodium	I-treatment
diet	I-treatment

Do	O
not	O
take	O
the	B-treatment
aspirin	I-treatment
unless	O
you	O
see	O
Dr	O
Pannell	O
.	O

Continue	O
to	O
take	O
the	B-treatment
insulin	I-treatment
as	O
you	O
were	O
taking	O
prior	O
to	O
hospital	O
visit	O
.	O

Keep	O
your	O
appointments	O
.	O

Please	O
see	O
your	O
doctor	O
(	O
Dr	O
Pannell	O
)	O
on	O
Friday	O
2018-08-10	O
for	O
a	B-test
blood	I-test
test	I-test
(	O
cbc	B-test
)	O
.	O

He	O
has	O
asked	O
you	O
call	O
the	O
clinic	O
Friday	O
morning	O
for	O
a	O
same	O
day	O
appointment	O
.	O

Continue	O
the	B-treatment
dialysis	I-treatment
three	O
times	O
a	O
week	O
.	O

Return	O
to	O
the	O
hospital	O
if	O
you	O
notice	O
bleeding	B-problem
or	O
any	B-problem
other	I-problem
symptoms	I-problem
of	O
concern	O
to	O
you	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O

Kim	O
Phone	O
:	O
512	O
0199	O
Date	O
/	O
Time	O
:	O
2018-08-17	O
9:30	O

Gastroenterology	O
-	O
9092	O
N.	O
Eighth	O
Cir.	O
,	O
Wisecup	O
Rose	O
-	O
1st	O
floor	O
.	O

Provider	O
:	O
Michelle	O
Susan	O
,	O
MD	O
Phone	O
:	O
(	O
544	O
)	O
439-6335	O
Date	O
/	O
Time	O
:	O
2018-08-14	O
8:20	O

Primary	O
doctor	O
-	O
Dr	O
Shirley	O
,	O
James	O
M.	O
444-1034	O
-	O
please	O
see	O
your	O
doctor	O
Mary	O
Powell	O
2018-08-10	O
for	O
a	B-test
blood	I-test
test	I-test
(	O
cbc	B-test
)	O
.	O

Dialysis	B-treatment
as	O
scheduled	O
.	O

Ruby	O
Charles	O
MD	O
75-829	O

Completed	O
by	O
:	O
William	O
Charles	O
MD	O
75-829	O
2018-08-08	O
@	O
0822	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Stoll	O
Delacy	O
on	O
:	O
Sandra	O
2018-08-09	O
4:36	O
PM	O

(	O
End	O
of	O
Report	O
)	O

176318078	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4189699	O
PAD-WORD	O

98761/1k47	O
PAD-WORD	O

867797	O
PAD-WORD	O

6/22/1994	O
12:00:00	O
AM	O

MITRAL	B-problem
STENOSIS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

06/22/94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

07/04/94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Mitral	B-problem
stenosis	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Tricuspid	B-problem
insufficiency	I-problem
,	O
atrial	B-problem
fibrillation	I-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
pulmonary	B-problem
hypertension	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

04/22/94	O
,	O
mitral	B-treatment
valve	I-treatment
replacement	I-treatment
and	O
tricuspid	B-treatment
valve	I-treatment
reconstruction	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
68	O
year	O
old	O
female	O
had	O
rheumatic	B-problem
fever	I-problem
in	O
the	O
past	O
,	O
and	O
has	O
had	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

She	O
has	O
had	O
progressive	B-problem
heart	I-problem
failure	I-problem
and	O
an	B-test
evaluation	I-test
demonstrated	O
worsening	B-problem
mitral	I-problem
stenosis	I-problem
with	O
severe	B-problem
pulmonary	I-problem
hypertension	I-problem
.	O

Because	O
of	O
her	O
deteriorating	O
status	O
,	O
she	O
underwent	O
prior	B-test
cardiac	I-test
catheterization	I-test
,	O
which	O
confirmed	O
severe	B-problem
mitral	I-problem
stenosis	I-problem
with	O
secondary	B-problem
tricuspid	I-problem
valve	I-problem
regurgitation	I-problem
due	O
to	O
pulmonary	B-problem
hypertension	I-problem
.	O

She	O
was	O
referred	O
for	O
valve	B-treatment
surgery	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
is	O
remarkable	O
for	O
chronic	B-problem
lung	I-problem
disease	I-problem
due	O
to	O
smoking	O
.	O

She	O
had	O
undergone	O
a	B-treatment
previous	I-treatment
nasal	I-treatment
arterial	I-treatment
embolization	I-treatment
for	O
treatment	B-treatment
of	O
recurrent	B-problem
epistaxis	I-problem
.	O

She	O
had	O
a	B-treatment
partial	I-treatment
gastrectomy	I-treatment
in	O
1972	O
.	O

Her	B-treatment
MEDICATIONS	I-treatment
ON	I-treatment
ADMISSION	I-treatment
included	O
Coumadin	B-treatment
,	O
digoxin	B-treatment
,	O
0.125	O
,	O
qD	O
,	O
Lasix	B-treatment
,	O
40	O
,	O
q.i.d.	O
,	O
and	O
Vanceril	B-treatment
inhaler	I-treatment
.	O

PERTINENT	B-test
EXAMINATION	I-test
demonstrated	O
mild	B-problem
elevation	I-problem
of	O
her	B-test
jugular	I-test
venous	I-test
pulse	I-test
,	O
with	O
prominent	B-problem
V-waves	I-problem
,	O
and	O
systolic	B-problem
and	I-problem
diastolic	I-problem
murmurs	I-problem
.	O

Peripheral	B-test
pulses	I-test
were	O
all	O
intact	O
,	O
and	O
there	O
was	O
venous	B-problem
stasis	I-problem
changes	I-problem
on	I-problem
her	I-problem
legs	I-problem
,	O
with	O
some	B-problem
edema	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
,	O
on	O
April	O
22	O
.	O

She	O
underwent	O
a	B-treatment
mitral	I-treatment
valve	I-treatment
replacement	I-treatment
,	O
utilizing	O
a	O
27	O
mm	O
.	O

St.	B-treatment
Jude	I-treatment
prosthesis	I-treatment
,	O
and	O
tricuspid	B-treatment
valve	I-treatment
reconstruction	I-treatment
by	O
ring	B-treatment
anuloplasty	I-treatment
.	O

She	O
weaned	O
from	O
cardiopulmonary	B-treatment
bypass	I-treatment
with	O
good	O
hemodynamics	O
.	O

She	O
initially	O
awoke	O
after	O
surgery	B-treatment
,	O
with	O
good	O
hemodynamics	O
.	O

She	O
was	O
transiently	O
in	O
sinus	O
rhythm	O
,	O
but	O
atrial	B-problem
fibrillation	I-problem
recurred	O
.	O

She	O
was	O
extubated	O
on	O
the	O
third	O
postoperative	O
day	O
,	O
and	O
was	O
initially	B-problem
slightly	I-problem
agitated	I-problem
and	O
confused	B-problem
,	O
largely	O
due	O
to	O
an	B-problem
Intensive	I-problem
Care	I-problem
Unit	I-problem
psychosis	I-problem
.	O

She	O
continued	O
to	O
improve	O
,	O
with	O
mobilization	O
of	O
fluid	O
.	O

She	O
was	O
initially	O
noted	O
to	O
have	O
a	B-problem
slow	I-problem
ventricular	I-problem
response	I-problem
in	O
atrial	B-problem
fibrillation	I-problem
,	O
but	O
this	O
gradually	O
improved	O
over	O
time	O
.	O

She	O
was	O
initially	O
noted	O
to	O
be	O
somewhat	B-problem
anemic	I-problem
,	O
and	O
received	O
transfusions	B-treatment
.	O

Coumadin	B-treatment
was	O
restarted	O
,	O
and	O
her	B-treatment
anticoagulation	I-treatment
came	O
into	O
range	O
.	O

She	O
was	O
ultimately	O
discharged	O
with	O
a	B-test
heart	I-test
rate	I-test
in	O
the	O
90	O
's	O
,	O
and	O
with	O
resolving	B-problem
edema	I-problem
and	O
a	O
clear	O
chest	O
.	O

Her	B-treatment
MEDICATIONS	I-treatment
ON	I-treatment
DISCHARGE	I-treatment
included	O
Lasix	B-treatment
,	O
40	O
,	O
b.i.d.	O
,	O
potassium	B-treatment
,	O
20	O
mEq.	O
,	O
b.i.d.	O
,	O
iron	B-treatment
,	O
and	O
folic	B-treatment
acid	I-treatment
replacement	I-treatment
,	O
and	O
Coumadin	B-treatment
.	O

RIEMUND	O
C.	O
ALL	O
,	O
M.D.	O

TR	O
:	O

dun	O
/	O
bmot	O

DD	O
:	O

7/12/94	O
PAD-WORD	O

TD	O
:	O

07/13/94	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Ca	O
Shuff	O
.	O

Admission	O
Date	O
:	O

2015-07-09	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-07-17	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1947-06-29	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service:	O
PAD-WORD	O

ADDENDUM	O
:	O

Leona	O
Wheeler	O
had	O
continued	O
episodes	O
of	O
atrial	B-problem
fibrillation	I-problem
which	O
were	O
treated	O
with	O
intravenous	B-treatment
Amiodarone	I-treatment
and	O
later	O
intravenous	B-treatment
Diltiazem	I-treatment
.	O

Her	B-treatment
Lopressor	I-treatment
dose	I-treatment
was	O
progressively	O
increased	O
to	O
100	O
mg	O
tid	O
.	O

Amiodarone	B-treatment
400	O
mg	O
tid	O
was	O
continued	O
as	O
well	O
.	O

Due	O
to	O
this	B-problem
continued	I-problem
atrial	I-problem
fibrillation	I-problem
,	O
Leona	O
Wheeler	O
was	O
anticoagulated	O
with	O
intravenous	B-treatment
Heparin	I-treatment
.	O

Coumadin	B-treatment
dose	I-treatment
was	O
started	O
and	O
her	B-test
INR	I-test
were	O
followed	O
.	O

These	O
episodes	O
of	O
atrial	B-problem
fibrillation	I-problem
have	O
diminished	O
and	O
she	O
has	O
been	O
in	O
sinus	O
rhythm	O
for	O
over	O
24	O
hours	O
now	O
.	O

At	O
this	O
time	O
Leona	O
Wheeler	O
was	O
felt	O
stable	O
to	O
be	O
transferred	O
to	O
rehabilitation	O
facility	O
.	O

She	O
will	O
be	O
monitored	O
with	O
a	B-test
King	I-test
of	I-test
Hearts	I-test
monitor	I-test
.	O

Changes	O
to	O
discharge	O
medications	O
:	O

Metoprolol	B-treatment
100	O
mg	O
tid	O
,	O
Amiodarone	B-treatment
400	O
mg	O
tid	O
times	O
7	O
days	O
,	O
then	O
bid	O
times	O
14	O
days	O
,	O
then	O
q	O
d	O
times	O
14	O
days	O
,	O
then	O
200	O
mg	O
q	O
d	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

Leona	O
Wheeler	O
is	O
to	O
be	O
transferred	O
on	O
2015-07-17	O
to	O
a	O
rehabilitation	O
facility	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Status	O
post	O
CABG	B-treatment
times	O
four	O
.	O

Meghan	O
G.	O
Bardin	O
,	O
M.D.	O
43-132	O

Dictated	O
By	O
:	O
Louise	O
B.	O
Robertson	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-07-17	O
08:39	O

T	O
:	O
2015-07-22	O
10:29	O

JOB	O
#	O
:	O
72575	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Derek	O
Vildosola	O
on	O
:	O
WED	O
2015-07-29	O
1:15	O
PM	O

(	O
End	O
of	O
Report	O
)	O

176318078_c	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4189699	O
PAD-WORD	O

78088/7792	O
PAD-WORD	O

080216	O
PAD-WORD	O

8/21/1993	O
12:00:00	O
AM	O

EPISTAXIS	B-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

8/21/93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

8/23/93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Epistaxis	B-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Mitral	B-problem
stenosis	I-problem
,	O
tricuspid	B-problem
regurgitation	I-problem
,	O
heart	B-problem
failure	I-problem
,	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
,	O
chronic	B-problem
ventricular	I-problem
ectopy	I-problem
,	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

Epistaxis	B-problem
on	O
Coumadin	B-treatment
in	O
the	O
past	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Partial	B-treatment
embolization	I-treatment
of	I-treatment
blood	I-treatment
supply	I-treatment
to	O
nose	O
,	O
8/22	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
68	O
year	O
old	O
female	O
has	O
rheumatic	B-problem
heart	I-problem
disease	I-problem
.	O

Mitral	B-treatment
and	I-treatment
possibly	I-treatment
tricuspid	I-treatment
valve	I-treatment
surgery	I-treatment
is	O
scheduled	O
for	O
Labor	O
Day	O
by	O
Dr.	O
Riemund	O
C.	O
Kennedy	O
.	O

Her	O
history	O
is	O
detailed	O
in	O
the	O
discharge	O
summary	O
of	O
August	O
10	O
of	O
this	O
year	O
.	O

She	O
is	O
admitted	O
now	O
for	O
a	B-treatment
neuro-interventional	I-treatment
radiology	I-treatment
procedure	I-treatment
to	O
decrease	O
the	O
likelihood	O
of	O
epistaxis	B-problem
on	O
Coumadin	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Chest	O
was	O
clear	O
.	O

Right	B-problem
neck	I-problem
and	I-problem
right	I-problem
groin	I-problem
catheterization	I-problem
sites	I-problem
were	O
benign	O
.	O

No	O
edema	B-problem
.	O

Examination	B-test
was	O
otherwise	O
unchanged	O
.	O

LABORATORY	O
DATA	O
:	O

Hematocrit	B-test
was	O
42	O
,	O
PT	B-test
was	O
10	O
,	O
potassium	B-test
was	O
3.6	O
,	O
BUN	B-test
was	O
29	O
,	O
creatinine	B-test
was	O
1.4	O
,	O
blood	B-test
sugar	I-test
was	O
111	O
.	O

EKG	B-test
showed	O
atrial	B-problem
fibrillation	I-problem
,	O
moderate	B-problem
ventricular	I-problem
response	I-problem
,	O
right	B-problem
ventricular	I-problem
hypertrophy	I-problem
,	O
right	B-problem
axis	I-problem
deviation	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	B-treatment
interventional	I-treatment
neuro-radiology	I-treatment
procedure	I-treatment
was	O
performed	O
by	O
Dr.	O
A	O
Skizeis	O
,	O
on	O
August	O
22	O
,	O
via	O
the	O
right	O
femoral	O
artery	O
.	O

The	O
right	O
internal	O
maxillary	O
artery	O
supply	O
to	O
the	O
nasal	O
mucosa	O
was	O
embolized	B-treatment
.	O

The	O
left	O
external	O
carotid	O
artery	O
was	O
occluded	B-problem
at	O
its	O
origin	O
,	O
with	O
collaterals	O
from	O
the	O
internal	O
carotid	O
artery	O
.	O

Thus	O
,	O
embolization	B-treatment
on	I-treatment
the	I-treatment
left	I-treatment
side	I-treatment
was	O
not	O
possible	O
.	O

The	O
patient	O
received	O
Coumadin	B-treatment
,	O
10	O
mg.	O
,	O
on	O
the	O
evening	O
following	O
the	O
procedure	O
,	O
and	O
is	O
discharged	O
the	O
next	O
day	O
.	O

Her	B-test
prothrombin	I-test
time	I-test
will	O
be	O
rechecked	O
on	O
August	O
27	O
by	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Naka	O
Gift	O
.	O

Once	O
her	B-test
prothrombin	I-test
time	I-test
is	O
in	O
therapeutic	O
range	O
,	O
she	O
will	O
be	O
observed	O
for	O
epistaxis	B-problem
.	O

She	O
will	O
take	O
her	O
last	O
dose	O
of	O
Coumadin	B-treatment
on	O
September	O
1	O
in	O
anticipation	O
of	O
cardiac	B-treatment
surgery	I-treatment
.	O

If	O
her	B-test
prothrombin	I-test
time	I-test
does	O
not	O
come	O
into	O
therapeutic	O
range	O
promptly	O
,	O
then	O
surgery	B-treatment
may	O
be	O
delayed	O
.	O

DISCHARGE	O
REGIMEN	O
:	O

Coumadin	B-treatment
,	O
5	O
mg.	O
,	O
alternating	O
with	O
2.5	O
mg.	O
,	O
qD	O
,	O
digoxin	B-treatment
,	O
0.125	O
mg.	O
,	O
qD	O
,	O
Lasix	B-treatment
,	O
80	O
mg.	O
,	O
qAM	O
and	O
40	O
mg.	O
,	O
qPM	O
,	O
Vanceril	B-treatment
,	O
3	O
puffs	O
,	O
b.i.d.	O

CA	O
N.	O
SHUFF	O
,	O
M.D.	O

TR	O
:	O

yqv	O
/	O
bmot	O

DD	O
:	O

8/23/93	O
PAD-WORD	O

TD	O
:	O

08/23/93	O
PAD-WORD	O

CC	O
:	O

A	O
copy	O
to	O
Dr.	O
Ca	O
Shuff	O
at	O
Valtawnprinceel	O
Community	O
Memorial	O
Hospital	O
,	O
a	O
copy	O
to	O
Dr.	O
A	O
Skizeis	O
,	O
a	O
copy	O
to	O
Dr.	O
Riemund	O
C.	O
Kennedy	O
,	O
and	O
three	O
copies	O
to	O
Dr.	O
Shuff	O
&apos;s	O
office	O
.	O

Admission	O
Date	O
:	O

2014-11-13	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-12-05	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2014-11-13	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Neonatology	O
PAD-WORD	O

HISTORY	O
:	O

Baby	O
Boy	O
Timberlake	O
was	O
born	O
to	O
a	O
25	O
-	O
year-old	O
G-8	O
,	O
P-4	O
to	O
5	O
mom	O
with	O
Julie	O
type	O
B	O
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
rubella	B-test
immune	I-test
,	O
RPR	B-test
nonreactive	O
,	O
GBS	B-problem
positive	I-problem
with	O
a	O
history	O
of	O
infrequent	O
prenatal	O
care	O
since	O
28	O
weeks	O
time	O
and	O
preterm	B-problem
labor	I-problem
.	O

Mother	O
had	O
a	O
history	O
of	O
anxiety	B-problem
and	O
asthma	B-problem
as	O
well	O
as	O
moderate	O
cigarette	O
smoking	O
.	O

The	O
baby	O
was	O
delivered	O
through	O
normal	O
spontaneous	O
vaginal	O
delivery	O
with	O
brief	B-treatment
blow	I-treatment
by	I-treatment
with	O
Apgars	B-test
of	O
8	O
and	O
9	O
.	O

Father	O
of	O
baby	O
not	O
involved	O
at	O
this	O
time	O
.	O

The	O
patient	O
's	O
pediatrician	O
is	O
Wellesley	O
House	O
and	O
is	O
Dr	O
.	O
Shaw	O
.	O

The	O
patient	O
has	O
many	O
siblings	O
,	O
all	O
of	O
which	O
are	O
girls	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
the	B-test
patient	I-test
's	I-test
birth	I-test
weight	I-test
was	O
1.705	O
kilograms	O
,	O
which	O
is	O
50th	O
percentile	O
.	O

Length	B-test
was	O
40	O
cm	O
,	O
50th	O
percentile	O
.	O

Head	B-test
circumference	I-test
was	O
30	O
cm	O
,	O
50th	O
percentile	O
.	O

The	O
patient	O
was	O
born	O
at	O
32	O
and	O
4/7	O
weeks	O
gestation	O
and	O
brought	O
directly	O
to	O
the	O
CMED	O
CSRU	O
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
systems	O
:	O

Respiratory	O
.	O

After	O
receiving	O
brief	B-treatment
blow	I-treatment
by	I-treatment
oxygen	I-treatment
in	O
the	O
delivery	O
room	O
,	O
the	O
patient	O
had	O
no	O
further	O
episodes	O
of	O
ventilatory	B-treatment
assistance	I-treatment
required	O
with	O
good	O
respiratory	O
rate	O
consistently	O
.	O

The	O
patient	O
was	O
never	O
placed	O
on	O
caffeine	B-treatment
.	O

He	O
is	O
stable	O
in	O
room	O
air	O
at	O
this	O
time	O
.	O

Cardiovascular	O
.	O

No	O
active	O
issues	O
.	O

No	O
history	O
of	O
hypotension	B-problem
.	O

On	O
no	O
medications	B-treatment
at	O
this	O
time	O
.	O

Notably	O
with	O
respect	O
to	O
apnea	B-problem
and	O
bradycardia	B-problem
of	O
prematurity	B-problem
,	O
the	O
patient	O
has	O
reached	O
5	O
days	O
without	O
significant	B-problem
apneic	I-problem
or	I-problem
bradycardic	I-problem
spells	I-problem
as	O
of	O
the	O
time	O
of	O
discharge	O
.	O

Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
.	O

The	O
patient	O
reached	O
full	O
volume	O
feeds	O
by	O
day	O
of	O
life	O
6	O
and	O
had	O
calories	O
increased	O
to	O
maximum	O
of	O
26	O
kilocalories	O
per	O
ounce	O
of	O
Similac	B-treatment
special	I-treatment
care	I-treatment
until	O
2014-12-03	O
,	O
at	O
which	O
point	O
this	O
was	O
weaned	O
to	O
24	O
kilocalories	O
per	O
ounce	O
of	O
straight	B-treatment
Similac	I-treatment
.	O

This	O
is	O
the	O
baby	O
's	O
discharge	O
feedings	O
and	O
he	O
is	O
p.o.	O
ad	O
lib	O
with	O
a	O
minimum	O
of	O
130	O
ml/kg/day	O
,	O
the	O
patient	O
has	O
taken	O
on	O
an	O
average	O
greater	O
than	O
150	O
ml/kg/day	O
ad	O
lib	O
over	O
each	O
of	O
the	O
past	O
5	O
days	O
.	O

GI	O
.	O

The	O
patient	O
with	O
peak	B-test
bilirubin	I-test
of	O
6.5	O
on	O
day	O
of	O
life	O
3	O
.	O

No	O
phototherapy	B-treatment
was	O
required	O
.	O

Hematology	O
/	O
Infectious	O
Disease	O
.	O

The	B-test
patient	I-test
's	I-test
hematocrit	I-test
at	O
delivery	O
was	O
48	O
,	O
with	O
a	B-test
white	I-test
count	I-test
of	O
11.2	O
and	O
platelets	B-test
of	O
301,000	O
.	O

Initial	B-test
differential	I-test
was	O
35	B-test
polys	I-test
and	O
zero	B-test
bands	I-test
,	O
not	O
suspicious	O
for	O
infectious	B-problem
condition	I-problem
.	O

The	O
patient	O
was	O
initially	O
treated	O
with	O
48	O
hours	O
of	O
ampicillin	B-treatment
and	O
gentamicin	B-treatment
until	O
blood	B-test
cultures	I-test
were	O
negative	O
.	O

The	O
infant	O
has	O
had	O
no	O
antibiotics	B-treatment
since	O
that	O
time	O
.	O

Neurology	O
.	O

No	O
issues	O
.	O

Sensory	O
.	O

Hearing	B-test
screen	I-test
was	O
performed	O
with	O
automated	B-test
auditory	I-test
brainstem	I-test
responses	I-test
and	O
was	O
normal	O
on	O
2014-11-24	O
.	O

Ophthalmology	O
.	O

The	O
patient	O
did	O
not	O
qualify	O
for	O
routine	B-test
ophthalmology	I-test
exams	I-test
due	O
to	O
his	O
gestational	O
age	O
at	O
birth	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Home	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Shaw	O
at	O
Wellesley	O
House	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Feedings	O
at	O
discharge	O
-	O
Similac	B-treatment
24	O
kilocalories	O
per	O
ounce	O
p.o.	O
ad	O
lib	O
.	O

If	O
the	O
patient	O
achieves	O
above	O
adequate	O
weight	O
gain	O
of	O
18-20	O
grams	O
per	O
kilogram	O
per	O
day	O
,	O
consider	O
decreasing	O
calories	O
to	O
standard	O
20	O
kilocalories	O
per	O
ounce	O
.	O

2.	O
Car	B-test
seat	I-test
positioning	I-test
screening	I-test
passed	O
.	O

3.	O
State	B-test
newborn	I-test
screening	I-test
sent	O
per	O
protocol	O
and	O
no	O
abnormal	B-problem
reports	I-problem
have	O
been	O
received	O
.	O

4.	O
Immunizations	B-treatment
received	O
:	O

Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
given	O
today	O
due	O
to	O
multiple	O
siblings	O
at	O
home	O
with	O
daycare	O
exposure	O
and	O
the	O
patient	O
being	O
between	O
32	O
and	O
35	O
weeks	O
.	O

Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
in	O
general	O
from	O
November	O
through	O
March	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
3	O
criteria	O
:	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
,	O

2.	O
Born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
2	O
of	O
the	O
following	O
:	O

Daycare	O
during	O
RSV	O
season	O
,	O
a	O
smoker	O
in	O
the	O
household	O
,	O
neuromuscular	B-problem
disease	I-problem
,	O
airway	B-problem
abnormalities	I-problem
or	O
school	O
age	O
sibling	O
,	O
or	O
3.	O
With	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
,	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

FOLLOW	O
UP	O
:	O

VNA	O
and	O
pediatric	O
primary	O
care	O
physician	O
appointments	O
to	O
be	O
scheduled	O
prior	O
to	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
.	O

2.	O
Apnea	B-problem
of	O
prematurity	B-problem
.	O

3.	O
Rule	O
out	O
sepsis	B-problem
.	O

Carol	O
Eddie	O
m.d	O
00-112	O

Dictated	O
By	O
:	O
John	O
KT	O
Bolling	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-12-05	O
15:53:11	O

T	O
:	O
2014-12-05	O
16:49:10	O

Job	O
#	O
:	O
28583	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Carol	O
Warren	O
on	O
:	O
MON	O
2014-12-08	O
11:49	O
AM	O

(	O
End	O
of	O
Report	O
)	O

180414134	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

8987576	O
PAD-WORD	O

39627	O
PAD-WORD	O

936967	O
PAD-WORD	O

09/08/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

PRUESSCHIRD	O
,	O
RIIE	O

UNIT	O
NUMBER	O
:	O

825-78-07	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

09/08/96	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

09/17/96	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
82	O
year	O
old	O
retired	O
engineer	O
has	O
had	O
multiple	O
admissions	O
to	O
the	O
Ph	O
University	O
Of	O
Medical	O
Center	O
for	O
multiple	B-problem
strokes	I-problem
and	O
a	B-problem
spontaneous	I-problem
subdural	I-problem
hematoma	I-problem
and	O
prostatic	B-problem
hypertrophy	I-problem
.	O

He	O
has	O
been	O
managing	O
at	O
home	O
on	O
restricted	B-treatment
activity	I-treatment
but	O
able	O
to	O
get	O
around	O
with	O
a	B-treatment
walker	I-treatment
but	O
on	O
the	O
day	O
before	O
admission	O
he	O
became	O
increasing	B-problem
dyspneic	I-problem
and	O
on	O
the	O
day	O
of	O
admission	O
he	O
collapsed	O
and	O
was	O
unable	O
to	O
walk	O
to	O
his	O
bed	O
.	O

For	O
this	O
he	O
was	O
admitted	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	B-test
physical	I-test
examination	I-test
the	O
patient	O
was	O
both	O
chronically	B-problem
and	I-problem
acutely	I-problem
ill	I-problem
,	O
dyspneic	B-problem
,	O
mildly	B-problem
febrile	I-problem
and	O
with	O
coarse	B-problem
rales	I-problem
in	I-problem
both	I-problem
bases	I-problem
.	O

He	O
was	O
in	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
and	O
his	B-test
vital	I-test
signs	I-test
were	O
otherwise	O
stable	O
.	O

His	O
abdomen	O
was	O
negative	O
.	O

His	B-problem
prostate	I-problem
enlarged	I-problem
and	O
he	O
had	O
no	O
peripheral	B-problem
edema	I-problem
.	O

LABORATORY	O
DATA	O
:	O

He	O
had	O
mild	B-problem
elevation	I-problem
of	O
the	B-test
WBC	I-test
intermittently	B-problem
grossly	I-problem
bloody	I-problem
urine	I-problem
.	O

No	O
cultures	B-test
were	O
positive	B-problem
but	O
the	B-test
chest	I-test
x-ray	I-test
showed	O
bilateral	B-problem
densities	I-problem
more	O
on	O
the	O
left	O
than	O
the	O
right	O
compatible	O
with	O
aspiration	B-problem
pneumonia	I-problem
.	O

There	O
were	O
no	O
radiographic	O
indications	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
started	O
on	O
Clindamycin	B-treatment
intravenous	I-treatment
and	O
Cefuroxime	B-treatment
intravenous	I-treatment
with	O
clearing	O
of	O
his	B-problem
fever	I-problem
but	O
persistence	O
of	O
cough	B-problem
,	O
choking	B-problem
,	O
and	O
intermittently	B-problem
many	I-problem
coarse	I-problem
rales	I-problem
in	I-problem
his	I-problem
base	I-problem
with	O
no	O
clearing	O
by	B-test
x-ray	I-test
.	O

His	O
ambulation	O
was	O
minimal	O
and	O
always	O
with	O
assistance	O
but	O
he	O
had	O
a	B-treatment
transurethral	I-treatment
resection	I-treatment
of	I-treatment
the	I-treatment
prostate	I-treatment
on	O
09/14/96	O
.	O

He	O
is	O
transferred	O
to	O
Louline	O
Mauikings	O
Medical	O
Center	O
for	O
future	B-treatment
rehabilitation	I-treatment
and	O
hopeful	O
return	O
home	O
with	O
considerable	O
support	O
and	O
assistance	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Aspiration	B-problem
pneumonia	I-problem
bilateral	I-problem
,	O
multiple	B-problem
strokes	I-problem
,	O
chronic	B-problem
atrial	I-problem
fibrillation	I-problem
,	O
prostatic	B-problem
hypertrophy	I-problem
with	O
gross	B-problem
hematuria	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Digoxin	B-treatment
0.25	O
mg	O
.	O

Hytrin	B-treatment
2mg	O
at	O
bedtime	O
.	O

Ticlid	B-treatment
0.25	O
g	O
po	O
bid	O
.	O

Bronchodilators	B-treatment
as	O
needed	O
.	O

DOCTOR	O
&apos;S	O
DISCHARGE	O
ORDERS	O
:	O

Strict	B-treatment
aspiration	I-treatment
precautions	I-treatment
with	O
avoidance	B-treatment
of	I-treatment
clear	I-treatment
liquids	I-treatment
and	O
all	O
other	O
liquids	O
thickened	O
.	O

Increased	O
ambulation	O
with	O
assistance	O
and	O
daily	B-treatment
pulmonary	I-treatment
physical	I-treatment
therapy	I-treatment
.	O

TOOB	O
OBESTIMEUPH	O
,	O
M.D.	O

TR	O
:	O

ua	O
PAD-WORD	O

DD	O
:	O

09/16/96	O
PAD-WORD	O

TD	O
:	O

09/16/96	O
4:10	O
P	O

cc	O
:	O

DOJE	O
EED	O
BOLMSHI	O
,	O
M.D.	O
TOOB	O
I	O
OBESTIMEUPH	O
,	O
M.D.	O
l1xk	O
STAT	O

Admission	O
Date	O
:	O

2010-02-05	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-02-06	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1986-06-14	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

TRAUMA	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
23	O
year	O
old	O
female	O
,	O
status	O
post	O
fall	O
from	O
standing	O
position	O
after	O
slipping	O
on	O
ice	O
.	O

She	O
had	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
.	O

She	O
recalled	O
the	O
entire	O
event	O
.	O

She	O
was	O
found	O
by	O
family	O
and	O
friends	O
to	O
be	O
somewhat	B-problem
confused	I-problem
and	O
was	O
therefore	O
taken	O
to	O
Newton-Wellesley	O
Hospital	O
thereafter	O
.	O

Workup	B-test
at	O
the	O
outside	O
hospital	O
included	O
a	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
revealing	O
a	O
possible	O
parietal	B-problem
subdural	I-problem
bleed	I-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
.	O

The	B-test
patient	I-test
's	I-test
GCS	I-test
was	O
15	O
.	O

She	O
was	O
hemodynamically	O
stable	O
.	O

She	O
was	O
thereafter	O
transferred	O
to	O
Beverly	O
Hospital	O
for	O
further	B-test
evaluation	I-test
and	O
management	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
depression	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Prozac	B-treatment
.	O

2.	O
Tetracycline	B-treatment
for	O
acne	B-problem
.	O

ALLERGIES	O
:	O

She	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
presentation	O
,	O
her	B-test
temperature	I-test
was	O
98.8	O
with	O
a	B-test
heart	I-test
rate	I-test
of	O
100	O
,	O
blood	B-test
pressure	I-test
110/65	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
and	O
she	O
was	O
saturating	O
at	O
100%	O
in	O
room	O
air	O
.	O

In	O
general	O
,	O
she	O
is	O
well	O
appearing	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
-	O
The	O
pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Extraocular	O
movements	O
are	O
intact	O
.	O

The	O
oropharynx	O
is	O
negative	O
.	O

Face	O
is	O
stable	O
.	O

No	O
obvious	O
evidence	O
of	O
trauma	B-problem
.	O

She	O
is	O
normocephalic	O
otherwise	O
.	O

Trachea	O
was	O
midline	O
.	O

The	O
heart	O
was	O
regular	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

No	O
crepitus	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
with	O
no	O
evidence	O
of	O
step-off	B-problem
,	O
palpable	O
pulses	O
peripherally	O
.	O

She	O
had	O
brisk	O
capillary	O
refill	O
.	O

Rectal	B-test
examination	I-test
was	O
heme	B-test
negative	O
with	O
normal	O
tone	O
.	O

Neurologic	B-test
examination	I-test
was	O
nonfocal	O
.	O

Neurosensory	O
was	O
intact	O
and	O
she	O
had	O
normal	O
motor	O
examination	O
with	O
5/5	O
strength	O
throughout	O
all	O
her	O
upper	O
and	O
lower	O
extremities	O
.	O

LABORATORY	O
DATA	O
:	O

Admission	B-test
laboratories	I-test
were	O
notable	O
for	O
a	B-test
white	I-test
count	I-test
of	O
13.1	O
,	O
hematocrit	B-test
34.0	O
,	O
platelet	B-test
count	I-test
280,000	O
.	O

Chemistries	B-test
were	O
notable	O
for	O
a	B-test
sodium	I-test
of	O
143	O
,	O
potassium	B-test
3.2	O
,	O
chloride	B-test
and	O
bicarbonate	B-test
of	O
104	O
and	O
24	O
,	O
respectively	O
,	O
with	O
blood	B-test
urea	I-test
nitrogen	I-test
and	O
creatinine	B-test
of	O
7	O
and	O
0.4	O
,	O
respectively	O
.	O

Blood	B-test
glucose	I-test
was	O
116	O
.	O

Her	B-test
admission	I-test
coagulation	I-test
studies	I-test
were	O
notable	O
for	O
a	B-test
prothrombin	I-test
time	I-test
INR	B-test
of	O
11.8	O
and	O
0.9	O
,	O
respectively	O
with	O
a	B-test
partial	I-test
thromboplastin	I-test
time	I-test
of	O
25.2	O
.	O

Admission	B-test
lactate	I-test
was	O
0.8	O
.	O

Amylase	B-test
was	O
87	O
.	O

Fibrinogen	B-test
was	O
346	O
.	O

HCG	B-test
was	O
negative	O
.	O

Serum	B-test
toxicology	I-test
and	O
urine	B-test
toxicology	I-test
were	O
negative	O
.	O

Urinalysis	B-test
obtained	O
on	O
admission	O
was	O
additionally	O
negative	O
.	O

She	O
had	O
three	B-test
views	I-test
of	I-test
the	I-test
cervical	I-test
spine	I-test
that	O
were	O
negative	O
.	O

Chest	B-test
x-ray	I-test
was	O
negative	O
.	O

Pelvis	B-test
film	I-test
was	O
negative	O
.	O

Head	B-test
CT	I-test
from	O
the	O
outside	O
hospital	O
just	O
revealed	O
a	B-problem
small	I-problem
right	I-problem
parietal	I-problem
subdural	I-problem
blood	I-problem
.	O

She	O
was	O
evaluated	O
.	O

Her	O
cervical	O
spine	O
was	O
cleared	O
.	O

She	O
was	O
off	O
TLS	B-treatment
precautions	I-treatment
.	O

She	O
was	O
sent	O
to	O
the	O
Intensive	O
Care	O
Unit	O
for	O
monitoring	O
overnight	O
for	O
neural	B-test
checks	I-test
and	O
neurosurgical	O
consultation	O
was	O
obtained	O
.	O

Neurosurgical	B-test
evaluation	I-test
just	O
recommended	O
serial	B-test
neurologic	I-test
checks	I-test
and	O
a	B-test
repeat	I-test
CAT	I-test
scan	I-test
on	O
the	O
second	O
day	O
of	O
admission	O
to	O
see	O
if	O
there	O
was	O
any	O
evidence	O
of	O
progression	O
of	O
the	B-problem
bleeding	I-problem
.	O

On	O
2010-02-05	O
,	O
the	O
patient	O
had	O
a	B-test
repeat	I-test
CAT	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
revealing	O
no	O
change	B-problem
in	I-problem
the	I-problem
subdural	I-problem
bleed	I-problem
.	O

Her	B-test
neurologic	I-test
examination	I-test
remained	O
nonfocal	O
.	O

She	O
was	O
kept	O
in	O
the	O
hospital	O
for	O
an	O
additional	O
24	O
hours	O
for	O
further	B-test
evaluation	I-test
.	O

By	O
2010-02-06	O
,	O
which	O
would	O
correlate	O
with	O
hospital	O
day	O
number	O
two	O
,	O
the	O
patient	O
had	O
no	O
complaints	O
except	O
for	O
some	B-problem
small	I-problem
frontal	I-problem
pressure	I-problem
in	O
the	O
region	O
of	O
where	O
the	B-problem
bleed	I-problem
had	O
been	O
localized	O
on	O
the	O
right	O
side	O
.	O

She	O
remained	O
afebrile	B-problem
and	O
hemodynamically	O
.	O

She	O
was	O
tolerating	O
diet	O
and	O
able	O
to	O
ambulate	O
without	O
difficulty	O
.	O

She	O
had	O
no	O
other	O
complaints	O
by	O
examination	B-test
.	O

Her	B-test
neurologic	I-test
examination	I-test
remained	O
completely	O
nonfocal	O
and	O
otherwise	O
normal	O
.	O

She	O
was	O
seen	O
by	O
the	O
trauma	O
attending	O
with	O
Dr.	O
Walters	O
and	O
she	O
was	O
cleared	O
for	O
discharge	O
to	O
home	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Tylenol	B-treatment
#3	I-treatment
one	O
to	O
two	O
tablets	O
p.o.	O
q	O
4-6	O
hours	O
p.r.n.	O

2.	O
Motrin	B-treatment
as	O
needed	O
.	O

3.	O
Prozac	B-treatment
20	O
mg	O
p.o.	O
once	O
daily	O
.	O

4.	O
Tetracycline	B-treatment
which	O
she	O
was	O
taking	O
for	O
her	B-problem
acne	I-problem
.	O

FOLLOW-UP	O
:	O

She	O
will	O
follow-up	O
with	O
Dr.	O
Langley	O
in	O
approximately	O
one	O
month	O
.	O

Her	O
trauma	O
clinic	O
follow-up	O
is	O
strictly	O
p.r.n.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Right	B-problem
parietal	I-problem
subdural	I-problem
bleed	I-problem
,	O
status	O
post	O
fall	O
from	O
standing	O
position	O
with	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
and	O
no	O
neurologic	B-problem
deficits	I-problem
or	O
progression	B-problem
.	O

2.	O
Depression	B-problem
.	O

3.	O
Acne	B-problem
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
.	O

Charles	O
I.	O
.	O
Sanders	O
,	O
M.D.	O
76-364	O

Dictated	O
By	O
:	O
Hayden	O
Y.	O
Ferguson	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2010-02-06	O
08:59	O

T	O
:	O
2010-02-06	O
09:10	O

JOB	O
#:	O
73118	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Theresa	O
MOORMAN	O
on	O
:	O
FRI	O
2010-02-26	O
3:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

186890029	O
PAD-WORD	O

SH	O
PAD-WORD	O

58809909	O
PAD-WORD	O

1/5/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/05/1994	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/25/1994	O
PAD-WORD	O

PRINCIPLE	O
DIAGNOSIS	O
:	O

METASTATIC	B-problem
ADENOCARCINOMA	I-problem
OF	I-problem
THE	I-problem
BREAST	I-problem
.	O

OTHER	O
PROBLEMS	O
:	O

1.	O
HYPONATREMIA	B-problem
,	O
1-13-94	O
.	O

2.	O
PULMONARY	B-problem
EMBOLUS	I-problem
,	O
1-14-94	O
.	O

3.	O
DIARRHEA	B-problem
,	O
NAUSEA	B-problem
AND	O
VOMITING	B-problem
,	O
FEVER	B-problem
.	O

4.	O
HISTORY	O
OF	O
OVARIAN	B-treatment
CYST	I-treatment
RESECTION	I-treatment
,	O
1975	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49	O
year	O
old	O
woman	O
with	O
a	B-problem
metastatic	I-problem
adenocarcinoma	I-problem
of	I-problem
the	I-problem
breast	I-problem
who	O
is	O
status	O
post	O
high	B-treatment
dose	I-treatment
chemotherapy	I-treatment
with	O
PBSE	B-treatment
and	O
CCSS	B-treatment
support	I-treatment
ending	O
June	O
1994	O
.	O

She	O
was	O
admitted	O
on	O
1-5-94	O
for	O
fever	B-problem
,	O
chest	B-problem
wall	I-problem
ulceration	I-problem
,	O
cellulitis	B-problem
and	O
pain	B-treatment
control	I-treatment
.	O

The	O
patient	O
first	O
presented	O
in	O
October	O
1991	O
with	O
a	B-problem
tender	I-problem
right	I-problem
axillary	I-problem
mass	I-problem
.	O

A	B-test
mammogram	I-test
done	O
in	O
November	O
1990	O
was	O
negative	O
.	O

However	O
,	O
mammography	B-test
repeated	O
in	O
October	O
1991	O
showed	O
bilateral	B-problem
breast	I-problem
masses	I-problem
,	O
suspicious	O
for	O
carcinoma	B-problem
.	O

Fine	B-test
needle	I-test
aspiration	I-test
on	O
October	O
23	O
,	O
1991	O
demonstrated	O
atypical	B-problem
cells	I-problem
which	O
occurred	O
singly	O
and	O
in	O
clusters	O
.	O

Staging	B-test
evaluation	I-test
included	O
normal	O
liver	O
function	O
tests	O
,	O
normal	O
blood	O
counts	O
and	O
normal	O
chest	O
x-ray	O
.	O

Bone	B-test
scan	I-test
showed	O
degenerative	B-problem
joint	I-problem
disease	I-problem
in	I-problem
the	I-problem
shoulders	I-problem
and	I-problem
lumbar	I-problem
spine	I-problem
as	O
well	O
as	O
increased	B-problem
radio	I-problem
chaser	I-problem
uptake	I-problem
in	I-problem
the	I-problem
breast	I-problem
bilaterally	I-problem
.	O

Dr.	O
Berca	O
Gachfrum	O
performed	O
a	B-treatment
right	I-treatment
modified	I-treatment
mastectomy	I-treatment
and	O
left	B-treatment
simple	I-treatment
mastectomy	I-treatment
on	O
November	O
4	O
,	O
1991	O
.	O

The	B-treatment
right	I-treatment
modified	I-treatment
radical	I-treatment
mastectomy	I-treatment
contained	O
a	B-problem
5.5	I-problem
cm	I-problem
poorly	I-problem
differentiated	I-problem
,	I-problem
Grade	I-problem
III	I-problem
out	I-problem
of	I-problem
III	I-problem
infiltrating	I-problem
ductal	I-problem
carcinoma	I-problem
.	O

The	O
margins	O
were	O
free	O
of	O
tumor	B-problem
,	O
but	O
10	O
out	O
of	O
21	O
lymph	O
nodes	O
were	O
positive	O
for	O
metastatic	B-problem
carcinoma	I-problem
.	O

Furthermore	O
there	O
was	O
a	B-problem
mass	I-problem
on	I-problem
the	I-problem
right	I-problem
pectoralis	I-problem
muscle	I-problem
which	O
is	O
supposed	O
to	O
be	O
metastatic	B-problem
cancer	I-problem
.	O

The	B-treatment
left	I-treatment
simple	I-treatment
mastectomy	I-treatment
also	O
contained	O
5.5	B-problem
cm	I-problem
poorly	I-problem
differentiated	I-problem
infiltrating	I-problem
ductal	I-problem
and	I-problem
intraductal	I-problem
carcinoma	I-problem
with	O
extensive	B-problem
lymphatic	I-problem
vessel	I-problem
invasion	I-problem
.	O

Estrogen	B-test
receptor	I-test
was	O
0%	O
by	O
ERICA	O
.	O

The	O
patient	O
developed	O
a	B-problem
large	I-problem
hematoma	I-problem
requiring	O
surgical	B-treatment
drainage	I-treatment
.	O

Therefore	O
she	O
had	O
a	B-problem
Stage	I-problem
III-A	I-problem
adenocarcinoma	I-problem
of	I-problem
the	I-problem
breast	I-problem
.	O

Since	O
she	O
was	O
at	O
high	O
risk	O
for	O
both	O
local	B-problem
and	I-problem
metastatic	I-problem
recurrence	I-problem
of	O
her	B-problem
tumor	I-problem
,	O
she	O
received	O
both	O
systemic	B-treatment
chemotherapy	I-treatment
and	O
radiation	B-treatment
therapy	I-treatment
.	O

The	O
patient	O
was	O
treated	O
with	O
CMSAP	B-treatment
,	O
which	O
is	O
Cytoxan	B-treatment
,	O
Methotrexate	B-treatment
,	O
Leukovoranrescue	B-treatment
,	O
5-FU	B-treatment
,	O
Adriamycin	B-treatment
and	O
Prednisone	B-treatment
for	O
four	O
cycles	O
.	O

There	O
were	O
no	O
dose	O
reductions	O
for	O
mucositis	B-problem
or	O
myelosuppression	B-problem
.	O

However	O
,	O
following	O
cycle	O
4	O
,	O
she	O
developed	O
a	B-problem
flu-like	I-problem
illness	I-problem
,	O
followed	O
by	O
fever	B-problem
,	O
nonproductive	B-problem
cough	I-problem
and	O
dyspnea	B-problem
on	O
exertion	O
.	O

ABGs	B-test
showed	O
a	B-test
pO2	I-test
of	O
79	O
,	O
pH	B-test
7.44	O
,	O
pO2	B-test
33	O
.	O

Chest	B-test
x-ray	I-test
showed	O
diffuse	B-problem
interstitial	I-problem
infiltrates	I-problem
.	O

The	O
differential	O
diagnosis	O
included	O
viral	B-problem
pneumonitis	I-problem
,	O
Mycoplasma	B-problem
,	O
Chlamydia	B-problem
.	O

Basically	O
in	O
December	O
1993	O
,	O
she	O
returned	O
to	O
the	O
Hem	O
/	O
Onc	O
Clinic	O
with	O
chest	B-problem
wall	I-problem
nodules	I-problem
which	O
turned	O
out	O
to	O
be	O
tumor	B-problem
recurrences	I-problem
and	O
biopsied	O
.	O

Although	O
she	O
had	O
mediastinal	B-problem
recurrence	I-problem
,	O
bone	B-test
scan	I-test
,	O
head	B-test
and	I-test
liver	I-test
CT	I-test
were	O
negative	O
for	O
metastatic	B-problem
disease	I-problem
.	O

She	O
was	O
thus	O
started	O
on	O
a	O
Protocol	O
of	O
high	B-treatment
dose	I-treatment
chemotherapy	I-treatment
with	O
GCSF	B-treatment
and	O
peripheral	B-treatment
stem	I-treatment
cell	I-treatment
support	I-treatment
.	O

Complications	B-problem
has	O
mainly	O
included	O
myelosuppression	B-problem
and	O
mucositis	B-problem
.	O

She	O
also	O
developed	O
Klebsiella	B-problem
UTI	I-problem
after	O
the	O
second	O
cycle	O
of	O
high	B-treatment
dose	I-treatment
chemotherapy	I-treatment
.	O

It	O
was	O
treated	O
with	O
gent	B-treatment
and	O
Cipro	B-treatment
.	O

Re-staging	B-test
done	O
in	O
April	O
1993	O
showed	O
a	B-problem
decrease	I-problem
in	I-problem
the	I-problem
pretracheal	I-problem
nodes	I-problem
with	O
question	O
of	O
some	B-problem
lymphangitic	I-problem
spread	I-problem
versus	O
some	B-problem
pneumonitis	I-problem
.	O

In	O
May	O
1994	O
she	O
received	O
her	O
first	O
course	O
of	O
thiotepa	B-treatment
and	O
Velban	B-treatment
and	O
Methotrexate	B-treatment
,	O
which	O
required	O
some	B-treatment
red	I-treatment
cell	I-treatment
transfusions	I-treatment
.	O

In	O
mid	O
May	O
she	O
was	O
admitted	O
for	O
fever	B-problem
and	O
neutropenia	B-problem
and	O
at	O
that	O
time	O
had	O
a	B-problem
UTI	I-problem
with	O
blood	B-problem
clots	I-problem
in	I-problem
the	I-problem
urine	I-problem
.	O

The	O
patient	O
presents	O
today	O
with	O
complaints	O
of	O
fever	B-problem
and	O
a	B-test
temperature	I-test
of	O
100	O
.	O

She	O
has	O
also	O
been	O
having	O
diarrhea	B-problem
since	O
November	O
and	O
her	O
other	O
complaints	O
of	O
admission	O
include	O
confusion	B-problem
,	O
nausea	B-problem
and	O
vomiting	B-problem
.	O

We	O
will	O
include	O
a	O
very	O
thorough	O
HPI	O
with	O
this	O
dictation	O
that	O
was	O
done	O
by	O
Dr.	O
Wedleung	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
metastatic	B-problem
breast	I-problem
cancer	I-problem
,	O
complicated	O
by	O
fever	B-problem
and	O
neutropenia	B-problem
.	O

UTIs	B-problem
,	O
obstruction	B-problem
of	I-problem
the	I-problem
right	I-problem
subclavian	I-problem
vein	I-problem
and	I-problem
right	I-problem
brachial	I-problem
cephalic	I-problem
vein	I-problem
,	O
herpes	B-problem
zoster	I-problem
.	O

Status	O
post	O
ovarian	B-treatment
cyst	I-treatment
resection	I-treatment
in	O
1975	O
.	O

She	O
had	O
menarche	O
at	O
age	O
15	O
.	O

She	O
used	O
the	B-treatment
pill	I-treatment
for	O
five	O
years	O
in	O
the	O
past	O
.	O

She	O
is	O
G	O
2	O
,	O
P	O
2	O
with	O
spontaneous	B-treatment
vaginal	I-treatment
deliveries	I-treatment
.	O

She	O
has	O
a	O
history	O
of	O
easy	B-problem
bruis	I-problem
ability	I-problem
.	O

She	O
is	O
allergic	B-problem
to	O
Augmentin	B-treatment
which	O
gives	O
her	O
a	B-problem
rash	I-problem
.	O

MEDICATIONS	O
:	O

MS	B-treatment
Contin	I-treatment
,	O
MSIR	B-treatment
,	O
and	O
Percocet	B-treatment
.	I-treatment

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

SOCIAL	O
HISTORY	O
:	O

Married	O
with	O
two	O
children	O
.	O

She	O
worked	O
as	O
an	O
occupational	O
therapist	O
at	O
a	O
professional	O
center	O
for	O
handicapped	O
children	O
.	O

She	O
denies	O
tobacco	O
and	O
drug	O
use	O
and	O
drinks	O
ethanol	O
socially	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

A	O
cachectic	O
white	O
female	O
.	O

T	B-test
100.1	O
,	O
P	B-test
104	O
,	O
blood	B-test
pressure	I-test
130/90	O
,	O
heart	B-test
rate	I-test
of	O
16	O
,	O
she	O
was	O
sating	B-test
95%	O
on	O
room	O
air	O
.	O

HEENT	O
-	O
Pupils	O
were	O
miotic	B-problem
,	O
measuring	O
2	O
mm	O
but	O
responsive	O
to	O
light	O
.	O

Neck	O
-	O
Tender	B-problem
on	O
the	O
leftside	O
with	O
no	O
lymphadenopathy	B-problem
or	O
thyromegaly	B-problem
.	O

Lungs	O
were	O
clear	O
.	O

Chest	O
actually	O
had	O
a	B-problem
5	I-problem
x	I-problem
7	I-problem
cm	I-problem
necrotic	I-problem
area	I-problem
on	O
the	O
left	O
chest	O
wall	O
with	O
some	B-problem
pus	I-problem
.	O

Cardiovascular	O
-	O
Normal	O
.	O

Abdomen	O
-	O
Normal	O
.	O

There	O
was	O
no	O
HSM	B-problem
.	O

Extremities	O
-	O
Her	O
left	O
arm	O
was	O
very	B-problem
swollen	I-problem
.	O

It	O
was	O
tested	O
with	O
no	B-problem
voluntary	I-problem
movement	I-problem
except	O
at	O
the	O
finger	O
tips	O
.	O

There	O
was	O
no	O
edema	B-problem
elsewhere	O
in	O
her	O
extremities	O
,	O
only	O
the	O
left	O
arm	O
.	O

Neuro	O
-	O
The	O
patient	O
was	O
oriented	O
to	O
place	O
,	O
but	O
had	O
difficulty	B-problem
with	I-problem
recent	I-problem
memory	I-problem
.	O

She	O
also	O
had	O
mild	B-problem
weakness	I-problem
in	I-problem
the	I-problem
left	I-problem
extremities	I-problem
,	O
both	O
upper	O
and	O
lower	O
.	O

Cranial	O
nerves	O
II	O
-	O
XII	O
were	O
grossly	O
intact	O
.	O

Toes	O
were	O
downgoing	O
.	O

LABORATORY	O
DATA	O
:	O

Of	O
note	O
-	O
Na	B-test
133	O
,	O
K	B-test
4	O
,	O
WBC	B-test
8.82	O
,	O
hematocrit	B-test
35.1	O
,	O
platelets	B-test
229	O
.	O

PT	B-test
13.8	O
with	O
an	B-test
INR	I-test
of	O
1.3	O
,	O
PTT	B-test
25.5	O
,	O
total	B-test
protein	I-test
was	O
6.2	O
,	O
albumin	B-test
3.4	O
,	O
globulin	B-test
of	O
2.8	O
,	O
calcium	B-test
of	O
9.1	O
,	O
phos	B-test
2.7	O
,	O
mag	B-test
2.1	O
,	O
urea	B-test
3.7	O
.	O

ALT	B-test
was	O
elevated	B-problem
at	O
240	O
,	O
AST	B-test
85	O
,	O
LDH	B-test
305	O
,	O
alk	B-test
phos	I-test
85	O
,	O
total	B-test
bilirubin	I-test
was	O
1.3	O
,	O
direct	B-test
bili	I-test
was	O
.8	O
.	O

Cholesterol	B-test
188	O
,	O
triglyceride	B-test
was	O
127	O
.	O

UA	B-test
-	O
trace	B-problem
protein	I-problem
,	O
trace	B-problem
ketones	I-problem
,	O
positive	B-problem
for	I-problem
bilirubin	I-problem
and	I-problem
nitrogen	I-problem
and	O
also	O
4	B-problem
to	I-problem
6	I-problem
wbcs	I-problem
with	O
1+	B-problem
bacteria	I-problem
.	O

Chest	B-test
x-ray	I-test
-	O
Showed	O
a	B-problem
left	I-problem
paratracheal	I-problem
adenopathy	I-problem
and	O
small	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
with	O
no	O
evidence	O
of	O
pneumonia	B-problem
.	O

In	O
summary	O
,	O
the	O
patient	O
is	O
a	O
49	O
year	O
old	O
woman	O
with	O
metastatic	B-problem
breast	I-problem
cell	I-problem
CA	I-problem
,	O
status	O
post	O
chemotherapy	B-treatment
with	O
CMSAP	B-treatment
and	O
PVSC	B-treatment
and	O
XRT	B-treatment
who	O
presented	O
with	O
fever	B-problem
,	O
four	O
days	O
of	O
diarrhea	B-problem
,	O
nausea	B-problem
and	O
vomiting	B-problem
and	O
had	O
been	O
on	O
Keflex	B-treatment
for	O
an	B-problem
erythema	I-problem
on	I-problem
her	I-problem
left	I-problem
chest	I-problem
wall	I-problem
.	O

The	B-treatment
Keflex	I-treatment
was	O
stopped	O
when	O
she	O
developed	O
the	B-problem
diarrhea	I-problem
.	O

When	O
she	O
arrived	O
the	O
plan	O
was	O
to	O
go	O
ahead	O
and	O
treat	O
here	B-problem
rythematous	I-problem
induration	I-problem
and	O
possible	O
cellulitis	B-problem
with	O
IV	B-treatment
antibiotics	I-treatment
.	O

So	O
she	O
was	O
put	O
on	O
dicloxicillin	B-treatment
and	O
we	O
did	O
local	B-treatment
wound	I-treatment
care	I-treatment
with	O
an	B-treatment
agent	I-treatment
called	O
Santyl	B-treatment
,	O
which	O
is	O
a	B-treatment
collagenace	I-treatment
ondebrided	I-treatment
which	O
worked	O
very	O
well	O
for	O
her	O
.	O

Also	O
at	O
the	O
time	O
of	O
admission	O
we	O
were	O
also	O
considering	O
palliative	B-treatment
Taxol	I-treatment
chemotherapy	I-treatment
,	O
which	O
the	O
patient	O
declined	O
.	O

She	O
refused	O
the	B-treatment
Taxol	I-treatment
therapy	I-treatment
so	O
that	O
was	O
not	O
done	O
.	O

Another	O
major	O
issue	O
with	O
this	O
patient	O
was	O
pain	B-treatment
control	I-treatment
.	O

She	O
had	O
been	O
in	O
a	O
whole	O
lot	O
of	O
pain	B-problem
from	O
her	B-problem
left	I-problem
arm	I-problem
lesion	I-problem
.	O

So	O
pain	B-treatment
control	I-treatment
was	O
a	O
big	O
issue	O
so	O
she	O
was	O
on	O
MS	B-treatment
Contin	I-treatment
and	O
MSIR	B-treatment
at	O
home	O
she	O
thought	O
that	O
clouded	O
her	O
thinking	O
,	O
so	O
we	O
tried	O
different	O
things	O
for	O
pain	B-treatment
management	I-treatment
.	O

One	O
of	O
them	O
was	O
to	O
do	O
a	B-treatment
subarachnoid	I-treatment
neurologic	I-treatment
block	I-treatment
at	I-treatment
C6-C7	I-treatment
interface	I-treatment
on	O
1-6-94	O
.	O

After	O
that	O
the	O
patient	O
had	O
minimal	O
relief	O
of	O
pain	B-problem
.	O

However	O
,	O
she	O
declined	O
further	B-treatment
blocks	I-treatment
,	O
which	O
were	O
offered	O
to	O
her	O
.	O

So	O
accepted	O
to	O
be	O
on	O
dilaudid	B-treatment
p.o.	I-treatment
which	O
was	O
started	O
at	O
a	O
dosage	O
of	O
2-4	O
meg	O
but	O
since	O
then	O
we	O
have	O
tapered	O
it	O
up	O
.	O

She	O
is	O
now	O
getting	O
dilaudid	B-treatment
8	O
mg	O
q2h	O
and	O
in	O
addition	O
she	O
has	O
been	O
on	O
fentanyl	B-treatment
patch	I-treatment
.	O

She	O
is	O
now	O
getting	O
75	O
micrograms	O
per	O
hour	O
of	O
the	B-treatment
fentanyl	I-treatment
patch	I-treatment
which	O
is	O
changed	O
every	O
72	O
hours	O
.	O

We	O
can	O
go	O
up	O
by	O
25	O
mg	O
on	O
the	B-treatment
fentanyl	I-treatment
patch	I-treatment
as	O
needed	O
to	O
control	O
her	B-problem
pain	I-problem
and	O
we	O
can	O
always	O
go	O
up	O
on	O
the	B-treatment
dilaudid	I-treatment
because	O
she	O
is	O
still	O
in	O
considerable	O
amount	O
of	O
pain	B-problem
.	O

Other	O
things	O
that	O
happened	O
during	O
this	O
admission	O
-	O
we	O
obtained	O
ahead	B-test
CT	I-test
for	O
her	O
on	O
the	O
8th	O
of	O
January	O
because	O
of	O
her	B-problem
clouded	I-problem
thinking	I-problem
and	O
altered	B-problem
mental	I-problem
status	I-problem
,	O
which	O
was	O
probably	O
due	O
to	O
the	B-treatment
morphine	I-treatment
that	O
she	O
was	O
taking	O
.	O

We	O
went	O
ahead	O
and	O
got	O
a	B-test
head	I-test
CT	I-test
scanand	O
it	O
showed	O
no	O
enhancing	B-problem
lesions	I-problem
.	O

In	O
addition	O
her	B-test
liver	I-test
transaminases	I-test
were	O
elevated	B-problem
,	O
we	O
thought	O
about	O
doing	O
further	B-test
work-up	I-test
,	O
but	O
that	O
was	O
deferred	O
because	O
the	O
patient	O
wanted	O
to	O
wait	O
on	O
that	O
.	O

That	O
has	O
been	O
stable	O
.	O

The	O
patient	O
on	O
January	O
13	O
became	O
hyponatremic	B-problem
.	O

Her	B-test
sodium	I-test
went	O
down	O
to	O
121	O
and	O
before	O
that	O
on	O
admission	O
she	O
was	O
133	O
.	O

A	O
renal	O
consult	O
was	O
obtained	O
and	O
their	B-test
assessment	I-test
was	O
that	O
this	O
was	O
probably	O
a	O
mixture	O
of	O
hypovolemia	B-problem
as	O
well	O
as	O
SIADH	B-problem
.	O

We	O
proceeded	O
to	O
do	O
for	O
her	B-problem
hyponatremia	I-problem
-	O
we	O
gave	O
her	O
some	B-treatment
fluid	I-treatment
and	O
her	B-test
urine	I-test
sodium	I-test
became	O
higher	O
than	O
her	B-test
serum	I-test
sodium	I-test
;	O
we	O
stopped	O
it	O
.	O

We	O
had	O
given	O
her	O
some	B-treatment
normal	I-treatment
saline	I-treatment
and	O
then	O
we	O
proceeded	O
to	O
just	O
do	O
fluid	B-treatment
restriction	I-treatment
.	O

In	O
addition	O
we	O
gave	O
her	O
a	B-treatment
sodium	I-treatment
chloride	I-treatment
one	O
gram	O
per	O
day	O
and	O
that	O
also	O
helped	O
,	O
so	O
that	O
now	O
at	O
the	O
time	O
of	O
discharge	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
sodium	I-test
is	O
between	O
126	O
and	O
129	O
;	O
prior	O
to	O
that	O
it	O
had	O
gone	O
down	O
to	O
as	O
low	O
116.	O

So	O
that	O
has	O
really	O
improved	O
.	O

We	O
suggest	O
continuing	O
increased	B-treatment
salt	I-treatment
intake	I-treatment
in	O
her	O
diet	O
and	O
also	O
continuing	O
with	O
the	B-treatment
fluid	I-treatment
restriction	I-treatment
of	I-treatment
free	I-treatment
water	I-treatment
intake	I-treatment
to	O
one	O
liter	O
per	O
day	O
.	O

On	O
the	O
14th	O
of	O
January	O
,	O
the	O
patient	O
developed	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
chest	B-test
x-ray	I-test
was	O
taken	O
showed	O
a	B-problem
wedge	I-problem
shaped	I-problem
infiltrate	I-problem
in	I-problem
the	I-problem
right	I-problem
upper	I-problem
lobe	I-problem
which	O
was	O
consistent	O
with	O
Hampton	B-problem
&apos;s	I-problem
hump	I-problem
.	O

Also	O
a	B-test
VQ	I-test
scan	I-test
obtained	O
the	O
next	O
day	O
showed	O
high	O
probability	O
for	O
PE	B-problem
.	O

So	O
we	O
proceeded	O
to	O
put	O
her	O
on	O
heparin	B-treatment
for	O
anticoagulation	B-treatment
and	O
then	O
when	O
she	O
was	O
therapeutic	O
on	O
heparin	B-treatment
,	O
we	O
went	O
ahead	O
and	O
started	O
her	O
on	O
coumadin	B-treatment
and	O
she	O
is	O
currently	O
on	O
coumadin	B-treatment
at	O
2.5	O
mg	O
q.h.s.	O

Her	B-test
INR	I-test
is	O
2.3	O
.	O

We	O
want	O
her	B-test
INR	I-test
to	O
remain	O
between	O
2	O
and	O
3	O
.	O

So	O
if	O
it	O
goes	O
much	O
lower	O
than	O
2	O
,	O
then	O
we	O
would	O
consider	O
increasing	O
it	O
to	O
perhaps	O
coumadin	B-treatment
2.5	O
and	O
5	O
alternating	O
every	O
other	O
night	O
.	O

However	O
,	O
we	O
would	O
leave	O
it	O
at	O
2.5	O
for	O
now	O
.	O

Other	O
major	O
issues	O
-	O
As	O
a	O
result	O
of	O
all	O
the	O
things	O
happened	O
and	O
with	O
her	B-problem
hyponatremia	I-problem
and	O
also	O
the	B-problem
other	I-problem
problems	I-problem
,	O
her	B-test
blood	I-test
pressure	I-test
was	O
elevated	B-problem
also	O
.	O

We	O
put	O
her	O
on	O
nifedipine	B-treatment
IR	I-treatment
,	O
SL	O
and	O
that	O
was	O
not	O
enough	O
to	O
control	O
her	B-test
blood	I-test
pressure	I-test
which	O
was	O
in	O
the	O
200s	O
in	O
the	B-test
systolic	I-test
,	O
so	O
we	O
had	O
started	O
her	O
on	O
atenolol	B-treatment
.	O

So	O
on	O
discharge	O
she	O
is	O
on	O
atenolol	B-treatment
100	O
.	O

If	O
needed	O
to	O
you	O
can	O
give	O
her	O
some	B-treatment
nifedipine	I-treatment
SL	I-treatment
to	O
decrease	O
her	B-test
blood	I-test
pressure	I-test
.	O

The	O
patient	O
also	O
has	O
significant	B-problem
edema	I-problem
in	I-problem
both	I-problem
arms	I-problem
now	O
and	O
also	O
some	B-problem
mild	I-problem
edema	I-problem
in	I-problem
the	I-problem
lower	I-problem
extremities	I-problem
,	O
so	O
I	O
think	O
that	O
fluid	B-treatment
restriction	I-treatment
should	O
help	O
with	O
that	O
.	O

She	O
is	O
also	O
a	B-problem
little	I-problem
dry	I-problem
.	O

The	O
patient	O
is	O
on	O
oxygen	B-treatment
.	O

Ever	O
since	O
the	B-problem
pulmonary	I-problem
embolus	I-problem
she	O
has	O
been	O
on	O
oxygen	B-treatment
.	O

She	O
was	O
on	O
4	B-treatment
liters	I-treatment
;	O
now	O
she	O
is	O
on	O
5	B-treatment
liters	I-treatment
,	O
sating	B-test
94	O
to	O
96%	O
on	O
5	B-treatment
liters	I-treatment
.	O

We	O
would	O
like	O
for	O
her	O
to	O
remain	O
on	O
the	B-treatment
oxygen	I-treatment
as	O
well	O
.	O

The	B-problem
complications	I-problem
that	O
I	O
have	O
listed	O
include	O
the	B-problem
hyponatremia	I-problem
,	O
pulmonary	B-problem
embolus	I-problem
and	O
also	O
the	B-problem
elevatd	I-problem
blood	I-problem
pressure	I-problem
.	O

DISPOSITION	O
:	O

Discharge	B-treatment
medications	I-treatment
-	O
Baclofen	B-treatment
10	O
p.o.	O
t.i.d.	O
,	O
MVI	B-treatment
one	O
tablet	O
p.o.	O
q.d.	O
,	O
Mycostatin	B-treatment
powder	I-treatment
TP	I-treatment
q.d.	O
to	O
be	O
applied	O
to	O
the	B-problem
rash	I-problem
in	I-problem
her	I-problem
left	I-problem
groin	I-problem
area	I-problem
,	O
also	O
dilaudid	B-treatment
8	O
mg	O
p.o.	O
q2h	O
,	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O
,	O
coumadin	B-treatment
2.5	O
mg	O
p.o.	O
q.h.s.	O
fentanyl	B-treatment
patch	I-treatment
75	O
micrograms	O
per	O
hour	O
topical	O
q72	O
hours	O
,	O
atenolol	B-treatment
100	O
mg	O
p.o.	O
q.d.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Fair	O
.	O

She	O
remains	O
very	B-problem
weak	I-problem
and	O
will	O
most	O
likely	O
benefit	O
from	O
some	B-treatment
physical	I-treatment
therapy	I-treatment
andshe	O
still	O
has	O
the	B-problem
bilateral	I-problem
edema	I-problem
.	O

She	O
is	O
to	O
go	O
to	O
the	O
Necsoncardel	O
Medical	O
Center	O
for	O
more	B-treatment
chronic	I-treatment
care	I-treatment
.	O

Follow-up	O
is	O
with	O
Dr.	O
Wedleung	O
in	O
the	O
Hem	O
/	O
Onc	O
in	O
two	O
weeks	O
.	O

The	O
appointment	O
has	O
already	O
been	O
made	O
.	O

The	O
patient	O
is	O
very	O
limited	O
in	O
how	O
much	O
she	O
can	O
do	O
right	O
now	O
because	O
of	O
her	B-problem
pain	I-problem
primarily	O
and	O
her	B-problem
difficulty	I-problem
breathing	I-problem
.	O

Dictated	O
By	O
:	O

JEABRIHARL	O
FIGEFREIERMFOTHGRENDCAJAQUE	O
,	O
M.D.	O

Attending	O
:	O

LA	O
INEMACISTIN	O
PRONTMANDES	O
,	O
M.D.	O
HD45	O
SY882/1177	O

Batch	O
:	O

020	O
PAD-WORD	O

Index	O
No.	O

YJQI3J9VU6	O
PAD-WORD	O

D	O
:	O

01/25/94	O
PAD-WORD	O

T	O
:	O

01/25/94	O
PAD-WORD	O

Admission	O
Date	O
:	O

2014-04-19	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-04-20	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2014-04-19	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
CSRU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Baby	O
Thomas	O
Moss	O
was	O
born	O
at	O
39	O
and	O
1/2	O
weeks	O
gestation	O
to	O
a	O
20-year-old	O
gravida	O
IV	O
,	O
para	O
III	O
,	O
now	O
IV	O
woman	O
.	O

The	B-test
mother	I-test
's	I-test
prenatal	I-test
screens	I-test
were	O
blood	B-test
type	I-test
B	O
positive	O
,	O
antibody	B-test
negative	O
,	O
rubella	B-test
immune	O
,	O
RPR	B-test
nonreactive	O
,	O
hepatitis	B-test
surface	I-test
antigen	I-test
negative	O
and	O
group	B-test
B	I-test
strep	I-test
negative	O
.	O

This	O
pregnancy	O
was	O
complicated	O
by	O
a	O
prenatal	O
diagnosis	O
of	O
a	B-problem
congenital	I-problem
cystic	I-problem
adenomatoid	I-problem
malformation	I-problem

(	O
CCAM	B-problem
).	O

The	O
mother	O
was	O
followed	O
in	O
the	O
Massachusetts	O
General	O
Hospital	O
Advanced	O
Fetal	O
Care	O
Center	O
and	O
was	O
followed	O
by	O
Dr.	O
Ralph	O
Wilson	O
.	O

The	O
mother	O
had	O
spontaneous	O
onset	O
of	O
labor	O
and	O
progressed	O
to	O
a	O
spontaneous	O
vaginal	O
delivery	O
.	O

The	O
infant	O
emerged	O
vigorous	O
with	O
Apgars	B-test
of	O
9	O
at	O
one	O
and	O
five	O
minutes	O
.	O

His	B-test
birth	I-test
weight	I-test
was	O
2905	O
grams	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Wt	B-test
2905	O
gm	O

Length	B-test
19	O
inches	O

HC	B-test
34.5	O
cm	O

His	B-test
admission	I-test
physical	I-test
exam	I-test
reveals	O
a	B-problem
vigorous	I-problem
nondysmorphic	I-problem
term	O
infant	O
.	O

Anterior	O
fontanelle	O
open	O
and	O
flat	O
.	O

Palate	O
intact	O
.	O

Red	B-test
reflex	I-test
not	O
checked	O
.	O

Neck	O
supple	O
and	O
without	O
masses	B-problem
.	O

Clavicles	O
intact	O
.	O

Lungs	O
clear	O
bilaterally	O
with	O
slightly	B-problem
decreased	I-problem
breath	I-problem
sounds	I-problem
on	I-problem
the	I-problem
right	I-problem
but	O
symmetric	O
chest	O
rise	O
and	O
fall	O
.	O

Heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
.	O

Femoral	B-test
pulses	I-test
present	O
bilaterally	O
.	O

Abdomen	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
active	O
bowel	O
sounds	O
.	O

Normal	O
male	O
genitalia	O
,	O
testes	O
descended	O
bilaterally	O
.	O

No	O
sacral	B-problem
anomalies	I-problem
.	O

Stable	O
hips	O
.	O

Patent	O
anus	O
.	O

Age	O
appropriate	O
tone	O
and	O
reflexes	O
.	O

CMED	O
CCU	O
:	O

By	O
systems	O
:	O

Respiratory	O
status	O
:	O

He	O
has	O
remained	O
in	O
room	O
air	O
well	O
saturated	O
with	O
comfortable	O
respirations	O
until	O
approximately	O
22	O
hours	O
of	O
age	O
when	O
he	O
started	O
with	O
increased	B-problem
work	I-problem
of	I-problem
breathing	I-problem
although	O
he	O
has	O
remained	O
well-saturated	O
in	O
room	O
air	O
.	O

His	B-test
chest	I-test
x-ray	I-test
was	O
initially	O
remarkable	O
for	O
some	B-problem
mediastinal	I-problem
shift	I-problem
due	O
to	O
the	B-problem
right-sided	I-problem
lesion	I-problem
with	O
increasing	B-problem
shift	I-problem
present	O
on	O
the	B-test
last	I-test
x-ray	I-test
.	O

Cardiovascular	O
status	O
:	O

He	O
has	O
remained	O
normotensive	O
throughout	O
his	O
CMED	O
stay	O
.	O

There	O
are	O
no	O
cardiovascular	B-problem
issues	I-problem
.	O

Fluid	O
,	O
electrolytes	O
and	O
nutrition	O
status	O
:	O

His	B-test
weight	I-test
at	O
the	O
time	O
of	O
transfer	O
is	O
2800	O
grams	O
.	O

He	O
has	O
been	O
breast	O
feeding	O
or	O
taking	O
20	O
calorie	O
per	O
ounce	O
formula	O
until	O
the	B-problem
increased	I-problem
respiratory	I-problem
distress	I-problem
so	O
that	O
at	O
the	O
time	O
of	O
transfer	O
he	O
is	O
NPO	B-treatment
with	O
a	B-treatment
peripheral	I-treatment
IV	I-treatment
with	O
total	B-treatment
fluids	I-treatment
of	O
150	O
ml	O
/	O
kg	O
/	O
day	O
of	O
10%	B-treatment
dextrose	I-treatment
with	O
electrolytes	B-treatment
.	O

He	O
has	O
had	O
no	O
blood	B-test
work	I-test
except	O
for	O
blood	B-test
glucose	I-test
checks	I-test
and	O
he	O
has	O
been	O
euglycemic	O
throughout	O
his	O
CMED	O
stay	O
with	O
his	B-test
blood	I-test
glucose	I-test
being	O
in	O
the	O
70s	O
.	O

Gastrointestinal	O
status	O
:	O

He	O
has	O
passed	O
meconium	O
stool	O
and	O
is	O
voiding	O
with	O
each	O
diaper	O
change	O
.	O

He	O
has	O
not	O
had	O
a	B-test
bilirubin	I-test
checked	O
.	O

Hematology	O
:	O

He	O
has	O
not	O
had	O
any	B-test
blood	I-test
work	I-test
done	O
.	O

Infectious	O
disease	O
:	O

He	O
has	O
had	O
no	O
antibiotic	B-treatment
therapy	I-treatment
or	O
blood	B-test
cultures	I-test
sent	O
.	O

Sensory	O
:	O

Audiology	O
:	O

Hearing	B-test
screening	I-test
is	O
recommended	O
prior	O
to	O
discharge	O
.	O

It	O
has	O
not	O
been	O
done	O
yet	O
.	O

Psychosocial	O
:	O

The	O
mother	O
has	O
3	O
older	O
children	O
who	O
are	O
alive	O
and	O
well	O
.	O

Her	O
own	O
mother	O
has	O
been	O
with	O
her	O
during	O
this	O
stay	O
.	O

The	O
infant	O
is	O
discharged	O
in	O
guarded	B-problem
condition	I-problem
.	O

He	O
is	O
being	O
transferred	O
to	O
Massachusetts	O
General	O
Hospital	O
Newborn	O
Intensive	O
Care	O
Unit	O
for	O
continuing	B-treatment
care	I-treatment
.	O

His	O
primary	O
pediatric	O
care	O
provider	O
will	O
be	O
Dr.	O
Schrader	O
at	O
Deaconess-Nashoba	O
Hospital	O
.	O

RECOMMENDATIONS	O
AFTER	O
DISCHARGE	O
:	O

1.	O
Feedings	O
:	O

The	O
infant	O
is	O
NPO	B-treatment
.	O

2.	O
He	O
is	O
on	O
peripheral	B-treatment
IV	I-treatment
of	O
total	B-treatment
fluids	I-treatment
150	O
ml	O
/	O
kg	O
/	O
day	O
of	O
10%	O
dextrose	B-treatment
with	O
2	O
mEq	O
of	O
sodium	B-treatment
chloride	I-treatment
per	O
100	O
ml	O
and	O
1	O
mEq	O
of	O
potassium	B-treatment
chloride	I-treatment
per	O
100	O
ml	O
.	O

3.	O
He	O
has	O
not	O
had	O
a	B-test
car	I-test
seat	I-test
position	I-test
screening	I-test
test	I-test
.	O

4.	O
A	B-test
State	I-test
newborn	I-test
screen	I-test
will	O
be	O
done	O
prior	O
to	O
transfer	O
.	O

5.	O
He	O
has	O
received	O
no	O
immunizations	B-treatment
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Term	O
male	O
newborn	O
.	O

2.	O
Right-sided	B-problem
congenital	I-problem
cystic	I-problem
adenomatoid	I-problem
malformation	I-problem
.	O

Kathy	O
Hougland	O
,	O
M.D.	O
50AHB	O

Dictated	O
By	O
:	O
Gina	O
C.K.	O
Brantner	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-04-20	O
07:20:44	O

T	O
:	O
2014-04-20	O
10:08:45	O

Job	O
#:	O
07882	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jaqueline	O
RHEIN	O
on	O
:	O
SUN	O
2014-04-20	O
8:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

190510002	O
PAD-WORD	O

TGCHO	O
PAD-WORD	O

3067319	O
PAD-WORD	O

364639	O
PAD-WORD	O

3/16/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

KOTE	O
,	O
LYFRANKLAPALM	O

MRN	O
:	O

3067319	O
PAD-WORD	O

Age	O
:	O

56y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

03/16/2003	O
05:16	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
KOTE	O
,	O
LYFRANKLAPALM	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Tecal	O
Galecounxopt	O
Community	O
Hospital	O
on	O
03/16/2003	O
05:16	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
INCREASED	B-problem
LETHARGY	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
TECAL	O
GALENCOUNXOPT	O
COMMUNITY	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
SCIMEWHILDAJESC	O
,	O
LA	O
R	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
DEHYDRATION	B-problem
..	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
418-196-2156	O
.	O

PCP	O
Name	O
:	O

NONE	O
,	O
PHYSICIAN	O

Provider	O
Number	O
:	O

75055	O
PAD-WORD	O

Admission	O
Date	O
:	O

2019-03-29	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-04-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1935-12-05	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEUROLOGY	O
PAD-WORD	O

Allergies	O
:	O

Lorazepam	B-treatment
/	O
Penicillins	B-treatment
/	O
Prednisone	B-treatment
/	O
Hydrochlorothiazide	B-treatment
/	O
Ceftriaxone	B-treatment
/	O
Phenytoin	B-treatment

Attending	O
:	O
Derrick	O
Z	O
Wooster	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
progressing	B-problem
slowing	I-problem
of	I-problem
mentation	I-problem
and	O
gait	B-problem
difficulties	I-problem
since	O
a	O
week	O
;	O
evaluation	B-test
for	O
ICH	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

The	O
patient	O
is	O
a	O
83	O
yo	O
R-handed	O
man	O
with	O
a	O
history	O
of	O
multiple	B-problem
intracranial	I-problem
hemorrhages	I-problem
during	O
the	O
last	O
few	O
years	O
,	O
pacemaker	B-treatment
,	O
hyperlipidemia	B-problem
,	O
arrhythmia	B-problem
who	O
now	O
presents	O
with	O
gradual	B-problem
decline	I-problem
in	I-problem
gait	I-problem
and	O
slowing	B-problem
of	I-problem
mentation	I-problem
over	O
the	O
last	O
week	O
.	O

The	O
patient	O
had	O
a	O
fall	O
about	O
ten	O
days	O
ago	O
,	O
when	O
he	O
was	O
walking	O
the	O
dog	O
.	O

The	O
leash	O
got	O
wrapped	O
around	O
his	O
legs	O
.	O

According	O
to	O
his	O
wife	O
he	O
had	O
a	B-problem
small	I-problem
abrasion	I-problem
on	O
the	O
top	O
of	O
his	O
head	O
,	O
but	O
nothing	O
major	O
.	O

He	O
did	O
not	O
complain	O
about	O
a	B-problem
headache	I-problem
.	O

He	O
was	O
at	O
baseline	O
with	O
respect	O
to	O
his	O
gait	O
(	O
at	O
baseline	O
unsteady	B-problem
,	O
though	O
he	O
refuses	O
to	O
walk	O
with	O
a	B-treatment
walker	I-treatment
)	O
and	O
his	O
mentation	O
(	O
at	O
baseline	O
difficulties	B-problem
with	I-problem
memory	I-problem
since	O
months	O
;	O
keeps	O
forgetting	O
appointments	O
).	O

Then	O
about	O
a	O
week	O
ago	O
,	O
the	O
patient	O
and	O
his	O
wife	O
noted	O
that	O
his	O
gait	O
became	O
even	B-problem
more	I-problem
unsteady	I-problem
,	O
though	O
he	O
did	O
not	O
fall	O
.	O

He	O
also	O
had	O
difficulties	B-problem
navigating	O
through	O
his	O
apartment	O
,	O
having	O
difficulties	B-problem
finding	O
the	O
fridge	O
for	O
example	O
.	O

They	O
were	O
concerned	O
that	O
the	O
fall	O
might	O
have	O
caused	O
another	B-problem
bleed	I-problem
,	O
as	O
had	O
happened	O
in	O
the	O
past	O
,	O
and	O
this	O
prompted	O
them	O
to	O
come	O
to	O
the	O
Deanna	O
.	O

No	O
headache	B-problem
,	O
neckpain	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
or	O
focal	B-problem
weakness	I-problem
/	O
numbness	B-problem
.	O

Review	O
of	O
systems	O
:	O
denies	O
any	B-problem
fever	I-problem
,	O
chills	B-problem
,	O
weight	B-problem
loss	I-problem
,	O
visual	B-problem
changes	I-problem
,	O
hearing	B-problem
changes	I-problem
,	O
dysphagia	B-problem
,	O
tingling	B-problem
,	O
numbness	B-problem
,	O
bowel-bladder	B-problem
dysfunction	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
dysuria	B-problem
,	O
hematuria	B-problem
,	O
or	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
.	O

His	O
legs	O
have	O
been	O
feeling	O
weaker	B-problem
,	I-problem
bilaterally	I-problem
since	O
the	O
last	O
week	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Previous	B-problem
interventricular	I-problem
hemorrhages	I-problem
:	O

06-30	O
resolved	O
as	O
of	O
repeat	B-test
head	I-test
CT	I-test
one	O
month	O
later	O
,	O
no	O
residual	B-problem
deficits;	I-problem
03-03	O
:	O
ICH	B-problem
in	I-problem
3rd	I-problem
,	I-problem
4th	I-problem
,	I-problem
and	I-problem
L-lat	I-problem
ventricle	I-problem
;	O
no	O
aneurysm	B-problem
;	O
07-01	O
:	O
ICH	B-problem
in	I-problem
R-temporal	I-problem
lobe	I-problem
;	O
question	O
of	O
underlying	B-problem
mass	I-problem
at	O
that	O
time	O
per	O
contrast	B-test
CT	I-test
;	O
decided	O
to	O
follow	O
up	O
with	O
serial	B-test
scans	I-test
rather	O
than	O
to	O
biopsy	B-test

2.	O
pacemaker	B-treatment
placement	I-treatment
for	O
arrhythmia	B-problem
,	O
Afibb	B-problem
;	O
during	O
last	O
hospitalization	O
episodes	O
of	O
NSVT	B-problem

3.	O
history	O
of	O
slowness	B-problem
of	I-problem
gait	I-problem
,	O
?	O
parkinsons	B-problem
?	O
and	O
possibly	O
dementia	B-problem
followed	O
by	O
Dr.	O
Ahern	O
(	O
Laurence	O
Eichorn	O
).	O

Sinemet	B-treatment
was	O
stopped	O
during	O
last	O
admission	O
06-30	O
as	O
he	O
was	O
thought	O
to	O
NOT	O
have	O
PD	B-problem
.	O

4.	O
Depression	B-problem

5.	O
COPD	B-problem

6.	O
hyperlipidemia	B-problem

7.	O
bilateral	B-treatment
cataract	I-treatment
surgery	I-treatment

8.	O
orthostatic	B-problem
hypotension	I-problem
,	O
on	O
midodrine	B-treatment

Social	O
History	O
:	O

The	O
pt.	O
is	O
married	O
,	O
independent	O
in	O
ADLS	O
,	O
lives	O
with	O
wife	O
in	O
a	O
retirement	O
community	O
.	O

Significant	O
tobacco	O
history	O
x	O
40	O
yrs	O
x	O
1ppd	O
,	O
quit	O
20	O
yrs	O
ago	O
,	O

Reported	O
occassional	O
glass	O
of	O
wine	O
,	O
no	O
illicit	O
drugs	O

He	O
is	O
a	O
retired	O
architect	O
.	O

Wife	O
states	O
that	O
he	O
would	O
NOT	O
want	O
to	O
be	O
recussitated	O
,	O
and	O
that	O
OSH	O
placed	O
ETT	B-treatment
before	O
asking	O
her	O
.	O

Family	O
History	O
:	O
no	O
kids	O
,	O
no	O
bleeds	B-problem
or	O
strokes	B-problem
in	O
other	O
family	O
members	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O

96.7	O
HR60	B-test
BP153/52	B-test
,	O
later	O
178/85	O
RR	B-test
18T	O
sO298%	B-test
RA	I-test

Gen	O
:	O

NAD	B-problem
,	O
in	O
bed	O

HEENT	O
:	O
mmm	O

Neck	O
:	O
no	O
LAD	B-problem
;	O
no	O
carotid	B-problem
bruits	I-problem
;	O
limited	B-problem
range	I-problem
neck	I-problem
movements	I-problem
bilaterally	I-problem

Lungs	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmurs	B-problem
,	O
gallops	B-problem
and	O
rubs	B-problem
.	O

Abdomen	O
:	O
normal	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem

Extremities	O
:	O
no	O
edema;	B-problem
cold	B-problem
feet	I-problem
bilaterally	I-problem

Mental	O
Status	O
:	O

Awake	O
and	O
alert	O
,	O
cooperative	O
with	O
exam	B-test
,	O
normal	O
affect	O
;	O
facial	B-problem
expression	I-problem
somewhat	I-problem
sparse	I-problem
.	O

Oriented	O
to	O
place	O
and	O
person	O
,	O
not	O
date	O
1996	O
.	O

Attention	O
:	O

DOYbw	O
.	O

Memory	O
:	O

Registration	O
:	O

03-29	O
items	O
;	O
Recall	O
03-29	O
at	O
5	O
min	O
.	O

Language	O
:	O
fluent	O
;	O
repetition	O
:	O
intact	O
;	O
Naming	O
intact	O
;	O
Comprehension	O
intact	O
;	O
no	O
dysarthria	B-problem
,	O
no	O
paraphasic	B-problem
errors	I-problem
.	O

East	O
Sandwich	O
:	O
intact	O
;	O

3D-construction	O
:	O
poor	O
,	O
difficulties	B-problem
putting	I-problem
handles	I-problem
in	I-problem
clock	I-problem
;	O
No	O
Apraxia	B-problem
.	O

No	O
Neglect	B-problem
.	O

Unable	O
to	O
do	O
luria	O
.	O

Named	O
10	O
animals	O
in	O
1	O
minute	O
,	O
no	O
perseveration	O
,	O
but	O
no	O
further	O
animals	O
after	O
30	O
secs	O
.	O

Cranial	O
Nerves	O
:	O

II	O
:	O

Visual	O
fields	O
are	O
full	O
to	O
confrontation	O
,	O
pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
both	O
directly	O
and	O
consensually	O
,	O
2.5	O
-->	O
2	O
mm	O
bilaterally	O
.	O

III	O
,	O
IV	O
,	O
VI	O
:	O

Extraocular	O
movements	O
intact	O
with	O
few	O
beats	O
of	O
horizontal	B-problem
endgaze	I-problem
nystagmus	I-problem
.	O

Limited	B-problem
CMED	I-problem
CCU	I-problem
movements	I-problem
in	I-problem
upgaze	I-problem
.	O

Fixation	O
and	O
saccades	O
are	O
normal	O
.	O

V	O
:	O

Facial	O
sensation	O
intact	O
to	O
light	B-test
touch	I-test
and	O
pinprick	B-test
.	O

VII	O
:	O

Facial	O
movement	O
symmetrical	O
;	O
no	O
facial	B-problem
droop	I-problem
.	O

VIII	O
:	O

Hearing	O
intact	O
to	O
finger	B-test
rub	I-test
bilaterally	O
.	O

IX	O
:	O

Palate	O
elevates	O
in	O
midline	O
.	O

XII	O
:	O

Tongue	O
protrudes	O
in	O
midline	O
,	O
no	O
fasciculations	B-problem
.	O

XI	O
:	O

Sternocleidomastoid	O
and	O
trapezius	O
normal	O
bilaterally	O
.	O

Motor	O
System	O
:	O

Decreased	B-problem
bulk	I-problem
throughout	I-problem
;	O
tone	O
normal	O
bilaterally	O
.	O

No	O
adventitious	B-problem
movements	I-problem
,	O
no	O
tremor	B-problem
,	O
no	O
asterixis	B-problem
.	O

Right	O
PAD-WORD	O

D	B-test
-	O
5	O
;	O
T	B-test
-	O
5	O
;	O
B	B-test
-	O
5	O
;	O
WF	B-test
-	O
5	O
;	O
WE	B-test
-	O
5	O
;	O
FiF	B-test
-	O
5	O
;	O
Bruner	B-test
-	O
5	O
;	O
Ip	B-test
-	O
5	O
;	O
Gl	B-test
-	O
5	O
;	O
Q	B-test
-	O
5-	O
;	O
H	B-test
-	O
5	O
;	O
AF	B-test
-	O
5	O
;	O
TF	B-test
-	O
5	O
;	O
TE	B-test
-	O
5	O

Left	O
PAD-WORD	O

D	B-test
-	O
5	O
;	O
T	B-test
-	O
5	O
;	O
B	B-test
-	O
5	O
;	O
WF	B-test
-	O
5	O
;	O
WE	B-test
-	O
5	O
;	O
FiF	B-test
-	O
5	O
;	O
Bruner	B-test
-	O
5	O
;	O
Ip	B-test
-	O
5	O
;	O
Gl	B-test
-	O
5	O
;	O
Q	B-test
-	O
5-	O
;	O
H	B-test
-	O
5	O
;	O
AF	B-test
-	O
5	O
;	O
TF	B-test
-	O
5	O
;	O
TE	B-test
-	O
5-	O

No	O
pronator	B-problem
drift	I-problem
.	O

No	O
rebound	B-problem
.	O

Sensory	O
system	O
:	O

Sensation	O
intact	O
to	O
light	B-test
touch	I-test
,	O
pin	B-test
prick	I-test
,	O
temperature	B-test
(	I-test
cold	I-test
)	I-test
.	O

Decreased	B-problem
vibration	I-problem
in	I-problem
feet	I-problem
and	I-problem
ankles	I-problem
bilaterally	I-problem
,	O
some	O
in	O
knees	O
;	O
proprioception	B-problem
decreased	I-problem
in	I-problem
his	I-problem
feet	I-problem
bilaterally	I-problem
.	O

Reflexes	B-test
:	O

Right	B-test
B	I-test
-	O
2	O
;	O
T	B-test
-	O
2	O
;	O
Br	B-test
-	O
2	O
;	O
Pa	B-test
-	O
1	O
;	O
Pl	B-test
-	O
0	O

Left	O
PAD-WORD	O

B	B-test
-	O
2	O
;	O
T	B-test
-	O
2	O
;	O
Br	B-test
-	O
2	O
;	O
Pa	B-test
-	O
1	O
;	O
Pl	B-test
-	O
0	O
(	O
Less	O
brisk	O
than	O
on	O
R	O
,	O
but	O
exam	B-test
limited	O
due	O
to	O
cuff	O
)	O

Toes	O
:	O
mute	O
bilaterally	O
;	O
TFL	B-problem
contracted	I-problem
on	I-problem
the	I-problem
L	I-problem
.	O

Coordination	O
:	O

Normal	O
Correa	O
,	O
Kimberly	O
,	O
HTS	O
.	O

No	O
dysmetria	B-problem
or	O
pastpointing	B-problem
.	O

Gait	O
:	O
not	O
tested	O

(	O
later	O
tested	O
and	O
patient	O
markedly	B-problem
unstable	I-problem
on	I-problem
feet	I-problem
)	O

Pertinent	O
Results	O
:	O

2019-03-29	O
10:59	O
PM	O

GLUCOSE	B-test
-	O
89	O

2019-03-29	O
10:59	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
128	O

2019-03-29	O
10:59	O
PM	O

CK	B-test
-	I-test
MB	I-test
-	O
6	O
cTropnT	B-test
-<	O
0.01	O

2019-03-29	O
04:00	O
PM	O
URINE	B-test

HOURS	O
-	O
RANDOM	O

2019-03-29	O
04:00	O
PM	O
URINE	B-test

GR	B-test
HOLD	O
-	O
HOLD	O

2019-03-29	O
04:00	O
PM	O
URINE	B-test

COLOR	B-test
-	O
Straw	O
APPEAR	B-test
-	O
Clear	O
SP	B-test
Stickney	I-test
-	O
1.017	O

2019-03-29	O
04:00	O
PM	O
URINE	B-test

BLOOD	B-test
-	O
NEG	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
NEG	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
7.0	O
LEUK	B-test
-	O
NEG	O

2019-03-29	O
02:00	O
PM	O

GLUCOSE	B-test
-	O
72	O
UREA	B-test
N	I-test
-	O
17	O
CREAT	B-test
-	O
0.8	O
SODIUM	B-test
-	O
140	O
POTASSIUM	B-test
-	O
4.4	O
CHLORIDE	B-test
-	O
103	O
TOTAL	B-test
CO2	I-test
-	O
29	O
ANION	B-test
GAP	I-test
-	O
12	O

2019-03-29	O
02:00	O
PM	O

WBC	B-test
-	O
6.7	O
RBC	B-test
-	O
4.53	O
*	O
HGB	B-test
-	O
14.8	O
HCT	B-test
-	O
44.6	O
MCV	B-test
-	O
99	O
*	O
MCH	B-test
-	O
32.8	O
*	O
MCHC	B-test
-	O
33.3	O
RDW	B-test
-	O
12.6	O

2019-03-29	O
02:00	O
PM	O

NEUTS	B-test
-	O
65.5	O
LYMPHS	B-test
-	O
25.8	O
MONOS	B-test
-	O
7.0	O
EOS	B-test
-	O
1.4	O
BASOS	B-test
-	O
0.2	O

2019-03-29	O
02:00	O
PM	O

MACROCYT	B-test
-	O
1+	O

2019-03-29	O
02:00	O
PM	O

PLT	B-test
COUNT	I-test
-	O
213	O

2019-03-29	O
02:00	O
PM	O

PT	B-test
-	O
12.3	O
PTT	B-test
-	O
24.5	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.1	O

CT	B-test
BRAIN	I-test
(	I-test
INITIAL	I-test
)	I-test

FINDINGS	O
:	O

There	O
is	O
a	O
41	O
x	O
23	O
mm	O
area	O
of	O
hyperdensity	B-problem
within	I-problem
the	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
,	O
with	O
moderate	B-problem
surrounding	I-problem
vasogenic	I-problem
edema	I-problem

(	O
series	O
2	O
,	O
image	O
23	O
)	O
,	O
compatible	O
with	O
acute	B-problem
intraparenchymal	I-problem
hemorrhage	I-problem
.	O

The	B-problem
chronic	I-problem
encephalomalacic	I-problem
changes	I-problem
at	I-problem
the	I-problem
adjacent	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
and	O
the	O
right	O
parietal	O
/	O
occipital	O
region	O
remain	O
stable	O
in	O
appearance	O
.	O

There	O
is	O
mild	B-problem
mass	I-problem
effect	I-problem
upon	I-problem
the	I-problem
anterior	I-problem
Mims	I-problem
of	O
the	O
right	O
lateral	O
ventricle	O
.	O

No	O
further	O
intraaxial	B-problem
or	I-problem
extraaxial	I-problem
fluid	I-problem
collections	I-problem
or	O
hematoma	B-problem
are	O
identified	O
.	O

There	O
is	O
no	O
displacement	B-problem
of	I-problem
the	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
,	O
hydrocephalus	B-problem
,	O
or	O
effacement	B-problem
of	I-problem
the	I-problem
basal	I-problem
cisterns	I-problem
at	O
present	O
.	O

Review	B-test
of	I-test
bone	I-test
windows	I-test
demonstrates	O
no	O
skull	B-problem
bulge	I-problem
or	O
skull	B-problem
base	I-problem
fracture	I-problem
.	O

There	O
is	O
an	B-problem
air	I-problem
/	I-problem
fluid	I-problem
level	I-problem
within	I-problem
the	I-problem
right	I-problem
maxillary	I-problem
sinus	I-problem
-	O
?	O
acute	B-problem
sinusitis	I-problem
,	O
but	O
acute	B-problem
blood	I-problem
cannot	O
be	O
excluded	O
,	O
in	O
the	O
setting	O
of	O
acute	B-problem
trauma	I-problem
.	O

CONCLUSION	O
:	O

41	B-problem
x	I-problem
23	I-problem
mm	I-problem
acute	I-problem
intraparenchymal	I-problem
hematoma	I-problem
at	I-problem
the	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
,	O
causing	O
mild	B-problem
mass	I-problem
effect	I-problem
upon	I-problem
the	I-problem
ipsilateral	I-problem
lateral	I-problem
ventricle	I-problem
,	O
suspicious	O
of	O
hemorrhage	B-problem
secondary	O
to	O
congophilic	B-problem
angiopathy	I-problem
in	O
this	O
age	O
group	O
.	O

Chronic	B-problem
encephalomalacic	I-problem
changes	I-problem
at	I-problem
the	I-problem
right	I-problem
frontal	I-problem
lobe	I-problem
and	O
right	O
parietal	O
/	O
occipital	O
region	O
are	O
unchanged	O
in	O
appearance	O
since	O
2018-11-27	O
.	O

REPEAT	B-test
HEAD	I-test
CT	I-test
03-30	O
:	O
no	O
significant	B-problem
change	I-problem
from	O
above	O
.	O

EKG	B-test
:	O

Atrial	B-treatment
pacing	I-treatment
.	O

Since	O
the	B-test
previous	I-test
tracing	I-test
of	O
2018-03-15	O
atrial	B-treatment
pacing	I-treatment
is	O
a	O
new	O
finding	O
.	O

The	B-test
electrocardiogram	I-test
is	O
otherwise	O
,	O
unchanged	O
and	O
continues	O
to	O
Weymouth	B-treatment
voltage	I-treatment
in	I-treatment
the	I-treatment
limb	I-treatment
leads	I-treatment
and	O
non-specific	B-problem
ST-T	I-problem
wave	I-problem
abnormalities	I-problem
.	O

Read	O
by	O
:	O

Stella	O
,	O
Kendra	O
B	O
.	O

Intervals	B-test
Axes	I-test

Rate	B-test
60	O
PR	B-test
188	O
QRS	B-test
104	O
QT/QTc	B-test
460/460	O
P	B-test
85	O
QRS	B-test
55	O
T	B-test
75	O

Brief	O
Hospital	O
Course	O
:	O

The	O
patient	O
is	O
a	O
83	O
yo	O
man	O
with	O
a	O
history	O
of	O
past	B-problem
intracranial	I-problem
hemorrhages	I-problem
(	O
most	O
recent	O
07-01	O
with	O
R-frontal	B-problem
hemorrhage	I-problem
)	O
who	O
presented	O
with	O
gradually	B-problem
slowing	I-problem
of	I-problem
mentation	I-problem
and	O
increased	B-problem
gait	I-problem
instability	I-problem
since	O
one	O
week	O
.	O

On	O
initial	B-test
exam	I-test
the	O
patient	O
was	O
not	B-problem
oriented	I-problem
to	I-problem
time	I-problem
,	O
seemed	O
somewhat	B-problem
slow	I-problem
,	O
and	O
had	O
difficulties	B-problem
generating	I-problem
a	I-problem
list	I-problem
of	I-problem
animals	I-problem
.	O

His	O
cranial	O
nerves	O
and	O
strength	O
were	O
full	O
,	O
and	O
the	B-test
sensory	I-test
exam	I-test
showed	O
mildly	B-problem
decreased	I-problem
vibration	I-problem
and	I-problem
proprioception	I-problem
in	I-problem
both	I-problem
LE	I-problem
,	O
suggesting	O
peripheral	B-problem
neuropathy	I-problem
.	O

A	B-test
CT	I-test
was	O
performed	O
in	O
the	O
Deanna	O
that	O
showed	O
a	B-problem
new	I-problem
significant	I-problem
R-frontal	I-problem
intraparenchymal	I-problem
hemorrhage	I-problem
in	I-problem
the	I-problem
same	I-problem
location	I-problem
as	O
the	B-problem
prior	I-problem
bleed	I-problem
.	O

The	O
patient	O
was	O
seen	O
by	O
both	O
neurology	O
and	O
neurosurgery	O
,	O
and	O
the	O
two	O
teams	O
agreed	O
that	O
the	O
etiology	O
seemed	O
to	O
be	O
related	O
to	O
underlying	B-problem
amyloidosis	I-problem
.	O

During	O
the	O
last	O
admission	O
the	O
question	O
of	O
a	B-problem
mass	I-problem
underlying	O
a	B-problem
hemorrhage	I-problem
in	I-problem
the	I-problem
R-frontal	I-problem
region	I-problem
was	O
raised	O
.	O

The	O
location	O
of	O
the	B-problem
hemorrhage	I-problem
was	O
not	O
felt	O
to	O
be	O
typical	O
for	O
hypertensive	B-problem
bleed	I-problem
(	I-problem
cortical	I-problem
)	I-problem
and	O
it	O
was	O
felt	O
to	O
be	O
unlikely	O
that	O
the	O
recent	O
fall	O
was	O
related	O
to	O
the	B-problem
bleed	I-problem
.	O

The	O
patient	O
could	O
not	O
undergo	O
an	B-test
MRI	I-test
due	O
to	O
his	B-treatment
pacer	I-treatment
.	O

He	O
was	O
admitted	O
to	O
the	O
neurology	O
ICU	O
for	O
closer	B-test
monitoring	I-test
and	O
was	O
stable	O
overnight	O
-	O
BP	B-test
was	O
initially	B-problem
elevated	I-problem
and	O
required	O
a	B-treatment
labetalol	I-treatment
drip	I-treatment
for	O
<	O
24	O
hours	O
,	O
then	O
stabilized	O
.	O

The	B-test
goal	I-test
SBP	I-test
of	O
<	O
150	O
was	O
achieved	O
.	O

Coags	B-test
and	O
UA	B-test
were	O
checked	O
and	O
were	O
normal	O
.	O

For	O
the	O
question	O
of	O
seizure	B-problem
activity	I-problem
associated	O
with	O
a	B-problem
cortical	I-problem
bleed	I-problem
,	O
he	O
was	O
started	O
prophylactically	O
on	O
Keppra	B-treatment
(	O
given	O
questionable	O
allergy	B-problem
to	O
dilantin	B-treatment
)	O
,	O
at	O
500	O
mg	O
bid	O
;	O
no	O
seizure	B-problem
activity	I-problem
was	O
seen	O
.	O

This	B-treatment
medication	I-treatment
should	O
be	O
continued	O
as	O
an	O
outpatient	O
at	O
least	O
while	O
the	B-problem
bleed	I-problem
has	O
time	O
to	O
clear	O
up	O
,	O
with	O
planned	O
titration	O
up	O
to	O
1000	O
mg	O
bid	O
on	O
04-05	O
.	O

Head	B-test
CT	I-test
repeated	O
on	O
03-30	O
was	O
unchanged	O
,	O
and	O
the	O
patient	O
remained	O
stable	O
with	O
only	O
very	O
suble	O
focal	O
exam	O
findings	O
(	O
very	B-problem
mild	I-problem
right	I-problem
pronator	I-problem
drift	I-problem
)	O
as	O
well	O
as	O
his	B-problem
persistently	I-problem
poor	I-problem
memory	I-problem
related	O
to	O
dementia	B-problem
.	O

The	O
plan	O
after	O
24	O
hours	O
was	O
to	O
transfer	O
him	O
to	O
the	O
floor	O
,	O
but	O
the	O
hospital	O
was	O
full	O
and	O
he	O
never	O
got	O
a	O
bed	O
.	O

Cardiovascularly	O
,	O
lipitor	B-treatment
and	O
amiodarone	B-treatment
were	O
continued	O
.	O

He	O
could	O
not	O
get	O
an	B-test
MRI	I-test
due	O
to	O
his	B-treatment
pacemaker	I-treatment
.	O

There	O
were	O
no	O
telemetry	B-problem
events	I-problem
,	O
and	O
he	O
ruled	O
out	O
by	O
enzyme	B-test
.	O

Pulmonlologically	O
,	O
his	B-test
chest	I-test
xray	I-test
was	O
negative	O
and	O
he	O
complained	O
of	O
no	O
breathing	B-problem
problems	I-problem
.	O

Endocrinologically	O
,	O
BG	B-test
was	O
monitored	O
to	O
improve	O
outcome	O
in	O
ICU	O
setting	O
though	O
he	O
had	O
no	O
history	O
of	O
DM	B-problem
.	O

Of	O
note	O
,	O
Hba1c	B-test
done	O
03-04	O
was	O
slightly	B-problem
elevated	I-problem
(	O
"	O
borderline	B-problem
DM	I-problem
"	O
)	O
at	O
6.3	O
;	O
this	O
was	O
repeated	O
and	O
was	O
still	O
pending	O
on	O
the	O
day	O
of	O
discharge	O
.	O

Ins	B-test
/	I-test
outs	I-test
and	O
electrolytes	B-test
were	O
monitored	O
and	O
were	O
not	O
abnormal	B-problem
;	O
he	O
was	O
on	O
a	B-treatment
bowel	I-treatment
regimen	I-treatment
,	O
VD	B-treatment
boots	I-treatment
and	O
PUD	B-treatment
prophylaxis	I-treatment
with	O
protonix	B-treatment
during	O
the	O
admission	O
.	O

Walking	O
was	O
assessed	O
later	O
and	O
the	O
patient	O
was	O
unstable	B-problem
on	I-problem
his	I-problem
feet	I-problem
.	O

PT	O
was	O
asked	O
to	O
see	O
him	O
for	O
this	B-problem
gait	I-problem
problem	I-problem
.	O

Brandon	O
felt	O
well	O
and	O
was	O
seen	O
by	O
PT	O
who	O
suggested	O
a	O
rehab/Hahnemann	O
Hospital	O
(	O
Worcester	O
)	O
to	O
work	O
on	O
walking	O
with	O
the	O
eventual	O
goal	O
of	O
returning	O
to	O
assisted	O
living	O
with	O
his	O
wife	O
when	O
walking	O
improved	O
.	O

Follow-up	O
was	O
arranged	O
with	O
neurosurgery	O
in	O
5-6	O
weeks	O
with	O
repeat	B-test
head	I-test
ct	I-test
to	O
be	O
arranged	O
by	O
neurosurgery	O
office	O
to	O
make	O
sure	O
blood	B-problem
has	O
cleared	O
,	O
and	O
if	O
indicated	O
,	O
to	O
look	O
for	O
a	O
possible	O
underlying	B-problem
lesion	I-problem
(	O
although	O
unlikely	O
)	O
.	O

Medications	O
on	O
Admission	O
:	O

Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
qod	O
-	O
in	O
March	O
,	O
should	O
be	O
on	O
odd	O
days	O
.	O

Donepezil	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Mirtazapine	B-treatment
30	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
at	O
bedtime	O
.	O

Ocuvite	B-treatment
Tablet	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Artificial	B-treatment
Tears	I-treatment
Drops	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
drop	O
Ophthalmic	O
twice	O
a	O
day	O
:	O
ou	O
.	O

Ensure	B-treatment
Liquid	I-treatment
Sig	O
:	O
0.5	O
to	O
1	O
can	O
PO	O
three	O
times	O
a	O
day	O
.	O

Midodrine	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
twice	O
a	O
day	O
:	O
at	O
8am	O
and	O
noon	O
.	O

Ritalin	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
see	O
below	O
Tablet	O
PO	O
see	O
below	O
:	O
1.5	O
tablets	O
at	O
10am	O
(	O
7.5mg	O
)	O
,	O
1	O
tablet	O
2pm	O
(	O
5mg	O
)	O
.	O

Prilosec	B-treatment
20	O
mg	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
once	O
a	O
day	O
.	O

Guaifenesin	B-treatment
100	O
mg	O
/	O
5	O
mL	O
Liquid	O
Sig	O
:	O
01-28	O
teaspoons	O
PO	O
every	O
six	O
(	O
6	O
)	O
hours	O
as	O
needed	O
for	O
cold	B-problem
symptoms	I-problem
.	O

Discharge	O
Medications	O
:	O

1.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
qod	O
-	O
in	O
March	O
,	O
should	O
be	O
on	O
odd	O
days	O
.	O

2.	O
Donepezil	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4.	O
Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Mirtazapine	B-treatment
30	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

6.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
at	O
bedtime	O
.	O

7.	O
Levetiracetam	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
:	O
on	O
04-05	O
,	O
please	O
increase	O
to	O
TWO	O
tablets	O
bid	O
(	O
1000	O
mg	O
bid	O
)	O
.	O

8.	O
Ocuvite	B-treatment
Tablet	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

9.	O
Artificial	B-treatment
Tears	I-treatment
Drops	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
drop	O
Ophthalmic	O
twice	O
a	O
day	O
:	O
ou	O
.	O

10.	O
Ensure	B-treatment
Liquid	I-treatment
Sig	O
:	O
0.5	O
to	O
1	O
can	O
PO	O
three	O
times	O
a	O
day	O
.	O

11.	O
Midodrine	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
twice	O
a	O
day	O
:	O
at	O
8	O
am	O
and	O
noon	O
.	O

12.	O
Ritalin	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
see	O
below	O
Tablet	O
PO	O
see	O
below	O
:	O
1.5	O
tablets	O
at	O
10	O
am	O
(	O
7.5	O
mg	O
)	O
,	O
1	O
tablet	O
2	O
pm	O
(	O
5	O
mg	O
)	O
.	O

13.	O
Prilosec	B-treatment
20	O
mg	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
once	O
a	O
day	O
.	O

14.	O
Guaifenesin	B-treatment
100	O
mg	O
/	O
5	O
mL	O
Liquid	O
Sig	O
:	O
01-28	O
teaspoons	O
PO	O
every	O
six	O
(	O
6	O
)	O
hours	O
as	O
needed	O
for	O
cold	B-problem
symptoms	I-problem
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Right	B-problem
sided	I-problem
intraparenchymal	I-problem
cerebral	I-problem
hemorrhage	I-problem

Discharge	O
Condition	O
:	O

Stable	O
-	O
still	O
with	O
difficulty	B-problem
walking	I-problem
,	O
and	O
mental	B-test
status	I-test
exam	I-test
with	O
memory	B-problem
loss	I-problem
c/w	O
dementia	B-problem
,	O
but	O
otherwise	O
no	O
focal	B-problem
weakness	I-problem
.	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
MD	O
or	O
return	O
to	O
Deanna	O
if	O
new	O
symptoms	O
suggestive	O
of	O
stroke	B-problem
or	O
brain	B-problem
hemorrhage	I-problem
including	O
weakness	B-problem
,	O
numbness	B-problem
/	O
tingling	B-problem
,	O
facial	B-problem
droop	I-problem
,	O
visual	B-problem
changes	I-problem
,	O
vertigo	B-problem
,	O
loss	B-problem
of	I-problem
coordination	I-problem
,	O
or	O
worsened	B-problem
problems	I-problem
with	I-problem
walking	I-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
f/u	O
with	O
Dr.	O
Hernandez	O
/	O
neurosurgery	O
in	O
6	O
weeks	O
-	O
patient	O
will	O
receive	O
a	O
call	O
from	O
the	O
neurosurgery	O
office	O
to	O
set	O
up	O
a	B-test
repeat	I-test
head	I-test
CT	I-test
prior	O
and	O
to	O
schedule	O
this	O
visit	O
.	O

Daniel	O
Laura	O
MD	O
,	O
PHD	O
13-279	O

Completed	O
by	O
:	O
Charles	O
Rodriguez	O
MD	O
38-818	O
2019-04-01	O
@	O
1518	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Stacie	O
Henry	O
on	O
:	O
MON	O
2019-05-06	O
12:14	O
PM	O

(	O
End	O
of	O
Report	O
)	O

194830718	O
YC	O

29157608	O
PAD-WORD	O

520377	O
PAD-WORD	O

10/25/1997	O
12:00:00	O
AM	O

DIVERTICULITIS	B-problem
,	O
S	O
/	O
P	O
AORTIC	B-treatment
VALVE	I-treatment
REPLACEMENT	I-treatment

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

10/25/1997	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

11/03/1997	O
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

Diverticulitis	B-problem
,	O
presenting	O
for	O
sigmoid	B-treatment
colectomy	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
67-year-old	O
woman	O
with	O
occasional	B-problem
abdominal	I-problem
pain	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
quadrant	I-problem
and	O
left	O
lower	O
quadrant	O
.	O

She	O
has	O
not	O
complained	O
of	O
any	B-problem
fever	I-problem
,	O
shaking	B-problem
,	O
or	O
chills	B-problem
.	O

No	O
nausea	B-problem
or	O
vomiting	B-problem
,	O
no	O
change	B-problem
in	I-problem
her	I-problem
bowel	I-problem
movements	I-problem
.	O

She	O
has	O
had	O
attacks	B-problem
treated	O
with	O
antibiotics	B-treatment
in	O
the	O
past	O
notably	O
in	O
12/96	O
and	O
08/97	O
.	O

She	O
has	O
had	O
a	O
diagnosis	O
of	O
diverticulitis	B-problem
flairs	I-problem
and	O
baseline	B-problem
diverticulosis	I-problem
flairing	I-problem
in	O
09/96	O
.	O

Also	O
,	O
three	O
years	O
prior	O
in	O
1993	O
,	O
she	O
had	O
an	B-problem
attack	I-problem
of	I-problem
diverticulitis	I-problem
.	O

She	O
has	O
been	O
worked	O
up	O
with	O
barium	B-test
enema	I-test
in	O
09/97	O
which	O
showed	O
multiple	B-problem
diverticula	I-problem
throughout	I-problem
the	I-problem
colon	I-problem
,	O
but	O
mostly	O
in	O
the	O
sigmoid	O
.	O

At	O
this	O
time	O
,	O
there	O
was	O
diverticulosis	B-problem
with	O
no	O
acute	B-problem
diverticulitis	I-problem
.	O

There	O
was	O
also	O
no	O
obstruction	B-problem
.	O

The	O
patient	O
is	O
also	O
status	O
post	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
in	O
1996	O
,	O
and	O
presented	O
for	O
heparinization	B-treatment
prior	O
to	O
her	B-treatment
elective	I-treatment
valve	I-treatment
surgery	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
hypothyroidism	B-problem
,	O
hypertension	B-problem
,	O
and	O
rheumatic	B-problem
fever	I-problem
age	O
6	O
with	O
aortic	B-problem
stenosis	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Aortic	B-treatment
valve	I-treatment
replacement	I-treatment
in	O
11/96	O
with	O
a	B-treatment
St.	I-treatment
Jude	I-treatment
valve	I-treatment
and	O
chronic	B-treatment
Coumadin	I-treatment
therapy	I-treatment
;	O
breast	B-test
biopsy	I-test
negative	O
in	O
1984	O
;	O
appendectomy	B-treatment
age	O
15	O
;	O
tonsillectomy	B-treatment
and	O
adenoidectomy	B-treatment
age	O
6	O
;	O
hysterotomy	B-treatment
age	O
30	O
;	O
C-section	B-treatment
age	O
37	O
due	O
to	O
placenta	B-problem
previa	I-problem
.	O

MEDICATIONS	O
:	O

Lopressor	B-treatment
50	O
mg	O
q.a.m.	O
,	O
25	O
mg	O
q.p.m.	O
,	O
and	O
25	O
mg	O
q.h.s.;	O
Synthroid	B-treatment
88	O
mcg	O
q.d.;	O
Norvasc	B-treatment
5	O
mg	O
q.d.;	O
Lescol	B-treatment
20	O
mg	O
q.p.m.	O
with	O
meal	O
;	O
Coumadin	B-treatment
is	O
usually	O
4	O
mg	O
p.o.	O
3x	O
a	O
week	O
and	O
3	O
mg	O
4x	O
a	O
week	O
.	O

It	O
was	O
held	O
the	O
day	O
prior	O
to	O
admission	O
.	O

ALLERGIES	O
:	O

Percodan	B-treatment
and	O
codeine	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

Alcohol	O
and	O
tobacco	O
histories	O
are	O
negative	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Negative	O
for	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
positive	O
for	O
occasional	B-problem
dyspnea	I-problem
on	O
exertion	O
,	O
negative	O
for	O
dyspnea	B-problem
and	O
she	O
has	O
excellent	O
exercise	O
tolerance	O
.	O

There	O
is	O
occasional	B-problem
left	I-problem
chest	I-problem
tightening	I-problem
which	O
is	O
brief	O
.	O

No	O
bleeding	B-problem
in	I-problem
her	I-problem
urine	I-problem
or	I-problem
stool	I-problem
.	O

Occasional	B-problem
bleeding	I-problem
when	O
she	O
flosses	O
and	O
occasional	B-problem
dizziness	I-problem
secondary	O
to	O
a	B-problem
drop	I-problem
in	O
blood	B-test
pressure	I-test
transiently	O
at	O
home	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

VITAL	O
SIGNS	O
-	O
Temp	B-test
98.8	O
,	O
pulse	B-test
60	O
,	O
BP	B-test
150/94	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
and	O
saturation	B-test
96%	O
on	O
room	O
air	O
.	O

GENERAL	O
-	O
The	O
patient	O
is	O
a	O
pleasant	O
older	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

HEENT	O
-	O
Normocephalic	O
,	O
atraumatic	B-problem
.	O

Oropharynx	O
is	O
not	O
injected	O
.	O

NECK	O
-	O
No	O
carotid	B-problem
bruits	I-problem
,	O
with	O
2+	B-test
carotid	I-test
pulses	I-test
.	O

LUNGS	O
-	O
Clear	O
.	O

HEART	O
-	O
Regular	O
,	O
with	O
a	B-problem
III	I-problem
/	I-problem
VI	I-problem
murmur	I-problem
at	I-problem
the	I-problem
upper	I-problem
left	I-problem
sternal	I-problem
border	I-problem
.	O

ABDOMEN	O
-	O
There	O
is	O
a	O
soft	O
abdomen	O
with	O
a	O
question	O
of	O
eventful	B-problem
hernia	I-problem
.	O

RECTAL	O
-	O
Guaiac	B-test
negative	O
with	O
normal	O
tone	O
.	O

EXTREMITIES	O
-	O
Bilateral	B-test
radial	I-test
,	O
dorsalis	B-test
pedis	I-test
,	O
posterior	B-test
tibial	I-test
,	O
and	O
femoral	B-test
pulses	I-test
are	O
all	O
2+	O
.	O

No	O
clubbing	B-problem
,	O
cyanosis	B-problem
,	O
or	O
edema	B-problem
of	I-problem
the	I-problem
extremities	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Coagulation	B-test
profile	I-test
notable	O
for	O
a	B-test
PT	I-test
18	O
,	O
PTT	B-test
36.7	O
and	O
an	B-test
INR	I-test
of	O
2.4	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
begun	O
on	O
cefotetan	B-treatment
and	O
Flagyl	B-treatment
,	O
as	O
well	O
as	O
heparin	B-treatment
.	O

Her	B-test
INR	I-test
dropped	O
to	O
1.6	O
prior	O
to	O
surgery	B-treatment
,	O
and	O
her	B-test
PTT	I-test
was	O
in	O
the	O
mid	O
80s	O
prior	O
to	O
surgery	B-treatment
.	O

She	O
was	O
admitted	O
and	O
placed	O
on	O
a	B-treatment
bowel	I-treatment
prep	I-treatment
two	O
days	O
before	O
surgery	B-treatment
and	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
hospital	O
day	O
#	O
3	O
,	O
10/28/97	O
.	O

At	O
that	O
time	O
,	O
she	O
underwent	O
sigmoid	B-treatment
colectomy	I-treatment
and	O
ventral	B-treatment
hernia	I-treatment
repair	I-treatment
.	O
(	O
A	O
full	O
account	O
of	O
this	B-treatment
operation	I-treatment
can	O
be	O
found	O
in	O
the	O
Operative	O
Note	O
)	O
.	O

She	O
tolerated	O
this	B-treatment
procedure	I-treatment
without	O
complications	B-problem
initially	O
and	O
was	O
taken	O
to	O
the	O
Recovery	O
Room	O
in	O
stable	O
condition	O
.	O

Postoperatively	O
,	O
she	O
had	O
her	B-treatment
heparin	I-treatment
restarted	O
,	O
and	O
had	O
a	B-test
PTT	I-test
rising	O
to	O
142.8	O
and	O
then	O
down	O
to	O
92	O
.	O

Her	O
primary	O
postoperative	O
development	O
was	O
the	B-problem
passage	I-problem
of	I-problem
some	I-problem
blood	I-problem
clots	I-problem
and	O
blood	B-problem
per	I-problem
rectum	I-problem
on	O
postoperative	O
day	O
#	O
2	O
.	O

She	O
continued	O
to	O
pass	O
blood	B-problem
per	I-problem
rectum	I-problem
and	O
was	O
transfused	O
with	O
one	B-treatment
unit	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

Her	B-test
preoperative	I-test
hematocrit	I-test
was	O
41	O
and	O
her	B-test
hematocrit	I-test
dropped	O
to	O
30.4	O
on	O
postoperative	O
day	O
#	O
2	O
.	O

This	O
was	O
a	O
drop	O
from	O
an	B-test
immediate	I-test
postoperative	I-test
hematocrit	I-test
of	O
35.4	O
.	O

Upon	O
receiving	O
the	B-treatment
one	I-treatment
unit	I-treatment
of	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
her	B-test
hematocrit	I-test
returned	O
to	O
33	O
,	O
and	O
in	O
the	O
two	O
days	O
subsequent	O
to	O
the	B-treatment
transfusion	I-treatment
,	O
returned	O
to	O
34	O
.	O

Otherwise	O
,	O
her	O
postoperative	O
course	O
was	O
uneventful	O
with	O
gradual	O
resolution	O
of	O
the	O
passage	O
of	O
blood	B-problem
per	I-problem
rectum	I-problem
.	O

Her	B-treatment
heparin	I-treatment
was	O
discontinued	O
when	O
it	O
was	O
noted	O
that	O
she	O
was	O
bleeding	B-problem
per	I-problem
rectum	I-problem
and	O
her	B-test
PTT	I-test
drifted	O
to	O
a	O
normal	O
range	O
of	O
35	O
by	O
postoperative	O
day	O
#	O
3	O
.	O

On	O
postoperative	O
day	O
#	O
1	O
,	O
the	O
patient	O
was	O
restarted	O
on	O
2	O
mg	O
of	O
Coumadin	B-treatment
.	O

However	O
,	O
due	O
to	O
the	O
episode	O
of	O
bleeding	B-problem
on	O
postoperative	O
day	O
#	O
2	O
,	O
the	B-treatment
Coumadin	I-treatment
was	O
held	O
for	O
two	O
consecutive	O
days	O
,	O
and	O
then	O
restarted	O
on	O
postoperative	O
day	O
#	O
4	O
.	O

At	O
this	O
time	O
,	O
she	O
is	O
given	O
3	O
mg	O
and	O
was	O
gradually	O
increased	O
to	O
her	B-treatment
regular	I-treatment
regimen	I-treatment
of	O
4	O
mg	O
alternating	O
with	O
3	O
mg.	O

The	B-test
patient	I-test
&apos;s	I-test
INR	I-test
had	O
dropped	O
to	O
1.7	O
at	O
the	O
time	O
of	O
operation	B-treatment
,	O
and	O
remained	O
in	O
this	O
range	O
initially	O
,	O
but	O
began	O
to	O
rise	O
to	O
2.0	O
with	O
her	B-treatment
Coumadin	I-treatment
dosing	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
it	O
was	O
1.9	O
,	O
for	O
which	O
she	O
received	O
4	O
mg.	O

On	O
the	O
next	O
day	O
,	O
it	O
was	O
1.6	O
and	O
she	O
returned	O
to	O
a	B-treatment
normal	I-treatment
dosing	I-treatment
of	O
4	O
mg	O
followed	O
by	O
outpatient	B-test
draws	I-test
to	O
determine	O
the	B-treatment
further	I-treatment
Coumadin	I-treatment
dosing	I-treatment
.	O

This	O
was	O
postoperative	O
day	O
#	O
6	O
,	O
at	O
which	O
time	O
she	O
is	O
ready	O
for	O
discharge	O
.	O

The	O
rest	O
of	O
her	O
hospital	O
course	O
was	O
unremarkable	O
,	O
with	O
perioperative	B-treatment
ampicillin	I-treatment
,	O
gentamicin	B-treatment
and	O
Flagyl	B-treatment
discontinued	O
on	O
postoperative	O
day	O
#	O
1	O
.	O

She	O
had	O
some	B-problem
initial	I-problem
nausea	I-problem
but	O
had	O
no	O
emesis	B-problem
.	O

Her	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
discontinued	O
on	O
postoperative	O
day	O
#	O
1	O
,	O
and	O
she	O
tolerated	O
a	O
regular	O
diet	O
by	O
postoperative	O
day	O
#	O
3	O
.	O

She	O
had	O
flatus	O
and	O
regular	O
bowel	O
movements	O
by	O
postoperative	O
day	O
#	O
5	O
.	O

She	O
also	O
complained	O
of	O
some	B-problem
slight	I-problem
dizziness	I-problem
upon	O
getting	O
up	O
.	O

For	O
this	O
reason	O
,	O
her	B-treatment
normal	I-treatment
Lopressor	I-treatment
and	O
Norvasc	B-treatment
were	O
held	O
.	O

It	O
was	O
felt	O
that	O
this	O
was	O
re-equalibration	O
after	O
being	O
sedentary	O
and	O
mostly	O
in	O
bed	O
following	O
the	B-treatment
operation	I-treatment
.	O

She	O
had	O
some	B-problem
slight	I-problem
headaches	I-problem
which	O
resolved	O
with	O
Tylenol	B-treatment
,	O
and	O
the	B-problem
dizziness	I-problem
resolved	O
as	O
well	O
.	O

She	O
was	O
ready	O
for	O
discharge	O
on	O
postoperative	O
day	O
#	O
6	O
.	O

Her	B-problem
wound	I-problem
remained	O
benign	O
and	O
was	O
healing	O
nicely	O
at	O
the	O
time	O
of	O
discharge	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Lopressor	B-treatment
50	O
mg	O
q.a.m.	O
,	O
25	O
mg	O
q.p.m.	O
,	O
and	O
25	O
mg	O
q.h.s.	O
,	O
Synthroid	B-treatment
88	O
mcg	O
q.d.	O
,	O
Norvasc	B-treatment
5	O
mg	O
q.d.	O
,	O
Lescol	B-treatment
20	O
mg	O
q.p.m.	O
with	O
meal	O
,	O
Coumadin	B-treatment
is	O
usually	O
4	O
mg	O
p.o.	O
3x	O
a	O
week	O
and	O
3	O
mg	O
4x	O
a	O
week	O
;	O
Percocet	B-treatment
1-2	O
tabs	O
q.4h.	O
p.r.n.	O
pain	B-problem
.	O

DISCHARGE	O
FOLLOW-UP	O
:	O

Follow-up	O
with	O
Dr.	O
Jesc	O
in	O
the	O
office	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Her	O
disposition	O
was	O
to	O
home	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

Estimated	O
disability	O
was	O
none	O
.	O

Dictated	O
By	O
:	O

BELL	O
REXBEATHEFARST	O
,	O
M.D.	O
NM82	O

Attending	O
:	O

LINEMASE	O
D.	O
JESC	O
,	O
M.D.	O
ZP2	O
SF477/5317	O

Batch	O
:	O

31967	O
PAD-WORD	O

Index	O
No.	O
PAWU09891C	O

D	O
:	O

11/07/97	O
PAD-WORD	O

T	O
:	O

11/07/97	O
PAD-WORD	O

Admission	O
Date	O
:	O

2019-12-28	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2020-01-20	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2019-12-28	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
:	O

Baby	O
Girl	O
Rizza-Gannaway	O
is	O
the	O
1515	O
gram	O
product	O
of	O
a	O
32	O
and	O
06-30	O
week	O
twin	O
gestation	O
born	O
to	O
a	O
37-year-old	O
G	O
-	O
2	O
,	O
P	O
-	O
0	O
,	O
now	O
2	O
,	O
mother	O
.	O

Prenatal	O
Edward	O
:	O

A	B-test
negative	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
rubella	B-test
immune	O
and	O
GBS	B-test
negative	O
.	O

Pregnancy	O
was	O
IUI	O
assisted	O
for	O
di-di	O
twin	O
gestation	O
and	O
was	O
relatively	O
uncomplicated	B-problem
until	O
mother	O
presented	O
on	O
12-15	O
,	O
with	O
spontaneous	O
rupture	O
of	O
membranes	O
.	O

She	O
was	O
found	O
to	O
be	O
having	O
preterm	B-problem
contractions	I-problem
without	O
cervical	B-problem
change	I-problem
and	O
was	O
admitted	O
for	O
bedrest	B-treatment
.	O

She	O
received	O
a	O
full	O
course	O
of	O
betamethasone	B-treatment
complete	O
on	O
12-17	O
,	O
magnesium	B-treatment
and	O
erythromycin	B-treatment
for	O
latency	O
through	O
12-21	O
.	O

Intermittent	B-problem
maternal	I-problem
hypertension	I-problem
noted	O
but	O
without	O
proteinuria	B-problem
.	O

Ultrasounds	B-test
have	O
been	O
reassuring	O
with	O
biophysicals	B-test
8	O
out	O
of	O
8	O
x2	O
.	O

On	O
the	O
evening	O
of	O
12-27	O
,	O
monitoring	B-test
noted	O
child	O
's	O
increased	B-problem
preterm	I-problem
contractions	I-problem
,	O
uterine	B-problem
tenderness	I-problem
and	O
mildly	B-problem
increased	I-problem
fetal	I-problem
heart	I-problem
rates	I-problem
,	O
due	O
to	O
concerns	O
of	O
possible	O
chorioamnionitis	B-problem
,	O
the	O
mother	O
was	O
taken	O
for	O
cesarean	B-treatment
delivery	I-treatment
.	O

The	O
infant	O
delivered	O
with	O
moderate	O
tone	O
and	O
respiratory	O
effort	O
responding	O
well	O
to	O
stimulation	B-treatment
and	O
brief	B-treatment
blow	I-treatment
by	I-treatment
O2	I-treatment
.	O

Apgars	B-test
were	O
8	O
and	O
8	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
weight	B-test
1515	O
grams	O
,	O
10th	O
to	O
25th	O
percentile	O
,	O
head	B-test
circumference	I-test
30	O
cm	O
,	O
25th	O
to	O
50th	O
percentile	O
,	O
length	B-test
41	O
cm	O
,	O
10th	O
to	O
25th	O
percentile	O
.	O

Warm	O
,	O
dry	O
,	O
premature	B-problem
infant	O
,	O
active	O
with	O
exam	B-test
,	O
mild	B-problem
respiratory	I-problem
distress	I-problem
at	O
rest	O
.	O

Overall	O
appearance	O
consistent	O
with	O
estimated	O
gestational	O
age	O
.	O

Thin	O
,	O
warm	O
,	O
dry	O
,	O
pink	O
,	O
no	O
rashes	B-problem
.	O

Fontanelle	O
soft	O
and	O
flat	O
.	O

Ears	O
normal	O
.	O

Palate	O
intact	O
.	O

Nondysmorphic	B-problem
.	O

Positive	O
red	B-test
reflex	I-test
bilaterally	I-test
.	O

Neck	O
supple	O
,	O
no	O
lesions	B-problem
.	O

Chest	O
moderately	O
aerated	O
.	O

Mild	B-problem
grunting	I-problem
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
,	O
femoral	B-test
pulses	I-test
2+	O
.	O

Abdomen	O
soft	O
,	O
no	O
hepatosplenomegaly	B-problem
,	O
quiet	O
bowel	O
sounds	O
,	O
3	O
vessel	O
cord	O
.	O

CMED	O
CSRU	O
:	O

Normal	O
female	O
,	O
anus	O
patent	O
.	O

Hips	O
stable	O
.	O

Back	O
normal	O
.	O

No	O
lesions	B-problem
.	O

Appropriate	O
tone	O
and	O
activity	O
for	O
gestational	O
age	O
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
systems	O
:	O

Respiratory	O
:	O

Pocasset	O
was	O
admitted	O
to	O
the	O
newborn	O
intensive	O
care	O
unit	O
with	O
mild	B-problem
respiratory	I-problem
distress	I-problem
.	O

Chest	B-test
x-ray	I-test
revealed	O
a	B-problem
left	I-problem
pneumothorax	I-problem
which	O
resolved	O
on	O
its	O
own	O
without	O
intervention	B-treatment
.	O

The	O
infant	O
has	O
remained	O
in	O
room	O
air	O
throughout	O
her	O
hospital	O
course	O
with	O
occasional	B-problem
apnea	I-problem
and	O
bradycardia	B-problem
episodes	I-problem
,	O
the	O
last	O
being	O
documented	O
on	O
2020-01-14	O
.	O

Cardiovascular	O
:	O

Attleboro	O
has	O
been	O
stable	O
throughout	O
her	O
newborn	O
intensive	O
care	O
course	O
without	O
issue	O
.	O

Fluids	O
and	O
electrolytes	O
:	O

Birth	B-test
weight	I-test
was	O
1515	O
grams	O
.	O

She	O
was	O
initially	O
started	O
on	O
80	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
D10W	B-treatment
.	O

Enteral	B-treatment
feedings	I-treatment
were	O
initiated	O
on	O
day	O
of	O
life	O
#1	O
.	O

Full	B-treatment
enteral	I-treatment
feedings	I-treatment
were	O
achieved	O
by	O
day	O
of	O
life	O
#7	O
.	O

The	O
infant	O
had	O
a	O
course	O
of	O
heme	B-problem
positive	I-problem
stools	I-problem
with	O
grossly	B-problem
bloody	I-problem
streaks	I-problem
and	O
mucus	B-problem
felt	O
to	O
be	O
protein	B-problem
allergy	I-problem
.	O

The	O
infant	O
is	O
now	O
receiving	O
breast	O
milk	O
with	O
Nutramigen	B-treatment
powder	I-treatment
concentrate	I-treatment
to	O
24	O
calorie	O
.	O

Stools	O
have	O
been	O
negative	O
to	O
trace	B-problem
positive	I-problem
and	O
abdominal	B-test
exam	I-test
is	O
reassuring	O
.	O

Discharge	B-test
weight	I-test
is	O
2040	O
gm	O
,	O
the	B-test
head	I-test
circumference	I-test
is	O
32	O
cm	O
and	O
the	B-test
length	I-test
is	O
46	O
cm.	O
.	O

GI	O
:	O

Peak	B-test
bilirubin	I-test
was	O
on	O
day	O
of	O
life	O
#2	O
of	O
4.8/0.3	O
.	O

Hematology	O
:	O

Hematocrit	B-test
on	O
admission	O
was	O
41	O
.	O

The	O
infant	O
did	O
not	O
require	O
any	B-treatment
blood	I-treatment
transfusions	I-treatment
during	O
this	O
hospital	O
course	O
.	O

Infectious	O
disease	O
:	O

CBC	B-test
and	O
blood	B-test
culture	I-test
were	O
obtained	O
on	O
admission	O
.	O

White	B-test
count	I-test
was	O
4.8	O
,	O
7	B-test
polys	I-test
,	O
zero	B-test
bands	I-test
,	O
platelet	B-test
count	I-test
of	O
316,000	O
.	O

ANC	B-test
at	O
that	O
time	O
was	O
336	O
.	O

A	B-test
24	I-test
hour	I-test
CBC	I-test
was	O
obtained	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
was	O
5.1	O
,	O
22	B-test
polys	I-test
,	O
zero	B-test
bands	I-test
with	O
a	B-test
hematocrit	I-test
of	O
39.3	O
and	O
platelets	B-test
of	O
313,000	O
.	O

The	O
infant	O
received	O
48	O
hours	O
of	O
ampicillin	B-treatment
and	O
gentamicin	B-treatment
which	O
were	O
discontinued	O
with	O
a	O
negative	O
blood	O
culture	O
.	O

Neurology	O
:	O

The	O
infant	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
.	O

Sensory	O
:	O

Audiology	B-test
hearing	I-test
screen	I-test
was	O
performed	O
with	O
automated	B-test
auditory	I-test
brainstem	I-test
responses	I-test
and	O
the	O
infant	O
passed	O
on	O
both	O
ears	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
home	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Donald	O
Carrion	O
,	O
telephone	O
number	O
(	O
861	O
)	O
840	O
7928	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Continue	O
breast	O
milk	O
24	O
calories	O
of	O
Nutramigen	B-treatment
for	O
concentration	O
.	O

2.	O
Medications	B-treatment
:	O
The	O
infant	O
is	O
receiving	O
Fer-in-Phillip	B-treatment
supplementation	I-treatment
of	O
0.15	O
ml	O
p.o.	O
once	O
daily	O
.	O

3.	O
Car	B-test
seat	I-test
position	I-test
screening	I-test
was	O
performed	O
for	O
screening	O
and	O
the	O
infant	O
passed	O
.	O

4.	O
State	B-test
newborn	I-test
screens	I-test
have	O
been	O
sent	O
per	O
protocol	O
,	O
most	O
recently	O
on	O
01-11	O
,	O
and	O
have	O
been	O
within	O
normal	O
limits	O
.	O

5.	O
Immunizations	B-treatment
received	O
:	O
Hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
on	O
2020-01-19	O
.	O

6.	O
Immunizations	B-treatment
recommended	O
:	O

Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
November	O
through	O
March	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
3	O
criteria	O
:	O

Born	O
at	O
less	O
than	O
32	O
weeks	O
,	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
2	O
of	O
the	O
following	O
:	O

Daycare	O
during	O
RSV	O
season	O
,	O
a	O
smoker	O
in	O
the	O
household	O
,	O
neuromuscular	B-problem
disease	I-problem
,	O
airway	B-problem
abnormalities	I-problem
or	O
school	O
age	O
sibling	O
,	O
or	O
3	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
,	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Premature	B-problem
twin	I-problem
#1	O
born	O
at	O
32	O
and	O
5/7	O
weeks	O
.	O

2.	O
Rule	O
out	O
sepsis	B-problem
with	O
antibiotics	B-treatment
.	O

3.	O
Respiratory	B-problem
distress	I-problem
with	O
left	B-problem
pneumothorax	I-problem
resolved	O
.	O

4.	O
Mild	B-problem
hyperbilirubinemia	I-problem
.	O

5.	O
Mild	B-problem
apnea	I-problem
and	I-problem
bradycardia	I-problem
of	O
prematurity	B-problem
resolved	O
.	O

6.	O
Possible	O
milk	B-problem
proteine	I-problem
allergy	I-problem

FOLLOW	O
UP	O
:	O

Appointments	O
recommended	O
:	O

A	B-test
hip	I-test
ultrasound	I-test
due	O
to	O
breech	B-problem
/	O
breech	B-problem
presentation	I-problem
of	I-problem
twins	I-problem
.	O

Tai	O
Pamela	O
Christopher	O
,	O
Oklahoma	O
05158	O

Dictated	O
By	O
:	O
John	O
T	O
Hall	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2020-01-19	O
02:52:47	O

T	O
:	O
2020-01-19	O
09:12:10	O

Job	O
#:	O
76780	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Charles	O
TRAN	O
on	O
:	O
MON	O
2020-01-20	O
8:22	O
AM	O

(	O
End	O
of	O
Report	O
)	O

196768414	O
YC	O

36611261	O
PAD-WORD	O

5472577	O
PAD-WORD	O

5/7/2003	O
12:00:00	O
AM	O

SAVD	B-treatment
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

05/07/2003	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

05/09/2003	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

BOORMKAYSSCAJE	O
,	O
PA	O
A.	O
967-94-23-8	O
R21	O

Room	O
:	O

FISHIP	O
HOSPITAL	O

Service	O
:	O

OBS	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

05/09/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

DOUETLEPSGISS	O
,	O
VALETO	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

dr.	O
kote	O
6	O
weeks	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

Spontaneous	B-problem
vaginal	I-problem
delivery	I-problem
Laceration	I-problem
2	O
degrees	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
SAVD	B-treatment

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

SAVD	B-treatment
PAD-WORD	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O
PAD-WORD	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T2	O
P0	O
A0	O
L2	O
Estimated	O

EDC	O
:	O

Maternal	O
transfer	O
:	O

No	O
PAD-WORD	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

DOUETLEPSGISS	O
,	O
VALETO	O
,	O
M.D.	O
(	O
MC71	O
)	O
05/07/03	O
03:46	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2014-01-26	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-02-09	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1937-06-05	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

NSU	O
PAD-WORD	O

ADDENDUM	O
:	O

Addendum	O
from	O
the	O
dates	O
of	O
2014-02-04	O
until	O
2014-02-09	O
.	O

The	O
patient	O
had	O
no	O
complications	B-problem
or	O
further	B-problem
events	I-problem
while	O
in	O
house	O
.	O

On	O
Thursday	O
-	O
2014-02-06	O
-	O
the	O
patient	O
did	O
have	O
two	O
episodes	O
of	O
chest	B-problem
discomfort	I-problem
;	O
for	O
which	O
he	O
was	O
given	O
nitroglycerin	B-treatment
and	O
those	O
resolved	O
.	O

The	O
patient	O
did	O
have	O
an	O
evaluation	O
of	O
electrocardiogram	B-test
done	O
by	O
Cardiology	O
which	O
was	O
negative	O
and	O
had	O
laboratory	B-test
results	I-test
for	O
rule	O
out	O
myocardial	B-problem
infarction	I-problem
which	O
were	O
also	O
negative	O
.	O

Cardiology	O
was	O
aware	O
of	O
the	O
patient	O
.	O

The	O
patient	O
had	O
no	O
further	O
episodes	O
of	O
chest	B-problem
discomfort	I-problem
and	O
remained	O
afebrile	B-problem
while	O
in	O
house	O
.	O

Per	O
Infectious	O
Disease	O
,	O
okay	O
for	O
the	O
patient	O
to	O
be	O
discharged	O
in	O
stable	O
condition	O
to	O
Waltham/Weston	O
Hospital	O
facility	O
.	O

Penny	O
Clayton	O
,	O
Texas	O
87120	O

Dictated	O
By	O
:	O
Eugene	O
F	O
Balboa	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-02-09	O
11:17:25	O

T	O
:	O
2014-02-09	O
17:20:17	O

Job	O
#:	O
66630	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Elizabeth	O
Fernandez	O
on	O
:	O
MON	O
2014-02-10	O
4:27	O
PM	O

(	O
End	O
of	O
Report	O
)	O

207132235	O
SC	O

51203606	O
PAD-WORD	O

132775	O
PAD-WORD	O

9/20/2000	O
12:00:00	O
AM	O

ENDOMETRIAL	B-problem
CARCINOMA	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

09/20/2000	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

09/22/2000	O
PAD-WORD	O

ADMISSION	O
DIAGNOSIS	O
:	O

ENDOMETRIAL	B-problem
CANCER	I-problem
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

ENDOMETRIAL	B-problem
CANCER	I-problem
.	O

PROCEDURES	O
:	O

TOTAL	B-treatment
ABDOMINAL	I-treatment
HYSTERECTOMY	I-treatment
AND	O
BILATERAL	B-treatment
SALPINGO-OOPHORECTOMY	I-treatment

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
48-year-old	O
G	O
3	O
P	O
3	O
who	O
presented	O
to	O
Dr.	O
Fuscmadril	O
&apos;s	O
clinic	O
after	O
having	O
an	B-problem
abnormal	I-problem
pap	I-problem
smear	I-problem
followed	O
by	O
an	B-test
endometrial	I-test
biopsy	I-test
that	O
was	O
suggestive	O
of	O
grade	B-problem
1	I-problem
endometrial	I-problem
cancer	I-problem
.	O

This	O
is	O
a	O
patient	O
who	O
,	O
over	O
the	O
past	O
year	O
,	O
has	O
had	O
no	B-problem
menses	I-problem
and	O
thought	O
she	O
had	O
become	O
menopausal	B-problem
.	O

She	O
then	O
began	O
spotting	B-problem
for	O
several	O
months	O
with	O
some	B-problem
constant	I-problem
brown	I-problem
discharge	I-problem
.	O

A	B-test
pap	I-test
smear	I-test
that	O
was	O
obtained	O
by	O
her	O
primary	O
care	O
physician	O
showed	O
an	B-problem
endometrial	I-problem
cell	I-problem
and	O
thus	O
she	O
was	O
referred	O
to	O
a	O
gynecologist	O
for	O
an	B-test
endometrial	I-test
biopsy	I-test
.	O

The	B-test
endometrial	I-test
biopsy	I-test
showed	O
grade	B-problem
1	I-problem
endometrial	I-problem
cancer	I-problem
.	O

A	O
decision	O
was	O
made	O
to	O
proceed	O
with	O
surgical	B-treatment
management	I-treatment
for	O
this	O
finding	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Migraines	B-problem
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Two	B-treatment
cesarean	I-treatment
sections	I-treatment
.	O

PAST	O
GYN	O
HISTORY	O
:	O

Menarche	O
at	O
13	O
,	O
regular	O
menses	O
to	O
the	O
age	O
of	O
46	O
.	O

Then	O
becoming	O
irregular	B-problem
for	O
several	O
years	O
.	O

She	O
had	O
her	O
first	O
child	O
at	O
age	O
21	O
.	O

She	O
has	O
had	O
one	O
normal	B-treatment
spontaneous	I-treatment
vaginal	I-treatment
delivery	I-treatment
and	O
two	O
cesarean	B-treatment
sections	I-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
was	O
a	O
prior	O
off-and-on	O
smoker	O
but	O
has	O
quit	O
in	O
01/19	O
.	O

She	O
is	O
married	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Imitrex	B-treatment
;	O
Indocin	B-treatment
;	O
Celebrex	B-treatment
;	O
Verapamil	B-treatment
for	O
migraines	B-problem
.	O

FAMILY	O
HISTORY	O
:	O

Mother	O
with	O
colonic	B-problem
polyps	I-problem
.	O

She	O
has	O
a	O
maternal	O
uncle	O
and	O
maternal	O
aunt	O
both	O
with	O
colon	B-problem
cancer	I-problem
who	O
have	O
passed	O
away	O
from	O
this	B-problem
disease	I-problem
.	O

There	O
was	O
no	O
additional	O
history	O
of	O
breast	B-problem
,	I-problem
ovarian	I-problem
or	I-problem
uterine	I-problem
cancer	I-problem
in	O
her	O
family	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

GENERAL	O
:	O

She	O
is	O
a	O
well-developed	O
,	O
well-nourished	O
female	O
.	O

She	O
is	O
5	O
foot	O
4	O
inches	O
and	O
159	O
pounds	O
.	O

BREASTS	O
:	O

No	O
masses	B-problem
.	O

LUNGS	O
:	O

Clear	O
to	O
auscultation	B-test
.	O

HEART	O
:	O

Regular	O
rate	O
and	O
rhythm	O
.	O

ABDOMEN	O
:	O

Soft	O
,	O
mildly	B-problem
obese	I-problem
with	O
Pfannenstiel	B-problem
scar	I-problem
visualized	O
.	O

PELVIC	O
:	O

Normal	O
introitus	O
,	O
normal	O
appearing	O
cervix	O
,	O
a	O
small	O
,	O
mobile	O
uterus	O
.	O

No	O
additional	B-problem
masses	I-problem
or	O
nodules	B-problem
appreciated	O
on	O
exam	B-test
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
the	O
day	O
of	O
her	B-treatment
surgery	I-treatment
which	O
was	O
09/20/00	O
.	O

She	O
underwent	O
a	B-treatment
TAH-BSO	I-treatment
which	O
was	O
uncomplicated	B-problem
.	O

Details	O
of	O
the	B-treatment
procedure	I-treatment
can	O
be	O
found	O
in	O
the	O
operative	O
dictation	O
.	O

In	O
short	O
,	O
frozen	B-test
pathology	I-test
from	I-test
the	I-test
uterus	I-test
showed	O
that	O
there	O
was	O
a	B-problem
grade	I-problem
1	I-problem
cancer	I-problem
with	O
no	O
invasion	B-problem
of	I-problem
the	I-problem
myometrium	I-problem
.	O

There	O
was	O
no	O
nodal	B-test
dissection	I-test
done	O
at	O
that	O
time	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
extremely	O
well	O
and	O
did	O
well	O
during	O
her	O
postoperative	O
course	O
.	O

By	O
postoperative	O
day	O
#2	O
she	O
was	O
eating	O
,	O
ambulating	O
and	O
voiding	O
on	O
her	O
own	O
.	O

She	O
decided	O
to	O
now	O
be	O
discharged	O
home	O
at	O
this	O
time	O
.	O

She	O
was	O
discharged	O
home	O
with	O
the	B-treatment
following	I-treatment
medications	I-treatment
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

Percocet	B-treatment
;	O
Colace	B-treatment
.	O

FOLLOWUP	O
:	O

She	O
will	O
have	O
a	O
follow	O
up	O
appointment	O
with	O
Dr.	O
Fuscmadril	O
in	O
four	O
weeks	O
.	O

Dictated	O
By	O
:	O

ARL	O
STIREDELS	O
,	O
M.D.	O
ZJ05	O

Attending	O
:	O

EAN	O
L.	O
FUSCMADRIL	O
,	O
M.D.	O
RY2	O
JE898/7007	O

Batch	O
:	O

91309	O
PAD-WORD	O

Index	O
No.	O
DOABVQ3G8W	O

D	O
:	O

09/22/00	O
PAD-WORD	O

T	O
:	O

09/23/00	O
PAD-WORD	O

Admission	O
Date	O
:	O

2015-08-22	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-08-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1946-09-05	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Leroy	O
F	O
Stalnaker	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Right-sided	B-problem
weakness	I-problem
and	O
difficulty	B-problem
speaking	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

TPA	B-treatment
administration	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

68	O
year	O
old	O
right	O
handed	O
man	O
with	O
multiple	B-problem
vascular	I-problem
risk	I-problem
factors	I-problem
,	O
including	O
2	B-problem
previous	I-problem
strokes	I-problem
and	O
two	B-problem
myocardial	I-problem
infarctions	I-problem
,	O
hypertension	B-problem
and	O
hypercholesterolemia	B-problem
,	O
who	O
presents	O
with	O
acute	B-problem
onset	I-problem
right	I-problem
sided	I-problem
hemiplegia	I-problem
and	O
dysarthria	B-problem
.	O

He	O
went	O
to	O
the	O
bathroom	O
on	O
his	O
own	O
at	O
6:12	O
AM	O
and	O
then	O
called	O
for	O
help	O
at	O
6:15	O
AM	O
.	O

His	O
wife	O
found	O
him	O
with	O
weak	B-problem
right	I-problem
leg	I-problem
,	O
flaccid	B-problem
right	I-problem
arm	I-problem
,	O
and	O
severe	B-problem
dysarthria	I-problem
.	O

She	O
called	O
911	O
and	O
he	O
was	O
brought	O
to	O
Hahnemann	O
General	O
Hospital	O
Lydia	O
.	O

ROS	O
:	O

Wife	O
denies	O
any	B-problem
recent	I-problem
bleeding	I-problem
,	O
surgeries	B-treatment
,	O
or	O
upper	B-problem
respiratory	I-problem
infection	I-problem
.	O

Past	O
Medical	O
History	O
:	O

1.	O
1992	O
anterior	B-problem
cerebellar	I-problem
infarction	I-problem

2.	O
Silent	B-problem
stroke	I-problem
affecting	O
anterior	O
part	O
of	O
brain	O

3.	O
2014-09-24	O
left	B-problem
MCA	I-problem
stroke	I-problem
leaving	O
him	O
with	O
right	B-problem
facial	I-problem
droop	I-problem

4.	O
CAD	B-problem
with	O
MI	B-problem
1999	O
and	O
CABG	B-treatment

5.	O
hypercholesterolinemia	B-problem

6.	O
hypertension	B-problem

7.	O
remote	O
smoking	O
history	O

8.	O
depression	B-problem

9.	O
bipolar	B-problem
disorder	I-problem

Social	O
History	O
:	O

He	O
is	O
N.	O
Quinn	O
educated	O
retired	O
data	O
processor	O
who	O
lives	O
with	O
his	O
wife	O
.	O

Brian	O
quit	O
smoking	O
and	O
drinking	O
in	O
1980s	O
.	O

No	O
history	O
of	O
ivdu	O

Family	O
History	O
:	O

Patient	O
's	O
mother	O
died	O
of	O
stroke	B-problem
at	O
the	O
age	O
of	O
54	O
.	O

Physical	O
Exam	O
:	O

Vitals	B-test
97.2	O
164/97	O
59	O
20	O
100%	O
room	O
air	O

General	B-test
exam	I-test
including	O
head	B-test
,	I-test
neck	I-test
,	I-test
heart	I-test
,	I-test
lung	I-test
,	I-test
abdominal	I-test
and	I-test
extremity	I-test
exam	I-test
,	O
was	O
normal	O
.	O

Neuro	O
exam	O
:	O

Awake	O
,	O
oriented	O
to	O
person	O
and	O
place	O

Nonfluent	B-problem
speech	I-problem
with	O
inability	O
to	O
repeat	O
.	O

Intact	O
to	O
simple	O
comprehension	O
such	O
as	O
"	O
show	O
your	O
left	O
hand	O
"	O
but	O
not	O
"	O
show	O
your	O
left	O
thumb	O
"	O
.	O

No	O
neglect	B-problem

CN	O
-	O
Pupil	O
3	O
to	O
2	O
mm	O
reactive	O
bilaterally	O
.	O

EOMI	O
.	O

Visual	O
field	O
full	O
to	O
hand	B-test
waving	I-test
.	O

Right	B-problem
facial	I-problem
droop	I-problem
.	O

Motor	O
-	O
Decreased	B-problem
tone	I-problem
on	I-problem
right	I-problem
arm	I-problem
.	O

Unable	O
to	O
move	O
right	O
arm	O
but	O
able	O
to	O
lift	O
right	O
leg	O
antigravity	O
for	O
less	O
than	O
5	O
seconds	O

Sensory	O
-	O
Dense	B-problem
loss	I-problem
to	O
touch	B-test
on	O
the	O
right	O
arm	O
and	O
leg	O

Reflex	B-test
-	O
1+	O
/	O
4	O
in	O
upper	O
extremity	O
,	O
2+	O
/	O
4	O
at	O
patellar	O
,	O
trace	O
ankle	O
.	O

Toe	O
upgoing	O
on	O
right	O
only	O
.	O

Coordination	O
:	O

Intact	O
on	O
left	O
finger	B-test
to	I-test
nose	I-test
but	O
limited	B-problem
on	O
right	O
due	O
to	O
weakness	B-problem

Pertinent	O
Results	O
:	O

Creatinine	B-problem
slightly	I-problem
elevated	I-problem
at	O
1.3	O
,	O
otherwise	O
CBC	B-test
,	O
chemistries	B-test
normal	O
.	O

Cardiac	B-test
enzymes	I-test
normal	O
.	O

Valproate	B-test
level	I-test
within	O
range	O
.	O

CT	B-test
head	I-test
:	O

Slight	B-problem
effacement	I-problem
of	I-problem
posterior	I-problem
insular	I-problem
cortex	I-problem
.	O

MRI	B-test
head	I-test
:	O

Restricted	B-problem
diffusion	I-problem
in	I-problem
left	I-problem
frontotemporal	I-problem
region	I-problem
in	O
the	O
distribution	O
of	O
the	O
right	O
middle	O
cerebral	O
artery	O
indicating	O
acute	B-problem
infarct	I-problem
.	O

Brain	B-problem
atrophy	I-problem
.	O

Changes	O
of	O
small	B-problem
vessel	I-problem
disease	I-problem
and	O
chronic	B-problem
lacunes	I-problem
bilaterally	I-problem
in	I-problem
basal	I-problem
ganglia	I-problem
.	O

Probable	O
chronic	B-problem
infarct	I-problem
in	I-problem
the	I-problem
right	I-problem
occipital	I-problem
cortex	I-problem
.	O

Also	O
a	B-problem
chronic	I-problem
infarction	I-problem
in	I-problem
the	I-problem
right	I-problem
cerebellum	I-problem
.	O

No	O
acute	B-problem
hemorrhage	I-problem
.	O

MRA	B-test
:	O

Subtle	B-problem
decreased	I-problem
flow	I-problem
signal	I-problem
within	I-problem
the	I-problem
Sylvian	I-problem
branches	I-problem
of	O
the	O
left	O
middle	O
cerebral	O
artery	O
.	O

No	O
evidence	O
of	O
major	B-problem
vascular	I-problem
occlusion	I-problem
seen	O
.	O

Carotid	B-test
ultrasound	I-test
:	O

No	O
stenosis	B-problem

Echo	B-test
:	O

Elongated	B-problem
left	I-problem
atrium	I-problem
.	O

LV	B-problem
cavity	I-problem
moderately	I-problem
dilated	I-problem
.	O

LVEF	B-test
30-35%	O
.	O

No	O
masses	B-problem
or	O
thrombi	B-problem
are	O
seen	O
in	O
the	O
left	O
ventricle	O
.	O

Resting	B-problem
regional	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
include	O
apical	B-problem
dyskinesis	I-problem
and	O
distal	O
anterior	O
,	O
septal	O
,	O
mid	O
and	O
distal	B-problem
inferior	I-problem
and	I-problem
inferolateral	I-problem
wall	I-problem
akinesis	I-problem
.	O

Normal	O
RV	O
size	O
and	O
function	O
.	O

Mildly	B-problem
dilated	I-problem
aortic	I-problem
root	I-problem
and	I-problem
ascending	I-problem
aorta	I-problem
.	O

No	O
aortic	B-problem
or	I-problem
mitral	I-problem
regurgitation	I-problem
.	O

No	O
pericardial	B-problem
effusion	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

Assessment	O
:	O

68M	O
with	O
multiple	B-problem
vascular	I-problem
risk	I-problem
factors	I-problem
presents	O
with	O
acute	B-problem
onset	I-problem
right-sided	I-problem
hemiparesis	I-problem
and	O
dysarthria	B-problem
,	O
aphasia	B-problem
concerning	O
for	O
acute	B-problem
left	I-problem
MCA	I-problem
infarct	I-problem
.	O

Patient	O
arrived	O
in	O
Daniel	O
within	O
3	O
hours	O
of	O
symptom	B-problem
onset	I-problem
and	O
head	B-test
CT	I-test
showed	O
no	O
evidence	O
of	O
bleed	B-problem
.	O

However	O
,	O
as	O
wife	O
had	O
not	O
seen	O
patient	O
before	O
he	O
became	O
symptomatic	B-problem
,	O
there	O
was	O
some	O
concern	O
that	O
he	O
had	O
symptoms	B-problem
earlier	O
than	O
6	O
am	O
,	O
and	O
therefore	O
would	O
be	O
outside	O
the	O
3	O
hour	O
window	O
for	O
TPA	B-treatment
.	O

MRI	B-test
was	O
performed	O
which	O
showed	O
diffusion	B-problem
abnormalities	I-problem
but	O
no	O
hyperintensity	B-problem
on	O
T2	B-test
/	I-test
FLAIR	I-test
imaging	I-test
supporting	O
the	O
acute	O
onset	O
.	O

Therefore	O
,	O
IV	B-treatment
tpa	I-treatment
thrombolytics	I-treatment
were	O
administered	O
within	O
3	O
hours	O
of	O
symptom	B-problem
onset	I-problem
.	O

Within	O
minutes	O
the	O
patient	O
showed	O
decreased	B-problem
right	I-problem
sided	I-problem
weakness	I-problem
and	O
improved	O
from	O
a	B-problem
global	I-problem
aphasia	I-problem
to	O
an	B-problem
anterior	I-problem
aphasia	I-problem
picture	I-problem
.	O

Given	O
the	O
likely	O
embolic	B-problem
etiology	I-problem
of	O
infarct	B-problem
,	O
carotid	B-test
doppler	I-test
and	O
TTE	B-test
were	O
performed	O
.	O

Doppler	B-test
revealed	O
no	O
hemodynamically	B-problem
significant	I-problem
lesions	I-problem
bilaterally	I-problem
.	O

Echo	B-test
did	O
not	O
reveal	O
potential	O
source	O
of	O
emboli	B-problem
,	O
but	O
showed	O
striking	B-problem
left	I-problem
ventricle	I-problem
akinesis	I-problem
and	O
hypokinesis	B-problem
presumbly	O
due	O
to	O
past	B-problem
MI	I-problem
x	O
2	O
.	O

Given	O
that	O
the	B-problem
stroke	I-problem
occurred	O
while	O
taking	O
aspirin	B-treatment
and	O
plavix	B-treatment
,	O
and	O
given	O
the	B-problem
severe	I-problem
akinesis	I-problem
of	I-problem
the	I-problem
left	I-problem
ventricle	I-problem
,	O
we	O
decided	O
to	O
initiate	O
anticoagulation	B-treatment
with	O
warfarin	B-treatment
to	O
help	O
prevent	O
future	B-problem
strokes	I-problem
.	O

Anticoagulation	B-treatment
therapy	I-treatment
was	O
initiated	O
with	O
heparin	B-treatment
and	O
coumadin	B-treatment
beginning	O
on	O
the	O
evening	O
of	O
2016-08-23	O
.	O

The	O
patient	O
and	O
his	O
wife	O
,	O
a	O
nurse	O
,	O
were	O
educated	O
on	O
low	B-treatment
molecular	I-treatment
wt	I-treatment
heparin	I-treatment
,	O
which	O
was	O
started	O
in	O
the	O
hospital	O
on	O
2015-08-26	O
with	O
close	O
follow-up	O
scheduled	O
with	O
Dr.	O
Demmert	O
of	O
the	O
Wareham	O
VA	O
primary	O
care	O
clinic	O
the	O
next	O
morning	O
.	O

His	B-treatment
depakote	I-treatment
was	O
continued	O
for	O
his	B-problem
bipolar	I-problem
disorder	I-problem
.	O

On	O
discharge	O
,	O
strength	O
was	O
nearly	O
intact	O
in	O
the	O
limbs	O
,	O
though	O
he	O
still	O
had	O
a	B-problem
right-sided	I-problem
facial	I-problem
droop	I-problem
.	O

Additionally	O
,	O
he	O
still	O
had	O
mild	B-problem
dysarthria	I-problem
and	O
mild	B-problem
anterior	I-problem
aphasia	I-problem
.	O

Additionally	O
,	O
risk	B-treatment
factor	I-treatment
modification	I-treatment
was	O
continued	O
.	O

Lipid	B-test
panel	I-test
was	O
checked	O
and	O
showed	O
good	O
control	O
of	O
lipids	O
on	O
his	B-treatment
home	I-treatment
dose	I-treatment
of	I-treatment
zocor	I-treatment
.	O

Patient	O
has	O
no	O
history	O
of	O
diabetes	B-problem
,	O
and	O
fasting	B-test
glucose	I-test
was	O
78	O
,	O
but	O
A1C	B-test
was	O
slightly	B-problem
elevated	I-problem
at	O
5.9	O
.	O

He	O
may	O
need	O
further	B-test
glucose	I-test
monitoring	I-test
in	O
the	O
future	O
.	O

His	B-treatment
home	I-treatment
hypertensive	I-treatment
medications	I-treatment
were	O
held	O
while	O
in	O
the	O
hospital	O
to	O
help	O
increase	O
cerebral	O
perfusion	O
and	O
prevent	O
further	B-problem
ischemia	I-problem
.	O

They	O
will	O
be	O
restarted	O
on	O
discharge	O
.	O

Speech	O
therapy	O
was	O
also	O
consulted	O
,	O
and	O
recommended	O
oupatient	B-treatment
speech	I-treatment
therapy	I-treatment
.	O

Similarly	O
,	O
outpatient	B-treatment
PT	I-treatment
was	O
recommended	O
for	O
his	B-problem
gait	I-problem
difficulties	I-problem
from	O
his	B-problem
previous	I-problem
strokes	I-problem
.	O

Residual	B-problem
deficits	I-problem
include	O
right	B-problem
side	I-problem
facial	I-problem
droop	I-problem
from	O
previous	B-problem
stroke	I-problem
and	O
moderately	B-problem
severe	I-problem
dysarthria	I-problem
and	O
anterior	B-problem
aphasia	I-problem
with	O
word	B-problem
finding	I-problem
difficulties	I-problem
.	O

Medications	O
on	O
Admission	O
:	O

Captopril	B-treatment
50	O
bid	O
,	O
asa	B-treatment
81	O
,	O
plavix	B-treatment
75	O
,	O
zocor	B-treatment
40	O
,	O
imdur	B-treatment
30	O
,	O
lasix	B-treatment
10	O
,	O
prozac	B-treatment
20	O
,	O
iron	B-treatment
,	O
mvi	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Enoxaparin	B-treatment
Sodium	I-treatment
80	O
mg	O
/	O
0.8	O
mL	O
Syringe	O
Sig	O
:	O
One	O
(	O
1	O
)	O
syringe	O
Subcutaneous	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
:	O
May	O
discontinue	O
once	O
INR	B-test
therapeutic	O
as	O
directed	O
by	O
your	O
physician	O
.	O

2.	O
Divalproex	B-treatment
Sodium	I-treatment
500	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QD	O
(	O
once	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

4.	O
Warfarin	B-treatment
Sodium	I-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

5.	O
Simvastatin	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

6.	O
Prozac	B-treatment
20	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
once	O
a	O
day	O
.	O

7.	O
Multivitamin	B-treatment
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
once	O
a	O
day	O
.	O

8.	O
Captopril	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
twice	O
a	O
day	O
.	O

9.	O
Imdur	B-treatment
30	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24HR	O
PO	O
once	O
a	O
day	O
.	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

Infarction	B-problem
of	I-problem
left	I-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
inferior	I-problem
division	I-problem
,	O
s/p	O

TPA	B-treatment
,	O
with	O
residual	B-problem
dysarthria	I-problem
and	O
aphasia	B-problem

Hypertension	B-problem
PAD-WORD	O

Hypercholesterolemia	B-problem
PAD-WORD	O

Coronary	B-problem
artery	I-problem
disease	I-problem

Discharge	O
Condition	O
:	O

Good	O
,	O
with	O
no	O
motor	B-problem
deficits	I-problem
,	O
mild	B-problem
dysarthria	I-problem
and	O
mild	B-problem
anterior	I-problem
aphasia	I-problem

Discharge	O
Instructions	O
:	O

Take	O
all	B-treatment
medications	I-treatment
as	O
directed	O
and	O
go	O
for	O
all	O
scheduled	O
appointments	O
for	O
anticoagulation	B-test
monitoring	I-test
.	O

If	O
problems	B-problem
with	I-problem
speech	I-problem
or	O
weakness	B-problem
worsen	O
,	O
go	O
immediately	O
to	O
an	O
emergency	O
room	O
for	O
evaluation	B-test
.	O

Followup	O
Instructions	O
:	O

Dr.	O
Demmert	O
at	O
Wareham	O
Taunton	O
State	O
Hospital	O
Clinic	O
Thursday	O
2015-08-27	O
10:30am	O
and	O
follow-up	O
as	O
scheduled	O
by	O
the	O
VA	O
in	O
their	O
coumadin	O
clinic	O
.	O

Follow-up	O
with	O
Dr.	O
Robert	O
in	O
1-2	O
weeks	O
.	O

Call	O
his	O
office	O
for	O
an	O
appointment	O
.	O

Follow-up	O
with	O
Dr.	O
Tina	O
Phillips	O
in	O
Stroke	O
Clinic	O
in	O
about	O
2	O
months	O
.	O

Call	O
415	O
9374	O
to	O
schedule	O
an	O
appointment	O
.	O

William	O
William	O
MD	O
,	O
PHD	O
13-279	O

Completed	O
by	O
:	O
Patricia	O
Francis	O
MD	O
16-284	O
2015-08-26	O
@	O
1922	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Exie	O
Culbreath	O
on	O
:	O
SUN	O
2015-09-06	O
10:03	O
PM	O

(	O
End	O
of	O
Report	O
)	O

210974938	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4139381	O
PAD-WORD	O

98764/u6tl	O
PAD-WORD	O

722206	O
PAD-WORD	O

5/30/1993	O
12:00:00	O
AM	O

INTRAVENOUS	B-treatment
CHEMOTHERAPY	I-treatment
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

5-30-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

6-2-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

INTRAVENOUS	B-treatment
CHEMOTHERAPY	I-treatment
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

LEFT	B-problem
UPPER	I-problem
LOBE	I-problem
LARGE	I-problem
CELL	I-problem
CARCINOMA	I-problem
OF	I-problem
THE	I-problem
LUNG	I-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

None	O
.	O

CLINICAL	O
INFECTIONS	O
:	O

None	O
PAD-WORD	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

Intravenous	B-treatment
chemotherapy	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
63	O
year	O
old	O
woman	O
with	O
a	O
history	O
of	O
mixed	B-problem
adenocarcinoma	I-problem
and	O
large	B-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
left	I-problem
upper	I-problem
lobe	I-problem
of	O
the	O
lung	O
who	O
is	O
being	O
admitted	O
for	O
Neoadjuvant	B-treatment
chemotherapy	I-treatment
with	O
Cisplatinum	B-treatment
,	O
5-FU	B-treatment
and	O
Velban	B-treatment
.	O

Her	O
history	O
has	O
been	O
well	O
documented	O
in	O
her	O
previous	O
notes	O
.	O

Briefly	O
,	O
she	O
was	O
originally	O
diagnosed	O
in	O
April	O
1993	O
with	O
lung	B-problem
carcinoma	I-problem
.	O

Bronchoscopy	B-test
and	O
mediastinoscopy	B-test
revealed	O
an	B-problem
unresectable	I-problem
mediastinal	I-problem
tumor	I-problem
with	O
the	O
left	O
tracheobronchial	O
angle	O
node	O
positive	O
for	O
cancer	B-problem
,	O
and	O
the	O
right	O
paratracheal	O
node	O
positive	O
for	O
anthracosis	B-problem
.	O

Formal	B-test
pathology	I-test
revealed	O
a	B-problem
poorly	I-problem
differentiated	I-problem
adenocarcinoma	I-problem
with	O
focal	B-problem
giant	I-problem
cells	I-problem
.	O

Bone	B-test
scan	I-test
,	O
head	B-test
CT	I-test
and	O
other	B-test
staging	I-test
studies	I-test
were	O
all	O
negative	O
for	O
evidence	O
of	O
metastatic	B-problem
disease	I-problem
.	O

The	O
patient	O
is	O
being	O
treated	O
with	O
preoperative	B-treatment
neoadjuvant	I-treatment
chemotherapy	I-treatment
using	I-treatment
5	I-treatment
FU	I-treatment
,	O
Vinblastine	B-treatment
,	O
Cisplatinum	B-treatment
and	O
concomitant	B-treatment
radiation	I-treatment
therapy	I-treatment
.	O

She	O
is	O
now	O
admitted	O
for	O
her	B-treatment
second	I-treatment
course	I-treatment
of	I-treatment
that	I-treatment
therapy	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

temperature	B-test
98.9	O
,	O
pulse	B-test
82	O
,	O
respirations	B-test
20	O
.	O

HEENT	O
:	O

pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
extra	O
ocular	O
movements	O
were	O
intact	O
.	O

Sclera	O
were	O
anicteric	B-problem
.	O

The	O
oropharynx	O
was	O
clear	O
.	O

The	O
neck	O
was	O
supple	O
without	O
JVD	B-problem
.	O

The	O
lungs	O
showed	O
decreased	B-problem
breath	I-problem
sounds	I-problem
at	I-problem
the	I-problem
right	I-problem
base	I-problem
,	O
otherwise	O
were	O
clear	O
.	O

The	B-test
cardiac	I-test
exam	I-test
showed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
I	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

Abdomen	O
was	O
soft	O
and	O
nontender	B-problem
,	O
without	O
masses	B-problem
or	O
hepatosplenomegaly	B-problem
.	O

Rectal	B-test
exam	I-test
was	O
guaiac	B-test
negative	O
.	O

Extremities	O
were	O
without	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

Neurologic	B-test
exam	I-test
revealed	O
a	B-problem
resting	I-problem
tremor	I-problem
in	I-problem
the	I-problem
right	I-problem
arm	I-problem
and	I-problem
hand	I-problem
.	O

LABORATORY	O
DATA	O
:	O

white	B-test
blood	I-test
count	I-test
6.2	O
,	O
hemoglobin	B-test
12.4	O
,	O
hematocrit	B-test
36.1	O
,	O
platelet	B-test
count	I-test
265,000	O
.	O

The	B-test
liver	I-test
function	I-test
tests	I-test
were	O
within	O
normal	O
limits	O
.	O

BUN	B-test
8	O
,	O
creatinine	B-test
0.9	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Oncology	O
Service	O
on	O
Founder	O
&apos;s	O
7	O
and	O
received	O
intravenous	B-treatment
chemotherapy	I-treatment
with	O
a	B-treatment
72	I-treatment
hour	I-treatment
continuous	I-treatment
infusion	I-treatment
of	I-treatment
5-FU	I-treatment
,	O
Vinblastine	B-treatment
on	O
day	O
1	O
and	O
day	O
3	O
,	O
and	O
Cisplatinum	B-treatment
on	O
day	O
1	O
.	O

She	O
tolerated	O
the	B-treatment
chemotherapy	I-treatment
well	O
with	O
mild	B-problem
nausea	I-problem
and	O
vomiting	B-problem
.	O

She	O
had	O
mild	B-problem
increase	I-problem
in	O
her	B-problem
hypertension	I-problem
during	O
the	O
hospitalization	O
,	O
likely	O
secondary	O
to	O
fluid	B-problem
overload	I-problem
.	O

She	O
also	O
had	O
some	B-problem
modest	I-problem
anemia	I-problem
,	O
at	O
the	O
time	O
of	O
discharge	O
her	B-test
hematocrit	I-test
was	O
30.9	O
.	O

Overall	O
there	O
were	O
no	O
unanticipated	B-problem
side	I-problem
effects	I-problem
of	O
this	B-treatment
chemotherapy	I-treatment
.	O

Following	O
her	O
recovery	O
from	O
chemotherapy	B-treatment
,	O
she	O
will	O
proceed	O
to	O
surgical	B-treatment
resection	I-treatment
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Intravenous	B-treatment
chemotherapy	I-treatment
for	O
lung	B-problem
cancer	I-problem
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

Slo-Mag	B-treatment
one	O
tab	O
p.o.	O
b.i.d.	O
Stelazine	B-treatment
2	O
mg.	O
p.o.	O
q.d.	O
Ativan	B-treatment
1	O
mg	O
p.o.	O
or	O
s.l.	O
q.	O
4-6	O
hr.	O
p.r.n.	O
nausea	B-problem
.	O

WORK	O
DISABILITY	O
AND	O
PROBABLE	O
DURATION	O
,	O
COMPLETE	O
.	O

Followup	O
will	O
be	O
with	O
Dr.	O
Guabenfranda	O
Day	O
in	O
his	O
office	O
.	O

CA	O
SHUFF	O
,	O
M.D.	O

TR	O
:	O

ds	O
/	O
bmot	O

DD	O
:	O

6-2	O
93	O

TD	O
:	O

06/04/93	O
PAD-WORD	O

CC	O
:	O

GUABENFRANDA	O
DAY	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2019-07-17	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-07-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1980-01-29	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Cephalosporins	B-treatment
/	O
Dilaudid	B-treatment
/	O
Metoclopramide	B-treatment

Attending	O
:	O
Bradley	O
A.	O
Goldware	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
respiratory	B-problem
failure	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
PAD-WORD	O

Central	B-treatment
line	I-treatment
placement	I-treatment

Bronchoscopy	B-test
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
a	O
39	O
year-old	O
female	O
with	O
a	O
history	O
of	O
diabetes	B-problem
type	I-problem
I	I-problem
on	O
an	B-treatment
insulin	I-treatment
pump	I-treatment
,	O
anemia	B-problem
,	O
hypothyroidism	B-problem
,	O
gastroparesis	B-problem
,	O
GERD	B-problem
,	O
who	O
was	O
transferred	O
from	O
Mediplex	O
Rehab	O
Hospital	O
Hospital	O
for	O
further	B-treatment
management	I-treatment
of	O
hypoxic	B-problem
respiratory	I-problem
failure	I-problem
.	O

She	O
arrived	O
at	O
Mediplex	O
Rehab	O
Hospital	O
Hospital	O
on	O
07-01	O
for	O
1	O
day	O
of	O
nausea	B-problem
and	O
vomiting	B-problem
and	O
was	O
found	O
to	O
be	O
febrile	B-problem
to	O
99	O
at	O
that	O
time	O
.	O

She	O
was	O
admitted	O
for	O
likely	O
gastroparesis	B-problem
and	O
eventually	O
had	O
a	B-test
complete	I-test
fever	I-test
work-up	I-test
that	O
included	O
a	O
negative	O
chest	O
x-ray	O
,	O
blood	O
cultures	O
,	O
and	O
urine	O
culture	O
.	O

She	O
was	O
discharged	O
on	O
07-02	O
and	O
represented	O
that	O
day	O
with	O
continued	B-problem
nause	I-problem
,	O
vomiting	B-problem
,	O
and	O
fever	B-problem
.	O

She	O
was	O
readmitted	O
and	O
had	O
a	B-test
complete	I-test
febrile	I-test
work-up	I-test
that	O
included	O
CT	B-test
abdomene	I-test
/	I-test
pelvis	I-test
,	O
chest	B-test
x-ray	I-test
,	O
blood	B-test
culture	I-test
's	I-test
,	O
urine	B-test
cultures	I-test
,	O
all	O
of	O
which	O
were	O
unremarkable	O
.	O

She	O
was	O
intubated	O
on	O
07-03	O
for	O
progressive	B-problem
respiratory	I-problem
failure	I-problem
.	O

Workup	B-test
continued	O
to	O
be	O
negative	O
.	O

Extubation	B-treatment
was	O
attempted	O
on	O
07-14	O
,	O
but	O
she	O
was	O
re-intubated	O
due	O
to	O
inspiratory	B-problem
stridor	I-problem
.	O

A	B-test
CT	I-test
neck	I-test
showed	O
soft	B-problem
tissue	I-problem
swelling	I-problem
obliterating	O
the	O
airway	O
surrounding	O
the	B-treatment
ETT	I-treatment
tube	I-treatment
.	O

She	O
was	O
transferred	O
to	O
Providence	O
Behavioral	O
Health	O
Hospital	O
for	O
further	O
management	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Type	B-problem
I	I-problem
diabetes	I-problem
diagnosed	O
at	O
age	O
27	O
.	O

She	O
is	O
usually	O
managed	O
on	O
an	B-treatment
insulin	I-treatment
pump	I-treatment
.	O

2.	O
Hashimoto	B-problem
's	I-problem
thyroiditis	I-problem
.	O

3.	O
Gastroparesis	B-problem

4.	O
History	O
of	O
bulemia	B-problem

5.	O
Anxiety	B-problem
on	O
clonazepam	B-treatment

6.	O
History	O
of	O
diabetic	B-problem
foot	I-problem
ulcer	I-problem
.	O

Social	O
History	O
:	O

She	O
is	O
married	O
and	O
lives	O
with	O
her	O
husband	O
.	O

She	O
has	O
a	O
10	O
month	O
old	O
child	O
.	O

She	O
denies	O
any	O
alcohol	O
,	O
tobacco	O
,	O
or	O
other	O
drugs	O
.	O

Family	O
History	O
:	O

Non-contributory	O
.	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O

Temperature	B-test
:	O
98.8	O
Pulse	B-test
:	O
79	O

Blood	B-test
Pressure	I-test
:	O
125/89	O

Respiratory	B-test
Rate	I-test
:	O
12	O

Oxygen	B-test
Saturation	I-test
:	O
100%	O
on	O
AC	B-treatment
500x12	O
,	O
PEEP5	B-treatment
,	O
50%	O

GENERAL	O
:	O

Intubated	B-treatment
,	O
sedated	B-treatment
,	O
not	B-problem
responsive	I-problem
to	O
command	B-test
,	O
retracts	O
to	O
pain	B-test

HEENT	O
:	O

Anicteric	B-problem
sclera	I-problem
bilat	I-problem
.	O

Pupils	B-problem
minimally	I-problem
reactive	I-problem

NECK	O
:	O

No	O
elevated	B-problem
JVP	I-problem
appreciated	O
.	O

CARDIAC	O
:	O

Regular	O
,	O
s1,s2	O
.	O

No	O
murmurs	B-problem

RESPIRATORY	O
:	O

Clear	O
to	O
auscultation	B-test
anteriorly	O
.	O

ABDOMEN	O
:	O

Soft	O
.	O

Nondistended	B-problem
.	O

No	O
hepatosplenomegally	B-problem
.	O

Mildly	B-problem
hypoactive	I-problem
bowelsounds	I-problem
.	O

EXTREMITIES	O
:	O

No	O
edema	B-problem
bilaterally	I-problem
.	O

Pulses	B-problem
diminished	I-problem
but	O
symmetric	O
.	O

NEURO	O
:	O

Sedated	B-treatment
.	O

Retracts	O
to	O
painful	B-test
stimuli	I-test

SKIN	O
:	O

No	O
rashes	B-problem

Pertinent	O
Results	O
:	O

Hematology	O
:	O

WBC	B-test
-	O
29.9	O
HGB	B-test
-	O
8.5	O
HCT	B-test
-	O
26.8	O
PLT	B-test
COUNT	I-test
-	O
323	O
NEUTS	B-test
-	O
75	O
BANDS	B-test
-	O
13	O
LYMPHS	B-test
-	O
6	O
MONOS	B-test
-	O
5	O
EOS	B-test
-	O
1	O
BASOS	B-test
-	O
0	O
ATYPS	B-test
-	O
0	O
METAS	B-test
-	O
0	O
MYELOS	B-test
-	O
0	O

Chemistries	O
:	O

SODIUM	B-test
-	O
137	O
POTASSIUM	B-test
-	O
4.5	O
CHLORIDE	B-test
-	O
106	O
TOTAL	B-test
CO2	I-test
-	O
22	O
UREA	B-test
N	I-test
-	O
41	O
*	O
CREAT	B-test
-	O
1.3	O
GLUCOSE	B-test
-	O
231	O
CALCIUM	B-test
-	O
7.7	O
PHOSPHATE	B-test
-	O
3.6	O
MAGNESIUM	B-test
-	O
2.4	O

Liver	O
Function	O
:	O

ALT	B-test
(	I-test
SGPT	I-test
)-	I-test
249	O
AST	B-test
(	I-test
SGOT	I-test
)-	I-test
147	O
LD	B-test
(	I-test
LDH	I-test
)-	I-test
241	O
ALK	B-test
PHOS	I-test
-	O
230	O
AMYLASE	B-test
-	O
28	O
TOT	B-test
BILI	I-test
-	O
0.9	O
LIPASE	B-test
-	O
12	O
ALBUMIN	B-test
-	O
2.6	O

Coagulation	O
:	O

PT	B-test
-	O
13.8	O
PTT	B-test
-	O
24.3	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.2	O

Thyroid	O
:	O

TSH	B-test
-	O
3.3	O

Imaging	O
:	O

1.	O
Nexk	B-test
CT	I-test
:	O

Increased	B-problem
soft	I-problem
tissues	I-problem
within	I-problem
the	I-problem
pharynx	I-problem
.	O

This	O
may	O
be	O
secondary	O
to	O
soft	B-problem
tissue	I-problem
swelling	I-problem
as	O
indicated	O
in	O
the	O
patient	O
's	O
history	O
,	O
and	O
some	O
may	O
be	O
secondary	O
to	O
secretions	B-problem
above	I-problem
the	I-problem
ETT	I-problem
balloon	I-problem
.	O

No	O
retropharyngeal	B-problem
fluid	I-problem
is	O
identified	O
.	O

Dependent	B-problem
atelectasis	I-problem
is	O
present	O
within	O
the	O
visualized	O
portions	O
of	O
the	O
lung	O
apices	O
.	O

2.	O
Chest	B-test
CT	I-test
:	O

Bilateral	B-problem
lower	I-problem
lobe	I-problem
consolidations	I-problem
mostly	O
in	O
dependent	O
portion	O
,	O
with	O
small	B-problem
pleural	I-problem
effusion	I-problem
and	O
diffuse	B-problem
ground-glass	I-problem
opacity	I-problem
in	I-problem
bilateral	I-problem
upper	I-problem
and	I-problem
lower	I-problem
lobes	I-problem
,	O
consistent	O
with	O
ARDS	B-problem
with	O
pulmonary	B-problem
edema	I-problem
given	O
the	O
history	O
.	O

Ground-glass	B-problem
opacity	I-problem
is	O
somewhat	O
more	O
prominent	O
in	O
right	O
upper	O
lobe	O
,	O
and	O
superimposed	B-problem
infection	I-problem
cannot	O
be	O
totally	O
excluded	O
.	O

Brief	O
Hospital	O
Course	O
:	O

This	O
is	O
a	O
39	O
year-old	O
female	O
with	O
diabetes	B-problem
type	I-problem
I	I-problem
,	O
hypothyroidism	B-problem
,	O
gastroparesis	B-problem
who	O
was	O
transfered	O
for	O
hypoxic	B-problem
respiratory	I-problem
failure	I-problem
.	O

1.	O
Hypoxic	B-problem
Rspiratory	I-problem
Failure	I-problem
:	O

She	O
arrived	O
intubated	B-treatment
and	O
sedated	B-treatment
from	O
Esteban	O
Hospital	O
.	O

On	O
arrival	O
a	B-test
chest	I-test
x-ray	I-test
showed	O
perihilar	B-problem
and	I-problem
bibasilar	I-problem
opacities	I-problem
,	O
which	O
appeared	O
conistent	O
with	O
pulmonary	B-problem
edema	I-problem
but	O
also	O
possibly	O
consistent	O
with	O
a	B-problem
pneumonia	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
ARDS	B-problem
.	O

She	O
was	O
known	O
to	O
have	O
gram-positive	B-problem
cocci	I-problem
in	I-problem
her	I-problem
sputum	I-problem
at	O
the	O
outside	O
hospital	O
.	O

A	B-test
bronchoscopy	I-test
with	O
BAL	B-test
was	O
performed	O
and	O
a	B-test
sputum	I-test
sample	I-test
eventually	O
grew	O
out	O
MRSA	B-problem
.	O

She	O
was	O
treated	O
with	O
vancomycin	B-treatment
to	O
cover	O
her	B-problem
MRSA	I-problem
pneumonia	I-problem
.	O

A	B-test
CT	I-test
scan	I-test
was	O
performed	O
on	O
07-17	O
to	O
evaluate	O
the	B-problem
soft	I-problem
tissue	I-problem
swelling	I-problem
seen	O
on	O
CT	B-test
at	O
the	O
outside	O
hospital	O
.	O

The	B-test
CT	I-test
showed	O
increased	B-problem
soft	I-problem
tissues	I-problem
within	I-problem
the	I-problem
pharynx	I-problem
which	O
was	O
felt	O
to	O
be	O
secondary	O
to	O
prolonged	B-treatment
intubation	I-treatment
/	O
trauma	B-problem
.	O

She	O
was	O
treated	O
with	O
steroids	B-treatment
for	O
this	B-problem
swelling	I-problem
at	O
the	O
outside	O
hospital	O
,	O
and	O
these	O
were	O
continued	O
.	O

It	O
was	O
decided	O
that	O
patient	O
should	O
receive	O
one	O
more	O
trial	O
off	O
the	B-treatment
vent	I-treatment
before	O
committing	O
her	O
to	O
a	B-treatment
tracheotomy	I-treatment
.	O

She	O
did	O
well	O
on	O
minimal	B-treatment
vent	I-treatment
settings	I-treatment
but	O
it	O
was	O
decided	O
to	O
delay	O
extubating	O
the	O
patient	O
until	O
the	O
morning	O
of	O
6/2	O
.	O

Overnight	O
,	O
the	O
patient	O
became	O
hypoxic	B-problem
,	O
dropping	O
to	O
the	O
80	O
's	O
.	O

A	B-test
chest	I-test
x-ray	I-test
showed	O
that	O
the	B-treatment
ET	I-treatment
tube	I-treatment
was	O
displaced	B-problem
to	O
very	O
high	O
in	O
the	O
trachea	O
.	O

The	B-treatment
cuff	I-treatment
was	O
deflated	O
and	O
the	O
patient	O
was	O
extubated	O
.	O

She	O
was	O
placed	O
in	O
supplemental	B-treatment
oxygen	I-treatment
by	O
shovel	B-treatment
mask	I-treatment
and	O
her	B-test
sats	I-test
immediately	O
improved	O
.	O

She	O
was	O
weaned	O
down	O
until	O
she	O
was	O
maintaining	O
her	B-test
oxygen	I-test
saturation	I-test
above	O
90%	O
on	O
6L	O
by	O
nasal	B-treatment
cannuala	I-treatment
.	O

As	O
she	O
was	O
doing	O
well	O
without	O
evidence	O
of	O
stridor	B-problem
,	O
the	B-treatment
steroids	I-treatment
were	O
stopped	O
.	O

She	O
did	O
well	O
and	O
was	O
weaned	O
from	O
supplemental	B-treatment
oxygen	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
she	O
was	O
oxygenating	O
well	O
on	O
room	O
air	O
.	O

She	O
Will	O
need	O
to	O
complete	O
a	O
14	O
day	O
course	O
of	O
vancomycin	B-treatment
for	O
her	B-problem
MRSA	I-problem
pneumonia	I-problem
on	O
2019-07-30	O
.	O

2.	O
Enterobacter	B-problem
bacteremia	I-problem
:	O

She	O
was	O
initially	O
covered	O
broadly	O
with	O
vancomycin	B-treatment
,	O
ciprofloxacin	B-treatment
,	O
and	O
falgyl	B-treatment
.	O

She	O
had	O
positive	B-problem
blood	I-problem
cultures	I-problem
at	O
Mediplex	O
Rehab	O
Hospital	O
Hospital	O
for	O
gram	B-problem
negative	I-problem
rods	I-problem
.	O

Subsequently	O
,	O
zosyn	B-treatment
was	O
added	O
.	O

The	B-test
cultures	I-test
grew	O
out	O
enterobacter	B-problem
cloacae	I-problem
.	O

It	O
was	O
unclear	O
the	O
source	O
of	O
her	B-problem
bacteremia	I-problem
.	O

Her	B-test
stool	I-test
cultures	I-test
were	O
negative	O
.	O

Her	B-treatment
central	I-treatment
line	I-treatment
was	O
removed	O
and	O
the	B-treatment
tip	I-treatment
was	O
culture	O
negative	O
.	O

She	O
was	O
transitioned	O
to	O
on	O
levofloxacin	B-treatment
for	O
her	B-problem
bacteremia	I-problem
.	O

She	O
had	O
no	O
positive	B-problem
cultures	I-problem
during	O
this	O
admission	O
.	O

Once	O
she	O
was	O
more	O
stable	O
,	O
an	B-test
abdominal	I-test
CT	I-test
was	O
performed	O
to	O
look	O
for	O
an	B-problem
abscess	I-problem
.	O

This	B-test
study	I-test
was	O
negative	O
.	O

However	O
,	O
the	B-test
study	I-test
was	O
limited	O
due	O
to	O
inadequate	O
po	O
contrast	O
intake	O
by	O
the	O
patient	O
;	O
it	O
did	O
show	O
a	O
question	O
of	O
a	B-problem
cecal	I-problem
cystic	I-problem
lesion	I-problem
verse	O
normal	O
loop	O
of	O
bowel	O
.	O

This	B-test
study	I-test
will	O
need	O
to	O
be	O
repeated	O
once	O
she	O
is	O
tolerating	O
po	O
's	O
.	O

She	O
will	O
complete	O
a	O
14	O
day	O
course	O
of	O
levofloxacin	B-treatment
for	O
her	B-problem
bacteremia	I-problem
on	O
2019-07-30	O
.	O

3.	O
Diabetes	B-problem
type	I-problem
I	I-problem
:	O

She	O
was	O
intially	O
maintained	O
on	O
an	B-treatment
insulin	I-treatment
drip	I-treatment
for	O
tight	B-treatment
glycemic	I-treatment
control	I-treatment
.	O

She	O
was	O
followed	O
by	O
Albano	O
during	O
the	O
admission	O
.	O

She	O
was	O
initially	O
maintained	O
on	O
D5W	B-treatment
,	O
which	O
was	O
increased	O
to	O
D10W	B-treatment
as	O
the	O
patient	O
was	O
persistently	B-problem
borderline	I-problem
hypoglycemic	I-problem
while	O
on	O
insulin	B-treatment
drip	I-treatment
.	O

Once	O
she	O
began	O
to	O
take	O
PO	O
's	O
,	O
the	B-treatment
insulin	I-treatment
drip	I-treatment
was	O
stopped	O
and	O
patient	O
was	O
started	O
on	O
glargine	B-treatment
with	O
a	B-treatment
humalog	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

While	O
her	O
po	O
intake	O
was	O
minimal	O
she	O
was	O
maintained	O
on	O
supplemental	B-treatment
IV	I-treatment
dextrose	I-treatment
to	O
suppress	O
ketosis	B-problem
.	O

While	O
she	O
was	O
on	O
the	B-treatment
IV	I-treatment
dextrose	I-treatment
,	O
she	O
required	O
up	O
to	O
26	O
units	O
of	O
glargine	B-treatment
for	O
glycemic	B-treatment
control	I-treatment
.	O

As	O
she	O
starting	O
taking	O
some	O
foods	O
,	O
her	B-treatment
glargine	I-treatment
was	O
decrease	O
.	O

At	O
the	O
time	O
of	O
discharge	O
her	B-treatment
glargine	I-treatment
was	O
10	O
.	O

Her	B-test
blood	I-test
glucose	I-test
were	O
under	O
good	O
control	O
.	O

The	O
day	O
prior	O
to	O
discharge	O
,	O
she	O
was	O
nauseated	B-problem
and	O
not	O
taking	O
pos	O
.	O

Therefore	O
,	O
she	O
received	O
1L	O
of	O
D5	B-treatment
,	O
and	O
her	B-test
sugars	I-test
were	O
elevated	B-problem
to	O
400	O
the	O
day	O
of	O
discharge	O
.	O

4.	O
Gastroparesis	B-problem
:	O

She	O
has	O
a	O
history	O
of	O
gastroparesis	B-problem
secondary	O
to	O
long-standing	B-problem
type	I-problem
I	I-problem
diabetes	I-problem
.	O

Once	O
she	O
was	O
extubated	O
,	O
she	O
was	O
nauseated	B-problem
with	O
emesis	B-problem
.	O

She	O
was	O
intially	O
treated	O
with	O
erythromycin	B-treatment
for	O
pro-motility	O
as	O
she	O
had	O
a	B-problem
bad	I-problem
reaction	I-problem
to	O
reglan	B-treatment
in	O
the	O
past	O
.	O

She	O
continued	O
to	O
remained	O
nauseated	B-problem
so	O
she	O
was	O
treated	O
with	O
phenergan	B-treatment
,	O
anzemet	B-treatment
,	O
zofran	B-treatment
,	O
and	O
ativan	B-treatment
.	O

She	O
intermittently	O
was	O
able	O
tolerate	O
pos	O
.	O

Her	B-problem
nausea	I-problem
was	O
accompanied	O
by	O
abdominal	B-problem
pain	I-problem
for	O
which	O
she	O
was	O
treated	O
with	O
morphine	B-treatment
.	O

She	O
was	O
transitioned	O
to	O
a	B-treatment
PCA	I-treatment
for	O
better	B-treatment
pain	I-treatment
control	I-treatment
.	O

She	O
continued	O
to	O
have	O
nausea	B-problem
despite	O
an	B-treatment
agressive	I-treatment
anti-emetic	I-treatment
regimen	I-treatment
.	O

It	O
was	O
felt	O
that	O
her	B-problem
symptoms	I-problem
were	O
secondary	O
to	O
gastroparesis	B-problem
.	O

However	O
,	O
other	O
causes	O
were	O
looked	O
for	O
including	O
adrenal	B-problem
insufficiency	I-problem
and	O
bowel	B-problem
obstruction	I-problem
.	O

She	O
had	O
a	O
normal	O
cortisol	O
stimulation	O
test	O
.	O

A	B-test
abdominal	I-test
plain	I-test
film	I-test
showed	O
non-specific	B-problem
bowel	I-problem
gas	I-problem
patterns	I-problem
that	O
may	O
represent	O
an	B-problem
early	I-problem
obstruction	I-problem
.	O

A	B-treatment
NG	I-treatment
tube	I-treatment
was	O
placed	O
for	O
decompression	B-treatment
given	O
the	O
signs	O
of	O
early	B-problem
obstruction	I-problem
the	O
day	O
of	O
transfer	O
.	O

The	O
GI	O
service	O
was	O
consulted	O
and	O
they	O
felt	O
that	O
her	B-problem
symptoms	I-problem
were	O
all	O
gastroparesis	B-problem
.	O

They	O
recommended	O
erythromycin	B-treatment
and	O
zelnorm	B-treatment
.	O

She	O
should	O
eventually	O
have	O
a	B-test
tissue	I-test
transglutaminase	I-test
to	O
rule	O
out	O
celiac	B-problem
disease	I-problem
.	O

5.	O
Transaminitis	B-problem
:	O

Per	O
report	O
,	O
She	O
had	O
elevated	B-problem
LFTs	I-problem
at	O
the	O
outside	O
hospital	O
.	O

A	B-test
right	I-test
upper	I-test
quadrant	I-test
ultrasound	I-test
was	O
performed	O
and	O
was	O
negative	O
for	O
any	B-problem
acute	I-problem
pathology	I-problem
.	O

Her	B-test
LFTs	I-test
trended	O
down	O
during	O
this	O
admission	O
.	O

6.	O
Hypothyroidism	B-problem
:	O

She	O
was	O
maintained	O
on	O
her	B-treatment
levothyroxine	I-treatment
.	O

While	O
she	O
was	O
not	O
taking	O
adequate	O
pos	O
,	O
she	O
was	O
on	O
IV	B-treatment
levothyroxine	I-treatment
.	O

7.	O
F/E/N	O
:	O

She	O
was	O
NPO	B-treatment
while	O
intubated	B-treatment
and	O
recived	O
tube	B-treatment
feedings	I-treatment
for	O
nutrition	O
.	O

After	O
extubation	B-treatment
,	O
patient	O
was	O
started	O
on	O
sips	O
and	O
had	O
a	B-test
speech	I-test
and	I-test
swallow	I-test
evaluation	I-test
.	O

She	O
was	O
cleared	O
to	O
advance	O
her	O
diet	O
as	O
tolerated	O
.	O

She	O
only	O
tolerated	O
some	O
clear	O
liquids	O
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
she	O
was	O
NPO	B-treatment
given	O
her	B-treatment
NG	I-treatment
tube	I-treatment
.	O

8.	O
Prophylaxis	B-treatment
:	O

PPI	B-treatment
,	O
Heparin	B-treatment
SQ	I-treatment
.	O

9.	O
Access	O
:	O

Her	B-treatment
central	I-treatment
line	I-treatment
was	O
removed	O
given	O
the	O
concern	O
for	O
a	B-problem
line	I-problem
infection	I-problem
.	O

She	O
had	O
a	B-treatment
double	I-treatment
lumen	I-treatment
PICC	I-treatment
place	O
.	O

10.	O
CODE	O
:	O

FULL	B-treatment
PAD-WORD	O

11.	O
Dispo	O
:	O

She	O
was	O
transfered	O
back	O
to	O
Mediplex	O
Rehab	O
Hospital	O
Hospital	O
per	O
the	O
patient	O
's	O
and	O
husband	O
's	O
request	O
so	O
that	O
she	O
would	O
be	O
closer	O
to	O
home	O
once	O
her	O
respiratory	O
status	O
was	O
stable	O
.	O

anti-GBM	B-test
is	O
pending	O
.	O

Medications	O
on	O
Admission	O
:	O

Meds	O
:	O

Vitamin	B-treatment
D	I-treatment
50000	O
4662442	O
one	O
time	O
a	O
week	O

Cozaar	B-treatment
25	O
mg	O
1	O
time	O
per	O
day	O

Procrit	B-treatment
-	O
Multidose	O
20000	O
u	O
/	O
ml	O
20,000	O
units	O
SQ	O
every	O
other	O
week	O

Levoxyl	B-treatment
150	O
mcg	O
1	O
1	O
time	O
per	O
day	O

Iron	B-treatment
325	O
(	O
65	O
)	O
mg	O
twice	O
a	O
day	O

Zoloft	B-treatment
100	O
mg	O
1	O
per	O
day	O
,	O
2	O
TABS	O

Freestyle	O
as	O
directed	O

Clonazepam	B-treatment
0.5	O
mg	O

Humalog	B-treatment
100	O
U	O
/	O
ml	O
1	O
as	O
directed	O
pump	O

Zofran	B-treatment
8	O
mg	O
1	O
as	O
directed	O

Prevacid	B-treatment
30	O
mg	O
1	O
1	O
time	O
per	O
day	O

Lorazepam	B-treatment
0.5	O
mg	O
1	O
to	O
2	O
tablets	O
twice	O
daily	O
if	O
needed	O

on	O
transfer	O
:	O

Cipro	B-treatment
400	O
"	O

Vanco	B-treatment
1	O
g	O
qD	O

Flagyl	B-treatment
500	O
q8	O

Levophed	B-treatment
gtt	I-treatment

Propofol	B-treatment
gtt	I-treatment

Solumedrol	B-treatment
40	O
q6	O

(	O
started	O
07-14	O
)	O

Pepcid	B-treatment
PAD-WORD	O

FeSo4	B-treatment
325	O
'	O

Insulin	B-treatment
35	O
lantus	B-treatment
qhs	O

Synthroid	B-treatment
150	O
'	O

Losartan	B-treatment
25	O
'	O

Zoloft	B-treatment
200	O
'	O

Zelnorm	B-treatment
6	O
"	O

MS	O
Lori	O
Harwood	O

Discharge	O
Medications	O
:	O

1.	O
Sertraline	B-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Heparin	B-treatment
(	I-treatment
Porcine	I-treatment
)	O
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

3.	O
Acetaminophen	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
headache	B-problem
.	O

4.	O
Ondansetron	B-treatment
HCl	I-treatment
2	O
mg	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
ML	O
Intravenous	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
as	O
needed	O
for	O
nausea	B-problem
.	O

5.	O
Pyridoxine	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Olanzapine	B-treatment
5	O
mg	O
Tablet	O
,	O
Rapid	O
Dissolve	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Rapid	O
Dissolve	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7.	O
Insulin	B-treatment
Glargine	I-treatment
100	O
unit	O
/	O
mL	O
Cartridge	O
Sig	O
:	O
Ten	O
(	O
10	O
)	O
units	O
Subcutaneous	O
once	O
a	O
day	O
.	O

8.	O
Humalog	B-treatment
100	O
unit	O
/	O
mL	O
Cartridge	O
Sig	O
:	O
asdir	O
Subcutaneous	O
once	O
a	O
day	O
:	O
see	O
attached	O
sheet	O
for	O
sliding	O
scale	O
.	O

9.	O
Morphine	B-treatment
2	O
mg	O
/	O
mL	O
Syringe	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Tegaserod	B-treatment
Hydrogen	I-treatment
Maleate	I-treatment
6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
bid	O
(	O
)	O
.	O

11.	O
Levofloxacin	B-treatment
500	O
mg	O
IV	O
Q24H	O

12.	O
Vancomycin	B-treatment
HCl	O
750	O
mg	O
IV	O
Q	O
12H	O

13.	O
Dolasetron	B-treatment
Mesylate	I-treatment
25	O
mg	O
IV	O
Q8H	O
:	O
PRN	O
nausea	B-problem

14.	O
Promethazine	B-treatment
HCl	I-treatment
25	O
mg	O
IV	O
Q6H	O
:	O
PRN	O

15.	O
Lorazepam	B-treatment
0.5-1	O
mg	O
IV	O
Q3-4H	O
:	O
PRN	O
anxiety	B-problem
,	O
nausea	B-problem
hold	O
for	O
sedation	B-problem
.	O

16.	O
Levothyroxine	B-treatment
Sodium	I-treatment
75	O
mcg	O
IV	O
DAILY	O

17.	O
Pantoprazole	B-treatment
40	O
mg	O
IV	O
Q12H	O

18.	O
Erythromycin	B-treatment
500	O
mg	O
IV	O
Q6H	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

MRSA	B-problem
pneumonia	I-problem

Gastroparesis	B-problem
PAD-WORD	O

Enterobacter	B-problem
bacteremia	I-problem

Diabetes	B-problem
type	I-problem
I	I-problem

Hypothyroidism	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O

Stable	O
.	O

She	O
was	O
oxygenating	O
well	O
on	O
room	O
air	O
.	O

She	O
continued	O
to	O
have	O
nausea	B-problem
and	O
vomiting	B-problem
.	O

She	O
was	O
unable	O
to	O
tolerate	O
pos	O
.	O

Discharge	O
Instructions	O
:	O

You	O
are	O
being	O
transfered	O
to	O
Mediplex	O
Rehab	O
Hospital	O
Hospital	O
for	O
further	O
care	O
as	O
you	O
have	O
requested	O
to	O
be	O
closer	O
to	O
home	O
.	O

Followup	O
Instructions	O
:	O

You	O
should	O
have	O
a	B-test
anti-Tissue	I-test
Transglutaminase	I-test
Antibody	I-test
,	O
IgA	B-test
to	O
rule	O
out	O
celiac	B-problem
disease	I-problem
given	O
your	B-problem
abdominal	I-problem
symptoms	I-problem
.	O

Jayme	O
Gary	O
MD	O
57-021	O

Completed	O
by	O
:	O
Melvina	O
Holland	O
MD	O
20-010	O
2019-07-27	O
@	O
1645	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Melvin	O
N.I.	O
Lichtenberger	O
on	O
:	O
WED	O
2019-07-31	O
7:26	O
AM	O

(	O
End	O
of	O
Report	O
)	O

216451163	O
PUMC	O

5642194	O
PAD-WORD	O

612016	O
PAD-WORD	O

023084	O
PAD-WORD	O

10/18/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

ZEISRHALTPROT	O
,	O
QUETSHA	O

MRN	O
:	O

5642194	O
PAD-WORD	O

Age	O
:	O

40y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

10/18/2001	O
09:18	O
AM	O

Provider	O
:	O

BIRI	O
WEERTLUC	O
PRELIMINARY	O
REPORT	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/18/2001	O
10:09	O

Discharge	O
Status	O
:	O

Discharged	O
PAD-WORD	O

Condition	O
on	O
Discharge	O
:	O

Stable	O
PAD-WORD	O

Patient	O
States	O
Complaint	O
:	O

BACK	B-problem
PIAN	I-problem
Standardized	O

Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
back	B-problem
pain	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

back	B-problem
pain	I-problem

Treatment	O
Rendered	O
:	O

evaluation	B-test
PAD-WORD	O

Discharge	O
Medications	O
:	O

ibuoprofen	B-treatment
800	O
every	O
6-8	O
hrs	O
as	O
needed	O
skelaxin	B-treatment
800mg	O
for	O
muscle	B-treatment
relaxation	I-treatment
vicodin	B-treatment
1	O
tab	O
po	O
every	O
4-6	O
hrs	O
for	O
severe	B-problem
pain	I-problem

Follow	O
up	O
Service	O
:	O

please	O
call	O
your	O
primary	O
care	O
doctor	O
on	O
monday	O
for	O
follow	O
up	O
next	O
week	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

take	O
medication	B-treatment
as	O
directed	O
,	O
return	O
for	O
severe	B-problem
or	I-problem
significantly	I-problem
worsening	I-problem
symptoms	I-problem
,	O
weakness	B-problem
or	O
loss	B-problem
of	I-problem
sensation	I-problem
work	O
restrictions	O
as	O
written	O
on	O
accompanying	O
form	O
.	O

PCP	O
Name	O
:	O

ASQUARCELMES	O
,	O
NOROBEBER	O

Provider	O
Number	O
:	O

20599	O
PAD-WORD	O

This	O
report	O
was	O
created	O
by	O
WEERTLUC	O
,	O
BIRI	O
10/18/2001	O
10:23	O
AM	O

Admission	O
Date	O
:	O

2017-06-12	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-06-14	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1946-06-16	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Penicillins	B-treatment
/	O
Keflex	B-treatment
/	O
Sulfa	B-treatment
(	I-treatment
Sulfonamides	I-treatment
)	O
/	O
Nickel	O
/	O
Erythromycin	B-treatment
Ethylsuccinate	I-treatment

Attending	O
:	O
Michael	O
Y.	O
R.	O
Xiang	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Disconnected	B-problem
pigtail	I-problem
catheter	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Removal	B-treatment
of	I-treatment
catheter	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

70	O
y/o	O
F	O
w/	O
tracheobronchomalacia	B-problem
,	O
COPD	B-problem
,	O
PMR	B-problem
,	O
recurrent	B-problem
pneumonias	I-problem
who	O
was	O
recently	O
discharged	O
from	O
Hallmark	O
Health	O
System	O
to	O
Pocasset	O
Mental	O
Health	O
Center	O

06-07	O
after	O
tracheobronchoplasty	B-treatment
/	O
tracheostomy	B-treatment
and	O
pigtail	B-treatment
catheter	I-treatment
placement	I-treatment
for	O
pleural	B-problem
effusions	I-problem
.	O

Since	O
discharge	O
pt	O
has	O
continued	O
at	O
rehab	O
on	O
ps	B-treatment
vent	I-treatment
settings	I-treatment
but	O
pigtail	B-treatment
catheter	I-treatment
fell	O
out	O
today	O
so	O
pt	O
was	O
referred	O
here	O
for	O
monitoring	O
.	O

On	O
ROS	B-test
,	O
she	O
notes	O
feeling	O
poorly	B-problem
,	O
nausea	B-problem
,	O
and	O
diarrhea	B-problem
since	O
d/c	O
.	O

She	O
has	O
pleuritic	B-problem
chest	I-problem
pain	I-problem
which	O
she	O
has	O
had	O
since	O
she	O
arrested	O
during	O
her	O
admission	O
here	O
and	O
had	O
CPR	B-treatment
.	O

Per	O
husband	O
she	O
has	O
no	O
cardiac	B-problem
history	I-problem
,	O
and	O
had	O
a	B-test
stress	I-test
test	I-test
(	O
unclr	O
how	O
recent	O
)	O
that	O
was	O
normal	O

Past	O
Medical	O
History	O
:	O

Past	O
CMED	O
Hx	O
:	O

Tracheobronchomalacia	B-problem
PAD-WORD	O

PMR	B-problem
s/p	O
TAH	B-treatment

COPD	B-problem
PAD-WORD	O

AFib	B-problem
post	O
op	O

Recent	B-problem
UTI	I-problem
rx	O
w/aztreonam	B-treatment

MRSA	B-problem
pna	I-problem
rx	O
w/vanc	B-treatment

Anxiety	B-problem
PAD-WORD	O

Hx	O
resp	B-problem
arrest	I-problem
post-op	O

husb	O
PAD-WORD	O

Social	O
History	O
:	O

Soc	O
Hx	O
:	O
lives	O
in	O
Va	O
with	O
her	O
husband	O
,	O
has	O
been	O
up	O
here	O
since	O
April	O
s/p	O
month	O
long	O
hospitalization	O
,	O
no	O
tob/etoh	O

Family	O
History	O
:	O
nc	O

Physical	O
Exam	O
:	O

VS	B-test
:	O

GEN	O
:	O

NAD	B-problem
PAD-WORD	O

HEENT	O
:	O

PERRLA	O
,	O
EOMI	O

RESP	O
:	O

CTA	O
-	O
ant	O

CV	O
:	O

RRR	O
,	O
nl	O
s1	O
,	O
s2	O
,	O
no	O
m/r/g	B-problem

abd	O
:	O
soft	O
,	O
nt,nd	B-problem
,	O
nabs	O

extrem	O
:	O

1+	B-problem
edema	I-problem
blt	I-problem

Neuro	O
:	O

CNII	O
-	O
XII	O
intact	O

Pertinent	O
Results	O
:	O

ECG	B-test
:	O
rate	B-test
66	O
,	O
sinus	O
w/PAC	B-problem
's	I-problem
,	O
QT	B-test
476	O
,	O
TWI	B-problem
in	I-problem
V1-6	I-problem
(	O
deep	O
in	O
v2-4	O
)	O

CXR	B-test
:	O

IMPRESSION	O
:	O

Interval	O
resolution	O
of	O
the	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
and	O
no	O
evidence	O
of	O
pneumothorax	B-problem
.	O

A	B-problem
small	I-problem
left	I-problem
pleural	I-problem
effusion	I-problem
?	O

No	O
changes	O
in	O
the	O
position	O
or	O
alignment	O
of	O
multiple	B-treatment
lines	I-treatment
and	O
tubes	B-treatment

PATIENT	O
/	O
TEST	O
INFORMATION	O
:	O

Indication	O
:	O

Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Left	O
ventricular	O
function	O
.	O

Height	B-test
:	O
(	O
in	O
)	O
62	O

Weight	B-test
(	O
lb	O
)	O
:	O
180	O

BSA	B-test
(	O
m2	O
)	O
:	O
1.83	O
m2	O

BP	B-test
(	O
mm	O
Hg	O
)	O
:	O
115/48	O

HR	B-test
(	O
bpm	O
)	O
:	O
60	O

Status	O
:	O
Inpatient	O

Date	O
/	O
Time	O
:	O
2017-06-13	O
at	O
15:47	O

Test	O
:	O
TTE	B-test
(	O
Complete	O
)	O

Doppler	B-test
:	O
Full	B-test
doppler	I-test
and	O
color	B-test
doppler	I-test

Contrast	O
:	O
None	O

Tape	O
Number	O
:	O
2005W251-0:21	O

Test	O
Location	O
:	O
West	O
Echo	O
Lab	O

Technical	O
Quality	O
:	O
Suboptimal	O

REFERRING	O
DOCTOR	O
:	O
DR.	O
Gregory	O
ERNST	O

DR.	O
Grace	O
ERNST	O

MEASUREMENTS	O
:	O

Left	B-test
Atrium	I-test
-	I-test
Four	I-test
Chamber	I-test
Length	I-test
:	O
5.1	O
cm	O
(	O
nl	O
<=	O
5.2	O
cm	O
)	O

Right	B-test
Atrium	I-test
-	I-test
Four	I-test
Chamber	I-test
Length	I-test
:	O
*	O
6.2	O
cm	O
(	O
nl	O
<=	O
5.0	O
cm	O
)	O

Left	B-test
Ventricle	I-test
-	I-test
Septal	I-test
Wall	I-test
Thickness	I-test
:	O
0.8	O
cm	O
(	O
nl	O
0.6	O
-	O
1.1	O
cm	O
)	O

Left	B-test
Ventricle	I-test
-	I-test
Inferolateral	I-test
Thickness	I-test
:	O
0.8	O
cm	O
(	O
nl	O
0.6	O
-	O
1.1	O
cm	O
)	O

Left	B-test
Ventricle	I-test
-	I-test
Diastolic	I-test
Dimension	I-test
:	O
5.3	O
cm	O
(	O
nl	O
<=	O
5.6	O
cm	O
)	O

Left	B-test
Ventricle	I-test
-	I-test
Ejection	I-test
Fraction	I-test
:	O
>=	O
40%	O
(	O
nl	O
>=	O
55%	O
)	O

Aortic	B-test
Valve	I-test
-	I-test
Peak	I-test
Velocity	I-test
:	O
1.4	O
m	O
/	O
sec	O
(	O
nl	O
<=	O
2.0	O
m	O
/	O
sec	O
)	O

Mitral	B-test
Valve	I-test
-	I-test
E	I-test
Wave	I-test
:	O
1.1	O
m	O
/	O
sec	O

Mitral	B-test
Valve	I-test
-	I-test
A	I-test
Wave	I-test
:	O
1.0	O
m	O
/	O
sec	O

Mitral	B-test
Valve	I-test
-	I-test
E/A	I-test
Ratio	I-test
:	O
1.10	O

TR	B-test
Gradient	I-test
(	I-test
+	I-test
RA	I-test
=	I-test
PASP	I-test
)	I-test
:	O
*	O
36	O
mm	O
Hg	O
(	O
nl	O
<=	O
25	O
mm	O
Hg	O
)	O

INTERPRETATION	O
:	O

Findings	O
:	O

This	B-test
study	I-test
was	O
compared	O
to	O
the	B-test
prior	I-test
study	I-test
of	O
2017-06-01	O
.	O

LEFT	O
ATRIUM	O
:	O

Normal	O
LA	O
size	O
.	O

LEFT	O
VENTRICLE	O
:	O

Wall	B-test
thickness	I-test
and	O
cavity	B-test
dimensions	I-test
were	O
obtained	O
from	O
2D	B-test
images	I-test
.	O

Normal	O
LV	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
.	O

Suboptimal	O
technical	O
quality	O
,	O
a	B-problem
focal	I-problem
LV	I-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
cannot	O
be	O
fully	O
excluded	O
.	O

No	O
resting	O
LVOT	O
gradient	O
.	O

RIGHT	O
VENTRICLE	O
:	O

Normal	O
RV	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
.	O

AORTA	O
:	O

Normal	O
aortic	O
root	O
diameter	O
.	O

Focal	B-problem
calcifications	I-problem
in	I-problem
aortic	I-problem
root	I-problem
.	O

AORTIC	O
VALVE	O
:	O

Normal	O
aortic	O
valve	O
leaflets	O
.	O

No	O
AR	B-problem
.	O

MITRAL	O
VALVE	O
:	O

Normal	O
mitral	O
valve	O
leaflets	O
.	O

Mild	B-problem
(	I-problem
1+	I-problem
)	I-problem
MR	I-problem
.	O

TRICUSPID	O
VALVE	O
:	O

Mild	B-problem
PA	I-problem
systolic	I-problem
hypertension	I-problem
.	O

PERICARDIUM	O
:	O

No	O
pericardial	B-problem
effusion	I-problem
.	O

GENERAL	O
COMMENTS	O
:	O

Suboptimal	O
image	O
quality	O
-	O
poor	O
echo	O
windows	O
.	O

Based	O
on	O
1997	O
AHA	O
endocarditis	O
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	O
low	O
risk	O
(	O
prophylaxis	B-treatment
not	O
recommended	O
).	O

Clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	B-treatment
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

Left	B-test
ventricular	I-test
wall	I-test
thicknesses	I-test
and	O
cavity	B-test
size	I-test
are	O
normal	O
.	O

Due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	B-problem
focal	I-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
cannot	O
be	O
fully	O
excluded	O
.	O

Overall	B-test
systolic	I-test
function	I-test
is	O
good	O
(	O
LVEF	B-test
>	O
40%	O
).	O

Right	B-test
ventricular	I-test
chamber	I-test
size	I-test
and	O
free	B-test
wall	I-test
motion	I-test
are	O
normal	O
.	O

The	O
aortic	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

No	O
aortic	B-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

Mild	B-problem
(	I-problem
1+	I-problem
)	I-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

There	O
is	O
mild	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

IMPRESSION	O
:	O

Good	O
global	O
biventricular	O
systolic	O
function	O
.	O

Mild	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

The	B-test
prior	I-test
study	I-test
of	O
2017-06-01	O
(	O
tape	O
reviewed	O
)	O
was	O
of	O
very	O
suboptimal	O
technical	O
quality	O
and	O
not	O
directly	O
comparable	O
to	O
the	B-test
current	I-test
study	I-test
.	O

If	O
more	O
definitive	O
information	O
regarding	O
ventricualr	O
fuynction	O
is	O
needed	O
,	O
a	B-test
cardiac	I-test
MRI	I-test
(	O
(	O
951	O
)	O
247-0244	O
)	O
or	O
radionuclide	B-test
study	I-test
is	O
suggested	O
.	O

Based	O
on	O
1997	O
AHA	O
endocarditis	O
prophylaxis	O
recommendations	O
,	O
the	O
echo	O
findings	O
indicate	O
a	B-problem
low	I-problem
risk	I-problem
(	O
prophylaxis	B-treatment
not	O
recommended	O
).	O

Clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	B-treatment
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data	O
.	O

Electronically	O
signed	O
by	O
Lisa	O
John	O
,	O
MD	O
on	O
2017-06-13	O
18:41	O
.	O

Oak	O
Bluffs	O
PHYSICIAN	O
:	O
Gregory,Domingo	O
J	O
.	O

Brief	O
Hospital	O
Course:	O

Pleural	B-problem
effusion	I-problem
:	O
s/p	O
pigtail	B-treatment
cath	I-treatment
drain	I-treatment
.	O

Imaging	B-test
indicated	O
that	O
the	B-problem
pleural	I-problem
effusions	I-problem
had	O
resolved	O
.	O

Thoracics	O
agreed	O
to	O
no	O
need	O
for	O
pigtail	B-treatment
placement	I-treatment
.	O

CHF	B-problem
:	O

Patient	O
was	O
seen	O
by	O
CHF	O
(	O
echo	O
results	O
are	O
detailed	O
above	O
)	O
.	O

They	O
recommended	O
continuing	O
beta-blocker	B-treatment
and	O
titarting	O
ace	B-treatment
as	O
tolerated	O
.	O

Patient	O
should	O
be	O
kept	O
euvolemic	O
once	O
peripheral	B-problem
edema	I-problem
resolves	O
(	O
may	O
use	O
lasix	B-treatment
to	O
decrease	O
edema	B-problem
).	O

She	O
will	O
need	O
a	B-test
repeat	I-test
echo	I-test
in	O
3-6	O
months	O
(	O
since	O
this	B-test
echo	I-test
showed	O
a	O
question	O
of	O
focal	B-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
).	O

Also	O
,	O
patient	O
was	O
started	O
on	O
amiodarone	B-treatment
and	O
digoxin	B-treatment
was	O
held	O
secondary	O
to	O
high	B-problem
levels	I-problem
(	O
please	O
restart	O
when	O
level	B-test
less	O
than	O
2	O
)	O

Diarrhea	B-problem
:	O

Stool	B-test
c.	I-test
diff	I-test
neg	O
x1	O
.	O

She	O
will	O
need	O
two	B-test
more	I-test
specimens	I-test
.	O

COPD	B-problem
:	O
cont	O
nebs	B-treatment
.	O

PAF	B-problem
:	O
started	O
on	O
amio	B-treatment
,	O
cont	O
b-blocker	B-treatment
,	O
and	O
patient	O
was	O
started	O
on	O
coumadin	B-treatment
-	O
levels	B-test
(	I-test
inr	I-test
)	I-test
should	O
be	O
monitored	O
.	O

Nutrition	O
:	O

Patient	O
should	O
be	O
started	O
on	O
tube	B-treatment
feeds	I-treatment
at	O
rehab	O

Rash	B-problem
:	O

Patient	O
developed	O
a	B-problem
diffuse	I-problem
erythematous	I-problem
rash	I-problem
,	O
though	O
to	O
be	O
an	B-problem
ID	I-problem
reaction	I-problem
to	O
a	B-problem
recent	I-problem
fungal	I-problem
infection	I-problem
.	O

She	O
has	O
been	O
satrted	O
on	O
benadryl	B-treatment
and	O
hydrocort	B-treatment
for	O
sx	O
relief	O
.	O

Please	O
monitor	O
this	O
(	O
may	O
need	O
dermatology	O
consult	O
).	O

Also	O
a	B-problem
drug	I-problem
reaction	I-problem
is	O
in	O
the	O
ddx	O
but	O
unlikely	O
as	O
rash	B-problem
started	O
at	O
rehab	O
prior	O
to	O
receiving	O
drugs	B-treatment
here	O
.	O

Medications	O
on	O
Admission	O
:	O

Meds	B-treatment
at	O
Pocasset	O
Mental	O
Health	O
Center	O
:	O

SQ	B-treatment
heparin	I-treatment
,	O
MVI	B-treatment
,	O
nystatin	B-treatment
,	O
colace	B-treatment
,	O
albuterol	B-treatment
,	O
atrovent	B-treatment
,	O
amiodarone	B-treatment
400	O
bid	O
,	O
pulmicort	B-treatment
,	O
digoxin	B-treatment
,	O
metoprolol	B-treatment
12.5	O
tid	O
,	O
reglan	B-treatment

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O
tracheobronchomalecia	B-problem
chf	B-problem

PAF	B-problem
PAD-WORD	O

COPD	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O
deconditioned	B-problem
but	O
stable	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
your	O
doctor	O
or	O
come	O
to	O
Robert	O
if	O
you	O
develop	O
fevers	B-problem
,	O
chills	B-problem
,	O
cp	B-problem
,	O
nausea	B-problem
or	O
vomiting	B-problem
,	O
or	O
any	B-problem
other	I-problem
concerning	I-problem
sx	I-problem

Followup	O
Instructions	O
:	O

Call	O
Dr.	O
Pederson	O
office	O
for	O
appointment	O
in	O
2-3	O
weeks	O
-(	O
869	O
)	O
263-1570.	O

you	O
will	O
need	O
a	B-test
repeat	I-test
echo	I-test
within	O
3-6	O
months	O

Please	O
call	O
your	O
PCP	O
for	O
an	O
appointment	O
within	O
1	O
week	O
-	O
number	O
to	O
call	O
is	O
(	O
489	O
)	O
489	O
0229	O
ext	O
7499	O

ARMIN	O
ERNST	O
MD	O
57-915	O

Completed	O
by	O
:	O
Neva	O
Rhonda	O
MD	O
77-523	O
2017-06-14	O
@	O
1112	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Rhonda	O
ERNST	O
on	O
:	O
FRI	O
2017-06-16	O
1:44	O
PM	O

(	O
End	O
of	O
Report	O
)	O

220536305	O
PAD-WORD	O

CMC	O
PAD-WORD	O

82863580	O
PAD-WORD	O

10/8/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

10/08/1994	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

10/18/1994	O
PAD-WORD	O

The	O
patient	O
was	O
scheduled	O
for	O
discharge	O
to	O
rehab	O
.	O

It	O
was	O
noted	O
on	O
10/8/94	O
that	O
she	O
had	O
a	B-problem
decreased	I-problem
range	I-problem
of	I-problem
motion	I-problem
in	O
both	O
her	O
knees	O
with	O
flexion	O
to	O
approximately	O
40	O
degrees	O
with	O
maximum	O
physical	B-treatment
therapy	I-treatment
.	O

It	O
was	O
decided	O
to	O
postpone	O
her	O
discharge	O
to	O
rehab	O
and	O
take	O
her	O
back	O
to	O
the	O
operating	O
room	O
for	O
a	B-treatment
manipulation	I-treatment
under	O
anesthesia	B-treatment
.	O

On	O
10/9/94	O
,	O
she	O
was	O
taken	O
back	O
to	O
the	O
operating	O
room	O
.	O

Dictated	O
By	O
:	O

NA	O
BENGSTEN	O
,	O
M.D	O
,	O
HM72	O

Attending	O
:	O

LUPEVICKETTE	O
L.	O
MELENA	O
,	O
M.D.	O
YL7	O
TD803/0252	O

Batch	O
:	O

473	O
PAD-WORD	O

Index	O
No.	O
KRUQ8L9	O
GVZ	O

D	O
:	O

10/17/94	O
PAD-WORD	O

T	O
:	O

10/18/94	O
PAD-WORD	O

0880410	O
PAD-WORD	O

Admission	O
Date	O
:	O

2013-07-23	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-08-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2013-07-23	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CSRU	O

HISTORY	O
:	O

Baby	O
Girl	O
Kathryn	O
Frazier	O
,	O
triplet	O
III	O
,	O
delivered	O
at	O
32	O
-	O
5/7	O
weeks	O
gestation	O
was	O
admitted	O
to	O
the	O
newborn	O
intensive	O
care	O
unit	O
for	O
management	B-treatment
of	O
prematurity	B-problem
.	O

Birth	B-test
weight	I-test
was	O
1630	O
grams	O
.	O

The	O
mother	O
is	O
a	O
31	O
-	O
year-old	O
Gravida	O
5	O
,	O
para	O
1	O
,	O
now	O
4	O
woman	O
with	O
estimated	O
date	O
of	O
delivery	O
2013-09-12	O
.	O

Prenatal	B-test
screens	I-test
included	O
blood	B-test
type	I-test
A+	O
,	O
antibody	B-test
screen	I-test
negative	O
,	O
rubella	B-test
immune	O
,	O
RPR	B-test
nonreactive	O
.	O

Hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
cystic	B-test
fibrosis	I-test
negative	O
,	O
and	O
Group	B-test
B	I-test
strep	I-test
unknown	O
.	O

Mother	O
's	O
medical	O
history	O
was	O
notable	O
for	O
depression	B-problem
treated	O
with	O
Zoloft	B-treatment
.	O

OB	O
history	O
notable	O
for	O
infertility	B-problem
treated	O
with	O
Clomid	B-treatment
.	O

This	O
pregnancy	O
was	O
complicate	O
by	O
triplet	B-problem
gestation	I-problem
,	O
cervical	B-problem
shortening	I-problem
,	O
and	O
pregnancy	B-problem
induced	I-problem
hypertension	I-problem
.	O

Delivery	O
was	O
by	O
cesarean	B-treatment
section	I-treatment
under	O
spinal	B-treatment
anesthesia	I-treatment
for	O
pre-eclampsia	B-problem
.	O

There	O
was	O
no	O
labor	B-problem
or	I-problem
maternal	I-problem
fever	I-problem
.	O

Membranes	O
were	O
ruptured	O
at	O
delivery	O
for	O
clear	O
fluid	O
.	O

Mother	O
did	O
not	O
receive	O
any	B-treatment
antibiotics	I-treatment
prior	O
to	O
delivery	O
.	O

The	O
infant	O
emerged	O
vigorous	O
,	O
was	O
dried	O
,	O
bulb	O
suctioned	O
and	O
given	O
free	B-treatment
flow	I-treatment
oxygen	I-treatment
.	O

Apgar	B-test
scores	I-test
were	O
7	O
at	O
one	O
minute	O
and	O
8	O
at	O
5	O
minutes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
birth	B-test
weight	I-test
1630	O
grams	O
(	O
50th	O
percentile	O
)	O
,	O
length	B-test
43.5	O
cm	O
(	O
50th	O
percentile	O
)	O
,	O
head	B-test
circumference	I-test
31.5	O
cm	O
(	O
75th	O
percentile	O
).	O

Infant	O
with	O
non-	B-problem
dysmorphic	I-problem
facies	I-problem
,	O
palate	O
intact	O
.	O

Anterior	O
fontanel	O
soft	O
and	O
flat	O
,	O
moderate	B-problem
nasal	I-problem
flaring	I-problem
.	O

Chest	O
with	O
moderate	B-problem
intercostal	I-problem
retractions	I-problem
,	O
fair	O
breath	O
sounds	O
bilaterally	O
,	O
no	O
crackles	B-problem
.	O

Cardiovascular	O
is	O
well	O
perfused	O
with	O
regular	O
rate	O
and	O
rhythm	O
and	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmur	B-problem
,	O
normal	O
pulses	O
and	O
perfusion	O
.	O

Abdomen	O
soft	O
,	O
not	O
distended	B-problem
.	O

No	O
organomegaly	B-problem
or	O
masses	B-problem
.	O

Bowel	O
sounds	O
are	O
active	O
,	O
patent	O
anus	O
,	O
three	O
vessel	O
umbilical	O
cord	O
.	O

Genitourinary	O
normal	O
female	O
genitalia	O
.	O

Skin	O
without	O
rashes	B-problem
or	O
lesions	B-problem
.	O

Spine	O
intact	O
.	O

Hips	O
stable	O
.	O

Active	O
,	O
alert	O
,	O
responding	O
to	O
stimulation	B-test
.	O

Tone	B-problem
decreased	I-problem
slightly	I-problem
in	O
symmetric	O
distribution	O
,	O
moves	O
all	O
extremities	O
equally	O
.	O

Suck	O
and	O
gag	O
present	O
.	O

Grasp	O
symmetric	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

Initially	O
was	O
placed	O
on	O
continuous	B-treatment
positive	I-treatment
airway	I-treatment
pressure	I-treatment
40%	B-treatment
oxygen	I-treatment
.	O

Due	O
to	O
increasing	B-problem
respiratory	I-problem
distress	I-problem
was	O
intubated	O
,	O
placed	O
on	O
conventional	B-treatment
ventilation	I-treatment
and	O
pressures	B-treatment
of	O
24/6	O
,	O
rate	B-treatment
of	O
25	O
.	O

She	O
received	O
one	O
dose	O
of	O
Survanta	B-treatment
and	O
then	O
weaned	O
well	O
on	O
ventilator	B-treatment
settings	I-treatment
.	O

She	O
was	O
extubated	O
to	O
room	O
air	O
at	O
13	O
hours	O
of	O
age	O
.	O

Has	O
remained	O
in	O
room	O
air	O
since	O
with	O
comfortable	O
work	O
of	O
breathing	O
,	O
respiratory	B-test
rates	I-test
in	O
the	O
40	O
's	O
to	O
70	O
's.	O

No	O
apnea	B-problem
.	O

Cardiovascular	O
has	O
been	O
hemodynamically	O
stable	O
throughout	O
hospital	O
stay	O
.	O

Heart	B-test
rates	I-test
range	O
in	O
the	O
140	O
to	O
160	O
's	O
,	O
no	O
heart	B-problem
murmur	I-problem
.	O

Recent	B-test
blood	I-test
pressure	I-test
71/31	O
with	O
a	O
mean	O
of	O
48	O
.	O

Fluids	O
,	O
electrolytes	O
,	O
nutrition	O
:	O

Was	O
initially	O
NPO	B-treatment
on	O
receiving	O
D10-W	B-treatment
by	O
peripheral	O
intravenous	O
.	O

Enteral	B-treatment
feeds	I-treatment
were	O
started	O
on	O
day	O
of	O
life	O
one	O
and	O
she	O
advanced	O
to	O
full	B-treatment
volume	I-treatment
feeds	I-treatment
of	O
breast	O
milk	O
or	O
special	B-treatment
care	I-treatment
formula	I-treatment
on	O
day	O
of	O
life	O
six	O
(	O
2013-07-29	O
)	O
without	O
problems	B-problem
.	O

She	O
is	O
presently	O
receiving	O
breast	O
milk	O
or	O
special	B-treatment
care	I-treatment
formula	I-treatment
24	O
cal	O
at	O
150	O
mls	O
per	O
kilo	O
per	O
day	O
with	O
tolerance	O
.	O

Voiding	O
and	O
stooling	O
appropriately	O
.	O

Most	B-test
recent	I-test
electrolytes	I-test
done	O
on	O
day	O
of	O
life	O
one	O
showed	O
a	B-test
sodium	I-test
of	O
132	O
,	O
potassium	B-test
6.1	O
,	O
chloride	B-test
100	O
,	O
Co2	B-test
20	O
.	O

Discharge	B-test
weight	I-test
is	O
1700	O
grams	O
up	O
15	O
grams	O
..	O

Gastrointestinal	O
:	O

Received	O
phototherapy	B-treatment
from	O
07-27	O
to	O
2013-07-28	O
for	O
a	B-test
peak	I-test
bilirubin	I-test
of	O
8.1	O
.	O

Phototherapy	B-treatment
was	O
discontinued	O
when	O
bilirubin	B-test
was	O
a	B-test
total	I-test
of	O
4.7	O
.	O

Most	B-test
recent	I-test
bilirubin	I-test
on	O
2013-07-29	O
total	B-test
of	O
4.2	O
,	O
direct	B-test
.4	O
.	O

Hematology	O
:	O

Hematocrit	B-test
on	O
admission	O
47%	O
.	O

No	O
transfusions	B-treatment
given	O
.	O

Infectious	O
Disease	O
:	O

Received	O
48	O
hours	O
of	O
Ampicillin	B-treatment
and	O
gentamicin	B-treatment
for	O
rule	O
out	O
sepsis	B-problem
.	O

CBC	B-test
on	O
admission	O
showed	O
a	B-test
white	I-test
count	I-test
of	O
9.3	O
with	O
37	B-test
polys	I-test
,	O
0	B-test
bands	I-test
,	O
platelets	B-test
399,000	O
.	O

The	B-test
blood	I-test
culture	I-test
was	O
negative	O
.	O

Neurology	O
:	O

Head	B-test
ultrasound	I-test
not	O
indicated	O
.	O

Sensory	O
:	O

A	B-test
hearing	I-test
screening	I-test
has	O
not	O
been	O
performed	O
,	O
will	O
need	O
prior	O
to	O
discharge	O
home	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
7	O
day	O
old	O
former	O
32-5/7	O
week	O
and	O
now	O
33-5/7	O
weeks	O
age	O
.	O

DISPOSITION	O
:	O

Saint	O
Vincent	O
Hospital	O
Hospital	O
.	O

PEDIATRICIAN	O
:	O

Dr.	O
Manuel	O
Burke	O
,	O
1	O
Parkway	O
,	O
Fall	O
River	O
,	O
New	O
Mexico	O
57362	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

1.	O
Feeds	O
.	O

Breast	O
milk	O
or	O
special	B-treatment
care	I-treatment
formula	I-treatment
24	O
calories	O
per	O
ounce	O
at	O
150	O
mls	O
per	O
kilo	O
per	O
day	O
with	O
plans	O
to	O
advance	O
calories	O
.	O

2.	O
Medications	O
:	O

Currently	O
on	O
no	O
medications	B-treatment
.	O

3.	O
State	B-test
newborn	I-test
screen	I-test
was	O
sent	O
on	O
2013-07-26	O
and	O
is	O
pending	O
.	O

4.	O
Has	O
not	O
received	O
any	B-treatment
immunization	I-treatment
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
AGA	O
32-5/7	O
week	O
pre-term	O
female	O
.	O

2.	O
Triplet	O
#3	O

3.	O
Respiratory	B-problem
distress	I-problem
syndrome	I-problem
resolved	O
.	O

4.	O
Physiologic	B-problem
jaundice	I-problem
.	O

5.	O
Perinatal	B-problem
sepsis	I-problem
ruled	O
out	O
.	O

Joseph	O
Clarence	O
,	O
Oklahoma	O
91525	O

Dictated	O
By	O
:	O
Doris	O
Q.	O
Marszalek	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-07-29	O
17:28:46	O

T	O
:	O
2013-07-29	O
18:39:50	O

Job	O
#	O
:	O
97834	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lance	O
GRAY	O
on	O
:	O
Maxine	O
2013-08-01	O
12:50	O
PM	O

(	O
End	O
of	O
Report	O
)	O

225281111	O
PAD-WORD	O

GH	O
PAD-WORD	O

59035229	O
PAD-WORD	O

7/4/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

07/04/1999	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

07/09/1999	O
PAD-WORD	O

ADMISSION	O
DIAGNOSIS	O
:	O

ABDOMINAL	B-problem
PAIN	I-problem
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

PARTIAL	B-problem
SMALL	I-problem
BOWEL	I-problem
OBSTRUCTION	I-problem
.	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
49	O
year-old	O
male	O
with	O
a	O
history	O
of	O
a	B-treatment
low	I-treatment
anterior	I-treatment
resection	I-treatment
in	O
May	O
of	O
1998	O
and	O
a	B-problem
recurrence	I-problem
of	O
metastasis	B-problem
with	O
asleeve	O
of	O
section	O
of	O
left	B-treatment
colon	I-treatment
diverting	I-treatment
ileostomy	I-treatment
for	O
recurrent	B-problem
metastasis	I-problem
later	O
in	O
May	O
of	O
1999	O
who	O
presents	O
with	O
anterior	B-problem
midepigastric	I-problem
abdominal	I-problem
pain	I-problem
.	O

The	O
patient	O
states	O
that	O
the	B-problem
pain	I-problem
began	O
at	O
10:30	O
on	O
the	O
day	O
of	O
admission	O
with	O
increase	O
during	O
the	O
day	O
of	O
admission	O
with	O
positive	O
nausea	B-problem
and	O
vomiting	B-problem
,	O
no	O
diarrhea	B-problem
,	O
decreased	B-problem
output	I-problem
from	I-problem
the	I-problem
ostomy	I-problem
,	O
and	O
the	B-problem
pain	I-problem
was	O
radiating	O
to	O
the	O
back	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Percocet	B-treatment
and	O
Naprosyn	B-treatment
.	O

ALLERGIES	O
:	O

Demerol	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
tobacco	O
and	O
no	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Temperature	B-test
98.8	O
,	O
heart	B-test
rate	I-test
68	O
,	O
blood	B-test
pressure	I-test
107/82	O
,	O
and	O
oxygen	B-test
saturation	I-test
99%	O
on	O
room	O
air	O
.	O

CHEST	O
:	O

Clear	O
to	O
auscultation	B-test
.	O

HEART	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-problem
.	O

ABDOMEN	O
:	O

Soft	O
,	O
mildly	B-problem
distended	I-problem
,	O
and	O
tympanic	B-problem
with	O
midepigastric	B-problem
tenderness	I-problem
to	O
palpation	B-test
and	O
no	O
rebound	B-problem
.	O

The	B-treatment
ostomy	I-treatment
was	O
pink	O
with	O
minimal	O
fluid	O
in	O
the	B-treatment
ostomy	I-treatment
bag	I-treatment
.	O

It	O
was	O
guaiac	B-test
negative	O
.	O

EXTREMITIES	O
:	O

No	O
signs	O
of	O
edema	B-problem
and	O
the	O
patient	O
had	O
warm	O
and	O
palpable	O
pulses	O
distally	O
.	O

HOSPITAL	O
COURSE	O
:	O

Assessment	B-test
was	O
continued	O
with	O
laboratory	B-test
studies	I-test
which	O
showed	O
the	O
patient	O
to	O
have	O
a	O
white	B-test
blood	I-test
cell	I-test
count	I-test
of	O
9	O
,	O
hematocrit	B-test
39	O
,	O
and	O
platelets	B-test
470	O
.	O

The	O
patient	O
had	O
a	O
normal	O
amylase	O
and	O
lipase	B-test
,	O
and	O
a	O
normal	O
basic	O
metabolic	O
panel	O
.	O

The	O
patient	O
had	O
KUB	B-test
that	O
showed	O
multiple	B-problem
dilated	I-problem
loops	I-problem
of	I-problem
small	I-problem
bowel	I-problem
and	O
was	O
admitted	O
for	O
a	O
partial	B-problem
small	I-problem
bowel	I-problem
obstruction	I-problem
.	O

An	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
placed	O
and	O
had	O
an	B-treatment
H2	I-treatment
blocker	I-treatment
started	O
,	O
and	O
was	O
admitted	O
for	O
bowel	B-treatment
rest	I-treatment
and	O
decompression	B-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
nasogastric	I-treatment
tube	I-treatment
well	O
.	O

The	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
removed	O
on	O
hsp	O
day	O
#	O
3	O
.	O

The	B-problem
pain	I-problem
improved	O
quickly	O
and	O
the	O
patient	O
was	O
started	O
on	O
a	O
clear	B-treatment
liquid	I-treatment
diet	I-treatment
which	O
was	O
advanced	O
as	O
tolerated	O
.	O

On	O
7/9/99	O
,	O
the	O
patient	O
was	O
tolerating	O
a	O
house	O
diet	O
.	O

The	O
patient	O
had	O
some	B-problem
minimal	I-problem
back	I-problem
pain	I-problem
that	O
occurred	O
after	O
food	O
but	O
with	O
negative	O
urinalysis	O
and	O
negative	O
fever	B-problem
spikes	I-problem
over	O
the	O
entire	O
course	O
of	O
this	O
stay	O
.	O

The	O
patient	O
will	O
be	O
discharged	O
home	O
on	O
Zantac	B-treatment
,	O
Simethicone	B-treatment
,	O
and	O
preoperative	B-treatment
medications	I-treatment
with	O
follow-up	O
with	O
Dr.	O
Ur	O
in	O
two	O
weeks	O
.	O

Dictated	O
By	O
:	O

NISTE	O
BLOCKER	O
,	O
M.D.	O
AQ36	O

Attending	O
:	O

STIE	O
FYFE	O
,	O
M.D.	O
BW3	O
BL436/5666	O

Batch	O
:	O

85114	O
PAD-WORD	O

Index	O
No.	O

FNQXCX58	O
EM	O

D	O
:	O

07/09/99	O
PAD-WORD	O

T	O
:	O

07/09/99	O
HP8	O

Admission	O
Date	O
:	O

2015-06-29	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-07-09	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1941-01-16	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Pedro	O
D.	O
Anderson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Chest	B-problem
Pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
persantine	B-test
MIBI	I-test
cardiac	I-test
stress	I-test
test	I-test
thoracentesis	B-test

Chest	B-treatment
Tube	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

74	O
yo	O
M	O
with	O
lung	B-problem
cancer	I-problem
DVT	B-problem
who	O
presents	O
with	O
1	O
day	O
of	O
substernal	B-problem
chest	I-problem
pain	I-problem
.	O

Patient	O
developed	O
chest	B-problem
pain	I-problem
the	O
night	O
prior	O
to	O
admission	O
.	O

The	B-problem
pain	I-problem
was	O
substernal	O
07-08	O
,	O
did	O
not	O
radiate	O
.	O

He	O
reports	O
that	O
the	B-problem
pain	I-problem
was	O
similar	O
to	O
his	B-problem
prior	I-problem
MI	I-problem
.	O

The	O
patient	O
had	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

In	O
the	O
Amanda	O
the	B-problem
patients	I-problem
pain	I-problem
resolved	O
with	O
NTG	B-treatment
and	O
morphine	B-treatment
.	O

he	O
was	O
given	O
ASA	B-treatment
and	O
bblocker	B-treatment
.	O

At	O
time	O
of	O
my	B-test
evaluation	I-test
,	O
the	O
patient	O
denied	O
nausea	B-problem
,	O
vomitting	B-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
dysuria	B-problem
,	O
dizziness	B-problem
,	O
changes	B-problem
in	I-problem
vision	I-problem
/hearing	I-problem

Past	O
Medical	O
History	O
:	O

-	O
Lung	B-problem
cancer	I-problem
-	O
Non-small	B-problem
cell	I-problem
lung	I-problem
cancer	I-problem
stage	I-problem
IIIA	I-problem
,	O
status	O
post	O
weekly	B-treatment
carboplatin	I-treatment
and	O
Taxol	B-treatment
chemotherapy	I-treatment
with	O
XRT	B-treatment
for	O
seven	O
weeks	O
followed	O
by	O
surgery	B-treatment
on	O
2015-04-14	O
.	O

-	O
CAD	B-problem
-	O
s/p	O
inferior	B-problem
STEMI	I-problem
12-03	O
,	O
stent	B-treatment
to	I-treatment
L	I-treatment
Cx	I-treatment

-	O
CHF	B-problem
(	O
EF	B-test
55%	O
on	O
05-04	O
)	O

-	O
HTN	B-problem

-	O
paroxismal	B-problem
afib	I-problem

-	O
CVA	B-problem

-	O
Left	B-problem
LE	I-problem
DVT	I-problem
on	O
coumadin	B-treatment

-	O
s/p	O
IVC	B-treatment
filter	I-treatment

Social	O
History	O
:	O
non-smoker	O
,	O
occasional	O
etoh	O
,	O
no	O
drugs	O

Family	O
History	O
:	O
father	O
and	O
mother	O
with	O
CAD	B-problem

Physical	O
Exam	O
:	O

VS	B-test
-	O
98.0	O
67	O
140/63	O
22	O
99%	O
on	O
RA	O

Gen	O
-	O
A+Ox3	O
,	O
NAD	B-problem

HEENT	O
-	O
EOMI	O
,	O
OP	O
clear	O

Neck	O
-	O
supple	O
,	O
no	O
LAD	B-problem
,	O
no	O
JVD	B-problem

Cor	O
-	O
RRR	O
no	O
murmurs	B-problem

Chest	O
-	O
R	O
base	O
with	O
poor	B-problem
excursion	I-problem
and	O
poor	B-problem
breath	I-problem
sounds	I-problem
.	O

Clear	O
otherwise	O
.	O

Abd	O
-	O
s/nt/nd	B-problem
+BS	O

Ext	O
-	O
w/wp	O
,	O
no	O
edema	B-problem
,	O
R	B-problem
leg	I-problem
swollen	I-problem
compared	O
to	O
left	O

Pertinent	O
Results	O
:	O

2015-06-29	O
05:15PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
67	O

2015-06-29	O
05:15PM	O

CK	B-test
-	I-test
MB	I-test
-	O
NotDone	O
cTropnT	B-test
-<	O
0.01	O

2015-06-29	O
09:55	O
AM	O

GLUCOSE	B-test
-	O
159	O
*	O
UREA	B-test
N	I-test
-	O
17	O
CREAT	B-test
-	O
1.0	O
SODIUM	B-test
-	O
137	O
POTASSIUM	B-test
-	O
3.6	O
CHLORIDE	B-test
-	O
100	O
TOTAL	B-test
CO2	I-test
-	O
27	O
ANION	B-test
GAP	I-test
-	O
14	O

2015-06-29	O
09:55	O
AM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
76	O

2015-06-29	O
09:55	O
AM	O
cTropnT	B-test
-<	O
0.01	O

2015-06-29	O
09:55	O
AM	O

CK	B-test
-	I-test
MB	I-test
-	O
NotDone	O

2015-06-29	O
09:55	O
AM	O

WBC	B-test
-	O
10.4	O
RBC	B-test
-	O
4.41	O
*#	O
HGB	B-test
-	O
12.8	O
*#	O
HCT	B-test
-	O
38.2	O
*#	O
MCV	B-test
-	O
87	O
MCH	B-test
-	O
29.0	O
MCHC	B-test
-	O
33.5	O
RDW	B-test
-	O
15.9	O
*	O

2015-06-29	O
09:55	O
AM	O

NEUTS	B-test
-	O
86.1	O
*	O
LYMPHS	B-test
-	O
5.4	O
*	O
MONOS	B-test
-	O
5.7	O
EOS	B-test
-	O
2.2	O
BASOS	B-test
-	O
0.6	O

2015-06-29	O
09:55	O
AM	O

MICROCYT	B-test
-	O
1+	O

2015-06-29	O
09:55	O
AM	O

PLT	B-test
COUNT	I-test
-	O
372	O

2015-06-29	O
09:50	O
AM	O
URINE	B-test

HOURS	O
-	O
RANDOM	O

2015-06-29	O
09:50	O
AM	O
URINE	B-test

GR	O
HOLD	O
-	O
HOLD	O

2015-06-29	O
09:50	O
AM	O

PT	B-test
-	O
20.4	O
*	O
PTT	B-test
-	O
28.6	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
2.0	O
*	O

2015-06-29	O
09:50	O
AM	O
URINE	B-test

COLOR	B-test
-	O
Yellow	O
APPEAR	O
-	O
Clear	O
SP	B-test
Dickson	I-test
-	O
1.013	O

2015-06-29	O
09:50	O
AM	O
URINE	B-test

BLOOD	B-test
-	O
MOD	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
NEG	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
6.0	O
LEUK	O
-	O
NEG	O

2015-06-29	O
09:50	O
AM	O
URINE	B-test

RBC	B-test
-	O
05-03	O
*	O
WBC	B-test
-	O
0	O
BACTERIA	B-test
-	O
NONE	O
YEAST	B-test
-	O
NONE	O
EPI	B-test
-<	O
1	O

CXR	B-test
-	O
Increased	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
and	O
partial	B-problem
collapse	I-problem
of	I-problem
the	I-problem
right	I-problem
upper	I-problem
lung	I-problem
.	O

EKG	B-test
-	O
NSR	O
70	O
,	O
nl	O
axis	O
,	O
nl	O
int	O
,	O
old	B-problem
TWI	I-problem
III	I-problem
,	O
F	O
;	O
old	B-problem
J	I-problem
pointing	I-problem
V	I-problem
04-04	O

07-03	O
CT	B-test

CT	B-test
CHEST	I-test
:	O

The	O
heart	O
,	O
pericardium	O
,	O
and	O
great	O
vessels	O
are	O
stable	O
.	O

There	O
is	O
a	O
small	O
amount	O
of	O
pericardial	B-problem
fluid	I-problem
.	O

No	O
definite	B-problem
axillary	I-problem
,	I-problem
mediastinal	I-problem
,	I-problem
or	I-problem
hilar	I-problem
lymphadenopathy	I-problem
is	O
seen	O
.	O

Again	O
seen	O
is	O
a	B-problem
moderate	I-problem
-	I-problem
to	I-problem
large	I-problem
-	I-problem
sized	I-problem
right	I-problem
pleural	I-problem
effusion	I-problem
.	O

There	O
has	O
been	O
interval	O
development	O
of	O
moderate	O
amount	O
of	O
high-attenuation	B-problem
fluid	I-problem
within	O
the	B-problem
effusion	I-problem
consistent	O
with	O
hemorrhage	B-problem
.	O

Patchy	B-problem
consolidation	I-problem
of	I-problem
the	I-problem
right	I-problem
lung	I-problem
is	O
stable	O
.	O

Hazy	B-problem
patchy	I-problem
opacities	I-problem
are	O
noted	O
in	O
the	O
left	O
lung	O
field	O
but	O
no	O
frank	B-problem
consolidation	I-problem
is	O
seen	O
.	O

CT	B-test
ABDOMEN	I-test
:	O

Within	O
the	O
limits	O
of	O
this	B-test
non-contrast	I-test
study	I-test
,	O
the	O
liver	O
,	O
gallbladder	O
,	O
pancreas	O
,	O
spleen	O
,	O
adrenal	O
glands	O
,	O
kidneys	O
,	O
stomach	O
,	O
and	O
small	O
bowel	O
loops	O
are	O
within	O
normal	O
limits	O
.	O

There	O
is	O
colonic	B-problem
diverticulosis	I-problem
most	O
prominent	O
at	O
the	O
hepatic	O
flexure	O
.	O

There	O
is	O
no	O
free	B-problem
air	I-problem
or	O
free	B-problem
fluid	I-problem
.	O

No	O
mesenteric	B-problem
or	I-problem
retroperitoneal	I-problem
lymphadenopathy	I-problem
is	O
identified	O
.	O

An	B-treatment
IVC	I-treatment
filter	I-treatment
is	O
seen	O
.	O

CT	B-test
PELVIS	I-test
:	O

The	O
bladder	O
is	O
unremarkable	O
.	O

The	O
patient	O
appears	O
to	O
be	O
status	O
post	O
prostatectomy	B-treatment
.	O

The	O
rectum	O
is	O
unremarkable	O
.	O

There	O
is	O
no	O
free	B-problem
fluid	I-problem
and	O
no	O
pelvic	B-problem
or	I-problem
inguinal	I-problem
lymphadenopathy	I-problem
.	O

BONE	O
WINDOWS	O
:	O

A	B-problem
lytic	I-problem
area	I-problem
is	O
again	O
seen	O
in	O
the	O
L5	O
vertebral	O
body	O
but	O
unchanged	O
from	O
prior	B-test
examination	I-test
.	O

Several	B-problem
subacute	I-problem
or	I-problem
chronic	I-problem
rib	I-problem
fractures	I-problem
are	O
identified	O
on	O
the	O
right	O
.	O

IMPRESSION	O
:	O

1.	O
Interval	O
development	O
of	O
a	O
moderate	O
amount	O
of	O
hemorrhage	B-problem
within	O
the	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
.	O

2.	O
No	O
acute	B-problem
intra-abdominal	I-problem
abnormalities	I-problem
identified	O
.	O

07-01	O
Stress	B-test
MIBI	I-test

New	B-problem
moderate	I-problem
and	I-problem
fixed	I-problem
inferior	I-problem
myocardial	I-problem
wall	I-problem
perfusion	I-problem
defect	I-problem
.	O

Mild	B-problem
inferior	I-problem
wall	I-problem
hypokinesis	I-problem
.	O

Calculated	B-test
LVEF	I-test
42%	O
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
74	O
yo	O
M	O
with	O
lung	B-problem
cancer	I-problem
,	O
DVT	B-problem
,	O
CAD	B-problem
s/p	O
MI	B-problem
presents	O
with	O
chest	B-problem
pain	I-problem
shortness	B-problem
of	I-problem
breath	I-problem
.	O

#	O
Chest	B-problem
Pain	I-problem
/	O
Ischemia	B-problem
-	O
Patient	O
with	O
history	O
of	O
CAD	B-problem
a/p	O
MI	B-problem
.	O

Now	O
with	O
an	O
episode	O
of	O
pain	B-problem
consistent	O
with	O
his	B-problem
anginal	I-problem
equivalent	I-problem
.	O

No	O
changes	B-problem
on	O
EKG	B-test
but	O
not	O
in	O
pain	B-problem
at	O
time	O
of	O
EKG	B-test
.	O

Patient	O
was	O
ruled	O
out	O
by	O
enzymes	B-test
.	O

He	O
also	O
had	O
a	B-test
stress	I-test
test	I-test
which	O
revealed	O
an	B-problem
irreversible	I-problem
deficit	I-problem
from	O
his	B-problem
prior	I-problem
known	I-problem
IMI	I-problem
.	O

Continued	O
on	O
asa	B-treatment
,	O
bblocker	B-treatment
,	O
Hicks	B-treatment
,	O
statin	B-treatment
,	O
plavix	B-treatment
.	O

BP	B-treatment
meds	I-treatment
held	O
while	O
was	O
unstable	B-problem
.	O

ASA	B-treatment
,	O
plavix	B-treatment
held	O
during	O
hemothorax	B-problem
.	O

#	O
CHF	B-problem
-	O
patient	O
does	O
not	O
seem	O
volume	B-problem
overloaded	I-problem
at	O
this	O
time	O
.	O

He	O
has	O
no	O
JVD	B-problem
,	O
no	O
edema	B-problem
in	I-problem
legs	I-problem
(	O
other	O
than	O
swelling	B-problem
from	O
DVT	B-problem
)	O
.	O

Last	B-test
Echo	I-test
with	O
EF	B-test
55%	O
.	O

Does	O
have	O
increased	B-problem
effusion	I-problem
although	O
loculated	O
.	O

Continued	O
on	O
lasix	B-treatment
,	O
bblocker	B-treatment
Robertson	O
.	O

BP	B-treatment
meds	I-treatment
held	O
while	O
unstable	B-problem
.	O

#	O
Afib	B-problem
-	O
In	O
sinus	O
during	O
admission	O
.	O

Patients	B-treatment
anticoag	I-treatment
held	O
during	O
hemothorax	B-problem
.	O

#	O
Shortness	B-problem
of	I-problem
Breath	I-problem
/	O
loculated	B-problem
Effusion	I-problem
-	O
patient	O
with	O
increaing	B-problem
loculated	I-problem
pleural	I-problem
effusion	I-problem
.	O

Has	O
chronic	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
which	O
has	O
worsened	O
over	O
the	O
past	O
few	O
days	O
.	O

No	O
sign	O
of	O
infeciton	B-problem
at	O
this	O
time	O
.	O

Had	O
thoracentesis	B-test
by	O
interventional	O
pumonology	O
on	O
2015-07-01	O
revealing	O
almost	O
2	O
L	O
of	O
serous	B-problem
exudative	I-problem
fluid	I-problem
.	O

Patient	O
had	O
improved	O
breathing	O
.	O

Cytology	B-test
was	O
negative	O
.	O

However	O
on	O
07-02	O
Hct	B-test
dropped	O
.	O

CT	B-test
revealed	O
hemothorax	B-problem
.	O

All	B-treatment
anticoagulation	I-treatment
stopped	O
despite	O
the	O
risk	O
of	O
DVT	B-problem
,	O
afib	B-problem
.	O

Risk	O
discussed	O
with	O
family	O
.	O

Thoracics	O
consulted	O
and	O
chest	B-treatment
tube	I-treatment
placed	O
.	O

Frank	B-problem
blood	I-problem
was	O
taken	O
out	O
.	O

Patient	O
continued	O
to	O
bleed	O
in	O
and	O
around	O
the	B-treatment
tube	I-treatment
.	O

Patient	O
sent	O
to	O
CMED	O
for	O
observation	B-test
after	O
Hct	B-test
continued	O
to	O
drop	O
.	O

Patient	O
spontaneously	O
stablized	O
and	O
output	B-test
of	O
CT	B-test
became	O
more	O
serous	O
.	O

Output	B-test
resent	O
for	O
cytology	B-test
which	O
was	O
pending	O
at	O
time	O
of	O
discharge	O
.	O

When	O
output	B-test
became	O
<	O
100	O
cc	O
the	B-treatment
tube	I-treatment
was	O
removed	O
.	O

Patient	O
follwed	O
with	O
serial	B-test
CXR	I-test
that	O
did	O
not	O
demonstrate	O
reaccumulation	B-problem
.	O

Hct	B-test
also	O
remained	O
stable	O
.	O

#	O
DVT	B-problem
-	O
patient	O
therapeutic	O
on	O
heparin	B-treatment
.	O

Improving	O
clots	B-problem
on	O
LENI	B-treatment
.	O

CTA	B-test
neg	O
for	O
PE	B-problem
.	O

Anticoagulaiton	B-treatment
held	O
during	O
hemothorax	B-problem
.	O

Patient	O
restarted	O
on	O
coumadin	B-treatment
and	O
will	O
be	O
discharged	O
on	O
3mg	O
coumadin	B-treatment
qday	O
.	O

#	O
Lung	B-problem
Cancer	I-problem
-	O
patient	O
currently	O
with	O
no	O
evidence	O
of	O
disease	B-problem
.	O

s/p	O
neoadjuvant	B-treatment
chemo/XRT	I-treatment
now	O
s/p	O
surgery	B-treatment
.	O

1st	B-test
cytology	I-test
negative	O
.	O

2ng	B-test
cytology	I-test
pending	O
.	O

WIll	O
follow	O
up	O
tih	O
outpatient	O
oncologist	O
.	O

Contacts	O
-	O
son	O
506-1596	O

Medications	O
on	O
Admission	O
:	O

Lipitor	B-treatment
80	O
mg	O
qday	O

Asa	B-treatment
81	O
mg	O
qday	O

bowel	B-treatment
reg	I-treatment

percocet	B-treatment
prn	O

plavix	B-treatment
75	O
mg	O
qday	O

losartan	B-treatment
25	O
mg	O
qday	O

coumadin	B-treatment
3	O
mg	O
qday	O

lasix	B-treatment
20	O
mg	O
qday	O

atenolol	B-treatment
25	O
mg	O
qday	O

Discharge	O
Medications	O
:	O

1.	O
Atorvastatin	B-treatment
80	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
100	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

8.	O
Nitroglycerin	B-treatment
0.3	O
mg	O
Tablet	O
,	O
Sublingual	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Sublingual	O
Sublingual	O
PRN	O
(	O
as	O
needed	O
)	O
.	O

9.	O
Atenolol	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Losartan	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

11.	O
Benzonatate	B-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
cough	B-problem
.	O

Disp	O
:*	O
60	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
3	O
*	O

12.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

13.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
50	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

14.	O
Codeine	B-treatment
-	O
Guaifenesin	B-treatment
10-100	O
mg	O
/	O
5	O
mL	O
Syrup	O
Sig	O
:	O
5-10	O
MLs	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*QS	O
1	O
month	O
ML	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

15.	O
Coumadin	B-treatment
3	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Angina	B-problem
PAD-WORD	O

Pleural	B-problem
Effusion	I-problem

Secondary	O
PAD-WORD	O

HTN	B-problem
PAD-WORD	O

Non	B-problem
small	I-problem
cell	I-problem
lung	I-problem
cancer	I-problem

CAD	B-problem
PAD-WORD	O

DVT	B-problem
h/o	O
afib	B-problem

Discharge	O
Condition	O
:	O
stable	O
,	O
eating	O
,	O
on	O
room	O
air	O

Discharge	O
Instructions	O
:	O

Please	O
take	O
all	B-treatment
medications	I-treatment
as	O
listed	O
in	O
the	O
discharge	O
paperwork	O
.	O

Please	O
make	O
all	O
appointments	O
listed	O
in	O
the	O
discharge	O
paperwork	O
.	O

If	O
you	O
have	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
nausea	B-problem
or	O
other	B-problem
concerning	I-problem
symptoms	I-problem
please	O
call	O
your	O
MD	O
or	O
come	O
to	O
the	O
emergency	O
room	O
.	O

I	O
have	O
changed	O
some	O
of	O
your	B-treatment
blood	I-treatment
pressure	I-treatment
meds	I-treatment
.	O

Your	B-treatment
atenolol	I-treatment
has	O
increased	O
to	O
50	O
mg	O
a	O
day	O
.	O

Your	B-treatment
losartan	I-treatment
has	O
increased	O
to	O
50	O
mg	O
a	O
day	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O

Kathleen	O
Shirley	O
,	O
MD	O
Phone	O
:(	O
870	O
)	O
559-0424	O

Date	O
/	O
Time	O
:	O
2015-08-06	O
9:00	O

You	O
should	O
call	O
Dr.	O
Worden	O
to	O
also	O
see	O
him	O
again	O
sooner	O
09-07	O
days	O
.	O

(	O
870	O
)	O
559-0424	O
.	O

Please	O
see	O
Dr.	O
Holbrook	O
(	O
984	O
)	O
452	O
0816	O
on	O
monday	O
and	O
have	O
your	B-test
coumadin	I-test
level	I-test
checked	O
.	O

Merle	O
Shirley	O
MD	O
87-502	O

Completed	O
by	O
:	O
Nannie	O
Brenda	O
MD	O
13-326	O
2015-07-10	O
@	O
1534	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Shanta	O
PARKS	O
on	O
:	O
TUE	O
2015-07-14	O
9:08	O
AM	O

(	O
End	O
of	O
Report	O
)	O

258418598	O
PAD-WORD	O

FIH	O
PAD-WORD	O

2044357	O
PAD-WORD	O

81841/8e23	O
PAD-WORD	O

715555	O
PAD-WORD	O

4/9/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

04-09-92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

04-20-92	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Kacholera	O
Junk	O
was	O
a	O
34	O
year	O
old	O
gentleman	O
with	O
no	O
significant	O
past	O
medical	O
history	O
except	O
for	O
a	O
history	O
of	O
of	O
intravenous	O
drug	O
abuse	O
.	O

He	O
was	O
status	O
post	O
a	B-treatment
rehabilitation	I-treatment
hospitalization	I-treatment
at	O
the	O
Raya	O
Ma	O
Den	O
Erinmarg	O
Hospital	O
with	O
a	O
recent	O
recrudescence	O
of	O
his	O
drug	O
abuse	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Sephsandpot	O
Center	O
on	O
the	O
morning	O
of	O
4/9	O
and	O
was	O
subsequently	O
transferred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
for	O
further	B-treatment
care	I-treatment
.	O

The	O
patient	O
was	O
apparently	O
well	O
until	O
one	O
day	O
prior	O
to	O
admission	O
.	O

His	O
family	O
reports	O
that	O
he	O
had	O
worked	O
that	O
day	O
.	O

He	O
relates	O
using	O
large	O
doses	O
of	O
Cocaine	O
and	O
Heroin	O
early	O
in	O
the	O
morning	O
on	O
the	O
day	O
of	O
admission	O
.	O

At	O
3:00	O
a.m.	O
on	O
the	O
day	O
of	O
admission	O
he	O
was	O
found	O
by	O
the	O
emergency	O
medical	O
technicians	O
&quot;	O
crawling	O
on	O
all	O
fours	O
&quot;	O
,	O
confused	B-problem
,	O
and	O
combative	B-problem
outside	O
his	O
home	O
.	O

He	O
gave	O
an	O
equivocal	O
history	O
of	O
fevers	B-problem
and	O
chills	B-problem
on	O
the	O
days	O
prior	O
to	O
admission	O
.	O

Bystanders	O
report	O
that	O
he	O
was	O
assaulted	O
about	O
20	O
minutes	O
earlier	O
and	O
the	O
nature	O
of	O
the	O
assault	O
was	O
not	O
known	O
.	O

He	O
was	O
taken	O
to	O
the	O
Sephsandpot	O
Center	O
where	O
he	O
was	O
hypotensive	B-problem
with	O
a	B-test
blood	I-test
pressure	I-test
of	O
105/85	O
,	O
tachycardic	B-problem
with	O
a	B-test
heart	I-test
rate	I-test
to	O
186	O
,	O
aneuric	B-problem
,	O
hyperthermic	B-problem
,	O
with	O
a	B-test
temperature	I-test
to	O
105	O
degrees	O
F	O
,	O
and	O
progressively	B-problem
more	I-problem
confused	I-problem
.	O

His	B-test
chest	I-test
x-ray	I-test
was	O
clear	O
.	O

He	O
was	O
treated	O
with	O
Dopamine	B-treatment
for	O
hypertension	B-problem
and	O
Inderal	B-treatment
for	O
tachycardia	B-problem
.	O

He	O
received	O
two	O
amps	O
of	O
Narcan	B-treatment
.	O

He	O
received	O
one	O
gram	O
of	O
Ceftriaxone	B-treatment
intravenously	O
after	O
blood	B-test
cultures	I-test
were	O
drawn	O
.	O

His	B-test
initial	I-test
arterial	I-test
blood	I-test
gas	I-test
at	O
the	O
Sephsandpot	O
Center	O
revealed	O
a	B-test
p02	I-test
of	O
76	O
,	O
pC02	B-test
14	O
,	O
and	O
a	B-test
pH	I-test
of	O
7.44	O
on	O
room	O
air	O
.	O

He	O
was	O
then	O
transferred	O
via	O
Med	O
Flight	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

He	O
denied	O
any	O
history	O
of	O
recent	O
travel	O
.	O

Toxicology	B-test
screen	I-test
at	O
Sephsandpot	O
Center	O
revealed	O
Cocaine	O
and	O
Quinine	B-treatment
.	O

Shortly	O
after	O
his	O
arrival	O
to	O
that	O
hospital	O
he	O
had	O
been	O
intubated	O
for	O
a	B-test
respiratory	I-test
rate	I-test
of	O
60	O
.	O

He	O
required	O
medical	B-treatment
paralysis	I-treatment
for	O
this	O
.	O

He	O
was	O
reported	O
to	O
have	O
a	B-problem
seizure	I-problem
,	O
although	O
the	O
nature	O
of	O
this	O
was	O
unclear	O
,	O
and	O
received	O
Valium	B-treatment
for	O
this	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

He	O
is	O
status	O
post	O
recent	B-treatment
left	I-treatment
knee	I-treatment
surgery	I-treatment
,	O
status	O
post	O
left	B-treatment
carpal	I-treatment
tunnel	I-treatment
release	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

His	B-treatment
meds	I-treatment
on	O
transfer	O
to	O
FIH	O
were	O
Levophed	B-treatment
,	O
Dopamine	B-treatment
,	O
and	O
Ceftriaxone	B-treatment
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
is	O
divorced	O
with	O
no	O
children	O
.	O

His	O
mother	O
and	O
father	O
are	O
alive	O
and	O
well	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
works	O
as	O
a	O
welder	O
.	O

He	O
has	O
a	O
history	O
of	O
intravenous	O
drug	O
abuse	O
,	O
no	O
alcohol	O
abuse	O
or	O
tobacco	O
abuse	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Revealed	O
an	O
obtunded	O
white	O
muscular	O
man	O
who	O
was	O
intubated	B-treatment
and	O
sedated	B-treatment
.	O

The	B-test
vital	I-test
signs	I-test
showed	O
a	B-test
blood	I-test
pressure	I-test
of	O
69	O
,	O
pulse	B-test
80	O
,	O
respirations	B-test
14	O
,	O
and	O
temperature	B-test
99.8	O
.	O

There	O
is	O
a	B-problem
contusion	I-problem
over	I-problem
the	I-problem
right	I-problem
eye	I-problem
but	O
no	O
laceration	B-problem
,	O
abrasion	B-problem
of	I-problem
her	I-problem
left	I-problem
shoulder	I-problem
,	O
no	O
flank	B-problem
discoloration	I-problem
,	O
blanching	B-problem
papules	I-problem
over	I-problem
the	I-problem
knees	I-problem
bilaterally	I-problem
without	O
central	B-problem
necrosis	I-problem
.	O

He	O
had	O
multiple	O
tattoos	O
.	O

Lymphatic-he	O
had	O
shotty	B-problem
cervical	I-problem
adenopathy	I-problem
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
exam	I-test
was	O
normocephalic	O
,	O
with	O
trauma	B-problem
as	O
described	O
,	O
pupils	O
were	O
2	O
mm	O
bilaterally	O
which	O
were	O
minimally	B-problem
reactive	I-problem
,	O
fundi	O
was	O
not	O
seen	O
,	O
conjunctivae	O
without	O
erythema	B-problem
,	O
sclerae	O
anicteric	B-problem
,	O
positive	O
corneal	B-test
reflexes	I-test
noted	O
.	O

Ears-the	O
tympanic	O
membranes	O
were	O
clear	O
with	O
no	O
hemorrhage	B-problem
at	O
the	O
time	O
of	O
admission	O
.	O

Nose-no	O
sinus	B-problem
discharge	I-problem
,	O
no	O
hemorrhage	B-problem
.	O

The	O
oropharynx	O
was	O
intubated	B-treatment
.	O

Lungs-clear	O
with	O
good	O
air	O
movement	O
bilaterally	O
.	O

He	O
had	O
scattered	B-problem
wheezes	I-problem
following	O
a	B-treatment
3	I-treatment
liter	I-treatment
bolus	I-treatment
for	O
hypotension	B-problem
.	O

No	O
effusion	B-problem
or	O
rub	B-problem
was	O
heard	O
.	O

The	B-test
cardiac	I-test
exam	I-test
showed	O
point	O
of	O
maximal	O
impulse	O
was	O
not	O
displaced	O
,	O
regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
,	O
S2	O
,	O
no	O
S3	B-problem
or	O
S4	B-problem
,	O
a	B-problem
grade	I-problem
II	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
murmur	I-problem
was	O
heard	O
at	O
the	O
left	O
upper	O
sternal	O
border	O
without	O
radiation	B-problem
,	O
likely	O
representing	O
a	B-problem
flow	I-problem
murmur	I-problem
.	O

No	O
peripheral	B-problem
edema	I-problem
was	O
noted	O
.	O

The	B-test
jugular	I-test
venous	I-test
pressure	I-test
was	O
not	O
assessed	O
secondary	O
to	O
cervical	B-treatment
collar	I-treatment
being	O
in	O
place	O
.	O

The	B-test
carotid	I-test
pulses	I-test
were	O
brisk	O
bilaterally	O
.	O

The	B-test
vascular	I-test
exam	I-test
showed	O
normal	O
pulses	O
bilaterally	O
without	O
bruits	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
bowel	O
sounds	O
of	O
normal	O
character	O
,	O
and	O
there	O
was	O
mild	B-problem
percussion	I-problem
tenderness	I-problem
and	O
tenderness	B-problem
to	O
modest	B-test
palpation	I-test
in	I-test
all	I-test
four	I-test
quadrants	I-test
.	O

It	O
was	O
unclear	O
whether	O
this	O
was	O
due	O
to	O
superficial	B-problem
tenderness	I-problem
or	O
abdominal	B-problem
tenderness	I-problem
.	O

He	O
had	O
marked	B-problem
voluntary	I-problem
guarding	I-problem
without	O
rigidity	B-problem
and	O
no	O
masses	B-problem
were	O
felt	O
.	O

The	B-test
genitourinary	I-test
exam	I-test
showed	O
normal	O
penis	O
with	O
normal	O
testicles	O
which	O
were	O
nontender	B-problem
.	O

There	O
was	O
no	O
urethritis	B-problem
,	O
no	O
balinitis	B-problem
,	O
normal	O
prostate	O
,	O
nontender	B-problem
.	O

There	O
was	O
tan	B-problem
guaiac	I-problem
positive	I-problem
stool	I-problem
with	O
no	O
masses	B-problem
.	O

The	B-test
musculoskeletal	I-test
exam	I-test
showed	O
well	O
developed	O
,	O
symmetrical	O
muscular	O
development	O
with	O
no	O
fasciculations	B-problem
,	O
no	O
joint	B-problem
erythema	I-problem
,	O
no	O
effusions	B-problem
.	O

Neuro	B-test
exam-the	I-test
Mental	B-test
Status	I-test
Exam	I-test
was	O
variable	O
,	O
intermittently	B-problem
responsive	I-problem
,	O
unable	B-problem
to	O
follow	O
commands	B-test
.	O

He	O
nods	O
appropriately	O
and	O
was	O
able	O
to	O
confirm	O
known	O
history	O
.	O

The	O
cranial	O
nerves	O
II-XII	O
grossly	O
intact	O
,	O
bilaterally	O
symmetric	O
.	O

The	B-test
motor	I-test
exam-moves	I-test
all	O
four	O
extremities	O
easily	O
and	O
on	O
command	O
.	O

The	B-test
sensory	I-test
exam	I-test
revealed	O
no	O
focal	B-problem
deficits	I-problem
to	O
limited	B-test
exam	I-test
.	O

Reflexes	B-test
were	O
trace	O
in	O
the	O
upper	O
extremities	O
and	O
absent	B-problem
in	I-problem
the	I-problem
knees	I-problem
with	O
downgoing	O
toes	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
the	B-test
sodium	I-test
was	O
144	O
,	O
potassium	B-test
2.6	O
,	O
chloride	B-test
114	O
,	O
bicarbonate	B-test
12.3	O
,	O
BUN	B-test
30	O
,	O
creatinine	B-test
4.0	O
,	O
glucose	B-test
89	O
.	O

The	B-test
SGOT	I-test
was	O
994	O
,	O
LDH	B-test
1,888	O
,	O
alkaline	B-test
phosphatase	I-test
92	O
,	O
total	B-test
bilirubin	I-test
2.9	O
and	O
direct	B-test
bilirubin	I-test
11.2	O
.	O

Lactate	B-test
was	O
6.3	O
,	O
acetone	B-test
negative	O
,	O
ammonia	B-test
26	O
,	O
uric	B-test
acids	I-test
26.9	O
,	O
albumin	B-test
4.0	O
,	O
globulin	B-test
3.0	O
,	O
amylase	B-test
259	O
,	O
lipase	B-test
34	O
,	O
magnesium	B-test
3.5	O
,	O
phosphorus	B-test
1.9	O
,	O
calcium	B-test
9.4.	O
The	B-test
white	I-test
blood	I-test
count	I-test
was	O
19.7	O
with	O
89%	O
polys	B-test
,	O
7%	O
bands	B-test
,	O
4%	O
lymphs	B-test
,	O
with	O
toxic	B-problem
granulations	I-problem
.	O

Hematocrit	B-test
was	O
45.2	O
with	O
a	B-test
platelet	I-test
count	I-test
of	O
132,000	O
,	O
falling	O
rapidly	O
to	O
24,000	O
.	O

The	B-test
MCV	I-test
is	O
88	O
.	O

The	B-test
prothrombin	I-test
time	I-test
is	O
27.7	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
is	O
greater	O
than	O
100	O
.	O

The	B-test
urinalysis	I-test
revealed	O
a	B-test
specific	I-test
gravity	I-test
of	O
1.15	O
,	O
pH	B-test
5.0	O
,	O
and	O
4+	B-problem
albumin	I-problem
,	O
positive	B-problem
occult	I-problem
blood	I-problem
,	O
with	O
0-5	B-problem
granular	I-problem
casts	I-problem
and	O
5-10	B-problem
RBCs	I-problem
and	O
3-5	B-problem
WBCs	I-problem
.	O

The	B-test
CK	I-test
was	O
17,890	O
with	O
0.6%	O
MB	B-test
.	O

The	B-test
urine	I-test
sodium	I-test
was	O
147	O
.	O

The	B-test
serum	I-test
toxicology	I-test
was	O
positive	B-problem
for	O
Cocaine	O
on	O
admission	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
as	O
well	O
as	O
the	O
Sephsandpot	O
Center	O
.	O

The	B-test
electrocardiogram	I-test
revealed	O
normal	O
sinus	O
rhythm	O
at	O
85	O
with	O
a	B-problem
prolonged	I-problem
QT	I-problem
at	O
0.572	O
.	O

An	B-test
I-head	I-test
CT	I-test
revealed	O
left	O
sphenoid	O
and	O
left	B-problem
maxillary	I-problem
sinusitis	I-problem
with	O
mild	B-problem
cerebral	I-problem
edema	I-problem
and	O
no	O
focal	B-problem
hemorrhages	I-problem
.	O

The	B-test
abdominal	I-test
CT	I-test
revealed	O
mesenteric	B-problem
adenopathy	I-problem
,	O
normal	O
bowels	O
,	O
hepatosplenomegaly	B-problem
,	O
and	O
?	O
fatty	B-problem
liver	I-problem
.	O

Chest	B-test
x-ray	I-test
revealed	O
early	B-problem
interstitial	I-problem
edema	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
the	O
diagnosis	O
of	O
Cocaine	B-problem
induced	I-problem
rhabdomyolysis	I-problem
,	O
renal	B-problem
failure	I-problem
,	O
disseminated	B-problem
intravascular	I-problem
coagulation	I-problem
,	O
shock	B-problem
,	O
hepatic	B-problem
failure	I-problem
,	O
pancreatitis	B-problem
,	O
and	O
thrombocytopenia	B-problem
in	O
the	O
setting	O
of	O
Cocaine	O
intoxication	O
.	O

He	O
was	O
accepted	O
at	O
the	O
Vo	O
Yd	O
Burgsygu	O
Hospital	O
Center	O
Intensive	O
Care	O
Unit	O
and	O
his	O
hospital	O
course	O
will	O
be	O
reviewed	O
by	O
problems	O
.	O

1-Rhabdomyolysis	B-problem
.	O

The	O
patient	O
had	O
massive	B-problem
Cocaine	I-problem
induced	I-problem
rhabdomyolysis	I-problem
.	O

This	O
resulted	O
in	O
tremendous	B-problem
third	I-problem
spacing	I-problem
of	I-problem
fluid	I-problem
and	O
persistent	B-problem
intervascular	I-problem
hypovolemia	I-problem
.	O

The	B-test
patient	I-test
&apos;s	I-test
creatinine	I-test
______________	I-test
kinase	I-test
peaked	O
at	O
56,160	O
with	O
negative	O
MB	B-test
percentages	I-test
.	O

The	B-test
aldolase	I-test
was	O
positive	O
at	O
142	O
.	O

This	O
was	O
further	O
complicated	O
by	O
hypocalcemia	B-problem
which	O
resulted	O
in	O
mild	B-problem
electrocardiographic	I-problem
abnormalities	I-problem
.	O

The	O
patient	O
&apos;s	O
urine	O
was	O
alkalinized	B-treatment
with	O
intravenous	B-treatment
bicarbonate	I-treatment
to	O
maximize	O
the	O
myoglobin	O
secretion	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
urine	I-test
output	I-test
was	O
further	O
augmented	O
by	O
adding	O
Dopamine	B-treatment
.	O

Nevertheless	O
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
renal	I-problem
failure	I-problem
continued	O
to	O
progress	O
.	O

Over	O
the	O
course	O
of	O
the	O
hospitalization	O
his	B-test
CK	I-test
fell	O
in	O
the	O
serum	O
.	O

Much	O
of	O
his	B-problem
diffuse	I-problem
pain	I-problem
was	O
felt	O
to	O
be	O
due	O
to	O
this	B-problem
massive	I-problem
rhabdomyolysis	I-problem
.	O

2-Renal	B-problem
failure	I-problem
.	O

The	B-test
creatinine	I-test
was	O
4.4	O
on	O
admission	O
and	O
peaked	O
at	O
10.5	O
on	O
the	O
15th	O
.	O

The	B-test
urinalysis	I-test
revealed	O
4+	B-problem
albumin	I-problem
with	O
marked	B-problem
occult	I-problem
blood	I-problem
.	O

Peritoneal	B-treatment
dialysis	I-treatment
was	O
instituted	O
on	O
4/11	O
after	O
a	B-treatment
Tenckhoff	I-treatment
catheter	I-treatment
was	O
placed	O
by	O
Drs.	O
Freierm	O
,	O
Le	O
,	O
and	O
Round	O
.	O

Subsequently	O
his	B-test
creatinine	I-test
rose	O
for	O
three	O
days	O
and	O
then	O
stabilized	O
at	O
10	O
.	O

He	O
continued	O
to	O
make	O
minimal	B-problem
urine	I-problem
throughout	O
the	O
hospitalization	O
.	O

3-Disseminated	B-problem
intravascular	I-problem
coagulation	I-problem
.	O

On	O
admission	O
the	B-test
patient	I-test
&apos;s	I-test
prothrombin	I-test
time	I-test
was	O
27.7	O
with	O
a	B-test
partial	I-test
thromboplastin	I-test
time	I-test
of	O
greater	O
than	O
100	O
and	O
a	B-test
d-dimer	I-test
positive	O
at	O
8	O
with	O
a	B-test
fibrinogen	I-test
of	O
69	O
.	O

He	O
went	O
on	O
to	O
develop	O
profound	B-problem
thrombocytopenia	I-problem
complicated	O
by	O
hemorrhage	B-problem
.	O

The	O
patient	O
was	O
supported	O
with	O
abundant	O
use	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
,	O
cryoprecipitate	B-treatment
,	O
platelets	B-treatment
,	O
and	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

His	B-problem
DIC	I-problem
was	O
further	O
complicated	O
by	O
hepatic	B-problem
failure	I-problem
which	O
resulted	O
in	O
poor	B-problem
endogenous	I-problem
production	I-problem
of	I-problem
clotting	I-problem
factors	I-problem
and	O
he	O
remained	O
fresh	B-problem
frozen	I-problem
plasma	I-problem
dependent	I-problem
.	O

4-Septic	B-problem
shock	I-problem
.	O

The	O
patient	O
remained	O
pressor	B-problem
dependent	I-problem
throughout	O
his	O
hospitalization	O
.	O

He	O
was	O
maintained	O
variously	O
on	O
Levophed	B-treatment
,	O
Dobutamine	B-treatment
,	O
Dopamine	B-treatment
,	O
and	O
ultimately	O
Epinephrine	B-treatment
for	O
blood	B-treatment
pressure	I-treatment
support	I-treatment
.	O

Hemodynamic	B-test
monitoring	I-test
revealed	O
low	B-problem
systemic	I-problem
vascular	I-problem
resistance	I-problem
and	O
high	B-problem
cardiac	I-problem
output	I-problem
.	O

He	O
had	O
multiple	O
sources	O
of	O
infection	B-problem
including	O
his	O
sinuses	O
,	O
lungs	O
,	O
and	O
multiple	B-treatment
lines	I-treatment
.	O

This	O
will	O
be	O
discussed	O
below	O
.	O

Further	O
he	O
had	O
massive	B-problem
muscle	I-problem
necrosis	I-problem
and	O
hepatic	B-problem
failure	I-problem
.	O

An	B-test
echocardiogram	I-test
on	O
4/12	O
revealed	O
a	B-problem
dilated	I-problem
left	I-problem
ventricle	I-problem
which	O
was	O
diffusely	B-problem
mildly	I-problem
hypokinetic	I-problem
with	O
no	O
vegetations	B-problem
.	O

His	B-test
ejection	I-test
fraction	I-test
was	O
55%	O
.	O

On	O
4/16	O
the	B-test
pulmonary	I-test
artery	I-test
catheter	I-test
was	O
placed	O
which	O
revealed	O
a	B-test
wedge	I-test
pressure	I-test
of	O
8	O
,	O
cardiac	B-test
index	I-test
of	O
4.5	O
,	O
and	O
an	B-test
SVR	I-test
of	O
5.8	O
.	O

5-Hepatic	B-problem
failure	I-problem
.	O

His	B-test
SGPT	I-test
on	O
admission	O
was	O
2,520	O
with	O
a	O
peak	O
at	O
7,680	O
on	O
hospital	O
day	O
two	O
.	O

He	O
had	O
complete	B-problem
loss	I-problem
of	I-problem
synthetic	I-problem
and	I-problem
conjugation	I-problem
function	I-problem
of	O
the	O
liver	O
with	O
rising	B-problem
bilirubin	I-problem
and	O
falling	B-problem
albumin	I-problem
with	O
dependence	B-problem
on	I-problem
transfusion	I-problem
for	O
support	O
of	O
his	B-test
prothrombin	I-test
time	I-test
.	O

He	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
GI	O
Service	O
and	O
the	O
Liver	O
Transplantation	O
Service	O
.	O

Given	O
his	B-problem
multiple	I-problem
other	I-problem
medical	I-problem
problems	I-problem
,	O
the	O
direness	O
of	O
his	O
situation	O
,	O
and	O
his	O
ongoing	O
substance	O
abuse	O
at	O
the	O
time	O
of	O
admission	O
he	O
was	O
deemed	O
not	O
to	O
be	O
a	O
candidate	O
for	O
a	B-treatment
liver	I-treatment
transplantation	I-treatment
.	O

6-Cocaine	O
intoxication	O
.	O

Serum	B-test
Cocaine	I-test
was	O
positive	B-problem
6-12	O
hours	O
ingestion	O
at	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

Further	O
,	O
at	O
Ceanotsit	O
Ortgold	O
Center	O
his	B-test
serum	I-test
toxicology	I-test
screens	I-test
were	O
positive	B-problem
.	O

This	O
is	O
thought	O
to	O
be	O
the	O
insighting	O
cause	O
of	O
his	B-problem
massive	I-problem
rhabdomyolysis	I-problem
and	O
hepatic	B-problem
failure	I-problem
.	O

7-Pneumonia	B-problem
.	O

The	O
patient	O
developed	O
two	B-problem
pneumonias	I-problem
with	O
two	B-problem
separate	I-problem
organisms	I-problem
.	O

The	O
first	O
was	O
Acinetobacter	B-problem
calcoaceticus	I-problem
subspecies	I-problem
anitratus	I-problem
,	O
treated	O
with	O
Ciprofloxacin	B-treatment
and	O
Gentamicin	B-treatment
.	O

He	O
subsequently	O
developed	O
a	B-problem
staphylococcus	I-problem
aureus	I-problem
pneumonia	I-problem
which	O
was	O
treated	O
with	O
Vancomycin	B-treatment
,	O
dosed	O
to	O
levels	O
appropriate	O
for	O
his	B-problem
renal	I-problem
failure	I-problem
.	O

He	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Infectious	O
Disease	O
Service	O
who	O
advised	O
us	O
on	O
antibiotic	B-treatment
choices	I-treatment
daily	O
.	O

8-Pancreatitis	B-problem
.	O

The	B-test
amylase	I-test
on	O
admission	O
was	O
279	O
with	O
a	B-test
lipase	I-test
of	O
161	O
.	O

Although	O
not	O
fully	O
this	O
may	O
have	O
contributed	O
to	O
his	B-problem
hypocalcemia	I-problem
and	O
volume	B-problem
requirements	I-problem
.	O

9-Catheter	B-problem
tip	I-problem
infections	I-problem
.	O

The	O
patient	O
grew	O
out	O
coagulase	B-problem
negative	I-problem
staphylococcus	I-problem
from	O
the	B-treatment
femoral	I-treatment
lines	I-treatment
which	O
were	O
placed	O
during	O
his	B-problem
profound	I-problem
hypertension	I-problem
.	O

These	O
were	O
treated	O
with	O
Vancomycin	B-treatment
.	O

10-Anemia	B-problem
.	O

The	B-test
patient	I-test
&apos;s	I-test
hematocrit	I-test
was	O
33%	O
on	O
admission	O
and	O
fell	O
to	O
28	O
requiring	O
4	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
over	O
the	O
course	O
of	O
his	O
hospitalization	O
.	O

11-Coma	B-problem
.	O

The	O
patient	O
,	O
although	O
initially	O
minimally	B-problem
responsive	I-problem
,	O
went	O
on	O
to	O
develop	O
a	B-problem
deep	I-problem
comatose	I-problem
state	I-problem
.	O

A	B-test
CT	I-test
scan	I-test
on	O
admission	O
revealed	O
no	O
evidence	O
of	O
hemorrhage	B-problem
though	O
he	O
did	O
have	O
sphenoid	B-problem
sinusitis	I-problem
.	O

The	B-test
lumbar	I-test
puncture	I-test
and	O
sinus	B-test
exploration	I-test
were	O
unable	O
to	O
be	O
performed	O
given	O
the	B-problem
patient	I-problem
&apos;s	I-problem
persistent	I-problem
coagulopathy	I-problem
.	O

The	O
patient	O
was	O
treated	O
empirically	O
with	O
Nafcillin	B-treatment
and	O
Ceftriaxone	B-treatment
for	O
meningitis	B-problem
and	O
sinusitis	B-problem
.	O

Further	O
complicating	O
this	O
was	O
his	B-problem
profound	I-problem
liver	I-problem
failure	I-problem
with	O
rising	B-problem
ammonias	I-problem
and	O
hepatic	B-problem
encephalopathy	I-problem
.	O

Despite	O
maximal	B-treatment
supports	I-treatment
the	O
patient	O
continued	O
to	O
be	O
hypotensive	B-problem
.	O

Mid-way	O
through	O
his	O
hospital	O
course	O
he	O
developed	O
trilobar	B-problem
pneumonia	I-problem
and	O
this	O
was	O
probably	O
complicated	O
further	O
by	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
and	O
the	B-problem
multi-organ	I-problem
system	I-problem
failure	I-problem
syndrome	I-problem
.	O

The	O
patient	O
remained	O
mechanically	B-treatment
ventilated	I-treatment
throughout	O
his	O
hospitalization	O
.	O

Nevertheless	O
,	O
he	O
developed	O
refractory	B-problem
hypoxemia	I-problem
,	O
hypotension	B-problem
,	O
and	O
ultimately	O
the	O
patient	O
died	O
despite	O
total	B-treatment
life	I-treatment
support	I-treatment
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Cocaine	O
intoxication	O
,	O
rhabdomyolysis	B-problem
,	O
renal	B-problem
failure	I-problem
,	O
disseminated	B-problem
intravascular	I-problem
coagulation	I-problem
,	O
septic	B-problem
shock	I-problem
,	O
hepatic	B-problem
failure	I-problem
,	O
pneumonia	B-problem
,	O
pancreatitis	B-problem
,	O
catheter	B-problem
tip	I-problem
infection	I-problem
,	O
anemia	B-problem
,	O
coma	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Peritoneal	B-treatment
dialysis	I-treatment
catheter	I-treatment
placement	I-treatment
,	O
peritoneal	B-treatment
dialysis	I-treatment
,	O
arterial	B-treatment
catheterization	I-treatment
,	O
venous	B-treatment
catheterization	I-treatment
,	O
continuous	B-treatment
mechanical	I-treatment
ventilation	I-treatment
,	O
and	O
parenteral	B-treatment
nutrition	I-treatment
.	O

COMPLICATIONS	O
DURING	O
ADMISSION	O
:	O

Neck	B-problem
hematoma	I-problem
secondary	O
to	O
pulmonary	B-treatment
artery	I-treatment
line	I-treatment
placement	I-treatment
requiring	O
transfusion	B-treatment
,	O
catheter	B-problem
tip	I-problem
infection	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

None	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
Samfer	O
Street	O
with	O
no	O
autopsy	O
.	O

LENNI	O
HEAD	O
,	O
M.D.	O

TR	O
:	O

be	O
/	O
bmot	O

DD	O
:	O

09-05-92	O
PAD-WORD	O

TD	O
:	O

09/07/92	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2010-03-11	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-03-28	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1946-10-26	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service:	O
PAD-WORD	O

ADMISSION	O
DIAGNOSIS:	O

1.	O
Unstable	B-problem
angina	I-problem
.	O

2.	O
Non-ST	B-problem
elevation	I-problem
myocardial	I-problem
infarction	I-problem
.	O

3.	O
Atrial	B-problem
fibrillation	I-problem
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Persistent	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

2.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

3.	O
Coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
times	O
two	O
.	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
63	O
-	O
year-old	O
man	O
with	O
a	O
history	O
of	O
hypertension	B-problem
and	O
prior	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
secondary	O
to	O
hyperthyroidism	B-problem
who	O
presented	O
to	O
an	O
outside	O
hospital	O
with	O
a	O
history	O
of	O
left-sided	B-problem
chest	I-problem
pain	I-problem
at	O
rest	O
.	O

The	O
patient	O
awoke	O
with	O
chest	B-problem
pressure	I-problem
radiating	O
to	O
the	O
right	O
chest	O
associated	O
with	O
diaphoresis	B-problem
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
a	B-test
blood	I-test
pressure	I-test
of	O
170/108	O
with	O
atrial	B-problem
fibrillation	I-problem
and	O
rapid	B-problem
ventricular	I-problem
response	I-problem
to	O
a	B-test
heart	I-test
rate	I-test
of	O
140s	O
.	O

The	O
patient	O
was	O
rate	O
controlled	O
and	O
transferred	O
to	O
the	O
Stillman	O
Infirmary	O
for	O
emergent	B-test
cardiac	I-test
catheterization	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Atrial	B-problem
fibrillation	I-problem
secondary	O
to	O
hyperthyroidism	B-problem
,	O
initially	O
diagnosed	O
in	O
2005	O
.	O

2.	O
Status	O
post	O
current	O
cardioversion	B-treatment
times	O
four	O
.	O

3.	O
Hyperthyroidism	B-problem
,	O
status	O
post	O
radioactive	B-treatment
iodine	I-treatment
ablation	I-treatment
.	O

4.	O
Status	O
post	O
carpal	B-treatment
tunnel	I-treatment
release	I-treatment
.	O

5.	O
Status	O
post	O
umbilical	B-treatment
hernia	I-treatment
repair	I-treatment
.	O

6.	O
Hypertension	B-problem
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Accupril	B-treatment
40	O
mg	O
q.d.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

3.	O
Clonidine	B-treatment
0.1	O
mg	O
b.i.d.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

General	O
:	O

The	O
patient	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
well	O
developed	O
.	O

Vital	O
signs	O
:	O

Stable	O
,	O
afebrile	B-problem
.	O

HEENT	O
:	O

Normocephalic	O
,	O
atraumatic	B-problem
.	O

PERRL	O
,	O
anicteric	B-problem
,	O
EOMI	O
.	O

The	O
throat	O
was	O
clear	O
.	O

Neck	O
:	O

Supple	O
,	O
midline	O
,	O
without	O
masses	B-problem
or	O
lymphadenopathy	B-problem
.	O

No	O
bruit	B-problem
or	O
JVD	B-problem
.	O

Cardiovascular	O
:	O

Irregularly	B-problem
/	I-problem
irregular	I-problem
without	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

Chest	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
without	O
masses	B-problem
or	O
organomegaly	B-problem
.	O

Extremities	O
:	O

Warm	O
,	O
noncyanotic	B-problem
,	O
nonedematous	B-problem
times	O
four	O
.	O

Neurological	O
:	O

Grossly	O
intact	O
.	O

ADMISSION	O
LABORATORY	O
DATA	O
:	O

CBC	B-test
11.3	O
/	O
15.7	O
/	O
44.6	O
/	O
183	O
.	O

PT	B-test
14	O
,	O
INR	B-test
1.3	O
,	O
PTT	B-test
115	O
.	O

Chemistries	B-test
:	O

137	O
/	O
4.3	O
/	O
104	O
/	O
22	O
/	O
14	O
/	O
0.7	O
/	O
155	O
.	O

ALT	B-test
27	O
,	O
AST	B-test
21	O
,	O
alkaline	B-test
phosphatase	I-test
72	O
,	O
total	B-test
bilirubin	I-test
1.2	O
,	O
amylase	B-test
47	O
.	O

The	B-test
U/A	I-test
was	O
negative	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
transferred	O
for	O
cardiac	B-test
catheterization	I-test
.	O

Emergent	B-test
cardiac	I-test
catheterization	I-test
revealed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
45%	O
,	O
right	B-problem
dominant	I-problem
coronary	I-problem
artery	I-problem
system	I-problem
with	O
occlusive	B-problem
single	I-problem
vessel	I-problem
disease	I-problem
of	I-problem
the	I-problem
LAD	I-problem
.	O

Multiple	B-treatment
wires	I-treatment
were	O
used	O
to	O
attempt	O
to	O
cross	O
the	B-problem
total	I-problem
occlusion	I-problem
,	O
but	O
were	O
ultimately	O
unsuccessful	O
.	O

The	O
patient	O
was	O
continued	O
on	O
a	B-treatment
heparin	I-treatment
drip	I-treatment
for	O
atrial	B-problem
fibrillation	I-problem
.	O

Cardiothoracic	O
Surgery	O
consultation	O
was	O
obtained	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
2010-03-12	O
for	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
times	O
two	O
;	O
LIMA	O
to	O
the	O
LAD	O
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
diagonal	I-treatment
artery	I-treatment
.	O

Subsequent	O
to	O
this	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
CRSU	O
for	O
closer	O
monitoring	O
.	O

He	O
was	O
deemed	O
to	O
be	O
too	B-problem
lethargic	I-problem
and	O
sleepy	B-problem
to	O
be	O
extubated	O
on	O
postoperative	O
day	O
number	O
zero	O
.	O

The	O
patient	O
was	O
extubated	O
early	O
on	O
postoperative	O
day	O
number	O
one	O
without	O
significant	B-problem
complication	I-problem
.	O

He	O
remained	O
in	O
atrial	B-problem
fibrillation	I-problem
.	O

The	O
EP	O
Service	O
was	O
consulted	O
regarding	O
the	B-problem
patient	I-problem
's	I-problem
atrial	I-problem
fibrillation	I-problem
.	O

This	O
was	O
his	B-problem
main	I-problem
issue	I-problem
in	O
the	O
postoperative	O
course	O
.	O

He	O
was	O
attempted	O
on	O
multiple	B-treatment
different	I-treatment
drugs	I-treatment
including	O
Procainamide	B-treatment
,	O
Diltiazem	B-treatment
,	O
Esmolol	B-treatment
,	O
Sotalol	B-treatment
,	O
Amiodarone	B-treatment
.	O

The	O
patient	O
was	O
kept	O
therapeutically	B-treatment
anticoagulated	I-treatment
throughout	O
this	O
period	O
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
digoxin	B-treatment
.	O

Ultimately	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
and	O
anticoagulation	B-treatment
with	O
Coumadin	B-treatment
was	O
begun	O
.	O

The	O
patient	O
arrived	O
on	O
the	O
floor	O
with	O
medications	B-treatment
as	O
follows	O
:	O

Sotalol	B-treatment
180	O
mg	O
b.i.d.	O
,	O
Diltiazem	B-treatment
90	O
mg	O
q.i.d.	O
,	O
digoxin	B-treatment
0.125	O
mg	O
q.d.	O

While	O
the	O
patient	O
was	O
awaiting	O
therapeutic	B-treatment
anticoagulation	I-treatment
with	O
Coumadin	B-treatment
,	O
he	O
spontaneously	O
converted	O
into	O
normal	O
sinus	O
rhythm	O
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
a	B-test
resting	I-test
heart	I-test
rate	I-test
of	O
approximately	O
50	O
subsequent	O
to	O
this	O
.	O

In	O
consultation	O
with	O
the	O
EP	O
Service	O
,	O
Diltiazem	B-treatment
was	O
stopped	O
.	O

After	O
approximately	O
24	O
hours	O
,	O
the	O
patient	O
converted	O
back	O
into	O
atrial	B-problem
fibrillation	I-problem
and	O
Diltiazem	B-treatment
was	O
restarted	O
at	O
60	O
mg	O
q.i.d.	O

The	O
patient	O
then	O
had	O
one	B-problem
more	I-problem
episode	I-problem
where	O
he	O
was	O
converted	O
to	O
normal	O
sinus	O
rhythm	O
but	O
this	O
lasted	O
only	O
a	O
few	O
hours	O
before	O
reverting	O
back	O
to	O
atrial	B-problem
fibrillation	I-problem
.	O

The	O
patient	O
was	O
ultimately	O
discharged	O
on	O
postoperative	O
day	O
number	O
16	O
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
and	O
adequate	O
pain	O
control	O
on	O
p.o.	B-treatment
pain	I-treatment
medications	I-treatment
,	O
having	O
no	O
anginal	B-problem
symptoms	I-problem
and	O
with	O
an	B-test
INR	I-test
of	O
2.0	O
.	O

The	O
patient	O
failed	O
multiple	O
attempts	O
at	O
cardioversion	B-treatment
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

INR	B-test
2.0.	O

DISPOSITION	O
:	O

To	O
home	O
.	O

DIET	O
:	O

Cardiac	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Percocet	B-treatment
5/325	O
mg	O
one	O
to	O
two	O
q.	O
four	O
hours	O
p.r.n.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

3.	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O

4.	O
Coumadin	B-treatment
5	O
mg	O
q.d.	O

5.	O
Sotalol	B-treatment
180	O
mg	O
b.i.d.	O

6.	O
Digoxin	B-treatment
0.125	O
mg	O
q.d.	O

7.	O
Diltiazem	B-treatment
60	O
mg	O
q.i.d.	O

8.	O
Ambien	B-treatment
5-10	O
mg	O
q.h.s.	O
p.r.n.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
should	O
follow-up	O
with	O
his	O
cardiologist	O
in	O
one	O
to	O
two	O
weeks	O
.	O

He	O
will	O
also	O
go	O
home	O
with	O
VNA	O
for	O
INRs	B-test
twice	O
weekly	O
with	O
the	O
results	O
reported	O
to	O
his	O
PCP	O
or	O
cardiologist	O
for	O
Coumadin	B-treatment
adjustment	I-treatment
.	O

The	O
patient	O
should	O
follow-up	O
with	O
Dr.	O
Halcomb	O
in	O
six	O
weeks	O
time	O
.	O

Octavia	O
W.	O
Levitre	O
,	O
M.D.	O
05-383	O

Dictated	O
By	O
:	O
James	O
Q.	O
Mitchell	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2010-03-28	O
10:15	O

T	O
:	O
2010-03-28	O
10:46	O

JOB	O
#	O
:	O
41466	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Janice	O
Carpenter	O
on	O
:	O
Andrea	O
2010-04-01	O
8:20	O
AM	O

(	O
End	O
of	O
Report	O
)	O

260257442	O
DH	O

0145802	O
PAD-WORD	O

292408	O
PAD-WORD	O

9739205	O
PAD-WORD	O

2/11/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

DUHETLAND	O
,	O
RIE	O

MRN	O
:	O

0145802	O
PAD-WORD	O

Age	O
:	O

29y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

02/11/2003	O
02:42	O
PM	O

Provider	O
:	O

AMINE	O
GUAYTREFTSCOST	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Yes	O
-	O
Direct	O
contact	O
with	O
PCP	O

Discharge	O
Date	O
/	O
Time	O
:	O

02/11/2003	O
16:52	O

Discharge	O
Status	O
:	O

Discharged	O
PAD-WORD	O

Condition	O
on	O
Discharge	O
:	O

Stable	O
PAD-WORD	O

Patient	O
States	O
Complaint	O
:	O

BACK	B-problem
PAIN	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
back	B-problem
pain	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Back	B-problem
pain	I-problem

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Call	O
your	O
doctor	O
in	O
the	O
morning	O
for	O
an	O
appointment	O
with	O
the	O
pain	O
clinic	O
.	O

If	O
you	O
have	O
any	O
bladder	B-problem
incontinence	I-problem
,	O
bowel	B-problem
incontinence	I-problem
,	O
worse	B-problem
numbness	I-problem
,	O
any	B-problem
weakness	I-problem
,	O
or	O
any	O
other	B-problem
concerns	I-problem
,	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
emergency	O
department	O
immediately	O
.	O

PCP	O
Name	O
:	O

PULESHUFF	O
,	O
SACA	O
G	O

Provider	O
Number	O
:	O

79863	O
PAD-WORD	O

This	O
report	O
was	O
created	O
by	O
GUAYTREFTSCOST	O
,	O
AMINE	O
02/11/2003	O
04:53	O
PM	O

Admission	O
Date	O
:	O

2012-05-13	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-05-22	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2012-05-13	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Neonatology	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Fred	O
Grauman	O
is	O
the	O
former	O
2.252	O
kg	O
product	O
of	O
a	O
35-1/7	O
week	O
gestation	O
pregnancy	O
born	O
to	O
a	O
37-year-old	O
G4	O
P3-5	O
woman	O
.	O

Prenatal	O
screens	O
:	O

Blood	B-test
type	I-test
O+	O
,	O
antibody	B-test
negative	O
,	O
rubella	B-test
immune	O
,	O
RPR	B-test
nonreactive	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
group	B-problem
beta	I-problem
Strep	I-problem
positive	I-problem
.	O

The	O
pregnancy	O
was	O
complicated	O
by	O
anemia	B-problem
.	O

Mother	O
has	O
a	O
prior	O
history	O
of	O
mitral	B-problem
valve	I-problem
prolapse	I-problem
.	O

She	O
had	O
a	B-treatment
prior	I-treatment
cesarean	I-treatment
section	I-treatment
done	O
,	O
two	O
vaginal	O
births	O
after	O
cesarean	B-treatment
section	I-treatment
.	O

She	O
presented	O
in	O
labor	O
on	O
the	O
day	O
of	O
delivery	O
.	O

These	O
infants	O
were	O
delivered	O
by	O
repeat	B-treatment
cesarean	I-treatment
section	I-treatment
,	O
this	O
twin	O
emerged	O
with	O
good	O
tone	O
,	O
color	O
,	O
and	O
cry	O
.	O

Apgars	B-test
were	O
eight	O
at	O
one	O
minute	O
and	O
nine	O
at	O
five	O
minutes	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
for	O
treatment	B-treatment
of	O
prematurity	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
UPON	O
ADMISSION	O
TO	O
THE	O
NEONATAL	O
INTENSIVE	O
CARE	O
UNIT	O
:	O

Weight	B-test
2.252	O
kg	O
,	O
65th	O
percentile;	O
length	B-test
46	O
cm	O
,	O
50th	O
percentile	O
;	O
head	B-test
circumference	I-test
33	O
cm	O
75th	O
percentile	O
.	O

General	O
:	O

A	O
nondysmorphic	O
preterm	O
35	O
week	O
gestation	O
male	O
.	O

Skin	O
:	O

Color	O
pink	O
in	O
room	O
air	O
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
:	O

Anterior	O
fontanel	O
open	O
,	O
level	O
and	O
soft	O
.	O

Sutures	O
are	O
proximated	O
.	O

Positive	O
red	O
reflex	O
bilaterally	O
.	O

Palate	O
intact	O
.	O

Chest	O
:	O

Mild	B-problem
retractions	I-problem
,	O
occasional	B-problem
grunting	I-problem
.	O

Breath	B-test
sounds	I-test
equal	O
with	O
good	O
aeration	O
.	O

Cardiovascular	O
:	O

Regular	O
,	O
rate	O
,	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
.	O

Pulses	B-test
+2	O
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
no	O
masses	B-problem
,	O
and	O
no	O
hepatosplenomegaly	B-problem
.	O

Genitourinary	O
:	O

Normal	O
male	O
,	O
testes	O
descended	O
.	O

Extremities	O
:	O

Hips	O
stable	O
,	O
moving	O
all	O
.	O

Spine	O
intact	O
.	O

Neurologic	O
:	O

Appropriate	O
tone	O
and	O
reflexes	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
INCLUDING	O
PERTINENT	O
LABORATORY	O
DATA:	O

1.	O
Respiratory	O
:	O

Raymond	O
required	O
some	B-treatment
intermittent	I-treatment
blow-by	I-treatment
oxygen	I-treatment
for	O
the	O
first	O
two	O
hours	O
of	O
birth	O
.	O

He	O
has	O
remained	O
in	O
room	O
air	O
since	O
that	O
time	O
.	O

The	B-problem
grunting	I-problem
noted	O
on	O
admission	O
resolved	O
within	O
the	O
first	O
few	O
hours	O
after	O
birth	O
.	O

He	O
did	O
not	O
have	O
any	O
episodes	O
of	O
spontaneous	B-problem
apnea	I-problem
or	O
bradycardia	B-problem
.	O

2.	O
Cardiovascular	O
:	O

No	O
murmurs	B-problem
were	O
noted	O
,	O
although	O
normal	O
heart	O
rates	O
and	O
blood	O
pressures	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
,	O
and	O
nutrition	O
:	O

Enteral	B-treatment
feeds	I-treatment
were	O
started	O
on	O
the	O
date	O
of	O
birth	O
and	O
gradually	O
advanced	O
to	O
full	O
volume	O
.	O

He	O
required	O
some	B-treatment
gavage	I-treatment
feeds	I-treatment
through	O
day	O
of	O
life	O
#4	O
,	O
and	O
has	O
been	O
all	O
po	O
since	O
day	O
of	O
life	O
#5	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
he	O
is	O
taking	O
Enfamil	B-treatment
20	I-treatment
calories	I-treatment
/	I-treatment
ounce	I-treatment
with	I-treatment
iron	I-treatment
.	O

Discharge	B-test
weight	I-test
is	O
2.37	O
kg	O
,	O
head	B-test
circumference	I-test
32	O
cm	O
,	O
length	B-test
47	O
cm	O
.	O

4.	O
Infectious	O
Disease	O
:	O

Due	O
to	O
the	B-problem
unknown	I-problem
group	I-problem
B	I-problem
Strep	I-problem
status	I-problem
and	O
prematurity	B-problem
,	O
Raymond	O
was	O
evaluated	O
for	O
sepsis	B-problem
.	O

A	B-test
complete	I-test
blood	I-test
count	I-test
had	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
13,800	O
with	O
17%	B-test
polys	I-test
,	O
0%	B-test
bands	I-test
.	O

A	O
repeat	O
on	O
day	O
of	O
life	O
two	O
,	O
had	O
a	B-test
white	I-test
count	I-test
of	O
13,000	O
with	O
50%	B-test
polys	I-test
,	O
0%	B-test
bands	I-test
.	O

A	B-test
blood	I-test
culture	I-test
obtained	O
prior	O
to	O
starting	O
antibiotics	B-treatment
was	O
no	O
growth	B-problem
at	O
48	O
hours	O
.	O

5.	O
Gastrointestinal	O
:	O

Peak	B-test
serum	I-test
bilirubin	I-test
occurred	O
on	O
day	O
of	O
life	O
#4	O
,	O
a	B-test
total	I-test
of	O
10.0/0.3	O
direct	B-test
.	O

A	B-test
repeat	I-test
bilirubin	I-test
on	O
2012-05-19	O
was	O
8.0/0.3	O
direct	B-test
.	O

6.	O
Hematological	O
:	O

Hematocrit	B-test
at	O
birth	O
was	O
43.8%.	O

Raymond	O
did	O
not	O
receive	O
any	B-treatment
transfusions	I-treatment
of	I-treatment
blood	I-treatment
products	I-treatment
during	O
admission	O
.	O

7.	O
Neurology	O
:	O

Raymond	O
has	O
maintained	O
normal	O
neurological	O
examination	O
throughout	O
admission	O
and	O
there	O
were	O
no	O
concerns	O
at	O
the	O
time	O
of	O
discharge	O
.	O

8.	O
Sensory	O
:	O

Audiology	B-test
hearing	I-test
screening	I-test
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Raymond	O
passed	O
in	O
both	O
ears	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
/	O
DISPOSITION	O
:	O

Home	O
with	O
parents	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Timothy	O
Alexander	O
,	O
Gloucester	O

Pediatric	O
Associate	O
,	O
8219	O
W.	O
Eighth	O
Rd.	O
,	O
Terry	O
,	O
Illinois	O
72097	O
,	O
phone	O
482-5289	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
AT	O
THE	O
TIME	O
OF	O
DISCHARGE	O
:	O

1.	O
Feeding	O
:	O

Adlib	O
po	B-treatment
Enfamil	I-treatment
with	I-treatment
iron	I-treatment
.	O

2.	O
No	O
medications	B-treatment
.	O

3.	O
Car	B-test
seat	I-test
position	I-test
screening	I-test
was	O
performed	O
successfully	O
.	O

4.	O
State	B-test
Newborn	I-test
Screen	I-test
was	O
sent	O
on	O
day	O
of	O
life	O
#3	O
.	O

A	O
report	O
of	O
an	B-problem
elevated	I-problem
17-OH	I-problem
was	O
called	O
to	O
the	O
CMED	O
CCU	O
.	O

A	B-test
subsequent	I-test
sample	I-test
was	O
done	O
(	O
05-21	O
)	O
and	O
results	O
are	O
pending	O
.	O

Newborn	O
State	O
Screen	O
phone	O
number	O
#(	O
822	O
)	O
923-2683	O
.	O

5.	O
Immunizations	B-treatment
received	O
:	O

Hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
was	O
administered	O
at	O
the	O
time	O
of	O
birth	O
on	O
2012-05-13	O
.	O

IMMUNIZATIONS	O
RECOMMENDED	O
:	O

1.	O
Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

1)	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
,	O

2)	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
daycare	O
during	O
RSV	O
season	O
,	O
with	O
a	O
smoker	O
in	O
the	O
household	O
,	O
or	O
with	O
preschool	O
siblings	O
,	O
or	O

3)	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

2.	O
Influenza	B-treatment
immunization	I-treatment
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	B-problem
infants	I-problem
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	B-treatment
against	O
influenza	B-problem
to	O
protect	O
the	O
infant	O
.	O

FOLLOW-UP	O
APPOINTMENT	O
:	O

Primary	O
pediatrician	O
recommended	O
within	O
three	O
days	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
A	O
35-1/7	O
week	O
gestation	O
.	O

2.	O
Twin	O
#2	O
of	O
twin	O
gestation	O
.	O

3.	O
Transitional	B-problem
respiratory	I-problem
distress	I-problem
.	O

4.	O
Suspicion	O
for	O
sepsis	B-problem
ruled	O
out	O
.	O

DR.	O
Gloria	O
,	O
Lonnie	O
55-454	O

Dictated	O
By	O
:	O
John	O
Z.	O
Toledo	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2012-05-22	O
07:06	O

T	O
:	O
2012-05-22	O
07:17	O

JOB	O
#	O
:	O
35651	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Freddy	O
King	O
on	O
:	O
WED	O
2012-05-23	O
9:05	O
AM	O

(	O
End	O
of	O
Report	O
)	O

268157859	O
YC	O

35980943	O
PAD-WORD	O

4198660	O
PAD-WORD	O

5/30/2005	O
12:00:00	O
AM	O

s	O
/	O
p	O
total	B-treatment
thyoidectomy	I-treatment

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

05/30/2005	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

05/31/2005	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KOTEBITZWEERTS	O
,	O
LIXYNA	O
N	O

306-08-68-0	O
K78	O

Room	O
:	O

58W-275	O
PAD-WORD	O

Service	O
:	O

GGI	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

05/31/05	O
AT	O
02:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

TLAND	O
,	O
JR	O
,	O
VOTRIBRENDEVE	O
N.	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

ROCALTROL	B-treatment
(	I-treatment
CALCITRIOL	I-treatment
)	I-treatment
0.5	O
MCG	O
PO	O
QD	O
Starting	O
Today	O
(	O
05/31	O
)	O

Instructions	O
:	O

Start	O
on	O
day	O
of	O
surgery	B-treatment
and	O
continue	O
throughout	O
hospitalization	O
.	O

SYNTHROID	B-treatment
(	I-treatment
LEVOTHYROXINE	I-treatment
SODIUM	I-treatment
)	I-treatment
125	O
MCG	O
PO	O
QD	O

Instructions	O
:	O

(	O
typical	O
dose	O
is	O
1	O
mcg	O
per	O
lb.	O
)	O

OXYCODONE	B-treatment
5-10	O
MG	O
PO	O
Q4H	O
PRN	O
Pain	B-problem
ADVAIR	B-treatment
DISKUS	I-treatment
100/50	O
(	O
FLUTICASONE	B-treatment
PROPIONATE/...	I-treatment
)	O
1	O
PUFF	O
INH	O
BID	O
CALCIUM	B-treatment
CARBONATE	I-treatment
2,400	O
MG	O
PO	O
QID	O
Starting	O
Today	O
(	O
05/31	O
)	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Tland	O
,	O
462-352-5678	O
1-2	O
weeks	O
please	O
call	O
for	O
appointment	O
if	O
not	O
made	O
,	O

ALLERGY	O
:	O

NKA	B-problem
ADMIT	O
DIAGNOSIS	O
:	O

total	B-treatment
thyroidectomy	I-treatment

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
total	B-treatment
thyoidectomy	I-treatment

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
asthma	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

05/30/05	O
TLAND	O
,	O
JR	O
,	O
VOTRIBRENDEVE	O
N.	O
,	O
M.D.	O
TOTAL	B-treatment
THYROIDECTOMY	I-treatment

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O
PAD-WORD	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

40F	O
with	O
hurtle	B-problem
cell	I-problem
tumor	I-problem
of	I-problem
thyroid	I-problem
had	O
total	B-treatment
thyroidectomy	I-treatment
without	O
complication	B-problem
.	O

POD#	O
1	O
pt	O
was	O
tolerating	O
regular	O
diet	O
,	O
ambulating	O
,	O
afebrile	B-problem
,	O
and	O
calcium	B-test
was	O
stable	O
.	O

Incicsion	B-problem
was	O
clean	O
dry	O
and	O
intact	O
and	O
pt	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O

ADDITIONAL	O
COMMENTS	O
:	O

Keep	O
incision	B-problem
clean	O
and	O
dry	O
,	O
may	O
shower	O
Wed	O
.	O

Do	O
not	O
drive	O
if	O
taking	O
narcotics	B-treatment
Call	O
doctor	O
if	O
fever	B-problem
&gt;	O
101.5	O
,	O
worsening	B-problem
pain	I-problem
,	O
swelling	B-problem
,	O
or	O
redness	B-problem
of	I-problem
wound	I-problem
,	O
numbness	B-problem
or	I-problem
tingling	I-problem
in	I-problem
extremities	I-problem
or	O
face	O
or	O
any	O
other	O
concerns	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

LILLETLANDTRIEV	O
,	O
ROSEEN	O
ERTONDON	O
(	O
BZ30	O
)	O
05/31/05	O
09:05	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2017-05-08	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-05-16	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1931-10-04	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Walter	O
G	O
Gaines	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
worsening	B-problem
chest	I-problem
pain	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
x	O
2	O
/	O
Aortic	B-treatment
valve	I-treatment
replacement	I-treatment
05-08	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Williams	O
is	O
an	O
85	O
yo	O
gentleman	O
who	O
has	O
a	B-problem
known	I-problem
cardiac	I-problem
history	I-problem
and	O
has	O
had	O
a	O
h/o	O
worsening	B-problem
chest	I-problem
pain	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

He	O
had	O
an	B-test
echocardiogram	I-test
which	O
showed	O
an	B-test
EF	I-test
40-45%	O
and	O
severe	B-problem
aortic	I-problem
stenosis	I-problem
.	O

He	O
underwent	O
cardiac	B-test
catheterization	I-test
which	O
showed	O
an	B-problem
80%	I-problem
LAD	I-problem
lesion	I-problem
,	O
chronically	B-problem
occluded	I-problem
RCA	I-problem
,	O
anneurysmal	B-problem
mid	I-problem
LCX	I-problem
w/50%	B-problem
lesion	I-problem
.	O

He	O
was	O
refered	O
to	O
Dr.	O
Barber	O
for	O
surgical	B-treatment
treatment	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

s/p	O
MI	B-problem
1992	O

AS	B-problem
PAD-WORD	O

h/o	O
prostate	B-problem
CA	I-problem
s/p	O
brachytherapy	B-treatment
and	O
hormone	B-treatment
treatment	I-treatment

hyperlipidemia	B-problem
PAD-WORD	O

HTN	B-problem
PAD-WORD	O

PAF	B-problem
h/o	O
rectal	B-problem
bleeding	I-problem
s/p	O
cauterization	B-treatment

cholelithiasis	B-problem
PAD-WORD	O

s/p	O
AAA	B-treatment
repair	I-treatment
'95	O

s/p	O
bilateral	B-treatment
hernia	I-treatment
repair	I-treatment

s/p	O
R	B-treatment
lung	I-treatment
surgery	I-treatment

CRI	B-problem
PAD-WORD	O

chronic	B-problem
lung	I-problem
disease	I-problem

Pertinent	O
Results:	O

2017-05-16	O
06:20	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
8.0	O
RBC	B-test
-	O
3.35	O
*	O
Hgb	B-test
-	O
10.3	O
*	O
Hct	B-test
-	O
31.0	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
30.7	O
MCHC	B-test
-	O
33.1	O
RDW	B-test
-	O
13.0	O
Plt	B-test
Ct	I-test
-	O
201	O

2017-05-16	O
06:20	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
201	O

2017-05-16	O
06:20	O
AM	O
BLOOD	B-test
PT	B-test
-	O
19.0	O
*	O
INR	B-test
(	I-test
PT	I-test
)-	O
2.3	O

2017-05-16	O
09:50	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
118	O
*	O
UreaN	B-test
-	O
18	O
Creat	B-test
-	O
1.6	O
*	O
Na	B-test
-	O
137	O
K	B-test
-	O
5.1	O
Cl	B-test
-	O
98	O
HCO3	B-test
-	O
29	O
AnGap	B-test
-	O
15	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Williams	O
was	O
admitted	O
to	O
Hallmark	O
Health	O
System	O
on	O
05-08	O
and	O
taken	O
to	O
the	O
operating	O
room	O
with	O
Dr.	O
Barber	O
for	O
a	B-treatment
CABGx2	I-treatment
and	O
AVR	B-treatment
w/	O
25	B-treatment
mm	I-treatment
pericardial	I-treatment
valve	I-treatment
.	O

Please	O
see	O
operative	O
note	O
for	O
full	O
details	O
.	O

He	O
was	O
transfered	O
to	O
the	O
ICU	O
in	O
stable	O
condition	O
.	O

He	O
was	O
weaned	O
and	O
extubated	O
from	O
mechanical	B-treatment
ventillation	I-treatment
on	O
POD#1	O
without	O
difficulty	B-problem
.	O

He	O
was	O
transfered	O
to	O
the	O
regular	O
part	O
of	O
the	O
hospital	O
on	O
POD#2	O
,	O
where	O
he	O
began	O
working	O
with	O
physical	O
therapy	O
.	O

He	O
developed	O
atrial	B-problem
fibrillation	I-problem
on	O
POD#2	O
with	O
well	O
controlled	O
rate	O
and	O
hemodynamically	O
stable	O
.	O

He	O
was	O
started	O
on	O
heparin	B-treatment
and	O
coumadin	B-treatment
for	O
anticoagulation	B-treatment
on	O
POD#5	O
.	O

On	O
POD#7	O
he	O
was	O
cleared	O
for	O
discharge	O
to	O
home	O
by	O
physical	O
therapy	O
and	O
on	O
POD#8	O
he	O
was	O
discharged	O
.	O

Medications	O
on	O
Admission	O
:	O

lasix	B-treatment
40	O
mg	O
q	O
M-W-F	O

Klorcon	B-treatment
10	O
mEq	O
q	O
M-W-F	O

Pepcid	B-treatment
40	O
mg	O
qd	O

colexa	B-treatment
10	O
mg	O
qd	O

metoprolol	B-treatment
50	O
mg	O
bid	O

lipitor	B-treatment
20	O
mg	O
qd	O

aspirin	B-treatment
325	O
mg	O
qd	O

flovent	B-treatment
110	O
mcg	O
inhaler	O
bid	O

atrovent	B-treatment
inhaler	I-treatment
tid	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Fluticasone	B-treatment
Propionate	I-treatment
110	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
1	O
canister	O
*	O
Refills	O
:*	O
0	O
*	O

4.	O
Oxycodone	B-treatment
-	I-treatment
Acetaminophen	I-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
40	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Ipratropium	B-treatment
Bromide	I-treatment
18	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
1	O
canister	O
*	O
Refills	O
:*	O
0	O
*	O

6.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Lipitor	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:	O
*	O
0	O
*	O

9.	O
Bacitracin	B-treatment
Zinc	I-treatment
500	O
unit	O
/	O
g	O
Ointment	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
1	O
tube	O
*	O
Refills	O
:*	O
0	O
*	O

10.	O
Celexa	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Tablet	O
(	O
s	O
)	O

11.	O
Warfarin	B-treatment
Sodium	I-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
Take	O
5	O
mg	O
on	O
04-18	O
.	O

MD	O
to	O
dose	O
daily	O
.	O

Disp	O
:*	O
150	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

12.	O
Lasix	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
q	O
M-W-F	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

13.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
q	O
M-W-F	O
.	O

Disp	O
:*	O
30	O
Capsule	O
,	O
Sustained	O
Release	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

14.	O
Coumadin	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
as	O
directed	O
for	O
goal	B-test
INR	I-test
2.0-2.5.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

Aortic	B-problem
stenosis	I-problem
.	O

Hyperlipidemia	B-problem
.	O

Atrial	B-problem
fibrillation	I-problem
.	O

Chronic	B-problem
renal	I-problem
insufficiency	I-problem

Discharge	O
Condition	O
:	O

Good	O
.	O

Discharge	O
Instructions	O
:	O

Shower	O
daily	O
and	O
wash	O
incisions	B-problem
with	O
soap	O
and	O
water	O
.	O

Rinse	O
well	O
.	O

Do	O
not	O
apply	O
any	O
creams	O
,	O
lotions	O
,	O
powders	O
,	O
or	O
ointments	O
.	O

No	O
bathing	O
in	O
tub	O
or	O
swimming	O
.	O

No	O
heavy	O
lifting	O
,	O
greater	O
than	O
10	O
pounds	O
.	O

No	O
driving	O
for	O
6	O
weeks	O
.	O

Followup	O
Instructions	O
:	O

Make	O
follow-appointment	O
with	O
Dr.	O
Barber	O
in	O
4-6	O
weeks	O
.	O

Make	O
follow-up	O
appointment	O
with	O
Dr.	O
Jo	O
in	O
1-2	O
weeks	O
.	O

Dustin	O
Elmer	O
MD	O
22-708	O

Completed	O
by	O
:	O
Ann	O
J.	O
Haley	O
PA	O
80-AXP	O
2017-05-17	O
@	O
1251	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jackie	O
Mcafee	O
on	O
:	O
TUE	O
2017-07-11	O
8:43	O
AM	O

(	O
End	O
of	O
Report	O
)	O

277175072	O
PAD-WORD	O

NVH	O
PAD-WORD	O

87686746	O
PAD-WORD	O

1/3/1997	O
12:00:00	O
AM	O

10%	B-problem
BODY	I-problem
BURNS	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/03/1997	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/07/1997	O
PAD-WORD	O

FINAL	O
DIAGNOSIS	O
:	O

(1)	O
THIRD	B-problem
DEGREE	I-problem
BURN	I-problem
TO	I-problem
RIGHT	I-problem
HAND	I-problem
AND	I-problem
FOREARM	I-problem

(2)	O
SECOND	B-problem
DEGREE	I-problem
BURN	I-problem
TO	I-problem
FACE	I-problem
PROCEDURE	O
:	O

(1)	O
1/5/97	O
:	O

DEBRIDEMENT	B-treatment
OF	O
BURN	B-problem
AND	O
APPLICATION	B-treatment
OF	I-treatment
ARTIFICIAL	I-treatment
SKIN	I-treatment

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
59	O
year	O
old	O
gentleman	O
who	O
experienced	O
a	B-problem
flash	I-problem
burn	I-problem
from	O
grease	O
while	O
working	O
on	O
a	O
stove	O
on	O
the	O
night	O
prior	O
to	O
admission	O
.	O

The	O
patient	O
at	O
that	O
time	O
treated	O
himself	O
symptomatically	O
at	O
home	O
but	O
presented	O
to	O
Roing	O
Hospital	O
on	O
the	O
day	O
after	O
the	O
event	O
and	O
was	O
transferred	O
to	O
the	O
Nimaconwood	O
Valley	O
Hospital	O
immediately	O
for	O
evaluation	B-test
because	O
of	O
his	B-problem
extensive	I-problem
burns	I-problem
.	O

The	O
patient	O
was	O
walking	O
,	O
talking	O
,	O
and	O
was	O
breathing	O
without	O
difficulty	B-problem
on	O
arrival	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

No	O
significant	O
history	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Only	O
significant	O
for	O
excessive	O
alcohol	O
use	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

99%	O
saturation	B-test
on	O
room	O
air	O
.	O

Heart	B-test
rate	I-test
76	O
,	O
blood	B-test
pressure	I-test
169/100	O
.	O

Other	B-test
vital	I-test
signs	I-test
were	O
within	O
normal	O
limits	O
.	O

The	O
patient	O
was	O
not	O
anxious	O
or	O
ill-appearing	B-problem
.	O

HEENT	O
:	O

Extensive	B-problem
first	I-problem
degree	I-problem
and	I-problem
second	I-problem
degree	I-problem
burns	I-problem
around	I-problem
the	I-problem
face	I-problem
,	O
superficial	O
in	O
nature	O
,	O
with	O
no	O
blistering	B-problem
.	O

His	O
oropharynx	O
was	O
wide	O
open	O
with	O
no	O
evidence	O
of	O
burn	B-problem
.	O

Lungs	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
:	O

Regular	O
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
:	O

Good	O
pulses	O
bilaterally	O
.	O

Skin	O
:	O

Third	B-problem
degree	I-problem
burn	I-problem
on	I-problem
dorsum	I-problem
of	O
forearm	O
and	O
on	O
dorsum	O
of	O
hand	O
with	O
extensive	B-problem
second	I-problem
degree	I-problem
burn	I-problem
around	O
the	O
remainder	O
of	O
his	O
hand	O
circumferentially	O
and	O
on	O
his	O
forearm	O
.	O

Pulses	O
were	O
intact	O
.	O

No	O
evidence	O
of	O
compartment	B-problem
syndrome	I-problem
.	O

Evaluation	B-test
in	O
the	O
emergency	O
room	O
revealed	O
the	O
patient	O
to	O
be	O
stable	O
and	O
he	O
was	O
evaluated	O
by	O
ophthalmology	O
who	O
also	O
felt	O
that	O
the	O
patient	O
had	O
no	O
injury	B-problem
to	I-problem
his	I-problem
eyes	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
from	O
the	O
emergency	O
room	O
and	O
transferred	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
for	O
airway	B-test
observation	I-test
.	O

He	O
was	O
given	O
three	O
liters	O
of	O
IV	B-treatment
hydration	I-treatment
with	O
good	O
urine	O
output	O
response	O
.	O

His	B-problem
wounds	I-problem
were	O
dressed	O
with	O
antiointment	B-treatment
and	O
Xeroform	B-treatment
with	O
the	O
plan	O
to	O
take	O
him	O
to	O
the	O
operating	O
room	O
for	O
debridement	B-treatment
under	O
general	B-treatment
anesthesia	I-treatment
and	O
application	B-treatment
of	I-treatment
artificial	I-treatment
skin	I-treatment
.	O

The	O
patient	O
remained	O
hemodynamically	O
stable	O
with	O
good	O
urine	O
output	O
.	O

While	O
in	O
the	O
Intensive	O
Care	O
Unit	O
the	O
patient	O
was	O
put	O
on	O
delirium	B-treatment
tremons	I-treatment
prophylaxis	I-treatment
with	O
Serax	B-treatment
around	O
the	O
clock	O
.	O

There	O
was	O
no	O
evidence	O
while	O
in	O
the	O
hospital	O
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
1/5/97	O
.	O

At	O
that	O
time	O
the	O
patient	O
underwent	O
debridement	B-treatment
of	O
his	B-problem
facial	I-problem
wounds	I-problem
and	O
debridement	B-treatment
of	I-treatment
his	I-treatment
right	I-treatment
hand	I-treatment
and	I-treatment
forearm	I-treatment
with	O
application	B-treatment
of	I-treatment
artificial	I-treatment
skin	I-treatment
which	O
is	O
the	O
dermagraft	B-treatment
TC	I-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

There	O
were	O
no	O
complications	B-problem
.	O

Postoperatively	O
the	O
patient	O
was	O
transferred	O
out	O
of	O
the	O
Intensive	O
Care	O
Unit	O
to	O
the	O
burn	O
floor	O
where	O
he	O
received	O
dressing	B-treatment
changes	I-treatment
p.r.n.	O

The	O
patient	O
remained	O
afebrile	B-problem
and	O
other	B-test
vital	I-test
signs	I-test
were	O
within	O
normal	O
limits	O
.	O

On	O
the	O
day	O
of	O
discharge	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
dressing	I-treatment
was	O
taken	O
down	O
completely	O
and	O
evaluation	B-test
of	O
the	B-treatment
derma	I-treatment
graft	I-treatment
was	O
made	O
.	O

At	O
that	O
time	O
it	O
appeared	O
well	O
adhered	O
to	O
the	O
underlying	O
skin	O
.	O

There	O
was	O
no	O
evidence	O
of	O
infection	B-problem
.	O

The	O
patient	O
was	O
screened	O
by	O
the	O
rehabilitation	O
facility	O
and	O
felt	O
to	O
be	O
an	O
acceptable	O
candidate	O
.	O

The	O
patient	O
and	O
his	O
family	O
agreed	O
to	O
transfer	O
from	O
Nimaconwood	O
Valley	O
Hospital	O
to	O
Ianehutche	O
Medical	O
Center	O
.	O

DISPOSITION	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O
,	O
Folate	B-treatment
1	O
mg	O
q.d.	O
,	O
Artificial	B-treatment
Tears	I-treatment
2	O
drops	O
each	O
eye	O
b.i.d.	O
and	O
p.r.n.	O
,	O
Serax	B-treatment
15	O
mg	O
p.o.	O
q6h	O
-	O
hold	O
if	O
patient	O
excessively	B-problem
sleepy	I-problem
,	O
Thiamine	B-treatment
100	O
mg	O
p.o.	O
q.d.	O
,	O
MS	B-treatment
-	I-treatment
Contin	I-treatment
30	O
mg	O
p.o.b.i.d.	O
,	O
multivitamin	B-treatment
q.d.	O
,	O
MSIR	B-treatment
15	O
mg	O
p.o.	O
q3-4h	O
p.r.n.	O
pain	B-problem
,	O
and	O
Axid	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O

The	O
patient	O
is	O
to	O
undergo	O
dry	B-treatment
dressing	I-treatment
changes	I-treatment
and	O
splint	B-treatment
to	I-treatment
his	I-treatment
right	I-treatment
arm	I-treatment
q.d.	O

DIET	O
:	O

Regular	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
is	O
to	O
be	O
seen	O
in	O
the	O
burn	O
clinic	O
two	O
days	O
after	O
discharge	O
.	O

The	O
patient	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

Dictated	O
By	O
:	O

TELSHEY	O
K.	O
PAP	O
,	O
M.D.	O
IK06	O

Attending	O
:	O

TELSHEY	O
K.	O
PAP	O
,	O
M.D.	O
BH2	O
MC084/4189	O

Batch	O
:	O

9441	O
PAD-WORD	O

Index	O
No.	O

YROINI4	O
PGM	O

D	O
:	O

01/07/97	O
PAD-WORD	O

T	O
:	O

01/07/97	O
PAD-WORD	O

CC	O
:	O

1.	O
ERFIBOULDNON	O
VALLEY	O
MEMORIAL	O
HOSPITAL	O

Admission	O
Date	O
:	O

2013-10-21	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-10-31	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1928-10-14	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Codeine	B-treatment
/	O
Shellfish	O
/	O
Ciprofloxacin	B-treatment

Attending	O
:	O
Pamela	O
I	O
Wickman	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Exertional	B-problem
angina	I-problem
and	O
dyspnea	B-problem
on	O
exertion	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2013-10-21	O
CABG	B-treatment
x	O
3	O
(	O
LIMA	O
->	O
LAD	O
,	O
SVG	O
->	O
OM	O
,	O
SVG	O
->	O
PDA	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
an	O
85	O
year	O
old	O
female	O
with	O
prior	O
history	O
of	O
non-hodgkins	B-problem
lymphoma	I-problem
,	O
s/p	O
Cytoxan	B-treatment
in	O
2003	O
a	O
with	O
recurrence	B-problem
in	O
2009	O
.	O

Follow	B-test
up	I-test
examinations	I-test
have	O
found	O
a	B-problem
suspicious	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
finding	I-problem
.	O

Cardiac	B-test
workup	I-test
prior	O
to	O
left	B-treatment
lower	I-treatment
lobe	I-treatment
resection	I-treatment
led	O
to	O
cardiac	B-test
catheterization	I-test
which	O
found	O
severe	B-problem
three	I-problem
vessel	I-problem
disease	I-problem
with	O
04-05+	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

She	O
now	O
present	O
for	O
surgical	B-treatment
intervention	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

Non-hodgkins	B-problem
lymphoma	I-problem
-	O
s/p	O
Cytoxan	B-treatment
in	O
2003	O
and	O
2001	O
,	O
History	O
of	O
Varicella	B-problem
Zoster	I-problem
with	O
opthalmic	B-problem
lesions	I-problem
,	O
History	O
of	O
Menieres	B-problem
Disease	I-problem
,	O
GERD	B-problem
,	O
Glaucoma	B-problem
,	O
History	O
of	O
chronic	B-problem
sinusitis	I-problem
,	O
s/p	O
cataract	B-treatment
surgery	I-treatment
,	O
s/p	O
TAH	B-treatment
and	O
BSO	B-treatment
,	O
s/p	O
appendectomy	B-treatment
,	O
s/p	O
bilateral	B-treatment
breast	I-treatment
reduction	I-treatment

Social	O
History	O
:	O

Retired	O
RN	O
.	O

Lives	O
alone	O
but	O
family	O
is	O
close	O
.	O

Denies	O
tobacco	O
and	O
ETOH	O
.	O

Family	O
History	O
:	O

Daughter	O
died	O
of	O
MI	B-problem
at	O
age	O
49	O
.	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O

BP	B-test
160-170/80-84	O
,	O
HR	B-test
82	O
,	O
Resp	B-test
20	O

General	O
:	O

Elderly	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem

HEENT	O
:	O

Oropharynx	O
benign	O

Neck	O
:	O

Supple	O
,	O
no	O
JVD	B-problem
,	O
no	O
carotid	B-problem
bruits	I-problem

Chest	O
:	O

Lungs	O
CTA	O
bilaterally	O

Heart	O
:	O

Regular	O
rate	O
,	O
04-07	O
holosystolic	B-problem
murmur	I-problem

Abdomen	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem

Ext	O
:	O

Warm	O
,	O
no	O
edema	B-problem

Pulses	B-test
:	O

2+	O
distally	O

Neuro	O
:	O

Nonfocal	O
PAD-WORD	O

Pertinent	O
Results	O
:	O

2013-10-29	O
06:10	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
10.9	O
RBC	B-test
-	O
3.99	O
*	O
Hgb	B-test
-	O
12.6	O
Hct	B-test
-	O
37.9	O
MCV	B-test
-	O
95	O
MCH	B-test
-	O
31.5	O
MCHC	B-test
-	O
33.2	O
RDW	B-test
-	O
13.9	O
Plt	B-test
Ct	I-test
-	O
330	O
#	O

2013-10-29	O
06:10	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
76	O
UreaN	B-test
-	O
12	O
Creat	B-test
-	O
0.9	O
Na	B-test
-	O
141	O
K	B-test
-	O
3.5	O
Cl	B-test
-	O
104	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
15	O

2013-10-30	O
06:28	O
AM	O
BLOOD	B-test
Phenyto	B-test
-	O
5.5	O
*	O

Brief	O
Hospital	O
Course	O
:	O

Mrs.	O
Mandelbaum	O
was	O
admitted	O
and	O
underwent	O
three	B-treatment
vessel	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
by	O
Dr.	O
Larry	O
Mckinney	O
.	O

Of	O
note	O
,	O
intraoperative	B-test
transesophageal	I-test
echocardiogram	I-test
evaluation	I-test
showed	O
only	O
mild	B-problem
mitral	I-problem
regurgitation	I-problem
,	O
so	O
no	O
repair/replacement	B-treatment
was	O
indicated	O
.	O

Following	O
the	B-treatment
operation	I-treatment
,	O
she	O
was	O
brought	O
to	O
the	O
CSRU	O
.	O

On	O
postoperative	O
day	O
one	O
,	O
she	O
was	O
noted	O
to	O
be	O
largely	B-problem
unresponsive	I-problem
with	O
left	B-problem
hemiparesis	I-problem
.	O

Restlessness	B-problem
with	O
body	B-problem
tremors	I-problem
were	O
also	O
noted	O
.	O

A	B-test
stat	I-test
MRI	I-test
was	O
notable	O
for	O
multiple	B-problem
abnormal	I-problem
foci	I-problem
consistent	O
with	O
systemic	B-problem
emboli	I-problem
.	O

These	O
were	O
found	O
in	O
the	O
right	O
cerebellar	O
,	O
occipital	O
and	O
anterior	O
parietal	O
lobes	O
.	O

The	O
neurology	O
service	O
was	O
consulted	O
and	O
attributed	O
these	O
findings	O
to	O
cholesterol	B-problem
emboli	I-problem
.	O

Due	O
to	O
seizure	B-problem
activity	I-problem
,	O
Dilantin	B-treatment
was	O
started	O
.	O

Anticoagulation	B-treatment
was	O
not	O
recommended	O
.	O

Over	O
the	O
next	O
several	O
days	O
,	O
her	O
neurological	O
status	O
slowly	O
improved	O
.	O

She	O
was	O
eventually	O
extubated	O
without	O
incident	B-problem
.	O

She	O
went	O
on	O
to	O
experience	O
paroxysmal	B-problem
atrial	I-problem
fibrillation	I-problem
which	O
was	O
initially	O
treated	O
with	O
intravenous	B-treatment
Amiodarone	I-treatment
.	O

She	O
concomitantly	O
had	O
loose	B-problem
stools	I-problem
which	O
were	O
C.	B-test
diff	I-test
negative	O
.	O

Her	O
clinical	O
status	O
stablized	O
and	O
she	O
transferred	O
to	O
the	O
step	O
down	O
unit	O
on	O
postoperative	O
day	O
six	O
.	O

She	O
remained	O
mostly	O
in	O
a	O
normal	O
sinus	O
rhythm	O
and	O
transitioned	O
to	O
oral	B-treatment
Amiodarone	I-treatment
which	O
will	O
need	O
to	O
continue	O
for	O
three	O
months	O
postop	O
.	O

She	O
tolerated	O
beta	B-treatment
blockade	I-treatment
which	O
was	O
slowly	O
advanced	O
as	O
tolerated	O
.	O

She	O
worked	O
daily	O
with	O
physical	O
and	O
occupational	O
therapy	O
.	O

Her	O
neurological	O
status	O
continued	O
to	O
improve	O
.	O

Acyclovir	B-treatment
was	O
eventually	O
increased	O
from	O
her	B-treatment
maintenance	I-treatment
dose	I-treatment
for	O
a	B-problem
herpes	I-problem
zoster	I-problem
breakout	I-problem
on	I-problem
her	I-problem
right	I-problem
upper	I-problem
back	I-problem
.	O

In	O
addition	O
,	O
she	O
was	O
empirically	O
started	O
on	O
Flagyl	B-treatment
for	O
persistent	B-problem
diarrhea	I-problem
(	O
despite	O
negative	O
C.	O
diff	O
cultures	O
)	O
,	O
however	O
she	O
developed	O
an	B-problem
additional	I-problem
rash	I-problem
on	I-problem
her	I-problem
buttocks	I-problem
after	O
the	O
first	O
dose	O
of	O
flagyl	B-treatment
,	O
so	O
the	B-treatment
flagyl	I-treatment
was	O
discontinued	O
.	O

She	O
developed	O
a	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
for	O
which	O
she	O
was	O
started	O
on	O
Bactrim	B-treatment
.	O

A	B-treatment
foley	I-treatment
catheter	I-treatment
was	O
inserted	O
given	O
her	O
mutiple	O
episodes	O
of	O
incontinence	B-problem
that	O
were	O
adding	O
to	O
skin	B-problem
irritation	I-problem
.	O

On	O
insertion	B-treatment
she	O
was	O
found	O
to	O
be	O
retaining	O
1400	O
cc	O
of	O
urine	O
,	O
so	O
the	B-treatment
foley	I-treatment
catheter	I-treatment
was	O
left	O
in	O
.	O

She	O
continued	O
to	O
make	O
clinical	O
improvements	O
and	O
was	O
cleared	O
for	O
discharge	O
to	O
rehab	O
on	O
postoperative	O
day	O
10	O
.	O

Medications	O
on	O
Admission	O
:	O

Acyclovir	B-treatment
800	O
qd	O
,	O
Nexium	B-treatment
40	O
qd	O
,	O
Lipitor	B-treatment
40	O
qd	O
,	O
Coreg	B-treatment
6.25	O
bid	O
,	O
Asa	B-treatment
81	O
qd	O
,	O
Timolol	B-treatment
CMED	I-treatment
CSRU	I-treatment
gtts	I-treatment
,	O
Calcium	B-treatment
,	O
MVI	B-treatment
,	O
Vitamin	B-treatment
C	I-treatment

Discharge	O
Medications	O
:	O

1.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
fever	B-problem
or	O
pain	B-problem
.	O

Tablet	O
(	O
s	O
)	O

2.	O
Metoprolol	B-treatment
Tartrate	I-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3.	O
Phenytoin	B-treatment
Sodium	I-treatment
Extended	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

4.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Tablet	O
(	O
s	O
)	O

5.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

6.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
7	O
days	O
:	O
400	O
mg	O
PO	O
daily	O
for	O
1	O
week	O
,	O
then	O
decrease	O
to	O
200	O
mg	O
PO	O
daily	O
.	O

Tablet	O
(	O
s	O
)	O

7.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

8.	O
Acyclovir	B-treatment
800	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
5X/D	O
(	O
5	O
times	O
a	O
day	O
)	O
for	O
5	O
days	O
:	O
Then	O
decrease	O
dose	O
to	O
800	O
mg	O
PO	O
daily	O
.	O

9.	O
Lipitor	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

10.	O
Potassium	B-treatment
Chloride	I-treatment
20	O
mEq	O
Packet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Packet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

11.	O
Trimethoprim	B-treatment
-	I-treatment
Sulfamethoxazole	I-treatment
160-800	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

12.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
-	O
s/p	O
CABG	B-treatment

Varicella	B-problem
Zoster	I-problem

Postop	B-problem
CVA	I-problem

Postop	B-problem
Atrial	I-problem
fibrillation	I-problem

Discharge	O
Condition	O
:	O

Good	O
.	O

Discharge	O
Instructions	O
:	O

Follow	O
medications	B-treatment
on	O
discharge	O
instructions	O
.	O

Do	O
not	O
lift	O
more	O
than	O
10	O
lbs.	O
for	O
2	O
months	O
.	O

Do	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

Call	O
our	O
office	O
for	O
sternal	B-problem
drainage	I-problem
,	O
temp	B-problem
>	O
101.5	O

No	O
lotions	O
,	O
creams	O
,	O
or	O
powders	O
on	O
wounds	B-problem
.	O

Followup	O
Instructions	O
:	O

Make	O
an	O
appointment	O
with	O
Dr.	O
Madden	O
for	O
1-2	O
weeks	O
.	O

Make	O
an	O
appointment	O
with	O
Dr.	O
Murray	O
for	O
4	O
weeks	O
.	O

Make	O
an	O
appointment	O
with	O
Dr.	O
Mclaughlin	O
in	O
neurology	O
clinic	O
for	O
4	O
weeks	O
.	O

Briley	O
von	O
der	O
Ross	O
MD	O
67-576	O

Completed	O
by	O
:	O
Ann	O
Kenneth	O
NP	O
80-BXH	O
2013-10-31	O
@	O
1005	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Santos	O
von	O
der	O
Ross	O
on	O
:	O
TUE	O
2013-11-05	O
7:12	O
AM	O

(	O
End	O
of	O
Report	O
)	O

280594741	O
PAD-WORD	O

FIH	O
PAD-WORD	O

7060363	O
PAD-WORD	O

70349/v957	O
PAD-WORD	O

068215	O
PAD-WORD	O

7/2/1993	O
12:00:00	O
AM	O

SEVERE	B-problem
BLUNT	I-problem
ABDOMINAL	I-problem
TRAUMA	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

7-2-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

7-30-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Severe	B-problem
blunt	I-problem
abdominal	I-problem
trauma	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Grade	B-problem
II	I-problem
/	I-problem
V	I-problem
laceration	I-problem
of	I-problem
liver	I-problem
,	O

2.	O
rupture	B-problem
of	I-problem
left	I-problem
renal	I-problem
vein	I-problem
,	O

3.	O
tear	B-problem
of	I-problem
transverse	I-problem
mesocolon	I-problem
,	O

4.	O
serosal	B-problem
tear	I-problem
of	I-problem
transverse	I-problem
colon	I-problem
,	O

5.	O
blunt	B-problem
fracture	I-problem
of	O
the	O
neck	O
of	O
the	O
pancreas	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
AND	O
HOSPITAL	O
COURSE	O
:	O

Mr.	O
Breath	O
was	O
a	O
32	O
year	O
old	O
previously	O
healthy	O
unbelted	O
driver	O
whose	O
car	O
was	O
hit	O
at	O
high	O
speed	O
by	O
a	O
vehicle	O
driven	O
by	O
an	O
intoxicated	O
driver	O
.	O

The	O
patient	O
was	O
ejected	O
and	O
his	O
vehicle	O
rolled	O
over	O
,	O
possibly	O
over	O
him	O
.	O

He	O
was	O
found	O
awake	O
at	O
the	O
scene	O
,	O
complaining	O
of	O
abdominal	B-problem
pain	I-problem
.	O

He	O
had	O
a	B-test
blood	I-test
pressure	I-test
of	O
60	O
systolic	O
upon	O
arrival	O
of	O
the	O
Giles	O
Min	O
General	O
Hospital	O
crew	O
.	O

Intravenous	B-treatment
fluids	I-treatment
was	O
given	O
.	O

He	O
was	O
paralyzed	B-problem
and	O
endotracheally	O
intubated	O
,	O
and	O
a	B-treatment
14	I-treatment
gauge	I-treatment
catheter	I-treatment
was	O
inserted	O
in	O
his	O
left	O
chest	O
because	O
of	O
poor	B-problem
breath	I-problem
sounds	I-problem
.	O

He	O
arrived	O
at	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
at	O
02:30	O
with	O
a	B-test
blood	I-test
pressure	I-test
of	O
86	O
and	O
a	B-test
heart	I-test
rate	I-test
of	O
170	O
.	O

Large	B-treatment
bore	I-treatment
cannulas	I-treatment
were	O
inserted	O
into	O
the	O
femoral	O
veins	O
,	O
bilateral	B-treatment
chest	I-treatment
tubes	I-treatment
were	O
placed	O
,	O
and	O
his	B-test
blood	I-test
pressure	I-test
rose	O
to	O
110	O
systolic	O
after	O
two	O
liters	O
of	O
crystalloid	B-treatment
.	O

He	O
had	O
an	B-problem
ecchymosis	I-problem
over	O
the	O
medial	O
right	O
costal	O
margin	O
and	O
his	O
abdomen	O
was	O
distended	B-problem
.	O

His	B-test
hematocrit	I-test
was	O
36	O
,	O
and	O
creatinine	B-test
1.6	O
.	O

The	B-test
abdominal	I-test
tap	I-test
was	O
grossly	B-problem
positive	I-problem
for	I-problem
blood	I-problem
.	O

His	B-test
blood	I-test
pressure	I-test
fell	O
to	O
60	O
systolic	O
as	O
he	O
was	O
being	O
transferred	O
to	O
the	O
computerized	O
tomography	O
scan	O
table	O
;	O
the	B-test
scan	I-test
was	O
aborted	O
and	O
he	O
was	O
taken	O
directly	O
to	O
the	O
operating	O
room	O
at	O
03:00	O
.	O

At	O
laparotomy	B-treatment
,	O
there	O
was	O
a	O
liter	O
of	O
blood	B-problem
in	I-problem
the	I-problem
peritoneal	I-problem
cavity	I-problem
.	O

There	O
was	O
a	B-problem
class	I-problem
II	I-problem
laceration	I-problem
of	I-problem
the	I-problem
left	I-problem
liver	I-problem
at	O
the	O
falciform	O
ligament	O
which	O
was	O
actively	O
bleeding	O
,	O
a	B-problem
tear	I-problem
of	I-problem
the	I-problem
transverse	I-problem
mesocolon	I-problem
from	O
its	O
base	O
to	O
the	O
bowel	O
wall	O
with	O
active	B-problem
bleeding	I-problem
,	O
a	B-problem
7	I-problem
cm	I-problem
serosal	I-problem
tear	I-problem
of	I-problem
the	I-problem
adjacent	I-problem
transverse	I-problem
colon	I-problem
,	O
and	O
a	B-problem
large	I-problem
central	I-problem
retroperitoneal	I-problem
hematoma	I-problem
.	O

Control	O
of	O
the	O
super-celiac	O
aorta	O
was	O
obtained	O
,	O
and	O
both	O
left	B-treatment
and	I-treatment
right	I-treatment
sided	I-treatment
&quot;	I-treatment
Mattox	I-treatment
&quot;	I-treatment
maneuvers	I-treatment
were	O
performed	O
.	O

The	O
retroperitoneum	O
was	O
opened	O
,	O
with	O
vigorous	B-problem
bleeding	I-problem
resulting	O
.	O

This	O
was	O
controlled	O
,	O
necessitating	O
ten	O
minutes	O
of	O
aortic	B-treatment
clamping	I-treatment
and	O
found	O
to	O
have	O
originated	O
from	O
the	B-problem
rupture	I-problem
of	I-problem
the	I-problem
left	I-problem
renal	I-problem
vein	I-problem
one	O
centimeter	O
from	O
its	O
junction	O
with	O
the	O
inferior	O
vena	O
cava	O
.	O

The	O
vein	O
was	O
divided	O
and	O
suture	B-treatment
ligated	O
.	O

Bleeding	B-problem
from	I-problem
the	I-problem
liver	I-problem
was	O
controlled	O
with	O
sutures	B-treatment
.	O

The	B-problem
tears	I-problem
in	I-problem
the	I-problem
transverse	I-problem
mesocolon	I-problem
and	I-problem
colon	I-problem
serosa	I-problem
were	O
repaired	O
.	O

The	B-test
examination	I-test
of	O
the	O
remainder	O
of	O
the	O
abdominal	O
contents	O
revealed	O
no	O
other	B-problem
injury	I-problem
;	O
in	O
particular	O
,	O
the	O
entire	O
anterior	O
surface	O
and	O
the	O
immediately	O
juxtaduodenal	O
posterior	O
surface	O
of	O
the	O
pancreas	O
were	O
normal	O
.	O

The	O
patient	O
was	O
now	O
very	O
stable	O
,	O
and	O
he	O
was	O
taken	O
to	O
the	O
Respiratory	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
had	O
received	O
ten	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
five	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
,	O
seven	O
units	O
of	O
platelets	B-treatment
,	O
and	O
nine	O
liters	O
of	O
Ringer	B-treatment
&apos;s	I-treatment
lactate	I-treatment
.	O

An	B-test
intracranial	I-test
pressure	I-test
monitoring	I-test
bolt	I-test
had	O
been	O
placed	O
by	O
the	O
Neurosurgery	O
Service	O
staff	O
during	O
the	B-treatment
laparotomy	I-treatment
.	O

Intracranial	B-test
pressures	I-test
were	O
normal	O
.	O

That	O
day	O
,	O
cranial	B-test
computerized	I-test
tomography	I-test
scan	I-test
and	O
cervical	B-test
spine	I-test
films	I-test
were	O
normal	O
.	O

An	B-test
arch	I-test
aortogram	I-test
was	O
normal	O
.	O

Over	O
the	O
ensuing	O
twenty-four	O
hours	O
,	O
bilateral	B-problem
infiltrates	I-problem
on	O
chest	B-test
X-ray	I-test
with	O
poor	B-problem
oxygenation	I-problem
and	O
labile	B-problem
blood	I-problem
pressure	I-problem
requiring	O
PA	B-treatment
line	I-treatment
guided	I-treatment
fluid	I-treatment
and	O
pressors	B-treatment
developed	O
.	O

The	O
patient	O
had	O
a	B-problem
large	I-problem
fluid	I-problem
requirement	I-problem
with	O
total	B-problem
body	I-problem
capillary	I-problem
leak	I-problem
,	O
decreasing	B-problem
SVR	I-problem
,	O
oliguria	B-problem
unresponsive	O
to	O
Lasix	B-treatment
/	O
Mannitol	B-treatment
accompanied	O
by	O
a	B-problem
rise	I-problem
in	O
creatinine	B-test
to	O
3.2	O
,	O
worsening	B-problem
ARDS	I-problem
,	O
a	B-problem
rise	I-problem
in	O
temperature	B-test
to	O
103	O
,	O
and	O
a	B-test
serum	I-test
amylase	I-test
of	O
1265	O
.	O

He	O
was	O
returned	O
to	O
the	O
operating	O
room	O
on	O
July	O
4	O
.	O

Three	O
liters	O
of	O
clear	B-problem
green	I-problem
fluid	I-problem
were	O
found	O
in	O
the	O
abdominal	O
cavity	O
.	O

Exploration	B-test
of	I-test
the	I-test
pancreas	I-test
revealed	O
a	B-problem
posterior	I-problem
fracture	I-problem
a	I-problem
the	I-problem
superior	I-problem
mesenteric	I-problem
vessels	I-problem
.	O

Because	O
of	O
the	B-problem
intense	I-problem
diffuse	I-problem
inflammatory	I-problem
reaction	I-problem
that	O
had	O
already	O
set	O
in	O
,	O
it	O
was	O
decided	O
that	O
neither	O
distal	B-treatment
pancreatic	I-treatment
resection	I-treatment
nor	O
Roux-en-Y	B-treatment
drainage	I-treatment
was	O
feasible	O
.	O

Four	B-treatment
large	I-treatment
flat	I-treatment
Jackson-Pratt	I-treatment
drains	I-treatment
were	O
placed	O
,	O
and	O
gastrostomy	B-treatment
,	O
jejunostomy	B-treatment
,	O
and	O
cholecystostomy	B-treatment
tubes	I-treatment
,	O
as	O
well	O
as	O
a	B-treatment
right	I-treatment
subclavian	I-treatment
Quinton	I-treatment
catheter	I-treatment
were	O
placed	O
.	O

The	O
patient	O
&apos;s	O
hemodynamics	O
had	O
improved	O
markedly	O
with	O
the	B-treatment
evacuation	I-treatment
of	O
the	B-problem
peritoneal	I-problem
pancreatic	I-problem
fluid	I-problem
,	O
so	O
that	O
he	O
was	O
no	O
longer	O
on	O
pressors	B-treatment
.	O

However	O
,	O
upon	O
transfer	O
from	O
the	O
operating	O
room	O
table	O
to	O
the	O
RICU	O
bed	O
,	O
he	O
suffered	O
a	B-problem
cardiac	I-problem
arrest	I-problem
,	O
which	O
upon	O
investigation	B-test
was	O
a	B-problem
primary	I-problem
respiratory	I-problem
arrest	I-problem
;	O
the	B-test
initial	I-test
arterial	I-test
blood	I-test
gas	I-test
was	O
32/88/6.92	O
.	O

He	O
was	O
successfully	O
resuscitated	O
after	O
fifteen	O
minutes	O
of	O
cardiopulmonary	B-treatment
resuscitation	I-treatment
and	O
he	O
was	O
taken	O
to	O
the	O
RICU	O
.	O

Continuous	B-treatment
venovenous	I-treatment
hemodialysis	I-treatment
was	O
started	O
on	O
July	O
5	O
,	O
and	O
continued	O
for	O
most	O
of	O
the	O
remainder	O
of	O
the	O
patient	O
&apos;s	O
course	O
.	O

Vancomycin	B-treatment
,	O
Flagyl	B-treatment
,	O
and	O
Aztreonam	B-treatment
were	O
given	O
for	O
gram	B-problem
negative	I-problem
Coccobacilli	I-problem
(	O
later	O
identified	O
as	O
Bacteroides	B-problem
)	O
that	O
had	O
grown	O
in	O
his	B-test
blood	I-test
cultures	I-test
and	O
gram	B-problem
negative	I-problem
rods	I-problem
(	I-problem
Enterobacter	I-problem
)	I-problem
in	O
his	B-test
peritoneal	I-test
fluid	I-test
.	O

He	O
was	O
kept	O
sedated	B-treatment
and	O
paralyzed	B-treatment
because	O
of	O
his	B-problem
severe	I-problem
adult	I-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
.	O

Total	B-treatment
parenteral	I-treatment
nutrition	I-treatment
was	O
started	O
on	O
July	O
5	O
.	O

Initial	O
improvement	O
was	O
followed	O
by	O
recurrence	O
of	O
low	B-problem
SVR	I-problem
,	O
high	B-problem
cardiac	I-problem
output	I-problem
,	O
ongoing	B-problem
acidosis	I-problem
,	O
requiring	O
norepinephrine	B-treatment
infusion	I-treatment
in	O
the	O
30	O
to	O
40	O
mcg	O
per	O
minute	O
range	O
;	O
drainage	B-problem
from	O
the	B-treatment
Jackson-Pratt	I-treatment
drains	I-treatment
were	O
minimal	O
despite	O
irrigation	B-treatment
and	O
manipulation	B-treatment
.	O

The	O
patient	O
was	O
returned	O
to	O
the	O
operating	O
room	O
on	O
July	O
10	O
,	O
where	O
several	B-problem
loculated	I-problem
thin	I-problem
fluid	I-problem
collections	I-problem
were	O
drained	O
and	O
obviously	B-problem
necrotic	I-problem
tissue	I-problem
was	O
debrided	O
.	O

It	O
was	O
decided	O
to	O
place	O
more	B-treatment
drains	I-treatment
and	O
pack	O
the	O
lesser	O
sac	O
with	O
Adaptic	B-treatment
and	O
laparotomy	B-treatment
pads	I-treatment
.	O

The	O
abdomen	O
was	O
left	O
open	O
,	O
with	O
the	B-problem
wound	I-problem
margins	I-problem
connected	O
by	O
a	O
sheet	O
of	O
Marlex	B-treatment
mesh	I-treatment
to	O
prevent	O
evisceration	B-problem
.	O

He	O
was	O
returned	O
to	O
the	O
operating	O
room	O
on	O
July	O
12	O
,	O
13	O
,	O
16	O
,	O
19	O
,	O
21	O
,	O
and	O
23	O
for	O
packing	B-treatment
change	I-treatment
,	O
irrigation	B-treatment
and	O
debridement	B-treatment
.	O

Tracheostomy	B-treatment
was	O
also	O
performed	O
on	O
July	O
17	O
.	O

There	O
was	O
severe	B-problem
diffuse	I-problem
peritonitis	I-problem
with	O
intense	B-problem
inflammation	I-problem
,	O
infection	B-problem
,	O
and	O
patchy	B-problem
necrosis	I-problem
of	I-problem
peritoneal	I-problem
surfaces	I-problem
and	O
of	O
the	O
distal	O
pancreas	O
.	O

The	O
subsequent	O
overall	O
course	O
was	O
a	O
slow	O
downhill	O
one	O
,	O
with	O
ongoing	B-problem
extreme	I-problem
hyperdynamic	I-problem
(	O
cardiac	B-test
output	I-test
12	O
to	O
15	O
liters	O
per	O
minute	O
)	O
and	O
catabolic	B-problem
state	I-problem
.	O

On	O
July	O
26	O
,	O
abdominal	B-treatment
irrigation	I-treatment
and	O
debridement	B-treatment
was	O
performed	O
in	O
the	O
RICU	O
;	O
this	O
was	O
repeated	O
daily	O
for	O
the	O
next	O
three	O
days	O
.	O

On	O
July	O
29	O
,	O
the	B-problem
septic	I-problem
state	I-problem
with	O
low	B-problem
SVR	I-problem
and	O
acidosis	B-problem
accelerated	O
beyond	O
the	O
control	O
of	O
maximal	B-treatment
support	I-treatment
.	O

His	B-test
blood	I-test
pressure	I-test
gradually	O
fell	O
,	O
and	O
he	O
died	O
early	O
on	O
July	O
30	O
,	O
1993	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Severe	B-problem
blunt	I-problem
abdominal	I-problem
trauma	I-problem
with	O
rupture	B-problem
of	I-problem
liver	I-problem
,	I-problem
left	I-problem
renal	I-problem
vein	I-problem
,	I-problem
pancreas	I-problem
,	I-problem
and	I-problem
transverse	I-problem
mesocolon	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

1.	O
7-2-93	O
,	O
emergency	O
room	O
exploratory	B-test
laparotomy	I-test
,	O
repair	B-treatment
of	O
liver	B-problem
laceration	I-problem
,	O
repair	B-treatment
of	O
torn	B-problem
transverse	I-problem
mesocolon	I-problem
,	O
repair	B-treatment
of	O
serosal	B-problem
tear	I-problem
of	I-problem
transverse	I-problem
colon	I-problem
,	O
ligation	B-treatment
and	O
division	B-treatment
of	O
ruptured	B-problem
left	I-problem
renal	I-problem
vein	I-problem
,	O
exploration	B-test
of	I-test
pancreas	I-test
,	O

2.	O
7-4-93	O
,	O
exploratory	B-test
laparotomy	I-test
,	O
irrigation	B-treatment
and	O
debridement	B-treatment
,	O
pancreatic	B-treatment
drainage	I-treatment
placement	I-treatment
,	O
gastrostomy	B-treatment
tube	I-treatment
,	O
jejunostomy	B-treatment
,	O
cholecystostomy	B-treatment
,	O
placement	B-treatment
of	I-treatment
right	I-treatment
subclavian	I-treatment
Quinton	I-treatment
catheter	I-treatment
,	O

3.	O
7-10-93	O
,	O
abdominal	B-treatment
irrigation	I-treatment
and	O
debridement	B-treatment
and	O
packing	B-treatment
of	I-treatment
pancreas	I-treatment
,	O

4.	O
7-12-93	O
,	O
7-14	O
,	O
7-20	O
,	O
7-22	O
,	O
and	O
7-24	O
,	O
were	O
the	O
same	O
as	O
7-10-93	O
,	O
and	O
7-17	O
was	O
the	O
same	O
with	O
the	O
addition	O
of	O
tracheostomy	B-treatment
were	O
same	O
as	O
7-10	O
,	O

COMPLICATIONS	O
:	O

Severe	B-problem
necrotizing	I-problem
pancreatitis	I-problem
and	O
diffuse	B-problem
peritonitis	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

N	O
/	O
A.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

N	O
/	O
A.	O

ESTIMATED	O
DISABILITY	O
AND	O
PROBABLE	O
DURATION	O
:	O

N	O
/	O
A.	O

DISPOSITION	O
:	O

Mason	O
Street	O
.	O

RISSPA	O
BREATH	O
,	O
M.D.	O

TR	O
:	O

un	O
/	O
bmot	O

DD	O
:	O

08-07-93	O
PAD-WORD	O

TD	O
:	O

08/08/93	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2011-09-18	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-09-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1962-05-08	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CCU	O

Allergies	O
:	O

Sulfonamides	B-treatment
/	O
Zithromax	B-treatment
/	O
Floxin	B-treatment
/	O
Penicillins	B-treatment
/	O
Neurontin	B-treatment
/	O
Demerol	B-treatment
/	O
Morphine	B-treatment
Sulfate	I-treatment
/	O
Ativan	B-treatment

Attending	O
:	O
James	O
I	O
Schultz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
see	O
dc	O
summary	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
see	O
dc	O
summary	O

History	O
of	O
Present	O
Illness	O
:	O
see	O
dc	O
summary	O

Past	O
Medical	O
History	O
:	O
see	O
dc	O
summary	O

Social	O
History	O
:	O
see	O
dc	O
summary	O

Family	O
History	O
:	O
see	O
dc	O
summary	O

Physical	O
Exam	O
:	O
see	O
dc	O
summary	O

Pertinent	O
Results	O
:	O
see	O
dc	O
summary	O

Brief	O
Hospital	O
Course	O
:	O
see	O
dc	O
summary	O

Medications	O
on	O
Admission	O
:	O
see	O
dc	O
summary	O

Discharge	O
Medications	O
:	O

Change	O
:	O

Pyridium	B-treatment
200	O
mg	O
po	O
three	O
times	O
a	O
day	O
for	O
UTI	B-problem
symptoms	I-problem
x	O
2	O
days	O
.	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O
see	O
dc	O
summary	O

Discharge	O
Condition	O
:	O
see	O
dc	O
summary	O

Discharge	O
Instructions	O
:	O
see	O
dc	O
summary	O

Followup	O
Instructions	O
:	O
see	O
dc	O
summary	O

Janine	O
Karina	O
MD	O
98-439	O

Completed	O
by	O
:	O

Harvey	O
Aaron	O
MD	O
37-052	O
2011-09-26	O
@	O
1232	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Stephen	O
Williams	O
on	O
:	O
SAT	O
2011-10-08	O
9:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

285864187	O
PAD-WORD	O

OMH	O
PAD-WORD	O

7792851	O
PAD-WORD	O

920021	O
PAD-WORD	O

1/1/1998	O
12:00:00	O
AM	O

1)	O
STAPH	B-problem
.	O

SEPSIS	B-problem
RELATED	O
TO	O
PICC	B-treatment
LINE	I-treatment
.	O

2)	O
PREVIOUS	B-problem
ANOXIC	I-problem

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

GACH	O
,	O
CH	O

UNIT	O
NUMBER	O
:	O

397-72-29	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

01/01/98	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

01/07/98	O
PAD-WORD	O

DIAGNOSES	O
:	O

1)	O
Staph.	B-problem
sepsis	I-problem
related	O
to	O
PICC	B-treatment
line	I-treatment
.	O

2)	O
Previous	B-problem
anoxicbrain	I-problem
damage	I-problem
.	O

3)	O
Previous	B-problem
myocardial	I-problem
infarction	I-problem
.	O

4)	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

5)	O
status	O
post	O
CABG	B-treatment
surgery	I-treatment
in	O
11/97	O
.	O

6)	O
paroxysmal	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

7)	O
mild	B-problem
chronic	I-problem
renal	I-problem
insufficiency	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

None	O
.	O

CLINICAL	O
INFECTION	O
:	O

Positive	B-problem
blood	I-problem
cultures	I-problem
with	O
Staph.	B-problem
aureus	I-problem
sensitiveto	O
Methicillin	B-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Hydralazine	B-treatment
10	O
mgs	O
PO	O
t.i.d.	O
,	O
Digoxin	B-treatment
0.125	O
mgs	O
PO	O
q.d.	O
,	O
thiamine	B-treatment
100	O
mgs	O
PO	O
q.d.	O
,	O
multi-vitamin	B-treatment
1	O
tab.	O
PO	O
q.d.	O
,	O
Peri	B-treatment
-	I-treatment
Colace	I-treatment
100	O
mgs	O
PO	O
t.i.d.	O
,	O
folate	B-treatment
1	O
mg	O
PO	O
q.d.	O
,	O
Norvasc	B-treatment
2.5	O
mgs	O
PO	O
q.HS	O
,	O
Ritalin	B-treatment
10	O
mgs	O
PO	O
b.i.d.	O
,	O
Trazodone	B-treatment
25	O
mgs	O
PO	O
q.HS	O
,	O
Nafcillin	B-treatment
2	O
gramsIV	O
q.4H	O
which	O
wil	O
conclude	O
at	O
the	O
end	O
of	O
the	O
day	O
on	O
1/16/98	O
,	O
Atroventnebulizer	B-treatment
PRN	O
,	O
Albuterol	B-treatment
nebulizer	I-treatment
PRN	O
,	O
Tylenol	B-treatment
650	O
mgs	O
PO	O
q.4H	O
PRN	O
pain	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Gach	O
is	O
an	O
80	O
year	O
old	O
man	O
with	O
aprevious	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
who	O
was	O
transferred	O
from	O
Linghs	O
County	O
Medical	O
Center	O
to	O
Oaksgekesser/	O
Memorial	O
Hospital	O
because	O
of	O
an	B-problem
apparent	I-problem
infected	I-problem
wound	I-problem
,	O
including	O
the	B-treatment
PICC	I-treatment
line	I-treatment
in	O
his	O
right	O
elbow	O
and	O
positive	B-problem
blood	I-problem
cultures	I-problem
for	O
Staph.	B-problem
aureus	I-problem
associated	O
with	O
fever	B-problem
.	O

He	O
has	O
a	O
history	O
of	O
myocardial	B-problem
infarctions	I-problem
in	O
1981	O
,	O
1992	O
and	O
08/97	O
with	O
thelast	O
episode	O
complicated	O
by	O
anoxic	B-problem
encephalopathy	I-problem
.	O

He	O
gradually	O
improved	O
but	O
had	O
recurrent	B-problem
angina	I-problem
requiring	O
cardiac	B-test
catheterization	I-test
,	O
demonstrating	O
90%	O
left	O
main	O
,	O
95%	O
ostial	O
LAD	O
and	O
30	O
to	O
40%	O
mid-LAD	O
with	O
an	B-problem
occluded	I-problem
RCA	I-problem
.	O

CABG	B-treatment
surgery	I-treatment
with	O
two	B-treatment
vessel	I-treatment
bypass	I-treatment
was	O
done	O
on	O
11/18/97	O
.	O

He	O
was	O
then	O
transferred	O
to	O
Linghs	O
County	O
Medical	O
Center	O
.	O

A	B-treatment
PICC	I-treatment
line	I-treatment
was	O
placed	O
in	O
his	O
left	O
antecubital	O
fossa	O
and	O
on	O
the	O
day	O
of	O
New	O
Years	O
Eve	O
he	O
developed	O
a	B-problem
fever	I-problem
of	O
102	O
and	O
became	O
lethargic	B-problem
.	O

The	B-treatment
PICC	I-treatment
line	I-treatment
site	I-treatment
was	O
erythematous	B-problem
.	O

Blood	B-test
cultures	I-test
grew	O
out	O
4	O
out	O
of	O
4	O
bottles	O
for	O
gram	B-problem
positive	I-problem
cocci	I-problem
,	O
which	O
thereafter	O
proved	O
to	O
be	O
Staph.	B-problem
aureus	I-problem
Methicillin	B-treatment
sensitive	O
.	O

He	O
had	O
no	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
diarrhea	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
ischemic	B-problem
cardiomyopathy	I-problem
with	O
an	B-test
echocardiogram	I-test
done	O
on	O
11/13/97	O
showing	O
an	B-test
ejection	I-test
fraction	I-test
of	O
28%	O
and	O
LV	O
that	O
is	O
diffusely	B-problem
hypokinetic	I-problem
.	O

OTHER	O
MEDICAL	O
PROBLEMS	O
:	O

1)	O
Dementia	B-problem
,	O

2)	O
paroxysmal	B-problem
atrial	I-problem
fibrillation,	I-problem

3)	O
hypertension	B-problem
,	O

4)	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
with	O
previous	B-treatment
left	I-treatment
femoral	I-treatment
popliteal	I-treatment
bypass	I-treatment
,	O

5)	O
diabetes	B-problem
mellitus	I-problem
,	O

6)	O
chronic	B-problem
renal	I-problem
insufficiency,	I-problem

7)	O
COPD	B-problem
,	O

8)	O
previous	B-treatment
abdominal	I-treatment
aortic	I-treatment
aneurysm	I-treatment
repair	I-treatment
in	O
1981	O
,	O

9)	O
benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
status	O
post	O
TURP	B-treatment
surgery	I-treatment
in	O
1982	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Aspirin	B-treatment
325	O
mgs	O
PO	O
q.d.	O
,	O
Prilosec	B-treatment
20	O
mgs	O
PO	O
q.d.	O
,	O
Azmacort	B-treatment
2	O
puffs	O
q.i.d.	O
PRN	O
,	O
Atrovent	B-treatment
2	O
puffs	O
q.i.d.	O
PRN	O
,	O
heparin	B-treatment
5,000	O
units	O
subcu.	O
b.i.d.	O
,	O
Digoxin	B-treatment
0.125	O
mgs	O
PO	O
q.d.	O
,	O
Wellbutrin	B-treatment
37.5	O
mgs	O
PO	O
b.i.d.	O
,	O
Kaopectate	B-treatment
PRN	O
,	O
Betoptic	B-treatment
0.25%	O
OU	O
q.d.	O
,	O
Ritalin	B-treatment
10	O
mgs	O
PO	O
q.a.m.	O
and	O
at	O
noon	O
time	O
,	O
Norvasc	B-treatment
2.5	O
mgs	O
PO	O
q.d.	O

The	O
patient	O
reported	O
disorientation	B-problem
with	O
Ambien	B-treatment
and	O
Halcyon	B-treatment
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

No	O
other	B-problem
medical	I-problem
problems	I-problem
other	O
than	O
stated	O
above	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Elderly	O
white	O
male	O
who	O
was	O
somnolent	B-problem
,	O
looking	O
his	O
stated	O
age	O
.	O

His	B-test
temperature	I-test
was	O
97.5	O
,	O
pulse	B-test
90	O
,	O
respiratory	B-test
rate	I-test
20	O
,	O
blood	B-test
pressure	I-test
104/60	O
,	O
o2	B-test
sat.	I-test
97%.	O

Eyes	O
-	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
,	O
sclera	O
non-icteric	B-problem
.	O

Neck	O
-	O
supple	O
without	O
masses	B-problem
or	O
thyromegaly	B-problem
.	O

Lungs	O
-	O
clear	O
to	O
percussion	B-test
and	O
auscultation	B-test
on	O
both	O
sides	O
.	O

Cardiovascular	O
examination	O
-	O
normal	O
jugular	O
venous	O
pressure	O
,	O
normal	O
carotid	O
upstrokes	O
with	O
bruits	B-problem
,	O
there	O
are	O
distant	B-problem
heart	I-problem
sounds	I-problem
,	O
S1	O
and	O
S2	O
are	O
normal	O
,	O
there	O
are	O
no	O
murmurs	B-problem
detected	O
.	O

Abdomen	O
-	O
soft	O
,	O
non-tender	B-problem
without	O
organomegaly	B-problem
or	O
masses	B-problem
.	O

Extremities	O
-	O
without	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

Neurologic	B-test
examination	I-test
-	O
somnolent	B-problem
,	O
awake	O
,	O
arousable	O
to	O
commands	O
,	O
though	O
he	O
falls	O
asleep	O
rapidly	O
.	O

Deep	B-test
tendon	I-test
reflexes	I-test
are	O
2+	O
and	O
symmetric	O
,	O
toes	O
were	O
up	B-problem
going	I-problem
bilaterally	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Sodium	B-test
131	O
,	O
potassium	B-test
4.5	O
,	O
BUN	B-test
45	O
,	O
creatinine	B-test
2.0	O
,	O
glucose	B-test
134	O
,	O
bilirubin	B-test
0.4.	O
Blood	B-test
gas	I-test
on	O
5	B-treatment
liters	I-treatment
nasal	I-treatment
o2	I-treatment
-	O
PO2	B-test
106	O
,	O
PCO227	B-test
,	O
pH	B-test
7.41	O
.	O

Blood	B-test
cultures	I-test
were	O
obtained	O
,	O
urine	B-test
cultures	I-test
were	O
obtained	O
.	O

Chest	B-test
x-ray	I-test
-	O
low	B-problem
lung	I-problem
volumes	I-problem
,	O
bibasilar	B-problem
opacities	I-problem
,	O
no	O
evidence	O
of	O
heart	B-problem
failure	I-problem
.	O

EKG	B-test
-	O
technically	O
poor	O
tracing	O
with	O
what	O
appears	O
to	O
be	O
normal	O
sinus	O
rhythm	O
with	O
very	B-problem
small	I-problem
P	I-problem
waves	I-problem
,	O
there	O
are	O
Q-waves	B-problem
in	I-problem
leads	I-problem
V1	I-problem
and	I-problem
V2	I-problem
,	O
as	O
well	O
as	O
in	O
V3	O
.	O

There	O
are	O
non-specific	B-problem
ST	I-problem
T	I-problem
wave	I-problem
changes.	I-problem

The	B-test
blood	I-test
cultures	I-test
at	O
Linghs	O
County	O
Medical	O
Center	O
grew	O
out	O
Staph.	B-problem
aureus	I-problem
sensitive	O
to	O
methicillin	B-treatment
.	O

The	B-test
blood	I-test
cultures	I-test
obtained	O
a	O
Oaksgekesser/	O
Memorial	O
Hospital	O
were	O
negative	O
.	O

An	B-test
echocardiogram	I-test
obtained	O
at	O
Oaksgekesser/	O
Memorial	O
Hospital	O
obtained	O
as	O
a	B-test
transthoracic	I-test
echocardiogram	I-test
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
33%	O
,	O
wall	B-test
thickness	I-test
12	O
mms	O
at	O
the	O
septum	O
,	O
posterior	B-test
wall	I-test
11	O
mms.	O
,	O
left	B-test
atrial	I-test
size	I-test
40	O
mms	O
.	O

There	O
is	O
anteroseptal	B-problem
hypokinesis	I-problem
with	O
mid	B-problem
and	I-problem
apical	I-problem
akinesis	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
treated	O
with	O
intravenous	B-treatment
antibiotics	I-treatment
.	O

A	B-test
lumbar	I-test
puncture	I-test
was	O
obtained	O
which	O
showed	O
normal	O
pressure	O
and	O
no	O
cells	B-problem
.	O

The	B-test
CSF	I-test
culture	I-test
was	O
negative	O
.	O

A	B-test
stool	I-test
assay	I-test
was	O
taken	O
for	O
Clostridium	B-problem
difficile	I-problem
which	O
was	O
negative	O
.	O

The	O
patient	O
gradually	O
improved	O
on	O
the	B-treatment
current	I-treatment
therapy	I-treatment
and	O
was	O
quite	O
awake	O
and	O
alert	O
,	O
though	O
still	O
appeared	O
to	O
have	O
some	O
evidence	O
of	O
dementia	B-problem
and	O
disorientation	B-problem
.	O

He	O
was	O
encouraged	O
to	O
eat	O
and	O
it	O
was	O
decided	O
not	O
to	O
place	O
either	O
a	B-treatment
feeding	I-treatment
tube	I-treatment
or	O
to	O
start	O
TPN	B-treatment
.	O

Dr.	O
Rhalttland	O
was	O
called	O
at	O
Sondi	O
Memorial	O
to	O
update	O
him	O
on	O
the	O
patient	O
&apos;s	O
condition	O
.	O

He	O
still	O
needs	O
much	B-treatment
intensive	I-treatment
rehabilitation	I-treatment
,	O
encouragement	O
to	O
eat	O
and	O
encouragement	O
to	O
get	O
out	O
of	O
bed	O
to	O
use	O
the	O
bathroom	O
rather	O
than	O
abed	B-treatment
pain	I-treatment
or	O
a	B-treatment
diaper	I-treatment
.	O

He	O
is	O
being	O
transferred	O
to	O
Linghs	O
County	O
Medical	O
Center	O
for	O
further	B-treatment
care	I-treatment
.	O

CONDITION	O
:	O

Stable	O
and	O
improved	O
.	O

LAKO	O
C.	O
WARM	O
,	O
M.D.	O
STAT	O

TR	O
:	O

lv	O
PAD-WORD	O

DD	O
:	O

01/06/98	O
PAD-WORD	O

TD	O
:	O

01/06/98	O
7:41	O

Pcc	O
:	O

LAKO	O
C	O
WARM	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2013-08-26	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-09-17	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1945-02-07	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service:	O
PAD-WORD	O

NOTE	O
:	O

The	O
Discharge	O
Date	O
of	O
2013-09-17	O
is	O
pending	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Briefly	O
,	O
this	O
68	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
,	O
was	O
admitted	O
originally	O
to	O
the	O
Podiatry	O
Service	O
for	O
a	B-problem
left	I-problem
patellar	I-problem
mid-foot	I-problem
ulcer	I-problem
.	O

He	O
underwent	O
angiogram	B-test
on	O
2013-08-28	O
,	O
to	O
evaluate	O
his	O
circulation	O
and	O
found	O
at	O
that	O
time	O
that	O
the	O
patient	O
had	O
a	B-problem
poor	I-problem
circulation	I-problem
to	I-problem
the	I-problem
left	I-problem
leg	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Vascular	O
Surgery	O
Service	O
for	O
bilateral	B-treatment
iliac	I-treatment
stenting	I-treatment
at	O
that	O
time	O
.	O

The	O
patient	O
also	O
at	O
that	O
time	O
was	O
followed	O
by	O
Cardiology	O
and	O
for	O
preoperative	B-test
evaluation	I-test
had	O
a	B-test
stress	I-test
test	I-test
which	O
was	O
positive	B-problem
and	O
he	O
became	O
diaphoretic	B-problem
but	O
denied	O
any	B-problem
chest	I-problem
pain	I-problem
.	O

Atropine	B-treatment
was	O
given	O
and	O
heart	B-test
rate	I-test
returned	O
to	O
the	O
70s	O
and	O
his	B-test
blood	I-test
pressure	I-test
returned	O
to	O
the	O
120s	O
over	O
80s	O
.	O

The	O
patient	O
denied	O
any	O
orthopnea	B-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
or	O
cough	B-problem
.	O

He	O
had	O
occasional	B-problem
leg	I-problem
swelling	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY:	O

1	O
.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
2006	O
and	O
1997	O
and	O
status	O
post	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
times	O
two	O
.	O

2.	O
Diabetes	B-problem
mellitus	I-problem
type	I-problem
2	I-problem
since	O
age	O
25	O
;	O
now	O
currently	O
on	O
insulin	B-treatment
,	O
which	O
is	O
complicated	O
by	O
peripheral	B-problem
neuropathy	I-problem
,	O
nephropathy	B-problem
and	O
Charcot	B-problem
's	I-problem
foot	I-problem
.	O

3.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

4.	O
Peripheral	B-problem
vascular	I-problem
disease	I-problem
status	O
post	O
left	B-treatment
iliac	I-treatment
stent	I-treatment
and	O
right	B-treatment
femoral	I-treatment
stent	I-treatment
.	O

5.	O
Hypertension	B-problem
.	O

6.	O
High	B-problem
cholesterol	I-problem
.	O

7.	O
Question	O
of	O
tendonitis	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Insulin	B-treatment
70/30	O
,	O
40	O
units	O
q.	O
a.m.	O
and	O
40	O
units	O
q.	O
p.m.	O

2.	O
Diovan	B-treatment
160	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Nortriptyline	B-treatment
25	O
mg	O
p.o.	O
q.	O
h.s.	O

4.	O
Norvasc	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Metoprolol	B-treatment
50	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

6.	O
Hydrochlorothiazide	B-treatment
,	O
15	O
mg	O
p.o.	O
q.	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
afebrile	B-problem
;	O
his	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

His	O
neck	O
was	O
supple	O
;	O
he	O
had	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

His	O
carotids	O
were	O
two	O
plus	O
bilaterally	O
without	O
bruits	B-problem
.	O

His	O
lungs	O
were	O
clear	O
.	O

His	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

His	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Bowel	O
sounds	O
are	O
present	O
.	O

He	O
had	O
bilateral	B-problem
femoral	I-problem
bruits	I-problem
and	O
he	O
had	O
one	B-test
plus	I-test
popliteal	I-test
pulses	I-test
.	O

His	B-test
pedal	I-test
pulses	I-test
are	O
absent	B-problem
.	O

LABORATORY	O
:	O

On	O
admission	O
,	O
his	B-test
BUN	I-test
was	O
13	O
,	O
creatinine	B-test
1.7	O
,	O
hematocrit	B-test
43	O
and	O
the	B-test
cholesterol	I-test
was	O
208	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
is	O
admitted	O
to	O
this	O
hospital	O
through	O
the	O
Podiatry	O
Service	O
;	O
however	O
,	O
the	B-test
stress	I-test
test	I-test
showed	O
multi-vessel	B-problem
disease	I-problem
.	O

Podiatry	O
continued	O
to	O
follow	O
for	O
evaluation	B-test
of	O
his	B-problem
left	I-problem
foot	I-problem
ulcer	I-problem
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
he	O
was	O
having	O
acetic	B-treatment
acid	I-treatment
wet-to-dry	I-treatment
dressing	I-treatment
changes	I-treatment
,	O
0.25%	O
q.	O
day	O
.	O

Vascular	O
Surgery	O
was	O
following	O
at	O
the	O
same	O
time	O
and	O
decided	O
that	O
bilateral	B-treatment
iliac	I-treatment
stenting	I-treatment
would	O
be	O
the	B-treatment
most	I-treatment
optimum	I-treatment
treatment	I-treatment
currently	O
and	O
suggested	O
that	O
the	O
patient	O
should	O
be	O
worked	O
up	O
for	O
cardiac	B-problem
disease	I-problem
prior	O
to	O
re-vascularization	B-treatment
.	O

Medicine	O
was	O
also	O
consulted	O
at	O
that	O
time	O
for	O
high	B-problem
blood	I-problem
pressure	I-problem
and	O
for	O
the	B-problem
biceps	I-problem
pain	I-problem
.	O

While	O
having	O
angiography	B-test
,	O
he	O
had	O
a	B-problem
transient	I-problem
increase	I-problem
in	O
his	B-test
blood	I-test
pressure	I-test
and	O
became	O
diaphoretic	B-problem
and	O
thus	O
precipitated	O
the	B-test
evaluation	I-test
for	O
cardiac	B-problem
disease	I-problem
.	O

Cardiology	O
was	O
consulted	O
at	O
that	O
time	O
to	O
evaluate	O
his	O
heart	O
.	O

The	O
patient	O
was	O
managed	O
on	O
the	O
Medical	O
Service	O
for	O
his	B-problem
drop	I-problem
in	O
blood	B-test
pressure	I-test
and	O
cardiac	B-test
evaluation	I-test
.	O

He	O
was	O
also	O
followed	O
by	O
Podiatry	O
and	O
Vascular	O
Surgery	O
.	O

He	O
was	O
taken	O
to	O
the	O
Cardiac	O
Catheterization	O
Laboratory	O
which	O
showed	O
multi-vessel	B-problem
disease	I-problem
and	O
Cardiothoracic	O
Surgery	O
was	O
consulted	O
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
2013-09-04	O
,	O
where	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
four	O
was	O
performed	O
,	O
left	B-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
to	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
diagonal	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
obtuse	I-treatment
marginal	I-treatment
and	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
PC	I-treatment
by	O
Dr.	O
Wright	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
CSRU	O
postoperatively	O
where	O
he	O
did	O
well	O
.	O

He	O
was	O
slowly	O
weaned	O
from	O
his	B-treatment
ventilator	I-treatment
and	O
was	O
able	O
to	O
be	O
extubated	O
.	O

The	O
patient	O
was	O
able	O
to	O
be	O
weaned	O
to	O
six	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
after	O
extubation	B-treatment
,	O
however	O
,	O
it	O
was	O
noted	O
on	O
chest	B-test
x-ray	I-test
that	O
he	O
had	O
a	B-problem
small	I-problem
apical	I-problem
pneumothorax	I-problem
.	O

A	B-test
repeat	I-test
chest	I-test
x-ray	I-test
showed	O
resolution	O
of	O
that	B-problem
pneumothorax	I-problem
.	O

The	O
patient	O
was	O
continued	O
on	O
an	B-treatment
insulin	I-treatment
drip	I-treatment
for	O
his	B-problem
diabetes	I-problem
mellitus	I-problem
but	O
continued	O
to	O
improve	O
.	O

His	B-treatment
chest	I-treatment
tube	I-treatment
was	O
in	O
place	O
for	O
a	B-problem
high	I-problem
chest	I-problem
tube	I-problem
output	I-problem
.	O

His	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
removed	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Floor	O
.	O

Physical	O
Therapy	O
was	O
consulted	O
in	O
order	O
to	O
assess	O
the	O
patient	O
's	O
ambulation	O
and	O
mobility	O
,	O
however	O
,	O
with	O
his	B-problem
foot	I-problem
infection	I-problem
and	O
associated	B-problem
pain	I-problem
,	O
it	O
was	O
difficult	O
to	O
assess	O
at	O
that	O
time	O
.	O

After	O
arriving	O
on	O
the	O
Floor	O
,	O
the	O
patient	O
had	O
an	O
episode	O
of	O
rapid	B-problem
atrial	I-problem
fibrillation	I-problem
which	O
was	O
treated	O
with	O
amiodarone	B-treatment
and	O
Lopressor	B-treatment
.	O

The	O
patient	O
resolved	O
,	O
however	O
,	O
Lasix	B-treatment
was	O
also	O
given	O
due	O
to	O
some	B-problem
pulmonary	I-problem
edema	I-problem
and	O
increasing	B-problem
oxygen	I-problem
need	I-problem
.	O

The	O
patient	O
continued	O
to	O
have	O
episodes	O
of	O
rapid	B-problem
atrial	I-problem
fibrillation	I-problem
while	O
on	O
the	O
Floor	O
,	O
which	O
required	O
continued	O
diuresis	B-treatment
as	O
well	O
as	O
intravenous	B-treatment
Lopressor	I-treatment
.	O

His	B-treatment
chest	I-treatment
tube	I-treatment
and	O
Foley	B-treatment
catheter	I-treatment
were	O
removed	O
on	O
postoperative	O
day	O
number	O
three	O
,	O
and	O
the	O
patient	O
had	O
aggressive	B-treatment
chest	I-treatment
Physical	I-treatment
Therapy	I-treatment
and	O
nebulizer	B-treatment
treatments	I-treatment
.	O

His	B-treatment
dressing	I-treatment
changes	I-treatment
for	I-treatment
his	I-treatment
foot	I-treatment
continued	O
per	O
the	O
Podiatry	O
Service	O
and	O
his	B-problem
leg	I-problem
ulcer	I-problem
was	O
noted	O
to	O
be	O
slowly	O
healing	O
.	O

The	O
patient	O
had	O
multiple	O
episodes	O
of	O
rapid	B-problem
atrial	I-problem
fibrillation	I-problem
which	O
again	O
required	O
intravenous	B-treatment
Lopressor	I-treatment
.	O

Amiodarone	B-treatment
boluses	I-treatment
were	O
given	O
and	O
the	O
patient	O
was	O
started	O
on	O
400	O
three	O
times	O
a	O
day	O
of	O
p.o.	B-treatment
amiodarone	I-treatment
,	O
aggressive	B-treatment
pulmonary	I-treatment
toilet	I-treatment
and	O
continued	B-treatment
diuresis	I-treatment
was	O
done	O
,	O
however	O
,	O
the	O
patient	O
continued	O
to	O
have	O
respiratory	B-problem
difficulties	I-problem
when	O
in	O
rapid	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

The	O
patient	O
was	O
evaluated	O
on	O
postoperative	O
day	O
number	O
five	O
and	O
it	O
was	O
decided	O
at	O
that	O
time	O
that	O
the	O
patient	O
should	O
be	O
transferred	O
back	O
to	O
the	O
Intensive	O
Care	O
Unit	O
for	O
respiratory	B-problem
difficulties	I-problem
.	O

He	O
was	O
transferred	O
back	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
where	O
he	O
was	O
aggressively	O
diuresed	O
as	O
well	O
as	O
his	B-test
rate	I-test
was	O
controlled	O
and	O
chest	B-treatment
Physical	I-treatment
Therapy	I-treatment
and	O
nebulizer	B-treatment
treatments	I-treatment
were	O
done	O
.	O

The	O
patient	O
improved	O
slowly	O
.	O

Also	O
,	O
his	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
found	O
to	O
rise	O
to	O
32.0	O
;	O
this	O
was	O
most	O
likely	O
due	O
to	O
a	B-problem
secondary	I-problem
infection	I-problem
of	I-problem
his	I-problem
foot	I-problem
and	O
Zosyn	B-treatment
was	O
started	O
.	O

The	O
patient	O
continued	O
to	O
do	O
well	O
and	O
his	B-problem
recurrent	I-problem
atrial	I-problem
fibrillation	I-problem
slowly	O
improved	O
;	O
p.o.	O
doses	O
of	O
Lopressor	B-treatment
slowly	O
increased	O
to	O
get	O
better	O
control	O
of	O
his	B-test
rate	I-test
and	O
the	O
patient	O
was	O
able	O
to	O
be	O
controlled	O
with	O
a	B-test
heart	I-test
rate	I-test
in	O
the	O
50s	O
to	O
60s	O
with	O
Lopressor	B-treatment
.	O

Following	O
initiation	O
of	O
his	B-treatment
Zosyn	I-treatment
,	O
the	B-test
white	I-test
count	I-test
continued	O
to	O
improve	O
and	O
the	O
patient	O
was	O
planned	O
for	O
a	B-treatment
PICC	I-treatment
line	I-treatment
for	O
long-term	B-treatment
intravenous	I-treatment
antibiotics	I-treatment
.	O

The	O
patient	O
was	O
started	O
on	O
Lopressor	B-treatment
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
with	O
good	O
control	O
with	O
a	B-test
heart	I-test
rate	I-test
of	O
50s	O
to	O
60s	O
.	O

He	O
is	O
in	O
sinus	O
rhythm	O
.	O

He	O
was	O
also	O
started	O
on	O
his	B-treatment
preoperative	I-treatment
medications	I-treatment
of	O
Amlodipine	B-treatment
and	O
Losartan	B-treatment
with	O
improvement	O
of	O
his	B-test
blood	I-test
pressure	I-test
.	O

The	O
patient	O
was	O
also	O
reduced	O
to	O
400	O
mg	O
q.	O
day	O
of	O
amiodarone	B-treatment
.	O

Pulmonary	O
was	O
consulted	O
at	O
this	O
time	O
for	O
this	B-problem
difficulty	I-problem
of	I-problem
diuresis	I-problem
and	O
pulmonary	B-problem
edema	I-problem
.	O

They	O
continued	O
to	O
agree	O
with	O
the	O
management	O
of	O
the	O
patient	O
and	O
with	O
aggressive	B-treatment
pulmonary	I-treatment
toilet	I-treatment
as	O
well	O
as	O
diuresis	B-treatment
and	O
nebulizer	B-treatment
treatment	I-treatment
.	O

The	O
patient	O
was	O
transferred	O
back	O
from	O
the	O
Intensive	O
Care	O
Unit	O
on	O
2013-09-13	O
,	O
and	O
upon	O
arriving	O
on	O
the	O
floor	O
,	O
he	O
continued	O
to	O
do	O
well	O
.	O

Pulmonary	B-treatment
toilet	I-treatment
and	O
aggressive	B-treatment
chest	I-treatment
Physical	I-treatment
Therapy	I-treatment
was	O
continued	O
and	O
the	O
patient	O
was	O
able	O
to	O
be	O
weaned	O
from	O
his	B-treatment
oxygen	I-treatment
.	O

Furthermore	O
,	O
his	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
removed	O
and	O
he	O
was	O
started	O
on	O
anti-coagulation	B-treatment
for	O
his	O
episodes	O
of	O
atrial	B-problem
fibrillation	I-problem
.	O

He	O
had	O
been	O
started	O
on	O
heparin	B-treatment
in	O
the	O
Intensive	O
Care	O
Unit	O
and	O
that	O
was	O
continued	O
.	O

Coumadin	B-treatment
was	O
then	O
begun	O
with	O
a	B-test
goal	I-test
INR	I-test
of	O
2.0	O
to	O
3.0	O
.	O

At	O
that	O
time	O
he	O
was	O
stabilized	O
from	O
a	O
cardiac	O
perspective	O
.	O

Podiatry	O
and	O
Vascular	O
Surgery	O
were	O
reconsulted	O
to	O
assess	O
the	O
patient	O
's	O
needs	O
for	O
revascularization	B-treatment
and	O
for	O
his	B-problem
foot	I-problem
ulcer	I-problem
.	O

It	O
was	O
decided	O
at	O
that	O
time	O
that	O
the	O
patient	O
could	O
be	O
discharged	O
in	O
follow-up	O
with	O
Vascular	O
Surgery	O
for	O
revascularization	B-treatment
and	O
Podiatry	O
thereafter	O
.	O

On	O
2013-08-28	O
,	O
the	O
patient	O
had	O
a	B-treatment
PICC	I-treatment
line	I-treatment
placed	O
for	O
a	O
six	O
week	O
course	O
of	O
intravenous	B-treatment
Zosyn	I-treatment
for	O
his	B-problem
foot	I-problem
ulcer	I-problem
and	O
his	B-treatment
Coumadin	I-treatment
was	O
also	O
continued	O
.	O

The	O
patient	O
did	O
well	O
and	O
was	O
discharged	O
to	O
a	O
rehabilitation	O
facility	O
at	O
that	O
time	O
.	O

His	O
discharge	O
date	O
is	O
pending	O
.	O

CURRENT	O
DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

2.	O
Coumadin	B-treatment
7.5	O
mg	O
p.o.	O
q.d.	O
for	O
an	B-test
INR	I-test
goal	I-test
of	O
2.0	O
to	O
3.0	O
and	O
adjust	O
the	O
dose	O
accordingly	O
.	O

3.	O
Acetic	B-treatment
acid	I-treatment
0.25%	O
wet-to-dry	B-treatment
dressing	I-treatment
changes	I-treatment
q.	O
day	O
for	O
his	B-problem
left	I-problem
foot	I-problem
ulcer	I-problem
.	O

4.	O
Amiodarone	B-treatment
400	O
mg	O
q.	O
day	O
.	O

5.	O
Albuterol	B-treatment
nebulizers	I-treatment
q.	O
four	O
hours	O
and	O
q.	O
two	O
hours	O
p.r.n.	O

6.	O
Losartan	B-treatment
50	O
mg	O
p.o.	O
q.	O
day	O
.	O

7.	O
Iron	B-treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O

8.	O
Albuterol	B-treatment
ipratropium	B-treatment
two	O
puffs	O
four	O
times	O
a	O
day	O
.	O

9.	O
Zosyn	B-treatment
4.5	O
grams	O
intravenously	O
q.	O
six	O
hours	O
times	O
six	O
weeks	O
;	O
started	O
on	O
09-10	O
.	O

10.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

11.	O
Amlodipine	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

12.	O
Nortriptyline	B-treatment
25	O
mg	O
p.o.	O
q.	O
h.s.	O

13.	O
Mecsazopam	B-treatment
15	O
to	O
30	O
mg	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O

14.	O
Dulcolax	B-treatment
10	O
mg	O
p.o.	O
or	O
p.r.	O
q.	O
day	O
p.r.n.	O

15.	O
Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
30	O
cc	O
,	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O

16.	O
Percocet	B-treatment
one	O
to	O
two	O
tablets	O
p.o.	O
q.	O
four	O
hours	O
p.r.n.	O

17.	O
Zantac	B-treatment
150	O
p.o.	O
twice	O
a	O
day	O
.	O

18.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

19.	O
Alexandria	O
Daly	O
20	O
mEq	O
p.o.	O
twice	O
a	O
day	O
.	O

20.	O
Lasix	B-treatment
20	O
mg	O
intravenous	O
twice	O
a	O
day	O
.	O

21.	O
Lopressor	B-treatment
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
rehabilitation	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Stable	O
condition	O
.	O

DISCHARGE	O
INSTRUCTIONS:	O

1.	O
He	O
is	O
instructed	O
to	O
follow-up	O
with	O
Dr.	O
Holloway	O
in	O
four	O
weeks	O
.	O

2.	O
He	O
is	O
to	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
in	O
one	O
to	O
two	O
weeks	O
.	O

3.	O
Follow-up	O
with	O
Cardiologist	O
in	O
four	O
weeks	O
.	O

4.	O
He	O
is	O
also	O
instructed	O
to	O
follow-up	O
with	O
Vascular	O
Surgery	O
and	O
Podiatry	O
for	O
revascularization	B-treatment
at	O
the	O
appropriate	O
time	O
frame	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
myocardial	B-problem
infarction	I-problem
status	O
post	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

2.	O
Diabetes	B-problem
mellitus	I-problem
type	I-problem
2	I-problem
,	O
now	O
currently	O
on	O
insulin	B-treatment
.	O

3.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

4.	O
Peripheral	B-problem
vascular	I-problem
disease	I-problem
status	O
post	O
bilateral	B-treatment
iliac	I-treatment
stenting	I-treatment
.	O

5.	O
Hypertension	B-problem
.	O

6.	O
High	B-problem
cholesterol	I-problem
.	O

7.	O
Question	O
tendonitis	B-problem
with	O
left	B-problem
biceps	I-problem
pain	I-problem
.	O

8.	O
Left	B-problem
foot	I-problem
ulcer	I-problem
status	O
post	O
debridement	B-treatment
.	O

PLEASE	O
SEE	O
ADDENDUM	O
FOR	O
ANY	O
CHANGE	O
IN	O
MEDICATIONS	O
AND	O
DISCHARGE	O
DATE	O
.	O

Donna	O
B.	O
Christensen	O
,	O
M.D.	O
31-932	O

Dictated	O
By	O
:	O
Ervin	O
Y.	O
Nobles	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-09-16	O
16:00	O

T	O
:	O
2013-09-16	O
16:11	O

JOB	O
#	O
:	O
82277	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kenneth	O
Din	O
on	O
:	O
TUE	O
2013-09-17	O
11:14	O
AM	O

(	O
End	O
of	O
Report	O
)	O

289724916	O
PAD-WORD	O

HLGMC	O
PAD-WORD	O

0051811	O
PAD-WORD	O

56075/pu8n	O
PAD-WORD	O

6/30/1992	O
12:00:00	O
AM	O

CARCINOMA	B-problem
OF	I-problem
THE	I-problem
KIDNEY	I-problem
,	O
HYPOVOLEMIA	B-problem
,	O
METASTATIC	B-problem
LIVER	I-problem

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

6-30-92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

7-1-92	O
(	O
SOUTHOBASSKING&apos;S	O
VILLEMARG	O
HOSPITAL	O
)	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

carcinoma	B-problem
of	I-problem
the	I-problem
kidney	I-problem
,	O
hypovolemia	B-problem
,	O
metastatic	B-problem
liver	I-problem
disease	I-problem
and	O
intrathoracic	B-problem
lymphadenopathy	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
history	O
of	O
this	O
49	O
year	O
old	O
male	O
is	O
provided	O
in	O
detail	O
in	O
the	O
typed	O
admission	O
note	O
dated	O
June	O
30	O
,	O
1992	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

(	O
at	O
time	O
of	O
admission	O
)	O
the	B-test
blood	I-test
pressure	I-test
100/65	O
;	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
throat	O
:	O

no	O
masses	B-problem
,	O
neck	O
revealed	O
lymphadenopathy	B-problem
.	O

The	O
lungs	O
were	O
clear	O
,	O
heart	O
normal	O
.	O

Abdomen	O
:	O

liver	B-problem
massively	I-problem
enlarged	I-problem
down	O
15	O
cm	O
.	O

Extremities	O
:	O

normal	O
;	O

neurological	B-test
examination	I-test
:	O

generally	O
intact	O
.	O

LABORATORY	O
DATA	O
:	O

(	O
at	O
time	O
of	O
admission	O
)	O
hematocrit	B-test
32.7	O
;	O
white	B-test
blood	I-test
count	I-test
9,000	O
;	O
platelet	B-test
count	I-test
336,000	O
;	O
sodium	B-test
126	O
,	O
potassium	B-test
4.3	O
,	O
chloride	B-test
93	O
,	O
CO2	B-test
19	O
,	O
BUN	B-test
36	O
,	O
creatinine	B-test
1.5	O
,	O
blood	B-test
sugar	I-test
84	O
,	O
calcium	B-test
11.7	O
;	O
the	B-test
chest	I-test
X-ray	I-test
normal	O
.	O

KUB	B-test
:	O

consistent	O
with	O
adynamic	B-problem
ileus	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
worsened	O
rapidly	O
following	O
admission	O
and	O
it	O
was	O
clear	O
to	O
his	O
family	O
and	O
to	O
his	O
physician	O
that	O
he	O
was	O
pre-terminal	O
.	O

All	O
efforts	O
were	O
directed	O
to	O
his	O
comfort	O
and	O
he	O
died	O
on	O
July	O
1	O
,	O
1992	O
.	O

Autopsy	O
permission	O
was	O
declined	O
by	O
the	O
family	O
.	O

NU	O
L.	O
GALL	O
,	O
M.D.	O

TR	O
:	O

vb	O
/	O
bmot	O

DD	O
:	O

7-30-92	O
PAD-WORD	O

TD	O
:	O

08/03/92	O
PAD-WORD	O

CC	O
:	O

DR.	O
VERD	O
CHURLAUNT	O

DR.	O
NU	O
L.	O
GALL	O
,	O
LI	O
HOSPITAL	O

Admission	O
Date	O
:	O

2016-12-15	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-12-21	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1980-08-17	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

OBSTETRICS	O
/	O
GYNECOLOGY	O

Allergies	O
:	O

Sulfonamides	B-treatment
PAD-WORD	O

Attending	O
:	O
Melissa	O
P	O
Lowery	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Term	O
pregnancy	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

SVD	B-treatment
PAD-WORD	O

D&C	B-treatment
PAD-WORD	O

Supracervical	B-treatment
hysterectomy	I-treatment

Reexploration	B-test
with	O
vaginal	B-treatment
artery	I-treatment
ligation	I-treatment

Multiple	B-treatment
transfusions	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

36	O
yo	O
G3P2	O
at	O
38+5	O
weeks	O
GA	O
presented	O
to	O
L&D	O
for	O
elective	B-treatment
induction	I-treatment
of	I-treatment
labor	I-treatment
.	O

Antenatal	O
course	O
benign	O
.	O

Past	O
Medical	O
History	O
:	O

PMHx	O
:	O

Narcolepsy	B-problem
.	O

R	B-problem
inguinal	I-problem
hernia	I-problem
.	O

ObHx	O
:	O

SVDX2	B-treatment
PAD-WORD	O

Social	O
History	O
:	O

Married	O
.	O

No	O
T/E/D	O

Family	O
History	O
:	O

NC	O
PAD-WORD	O

Physical	O
Exam	O
:	O

Vital	B-test
signs	I-test
stable	O
on	O
admission	O
.	O

Heart	O
RRR	O

Lungs	O
CTAB	O

Abd	B-problem
Gravid	I-problem
,	O
NT	B-problem

Ext	O
without	O
edema	B-problem

Cervix	O
1	O
cm	O
dilated	O
.	O

Pertinent	O
Results	O
:	O

2016-12-15	O
03:31	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
6.2	O
RBC	B-test
-	O
3.82	O
*	O
Hgb	B-test
-	O
12.2	O
Hct	B-test
-	O
34.5	O
*	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
32.0	O
MCHC	B-test
-	O
35.4	O
*	O
RDW	B-test
-	O
12.7	O
Plt	B-test
Ct	I-test
-	O
246	O

2016-12-21	O
07:45	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
6.6	O
RBC	B-test
-	O
2.79	O
*	O
Hgb	B-test
-	O
8.5	O
*	O
Hct	B-test
-	O
23.9	O
*	O
MCV	B-test
-	O
86	O
MCH	B-test
-	O
30.5	O
MCHC	B-test
-	O
35.7	O
*	O
RDW	B-test
-	O
16.9	O
*	O
Plt	B-test
Ct	I-test
-	O
222	O
#	O

Brief	O
Hospital	O
Course	O
:	O

After	O
admission	O
to	O
L&D	O
,	O
the	O
patient	O
was	O
administered	O
Pitocin	B-treatment
for	O
elective	B-treatment
induction	I-treatment
of	I-treatment
labor	I-treatment
and	O
progressed	O
uneventfully	O
and	O
went	O
on	O
to	O
deliver	O
a	O
viable	O
female	O
infant	O
,	O
weight	B-test
3595	O
g	O
,	O
Apgars	B-test
11-11	O
.	O

EBL	B-problem
during	O
delivery	O
was	O
300	O
cc	O
.	O

Patient	O
was	O
transferred	O
to	O
the	O
PP	O
floor	O
in	O
stable	O
condition	O
.	O

Soon	O
after	O
transfer	O
,	O
patient	O
had	O
a	B-problem
large	I-problem
post	I-problem
partum	I-problem
hemorrhage	I-problem
.	O

This	O
was	O
treated	O
with	O
transfer	O
back	O
to	O
L&D	O
,	O
bimanual	B-treatment
massage	I-treatment
,	O
administration	O
of	O
various	B-treatment
uterotonics	I-treatment
,	O
namely	O
pitocin	B-treatment
100	O
U	O
,	O
Methergine	B-treatment
x	O
1	O
,	O
Hemabate	B-treatment
x	O
1	O
,	O
and	O
cytotec	B-treatment
1000	O
mcgs	O
with	O
minimal	O
response	O
.	O

Patient	O
underwent	O
suction	B-treatment
curettage	I-treatment
and	O
finally	O
a	B-treatment
supercervical	I-treatment
hysterectomy	I-treatment
.	O

EBL	B-problem
4000	O
cc	O
;	O
IVF	B-treatment
6000	O
cc	O
crystalloid	B-treatment
;	O
U/O	B-test
3500	O
cc	O
.	O

Products	O
:	O

8	B-treatment
units	I-treatment
RBC	I-treatment
,	O
6FFP	B-treatment
,	O
1	B-treatment
cryo	I-treatment
,	O
1	B-treatment
pack	I-treatment
plt	I-treatment
.	O

After	O
this	B-treatment
procedure	I-treatment
,	O
the	O
patient	O
again	O
hemorrhaged	O
in	O
the	O
ICU	O
and	O
was	O
taken	O
back	O
to	O
the	O
OR	O
for	O
reexploration	B-test
and	O
ligation	B-treatment
of	O
a	B-problem
bleeding	I-problem
vaginal	I-problem
artery	I-problem
.	O

EBL	B-problem
3500	O
;	O
IVF	B-treatment
4000	O
;	O
UO	B-test
45	O
;	O
RBC	B-treatment
9U	O
;	O
Plt	B-treatment
12	O
pack	O
;	O
1u	B-treatment
Cryo	I-treatment
;	O
6U	B-treatment
FFP	I-treatment
.	O

For	O
details	O
of	O
these	B-treatment
procedures	I-treatment
,	O
please	O
see	O
op	O
notes	O
dictated	O
by	O
Dr.	O
Day	O
on	O
2016-12-16	O
.	O

Overall	O
,	O
the	O
pt	O
maintained	O
good	O
BP	B-test
throughout	O
and	O
was	O
on	O
pressors	B-treatment
only	O
briefly	O
.	O

Hct	B-test
was	O
maintained	O
in	O
stable	O
range	O
with	O
product	B-treatment
transfusions	I-treatment
.	O

Patient	O
did	O
well	O
and	O
was	O
extubated	O
uneventfully	O
on	O
12-17	O
.	O

She	O
was	O
transferred	O
from	O
the	O
ICU	O
back	O
to	O
the	O
PP	O
floor	O
on	O
12-19	O
.	O

There	O
,	O
she	O
made	O
great	O
progress	O
.	O

Her	B-test
vital	I-test
signs	I-test
were	O
stable	O
,	O
she	O
remained	O
afebrile	B-problem
off	O
antibiotics	B-treatment
.	O

Her	B-problem
pain	I-problem
was	O
controlled	O
with	O
percocet	B-treatment
and	O
motrin	B-treatment
.	O

Her	B-treatment
foley	I-treatment
was	O
removed	O
and	O
she	O
voided	O
without	O
problems	B-problem
.	O

She	O
John	O
,	O
tolerated	O
a	O
regular	O
diet	O
,	O
and	O
was	O
discharged	O
home	O
in	O
good	O
condition	O
on	O
12-21	O
.	O

Medications	O
on	O
Admission	O
:	O

Cylert	B-treatment
.	O

Discharge	O
Medications	O
:	O

1.	O
Ibuprofen	B-treatment
600	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
25	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:	O
*	O
0	O
*	O

2.	O
Oxycodone	B-treatment
-	I-treatment
Acetaminophen	I-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

Full	O
term	O
pregnancy	O
,	O
s/p	O
SVD	B-treatment

Uterine	B-problem
atony	I-problem
,	O
postpartum	B-problem
hemorrhage	I-problem

Severe	B-problem
anemia	I-problem

Discharge	O
Condition	O
:	O

Stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Follow	O
printed	O
instructions	O

Followup	O
Instructions	O
:	O

6	O
wks	O
for	O
postpartum	B-test
exam	I-test

MOnday	O
for	O
staple	B-treatment
removal	I-treatment
.	O

James	O
Tricia	O
MD	O
61-345	O

Completed	O
by	O
:	O
Greg	O
Allen	O
MD	O
53-372	O
2016-12-22	O
@	O
1825	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Katherine	O
Beaulieu	O
Brush	O
on	O
:	O
WED	O
2017-01-25	O
12:05	O
AM	O

(	O
End	O
of	O
Report	O
)	O

291181306	O
PAD-WORD	O

FIH	O
PAD-WORD	O

0231078	O
PAD-WORD	O

718719	O
PAD-WORD	O

9555422	O
PAD-WORD	O

03/11/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

GETZZOCHTLAND	O
,	O
SYNNANI	O
F	O

UNIT	O
NUMBER	O
:	O

451-52-66	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

03/11/2002	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

03/14/2002	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
hip	I-problem
osteoarthritis	I-problem
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Asthma	B-problem
,	O
gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
,	O
and	O
constipation	B-problem
.	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Right	B-treatment
total	I-treatment
hip	I-treatment
arthroplasty	I-treatment
.	O

CHIEF	O
COMPLAINT	O
:	O

Right	B-problem
hip	I-problem
pain	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
62-year-old	O
hospice	O
chaplain	O
who	O
was	O
referred	O
by	O
Dr.	O
Tomedankell	O
Flowayles	O
and	O
Dr.	O
Es	O
Oarekote	O
for	O
evaluation	B-test
of	O
his	B-problem
right	I-problem
hip	I-problem
pain	I-problem
.	O

He	O
states	O
that	O
his	B-problem
pain	I-problem
has	O
been	O
of	O
seven	O
to	O
eight	O
durations	O
,	O
and	O
rated	O
as	O
moderate	O
to	O
severe	O
(	O
7/10	O
)	O
.	O

He	O
does	O
limp	O
.	O

He	O
does	O
not	O
use	O
a	B-treatment
cane	I-treatment
and	O
he	O
requires	O
a	O
bannister	O
for	O
going	O
up	O
and	O
down	O
stairs	O
.	O

He	O
has	O
trouble	O
with	O
his	O
shoes	O
and	O
socks	O
.	O

He	O
uses	O
a	B-treatment
walker	I-treatment
.	O

He	O
can	O
walk	O
about	O
a	O
quarter	O
of	O
a	O
mile	O
without	O
stopping	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Asthma	B-problem
,	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
,	O
non-small-cell	B-problem
lung	I-problem
cancer	I-problem
removed	O
from	O
his	O
right	O
lung	O
by	O
Dr.	O
Vital	O
four	O
years	O
prior	O
to	O
admission	O
,	O
status	O
post	O
chemotherapy	B-treatment
and	O
radiation	B-treatment
for	O
the	B-problem
non-small-cell	I-problem
lung	I-problem
cancer	I-problem
,	O
gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
,	O
and	O
history	O
of	O
constipation	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Prilosec	B-treatment
,	O
20	O
mg.	O
PO	O
q.day	O
;	O
Singulair	B-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
is	O
5	O
feet	O
,	O
9	O
inches	O
,	O
225	O
pounds	O
.	O

He	O
walks	O
with	O
a	B-problem
limp	I-problem
related	O
to	O
his	O
right	O
hip	O
.	O

His	O
right	O
hip	O
is	O
irritable	B-problem
with	O
a	B-problem
10-degree	I-problem
fixed	I-problem
flexion	I-problem
contracture	I-problem
.	O

He	O
is	O
able	O
to	O
flex	O
his	O
right	O
hip	O
to	O
100	O
degrees	O
.	O

He	O
has	O
10	O
degrees	O
of	O
internal	O
and	O
external	O
rotation	O
.	O

He	O
has	O
intact	O
distal	O
pulses	O
and	O
5/5	O
muscle	O
strength	O
in	O
all	O
major	O
muscle	O
groups	O
.	O

His	B-test
X-rays	I-test
show	O
advanced	B-problem
osteoarthritis	I-problem
of	I-problem
his	I-problem
right	I-problem
hip	I-problem
.	O

IMPRESSION	O
AND	O
PLAN	O
:	O

This	O
is	O
a	O
62-year-old	O
male	O
with	O
severe	B-problem
osteoarthritis	I-problem
of	I-problem
the	I-problem
right	I-problem
hip	I-problem
who	O
after	O
discussion	O
,	O
including	O
the	O
nature	O
,	O
risks	O
,	O
benefits	O
and	O
alternative	O
treatment	O
plans	O
,	O
signed	O
informed	O
consent	O
for	O
a	B-treatment
right	I-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
March	O
11	O
,	O
2002	O
,	O
and	O
underwent	O
an	B-treatment
uncomplicated	I-treatment
right	I-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
Post	O
Anesthesia	O
Care	O
Unit	O
and	O
then	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

On	O
postoperative	B-test
check	I-test
,	O
he	O
was	O
doing	O
well	O
.	O

He	O
was	O
afebrile	B-problem
and	O
his	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

He	O
was	O
neurovascularly	O
intact	O
.	O

His	B-test
hematocrit	I-test
was	O
34.7	O
.	O

He	O
was	O
started	O
on	O
Coumadin	B-treatment
for	O
DVT	B-treatment
prophylaxis	I-treatment
and	O
Ancef	B-treatment
for	O
routine	B-treatment
antimicrobial	I-treatment
coverage	I-treatment
.	O

He	O
was	O
made	O
partial	O
weight-bearing	O
for	O
his	O
right	O
lower	O
extremity	O
.	O

He	O
was	O
placed	O
on	O
posterior	B-treatment
hip	I-treatment
dislocation	I-treatment
precautions	I-treatment
and	O
was	O
out	O
of	O
bed	O
with	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
.	O

On	O
postoperative	O
day	O
one	O
,	O
there	O
were	O
no	O
active	O
issues	O
.	O

He	O
was	O
afebrile	B-problem
.	O

His	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

He	O
was	O
neurovascularly	O
intact	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
he	O
was	O
afebrile	B-problem
,	O
vital	B-test
signs	I-test
were	O
stable	O
.	O

His	B-problem
incision	I-problem
was	O
clean	O
,	O
dry	O
and	O
intact	O
with	O
no	O
erythema	B-problem
.	O

He	O
remained	O
neurovascularly	O
intact	O
.	O

His	B-test
hematocrit	I-test
was	O
34.8	O
.	O

On	O
postoperative	O
day	O
three	O
,	O
lower	B-test
extremity	I-test
noninvasive	I-test
ultrasounds	I-test
were	O
performed	O
,	O
which	O
showed	O
no	O
evidence	O
of	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
in	I-problem
the	I-problem
lower	I-problem
extremities	I-problem
.	O

The	O
remainder	O
of	O
his	O
hospitalization	O
was	O
uncomplicated	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Folic	B-treatment
acid	I-treatment
,	O
1	O
mg.	O
PO	O
q.d.;	O
multivitamin	B-treatment
,	O
one	O
capsule	O
PO	O
q.day	O
;	O

ferrous	B-treatment
sulfate	I-treatment
,	O
325	O
mg.	O
PO	O
t.i.d.;	O

Colace	B-treatment
,	O
100	O
mg.	O
PO	O
t.i.d.;	O

Tylenol	B-treatment
,	O
650	O
mg.	O
PO	O
q.4	O
hours	O
,	O
p.r.n.	O
pain	B-problem
;	O

Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
,	O
30	O
ml.	O
PO	O
q.day	O
,	O
p.r.n.	O
constipation	B-problem
;	O

Coumadin	B-treatment
,	O
2.5	O
mg.	O
PO	O
q.p.m.	O
,	O
dose	O
to	O
vary	O
per	O
INR	B-test
level	I-test
;	O

Percocet	B-treatment
5/325	O
mg.	O
s	O
,	O
one	O
to	O
two	O
tablets	O
PO	O
q.4	O
to	O
6	O
hours	O
p.r.n.	O
pain	B-problem
;	O

Singulair	B-treatment
,	O
10	O
mg.	O
PO	O
q.h.s.;	O

Nexium	B-treatment
,	O
10	O
mg.	O
PO	O
q.day	O
;	O

Metamucil	B-treatment
instant	I-treatment
mix	I-treatment
,	O
one	O
teaspoon	O
PO	O
q.day	O
;	O

Peri-Colace	B-treatment
,	O
two	O
capsules	O
PO	O
b.i.d.;	O
Dulcolax	B-treatment
,	O
10	O
mg.	O
PR	O
q.day	O
,	O
p.r.n.	O
constipation	B-problem
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Class	O
six	O
weeks	O
from	O
the	O
date	O
of	O
surgery	B-treatment
.	O

His	B-treatment
staples	I-treatment
should	O
be	O
removed	O
10	O
to	O
14	O
days	O
from	O
the	O
date	O
of	O
surgery	B-treatment
.	O

If	O
his	B-problem
wound	I-problem
is	O
dry	O
,	O
he	O
may	O
shower	O
.	O

He	O
is	O
to	O
ambulate	O
with	O
crutches	B-treatment
or	O
a	B-treatment
walker	I-treatment
and	O
be	O
on	O
posterior	B-treatment
hip	I-treatment
dislocation	I-treatment
precautions	I-treatment
for	O
three	O
months	O
following	O
the	O
date	O
of	O
surgery	B-treatment
.	O

He	O
should	O
be	O
on	O
Coumadin	B-treatment
for	O
anticoagulation	B-treatment
for	O
three	O
weeks	O
from	O
the	O
date	O
of	O
surgery	B-treatment
with	O
twice	O
weekly	O
blood	B-test
draws	I-test
for	O
INR	B-test
with	O
a	O
goal	O
of	O
1.5	O
to	O
2.0	O
.	O

He	O
is	O
to	O
call	O
Dr.	O
Class	O
&apos;s	O
office	O
with	O
any	O
questions	O
or	O
concerns	O
.	O

LENNI	O
E.	O
BREUTZOLN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
LI	O
RIJARRED	O
CLASS	O
,	O
M.D.	O
03/27/2002	O
12:39	O
_____________________________	O
LI	O
RIJARRED	O
CLASS	O
,	O
M.D.	O

TR	O
:	O

jt	O
PAD-WORD	O

DD	O
:	O

03/13/2002	O
PAD-WORD	O

TD	O
:	O

03/13/2002	O
10:05	O
P	O
718719	O

cc	O
:	O

LI	O
RIJARRED	O
CLASS	O
,	O
M.D.	O
STAT	O

Admission	O
Date	O
:	O

2013-08-24	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-08-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1987-09-08	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Trauma	O
Surgery	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
25	O
-	O
year-old	O
gentleman	O
who	O
is	O
status	O
post	O
a	O
motor	O
vehicle	O
accident	O
in	O
which	O
he	O
was	O
the	O
unrestrained	O
driver	O
and	O
struck	O
a	O
telephone	O
pole	O
.	O

He	O
was	O
ejected	O
from	O
the	O
car	O
and	O
landed	O
on	O
his	O
face	O
.	O

Extreme	O
damage	O
was	O
reported	O
to	O
the	O
vehicle	O
by	O
first	O
responders	O
.	O

It	O
was	O
presumed	O
high-speed	O
motor	O
vehicle	O
collision	O
.	O

The	O
patient	O
was	O
CMED-flighted	O
to	O
Quincy	O
Medical	O
Center	O
,	O
and	O
he	O
was	O
intubated	O
upon	O
arrival	O
in	O
the	O
Emergency	O
Department	O
.	O

After	O
initial	B-test
trauma	I-test
assessment	I-test
and	O
initiation	O
of	O
resuscitation	B-treatment
,	O
a	B-test
CT	I-test
scan	I-test
was	O
performed	O
.	O

Images	B-test
of	I-test
his	I-test
head	I-test
,	I-test
abdomen	I-test
,	I-test
and	I-test
thorax	I-test
were	O
obtained	O
.	O

His	B-problem
injuries	I-problem
included	O
bilateral	B-problem
zygomal	I-problem
and	I-problem
orbital	I-problem
rim	I-problem
fractures	I-problem
,	O
a	B-problem
right	I-problem
temporal	I-problem
fracture	I-problem
,	O
bilateral	B-problem
frontal	I-problem
contusions	I-problem
,	O
and	O
a	B-problem
right	I-problem
temporal	I-problem
epidural	I-problem
versus	O
subdural	B-problem
hematoma	I-problem
.	O

The	O
anterior	O
and	O
posterior	O
of	O
the	O
frontal	O
sinus	O
was	O
fractured	B-problem
with	O
communication	B-problem
with	I-problem
the	I-problem
ethmoid	I-problem
air	I-problem
cells	I-problem
,	O
presumably	O
caused	O
air	B-problem
in	I-problem
the	I-problem
orbit	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Denies	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Denies	O
.	O

SOCIAL	O
HISTORY	O
:	O

Denies	O
.	O

ALLERGIES	O
:	O

Denies	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Denies	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Initial	B-test
examination	I-test
revealed	O
the	O
patient	O
had	O
a	B-test
heart	I-test
rate	I-test
in	O
the	O
80s	O
,	O
with	O
a	B-test
blood	I-test
pressure	I-test
of	O
150/80s	O
.	O

He	O
was	O
intubated	B-treatment
with	O
multiple	B-problem
abrasions	I-problem
,	O
and	O
severe	B-problem
swelling	I-problem
and	O
contusions	B-problem
of	I-problem
his	I-problem
face	I-problem
.	O

He	O
was	O
not	O
following	O
commands	O
.	O

His	B-test
Boston	I-test
Coma	I-test
Scale	I-test
was	O
16	O
.	O

His	O
pupils	O
were	O
reactive	O
on	O
the	O
right	O
going	O
from	O
3	O
mm	O
to	O
2	O
mm	O
of	O
light	O
.	O

The	B-test
response	I-test
was	O
brisk	O
.	O

On	O
the	O
left	O
,	O
his	O
pupils	O
went	O
from	O
2.5	O
mm	O
to	O
2	O
mm	O
,	O
also	O
brisk	O
.	O

Initial	B-test
evaluation	I-test
revealed	O
corticate	B-problem
posturing	I-problem
was	O
noted	O
by	O
the	O
trauma	O
team	O
.	O

He	O
withdrew	O
equally	O
and	O
purposefully	O
after	O
20	O
minutes	O
in	O
the	O
trauma	O
bay	O
.	O

He	O
withdrew	O
to	O
noxious	B-test
stimuli	I-test
equally	O
and	O
purposefully	O
after	O
20	O
minutes	O
in	O
the	O
trauma	O
bay	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

1.	O
NEUROLOGY	O
:	O

Mr.	O
Roach	O
was	O
transported	O
to	O
Intensive	O
Care	O
Unit	O
from	O
the	O
trauma	O
bay	O
.	O

Upon	O
arrival	O
,	O
Neurosurgery	O
promptly	O
placed	O
V.	B-treatment
Holtzen	I-treatment
bolt	I-treatment
.	O

This	O
allowed	O
continuous	B-test
monitoring	I-test
of	I-test
intracranial	I-test
pressure	I-test
.	O

Notably	O
,	O
intracranial	B-test
pressure	I-test
was	O
17	O
when	O
the	B-treatment
bolt	I-treatment
was	O
placed	O
.	O

During	O
his	O
hospitalization	O
,	O
his	B-test
intracranial	I-test
pressure	I-test
was	O
monitored	O
very	O
closely	O
and	O
maintained	O
to	O
a	O
level	O
of	O
less	O
than	O
20	O
.	O

To	O
do	O
this	O
,	O
mannitol	B-treatment
25	O
mg	O
q.	O
6h.	O
was	O
used	O
.	O

While	O
using	O
mannitol	B-treatment
,	O
his	B-test
serum	I-test
osmolalities	I-test
were	O
followed	O
closely	O
.	O

In	O
addition	O
,	O
to	O
monitoring	O
his	B-test
intracranial	I-test
pressure	I-test
,	O
his	B-test
systemic	I-test
blood	I-test
pressures	I-test
were	O
maintained	O
in	O
such	O
a	O
manner	O
that	O
his	B-test
cerebral	I-test
perfusion	I-test
pressure	I-test
was	O
maintained	O
at	O
70	O
mmHg	O
.	O

A	B-test
parameter	I-test
monitor	I-test
for	O
his	O
neurologic	O
status	O
PaCO2	B-test
which	O
was	O
maintained	O
between	O
35	O
and	O
40	O
during	O
his	O
hospitalization	O
.	O

Mr.	O
Roach	O
was	O
kept	O
sedated	B-treatment
with	O
propofol	B-treatment
and	O
was	O
given	O
Fentanyl	B-treatment
and	O
/	O
or	O
morphine	B-treatment
boluses	I-treatment
for	O
pain	B-problem
.	O

Neurologic	B-test
checks	I-test
were	O
followed	O
initially	O
every	O
one	O
hour	O
and	O
then	O
every	O
two	O
hours	O
to	O
monitor	O
for	O
change	B-problem
in	I-problem
neurologic	I-problem
examination	I-problem
.	O

During	O
his	O
hospitalization	O
,	O
two	O
subsequent	O
CAT	B-test
scans	I-test
were	O
obtained	O
;	O
one	O
on	O
hospital	O
day	O
two	O
.	O

This	B-test
CAT	I-test
scan	I-test
revealed	O
possible	O
worsening	O
and	O
was	O
read	O
as	O
epidural	B-problem
versus	O
subdural	B-problem
bleed	I-problem
.	O

After	O
a	O
discussion	O
with	O
both	O
Radiology	O
and	O
Neurosurgery	O
,	O
the	O
decision	O
was	O
made	O
that	O
the	O
worsening	O
did	O
not	O
appear	O
significant	O
,	O
and	O
this	O
was	O
not	O
accompanied	O
by	O
a	B-problem
change	I-problem
in	I-problem
his	I-problem
clinical	I-problem
condition	I-problem
.	O

His	B-test
intracranial	I-test
pressure	I-test
remained	O
stable	O
,	O
and	O
his	B-test
clinical	I-test
examination	I-test
was	O
unchanged	O
.	O

An	B-test
additional	I-test
CT	I-test
scan	I-test
was	O
obtained	O
on	O
hospital	O
day	O
three	O
.	O

This	B-test
examination	I-test
was	O
unchanged	O
from	O
the	B-test
previous	I-test
examination	I-test
.	O

Again	O
,	O
his	B-test
intracranial	I-test
pressure	I-test
and	O
neurologic	B-test
examination	I-test
remained	O
the	O
same	O
,	O
and	O
conservative	B-treatment
treatment	I-treatment
was	O
opted	O
for	O
.	O

2.	O
CARDIOVASCULAR	O
:	O

As	O
described	O
in	O
previous	O
section	O
,	O
Neo-Synephrine	B-treatment
and	O
eventually	O
Levophed	B-treatment
were	O
used	O
to	O
maintain	O
a	B-test
coronary	I-test
perfusion	I-test
pressure	I-test
of	O
greater	O
than	O
70	O
.	O

A	B-treatment
pulmonary	I-treatment
artery	I-treatment
catheter	I-treatment
was	O
placed	O
on	O
hospital	O
day	O
four	O
.	O

This	B-treatment
catheter	I-treatment
was	O
placed	O
when	O
the	O
patient	O
started	O
to	O
demonstrate	O
septic	B-problem
physiology	I-problem
and	O
for	O
increasing	O
pressor	B-treatment
support	I-treatment
.	O

Please	O
see	O
Infectious	O
Disease	O
section	O
for	O
more	O
details	O
.	O

3.	O
GASTROINTESTINAL	O
:	O

Mr.	O
Roach	O
was	O
n.p.o.	B-treatment
from	O
the	O
time	O
of	O
his	O
admission	O
.	O

A	B-treatment
orogastric	I-treatment
tube	I-treatment
was	O
passed	O
.	O

Initially	O
during	O
admission	O
,	O
carafate	B-treatment
was	O
given	O
down	O
the	B-treatment
orogastric	I-treatment
tube	I-treatment
.	O

However	O
,	O
on	O
a	B-test
routine	I-test
chest	I-test
x-ray	I-test
shot	O
on	O
hospital	O
day	O
three	O
,	O
a	B-problem
mediastinum	I-problem
was	O
noted	O
.	O

This	O
raised	O
the	O
question	O
of	O
potential	O
esophageal	B-problem
rupture	I-problem
.	O

Gastroenterology	O
was	O
consulted	O
for	O
this	O
.	O

Gastroenterology	O
was	O
consulted	O
to	O
assist	O
in	O
creating	O
the	O
most	O
appropriate	O
diagnostic	O
rhythm	O
given	O
his	O
intubated	O
and	O
sedated	O
status	O
.	O

At	O
this	O
point	O
,	O
his	B-treatment
carafate	I-treatment
was	O
switched	O
to	O
intravenous	B-treatment
Protonix	I-treatment
and	O
he	O
was	O
strictly	B-treatment
n.p.o.	I-treatment

4.	O
HEMATOLOGY	O
:	O

Throughout	O
Mr.	O
Richard	O
admission	O
,	O
his	B-test
hematocrit	I-test
remained	O
stable	O
in	O
the	O
low	O
30s	O
.	O

As	O
will	O
be	O
discussed	O
in	O
the	O
Infectious	O
Disease	O
section	O
,	O
he	O
developed	O
an	O
episode	O
of	O
what	O
appeared	O
to	O
be	O
sepsis	B-problem
,	O
and	O
his	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
peaked	O
at	O
23	O
.	O

Mr.	O
Roach	O
was	O
on	O
Pneumo	B-treatment
boots	I-treatment
spontaneous	I-treatment
compression	I-treatment
devices	I-treatment
for	O
deep	B-treatment
venous	I-treatment
thrombosis	I-treatment
prophylaxis	I-treatment
.	O

He	O
was	O
not	O
a	O
candidate	O
for	O
subcutaneous	B-treatment
heparin	I-treatment
as	O
we	O
were	O
concerned	O
of	O
an	B-problem
intracranial	I-problem
hemorrhage	I-problem
.	O

An	B-treatment
inferior	I-treatment
vena	I-treatment
cava	I-treatment
filter	I-treatment
was	O
considered	O
but	O
was	O
deferred	O
,	O
as	O
it	O
was	O
felt	O
that	O
Mr.	O
Roach	O
was	O
too	B-problem
unstable	I-problem
to	O
undergo	O
the	B-treatment
procedure	I-treatment
.	O

5.	O
ENDOCRINE	O
:	O

Mr.	O
Marian	O
blood	B-test
sugar	I-test
was	O
maintained	O
under	O
tight	O
control	O
from	O
100	O
to	O
130	O
using	O
a	B-treatment
regular	I-treatment
insulin	I-treatment
sliding-scale	I-treatment
.	O

6.	O
INFECTIOUS	O
DISEASE	O
:	O

Mr.	O
Roach	O
had	O
a	B-problem
spike	I-problem
in	I-problem
white	I-problem
blood	I-problem
cell	I-problem
count	I-problem
and	O
developed	O
fevers	B-problem
.	O

His	O
blood	O
urine	O
and	O
sputum	O
were	O
all	O
cultured	O
.	O

Blood	B-test
cultures	I-test
were	O
pertinent	O
for	O
one	O
bottle	O
of	O
gram	B-problem
-	I-problem
positive	I-problem
coagulase	I-problem
-	I-problem
negative	I-problem
Staphylococcus	I-problem
which	O
grew	O
from	O
08-25	O
.	O

His	B-test
preliminary	I-test
cultures	I-test
including	O
sputum	O
from	O
08-25	O
grew	O
Escherichia	B-problem
coli	I-problem
.	O

Sputum	B-test
from	O
08-27	O
grew	O
gram-negative	B-problem
rods	I-problem
,	O
not	O
yet	O
speciated	O
,	O
and	O
from	O
08-27	O
a	B-test
bronchoalveolar	I-test
lavage	I-test
grew	O
1+	B-problem
gram-negative	I-problem
rods	I-problem
and	O
4+	B-problem
polymorphonuclear	I-problem
lymphocytes	I-problem
.	O

Throughout	O
this	O
time	O
,	O
Mr.	O
Richard	O
temperature	B-test
continued	O
to	O
increase	O
and	O
was	O
such	O
that	O
on	O
hospital	O
day	O
four	O
,	O
his	B-test
temperature	I-test
maximum	I-test
was	O
42.2	O
degrees	O
centigrade	O
.	O

During	O
his	O
hospitalization	O
,	O
his	O
was	O
treated	O
with	O
vancomycin	B-treatment
for	O
his	B-problem
gram-negative	I-problem
rods	I-problem
,	O
imipenem	B-treatment
,	O
and	O
Flagyl	B-treatment
.	O

Initially	O
,	O
he	O
had	O
been	O
placed	O
on	O
clindamycin	B-treatment
to	O
cover	O
his	B-treatment
drain	I-treatment
,	O
but	O
his	B-test
cultures	I-test
became	O
positive	B-problem
,	O
and	O
his	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
increased	O
.	O

He	O
was	O
switched	O
from	O
clindamycin	B-treatment
to	O
the	B-treatment
imipenem	I-treatment
and	O
Flagyl	B-treatment
.	O

Vancomycin	B-treatment
was	O
added	O
when	O
we	O
had	O
the	B-problem
positive	I-problem
blood	I-problem
culture	I-problem
.	O

With	O
a	B-problem
fever	I-problem
of	O
102	O
,	O
up	O
to	O
42	O
degrees	O
centigrade	O
,	O
aggressive	B-treatment
measures	I-treatment
including	O
cooling	B-treatment
blankets	I-treatment
,	O
alcohol	B-treatment
swabs	I-treatment
,	O
and	O
fans	B-treatment
were	O
used	O
in	O
an	O
attempt	O
to	O
bring	O
his	B-test
body	I-test
temperature	I-test
down	O
.	O

Hypercarbia	B-problem
would	O
result	O
and	O
increase	O
in	O
cerebral	O
perfusion	O
,	O
paralysis	B-treatment
was	O
initiated	O
to	O
decrease	O
genesis	O
of	O
carbon	O
dioxide	O
secreted	O
during	O
shivering	B-problem
.	O

7.	O
PULMONARY	O
:	O

As	O
discussed	O
in	O
the	O
Infectious	O
Disease	O
section	O
,	O
Mr.	O
Roach	O
developed	O
a	B-problem
pneumonia	I-problem
likely	O
from	O
gram-negative	B-problem
organisms	I-problem
,	O
but	O
most	O
likely	O
from	O
Escherichia	B-problem
coli	I-problem
.	O

For	O
this	B-problem
pneumonia	I-problem
,	O
he	O
was	O
placed	O
empirically	O
on	O
imipenem	B-treatment
,	O
vancomycin	B-treatment
,	O
and	O
Flagyl	B-treatment
.	O

On	O
hospital	O
day	O
three	O
,	O
Mr.	O
Roach	O
had	O
developed	O
an	O
episode	O
of	O
tachycardia	B-problem
and	O
tachypnea	B-problem
.	O

For	O
this	O
,	O
a	B-test
CT	I-test
angiogram	I-test
was	O
obtained	O
which	O
demonstrated	O
no	O
pulmonary	B-problem
embolism	I-problem
.	O

On	O
hospital	O
day	O
four	O
,	O
a	B-test
routine	I-test
chest	I-test
x-ray	I-test
revealed	O
a	B-problem
left-sided	I-problem
pneumothorax	I-problem
.	O

For	O
this	O
,	O
a	B-treatment
left	I-treatment
#34	I-treatment
Caucasian	I-treatment
chest	I-treatment
tube	I-treatment
was	O
placed	O
.	O

On	O
the	O
evening	O
of	O
hospital	O
day	O
four	O
,	O
Mr.	O
Roach	O
had	O
an	B-problem
acute	I-problem
episode	I-problem
whereby	O
his	B-test
central	I-test
venous	I-test
pressure	I-test
rose	O
sharply	O
and	O
immediately	O
followed	O
by	O
a	O
period	O
of	O
asystole	B-problem
.	O

Urgent	B-treatment
resuscitation	I-treatment
measures	I-treatment
were	O
initiated	O
.	O

The	B-treatment
measures	I-treatment
included	O
attempts	O
at	O
pacing	B-treatment
.	O

Epinephrine	B-treatment
and	O
atropine	B-treatment
were	O
administered	O
as	O
were	O
bicarbonate	B-treatment
and	O
calcium	B-treatment
.	O

He	O
had	O
a	O
differential	O
diagnosis	O
of	O
asystole	B-problem
preceded	O
by	O
an	B-problem
acute	I-problem
rise	I-problem
in	I-problem
central	I-problem
venous	I-problem
pressure	I-problem
included	O
attention	B-problem
pneumothorax	I-problem
,	O
cardiac	B-problem
tamponade	I-problem
,	O
and	O
pulmonary	B-problem
embolism	I-problem
.	O

During	O
the	B-treatment
resuscitation	I-treatment
afterwards	O
,	O
it	O
was	O
noted	O
that	O
a	B-treatment
patent	I-treatment
left	I-treatment
chest	I-treatment
tube	I-treatment
was	O
present	O
in	O
the	O
left	O
chest	O
,	O
so	O
initially	O
neo-decompression	B-treatment
was	O
attempted	O
in	O
the	O
right	O
chest	O
.	O

There	O
was	O
no	O
sign	O
of	O
attention	B-problem
pneumothorax	I-problem
with	O
decompression	B-treatment
,	O
and	O
a	B-treatment
right	I-treatment
chest	I-treatment
tube	I-treatment
was	O
placed	O
.	O

During	O
this	O
time	O
,	O
a	B-test
needle	I-test
aspiration	I-test
of	O
what	O
was	O
felt	O
to	O
be	O
the	O
pericardium	O
was	O
performed	O
revealing	O
bloody	B-problem
fluid	I-problem
coming	O
back	O
.	O

A	B-treatment
left	I-treatment
anterior	I-treatment
thoracotomy	I-treatment
was	O
made	O
by	O
the	O
Cardiac	O
Surgery	O
fellow	O
who	O
was	O
present	O
.	O

After	O
30	O
minutes	O
of	O
active	B-treatment
resuscitation	I-treatment
including	O
internal	B-treatment
cardiac	I-treatment
massage	I-treatment
,	O
there	O
was	O
no	O
evidence	O
of	O
return	O
of	O
vital	B-test
signs	I-test
or	O
electric	B-test
activity	I-test
to	I-test
the	I-test
heart	I-test
as	O
noted	O
on	O
electrocardiogram	B-test
monitors	I-test
.	O

Resuscitation	B-treatment
was	O
terminated	O
at	O
1914	O
on	O
08-27	O
.	O

After	O
the	O
termination	O
of	O
resuscitation	B-treatment
,	O
both	O
the	O
anesthesia	O
Intensive	O
Care	O
Unit	O
attending	O
and	O
the	O
surgical	O
attending	O
were	O
present	O
to	O
discuss	O
the	O
proceedings	O
events	O
with	O
the	O
patient	O
's	O
family	O
members	O
including	O
his	O
next	O
of	O
kin	O
,	O
his	O
mother	O
.	O

Permission	O
for	O
a	B-test
postmortem	I-test
examination	I-test
was	O
granted	O
.	O

Matthew	O
M.	O
Barnett	O
,	O
M.D.	O
78-102	O

Dictated	O
By	O
:	O
Mark	O
D.	O
Eng	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-08-28	O
00:21	O

T	O
:	O
2013-09-03	O
11:11	O

JOB	O
#	O
:	O
24887	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Katherin	O
Toth	O
on	O
:	O
MON	O
2013-10-14	O
3:05	O
PM	O

(	O
End	O
of	O
Report	O
)	O

300423900	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

7191549	O
PAD-WORD	O

32395/a42u	O
PAD-WORD	O

265407	O
PAD-WORD	O

12/4/1995	O
12:00:00	O
AM	O

MAINTENANCE	B-treatment
CHEMOTHERAPY	I-treatment
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12/4/95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

12/8/95	O
PAD-WORD	O

His	O
date	O
of	O
birth	O
is	O
11/7/32	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

maintenance	B-treatment
chemotherapy	I-treatment
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

malignant	B-problem
fibrous	I-problem
histiocytoma	I-problem
of	I-problem
duodenum	I-problem
,	O
metastases	B-problem
to	I-problem
liver	I-problem
,	O
anemia	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

intravenous	B-treatment
chemotherapy	I-treatment
12/4/95	O
through	O
12/8/95	O
.	O

DISCHARGE	O
ORDERS	O
:	O

Ativan	B-treatment
1	O
mg	O
or	O
Trilafon	B-treatment
4	O
mg	O
q	O
4	O
hours	O
prn	O
nausea	B-problem
,	O
Carafate	B-treatment
one	O
gram	O
q.i.d.	O

PRESENT	O
ILLNESS	O
:	O

This	O
63-year-old	O
man	O
had	O
a	B-problem
mass	I-problem
in	I-problem
the	I-problem
duodenum	I-problem
,	O
discovered	O
in	O
02/95	O
.	O

A	B-problem
leiomyosarcoma	I-problem
was	O
resected	B-treatment
after	O
embolization	B-treatment
of	I-treatment
the	I-treatment
splenic	I-treatment
artery	I-treatment
.	O

However	O
,	O
it	O
could	O
not	O
be	O
completely	O
excised	O
,	O
moreover	O
the	B-problem
tumor	I-problem
metastasized	O
to	O
the	O
liver	O
was	O
discovered	O
on	O
follow	B-test
up	I-test
scan	I-test
in	O
06/95	O
.	O

He	O
has	O
been	O
receiving	O
chemotherapy	B-treatment
since	O
then	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
generally	O
looks	O
well	O
.	O

Vital	B-test
signs	I-test
are	O
normal	O
.	O

The	O
skin	O
is	O
intact	O
.	O

His	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
throat	O
is	O
clear	O
.	O

The	O
neck	O
is	O
without	O
adenopathy	B-problem
.	O

Chest	O
clear	O
.	O

Heart	O
without	O
gallop	B-problem
.	O

Abdomen	O
without	O
mass	B-problem
.	O

Extremities	O
without	O
edema	B-problem
.	O

Neurological	B-test
examination	I-test
intact	O
.	O

LABORATORY	O
EXAMINATION	O
:	O

hematocrit	B-test
33	O
,	O
white	B-test
count	I-test
4.4	O
,	O
with	O
28%	O
monos	B-test
and	O
30%	O
polys	B-test
and	O
bands	B-test
.	O

Platelets	B-test
253	O
thousand	O
.	O

Creatinine	B-test
0.6	O
,	O
SGOT	B-test
52	O
,	O
bilirubin	B-test
0.5	O
.	O

COURSE	O
IN	O
HOSPITAL	O
:	O

The	O
patient	O
was	O
hydrated	O
well	O
and	O
given	O
Adriamycin	B-treatment
27	O
mg	O
and	O
DTIC	B-treatment
450	O
mg	O
daily	O
for	O
four	O
days	O
.	O

He	O
also	O
got	O
ifosfamide	B-treatment
3.6	O
grams	O
a	O
day	O
with	O
mesna	B-treatment
.	O

He	O
tolerated	O
treatment	B-treatment
well	O
and	O
was	O
discharged	O
in	O
good	O
condition	O
.	O

FOLLOWUP	O
:	O

by	O
private	O
physician	O
.	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O

TR	O
:	O

by	O
/	O
bmot	O

DD	O
:	O

12/10/95	O
PAD-WORD	O

TD	O
:	O

12/13/95	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2019-10-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-10-19	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1994-01-10	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

ORTHOPAEDICS	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
George	O
G	O
Lindsey	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
s/p	O
fall	O
with	O
Left	B-problem
arm	I-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2019-10-11	O
:	O

ORIF	B-treatment
Left	B-problem
distal	I-problem
radius	I-problem
fracture	I-problem

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Steadman	O
is	O
a	O
25	O
year	O
old	O
man	O
who	O
was	O
locked	O
out	O
of	O
his	O
apartment	O
and	O
tried	O
to	O
enter	O
by	O
climbing	O
up	O
two	O
stories	O
to	O
get	O
in	O
by	O
a	O
window	O
.	O

He	O
fell	O
15-20	O
feet	O
onto	O
concrete	O
,	O
denies	O
any	O
loss	B-problem
of	I-problem
consiousness	I-problem
.	O

Past	O
Medical	O
History	O
:	O
denies	O

Social	O
History	O
:	O

+ETOH	O
,	O
had	O
12	O
cans	O
of	O
beer	O
prior	O
to	O
accident	O

Family	O
History	O
:	O
n/a	O

Physical	O
Exam	O
:	O

Upon	O
admission	O
:	O

Alert	O
and	O
oriented	O

Cardiac	O
:	O

Tachycardiac	B-problem
120-140	O
,	O
regular	O

Chest	O
:	O

Clear	O
to	O
auscultation	B-test

Abdomen	O
:	O

Soft	O
non-tender	B-problem
non-distended	B-problem

Extremities	O
:	O

Left	B-problem
elbow	I-problem
,	I-problem
gross	I-problem
deformity	I-problem
swelling	I-problem
over	I-problem
dorsal	I-problem
forearm	I-problem
,	O
gross	B-problem
deformity	I-problem
left	I-problem
wrist	I-problem
,	O
no	O
skin	B-problem
lacerations	I-problem
.	O

SILT	O
PAD-WORD	O

R/U/M	O
LUE	O

Bilateral	O
lower	O
extremities	O
:	O

+	O
sensation	O
,	O
movment	O
,	O
pulses	O
,	O
some	B-problem
pain	I-problem
with	O
ROM	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Steadman	O
is	O
a	O
25	O
year	O
old	O
man	O
who	O
presented	O
to	O
the	O
The	O
Hospital	O
for	O
Orthopedics	O
on	O

2019-10-10	O
via	O
ambulance	O
after	O
falling	O
15-20	O
feet	O
onto	O
concrete	O
.	O

He	O
was	O
evaluated	O
by	O
the	O
trauma	O
surgery	O
department	O
and	O
the	O
orthopaedic	O
surgery	O
department	O
.	O

He	O
was	O
intoxicated	O
and	O
tachycardic	B-problem
in	O
the	O
trauma	O
bay	O
.	O

His	B-problem
injuries	I-problem
were	O
identified	O
as	O
a	B-problem
left	I-problem
elbow	I-problem
disloaction	I-problem
with	O
was	O
reduced	O
and	O
splinted	O
.	O

Also	O
a	B-problem
left	I-problem
distal	I-problem
radius	I-problem
fracture	I-problem
with	O
was	O
reduced	O
and	O
splinted	O
.	O

Also	O
a	B-problem
Left	I-problem
non	I-problem
displaced	I-problem
sacral	I-problem
wing	I-problem
fracture	I-problem
and	O
left	B-problem
inferior	I-problem
pubic	I-problem
ramus	I-problem
fx	I-problem
extending	O
the	O
to	O
inferior	O
acetabulum	O
.	O

He	O
was	O
admitted	O
to	O
the	O
trauma	O
intensive	O
care	O
unit	O
due	O
to	O
his	B-problem
tachycardia	I-problem
which	O
was	O
not	O
resolved	O
with	O
pain	B-treatment
medication	I-treatment
.	O

On	O
2019-10-11	O
he	O
was	O
started	O
on	O
lopressor	B-treatment
for	O
his	B-problem
tachycardia	I-problem
which	O
had	O
good	O
effect	O
.	O

He	O
was	O
then	O
transfered	O
to	O
the	O
floor	O
in	O
the	O
care	O
of	O
the	O
orthopaedic	O
surgery	O
service	O
.	O

Also	O
on	O
2019-10-11	O
he	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
an	B-treatment
ORIF	I-treatment
of	O
his	B-problem
left	I-problem
distal	I-problem
radius	I-problem
fracture	I-problem
.	O

His	B-problem
pelvis	I-problem
fracture	I-problem
are	O
closed	O
treated	O
and	O
he	O
can	O
be	O
weight	O
bearing	O
as	O
tolerated	O
on	O
his	O
right	O
leg	O
and	O
and	O
nonweight	O
bearing	O
on	O
his	O
left	O
leg	O
.	O

He	O
tolerated	O
the	B-treatment
procedure	I-treatment
without	O
difficulty	B-problem
.	O

He	O
begain	O
to	O
work	O
with	O
physical	O
therapy	O
to	O
improve	O
his	O
strenght	O
and	O
mobility	O
.	O

His	B-test
heart	I-test
rate	I-test
continued	O
to	O
be	O
well	O
controlled	O
with	O
his	B-treatment
lopressor	I-treatment
.	O

Throught	O
the	O
stay	O
his	B-test
labs	I-test
remained	O
normal	O
and	O
his	B-problem
pain	I-problem
controlled	O
.	O

He	O
was	O
discharged	O
home	O
in	O
stable	O
conditions	O
.	O

He	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
Dr.	O
Conway	O
in	O
2	O
weeks	O
and	O
an	O
appointment	O
was	O
made	O
on	O
11-15	O
for	O
him	O
at	O
the	O
Louis	O
Schubert	O
Community	O
Health	O
Center	O
to	O
follow	O
his	B-test
heart	I-test
rate	I-test
and	O
continued	O
need	O
for	O
lopressor	B-treatment
.	O

Medications	O
on	O
Admission	O
:	O
none	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Enoxaparin	B-treatment
30	O
mg	O
/	O
0.3	O
mL	O
Syringe	O
Sig	O
:	O
One	O
(	O
1	O
)	O
30	O
mg	O
syringe	O
Subcutaneous	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
4	O
weeks	O
.	O

Disp	O
:*	O
56	O
30	O
mg	O
syringe	O
*	O
Refills	O
:*	O
0	O
*	O

3.	O
Oxycodone	B-treatment
-	O
Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
90	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O
s/p	O
fall	O
from	O
15-20	O
feet	O

Discharge	O
Condition	O
:	O

Stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Continue	O
to	O
be	O
non-weight	O
bearing	O
on	O
your	O
left	O
leg	O

Continue	O
to	O
wear	O
your	B-treatment
left	I-treatment
arm	I-treatment
splint	I-treatment
,	O
but	O
take	O
it	O
off	O
daily	O
to	O
inspect	O
your	O
skin	O

Continue	O
your	B-treatment
Lovenox	I-treatment
injections	I-treatment
as	O
instructed	O

If	O
you	O
notice	O
any	O
increase	B-problem
in	I-problem
swelling	I-problem
or	O
erythemia	B-problem
at	O
the	B-problem
incisions	I-problem
,	O
or	O
if	O
you	O
become	O
short	B-problem
of	I-problem
breath	I-problem
or	O
if	O
you	O
have	O
a	B-test
temperature	I-test
greater	O
than	O
101.4	O
please	O
call	O
the	O
office	O
or	O
go	O
to	O
the	O
emergency	O
room	O

Physical	O
Therapy	O
:	O

Activity	O
:	O

Activity	O
as	O
tolerated	O

Left	O
upper	O
extremity	O
:	O

Non	O
weight	O
bearing	O

Non-weight	O
bearing	O
left	O
leg	O

Treatments	O
Frequency	O
:	O
splint	B-treatment
to	I-treatment
left	I-treatment
arm	I-treatment

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Bergeron	O
in	O
clinic	O
in	O
2	O
weeks	O
,	O
please	O
call	O
953	O
6923	O
to	O
Posada	O
that	O
appointment	O
.	O

An	O
appointment	O
has	O
been	O
made	O
for	O
you	O
with	O
Nurse	O
Daniel	O
Crump	O
at	O
the	O
Loretta	O
Schubert	O
Community	O
Health	O
Center	O
on	O
Friday	O
Novemeber	O
24	O
at	O
2pm	O
.	O

It	O
is	O
located	O
at	O
2249	O
S.	O
Lincoln	O
Ave.	O
in	O
Nantucket	O
Cottage	O
Hospital	O
the	O
phone	O
to	O
the	O
clinic	O
is	O
(	O
451	O
)	O
376-3200	O
.	O

They	O
will	O
monitor	O
your	B-test
blood	I-test
pressure	I-test
and	O
heart	B-test
rate	I-test
and	O
lopressor	B-treatment
.	O

Gregory	O
Robert	O
MD	O
06-807	O

Completed	O
by	O
:	O
Genevieve	O
Gehlert	O
PA	O
80-BZQ	O
2019-10-19	O
@	O
1248	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ron	O
Scott	O
on	O
:	O
WED	O
2019-11-27	O
7:42	O
AM	O

(	O
End	O
of	O
Report	O
)	O

303694252	O
EH	O

14027692	O
PAD-WORD	O

097370	O
PAD-WORD	O

08/05/2001	O
12:00:00	O
AM	O

erosive	B-problem
esophagitis	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

08/05/2001	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

08/08/2001	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

RHALTHEAGLE	O
,	O
LEELO	O
506-20-55-6	O
K40	O

Room	O
:	O

89N-803	O
PAD-WORD	O

Service	O
:	O

MED	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

08/08/01	O
AT	O
04:00	O
PM	O

CONTINGENT	O
UPON	O

SNF	O
/	O
rehab	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

GRENDZISKLEEB	O
,	O
FACISA	O
TIELO	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

No	O
CPR	B-treatment
/	O
No	O
defib	B-treatment
/	O

DISPOSITION	O
:	O

No-	O
Ter	O
Chipold	O
Medical	O
Center	O

DISCHARGE	O
MEDICATIONS	O
:	O

ROBITUSSIN	B-treatment
(	I-treatment
GUAIFENESIN	I-treatment
)	I-treatment
10	O
MILLILITERS	O
PO	O
Q4H	O
PRN	O
cough	B-problem
FLAGYL	B-treatment
(	I-treatment
METRONIDAZOLE	I-treatment
)	I-treatment
500	O
MG	O
PO	O
TID	O
X	O
5	O
Days	O
Starting	O
Today	O
(	O
08/08	O
)	O
NITROGLYCERIN	B-treatment
1/150	O
(	O
0.4	O
MG	O
)	O
1	O
TAB	O
SL	O
q5min	O
x	O
3	O
PRN	O
chest	B-problem
pain	I-problem

HOLD	O
IF	O
:	O

SBP	B-test
&lt;	O
100	O
AMBIEN	B-treatment
(	I-treatment
ZOLPIDEM	I-treatment
TARTRATE	I-treatment
)	I-treatment
5	O
MG	O
PO	O
QHS	O
PRN	O
insomnia	B-problem

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

5	B-treatment
LEVOFLOXACIN	I-treatment
250	O
MG	O
PO	O
QD	O
X	O
5	O
Days	O
Starting	O
Today	O
(	O
08/08	O
)	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
08/08/01	O
by	O
:	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

HALOPERIDOL	B-treatment
and	O
LEVOFLOXACIN	B-treatment

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

HALOPERIDOL	B-treatment
and	O
LEVOFLOXACIN	B-treatment

Reason	O
for	O
override	O
:	O

aware	O
PAD-WORD	O

Previous	O
Override	O
Notice	O

Override	O
added	O
on	O
08/07/01	O
by	O
ZISKFUSCJALK	O
,	O
ACRI	O
,	O
M.D.	O
on	O
order	O
for	O
HALDOL	B-treatment
IM	I-treatment
(	O
ref	O
#	O
09647807	O
)	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

LEVOFLOXACIN	B-treatment
and	O
HALOPERIDOL	B-treatment

Reason	O
for	O
override	O
:	O

awre	O
PAD-WORD	O

Previous	O
override	O
information	O
:	O

Override	O
added	O
on	O
08/07/01	O
by	O
ZISKFUSCJALK	O
,	O
ACRI	O
,	O
M.D.	O
on	O
order	O
for	O
HALDOL	B-treatment
PO	I-treatment
(	O
ref	O
#	O
60739147	O
)	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

LEVOFLOXACIN	B-treatment
and	O
HALOPERIDOL	B-treatment

Reason	O
for	O
override	O
:	O

aware	O
PAD-WORD	O

OMEPRAZOLE	B-treatment
40	O
MG	O
PO	O
BID	O
X	O
45	O
Days	O
ATENOLOL	B-treatment
25	O
MG	O
PO	O
BID	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

RETURN	O
TO	O
WORK	O
:	O

Not	O
Applicable	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Scaher	O
Grend	O
,	O
RAMMCO	O
8/20	O
,	O
3:30pm	O
scheduled	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

hematemesis	B-problem
PAD-WORD	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
erosive	B-problem
esophagitis	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
right	B-problem
scrotal	I-problem
hydrocele	I-problem
bph	B-problem
(	I-problem
benign	I-problem
prostatic	I-problem
hypertrophy	I-problem
)	I-problem
?	O
nph	B-problem
(	O
?	O
hydrocephalus	B-problem
)	O
dementia	B-problem
(	I-problem
dementia	I-problem
)	I-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Esophagogastroduodenoscopy	B-treatment
PAD-WORD	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

86	O
yo	O
male	O
with	O
one	O
day	O
of	O
hematemesis	B-problem
(	O
history	O
unclear	O
)	O
.	O

No	O
known	O
TB	B-problem
or	O
CA	B-problem
history	O
.	O

No	O
SOB	B-problem
,	O
?	O
fever	B-problem
at	O
home	O
.	O

No	O
known	O
dysphagia	B-problem
.	O

Also	O
c	O
/	O
o	O
chest	B-problem
pain	I-problem
,	O
substernal	B-problem
discomfort	I-problem
for	O
past	O
few	O
days	O
.	O

Brought	O
in	O
from	O
assisted	O
living	O
facility	O
.	O

In	O
ED	O
HR	B-test
70	O
,	O
BP	B-test
130/80	O
,	O
O2sat	B-test
96%	O
.	O

Hct	B-test
44	O
.	O

CXR	B-test
notable	O
for	O
RLL	B-problem
infiltrate	I-problem
with	O
old	B-problem
B	I-problem
upper	I-problem
lung	I-problem
field	I-problem
granulomas	I-problem
.	O

Chest	B-test
CT	I-test
notable	O
for	O
esophageal	B-problem
diverticulum	I-problem
and	O
thickened	B-problem
distal	I-problem
1/3	I-problem
of	I-problem
esophagus	I-problem
,	O
suspicious	O
for	O
malignancy	B-problem
.	O

+	O
alveolar	B-problem
opacities	I-problem
c	O
/	O
w	O
alveolar	B-problem
hemorrhage	I-problem
or	O
aspirated	B-problem
blood	I-problem
.	O

Also	O
with	O
multiple	B-problem
cystic	I-problem
hypodensities	I-problem
in	I-problem
liver	I-problem
seen	O
in	O
previous	O
scans	B-test
.	O

1	O
)	O
GI	O
:	O

Throughout	O
admission	O
,	O
hematemesis	B-problem
flow	O
decreased	O
while	O
on	O
PPI	B-treatment
and	O
clear	B-treatment
liquids	I-treatment
.	O

EGD	B-test
08/08/01	O
showed	O
mulitple	B-problem
non-bleeding	I-problem
linear	I-problem
erosions	I-problem
with	O
an	B-problem
irregular	I-problem
circumfrencial	I-problem
ulcer	I-problem
at	I-problem
the	I-problem
GE	I-problem
junction	I-problem
.	O

Tolerated	O
advancement	O
to	O
a	B-treatment
soft	I-treatment
mechanical	I-treatment
diet	I-treatment
well	O
.	O

Started	O
on	O
omeprazole	B-treatment
40	O
mg	O
po	O
bid	O
x6	O
wks	O
.	O

2	O
)	O
CV	O
:	O

CP	B-problem
,	O
low	O
prob	O
with	O
atypical	B-problem
chest	I-problem
pain	I-problem
,	O
CK	B-test
&apos;s	O
x3	O
flat	O
,	O
and	O
no	O
further	O
episodes	O
of	O
CP	B-problem
during	O
the	O
admission	O
.	O

BP	B-test
remained	O
stable	O
throughout	O
the	O
admission	O
;	O
initially	O
,	O
BP	B-treatment
meds	I-treatment
were	O
held	O
,	O
but	O
as	O
VS	B-test
remai	O
ned	O
stable	O
and	O
bleeding	B-problem
subsided	O
,	O
lopressor	B-treatment
was	O
titrated	O
up	O
to	O
25	O
mg	O
po	O
tid	O
.	O

He	O
was	O
switched	O
back	O
to	O
his	O
home	O
dose	O
of	O
atenolol	B-treatment
25	O
mg	O
po	O
bid	O

3	O
)	O
ID	O
:	O

Levo	B-treatment
and	O
flagyl	B-treatment
for	O
presumed	O
aspiration	B-problem
pneumonia	I-problem
/	O
pneuomonitis	B-problem
.	O

4	O
)	O
GU	O
:	O

h	O
/	O
o	O
obstructive	B-problem
uropathy	I-problem
--	O
UOP	B-test
was	O
erratic	O
,	O
but	O
no	O
foley	B-treatment
was	O
needed	O
.	O

Bun	B-test
/	O
Cr	B-test
were	O
stable	O
.	O

5	O
)	O
FEN	O
:	O

Started	O
on	O
clear	B-treatment
liquids	I-treatment
.	O

Once	O
bleed	B-problem
ing	I-problem
stopped	O
,	O
advanced	O
diet	O
to	O
soft-mechanical	B-treatment
.	O

CODE	O
:	O

DNR	B-treatment
,	O
NO	O
CPR	B-treatment
,	O
may	O
intubate	O
for	O
airway	B-treatment
protection	I-treatment
,	O
call	O
son	O
.	O

Disposition	O
Plans	O
:	O

Will	O
follow-up	O
with	O
his	O
PMD	O
;	O
biopsy	O
results	O
to	O
be	O
followed	O
closely	O
.	O

If	O
biopsy	O
results	O
abnormal	B-problem
,	O
will	O
need	O
follow-up	B-test
intra-esophageal	I-test
ultrasound	I-test
by	O
GI	O
service	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

You	O
have	O
been	O
admitted	O
for	O
evaluation	B-test
of	O
an	B-problem
esophageal	I-problem
bleed	I-problem
.	O

You	O
have	O
some	B-problem
erosions	I-problem
in	I-problem
the	I-problem
esophagus	I-problem
which	O
are	O
no	O
longer	O
bleeding	B-problem
.	O

You	O
will	O
need	O
to	O
continue	O
to	O
take	O
special	B-treatment
medications	I-treatment
for	O
these	B-problem
erosions	I-problem
.	O

If	O
you	O
experience	O
further	B-problem
bleeding	I-problem
or	O
increasing	B-problem
discomfort	I-problem
with	O
swallowing	O
,	O
you	O
must	O
tell	O
your	O
nurse	O
and	O
call	O
your	O
doctor	O
right	O
away	O
.	O

Please	O
follow-up	O
the	O
biopsy	O
results	O
with	O
your	O
doctor	O
.	O

You	O
may	O
need	O
to	O
have	O
further	B-test
studies	I-test
at	O
a	O
later	O
date	O
.	O

Continue	O
all	O
your	B-treatment
previous	I-treatment
medications	I-treatment
as	O
directed	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Satisfactory	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

1	O
)	O
Follow-up	O
esophageal	O
biopsy	O
results	O

2	O
)	O
Schedule	O
GI	O
follow-up	O
if	O
biopsy	O
results	O
abnormal	B-problem
or	O
if	O
continued	B-problem
bleeding	I-problem
.	O

3	O
)	O
Consider	O
oncology	O
follow-up	O
if	O
biopsies	B-test
suggestive	O
of	O
malignancy	B-problem

4	O
)	O
Omeprazole	B-treatment
40	O
mg	O
po	O
bid	O
x6	O
wks	O
.	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

ZISKFUSCJALK	O
,	O
ACRI	O
,	O
M.D.	O
(	O
AN36	O
)	O

08/08/01	O
03:06	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2014-03-05	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-04-04	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1942-08-15	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
SURGERY	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
71	O
-	O
year-old	O
gentleman	O
who	O
was	O
admitted	O
to	O
the	O
St.	O
Anne	O
's	O
Hospital	O
as	O
a	O
transfer	O
from	O
the	O
Kindred	O
Park	O
View	O
Specialty	O
Hospital	O
of	O
Springfield	O
.	O

Prior	O
to	O
admission	O
,	O
he	O
had	O
a	O
long	O
and	O
complicated	O
hospital	O
course	O
at	O
the	O
outside	O
hospital	O
.	O

His	O
hospital	O
course	O
began	O
on	O
2014-02-13	O
when	O
he	O
underwent	O
a	B-treatment
right	I-treatment
carotid	I-treatment
endarterectomy	I-treatment
for	O
95%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
carotid	I-problem
artery	I-problem
.	O

His	O
postoperative	O
course	O
was	O
complicated	O
by	O
nonspecific	B-problem
T	I-problem
wave	I-problem
changes	I-problem
consistent	O
with	O
myocardial	B-problem
infarction	I-problem
postoperatively	O
as	O
well	O
as	O
hematoma	B-problem
formation	I-problem
.	O

The	B-problem
hematoma	I-problem
formation	I-problem
was	O
rapidly	O
expanding	O
and	O
he	O
received	O
an	B-treatment
emergent	I-treatment
surgical	I-treatment
airway	I-treatment
in	O
the	O
Intensive	O
Care	O
Unit	O
.	O

This	B-treatment
emergent	I-treatment
cricothyroidotomy	I-treatment
was	O
converted	O
then	O
to	O
a	B-treatment
formal	I-treatment
tracheostomy	I-treatment
.	O

During	O
his	O
subsequent	O
hospital	O
course	O
,	O
he	O
had	O
an	B-problem
additional	I-problem
CHF	I-problem
exacerbation	I-problem
.	O

He	O
was	O
medically	O
managed	O
and	O
eventually	O
his	B-treatment
tracheostomy	I-treatment
was	O
decannulated	O
.	O

However	O
,	O
just	O
prior	O
to	O
admission	O
to	O
Mass.	O
Eye	O
&	O
Ear	O
Infirmary	O
he	O
had	O
another	B-problem
acute	I-problem
decompensation	I-problem
with	O
CHF	B-problem
exacerbation	I-problem
.	O

This	O
necessitated	O
emergent	B-treatment
intubation	I-treatment
.	O

With	O
EKG	B-problem
changes	I-problem
consistent	O
with	O
myocardial	B-problem
infarction	I-problem
,	O
he	O
was	O
transferred	O
to	O
the	O
Mass.	O
Eye	O
&	O
Ear	O
Infirmary	O
for	O
further	O
management	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Diabetes	B-problem
type	I-problem
2	I-problem
treated	O
with	O
oral	B-treatment
medication	I-treatment
.	O

2.	O
Cerebrovascular	B-problem
disease	I-problem
,	O
status	O
post	O
left	B-treatment
carotid	I-treatment
endarterectomy	I-treatment
in	O
2008	O
.	O

3.	O
Status	O
post	O
right	B-problem
cerebrovascular	I-problem
accident	I-problem
in	O
2009	O
with	O
residual	B-problem
left-sided	I-problem
weakness	I-problem
.	O

4.	O
Status	O
post	O
right	B-treatment
carotid	I-treatment
endarterectomy	I-treatment
on	O
2014-02-13	O
.	O

5.	O
Fall	O
from	O
standing	O
on	O
2014-01-29	O
with	O
resultant	O
displaced	B-problem
radial	I-problem
fracture	I-problem
which	O
was	O
reduced	O
,	O
closed	O
,	O
and	O
casted	O
.	O

6.	O
Hypertension	B-problem
.	O

7.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

No	O
history	O
of	O
catheterization	B-test
prior	O
to	O
admission	O
to	O
the	O
Saint	O
Vincent	O
Hospital	O
.	O

8.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
a	B-test
baseline	I-test
creatinine	I-test
of	O
2.0	O
to	O
2.7.	O

MEDICATIONS	O
ON	O
TRANSFER	O
THE	O
Stillman	O
Infirmary	O
:	O

1.	O
Lovenox	B-treatment
1	O
mg	O
per	O
kilogram	O
subcutaneously	O
b.i.d.	O

2.	O
Aspirin	B-treatment
81	O
mg	O
p.o.	O
q.d.	O

3.	O
Lopressor	B-treatment
50	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Lansoprazole	B-treatment
30	O
mg	O
p.o.	O
q.d.	O

5.	O
Regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

6.	O
Captopril	B-treatment
6.25	O
mg	O
q.i.d.	O

7.	O
Lasix	B-treatment
drip	I-treatment
at	O
2	O
per	O
hour	O
.	O

8.	O
Versed	B-treatment
drip	I-treatment
.	O

9.	O
TPN	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

This	O
is	O
a	O
gentleman	O
who	O
is	O
intubated	B-treatment
,	O
comfortable	O
,	O
with	O
minimal	B-treatment
sedation	I-treatment
.	O

He	O
was	O
afebrile	B-problem
with	O
a	B-test
temperature	I-test
of	O
99.1	O
.	O

His	B-test
pulse	I-test
was	O
in	O
the	O
70s	O
,	O
blood	B-test
pressure	I-test
119/58	O
.	O

He	O
was	O
breathing	O
12	O
per	O
minute	O
and	O
saturating	O
98%	O
.	O

His	B-test
CVP	I-test
is	O
ranging	O
from	O
07-27	O
.	O

He	O
was	O
intubated	O
and	O
has	O
a	B-treatment
nasogastric	I-treatment
tube	I-treatment
.	O

His	O
neck	O
has	O
a	B-problem
well-healed	I-problem
right	I-problem
carotid	I-problem
endarterectomy	I-problem
scar	I-problem
.	O

There	O
is	O
also	O
a	B-problem
well-healing	I-problem
tracheostomy	I-problem
scar	I-problem
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

The	O
heart	O
was	O
regular	O
with	O
an	O
S1	O
and	O
S2	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
with	O
normoactive	O
bowel	O
sounds	O
.	O

The	O
extremities	O
were	O
without	O
edema	B-problem
.	O

The	O
left	O
arm	O
was	O
in	O
a	B-treatment
cast	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

Mr.	O
Knueppel	O
was	O
admitted	O
to	O
the	O
CCU	O
at	O
the	O
Mass.	O
Eye	O
&	O
Ear	O
Infirmary	O
.	O

Upon	O
admission	O
,	O
he	O
was	O
treated	O
for	O
his	B-problem
pneumonia	I-problem
.	O

He	O
was	O
medically	O
managed	O
for	O
CHF	B-problem
and	O
underwent	O
a	B-test
cardiac	I-test
catheterization	I-test
on	O
2014-03-06	O
.	O

His	B-test
catheterization	I-test
revealed	O
70%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
distal	I-problem
left	I-problem
main	I-problem
coronary	I-problem
artery	I-problem
,	O
90%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
LAD	I-problem
,	O
80%	B-problem
stenosis	I-problem
of	I-problem
the	I-problem
circumflex	I-problem
,	O
90%	B-problem
stenosis	I-problem
of	I-problem
OM2	I-problem
and	O
a	B-problem
proximally	I-problem
occluded	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
.	O

After	O
reviewing	O
cardiac	B-test
catheterization	I-test
data	I-test
,	O
a	O
consultation	O
was	O
made	O
with	O
Cardiothoracic	O
Surgery	O
who	O
deemed	O
that	O
he	O
was	O
a	O
good	O
candidate	O
for	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

Over	O
the	O
ensuing	O
days	O
,	O
Mr.	O
Nina	O
CHF	B-problem
was	O
managed	O
by	O
the	O
CCU	O
Team	O
and	O
he	O
received	O
treatment	B-treatment
for	O
what	O
was	O
now	O
determined	O
to	O
be	O
a	B-problem
Klebsiella	I-problem
pneumonia	I-problem
.	O

He	O
was	O
treated	O
with	O
a	O
full	O
course	O
of	O
Zosyn	B-treatment
.	O

On	O
2014-03-11	O
,	O
Mr.	O
Knueppel	O
went	O
to	O
the	O
Operating	O
Room	O
with	O
Dr.	O
Streeter	O
.	O

He	O
underwent	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
of	I-treatment
four	I-treatment
vessels	I-treatment
.	O

He	O
had	O
a	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
his	I-treatment
LAD	I-treatment
and	I-treatment
diagonal	I-treatment
in	O
a	O
sequential	O
fashion	O
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
his	I-treatment
PDA	I-treatment
and	O
a	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
his	I-treatment
OM	I-treatment
.	O

The	B-treatment
procedure	I-treatment
was	O
performed	O
by	O
Dr.	O
Streeter	O
and	O
assisted	O
by	O
Dr	O
.	O
.....................	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
without	O
complication	B-problem
and	O
was	O
transferred	O
to	O
the	O
Cardiac	O

Surgery	O
Recovery	O
Unit	O
without	O
complication	B-problem
.	O

Please	O
see	O
the	O
previously	O
dictated	O
operative	O
note	O
for	O
more	O
details	O
.	O

Mr.	O
Knueppel	O
had	O
a	O
long	O
postoperative	O
course	O
.	O

His	O
postoperative	O
course	O
was	O
complicated	O
by	O
hypertension	B-problem
which	O
was	O
managed	O
medically	O
.	O

During	O
his	O
postoperative	O
course	O
,	O
he	O
did	O
not	O
suffer	O
from	O
any	B-problem
arrhythmias	I-problem
nor	O
did	O
he	O
have	O
any	O
episode	O
of	O
hypotension	B-problem
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
he	O
was	O
on	O
a	B-treatment
stable	I-treatment
antihypertensive	I-treatment
regimen	I-treatment
appropriate	O
for	O
someone	O
with	O
a	B-problem
decreased	I-problem
ejection	I-problem
fraction	I-problem
.	O

Mr.	O
Knueppel	O
had	O
had	O
a	O
long	O
protracted	O
period	O
of	O
intubation	B-treatment
prior	O
to	O
the	O
operation	B-treatment
.	O

The	O
status	O
of	O
Mr.	O
Nina	O
pulmonary	O
system	O
necessitated	O
a	B-treatment
prolonged	I-treatment
postoperative	I-treatment
intubation	I-treatment
.	O

After	O
a	O
very	O
slow	O
wean	O
from	O
ventilatory	B-treatment
support	I-treatment
,	O
Mr.	O
Knueppel	O
was	O
successfully	O
extubated	O
on	O
postoperative	O
day	O
number	O
nine	O
.	O

He	O
continued	O
to	O
be	O
very	O
tenuous	O
from	O
a	O
pulmonary	O
point	O
of	O
view	O
and	O
required	O
frequent	B-treatment
chest	I-treatment
PT	I-treatment
.	O

For	O
this	O
reason	O
,	O
Mr.	O
Knueppel	O
was	O
kept	O
in	O
the	O
Intensive	O
Care	O
Unit	O
where	O
very	O
close	O
monitoring	O
could	O
be	O
performed	O
.	O

In	O
addition	O
,	O
he	O
had	O
chest	B-treatment
PT	I-treatment
performed	O
at	O
very	O
regular	O
intervals	O
by	O
the	O
ICU	O
staff	O
.	O

His	O
pulmonary	O
status	O
was	O
so	O
tenuous	O
that	O
we	O
were	O
unable	O
to	O
transfer	O
him	O
to	O
the	O
regular	O
patient	O
care	O
floor	O
during	O
his	O
hospitalization	O
.	O

Mr.	O
Knueppel	O
had	O
an	B-treatment
emergent	I-treatment
cricothyroidotomy	I-treatment
followed	O
by	O
a	B-treatment
formal	I-treatment
tracheostomy	I-treatment
at	O
the	O
outside	O
hospital	O
.	O

There	O
is	O
much	B-problem
scarring	I-problem
surrounding	I-problem
his	I-problem
larynx	I-problem
.	O

Such	O
a	O
situation	O
frequently	O
makes	O
it	O
very	O
difficult	O
to	O
swallow	O
without	O
aspirating	O
.	O

As	O
is	O
expected	O
,	O
Mr.	O
Knueppel	O
failed	O
a	B-test
swallowing	I-test
study	I-test
early	O
on	O
in	O
his	O
Boston	O
Regional	O
Medical	O
Centerr	O
hospital	O
course	O
.	O

The	B-test
study	I-test
was	O
repeated	O
and	O
yet	O
again	O
Mr.	O
Knueppel	O
was	O
unable	O
to	O
swallow	O
without	O
evidence	O
of	O
aspiration	B-problem
.	O

After	O
a	O
prolonged	O
period	O
of	O
being	O
fed	O
via	O
nasogastric	B-treatment
tube	I-treatment
,	O
Mr.	O
Knueppel	O
finally	O
had	O
a	B-treatment
formal	I-treatment
percutaneous	I-treatment
endoscopic	I-treatment
gastrostomy	I-treatment
tube	I-treatment
placed	O
in	O
the	O
Intensive	O
Care	O
Unit	O
.	O

This	O
was	O
performed	O
on	O
2014-04-01	O
,	O
postoperative	O
day	O
number	O
21	O
.	O

This	B-treatment
procedure	I-treatment
was	O
performed	O
by	O
Dr.	O
Kevin	O
Taussig	O
and	O
assisted	O
by	O
Dr.	O
Carla	O
Solan	O
.	O

The	B-treatment
procedure	I-treatment
was	O
performed	O
under	O
endoscopic	B-treatment
guidance	I-treatment
in	O
the	O
Intensive	O
Care	O
Unit	O
without	O
complication	B-problem
.	O

Please	O
see	O
the	O
previously	O
dictated	O
operative	O
note	O
for	O
more	O
details	O
.	O

Mr.	O
Knueppel	O
Robertson	O
a	B-problem
distal	I-problem
radius	I-problem
fracture	I-problem
prior	O
to	O
arriving	O
to	O
the	O
hospital	O
.	O

This	B-problem
injury	I-problem
had	O
been	O
reduced	O
and	O
casted	O
at	O
the	O
outside	O
institution	O
.	O

Postoperatively	O
,	O
there	O
was	O
much	B-problem
edema	I-problem
associated	O
in	O
the	O
postoperative	O
course	O
from	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

His	B-treatment
cast	I-treatment
was	O
removed	O
by	O
the	O
Orthopedic	O
Service	O
in	O
anticipation	O
of	O
this	B-problem
edema	I-problem
and	O
to	O
avoid	O
compartment	B-problem
syndrome	I-problem
.	O

The	B-treatment
cast	I-treatment
was	O
replaced	O
by	O
a	B-treatment
plaster	I-treatment
splint	I-treatment
.	O

Mr.	O
Knueppel	O
should	O
follow-up	O
with	O
his	O
orthopedic	O
surgeon	O
in	O
the	O
Worcester	O
State	O
Hospital	O
for	O
reassessment	B-test
of	O
his	B-problem
injury	I-problem
and	O
possible	O
removal	B-treatment
of	O
the	B-treatment
splint	I-treatment
.	O

By	O
postoperative	O
day	O
number	O
23	O
,	O
Mr.	O
Nina	O
pulmonary	O
status	O
was	O
deemed	O
sufficiently	O
stable	O
.	O

His	B-problem
hypertension	I-problem
was	O
well	O
controlled	O
and	O
he	O
was	O
tolerating	O
tube	B-treatment
feeds	I-treatment
.	O

At	O
this	O
point	O
,	O
he	O
was	O
ready	O
to	O
be	O
discharged	O
to	O
rehabilitation	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
,	I-treatment
four	I-treatment
vessels	I-treatment
.	O

2.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

3.	O
Klebsiella	B-problem
pneumonia	I-problem
.	O

4.	O
Failed	B-problem
swallow	I-problem
study	I-problem
status	O
post	O
percutaneous	B-treatment
endoscopic	I-treatment
gastrostomy	I-treatment
tube	I-treatment
placement	I-treatment
.	O

5.	O
Central	B-test
line	I-test
culture	I-test
positive	O
for	O
coagulase	B-problem
-	I-problem
negative	I-problem
Staphylococcus	I-problem
aureus	I-problem
,	O
status	O
post	O
a	B-treatment
14	I-treatment
day	I-treatment
treatment	I-treatment
with	O
vancomycin	B-treatment
and	O
removal	B-treatment
of	O
the	B-treatment
line	I-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Methylphenidate	B-treatment
5	O
mg	O
p.o.	O
q.d.	O

2.	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
b.i.d.	O

3.	O
Captopril	B-treatment
50	O
mg	O
p.o.	O
t.i.d.	O

4.	O
Glyburide	B-treatment
10	O
mg	O
p.o.	O
b.i.d.	O

5.	O
Miconazole	B-treatment
powder	I-treatment
2%	O
,	O
apply	O
q.i.d.	O
p.r.n.	O

6.	O
Paxil	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

7.	O
Albuterol	B-treatment
nebulizer	I-treatment
solution	I-treatment
one	O
nebulizer	O
q.	O
four	O
hours	O
.	O

8.	O
Metoprolol	B-treatment
100	O
mg	O
p.o.	O
t.i.d.	O

9.	O
Heparin	B-treatment
5,000	O
units	O
subcutaneously	O
q.	O
12	O
hours	O
.	O

10.	O
Amlodipine	B-treatment
5	O
mg	O
p.o.	O
b.i.d.	O

11.	O
Percocet	B-treatment
one	O
to	O
two	O
tablets	O
p.o.	O
q.	O
four	O
hours	O
p.r.n.	O
pain	B-problem
.	O

12.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

13.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
q.d.	O

14.	O
Tube	B-treatment
feedings	I-treatment
;	O
Mr.	O
Knueppel	O
is	O
to	O
be	O
discharged	O
on	O
tube	B-treatment
feeds	I-treatment
,	O
Promote	B-treatment
,	I-treatment
with	I-treatment
fiber	I-treatment
full-strength	I-treatment
at	O
80	O
cc	O
per	O
hour	O
around	O
the	O
clock	O
.	O

His	B-treatment
PEG	I-treatment
tube	I-treatment
should	O
be	O
flushed	O
with	O
30	O
cc	O
of	O
water	O
after	O
every	O
use	O
.	O

ACTIVITY	O
:	O

Mr.	O
Nina	O
activity	O
is	O
ad	O
lib	O
.	O

He	O
is	O
also	O
to	O
be	O
strict	B-treatment
n.p.o.	I-treatment

He	O
should	O
be	O
n.p.o.	B-treatment
until	O
he	O
has	O
a	B-test
repeat	I-test
swallow	I-test
evaluation	I-test
which	O
demonstrates	O
his	O
ability	O
to	O
swallow	O
without	O
aspiration	B-problem
.	O

FOLLOW-UP	O
:	O

The	O
patient	O
will	O
follow-up	O
with	O
Dr.	O
Streeter	O
in	O
his	O
office	O
in	O
four	O
to	O
six	O
weeks	O
.	O

The	O
patient	O
should	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
within	O
one	O
week	O
.	O

The	O
patient	O
should	O
follow-up	O
with	O
his	O
orthopedic	O
surgeon	O
at	O
the	O
next	O
convenient	O
time	O
to	O
determine	O
the	O
length	O
of	O
duration	O
of	O
his	B-treatment
casting	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
DISCHARGE	O
:	O

Mr.	O
Knueppel	O
is	O
afebrile	B-problem
with	O
a	B-test
temperature	I-test
of	O
97.1	O
,	O
pulse	B-test
77	O
,	O
sinus	O
rhythm	O
.	O

His	B-test
blood	I-test
pressure	I-test
was	O
142/68	O
,	O
breathing	O
21	O
breaths	O
per	O
minute	O
,	O
94%	O
on	O
2	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
.	O

His	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
.	O

Extraocular	O
muscles	O
intact	O
.	O

His	O
head	O
was	O
normocephalic	O
,	O
atraumatic	B-problem
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

The	O
heart	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

He	O
had	O
a	B-treatment
PEG	I-treatment
tube	I-treatment
in	I-treatment
his	I-treatment
left	I-treatment
upper	I-treatment
quadrant	I-treatment
.	O

The	B-problem
site	I-problem
was	O
clean	O
and	O
dry	O
.	O

There	O
was	O
no	O
evidence	O
of	O
necrosis	B-problem
,	O
erythema	B-problem
or	O
exudate	B-problem
at	O
the	B-problem
site	I-problem
.	O

The	O
extremities	O
were	O
warm	O
and	O
well	O
perfuse	O
.	O

There	O
was	O
trace	B-problem
edema	I-problem
in	I-problem
both	I-problem
lower	I-problem
extremities	I-problem
.	O

His	O
right	O
lower	O
extremity	O
has	O
ecchymosis	B-problem
related	O
to	O
a	B-problem
saphenectomy	I-problem
site	I-problem
.	O

This	B-problem
ecchymosis	I-problem
is	O
much	O
improved	O
from	O
previous	B-test
examinations	I-test
.	O

There	O
was	O
no	O
increased	B-problem
warmth	I-problem
over	O
this	O
area	O
nor	O
is	O
there	O
any	B-problem
exudate	I-problem
from	O
his	B-problem
wounds	I-problem
.	O

All	O
of	O
his	B-problem
wounds	I-problem
including	O
sternotomy	B-problem
wound	I-problem
were	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O

Timothy	O
M	O
Geibel	O
,	O
M.D.	O
92-534	O

Dictated	O
By	O
:	O
Melinda	O
U	O
Yantis	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-04-04	O
02:23	O

T	O
:	O
2014-04-04	O
15:35	O

JOB	O
#	O
:	O
79430	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Timothy	O
B.	O
Chew	O
on	O
:	O
TUE	O
2014-06-03	O
4:10	O
PM	O

(	O
End	O
of	O
Report	O
)	O

305265793_b	O
PAD-WORD	O

FIH	O
PAD-WORD	O

2833679	O
PAD-WORD	O

44807/072t	O
PAD-WORD	O

458891	O
PAD-WORD	O

5/14/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

5/14/92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

5/19/92	O
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

Right	B-problem
foot	I-problem
pain	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
71	O
year	O
old	O
white	O
female	O
with	O
metastatic	B-problem
ovarian	I-problem
carcinoma	I-problem
,	O
who	O
recently	O
underwent	O
an	B-test
exploratory	I-test
laparotomy	I-test
on	O
5/2	O
by	O
Dr.	O
Korcblinknud	O
.	O

She	O
was	O
found	O
to	O
have	O
widely	B-problem
metastatic	I-problem
ovarian	I-problem
carcinoma	I-problem
.	O

There	O
was	O
sigmoid	B-problem
narrowing	I-problem
near	O
a	B-problem
large	I-problem
left	I-problem
ovarian	I-problem
mass	I-problem
,	O
and	O
distal	B-problem
ileal	I-problem
narrowing	I-problem
by	O
a	B-problem
right	I-problem
ovarian	I-problem
mass	I-problem
.	O

The	O
patient	O
had	O
an	B-treatment
ileostomy	I-treatment
performed	O
and	O
had	O
had	O
her	O
first	O
course	O
of	O
chemotherapy	B-treatment
and	O
later	O
debulking	B-treatment
operation	I-treatment
by	O
Dr.	O
Median	O
.	O

She	O
was	O
well	O
at	O
home	O
until	O
8:30	O
p.m.	O
on	O
the	O
day	O
of	O
admission	O
,	O
when	O
she	O
developed	O
acute	O
onset	O
of	O
right	B-problem
foot	I-problem
pain	I-problem
,	O
which	O
was	O
worse	O
with	O
walking	O
.	O

She	O
complained	O
of	O
increased	B-problem
numbness	I-problem
of	I-problem
the	I-problem
right	I-problem
foot	I-problem
over	O
time	O
,	O
and	O
was	O
seen	O
at	O
Sephsandpot	O
Center	O
,	O
where	O
she	O
was	O
found	O
to	O
have	O
palpable	O
right	O
femoral	O
and	O
popliteal	O
pulses	O
,	O
and	O
no	B-problem
pedal	I-problem
pulses	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

She	O
had	O
previous	O
history	O
of	O
claudication	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
glaucoma	B-problem
,	O
right	B-treatment
knee	I-treatment
arthroscopic	I-treatment
surgery	I-treatment
in	O
1988	O
,	O
appendectomy	B-treatment
,	O
dilation	B-treatment
and	I-treatment
curettage	I-treatment
times	O
two	O
,	O
and	O
a	B-problem
hiatus	I-problem
hernia	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lorazepam	B-treatment
1	O
mg.	O
PO	O
q6	O
hours	O
PRN	O
,	O
and	O
Timoptic	B-treatment
0.5%	O
1	O
drop	O
b.i.d.	O

ALLERGIES	O
:	O

Iodine	B-treatment
and	O
shellfish	O
cause	O
throat	B-problem
tightening	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
history	O
of	O
smoking	O
and	O
ethanol	O
use	O
.	O

She	O
lives	O
with	O
her	O
husband	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Negative	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Showed	O
a	O
71	O
year	O
old	O
white	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
vital	I-test
signs	I-test
were	O
blood	B-test
pressure	I-test
155/82	O
,	O
pulse	B-test
88	O
,	O
temperature	B-test
96.0.	O

Her	O
right	O
foot	O
was	O
without	B-problem
capillary	I-problem
refill	I-problem
,	O
with	O
a	B-problem
marked	I-problem
change	I-problem
of	O
temperature	B-test
at	O
a	O
level	O
of	O
the	O
mid	O
calf	O
.	O

There	O
was	O
decreased	B-problem
sensation	I-problem
to	O
touch	B-test
over	O
the	O
entire	O
foot	O
.	O

She	O
was	O
able	O
to	O
move	O
her	O
foot	O
and	O
toes	O
.	O

Radial	B-test
,	I-test
carotid	I-test
and	I-test
femoral	I-test
pulses	I-test
were	O
symmetric	O
and	O
strong	O
.	O

The	B-test
popliteal	I-test
pulse	I-test
on	I-test
the	I-test
right	I-test
side	I-test
was	O
diminished	B-problem
.	O

There	O
was	O
no	B-problem
dorsal	I-problem
,	I-problem
pedal	I-problem
pulse	I-problem
on	I-problem
the	I-problem
right	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

ON	O
5/14/92	O
,	O
the	O
patient	O
received	O
an	B-test
arteriogram	I-test
which	O
demonstrated	O
an	B-problem
embolus	I-problem
in	I-problem
the	I-problem
right	I-problem
profunda	I-problem
/	I-problem
femoral	I-problem
artery	I-problem
.	O

There	O
was	O
an	B-problem
occlusion	I-problem
in	I-problem
the	I-problem
proximal	I-problem
calf	I-problem
,	O
of	O
the	O
peroneal	O
and	O
anterior	O
tibial	O
arteries	O
.	O

There	O
was	O
an	B-problem
occlusion	I-problem
of	I-problem
posterior	I-problem
tibial	I-problem
artery	I-problem
at	O
the	O
ankle	O
.	O

She	O
was	O
taken	O
urgently	O
to	O
the	O
operating	O
room	O
,	O
where	O
she	O
underwent	O
embolectomy	B-treatment
of	I-treatment
the	I-treatment
profunda	I-treatment
superficial	I-treatment
femoral	I-treatment
vessels	I-treatment
.	O

The	B-test
estimated	I-test
blood	I-test
loss	I-test
was	O
200	O
cc.	O
and	O
she	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

Postoperatively	O
,	O
she	O
was	O
again	O
noted	O
to	O
have	O
a	B-problem
cold	I-problem
right	I-problem
lower	I-problem
extremity	I-problem
with	O
diminished	B-problem
pulses	I-problem
and	O
was	O
again	O
taken	O
to	O
the	O
operating	O
room	O
,	O
where	O
she	O
underwent	O
a	B-test
right	I-test
popliteal	I-test
exploration	I-test
and	O
thrombectomy	B-treatment
.	O

She	O
again	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
did	O
well	O
postoperatively	O
.	O

On	O
5/19	O
,	O
she	O
had	O
an	B-test
echocardiogram	I-test
done	O
which	O
was	O
to	O
be	O
evaluated	O
as	O
an	O
out	O
patient	O
.	O

By	O
discharge	O
she	O
was	O
walking	O
and	O
taking	O
PO&apos;s	O
without	O
problem	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Thromboembolus	B-problem
to	I-problem
the	I-problem
right	I-problem
profunda	I-problem
femoris	I-problem
,	I-problem
and	I-problem
right	I-problem
superficial	I-problem
femoral	I-problem
artery	I-problem
.	O

MA	O
JAMTLANDBRANTESSLIGH	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

COR	O
TLAND	O
,	O
M.D.	O

TR	O
:	O

qa	O
/	O
bmot	O

DD	O
:	O

07/02/92	O
PAD-WORD	O

TD	O
:	O

07/07/92	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2013-02-18	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-02-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1934-03-07	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Karen	O
U.O.	O
Berliner	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
abdominal	B-problem
pain	I-problem
/	O
nausea	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
PAD-WORD	O

IR	B-treatment
guided	I-treatment
nephrostomy	I-treatment
placement	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

The	O
patient	O
is	O
a	O
78	O
y/o	O
WF	O
w/a	O
PMH	O
significant	O
for	O
HTN	B-problem
and	O
afib	B-problem
who	O
presented	O
to	O
an	O
OSH	O
w/	O
complaints	O
of	O
abd	B-problem
pain	I-problem
and	O
nausea	B-problem
.	O

She	O
was	O
found	O
to	O
have	O
a	B-problem
R	I-problem
ureteral	I-problem
stone	I-problem
w/	O
resultant	O
hydronephrosis	B-problem
and	O
was	O
transferred	O
to	O
Nantucket	O
Cottage	O
Hospital	O
for	O
ureteral	B-treatment
stent	I-treatment
placement	I-treatment
.	O

Her	B-test
INR	I-test
was	O
found	O
to	O
be	O
elevated	B-problem
when	O
admitted	O
and	O
,	O
in	O
the	O
course	O
of	O
waiting	O
for	O
this	O
to	O
normalize	O
,	O
the	O
patient	O
spiked	O
a	B-test
temperature	I-test
to	O
105	O
and	O
became	O
hypotensive	B-problem
to	O
the	O
70s	O
.	O

She	O
was	O
bolused	O
w/out	O
effect	O
and	O
had	O
little	O
response	O
to	O
neo	B-treatment
so	O
she	O
was	O
changed	O
to	O
levophed	B-treatment
,	O
given	O
doses	O
of	O
cipro	B-treatment
/	O
vanco	B-treatment
/	O
gent	B-treatment
and	O
transferred	O
to	O
the	O
CMED	O
CSRU	O
for	O
management	O
.	O

In	O
the	O
CMED	O
,	O
urology	O
was	O
consulted	O
and	O
the	O
patient	O
received	O
a	B-treatment
R	I-treatment
nephrostomy	I-treatment
tube	I-treatment
.	O

However	O
,	O
tube	B-treatment
placement	I-treatment
was	O
complicated	O
by	O
renal	B-problem
artery	I-problem
puncture	I-problem
,	O
afib	B-problem
,	O
and	O
increased	B-problem
dyspnea	I-problem
.	O

She	O
was	O
intubated	O
for	O
this	B-problem
hypoxia	I-problem
and	O
treated	O
with	O
lasix	B-treatment
,	O
metoprolol	B-treatment
,	O
and	O
diltiazem	B-treatment
.	O

She	O
was	O
weaned	O
off	O
her	B-treatment
pressors	I-treatment
on	O
02-21	O
and	O
maintained	O
her	O
pressure	O
w/out	O
additional	B-treatment
fluid	I-treatment
boluses	I-treatment
.	O

Her	B-treatment
sedation	I-treatment
was	O
weaned	O
down	O
and	O
she	O
was	O
successfully	O
extubated	O
shortly	O
thereafter	O
.	O

UCx	B-test
grew	O
proteus	B-problem
and	O
her	B-treatment
abx	I-treatment
were	O
changed	O
to	O
levaquin	B-treatment
alone	O
and	O
she	O
remained	O
afebrile	B-problem
for	O
>	O
24	O
hr	O
on	O
this	B-treatment
regimen	I-treatment
.	O

She	O
continued	O
to	O
have	O
trouble	O
with	O
afib	B-problem
and	O
required	O
a	B-treatment
dilt	I-treatment
gtt	I-treatment
on	O
the	O
day	O
prior	O
to	O
call-out	O
to	O
control	O
this	O
rhythm	O
but	O
she	O
was	O
transitioned	O
to	O
PO	B-treatment
diltiazem	I-treatment
and	O
has	O
been	O
in	O
NSR	O
since	O
this	O
time	O
.	O

She	O
was	O
restarted	O
on	O
heparin	B-treatment
prior	O
to	O
d/c	O
as	O
a	O
bridge	O
to	O
therapeutic	B-treatment
coumadin	I-treatment
anticoagulation	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

1.	O
HTN	B-problem

2.	O
A.fib	B-problem
on	O
Coumadin	B-treatment

3.	O
Cataract	B-problem
disease	I-problem

4.	O
01-22	O
closed	B-problem
fracture	I-problem
of	I-problem
radius	I-problem
s/p	O
closed	B-treatment
reduction	I-treatment

5.	O
MV	B-problem
,	I-problem
AV	I-problem
,	I-problem
TV	I-problem
insufficiency	I-problem

Social	O
History	O
:	O

Single	O
,	O
lives	O
with	O
her	O
daughter	O
,	O
doesn	O
't	O
smoke	O
,	O
doesn	O
't	O
drink	O
,	O
worked	O
for	O
bag	O
company	O

Family	O
History	O
:	O

Brother	O
with	O
"	O
heart	B-problem
trouble	I-problem
"	O
.	O

Physical	O
Exam	O
:	O

140/66	O
,	O
92	O
,	O
18	O
,	O
96%	O
2L	O

Gen	O
:	O

Pleasant	O
obese	O
female	O
in	O
NAD	B-problem
,	O
in	O
wrist	B-treatment
restraints	I-treatment

HEENT	O
:	O

EOMI	O
,	O
PERRLA	O
,	O
MM	B-problem
dry	I-problem
,	O
O/P	O
clear	O

Lungs	O
:	O
clear	O
anteriorly	O

CV	O
:	O

RRR	O
,	O
S1/S2	O
intact	O
,	O
3/6	B-problem
SEM	I-problem
at	I-problem
the	I-problem
USB	I-problem

Abd	O
:	O

S/NT/ND	B-problem
,	O
obese	B-problem
,	O
+BS	O

Back	O
:	O

R	B-treatment
nephrostomy	I-treatment
tube	I-treatment
in	O
place	O
and	O
draining	O

Ext	O
:	O
brace	B-treatment
on	I-treatment
L	I-treatment
wrist	I-treatment
,	O
2+	B-problem
LE	I-problem
edema	I-problem

Neuro	O
:	O
CN	O
03-31	O
grossly	O
intact	O
,	O
strength	O
5/5	O
bilaterally	O
,	O
AAO	O
to	O
person	O
,	O
place	O
(	O
hospital	O
in	O
Burlington	O
)	O
,	O
and	O
time	O
(	O
1997-02-23	O
)	O

Pertinent	O
Results	O
:	O

CXR	B-test
2013-02-21	O
:	O

Right	B-treatment
subclavian	I-treatment
CV	I-treatment
line	I-treatment
overlies	O
proximal	O
SVC	O
.	O

There	O
is	O
cardiomegaly	B-problem
and	O
tortuosity	B-problem
of	I-problem
the	I-problem
thoracic	I-problem
aorta	I-problem
with	O
small	B-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem
consistent	O
with	O
CHF	B-problem
.	O

No	O
pneumothorax	B-problem
.	O

Overall	O
appearances	O
are	O
essentially	O
unchanged	O
since	O
the	B-test
prior	I-test
film	I-test
of	O
2013-02-20	O
,	O
apart	O
from	O
removal	B-treatment
of	O
the	B-treatment
ET	I-treatment
tube	I-treatment
.	O

CT	B-test
Abd	I-test
2013-02-18	O
:	O

1)	O
Moderate	B-problem
to	I-problem
severe	I-problem
right	I-problem
hydroureteronephrosis	I-problem
with	O
two	B-problem
obstructing	I-problem
distal	I-problem
right	I-problem
ureteral	I-problem
stones	I-problem
,	O
8	O
mm	O
and	O
6	O
mm	O
respectively	O
.	O

2)	O
Probable	O
obstructing	B-problem
5	I-problem
mm	I-problem
right	I-problem
mid	I-problem
ureteral	I-problem
calculus	I-problem
causing	O
mild	B-problem
hydroureter	I-problem
,	O
though	O
it	O
is	O
difficult	O
to	O
tell	O
definitively	O
if	O
this	B-problem
stone	I-problem
is	O
within	O
or	O
just	O
medial	O
to	O
the	O
right	O
ureter	O
on	O
this	B-test
CT	I-test
without	I-test
IV	I-test
contrast	I-test
.	O

3)	O
Small	B-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem
.	O

4)	O
Coronary	B-problem
artery	I-problem
calcification	I-problem
.	O

ECHO	B-test
2013-02-19	O
:	O

1.	O
The	O
left	O
atrium	O
is	O
mildly	B-problem
dilated	I-problem
.	O

2.	O
The	B-test
left	I-test
ventricular	I-test
cavity	I-test
size	I-test
is	O
normal	O
.	O

Due	O
to	O
suboptimal	O
technical	O
quality	O
,	O
a	B-problem
focal	I-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
cannot	O
be	O
fully	O
excluded	O
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
normal	O
LVEF	B-test
>	O
55%	O
)	O
.	O

3.	O
The	O
right	O
ventricular	O
cavity	O
is	O
dilated	B-problem
.	O

Right	B-test
ventricular	I-test
systolic	I-test
function	I-test
appears	O
depressed	B-problem
.	O

4.	O
The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	B-problem
thickened	I-problem
.	O

There	O
is	O
mild	B-problem
aortic	I-problem
valve	I-problem
stenosis	I-problem
.	O

5.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

There	O
is	O
severe	B-problem
mitral	I-problem
annular	I-problem
calcification	I-problem
.	O

Trivial	B-problem
mitral	I-problem
regurgitation	I-problem
is	O
present	O
.	O

6.	O
Moderate	B-problem
to	I-problem
severe	I-problem
[	I-problem
3+	I-problem
]	I-problem
tricuspid	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

There	O
is	O
moderate	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

2013-02-18	O
05:49	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
36.6	O
*	O
RBC	B-test
-	O
4.29	O
Hgb	B-test
-	O
13.4	O
Hct	B-test
-	O
38.8	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
31.3	O
MCHC	B-test
-	O
34.6	O
RDW	B-test
-	O
13.2	O
Plt	B-test
Ct	I-test
-	O
132	O
*	O

2013-02-27	O
05:17	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
11.8	O
*	O
RBC	B-test
-	O
3.61	O
*	O
Hgb	B-test
-	O
10.8	O
*	O
Hct	B-test
-	O
32.2	O
*	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
29.8	O
MCHC	B-test
-	O
33.5	O
RDW	B-test
-	O
13.2	O
Plt	B-test
Ct	I-test
-	O
346	O

2013-02-18	O
05:49	O
PM	O
BLOOD	B-test
PT	B-test
-	O
20.6	O
*	O
PTT	B-test
-	O
31.6	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
3.0	O

2013-02-27	O
05:17	O
AM	O
BLOOD	B-test
PT	B-test
-	O
15.5	O
*	O
PTT	B-test
-	O
75.0	O
*	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.6	O

2013-02-18	O
05:49	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
127	O
*	O
UreaN	B-test
-	O
26	O
*	O
Creat	B-test
-	O
1.7	O
*	O
Na	B-test
-	O
136	O
K	B-test
-	O
3.9	O
Cl	B-test
-	O
103	O
HCO3	B-test
-	O
20	O
*	O
AnGap	B-test
-	O
17	O

2013-02-27	O
05:17	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
97	O
UreaN	B-test
-	O
14	O
Creat	B-test
-	O
1.2	O
*	O
Na	B-test
-	O
144	O
K	B-test
-	O
3.9	O
Cl	B-test
-	O
106	O
HCO3	B-test
-	O
29	O
AnGap	B-test
-	O
13	O

2013-02-22	O
03:00	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
52	O
*	O
AST	B-test
-	O
50	O
*	O
LD	B-test
(	I-test
LDH	I-test
)-	I-test
300	O
*	O
CK	B-test
(	I-test
CPK	I-test
)-	I-test
41	O
AlkPhos	B-test
-	O
280	O
*	O
TotBili	B-test
-	O
0.8	O

2013-02-18	O
05:49	O
PM	O
BLOOD	B-test
Calcium	B-test
-	O
7.7	O
*	O
Phos	B-test
-	O
3.3	O
Mg	B-test
-	O
1.1	O
*	O

2013-02-27	O
05:17	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
8.7	O
Phos	B-test
-	O
4.0	O
Mg	B-test
-	O
1.9	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

78	O
year	O
old	O
female	O
with	O
history	O
of	O
HTN	B-problem
,	O
a.fib	B-problem
presenting	O
with	O
ureteral	B-problem
stone	I-problem
,	O
hydronephrosis	B-problem
,	O
and	O
urosepsis	B-problem
.	O

She	O
originally	O
had	O
hypotension	B-problem
and	O
a	B-problem
leukocytosis	I-problem
in	O
the	O
ER	O
and	O
was	O
admitted	O
to	O
the	O
CMED	O
CCU	O
.	O

In	O
the	O
CMED	O
,	O
urology	O
was	O
consulted	O
and	O
the	O
patient	O
received	O
a	B-treatment
R	I-treatment
nephrostomy	I-treatment
tube	I-treatment
.	O

However	O
,	O
tube	B-treatment
placement	I-treatment
was	O
complicated	O
by	O
renal	B-problem
artery	I-problem
puncture	I-problem
,	O
afib	B-problem
,	O
and	O
increased	B-problem
dyspnea	I-problem
.	O

She	O
was	O
intubated	O
for	O
this	B-problem
hypoxia	I-problem
and	O
treated	O
with	O
lasix	B-treatment
,	O
metoprolol	B-treatment
,	O
and	O
diltiazem	B-treatment
.	O

She	O
was	O
weaned	O
off	O
her	B-treatment
pressors	I-treatment
on	O
02-21	O
and	O
maintained	O
her	B-test
pressure	I-test
w/out	O
additional	B-treatment
fluid	I-treatment
boluses	I-treatment
.	O

Her	B-treatment
sedation	I-treatment
was	O
weaned	O
down	O
and	O
she	O
was	O
successfully	O
extubated	O
shortly	O
thereafter	O
.	O

UCx	B-test
grew	O
proteus	B-problem
and	O
her	B-treatment
abx	I-treatment
were	O
changed	O
to	O
levaquin	B-treatment
alone	O
and	O
she	O
remained	O
afebrile	B-problem
for	O
>	O
24hr	O
on	O
this	B-treatment
regimen	I-treatment
.	O

She	O
continued	O
to	O
have	O
trouble	O
with	O
afib	B-problem
and	O
required	O
a	B-treatment
dilt	I-treatment
gtt	I-treatment
on	O
the	O
day	O
prior	O
to	O
call-out	O
to	O
control	O
this	O
rhythm	O
but	O
she	O
was	O
transitioned	O
to	O
PO	B-treatment
diltiazem	I-treatment
on	O
the	O
day	O
of	O
call-out	O
.	O

1.	O
Sepsis	B-problem
-	O
The	O
patient	O
was	O
septic	B-problem
in	O
the	O
ER	O
and	O
her	B-test
blood	I-test
cultures	I-test
eventually	O
grew	O
proteus	B-problem
.	O

Her	B-test
Bcx	I-test
remained	O
negative	O
throughout	O
her	O
stay	O
.	O

She	O
was	O
treated	O
with	O
levaquin	B-treatment
on	O
the	O
floor	O
and	O
will	O
complete	O
a	O
14d	O
course	O
at	O
rehab	O
.	O

She	O
has	O
been	O
afebrile	B-problem
since	O
she	O
was	O
called	O
out	O
to	O
the	O
floor	O
.	O

2.	O
Ureteral	B-problem
stone	I-problem
-	O
The	O
patient	O
had	O
a	B-treatment
nephrostomy	I-treatment
tube	I-treatment
placed	O
by	O
IR	O
to	O
relieve	O
her	B-problem
hydronephrosis	I-problem
.	O

She	O
was	O
followed	O
by	O
urology	O
during	O
her	O
stay	O
and	O
will	O
see	O
them	O
again	O
2	O
wk	O
after	O
d/c	O
for	O
definitive	B-treatment
treatment	I-treatment
of	O
her	B-problem
nephrolithiasis	I-problem
.	O

At	O
this	O
time	O
,	O
urology	O
will	O
coordinate	O
removal	B-treatment
of	O
her	B-treatment
nephrostomy	I-treatment
tube	I-treatment
with	O
IR	O
.	O

Her	B-treatment
nephrostomy	I-treatment
tube	I-treatment
was	O
draining	O
clear	O
yellow	O
urine	O
at	O
the	O
time	O
of	O
d/c	O
.	O

3.	O
a.fib	B-problem
-	O
The	O
patient	O
has	O
a	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
controlled	O
with	O
beta	B-treatment
blockers	I-treatment
at	O
home	O
.	O

She	O
was	O
treated	O
in	O
the	O
CMED	O
as	O
above	O
.	O

Once	O
on	O
the	O
floor	O
,	O
the	O
patient	O
had	O
one	O
episode	O
of	O
afib	B-problem
w/	O
RVR	B-problem
that	O
responded	O
immediately	O
to	O
IV	B-treatment
metoprolol	I-treatment
.	O

Because	O
of	O
this	O
,	O
the	B-treatment
patient	I-treatment
's	I-treatment
diltiazem	I-treatment
was	O
stopped	O
and	O
she	O
was	O
started	O
on	O
tid	B-treatment
metoprolol	I-treatment
.	O

After	O
this	O
,	O
the	O
patient	O
had	O
no	O
further	B-problem
problems	I-problem
with	O
her	B-treatment
rate	I-treatment
control	I-treatment
.	O

She	O
was	O
maintained	O
on	O
a	B-treatment
heparin	I-treatment
gtt	I-treatment
for	O
bridge	O
to	O
coumadin	B-treatment
while	O
on	O
the	O
floor	O
after	O
this	O
was	O
cleared	O
by	O
IR	O
and	O
urology	O
.	O

She	O
will	O
be	O
d/c	O
w/out	O
her	B-treatment
heparin	I-treatment
as	O
she	O
is	O
trending	O
upwards	O
with	O
her	B-test
INR	I-test
and	O
has	O
no	O
MR	B-problem
Paul	I-problem
Paquettec	I-problem
heart	I-problem
disease	I-problem
.	O

She	O
will	O
continue	O
her	B-treatment
coumadin	I-treatment
at	O
rehab	O
to	O
achieve	O
an	B-test
INR	I-test
between	O
03-22	O
.	O

4.	O
delirium	B-problem
-	O
The	O
patient	O
had	O
troubles	O
with	O
agitation	B-problem
while	O
in	O
the	O
CMED	O
CCU	O
.	O

She	O
received	O
prn	B-treatment
haldol	I-treatment
w/	O
little	O
effect	O
and	O
improved	O
as	O
her	B-problem
infection	I-problem
cleared	O
.	O

Medications	O
on	O
Admission	O
:	O
toprol	B-treatment
(	O
unknown	O
dose	O
)	O
coumadin	B-treatment
1	O
mg	O
qhs	O

Discharge	O
Medications	O
:	O

1.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

2.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

3.	O
Levofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
7	O
days	O
.	O

4.	O
Warfarin	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

5.	O
Miconazole	B-treatment
Nitrate	I-treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

6.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
neb	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

7.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

8.	O
Polyvinyl	B-treatment
Alcohol	I-treatment
1.4	O
%	O
Drops	O
Sig	O
:	O
1-2	O
Drops	O
Ophthalmic	O
PRN	O
(	O
as	O
needed	O
)	O
.	O

9.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Outpatient	B-test
Lab	I-test
Work	I-test
please	O
have	O
your	B-test
INR	I-test
checked	O
at	O
the	O
rehab	O
center	O
with	O
a	O
goal	O
of	O
03-22	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Danvers	O
State	O
Hospital	O
&	O
Rehab	O
Center	O
-	O
Beverly	O

Discharge	O
Diagnosis	O
:	O

Urosepsis	B-problem
PAD-WORD	O

Nephrolithiasis	B-problem
PAD-WORD	O

Atrial	B-problem
fibrillation	I-problem

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
take	O
your	B-treatment
medications	I-treatment
as	O
directed	O

Please	O
keep	O
your	O
follow-up	O
appointments	O

Followup	O
Instructions	O
:	O

Dr.	O
Emma	O
Attar	O
2013-03-26	O
10:15	O
AM	O

George	O
Yvonne	O
,	O
MD	O
Phone	O
:	O
440-401-5366	O
Date	O
/	O
Time	O
:	O
2013-03-19	O
10:40	O

Deborah	O
Walter	O
MD	O
17-478	O

Completed	O
by	O
:	O
Richard	O
LYNCH	O
MD	O
72-568	O
2013-02-27	O
@	O
1558	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
BELL	O
on	O
:	O
WED	O
2013-04-17	O
3:18	O
PM	O

(	O
End	O
of	O
Report	O
)	O

305265793_g	O
PAD-WORD	O

FIH	O
PAD-WORD	O

2833679	O
PAD-WORD	O

74738/2av5	O
PAD-WORD	O

543247	O
PAD-WORD	O

09/21/1992	O
12:00:00	O
AM	O

STAGE	B-problem
3C	I-problem
PAPILLARY	I-problem
SEROUS	I-problem
CARCINOMA	I-problem
OF	I-problem
THE	I-problem
OVARY	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

09/21/92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

09/24/92	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Stage	B-problem
3C	I-problem
papillary	I-problem
serous	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
ovary	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Patient	O
was	O
admitted	O
to	O
the	O
GYN	O
Oncology	O
SErvice	O
in	O
1980	O
by	O
Dr.	O
Slaineaee	O
Ganz	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
seventy-one	O
year	O
old	O
white	O
female	O
with	O
stenotic	B-problem
area	I-problem
on	I-problem
her	I-problem
mid	I-problem
sigmoid	I-problem
,	O
noticed	O
on	O
barium	B-test
enema	I-test
.	O

The	B-test
ultrasound	I-test
showed	O
ascites	B-problem
and	O
question	O
of	O
pelvic	B-problem
mass	I-problem
.	O

The	O
patient	O
was	O
explored	O
by	O
General	O
surgery	O
,	O
who	O
saw	O
the	B-problem
3C	I-problem
ovarian	I-problem
carcinoma	I-problem
.	O

The	O
patient	O
also	O
had	O
an	B-treatment
omentectomy	I-treatment
and	O
ileostomy	B-treatment
.	O

The	O
patient	O
was	O
admitted	O
for	O
one	O
cycle	O
of	O
Cytoxan	B-treatment
and	O
Cisplatin	B-treatment
,	O
and	O
subsequently	O
underwent	O
debulking	B-treatment
in	O
June	O
1992	O
,	O
as	O
well	O
as	O
a	B-treatment
total	I-treatment
abdominal	I-treatment
hysterectomy/	I-treatment
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
,	O
omentectomy	B-treatment
,	O
splenectomy	B-treatment
,	O
rectosigmoid	B-treatment
resection	I-treatment
with	O
a	B-treatment
take	I-treatment
down	I-treatment
of	I-treatment
the	I-treatment
ileostomy	I-treatment
.	O

Also	O
ileal	B-treatment
cecal	I-treatment
resection	I-treatment
,	O
MDR	B-test
showed	O
that	O
Cisplatin	B-treatment
and	O
VP	B-treatment
16	I-treatment
were	O
more	O
effective	O
.	O

The	O
patient	O
now	O
presents	O
for	O
line	O
1	O
,	O
cycle	O
4	O
to	O
15	O
of	O
VP	B-treatment
16	I-treatment
and	I-treatment
Cisplatin	I-treatment
chemotherapy	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
past	O
medical	O
history	O
is	O
unremarkable	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

As	O
above	O
,	O
including	O
an	B-treatment
embolectomy	I-treatment
in	O
June	O
1992	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Coumadin	B-treatment
2.5	O
mg.	O
five	O
times	O
a	O
week	O
,	O
Ativan	B-treatment
and	O
Lomotil	B-treatment
prn	O
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem
,	O
but	O
has	O
shellfish	B-problem
allergy	I-problem
,	O
and	O
question	O
of	O
an	B-problem
Iodine	I-problem
allergy	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
exam	I-test
the	O
patient	O
is	O
a	O
well	O
appearing	O
,	O
elderly	O
white	O
female	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
blood	I-test
pressure	I-test
is	O
120/82	O
,	O
heart	B-test
rate	I-test
88	O
,	O
weight	B-test
125	O
pounds	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
exam	I-test
was	O
notable	O
for	O
alopecia	B-problem
,	O
otherwise	O
unremarkable	O
.	O

Chest	O
was	O
clear	O
,	O
bilateral	B-test
cardiac	I-test
exam	I-test
showed	O
regular	O
rate	O
and	O
rhythm	O
,	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
except	O
for	O
mild	B-problem
left	I-problem
upper	I-problem
quadrant	I-problem
tenderness	I-problem
with	O
a	B-problem
well	I-problem
healed	I-problem
,	I-problem
midline	I-problem
abdominal	I-problem
scar	I-problem
.	O

No	O
other	B-problem
lower	I-problem
quadrant	I-problem
tenderness	I-problem
.	O

Extremities	O
were	O
unremarkable	O
.	O

Neurological	O
:	O

exam	B-test
was	O
nonfocal	O
,	O
and	O
there	O
was	O
no	O
significant	B-problem
lymphadenopathy	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Notable	O
for	O
a	B-test
white	I-test
blood	I-test
cell	I-test
of	O
9.5	O
,	O
ANC	B-test
7.7	O
,	O
hematocrit	B-test
26	O
,	O
platelets	B-test
of	O
248	O
,	O
BUN	B-test
and	O
creatinine	B-test
12.	O
and	O
1.2	O
respectively	O
,	O
magnesium	B-test
1.1	O
,	O
calcium	B-test
8.7	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
and	O
received	O
two	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
for	O
her	B-test
hematocrit	I-test
of	O
26	O
,	O
and	O
had	O
a	B-treatment
magnesium	I-treatment
repleted	O
.	O

The	O
patient	O
received	O
three	O
days	O
of	O
chemotherapy	B-treatment
,	O
consisting	O
of	O
45	O
mg.	O
of	O
Cisplatin	B-treatment
160	O
mg.	O
of	O
VP	B-treatment
16	I-treatment
,	O
and	O
tolerated	O
chemotherapy	B-treatment
resonably	O
well	O
.	O

Serial	B-test
PTs	I-test
were	O
obtained	O
,	O
and	O
the	O
patient	O
was	O
noted	O
to	O
have	O
an	B-test
initial	I-test
PT	I-test
of	O
10.9	O
on	O
admission	O
,	O
despite	O
Coumadin	B-treatment
at	O
home	O
.	O

She	O
was	O
given	O
10	O
mg.	O
on	O
hospital	O
day	O
#	O
1	O
,	O
and	O
5	O
mg.	O
on	O
hospital	O
day	O
2	O
,	O
and	O
back	O
to	O
2.5	O
qhs	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
pro	I-test
time	I-test
bumped	O
to	O
19.5	O
on	O
hospital	O
day	O
#	O
3	O
,	O
and	O
the	O
patient	O
was	O
instructed	O
to	O
continue	O
with	O
2	O
1/2	O
mg.	O
qhs	O
and	O
is	O
to	O
followup	O
with	O
Anticoagulation	O
Clinic	O
in	O
one	O
week	O
for	O
further	B-test
pro	I-test
time	I-test
checks	I-test
and	O
adjustments	B-treatment
.	O

The	O
patient	O
did	O
develop	O
some	B-problem
hypertension	I-problem
during	O
infusion	B-treatment
of	I-treatment
her	I-treatment
VP	I-treatment
16	I-treatment
to	O
the	O
170/100	O
range	O
,	O
which	O
apparently	O
happened	O
during	O
her	B-treatment
prior	I-treatment
chemotherapy	I-treatment
.	O

The	O
patient	O
was	O
instructed	O
to	O
followup	O
with	O
her	O
internist	O
regarding	O
further	B-test
evaluation	I-test
of	O
her	B-problem
hypertension	I-problem
,	O
and	O
should	O
be	O
assessed	O
regarding	O
further	B-treatment
management	I-treatment
,	O
as	O
an	O
inpatient	O
,	O
or	O
while	O
receiving	O
chemotherapy	B-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
discharged	O
home	O
on	O
Coumadin	B-treatment
2.5	O
mg.	O
po	O
q	O
d	O
,	O
and	O
Ativan	B-treatment
and	O
Lomotil	B-treatment
prn	O
.	O

The	O
patient	O
is	O
to	O
followup	O
with	O
Dr.	O
Slaineaee	O
Ganz	O
and	O
was	O
discharged	O
home	O
in	O
good	O
condition	O
.	O

TOMEDANKELL	O
FLOWAYLES	O
,	O
M.D.	O
DICTATING	O
FOR	O
;	O
SLAINEAEE	O
GANZ	O
,	O
M.D.	O

TR	O
:	O

qo	O
/	O
bmot	O

DD	O
:	O

09/24/92	O
PAD-WORD	O

TD	O
:	O

09/27/92	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2017-04-26	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-05-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1955-02-25	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARD	O
CMED	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
62	O
year	O
old	O
gentleman	O
who	O
underwent	O
an	B-test
exercise	I-test
treadmill	I-test
test	I-test
for	O
screening	B-test
through	O
the	O
Beth	O
Israel	O
Deaconess	O
Hospital-Needham	O
Clinic	O
.	O

The	B-test
test	I-test
was	O
positive	O
for	O
EKG	B-problem
changes	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
has	O
no	O
history	O
of	O
chest	B-problem
pain;	I-problem
no	O
history	O
of	O
myocardial	B-problem
infarction	I-problem
.	O

The	O
patient	O
was	O
referred	O
to	O
Cambridge	O
Health	O
Alliance	O
for	O
cardiac	B-test
catheterization	I-test
.	O

Cardiac	B-test
catheterization	I-test
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
50%	O
,	O
left	B-test
ventricular	I-test
end	I-test
diastolic	I-test
pressure	I-test
of	O
20	O
,	O
90%	B-problem
left	I-problem
anterior	I-problem
descending	I-problem
lesion	I-problem
,	O
80%	B-problem
left	I-problem
circumflex	I-problem
lesion	I-problem
,	O
80%	B-problem
mid	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
lesion	I-problem
and	O
80%	B-problem
distal	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
lesion	I-problem
.	O

The	O
patient	O
was	O
referred	O
to	O
Dr.	O
Rota	O
for	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
.	O

2.	O
Type	B-problem
2	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

4.	O
Thirty	O
pack	O
year	O
tobacco	O
history	O
,	O
quit	O
one	O
month	O
ago	O
.	O

5.	O
Gout	B-problem
.	O

6.	O
Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

7.	O
History	O
of	O
salivary	B-treatment
gland	I-treatment
removal	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PREOPERATIVE	O
MEDICATIONS	O
:	O

1.	O
Glucophage	B-treatment
XR	O
1000	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Avandia	B-treatment
4	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Diovan	B-treatment
160	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Atenolol	B-treatment
25	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

6.	O
Niaspan	B-treatment
500	O
mg	O
p.o.	O
q.	O
day	O
.	O

7.	O
Enteric-coated	B-treatment
aspirin	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Saint	O
Vincent	O
Hospital	O
on	O
2017-04-26	O
and	O
underwent	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
four	O
with	O
left	B-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
to	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
right	I-treatment
coronary	I-treatment
artery	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
PDA	I-treatment
and	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
obtuse	I-treatment
marginal	I-treatment
with	O
Dr.	O
Rota	O
.	O

Please	O
see	O
the	O
Operative	O
Note	O
for	O
further	O
details	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
on	O
Neo-Synephrine	B-treatment
infusion	I-treatment
.	O

The	O
patient	O
was	O
weaned	O
the	O
next	O
day	O
from	O
mechanical	B-treatment
ventilation	I-treatment
on	O
his	O
first	O
postoperative	O
night	O
.	O

Postoperative	O
days	O
one	O
and	O
two	O
,	O
the	O
patient	O
continued	O
to	O
require	O
Neo-Synephrine	B-treatment
to	O
maintain	O
systolic	B-test
blood	I-test
pressures	I-test
greater	O
than	O
100	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
the	B-test
patient	I-test
's	I-test
hematocrit	I-test
was	O
noted	O
to	O
be	O
23.1	O
;	O
he	O
was	O
transfused	O
one	O
unit	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
as	O
well	O
as	O
given	O
a	O
dose	O
of	O
Lasix	B-treatment
.	O

The	B-treatment
Neo-Synephrine	I-treatment
was	O
weaned	O
off	O
by	O
postoperative	O
day	O
number	O
three	O
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
chest	I-treatment
tubes	I-treatment
were	O
removed	O
on	O
postoperative	O
day	O
three	O
without	O
incident	B-problem
.	O

The	O
patient	O
was	O
started	O
on	O
low	B-treatment
dose	I-treatment
Lasix	I-treatment
and	O
Lopressor	B-treatment
which	O
he	O
tolerated	O
well	O
.	O

On	O
postoperative	O
day	O
number	O
four	O
,	O
the	O
patient	O
was	O
transferred	O
from	O
the	O
Intensive	O
Care	O
Unit	O
to	O
the	O
regular	O
part	O
of	O
the	O
hospital	O
where	O
he	O
began	O
working	O
with	O
Physical	O
Therapy	O
and	O
on	O
his	O
first	O
session	O
he	O
was	O
able	O
to	O
ambulate	O
500	O
feet	O
and	O
climb	O
one	O
flight	O
of	O
stairs	O
while	O
remaining	O
hemodynamically	O
stable	O
without	O
requiring	O
any	B-treatment
oxygen	I-treatment
.	O

On	O
postoperative	O
day	O
number	O
five	O
,	O
the	O
patient	O
continued	O
to	O
remain	O
hemodynamically	O
stable	O
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
epicardial	I-treatment
pacing	I-treatment
wires	I-treatment
were	O
removed	O
without	O
incident	B-problem
and	O
the	O
patient	O
was	O
cleared	O
for	O
discharge	O
to	O
home	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Temperature	B-test
maximum	I-test
99.8	O
F.	O
;	O
pulse	B-test
76	O
and	O
sinus	O
rhythm	O
;	O
blood	B-test
pressure	I-test
107/61	O
;	O
respiratory	B-test
rate	I-test
18	O
;	O
room	B-test
air	I-test
oxygen	I-test
saturation	I-test
95%	O
.	O

The	B-test
patient	I-test
's	I-test
weight	I-test
on	O
05-01	O
was	O
101.4	O
.	O

The	O
patient	O
weighed	O
100	O
kilograms	O
preoperatively	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
5.8	O
,	O
hematocrit	B-test
23.5	O
,	O
platelet	B-test
count	I-test
118	O
.	O

Sodium	B-test
140	O
,	O
potassium	B-test
3.9	O
,	O
chloride	B-test
103	O
,	O
bicarbonate	B-test
18	O
,	O
BUN	B-test
11	O
,	O
creatinine	B-test
0.8	O
,	O
glucose	B-test
144	O
.	O

PT	B-test
29	O
,	O
INR	B-test
1.1	O
and	O
PTT	B-test
22.9	O
.	O

Neurologically	O
,	O
the	O
patient	O
is	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
anxious	O
.	O

Neurological	B-test
examination	I-test
is	O
non-focal	O
.	O

Heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
without	O
rub	B-problem
or	O
murmur	B-problem
.	O

Respiratory	B-test
breath	I-test
sounds	I-test
are	O
clear	O
bilaterally	O
,	O
decreased	B-problem
at	I-problem
the	I-problem
bases	I-problem
.	O

Abdomen	O
with	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
tolerating	O
a	O
regular	O
diet	O
.	O

Sternal	B-treatment
incision	I-treatment
staples	I-treatment
are	O
intact	O
and	O
open	O
to	O
air	O
.	O

Incision	B-problem
is	O
clean	O
and	O
dry	O
.	O

There	O
is	O
no	O
erythema	B-problem
and	O
sternum	O
is	O
stable	O
.	O

Right	B-problem
lower	I-problem
extremity	I-problem
vein	I-problem
harvest	I-problem
site	I-problem
has	O
a	O
moderate	O
amount	O
of	O
ecchymosis	B-problem
at	O
the	O
very	O
distal	O
portion	O
of	O
the	B-problem
incision	I-problem
at	I-problem
the	I-problem
ankle	I-problem
.	O

There	O
is	O
a	O
minimum	O
amount	O
of	O
serosanguinous	B-problem
drainage	I-problem
.	O

There	O
is	O
no	O
erythema	B-problem
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

2.	O
Status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
four	O
.	O

3.	O
Type	B-problem
2	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

4.	O
Postoperative	B-problem
anemia	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Atenolol	B-treatment
25	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
times	O
seven	O
days	O
.	O

3.	O
Potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
p.o.	O
q.	O
day	O
times	O
seven	O
days	O
.	O

4.	O
Niferex	B-treatment
150	O
mg	O
p.o.	O
q.	O
day	O
times	O
one	O
month	O
.	O

5.	O
Vitamin	B-treatment
C	I-treatment
500	O
mg	O
p.o.	O
twice	O
a	O
day	O
times	O
one	O
month	O
.	O

6.	O
Multivitamin	B-treatment
one	O
p.o.	O
q.	O
day	O
times	O
one	O
month	O
.	O

7.	O
Ambien	B-treatment
5	O
mg	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O

8.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

9.	O
Avandia	B-treatment
4	O
mg	O
p.o.	O
q.	O
day	O
.	O

10.	O
Glucophage	B-treatment
500	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

11.	O
Lipitor	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

12.	O
Zantac	B-treatment
150	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

13.	O
Niaspan	B-treatment
500	O
mg	O
p.o.	O
q.	O
day	O
.	O

14.	O
Percocet	B-treatment
5/325	O
one	O
to	O
two	O
p.o.	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
condition	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Neri	O
in	O
one	O
to	O
two	O
weeks	O
.	O

2.	O
The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Rota	O
in	O
three	O
to	O
four	O
weeks	O
.	O

3.	O
The	O
patient	O
is	O
to	O
return	O
to	O
Smith	O
on	O
or	O
about	O
05-17	O
to	O
have	O
his	B-treatment
staples	I-treatment
removed	O
.	O

Gabriela	O
E.	O
D.	O
Castillo	O
,	O
M.D.	O
05-025	O

Dictated	O
By	O
:	O
Julia	O
Q	O
Mcafee	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2017-05-01	O
15:06	O

T	O
:	O
2017-05-01	O
15:37	O

JOB	O
#	O
:	O
59432	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kathy	O
Brendel	O
on	O
:	O
TUE	O
2017-05-02	O
8:08	O
AM	O

(	O
End	O
of	O
Report	O
)	O

313251236	O
WGH	O

1429918	O
PAD-WORD	O

816995	O
PAD-WORD	O

0854768	O
PAD-WORD	O

5/1/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

KATESJESC	O
,	O
RAI	O

MRN	O
:	O

1429918	O
PAD-WORD	O

Age	O
:	O

60y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

05/01/2004	O
06:30	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
KATESJESC	O
,	O
RAI	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Well	O
General	O
Hospital	O
on	O
05/01/2004	O
06:30	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SSCP	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
WELL	O
GENERAL	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
REKE	O
,	O
ATOTA	O
S	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
ACS	B-problem
..	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
366-686-5449	O
.	O

PCP	O
Name	O
:	O

REKE	O
,	O
ATOTA	O
S	O

Provider	O
Number	O
:	O

36860	O
PAD-WORD	O

0488076	O
PAD-WORD	O

Admission	O
Date	O
:	O

2015-07-12	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-07-19	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1970-05-06	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
48	O
-	O
year-old	O
woman	O
who	O
was	O
transferred	O
from	O
Shaugnessy-Kaplan	O
Rehab	O
Hospital	O
.	O

The	O
patient	O
originally	O
presented	O
to	O
her	O
PCP	O
approximately	O
one	O
week	O
prior	O
to	O
admission	O
here	O
with	O
increasing	B-problem
cough	I-problem
,	O
dyspnea	B-problem
and	O
fatigue	B-problem
.	O

She	O
was	O
given	O
a	B-treatment
Z-Pak	I-treatment
for	O
treatment	B-treatment
along	O
with	O
albuterol	B-treatment
.	O

Despite	O
this	O
,	O
she	O
continued	O
to	O
worsen	O
and	O
became	O
febrile	B-problem
.	O

So	O
,	O
she	O
was	O
admitted	O
to	O
Shaugnessy-Kaplan	O
Rehab	O
Hospital	O
on	O
2015-07-10	O
.	O

At	O
the	O
hospital	O
,	O
she	O
was	O
started	O
on	O
Rocephin	B-treatment
and	O
Levaquin	B-treatment
for	O
a	B-problem
right	I-problem
lower	I-problem
lobe	I-problem
pneumonia	I-problem
seen	O
on	O
chest	B-test
x-ray	I-test
.	O

She	O
continued	O
to	O
have	O
increasing	B-problem
respiratory	I-problem
distress	I-problem
with	O
hypoxia	B-problem
.	O

She	O
was	O
also	O
significantly	B-problem
tachypneic	I-problem
.	O

At	O
this	O
time	O
,	O
repeat	B-test
chest	I-test
x-ray	I-test
showed	O
bilateral	B-problem
diffuse	I-problem
infiltrates	I-problem
consistent	O
with	O
ARDS	B-problem
.	O

The	O
patient	O
was	O
intubated	O
and	O
then	O
transferred	O
to	O
Hahnemann	O
General	O
Hospital	O
CMED	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypothyroidism	B-problem
.	O

Depression	B-problem
.	O

Anxiety	B-problem
disorder	I-problem
.	O

MEDICATIONS	O
:	O

1.	O
Levoxyl	B-treatment
112	O
mcg	O
q.d.	O

2.	O
Prozac	B-treatment
.	O

3.	O
Codeine	B-treatment
for	O
cough	B-problem
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
unemployed	O
.	O

She	O
smokes	O
approximately	O
one	O
pack	O
per	O
day	O
.	O

She	O
drinks	O
alcohol	O
socially	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
vital	B-test
signs:	I-test

Temperature	B-test
101.4	O
,	O
blood	B-test
pressure	I-test
101/62	O
,	O
pulse	B-test
80	O
,	O
respiratory	B-test
rate	I-test
19	O
on	O
a	B-treatment
ventilator	I-treatment
with	O
settings	O
of	O
assist	B-treatment
control	I-treatment
at	O
500/12	O
and	O
a	B-treatment
PEEP	I-treatment
of	O
5	O
.	O

General	O
:	O

The	O
patient	O
is	O
intubated	B-treatment
and	O
sedated	B-treatment
,	O
but	O
easily	O
arousable	O
.	O

HEENT	O
:	O

Pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Sclerae	O
are	O
anicteric	B-problem
.	O

ET	B-treatment
tube	I-treatment
is	O
in	O
place	O
.	O

Neck	O
:	O

Soft	O
and	O
supple	O
.	O

Cardiovascular	O
:	O

Normal	O
.	O

Chest	O
:	O

Faint	B-problem
scattered	I-problem
wheezes	I-problem
bilaterally	I-problem
.	O

Abdomen	O
:	O

Benign	O
.	O

Extremities	O
:	O

Warm	O
with	O
good	O
distal	O
pulses	O
.	O

There	O
is	O
no	O
edema	B-problem
.	O

Neurologic	O
:	O

Able	O
to	O
follow	O
simple	O
commands	O
.	O

LABORATORY	O
DATA	O
:	O

Labs	B-test
on	O
admission	O
from	O
outside	O
hospital	O
,	O
CBC	B-test
notable	O
for	O
a	B-test
white	I-test
count	I-test
of	O
21.9	O
with	O
hematocrit	B-test
of	O
36.3	O
and	O
normal	O
platelets	O
.	O

Chem-7	B-test
notable	O
for	O
potassium	B-test
of	O
3.2	O
and	O
bicarbonate	B-test
of	O
30	O
.	O

LFTs	B-test
show	O
an	B-problem
elevated	I-problem
ALT	I-problem
of	O
52	O
and	O
AST	B-test
of	O
101	O
with	O
normal	O
alkaline	O
phosphatase	O
and	O
total	B-test
bilirubin	I-test
.	O

Latest	B-test
arterial	I-test
blood	I-test
gas	I-test
with	O
pH	B-test
of	O
7.45	O
,	O
pCO2	B-test
43	O
and	O
pO2	B-test
155	O
on	O
100	B-treatment
percent	I-treatment
oxygen	I-treatment
via	O
ventilator	B-treatment
.	O

RADIOGRAPHIC	O
STUDIES	O
:	O

Chest	B-test
x-ray	I-test
shows	O
right	B-problem
middle	I-problem
lobe	I-problem
,	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
,	I-problem
and	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
infiltrates	I-problem
.	O

EKG	B-test
shows	O
normal	O
sinus	O
rhythm	O
at	O
70	O
beats	O
per	O
minute	O
with	O
normal	O
axis	O
and	O
intervals	O
,	O
borderline	B-problem
LVH	I-problem
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

Respiratory	O
:	O

On	O
admission	O
,	O
the	O
patient	O
had	O
what	O
appeared	O
to	O
be	O
acute	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
secondary	O
to	O
community	B-problem
-	I-problem
acquired	I-problem
pneumonia	I-problem
.	O

She	O
was	O
maintained	O
on	O
a	B-treatment
ventilator	I-treatment
and	O
ventilated	O
according	O
to	O
ARDSNet	O
protocol	O
.	O

For	O
antibiotic	B-treatment
coverage	I-treatment
of	O
her	B-problem
pneumonia	I-problem
,	O
she	O
was	O
started	O
on	O
Levaquin	B-treatment
,	O
ceftriaxone	B-treatment
,	O
and	O
vancomycin	B-treatment
.	O

Over	O
the	O
next	O
two	O
days	O
after	O
admission	O
,	O
the	B-treatment
patient	I-treatment
's	I-treatment
vent	I-treatment
settings	I-treatment
were	O
gradually	O
weaned	O
,	O
and	O
she	O
was	O
extubated	O
two	O
days	O
after	O
being	O
transferred	O
to	O
this	O
hospital	O
.	O

After	O
extubation	B-treatment
,	O
the	O
patient	O
was	O
oxygenating	O
well	O
on	O
face	B-treatment
mask	I-treatment
.	O

She	O
did	O
continue	O
to	O
have	O
a	B-problem
persistent	I-problem
fairly	I-problem
severe	I-problem
cough	I-problem
;	O
however	O
,	O
her	B-problem
cough	I-problem
was	O
weak	B-problem
due	O
to	O
abdominal	B-problem
muscle	I-problem
pain	I-problem
from	O
repeated	B-problem
coughing	I-problem
.	O

The	B-problem
cough	I-problem
was	O
mostly	B-problem
nonproductive	I-problem
.	O

The	O
patient	O
was	O
breathing	O
comfortably	O
.	O

As	O
there	O
was	O
no	O
identified	B-problem
bacterial	I-problem
pathogen	I-problem
on	O
any	B-test
cultures	I-test
,	O
the	O
patient	O
was	O
continued	O
on	O
the	B-treatment
triple	I-treatment
antibiotics	I-treatment
for	O
first	O
several	O
days	O
of	O
the	O
hospitalization	O
.	O

She	O
was	O
also	O
on	O
round-the-clock	B-treatment
Atrovent	I-treatment
and	O
albuterol	B-treatment
nebulizers	I-treatment
.	O

Once	O
the	O
patient	O
was	O
transferred	O
out	O
of	O
the	O
ICU	O
and	O
after	O
extubation	B-treatment
,	O
the	B-treatment
antibiotics	I-treatment
were	O
gradually	O
narrowed	O
.	O

The	B-treatment
vancomycin	I-treatment
and	O
Levaquin	B-treatment
were	O
discontinued	O
after	O
approximately	O
four	O
days	O
in	O
the	O
hospital	O
.	O

The	B-treatment
ceftriaxone	I-treatment
was	O
discontinued	O
after	O
four	O
days	O
in	O
the	O
hospital	O
,	O
and	O
the	O
patient	O
was	O
to	O
continue	O
on	O
Levaquin	B-treatment
.	O

The	O
patient	O
had	O
gradual	O
improvement	O
in	O
her	B-test
oxygenation	I-test
.	O

Pain	B-treatment
control	I-treatment
:	O

The	O
patient	O
had	O
fairly	B-problem
significant	I-problem
abdominal	I-problem
pain	I-problem
secondary	O
to	O
persistent	B-problem
cough	I-problem
.	O

She	O
was	O
started	O
on	O
a	O
regimen	O
of	O
MS	B-treatment
Contin	I-treatment
with	O
oxycodone	B-treatment
for	O
breakthrough	B-problem
pain	I-problem
.	O

This	O
helped	O
her	O
somewhat	O
though	O
she	O
has	O
continued	O
to	O
have	O
difficulty	B-problem
coughing	I-problem
due	O
to	O
the	B-problem
pain	I-problem
.	O

Tylenol	B-treatment
and	O
ibuprofen	B-treatment
were	O
also	O
added	O
for	O
better	O
control	O
.	O

Transaminitis	B-problem
:	O

The	O
patient	O
was	O
noted	O
to	O
have	O
mild	B-problem
transaminitis	I-problem
on	O
admission	O
.	O

However	O
,	O
this	O
was	O
felt	O
to	O
be	O
due	O
to	O
her	B-problem
significant	I-problem
infection	I-problem
.	O

This	O
should	O
continue	O
to	O
be	O
followed	O
as	O
an	O
outpatient	O
to	O
assure	O
that	O
it	O
returns	O
back	O
to	O
normal	O
.	O

Anemia	B-problem
:	O

The	B-test
patient	I-test
's	I-test
reticulocyte	I-test
count	I-test
showed	O
inadequate	B-problem
production	I-problem
.	O

Iron	B-test
studies	I-test
showed	O
a	O
mixed	O
picture	O
with	O
decreased	B-problem
iron	I-problem
and	O
decreased	B-problem
iron	I-problem
to	I-problem
TIBC	I-problem
ratio	I-problem
suggestive	O
of	O
iron-deficiency	B-problem
anemia	I-problem
,	O
but	O
also	O
normal	O
to	O
high	B-problem
MCV	I-problem
.	O

B12	B-test
was	O
noted	O
to	O
be	O
low	B-problem
and	O
the	O
patient	O
was	O
given	O
an	O
injection	O
of	O
IM	B-treatment
B12	I-treatment
while	O
in	O
the	O
hospital	O
.	O

She	O
was	O
also	O
started	O
on	O
iron	B-treatment
supplementation	I-treatment
.	O

Hypothyroidism	B-problem
:	O

The	O
patient	O
was	O
continued	O
on	O
Synthroid	B-treatment
for	O
her	B-problem
chronic	I-problem
hypothyroidism	I-problem
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
was	O
discharged	O
home	O
with	O
services	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Good	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Community-acquired	B-problem
pneumonia	I-problem
.	O

Acute	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
.	O

Iron-deficiency	B-problem
anemia	I-problem
.	O

Hypothyroidism	B-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Levothyroxine	B-treatment
75	O
mcg	O
q.d.	O

2.	O
Prozac	B-treatment
40	O
mg	O
q.d.	O

3.	O
Levaquin	B-treatment
500	O
mg	O
q.d.	O
for	O
7	O
days	O
after	O
discharge	O
.	O

4.	O
Guaifenesin	B-treatment
syrup	I-treatment
p.r.n.	O
cough	B-problem
.	O

5.	O
Oxycodone	B-treatment
10	O
mg	O
q.4	O
h.	O
p.r.n.	O
for	O
pain	B-problem
.	O

6.	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O

7.	O
MS	B-treatment
Contin	I-treatment
30	O
mg	O
b.i.d.	O

8.	O
Ibuprofen	B-treatment
800	O
mg	O
q.8	O
h	O
.	O

9.	O
Albuterol	B-treatment
1	O
to	O
2	O
puffs	O
q.6	O
h.	O
p.r.n.	O

10.	O
Atrovent	B-treatment
1	O
puff	O
q.6	O
h.	O
p.r.n.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Follow-up	O
Plans	O
:	O

The	O
patient	O
was	O
instructed	O
to	O
call	O
her	O
PCP	O
,	O
Dr.	O
Ruby	O
Godfrey	O
,	O
to	O
follow	O
up	O
the	O
week	O
of	O
discharge	O
.	O

She	O
is	O
also	O
to	O
call	O
her	O
PCP	O
if	O
she	O
has	O
increasing	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
or	O
fevers	B-problem
.	O

Richard	O
Wanita	O
,	O
Washington	O
30778	O

Dictated	O
By	O
:	O
Christopher	O
QX	O
Morse	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-09-14	O
17:19:48	O

T	O
:	O
2015-09-15	O
00:27:21	O

Job	O
#	O
:	O
18355	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Phillip	O
Garcia	O
on	O
:	O
WED	O
2015-09-16	O
5:10	O
PM	O

(	O
End	O
of	O
Report	O
)	O

316810105	O
PAD-WORD	O

BH	O
PAD-WORD	O

5442905	O
PAD-WORD	O

550393	O
PAD-WORD	O

03/17/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

KAYSLANCE	O
,	O
ICEROYLN	O

MRN	O
:	O

5442905	O
PAD-WORD	O

Age	O
:	O

58y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

03/17/2003	O
02:52	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
KAYSLANCE	O
,	O
ICEROYLN	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Bri	O
Health	O
on	O
03/17/2003	O
02:52	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
LEFT	B-problem
LEG	I-problem
FX	I-problem
HIP	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
ofthe	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
BRI	O
HEALTH	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
HEAGLEINCHIRD	O
,	O
JEANSIA	O
S	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
HIP	B-problem
FRACTURE	I-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
442-025-0303	O
.	O

PCP	O
Name	O
:	O

NONE	O
,	O
PHYSICIAN	O

Provider	O
Number	O
:	O

27715	O
PAD-WORD	O

Admission	O
Date	O
:	O

2017-09-13	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-09-15	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1972-05-09	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

NSU	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
45	O
-	O
year-old	O
female	O
here	O
for	O
a	B-test
diagnostic	I-test
cerebral	I-test
angiogram	I-test
with	O
coiling	B-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
admission	O
,	O
the	B-test
patient	I-test
's	I-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

Her	B-test
blood	I-test
pressure	I-test
was	O
102/82	O
.	O

Her	B-test
heart	I-test
rate	I-test
was	O
71	O
.	O

Her	B-test
SPO2	I-test
was	O
98	O
percent	O
on	O
room	O
air	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Plavix	B-treatment
75	O
mg	O
times	O
6	O
doses	O
.	O

2.	O
Xanax	B-treatment
q.d.	O

3.	O
Prozac	B-treatment
20	O
mg	O
q.d.	O

4.	O
Cyclobenzaprine	B-treatment
10	O
mg	O
q.d.	O

5.	O
Aspirin	B-treatment
325	O
mg	O
times	O
3	O
doses	O
.	O

6.	O
Vitamin	B-treatment
E	I-treatment
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Tubal	B-treatment
ligation	I-treatment
,	O
1986	O
.	O

Cystectomy	B-treatment
,	O
1992	O
and	O
1998	O
.	O

Breast	B-treatment
lesion	I-treatment
excision	I-treatment
,	O
1989	O
.	O

ALLERGIES	O
:	O

TETRACYCLINE	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
uses	O
alcohol	O
socially	O
;	O
was	O
a	O
smoker	O
,	O
used	O
tobacco	O
,	O
she	O
quit	O
4	O
years	O
ago	O
;	O
denies	O
using	O
recreational	O
drug	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
had	O
complaint	O
of	O
headaches	B-problem
in	O
the	O
past	O
.	O

She	O
has	O
fibromyalgia	B-problem
and	O
a	O
history	O
of	O
slurred	B-problem
speech	I-problem
.	O

Her	O
last	O
menstrual	O
period	O
was	O
on	O
2017-08-29	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
2017-09-13	O
,	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
and	O
underwent	O
a	B-treatment
coiling	I-treatment
with	O
stent	B-treatment
placement	I-treatment
of	O
the	B-problem
left	I-problem
carotid	I-problem
ophthalmic	I-problem
aneurysm	I-problem
.	O

The	O
patient	O
underwent	O
coiling	B-treatment
and	O
stent	B-treatment
placement	I-treatment
without	O
complications	B-problem
.	O

She	O
was	O
discharged	O
to	O
the	O
PACU	O
in	O
stable	O
condition	O
.	O

Postoperative	B-test
check	I-test
,	O
the	B-test
patient	I-test
's	I-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

Her	B-test
temperature	I-test
was	O
96.3	O
degrees	O
,	O
blood	B-test
pressure	I-test
was	O
128/63	O
.	O

Her	B-test
pulse	I-test
was	O
61	O
,	O
respirations	B-test
12	O
,	O
and	O
her	B-test
O2	I-test
saturation	I-test
was	O
98	O
percent	O
on	O
room	O
air	O
.	O

Her	B-test
labs	I-test
showed	O
a	B-test
white	I-test
blood	I-test
count	I-test
of	O
7.7	O
,	O
hematocrit	B-test
of	O
33.3	O
,	O
and	O
platelets	B-test
were	O
305	O
.	O

Her	B-test
coags	I-test
,	O
her	B-test
PT	I-test
was	O
14.5	O
,	O
PTT	B-test
was	O
143.4	O
,	O
and	O
her	B-test
INR	I-test
was	O
1.3	O
.	O

Her	B-test
electrolytes	I-test
were	O
all	O
within	O
normal	O
limits	O
.	O

On	O
physical	B-test
exam	I-test
,	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
times	O
3	O
.	O

She	O
had	O
a	O
symmetric	O
smile	O
.	O

Her	O
extraocular	O
movements	O
were	O
full	O
.	O

Her	O
pupils	O
were	O
3	O
to	O
2	O
bilaterally	O
,	O
briskly	O
reactive	O
.	O

The	O
visual	O
fields	O
were	O
intact	O
.	O

Her	O
strength	O
was	O
05-31	O
throughout	O
except	O
for	O
right	O
was	O
not	O
tested	O
due	O
to	O
the	B-problem
angiocele	I-problem
in	I-problem
her	I-problem
groin	I-problem
.	O

Angiocele	B-problem
was	O
intact	O
without	O
hematoma	B-problem
,	O
and	O
she	O
exhibited	O
strong	O
pedal	O
pulses	O
on	O
the	O
right	O
side	O
.	O

The	B-test
assessment	I-test
at	O
that	O
time	O
was	O
she	O
was	O
neurologically	O
stable	O
.	O

The	O
plan	O
was	O
q.	O
1-hour	O
neuro	B-test
checks	I-test
.	O

She	O
was	O
started	O
on	O
a	B-treatment
heparin	I-treatment
drip	I-treatment
at	O
800	O
per	O
hour	O
.	O

Her	B-test
PTT	I-test
goes	O
50	O
to	O
60	O
at	O
that	O
time	O
.	O

She	O
was	O
cleared	O
to	O
take	O
sips	O
of	O
clear	O
fluids	O
and	O
was	O
to	O
remain	O
flat	O
for	O
4	O
hours	O
.	O

On	O
postoperative	O
day	O
1	O
,	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
3	O
.	O

She	O
exhibited	O
no	O
drift	B-problem
.	O

Her	B-test
IPs	I-test
were	O
full	O
at	O
5/5	O
.	O

She	O
had	O
no	O
hematoma	B-problem
in	I-problem
her	I-problem
groin	I-problem
site	I-problem
.	O

Visual	O
fields	O
were	O
full	O
,	O
her	O
pupils	O
were	O
round	O
and	O
reactive	O
bilaterally	O
.	O

Her	B-test
vital	I-test
signs	I-test
were	O
stable	O
with	O
a	B-test
temperature	I-test
of	O
97.8	O
degrees	O
,	O
blood	B-test
pressure	I-test
was	O
104	O
to	O
121	O
over	O
50s	O
.	O

Pulse	B-test
was	O
60	O
to	O
70	O
.	O

Respirations	B-test
were	O
15	O
,	O
and	O
she	O
was	O
saturating	O
at	O
96	O
percent	O
on	O
room	O
air	O
.	O

Her	B-test
PTT	I-test
at	O
that	O
time	O
was	O
67.8	O
.	O

She	O
was	O
started	O
on	O
aspirin	B-treatment
325	O
mg	O
q.d.	O
and	O
Plavix	B-treatment
75	O
mg	O
q.d.	O

On	O
2017-09-14	O
,	O
she	O
was	O
transferred	O
to	O
the	O
regular	O
floor	O
at	O
Far	O
5	O
.	O

Postoperative	O
day	O
2	O
,	O
the	O
patient	O
was	O
stable	O
without	O
events	O
,	O
all	B-test
vital	I-test
signs	I-test
were	O
stable	O
.	O

She	O
was	O
moving	O
all	O
extremities	O
and	O
exhibiting	O
good	O
strength	O
.	O

Her	O
visual	O
fields	O
were	O
intact	O
.	O

Her	O
extraocular	O
movements	O
were	O
full	O
.	O

Angio	B-problem
site	I-problem
was	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
without	O
bleeding	B-problem
or	O
drainage	B-problem
.	O

She	O
was	O
to	O
be	O
discharged	O
today	O
and	O
encouraged	O
to	O
ambulate	O
on	O
her	O
own	O
.	O

Discharge	O
condition	O
for	O
this	O
patient	O
was	O
good	O
.	O

She	O
was	O
ambulating	O
on	O
her	O
own	O
and	O
tolerating	O
a	O
p.o.	O
diet	O
.	O

She	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Plavix	B-treatment
75	O
mg	O
q.d.	O

2.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

She	O
is	O
to	O
continue	O
taking	O
medications	B-treatment
as	O
prescribed	O
.	O

She	O
is	O
to	O
undergo	O
no	O
strenuous	O
activity	O
until	O
follow-up	O
in	O
2	O
weeks	O
.	O

FINAL	O
DIAGNOSIS	O
:	O

She	O
is	O
status	O
post	O
coiling	B-treatment
with	O
stent	B-treatment
placement	I-treatment
for	O
left	B-problem
carotid	I-problem
ophthalmic	I-problem
aneurysm	I-problem
.	O

RECOMMENDED	O
FOLLOW-UP	O
:	O

She	O
is	O
following	O
up	O
with	O
Dr.	O
Mcmaster	O
on	O
2017-09-29	O
at	O
11:30	O
a.m.	O

She	O
is	O
also	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
to	O
review	O
her	B-treatment
hypertensive	I-treatment
medications	I-treatment
.	O

SURGICAL	O
INTERVENTION	O
:	O

Coiling	B-treatment
with	O
a	B-treatment
stent	I-treatment
placement	I-treatment
for	O
left	B-problem
carotid	I-problem
artery	I-problem
aneurysm	I-problem
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

She	O
is	O
neurologically	O
stable	O
.	O

Helen	O
Cynthia	O
,	O
New	O
York	O
10969	O

Dictated	O
By	O
:	O
Scott	O
T	O
Little	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2017-09-15	O
09:28:45	O

T	O
:	O
2017-09-15	O
15:37:05	O

Job	O
#	O
:	O
23470	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Mae	O
Behlmer	O
on	O
:	O
MON	O
2017-10-09	O
5:18	O
AM	O

(	O
End	O
of	O
Report	O
)	O

325924358	O
PAD-WORD	O

FIH	O
PAD-WORD	O

7061594	O
PAD-WORD	O

795820	O
PAD-WORD	O

418796	O
PAD-WORD	O

08/15/1998	O
12:00:00	O
AM	O

CORONARY	B-problem
ARTERY	I-problem
DISEASE	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

TLANDRAC	O
,	O
NI	O

UNIT	O
NUMBER	O
:	O

388-23-03	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

08/15/1998	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

08/22/1998	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Failed	B-problem
coronary	I-problem
artery	I-problem
bypass	I-problem
graft	I-problem
,	O
prior	B-problem
myocardial	I-problem
infarction	I-problem
,	O
hypertension	B-problem
,	O
elevated	B-problem
cholesterol	I-problem
,	O
renal	B-problem
insufficiency	I-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

08/20/98	O
dual	B-treatment
chamber	I-treatment
pacemaker	I-treatment
generator	I-treatment
change	I-treatment
(	O
CPI	O
1276	O
Meridian	O
DR	O
)	O
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

08/15/98	O
bilateral	B-test
heart	I-test
catheterization	I-test
;	O
08/15/98	O
left	B-test
ventriculography	I-test
;	O
08/15/98	O
bilateral	B-test
coronary	I-test
angiography	I-test
;	O
08/15/98	O
bypass	B-test
graft	I-test
angiography	I-test
;	O
08/15/98	O
internal	B-test
mammary	I-test
artery	I-test
angiography	I-test
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Aspirin	B-treatment
325	O
mg.	O
PO	O
q.d.	O

Lipitor	B-treatment
80	O
mg.	O
PO	O
q.d.	O

Toprol	B-treatment
XL	I-treatment
50	O
mg.	O
PO	O
q.d.	O

Lasix	B-treatment
80	O
mg.	O
q.a.m.	O
and	O
40	O
mg.	O
q.p.m.	O

Potassium	B-treatment
chloride	I-treatment
20	O
mEq.	O
PO	O
b.i.d.	O

Citracal	B-treatment
1	O
packet	O
q.d.	O

Imdur	B-treatment
60	O
mg.	O
PO	O
q.d.	O

Vitamin	B-treatment
E	I-treatment
400	O
international	O
units	O
q.d.	O

Prilosec	B-treatment
20	O
mg.	O
PO	O
q.d.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Breunlinke	O
is	O
a	O
70-year-old	O
patient	O
of	O
Dr.	O
Brendniungand	O
Asilbekote	O
in	O
California	O
.	O

She	O
is	O
referred	O
for	O
progressive	B-problem
angina	I-problem
.	O

She	O
had	O
rheumatoid	B-problem
fever	I-problem
as	O
a	O
child	O
and	O
a	B-problem
heart	I-problem
murmur	I-problem
noted	O
but	O
no	O
further	B-test
testing	I-test
.	O

She	O
has	O
used	O
antibiotic	B-treatment
prophylaxis	I-treatment
since	O
1980	O
.	O

In	O
1980	O
she	O
had	O
quadruple	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
surgery	I-treatment
by	O
Dr.	O
Elks	O
at	O
Feargunwake	O
Otacaa	O
Community	O
Hospital	O
and	O
did	O
well	O
until	O
1988	O
when	O
she	O
had	O
exertional	B-problem
angina	I-problem
and	O
a	B-problem
positive	I-problem
stress	I-problem
test	I-problem
and	O
found	O
that	O
three	B-treatment
or	I-treatment
four	I-treatment
grafts	I-treatment
were	O
occluded	B-problem
.	O

In	O
October	O
,	O
1989	O
,	O
Dr.	O
No	O
re-did	O
her	B-treatment
bypass	I-treatment
operation	I-treatment
.	O

She	O
had	O
a	B-treatment
left	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
obtuse	I-treatment
marginal	I-treatment
1	I-treatment
and	O
a	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
obtuse	I-treatment
marginal	I-treatment
2	I-treatment
.	O

In	O
1993	O
she	O
had	O
a	B-treatment
DDD	I-treatment
pacemaker	I-treatment
for	O
complete	B-problem
heart	I-problem
block	I-problem
.	O

She	O
had	O
exertional	B-problem
angina	I-problem
at	O
that	O
time	O
.	O

In	O
November	O
,	O
1997	O
she	O
had	O
a	B-problem
small	I-problem
myocardial	I-problem
infarction	I-problem
as	O
was	O
transferred	O
to	O
Ona	O
Hospital	O
where	O
a	B-test
cardiac	I-test
catheterization	I-test
showed	O
a	B-problem
tight	I-problem
left	I-problem
internal	I-problem
mammary	I-problem
artery	I-problem
to	O
left	B-problem
anterior	I-problem
descending	I-problem
stenosis	I-problem
,	O
high	O
grade	O
saphenous	O
vein	O
graft	O
to	O
obtuse	B-problem
marginal	I-problem
1	I-problem
stenosis	I-problem
and	O
patent	O
obtuse	O
marginal	O
2	O
graft	O
.	O

She	O
had	O
normal	O
left	O
ventricular	O
function	O
with	O
apical	B-problem
tip	I-problem
akinesis	I-problem
.	O

Since	O
that	O
time	O
she	O
has	O
continued	O
to	O
have	O
exertional	B-problem
left	I-problem
chest	I-problem
burning	I-problem
,	O
radiating	O
to	O
the	O
left	O
neck	O
and	O
arm	O
,	O
relieved	O
by	O
nitroglycerin	B-treatment
.	O

She	O
was	O
turned	O
down	O
for	O
re-do	B-treatment
surgery	I-treatment
at	O
that	O
time	O
and	O
did	O
not	O
have	O
a	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
.	O

Because	O
these	B-problem
symptoms	I-problem
have	O
been	O
increasing	O
,	O
particularly	O
at	O
cardiac	O
rehabilitation	O
,	O
she	O
was	O
referred	O
here	O
.	O

In	O
May	O
,	O
1998	O
she	O
had	O
an	B-test
exercise	I-test
tolerance	I-test
test	I-test
in	O
which	O
her	B-test
heart	I-test
rate	I-test
went	O
to	O
112	O
and	O
her	B-test
blood	I-test
pressure	I-test
fell	O
to	O
95	O
systolic	O
.	O

She	O
had	O
diffuse	B-problem
ischemic	I-problem
ST	I-problem
segment	I-problem
changes	I-problem
and	O
increased	B-problem
lung	I-problem
uptake	I-problem
and	O
a	B-problem
reversible	I-problem
anterior	I-problem
and	I-problem
lateral	I-problem
defect	I-problem
.	O

She	O
has	O
had	O
no	O
syncope	B-problem
.	O

Her	O
cardiac	O
risk	O
factors	O
are	O
hypertension	B-problem
and	O
elevated	B-problem
cholesterol	I-problem
.	O

She	O
has	O
a	O
very	O
strong	O
family	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
with	O
a	O
mother	O
,	O
sister	O
and	O
brother	O
dying	O
of	O
myocardial	B-problem
infarction	I-problem
.	O

She	O
is	O
a	O
remote	O
cigarette	O
smoker	O
.	O

She	O
also	O
has	O
a	O
history	O
of	O
lactose	B-problem
intolerance	I-problem
,	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
,	O
with	O
a	B-problem
remote	I-problem
gastrointestinal	I-problem
bleed	I-problem
and	O
multiple	B-problem
ectopic	I-problem
pregnancies	I-problem
and	O
mid	B-problem
term	I-problem
miscarriages	I-problem
.	O

She	O
has	O
had	O
a	B-treatment
total	I-treatment
abdominal	I-treatment
hysterectomy	I-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
a	O
widow	O
for	O
20	O
years	O
and	O
retired	O
18	O
years	O
from	O
Palmci	O

She	O
lives	O
alone	O
.	O

Her	O
son	O
,	O
Nertland	O
is	O
nearby	O
and	O
he	O
works	O
at	O
the	O
Em	O
Nysonken	O
Medical	O
Center	O
on	O
Verville	O
.	O

They	O
live	O
in	O
Ohio	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
a	O
healthy	O
appearing	O
female	O
,	O
5	O
foot	O
120	O
pounds	O
.	O

Her	B-test
blood	I-test
pressure	I-test
was	O
120/70	O
,	O
pulse	B-test
60	O
and	O
regular	O
.	O

Neck	O
veins	O
are	O
not	O
distended	B-problem
.	O

Respiratory	B-test
rate	I-test
12	O
.	O

Carotids	O
:	O

no	O
bruits	B-problem
.	O

Lungs	O
were	O
clear	O
.	O

Cardiac	O
:	O

1/6	B-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

Abdomen	O
was	O
benign	O
.	O

Peripheral	B-test
pulses	I-test
intact	O
.	O

Neurological	B-test
examination	I-test
non-focal	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
includes	O
an	B-test
electrocardiogram	I-test
that	O
shows	O
DDD	B-treatment
pacing	I-treatment
.	O

Hematocrit	B-test
39	O
percent	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
4500	O
,	O
PT	B-test
and	O
PTT	B-test
normal	O
.	O

Sodium	B-test
140	O
,	O
potassium	B-test
4.2	O
,	O
chloride	B-test
105	O
,	O
carbon	B-test
dioxide	I-test
30	O
,	O
BUN	B-test
24	O
,	O
creatinine	B-test
1.0	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Cardiac	O
Catheterization	O
Laboratory	O
.	O

There	O
,	O
her	B-test
pulmonary	I-test
wedge	I-test
pressure	I-test
was	O
12	O
and	O
her	B-test
right	I-test
atrial	I-test
pressure	I-test
was	O
4	O
and	O
pulmonary	B-test
artery	I-test
pressure	I-test
44/17	O
.	O

Her	B-test
left	I-test
ventricular	I-test
contraction	I-test
showed	O
akinesis	B-problem
of	I-problem
the	I-problem
anterior	I-problem
wall	I-problem
with	O
dyskinesis	B-problem
of	I-problem
the	I-problem
apex	I-problem
.	O

She	O
had	O
preserved	O
inferior	O
contraction	O
and	O
basal	O
contraction	O
.	O

Her	O
native	O
right	O
and	O
left	O
anterior	O
descending	O
vessels	O
were	O
occluded	B-problem
as	O
was	O
an	O
obtuse	O
marginal	O
branch	O
.	O

The	O
saphenous	O
vein	O
to	O
the	O
high	O
diagonal	O
or	O
high	O
obtuse	O
marginal	O
was	O
occluded	B-problem
.	O

The	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
left	O
anterior	O
descending	O
was	O
also	O
occluded	B-problem
.	O

The	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
second	I-treatment
obtuse	I-treatment
marginal	I-treatment
was	O
open	O
with	O
no	O
significant	B-problem
stenosis	I-problem
,	O
but	O
there	O
was	O
an	B-problem
outflow	I-problem
lesion	I-problem
in	I-problem
the	I-problem
obtuse	I-problem
marginal	I-problem
2	I-problem
as	O
well	O
as	O
severe	B-problem
distal	I-problem
lesion	I-problem
as	O
the	O
obtuse	O
marginal	O
2	O
fed	O
the	O
posterior	O
descending	O
artery	O
.	O

This	O
was	O
considered	O
her	B-problem
culprit	I-problem
lesion	I-problem
.	O

This	O
was	O
considered	O
too	O
high	O
risk	O
for	O
angioplasty	B-treatment
because	O
of	O
the	B-problem
severe	I-problem
disease	I-problem
in	O
the	B-treatment
graft	I-treatment
.	O

In	O
addition	O
,	O
it	O
was	O
noted	O
that	O
she	O
had	O
saphenous	O
vein	O
harvested	O
from	O
both	O
thighs	O
.	O

Her	O
left	O
internal	O
mammary	O
artery	O
was	O
also	O
unused	O
.	O

It	O
was	O
also	O
noted	O
that	O
she	O
had	O
failure	O
to	O
sense	O
with	O
the	O
atrial	O
lead	O
.	O

She	O
would	O
not	O
sense	O
the	O
atrial	O
contraction	O
and	O
the	O
fire	O
and	O
this	O
occasionally	O
led	O
to	O
competition	B-problem
of	I-problem
firing	I-problem
.	O

This	O
was	O
intermittent	O
.	O

The	B-test
P	I-test
wave	I-test
amplitude	I-test
was	O
.6	O
and	O
this	O
could	O
not	O
be	O
totally	O
sensed	O
.	O

The	O
patient	O
was	O
admitted	O
for	O
management	B-treatment
of	O
her	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
and	O
evaluation	B-test
of	O
her	B-treatment
pacemaker	I-treatment
.	O

It	O
was	O
noted	O
that	O
she	O
became	O
very	B-problem
symptomatic	I-problem
when	O
she	O
was	O
not	O
on	O
a	B-treatment
beta	I-treatment
blocker	I-treatment
but	O
that	O
on	O
a	B-treatment
beta	I-treatment
blocker	I-treatment
she	O
had	O
significant	B-problem
pacemaker	I-problem
failure	I-problem
.	O

Her	B-treatment
pacemaker	I-treatment
was	O
set	O
to	O
a	O
VVI	O
mode	O
which	O
sensed	O
appropriately	O
.	O

She	O
was	O
in	O
sinus	O
rhythm	O
with	O
most	O
of	O
the	O
time	O
.	O

When	O
her	B-treatment
pacemaker	I-treatment
was	O
in	O
a	O
sinus	O
rhythm	O
without	O
a	B-treatment
beta	I-treatment
blocker	I-treatment
,	O
she	O
had	O
significant	B-problem
angina	I-problem
.	O

Carotid	B-test
non-invasive	I-test
testing	I-test
was	O
unremarkable	O
.	O

The	O
situation	O
was	O
reviewed	O
with	O
Dr.	O
Niste	O
Graft	O
.	O

He	O
felt	O
the	O
patient	O
was	O
not	O
a	O
coronary	O
artery	O
bypass	O
graft	O
candidate	O
because	O
of	O
the	B-problem
lack	I-problem
of	I-problem
conduit	I-problem
and	O
because	O
of	O
the	O
presence	O
of	O
a	B-problem
large	I-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

For	O
this	O
reason	O
,	O
it	O
was	O
decided	O
to	O
maximize	O
her	B-treatment
beta	I-treatment
blockers	I-treatment
and	O
nitrates	B-treatment
.	O

The	O
situation	O
was	O
reviewed	O
with	O
Dr.	O
No	O
of	O
the	O
Pacemaker	O
Service	O
.	O

On	O
August	O
20	O
,	O
under	O
local	B-treatment
anesthesia	I-treatment
the	O
right	O
pectoral	O
region	O
was	O
explored	O
and	O
the	O
leads	O
disconnected	O
and	O
the	B-treatment
pulse	I-treatment
generator	I-treatment
changed	O
to	O
a	B-treatment
CPI	I-treatment
unit	I-treatment
in	O
which	O
the	O
sensitivity	O
could	O
be	O
adjusted	O
to	O
.15	O
mm.	O
,	O
which	O
permitted	O
appropriate	O
atrial	O
sensing	O
.	O

There	O
was	O
nothing	O
wrong	O
with	O
the	B-treatment
prior	I-treatment
generator	I-treatment
and	O
nothing	O
wrong	O
with	O
the	B-treatment
leads	I-treatment
.	O

It	O
just	O
needed	O
a	O
unit	O
that	O
could	O
have	O
more	O
sensitivity	O
in	O
the	O
atrial	O
mode	O
.	O

She	O
tolerated	O
this	O
well	O
.	O

Her	B-treatment
medications	I-treatment
were	O
resumed	O
.	O

She	O
ambulated	O
without	O
difficulty	O
and	O
was	O
discharged	O
to	O
home	O
to	O
be	O
followed	O
medically	O
for	O
her	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
following	O
two	B-treatment
failed	I-treatment
bypass	I-treatment
graft	I-treatment
procedure	I-treatment
by	O
Dr.	O
Brendniungand	O
Asilbekote	O
in	O
Bi	O
Masase	O
,	O
KS	O
.	O

ACHASTHA	O
N.	O
GRAFT	O
,	O
M.D.	O

TR	O
:	O

hfr	O
PAD-WORD	O

DD	O
:	O

08/22/1998	O
PAD-WORD	O

TD	O
:	O

08/27/1998	O
3:56	O
P	O

cc	O
:	O

ACHASTHA	O
NICEMAEN	O
GRAFT	O
,	O
M.D.	O
GITTETUMN	O
DARNNAMAN	O
NO	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2017-07-12	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-07-17	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1959-10-16	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Clindamycin	B-treatment
/	O
Erythromycin	B-treatment
Base	I-treatment
/	O
Amoxicillin	B-treatment
/	O
Keflex	B-treatment
/	O
Wellbutrin	B-treatment

Attending	O
:	O
Jerry	O
R	O
Morris	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
syncope	B-problem
and	O
hypotension	B-problem
on	O
Heywood	O
Memorial	O
Hospital	O
4	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Central	B-treatment
line	I-treatment
attempted	O
but	O
never	O
placed	O

History	O
of	O
Present	O
Illness	O
:	O

57	O
y/o	O
F	O
with	O
multiple	B-problem
medical	I-problem
problems	I-problem
including	O
polyendocrine	B-problem
deficiency	I-problem
comprised	O
of	O
adrenal	B-problem
insufficiency	I-problem
,	O
DM	B-problem
,	O
premature	B-problem
ovarian	I-problem
failure	I-problem
,	O
hypoparathyroidism	B-problem
,	O
addison	B-problem
's	I-problem
disease	I-problem
and	O
also	O
breast	B-problem
CA	I-problem
and	O
depression	B-problem
with	O
multiple	O
suicide	O
attempts	O
in	O
the	O
past	O
who	O
originally	O
presented	O
s/p	O
tylenol	B-problem
with	I-problem
codeine	I-problem
overdose	I-problem
and	O
hypotension	B-problem
,	O
was	O
intubated	O
and	O
admitted	O
to	O
the	O
FICU	O
.	O

She	O
was	O
eventually	O
stabilized	O
and	O
transfered	O
out	O
of	O
the	O
ICU	O
to	O
the	O
medical	O
Mary	O
Lane	O
Hospital	O
.	O

Subsequently	O
,	O
she	O
was	O
transfered	O
to	O
the	O
psychiatric	O
Mary	O
Lane	O
Hospital	O
in	O
Boston	O
Medical	O
Center	O
4	O
for	O
further	B-test
psychiatric	I-test
w/u	I-test
.	O

This	O
morning	O
,	O
2017-07-12	O
,	O
Ms.	O
Gallegos	O
King	O
feeling	O
weaker	B-problem
than	I-problem
usual	I-problem
.	O

She	O
noted	O
that	O
she	O
had	O
increased	B-problem
pain	I-problem
in	I-problem
her	I-problem
lower	I-problem
back	I-problem
,	O
which	O
she	O
attributed	O
to	O
her	B-problem
arthritis	I-problem
.	O

She	O
ate	O
a	O
normal	O
breakfast	O
of	O
cereal	O
and	O
milk	O
.	O

Later	O
that	O
am	O
,	O
she	O
stood	O
from	O
her	B-treatment
wheelchair	I-treatment
,	O
had	O
a	B-problem
prodrome	I-problem
of	I-problem
LH	I-problem
and	O
then	O
reports	O
LOC	B-problem
and	O
fall	O
.	O

She	O
denies	O
any	B-problem
tunnel	I-problem
vision	I-problem
,	O
darkened	B-problem
vision	I-problem
,	O
or	O
focal	B-problem
weakness	I-problem
this	O
morning	O
.	O

No	O
bowel	B-problem
/	I-problem
bladder	I-problem
incont	I-problem
,	O
no	O
aura	B-problem
,	O
no	O
postictal	B-problem
state	I-problem
.	O

She	O
does	O
not	O
recall	O
falling	O
,	O
but	O
does	O
recall	O
waking	O
up	O
with	O
people	O
surrounding	O
her	O
.	O

During	O
the	O
fall	O
she	O
hit	O
her	O
nose	O
and	O
her	O
R	O
knee	O
.	O

She	O
does	O
not	O
recall	O
hitting	O
her	O
head	O
.	O

She	O
does	O
not	O
describe	O
decreased	B-problem
PO	I-problem
intake	I-problem
from	O
her	O
norm	O
this	O
morning	O
,	O
but	O
did	O
feel	O
dehydrated	B-problem
at	O
the	O
time	O
of	O
her	O
fall	O
.	O

LOC	B-problem
was	O
unwitnessed	O
.	O

Early	O
this	O
morning	O
before	O
breakfast	O
her	B-test
BS	I-test
was	O
reportedly	O
145	O
,	O
and	O
after	O
LOC	B-problem
,	O
her	B-test
BS	I-test
was	O
reportedly	O
207	O
.	O

She	O
reports	O
that	O
her	B-test
BP	I-test
was	O
read	O
at	O
60/48	O
after	O
her	O
fall	O
.	O

Her	B-test
systolic	I-test
BP	I-test
measurements	I-test
have	O
been	O
running	O
around	O
100-110	O
over	O
the	O
past	O
few	O
weeks	O
.	O

Ms.	O
Cassata	O
has	O
a	O
history	O
of	O
"	O
passing	O
out	O
"	O
in	O
August	O
of	O
2004	O
,	O
(	O
?	O
7	O
hours	O
)	O
,	O
and	O
reports	O
that	O
this	O
episode	O
did	O
not	O
feel	O
similar	O
.	O

ROS	O
:	O

She	O
denies	O
any	B-problem
recent	I-problem
nausea	I-problem
,	O
but	O
had	O
an	O
episode	O
of	O
vomiting	B-problem
last	O
week	O
.	O

She	O
denies	O
any	B-problem
pain	I-problem
with	I-problem
urination	I-problem
or	O
incontinence	B-problem
.	O

She	O
also	O
denies	O
any	B-problem
recent	I-problem
cough	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
chest	B-problem
palpitations	I-problem
,	O
heart	B-problem
racing	I-problem
.	O

She	O
reports	O
2	O
nights	O
with	O
soaking	B-problem
NS	I-problem
.	O

Denies	O
subj	B-problem
/	I-problem
obj	I-problem
fevers	I-problem
or	O
chills	B-problem
.	O

She	O
describes	O
her	O
mood	O
as	O
depressed	B-problem
,	O
however	O
she	O
denies	O
suicidal	B-problem
ideation	I-problem
at	O
this	O
time	O
.	O

She	O
reports	O
that	O
she	O
took	O
all	B-treatment
her	I-treatment
medications	I-treatment
as	O
usual	O
this	O
morning	O
,	O
with	O
no	O
changes	O
.	O

Past	O
Medical	O
History	O
:	O

1)	O
Polyendocrine	B-problem
deficiency	I-problem
syndrome	I-problem
Type	I-problem
I	I-problem
which	O
is	O
comprised	O
of	O
the	O
following	O
:	O

a)	O
Hypoparathyroidism	B-problem
,	O
dxed	O
1954	O

b)	O
Addison	B-problem
's	I-problem
disease	I-problem
,	O
dxed	O
1960	O

c)	O
Premature	B-problem
ovarian	I-problem
failure	I-problem
,	O
dxed	O
1967	O

d)	O
Alopecia	B-problem
areata	I-problem
and	I-problem
totalis	I-problem
,	O
dxed	O
1970s	O

e)	O
mucocutaneous	B-problem
candidiasis	I-problem

f)	O
Diabetes	B-problem
type	I-problem
I	I-problem

2)	O
colonic	B-problem
dysfunction	I-problem
alternating	O
with	O
diarrhea	B-problem
and	O
constipation	B-problem

3)	O
?	O
unstable	B-problem
serum	I-problem
calcium	I-problem
since	O
1999	O

4)	O
Generalized	B-problem
osteoarthritis	I-problem

5)	O
depression	B-problem
requiring	O
ECT	B-treatment
therapy	I-treatment
in	O
the	O
past	O

6)	O
bilateral	B-problem
Neuropathy	I-problem
of	I-problem
lower	I-problem
extremities	I-problem

7)	O
Bilateral	B-problem
cataracts	I-problem

8)	O
PVD	B-problem

9)	O
Spontaneous	B-problem
dislocation	I-problem
of	I-problem
left	I-problem
hip	I-problem
in	O
2014	O

10)	O
GERD	B-problem

11)	O
Low	B-problem
grade	I-problem
anemia	I-problem

12)	O
Elevated	B-problem
liver	I-problem
enzymes	I-problem

13)	O
h/o	O
amputation	B-treatment
of	I-treatment
right	I-treatment
2nd	I-treatment
toe	I-treatment
secondary	O
to	O
osteomyelitis	B-problem
in	O
2005	O

14)	O
h/o	O
hemorrhoidectomy	B-treatment
in	O
2007	O

15)	O
h/o	O
left	B-treatment
hip	I-treatment
joint	I-treatment
replacement	I-treatment
in	O
2008	O

16)	O
h/o	O
total	B-treatment
hysterectomy	I-treatment
in	O
2009	O

17)	O
h/o	O
breast	B-problem
CA	I-problem
s/p	O
mastectomies	B-treatment

18)	O
recent	O
suicide	O
attempt	O
with	O
tylenol	B-treatment
#3	I-treatment
requiring	O
CMED	O
admission	O
but	O
relatively	O
Jennifer	O
transaminitis	B-problem
with	O
full	O
recovery	O

PCP	O
at	O
Cynthia	O
(	O
656	O
)	O
302	O
4444	O
Dr.	O
Mosier	O
.	O

Has	O
been	O
hospitalized	O
at	O
Pocasset	O
Mental	O
Health	O
Center	O
and	O
Children	O
's	O
Hospital	O
Boston	O
numerous	O
times	O
.	O

Social	O
History	O
:	O
lives	O
in	O
VA	O
Hospital	O
Northampton	O
.	O

Denies	O
etoh	O
,	O
illicits	O
.	O

Multiple	O
past	O
suicide	O
attempts	O
.	O

Medically	O
savvy	O
-	O
has	O
spent	O
much	O
of	O
her	O
life	O
in	O
the	O
hospital	O
with	O
her	B-problem
multiple	I-problem
medical	I-problem
problems	I-problem
.	O

Family	O
History	O
:	O
father	O
with	O
history	O
of	O
liver	B-problem
cancer	I-problem
at	O
a	O
late	O
age	O

Physical	O
Exam	O
:	O

T	B-test
98.4	O
RR	B-test
20	O
Sat	B-test
100%	O
RA	O
,	O
P	B-test
100	O
in	O
bed	O
&	O
same	O
standing	O
,	O
BP	B-test
=	O
120/65	O
in	O
bed	O
,	O
same	O
standing	O
.	O

Gen	O
:	O

NAD	B-problem
,	O
cooperative	O
and	O
conversant	O
,	O
able	O
to	O
ambulate	O
independently	O
around	O
room	O
using	O
crutches	B-treatment

HEENT	O
:	O

NCAT	B-problem
,	O
no	O
tenderness	B-problem
to	O
palpation	B-test
of	I-test
scalp	I-test
,	O
PERRL	O
,	O
EOMI	O
,	O
alopecia	B-problem
,	O
no	O
scleral	B-problem
icterus	I-problem
,	O
mucus	B-problem
membranes	I-problem
moderately	I-problem
dry	I-problem
,	O
slight	O
amount	O
of	O
crusted	B-problem
blood	I-problem
on	I-problem
tip	I-problem
of	O
R	O
nostril	O
from	O
fall	B-problem
injury	I-problem

Neck	O
:	O
supple	O
,	O
no	O
supraclavicular	B-problem
LAD	I-problem
,	O
no	O
JVD	B-problem

CV	O
:	O
tachycardic	B-problem
,	O
regular	O
rhythm	O
,	O
III/VI	B-problem
systolic	I-problem
,	O
crescendo-decrescendo	B-problem
at	I-problem
USB	I-problem
bilaterally	I-problem
.	O

Harsher	B-problem
holosystolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
apex	I-problem
heard	O
best	O
with	O
bell	O
.	O

Pulm	O
:	O

CTAB	O
aside	O
from	O
slightly	B-problem
dull	I-problem
breath	I-problem
sounds	I-problem
at	I-problem
the	I-problem
bases	I-problem

Abd	O
:	O
soft	O
,	O
slightly	B-problem
obese	I-problem
,	O
nondistended	B-problem
,	O
+BS	O

Ext	O
:	O
no	O
edema	B-problem
/	O
cyanosis	B-problem
,	O
2+	B-test
peripheral	I-test
pulses	I-test
,	O
small	B-problem
1	I-problem
cm	I-problem
abrasion	I-problem
on	I-problem
R	I-problem
knee	I-problem
,	O
no	O
active	B-problem
bleeding	I-problem
,	O
no	O
brusing	B-problem
,	O
no	O
limited	O

ROM	B-problem
,	O
no	O
signs	O
of	O
effusion	B-problem

Neuro	O
:	O

A&Ox3	O
,	O
no	O
asterixis	B-problem
,	O
strength	O
4+	O
/	O
5	O
equal	O
throughout	O
,	O
sensation	O
light	O
touch	O
intact	O
,	O
toes	O
upgoing	O
bilaterally	O
,	O
no	O
pronator	B-problem
drift	I-problem
.	O

Gait	O
does	O
not	O
appear	O
unsteady	B-problem
,	O
uses	O
crutches	B-treatment
for	O
support	O
.	O

Pertinent	O
Results	O
:	O

ADMISSION	O
LABS	O
:	O

2017-07-12	O
10:40	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
17.1	O
*	O
RBC	B-test
-	O
3.37	O
*	O
Hgb	B-test
-	O
10.1	O
*	O
Hct	B-test
-	O
30.1	O
*	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
30.0	O
MCHC	B-test
-	O
33.6	O
RDW	B-test
-	O
18.8	O
*	O
Plt	B-test
Ct	I-test
-	O
526	O
*	O

2017-07-12	O
10:40	O
AM	O
BLOOD	B-test
Neuts	B-test
-	O
86	O
*	O
Bands	B-test
-	O
5	O
Lymphs	B-test
-	O
4	O
*	O
Monos	B-test
-	O
5	O
Eos	B-test
-	O
0	O
Baso	B-test
-	O
0	O
Atyps	B-test
-	O
0	O
Metas	B-test
-	O
0	O
Myelos	B-test
-	O
0	O

2017-07-12	O
10:40	O
AM	O
BLOOD	B-test
Plt	B-test
Smr	I-test
-	O
HIGH	B-problem
Plt	I-problem
Ct	I-problem
-	O
526	O
*	O

2017-07-13	O
05:30	O
AM	O
BLOOD	B-test
PT	B-test
-	O
11.3	O
PTT	B-test
-	O
24.9	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.0	O

2017-07-11	O
08:00	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
137	O
*	O
UreaN	B-test
-	O
19	O
Creat	B-test
-	O
1.0	O
Na	B-test
-	O
142	O
K	B-test
-	O
4.0	O
Cl	B-test
-	O
105	O
HCO3	B-test
-	O
29	O
AnGap	B-test
-	O
12	O

2017-07-13	O
05:30	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
85	O
*	O
AST	B-test
-	O
238	O
*	O
LD	B-test
(	I-test
LDH	I-test
)-	I-test
316	O
*	O
CK	B-test
(	I-test
CPK	I-test
)-	I-test
55	O
AlkPhos	B-test
-	O
122	O
*	O
Amylase	B-test
-	O
65	O
TotBili	B-test
-	O
0.3	O

2017-07-13	O
05:30	O
AM	O
BLOOD	B-test
Lipase	B-test
-	O
35	O

2017-07-14	O
05:20	O
AM	O
BLOOD	B-test
CK	B-test
-	I-test
MB	I-test
-	O
NotDone	O
cTropnT	B-test
-<	O
0.01	O

2017-07-13	O
01:12	O
PM	O
BLOOD	B-test
CK	B-test
-	I-test
MB	I-test
-	O
2	O
cTropnT	B-test
-<	O
0.01	O

2017-07-13	O
05:30	O
AM	O
BLOOD	B-test
CK	B-test
-	I-test
MB	I-test
-	O
NotDone	O
cTropnT	B-test
-<	O
0.01	O

2017-07-11	O
08:00	O
AM	O
BLOOD	B-test
Albumin	B-test
-	O
3.4	O
Calcium	B-test
-	O
8.0	O
*	O
Phos	B-test
-	O
5.0	O
*	O
Mg	B-test
-	O
1.6	O

2017-07-13	O
01:12	O
PM	O
BLOOD	B-test
HBsAg	B-test
-	O
NEGATIVE	O
HBsAb	B-test
-	O
NEGATIVE	O
HBcAb	B-test
-	O
NEGATIVE	O

2017-07-13	O
05:30	O
AM	O
BLOOD	B-test
Acetmnp	B-test
-	O
NEG	O

2017-07-13	O
01:12	O
PM	O
BLOOD	B-test
HCV	B-test
Ab	I-test
-	O
NEGATIVE	O

2017-07-13	O
08:40	O
AM	O
BLOOD	B-test
Type	B-test
-	O
ART	O
pO2	B-test
-	O
72	O
*	O
pCO2	B-test
-	O
34	O
*	O
pH	B-test
-	O
7.46	O
*	O
calHCO3	B-test
-	O
25	O
Base	B-test
XS	I-test
-	O
0	O

2017-07-13	O
08:40	O
AM	O
BLOOD	B-test
Lactate	B-test
-	O
2.0	O

2017-07-13	O
08:40	O
AM	O
BLOOD	B-test
freeCa	B-test
-	O
0.90	O
*	O

STUDIES	O
:	O

EKG	B-test
:	O

2017-07-12	O
NSR	O
,	O
normal	O
axis	O
,	O
likely	O
V1	B-problem
and	I-problem
V2	I-problem
reversal	I-problem
,	O
TWI	B-problem
in	I-problem
V2	I-problem
,	O
?	O
ST	B-problem
depr	I-problem
<	O
0.5	O
mm	O
in	O
II	O
and	O
V5/6	O
-	O
repeat	B-test
EKG	I-test
without	O
these	B-problem
changes	I-problem
.	O

No	O
change	O
from	O
prior	B-test
EKG	I-test
.	O

CXR	B-test
2017-07-12	O
:	O

Heart	O
normal	O
in	O
size	O
,	O
mediastinal	O
and	O
hilar	O
contours	O
are	O
normal	O
.	O

Pulmonary	O
vascularity	O
is	O
normal	O
,	O
lungs	O
are	O
clear	O
.	O

No	O
effusions	B-problem
or	O
pneumothorax	B-problem
.	O

Multiple	B-problem
healed	I-problem
bilateral	I-problem
rib	I-problem
fractures	I-problem
are	O
demonstrated	O
.	O

Clips	B-treatment
in	I-treatment
the	I-treatment
left	I-treatment
axilla	I-treatment
demonstrate	O
prior	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
.	O

Overall	O
,	O
no	O
acute	B-problem
cardiopulmonary	I-problem
abnormality	I-problem
.	O

2017-07-13	O
CXR	B-test
:	O

UPRIGHT	O
AP	O
VIEW	O
OF	O
THE	O
CHEST	O
:	O

Aside	O
from	O
low	B-problem
lung	I-problem
volumes	I-problem
,	O
the	O
lungs	O
are	O
clear	O
.	O

The	O
heart	O
size	O
,	O
and	O
mediastinal	O
and	O
hilar	O
contours	O
are	O
normal	O
.	O

The	O
pleurae	O
are	O
normal	O
.	O

Clips	B-treatment
in	I-treatment
the	I-treatment
left	I-treatment
axilla	I-treatment
denote	O
prior	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
.	O

Multiple	B-problem
bilateral	I-problem
healed	I-problem
rib	I-problem
fractures	I-problem
are	O
present	O
.	O

2017-07-13	O
RUQ	B-test
U/S	I-test
:	O

IMPRESSION	O
:	O

1.	O
Normal	O
liver	O
.	O

No	O
evidence	O
of	O
bile	B-problem
duct	I-problem
dilatation	I-problem
.	O

2.	O
Gallbladder	B-problem
polyp	I-problem
and	O
possible	O
tiny	B-problem
stones	I-problem
.	O

No	O
cholecystitis	B-problem
.	O

2017-07-14	O
ECHO	B-test
:	O

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

There	O
is	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

The	B-test
left	I-test
ventricular	I-test
cavity	I-test
size	I-test
is	O
normal	O
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
normal	O
(	O
LVEF	B-test
>	O
55%	O
).	O

Right	B-test
ventricular	I-test
chamber	I-test
size	I-test
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	B-problem
thickened	I-problem
.	O

There	O
is	O
mild	B-problem
aortic	I-problem
valve	I-problem
stenosis	I-problem
.	O

Trace	B-problem
aortic	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

No	O
mitral	B-problem
regurgitation	I-problem
is	O
seen	O
.	O

There	O
is	O
a	B-problem
small	I-problem
pericardial	I-problem
effusion	I-problem
.	O

There	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B-problem
.	O

Compared	O
with	O
the	O
report	O
of	O
the	B-test
prior	I-test
study	I-test
(	O
images	O
unavailable	O
for	O
review	O
)	O
of	O
2017-06-13	O
,	O
there	O
is	O
no	O
significant	B-problem
change	I-problem
.	O

DISCHARGE	O
LABS	O
:	O

2017-07-17	O
04:50	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
7.2	O
RBC	B-test
-	O
2.69	O
*	O
Hgb	B-test
-	O
8.0	O
*	O
Hct	B-test
-	O
24.0	O
*	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
29.7	O
MCHC	B-test
-	O
33.3	O
RDW	B-test
-	O
18.7	O
*	O
Plt	B-test
Ct	I-test
-	O
363	O

2017-07-17	O
04:50	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
363	O

2017-07-17	O
04:50	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
60	O
*	O
UreaN	B-test
-	O
13	O
Creat	B-test
-	O
0.9	O
Na	B-test
-	O
147	O
*	O
K	B-test
-	O
3.0	O
*	O
Cl	B-test
-	O
109	O
*	O
HCO3	B-test
-	O
29	O
AnGap	B-test
-	O
12	O

2017-07-17	O
04:50	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
73	O
*	O
AST	B-test
-	O
50	O
*	O
LD	B-test
(	I-test
LDH	I-test
)-	O
195	O
AlkPhos	B-test
-	O
112	O
TotBili	B-test
-	O
0.3	O

2017-07-15	O
06:47	O
AM	O
BLOOD	B-test
Lipase	B-test
-	O
17	O

2017-07-17	O
04:50	O
AM	O
BLOOD	B-test
Calcium	B-test
-	O
8.2	O
*	O
Phos	B-test
-	O
3.2	O
Mg	B-test
-	O
1.5	O
*	O

2017-07-13	O
01:12	O
PM	O
BLOOD	B-test
HBsAg	B-test
-	O
NEGATIVE	O
HBsAb	B-test
-	O
NEGATIVE	O
HBcAb	B-test
-	O
NEGATIVE	O

2017-07-13	O
05:30	O
AM	O
BLOOD	B-test
Acetmnp	B-test
-	O
NEG	O

2017-07-13	O
01:12	O
PM	O
BLOOD	B-test
HCV	B-test
Ab	I-test
-	O
NEGATIVE	O

Brief	O
Hospital	O
Course	O
:	O

BRIEF	O
OVERVIEW	O
:	O

57	O
yo	O
F	O
with	O
h/o	O
polyglandular	B-problem
autoimmune	I-problem
syndrome	I-problem
initially	O
admitted	O
in	O
May	O
to	O
FICU	O
for	O
suicide	B-problem
overdose	I-problem
then	O
transferred	O
to	O
Whittier	O
Rehab	O
Hospital	O
4	O
for	O
depression	B-problem
,	O
who	O
was	O
transferred	O
to	O
the	O
medical	O
floor	O
for	O
a	B-problem
syncopal	I-problem
episode	I-problem
and	O
hypotension	B-problem
to	O
60	B-test
systolic	I-test
that	O
returned	O
to	O
baseline	O
with	O
2.5L	O
IVF	B-treatment
who	O
was	O
subsequently	O
transferred	O
to	O
the	O
CMED	O
CSRU	O
for	O
a	O
recurrent	O
episode	O
of	O
hypotension	B-problem
,	O
fevers	B-problem
and	O
concern	O
for	O
sepsis	B-problem
.	O

Initially	O
when	O
she	O
arrived	O
to	O
the	O
floor	O
she	O
was	O
afebrile	B-problem
,	O
normotensive	O
without	O
signs	O
of	O
orthostasis	B-problem
,	O
had	O
a	O
negative	O
UA	O
,	O
a	O
clear	O
chest	O
xray	O
and	O
no	O
signs	O
/	O
symptoms	O
of	O
a	B-problem
fever	I-problem
.	O

She	O
was	O
slightly	B-problem
tachycardic	I-problem
.	O

She	O
was	O
initially	O
not	O
started	O
on	O
antibiotics	B-treatment
.	O

She	O
was	O
given	O
a	B-treatment
standing	I-treatment
IVF	I-treatment
order	I-treatment
.	O

Overnight	O
she	O
became	O
febrile	B-problem
to	O
102.3	O
,	O
increasingly	B-problem
tachycardic	I-problem
to	O
125	O
,	O
and	O
hypotensive	B-problem
to	O
80	B-test
systolic	I-test
.	O

She	O
was	O
started	O
on	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
and	O
levo	B-treatment
,	O
flagyl	B-treatment
,	O
and	O
vanco	B-treatment
.	O

She	O
was	O
given	O
4L	O
of	O
fluid	B-treatment
boluses	I-treatment
and	O
transfered	O
to	O
the	O
CMED	O
CSRU	O
.	O

In	O
the	O
CMED	O
CSRU	O
,	O
repeated	O
attempts	O
to	O
place	O
lines	B-treatment
were	O
unsuccessful	O
.	O

The	B-treatment
above	I-treatment
treatments	I-treatment
were	O
continued	O
.	O

Urine	B-test
cultures	I-test
returned	O
with	O
10-100,000	O
organisms	B-problem
coag	O
negative	O
staph	B-problem
.	O

Blood	B-test
cultures	I-test
remained	O
negative	O
.	O

Vital	B-test
signs	I-test
stabilized	O
and	O
she	O
was	O
transfered	O
back	O
to	O
the	O
medical	O
floor	O
after	O
2	O
days	O
in	O
the	O
ICU	O
.	O

Stress	B-treatment
dose	I-treatment
steroids	I-treatment
were	O
planned	O
for	O
a	O
7	O
day	O
course	O
,	O
antibiotics	B-treatment
were	O
peeled	O
back	O
to	O
levofloxacin	B-treatment
alone	O
,	O
and	O
a	B-test
R	I-test
hip	I-test
film	I-test
revealed	O
no	O
loosening	B-problem
nor	O
inflammation	B-problem
.	O

Echo	B-test
showed	O
normal	O
function	O
,	O
trace	B-problem
AR	I-problem
,	O
and	O
no	O
MR	B-problem
.	O

She	O
had	O
a	O
normal	O
RUQ	O
US	O
,	O
as	O
well	O
.	O

On	O
the	O
floor	O
the	O
patient	O
remained	O
stable	O
hemodynamically	O
without	O
recurrent	B-problem
fever	I-problem
and	O
was	O
stable	O
for	O
transfer	O
back	O
to	O
Franciscan	O
Children	O
's	O
Hospital	O
&	O
Rehab	O
Center	O
4	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
her	B-test
potassium	I-test
had	O
been	O
low	B-problem
despite	O
repletion	B-treatment
,	O
Na	B-test
was	O
elevated	B-problem
,	O
as	O
was	O
blood	B-test
pressure	I-test
.	O

On	O
recommendation	O
from	O
endocrine	O
,	O
her	B-treatment
fludrocortisone	I-treatment
was	O
decreased	O
from	O
0.2	O
to	O
0.1	O
(	O
higher	O
than	O
required	O
doses	O
of	O
fludrocort	B-treatment
can	O
cause	O
these	B-problem
symptoms	I-problem
.	O
)	O
.	O

1.	O
Hypotension	B-problem
:	O

Patient	O
presented	O
after	O
episode	O
of	O
hypotension	B-problem
and	O
syncope	B-problem
on	O
Mass.	O
Mental	O
Health	O
Center	O
5	O
.	O

Initially	O
it	O
was	O
felt	O
that	O
this	O
was	O
a	O
result	O
of	O
poor	B-problem
PO	I-problem
intake	I-problem
.	O

She	O
was	O
afebrile	B-problem
without	O
orthostatic	B-problem
vital	I-problem
signs	I-problem
nor	O
hypotension	B-problem
.	O

She	O
had	O
no	O
symptoms	O
of	O
infectious	B-problem
source	I-problem
,	O
normal	O
UA	O
,	O
normal	O
chest	O
xray	O
,	O
and	O
no	O
symptoms	O
nor	O
signs	O
of	O
injury	B-problem
after	O
her	O
fall	O
with	O
syncope	B-problem
.	O

Neuro	B-test
exam	I-test
was	O
normal	O
.	O

Subsequently	O
overnight	O
,	O
she	O
developed	O
a	B-problem
fever	I-problem
to	O
102.3	O
and	O
recurrent	B-problem
hypotension	I-problem
in	O
the	O
setting	O
of	O
fevers	B-problem
and	O
tachycardia	B-problem
that	O
was	O
concerning	O
for	O
an	B-problem
infectious	I-problem
source	I-problem
.	O

She	O
still	O
had	O
no	O
localizing	O
signs	O
of	O
infection	B-problem
and	O
culture	B-test
data	I-test
was	O
negative	O
to	O
be	O
negative	O
.	O

RUQ	B-test
US	I-test
was	O
ordered	O
and	O
returned	O
without	O
signs	O
of	O
infection	B-problem
later	O
.	O

She	O
was	O
started	O
on	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
.	O

She	O
had	O
cultures	B-test
drawn	O
,	O
was	O
given	O
tylenol	B-treatment
(	O
tylenol	B-test
screen	I-test
prior	O
to	O
this	O
dose	O
was	O
negative	O
,	O
as	O
was	O
a	B-test
urine	I-test
tox	I-test
)	O
,	O
was	O
started	O
on	O
levofloxacin	B-treatment
,	O
metronidazole	B-treatment
,	O
and	O
vancomycin	B-treatment
to	O
cover	O
emperically	O
for	O
hospital	B-problem
aquired	I-problem
pneumonia	I-problem
,	O
GI	B-problem
sources	I-problem
,	O
and	O
a	O
potential	O
hip	B-problem
infection	I-problem
.	O

Her	B-test
transaminases	I-test
were	O
slightly	B-problem
elevated	I-problem
,	O
which	O
was	O
later	O
attributed	O
to	O
shock	B-problem
liver	I-problem
as	O
a	O
result	O
of	O
her	O
period	O
of	O
hypotension	B-problem
.	O

Lipase	B-test
and	O
amylase	B-test
remained	O
normal	O
.	O

In	O
the	O
ICU	O
she	O
also	O
received	O
an	B-test
echo	I-test
that	O
revealed	O
normal	O
function	O
and	O
little	B-problem
valvular	I-problem
disease	I-problem
(	O
she	O
has	O
two	B-problem
loud	I-problem
systolic	I-problem
murmurs	I-problem
on	O
exam	B-test
)	O
,	O
and	O
a	B-test
hip	I-test
film	I-test
revealing	O
no	O
inflammation	B-problem
nor	O
loosening	B-problem
.	O

Urine	B-test
culture	I-test
twice	O
grew	O
10-100,000	O
coag	B-problem
negative	O
staph	B-problem
.	O

A	B-treatment
line	I-treatment
could	O
not	O
be	O
placed	O
for	O
technical	O
reasons	O
,	O
however	O
after	O
4L	O
NS	B-treatment
on	O
the	O
floor	O
and	O
01-30	O
more	O
in	O
the	O
ICU	O
via	O
peripheral	B-treatment
IV	I-treatment
's	I-treatment
she	O
was	O
stable	O
.	O

She	O
remained	O
hemodynamically	O
stable	O
with	O
good	O
UOP	O
in	O
the	O
setting	O
of	O
being	O
started	O
on	O
abx	B-treatment
and	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
.	O

The	B-treatment
steroids	I-treatment
were	O
thought	O
to	O
have	O
helped	O
significantly	O
in	O
in	O
the	O
setting	O
of	O
Addison	B-problem
's	I-problem
with	O
possibely	O
superimposed	B-problem
infection	I-problem
.	O

The	O
patient	O
was	O
planned	O
for	O
a	O
7	O
day	O
course	O
of	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
followed	O
by	O
a	O
return	O
to	O
her	B-treatment
basal	I-treatment
predinisone	I-treatment
/	O
fludrocortisone	B-treatment
dose	I-treatment
.	O

2.	O
Elevated	B-problem
LFTs	I-problem
:	O

LFTs	B-test
wre	O
elevated	B-problem
at	O
presentation	O
.	O

Initially	O
the	O
differential	O
was	O
thought	O
to	O
include	O
shock	B-problem
liver	I-problem
from	O
hypotension	B-problem
,	O
hepatitis	B-problem
,	O
cholangitis	B-problem
or	O
choledocholithiasis	B-problem
.	O

Hepatitis	B-test
serologies	I-test
were	O
negative	O
and	O
the	O
pt	O
was	O
eventually	O
felt	O
to	O
have	O
had	O
shock	B-problem
liver	I-problem
from	O
her	B-problem
hypotensive	I-problem
episode	I-problem
as	O
the	B-problem
transaminitis	I-problem
resolved	O
over	O
time	O
.	O

3.	O
Hypoparathyroidism	B-problem
:	O

This	O
is	O
a	B-problem
chronic	I-problem
problem	I-problem
.	O

calcium	B-test
levels	I-test
were	O
followed	O
with	O
a	O
goal	O
to	O
keep	O
them	O
around	O
8.0	O
by	O
continuing	O
Calcium	B-treatment
carbonate	I-treatment
,	O
calcitriol	B-treatment
.	O

The	O
pt	O
required	O
calcium	B-treatment
gluconate	I-treatment
x1	O
the	O
day	O
prior	O
to	O
discharge	O
.	O

Per	O
endocrine	O
at	O
the	O
time	O
of	O
discharge	O
,	O
the	O
pt	O
may	O
need	O
an	O
increase	O
in	O
calcium	B-treatment
PO	I-treatment
,	O
but	O
at	O
this	O
time	O
they	O
recommended	O
no	O
change	O
.	O

It	O
will	O
need	O
to	O
be	O
monitored	O
over	O
time	O
.	O

4.	O
Addison	B-problem
's-	I-problem
The	O
patient	O
is	O
on	O
basal	B-treatment
prednisone	I-treatment
/	O
fludrocortisone	B-treatment
.	O

These	O
were	O
initially	O
continued	O
as	O
above	O
and	O
later	O
,	O
when	O
she	O
became	O
hypotensive	B-problem
and	O
febrile	B-problem
,	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
were	O
started	O
and	O
planned	O
for	O
a	O
7	O
day	O
course	O
followed	O
by	O
a	O
return	O
to	O
her	O
prior	O
dose	O
of	O
prednisone	B-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
her	B-test
potassium	I-test
had	O
been	O
low	B-problem
despite	O
repletion	B-treatment
,	O

Na	B-test
was	O
elevated	B-problem
,	O
as	O
was	O
blood	B-test
pressure	I-test
.	O

On	O
recommendation	O
from	O
endocrine	O
,	O
her	B-treatment
fludrocortisone	I-treatment
was	O
decreased	O
from	O
0.2	O
to	O
0.1	O
(	O
higher	O
than	O
required	O
doses	O
of	O
fludrocort	B-treatment
can	O
cause	O
these	B-problem
symptoms.	I-problem
)	O
.	O

5.	O
DM	B-problem
:	O

Light	O
followed	O
the	O
patient	O
.	O

She	O
was	O
continued	O
on	O
her	O
prior	O
dose	O
of	O
steroids	B-treatment
with	O
sliding	B-treatment
scale	I-treatment
per	O
patient	O
using	O
a	B-treatment
1:15	I-treatment
carb	I-treatment
counting	I-treatment
scheme	I-treatment
with	O
a	B-treatment
1:30	I-treatment
correction	I-treatment
factor	I-treatment
.	O

On	O
the	O
day	O
of	O
discharge	O
her	B-treatment
glargine	I-treatment
was	O
decreased	O
by	O
one	O
unit	O
because	O
her	B-test
glucose	I-test
remained	O
somewhat	B-problem
low	I-problem
in	O
the	O
mornings	O
.	O

6.	O
R	B-problem
Hip	I-problem
pain	I-problem
:	O

Later	O
in	O
her	O
hospital	O
course	O
,	O
the	O
pt	O
complained	O
of	O
hip	B-problem
pain	I-problem
.	O

A	B-test
R	I-test
hip	I-test
film	I-test
was	O
negative	O
for	O
pathology	B-problem
or	O
failure	B-problem
of	O
her	B-treatment
hip	I-treatment
replacement	I-treatment
.	O

Pain	B-problem
was	O
controlled	O
with	O
tylenol	B-treatment
and	O
the	O
pt	O
was	O
reassured	O
.	O

PT	O
was	O
consulted	O
.	O

The	O
pt	O
uses	O
a	B-treatment
wheelchair	I-treatment
often	O
at	O
baseline	O
due	O
to	O
pain	B-problem
from	O
arthritis	B-problem
.	O

7.	O
Depression	B-problem
:	O

The	O
pt	O
was	O
being	O
treated	O
at	O
Mediplex	O
Rehab	O
Hospital	O
4	O
for	O
suicidal	B-problem
ideation	I-problem
and	O
a	O
suicide	O
attempt	O
on	O
original	O
admission	O
with	O
tylenol	B-treatment
and	O
oxycodone	B-treatment
.	O

She	O
had	O
planned	O
this	O
attempt	O
carefully	O
without	O
the	O
knowledge	O
of	O
those	O
close	O
to	O
her	O
and	O
very	O
much	O
expected	O
her	O
attempt	O
to	O
work	O
.	O

She	O
had	O
been	O
depressed	B-problem
for	O
some	O
time	O
but	O
her	O
loved	O
ones	O
were	O
very	O
surprised	O
at	O
her	O
attempt	O
.	O

She	O
remained	O
very	B-problem
depressed	I-problem
at	O
her	O
inpatient	O
admission	O
and	O
refractory	B-problem
to	O
treatment	B-treatment
.	O

One	O
day	O
prior	O
to	O
her	O
transfer	O
to	O
the	O
medical	O
floor	O
she	O
was	O
sectioned	O
to	O
initiate	O
ECT	B-treatment
,	O
which	O
she	O
had	O
previously	O
refused	O
.	O

As	O
a	O
result	O
,	O
she	O
was	O
maintained	O
on	O
her	B-treatment
ativan	I-treatment
,	O
mirtazapine	B-treatment
,	O
risperidone	B-treatment
,	O
duloxetine	B-treatment
.	O

She	O
did	O
not	O
exhibit	O
psychotic	B-problem
symptoms	I-problem
.	O

She	O
had	O
a	O
1:1	O
sitter	O
at	O
all	O
times	O
.	O

She	O
denied	O
any	B-problem
suicidality	I-problem
but	O
did	O
endorse	O
depression	B-problem
.	O

She	O
denied	O
HI	B-problem
,	O
SI	B-problem
,	O
and	O
illusions	B-problem
/	O
hallucinations	B-problem
.	O

Her	O
mood	O
appeared	O
stable	O
throughout	O
her	O
hospitalization	O
.	O

She	O
was	O
followed	O
by	O
psychiatry	O
in	O
consultation	O
while	O
she	O
was	O
on	O
the	O
medical	O
floor	O
.	O

The	O
patient	O
did	O
have	O
heparin	B-treatment
subcutaneously	I-treatment
while	O
on	O
the	O
medical	O
floor	O
and	O
in	O
the	O
ICU	O
.	O

She	O
remained	O
full	B-treatment
code	I-treatment
throughout	O
the	O
hospitalization	O
.	O

As	O
on	O
prior	O
hospitalization	O
,	O
her	O
HCP	O
was	O
shared	O
by	O
Dianne	O
White	O
.	O

Medications	O
on	O
Admission	O
:	O

Meds	O
on	O
transfer	O
:	O

Fludrocortisone	B-treatment
Acetate	I-treatment
0.2	O
mg	O
PO	O
DAILY	O
07-12	O
@	O
1033	O

Acetaminophen	B-treatment
650	O
mg	O
PO	O
BID	O
07-11	O
@	O
1503	O
View	O

Ibuprofen	B-treatment
400	O
mg	O
PO	O
BID	O
07-11	O
@	O
1503	O
View	O

Ibuprofen	B-treatment
400	O
mg	O
PO	O
Q8H	O
:	O
PRN	O
07-11	O
@	O
1503	O
View	O

Insulin	B-treatment
SC	I-treatment
(	O
per	O
Insulin	O
Flowsheet	O
)	O

Risperidone	B-treatment
1	O
mg	O
PO	O
HS	O
07-10	O
@	O
1135	O
View	O

Risperidone	B-treatment
0.5	O
mg	O
PO	O
DAILY	O
07-10	O
@	O
1135	O
View	O

Potassium	B-treatment
Chloride	I-treatment
20	O
mEq	O
PO	O
BID	O

Calcium	B-treatment
Carbonate	I-treatment
1500	O
mg	O
PO	O
TID	O
07-04	O
@	O
1126	O
View	O

Mirtazapine	B-treatment
15	O
mg	O
PO	O
HS	O
07-03	O
@	O
1220	O
View	O

Duloxetine	B-treatment
30	O
mg	O
PO	O
BID	O
Start	O
:	O
In	O
am	O
07-03	O
@	O
1214	O

Psyllium	B-treatment
1	O
PKT	O
PO	O
TID	O
:	O
PRN	O
06-30	O
@	O
1248	O
View	O

Memantine	B-treatment
*	O
N	O
F*	O
10	O
mg	O
Oral	O
daily	O
06-27	O
@	O
1124	O
View	O

Calcitriol	B-treatment
0.25	O
mcg	O
PO	O
EVERY	O
OTHER	O
DAY	O
t/th/s/s	O

Calcitriol	B-treatment
0.5	O
mcg	O
PO	O
EVERY	O
OTHER	O
DAY	O
06-27	O
@	O
1051	O

Lorazepam	B-treatment
2	O
mg	O
PO	O
HS	O
06-23	O
@	O
1215	O
View	O

Alendronate	B-treatment
Sodium	I-treatment
70	O
mg	O
PO	O
QSUN	O
06-22	O
@	O
1106	O
View	O

Lactulose	B-treatment
60	O
ml	O
PO	O
QTHUR	O
06-21	O
@	O
1600	O
View	O

Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
60	O
ml	O
PO	O
QTHUR	O
06-21	O
@	O
1600	O
View	O

Arimidex	B-treatment
*	O
N	O
F*	O
1	O
mg	O
Oral	O
daily	O
06-21	O
@	O
1414	O
View	O

Magnesium	B-treatment
Oxide	I-treatment
400	O
mg	O
PO	O
BID	O
06-20	O
@	O
2017	O
View	O

Atorvastatin	B-treatment
20	O
mg	O
PO	O
DAILY	O
06-20	O
@	O
2017	O
View	O

Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
PO	O
TID	O
06-20	O
@	O
2017	O
View	O

Pantoprazole	B-treatment
40	O
mg	O
PO	O
Q24H	O
06-20	O
@	O
2017	O
View	O

Prednisone	B-treatment
2.5	O
mg	O
PO	O
Q3PM	O
06-20	O
@	O
2017	O
View	O

Prednisone	B-treatment
5	O
mg	O
PO	O
QAM	O
06-20	O
@	O
2017	O
View	O

Chlorothiazide	B-treatment
500	O
mg	O
PO	O
DAILY	O
06-20	O
@	O
2017	O
View	O

Aspirin	B-treatment
81	O
mg	O
PO	O
DAILY	O

Multivitamins	B-treatment
1	O
CAP	O
PO	O
DAILY	O

Allergies	O
:	O

Clindamycin	B-treatment
/	O
Erythromycin	B-treatment
Base	I-treatment
/	O
Amoxicillin	B-treatment
/	O
Keflex	B-treatment
/	O
Wellbutrin	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Risperidone	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

2.	O
Risperidone	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Mirtazapine	B-treatment
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
.	O

4.	O
Duloxetine	B-treatment
30	O
mg	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5.	O
Calcitriol	B-treatment
0.25	O
mcg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
EVERY	O
OTHER	O
DAY	O
(	O
Every	O
Other	O
Day	O
)	O
.	O

6.	O
Calcitriol	B-treatment
0.5	O
mcg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
EVERY	O
OTHER	O
DAY	O
(	O
Every	O
Other	O
Day	O
)	O
.	O

7.	O
Alendronate	B-treatment
70	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QSUN	O
(	O
every	O
Sunday	O
)	O
.	O

8.	O
Lactulose	B-treatment
10	O
g	O
/	O
15	O
mL	O
Syrup	O
Sig	O
:	O
Sixty	O
(	O
60	O
)	O
ML	O
PO	O
EVERY	O
THURSDAY	O
(	O
)	O
.	O

9.	O
Magnesium	B-treatment
Hydroxide	I-treatment
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Anastrozole	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
daily	O
(	O
)	O
.	O

11.	O
Atorvastatin	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

12.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

13.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

14.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

15.	O
Multivitamin	B-treatment
Capsule	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

16.	O
Ibuprofen	B-treatment
400	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

17.	O
Ferrous	B-treatment
Sulfate	I-treatment
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

18.	O
Maalox	B-treatment
200-200-20	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Fifteen	O
(	O
15	O
)	O
ML	O
PO	O
PRN	O
(	O
as	O
needed	O
)	O
.	O

19.	O
Levofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
2	O
days	O
.	O

20.	O
Calcium	B-treatment
Carbonate	I-treatment
500	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

21.	O
Calcium	B-treatment
Carbonate	I-treatment
500	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

22.	O
Heparin	B-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
5000	O
(	O
5000	O
)	O
units	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

23.	O
Prednisone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

24.	O
Prednisone	B-treatment
2.5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q	O
3PM	O
(	O
)	O
.	O

25.	O
Chlorothiazide	B-treatment
250	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

26.	O
Fludrocortisone	B-treatment
0.1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

27.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

28.	O
Lorazepam	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

29.	O
Memantine	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
daily	O
(	O
)	O
.	O

30.	O
Insulin	B-treatment
Glargine	I-treatment
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
AS	O
INSTRUCTED	O
Subcutaneous	O
twice	O
a	O
day	O
:	O
7	O
units	O
in	O
the	O
morning	O
,	O
18	O
units	O
in	O
the	O
evening	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Quincy	O
Medical	O
Center	O
4	O

Discharge	O
Diagnosis	O
:	O

Hypotension	B-problem
PAD-WORD	O

Early	B-problem
Sepsis	I-problem

Adrenal	B-problem
Insufficiency	I-problem

Diabetes	B-problem
I	I-problem

Hypocalcemia	B-problem
(	O
Hypoparathyroidism	B-problem
)	O

Depression	B-problem
PAD-WORD	O

Transaminitis	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O

Stable	O
vitals	O
,	O
depressed	B-problem
.	O

Discharge	O
Instructions	O
:	O

You	O
were	O
admitted	O
with	O
a	B-problem
low	I-problem
blood	I-problem
pressure	I-problem
and	O
developed	O
a	B-problem
fever	I-problem
.	O

You	O
are	O
finishing	O
a	O
course	O
of	O
antibiotics	B-treatment
and	O
have	O
been	O
stable	O
for	O
days	O
.	O

If	O
you	O
lose	O
consciousness	O
,	O
develop	O
a	B-problem
low	I-problem
BP	I-problem
,	O
have	O
lightheadedness	B-problem
with	O
standing	O
,	O
develop	O
a	B-problem
fever	I-problem
,	O
or	O
have	O
other	B-problem
worrisome	I-problem
symptoms	I-problem
,	O
please	O
seek	O
medical	B-treatment
care	I-treatment
.	O

Followup	O
Instructions	O
:	O

As	O
planned	O
-	O
continued	O
consultation	O
by	O
Light	O
and	O
Endocrine	O

Vivian	O
LIEN	O
MD	O
88-143	O

Completed	O
by	O
:	O
Mildred	O
BERRY	O
MD	O
38-748	O
2017-07-18	O
@	O
0548	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Edith	O
LIEN	O
on	O
:	O
MON	O
2017-07-24	O
1:03	O
PM	O

(	O
End	O
of	O
Report	O
)	O

333145593	O
PAD-WORD	O

FIH	O
PAD-WORD	O

9229891	O
PAD-WORD	O

50096/c65m	O
PAD-WORD	O

571634	O
PAD-WORD	O

12/5/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12/05/93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

12/17/93	O
PAD-WORD	O

CAUSE	O
OF	O
DEATH	O
:	O

Cardiogenic	B-problem
shock	I-problem
.	O

CAUSATIVE	O
FACTORS	O
:	O

Including	O
cardiomyopathy	B-problem
,	O
aortic	B-problem
stenosis	I-problem
,	O
status	O
post	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
with	O
congestive	B-problem
heart	I-problem
failure	I-problem
and	O
pulmonary	B-problem
edema	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65	O
year	O
old	O
male	O
who	O
sustained	O
a	B-problem
small	I-problem
myocardial	I-problem
infarction	I-problem
first	O
in	O
1978	O
,	O
with	O
course	O
thereafter	O
including	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
by	O
Dr.	O
Wierst	O
______________at	O
Noughwell	O
Entanbon	O
Health	O
in	O
1986	O
.	O

In	O
1991	O
he	O
presented	O
with	O
congestive	B-problem
heart	I-problem
failure	I-problem
and	O
he	O
underwent	O
porcine	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
.	O

In	O
the	O
seven	O
to	O
eight	O
months	O
preceding	O
admission	O
,	O
he	O
developed	O
recurrent	B-problem
angina	I-problem
with	O
dyspnea	B-problem
on	O
exertion	O
.	O

The	O
patient	O
was	O
admitted	O
for	O
cardiac	B-test
catheterization	I-test
in	O
early	O
December	O
,	O
1993	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
vertebrobasilar	B-problem
insufficiency	I-problem
,	O
bipolar	B-problem
mood	I-problem
disorder	I-problem
,	O
and	O
hypercholesterolemia	B-problem
,	O
as	O
well	O
as	O
some	B-problem
baseline	I-problem
renal	I-problem
insufficiency	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Procardia	B-treatment
sustained	I-treatment
release	I-treatment
60	O
mg.	O
po	O
q.day	O
,	O
Digoxin	B-treatment
.25	O
mg.	O
po	O
q.day	O
,	O
Lasix	B-treatment
30	O
mg.	O
(	O
interval	O
unspecified	O
)	O
,	O
Prozac	B-treatment
40	O
mg.	O
po	O
q.day	O
,	O
Lovestatin	B-treatment
20	O
mg.	O
po	O
bid	O
,	O
aspirin	B-treatment
q.	O
day	O
and	O
supplemental	B-treatment
potassium	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Remarkable	O
for	O
an	O
oriented	O
,	O
alert	O
male	O
in	O
no	O
acute	B-problem
distress	I-problem
with	O
decreased	B-problem
breath	I-problem
sounds	I-problem
at	I-problem
the	I-problem
right	I-problem
base	I-problem
consistent	O
with	O
effusion	B-problem
and	O
a	B-problem
3/6	I-problem
systolic	I-problem
murmur	I-problem
consistent	O
with	O
aortic	B-problem
stenosis	I-problem
.	O

His	B-test
pulse	I-test
exam	I-test
was	O
intact	O
.	O

Cardiac	B-test
catheterization	I-test
demonstrated	O
elevated	B-problem
right	I-problem
and	I-problem
left-sided	I-problem
filling	I-problem
pressures	I-problem
at	O
rest	O
,	O
with	O
pulmonary	B-problem
hypertension	I-problem
and	O
normal	O
cardiac	O
index	O
.	O

There	O
was	O
severe	B-problem
aortic	I-problem
stenosis	I-problem
of	O
70	O
millimeter	O
peak	O
gradient	O
,	O
native	B-problem
three	I-problem
vessel	I-problem
disease	I-problem
with	O
patent	B-treatment
left	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
circumflex	I-treatment
,	O
dissection	B-problem
of	I-problem
the	I-problem
left	I-problem
main	I-problem
was	O
induced	O
by	O
the	B-treatment
catheter	I-treatment
tip	I-treatment
.	O

A	B-treatment
patent	I-treatment
right	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
artery	I-treatment
and	I-treatment
diagonal	I-treatment
was	O
noted	O
,	O
and	O
a	B-treatment
patent	I-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
posterior	I-treatment
descending	I-treatment
artery	I-treatment
was	O
present	O
.	O

Also	O
of	O
note	O
,	O
pulmonary	B-problem
edema	I-problem
was	O
induced	O
by	O
dye	B-treatment
and	O
anxiety	B-problem
and	O
treated	O
with	O
Lasix	B-treatment
,	O
Morphine	B-treatment
,	O
oxygen	B-treatment
and	O
nitroglycerin	B-treatment
.	O

Post-procedure	O
he	O
was	O
admitted	O
to	O
the	O
CCU	O
because	O
of	O
the	O
history	O
of	O
left	B-problem
main	I-problem
dissection	I-problem
.	O

He	O
remained	O
hemodynamically	O
stable	O
but	O
of	O
note	O
,	O
would	O
not	O
tolerate	O
a	B-test
transesophageal	I-test
echo	I-test
because	O
of	O
anxiety-he	B-problem
would	O
not	O
swallow	O
the	B-treatment
probe	I-treatment
.	O

Transthoracic	B-test
echo	I-test
demonstrated	O
gradients	O
of	O
100	O
peak	O
and	O
65	O
mean	O
across	O
the	O
aortic	O
valve	O
and	O
there	O
was	O
mild	B-problem
aortic	I-problem
insufficiency	I-problem
and	O
ejection	B-test
fraction	I-test
was	O
noted	O
to	O
be	O
18%	O
with	O
global	B-problem
hypokinesis	I-problem
.	O

The	O
next	O
several	O
days	O
were	O
remarkable	O
for	O
events	O
in	O
which	O
the	O
patient	O
was	O
quite	B-problem
agitated	I-problem
and	O
was	O
evaluated	O
by	O
Psychiatry	O
and	O
treated	O
with	O
Ativan	B-treatment
.	O

The	O
patient	O
was	O
then	O
evaluated	O
by	O
Cardiac	O
Surgery	O
for	O
probable	O
re-do	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
and	O
possible	O
re-do	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

In	O
the	O
course	O
of	O
preoperative	B-test
workup	I-test
,	O
Mr.	O
Has	O
was	O
evaluated	O
completely	O
by	O
Psychiatry	O
with	O
diagnoses	O
including	O
underlying	B-problem
chronic	I-problem
depression	I-problem
well-controlled	O
on	O
Prozac	B-treatment
,	O
underlying	B-problem
organ	I-problem
brain	I-problem
vulnerability	I-problem
of	O
unclear	O
etiology	O
,	O
possibly	O
microvascular	B-problem
infarct	I-problem
,	O
acute	B-problem
paranoid	I-problem
and	I-problem
belligerent	I-problem
behavior	I-problem
,	O
possibly	O
due	O
to	O
medications	B-treatment
.	O

On	O
December	O
12	O
the	O
patient	O
underwent	O
surgery	B-treatment
,	O
including	O
a	B-treatment
re-do	I-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
with	O
#	B-treatment
25	I-treatment
St.	I-treatment
Jude	I-treatment
and	O
re-do	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
times	I-treatment
one	I-treatment
;	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
posterior	I-treatment
descending	I-treatment
artery	I-treatment
as	O
a	B-treatment
veno-venous	I-treatment
jump	I-treatment
graft	I-treatment
.	O

The	O
total	O
bypass	O
time	O
:	O

2	O
hours	O
25	O
minutes	O
.	O

Total	O
crossclamp	O
time	O
:	O

1	O
hour	O
and	O
48	O
minutes	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
postoperatively	O
with	O
stable	O
hemodynamics	O
on	O
Lidocaine	B-treatment
at	O
one	O
,	O
Dobutamine	B-treatment
at	O
200	O
and	O
Nipride	B-treatment
.	O

The	O
patient	O
was	O
extubated	O
by	O
postoperative	O
day	O
#	O
1	O
but	O
was	O
noted	O
to	O
be	O
relatively	B-problem
hypoxemic	I-problem
with	O
high	B-problem
oxygen	I-problem
requirement	I-problem
.	O

Chest	B-test
x-ray	I-test
demonstrating	O
pulmonary	B-problem
edema	I-problem
.	O

Aggressive	B-treatment
diuresis	I-treatment
was	O
undertaken	O
and	O
the	O
patient	O
responded	O
,	O
albeit	O
sluggishly	O
.	O

In	O
addition	O
,	O
he	O
remained	O
agitated	B-problem
.	O

This	O
was	O
attributed	O
to	O
mild	B-problem
hypoxia	I-problem
and	O
/	O
or	O
his	B-problem
underlying	I-problem
psychiatric	I-problem
diagnoses	I-problem
and	O
he	O
was	O
treated	O
with	O
Haldol	B-treatment
appropriately	O
.	O

On	O
day	O
#	O
2	O
the	O
patient	O
continued	O
to	O
diurese	O
and	O
this	O
was	O
maintained	O
with	O
the	B-treatment
Lasix/	I-treatment
Mannitol	I-treatment
infusion	I-treatment
.	O

His	B-test
urine	I-test
output	I-test
remained	O
at	O
150	O
to	O
200	O
cc.	O
an	O
hour	O
.	O

Despite	O
this	O
,	O
his	B-test
chest	I-test
x-ray	I-test
continued	O
to	O
show	O
severe	B-problem
pulmonary	I-problem
edema	I-problem
and	O
the	O
clinical	O
picture	O
correlated	O
.	O

He	O
required	O
anti-hypertensive	B-treatment
therapy	I-treatment
initially	O
with	O
Nipride	B-treatment
which	O
was	O
changed	O
to	O
Hydralazine	B-treatment
to	O
avoid	O
shunting	B-problem
.	O

He	O
received	O
several	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
to	O
increase	O
his	B-test
hematocrit	I-test
and	O
oncotic	B-test
pressure	I-test
.	O

Very	O
early	O
in	O
the	O
morning	O
on	O
postoperative	O
day	O
#	O
3	O
,	O
the	O
patient	O
became	O
acutely	B-problem
hypoxic	I-problem
after	O
several	O
hours	O
of	O
marginal	B-problem
oxygenation	I-problem
with	O
respiratory	B-test
rates	I-test
in	O
the	O
thirties	O
and	O
the	O
patient	O
was	O
urgently	O
intubated	O
,	O
without	O
complication	B-problem
.	O

With	O
positive	B-treatment
pressure	I-treatment
ventilation	I-treatment
and	O
continued	B-treatment
diuresis	I-treatment
,	O
his	B-test
arterial	I-test
blood	I-test
gases	I-test
improved	O
.	O

Throughout	O
this	O
he	O
remained	O
hemodynamically	O
stable	O
.	O

Exception	O
was	O
a	O
ten	O
beat	O
run	O
of	O
ventricular	B-problem
tachycardia	I-problem
which	O
was	O
thought	O
to	O
be	O
ischemic	B-problem
in	O
origin	O
and	O
treated	O
with	O
nitrates	B-treatment
and	O
Lidocaine	B-treatment
.	O

His	B-test
chest	I-test
x-ray	I-test
blossomed	O
to	O
demonstrate	O
pulmonary	B-problem
infiltrate	I-problem
and	O
the	O
patient	O
began	O
to	O
produce	O
sputum	B-problem
.	O

Infectious	O
Disease	O
consultation	O
was	O
obtained	O
for	O
evaluation	B-test
of	O
his	B-problem
purulent	I-problem
sputum	I-problem
and	O
the	O
patient	O
was	O
covered	O
with	O
Vancomycin	B-treatment
,	O
Ceftazidime	B-treatment
and	O
Gentamicin	B-treatment
.	O

Cardiology	B-test
evaluation	I-test
commented	O
on	O
the	B-problem
patient	I-problem
&apos;s	I-problem
increasing	I-problem
ventricular	I-problem
ectopy	I-problem
and	O
suggested	O
that	O
these	O
were	O
due	O
to	O
an	B-problem
R	I-problem
and	I-problem
T	I-problem
phenomenon	I-problem
from	O
his	B-treatment
pacer	I-treatment
in	O
the	O
setting	O
of	O
prolonged	B-problem
QT	I-problem
interval	I-problem
.	O

Consequently	O
his	B-treatment
Pronestyl	I-treatment
was	O
discontinued	O
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
given	O
magnesium	B-treatment
to	O
bring	O
his	B-test
level	I-test
above	O
2	O
.	O

On	O
the	O
evening	O
of	O
the	O
18th	O
,	O
the	O
patient	O
continued	O
to	O
remain	O
hemodynamically	O
stable	O
,	O
although	O
his	B-test
oxygenation	I-test
was	O
clearly	O
deteriorating	O
and	O
more	O
marginal	O
.	O

On	O
60%	O
FIO2	B-treatment
his	O
pO2	B-test
was	O
63	O
.	O

It	O
was	O
increased	O
to	O
65%	O
with	O
pO2	B-test
of	O
81	O
.	O

At	O
approximately	O
7:50	O
a.m.	O
,	O
house	O
officer	O
was	O
called	O
to	O
the	O
room	O
for	O
blood	B-test
pressure	I-test
of	O
70/40	O
with	O
falling	B-problem
oxygen	I-problem
saturations	I-problem
.	O

The	O
patient	O
was	O
immediately	O
given	O
400	O
mg.	O
of	O
Calcium	B-treatment
Chloride	I-treatment
i.v.	I-treatment
push	I-treatment
and	O
ventilator	B-treatment
disconnected	O
and	O
the	O
patient	O
manually	B-treatment
ventilated	I-treatment
.	O

Within	O
one	O
minute	O
,	O
the	O
patient	O
lost	O
his	B-test
blood	I-test
pressure	I-test
and	O
CPR	B-treatment
was	O
initiated	O
and	O
code	O
was	O
called	O
.	O

The	O
patient	O
initially	O
continued	O
to	O
have	O
rhythm	O
consistent	O
with	O
EMV	B-problem
and	O
he	O
was	O
bolused	O
with	O
Levophed	B-treatment
and	O
given	O
some	O
volume	O
while	O
compressions	B-treatment
continued	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
prothrombin	I-test
time	I-test
had	O
been	O
23	O
early	O
the	O
same	O
morning	O
and	O
tamponade	B-problem
was	O
considered	O
and	O
thoracotomy	B-treatment
instruments	I-treatment
obtained	O
.	O

The	O
chest	O
was	O
opened	O
partially	O
and	O
through	O
sub-xyphoid	O
area	O
it	O
was	O
determined	O
that	O
there	O
was	O
no	O
evidence	O
of	O
tamponade	B-problem
.	O

Compressions	B-treatment
were	O
continued	O
and	O
adequate	O
pulse	O
was	O
felt	O
and	O
arterial	B-test
blood	I-test
gases	I-test
demonstrated	O
adequate	O
oxygenation	O
and	O
perfusion	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
rhythm	I-test
degenerated	O
to	O
ventricular	B-problem
tachycardia	I-problem
and	O
he	O
was	O
shocked	O
,	O
initially	O
without	O
response	O
but	O
after	O
several	O
doses	O
of	O
Epinephine	B-treatment
,	O
one-half	O
mg.	O
of	O
Atropine	B-treatment
and	O
a	O
bolus	O
of	O
Lidocaine	B-treatment
we	O
were	O
able	O
to	O
obtain	O
a	B-test
blood	I-test
pressure	I-test
and	O
rhythm	B-test
only	O
briefly	O
,	O
and	O
quickly	O
deteriorated	O
back	O
to	O
ventricular	B-problem
fibrillation	I-problem
.	O

Further	O
attempts	O
at	O
resuscitation	B-treatment
were	O
unsuccessful	O
and	O
the	O
patient	O
was	O
pronounced	O
dead	O
at	O
8:30	O
a.m.	O

The	O
family	O
has	O
been	O
notified	O
and	O
autopsy	O
consent	O
has	O
been	O
obtained	O
.	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O

TR	O
:	O

bp	O
/	O
bmot	O

DD	O
:	O

12/17/93	O
PAD-WORD	O

TD	O
:	O

12/18/93	O
PAD-WORD	O

CC	O
:	O

G	O
Hemp	O
,	O
M.D.	O
Taarnna	O
Has	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2020-01-20	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2020-01-21	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1977-11-23	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Lipitor	B-treatment
/	O
Codeine	B-treatment

Attending	O
:	O
Sam	O
M	O
Ennis	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

GIB	B-problem
PAD-WORD	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Endoscopy	B-test
2020-01-20	O

History	O
of	O
Present	O
Illness	O
:	O

42	O
yom	O
with	O
PMH	O
of	O
HTN	B-problem
,	O
hyperchol	B-problem
admitted	O
to	O
OSH	O
1	O
day	O
ago	O
with	O
black	B-problem
tarry	I-problem
stools	I-problem
X	O
2	O
days	O
.	O

Patient	O
states	O
that	O
he	O
had	O
chronically	O
had	O
loose	B-problem
stools	I-problem
but	O
over	O
2	O
preeceeding	O
days	O
noticed	O
the	O
stool	O
to	O
be	O
dark	B-problem
and	O
tarry	B-problem
.	O

+	O
Epigastric	B-problem
discomfort	I-problem
,	O
gurgling	B-problem
gas-like	I-problem
pain	I-problem
,	O
no	O
association	O
with	O
food	O
.	O

+	O
lightheadedness	B-problem
when	O
he	O
stood	O
up	O
prompting	O
him	O
to	O
go	O
to	O
OSH	O
Nellie	O
.	O

He	O
states	O
that	O
he	O
takes	O
ASA	B-treatment
daily	O
and	O
takes	O
motrin	B-treatment
800	O
mg	O
tid	O
sometimes	O
for	O
pain	B-problem
,	O
last	O
use	O
2	O
wks	O
PTA	O
.	O

Denies	O
BRBPR	B-problem
,	O
n/v/d	B-problem
.	O

Denies	O
recent	B-problem
fevers	I-problem
,	O
chills	B-problem
.	O

Denies	O
any	B-problem
hemetemesis	I-problem
.	O

At	O
OSH	O
initial	B-test
Hct	I-test
=	O
26	O
,	O
and	O
22	O
upon	O
repeat	O
.	O

He	O
was	O
also	O
orthostatic	B-problem
given	O
3	O
units	O
PRBC	B-treatment
and	O
IVF	B-treatment
.	O

EGD	B-test
attempted	O
but	O
pt	O
unable	O
to	O
tolerate	O
.	O

He	O
is	O
now	O
transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
for	O
futher	B-test
workup	I-test
and	O
Rx	B-treatment
.	O

On	O
transfer	O
pt	O
denies	O
any	O
complaints	O
.	O

States	O
that	O
lightheadedness	B-problem
is	O
resolved	O
.	O

Past	O
Medical	O
History	O
:	O

HTN	B-problem
PAD-WORD	O

Hyperchol	B-problem
h/o	O
A.	B-problem
fib	I-problem
6	O
yrs	O
ago	O
->	O
cardioverted	O
.	O

Social	O
History	O
:	O

Social	O
Hx	O
:	O

Works	O
as	O
a	O
police	O
oficer	O
,	O
married	O
,	O
denies	O
smoking	O
,	O
etoh	O
.	O

Family	O
History	O
:	O

Family	O
Hx	O
:	O
father	O
with	O
lung	B-problem
ca	I-problem
.	O

Physical	O
Exam	O
:	O

Physical	O
Exam	O
:	O

Vitals	O
:	O

T	B-test
:	O
98	O

P	B-test
:	O
66	O

R	B-test
:	O
15	O

BP	B-test
:	O
122/51	O

SaO2	B-test
:	O
100%	O
RA	O

General	O
:	O
young	O
male	O
in	O
nad	B-problem
,	O
awake	O
alert	O
oriented	O

HEENT	O
:	O

MMM	O
,	O
eomi	O
,	O
OP	O
clear	O

Neck	O
:	O
supple	O
,	O
no	O
JVD	B-problem

Pulmonary	O
:	O

Lungs	O
CTA	O
bilaterally	O
without	O
R/R/W	B-problem

Cardiac	O
:	O

RRR	O
,	O
nl.	O
S1S2	O
,	O
no	O
M/R/G	B-problem
noted	O

Abdomen	O
:	O
obese	B-problem
,	O
soft	O
,	O
mild	B-problem
epigastric	I-problem
tenderness	I-problem
,	O
NABS	O

Extremities	O
:	O

No	O
C/C/E	B-problem
bilaterally	I-problem
,	O
2+	B-test
radial	I-test
,	I-test
DP	I-test
and	I-test
PT	I-test
pulses	I-test
b/l	I-test
.	O

Rectal	O
:	O
no	O
hemrroiids	B-problem
,	O
guiac	B-problem
positive	I-problem
brown	I-problem
stool	I-problem
.	O

Pertinent	O
Results	O
:	O

OSH	O
27.5	O
hct	B-test
at	O
2:50	O
AM	O
01-20	O
.	O

EKG	B-test
:	O

OSH	O
-	O
sinus	B-problem
tach	I-problem
at	O
108	O
,	O
nl	O
axis	O
,	O
nl	O
intevals	O
.	O

No	O
st-t	B-problem
abnormalities	I-problem
.	O

2020-01-20	O
06:17	O
AM	O

PT	B-test
-	O
13.2	O
*	O
PTT	B-test
-	O
27.2	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.1	O

2020-01-20	O
06:17	O
AM	O

PLT	B-test
COUNT	I-test
-	O
259	O

2020-01-20	O
06:17	O
AM	O

WBC	B-test
-	O
9.3	O
RBC	B-test
-	O
3.21	O
*	O
HGB	B-test
-	O
9.6	O
*	O
HCT	B-test
-	O
27.3	O
*	O
MCV	B-test
-	O
85	O
MCH	B-test
-	O
29.9	O
MCHC	B-test
-	O
35.2	O
*	O
RDW	B-test
-	O
15.6	O
*	O

2020-01-20	O
09:50	O
PM	O

WBC	B-test
-	O
8.0	O
RBC	B-test
-	O
3.20	O
*	O
HGB	B-test
-	O
9.6	O
*	O
HCT	B-test
-	O
27.8	O
*	O
MCV	B-test
-	O
87	O
MCH	B-test
-	O
30.1	O
MCHC	B-test
-	O
34.7	O
RDW	B-test
-	O
15.7	O
*	O

2020-01-20	O
09:50	O
PM	O

PLT	B-test
COUNT	I-test
-	O
264	O

2020-01-20	O
12:38	O
PM	O

WBC	B-test
-	O
7.4	O
RBC	B-test
-	O
3.38	O
*	O
HGB	B-test
-	O
10.1	O
*	O
HCT	B-test
-	O
29.2	O
*	O
MCV	B-test
-	O
86	O
MCH	B-test
-	O
29.8	O
MCHC	B-test
-	O
34.5	O
RDW	B-test
-	O
15.5	O

Brief	O
Hospital	O
Course	O
:	O

Assessment	O
and	O
Plan	O
:	O

42	O
yom	O
with	O
h/o	O
NSAID	B-treatment
use	O
transferred	O
from	O
OSH	O
with	O
black	B-problem
tarry	I-problem
stools	I-problem
at	O
home	O
.	O

Patient	O
was	O
admitted	O
to	O
CMED	O
CCU	O
with	O
tid	O
Hct	B-test
check	I-test
.	O

GI	O
was	O
consulted	O
and	O
performed	O
Endoscopy	B-test
under	O
general	B-treatment
anesthesia	I-treatment
which	O
revealed	O
a	B-problem
non	I-problem
bleeding	I-problem
ulcer	I-problem
and	O
gastritis	B-problem
.	O

Patient	O
was	O
continued	O
on	O
BID	O
PPI	B-treatment
,	O
H	B-treatment
.	O

Pylori	B-test
serology	I-test
checked	O
(	O
pending	O
at	O
time	O
of	O
discharge	O
)	O
.	O

His	B-treatment
antihypertensives	I-treatment
were	O
held	O
given	O
concern	O
for	O
GI	B-problem
bleed	I-problem
and	O
should	O
be	O
restarted	O
at	O
follow	O
up	O
appointment	O
with	O
PCP	O
.	O

Marie	O
was	O
discharged	O
with	O
goal	B-treatment
PPI	I-treatment
twice	O
day	O
for	O
1	O
month	O
followed	O
by	O
once	O
a	O
day	O
.	O

He	O
is	O
scheduled	O
to	O
follow	O
up	O
with	O
daughter	O
in	O
2	O
days	O
.	O

Medications	O
on	O
Admission	O
:	O

Medications	B-treatment
on	O
transfer	O
:	O
esmopreazole	B-treatment
40	O
mg	O
iv	O
bid	O
hydrochlorthiazide	B-treatment
25	O
mg	O
daily	O
lisinopril	B-treatment
5	O
mg	O
daily	O
loratadine	B-treatment
10	O
mg	O
daily	O
metprolol	B-treatment
150	O
mg	O
daily	B-treatment
multivitamin	I-treatment
niacin	I-treatment
500	O
mg	O
daily	O

Medications	O
at	O
home	O
:	O

ASA	B-treatment
325	O
mg	O
daily	O

motrin	B-treatment
800	O
mg	O
tid	O

lisinopril	B-treatment
5	O
mg	O
daily	O

hydrochlorthiazide	B-treatment
25	O
mg	O
daily	O

toprol	B-treatment
xl	I-treatment
150	O
mg	O
daily	O

niaspan	B-treatment
500	O
mg	O
daily	O

loratidine	B-treatment
10	O
mg	O
daily	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Niacin	B-treatment
500	O
mg	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
:	O

Twice	O
a	O
day	O
for	O
one	O
month	O
,	O
followed	O
by	O
one	O
tablet	O
per	O
day	O
.	O

Disp	O
:*	O
60	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

GI	B-problem
Bleeding	I-problem

Peptic	B-problem
Ulcer	I-problem
disease	I-problem

Gastritis	B-problem
PAD-WORD	O

Hypertension	B-problem
PAD-WORD	O

Hypercholestrolemia	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
continue	O
to	O
take	O
all	B-treatment
your	I-treatment
medicaitons	I-treatment
and	O
follow	O
up	O
with	O
your	O
appointments	O
as	O
below	O
.	O

You	O
should	O
avoid	O
aspirin	B-treatment
,	O
motrin	B-treatment
or	O
any	B-treatment
other	I-treatment
nonsteroidal	I-treatment
antiinflammatory	I-treatment
agents	I-treatment
.	O

You	O
should	O
restart	O
your	B-treatment
BP	I-treatment
medications	I-treatment
after	O
you	O
see	O
your	O
PCP	O
.	O

If	O
you	O
have	O
any	B-problem
further	I-problem
black	I-problem
stools	I-problem
,	O
bleeding	B-problem
,	O
lightheadedness	B-problem
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
please	O
contact	O
your	O
PCP	O
or	O
return	O
to	O
the	O
emergency	O
room	O
.	O

Followup	O
Instructions	O
:	O

Please	O
call	O
your	O
PCP	O
X.	O
Neuse	O
at	O
(	O
536	O
)	O
671-1515	O
to	O
set	O
up	O
an	O
appointment	O
by	O
Friday	O
this	O
week	O
.	O

Richard	O
Campbell	O
MD	O
99-028	O

Completed	O
by	O
:	O

James	O
Monique	O
MD	O
11-259	O
2020-01-21	O
@	O
1445	O

Signed	O
electronically	O
by	O
:	O
DR.	O
William	O
Dunbar	O
on	O
:	O
FRI	O
2020-09-25	O
1:30	O
PM	O

(	O
End	O
of	O
Report	O
)	O

339460011	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

5569091	O
PAD-WORD	O

946797	O
PAD-WORD	O

6020656	O
PAD-WORD	O

4/14/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

AKOTE	O
,	O
RALPRI	O

MRN	O
:	O

5569091	O
PAD-WORD	O

Age	O
:	O

77y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

04/14/2004	O
02:47	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
AKOTE	O
,	O
RALPRI	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
04/14/2004	O
02:47	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SOB	B-problem
,	O
FEVER	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
PH	O
UNIVERSITY	O
OF	O
MEDICAL	O
CENTER	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
CHIRD	O
,	O
GRAJORD	O
C	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
PNA	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
639-873-2993	O
.	O

PCP	O
Name	O
:	O

FTLOYD	O
,	O
LETTE	O
D	O

Provider	O
Number	O
:	O

49622	O
PAD-WORD	O

Admission	O
Date	O
:	O

2012-07-17	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-07-22	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1953-12-04	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

SURGERY	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Steve	O
M.	O
Estes	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

ABDOMENAL	B-problem
PAIN	I-problem
AND	O
NAUSEA	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

SMALL	B-treatment
BOWEL	I-treatment
RESECTION	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

58	O
YEAR-OLD	O
FEMALE	O
S/P	O
GASTRIC	B-treatment
BYPASS	I-treatment
03-01	O
WITHOUT	O
COMPLICATIONS	B-problem
POST-OPERATIVELY	O
,	O
NOW	O
PRESENTS	O
WITH	O
ABOMENAL	B-problem
AND	I-problem
AND	I-problem
ASCOCIATED	I-problem
NAUSEA	I-problem
SINCE	O
THE	O
NIGHT	O
BEFORE	O
ADMISSION	O
.	O

PAIN	B-problem
IS	O
DIFFUSED	O
,	O
06-05	O
OUT	O
OF	O
10	O
IN	O
INTENSITY	O
,	O
AND	O
HAS	O
NOT	O
IMPROVED	O
OVERNIGHT	O
.	O

NO	O
FLATUS	B-problem
X	O
1	O
DAY	O
.	O

Past	O
Medical	O
History	O
:	O

OBESITY	B-problem
PAD-WORD	O

HYPERTENSION	B-problem
PAD-WORD	O

GERD	B-problem
PAD-WORD	O

HYPERLIPIDEMIA	B-problem
PAD-WORD	O

APPENDECTOMY	B-treatment
PAD-WORD	O

OVARIAN	B-problem
CYST	I-problem

Physical	O
Exam	O
:	O

AFEBRILE	B-problem
,	O
PULSE	B-test
70-80	O
'S	O
,	O
VITAL	B-test
STABLE	O
AND	O
WITHIN	O
NORMAL	O
LIMITS	O

GENERAL	O
:	O

ALERT	O
,	O
ANICTERUS	B-problem
,	O
OROPHARYNX	O
CLEAR	O

NO	O
LYMPHANOPATHY	B-problem

LUNGS	O
CLEAR	O
TO	O
ASCULTATION	B-test

HEART	O
REGULAR	O
RATE	O
RHYTHM	O

ABDOMEN	O
SOFT	O
,	O
NON-DISTENDED	B-problem
,	O
DIFFUSE	B-problem
TENDERNESS	I-problem
,	O
NO	O
PERITOMEAL	B-problem

SIGNS	O
PAD-WORD	O

EXTREMITIES	O
NO	O
EDEMA	B-problem

Pertinent	O
Results	O
:	O

CT	B-test
PELVIS	I-test
(	O
07-17	O
)	O
An	B-problem
abnormal	I-problem
loop	I-problem
of	O
slightly	B-problem
dilated	I-problem
small	I-problem
bowel	I-problem
with	O
fecalization	B-problem
and	O
possible	O
bowel	B-problem
wall	I-problem
thickening	I-problem
.	O

A	O
clear	O
transit	O
point	O
is	O
not	O
visualized	O
.	O

This	B-problem
small	I-problem
bowel	I-problem
obstruction	I-problem
is	O
likely	O
secondary	O
to	O
closed	B-problem
loop	I-problem
obstruction	I-problem
.	O

This	O
could	O
be	O
due	O
to	O
internal	B-problem
hernia	I-problem
or	O
could	O
be	O
stricture	B-problem
related	O
.	O

Other	O
differential	O
includes	O
ischemia	B-problem
.	O

Infectious	B-problem
etiology	I-problem
is	O
less	O
likely	O
due	O
to	O
the	O
focal	O
nature	O
of	O
the	O
involvement	O
.	O

Brief	O
Hospital	O
Course	O
:	O

UPON	O
PRESENTATION	O
TO	O
THE	O
HOSPITAL	O
AND	O
INTIAL	B-test
WORK-UP	I-test
,	O
THE	O
PATIENT	O
WAS	O
IMMEDIATELY	O
TAKEN	O
TO	O
THE	O
OPERATING	O
ROOM	O
FOR	O
AN	B-test
EXPLORATORY	I-test
LAPORATOMY	I-test
.	O

INTRAOPERATIVELY	O
,	O
THE	O
PATIENT	O
WAS	O
FOUND	O
TO	O
HAVE	O
SMALL	B-problem
BOWEL	I-problem
OBSTRUCTION	I-problem
WITH	O
ISCHEMIC	B-problem
SMALL	I-problem
BOWEL	I-problem
.	O

PORTIONS	O
OF	O
THE	O
SMALL	O
BOWEL	O
WERE	O
RESECTED	O
.	O

SHE	O
TOLERATED	O
THE	B-treatment
PROCEDURE	I-treatment
AND	O
WAS	O
ADMITTED	O
TO	O
THE	O
INTENSIVE	O
CARE	O
UNIT	O
.	O

SHE	O
DID	O
WELL	O
IN	O
THE	O
ICU	O
AND	O
WAS	O
SUBSEQUENTLY	O
TRANSFERED	O
TO	O
THE	O
FLOOR	O
.	O

SHE	O
HAS	O
BEEN	O
AFEBRILE	B-problem
POST-OPERATIVELY	O
,	O
MAKING	O
GOOD	O
URINE	O
,	O
AMBULATING	O
,	O
EATING	O
A	O
REGULAR	O
DIET	O
WITHOUT	O
ANY	B-problem
COMPLICATIONS	I-problem
.	O

SHE	O
WILL	O
BE	O
DISCHARGED	O
IN	O
GOOD	O
CONDITION	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Oxycodone-Acetaminophen	B-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
40	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Discharge	O
Disposition	O
:	O

Home	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

SMALL	B-problem
BOWEL	I-problem
OBSTRUCTION	I-problem

ISCHEMIC	B-problem
SMALL	I-problem
BOWEL	I-problem

Discharge	O
Condition	O
:	O

GOOD	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

PLEASE	O
TAKE	O
MEDICATIONS	B-treatment
AS	O
PRESCRIBED	O
AND	O
READ	O
WARNING	O
LABELS	O
CAREFULLY	O
.	O

IF	O
SIGNS	O
AND	O
SYMPTOMS	O
OF	O
WOUND	B-problem
INFECTION	I-problem
,	O
SUCH	O
AS	O
SUDDEN	B-problem
FEVER	I-problem
,	O
INCREASED	B-problem
PAIN	I-problem
,	O
NAUSEA	B-problem
/	O
VOMITING	B-problem
,	O
PURULENT	B-problem
DISCHARGE	I-problem
,	O
PLEASE	O
GO	O
TO	O
THE	O
EMERGENCY	O
ROOM	O
OR	O
CALL	O
.	O

MAY	O
SHOWER	O
,	O
NO	O
BATHS	O
.	O

PAD	O
DRY	O
--	O
DO	O
NOT	O
SCRUB	O
WOUND	B-problem
.	O

Followup	O
Instructions	O
:	O

PLEASE	O
CALL	O
DR.	O
Barnett	O
OFFICE	O
(	O
(	O
443	O
)	O
316	O
6447	O
FOR	O
A	O
FOLLOW-UP	O
APPOINTMENT	O
IN	O
1-2	O
WEEKS	O
.	O

Ruby	O
John	O
MD	O
54-596	O

Completed	O
by	O
:	O

Thomas	O
Louis	O
MD	O
12-223	O
2012-07-22	O
@	O
1423	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Edgar	O
SCHNEIDER	O
on	O
:	O
SUN	O
2012-07-22	O
2:47	O
PM	O

(	O
End	O
of	O
Report	O
)	O

341909688	O
EH	O

48646747	O
PAD-WORD	O

6988856	O
PAD-WORD	O

2/14/2003	O
12:00:00	O
AM	O

s	O
/	O
p	O
ventral	B-treatment
hernia	I-treatment
repair	I-treatment

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/14/2003	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

02/15/2003	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KAYSKUDZ	O
,	O
NARO	O
307-36-32-7	O
E32	O

Room	O
:	O

80A-171	O
PAD-WORD	O

Service	O
:	O

GGI	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

02/15/03	O
AT	O
02:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

GRENDWIERST	O
,	O
SONLYN	O
R.	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
BID	O
PERCOCET	B-treatment
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
pain	B-problem

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Avoid	O
any	O
heavy	O
lifting	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Grendwierst	O
1-2	O
weeks	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

s	O
/	O
p	O
ventral	B-treatment
hernia	I-treatment
repair	I-treatment

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
ventral	B-treatment
hernia	I-treatment
repair	I-treatment

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
s	O
/	O
p	O
Roux	B-treatment
en	I-treatment
Y	I-treatment
gastric	I-treatment
bypass	I-treatment
.	O

s	O
/	O
p	O
c-section	B-treatment
B12	B-problem
deficiency	I-problem
Anemia	I-problem

GERD	B-treatment
OPERATIONS	I-treatment
AND	O
PROCEDURES	B-treatment
:	O

02/14/03	O
GRENDWIERST	O
,	O
SONLYN	O
R.	O
,	O
M.D.	O
VENTRAL	B-treatment
HERNIA	I-treatment
REPAIR	I-treatment
W	I-treatment
/	I-treatment
MESH	I-treatment

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

None	O
PAD-WORD	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

This	O
is	O
a	O
39	O
year	O
old	O
female	O
,	O
s	O
/	O
p	O
Roux-en-Y	B-treatment
gastric	I-treatment
bypass	I-treatment
in	O
09/06	O
who	O
is	O
admitted	O
for	O
elective	B-treatment
repair	I-treatment
of	O
a	B-problem
ventral	I-problem
hernia	I-problem
.	O

The	O
patient	O
went	O
to	O
the	O
operating	O
room	O
on	O
2/14/03	O
for	O
repair	B-treatment
of	O
the	B-problem
hernia	I-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
overnight	O
for	O
pai	B-treatment
n	I-treatment
management	I-treatment
in	O
the	O
setting	O
of	O
a	B-problem
large	I-problem
incision	I-problem
with	O
large	O
amounts	O
of	O
dissection	B-problem
during	O
the	B-treatment
procedure	I-treatment
.	O

She	O
did	O
well	O
overnight	O
with	O
minimal	B-problem
pain	I-problem
medication	I-problem
requirements	I-problem
.	O

She	O
voided	O
on	O
the	O
morning	O
of	O
POD	O
#	O
1	O
.	O

She	O
had	O
no	O
complaints	O
of	O
nausea	B-problem
or	O
vomiting	B-problem
and	O
was	O
tolerating	O
PO&apos;s	O
well	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

No	O
heavy	O
lifting	O
x	O
3	O
weeks	O
.	O

Keep	O
the	B-treatment
dressing	I-treatment
on	O
and	O
dry	O
for	O
48	O
hours	O
after	O
the	B-treatment
surgery	I-treatment
.	O

You	O
can	O
shower	O
when	O
you	O
get	O
home	O
.	O

Avoid	O
getting	O
the	B-problem
incision	I-problem
soaking	O
wet	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

You	O
should	O
follow-up	O
with	O
Dr.	O
Grendwierst	O
.	O

Call	O
his	O
office	O
to	O
make	O
an	O
appointment	O
.	O

Take	O
the	B-treatment
pain	I-treatment
medication	I-treatment
as	O
prescribed	O
.	O

You	O
can	O
take	O
regular	O
tylenol	B-treatment
or	O
motrin	B-treatment
for	O
pain	B-problem
and	O
use	O
the	B-treatment
percocet	I-treatment
for	O
breakthrough	B-problem
pain	I-problem
.	O

REturn	O
to	O
the	O
ER	O
or	O
call	O
your	O
doctor	O
if	O
you	O
develop	O
fevers	B-problem
,	O
notice	O
pus	B-problem
from	O
the	B-problem
incision	I-problem
,	O
develop	O
surrounding	B-problem
redness	I-problem
,	O
have	O
abdominal	B-problem
pain	I-problem
,	O
have	O
vomiting	B-problem
where	O
you	O
can	O
&apos;t	O
keep	O
anything	O
down	O
or	O
develop	O
any	B-problem
symptoms	I-problem
that	O
concern	O
you	O
.	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

MSSHUFFBREUN	O
,	O
RERE	O
N.	O
,	O
M.D.	O
(	O
KX79	O
)	O

02/15/03	O
01:29	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2018-12-29	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-01-04	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2018-12-29	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Neonatology	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Baby	O
Davis	O
is	O
the	O
3.160	O
kilogram	O
product	O
of	O
a	O
term	O
pregnancy	O
.	O

He	O
was	O
born	O
to	O
a	O
38	O
-	O
year-old	O
gravida	O
I	O
,	O
para	O
0	O
(	O
now	O
1	O
)	O
mother	O
at	O
37	O
and	O
1/7	O
weeks	O
.	O

The	O
pregnancy	O
was	O
benign	O
with	O
an	O
EDC	O
of	O
2019-01-18	O
.	O

Prenatal	B-test
screens	I-test
were	O
O	O
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
surface	I-test
antigen	I-test
negative	O
,	O
rapid	B-test
plasma	I-test
reagent	I-test
nonreactive	O
,	O
rubella	B-test
immune	O
,	O
group	B-test
B	I-test
strep	I-test
negative	O
.	O

The	O
infant	O
delivered	O
by	O
spontaneous	O
vaginal	O
delivery	O
with	O
Apgar	B-test
scores	I-test
of	O
8	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
the	O
Baby	O
Lucas	O
is	O
well	O
appearing	O
,	O
no	O
jaundice	B-problem
.	O

He	O
has	O
bilateral	O
breath	O
sounds	O
that	O
are	O
clear	O
and	O
equal	O
.	O

The	B-test
heart	I-test
rate	I-test
is	O
regular	O
without	O
murmur	B-problem
.	O

Pulses	B-test
are	O
2+	O
and	O
symmetrical	O
.	O

The	O
abdomen	O
is	O
soft	O
and	O
nontender	B-problem
with	O
no	O
hepatosplenomegaly	B-problem
.	O

His	B-test
weight	I-test
is	O
3.160	O
kilograms	O
(	O
7	O
pounds	O
3	O
ounces	O
)	O
at	O
birth	O
.	O

He	O
is	O
circumcised	O
with	O
testes	O
descended	O
bilaterally	O
.	O

His	O
hips	O
are	O
stable	O
.	O

His	O
tone	O
is	O
normal	O
.	O

Normal	O
neonatal	O
reflexes	O
.	O

He	O
is	O
tolerating	O
his	O
feedings	O
well	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Respiratory	O
.	O

Without	O
issues	O
on	O
this	O
admission	O
.	O

Breath	O
sounds	O
are	O
clear	O
and	O
equal	O
.	O

2.	O
Cardiovascular	O
.	O

Without	O
issues	O
on	O
this	O
admission	O
.	O

He	O
had	O
a	O
regular	O
heart	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
,	O
pulses	B-test
were	O
2+	O
and	O
symmetric	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
.	O

The	B-test
baby	I-test
's	I-test
weight	I-test
was	O
3.160	O
kilograms	O
(	O
7	O
pounds	O
3	O
ounces	O
).	O

He	O
is	O
breast	O
and	O
bottle	O
feeding	O
every	O
3	O
hours	O
with	O
expressed	O
breast	O
milk	O
and	O
/	O
or	O
Enfamil	B-treatment
.	O

He	O
is	O
feeding	O
well	O
.	O

His	B-test
discharge	I-test
weight	I-test
is	O
3025	O
gm	O
,	O
and	O
has	O
been	O
stable	O
for	O
past	O
2	O
days	O
.	O

4.	O
Gastrointestinal	O
.	O

The	B-test
baby	I-test
's	I-test
bilirubin	I-test
on	O
2018-12-31	O
,	O
was	O
15.5	O
/	O
0.5	O
at	O
which	O
time	O
double	B-treatment
phototherapy	I-treatment
was	O
started	O
.	O

On	O
01-01	O
,	O
his	B-test
bilirubin	I-test
was	O
17.3	O
/	O
0.4	O
at	O
which	O
time	O
triple	B-treatment
phototherapy	I-treatment
was	O
started	O
and	O
then	O
his	B-test
subsequent	I-test
bilirubins	I-test
are	O
16.5	O
/	O
0.4	O
on	O
2019-01-01	O
,	O
and	O
16.2	O
/	O
0.5	O
on	O
2019-01-02	O
.	O

Phototherapy	B-treatment
was	O
discontinued	O
on	O
2019-01-04	O
for	O
a	B-test
bilirubin	I-test
of	O
12.1	O
,	O
and	O
a	B-test
rebound	I-test
bilirubin	I-test
will	O
be	O
checked	O
on	O
01-05	O
.	O

5.	O
Hematology	O
.	O

The	B-test
hematocrit	I-test
on	O
01-02	O
,	O
was	O
61	O
with	O
a	B-test
reticulocyte	I-test
of	O
2.6%	O
.	O

His	B-test
blood	I-test
type	I-test
is	O
A+	O
,	O
Coombs	B-test
negative	O
.	O

6.	O
Infectious	O
disease	O
.	O

No	O
issues	O
on	O
this	O
admission	O
.	O

7.	O
Neurological	O
.	O

The	O
baby	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
with	O
normal	O
newborn	O
reflexes	O
.	O

8.	O
Sensory	O
.	O

Auditory	B-test
hearing	I-test
screening	I-test
was	O
performed	O
with	O
automated	O
brainstem	O
responses	O
.	O

The	O
infant	O
passed	O
both	O
ears	O
on	O
2018-12-30	O
.	O

9.	O
Psychosocial	O
.	O

The	O
family	O
is	O
invested	O
and	O
involved	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Home	O
.	O

PRIMARY	O
PEDIATRIC	O
CARE	O
:	O

Source	O
of	O
primary	O
pediatric	O
care	O
is	O
David	O
Bull	O
at	O
1899	O
S.	O
Fifth	O
Rd.	O
,	O
Salem	O
,	O
Florida	O
92564	O
.	O

Phone	O
is	O
(	O
(	O
256	O
)	O
348-3764	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Continue	O
breast	O
feeding	O
with	O
post-feed	B-treatment
supplemental	I-treatment
EBM	I-treatment
.	O

2.	O
Follow-up	B-test
bilirubin	I-test
in	O
1	O
day	O
;	O
f/u	O
with	O
PMD	O
in	O
1-3	O
days	O
.	O

3.	O
Medications	O
:	O

Not	O
applicable	O
.	O

4.	O
Car	B-test
seat	I-test
position	I-test
and	I-test
screening	I-test
:	O
Not	O
applicable	O
.	O

5.	O
State	B-test
newborn	I-test
screens	I-test
were	O
sent	O
on	O
2018-12-31	O
,	O
and	O
the	O
results	O
are	O
pending	O
.	O

6.	O
Immunizations	B-treatment
received	O
:	O
Hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
on	O
12-31	O
,	O
2006	O
.	O

7.	O
Immunization	B-treatment
recommended	O
:	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
(	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
)	O
,	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
all	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Term	O
(	O
37	O
and	O
1/7	O
weeks	O
)	O
appropriate	O
for	O
gestational	O
age	O
male	O
neonate	O
.	O

2.	O
Exaggerated	B-problem
physiologic	I-problem
hyperbilirubinemia	I-problem
responsive	O
to	O
phototherapy	B-treatment
.	O

Nicole	O
Monica	O
,	O
MD	O
48-041	O

Dictated	O
By	O
:	O
Michelle	O
A	O
Sweeney	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2019-01-02	O
12:16:10	O

T	O
:	O
2019-01-02	O
13:00:35	O

Job	O
#	O
:	O
38170	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Victoria	O
Cox	O
on	O
:	O
FRI	O
2019-01-04	O
11:25	O
AM	O

(	O
End	O
of	O
Report	O
)	O

348983165	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4912803	O
PAD-WORD	O

97509/32z1	O
PAD-WORD	O

028205	O
PAD-WORD	O

4/14/1994	O
12:00:00	O
AM	O

SELF	B-problem
INFLICTED	I-problem
GUNSHOT	I-problem
WOUND	I-problem
TO	I-problem
THE	I-problem
HEAD	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

4/14/94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

4/20/94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Self	B-problem
inflicted	I-problem
gunshot	I-problem
wound	I-problem
to	I-problem
the	I-problem
head	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

hypertension	B-problem
,	O
poor	B-problem
dentition	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Suture	B-treatment
of	O
right	B-problem
temporal	I-problem
head	I-problem
wound	I-problem
,	O
performed	O
on	O
April	O
14	O
,	O
1994	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Le	O
is	O
a	O
seventy	O
three	O
year	O
old	O
male	O
who	O
presents	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
following	O
a	B-problem
self	I-problem
inflicted	I-problem
gunshot	I-problem
wound	I-problem
to	I-problem
the	I-problem
head	I-problem
.	O

Mr.	O
Le	O
was	O
found	O
in	O
bed	O
with	O
a	O
32	O
caliber	O
revolver	O
at	O
his	O
side	O
.	O

The	O
patient	O
was	O
apparently	O
alone	O
at	O
home	O
,	O
his	O
neighbors	O
heard	O
a	O
single	O
shot	O
,	O
and	O
the	O
paramedics	O
were	O
called	O
.	O

Upon	O
arrival	O
,	O
they	O
found	O
the	O
patient	O
in	O
bed	O
,	O
with	O
notes	O
nearby	O
,	O
listing	O
his	O
funeral	O
home	O
preferences	O
and	O
information	O
on	O
his	O
next	O
of	O
kin	O
.	O

The	O
patient	O
indicates	O
that	O
his	O
neighbors	O
were	O
making	O
excessive	O
noise	O
upstairs	O
from	O
his	O
dwelling	O
,	O
and	O
he	O
found	O
it	O
unbearable	O
.	O

He	O
therefore	O
decided	O
to	O
take	O
his	O
life	O
with	O
a	O
gun	O
which	O
he	O
had	O
found	O
in	O
the	O
house	O
.	O

Apparently	O
,	O
the	O
gun	O
belonged	O
to	O
his	O
father	O
.	O

On	O
further	O
questioning	O
,	O
the	O
patient	O
described	O
that	O
his	O
father	O
passed	O
away	O
approximately	O
forty	O
to	O
fifty	O
years	O
prior	O
to	O
his	O
admission	O
,	O
and	O
the	O
gun	O
was	O
found	O
in	O
a	O
box	O
in	O
their	O
home	O
.	O

The	O
patient	O
expressed	O
concern	O
that	O
he	O
had	O
several	O
utility	O
bills	O
that	O
he	O
was	O
unable	O
to	O
pay	O
.	O

The	O
patient	O
&apos;s	O
sister	O
died	O
eight	O
years	O
prior	O
to	O
the	O
patient	O
&apos;s	O
admission	O
of	O
leukemia	B-problem
,	O
and	O
he	O
otherwise	O
has	O
no	O
next	O
of	O
kin	O
with	O
the	O
exception	O
of	O
one	O
brother	O
in	O
Washington	O
,	O
with	O
whom	O
his	O
relationship	O
is	O
tenuous	O
.	O

On	O
initial	O
questioning	O
,	O
however	O
,	O
the	O
patient	O
denies	O
any	O
recent	O
losses	O
.	O

On	O
admission	O
,	O
the	O
patient	O
denies	O
any	B-problem
suicidal	I-problem
or	I-problem
homicidal	I-problem
ideation	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
hypertension	B-problem
,	O

2.	O
poor	B-problem
dentition	I-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

NOne	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
retired	O
employee	O
of	O
the	O
City	O
of	O
Avi	O
Den	O
,	O
Hawaii	O
,	O
lives	O
on	O
a	O
pension	O
and	O
Social	O
Security	O
.	O

The	O
patient	O
has	O
never	O
been	O
married	O
and	O
has	O
no	O
children	O
.	O

He	O
has	O
a	O
sixty	O
to	O
seventy	O
five	O
pack	O
year	O
smoking	O
history	O
and	O
drinks	O
alcohol	O
approximately	O
one	O
time	O
per	O
week	O
.	O

He	O
denies	O
any	O
ilicit	O
drug	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
an	O
obese	O
male	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
vital	I-test
signs	I-test
temperature	B-test
98.0	O
,	O
heart	B-test
rate	I-test
78	O
,	O
blood	B-test
pressure	I-test
186/69	O
,	O
respirations	B-test
18	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
revealed	O
an	B-problem
entry	I-problem
wound	I-problem
approximately	O
1	O
1/2	O
inches	O
above	O
the	O
right	O
ear	O
,	O
which	O
is	O
approximately	O
1	O
cm.	O
in	O
length	O
and	O
surrounded	O
by	O
powder	B-problem
burn	I-problem
.	O

There	O
is	O
a	B-problem
lump	I-problem
in	I-problem
the	I-problem
right	I-problem
parietal	I-problem
region	I-problem
,	O
which	O
corresponds	O
with	O
the	O
bullet	O
seen	O
on	O
the	B-test
computerized	I-test
tomography	I-test
scan	I-test
.	O

There	O
is	O
no	O
bruising	B-problem
about	I-problem
the	I-problem
eyes	I-problem
or	I-problem
mastoid	I-problem
sinuses	I-problem
,	O
and	O
there	O
is	O
no	O
fluid	B-problem
from	I-problem
the	I-problem
nose	I-problem
or	I-problem
ears	I-problem
.	O

The	O
neck	O
was	O
supple	O
,	O
and	O
without	O
adenopathy	B-problem
.	O

The	O
lungs	O
are	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

The	B-test
heart	I-test
sounds	I-test
are	O
regular	O
rate	O
and	O
rhythm	O
and	O
no	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
are	O
appreciated	O
.	O

The	O
abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
without	O
hepatosplenomegaly	B-problem
.	O

There	O
are	O
no	O
masses	B-problem
and	O
the	B-test
bowel	I-test
sounds	I-test
are	O
present	O
.	O

The	O
extremities	O
are	O
well	O
perfused	O
and	O
there	O
is	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

Neurological	O
:	O

examination	B-test
revealed	O
a	O
patient	O
who	O
was	O
alert	O
and	O
oriented	O
X	O
3	O
,	O
with	O
short	O
term	O
recall	O
of	O
2/3	O
objects	O
at	O
five	O
minutes	O
and	O
fluent	O
speech	O
.	O

The	O
patient	O
remembers	O
the	O
presidents	O
as	O
Carter-Bush-Regan-Truman-Roosevelt	O
.	O

The	O
patient	O
was	O
able	O
to	O
spell	O
world	O
backwards	O
on	O
the	O
third	O
attempt	O
.	O

He	O
performed	O
serial	O
7	O
&apos;s	O
accurately	O
.	O

He	O
demonstrated	O
poor	B-problem
ability	I-problem
for	I-problem
abstract	I-problem
thinking	I-problem
.	O

Cranial	O
nerves	O
II-XII	O
were	O
grossly	O
intact	O
.	O

The	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
and	O
the	B-test
extra	I-test
ocular	I-test
movements	I-test
are	O
intact	O
.	O

The	O
fundi	O
are	O
benign	O
and	O
the	O
discs	O
are	O
sharp	O
.	O

The	O
patient	O
&apos;s	O
strength	O
is	O
5/5	O
throughout	O
and	O
the	O
sensorium	O
is	O
intact	O
.	O

The	B-test
deep	I-test
tendon	I-test
reflexes	I-test
are	O
2+	O
and	O
symmetrical	O
throughout	O
.	O

LABORATORY	O
DATA	O
:	O

A	B-test
panel	I-test
of	I-test
serum	I-test
electrolytes	I-test
is	O
normal	O
.	O

The	B-test
white	I-test
blood	I-test
count	I-test
is	O
9.4	O
,	O
hematocrit	B-test
47.1	O
,	O
and	O
the	B-test
platelets	I-test
253,000	O
.	O

Blood	B-test
coagulation	I-test
times	I-test
are	O
normal	O
.	O

Serum	B-test
toxic	I-test
screen	I-test
is	O
negative	O
.	O

Leukocyte	B-test
differential	I-test
count	I-test
reveals	O
64	B-test
neutrophils	I-test
,	O
24%	B-test
lymphocytes	I-test
,	O
8%	B-test
monocytes	I-test
,	O
2%	B-test
eosinophils	I-test
,	O
and	O
2%	B-test
basophils	I-test
.	O

A	B-test
panel	I-test
of	I-test
serum	I-test
enzymes	I-test
suggest	O
normal	O
hepatic	O
function	O
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
of	I-test
the	I-test
head	I-test
reveals	O
a	B-problem
small	I-problem
external	I-problem
skull	I-problem
fracture	I-problem
,	O
approximately	O
1-2	O
millemeters	O
in	O
size	O
,	O
near	O
the	O
right	O
frontoparietal	O
apex	O
.	O

A	B-problem
right	I-problem
parietal	I-problem
contusion	I-problem
is	O
also	O
identified	O
,	O
with	O
blood	O
tracking	O
into	O
the	O
middle	O
focus	O
.	O

Standard	B-test
12	I-test
lead	I-test
electrocardiogram	I-test
revealed	O
normal	O
sinus	O
rhythm	O
at	O
a	B-test
rate	I-test
of	O
85	O
,	O
with	O
poor	B-problem
R	I-problem
wave	I-problem
progression	I-problem
in	O
leads	O
V1	O
through	O
V3	O
suggesting	O
the	O
possibility	O
of	O
an	B-problem
old	I-problem
anteroseptal	I-problem
myocardial	I-problem
infarction	I-problem
.	O

Nonspecific	B-problem
ST	I-problem
segment	I-problem
and	I-problem
T	I-problem
wave	I-problem
abnormalities	I-problem
are	O
present	O
as	O
well	O
.	O

Otherwise	O
,	O
the	O
axis	O
is	O
normal	O
and	O
the	O
intervals	O
are	O
normal	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
on	O
the	O
Neurological	O
Surgery	O
Service	O
of	O
Lupevickette	O
L.	O
Ca	O
,	O
M.D.	O

Prior	O
to	O
his	O
admission	O
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
gunshot	I-problem
wound	I-problem
was	O
sutured	O
close	O
in	O
the	O
emergency	O
room	O
.	O

The	O
patient	O
was	O
placed	O
on	O
suicide	B-treatment
precautions	I-treatment
,	O
and	O
was	O
hydrated	O
with	O
an	B-treatment
infusion	I-treatment
of	I-treatment
intravenous	I-treatment
fluid	I-treatment
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Psychiatry	O
Service	O
,	O
who	O
began	O
a	O
battery	O
of	O
testing	B-test
,	O
which	O
continues	O
at	O
the	O
time	O
of	O
discharge	O
.	O

The	O
Consulting	O
Psychiatrist	O
recommended	O
a	O
minimum	O
of	O
2	B-treatment
point	I-treatment
restraints	I-treatment
at	O
all	O
times	O
,	O
and	O
recommended	O
the	O
patient	O
be	O
monitored	O
by	O
a	O
sitter	O
.	O

Allowing	O
the	O
patient	O
to	O
ambulate	O
was	O
not	O
recommended	O
.	O

From	O
a	O
medical	O
standpoint	O
,	O
the	O
patient	O
did	O
well	O
.	O

He	O
was	O
initially	O
admitted	O
to	O
the	O
Neurological	O
Intensive	O
Care	O
Unit	O
where	O
he	O
was	O
closely	O
monitored	O
during	O
the	O
first	O
two	O
days	O
of	O
his	O
hospitalization	O
.	O

The	O
chief	O
obstacle	O
was	O
bringing	O
his	B-test
blood	I-test
pressure	I-test
under	O
control	O
and	O
this	O
was	O
ultimately	O
achieved	O
with	O
a	O
combination	O
of	O
Captopril	B-treatment
and	O
Nifedipine	B-treatment
.	O

After	O
his	B-test
blood	I-test
pressure	I-test
had	O
stabilized	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Neurology	O
Ward	O
.	O

Close	B-test
monitoring	I-test
demonstrated	O
his	B-test
blood	I-test
pressure	I-test
to	O
be	O
stable	O
and	O
within	O
an	O
acceptable	O
rang	O
on	O
his	B-treatment
dosage	I-treatment
regimen	I-treatment
.	O

The	O
Psychiatry	O
Service	O
followed	O
up	O
extensively	O
with	O
the	O
patient	O
,	O
and	O
his	O
Psychiatric	O
progress	O
is	O
detailed	O
in	O
the	O
Psychiatry	O
transfer	O
note	O
.	O

By	O
the	O
7th	O
hospital	O
day	O
,	O
the	O
patient	O
was	O
medically	O
stable	O
.	O

He	O
had	O
undergone	O
full	B-test
Psychiatric	I-test
evaluation	I-test
,	O
and	O
was	O
prepared	O
for	O
transfer	O
to	O
a	O
Psychiatric	O
Hospital	O
.	O

Therefore	O
,	O
because	O
of	O
his	O
need	O
for	O
intense	B-treatment
psychiatric	I-treatment
care	I-treatment
,	O
the	O
patient	O
is	O
discharged	O
to	O
the	O
Vo	O
Black	O
Doylestrictshore	O
Ft.	O
Clinics	O
Medical	O
Center	O
on	O
the	O
7th	O
hospital	O
day	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Improved	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

Discharged	O
to	O
Sonpathcermu	O
Jords	O
Hospital	O
.	O

2.	O
diet	O
as	O
tolerated	O
.	O

3.	O
Activity	O
ad	O
lib	O
,	O
with	O
restrictions	O
as	O
indicated	O
by	O
the	O
Psychiatry	O
Transfer	O
Note	O
.	O

4.	O
Followup	O
with	O
Dr.	O
Rourdrick	O
in	O
four	O
weeks	O
time	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Dilantin	B-treatment
100	O
mg.	O
po	O
tid	O
,	O
Mylanta	B-treatment
30	O
cc.	O
po	O
q	O
4	O
hours	O
prn	O
,	O
Dyspepsia	B-problem
,	O
Milk	B-treatment
of	I-treatment
Magnesia	I-treatment
30	O
cc.	O
po	O
q	O
4	O
hours	O
prn	O
constipation	B-problem
,	O
Cimetidine	B-treatment
400	O
mg.	O
po	O
bid	O
,	O
Haloperidol	B-treatment
1	O
mg.	O
po	O
or	O
IM	O
q	O
3	O
hours	O
prn	O
agitation	B-problem
.	O

Colace	B-treatment
100	O
mg.	O
po	O
bid	O
,	O
Captopril	B-treatment
50	O
mg.	O
po	O
tid	O
,	O
Nifedipine	B-treatment
20	O
mg.	O
po	O
q	O
6	O
hours	O
and	O
Nifedipine	B-treatment
20	O
mg.	O
po	O
or	O
sublingual	O
q	O
3	O
hours	O
prn	O
systolic	B-problem
blood	I-problem
pressure	I-problem
greater	I-problem
than	I-problem
160	I-problem
millemeters	I-problem
of	I-problem
Mercury	I-problem
.	O

LUPEVICKETTE	O
CA	O
,	O
M.D.	O

TR	O
:	O

yz	O
/	O
bmot	O

DD	O
:	O

4/19/94	O
PAD-WORD	O

TD	O
:	O

04/19/94	O
PAD-WORD	O

CC	O
:	O

stat	O
PAD-WORD	O

Admission	O
Date	O
:	O

2017-05-14	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-06-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2017-05-14	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Jadiara	O
Harrison	O
is	O
twin	O
#1	O
born	O
to	O
a	O
17	O
year-old	O
primiparous	O
mother	O
at	O
31	O
weeks	O
gestation	O
.	O

Mother	O
was	O
admitted	O
to	O
the	O
Nantucket	O
Cottage	O
Hospital	O
from	O
Lawrence	O
General	O
Hospital	O
Hospital	O
on	O
05-01	O
with	O
cervical	O
effacement	O
and	O
preterm	B-problem
labor	I-problem
.	O

She	O
was	O
treated	O
with	O
magnesium	B-treatment
sulfate	I-treatment
.	O

She	O
had	O
previously	O
been	O
admitted	O
here	O
at	O
the	O
24th	O
week	O
after	O
a	O
motor	O
vehicle	O
accident.	O
She	O
was	O
treated	O
with	O
tocolysis	B-treatment
and	O
betamethasone	B-treatment
at	O
that	O
time	O
.	O

Due	O
to	O
progressing	O
labor	O
and	O
presentation	O
of	O
twins	O
,	O
delivery	O
was	O
by	O
Cesarean	B-treatment
section	I-treatment
.	O

Prenatal	B-test
screens	I-test
were	O
notable	O
for	O
blood	B-test
type	I-test
0	O
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
.	O

Rubella	B-test
status	I-test
was	O
not	O
documented	O
.	O

Group	B-test
B	I-test
strep	I-test
status	I-test
was	O
unknown	O
.	O

Infant	O
emerged	O
from	O
the	B-problem
breech	I-problem
position	I-problem
.	O

She	O
was	O
vigorous	O
.	O

She	O
was	O
given	O
blow-by	B-treatment
oxygen	I-treatment
and	O
stimulation	B-treatment
.	O

Her	B-test
Apgars	I-test
were	O
7	O
at	O
1	O
minute	O
and	O
9	O
at	O
5	O
minutes	O
.	O

She	O
was	O
brought	O
to	O
the	O
CMED	O
CSRU	O
for	O
further	B-test
evaluation	I-test
.	O

PHYSICAL	O
EXAMINATION	O
:	O

ON	O
admission	O
,	O
physical	B-test
examination	I-test
reveals	O
a	B-problem
non	I-problem
dysmorphic	I-problem
infant	I-problem
,	O
well	O
saturated	O
and	O
perfused	O
with	O
multiple	B-problem
bruises	I-problem
noted	O
over	O
the	O
upper	O
legs	O
,	O
left	O
arm	O
and	O
chest	O
.	O

No	O
bony	B-problem
abnormalities	I-problem
or	O
petechiae	B-problem
noted	O
.	O

She	O
was	O
moving	O
all	O
joints	O
and	O
extremities	O
well	O
.	O

HEENT	O
:	O

Within	O
normal	O
limits	O
.	O

CV	O
:	O

Normal	O
S1	O
and	O
S2	O
without	O
a	B-problem
murmur	I-problem
.	O

Lungs	O
were	O
clear	O
.	O

Abdomen	O
was	O
benign	O
.	O

Genitalia	O
normal	O
.	O

Premature	O
female	O
.	O

Neuro	O
:	O

Non	O
focal	O
and	O
age	O
appropriate	O
.	O

Hips	O
normal	O
,	O
held	O
in	O
the	O
breech	O
position	O
.	O

Anus	O
patent	O
.	O

Spine	O
intact	O
.	O

HOSPITAL	O
COURSE	O
:	O

Respiratory	O
:	O

On	O
admission	O
,	O
infant	O
did	O
not	O
require	O
supplemental	B-treatment
oxygen	I-treatment
or	O
respiratory	B-treatment
support	I-treatment
.	O

Since	O
that	O
time	O
,	O
Jadiara	O
has	O
always	O
been	O
in	O
room	O
air	O
without	O
requiring	O
supplemental	B-treatment
oxygen	I-treatment
.	O

She	O
was	O
noted	O
to	O
have	O
apnea	B-problem
of	I-problem
prematurity	I-problem
,	O
treated	O
with	O
caffeine	B-treatment
until	O
2017-06-04	O
.	O

Since	O
that	O
time	O
,	O
she	O
has	O
had	O
very	B-problem
rare	I-problem
spells	I-problem
,	O
with	O
none	O
for	O
over	O
one	O
week	O
by	O
the	O
time	O
of	O
discharge	O
.	O

Cardiovascular	O
:	O

She	O
was	O
hemodynamically	O
stable	O
upon	O
admission	O
with	O
normal	O
blood	O
pressures	O
and	O
heart	O
rate	O
.	O

On	O
day	O
of	O
life	O
15	O
,	O
she	O
was	O
noted	O
to	O
have	O
a	B-problem
murmur	I-problem
,	O
eventually	O
prompting	O
evaluation	B-test
by	I-test
ECHO	I-test
.	O

The	B-test
ECHO	I-test
revealed	O
an	B-problem
anomalous	I-problem
left	I-problem
coronary	I-problem
,	O
with	O
one	O
end	O
entering	O
the	O
right	O
ventricular	O
outflow	O
tract	O
and	O
the	O
other	O
end	O
not	O
clearly	O
defined	O
.	O

It	O
was	O
unable	O
to	O
be	O
delineated	O
whether	O
this	O
represented	O
an	B-problem
anomalous	I-problem
left	I-problem
coronary	I-problem
artery	I-problem
arising	I-problem
from	I-problem
the	I-problem
pulmonary	I-problem
artery	I-problem
(	I-problem
LCAPA	I-problem
)	I-problem
or	O
a	B-problem
left	I-problem
coronary	I-problem
artery	I-problem
fistula	I-problem
to	I-problem
the	I-problem
pulmonar	I-problem
artery	I-problem
.	O

The	O
right	O
coronary	O
was	O
prominent	O
,	O
and	O
there	O
appeared	O
to	O
be	O
coronary	B-problem
artery	I-problem
collateral	I-problem
vessels	I-problem
in	I-problem
the	I-problem
posterior	I-problem
apical	I-problem
myocardium	I-problem
.	O

A	B-problem
small	I-problem
apical	I-problem
muscular	I-problem
VSD	I-problem
was	O
also	O
noted	O
.	O

Several	B-test
additional	I-test
ECHOs	I-test
were	O
performed	O
,	O
including	O
an	B-test
ECHO	I-test
in	O
the	O
cardiology	O
department	O
at	O
HealthSouth	O
Rehab	O
Hospital	O
of	O
Western	O
Mass.	O
,	O
but	O
the	O
anatomy	O
of	O
the	O
left	O
coronary	O
artery	O
could	O
not	O
be	O
further	O
defined	O
.	O

Due	O
to	O
the	O
risks	O
of	O
coronary	B-problem
ischemia	I-problem
if	O
this	O
represented	O
an	B-problem
LCAPA	I-problem
,	O
the	O
infant	O
was	O
followed	O
with	O
regular	B-test
ECHOs	I-test
and	O
EKGs	B-test
during	O
the	O
remainder	O
of	O
hospitalization	O
,	O
with	O
no	O
evidence	O
of	O
ischemia	B-problem
,	O
valvular	B-problem
regurgitation	I-problem
,	O
or	O
compromised	B-problem
ventricular	I-problem
function	I-problem
.	O

She	O
will	O
be	O
continued	O
to	O
be	O
followed	O
closely	O
by	O
cardiology	O
as	O
an	O
outpatient	O
,	O
with	O
likely	O
plans	O
for	O
cardiac	B-test
catheterization	I-test
and	O
surgical	B-treatment
repair	I-treatment
when	O
she	O
grows	O
to	O
3.5	O
to	O
4	O
kg	O
.	O

Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	O
infant	O
was	O
initially	O
maintained	O
on	O
IVF	B-treatment
,	O
with	O
introduction	O
of	O
enteral	B-treatment
feeds	I-treatment
on	O
day	O
of	O
life	O
2	O
.	O

She	O
was	O
advanced	O
to	O
full	B-treatment
volume	I-treatment
enteral	I-treatment
feeds	I-treatment
by	O
day	O
of	O
life	O
7	O
,	O
and	O
then	O
to	O
a	B-treatment
maximum	I-treatment
caloric	I-treatment
density	I-treatment
of	O
28	O
cals	O
/	O
oz	O
.	O

Oral	O
feedings	O
were	O
introduced	O
as	O
tolerated	O
.	O

By	O
the	O
time	O
of	O
discharge	O
,	O
infant	O
is	O
feedign	O
BM	O
or	O
enfamil	B-treatment
24	O
cals	O
/	O
oz	O
PO	O
ad	O
lib	O
,	O
with	O
adequate	O
intake	O
and	O
adequate	O
weight	O
gain	O
.	O

Last	B-test
nutrition	I-test
labs	I-test
were	O
on	O
06-20	O
with	O
AP	B-test
of	O
208	O
,	O
Ca	B-test
10.8	O
,	O
and	O
Phos	B-test
7.4.	O

Gastrointestinal	O
:	O

The	O
infant	O
required	O
phototherapy	B-treatment
for	O
hyperbilirubinemia	B-problem
through	O
day	O
of	O
life	O
7	O
,	O
with	O
peak	B-test
bilirubin	I-test
of	O
7	O
/	O
0.3	O
on	O
day	O
of	O
life	O
3	O
,	O
and	O
last	B-test
bilirubin	I-test
of	O
4.9	O
/	O
0.3	O
on	O
day	O
of	O
life	O
9	O
.	O

Hematologic	O
/	O
Infectious	O
disease	O
:	O

CBC	B-test
and	O
blood	B-test
culture	I-test
were	O
obtained	O
upon	O
admission	O
revealing	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
9.0	O
with	O
25	B-test
polys	I-test
and	O
0	B-test
bands	I-test
;	O
hematocrit	B-test
was	O
46.9%	O
and	O
platelets	B-test
of	O
222,000	O
.	O

Baby	O
received	O
48	O
hours	O
of	O
Ampicillin	B-treatment
and	O
Gentamycin	B-treatment
with	O
negative	O
cultures	O
and	O
a	O
stable	O
clinical	O
course	O
.	O

Infant	O
was	O
treated	O
with	O
supplemental	B-treatment
iron	I-treatment
,	O
and	O
did	O
not	O
receive	O
any	B-treatment
blood	I-treatment
transfusions	I-treatment
.	O

Last	B-test
Hct	I-test
was	O
30.6	O
on	O
06-20	O
with	O
a	B-test
reticulocyte	I-test
count	I-test
of	O
6.5%.	O

Neurologic	O
:	O

Baby	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
.	O

Social	O
:	O

Mother	O
is	O
17	O
years	O
old	O
,	O
and	O
has	O
been	O
accompanied	O
on	O
the	O
majority	O
of	O
her	O
visits	O
by	O
her	O
parents	O
,	O
both	O
of	O
whom	O
are	O
students	O
.	O

The	O
infant	O
's	O
maternal	O
grandparents	O
have	O
been	O
very	O
involved	O
in	O
her	O
care	O
.	O

Sensory	O
:	O

Initial	B-test
opthalmologic	I-test
exam	I-test
on	O
06-05	O
revealed	O
immature	B-problem
retinas	I-problem
in	O
zone	O
3	O
,	O
and	O
repeat	B-test
exam	I-test
on	O
06-26	O
revealed	O
mature	O
retinas	O
bilaterally	O
.	O

Infant	O
passed	O
hearing	B-test
screen	I-test
prior	O
to	O
discharge	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
home	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Robinson	O
,	O
Lawrence	O
General	O
Hospital	O
Hospital	O

Pediatrics	O
,	O
4952	O
Washington	O
St.	O
in	O
Dr.	O
John	O
C.	O
Corrigan	O
Mental	O
Health	O
Center	O
.	O

(	O
589	O
)	O
690-3703	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

Diet	O
:	O

Enfamil	B-treatment
or	O
breast	O
milk	O
24	O
calories	O
per	O
oz	O
,	O
with	O
enfamil	O
powder	O
.	O

Medications	O
:	O

Ferinsol	B-treatment
0.2	O
mL	O
po	O
qd	O
.	O

Newborn	B-test
screen	I-test
:	O

Sent	O
as	O
per	O
protocol;	O
one	B-test
specimen	I-test
from	O
2017-05-28	O
returned	O
with	O
borderline	B-problem
low	I-problem
thyroxine	I-problem
,	O
but	O
repeat	B-test
was	O
within	O
normal	O
limits	O
.	O

Immunizations	O
:	O

Hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
given	O
06-17	O
.	O

Car	O
seat	O
:	O

Car	B-test
seat	I-test
safety	I-test
screening	I-test
passed	O
prior	O
to	O
discharge	O
.	O

Follow-up	O
:	O

Infant	O
will	O
follow-up	O
with	O
primary	O
pediatrician	O
within	O
2	O
days	O
of	O
discharge	O
,	O
and	O
will	O
see	O
Dr.	O
Dale	O
Merkel	O
of	O
Pediatric	O
Cardiology	O
in	O
Dr.	O
John	O
C.	O
Corrigan	O
Mental	O
Health	O
Center	O
on	O
2017-07-07	O
at	O
1:30	O
pm	O
.	O

Due	O
to	O
breech	B-problem
presentation	I-problem
,	O
a	B-test
hip	I-test
ultrasound	I-test
can	O
be	O
considered	O
in	O
2-4	O
weeks	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
at	O
31	O
weeks	O
,	O
twin	O
#1	O
.	O

2.	O
Breech	B-problem
presentation	I-problem
.	O

3.	O
Sepsis	B-problem
suspect	O
ruled	O
out	O
with	O
antibiotics	B-treatment
.	O

4.	O
Physiologic	B-problem
jaundice	I-problem
.	O

5.	O
Apnea	B-problem
of	I-problem
prematurity	I-problem
.	O

6.	O
Anemia	B-problem
of	I-problem
prematurity	I-problem
.	O

7.	O
Aberrant	B-problem
left	I-problem
coronary	I-problem
artery	I-problem
.	O

8.	O
Muscular	B-problem
ventricular	I-problem
septal	I-problem
defect	I-problem
.	O

Lisa	O
Annie	O
,	O
MD	O
50ABQ	O

Dictated	O
By	O
:	O
Ehtel	O
Z	O
Ebert	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2017-06-02	O
03:49:08	O

T	O
:	O
2017-06-02	O
05:32:26	O

Job	O
#	O
:	O
12559	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ann	O
Nguyen	O
on	O
:	O
TUE	O
2017-06-27	O
8:40	O
AM	O

(	O
End	O
of	O
Report	O
)	O

356529973_a	O
PAD-WORD	O

FIH	O
PAD-WORD	O

2102647	O
PAD-WORD	O

14892/3n8v	O
PAD-WORD	O

481088	O
PAD-WORD	O

7/9/1993	O
12:00:00	O
AM	O

OVARIAN	B-problem
MASS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

7-9-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

7-15-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Ovarian	B-problem
mass	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Papanicolaou	B-test
smear	I-test
positive	O
for	O
somomabodies	B-problem
,	O
incontinence	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
,	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
open	B-treatment
laparoscopy	I-treatment
,	O
Birch	B-treatment
procedure	I-treatment
,	O
suprapubic	B-treatment
bladder	I-treatment
catheter	I-treatment
placement	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
52	O
year	O
old	O
female	O
with	O
gravida	O
3	O
para	O
3	O
who	O
presents	O
with	O
complains	O
of	O
abdominal	B-problem
pain	I-problem
and	O
enlarged	B-problem
ovary	I-problem
by	O
ultrasound	B-test
.	O

The	O
patient	O
is	O
also	O
complaining	O
of	O
several	B-problem
years	I-problem
urinary	I-problem
incontinence	I-problem
.	O

The	O
patient	O
&apos;s	O
recent	O
history	O
is	O
also	O
notable	O
for	O
a	B-test
Papanicolaou	I-test
smear	I-test
which	O
revealed	O
somomabodies	B-problem
.	O

The	O
patient	O
also	O
had	O
vaginal	B-problem
bleeding	I-problem
in	O
April	O
1992	O
following	O
radiation	B-treatment
therapy	I-treatment
.	O

The	O
patient	O
initially	O
presented	O
with	O
hypercalcemia	B-problem
and	O
underwent	O
a	B-treatment
parathyroidectomy	I-treatment
on	O
June	O
22	O
,	O
1993	O
.	O

It	O
was	O
at	O
that	O
time	O
that	O
her	B-test
abnormal	I-test
Papanicolaou	I-test
smear	I-test
was	O
obtained	O
.	O

The	O
patient	O
is	O
now	O
admitted	O
for	O
exploratory	B-test
laparotomy	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
is	O
notable	O
for	O
lymphosarcoma	B-problem
in	O
1970	O
.	O

She	O
was	O
treated	O
with	O
radiation	B-treatment
therapy	I-treatment
.	O

In	O
1980	O
,	O
the	O
patient	O
had	O
a	B-problem
left	I-problem
axillary	I-problem
recurrence	I-problem
that	O
was	O
treated	O
with	O
radiation	B-treatment
therapy	I-treatment
.	O

The	O
patient	O
also	O
has	O
a	O
history	O
of	O
hyperparathyroidism	B-problem
secondary	O
to	O
papillary	B-problem
thyroid	I-problem
cancer	I-problem
.	O

The	O
history	O
is	O
also	O
notable	O
for	O
gallstones	B-problem
,	O
kidney	B-problem
stones	I-problem
,	O
episodic	B-problem
tachycardia	I-problem
,	O
chronic	B-problem
pancreatitis	I-problem
.	O

Of	O
note	O
,	O
the	O
patient	O
also	O
has	O
a	O
history	O
of	O
incontinence	B-problem
.	O

The	O
patient	O
also	O
has	O
hypothyroidism	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
past	O
surgical	O
history	O
is	O
notable	O
for	O
the	B-treatment
removal	I-treatment
of	O
a	B-problem
thyroid	I-problem
nodule	I-problem
in	O
February	O
1989	O
.	O

This	O
revealed	O
papillary	B-problem
thyroid	I-problem
cancer	I-problem
and	O
the	O
patient	O
received	O
radioactive	B-treatment
iodine	I-treatment
ablation	I-treatment
.	O

In	O
June	O
1993	O
,	O
the	O
patient	O
had	O
a	B-treatment
parathyroidectomy	I-treatment
and	O
also	O
of	O
note	O
,	O
in	O
September	O
1992	O
,	O
the	O
patient	O
had	O
an	B-test
exploratory	I-test
laparotomy	I-test
for	O
pain	B-problem
and	O
chronic	B-problem
pancreatitis	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Include	O
Librax	B-treatment
1	O
PO	O
before	O
meals	O
,	O
Pancrease	B-treatment
2	O
tabs	O
before	O
meals	O
,	O
Synthroid	B-treatment
0.125	O
mg	O
PO	O
qd	O
.	O

Tenormin	B-treatment
50	O
mg	O
bid	O
,	O
Valium	B-treatment
5	O
mg	O
bid	O
to	O
tid	O
,	O
Premarin	B-treatment
0.625	O
mg	O
qd	O
,	O
Provera	B-treatment
2.5	O
mg	O
qod	O
,	O
Desyrel	B-treatment
50	O
mg	O
qhs	O
.	O

ALLERGIES	O
:	O

The	B-problem
patient	I-problem
&apos;s	I-problem
allergies	I-problem
include	O
Septra	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
social	O
history	O
is	O
notable	O
for	O
a	O
heavy	O
smoking	O
history	O
.	O

She	O
is	O
interested	O
in	O
quitting	O
smoking	O
.	O

The	O
patient	O
has	O
no	O
history	O
of	O
alcohol	O
abuse	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
preoperative	I-test
examination	I-test
is	O
notable	O
for	O
normal	O
breasts	O
,	O
normal	O
heart	O
and	O
lungs	O
.	O

The	B-test
pelvic	I-test
examination	I-test
is	O
normal	O
except	O
for	O
the	O
presence	O
of	O
a	B-problem
full	I-problem
right	I-problem
ovary	I-problem
.	O

The	B-test
rectovaginal	I-test
examination	I-test
is	O
normal	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
judged	O
to	O
be	O
at	O
risk	O
secondary	O
to	O
her	O
history	O
of	O
somomabodies	B-problem
and	O
vaginal	B-problem
bleeding	I-problem
.	O

Her	O
differential	O
diagnosis	O
included	O
ovarian	B-problem
cancer	I-problem
.	O

The	O
patient	O
was	O
admitted	O
on	O
July	O
9	O
to	O
the	O
operating	O
room	O
.	O

She	O
underwent	O
an	B-treatment
open	I-treatment
laparoscopy	I-treatment
,	O
total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
,	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
Birch	B-treatment
procedure	I-treatment
,	O
and	O
suprapubic	B-treatment
Foley	I-treatment
catheter	I-treatment
placement	I-treatment
and	O
Jackson-Pratt	B-treatment
drain	I-treatment
placement	I-treatment
.	O

The	B-test
estimated	I-test
blood	I-test
loss	I-test
was	O
300	O
cc	O
.	O

There	O
were	O
no	O
complications	B-problem
during	O
the	B-treatment
procedure	I-treatment
and	O
the	O
patient	O
returned	O
to	O
the	O
recovery	O
room	O
in	O
stable	O
condition	O
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
well	O
.	O

Her	B-test
calcium	I-test
was	O
followed	O
daily	O
and	O
repleted	O
as	O
needed	O
.	O

Her	B-treatment
Jackson-Pratt	I-treatment
drain	I-treatment
was	O
removed	O
on	O
postoperative	O
day	O
number	O
two	O
.	O

The	O
patient	O
had	O
a	B-test
temperature	I-test
of	O
101.6	O
on	O
postoperative	O
day	O
two	O
.	O

Her	O
lungs	O
revealed	O
coarse	B-problem
breath	I-problem
sounds	I-problem
.	O

She	O
was	O
encouraged	O
to	O
ambulate	O
and	O
deep	O
breath	O
.	O

The	O
patient	O
was	O
started	O
on	O
nebulizer	B-treatment
treatment	I-treatment
.	O

The	O
patient	O
did	O
well	O
and	O
her	B-treatment
suprapubic	I-treatment
tube	I-treatment
was	O
clamped	B-treatment
starting	O
on	O
postoperative	O
day	O
four	O
.	O

The	O
patient	O
voided	O
spontaneously	O
.	O

Clamping	O
continued	O
until	O
postoperative	O
day	O
six	O
.	O

At	O
this	O
time	O
,	O
her	B-test
post-void	I-test
residuals	I-test
range	O
from	O
2	O
cc	O
to	O
25	O
cc	O
.	O

The	B-treatment
suprapubic	I-treatment
tube	I-treatment
was	O
therefore	O
discontinued	O
.	O

By	O
postoperative	O
day	O
six	O
,	O
the	O
patient	O
was	O
also	O
tolerating	O
a	O
regular	O
diet	O
and	O
passing	O
flatus	O
.	O

A	B-test
chest	I-test
X-ray	I-test
was	O
performed	O
secondary	O
to	O
the	B-problem
patient	I-problem
&apos;s	I-problem
coarse	I-problem
breath	I-problem
sounds	I-problem
,	O
however	O
,	O
the	B-test
chest	I-test
X-ray	I-test
was	O
clear	O
except	O
for	O
a	O
small	O
amount	O
of	O
atelectasis	B-problem
.	O

The	O
patient	O
was	O
discharged	O
home	O
.	O

final	B-test
pathology	I-test
revealed	O
right	O
Fallopian	O
tube	O
and	O
ovary	O
with	O
benign	B-problem
paratubal	I-problem
cysts	I-problem
and	O
adhesions	B-problem
.	O

The	O
cervix	O
revealed	O
squamous	B-problem
metaplasia	I-problem
.	O

The	O
patient	O
was	O
discharged	O
home	O
on	O
admission	B-treatment
medications	I-treatment
.	O

In	O
addition	O
,	O
she	O
will	O
take	O
Ciprofloxacin	B-treatment
for	O
nine	O
more	O
days	O
.	O

She	O
will	O
also	O
take	O
Percocet	B-treatment
.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
home	O
and	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Cancer	O
,	O
as	O
well	O
as	O
Dr.	O
Kotefold	O
and	O
Dr.	O
Cancer	O
.	O

KITRI	O
CURB	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

EARNRA	O
CANCER	O
,	O
M.D.	O

TR	O
:	O

nx	O
/	O
bmot	O

DD	O
:	O

07-15-93	O
PAD-WORD	O

TD	O
:	O

07/16/93	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Ertca	O
Cancer	O
,	O
Dr.	O
Kotefold	O

648746074	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

84164942	O
PAD-WORD	O

960919	O
PAD-WORD	O

9/7/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

09/07/1992	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

09/12/1992	O
PAD-WORD	O

ADMISSION	O
DIAGNOSES	O
:	O

1.	O
STAGE	B-problem
IV	I-problem
ENDOMETRIAL	I-problem
CANCER	I-problem

2.	O
STAGE	B-problem
III-C	I-problem
OVARIAN	I-problem
CANCER	I-problem

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
STAGE	B-problem
IV	I-problem
ENDOMETRIAL	I-problem
CANCER	I-problem

2.	O
STAGE	B-problem
III-C	I-problem
OVARIAN	I-problem
CANCER	I-problem

TREATMENTS	O
:	O

Chemotherapy	B-treatment
of	O
IFEX	B-treatment
,	O
MESNA	B-treatment
and	O
VP-16	B-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
31	O
year	O
old	O
gravida	O
0	O
with	O
stage	B-problem
IV	I-problem
endometrial	I-problem
cancer	I-problem
and	O
stage	B-problem
III-C	I-problem
ovarian	I-problem
cancer	I-problem
vs	O
metastatic	B-problem
endometrial	I-problem
cancer	I-problem
for	O
line	O
2	O
,	O
cycle	B-treatment
1	I-treatment
chemotherapy	I-treatment
.	O

The	O
patient	O
presented	O
in	O
10-90	O
,	O
with	O
heavy	B-problem
bleeding	I-problem
per	I-problem
vagina	I-problem
.	O

D	B-test
and	I-test
C	I-test
showed	O
grade	B-problem
II-III	I-problem
adenocarcinoma	I-problem
with	O
squamous	B-problem
differentiation	I-problem
at	O
Wellla	O
Uxinny	O
:	O
mount	O
Medical	O
Center	O
in	O
Com	O
St.	O
,	O
Tton	O
,	O
Arkansas	O
32167	O
.	O

The	O
patient	O
underwent	O
TAH	B-treatment
/	O
BSO	B-treatment
,	O
partial	B-treatment
omentectomy	I-treatment
at	O
CTMC	O
in	O
10-90	O
.	O

At	O
that	O
time	O
,	O
tumor	B-problem
was	O
found	O
to	O
be	O
studding	B-problem
on	I-problem
the	I-problem
right	I-problem
diaphragm	I-problem
,	O
gross	B-problem
tumor	I-problem
in	I-problem
the	I-problem
omentum	I-problem
and	I-problem
large	I-problem
bowel	I-problem
,	O
tumor	B-problem
through	I-problem
the	I-problem
uterine	I-problem
serosa	I-problem
.	O

Pathology	B-test
showed	O
grade	B-problem
II-III	I-problem
papillary	I-problem
adenocarcinoma	I-problem
of	I-problem
the	I-problem
endometrium	I-problem
with	O
squamous	B-problem
differentiation	I-problem
which	O
was	O
focally	B-problem
invasive	I-problem
and	O
superficial	B-problem
myometrium	I-problem
.	O

The	O
ovary	O
showed	O
papillary	B-problem
serous	I-problem
adeno	I-problem
with	O
omental	B-problem
involvement	I-problem
consistent	O
with	O
an	B-problem
endometroid	I-problem
adenocarcinoma	I-problem
.	O

The	O
question	O
was	O
whether	O
or	O
not	O
whether	O
she	O
had	O
two	B-problem
primaries	I-problem
vs	O
metastatic	B-problem
endometrial	I-problem
cancer	I-problem
.	O

The	O
patient	O
underwent	O
6	O
cycles	O
of	O
CAP	B-treatment
in	O
Pemrancetul	O
Tonsst.	O
.	O

However	O
,	O
during	O
the	B-treatment
fourth	I-treatment
cycle	I-treatment
,	O
Cytoxan	B-treatment
was	O
dropped	O
.	O

Her	B-test
CA-125	I-test
on	O
6-27-91	O
,	O
was	O
249	O
and	O
on	O
8-29-91	O
,	O
was	O
734	O
.	O

In	O
05-92	O
,	O
the	O
patient	O
was	O
admitted	O
to	O
Wellla	O
Uxinny	O
:	O
mount	O
Medical	O
Center	O
with	O
left	B-problem
leg	I-problem
DVT	I-problem
and	O
started	O
on	O
Heparin	B-treatment
therapy	I-treatment
.	O

She	O
was	O
discharged	O
from	O
there	O
on	O
Coumadin	B-treatment
therapy	I-treatment
.	O

On	O
admission	O
,	O
the	O
patient	O
has	O
no	O
complaints	O
except	O
anxiety	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Negative	O
except	O
as	O
above	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Negative	O
except	O
as	O
above	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Coumadin	B-treatment
5	O
mg	O
po	O
q	O
d	O
,	O
Tagamet	B-treatment
400	O
mg	O
po	O
q	O
d	O
,	O
Amoxicillin	B-treatment
which	O
was	O
started	O
on	O
Labor	O
Day	O
,	O
for	O
a	B-problem
sore	I-problem
throat	I-problem
and	O
Ativan	B-treatment
1	O
mg	O
po	O
prn	O
nausea	B-problem
/	O
anxiety	B-problem
.	O

ALLERGIES	O
:	O

The	O
patient	O
gets	O
hives	B-problem
to	O
aspirin	B-treatment
and	O
tomatoes	O
also	O
cause	O
her	O
hives	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
temp	I-test
was	O
99.4	O
,	O
BP	B-test
114/78	O
,	O
pulse	B-test
128	O
and	O
respirations	B-test
20	O
.	O

She	O
was	O
an	O
anxious	O
female	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

HEENT	B-test
exam	I-test
showed	O
PERRLA	O
,	O
EOMI	O
,	O
oropharynx	O
benign	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
.	O

CV	O
was	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmurs	B-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
positive	O
bowel	O
sounds	O
,	O
non	B-problem
tender	I-problem
,	O
large	B-problem
,	I-problem
hard	I-problem
mass	I-problem
occupying	O
the	O
lower	O
abdomen	O
and	O
left	O
upper	O
quadrant	O
.	O

The	O
extremities	O
were	O
non	B-problem
tender	I-problem
without	O
edema	B-problem
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
the	B-test
sodium	I-test
was	O
136	O
,	O
potassium	B-test
3.0	O
,	O
chloride	B-test
98	O
,	O
CO2	B-test
20	O
,	O
BUN	B-test
8	O
,	O
creatinine	B-test
0.8	O
and	O
glucose	B-test
94	O
,	O
ALT	B-test
5	O
,	O
AST	B-test
10	O
,	O
LDH	B-test
166	O
,	O
alkaline	B-test
phosphatase	I-test
81	O
,	O
total	B-test
bili	I-test
0.6	O
,	O
direct	B-test
bili	I-test
.3	O
,	O
albumin	B-test
3.3	O
,	O
calcium	B-test
8.8	O
and	O
uric	B-test
acid	I-test
3.1	O
.	O

She	O
had	O
CA-125	B-test
which	O
was	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Her	B-test
hematocrit	I-test
was	O
31.1	O
,	O
WBC	B-test
11.6	O
and	O
151,000	O
platelets	B-test
.	O

PLAN	O
:	O

The	O
patient	O
is	O
thus	O
stage	B-problem
IV	I-problem
endometrial	I-problem
and	O
stage	B-problem
III-C	I-problem
ovarian	I-problem
vs	O
metastatic	B-problem
endometrial	I-problem
for	I-problem
line	I-problem
II	I-problem
,	O
cycle	B-treatment
I	I-treatment
chemotherapy	I-treatment
IFEX	B-treatment
,	O
MESNA	B-treatment
and	O
VP-16	B-treatment
.	O

The	O
plan	O
was	O
for	O
urinalysis	B-test
q	O
d	O
.	O

With	O
the	O
history	O
of	O
DVT	B-problem
,	O
we	O
plan	O
Coumadin	B-treatment
and	O
check	O
her	B-test
coags	I-test
.	O

The	O
patient	O
was	O
tachycardiac	B-problem
on	O
admission	O
and	O
it	O
was	O
felt	O
she	O
was	O
dehydrated	B-problem
and	O
/	O
or	O
anxious	B-problem
at	O
the	O
time	O
of	O
her	B-test
initial	I-test
evaluation	I-test
.	O

EKG	B-test
showed	O
sinus	B-problem
tachycardia	I-problem
and	O
incomplete	B-problem
right	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
.	O

When	O
compared	O
with	O
ECG	B-test
of	O
11-06-90	O
,	O
there	O
was	O
borderline	O
criteria	O
for	O
anterior	B-problem
MI	I-problem
although	O
the	O
patient	O
denied	O
any	B-problem
chest	I-problem
pain	I-problem
at	O
any	O
point	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
underwent	O
chemotherapy	B-treatment
on	O
the	O
following	O
doses	O
:	O

IFEX	B-treatment
1.2	O
grams	O
per	O
meter	O
squared	O
x	O
3	O
days	O
,	O
MESNA	B-treatment
1.2	O
grams	O
per	O
meter	O
squared	O
x	O
3	O
days	O
continuous	B-treatment
IV	I-treatment
infusion	I-treatment
.	O

She	O
had	O
VP-16	B-treatment
mixed	O
with	O
250	O
cc	O
IV	B-treatment
fluid	I-treatment
given	O
over	O
1	O
hour	O
each	O
day	O
for	O
3	O
days	O
.	O

She	O
also	O
had	O
MESNA	B-treatment
dose	I-treatment
of	O
.6	O
grams	O
per	O
meter	O
squared	O
after	O
her	B-treatment
IFEX	I-treatment
/	O
MESNA	B-treatment
were	O
completed	O
.	O

The	B-test
patient	I-test
's	I-test
urinalysis	I-test
on	O
admission	O
was	O
significant	O
for	O
red	B-problem
blood	I-problem
cells	I-problem
which	O
were	O
TNTC	O
as	O
well	O
as	O
uric	B-test
acid	I-test
.	O

Because	O
it	O
was	O
felt	O
the	O
patient	O
was	O
bleeding	O
and	O
the	O
patient	O
was	O
contaminated	O
,	O
she	O
received	O
her	O
IFEX	B-treatment
/	O
MESNA	B-treatment
.	O

A	B-test
repeat	I-test
straight	I-test
cath	I-test
was	O
negative	O
for	O
RBC	B-problem
's	I-problem
.	O

After	O
1	O
day	O
of	O
chemotherapy	B-treatment
,	O
the	O
patient	O
had	O
8-10	B-problem
RBC	I-problem
's	I-problem
in	I-problem
her	I-problem
urine	I-problem
but	O
by	O
the	O
second	O
day	O
of	O
her	B-treatment
IFEX	I-treatment
infusion	I-treatment
,	O
she	O
had	O
50-80	B-problem
RBC	I-problem
's	I-problem
in	I-problem
her	I-problem
urine	I-problem
as	O
well	O
as	O
a	B-problem
few	I-problem
transitional	I-problem
epithelial	I-problem
cells	I-problem
.	O

Because	O
of	O
this	O
finding	O
,	O
her	B-treatment
IFEX	I-treatment
was	O
stopped	O
before	O
completion	O
of	O
her	O
second	O
day	O
of	O
infusion	B-treatment
.	O

Her	B-treatment
MESNA	I-treatment
alone	O
was	O
continued	O
at	O
that	O
time	O
for	O
IV	B-treatment
infusion	I-treatment
.	O

She	O
did	O
receive	O
her	B-treatment
VP-16	I-treatment
without	O
complication	B-problem
.	O

Other	O
significant	O
issues	O
were	O
the	B-test
patient	I-test
's	I-test
hematocrit	I-test
on	O
admission	O
at	O
31.1	O
which	O
dwindled	O
down	O
to	O
26.2	O
by	O
9-10	O
.	O

The	O
patient	O
was	O
counselled	O
and	O
received	O
2	O
units	O
of	O
packed	B-treatment
RBC	I-treatment
's	I-treatment
at	O
that	O
time	O
.	O

However	O
,	O
the	B-test
patient	I-test
's	I-test
hematocrit	I-test
bumped	O
only	O
to	O
28.1	O
and	O
a	O
repeat	O
later	O
on	O
9-11	O
,	O
showed	O
hematocrit	B-test
of	O
27.6	O
.	O

At	O
this	O
time	O
,	O
an	O
additional	O
2	O
units	O
of	O
packed	B-treatment
RBC	I-treatment
's	I-treatment
were	O
transfused	O
.	O

The	O
third	O
issue	O
was	O
that	O
her	B-treatment
anticoagulation	I-treatment
was	O
grossly	O
out	O
of	O
control	O
on	O
admission	O
with	O
PT	B-test
of	O
25.6	O
and	O
PTT	B-test
of	O
42.2	O
.	O

Her	O
repeat	O
on	O
9-8	O
,	O
was	O
36.0	O
/	O
68.2	O
and	O
her	B-treatment
Coumadin	I-treatment
was	O
held	O
.	O

She	O
received	O
no	O
Coumadin	B-treatment
during	O
her	O
admission	O
and	O
by	O
the	O
time	O
of	O
discharge	O
,	O
her	B-test
PT	I-test
was	O
down	O
to	O
16.2	O
.	O

She	O
was	O
restarted	O
on	O
Coumadin	B-treatment
2.5	O
mg	O
per	O
day	O
.	O

The	B-test
patient	I-test
's	I-test
hematocrit	I-test
on	O
the	O
day	O
of	O
discharge	O
was	O
35.6	O
showing	O
significant	O
bump	O
in	O
her	B-test
count	I-test
after	O
her	O
second	O
two	O
units	O
of	O
packed	B-treatment
RBC	I-treatment
's	I-treatment
.	O

Her	B-test
PT	I-test
on	O
the	O
day	O
of	O
discharge	O
was	O
13.2	O
and	O
she	O
was	O
started	O
on	O
Coumadin	B-treatment
2.5	O
mg	O
po	O
q	O
d	O
as	O
mentioned	O
.	O

The	O
patient	O
was	O
discharged	O
on	O
9-12-92	O
,	O
with	O
the	O
approval	O
of	O
her	O
attending	O
physiciana	O
,	O
Dr.	O
Porriede	O
Friednantflirt	O
.	O

FOLLOW	O
UP	O
CARE	O
:	O

On	O
9-28-92	O
,	O
the	O
patient	O
will	O
return	O
for	O
chemotherapy	B-treatment
and	O
she	O
will	O
follow	O
up	O
with	O
her	O
primary	O
doctor	O
,	O
Dr.	O
Jescspald	O
,	O
for	O
repeat	B-test
PT	I-test
and	O
Coumadin	B-treatment
dosing	I-treatment
on	O
Monday	O
,	O
9-14-02	O
.	O

LT503/7456	O
LAKO	O
C.	O
SCARVTWI	O
,	O
M.D.	O
TH0	O

D	O
:	O
09/14/92	O

Batch	O
:	O
3799	O

Report	O
:	O
V1670V4	O

T	O
:	O
09/15/92	O

Dicatated	O
By	O
:	O
GRA	O
A.	O
SPARDBOUILLNAPPS	O
,	O
M.D.	O
AM57	O

[	O
report	O
_	O
end	O
]	O

359487751	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

9075321	O
PAD-WORD	O

07676	O
PAD-WORD	O

021768	O
PAD-WORD	O

12/7/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

ELKSCHIRD	O
,	O
EBERTA	O
R	O

UNIT	O
NUMBER	O
:	O

882-95-20	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12/07/96	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

12/14/96	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

76-year-old	O
male	O
with	O
right	B-problem
hip	I-problem
pain	I-problem
X	O
five	O
years	O
.	O

The	B-problem
pain	I-problem
is	O
often	O
severely	O
and	O
increasing	O
at	O
night	O
especially	O
when	O
he	O
is	O
lying	O
on	O
the	O
right	O
side	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Tonsillectomy	B-treatment
.	O

History	O
of	O
high	B-problem
blood	I-problem
pressure	I-problem
,	O
enlarged	B-problem
heart	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Zantac	B-treatment
.	O

Furosemide	B-treatment
.	O

Aerobid	B-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem

PHYSICAL	O
EXAMINATION	O
:	O

The	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
unremarkable	O
.	O

The	O
lungs	O
were	O
clear	O
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
non-tender	B-problem
.	O

Left	O
hip	O
shows	O
flexion	B-test
and	O
extension	B-test
40	O
.	O

Right	B-test
hip	I-test
flexion	I-test
and	O
extension	B-test
40	O
and	O
0	O
.	O

IMPRESSION	O
:	O

Right	B-problem
hip	I-problem
pain	I-problem
degenerative	B-problem
joint	I-problem
disease	I-problem
for	O
right	B-treatment
total	I-treatment
hip	I-treatment
replacement	I-treatment
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
as	O
a	O
postoperative	O
admit	O
on	O
December	O
7	O
for	O
total	B-treatment
hip	I-treatment
replacement	I-treatment
.	O

For	O
further	O
details	O
of	O
this	B-treatment
procedure	I-treatment
see	O
operative	O
note	O
.	O

Postoperatively	O
he	O
did	O
well	O
initially	O
in	O
the	O
first	O
12	O
hours	O
.	O

However	O
he	O
had	O
a	O
report	O
of	O
emesis	B-problem
of	I-problem
coffee	I-problem
grounds	I-problem
on	O
postoperative	O
night	O
#1	O
.	O

This	O
with	O
no	O
electrocardiogram	B-problem
changes	I-problem
.	O

Due	O
to	O
this	O
GI	O
was	O
consulted	O
and	O
felt	O
that	O
he	O
would	O
be	O
a	O
candidate	O
for	O
esophagogastroduodenoscopy	B-test
.	O

He	O
was	O
placed	O
nothing	B-treatment
by	I-treatment
mouth	I-treatment
and	O
the	B-test
esophagogastroduodenoscopy	I-test
was	O
done	O
by	O
the	O
GI	O
Service	O
.	O

Findings	O
showed	O
a	B-problem
Mallory	I-problem
Weiss	I-problem
tear	I-problem
,	O
nonspecific	B-problem
duodenitis	I-problem
.	O

He	O
was	O
placed	O
on	O
Zantac	B-treatment
150	O
mg.	O
PO	O
b.i.d.	O
and	O
H	B-test
Pylori	I-test
serology	I-test
was	O
sent	O
.	O

Post	O
EGD	B-test
his	O
diet	O
was	O
advanced	O
slowly	O
and	O
he	O
did	O
exceptionally	O
well	O
.	O

At	O
the	O
time	O
of	O
discharge	O
he	O
was	O
tolerating	O
a	O
full	O
diet	O
,	O
out	O
of	O
bed	O
with	O
pain	B-problem
,	O
tolerated	O
on	O
po.	B-treatment
medications	I-treatment
.	O

His	B-problem
wound	I-problem
was	O
intact	O
with	O
no	O
evidence	O
of	O
infection	B-problem
.	O

Distal	O
neurovascular	O
status	O
was	O
intact	O
.	O

There	O
was	O
no	O
calf	B-problem
tenderness	I-problem
and	O
lower	B-test
extremity	I-test
arterial	I-test
non-invasive	I-test
studies	I-test
were	O
negative	O
.	O

He	O
was	O
generally	O
well	O
in	O
all	O
regards	O
.	O

The	B-test
physical	I-test
examination	I-test
was	O
unremarkable	O
and	O
he	O
had	O
no	O
recurrent	O
symptoms	O
of	O
coffee	B-problem
ground	I-problem
emesis	I-problem
.	O

He	O
was	O
doing	O
exceptionally	O
well	O
at	O
discharge	O
with	O
plans	O
to	O
follow	O
up	O
with	O
Dr.	O
Rhalttland	O
.	O

Discharge	O
instructions	O
have	O
been	O
given	O
.	O

ROYNEO	O
WALLA	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

LI	O
RHALTTLAND	O
,	O
M.D.	O

TR	O
:	O

hbq	O
PAD-WORD	O

DD	O
:	O

12/12/96	O
PAD-WORD	O

TD	O
:	O

12/12/96	O
9:00	O
A	O

cc	O
:	O

LI	O
RIJARRED	O
RHALTTLAND	O
,	O
M.D.	O
ROYNEO	O
MAMAIRE	O
WALLA	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2012-04-27	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-04-30	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1933-02-05	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

Neurosurgery	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
79	O
-	O
year-old	O
female	O
with	O
a	O
history	O
of	O
cataracts	B-problem
,	O
glaucoma	B-problem
,	O
and	O
diabetes	B-problem
,	O
who	O
fell	O
and	O
tripped	O
over	O
a	O
wheelchair	O
of	O
a	O
friend	O
with	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
no	O
dizziness	B-problem
,	O
no	O
chest	B-problem
pain	I-problem
,	O
and	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

PHYSICAL	O
EXAM	O
:	O

She	O
was	O
afebrile	B-problem
.	O

Heart	B-test
rate	I-test
was	O
77	O
.	O

Blood	B-test
pressure	I-test
132/48	O
.	O

Respiratory	B-test
rate	I-test
was	O
17	O
.	O

Sats	B-test
96%	O
on	O
room	O
air	O
.	O

Her	B-test
temperature	I-test
was	O
97.6	O
.	O

She	O
neurologically	O
,	O
she	O
had	O
a	O
nonfocal	O
neurologic	O
examination	O
.	O

Her	O
cardiovascular	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

Her	O
pulmonary	O
:	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Extremities	O
:	O

No	O
cyanosis	B-problem
,	O
clubbing	B-problem
,	O
or	O
edema	B-problem
.	O

Head	B-test
CT	I-test
showed	O
a	B-problem
front	I-problem
focal	I-problem
hemorrhage	I-problem
in	I-problem
the	I-problem
left	I-problem
occipital	I-problem
lobe	I-problem
adjacent	O
to	O
the	O
falx	O
with	O
intraparenchymal	B-problem
hemorrhage	I-problem
or	O
epidural	B-problem
or	I-problem
subdural	I-problem
hemorrhage	I-problem
near	I-problem
the	I-problem
falx	I-problem
with	O
no	O
shift	B-problem
.	O

CT	B-test
of	I-test
the	I-test
C	I-test
spine	I-test
was	O
negative	O
and	O
her	O
cervical	O
spine	O
was	O
cleared	O
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
was	O
admitted	O
to	O
the	O
ICU	O
for	O
close	B-test
neurosurgical	I-test
and	I-test
neurological	I-test
observation	I-test
.	O

She	O
remained	O
neurologically	O
stable	O
.	O

Repeat	B-test
head	I-test
CT	I-test
showed	O
stable	B-problem
bleed	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
regular	O
floor	O
.	O

She	O
was	O
out	O
of	O
bed	O
ambulating	O
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
voiding	O
spontaneously	O
.	O

She	O
will	O
be	O
discharged	O
to	O
home	O
with	O
followup	O
with	O
Dr.	O
Wilson	O
in	O
two	O
weeks	O
with	O
a	B-test
repeat	I-test
head	I-test
CT	I-test
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Levofloxacin	B-treatment
250	O
mg	O
p.o.	O
q.24h.	O
x3	O
days	O
.	O

2.	O
Dilantin	B-treatment
100	O
mg	O
p.o.	O
t.i.d.	O

3.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

4.	O
Timoptic	B-treatment
0.25	O
one	O
drop	O
O.U.	O
b.i.d.	O

5.	O
Lantoprost	B-treatment
0.005	O
ophthalmic	O
solution	O
one	O
drop	O
O.U.	O
q.h.s.	O

6.	O
Zantac	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O

7.	O
Insulin-sliding	B-treatment
scale	I-treatment
as	O
well	O
as	O
40	O
units	O
of	O
Humalog	B-treatment
in	O
the	O
a.m.	O
and	O
20	O
at	O
night	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

FOLLOW-UP	O
INSTRUCTIONS	O
:	O

She	O
will	O
follow	O
up	O
with	O
Dr.	O
Perez	O
in	O
two	O
weeks	O
with	O
repeat	B-test
head	I-test
CT	I-test
.	O

Danvers	O
T	O
Sharp	O
,	O
M.D.	O

16-530	O
PAD-WORD	O

Dictated	O
By	O
:	O
David	O
GA	O
Crane	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2012-04-30	O
11:30	O

T	O
:	O
2012-05-01	O
08:13	O

JOB	O
#:	O
10027	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Margarita	O
Martin	O
on	O
:	O
TUE	O
2012-06-05	O
8:08	O
AM	O

(	O
End	O
of	O
Report	O
)	O

369195584	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

26248578	O
PAD-WORD	O

130467	O
PAD-WORD	O

3/10/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

03/10/1992	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

03/22/1992	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Prostate	B-problem
cancer	I-problem
.	O

2.	O
Alzheimer	B-problem
's	I-problem
disease	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
an	O
87-year-old	O
male	O
with	O
stage	B-problem
D	I-problem
prostate	I-problem
was	O
cancer	B-problem
,	O
was	O
admitted	O
for	O
fluid	B-treatment
hydration	I-treatment
on	O
the	O
10th	O
of	O
March	O
.	O

The	O
patient	O
was	O
initially	O
diagnosed	O
with	O
prostate	B-problem
cancer	I-problem
in	O
August	O
of	O
1989	O
.	O

He	O
presented	O
with	O
gross	B-problem
hematuria	I-problem
at	O
that	O
time	O
.	O

Subsequent	B-test
prostatic	I-test
biopsy	I-test
revealed	O
a	B-problem
Gleason	I-problem
's	I-problem
IV	I-problem
,	I-problem
plus	I-problem
V	I-problem
tumor	I-problem
and	O
the	B-test
CT	I-test
showed	O
an	B-problem
irregular	I-problem
large	I-problem
prostate	I-problem
with	O
tumor	B-problem
invasion	I-problem
into	I-problem
the	I-problem
bladder	I-problem
and	O
evidence	O
of	O
bilateral	B-problem
retroperitoneal	I-problem
lymph	I-problem
node	I-problem
spread	I-problem
.	O

There	O
was	O
also	O
evidence	O
of	O
bone	B-problem
metastasis	I-problem
at	O
that	O
time	O
.	O

The	O
patient	O
was	O
admitted	O
in	O
October	O
of	O
1991	O
for	O
urinary	B-problem
retention	I-problem
and	O
acute	B-problem
renal	I-problem
failure	I-problem
and	O
was	O
treated	O
with	O
fluid	B-treatment
rehydration	I-treatment
and	O
Foley	B-treatment
catheter	I-treatment
placement	I-treatment
.	O

Over	O
the	O
past	O
one	O
month	O
prior	O
to	O
admission	O
,	O
the	O
patient	O
's	O
wife	O
has	O
noticed	O
a	B-problem
marked	I-problem
decrease	I-problem
in	I-problem
p.o.	I-problem
intake	I-problem
and	O
also	O
noted	O
a	B-problem
weight	I-problem
loss	I-problem
of	O
approximately	O
ten	O
pounds	O
in	O
the	O
preceding	O
two	O
weeks	O
.	O

The	O
patient	O
has	O
been	O
lethargic	B-problem
and	O
bed	B-problem
ridden	I-problem
for	O
the	O
past	O
two	O
weeks	O
,	O
although	O
there	O
was	O
no	O
evidence	O
of	O
fever	B-problem
or	O
chills	B-problem
over	O
this	O
time	O
.	O

The	O
patient	O
is	O
now	O
admitted	O
for	O
fluid	B-treatment
rehydration	I-treatment
therapy	I-treatment
and	O
observation	B-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

MEDICATIONS	O
:	O

None	O
currently	O
.	O

ALLERGIES	O
:	O

None	O
.	O

HABITS	O
:	O

No	O
history	O
of	O
cigarette	O
smoking	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
afebrile	B-problem
with	O
a	B-test
recumbent	I-test
blood	I-test
pressure	I-test
of	O
128/16	O
,	O
pulse	B-test
of	O
76	O
,	O
and	O
standing	B-test
blood	I-test
pressure	I-test
of	O
110/60	O
with	O
a	B-test
pulse	I-test
of	O
88	O
.	O

Respirations	B-test
are	O
unlabored	B-problem
at	O
16	O
.	O

HEENT	O
:	O

Noted	O
for	O
nonicteric	B-problem
sclerae	I-problem
and	O
lungs	O
that	O
are	O
clear	O
to	O
auscultation	B-test
.	O

No	O
CVA	B-problem
tenderness	I-problem
was	O
appreciated	O
in	O
the	O
heart	O
and	O
the	O
heart	O
appears	O
to	O
be	O
in	O
regular	O
rate	O
and	O
rhythm	O
.	O

EXTREMITIES	O
:	O

Without	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

ABDOMEN	O
:	O

Soft	O
and	O
nontender	B-problem
.	O

SKIN	O
:	O

Decreased	B-problem
turgor	I-problem
with	O
dry	B-problem
mucous	I-problem
membranes	I-problem
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
count	I-test
of	O
7.75	O
,	O
hematocrit	B-test
of	O
46.2%	O
,	O
sodium	B-test
144	O
,	O
potassium	B-test
3.9	O
,	O
creatinine	B-test
25	O
,	O
and	O
BUN	B-test
was	O
1.4	O
with	O
a	B-test
blood	I-test
sugar	I-test
of	O
88	O
.	O

Urinalysis	B-test
demonstrated	O
30-50	B-problem
white	I-problem
blood	I-problem
cells	I-problem
with	O
red	B-problem
blood	I-problem
cells	I-problem
too	O
numerous	O
to	O
count	O
and	O
2+	B-problem
bacteria	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
a	O
diagnosis	O
of	O
prostate	B-problem
CA	I-problem
,	O
for	O
fluid	B-treatment
rehydration	I-treatment
.	O

Initially	O
,	O
the	O
patient	O
was	O
begun	O
on	O
Bactrim	B-treatment
for	O
presumptive	O
urinary	B-problem
tract	I-problem
infection	I-problem
and	O
the	O
initial	O
course	O
of	O
his	O
hospitalization	O
,	O
he	O
took	O
p.o.'	O
s	O
poorly	O
.	O

The	O
patient	O
remained	O
afebrile	B-problem
,	O
however	O
,	O
and	O
his	B-test
electrolytes	I-test
were	O
within	O
normal	O
limits	O
.	O

By	O
hospital	O
day	O
number	O
six	O
,	O
however	O
,	O
the	O
patient	O
became	O
febrile	B-problem
to	O
100.7	O
and	O
repeat	B-test
urinalysis	I-test
showed	O
20-30	B-problem
white	I-problem
blood	I-problem
cells	I-problem
and	O
1+	B-problem
bacteria	I-problem
.	O

Antibiotics	B-treatment
were	O
switched	O
to	O
IV	B-treatment
Ciprofloxacin	I-treatment
and	O
the	O
patient	O
defervesced	O
;	O
however	O
,	O
by	O
hospital	O
day	O
number	O
seven	O
,	O
the	O
patient	O
was	O
found	O
to	O
be	O
passing	O
very	O
little	O
urine	O
through	O
his	B-treatment
condom	I-treatment
catheter	I-treatment
and	O
electrolyte	B-test
screen	I-test
and	O
electrolytes	B-test
from	O
hospital	O
day	O
number	O
seven	O
showed	O
a	B-test
BUN	I-test
of	O
27	O
and	O
a	B-test
creatinine	I-test
of	O
2.7	O
.	O

The	O
patient	O
was	O
vigorously	B-treatment
fluid	I-treatment
rehydrated	I-treatment
;	O
however	O
,	O
by	O
hospital	O
day	O
number	O
nine	O
,	O
BUN	B-test
was	O
22	O
,	O
creatinine	B-test
was	O
3.5	O
.	O

A	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
placed	O
at	O
that	O
time	O
with	O
the	O
recovery	O
of	O
approximately	O
800	O
cc	O
of	O
urine	O
.	O

Subsequently	O
,	O
the	O
patient	O
began	O
vigorously	O
diuresing	O
with	O
4	O
liters	O
urine	O
recovered	O
the	O
following	O
hospital	O
day	O
.	O

Blood	B-test
electrolytes	I-test
were	O
remarkable	O
for	O
a	B-test
sodium	I-test
of	O
148	O
and	O
a	B-test
potassium	I-test
of	O
5.1	O
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
fluid	I-treatment
hydration	I-treatment
from	O
D5	B-treatment
one-half	I-treatment
normal	I-treatment
saline	I-treatment
with	O
20	O
mEq	O
of	O
K	B-treatment
to	O
D5W	B-treatment
and	O
acuchecks	B-test
from	O
this	O
time	O
showed	O
blood	B-test
sugars	I-test
routinely	O
between	O
20	O
and	O
50	O
.	O

The	O
patient	O
was	O
given	O
one	O
Amp	O
of	O
D50	B-treatment
for	O
each	B-test
acucheck	I-test
for	O
blood	B-test
sugars	I-test
of	O
less	O
than	O
40	O
.	O

Gradually	O
over	O
the	O
course	O
of	O
the	O
following	O
days	O
,	O
the	B-test
patient	I-test
's	I-test
electrolytes	I-test
again	O
normalized	O
;	O
however	O
,	O
as	O
the	O
patient	O
continues	O
to	O
take	O
p.o.'	O
s	O
poorly	O
,	O
the	O
patient	O
remained	O
on	O
IV	B-treatment
hydration	I-treatment
therapy	I-treatment
.	O

On	O
hospital	O
day	O
number	O
fourteen	O
,	O
electrolytes	B-test
were	O
sodium	B-test
of	O
140	O
,	O
potassium	B-test
3.9	O
,	O
BUN	B-test
of	O
11	O
,	O
creatinine	B-test
1.3	O
with	O
a	B-test
blood	I-test
sugar	I-test
of	O
125	O
and	O
a	B-test
magnesium	I-test
of	O
1.9	O
.	O

The	O
patient	O
was	O
taking	O
470	O
cc	O
of	O
liquid	O
p.o.	O
and	O
is	O
now	O
in	O
stable	O
condition	O
and	O
ready	O
for	O
transfer	O
to	O
El	O
Hospital	O
to	O
continue	O
his	O
recovery	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
transferred	O
to	O
El	O
Hospital	O
,	O
still	O
receiving	O
IV	B-treatment
hydration	I-treatment
at	O
a	O
rate	O
currently	O
of	O
50	O
cc	O
an	O
hour	O
of	O
D5	B-treatment
one-half	I-treatment
normal	I-treatment
with	O
20	O
mEq	O
of	O
K	B-treatment
.	O

Should	O
the	O
patient	O
's	O
p.o.	O
intake	O
drop	O
to	O
below	O
500	O
,	O
the	O
patient	O
should	O
be	O
hydrated	O
at	O
75	O
cc/hour	O
.	O

If	O
the	O
patient	O
's	O
p.o.	O
intake	O
drop	O
below	O
300	O
cc	O
per	O
day	O
,	O
the	O
patient	O
should	O
be	O
hydrated	O
at	O
100	O
cc	O
an	O
hour	O
.	O

The	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
in	O
place	O
and	O
the	B-treatment
Bacitracin	I-treatment
ointment	I-treatment
should	O
be	O
applied	O
to	O
the	O
urethral	O
meatus	O
twice	O
a	O
day	O
.	O

Periodic	B-test
urinalysis	I-test
should	O
be	O
conducted	O
to	O
monitor	O
the	O
development	O
of	O
possible	O
urinary	B-problem
tract	I-problem
infection	I-problem
.	O

It	O
should	O
be	O
noted	O
that	O
while	O
in	O
the	O
hospital	O
,	O
the	O
patient	O
received	O
an	B-test
abdominal	I-test
ultrasound	I-test
which	O
is	O
significant	O
for	O
a	B-problem
grossly	I-problem
enlarged	I-problem
liver	I-problem
with	O
multiple	B-problem
foci	I-problem
of	I-problem
cancer	I-problem
.	O

The	O
patient	O
is	O
discharged	O
on	O
Mylanta	B-treatment
30	O
cc	O
with	O
meals	O
,	O
Carafate	B-treatment
1	O
gm	O
q.	O
6	O
,	O
Heparin	B-treatment
5000	O
units	O
subcutaneous	O
b.i.d.	O
until	O
the	O
patient	O
regains	O
full	O
activity	O
and	O
IV	B-treatment
hydration	I-treatment
.	O

The	B-treatment
Foley	I-treatment
should	O
be	O
in	O
place	O
until	O
a	O
follow-up	O
appointment	O
with	O
Dr.	O
Aarhalt	O
can	O
be	O
scheduled	O
in	O
approximately	O
one	O
to	O
two	O
weeks	O
at	O
which	O
time	O
a	O
decision	O
regarding	O
the	O
status	O
of	O
the	B-problem
patient	I-problem
's	I-problem
urinary	I-problem
obstruction	I-problem
will	O
be	O
addressed	O
.	O

Dictated	O
By	O
:	O

CHIEROBEBREUTZ	O
,	O
M.D.	O
AA578/3804	O
CONRELLIE	O
S.	O
KOTERUDES	O
,	O
M.D.	O
KQ9	O

D	O
:	O

03/22/92	O
PAD-WORD	O

T	O
:	O

03/22/92	O
PAD-WORD	O

Batch	O
:	O

S541	O
PAD-WORD	O

Report	O
:	O

FS984Q01	O
PAD-WORD	O

Admission	O
Date	O
:	O

2013-02-11	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-02-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1932-07-08	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

KURLIND	O
PAD-WORD	O

ADDENDUM	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
Milton/Haverhill	O
per	O
family	O
request	O
for	O
pain	B-problem
and	O
comfort	B-treatment
(	I-treatment
hospice	I-treatment
)	I-treatment
management	I-treatment
.	O

Please	O
refer	O
to	O
full	O
discharge	O
summary	O
for	O
details	O
.	O

Patricia	O
E.	O
Burnett	O
,	O
M.D.	O

54-256	O
PAD-WORD	O

Dictated	O
By	O
:	O
Sarah	O
G	O
Sheahan	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-05-01	O
10:33	O

T	O
:	O
2013-05-01	O
12:59	O

JOB	O
#:	O
23157	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Edward	O
Larue	O
on	O
:	O
TUE	O
2013-05-14	O
5:11	O
AM	O

(	O
End	O
of	O
Report	O
)	O

383938711	O
ELMVH	O

08236772	O
PAD-WORD	O

6307693	O
PAD-WORD	O

10/30/2006	O
12:00:00	O
AM	O

s	O
/	O
p	O
Multiple	O
falls	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

10/30/2006	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

11/03/2006	O
PAD-WORD	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

TROUITSA	O
,	O
WIN	O

509-64-03-7	O
E03	O

Room	O
:	O

40R-480	O
PAD-WORD	O

Service	O
:	O

RNM	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

11/03/06	O
AT	O
10:45	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

FYFE	O
,	O
NAAN	O
ACANDEA	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O
w/	O
services	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	B-treatment
(	I-treatment
ACETAMINOPHEN	I-treatment
)	I-treatment
650	O
MG	O
PO	O
Q4H	O
Starting	O
Today	O
(	O
11/02	O
)	O
PRN	O
Headache	B-problem

Instructions	O
:	O

Do	O
not	O
take	O
more	O
than	O
4gm	O
/	O
day	O
ACETYLSALICYLIC	B-treatment
ACID	I-treatment
325	O
MG	O
PO	O
DAILY	O
PHOSLO	B-treatment
(	I-treatment
CALCIUM	I-treatment
ACETATE	I-treatment
(	O
1	O
GELCAP	O
=	O
667	O
MG	O
)	O
)	O
1,334	O
MG	O
PO	O
TID	O

Instructions	O
:	O

Please	O
give	O
with	O
meals	O
FLOVENT	B-treatment
HFA	I-treatment
(	I-treatment
FLUTICASONE	I-treatment
PROPIONATE	I-treatment
)	I-treatment
44	O
MCG	O
INH	O
BID	O
LABETALOL	B-treatment
HCL	I-treatment
300	O

MG	O
PO	O
BID	O

HOLD	O
IF	O
:	O

SBP	B-test
&lt;	O
100	O
or	O
HR	B-test
&lt;	O
55	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

COZAAR	B-treatment
(	I-treatment
LOSARTAN	I-treatment
)	I-treatment
50	O

MG	O
PO	O
DAILY	O
HOLD	O
IF	O
:	O

SBP	B-test
&lt;	O
100	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

3	O
PAD-WORD	O

NEPHROCAPS	B-treatment
(	I-treatment
NEPHRO-VIT	I-treatment
RX	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
DAILY	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
10/30/06	O
by	O
FELSAPPRYDEFUSC	O
,	O
ERI	O
N.	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

SIMVASTATIN	B-treatment
and	O
NIACIN	B-treatment
,	O
VIT.	B-treatment
B-3	I-treatment

Reason	O
for	O
override	O
:	O

will	O
monitor	O

ZOCOR	B-treatment
(	I-treatment
SIMVASTATIN	I-treatment
)	I-treatment
40	O
MG	O
PO	O
BEDTIME	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Avoid	O
grapefruit	O
unless	O
MD	O
instructs	O
otherwise	O
.	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
10/30/06	O
by	O
FELSAPPRYDEFUSC	O
,	O
ERI	O
N.	O
,	O
M.D.	O
on	O
order	O
for	O
NEPHROCAPS	B-treatment
PO	I-treatment
(	O
ref	O
#	O
581988585	O
)	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

SIMVASTATIN	B-treatment
and	O
NIACIN	B-treatment
,	O
VIT	B-treatment
.	I-treatment

B-3	B-treatment
PAD-WORD	O

Reason	O
for	O
override	O
:	O

will	O
monitor	O

DIET	O
:	O

House	O
/	O
2	O
gm	O
Na	O
/	O
Low	O
saturated	O
fat	O
low	O
cholesterol	O
/	O
2	O
gram	O
K+	O
,	O
Renal	B-treatment
diet	I-treatment
&lt;	O
I	O
&gt;	O
&lt;	O
FDI	O
&gt;	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Hemodialysis	B-treatment
MWF	O
,	O
Dr.	O
Gaetz	O
220-871-6906	O
1-2	O
weeks	O
,	O
Dr.	O
Clow	O
836-771-4924	O
1	O
week	O
,	O
Cardiology	O
Clinic	O
452-860-1428	O
,	O
please	O
call	O
to	O
make	O
an	O
appointment	O
in	O
1-2	O
weeks	O
with	O
a	O
cardiology	O
fellow	O
,	O

ALLERGY	O
:	O

NKA	B-problem
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

s	O
/	O
p	O
Multiple	O
falls	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
Multiple	O
falls	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

IHSS	B-problem
AF	B-problem
ESRD	B-problem
on	O
HD	B-treatment
,	O
IgA	B-problem
nephropathy	I-problem
on	O
transplant	O
list	O
,	O
COPD	B-problem
,	O
s	O
/	O
p	O
pacemaker	B-treatment
for	O
afib	B-problem
,	O
BPH	B-problem
s	O
/	O
p	O
TURP	B-treatment
,	O
HTN	B-problem
,	O
hypothyroidism	B-problem
,	O
gout	B-problem
,	O
h	O
/	O
o	O
positive	B-problem
PPD	I-problem
MR	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

None	O
PAD-WORD	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Hemodialysis	B-treatment
s	O
/	O
p	O
abdominal	B-test
fat	I-test
pad	I-test
biopsy	I-test
11/2/06	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

cc	O
:	O

falls	O
PAD-WORD	O

HPI	O
:	O

62	O
yo	O
m	O
w	O
/	O
IgA	B-problem
nephropathy	I-problem
,	O
developmental	B-problem
delay	I-problem
,	O
began	O
HD	B-treatment
7/31	O
.	O

Was	O
seen	O
in	O
dialysis	O
on	O
day	O
of	O
admission	O
and	O
was	O
seen	O
to	O
have	O
&quot;	B-problem
raccoon	I-problem
eyes	I-problem
&quot;	I-problem
and	O
HD	O
staff	O
was	O
worried	O
about	O
sending	O
home	O
.	O

Head	B-test
CT	I-test
w	O
/	O
o	O
bleed	B-problem
.	O

Trauma	B-test
series	I-test
normal	O
.	O

Pt	O
denies	O
abuse	O
or	O
loc	B-problem
associated	O
w	O
/	O
fall	O
,	O
but	O
has	O
noticed	O
several	O
recent	O
falls	O
.	O

Recent	B-test
neuro	I-test
w	I-test
/	I-test
u	I-test
including	O
EEG	B-test
,	O
carotid	B-test
u	I-test
/	I-test
s	I-test
,	O
head	B-test
ct	I-test
(	O
old	B-problem
stroke	I-problem
)	O
,	O
dobutamine-MIBI	B-test
(	O
fixed	B-problem
defect	I-problem
and	O
small	B-problem
inferolateral	I-problem
reversible	I-problem
)	O
were	O
all	O
negative	O
.	O

Notable	O
PAD-WORD	O

PMH	O
:	O

ESRD	B-problem
from	O
IgA	B-problem
,	O
s	O
/	O
p	O
PPI	B-treatment
after	O
nodal	B-treatment
ablation	I-treatment
,	O
HTN	B-problem
,	O
COPD	B-problem
,	O
hypothyroid	B-problem
,	O
hypertrophic	B-problem

CM	O
PE	O
:	O

T	B-test
96.5	O
,	O
BP	B-test
145/97	O
,	O
p	B-test
70	O
,	O
Pox	B-test
98%	O
Gen	O
AO	O
x	O
3	O
,	O
raccoon	B-problem
eyes	I-problem
,	O
large	B-problem
forehead	I-problem
hematoma	I-problem

Lungs	O
:	O

clear	O
PAD-WORD	O

Abd	O
:	O

soft	O
,	O
NT	B-problem

Ext	O
:	O

1+	B-problem
edema	I-problem
b	I-problem
/	I-problem
l	I-problem

Skin	O
:	O

warm	O
,	O
smooth	O
,	O
no	O
rashes	B-problem

Access	O
site	O
:	O

clean	O
w	O
/	O
o	O
inflammation	B-problem

Labs	O
:	O

K	B-test
3.5	O
,	O
Creat	B-test
3.8	O
,	O
Trop-I	B-test
0.45	O
,	O
INR	B-test
1.6	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Falls-A	O
PT	O
consult	O
was	O
obtained	O
to	O
assist	O
with	O
ambulation	O
.	O

A	O
social	O
work	O
consult	O
was	O
also	O
obtained	O
and	O
deemed	O
that	O
the	O
patient	O
has	O
appropriate	O
support	O
at	O
home	O
and	O
is	O
safe	O
at	O
home	O
.	O

The	O
patient	O
was	O
placed	O
on	O
telemetry	B-test
and	O
had	O
no	O
telemetry	B-problem
events	I-problem
while	O
an	O
inpatient	O
.	O

He	O
was	O
also	O
seen	O
by	O
the	O
Electrophysiology	O
service	O
,	O
his	B-treatment
pacemaker	I-treatment
was	O
interrogated	O
and	O
working	O
fine	O
,	O
with	O
no	O
signs	O
of	O
recent	B-problem
ventricular	I-problem
arrhythmia	I-problem
.	O

The	O
patient	O
his	O
undergoing	O
a	B-test
TTE	I-test
prior	O
to	O
discharge	O
to	O
rule	O
out	O
a	B-problem
thrombus	I-problem
.	O

His	B-test
TTE	I-test
showed	O
EF	B-test
45-50%	O
,	O
moderate	B-problem
cLVH	I-problem
,	O
abnormal	B-problem
diastolic	I-problem
function	I-problem
,	O
moderate	B-problem
MR	I-problem
,	O
moderate	B-problem
TR	I-problem
and	O
severe	B-problem
LAE	I-problem
.	O

THere	O
was	O
a	O
question	O
of	O
ionfiltrative	B-problem
cardiomyopathy	I-problem
,	O
and	O
the	O
patient	O
underwent	O
abdominal	B-test
fat	I-test
pad	I-test
biopsy	I-test
to	O
assess	O
for	O
amyloidosis	B-problem
.	O

He	O
also	O
currently	O
has	O
an	B-test
SPEP	I-test
/	O
UPEP/Beta	B-test
2	I-test
microglobulin	I-test
/	O
ACE	B-test
test	I-test
that	O
are	O
currently	O
pending	O
.	O

These	O
should	O
be	O
followed	O
up	O
as	O
an	O
outaptient	O
.	O

He	O
had	O
carotid	B-test
ultrasound	I-test
studies	I-test
3	O
months	O
ago	O
that	O
were	O
normal	O
without	O
evidence	O
for	O
stenosis	B-problem
.	O

2.	O
Renal	O
-	O
cont	O
MWF	O
HD	B-treatment
;	O
electrolytes	B-test
have	O
been	O
stable	O
.	O

Perhaps	O
his	O
recent	O
falls	O
are	O
related	O
to	O
orthostatic	B-problem
hypotension	I-problem
after	O
dialysis	B-treatment
.	O

3.	O
CV	O
-The	O
pt	O
has	O
a	O
small	O
area	O
of	O
reversible	B-problem
ischemia	I-problem
on	O
recent	B-test
MIBI	I-test
,	O
and	O
has	O
troponins	B-problem
persistently	I-problem
elevated	I-problem
in	O
the	O
setting	O
of	O
his	B-problem
renal	I-problem
disease	I-problem
.	O

His	B-test
troponins	I-test
remained	O
lower	O
than	O
his	O
baseline	O
levels	O
and	O
there	O
was	O
no	O
suspicion	O
of	O
ACS	B-problem
causing	O
syncope	B-problem
.	O

He	O
continued	O
on	O
his	B-treatment
zocor	I-treatment
,	O
cozaar	B-treatment
and	O
labetalol	B-treatment
.	O

We	O
will	O
now	O
hold	O
his	B-treatment
coumadin	I-treatment
given	O
his	O
recent	O
falls	O
and	O
bleeding	B-problem
risk	I-problem
.	O

His	B-treatment
aspirin	I-treatment
was	O
restarted	O
prior	O
to	O
discharge	O
.	O

4.	O
Endo	O
-	O
TSH	B-test
was	O
4.7	O
and	O
normal	O
.	O

5.	O
Heme	O
:	O

The	O
patient	O
has	O
a	B-problem
macrocytosis	I-problem
.	O

His	B-test
B12	I-test
level	I-test
was	O
418	O
and	O
normal	O
.	O

He	O
does	O
have	O
a	O
history	O
of	O
B12	B-problem
deficiency	I-problem
in	O
the	O
past	O
,	O
and	O
evidence	O
for	O
peripheral	B-problem
neuropathy	I-problem
BLE	I-problem
which	O
may	O
also	O
be	O
contributing	O
to	O
his	O
recent	O
falls	O
.	O
?	O
EtOH	O

6.	O
Psych	O
:	O

watch	O
for	O
EtOH	B-problem
WD	I-problem
.	O

THe	O
patient	O
had	O
no	O
signs	O
of	O
alcohol	B-problem
withdrawal	I-problem
.	O

His	B-test
serum	I-test
toxicology	I-test
screen	I-test
was	O
negative	O
.	O

7.	O
Pulm	O
:	O

COPD	B-problem
and	O
R	B-problem
pleural	I-problem
effusion	I-problem
,	O
off	O
oxygen	B-treatment
and	O
stable	O
.	O

8.	O
GU	O
:	O

R	B-problem
complex	I-problem
renal	I-problem
cyst	I-problem
,	O
bladder	B-problem
diverticula	I-problem
.	O

THe	O
patient	O
will	O
need	O
a	B-test
follow	I-test
up	I-test
ultrasound	I-test
to	O
further	O
evaluate	O
these	B-problem
incidental	I-problem
findings	I-problem
seen	O
on	O
imaging	B-test
upon	O
admission	O
.	O

9.	O
ID	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
urinalysis	I-test
was	O
normal	O
.	O

He	O
had	O
no	O
fecal	B-problem
leukocytes	I-problem
.	O

A	B-test
c.difficile	I-test
test	I-test
is	O
negative	O
on	O
prelim	O
read	O
,	O
however	O
very	O
low	O
suspicion	O
given	O
no	O
recent	B-treatment
antibiotic	I-treatment
use	I-treatment
.	O

ADDITIONAL	O
COMMENTS	O
:	O

Please	O
return	O
to	O
the	O
hospital	O
if	O
you	O
have	O
falls	B-problem
,	O
headache	B-problem
,	O
visual	B-problem
changes	I-problem
,	O
muscle	B-problem
weakness	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

1)	O
Hemodialysis	B-treatment

2)	O
Please	O
do	O
not	O
take	O
coumadin	B-treatment
.	O

3)	O
Please	O
follow	O
up	O
with	O
PCP	O
to	O
have	O
ultrasound	B-test
of	I-test
right	I-test
kidney	I-test
and	I-test
bladder	I-test
to	O
assess	O
right	B-problem
kidney	I-problem
cyst	I-problem
and	O
bladder	B-problem
diverticula	I-problem
seen	O
incidentally	O

4)	O
Please	O
follow	O
up	O
with	O
Dr.	O
Clow	O
to	O
follow	O
up	O
results	O
of	O
abdominal	B-test
fat	I-test
pad	I-test
biopsy	I-test
and	O
blood	B-test
tests	I-test
to	O
assess	O
for	O
amyloid	B-problem
.	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

FELSAPPRYDEFUSC	O
,	O
ERI	O
N.	O
,	O
M.D.	O
(	O
NT717	O
)	O
11/03/06	O
10:51	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2018-05-12	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2018-05-14	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2018-05-07	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Neonatology	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Melba	O
Barnett	O
is	O
the	O
3.710	O
-	O
kg	O
(	O
8	O
-	O
pound	O
3	O
-	O
ounce	O
)	O
product	O
of	O
a	O
term	O
gestation	O
.	O

He	O
was	O
born	O
to	O
a	O
35	O
-	O
year-old	O
gravida	O
2	O
,	O
para	O
1	O
(	O
now	O
2	O
)	O
mother	O
.	O

Readmitted	O
for	O
hyperbilirubinemia	B-problem
on	O
day	O
of	O
life	O
#5	O
.	O

The	O
pregnancy	O
was	O
benign	O
with	O
an	O
EDC	O
of	O
2018-05-07	O
.	O

Prenatal	B-test
screens	I-test
were	O
O+	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
surface	I-test
antigen	I-test
negative	O
,	O
rapid	B-test
plasma	I-test
reagin	I-test
nonreactive	O
,	O
rubella	B-test
immune	O
,	O
group	B-test
B	I-test
strep	I-test
positive	O
.	O

The	O
infant	O
delivered	O
vaginally	O
with	O
Apgar	B-test
scores	I-test
of	O
9	O
at	O
one	O
minute	O
and	O
9	O
at	O
five	O
minutes	O
.	O

Alleyne	B-test
blood	I-test
type	I-test
is	O
O+	O
/	O
Coombs	B-test
negative	O
.	O

He	O
was	O
readmitted	O
for	O
phototherapy	B-treatment
on	O
day	O
of	O
life	O
#5	O
for	O
a	B-test
bilirubin	I-test
of	O
23.3	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

On	O
admission	O
,	O
Thomas	O
was	O
well-appearing	O
though	O
slightly	B-problem
sleepy	I-problem
with	O
jaundice	B-problem
.	O

He	O
had	O
bilateral	O
breath	O
sounds	O
that	O
were	O
clear	O
and	O
equal	O
.	O

The	B-test
heart	I-test
rate	I-test
was	O
regular	O
without	O
murmur	B-problem
,	O
and	O
pulses	B-test
were	O
2+	O
and	O
symmetrical	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	B-problem
with	O
no	O
hepatosplenomegaly	B-problem
.	O

His	B-test
weight	I-test
was	O
3.505	O
(	O
7	O
pounds	O
/	O
12	O
ounces	O
)	O
on	O
readmission	O
.	O

He	O
had	O
normal	O
male	O
genitalia	O
with	O
bilaterally	O
descended	O
testes	O
.	O

His	O
hips	O
were	O
stable	O
.	O

His	B-test
tone	I-test
was	O
normal	O
with	O
normal	O
neonatal	O
reflexes	O
.	O

He	O
is	O
tolerating	O
his	O
feedings	O
well	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

RESPIRATORY	O
:	O

Without	O
issues	O
on	O
this	O
admission	O
.	O

Breath	B-test
sounds	I-test
are	O
clear	O
and	O
equal	O
.	O

CARDIOVASCULAR	O
:	O

Without	O
issues	O
on	O
this	O
admission	O
.	O

He	O
had	O
a	O
regular	O
heart	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
,	O
and	O
pulses	B-test
were	O
2+	O
and	O
symmetric	O
.	O

FLUIDS	O
,	O
ELECTROLYTES	O
AND	O
NUTRITION	O
:	O

Alleyne	O
birth	B-test
weight	I-test
was	O
3.710	O
kg	O
(	O
8	O
pounds	O
/	O
3	O
ounces	O
).	O

His	B-test
weight	I-test
on	O
this	O
admission	O
was	O
3.505	O
kg	O
(	O
7	O
pounds	O
/	O
12	O
ounces	O
).	O

Linda	O
is	O
breast	O
feeding	O
every	O
3	O
hours	O
and	O
supplementing	O
with	O
expressed	O
breast	O
milk	O
.	O

He	O
is	O
feeding	O
well	O
.	O

His	B-test
discharge	I-test
weight	I-test
is	O
3585	O
grams	O
(	O
7	O
pounds	O
13	O
ounces	O
)	O
.	O

GASTROINTESTINAL	O
:	O

Alleyne	O
bilirubin	B-test
on	O
2018-05-09	O
was	O
10.4	O
;	O
at	O
which	O
time	O
he	O
was	O
discharged	O
to	O
home	O
.	O

At	O
the	O
primary	O
pediatrician	O
's	O
office	O
on	O
2018-05-12	O
his	B-test
bilirubin	I-test
had	O
been	O
23	O
,	O
at	O
which	O
time	O
he	O
was	O
readmitted	O
to	O
the	O
HealthSouth	O
Rehab	O
Hospital	O
of	O
Western	O
Mass.	O
and	O
double	B-treatment
phototherapy	I-treatment
was	O
started	O
.	O

His	B-test
bilirubin	I-test
on	O
05-13	O
was	O
18.4	O
;	O
and	O
on	O
05-14	O
it	O
was	O
14.7	O
.	O

Phototherapy	B-treatment
was	O
discontinued	O
on	O
2018-05-14	O
,	O
and	O
a	B-test
rebound	I-test
bilirubin	I-test
will	O
be	O
checked	O
in	O
the	O
pediatrician	O
's	O
office	O
.	O

HEMATOLOGY	O
:	O

The	B-test
hematocrit	I-test
on	O
05-12	O
was	O
48.7	O
with	O
a	B-test
reticulocyte	I-test
count	I-test
of	O
1.9	O
,	O
and	O
his	B-test
blood	I-test
type	I-test
is	O
O+	O
/	O
Coombs	B-test
negative	O
.	O

INFECTIOUS	O
DISEASE	O
:	O

No	O
issues	O
on	O
this	O
admission	O
.	O

NEUROLOGICAL	O
:	O

The	O
infant	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
.	O

SENSORY	O
:	O

Auditory	B-test
hearing	I-test
screening	I-test
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
,	O
and	O
the	O
infant	O
passed	O
both	O
ears	O
on	O
his	O
previous	O
admission	O
.	O

Hearing	B-test
screens	I-test
were	O
repeated	O
on	O
2018-05-13	O
and	O
he	O
passed	O
both	O
ears	O
.	O

PSYCHOSOCIAL	O
:	O

Family	O
is	O
invested	O
and	O
involved	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
home	O
.	O

SOURCE	O
OF	O
PRIMARY	O
PEDIATRIC	O
CARE	O
:	O

South	O
Cove	O
Community	O
Health	O
Center	O
at	O
5368	O
W.	O
Sixth	O
Rd.	O
,	O
Burlington	O
,	O
Oregon	O
55832	O
;	O
telephone	O
number	O
(	O
391-5273	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Continue	O
ad	O
lib	O
feeding	O
.	O

2.	O
Follow	O
up	O
with	O
pediatrician	O
at	O
SCCHC	O
on	O
Tuesday	O
2018-05-15	O
.	O

3.	O
Medications	O
:	O

Not	O
applicable	O
.	O

4.	O
Car	B-test
seat	I-test
positioning	I-test
screen	I-test
:	O

Not	O
applicable	O
.	O

5.	O
State	B-test
newborn	I-test
screens	I-test
were	O
sent	O
on	O
2018-05-09	O
;	O
and	O
results	O
are	O
pending	O
.	O

On	O
his	O
previous	O
admission	O
,	O
Terrance	O
received	O
hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
on	O
2018-05-09	O
.	O

6.	O
Immunization	B-treatment
recommended	O
:	O

Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
Fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
(	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
)	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Term	O
,	O
appropriate	O
for	O
gestational	O
age	O
,	O
male	O
neonate	O
.	O

2.	O
Exaggerated	B-problem
physiologic	I-problem
hyperbilirubinemia	I-problem
responsive	O
to	O
phototherapy	B-treatment
.	O

Jennifer	O
Martin	O
,	O
North	O
Dakota	O
07287	O

Dictated	O
By	O
:	O
Jean	O
TE	O
Fletcher	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2018-05-13	O
13:07:31	O

T	O
:	O
2018-05-13	O
14:24:41	O

Job	O
#:	O
75582	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Deloris	O
O.	O
Williams	O
on	O
:	O
MON	O
2018-05-14	O
9:37	O
AM	O

(	O
End	O
of	O
Report	O
)	O

385215362	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

47531332	O
PAD-WORD	O

8504886	O
PAD-WORD	O

11/17/2003	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

11/17/2003	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

PROGRESSIVE	B-problem
ACANTHAMOEBA	I-problem
INFECTION	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65-year-old	O
man	O
with	O
refractory	B-problem
CLL	I-problem
,	O
status	O
post	O
non-myeloblative	B-treatment
stem	I-treatment
cell	I-treatment
transplant	I-treatment
approximately	O
nine	O
months	O
prior	O
to	O
admission	O
,	O
and	O
status	O
post	O
prolonged	O
recent	O
Retelk	O
County	O
Medical	O
Center	O
stay	O
for	O
Acanthamoeba	B-problem
infection	I-problem
of	I-problem
skin	I-problem
and	O
sinuses	O
,	O
complicated	O
by	O
ARS	B-problem
due	O
to	O
medication	B-problem
toxicity	I-problem
,	O
as	O
well	O
as	O
GVHD	B-problem
and	O
recent	B-problem
CMV	I-problem
infection	I-problem
,	O
readmitted	O
for	O
new	B-problem
fever	I-problem
,	O
increasing	B-problem
creatinine	I-problem
,	O
hepatomegaly	B-problem
and	O
fluid	B-problem
surge	I-problem
spacing	I-problem
,	O
in	O
the	O
setting	O
of	O
hyponatremia	B-problem
.	O

Patient	O
initially	O
presented	O
in	O
1991	O
with	O
cervical	B-problem
lymphadenopathy	I-problem
,	O
was	O
treated	O
with	O
MACE	B-treatment
/	O
CytaBOM	B-treatment
,	O
and	O
did	O
well	O
until	O
1997	O
,	O
when	O
he	O
received	O
six	O
cycles	O
of	O
fludarabine	B-treatment
for	O
progressive	B-problem
disease	I-problem
.	O

In	O
November	O
,	O
2001	O
,	O
he	O
progressed	O
to	O
leukemic	B-problem
phase	I-problem
,	O
received	O
Rituxan	B-treatment
and	O
CVP	B-treatment
.	O

Started	O
Campath	B-treatment
in	O
July	O
,	O
2001	O
,	O
complicated	O
by	O
lymphopenia	B-problem
/	O
neutropenia	B-problem
and	O
CMV	B-problem
infection	I-problem
,	O
and	O
underwent	O
MUD	B-treatment
stem	I-treatment
cell	I-treatment
transplant	I-treatment
in	O
December	O
,	O
2002	O
.	O

The	O
patient	O
had	O
bone	B-test
marrow	I-test
biopsy	I-test
,	O
August	O
,	O
2003	O
,	O
for	O
persistent	B-problem
pancytopenia	I-problem
,	O
revealing	O
mild	B-problem
hypercelluarity	I-problem
with	O
80%	B-problem
leukemic	I-problem
cells	I-problem
.	O

He	O
was	O
again	O
treated	O
with	O
Campath	B-treatment
,	O
had	O
recurrent	B-problem
fever	I-problem
in	O
association	O
with	O
sinus	B-problem
symptoms	I-problem
,	O
with	O
CT	B-test
scan	I-test
showing	O
left	B-problem
maxillary	I-problem
sinusitis	I-problem
in	O
association	O
with	O
new	B-problem
skin	I-problem
nodules	I-problem
on	I-problem
right	I-problem
elbow	I-problem
and	I-problem
buttocks	I-problem
.	O

Patient	O
was	O
hospitalized	O
September	O
26	O
to	O
November	O
11	O
for	O
what	O
was	O
diagnosed	O
by	O
skin	B-test
biopsy	I-test
and	O
sinus	B-test
washings	I-test
as	O
Acanthamoeba	B-problem
infection	I-problem
of	I-problem
skin	I-problem
and	O
sinuses	O
,	O
without	O
any	O
progression	O
to	O
neurologic	B-problem
infection	I-problem
(	O
as	O
assessed	O
by	O
head	B-test
CT	I-test
and	O
MRI	B-test
)	O
.	O

ID	O
consult	O
was	O
obtained	O
and	O
he	O
was	O
initially	O
treated	O
with	O
azithromycin	B-treatment
,	O
itraconazole	B-treatment
,	O
and	O
pentamidine	B-treatment
,	O
with	O
progression	O
of	O
skin	B-problem
infection	I-problem
.	O

Subsequent	O
discontinuance	O
of	O
azithromycin	B-treatment
,	O
trial	B-treatment
of	I-treatment
5-FC	I-treatment
,	O
with	O
increasing	B-problem
neutropenia	I-problem
requiring	O
discontinuance	O
,	O
change	O
if	O
itraconazole	B-treatment
to	O
voriconazole	B-treatment
,	O
given	O
continued	B-problem
neutropenia	I-problem
,	O
and	O
trial	O
of	O
sulfadiazine	B-treatment
,	O
discontinued	O
for	O
increasing	B-problem
ARS	I-problem
.	O

Patient	O
was	O
maintained	O
on	O
p.o.	B-treatment
voriconazole	I-treatment
and	O
IV	B-treatment
pentamidine	I-treatment
,	O
with	O
pentamidine	B-treatment
nasal	I-treatment
washings	I-treatment
,	O
with	O
re-CT	B-test
of	I-test
sinuses	I-test
near	O
end	O
of	O
stay	O
showing	O
no	O
change	O
in	O
disease	B-problem
burden	I-problem
.	O

He	O
has	O
had	O
recurrent	B-problem
CMB	I-problem
infection	I-problem
in	O
the	O
setting	O
of	O
Campath	B-treatment
therapy	I-treatment
,	O
requiring	O
IV	B-treatment
Foscarnet	I-treatment
therapy	I-treatment
during	O
stay	O
,	O
with	O
inability	O
to	O
tolerate	O
valganciclovir	B-treatment
maintenance	I-treatment
suppression	I-treatment
subsequently	O
due	O
to	O
increasing	B-problem
ARS	I-problem
.	O

Hypercapture	B-test
near	O
end	O
of	O
stay	O
was	O
negative	O
.	O

Patient	O
experienced	O
acute	B-problem
renal	I-problem
failure	I-problem
on	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
,	O
with	O
previous	B-test
baseline	I-test
creatinine	I-test
1.6	O
,	O
felt	O
to	O
be	O
due	O
to	O
medication	B-problem
toxicity	I-problem
,	O
requiring	O
Kayexalate	B-treatment
and	O
Phoslo	B-treatment
to	O
manage	O
electrolytes	B-test
,	O
but	O
never	O
any	O
need	O
for	O
hemodialysis	B-treatment
,	O
with	O
mild	O
improvement	O
of	O
creatinine	B-test
by	O
discharge	O
,	O
with	O
peak	B-test
creatinine	I-test
3.4	O
,	O
discharge	B-test
creatinine	I-test
2.6	O
.	O

Patient	O
struggled	O
with	O
GVHD	B-problem
,	O
with	O
extensive	B-problem
skin	I-problem
involvement	I-problem
,	O
taking	O
Cellcept	B-treatment
,	O
prednisone	B-treatment
and	O
cyclosporine	B-treatment
at	O
time	O
of	O
last	O
admission	O
.	O

Cellcept	B-treatment
was	O
discontinued	O
in	O
the	O
setting	O
of	O
infection	B-problem
,	O
but	O
attempts	O
to	O
decrease	O
prednisone	B-treatment
or	O
cyclosporine	B-treatment
were	O
unsuccessful	O
.	O

Patient	O
returns	O
from	O
rehabilitation	B-treatment
after	O
discharge	O
on	O
November	O
11	O
,	O
with	O
new	B-problem
fever	I-problem
up	O
to	O
102.0	O
in	O
DSCI	O
clinic	O
,	O
increasing	B-problem
hepatomegaly	I-problem
as	O
assessed	O
by	O
examination	B-test
in	O
clinic	O
,	O
and	O
increasing	B-problem
creatinine	I-problem
.	O

Patient	O
reports	O
no	O
significant	O
changes	O
in	O
how	O
he	O
feels	O
over	O
the	O
past	O
week	O
.	O

Denies	O
cough	B-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
diarrhea	B-problem
,	O
dysuria	B-problem
,	O
neck	B-problem
stiffness	I-problem
,	O
new	B-problem
skin	I-problem
lesions	I-problem
,	O
worsening	B-problem
red	I-problem
petechiae	I-problem
,	O
or	O
increasing	B-problem
sinus	I-problem
symptoms	I-problem
.	O

Patient	O
reports	O
persistent	B-problem
mild	I-problem
right	I-problem
upper	I-problem
quadrant	I-problem
discomfort	I-problem
,	O
recent	B-problem
poor	I-problem
appetite	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Refractory	B-problem
CLL	I-problem
with	O
bone	B-problem
marrow	I-problem
involvement	I-problem
,	O
status	O
post	O
MUD	B-treatment
,	I-treatment
mini-allo	I-treatment
stem	I-treatment
cell	I-treatment
transplant	I-treatment
,	O
December	O
,	O
2002	O
,	O
Acanthamoeba	B-problem
infection	I-problem
of	I-problem
skin	I-problem
and	I-problem
sinuses	I-problem
,	O
recently	O
treated	O
with	O
IV	B-treatment
pentamidine	I-treatment
and	O
p.o.	B-treatment
voriconazole	I-treatment
,	O
history	O
of	O
recurrent	B-problem
CMB	I-problem
infection	I-problem
,	O
recent	B-problem
ARS	I-problem
on	O
CRI	B-problem
,	O
thought	O
due	O
to	O
medication	B-problem
toxicity	I-problem
(	O
creatinine	B-test
on	O
discharge	O
from	O
Retelk	O
County	O
Medical	O
Center	O
on	O
October	O
16	O
was	O
2.6)	O
.	O

No	O
history	O
of	O
hemodialysis	B-treatment
.	O

Graft	B-problem
versus	I-problem
host	I-problem
disease	I-problem
,	O
recently	O
on	O
cyclosporine	B-treatment
50	O
b.i.d.	O
and	O
prednisone	B-treatment
60	O
q.d.	O

History	O
of	O
SVT	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Pentamidine	B-treatment
300	O
mg	O
IV	O
q.	O
36	O
hours	O
,	O
Pentamidine	B-treatment
nasal	I-treatment
wash	I-treatment
60	O
mg	O
per	O
6	O
ml	O
of	O
sterile	B-treatment
water	I-treatment
q.d.	O
,	O
voriconazole	B-treatment
200	O
mg	O
p.o.	O
b.i.d.	O
,	O
acyclovir	B-treatment
400	O
mg	O
p.o.	O
b.i.d.	O
,	O
cyclosporine	B-treatment
50	O
mg	O
p.o.	O
b.i.d.	O
,	O
prednisone	B-treatment
60	O
mg	O
p.o.	O
q.d.	O
,	O
GCSF	B-treatment
480	O
mcg	O
IV	O
q.d.	O
,	O
Epogen	B-treatment
40,000	O
units	O
subcu	O
q.	O
week	O
,	O
Protonix	B-treatment
40	O
mg	O
q.d.	O
,	O
Simethicone	B-treatment
80	O
mg	O
p.o.	O
q.	O
8	O
,	O
nitroglycerin	B-treatment
paste	I-treatment
1	O
&quot;	O
q.	O
4	O
h.	O
p.r.n.	O
,	O
flunisolide	B-treatment
nasal	I-treatment
inhaler	I-treatment
,	O
2	O
puffs	O
q.	O
8	O
,	O
OxyCodone	B-treatment
10-15	O
mg	O
p.o.	O
q.	O
6	O
p.r.n.	O
,	O
Sudafed	B-treatment
30	O
mg	O
q.	O
6	O
p.o.	O
p.r.n.	O
,	O
Fluconazole	B-treatment
2%	I-treatment
cream	I-treatment
b.i.d.	O
to	O
erythematous	B-problem
skin	I-problem
lesions	I-problem
,	O
Ditropan	B-treatment
5	O
mg	O
p.o.	O
b.i.d.	O
,	O
Tylenol	B-treatment
650	O
mg	O
p.o.	O
q.	O
4	O
h.	O
p.r.n.	O
,	O
Ambien	B-treatment
5-10	O
mg	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O
,	O
Neurontin	B-treatment
100	O
mg	O
q.	O
a.m.	O
,	O
200	O
mg	O
q.	O
p.m.	O
,	O
Aquaphor	B-treatment
cream	I-treatment
b.i.d.	O
p.r.n.	O
,	O
Lotrimin	B-treatment
1%	I-treatment
cream	I-treatment
b.i.d.	O
to	O
feet	O
,	O
Dulcolax	B-treatment
5-10	O
mg	O
p.o.	O
q.d.	O
p.r.n.	O
,	O
Phoslo	B-treatment
667	O
mg	O
p.o.	O
t.i.d.	O
,	O
Peridex	B-treatment
0.12%	O
,	O
15	O
ml	O
p.o.	O
b.i.d.	O
mouthwash	O
,	O
Benadryl	B-treatment
25-50	O
mg	O
q.	O
4-6	O
h.	O
p.r.n.	O
pruritus	B-problem
,	O
Sarna	B-treatment
cream	I-treatment
q.d.	O
p.r.n.	O
pruritus	B-problem
,	O
Nystatin	B-treatment
5	O
ml	O
p.o.	O
q.i.d.	O
swish	O
and	O
!	O

spit	O
,	O
folate	O
1	B-treatment
mg	O
p.o.	O
q.d.	O
,	O
vitamin	O
E	B-treatment
400	I-treatment
units	O
p.o.	O
q.d.	O
,	O
Haldol	O
2	B-treatment
mg	O
IV	O
q.	O
6	O
p.r.n.	O
agitation	O
,	B-problem
Colace	O
100	B-treatment
mg	O
b.i.d.	O
,	O
Senna	O
2	B-treatment
tablets	O
p.o.	O
b.i.d.	O

ALLERGIES	O
:	O

BACTRIM	B-treatment
(	O
SEVERE	B-problem
RASH	I-problem
)	O
,	O
GANCICLOVIR	B-treatment
(	O
RASH	B-problem
,	O
HAS	O
BEEN	O
DESENSITIZED	O
)	O
.	O

SOCIAL	O
HISTORY	O
:	O

Patient	O
works	O
formerly	O
as	O
a	O
structural	O
engineer	O
,	O
has	O
not	O
been	O
employed	O
over	O
the	O
last	O
two	O
years	O
.	O

Patient	O
is	O
married	O
,	O
an	O
immigrant	O
from	O
Mondca	O
,	O
South	O
Carolina	O
who	O
lived	O
close	O
to	O
Scond	O
at	O
time	O
of	O
nuclear	O
disaster	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

VITAL	O
SIGNS	O
:	O

98.6	O
,	O
85	O
,	O
130/80	O
,	O
20	O
,	O
97%	O
on	O
room	O
air	O
,	O
82.2	O
kg	O
.	O

GENERAL	O
:	O

Comfortable	O
,	O
conversational	O
,	O
appears	O
same	O
as	O
week	O
prior	O
,	O
no	O
apparent	B-problem
distress	I-problem
.	O

HEENT	O
:	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
,	O
anicteric	B-problem
.	O

Oropharynx	O
clear	O
.	O

CARDIOVASCULAR	O
:	O

Regular	O
,	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmurs	B-problem
,	O
gallops	B-problem
or	O
rubs	B-problem
.	O

JVP	B-test
flat	O
.	O

RESPIRATORY	O
:	O

Lungs	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

ABDOMEN	O
:	O

Normoactive	O
bowel	O
sounds	O
,	O
soft	O
,	O
mild	B-problem
right	I-problem
upper	I-problem
quadrant	I-problem
tenderness	I-problem
,	O
not	O
dissimilar	O
from	O
week	O
prior	O
,	O
pronounced	B-problem
hepatomegaly	I-problem
with	O
liver	O
edge	O
7	O
cm	O
below	O
costal	O
margin	O
,	O
midclavicular	O
line	O
,	O
no	O
splenomegaly	B-problem
,	O
no	O
CVA	B-problem
tenderness	I-problem
.	O

EXTREMITIES	O
:	O

Slightly	B-problem
cool	I-problem
,	O
3-4+	B-problem
edema	I-problem
bilaterally	I-problem
.	O

DERMATOLOGY	O
:	O

Erythematous	B-problem
eruption	I-problem
on	O
80%	O
of	O
body	O
,	O
not	O
much	O
change	O
from	O
week	O
prior	O
.	O

Erythematous	B-problem
nodules	I-problem
on	I-problem
arms	I-problem
at	O
elbows	O
and	O
on	O
right	O
thigh	O
,	O
as	O
previous	O
.	O

NEUROLOGIC	O
:	O

Alert	O
and	O
appropriate	O
.	O

ADMISSION	O
LABORATORY	O
DATA	O
:	O

Sodium	B-test
129	O
,	O
creatinine	B-test
3.0	O
,	O
BUN	B-test
70	O
,	O
potassium	B-test
5.0	O
,	O
bicarbonate	B-test
23	O
,	O
chloride	B-test
99	O
,	O
ALT	B-test
36	O
,	O
AST	B-test
30	O
,	O
alkaline	B-test
phosphatase	I-test
215	O
,	O
total	B-test
bilirubin	I-test
1.1	O
,	O
albumin	B-test
2.6	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
2.0	O
,	O
hematocrit	B-test
30.5	O
,	O
platelets	B-test
60	O
.	O

HOSPITAL	O
COURSE	O
:	O

Patient	O
was	O
admitted	O
for	O
diagnosis	O
and	O
treatment	B-treatment
of	O
new	B-problem
fever	I-problem
.	O

Workup	B-test
on	I-test
admission	I-test
included	O
a	B-test
chest	I-test
x-ray	I-test
negative	O
for	O
pneumonia	B-problem
,	O
an	B-test
MRI	I-test
of	I-test
the	I-test
liver	I-test
to	O
investigate	O
for	O
focal	B-problem
lesion	I-problem
,	O
with	O
no	O
evidence	O
for	O
abscess	B-problem
or	O
focal	B-problem
lesion	I-problem
on	O
report	O
.	O

Blood	B-test
and	I-test
urine	I-test
cultures	I-test
with	O
only	O
positive	O
culture	O
a	B-test
blood	I-test
culture	I-test
on	O
November	O
20	O
,	O
with	O
one	O
of	O
two	O
bottles	O
positive	O
for	O
coagulase	B-problem
negative	I-problem
Staphylococcus	I-problem
.	O

A	B-test
repeat	I-test
CMV	I-test
hypercapture	I-test
,	O
negative	O
for	O
presence	O
of	O
CMV	B-problem
.	O

A	B-test
repeat	I-test
CAT	I-test
scan	I-test
of	I-test
the	I-test
sinuses	I-test
with	O
finding	O
of	O
progressive	B-problem
thickening	I-problem
of	I-problem
the	I-problem
left	I-problem
maxillary	I-problem
sinus	I-problem
and	O
both	O
sets	O
of	O
ethmoid	O
air	O
cells	O
since	O
prior	O
study	O
of	O
November	O
9	O
,	O
indicating	O
progressive	B-problem
infection	I-problem
of	I-problem
Acanthamoeba	I-problem
and	O
any	O
possible	O
superinfection	B-problem
with	O
bacterial	B-problem
sinusitis	I-problem
.	O

In	O
the	O
days	O
following	O
admission	O
,	O
there	O
was	O
clear	O
evidence	O
for	O
progression	O
of	O
erythematous	B-problem
nodules	I-problem
over	I-problem
both	I-problem
arms	I-problem
and	O
right	O
thigh	O
at	O
foci	O
of	O
Acanthamoeba	B-problem
infection	I-problem
,	O
suggesting	O
progressive	B-problem
skin	I-problem
involvement	I-problem
with	O
Acanthamoeba	B-problem
.	O

Infectious	O
disease	O
consult	O
was	O
obtained	O
and	O
recommendation	O
was	O
to	O
switch	O
from	O
voriconazole	B-treatment
to	O
itraconazole	B-treatment
,	O
on	O
which	O
there	O
was	O
more	O
existing	O
data	O
on	O
treatment	B-treatment
of	O
Acanthamoeba	B-problem
infection	I-problem
.	O

Pentamidine	B-treatment
intravenous	I-treatment
and	I-treatment
nasal	I-treatment
washings	I-treatment
were	O
continued	O
.	O

Clinical	O
progression	O
of	O
skin	B-problem
and	I-problem
sinus	I-problem
infection	I-problem
on	O
maximal	B-treatment
antimicrobial	I-treatment
therapy	I-treatment
continued	O
,	O
with	O
emergence	O
on	O
November	O
20	O
of	O
a	B-problem
new	I-problem
right-sided	I-problem
ptosis	I-problem
in	O
association	O
with	O
a	B-problem
left	I-problem
homonymous	I-problem
hemianopsia	I-problem
,	O
and	O
fleeting	B-problem
confusion	I-problem
while	O
febrile	B-problem
,	O
prompting	O
head	B-test
MRI	I-test
which	O
revealed	O
a	O
large	O
5	O
x	O
2	O
x	O
4.3	O
cm	O
region	O
in	O
the	O
right	O
occipital	O
lobe	O
of	O
hemorrhage	B-problem
and	O
edema	B-problem
,	O
with	O
dural	B-problem
and	I-problem
,	I-problem
likely	I-problem
,	I-problem
leptomeningeal	I-problem
enhancement	I-problem
in	O
association	O
with	O
small	B-problem
foci	I-problem
in	I-problem
the	I-problem
right	I-problem
cerebellum	I-problem
and	O
pons	O
,	O
concerning	O
for	O
early	B-problem
lesions	I-problem
of	O
similar	O
type	O
.	O

Idiosyncratic	B-problem
reaction	I-problem
to	O
cyclosporine	B-treatment
was	O
considered	O
as	O
cause	O
for	O
cerebritis	B-problem
,	O
and	O
cyclosporine	B-treatment
was	O
discontinued	O
.	O

However	O
,	O
much	O
more	O
likely	O
explanation	O
is	O
progressive	B-problem
infection	I-problem
of	O
Acanthamoeba	B-problem
with	O
new	B-problem
neurologic	I-problem
involvement	I-problem
.	O

Most	O
likely	O
source	O
of	O
fevers	B-problem
was	O
judged	O
to	O
be	O
progressive	B-problem
Acanthamoeba	I-problem
infection	I-problem
,	O
even	O
on	O
maximal	B-treatment
antimicrobial	I-treatment
therapy	I-treatment
.	O

A	B-test
single	I-test
blood	I-test
culture	I-test
positive	O
for	O
coagulase	B-problem
negative	I-problem
Staphylococcus	I-problem
was	O
treated	O
with	O
a	O
course	O
of	O
vancomycin	B-treatment
in	O
the	O
setting	O
of	O
a	B-treatment
PICC	I-treatment
line	I-treatment
and	O
a	B-test
chest	I-test
x-ray	I-test
on	O
November	O
20	O
indicating	O
possible	O
developing	B-problem
pneumonia	I-problem
,	O
resulted	O
in	O
a	O
course	O
of	O
levofloxacin	B-treatment
,	O
for	O
both	O
possible	O
pneumonia	B-problem
,	O
as	O
well	O
as	O
treatment	B-treatment
of	O
any	B-problem
bacterial	I-problem
superinfection	I-problem
of	O
Acanthamoeba	B-problem
sinusitis	I-problem
.	O

Patient	O
experienced	O
steady	O
decline	O
,	O
with	O
persistent	B-problem
fevers	I-problem
despite	O
all	B-treatment
above	I-treatment
measures	I-treatment
,	O
progressive	O
areas	O
of	O
skin	B-problem
infection	I-problem
,	O
more	O
frequent	O
episodes	O
of	O
confusion	B-problem
,	O
and	O
decreasing	B-problem
oxygen	I-problem
saturation	I-problem
in	O
the	O
setting	O
of	O
bilateral	B-problem
effusion	I-problem
,	O
in	O
the	O
setting	O
of	O
fluid	B-problem
surge	I-problem
spacing	I-problem
.	O

On	O
November	O
30	O
,	O
a	O
family	O
meeting	O
with	O
patient	O
&apos;s	O
daughter	O
and	O
spouse	O
,	O
along	O
with	O
primary	O
oncologist	O
,	O
Dr.	O
Tomedankell	O
Bile	O
,	O
attending	O
physician	O
,	O
Dr.	O
Mellerny	O
Close	O
,	O
and	O
house	O
staff	O
,	O
was	O
held	O
to	O
discuss	O
patient	B-problem
&apos;s	I-problem
critical	I-problem
condition	I-problem
and	O
inability	O
to	O
prevent	O
progression	O
of	O
skin	B-problem
,	I-problem
sinus	I-problem
and	I-problem
neurological	I-problem
Acanthamoeba	I-problem
infection	I-problem
on	O
maximal	B-treatment
antimicrobial	I-treatment
therapy	I-treatment
.	O

Decision	O
was	O
made	O
to	O
withdraw	O
aggressive	B-treatment
measures	I-treatment
of	I-treatment
care	I-treatment
,	O
with	O
priority	O
on	O
patient	O
&apos;s	O
comfort	O
.	O

Pentamidine	B-treatment
,	O
itraconazole	B-treatment
,	O
Levaquin	B-treatment
,	O
acyclovir	B-treatment
and	O
GCSF	B-treatment
were	O
discontinued	O
,	O
along	O
with	O
other	B-treatment
medications	I-treatment
nonessential	O
to	O
patient	O
&apos;s	O
comfort	O
.	O

DNR	O
/	O
DNI	O
status	O
initially	O
established	O
early	O
during	O
hospital	O
stay	O
remained	O
in	O
effect	O
.	O

The	O
patient	O
was	O
made	O
comfortable	O
with	O
morphine	B-treatment
for	O
pain	B-problem
and	O
for	O
air	B-problem
hunger	I-problem
,	O
and	O
sinus	B-treatment
suctioning	I-treatment
was	O
continued	O
to	O
relieve	O
congestion	B-problem
,	O
in	O
conjunction	O
with	O
continuation	O
of	O
nasal	B-treatment
sprays	I-treatment
.	O

Tylenol	B-treatment
was	O
continued	O
to	O
control	O
fevers	B-problem
and	O
prednisone	B-treatment
was	O
continued	O
to	O
control	O
inflammation	B-problem
and	O
prevent	O
precipitation	O
of	O
adrenal	B-problem
insufficiency	I-problem
.	O

Such	O
measures	O
have	O
been	O
continued	O
through	O
December	O
3	O
,	O
and	O
patient	O
remains	O
comfortable	O
through	O
this	O
time	O
.	O

This	O
interim	O
dictation	O
to	O
be	O
followed	O
by	O
an	O
addendum	O
detailing	O
end	O
of	O
hospital	O
course	O
.	O

Dictated	O
By	O
:	O

SHAA	O
KACHOLERA	O
STONGE	O
,	O
M.D.	O
LN00	O

Attending	O
:	O

LA	O
K.	O
SKI	O
,	O
M.D.	O
OF1	O
WS584/564649	O

Batch	O
:	O

2235	O
PAD-WORD	O

Index	O
No.	O
UWHS3TCPJ2	O

D	O
:	O

12/03/03	O
PAD-WORD	O

T	O
:	O

12/04/03	O
PAD-WORD	O

Admission	O
Date	O
:	O

2014-12-29	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-01-20	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1944-09-05	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

SURGERY	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Patricia	O
H	O
Leonard	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

End	B-problem
stage	I-problem
liver	I-problem
disease	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Piggyback	B-treatment
orthotopic	I-treatment
liver	I-treatment
transplant	I-treatment

Liver	B-test
biopsy	I-test

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Reese	O
is	O
a	O
70	O
-	O
year-old	O
gentleman	O
with	O
end	B-problem
stage	I-problem
liver	I-problem
disease	I-problem
secondary	O
to	O
alcoholic	B-problem
cirrhosis	I-problem
.	O

Of	O
note	O
,	O
he	O
underwent	O
radiofrequency	B-treatment
ablation	I-treatment
of	I-treatment
two	I-treatment
small	I-treatment
liver	I-treatment
nodules	I-treatment
,	O
one	O
in	O
segment	O
VI	O
and	O
the	O
other	O
in	O
the	O
caudate	O
lobe	O
.	O

Both	O
are	O
less	O
than	O
2	O
cm	O
.	O

Cytology	B-test
on	O
these	B-problem
nodules	I-problem
was	O
suspicious	O
for	O
hepatocellular	B-problem
carcinoma	I-problem
.	O

The	B-treatment
ablation	I-treatment
was	O
done	O
on	O
2013-12-04	O
.	O

He	O
had	O
decompensation	O
of	O
his	B-problem
cirrhosis	I-problem
in	O
2011	O
with	O
ascites	B-problem
and	O
SBP	B-problem
.	O

He	O
also	O
had	O
encephalopathy	B-problem
during	O
that	O
period	O
.	O

The	O
liver	O
was	O
from	O
a	O
62	O
year-old	O
gentleman	O
who	O
had	O
died	O
from	O
CVA	B-problem
with	O
normal	O
liver	O
function	O
.	O

He	O
has	O
no	O
history	O
of	O
a	B-problem
GI	I-problem
bleed	I-problem
or	O
varices	B-problem
by	O
endoscopy	B-test
.	O

His	O
last	O
drink	O
was	O
in	O
2009-11-11	O
.	O

Prior	O
to	O
this	O
,	O
he	O
drank	O
a	O
bottle	O
of	O
wine	O
a	O
day	O

Past	O
Medical	O
History	O
:	O

His	O
past	O
medical	O
history	O
is	O
also	O
remarkable	O
for	O
non-insulin	B-problem
dependent	I-problem
diabetes	I-problem
and	O
hypertension	B-problem
.	O

He	O
has	O
coronary	B-problem
artery	I-problem
disease	I-problem
and	O
underwent	O
a	B-treatment
CABG	I-treatment
in	O
1998	O
.	O

He	O
has	O
a	O
history	O
of	O
gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
and	O
anemia	B-problem
.	O

He	O
also	O
has	O
had	O
a	B-treatment
prior	I-treatment
inguinal	I-treatment
hernia	I-treatment
repair	I-treatment
.	O

Social	O
History	O
:	O

The	O
patient	O
obtained	O
a	O
degree	O
in	O
law	O
.	O

He	O
worked	O
for	O
the	O
attorney	O
general	O
's	O
office	O
early	O
in	O
his	O
career	O
but	O
eventually	O
started	O
his	O
own	O
business	O
in	O
foreign	O
currency	O
exchange	O
from	O
which	O
he	O
retired	O
in	O
2009	O
.	O

He	O
does	O
not	O
smoke	O
,	O
and	O
there	O
is	O
no	O
history	O
of	O
IV	O
drug	O
abuse	O
.	O

Physical	O
Exam	O
:	O

On	O
pre-operative	B-test
exam	I-test
,	O
he	O
was	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
x3	O
.	O

He	O
was	O
not	O
in	O
any	B-problem
apparent	I-problem
distress	I-problem
.	O

He	O
was	O
afebrile	B-problem
with	O
normal	O
vitals	O
.	O

He	O
is	O
6	O
feet	O
1	O
inches	O
tall	O
and	O
has	O
a	B-test
pre-op	I-test
weight	I-test
of	O
181	O
pounds	O
.	O

He	O
had	O
no	O
pallor	B-problem
or	O
obvious	B-problem
jaundice	I-problem
.	O

He	O
had	O
no	O
asterixis	B-problem
.	O

He	O
had	O
palmar	B-problem
erythema	I-problem
.	O

There	O
was	O
no	O
clubbing	B-problem
.	O

He	O
had	O
no	O
lymphadenopathy	B-problem
.	O

His	O
chest	O
was	O
clear	O
to	O
ascultation	B-test
.	O

His	B-test
heart	I-test
sounds	I-test
were	O
regular	O
rate	O
rhythm	O
.	O

His	O
abdomen	O
is	O
soft	O
and	O
nontender	B-problem
.	O

No	O
masses	B-problem
or	O
viscera	B-problem
was	O
felt	O
.	O

He	O
had	O
good	O
femoral	O
pulses	O
bilaterally	O
.	O

He	O
had	O
no	O
pedal	B-problem
edema	I-problem
or	O
lower	B-problem
extremity	I-problem
lesions	I-problem
.	O

His	B-test
neurological	I-test
exam	I-test
was	O
intact	O
.	O

Pertinent	O
Results	O
:	O

2014-12-30	O
10:34	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
699	O
*	O
AST	B-test
-	O
1434	O
*	O
AlkPhos	B-test
-	O
65	O
Amylase	B-test
-	O
46	O
TotBili	B-test
-	O
5.9	O
*	O

2015-01-01	O
11:46	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
1423	O
*	O
AST	B-test
-	O
1066	O
*	O
AlkPhos	B-test
-	O
72	O
TotBili	B-test
-	O
6.2	O
*	O

2015-01-19	O
04:47	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
355	O
*	O
AST	B-test
-	O
90	O
*	O
AlkPhos	B-test
-	O
352	O
*	O
TotBili	B-test
-	O
3.2	O
*	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Reese	O
Jones	O
the	B-treatment
procedure	I-treatment
well	O
.	O

Post-operatively	O
,	O
he	O
was	O
slow	O
to	O
recover	O
but	O
did	O
progressed	O
nicely	O
.	O

Within	O
the	O
fist	O
few	O
days	O
after	O
the	B-treatment
surgery	I-treatment
,	O
his	B-test
liver	I-test
function	I-test
tests	I-test
were	O
elevated	B-problem
to	O
as	O
high	O
as	O
1484	O
for	O
ALT	B-test
,	O
915	O
for	O
AST	B-test
,	O
and	O
7.6	O
for	O
total	B-test
bilirubin	I-test
.	O

His	B-test
Alk	I-test
Phos	I-test
were	O
inititially	O
low	B-problem
a	O
few	O
days	O
after	O
the	B-treatment
operation	I-treatment
,	O
but	O
it	O
rised	O
up	O
to	O
422	O
two	O
weeks	O
after	O
,	O
but	O
down-trended	O
,	O
as	O
with	O
the	O
rest	O
of	O
his	B-test
liver	I-test
function	I-test
test	I-test
by	O
the	O
time	O
he	O
left	O
the	O
hospital	O
.	O

Several	O
tests	O
,	O
including	O
Duplex	B-test
Ultrasound	I-test
,	O
CT	B-test
of	I-test
the	I-test
Abdomen	I-test
,	O
and	O
Abdominal	B-test
A-gram	I-test
all	O
showed	O
patent	O
right	O
and	O
left	O
hepatic	O
arteries	O
arising	O
from	O
the	O
celiac	O
trunk	O
.	O

An	B-test
ERCP	I-test
was	O
also	O
done	O
,	O
showing	O
a	B-problem
filling	I-problem
defect	I-problem
from	O
a	B-problem
narrowed	I-problem
donor	I-problem
duct	I-problem
,	O
but	O
no	O
strictures	B-problem
.	O

A	B-treatment
sphincterotomy	I-treatment
wss	O
done	O
to	O
drain	O
the	B-problem
sludge	I-problem
from	I-problem
the	I-problem
central	I-problem
common	I-problem
duct	I-problem
.	O

There	O
was	O
a	B-problem
small	I-problem
bleed	I-problem
resulting	O
from	O
the	B-treatment
sphincterotomy	I-treatment
,	O
but	O
it	O
was	O
controlled	O
by	O
epinepherine	B-treatment
injections	I-treatment
.	O

Initial	B-test
biopsy	I-test
of	I-test
the	I-test
allograft	I-test
three	O
days	O
after	O
the	B-treatment
operation	I-treatment
was	O
consistent	O
with	O
preservation	B-problem
/	I-problem
ischemic	I-problem
injury	I-problem
.	O

Result	O
of	O
a	B-test
second	I-test
biopsy	I-test
,	O
which	O
was	O
done	O
three	O
weeks	O
after	O
the	B-treatment
operation	I-treatment
,	O
is	O
still	O
pending	O
.	O

During	O
his	O
hospital	O
stay	O
,	O
his	B-test
blood	I-test
glucose	I-test
were	O
elevated	B-problem
and	O
labile	B-problem
ranging	O
from	O
below	B-problem
normal	I-problem
values	I-problem
[	O
40-60	O
's]	O
to	O
the	O
200-300	O
's	O
.	O

He	O
was	O
completely	O
assymptomatic	B-problem
while	O
below	B-problem
normal	I-problem
values	I-problem
.	O

At	O
one	O
point	O
,	O
he	O
had	O
to	O
be	O
on	O
an	B-treatment
insulin	I-treatment
drip	I-treatment
.	O

However	O
with	O
the	O
help	O
of	O
Albano	O
,	O
his	B-test
blood	I-test
glucose	I-test
began	O
to	O
normalize	O
.	O

He	O
has	O
also	O
been	O
working	O
with	O
Physical	O
Therapy	O
to	O
regain	O
his	O
strength	O
.	O

He	O
has	O
been	O
ambulating	O
on	O
his	O
own	O
several	O
times	O
a	O
day	O
.	O

Also	O
,	O
he	O
has	O
been	O
afebrile	B-problem
with	O
stable	O
vitals	O
,	O
tolerating	O
a	O
regular	O
diet	O
,	O
producing	O
good	O
urine	O
and	O
adequate	O
stool	O
.	O

Furthermore	O
,	O
he	O
has	O
had	O
no	O
complaints	B-problem
,	O
including	O
pain	B-problem
,	O
while	O
his	B-test
lab	I-test
values	I-test
are	O
normalizing	O
.	O

He	O
will	O
be	O
discharged	O
to	O
home	O
,	O
in	O
good	O
condition	O
,	O
with	O
very	O
specific	O
intructions	O
to	O
follow	O
up	O
with	O
Albano	O
for	O
his	B-treatment
diabetic	I-treatment
care	I-treatment
and	O
the	O
Transplant	O
Clinic	O
for	O
his	B-treatment
transplant	I-treatment
care	I-treatment
.	O

Discharge	O
Medications	O
:	O

1.	O
Trimethoprim	B-treatment
-	I-treatment
Sulfamethoxazole	I-treatment
80-400	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Mycophenolate	B-treatment
Mofetil	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
120	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Prednisone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

5.	O
Valganciclovir	B-treatment
450	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

6.	O
Ursodiol	B-treatment
300	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

7.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

8.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

9.	O
Fluconazole	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Insulin	B-treatment
SS	I-treatment
and	O
fixed	B-treatment
dose	I-treatment

Fingerstick	B-test
QACHS	O
,	O
3	O
AM	O
Insulin	B-treatment
SC	I-treatment
Fixed	I-treatment
Dose	I-treatment
Orders	O

Breakfast	O
PAD-WORD	O

NPH	O
PAD-WORD	O

17	O
Units	O

Insulin	B-treatment
SC	I-treatment
Sliding	I-treatment
Scale	I-treatment

Breakfast	O
Lunch	O
Dinner	O
Bedtime	O

Regular	O
Regular	O
Regular	O
Regular	O

Glucose	O
Insulin	O
Dose	O
Insulin	O
Dose	O
Insulin	O
Dose	O
Insulin	O
Dose	O

0-60	O
mg	O
/	O
dL	O
4	O
oz.	O
Juice	O
4	O
oz.	O
Juice	O
4	O
oz.	O
Juice	O
4	O
oz.	O
Juice	O

61-120	O
mg	O
/	O
dL	O
1	O
Units	O
0	O
Units	O
0	O
Units	O
0	O
Units	O

121-160	O
mg	O
/	O
dL	O
2	O
Units	O
0	O
Units	O
1	O
Units	O
0	O
Units	O

161-200	O
mg	O
/	O
dL	O
3	O
Units	O
4	O
Units	O
2	O
Units	O
0	O
Units	O

201-240	O
mg	O
/	O
dL	O
5	O
Units	O
6	O
Units	O
4	O
Units	O
0	O
Units	O

241-280	O
mg	O
/	O
dL	O
6	O
Units	O
7	O
Units	O
5	O
Units	O
1	O
Units	O

281-320	O
mg	O
/	O
dL	O
7	O
Units	O
8	O
Units	O
6	O
Units	O
2	O
Units	O

321-360	O
mg	O
/	O
dL	O
9	O
Units	O
10	O
Units	O
8	O
Units	O
3	O
Units	O

361-400	O
mg	O
/	O
dL	O
11	O
Units	O
11	O
Units	O
10	O
Units	O
4	O
Units	O

>	O
400	O
mg	O
/	O
dL	O
Notify	O
M.D.	O
Notify	O
M.D.	O
Notify	O
M.D.	O
Notify	O
M.D.	O

11.	O
Tacrolimus	B-treatment
0.5	O
mg	O
Capsule	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Capsule	O
PO	O
twice	O
a	O
day	O
.	O

Disp	O
:*	O
180	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

12.	O
Insulin	B-treatment
NPH	I-treatment
Human	I-treatment
Recomb	I-treatment
100	O
unit	O
/	O
mL	O
Cartridge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Subcutaneous	O
at	O
breakfast	O
:	O
Please	O
take	O
as	O
prescribed	O
by	O
Albano	O
/	O
Transplant	O
Team	O
.	O

Disp	O
:*	O
10	O
*	O
Refills	O
:*	O
2	O
*	O

13.	O
Insulin	B-treatment
Regular	I-treatment
Human	I-treatment
300	O
unit	O
/	O
3	O
mL	O
Insulin	O
Pen	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
Please	O
take	O
as	O
prescribed	O
by	O
Albano	O
/	O
Transplant	O
team	O
.	O

Disp	O
:*	O
10	O
*	O
Refills	O
:*	O
2	O
*	O

14.	O
Insulin	B-treatment
Syringe	I-treatment
Needless	I-treatment
(	O
Disp	O
)	O
1	O
mL	O
Syringe	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Miscell.	O
as	O
directed	O
by	O
Albano	O
/	O
Trasplant	O
.	O

Disp	O
:*	O
150	O
*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

End	B-problem
stage	I-problem
liver	I-problem
disease	I-problem

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
take	O
medications	B-treatment
as	O
prescribed	O
and	O
read	O
warning	O
labels	O
carefully	O
.	O

If	O
symptoms	O
such	O
as	O
fever	B-problem
/	O
chills	B-problem
,	O
nausea	B-problem
/	O
vomiting	B-problem
,	O
increasing	B-problem
pain	I-problem
/	O
redness	B-problem
/	O
purulent	B-problem
discharge	I-problem
from	O
incision	B-problem
,	O
increasing	B-problem
jaundice	I-problem
,	O
please	O
call	O
or	O
go	O
to	O
the	O
emergency	O
room	O
immediately	O
.	O

Remember	O
to	O
call	O
for	O
a	O
follow	O
up	O
appointment	O
(	O
bellow	O
)	O
.	O

Light	O
activities	O
until	O
seen	O
in	O
clinic	O
.	O

May	O
eat	O
regular	O
food	O
.	O

May	O
shower	O
but	O
no	O
baths	O
.	O

Pat	O
incision	B-problem
wounds	I-problem
dry	O
,	O
do	O
not	O
scrub	O
wound	B-problem
when	O
showering	O
.	O

Absolutely	O
no	O
smoking	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O

Francis	O
Britni	O
,	O
MD	O
Phone	O
:(	O
646	O
)	O
444-8240	O

Date	O
/	O
Time	O
:	O
2015-01-22	O
10:40	O

Provider	O
:	O

Francis	O
Britni	O
,	O
MD	O
Phone	O
:(	O
646	O
)	O
444-8240	O

Date	O
/	O
Time	O
:	O
2015-01-29	O
10:40	O

Provider	O
:	O

Francis	O
Britni	O
,	O
MD	O
Phone	O
:(	O
646	O
)	O
444-8240	O

Date	O
/	O
Time	O
:	O
2015-02-05	O
9:20	O

Please	O
follow	O
up	O
with	O
Albano	O
,	O
as	O
direct	O
by	O
them	O
,	O
a	O
few	O
days	O
after	O
discharge	O
from	O
the	O
hospital	O
(	O
(	O
371	O
)	O
400	O
5776	O
.	O

Francis	O
Britni	O
MD	O
34-902	O

Completed	O
by	O
:	O
Wayne	O
Chris	O
MD	O
18-062	O
2015-01-20	O
@	O
1208	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Francis	O
VU	O
Vila	O
on	O
:	O
MON	O
2015-01-26	O
6:12	O
PM	O

(	O
End	O
of	O
Report	O
)	O

387946944	O
PAD-WORD	O

FIH	O
PAD-WORD	O

6652087	O
PAD-WORD	O

713765	O
PAD-WORD	O

7284844	O
PAD-WORD	O

9/21/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

DOUETTWIDOUET	O
,	O
TAROBY	O

MRN	O
:	O

6652087	O
PAD-WORD	O

Age	O
:	O

80y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

09/21/2003	O
06:51	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
DOUETTWIDOUET	O
,	O
TAROBY	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
on	O
09/21/2003	O
06:51	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
WEAK	B-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
FAIRM	O
OF	O
IJORDCOMPMAC	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
SAPSCLYSS	O
,	O
LEO	O
R	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
WEAKNESS	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
834-226-3369	O
.	O

PCP	O
Name	O
:	O

ROSORB	O
,	O
ASALEYSEAN	O
I	O

Provider	O
Number	O
:	O

80629	O
PAD-WORD	O

Admission	O
Date	O
:	O

2017-06-16	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-07-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1959-03-24	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Andre	O
K.	O
Young	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Fever	B-problem
,	O
tachycardia	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

Patient	O
is	O
a	O
58	O
year	O
old	O
male	O
with	O
a	O
recent	O
admission	O
for	O
abdominal	B-problem
pain	I-problem
s/p	O
negative	O
exploratory	O
laparotomy	O
for	O
suspected	O
intussuception	B-problem
now	O
returns	O
on	O
day	O
of	O
discharge	O
with	O
fever	B-problem
and	O
tachycardia	B-problem
.	O

Patient	O
has	O
a	O
history	O
for	O
terrible	B-problem
vasculopathy	I-problem
s/p	O
recent	B-treatment
right	I-treatment
BKA	I-treatment
with	O
dry	B-problem
gangrene	I-problem
of	I-problem
the	I-problem
distal	I-problem
stump	I-problem
.	O

Patient	O
's	O
last	O
admission	O
was	O
significant	O
for	O
a	O
negative	O
ex-lap	O
.	O

Post-operatively	O
,	O
his	O
course	O
was	O
complicated	O
by	O
respiratory	B-problem
distress	I-problem
necessitating	O
an	O
urgent	O
return	O
to	O
the	O
ICU	O
and	O
was	O
intubated	O
.	O

After	O
multuple	O
failed	O
attempts	O
at	O
extubation	B-treatment
,	O
the	O
patient	O
was	O
trached	O
.	O

Patient	O
then	O
did	O
well	O
on	O
a	B-treatment
trach	I-treatment
mask	I-treatment
and	O
was	O
transferred	O
to	O
rehab	O
on	O
the	O
day	O
of	O
admission	O
but	O
now	O
returns	O
with	O
tachycardia	B-problem
to	O
the	O
120	O
's	O
,	O
and	O
fever	B-problem
to	O
102	O
degrees	O
F	O
.	O

Past	O
Medical	O
History	O
:	O

PVD	B-problem
s/p	O
multiple	B-problem
failed	I-problem
femoral	I-problem
distal	I-problem
bypass	I-problem

Diabetes	B-problem
mellitus	I-problem

CAD	B-problem
s/p	O
CABG	B-treatment
2003	O
s/p	O

ex	B-test
lap	I-test
05-23	O

Physical	O
Exam	O
:	O

T	B-test
101	O
HR	B-test
120	O
BP	B-test
144/90	O
RR	B-test
18	O
SpO2	B-test
99%	O
on	O
70%	O
TM	B-treatment

Moderately	B-problem
distressed	I-problem

Coarse	B-problem
breath	I-problem
sounds	I-problem
b/l	I-problem

Tachycardic	B-problem
,	O
nl	O
S1	O
and	O
S2	O

Abd	O
soft	O
,	O
NT/ND	B-problem

Right	B-problem
AKA	I-problem
stump	I-problem
with	O
dry	B-problem
gangrene	I-problem

Left	O
lower	O
extremity	O
warm	O
and	O
well-perfused	O

Pertinent	O
Results	O
:	O

MRI	B-test
HEAD	I-test
:	O

The	O
diffusion	O
images	O
demonstrate	O
no	O
evidence	O
of	O
slow	B-problem
diffusion	I-problem
to	O
indicate	O
acute	B-problem
infarct	I-problem
.	O

There	O
is	O
moderate	B-problem
prominence	I-problem
of	I-problem
ventricles	I-problem
and	I-problem
sulci	I-problem
,	O
inappropriate	O
for	O
the	O
patient	O
's	O
age	O
.	O

There	O
is	O
no	O
midline	B-problem
shift	I-problem
,	O
mass	B-problem
effect	I-problem
,	O
hydrocephalus	B-problem
,	O
or	O
territorial	B-problem
infarct	I-problem
.	O

Following	O
gadolinium	B-test
,	O
no	O
evidence	O
of	O
abnormal	B-problem
parenchymal	I-problem
,	I-problem
vascular	I-problem
,	I-problem
or	I-problem
meningeal	I-problem
enhancement	I-problem
seen	O
.	O

Gastric	B-test
biopsy	I-test
:	O
negative	O
for	O
H.	B-problem
pylori	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

The	O
patient	O
was	O
re-admitted	O
to	O
the	O
surgical	O
service	O
and	O
taken	O
to	O
the	O
CMED	O
.	O

A	B-test
chest	I-test
x-ray	I-test
on	O
admission	O
showed	O
effusions	B-problem
consistent	O
with	O
CHF	B-problem
along	O
with	O
overlying	B-problem
pnumonia	I-problem
.	O

Urine	B-test
cultures	I-test
were	O
significant	O
for	O
Klebsiella	B-problem
UTI	I-problem
and	O
sputum	B-test
cultures	I-test
were	O
significant	O
for	O
MRSA	B-problem
.	O

He	O
was	O
placed	O
on	O
vancomycin	B-treatment
,	O
levofloxacin	B-treatment
and	O
fluconazole	B-treatment
.	O

He	O
underwent	O
PICC	B-treatment
line	I-treatment
placement	I-treatment
on	O
06-18	O
.	O

A	B-treatment
trach	I-treatment
collar	I-treatment
was	O
placed	O
on	O
06-19	O
.	O

GI	O
was	O
consulted	O
for	O
colonoscopy	B-test
.	O

Patient	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
06-20	O
.	O

He	O
was	O
seen	O
by	O
respiratory	O
therapy	O
and	O
suctioned	O
continually	O
throughout	O
his	O
hospital	O
course	O
.	O

His	O
respiratory	O
status	O
improved	O
.	O

He	O
tolerated	O
his	B-treatment
trach	I-treatment
collar	I-treatment
,	O
and	O
tube	B-treatment
feeds	I-treatment
at	O
goal	O
.	O

The	B-treatment
fluconazole	I-treatment
was	O
discontinued	O
.	O

On	O
06-21	O
the	O
patient	O
was	O
seen	O
by	O
physical	O
therapy	O
.	O

A	O
nutrition	O
consult	O
was	O
obtained	O
on	O
06-22	O
.	O

He	O
underwent	O
a	B-problem
failed	I-problem
bedside	I-problem
swallow	I-problem
study	I-problem
.	O

Based	O
on	O
a	B-test
chest	I-test
x-ray	I-test
that	O
showed	O
a	B-problem
small	I-problem
hydro-pneumothorax	I-problem
on	I-problem
the	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
of	O
the	O
lung	O
,	O
a	O
thoracic	O
surgery	O
consult	O
was	O
obtained	O
,	O
though	O
no	O
specific	B-treatment
interventions	I-treatment
were	O
warranted	O
at	O
the	O
time	O
.	O

On	O
06-23	O
the	B-treatment
patient	I-treatment
's	I-treatment
tube	I-treatment
feed	I-treatment
were	O
changed	O
from	O
Respalor	B-treatment
to	O
Deliver	B-treatment
2.0	I-treatment
to	O
give	O
increased	O
calories	O
.	O

On	O
06-25	O
,	O
urine	B-test
cultures	I-test
grew	O
out	O
VRE	B-problem
,	O
and	O
a	B-test
C	I-test
diff	I-test
was	O
negative	O
.	O

He	O
experienced	O
low	B-problem
grade	I-problem
fevers	I-problem
.	O

He	O
was	O
pan-cultured	O
on	O
06-26	O
for	O
continued	B-problem
fevers	I-problem
.	O

On	O
06-27	O
,	O
his	B-treatment
nutrition	I-treatment
regimen	I-treatment
was	O
changed	O
to	O
Deliver	B-treatment
2.0	I-treatment
at	O
70	O
cc	O
/	O
hr	O
with	O
15	O
g	O
ProMod	B-treatment
.	O

On	O
06-28	O
,	O
the	O
patient	O
experienced	O
PVC	B-problem
's	I-problem
.	O

An	B-test
EKG	I-test
showed	O
ST	B-problem
segment	I-problem
depression	I-problem
along	O
the	O
lateral	O
pre-cordial	O
leads	O
.	O

Serial	B-test
enzymes	I-test
showed	O
mild	B-problem
elevation	I-problem
of	O
troponins	B-test
.	O

A	O
cardiology	O
consult	O
was	O
obtained	O
.	O

The	O
cardiology	O
service	O
simply	O
recommended	O
increasing	O
the	B-treatment
beta-blockade	I-treatment
and	O
maximizing	O
the	O
patient	O
's	O
electrolyte	O
status	O
.	O

On	O
06-29	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
medical	O
service	O
.	O

Pt	B-treatment
's	I-treatment
vancomycin	I-treatment
was	O
stopped	O
after	O
14	O
days	O
of	O
treatment	B-treatment
.	O

HIV	B-test
test	I-test
was	O
found	O
to	O
be	O
negative	O
.	O

MRI	B-test
head	I-test
was	O
obtained	O
to	O
further	O
w/u	O
patient	B-problem
's	I-problem
apparent	I-problem
cognitive	I-problem
decline	I-problem
.	O

MRI	B-test
showed	O
prominent	B-problem
sulci	I-problem
and	O
enlarged	B-problem
ventricles	I-problem
abnormal	O
for	O
the	O
patient	O
's	O
age	O
.	O

Due	O
to	O
concerns	O
for	O
dementia	B-problem
,	O
neurology	O
consult	O
was	O
obtained	O
.	O

Neurology	O
felt	O
that	O
the	B-problem
patient	I-problem
's	I-problem
cognitive	I-problem
symptoms	I-problem
were	O
consistent	O
w/	O
metabolic	B-problem
encephalopathy	I-problem
due	O
to	O
his	B-problem
multiple	I-problem
medical	I-problem
problems	I-problem
.	O

They	O
felt	O
that	O
his	O
mental	O
status	O
would	O
improve	O
as	O
his	O
health	O
improved	O
.	O

Underlying	B-problem
dementia	I-problem
was	O
possible	O
but	O
difficult	O
to	O
assess	O
with	O
an	B-problem
overlying	I-problem
delerium	I-problem
.	O

The	O
patient	O
continued	O
to	O
pull	O
out	O
his	B-treatment
doboff	I-treatment
tube	I-treatment
.	O

Pt	O
had	O
EGD	B-test
performed	O
to	O
evaluate	O
his	B-problem
poor	I-problem
nutritional	I-problem
status	I-problem
.	O

He	O
was	O
found	O
to	O
have	O
a	B-problem
large	I-problem
gastric	I-problem
ulcer	I-problem
and	O
high	B-treatment
dose	I-treatment
PPI	I-treatment
was	O
started	O
.	O

The	B-test
gastric	I-test
biopsy	I-test
and	O
the	B-test
serology	I-test
were	O
both	O
negative	O
for	O
H.	B-problem
pylori	I-problem
.	O

PEG	B-treatment
placement	I-treatment
was	O
unsuccessful	O
by	O
GI	O
due	O
to	O
the	O
patient	O
's	O
anantomy	O
.	O

07-05	O
the	O
patient	O
had	O
a	B-treatment
J	I-treatment
tube	I-treatment
placed	O
in	O
interventional	O
radiology	O
for	O
nutritional	B-treatment
support	I-treatment
.	O

He	O
was	O
re-started	O
on	O
tube	B-treatment
feeds	I-treatment
.	O

07-06	O
patient	O
failed	O
a	B-test
repeat	I-test
swallow	I-test
evaluation	I-test
due	O
to	O
discoordinated	B-problem
swallow	I-problem
.	O

07-07	O
the	O
patient	O
was	O
taken	O
for	O
colonoscopy	B-test
and	O
found	O
to	O
have	O
a	O
normal	O
colon	O
to	O
cecum	O
.	O

07-12	O
the	O
patient	O
was	O
found	O
to	O
be	O
C	B-problem
diff	I-problem
positive	I-problem
and	O
was	O
started	O
on	O
14	O
day	O
course	O
of	O
Flagyl	B-treatment
.	O

On	O
07-18	O
,	O
as	O
his	O
mental	O
status	O
improved	O
,	O
he	O
did	O
well	O
at	O
the	B-test
bed	I-test
side	I-test
swall	I-test
evaluation	I-test
.	O

On	O
07-19	O
,	O
he	O
underwent	O
video	B-test
swallow	I-test
evaluation	I-test
and	O
was	O
able	O
to	O
tolerate	O
ground	B-treatment
consistent	I-treatment
food	I-treatment
and	O
thin	B-treatment
liquids	I-treatment
.	O

His	B-treatment
meds	I-treatment
should	O
be	O
crushed	O
and	O
mixed	O
with	O
puree	B-treatment
thick	I-treatment
liquid	I-treatment
.	O

He	O
has	O
gained	O
30	B-problem
lb	I-problem
since	O
the	B-treatment
tubefeed	I-treatment
was	O
initiated	O
(	O
70	O
lb	O
to	O
100	O
lb	O
)	O
during	O
this	O
admission	O
.	O

He	O
will	O
still	O
need	O
to	O
be	O
on	O
tubefeed	B-treatment
to	O
support	O
his	O
nutrition	O
until	O
he	O
is	O
cleared	O
by	O
a	O
nutritionist	O
.	O

In	O
terms	O
of	O
his	O
mental	O
status	O
,	O
he	O
continued	O
to	O
improve	O
steadily	O
over	O
the	O
last	O
few	O
weeks	O
of	O
his	O
hospital	O
stay	O
.	O

He	O
was	O
more	O
alert	O
and	O
engaged	O
with	O
activity	O
.	O

He	O
did	O
much	O
better	O
with	O
PT	B-treatment
and	O
OT	B-treatment
at	O
the	O
end	O
after	O
his	O
mental	O
status	O
improved	O
.	O

As	O
noted	O
above	O
,	O
his	B-problem
mental	I-problem
status	I-problem
change	I-problem
was	O
likely	O
toxic-metabolic	B-problem
from	O
acute	B-problem
infection	I-problem
.	O

He	O
started	O
to	O
develop	O
more	B-problem
pain	I-problem
around	I-problem
the	I-problem
right	I-problem
stump	I-problem
since	O
07-17	O
.	O

He	O
was	O
seen	O
by	O
the	O
vascular	O
surgery	O
who	O
felt	O
that	O
he	O
is	O
too	O
medically	B-problem
sick	I-problem
and	O
malnourished	B-problem
to	O
have	O
surgery	B-treatment
at	O
this	O
time	O
.	O

He	O
will	O
follow	O
up	O
with	O
Dr.	O
Javier	O
as	O
outpatient	O
.	O

Initially	O
,	O
his	B-problem
pain	I-problem
was	O
controlled	O
with	O
titrating	O
up	O
the	B-treatment
Oxycontin	I-treatment
.	O

However	O
,	O
it	O
was	O
titrated	O
too	O
quickly	O
from	O
10	O
mg	O
bid	O
to	O
30	O
mg	O
bid	O
.	O

He	O
then	O
developed	O
urinary	B-problem
retention	I-problem
requiring	O
foley	B-treatment
placement	I-treatment
.	O

After	O
he	O
passed	O
the	B-test
video	I-test
swallowing	I-test
,	O
he	O
was	O
tolerating	O
ground	B-treatment
consistent	I-treatment
solids	I-treatment
.	O

On	O
07-24	O
,	O
he	O
had	O
an	B-problem
emesis	I-problem
x	O
1	O
,	O
and	O
had	O
aspiration	B-problem
pneumonia	I-problem
(	O
+	O
interstital	B-problem
markings	I-problem
on	O
the	O
left	O
on	O
CXR	B-test
,	O
fever	B-problem
,	O
leukocytosis	B-problem
)	O
.	O

His	B-treatment
Flagyl	I-treatment
course	I-treatment
was	O
extended	O
,	O
and	O
Vanc	B-treatment
/	O
Levo	B-treatment
were	O
added	O
.	O

His	B-test
sputum	I-test
showed	O
many	B-problem
GPC	I-problem
which	O
later	O
grew	O
Staph	B-problem
aureus	I-problem
.	O

Given	O
his	B-problem
recent	I-problem
MRSA	I-problem
pneumonia	I-problem
,	O
he	O
will	O
be	O
treated	O
with	O
2	O
week	O
course	O
of	O
Vanc	B-treatment
/	O
Levo	B-treatment
/	O
Flagyl	B-treatment
.	O

He	O
was	O
seen	O
by	O
the	O
pain	O
service	O
who	O
recommended	O
to	O
discontinue	O
Oxycontin	B-treatment
,	O
and	O
start	O
Neurontin	B-treatment
,	O
MSIR	B-treatment
,	O
and	O
lidocaine	B-treatment
patch	I-treatment
in	O
addition	O
to	O
the	B-treatment
standing	I-treatment
Tylenol	I-treatment
.	O

On	O
07-25	O
,	O
his	B-treatment
J-tube	I-treatment
was	O
noted	O
to	O
be	O
obstructed	B-problem
but	O
was	O
able	O
to	O
be	O
flushed	O
by	O
IR	O
on	O
07-26	O
.	O

Tubefeed	B-treatment
was	O
resumed	O
without	O
any	B-problem
difficulty	I-problem
since	O
.	O

Since	O
oxycontin	B-treatment
was	O
discontinued	O
,	O
the	B-treatment
foley	I-treatment
was	O
removed	O
on	O
07-27	O
and	O
was	O
able	O
to	O
void	O
without	O
any	B-problem
difficulty	I-problem
.	O

Medications	O
on	O
Admission	O
:	O

Lopressor	B-treatment
50	O
mg	O
BID	O

percocet	B-treatment
PAD-WORD	O

nebulizer	B-treatment
PAD-WORD	O

lipitor	B-treatment
PAD-WORD	O

klonopin	B-treatment
0.5	O
mg	O
TID	O

RISS	B-treatment
PAD-WORD	O

heparin	B-treatment
sc	I-treatment

lasix	B-treatment
40	O
mg	O
TID	O

prevacid	B-treatment
PAD-WORD	O

milk	B-treatment
of	I-treatment
mag	I-treatment

multivitamin	B-treatment
PAD-WORD	O

papain	B-treatment
PAD-WORD	O

zinc	B-treatment
PAD-WORD	O

Discharge	O
Medications	O
:	O

1.	O
Albuterol	B-treatment
-	O
Ipratropium	B-treatment
103-18	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
02-19	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

2.	O
Multivitamins	B-treatment
Tablet	I-treatment
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Magnesium	B-treatment
Hydroxide	I-treatment
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

4.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
.	O

5.	O
Heparin	B-treatment
Sodium	I-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

6.	O
Atorvastatin	B-treatment
Calcium	I-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Papain	B-treatment
-	I-treatment
Urea	I-treatment
830,000-10	O
unit	O
-%	O
Spray	O
,	O
Non-Aerosol	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
DAILY	O
(	O
Daily	O
)	O
.	O

8.	O
Insulin	B-treatment
Regular	I-treatment
Human	I-treatment
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
Sliding	B-treatment
scale	I-treatment
Injection	I-treatment
ASDIR	O
(	O
AS	O
DIRECTED	O
)	O
:	O
See	O
the	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

9.	O
Zinc	B-treatment
Sulfate	I-treatment
220	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

10.	O
Ascorbic	B-treatment
Acid	I-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

11.	O
Metoprolol	B-treatment
Tartrate	I-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

12.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

13.	O
Clopidogrel	B-treatment
Bisulfate	I-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

14.	O
Metronidazole	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
6	O
days	O
:	O
Last	O
day	O
2017-07-25	O
.	O

15.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
.	O

16.	O
Olanzapine	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
confusion	B-problem
.	O

17.	O
Protonix	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
twice	O
a	O
day	O
.	O

18.	O
Morphine	B-treatment
Sulfate	I-treatment
15	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

19.	O
Levofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
:	O
Last	O
day	O
08-07	O
.	O

20.	O
Vancomycin	B-treatment
HCl	I-treatment
in	O
Dextrose	B-treatment
1	O
g	O
/	O
200	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
Q	O
12H	O
(	O
Every	O
12	O
Hours	O
)	O
:	O
Last	O
day	O
08-07	O
.	O

21.	O
Gabapentin	B-treatment
300	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

22.	O
Lidocaine	B-treatment
5	O
%(	O
700	O
mg	O
/	O
patch	O
)	O
Adhesive	O
Patch	O
,	O
Medicated	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Adhesive	O
Patch	O
,	O
Medicated	O
Topical	O
QD	O
(	O
)	O
.	O

23.	O
Morphine	B-treatment
Sulfate	I-treatment
2	O
mg	O
/	O
mL	O
Syringe	O
Sig	O
:	O
02-19	O
Injection	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
as	O
needed	O
.	O

24.	O
Prochlorperazine	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Mediplex	O
Rehab	O
Hospital	O
-	O
Lawrence	O

Discharge	O
Diagnosis	O
:	O

Primary	O
:	O

1)	O
Gangrenous	B-problem
leg	I-problem

2)	O
Urinary	B-problem
tract	I-problem
infection	I-problem

3)	O
MRSA	B-problem
pneumonia	I-problem

4)	O
Failure	B-problem
to	I-problem
thrive	I-problem
and	O
weight	B-problem
loss	I-problem

5)	O
Altered	B-problem
mental	I-problem
status	I-problem

6)	O
Gastric	B-problem
ulcer	I-problem

7)	O
C.diff	B-problem
colitis	I-problem

Secondary	O
:	O

1)	O
Coronary	B-problem
artery	I-problem
disease	I-problem

2)	O
Anemia	B-problem

3)	O
Congestive	B-problem
heart	I-problem
failure	I-problem

4)	O
Peripheral	B-problem
vascular	I-problem
disease	I-problem

5)	O
Diabetes	B-problem
mellitus	I-problem

6)	O
Hypertension	B-problem

Discharge	O
Condition	O
:	O

Hemodynamically	O
stable	O
,	O
pt	O
doing	O
much	O
better	O
with	O
physical	B-treatment
therapy	I-treatment
,	O
passed	O
video	B-test
swallow	I-test
evaluation	I-test
tolerating	O
po	O
.	O

Discharge	O
Instructions	O
:	O

Patient	O
needs	O
to	O
take	O
all	O
of	O
the	B-treatment
medications	I-treatment
as	O
directed	O
.	O

Patient	O
needs	O
to	O
continue	O
the	B-treatment
tube	I-treatment
feed	I-treatment
nutrition	I-treatment
until	O
re-assessed	O
by	O
the	O
nutrionist	O
.	O

He	O
can	O
also	O
take	O
oral	O
food	O
as	O
directed	O
below	O
.	O

He	O
needs	O
to	O
seek	O
medical	O
attention	O
if	O
he	O
develops	O
fever	B-problem
,	O
chills	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
worsening	B-problem
pain	I-problem
,	O
worsening	B-problem
wound	I-problem
,	O
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Cynthia	O
Kabzinski	O
(	O
672-3879	O
)	O
on	O
2017-08-08	O

10:45	O
PAD-WORD	O

Provider	O
:	O

Sarah	O
,	O
Santo	O
S.	O
Isom	O

SURGERY	O
PAD-WORD	O

Where	O
:	O

VASCULAR	O
SURGERY	O

Date	O
/	O
Time	O
:	O
2017-08-08	O
10:45	O

Vernon	O
Karen	O
MD	O
28-960	O

Completed	O
by	O
:	O
Marquita	O
Sherry	O
MD	O
09-161	O
2017-07-27	O
@	O
1440	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Frank	O
Z.K.	O
Delgado	O
on	O
:	O
Maxine	O
2017-07-27	O
3:37	O
PM	O

(	O
End	O
of	O
Report	O
)	O

389977469	O
PAD-WORD	O

SH	O
PAD-WORD	O

30431630	O
PAD-WORD	O

12/19/2004	O
12:00:00	O
AM	O

abdominal	B-problem
pain	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

12/19/2004	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/23/2004	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS******	O

MEEDHEYSKUDZRO	O
,	O
LEENLEE	O
C	O

360-93-28-7P31	O
PAD-WORD	O

Room	O
:	O

3M-963	O
PAD-WORD	O

Service	O
:	O

PUL	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/23/04	O
AT	O
05:00	O
PM	O

CONTINGENT	O
UPON	O
Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

SADDCHIRD	O
,	O
ALINE	O
CHPIE	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

No	O
CPR	B-treatment
/	O
No	O
defib	B-treatment
/	O
No	O
intubation	B-treatment
/	O
No	O
pressors	B-treatment

/DISPOSITION	O
:	O

Home	O
w/	O
services	O

DISCHARGE	O
MEDICATIONS	O
:	O

ALBUTEROL	B-treatment
INHALER	I-treatment
2	O
PUFF	O
INH	O
QID	O
PRN	O
Shortness	B-problem
of	I-problem
Breath	I-problem
,	O
Wheezing	B-problem
VITAMIN	B-treatment
C	I-treatment
(	I-treatment
ASCORBIC	I-treatment
ACID	I-treatment
)	I-treatment
500	O
MG	O
PO	O
BID	O
MIACALCIN	B-treatment
(	I-treatment
CALCITONIN	I-treatment
-	I-treatment
SALMON	I-treatment
)	I-treatment
1	O
SPRAY	O
INH	O
QD	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

1MAG	B-treatment
CITRATE	I-treatment
(	I-treatment
CITRATE	I-treatment
OF	I-treatment
MAGNESIA	I-treatment
)	I-treatment
300	O
MILLILITERS	O
PO	O
QD	O
PRN	O
Constipation	B-problem
COLACE	B-treatment
(	I-treatment
DOCUSATE	I-treatment
SODIUM	I-treatment
)	I-treatment
100	O
MG	O
PO	O
TID	O
GLYBURIDE	B-treatment
5	O
MG	O
PO	O
BID	O
Starting	O
IN	O
AM	O
on	O
12/21/04	O
LACTULOSE	B-treatment
30	O
MILLILITERS	O
PO	O
Q6	O

HOLD	O
IF	O
:	O

diarrhea	B-problem
PAD-WORD	O

SENNA	B-treatment
TABLETS	I-treatment
2	O
TAB	O
PO	O
BID	O
SIMETHICONE	B-treatment
160	O
MG	O
PO	O
QID	O
Starting	O
Today	O
(	O
12/23	O
)	O
PRN	O

Other	O
:	O

gas	B-problem
,	O
upset	B-problem
stomach	I-problem
.	O

TAMOXIFEN	B-treatment
20	O
MG	O
PO	O
QD	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/19/04	O
by	O
SAPMOORES	O
,	O
NELL	O
RILET	O
,	O
M.D.	O
on	O
order	O
for	O
LEVOFLOXACIN	B-treatment
PO	I-treatment
(	O
ref	O
#	O
88006031	O
)	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

TAMOXIFEN	B-treatment
CITRATE	I-treatment
and	O
LEVOFLOXACIN	B-treatment

Reason	O
for	O
override	O
:	O

aware	O
MVI	B-treatment
THERAPEUTIC	I-treatment
W	I-treatment
/	I-treatment
MINERALS	I-treatment
(	I-treatment
THERAP	I-treatment
VITS	I-treatment
/	I-treatment
MINERALS	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O
PILOCARPINE	B-treatment
4%	I-treatment
SOLUTION	I-treatment
1	O
DROP	O
OS	O
QID	O
FLONASE	B-treatment
(	I-treatment
FLUTICASONE	I-treatment
NASAL	I-treatment
SPRAY	I-treatment
)	I-treatment
2	O
SPRAY	O
INH	O
BID	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

2	B-treatment
ALPHAGAN	I-treatment
(	I-treatment
BRIMONIDINE	I-treatment
TARTRATE	I-treatment
)	I-treatment
1	O
DROP	O
OS	O
BID	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

2	B-treatment
LEVOFLOXACIN	I-treatment
250	O
MG	O
PO	O
QD	O
X	O
1	O
Days	O
Starting	O
Today	O
(	O
12/21	O
)	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Administer	O
iron	B-treatment
products	I-treatment
a	O
minimum	O
of	O
2	O
hours	O
before	O
or	O
after	O
a	B-treatment
levofloxacin	I-treatment
or	O
ciprofloxacin	B-treatment
dose	O
dose	O

If	O
on	O
tube	B-treatment
feeds	I-treatment
,	O
please	O
cycle	O
(	O
hold	O
1	O
hr	O
before	O
to	O
2	O
hr	O
after	O
)	O

Take	O
2	O
hours	O
before	O
or	O
2	O
hours	O
after	O
dairy	O
products	O
.	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/19/04	O
by	O
SAPMOORES	O
,	O
NELL	O
RILET	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

TAMOXIFEN	B-treatment
CITRATE	I-treatment
and	O
LEVOFLOXACIN	B-treatment

Reason	O
for	O
override	O
:	O

aware	O
PAD-WORD	O

CELEXA	B-treatment
(	I-treatment
CITALOPRAM	I-treatment
)	I-treatment
20	O
MG	O
PO	O
QD	O
CALCIUM	B-treatment
CARB	I-treatment
+	I-treatment
D	I-treatment
(	O
600MG	O
ELEM	B-treatment
CA	I-treatment
+	I-treatment
VIT	I-treatment
D/200	I-treatment
IU	O
)	O
1	O
TAB	O
PO	O
BID	O
LUMIGAN	B-treatment
(	I-treatment
BIMATOPROST	I-treatment
0.03%	I-treatment
)	I-treatment
1	O
DROP	O
OU	O
QHS	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Faleschird	O
,	O
Dr.	O
Cuchbreunjesc	O
,	O
Dr.	O
Roziesc	O
,	O

ALLERGY	O
:	O

CEFUROXIME	B-treatment
AXETILADMIT	O
DIAGNOSIS	O
:	O

abdominal	B-problem
pain	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
abdominal	B-problem
pain	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
Allergies	B-problem
-	O
PCN	B-treatment
-	O
rash	B-problem
-	O
Bactrim	B-treatment
-	O
hives	B-problem
-	O
Erythro	B-treatment
-	O
nausea	B-problem
-	O
Ceclor	B-treatment
-	O
nausea	B-problem
-	O
Clarythro	B-treatment
=	O
rash	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

None	O
.	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

NONEBRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

67	O
y/o	O
F	O
w/	O
hx	O
poliomyelitis	B-problem
,	O
breast	B-problem
CA	I-problem
stable	O
on	O
tamoxifen	B-treatment
,	O
vent	B-problem
dependent	I-problem
in	O
an	B-treatment
iron	I-treatment
lung	I-treatment
admitted	O
w/	O
1	O
day	O
hx	O
of	O
abdominal	B-problem
pain	I-problem
.	O

Pt	O
was	O
recently	O
admitted	O
1	O
week	O
ago	O
w/	O
epigastric	B-problem
pain	I-problem
.	O

Pain	B-problem
worse	O
with	O
movement	O
.	O

She	O
denies	O
any	B-problem
fever	I-problem
,	O
BRBPR	B-problem
,	O
melena	B-problem
,	O
dysuria	B-problem
.	O

On	O
admision	O
,	O
T	B-test
97.5	O
,	O
HR	B-test
86	O
,	O
BP	B-test
111/47	O
,	O
R	B-test
20	O
.	O

Sat	B-test
94%	O
on	O
4L	B-treatment
.	O

Exam	B-test
notable	O
for	O
hyperactive	B-problem
bowel	I-problem
sounds	I-problem
with	O
abd	B-problem
distention	I-problem
and	O
tenderness	B-problem
to	O
palpation	B-test
at	I-test
LLQ	I-test
and	O
RLQ	O
.	O

No	O
rebound	B-problem
or	O
guarding	B-problem
.	O

Abd	B-test
CT	I-test
showed	O
stable	O
findings	O
compared	O
to	O
12/10/04	O
except	O
for	O
distended	B-problem
right	I-problem
colon	I-problem
consistent	O
with	O
ileus	B-problem
.	O

Hospital	O
course	O
:	O

GI	O
:	O

pt	O
&apos;s	O
clinical	O
picture	O
was	O
consistent	O
with	O
constipation-related	B-problem
abdominal	I-problem
pain	I-problem
.	O

pt	O
was	O
started	O
on	O
bowel	B-treatment
regimen	I-treatment
with	O
Senna	B-treatment
,	O
magcitrate	B-treatment
and	O
Lactulose	B-treatment
.	O

Several	O
loose	O
bowel	O
movements	O
were	O
induced	O
with	O
above	O
regimen	O
.	O

Her	B-problem
abd	I-problem
distention	I-problem
and	O
tenderness	B-problem
improved	O
after	O
bowel	O
movement	O
.	O

ID	O
:	O

pt	O
was	O
Levo	B-treatment
250mg	O
x	O
3	O
days	O
for	O
UTI	B-problem
(	O
pyuria	B-problem
on	O
admisstion	O
)	O
.	O

Pulm	O
:	O

pt	O
has	O
been	O
using	O
iron	B-treatment
lung	I-treatment
for	O
breathing	O
and	O
has	O
been	O
satting	O
well	O
duing	O
her	O
hospital	O
course	O
.	O

Code	O
:	O

DNR	O
/	O
DNI	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

1.	O
Please	O
follow	O
up	O
with	O
Dr.	O
Faleschird	O
,	O
Dr.	O
Cuchbreunjesc	O
and	O
Dr.	O
Roziesc	O
.	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

LEESEPLASSBREAN	O
,	O
RIDELT	O
,	O
M.D.	O
(	O
FR98	O
)	O

12/23/04	O
04:37	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2014-05-12	O
PAD-WORD	O

Discharge	O
Date:	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

Service	O
:	O

ADMISSION	O
DIAGNOSES	O
:	O

1.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

2.	O
Dilated	B-problem
cardiomyopathy	I-problem
.	O

3.	O
A	O
27	O
week	O
intrauterine	B-problem
pregnancy	I-problem
.	O

4.	O
Chronic	B-problem
hypertension	I-problem
.	O

5.	O
Asthma	B-problem
.	O

6.	O
History	O
of	O
atrioseptal	B-problem
defect	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
28	O
-	O
year-old	O
,	O
gravida	O
3	O
,	O
para	O
1	O
,	O
at	O
approximately	O
27	O
weeks	O
gestation	O
,	O
who	O
was	O
admitted	O
on	O
2014-05-12	O
due	O
to	O
increasing	O
symptoms	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

She	O
has	O
known	B-problem
dilated	I-problem
cardiomyopathy	I-problem
with	O
a	B-test
baseline	I-test
ejection	I-test
fraction	I-test
of	O
approximately	O
25%	O
.	O

She	O
had	O
been	O
managed	O
as	O
an	O
outpatient	O
during	O
her	O
pregnancy	O
and	O
was	O
on	O
multiple	B-treatment
medications	I-treatment
including	O
Lasix	B-treatment
40	O
mg	O
daily	O
,	O
Hydralazine	B-treatment
25	O
mg	O
daily	O
,	O
Toprol	B-treatment
XL	I-treatment
100	O
mg	O
daily	O
,	O
digoxin	B-treatment
0.5	O
mg	O
daily	O
and	O
Lovenox	B-treatment
40	O
mg	O
twice	O
daily	O
subcutaneously	O
.	O

She	O
also	O
took	O
albuterol	B-treatment
on	O
a	O
p.r.n.	O
basis	O
for	O
her	B-problem
asthma	I-problem
.	O

She	O
has	O
known	B-problem
allergy	I-problem
to	O
penicillin	B-treatment
,	O
vancomycin	B-treatment
and	O
erythromycin	B-treatment
.	O

She	O
was	O
evaluated	O
upon	O
presentation	O
by	O
the	O
Maternal	O
Fetal	O
Medicine	O
attending	O
on	O
call	O
as	O
well	O
as	O
by	O
Cardiology	O
.	O

She	O
was	O
found	O
to	O
have	O
symptoms	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
as	O
well	O
as	O
decreased	B-problem
fetal	I-problem
movement	I-problem
.	O

Fetal	B-test
monitoring	I-test
initially	O
on	O
admission	O
was	O
appropriate	O
for	O
gestational	O
age	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
exam	I-test
,	O
she	O
was	O
noted	O
to	O
have	O
bilateral	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
,	O
mildly	B-problem
elevated	I-problem
pressures	I-problem
in	O
the	O
140	O
to	O
150/90	O
range	O
,	O
and	O
jugular	B-problem
venous	I-problem
distension	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

After	O
consultation	O
with	O
Cardiology	O
as	O
well	O
as	O
Anesthesia	O
on	O
call	O
that	O
evening	O
,	O
it	O
was	O
decided	O
to	O
transfer	O
the	O
patient	O
to	O
the	O
ICU	O
for	O
intensive	B-test
monitoring	I-test
.	O

Central	B-treatment
IV	I-treatment
access	I-treatment
was	O
obtained	O
.	O

The	O
patient	O
was	O
carefully	O
diuresed	O
over	O
the	O
next	O
48	O
hours	O
.	O

Symptoms	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
gradually	O
abated	O
over	O
the	O
next	O
48	O
to	O
72	O
hours	O
.	O

The	O
patient	O
was	O
given	O
antenatal	B-treatment
corticosteroids	I-treatment
for	O
fetal	O
lung	O
maturity	O
.	O

A	O
Neonatology	O
consultation	O
was	O
obtained	O
during	O
the	O
course	O
of	O
the	O
hospitalization	O
.	O

After	O
discussion	O
,	O
it	O
was	O
decided	O
to	O
attempt	O
to	O
obtain	O
28	O
weeks	O
gestation	O
and	O
then	O
deliver	O
electively	O
by	O
cesarean	B-treatment
section	I-treatment
given	O
the	B-problem
decompensation	I-problem
in	O
the	O
third	O
trimester	O
.	O

The	O
patient	O
underwent	O
primary	B-treatment
low	I-treatment
transverse	I-treatment
cesarean	I-treatment
section	I-treatment
on	O
2014-05-19	O
at	O
approximately	O
28	O
weeks	O
gestation	O
.	O

The	B-treatment
cesarean	I-treatment
section	I-treatment
was	O
performed	O
on	O
the	O
West	O
Campus	O
in	O
the	O
Cardiothoracic	O
Surgical	O
Suite	O
.	O

This	O
was	O
performed	O
in	O
this	O
location	O
in	O
case	O
any	B-problem
acute	I-problem
cardiac	I-problem
decompensation	I-problem
occurred	O
during	O
the	O
time	O
of	O
cesarean	B-treatment
section	I-treatment
.	O

Cardiothoracic	O
Surgery	O
was	O
on	O
standby	O
during	O
the	B-treatment
surgery	I-treatment
.	O

The	O
patient	O
went	O
to	O
the	O
cardiac	O
Intensive	O
Care	O
Unit	O
on	O
the	O
West	O
Campus	O
postoperatively	O
.	O

She	O
did	O
well	O
during	O
the	O
postoperative	O
period	O
.	O

She	O
required	O
several	O
episodes	O
of	O
diuresis	B-treatment
due	O
to	O
increasing	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
on	O
postoperative	O
day	O
#1	O
and	O
postoperative	O
day	O
#2	O
due	O
to	O
worsening	O
symptoms	O
of	O
shortness	B-problem
of	I-problem
breath	I-problem
from	O
fluid	B-problem
shifts	I-problem
that	O
normally	O
occur	O
during	O
the	O
postpartum	O
period	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
West	O
Campus	O
on	O
postoperative	O
day	O
#2	O
in	O
stable	O
condition	O
.	O

She	O
did	O
well	O
during	O
the	O
remainder	O
of	O
her	O
postoperative	O
course	O
and	O
was	O
continued	O
on	O
her	B-treatment
medication	I-treatment
regimen	I-treatment
that	O
she	O
had	O
been	O
on	O
during	O
the	O
antepartum	O
period	O
.	O

She	O
was	O
discharged	O
to	O
home	O
on	O
postoperative	O
day	O
#4	O
.	O

She	O
was	O
to	O
followup	O
with	O
Maternal	O
Fetal	O
Medicine	O
in	O
5	O
to	O
7	O
days	O
.	O

She	O
had	O
followup	O
with	O
her	O
primary	O
cardiologist	O
in	O
Shaugnessy-Kaplan	O
Rehab	O
Hospital	O
scheduled	O
for	O
1	O
week	O
postoperatively	O
.	O

Of	O
note	O
,	O
the	O
patient	O
also	O
underwent	O
tubal	B-treatment
ligation	I-treatment
at	O
the	O
time	O
of	O
cesarean	B-treatment
section	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Toprol	B-treatment
XL	I-treatment
100	O
mg	O
daily	O
,	O
Hydralazine	B-treatment
25	O
mg	O
daily	O
,	O
Lasix	B-treatment
40	O
mg	O
twice	O
a	O
day	O
,	O
digoxin	B-treatment
0.75	O
mg	O
daily	O
,	O
Lovenox	B-treatment
40	O
mg	O
twice	O
daily	O
subcutaneously	O
and	O
albuterol	B-treatment
p.r.n.	O

Peter	O
Richard	O
,	O
MD	O

Dictated	O
By	O
:	O
Michael	O
O.	O
Tucker	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2016-01-29	O
09:07:27	O

T	O
:	O
2016-01-29	O
09:49:48	O

Job	O
#:	O
72842	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Homer	O
Peterson	O
on	O
:	O
FRI	O
2016-01-29	O
11:36	O
AM	O

(	O
End	O
of	O
Report	O
)	O

395715290	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

2681723	O
PAD-WORD	O

64704/9r71	O
PAD-WORD	O

946667	O
PAD-WORD	O

4/6/1995	O
12:00:00	O
AM	O

ACUTE	B-problem
MYOCARDIAL	I-problem
INFARCTION	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

4/6/95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

4/16/95	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Acute	B-problem
myocardial	I-problem
infarction	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

status	O
post	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Percutaneous	B-treatment
angioplasty	I-treatment
of	I-treatment
the	I-treatment
right	I-treatment
coronary	I-treatment
artery	I-treatment
,	O
4/9/95	O
.	O

OTHER	O
PROCEDURES	O
:	O

directional	B-treatment
angioplasty	I-treatment
of	I-treatment
the	I-treatment
right	I-treatment
coronary	I-treatment
artery	I-treatment
,	I-treatment
left	I-treatment
main	I-treatment
and	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
vessels	I-treatment
.	O

4/11/95	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

Lanoxin	B-treatment
0.375	O
mg.	O
daily	O
.	O

Coumadin	B-treatment
as	O
adjusted	O
by	O
Prothrombin	B-test
times	I-test
,	O
Isordil	B-treatment
20	O
mg.	O
tid	O
,	O
Micronase	B-treatment
1.25	O
mg.	O
daily	O
,	O
aspirin	B-treatment
81	O
mg.	O
daily	O
,	O
nitroglycerin	B-treatment
0.3	O
mg.	O
SL	O
prn	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
seventy	O
two	O
year	O
old	O
man	O
who	O
a	O
number	O
of	O
years	O
ago	O
underwent	O
coronary	B-treatment
bypass	I-treatment
surgery	I-treatment
at	O
another	O
institution	O
.	O

This	O
took	O
place	O
in	O
1983	O
.	O

In	O
1992	O
he	O
underwent	O
redo	B-treatment
surgery	I-treatment
and	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
.	O

In	O
April	O
1994	O
he	O
presented	O
with	O
an	B-problem
acute	I-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
and	O
was	O
given	O
Streptokinase	B-treatment
.	O

He	O
had	O
recurrent	B-problem
pain	I-problem
and	O
went	O
to	O
the	O
Catheter	O
Laboratory	O
where	O
a	B-problem
proximal	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
lesion	I-problem
was	O
angioplastied	O
.	O

A	O
relook	O
several	O
days	O
later	O
led	O
to	O
a	B-treatment
repeat	I-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
.	O

He	O
has	O
has	O
stable	B-problem
,	I-problem
mild	I-problem
angina	I-problem
,	O
subsequently	O
,	O
mostly	O
in	O
the	O
setting	O
of	O
stress	B-problem
.	O

Slightly	O
increased	O
in	O
recent	O
months	O
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
he	O
was	O
involved	O
in	O
a	O
minor	O
motor	O
vehicle	O
accident	O
,	O
and	O
there	O
was	O
some	O
apparent	O
controversy	O
with	O
the	O
driver	O
of	O
the	O
other	O
vehicle	O
,	O
during	O
the	O
course	O
of	O
which	O
he	O
developed	O
substernal	B-problem
chest	I-problem
pain	I-problem
radiating	O
to	O
the	O
left	O
arm	O
and	O
shoulder	O
.	O

This	O
waxed	O
and	O
waned	O
for	O
thirty	O
to	O
sixty	O
minutes	O
,	O
and	O
he	O
took	O
a	O
number	O
of	O
nitroglycerins	B-treatment
.	O

After	O
returning	O
home	O
after	O
conferring	O
with	O
his	O
wife	O
,	O
and	O
the	B-problem
pain	I-problem
lasted	O
another	O
half	O
hour	O
,	O
he	O
came	O
to	O
the	O
emergency	O
room	O
.	O

His	B-test
electrocardiogram	I-test
showed	O
increased	B-problem
T	I-problem
wave	I-problem
inversions	I-problem
in	I-problem
V3	I-problem
and	O
V4	O
and	O
1	O
mm	O
.	O

ST	B-problem
segment	I-problem
depression	I-problem
in	I-problem
V3	I-problem
through	O
V6	O
.	O

His	B-test
examination	I-test
was	O
largely	O
benign	O
after	O
he	O
was	O
made	O
pain	B-problem
free	O
.	O

The	B-test
pulse	I-test
was	O
75	O
,	O
blood	B-test
pressure	I-test
120/80	O
,	O
respirations	B-test
18	O
,	O
and	O
he	O
was	O
afebrile	B-problem
.	O

The	O
jugular	O
veins	O
were	O
not	O
distended	B-problem
,	O
the	B-test
carotid	I-test
volume	I-test
was	O
diminished	B-problem
.	O

The	O
chest	O
was	O
clear	O
and	O
the	O
cardiac	O
rhythm	O
was	O
regular	O
.	O

There	O
were	O
normal	B-treatment
prothetic	I-treatment
valves	I-treatment
.	O

There	O
was	O
a	B-problem
grade	I-problem
II-II	I-problem
apical	I-problem
and	I-problem
systolic	I-problem
murmur	I-problem
.	O

The	O
abdomen	O
was	O
negative	O
and	O
there	O
was	O
no	O
edema	B-problem
of	I-problem
the	I-problem
feet	I-problem
.	O

The	B-test
electrocardiogram	I-test
demonstrated	O
normal	O
sinus	O
rhythm	O
with	O
poor	B-problem
R	I-problem
wave	I-problem
progression	I-problem
,	O
left	B-problem
atrial	I-problem
enlargement	I-problem
and	O
T	B-problem
wave	I-problem
inversion	I-problem
in	I-problem
leads	I-problem
V	I-problem
4	I-problem
,	I-problem
5	I-problem
,	O
and	O

Admission	O
Date	O
:	O

2020-05-23	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2020-05-29	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1955-11-14	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Sabrina	O
Q.	O
G.	O
King	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
change	B-problem
in	I-problem
mental	I-problem
status	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
PAD-WORD	O

Central	B-treatment
line	I-treatment
placement	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

64	O
F	O
with	O
breast	B-problem
CA	I-problem
s/p	O
mastectomy	B-treatment
17	O
y	O
ago	O
with	O
local	B-problem
recurrence	I-problem
leading	O
to	O
paralysis	B-problem
of	I-problem
L	I-problem
arm	I-problem
~	O
5-6	O
y	O
ago	O
.	O

Now	O
declining	O
gradually	O
since	O
January	O
(	O
30	B-problem
lbs	I-problem
weight	I-problem
loss	I-problem
,	O
becoming	O
more	B-problem
confused	I-problem
,	O
decreased	B-problem
appetite	I-problem
).	O

Patient	O
declined	O
workup	B-test
/	O
imaging	B-test
for	O
mets	B-problem
as	O
outpatient	O
.	O

Moving	O
toward	O
home	O
hospice	O
.	O

Over	O
the	O
last	O
2	O
weeks	O
,	O
husband	O
reports	O
patient	O
becoming	O
increasingly	B-problem
weak	I-problem
,	O
unable	O
to	O
leave	O
bed	O
,	O
confused	B-problem
,	O
unable	O
to	O
feed	O
herself	O
.	O

Seen	O
by	O
VNA	O
and	O
noted	O
to	O
be	O
tachycardic	B-problem
and	O
sent	O
to	O
Middleboroughfor	O
evaluation	B-test
.	O

Now	O
sent	O
in	O
to	O
Amesbury	O
by	O
VNA	O
because	O
of	O
asymptomatic	B-problem
sinus	I-problem
tachycardia	I-problem
.	O

Transferred	O
here	O
for	O
workup	B-test
for	O
CNS	B-problem
mets	I-problem
and	O
admission	O
.	O

In	O
John	O
,	O
VS	B-test
-	O
99.6	O
,	O
135	O
,	O
122/65	O
,	O
20	O
.	O

Neurology	O
evaluated	O
pt	O
and	O
felt	O
to	O
have	O
intact	O
brainstem	O
reflexes	O
but	O
poor	O
prognosis	O
.	O

Neurosurg	O
evaluated	O
pt	O
and	O
felt	O
to	O
not	O
be	O
surgical	O
candidate	O
;	O
recommended	O
dilantin	B-treatment
load	I-treatment
and	O
decadron	B-treatment
.	O

Received	O
lorazepam	B-treatment
prior	O
to	O
CT	B-test
scan	I-test
.	O

Intubated	O
for	O
MS	B-problem
changes	I-problem
and	O
lethargy	B-problem
and	O
concern	O
for	O
airway	B-treatment
protection	I-treatment
.	O

Post	O
intubation	B-treatment
,	O
hypotensive	B-problem
and	O
started	O
on	O
dopamine	B-treatment
and	O
transitioned	O
to	O
levophed	B-treatment
.	O

Received	O
vancomycin	B-treatment
/	O
levafloxacin	B-treatment
at	O
OSH	O
.	O

Received	O
metronidazole	B-treatment
at	O
Ricky	O
in	O
Mediplex	O
Rehab	O
Hospital	O
.	O

In	O
CMED	O
CCU	O
,	O
pt.	O
responsive	O
to	O
noxious	B-test
stimuli	I-test
only	O
.	O

History	O
obtained	O
from	O
husband	O
as	O
above	O
.	O

Past	O
Medical	O
History	O
:	O

PMHx	O
:	O

1.	O
Left	O
breast	O
status	O
post	O
radical	B-treatment
mastectomy	I-treatment
in	O
2002	O
with	O
adjuvant	B-treatment
Tamoxifen	I-treatment
for	O
five	O
years	O
.	O

This	O
was	O
followed	O
by	O
later	O
development	O
of	O
lymphedema	B-problem
and	O
left	B-problem
arm	I-problem
(	I-problem
distal	I-problem
>	I-problem
proximal	I-problem
)	I-problem
weakness	I-problem
due	O
to	O
metastatic	B-problem
disease	I-problem
in	I-problem
left	I-problem
axilla	I-problem
ensheathing	I-problem
nerve	I-problem
plexus	I-problem
.	O

Treated	O
with	O
course	O
of	O
local	B-treatment
XRT	I-treatment
in	O
Springfield	O
Municipal	O
Hospital	O
and	O
Tamoxifen	B-treatment
.	O

Switched	O
to	O
Arimedex	B-treatment
in	O
2019-02-10	O
due	O
to	O
vaginal	B-problem
bleeding	I-problem
on	O
Tamoxifen	B-treatment
.	O

Self	O
discontinued	O
Arimedex	B-treatment
last	O
month	O
.	O

No	O
prior	O
history	O
of	O
intracranial	B-problem
disease	I-problem
.	O

2.	O
Metastatic	B-problem
disease	I-problem
in	I-problem
left	I-problem
arm	I-problem
,	I-problem
brachial	I-problem
plexus	I-problem
resulting	O
in	O
left	B-problem
arm	I-problem
paresis	I-problem
,	O
as	O
above	O

Social	O
History	O
:	O

Married	O
,	O
lives	O
with	O
husband	O
.	O

Victoria	O
't	O
worked	O
since	O
2008	O
,	O
prior	O
to	O
that	O
worked	O
in	O
a	O
school	O
cafeteria	O
.	O

+	O
children	O
(	O
husband	O
Gracia	O
't	O
quantify	O
).	O

Social	O
smoker	O
in	O
her	O
youth	O
.	O

Distant	O
smoking	O
history	O
.	O

Occasional	O
alcohol	O
use	O
.	O

Family	O
History	O
:	O

Maternal	O
aunt	O
with	O
breast	B-problem
cancer	I-problem
.	O

Mother	O
aged	O
85	O
,	O
alive	O
and	O
well	O
.	O

Three	O
healthy	O
siblings	O
.	O

Father	O
deceased	O
from	O
complications	B-problem
from	O
MS	B-problem
.	O

Physical	O
Exam	O
:	O

T	B-test
99.8	O

HR	B-test
124	O

SBP	B-test
135/58	O

RR	B-test
16	O

Ox	B-test
100	O

Gen	O
:	O

Cachectic	B-problem
,	O
lays	O
with	O
eyes	O
closed	O
.	O

HEENT	O
:	O

Temporal	B-problem
wasting	I-problem
.	O

NC/AT	B-problem
.	O

Anicteric	B-problem
.	O

Mucosa	B-problem
dry	I-problem
.	O

Neck	O
:	O

Supple	O
.	O

Lungs	O
:	O

Clear	O
anterolaterally	O
.	O

No	O
R/R/W	B-problem
.	O

Cardiac	O
:	O

Tachycardic	B-problem
,	O
regular	O
.	O

S1/S2	O
.	O

No	O
M/R/G	B-problem
.	O

Abd	O
:	O

Soft	O
,	O
NT	B-problem
,	O
ND	B-problem
,	O
+	O
NABS	O
.	O

No	O
rebound	B-problem
or	O
guarding	B-problem
.	O

No	O
HSM	B-problem
.	O

Extrem	O
:	O

Wasted	B-problem
.	O

Legs	O
are	O
rigid	B-problem
.	O

Pertinent	O
Results	O
:	O

Head	B-test
CT	I-test
There	O
is	O
diffuse	B-problem
metastatic	I-problem
disease	I-problem
.	O

Three	B-problem
discrete	I-problem
lesions	I-problem
are	O
seen	O
within	O
the	O
left	O
frontal	O
,	O
right	O
occipital	O
,	O
and	O
left	O
parietal	O
lobes	O
with	O
significant	B-problem
surrounding	I-problem
vasogenic	I-problem
edema	I-problem
.	O

The	B-problem
largest	I-problem
single	I-problem
lesion	I-problem
measures	O
3.7	O
x	O
3.4	O
cm	O
.	O

There	O
is	O
moderate	B-problem
surrounding	I-problem
edema	I-problem
with	O
10	O
mm	O
rightward	B-problem
shift	I-problem
of	I-problem
the	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
with	O
associated	B-problem
mass	I-problem
effect	I-problem
on	I-problem
the	I-problem
lateral	I-problem
ventricles	I-problem
.	O

The	O
basilar	O
cistern	O
is	O
preserved	O
and	O
there	O
is	O
no	O
uncal	B-problem
herniation	I-problem
.	O

The	O
osseous	O
structures	O
are	O
unremarkable	O
.	O

The	O
paranasal	O
sinuses	O
and	O
mastoid	O
air	O
cells	O
are	O
well	O
aerated	O
.	O

CT	B-test
torso	I-test

1.	O
Right	B-problem
middle	I-problem
lobe	I-problem
lung	I-problem
nodule	I-problem
,	O
suspicious	O
for	O
metastatic	B-problem
disease	I-problem
.	O

2.	O
Right	B-problem
upper	I-problem
lobe	I-problem
lung	I-problem
opacities	I-problem
which	O
appear	O
confluent	B-problem
,	O
most	O
suggestive	O
of	O
infectious	B-problem
etiology	I-problem
,	O
however	O
,	O
cannot	O
entirely	O
exclude	O
metastatic	B-problem
lesions	I-problem
.	O

Recommend	O
follow	B-test
up	I-test
CT	I-test
to	O
ensure	O
resolution	O
.	O

3.	O
Multiple	B-problem
hypodense	I-problem
liver	I-problem
lesions	I-problem
which	O
are	O
mildly	B-problem
enhancing	I-problem
,	O
most	O
consistent	O
with	O
metastatic	B-problem
disease	I-problem
.	O

4.	O
Bilateral	B-problem
small	I-problem
pleural	I-problem
effusion	I-problem
,	O
which	O
certainly	O
could	O
be	O
malignant	B-problem
given	O
today	B-test
's	I-test
findings	I-test
and	O
history	O
of	O
breast	B-problem
cancer	I-problem
.	O

5.	O
No	O
evidence	O
of	O
bony	B-problem
metastases	I-problem
.	O

6.	O
Uterine	O
cavity	O
fluid	O
of	O
unclear	O
etiology	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Metastatic	B-problem
breast	I-problem
CA	I-problem
-	O
Large	B-problem
brain	I-problem
mets	I-problem
with	O
midline	B-problem
shift	I-problem
.	O

Intubated	O
for	O
airway	B-treatment
protection	I-treatment
.	O

Treated	O
with	O
IV	B-treatment
dilantin	I-treatment
and	O
decadron	B-treatment
.	O

Patient	O
mental	O
status	O
improved	O
slightly	O
.	O

After	O
discussion	O
with	O
primary	O
oncologist	O
goals	O
of	O
care	O
where	O
change	O
to	O
comfort	O
.	O

Dilantin	B-treatment
was	O
stopped	O
.	O

Will	O
go	O
home	O
with	O
prn	O
morphine	B-treatment
,	O
ativan	B-treatment
,	O
and	O
PR	B-treatment
decadron	I-treatment
.	O

Pnuemonia	B-problem
-	O
Possible	O
aspiration	B-problem
.	O

Completed	O
a	O
7	O
day	O
course	O
of	O
vancomycin	B-treatment
and	O
levofloxacin	B-treatment
.	O

Medications	O
on	O
Admission	O
:	O
none	O

Discharge	O
Medications	O
:	O

1.	O
Morphine	B-treatment
Concentrate	I-treatment
20	O
mg	O
/	O
mL	O
Solution	O
Sig	O
:	O
2.5-20	O
mg	O
PO	O
Q1-2H	O
(	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
30	O
ml	O
*	O
Refills	O
:*	O
0	O
*	O

2.	O
Lorazepam	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
0.5-2	O
mg	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
aggitation	B-problem
/	O
seizure	B-problem
:	O
Please	O
dispense	O
liquid	O
.	O

Disp	O
:*	O
50	O
ml	O
*	O
Refills	O
:*	O
0	O
*	O

3.	O
Dexamethasone	B-treatment
4	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
:	O
please	O
give	O
8	O
mg	O
suppository	O
.	O

Disp	O
:*	O
90	O
suppository	O
*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Breast	B-problem
cancer	I-problem

Discharge	O
Condition	O
:	O

Stable	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
hospice	O
for	O
questions	O
.	O

Followup	O
Instructions	O
:	O
as	O
needed	O

Ramirez	O
Mary	O
Lenora	O
MD	O
74-114	O

Completed	O
by	O
:	O
Tony	O
Cervantes	O
MD	O
43-424	O
2020-05-29	O
@	O
0951	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Patricia	O
Noland	O
on	O
:	O
SAT	O
2020-05-30	O
9:10	O
AM	O

(	O
End	O
of	O
Report	O
)	O

399210956	O
PAD-WORD	O

FIH	O
PAD-WORD	O

6954426	O
PAD-WORD	O

59986/3015	O
PAD-WORD	O

071004	O
PAD-WORD	O

08/27/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

08-27-92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

09-05-92	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
75	O
year	O
old	O
Hispanic	O
male	O
with	O
insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
status	O
post	O
a	B-treatment
right	I-treatment
above-knee	I-treatment
amputation	I-treatment
about	O
five	O
years	O
ago	O
,	O
who	O
reportedly	O
approximately	O
four	O
months	O
ago	O
,	O
he	O
developed	O
a	B-problem
small	I-problem
ulceration	I-problem
in	I-problem
the	I-problem
left	I-problem
great	I-problem
toe	I-problem
,	O
which	O
progressively	O
worsened	O
.	O

He	O
was	O
seen	O
by	O
a	O
doctor	O
in	O
Arizona	O
and	O
treated	O
with	O
dressing	B-treatment
changes	I-treatment
and	O
debridement	B-treatment
until	O
approximately	O
six	O
weeks	O
ago	O
,	O
when	O
antibiotics	B-treatment
were	O
started	O
with	O
Ciprofloxacin	B-treatment
.	O

The	O
patient	O
was	O
seen	O
and	O
it	O
was	O
suggested	O
that	O
he	O
should	O
have	O
an	B-treatment
amputation	I-treatment
and	O
he	O
decided	O
to	O
come	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
for	O
further	B-test
evaluation	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
for	O
fifteen	O
years	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

right	B-treatment
above-knee	I-treatment
amputation	I-treatment
five	O
years	O
ago	O
,	O
status	O
post	O
motor	O
vehicle	O
accident	O
.	O

He	O
sustained	O
left	B-problem
humerus	I-problem
fracture	I-problem
and	O
left	B-problem
tib-fib	I-problem
fracture	I-problem
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Tylenol	B-treatment
,	O
Ciprofloxacin	B-treatment
and	O
Insulin	B-treatment
,	O
about	O
16	O
units	O
of	O
NPH	B-treatment
qa.m.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

On	O
review	B-test
of	I-test
systems	I-test
,	O
denies	O
fevers	B-problem
,	O
has	O
pain	B-problem
in	I-problem
the	I-problem
left	I-problem
foot	I-problem
,	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
chest	B-problem
pain	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
physical	I-test
examination	I-test
reveals	O
him	O
to	O
be	O
an	O
elderly	O
gentleman	O
who	O
is	O
alert	O
and	O
oriented	O
and	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
was	O
unremarkable	O
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
.	O

Cardiovascular	O
exam	O
:	O

regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
no	O
visceromegaly	B-problem
.	O

The	B-test
rectal	I-test
examination	I-test
showed	O
normal	O
prostate	O
,	O
guaiac	B-test
negative	O
.	O

His	B-test
neurological	I-test
examination	I-test
was	O
nonfocal	O
.	O

Pulses	B-test
remained	O
,	O
aside	O
from	O
the	B-treatment
above-knee	I-treatment
amputation	I-treatment
on	I-treatment
the	I-treatment
right	I-treatment
side	I-treatment
,	O
they	O
remained	O
symmetrical	O
bilaterally	O
with	O
3+	B-test
carotid	I-test
,	O
2+	B-test
brachial	I-test
,	O
1+	B-test
radial	I-test
,	O
3+	B-test
femoral	I-test
.	O

LABORATORY	O
DATA	O
:	O

significant	O
for	O
a	B-test
white	I-test
blood	I-test
count	I-test
of	O
6.0	O
,	O
hematocrit	B-test
35.9	O
,	O
electrolytes	B-test
within	O
normal	O
limits	O
,	O
BUN	B-test
and	O
creatinine	B-test
of	O
13	O
and	O
0.8	O
,	O
amylase	B-test
of	O
56	O
.	O

The	O
patient	O
had	O
an	B-test
electrocardiogram	I-test
which	O
showed	O
no	O
acute	B-problem
ischemic	I-problem
change	I-problem
.	O

His	B-test
chest	I-test
X-ray	I-test
ruled	O
out	O
acute	B-problem
cardiopulmonary	I-problem
process	I-problem
.	O

Left	B-problem
foot	I-problem
changes	I-problem
consistent	O
with	O
osteomyelitis	B-problem
of	I-problem
the	I-problem
left	I-problem
great	I-problem
toe	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
intravenous	B-treatment
antibiotics	I-treatment
and	O
a	O
question	O
of	O
evaluation	B-test
of	I-test
circulation	I-test
to	O
the	O
left	O
great	O
toe	O
and	O
also	O
possible	O
debridement	B-treatment
and	O
possibly	O
a	B-treatment
toe	I-treatment
amputation	I-treatment
.	O

The	O
patient	O
had	O
the	O
following	O
radiological	O
studies	O
:	O

08-27-92	O
,	O
left	B-test
foot	I-test
film	I-test
,	O
correlation	O
,	O
patient	O
consistent	O
with	O
osteomyelitis	B-problem
involving	I-problem
the	I-problem
first	I-problem
digit	I-problem
and	O
possibly	O
the	O
second	O
digit	O
of	O
the	O
left	O
foot	O
.	O

The	B-test
chest	I-test
X-ray	I-test
reveals	O
no	O
evidence	O
of	O
acute	B-problem
disease	I-problem
.	O

The	O
patient	O
had	O
lower	B-test
extremity	I-test
arterial	I-test
non-invasive	I-test
study	I-test
which	O
showed	O
good	O
arterial	O
hemodynamics	O
of	O
the	O
left	O
lower	O
extremity	O
,	O
perfusion	O
to	O
the	O
TM	O
level	O
,	O
but	O
there	O
was	O
evidence	O
of	O
diabetic	B-problem
small	I-problem
vessel	I-problem
disease	I-problem
and	O
spasm	B-problem
of	I-problem
his	I-problem
digits	I-problem
.	O

The	O
arterial	O
circulation	O
is	O
adequate	O
for	O
healing	O
of	O
his	B-problem
left	I-problem
great	I-problem
toe	I-problem
ulcer	I-problem
,	O
noncompressible	B-problem
left	I-problem
thigh	I-problem
and	I-problem
calf	I-problem
pressures	I-problem
highly	B-problem
calcified	I-problem
arterial	I-problem
system	I-problem
.	O

On	O
09-03-92	O
,	O
patient	O
underwent	O
a	B-treatment
left	I-treatment
great	I-treatment
toe	I-treatment
buttontoe	I-treatment
amputation	I-treatment
under	O
regional	B-treatment
ankle	I-treatment
block	I-treatment
for	O
chronic	B-problem
ulcer	I-problem
and	O
osteomyelitis	B-problem
of	I-problem
the	I-problem
left	I-problem
great	I-problem
toe	I-problem
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

There	O
were	O
no	O
complications	B-problem
during	O
the	B-treatment
procedure	I-treatment
.	O

There	O
was	O
a	B-treatment
small	I-treatment
Penrose	I-treatment
drain	I-treatment
postoperatively	O
that	O
was	O
placed	O
intraoperatively	O
and	O
discontinued	O
on	O
approximately	O
postoperative	O
day	O
number	O
three	O
.	O

The	O
patient	O
was	O
preoperatively	O
treated	O
with	O
about	O
a	O
seven	O
day	O
course	O
of	O
intravenous	B-treatment
Unasyn	I-treatment
and	O
postoperatively	O
treated	O
for	O
approximately	O
four	O
days	O
of	O
intravenous	B-treatment
Unasyn	I-treatment
.	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
on	O
postoperative	O
day	O
number	O
five	O
,	O
without	O
any	B-problem
complications	I-problem
.	O

The	B-problem
incision	I-problem
from	O
buttontoe	B-treatment
amputation	I-treatment
of	I-treatment
the	I-treatment
left	I-treatment
foot	I-treatment
healing	O
well	O
,	O
without	O
any	O
further	B-problem
complications	I-problem
.	O

FOLLOWUP	O
:	O

The	O
patient	O
is	O
to	O
follow	O
up	O
in	O
clinic	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Included	O
his	B-treatment
pre-admission	I-treatment
medications	I-treatment
.	O

A	O
HAS	O
,	O
M.D.	O

TR	O
:	O

yy	O
/	O
bmot	O

DD	O
:	O

10-21-92	O
PAD-WORD	O

TD	O
:	O

10/22/92	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2010-06-07	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-06-12	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1955-03-30	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
SURGERY	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
55	O
-	O
year-old	O
male	O
with	O
critical	B-problem
aortic	I-problem
stenosis	I-problem
who	O
was	O
referred	O
to	O
Dr.	O
Brenda	O
Hummer	O
for	O
discussion	O
for	O
surgical	B-treatment
options	I-treatment
to	O
free	O
this	B-problem
condition	I-problem
.	O

The	O
patient	O
reportedly	O
had	O
been	O
experiencing	O
increasing	B-problem
fatigue	I-problem
and	O
dyspnea	B-problem
with	O
exertion	O
for	O
the	O
year	O
prior	O
to	O
his	O
admission	O
.	O

The	O
patient	O
reported	O
increasingly	O
frequent	O
episodes	O
of	O
dizziness	B-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
accompanied	O
with	O
coughing	B-problem
spells	I-problem
after	O
walking	O
approximately	O
a	O
half	O
a	O
mile	O
or	O
climbing	O
three	O
flights	O
of	O
stairs	O
.	O

On	O
2010-05-27	O
,	O
an	B-test
echocardiogram	I-test
was	O
done	O
which	O
revealed	O
critical	B-problem
fibrocalcific	I-problem
aortic	I-problem
stenosis	I-problem
with	O
a	B-test
peak	I-test
gradient	I-test
of	O
125	O
mmHg	O
,	O
a	B-test
mean	I-test
gradient	I-test
of	O
74	O
mmHg	O
,	O
an	B-test
Oak	I-test
Bluffs	I-test
of	O
0.44	O
,	O
and	O
1+	B-problem
aortic	I-problem
and	I-problem
mitral	I-problem
insufficiency	I-problem
.	O

The	O
patient	O
subsequently	O
underwent	O
a	B-test
cardiac	I-test
catheterization	I-test
on	O
2010-06-01	O
,	O
which	O
demonstrated	O
no	O
hemodynamically	B-problem
significant	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
,	O
but	O
critical	B-problem
aortic	I-problem
stenosis	I-problem
consistent	O
with	O
his	B-test
echocardiogram	I-test
study	I-test
results	I-test
.	O

The	O
patient	O
was	O
subsequently	O
scheduled	O
for	O
a	B-treatment
mechanical	I-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
procedure	I-treatment
with	O
aortic	B-treatment
replacement	I-treatment
on	O
2010-06-07	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Diabetes	B-problem
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Seasonal	B-problem
allergies	I-problem
.	O

4.	O
Arthritis	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Negative	O
.	O

AT	O
-	O
HOME	O
MEDICATIONS	O
:	O

1.	O
Metformin	B-treatment
.	O

2.	O
Celexa	B-treatment
.	O

3.	O
Lipitor	B-treatment
.	O

4.	O
Aspirin	B-treatment
.	O

5.	O
Toprol	B-treatment
XL	I-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
penicillin	B-treatment
and	O
shell	O
fish	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
with	O
two	O
children	O
and	O
is	O
currently	O
unemployed	O
.	O

The	O
patient	O
denied	O
any	O
tobacco	O
or	O
alcohol	O
history	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
2010-06-07	O
,	O
the	O
patient	O
underwent	O
a	B-treatment
mechanical	I-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
with	O
a	B-treatment
23	I-treatment
mm	I-treatment
Carbomedics	I-treatment
mechanical	I-treatment
valve	I-treatment
and	O
a	B-treatment
Supra	I-treatment
coronary	I-treatment
aortic	I-treatment
graft	I-treatment
with	O
gelweave	B-treatment
28	O
mm	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
with	O
a	B-treatment
bypass	I-treatment
time	I-treatment
of	O
155	O
minutes	O
and	O
a	B-treatment
crossclamp	I-treatment
time	I-treatment
of	O

130	O
minutes	O
,	O
and	O
a	O
rest	O
time	O
of	O
16	O
minutes	O
.	O

The	O
patient	O
's	O
pericardium	O
was	O
left	O
open	O
;	O
lines	B-treatment
placed	O
included	O
a	B-treatment
right	I-treatment
radial	I-treatment
line	I-treatment
and	O
a	B-treatment
right	I-treatment
IJ	I-treatment
line	I-treatment
;	O
both	O
ventricular	B-treatment
and	I-treatment
atrial	I-treatment
wires	I-treatment
were	O
placed	O
;	O
two	B-treatment
mediastinal	I-treatment
tubes	I-treatment
were	O
placed	O
.	O

The	O
patient	O
was	O
subsequently	O
transferred	O
to	O
the	O
Cardiac	O
Surgery	O
Recovery	O
Unit	O
,	O
intubated	B-treatment
,	O
for	O
further	B-test
evaluation	I-test
and	O
management	O
.	O

On	O
transfer	O
,	O
the	B-test
patient	I-test
's	I-test
mean	I-test
arterial	I-test
pressure	I-test
was	O
76	O
,	O
CVP	B-test
12	O
,	O
PAD	B-test
17	O
,	O
and	O
his	B-test
Bennie	I-test
was	O
25	O
.	O

The	O
patient	O
was	O
AV	B-treatment
paced	I-treatment
at	O
a	O
rate	O
of	O
88	O
beats	O
per	O
minute	O
.	O

Active	B-treatment
drips	I-treatment
included	O
milrinone	B-treatment
,	O
Levophed	B-treatment
,	O
propofol	B-treatment
,	O
and	O
insulin	B-treatment
.	O

On	O
postoperative	O
day	O
number	O
one	O
,	O
the	O
patient	O
was	O
successfully	O
weaned	O
and	O
extubated	O
without	O
complication	B-problem
.	O

The	O
patient	O
was	O
then	O
advanced	O
to	O
oral	O
intake	O
which	O
he	O
tolerated	O
without	O
complication	B-problem
.	O

On	O
postoperative	O
day	O
number	O
two	O
,	O
the	B-treatment
patient	I-treatment
's	I-treatment
chest	I-treatment
tubes	I-treatment
were	O
removed	O
without	O
complication	B-problem
and	O
the	O
patient	O
was	O
subsequently	O
cleared	O
for	O
transfer	O
to	O
the	O
floor	O
.	O

The	O
patient	O
was	O
subsequently	O
admitted	O
to	O
the	O
cardiothoracic	O
service	O
under	O
the	O
direction	O
of	O
Dr.	O
Brenda	O
Hummer	O
.	O

Postoperatively	O
,	O
the	O
patient	O
's	O
clinical	O
course	O
was	O
largely	O
unremarkable	O
.	O

The	O
patient	O
was	O
evaluated	O
by	O
Physical	O
Therapy	O
,	O
who	O
declared	O
him	O
a	O
suitable	O
candidate	O
for	O
discharge	O
directly	O
to	O
home	O
following	O
resolution	O
of	O
his	B-treatment
medical	I-treatment
therapy	I-treatment
.	O

The	O
patient	O
was	O
advanced	O
to	O
a	O
full	O
regular	O
diet	O
,	O
which	O
he	O
tolerated	O
without	O
complication	B-problem
,	O
and	O
had	O
adequate	B-treatment
pain	I-treatment
control	I-treatment
provided	O
via	O
oral	B-treatment
pain	I-treatment
medications	I-treatment
.	O

The	O
patient	O
was	O
begun	O
on	O
anticoagulation	B-treatment
therapy	I-treatment
for	O
a	B-test
target	I-test
INR	I-test
of	O
2.5	O
.	O

On	O
the	O
evening	O
of	O
postoperative	O
day	O
number	O
four	O
,	O
the	O
patient	O
had	O
a	O
transient	O
episode	O
of	O
disorientation	B-problem
and	O
confusion	B-problem
which	O
subsequently	O
resolved	O
spontaneously	O
.	O

By	O
postoperative	O
day	O
number	O
five	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
afebrile	B-problem
and	O
stable	O
.	O

His	B-problem
incision	I-problem
was	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
no	O
evidence	O
of	O
cellulitis	B-problem
or	O
purulent	B-problem
drainage	I-problem
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
independently	O
ambulatory	O
and	O
was	O
productive	O
of	O
adequate	O
amounts	O
of	O
urine	O
.	O

The	O
patient	O
was	O
tolerant	O
of	O
a	O
full	O
regular	O
diet	O
and	O
had	O
his	B-problem
pain	I-problem
well	O
controlled	O
via	O
oral	B-treatment
pain	I-treatment
medications	I-treatment
.	O

The	B-test
patient	I-test
's	I-test
INR	I-test
was	O
noted	O
to	O
be	O
2.3	O
.	O

The	O
patient	O
was	O
subsequently	O
cleared	O
for	O
discharge	O
to	O
home	O
with	O
instructions	O
for	O
follow-up	O
on	O
postoperative	O
day	O
number	O
five	O
,	O
2010-06-12	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
with	O
instructions	O
for	O
follow-up	O
.	O

STATUS	O
AT	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lopressor	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O

2.	O
Lasix	B-treatment
20	O
mg	O
p.o.	O
q.	O
12	O
hours	O
times	O
seven	O
days	O
.	O

3.	O
Potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
p.o.	O
q.	O
12	O
hours	O
times	O
seven	O
days	O
.	O

4.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

5.	O
Metformin	B-treatment
500	O
mg	O
p.o.	O
b.i.d.	O

6.	O
Percocet	B-treatment
5/325	O
one	O
to	O
two	O
tablets	O
p.o.	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O

7.	O
Celexa	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

8.	O
Lipitor	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

9.	O
Warfarin	B-treatment
5	O
mg	O
p.o.	O
q.d.	O
times	O
four	O
days	O
,	O
after	O
which	O
point	O
the	O
patient	O
's	O
dosage	O
schedule	O
is	O
to	O
be	O
coordinated	O
by	O
his	O
PCP	O
,	O
Dr.	O
Jerold	O
Esqueda	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
is	O
to	O
maintain	O
his	B-problem
incisions	I-problem
clean	O
and	O
dry	O
at	O
all	O
times	O
.	O

The	O
patient	O
may	O
shower	O
but	O
should	O
pat	O
dry	O
incisions	B-problem
afterwards	O
;	O
no	O
bathing	O
or	O
swimming	O
until	O
further	O
notice	O
.	O

The	O
patient	O
may	O
resume	O
a	B-treatment
Heart	I-treatment
Healthy	I-treatment
Diet	I-treatment
.	O

The	O
patient	O
had	O
been	O
advised	O
to	O
limit	O
his	O
physical	O
exercise	O
;	O
no	O
heavy	O
exertion	O
.	O

No	O
driving	O
while	O
taking	O
prescription	B-treatment
pain	I-treatment
medications	I-treatment
.	O

The	O
patient	O
is	O
to	O
have	O
his	B-treatment
Coumadin	I-treatment
managed	O
by	O
his	O
primary	O
care	O
provider	O
,	O
Dr.	O
Jerold	O
Esqueda	O
,	O
for	O
a	B-test
target	I-test
INR	I-test
of	O
2.5	O
.	O

The	O
patient	O
is	O
to	O
report	O
to	O
Dr.	O
Jones	O
office	O
on	O
2010-06-14	O
for	O
an	B-test
initial	I-test
blood	I-test
draw	I-test
and	O
subsequent	B-treatment
Coumadin	I-treatment
titration	I-treatment
;	O
Coumadin	B-test
levels	I-test
are	O
to	O
be	O
monitored	O
per	O
his	O
PCP	O
David	O
.	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Leanne	O
Larimore	O
in	O
Cardiology	O
within	O
two	O
to	O
three	O
weeks	O
following	O
discharge	O
.	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Brenda	O
Hummer	O
four	O
weeks	O
following	O
discharge	O
.	O

The	O
patient	O
is	O
to	O
call	O
to	O
schedule	O
all	O
appointments	O
.	O

Tracy	O
X.	O
Carmen	O
,	O
M.D.	O

76-050	O
PAD-WORD	O

Dictated	O
By	O
:	O
Gerald	O
R.	O
Quiroz	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2010-06-12	O
02:00	O

T	O
:	O
2010-06-12	O
14:21	O

JOB	O
#:	O
47222	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Tiffany	O
D.	O
Picklesimer	O
on	O
:	O
WED	O
2010-07-28	O
4:41	O
PM	O

(	O
End	O
of	O
Report	O
)	O

405728860	O
PAD-WORD	O

FIH	O
PAD-WORD	O

7150860	O
PAD-WORD	O

05849/1xpu	O
PAD-WORD	O

994032	O
PAD-WORD	O

1/3/1994	O
12:00:00	O
AM	O

MEDIASTINAL	B-problem
TUMOR	I-problem
MASS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

1-3-94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

1-9-94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Mediastinal	B-problem
tumor	I-problem
mass	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

History	O
of	O
colon	B-problem
cancer	I-problem
,	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
obesity	B-problem
,	O
hypertension	B-problem
,	O
history	O
of	O
myocardial	B-problem
infarction	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

January	O
3	O
,	O
1994	O
,	O
median	B-test
sternotomy	I-test
with	O
mediastinal	B-test
exploration	I-test
,	O
radical	B-treatment
resection	I-treatment
of	O
tumor	B-problem
and	O
aortopulmonary	B-problem
window	I-problem
;	O
partial	B-treatment
resection	I-treatment
of	I-treatment
adjacent	I-treatment
lung	I-treatment
,	O
en	B-treatment
bloc	I-treatment
resection	I-treatment
of	I-treatment
vagus	I-treatment
and	I-treatment
phrenic	I-treatment
nerves	I-treatment
;	O
partial	B-treatment
pericardectomy	I-treatment
;	O
fiberoptic	B-test
bronchoscopy	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
66	O
year	O
old	O
white	O
female	O
with	O
metastatic	B-problem
colon	I-problem
carcinoma	I-problem
with	O
a	B-problem
mass	I-problem
in	I-problem
the	I-problem
left	I-problem
superhilar	I-problem
region	I-problem
,	O
who	O
presents	O
for	O
bronchoscopy	B-test
,	O
mediastinal	B-test
exploration	I-test
and	O
resection	B-treatment
.	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
she	O
experienced	O
the	O
onset	O
of	O
abdominal	B-problem
pain	I-problem
in	O
early	O
1992	O
.	O

In	O
December	O
of	O
1992	O
,	O
she	O
underwent	O
a	B-treatment
transverse	I-treatment
colectomy	I-treatment
for	O
colon	B-problem
carcinoma	I-problem
which	O
was	O
Duke	B-problem
&apos;s	I-problem
grade	I-problem
B-II	I-problem
,	O
lymph	O
nodes	O
were	O
negative	O
.	O

She	O
received	O
postoperative	B-treatment
chemotherapy	I-treatment
.	O

In	O
September	O
of	O
1992	O
,	O
she	O
underwent	O
an	B-test
exploratory	I-test
laparotomy	I-test
because	O
of	O
an	B-problem
increased	I-problem
level	I-problem
of	I-problem
CEA	I-problem
in	O
her	B-test
blood	I-test
with	O
the	O
presence	O
of	O
a	B-problem
liver	I-problem
abnormality	I-problem
on	O
computerized	B-test
tomography	I-test
scan	I-test
.	O

The	B-test
exploratory	I-test
laparotomy	I-test
was	O
negative	O
.	O

She	O
continued	O
to	O
have	O
a	B-problem
rise	I-problem
in	O
her	B-test
CEA	I-test
level	I-test
which	O
prompted	O
a	B-test
further	I-test
work	I-test
up	I-test
.	O

In	O
September	O
of	O
1993	O
,	O
an	B-test
abdominal	I-test
and	I-test
pelvic	I-test
computerized	I-test
tomography	I-test
scan	I-test
was	O
negative	O
and	O
in	O
June	O
of	O
1993	O
,	O
she	O
had	O
a	B-test
negative	I-test
bone	I-test
scan	I-test
.	O

In	O
December	O
of	O
1994	O
,	O
a	B-test
thoracic	I-test
computerized	I-test
tomography	I-test
scan	I-test
showed	O
a	B-problem
four	I-problem
centimeter	I-problem
soft	I-problem
tissue	I-problem
mass	I-problem
on	I-problem
the	I-problem
left	I-problem
suprahilar	I-problem
region	I-problem
,	O
adjacent	O
to	O
the	B-problem
aortopulmonary	I-problem
window	I-problem
.	O

She	O
also	O
experienced	O
increased	B-problem
hoarseness	I-problem
over	O
the	O
preceding	O
months	O
,	O
which	O
was	O
due	O
to	O
left	B-problem
vocal	I-problem
cord	I-problem
paralysis	I-problem
.	O

She	O
also	O
complains	O
of	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
for	O
the	O
preceding	O
month	O
and	O
now	O
presents	O
for	O
mediastinal	B-test
exploration	I-test
and	O
resection	B-treatment
of	O
her	O
probable	O
metastatic	B-problem
mass	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
hypertension	B-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
previous	B-problem
myocardial	I-problem
infarction	I-problem
in	O
1983	O
,	O
hypothyroidism	B-problem
,	O
history	O
of	O
breast	B-problem
cancer	I-problem
and	O
history	O
of	O
colon	B-problem
cancer	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

The	O
past	O
surgical	O
history	O
is	O
notable	O
for	O
a	O
1971	O
mastectomy	B-treatment
on	I-treatment
the	I-treatment
right	I-treatment
,	O
1937	O
appendectomy	B-treatment
,	O
1991	O
cholecystectomy	B-treatment
,	O
1992	O
transverse	B-treatment
colectomy	I-treatment
,	O
1992	O
exploratory	B-test
laparotomy	I-test
,	O
1991	O
bilateral	B-treatment
cataract	I-treatment
surgery	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Levoxine	B-treatment
0.125	O
mg	O
PO	O
q.day	O
,	O
Vasotec	B-treatment
10	O
mg	O
PO	O
b.i.d.	O
,	O
Maxzide	B-treatment
75/50	O
,	O
30	O
mg	O
PO	O
q.day	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
sulfa	B-treatment
.	O

HABITS	O
:	O

50	O
pack	O
year	O
smoking	O
history	O
,	O
still	O
smoking	O
currently	O
.	O

Ethanol	O
:	O

none	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
she	O
is	O
an	O
obese	O
white	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
with	O
a	B-problem
hoarse	I-problem
voice	I-problem
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
shows	O
that	O
she	O
is	O
normocephalic	O
,	O
atraumatic	B-problem
,	O
extra	O
ocular	O
movements	O
are	O
intact	O
,	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
and	O
the	O
oropharynx	O
was	O
clear	O
,	O
neck	O
was	O
supple	O
without	O
lymphadenopathy	B-problem
,	O
either	O
axillary	O
or	O
supraclavicular	O
.	O

Chest	O
is	O
clear	O
with	O
decreased	B-problem
breath	I-problem
sounds	I-problem
at	I-problem
the	I-problem
left	I-problem
base	I-problem
.	O

She	O
has	O
a	B-treatment
previous	I-treatment
right	I-treatment
mastectomy	I-treatment
.	O

Cardiovascular	O
exam	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
without	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
.	O

Abdomen	O
:	O

obese	B-problem
with	O
multiple	B-problem
well	I-problem
healed	I-problem
surgical	I-problem
incisions	I-problem
,	O
positive	O
bowel	O
sounds	O
.	O

The	B-test
rectal	I-test
examination	I-test
is	O
guaiac	B-test
negative	O
without	O
masses	B-problem
.	O

Extremities	O
:	O

no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

The	B-test
neurological	I-test
examination	I-test
is	O
nonfocal	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
January	O
3	O
,	O
1994	O
where	O
she	O
underwent	O
a	B-treatment
median	I-treatment
sternotomy	I-treatment
with	O
removal	B-treatment
of	O
her	B-problem
mediastinal	I-problem
mass	I-problem
.	O

This	B-problem
mass	I-problem
was	O
situated	O
in	O
the	B-problem
aortopulmonary	I-problem
window	I-problem
and	O
was	O
sent	O
to	O
pathology	O
.	O

The	B-test
frozen	I-test
section	I-test
analysis	I-test
revealed	O
this	O
to	O
be	O
adenocarcinoma	B-problem
,	O
metastatic	B-problem
disease	I-problem
from	I-problem
the	I-problem
colon	I-problem
most	O
likely	O
.	O

She	O
had	O
a	B-treatment
chest	I-treatment
tube	I-treatment
placed	O
intraoperatively	O
and	O
another	O
placed	O
postoperatively	O
in	O
the	O
recovery	O
room	O
,	O
for	O
what	O
was	O
presumed	O
to	O
be	O
a	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

This	B-treatment
tube	I-treatment
drained	O
only	O
a	O
small	O
amount	O
of	O
fluid	O
and	O
it	O
was	O
likely	O
that	O
the	B-problem
effusion	I-problem
was	O
made	O
to	O
look	O
more	O
severe	O
in	O
the	O
presence	O
of	O
left	B-problem
hemidiaphragm	I-problem
elevation	I-problem
.	O

This	B-treatment
additional	I-treatment
chest	I-treatment
tube	I-treatment
was	O
removed	O
the	O
following	O
day	O
.	O

Her	B-test
postoperative	I-test
hematocrit	I-test
was	O
31	O
,	O
compared	O
to	O
a	B-test
preoperative	I-test
level	I-test
of	O
43	O
.	O

Her	O
postoperative	O
recovery	O
was	O
really	O
quite	O
remarkable	O
.	O

Mediastinal	B-treatment
chest	I-treatment
tube	I-treatment
was	O
removed	O
on	O
postoperative	O
day	O
three	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
on	O
postoperative	O
day	O
six	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

Percocet	B-treatment
for	O
pain	B-problem
.	O

Follow	O
up	O
with	O
Dr.	O
Fede	O
Duhenile	O
.	O

She	O
will	O
have	O
a	O
home	O
health	O
aide	O
to	O
visit	O
and	O
help	O
her	O
with	O
meals	O
.	O

CA	O
SHUFF	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

FEDE	O
LEVEL	O
,	O
M.D.	O

TR	O
:	O

kw	O
/	O
bmot	O

DD	O
:	O

1-9-94	O
PAD-WORD	O

TD	O
:	O

01/10/94	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2016-02-14	O
PAD-WORD	O

Discharge	O
Date	O
:	O

Date	O
of	O
Birth	O
:	O

1952-03-27	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

ADMISSION	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

2.	O
Status	O
post	O
off	B-treatment
pump	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
three	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
63	O
year	O
old	O
gentleman	O
who	O
had	O
initially	O
presented	O
with	O
exertional	B-problem
chest	I-problem
pressure	I-problem
several	O
weeks	O
prior	O
to	O
this	O
admission	O
that	O
would	O
resolve	O
with	O
rest	O
.	O

Stress	B-test
echocardiogram	I-test
demonstrated	O
an	B-test
ejection	I-test
fraction	I-test
of	O
40%	O
,	O
hypokinesis	B-problem
of	I-problem
distal	I-problem
anterior	I-problem
wall	I-problem
,	O
akinesis	B-problem
of	I-problem
distal	I-problem
inferior	I-problem
wall	I-problem
and	I-problem
apex	I-problem
.	O

The	O
patient	O
had	O
a	B-test
cardiac	I-test
catheterization	I-test
which	O
revealed	O
three	B-problem
vessel	I-problem
disease	I-problem
and	O
the	O
patient	O
now	O
presents	O
for	O
elective	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
.	O

2.	O
Hypercholesterolemia	B-problem
.	O

3.	O
Diabetes	B-problem
mellitus	I-problem
.	O

4.	O
End	B-problem
stage	I-problem
renal	I-problem
disease	I-problem
.	O

5.	O
Status	O
post	O
cadaveric	B-treatment
kidney	I-treatment
transplant	I-treatment
in	O
2012-09-21	O
.	O

6.	O
Chronic	B-problem
allograft	I-problem
nephropathy	I-problem
.	O

7.	O
Chronic	B-problem
anemia	I-problem
.	O

8.	O
History	O
of	O
upper	B-problem
gastrointestinal	I-problem
bleed	I-problem
.	O

9.	O
Depression	B-problem
.	O

10.	O
Gout	B-problem
.	O

11.	O
Question	O
of	O
transient	B-problem
ischemic	I-problem
attack	I-problem
.	O

12.	O
Status	O
post	O
left	B-treatment
AV	I-treatment
fistula	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
once	O
daily	O
.	O

2.	O
Neoral	B-treatment
25	O
mg	O
three	O
times	O
a	O
day	O
.	O

3.	O
Diltiazem	B-treatment
240	O
mg	O
once	O
daily	O
.	O

4.	O
Allopurinol	B-treatment
100	O
mg	O
p.o.	O
once	O
daily	O
.	O

5.	O
Hydralazine	B-treatment
100	O
mg	O
twice	O
a	O
day	O
.	O

6.	O
Enalapril	B-treatment
10	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

7.	O
Avandia	B-treatment
4	O
mg	O
once	O
daily	O
.	O

8.	O
Lipitor	B-treatment
10	O
mg	O
once	O
daily	O
.	O

9.	O
Bactrim	B-treatment
double	I-treatment
strength	I-treatment
once	O
daily	O
.	O

10.	O
Hydrochlorothiazide	B-treatment
25	O
mg	O
once	O
daily	O
.	O

11.	O
Toprol	B-treatment
XL	I-treatment
25	O
mg	O
once	O
daily	O
.	O

12.	O
Prednisone	B-treatment
5	O
mg	O
once	O
daily	O
.	O

LABORATORY	O
DATA	O
:	O

Preoperative	O
laboratory	O
values	O
showed	O
white	B-test
blood	I-test
cell	I-test
count	I-test
6.8	O
,	O
hematocrit	B-test
33.3	O
,	O
platelet	B-test
count	I-test

283,000	O
.	O

INR	B-test
1.1	O
.	O

Chem7	B-test
showed	O
sodium	B-test
138	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
107	O
,	O
bicarbonate	B-test
20	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
49	O
,	O
creatinine	B-test
2.5	O
,	O
glucose	B-test
156	O
.	O

Calcium	B-test
9.2	O
,	O
magnesium	B-test
1.8	O
,	O
and	O
phosphorus	B-test
4.2	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
in	O
general	O
,	O
the	O
patient	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
comfortable	O
.	O

Vital	B-test
signs	I-test
showed	O
temperature	B-test
96.3	O
,	O
pulse	B-test
64	O
,	O
blood	B-test
pressure	I-test
170/70	O
,	O
respiratory	B-test
rate	I-test
20	O
,	O
oxygen	B-test
saturation	I-test
98%	O
in	O
room	O
air	O
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
is	O
normocephalic	O
and	O
atraumatic	B-problem
.	O

Extraocular	O
movements	O
are	O
intact	O
.	O

The	O
pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Anicteric	B-problem
.	O

Throat	O
is	O
clear	O
.	O

The	O
chest	O
is	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Neck	O
was	O
supple	O
with	O
no	O
lymphadenopathy	B-problem
.	O

Cardiovascular	O
shows	O
grade	B-problem
II/VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
,	O
regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
with	O
a	B-problem
small	I-problem
umbilical	I-problem
hernia	I-problem
.	O

Extremities	O
are	O
warm	O
,	O
noncyanotic	B-problem
and	O
nonedematous	B-problem
times	O
four	O
.	O

There	O
is	O
no	O
peripheral	B-problem
edema	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
initially	O
admitted	O
to	O
the	O
medical	O
service	O
for	O
optimization	O
prior	O
to	O
his	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

The	O
patient	O
was	O
given	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
on	O
the	O
day	O
prior	O
to	O
his	B-treatment
surgery	I-treatment
.	O

He	O
was	O
closely	O
followed	O
from	O
his	O
admission	O
through	O
to	O
his	O
discharge	O
by	O
the	O
renal	O
service	O
for	O
his	B-problem
transplant	I-problem
issues	I-problem
.	O

On	O
2016-02-15	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
and	O
had	O
an	B-treatment
off	I-treatment
pump	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
performed	O
with	O
the	B-treatment
left	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
obtuse	I-treatment
marginal	I-treatment
and	O
posterior	O
descending	O
artery	O
.	O

For	O
details	O
of	O
this	B-treatment
operation	I-treatment
,	O
please	O
see	O
the	O
previously	O
dictated	O
operative	O
note	O
.	O

Postoperatively	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
close	B-test
monitoring	I-test
.	O

On	O
the	O
evening	O
of	O
postoperative	O
day	O
number	O
zero	O
,	O
the	O
patient	O
had	O
decreased	B-problem
urine	I-problem
output	I-problem
and	O
was	O
placed	O
on	O
a	B-treatment
Lasix	I-treatment
drip	I-treatment
for	O
diuresis	B-treatment
.	O

The	O
patient	O
tolerated	O
this	O
well	O
.	O

The	O
renal	O
service	O
continued	O
to	O
follow	O
close	B-treatment
management	I-treatment
of	O
his	B-treatment
immunosuppression	I-treatment
.	O

On	O
postoperative	O
day	O
number	O
one	O
,	O
the	O
patient	O
was	O
extubated	O
and	O
awakened	O
from	O
sedation	B-treatment
.	O

He	O
did	O
well	O
on	O
this	O
and	O
his	B-treatment
Levophed	I-treatment
drip	I-treatment
was	O
weaned	O
to	O
off	O
as	O
tolerated	O
.	O

Over	O
the	O
course	O
of	O
his	O
Intensive	O
Care	O
Unit	O
stay	O
,	O
the	O
patient	O
received	O
six	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
for	O
a	B-problem
low	I-problem
hematocrit	I-problem
.	O

He	O
otherwise	O
had	O
a	O
fairly	O
uncomplicated	O
postoperative	O
course	O
.	O

On	O
postoperative	O
day	O
number	O
three	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
.	O

On	O
postoperative	O
day	O
number	O
four	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	B-problem
low	I-problem
platelet	I-problem
level	I-problem
of	O
43,000	O
.	O

Heparin	B-test
induced	I-test
thrombocytopenia	I-test
antibody	I-test
panel	I-test
was	O
sent	O
.	O

Other	O
than	O
this	O
,	O
the	O
patient	O
did	O
very	O
well	O
.	O

Chest	B-treatment
tubes	I-treatment
were	O
removed	O
when	O
output	B-test
was	O
low	O
.	O

Pacing	B-treatment
wires	I-treatment
were	O
removed	O
.	O

Physical	O
therapy	O
saw	O
the	O
patient	O
and	O
cleared	O
the	O
patient	O
for	O
discharge	O
.	O

Ultimately	O
,	O
the	O
patient	O
was	O
discharged	O
on	O
postoperative	O
day	O
number	O
six	O
tolerating	O
a	O
regular	O
diet	O
,	O
adequate	O
pain	B-treatment
control	I-treatment
on	O
p.o.	B-treatment
pain	I-treatment
medications	I-treatment
,	O
and	O
ambulating	O
well	O
with	O
clearance	O
of	O
physical	O
therapy	O
.	O

DISPOSITION	O
:	O

To	O
home	O
.	O

DIET	O
:	O

Cardiac	B-treatment
and	I-treatment
diabetic	I-treatment
diet	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
DISCHARGE	O
:	O

The	O
chest	O
is	O
clear	O
to	O
auscultation	B-test
bilaterally	O
without	O
sternal	B-problem
click	I-problem
or	O
discharge	B-problem
.	O

Cardiovascular	O
is	O
regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
is	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
are	O
warm	O
,	O
noncyanotic	B-problem
,	O
minimal	B-problem
peripheral	I-problem
edema	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Percocet	B-treatment
5/325	O
one	O
to	O
two	O
q4hours	O
p.r.n.	O

2.	O
Plavix	B-treatment
75	O
mg	O
once	O
daily	O
.	O

3.	O
Aspirin	B-treatment
325	O
mg	O
once	O
daily	O
.	O

4.	O
Bactrim	B-treatment
double	I-treatment
strength	I-treatment
one	O
tablet	O
once	O
daily	O
.	O

5.	O
Prednisone	B-treatment
5	O
mg	O
once	O
daily	O
.	O

6.	O
Lipitor	B-treatment
10	O
mg	O
once	O
daily	O
.	O

7.	O
Lopressor	B-treatment
25	O
mg	O
twice	O
a	O
day	O
.	O

8.	O
Hydralazine	B-treatment
75	O
mg	O
q6hours	O
.	O

9.	O
Cyclosporin	B-treatment
75	O
mg	O
twice	O
a	O
day	O
.	O

10.	O
Rosiglitazone	B-treatment
4	O
mg	O
once	O
daily	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Herrick	O
in	O
four	O
weeks	O
time	O
.	O

He	O
should	O
follow-up	O
with	O
his	O
cardiologist	O
in	O
one	O
to	O
two	O
weeks	O
for	O
optimization	O
of	O
his	B-treatment
medications	I-treatment
.	O

The	O
patient	O
should	O
return	O
or	O
contact	O
the	O
office	O
if	O
he	O
has	O
a	B-problem
fever	I-problem
,	O
sternal	B-problem
discharge	I-problem
or	O
other	B-problem
significant	I-problem
chest	I-problem
pain	I-problem
.	O

Ellen	O
Z	O
Neher	O
,	O
M.D.	O

65-969	O
PAD-WORD	O

Dictated	O
By	O
:	O
Ann	O
C	O
Vinson	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2016-02-21	O
11:42	O

T	O
:	O
2016-02-21	O
13:33	O

JOB	O
#:	O
94475	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Georgia	O
K.	O
Dover	O
on	O
:	O
FRI	O
2016-03-18	O
3:35	O
PM	O

(	O
End	O
of	O
Report	O
)	O

421179499	O
PAD-WORD	O

BH	O
PAD-WORD	O

0940729	O
PAD-WORD	O

770923	O
PAD-WORD	O

3/30/1997	O
12:00:00	O
AM	O

ASPIRATION	B-problem
PNEUMONIA	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

STRAPEFREIRE	O
,	O
VATALY	O
C	O

UNIT	O
NUMBER	O
:	O

972-02-46	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

03/30/97	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

04/01/97	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Aspiration	B-problem
pneumonia	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Dementia	B-problem
;	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

The	O
patient	O
was	O
a	O
108-year-old	O
nursing	O
home	O
resident	O
,	O
who	O
was	O
admitted	O
with	O
a	O
two-day	O
history	O
of	O
increased	B-problem
respiratory	I-problem
secretions	I-problem
and	O
a	O
24-hour	O
history	O
of	O
elevated	B-problem
fever	I-problem
.	O

Despite	O
Augmentin	B-treatment
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
delirium	I-problem
worsened	O
in	O
the	O
24	O
hours	O
prior	O
to	O
admission	O
,	O
and	O
her	B-test
temperature	I-test
was	O
up	O
to	O
102	O
.	O

She	O
was	O
refusing	O
to	O
take	O
p.o.&apos;s	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Recurrent	B-problem
urinary	I-problem
tract	I-problem
infections	I-problem
,	O
most	O
recently	O
on	O
2/23/97	O
;	O
recurrent	B-problem
aspiration	I-problem
pneumonias	I-problem
,	O
most	O
recently	O
on	O
2/21/97	O
;	O
multi-infarct	B-problem
dementia	I-problem
with	O
associated	B-problem
dysphasia	I-problem
;	O
mitral	B-problem
regurgitation	I-problem
;	O
history	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
;	O
pernicious	B-problem
anemia	I-problem
;	O
chronic	B-problem
venous	I-problem
stasis	I-problem
;	O
status	O
post	O
left	B-problem
femoral	I-problem
neck	I-problem
fracture	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Augmentin	B-treatment
500	O
mg	O
t.i.d.	O

Senokot	B-treatment
one	O
q.h.s.	O

Sertraline	B-treatment
75	O
mg	O
q.day	O
.	O

Aspirin	B-treatment
81	O
mg	O
q.day	O
.	O

Vitamin	B-treatment
B12	I-treatment
100	O
mcg	O
IM	O
q.month	O
.	O

Urecholine	B-treatment
25	O
mg	O
t.i.d.	O
Colace	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
resides	O
in	O
the	O
Pcaer,ter	O
Medical	O
Center	O
,	O
is	O
nonambulatory	B-problem
,	O
and	O
her	O
code	O
status	O
is	O
do	O
not	O
resuscitate	O
/	O
do	O
not	O
intubate	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
nonverbal	B-problem
,	O
but	O
was	O
able	O
to	O
open	O
her	O
eyes	O
and	O
nod	O
.	O

No	O
respiratory	B-problem
distress	I-problem
.	O

Her	B-test
temperature	I-test
was	O
102.2	O
;	O
blood	B-test
pressure	I-test
135/64	O
;	O
pulse	B-test
rate	I-test
108	O
;	O
respirations	B-test
24	O
;	O
oxygen	B-test
saturations	I-test
on	I-test
room	I-test
air	I-test
94%	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
revealed	O
no	O
ocular	B-problem
abnormalities	I-problem
.	O

Neck	O
-	O
no	O
lymphadenopathy	B-problem
;	O
no	O
carotid	B-problem
bruits	I-problem
;	O
jugular	B-test
venous	I-test
pressure	I-test
not	O
elevated	B-problem
;	O
no	O
goiter	B-problem
.	O

Chest	O
-	O
reduced	B-problem
breath	I-problem
sounds	I-problem
at	I-problem
the	I-problem
bases	I-problem
with	O
faint	B-problem
inspiratory	I-problem
rhonchi	I-problem
anteriorly	I-problem
.	O

Cardiac	O
-	O
regular	O
rate	O
and	O
rhythm	O
with	O
frequent	B-problem
premature	I-problem
beats	I-problem
and	O
a	B-problem
2/6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
at	I-problem
the	I-problem
apex	I-problem
.	O

The	O
abdomen	O
was	O
non-tender	B-problem
,	O
nondistended	B-problem
,	O
no	O
hepatomegaly	B-problem
,	O
normal	O
bowel	O
sounds	O
.	O

Extremities	O
-	O
1+	B-problem
edema	I-problem
;	O
2+	B-test
pulses	I-test
.	O

Skin	O
-	O
intact	O
with	O
diaper	B-treatment
.	O

LABORATORY	O
DATA	O
:	O

The	B-test
sodium	I-test
was	O
142	O
;	O
potassium	B-test
4.5	O
;	O
chloride	B-test
105	O
;	O
bicarbonate	B-test
27	O
;	O
BUN	B-test
and	O
creatinine	B-test
31	O
and	O
1.3	O
;	O
glucose	B-test
107	O
;	O
total	B-test
protein	I-test
7.7	O
;	O
albumin	B-test
3.2	O
;	O
globulin	B-test
4.5	O
;	O
uric	B-test
acid	I-test
4.2	O
;	O
alkaline	B-test
phosphatase	I-test
114	O
;	O
serum	B-test
glutamic	I-test
oxaloacetic	I-test
transaminase	I-test
46	O
;	O
lactic	B-test
acid	I-test
dehydrogenase	I-test
370	O
;	O
white	B-test
blood	I-test
count	I-test
11,000	O
with	O
83	O
polymorphonuclear	B-test
leukocytes	I-test
;	O
hematocrit	B-test
42	O
;	O
platelet	B-test
count	I-test
227,000	O
.	O

A	B-test
chest	I-test
x-ray	I-test
showed	O
consolidation	B-problem
bilateral	I-problem
lyin	I-problem
the	I-problem
lower	I-problem
lobes	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
treatment	B-treatment
of	O
a	O
presumed	O
aspiration	B-problem
pneumonia	I-problem
and	O
for	O
rehydration	B-treatment
.	O

She	O
was	O
started	O
on	O
Clindamycin	B-treatment
and	O
Ofloxacin	B-treatment
at	O
renal	O
dose	O
to	O
cover	O
the	B-problem
aspiration	I-problem
pneumonia	I-problem
and	O
positive	B-problem
urine	I-problem
culture	I-problem
,	O
which	O
subsequently	O
came	O
back	O
.	O

She	O
had	O
some	B-problem
wheezing	I-problem
,	O
which	O
responded	O
well	O
to	O
Albuterol	B-treatment
nebulizers	I-treatment
.	O

She	O
was	O
generally	O
doing	O
well	O
with	O
resolution	O
of	O
her	B-test
temperature	I-test
until	O
4/1/97	O
at	O
9:20	O
P.M.	O
,	O
when	O
she	O
was	O
noted	O
to	O
be	O
unresponsive	B-problem
with	O
fixed	B-problem
dilated	I-problem
pupils	I-problem
.	O

She	O
was	O
certified	O
dead	O
at	O
9:20	O
P.M.	O

MI	O
CUCHSLI	O
,	O
M.D.	O

TR	O
:	O

vgo	O
PAD-WORD	O

DD	O
:	O

05/11/97	O
PAD-WORD	O

TD	O
:	O

05/15/97	O
8:26	O

Acc	O
:	O

MI	O
CUCHSLI	O
,	O
M.D.	O

cc	O
:	O

Nursing	O
Director	O
Pcaer,ter	O
Medical	O
Center	O
Sco	O
,	O
Ohio	O

Admission	O
Date	O
:	O

2018-05-26	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2018-06-13	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1966-02-20	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Collette	O
C.	O
Higa	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Altered	B-problem
Mental	I-problem
Status	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubatation	B-treatment
PAD-WORD	O

Central	B-treatment
line	I-treatment
placement	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

52	O
y.o.	O
male	O
with	O
ESLD	B-problem
due	O
to	O
HCV	B-problem
/	O
EtOH	B-problem
Cirrhosis	I-problem
now	O
with	O
delta	B-problem
MS	I-problem
.	O

Recently	O
d/c	O
'd	O
on	O
05-15	O
after	O
admission	O
for	O
hepatic	B-problem
encephalopathy	I-problem
versus	O
opiate	B-problem
abuse	I-problem
.	O

Brought	O
in	O
by	O
family	O
for	O
ams	B-problem
.	O

No	O
hx	O
available	O
at	O
Youville	O
Hospital	O
Katherine	O
,	O
except	O
for	O
abdominal	B-problem
pain	I-problem
.	O

Increasing	B-problem
tachypnea	I-problem
and	O
tachycardia	B-problem
in	O
Leola	O
,	O
cxr	B-test
with	O
likely	O
aspiration	B-problem
pna	I-problem
versus	O
chf	B-problem
,	O
intubated	B-treatment
.	O

Started	O
on	O
levo	B-treatment
/	O
flagyl	B-treatment
/	O
ceftriaxone	B-treatment
and	O
lasix	B-treatment
for	O
sbp	B-problem
and	O
questionable	O
meningitis	B-problem
.	O

Past	O
Medical	O
History	O
:	O

1.	O
HCV/ETOH	B-problem
Cirrhosis	I-problem

2.	O
H/O	O
SBP	B-problem

3.	O
Esoph	B-problem
Varices	I-problem
(	I-problem
Grade	I-problem
I	I-problem
)	I-problem

4.	O
Depression	B-problem

5.	O
H/O	O
IVDU	O
(	O
Heroin	O
)	O

6.	O
Recurrent	B-problem
ARF	I-problem

7.	O
H/O	O
Seizure	B-problem

8.	O
Chronic	B-problem
LBP	I-problem

9.	O
Anemia	B-problem

Social	O
History	O
:	O

The	O
patient	O
lives	O
with	O
his	O
two	O
sons	O
.	O

Charles	O
quit	O
using	O
Cocaine	O
,	O
ETOH	O
,	O
and	O
IV	O
Heroin	O
two	O
years	O
ago	O
,	O
and	O
his	O
son	O
is	O
unaware	O
of	O
any	O
relapses	O
.	O

He	O
currently	O
smokes	O
,	O
about	O
1	O
ppd	O
.	O

Family	O
History	O
:	O

His	O
father	O
had	O
Hemochromatosis	B-problem
and	O
DMII	B-problem
.	O

Physical	O
Exam	O
:	O

101.8	O
,	O
100	O
,	O
144/92	O
,	O
18	O
,	O
98%	O
3lnc	O
lying	O
in	O
bed	O
,	O
oriented	O
hospital	O
only	O
scleral	B-problem
icterus	I-problem
tachy	B-problem
but	O
reg	B-problem
diffusely	I-problem
ttp	I-problem
and	O
guaiac	B-test
negative	O
non-pitting	B-problem
brawny	I-problem
edema	I-problem
with	O
lichenification	B-problem

Pertinent	O
Results	O
:	O
wbc	B-test
6.7	O
46%	O
pmn	O
40%	O
bands	B-test
,	O
na	B-test
128	O
tbili	B-test
9.1	O
,	O
alb	B-test
2.3	O
,	O
inr	B-test
2.1	O
,	O
lactate	B-test
4.4	O
ecg	B-test
unremarkable	O

1st	B-test
cxr	I-test
normal	O
;	O
2nd	O
prior	O
to	O
intubation	B-treatment
?	O
rll	B-problem
opacity	I-problem
(	O
mild	B-problem
chf	I-problem
?	O
)	O
ascites	B-problem
:	O

2900	B-test
wbc	I-test
98%	O
pmn	O
,	O
suspcious	O
for	O
intra	B-problem
/	I-problem
extracellular	I-problem
bact	I-problem

Brief	O
Hospital	O
Course	O
:	O

SBP	B-problem
:	O

Pt	O
admitted	O
with	O
E	B-problem
coli	I-problem
SPB	I-problem
and	O
bacteremia	B-problem
.	O

Was	O
treated	O
with	O
ceftriaxone	B-treatment
2	O
gm	O
IV	O
daily	O
with	O
multiple	B-treatment
repeat	I-treatment
paracenteses	I-treatment
.	O

Repeat	B-test
taps	I-test
did	O
not	O
revealed	O
evidence	O
of	O
infection	B-problem
.	O

Patient	O
was	O
treated	O
with	O
14	O
days	O
of	O
levoflox	B-treatment
.	O

Resp	B-problem
failure	I-problem
:	O

Unclear	O
etiology	O
,	O
but	O
likely	O
aspiration	B-problem
event	I-problem
in	O
Monica	O
.	O

Treated	O
aspiration	B-problem
pneumonia	I-problem
.	O

Weaning	O
and	O
potential	B-treatment
extubation	I-treatment
complicated	O
by	O
mechanical	B-problem
disadvantage	I-problem
from	O
large	B-problem
ascites	I-problem
as	O
well	O
as	O
continued	B-problem
somnolence	I-problem
(	O
off	O
sedation	B-treatment
).	O

we	O
Performed	O
frequent	B-treatment
large	I-treatment
vol	I-treatment
taps	I-treatment
and	O
attempted	O
to	O
give	O
diuretics	B-treatment
,	O
but	O
were	O
limited	O
by	O
renal	B-problem
failure	I-problem
.	O

The	B-problem
ascites	I-problem
quickly	O
accumulated	O
after	O
each	B-treatment
tap	I-treatment
.	O

Patient	O
was	O
not	O
a	O
TIPS	O
candidate	O
.	O

Cirrhosis	B-problem
:	O

End-stage	B-problem
cirrhosis	I-problem
with	O
refractory	B-problem
ascites	I-problem
.	O

Each	O
time	O
we	O
have	O
initiated	O
diuretics	B-treatment
,	O
creatinine	B-test
rose	O
.	O

Patient	O
was	O
continued	O
on	O
nadolol	B-treatment
(	O
as	O
bp	B-test
tolerated	O
)	O
and	O
lactulose	B-treatment
)	O

Renal	B-problem
failure	I-problem
:	O

Creatinine	B-problem
elevation	I-problem
appears	O
to	O
be	O
related	O
to	O
both	O
elevated	B-problem
abdominal	I-problem
pressures	I-problem
from	O
ascites	B-problem
as	O
well	O
as	O
to	O
attempts	O
at	O
diuresis	B-treatment
.	O

AMS	B-problem
:	O

Likely	O
hepatic	B-problem
encepholopathy	I-problem
initially	O
,	O
and	O
later	O
likely	O
related	O
to	O
sedation	B-treatment
and	O
delayed	B-problem
clearance	I-problem
from	O
liver	B-problem
disease	I-problem
.	O

Patient	O
became	O
increasingly	O
hypotensive	B-problem
with	O
a	B-problem
rising	I-problem
cr	I-problem
,	O
eventually	O
becoming	O
pressor	B-problem
dependent	I-problem
.	O

Family	O
meeting	O
was	O
held	O
to	O
discuss	O
grave	O
prognosis	O
,	O
and	O
patient	O
was	O
made	O
cmo	B-treatment
.	O

He	O
passed	O
away	O
shortly	O
thereafter	O
.	O

Medications	O
on	O
Admission	O
:	O
patient	O
passed	O
away	O

Discharge	O
Medications	O
:	O
patient	O
passed	O
away	O

Discharge	O
Disposition	O
:	O

Expired	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O
patient	O
passed	O
away	O

Discharge	O
Condition	O
:	O
patient	O
passed	O
away	O

Discharge	O
Instructions	O
:	O
patient	O
passed	O
away	O

Followup	O
Instructions	O
:	O
patient	O
passed	O
away	O

Efrain	O
Zavala	O
MD	O
02-024	O

Completed	O
by	O
:	O
Marcel	O
L	O
Beatty	O
,	O
M.D.	O

435216075	O
YC	O

93004953	O
PAD-WORD	O

1966777	O
PAD-WORD	O

5/26/2005	O
12:00:00	O
AM	O

Atypical	B-problem
chest	I-problem
pain	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

05/26/2005	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

05/27/2005	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

CHEAMPBUR	O
,	O
STEENRA	O
R.	O

789-41-40-5	O
N56	O

Room	O
:	O

0W-320	O
PAD-WORD	O

Service	O
:	O

CAR	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

05/27/05	O
AT	O
05:30	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

SEISE	O
,	O
JR	O
,	O
EJAKE	O
L.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

ECASA	B-treatment
(	I-treatment
ASPIRIN	I-treatment
ENTERIC	I-treatment
COATED	I-treatment
)	I-treatment
81	O
MG	O
PO	O
QD	O
LEVOXYL	B-treatment
(	I-treatment
LEVOTHYROXINE	I-treatment
SODIUM	I-treatment
)	I-treatment
25	O
MCG	O
PO	O
QD	O
SYNAREL	B-treatment
(	I-treatment
NAFARELIN	I-treatment
ACETATE	I-treatment
)	I-treatment
1	O
PUFF	O
NA	O
BID	O
NITROGLYCERIN	B-treatment
1/150	O
(	O
0.4	O
MG	O
)	O
1	O
TAB	O
SL	O
Q5MIN	O
X	O
3	O
doses	O
PRN	O
Chest	B-problem
Pain	I-problem
MULTIVITAMIN	B-treatment
THERAPEUTIC	I-treatment
(	I-treatment
THERAPEUTIC	I-treatment
MULTIVI	I-treatment
...	I-treatment
)	I-treatment
1	O
TAB	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
05/26/05	O
by	O
SAGELYSS	O
,	O
TYTUMZE	O
V.	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

SIMVASTATIN	B-treatment
and	O
NIACIN	B-treatment
,	O
VIT	O
.	O

B-3	O
Reason	O
for	O
override	O
:	O

ok	O
TOPROL	B-treatment
XL	I-treatment
(	I-treatment
METOPROLOL	I-treatment
(	I-treatment
SUST.	I-treatment
REL.	I-treatment
)	I-treatment
)	O
200	O
MG	O
PO	O
QD	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

8	O
PLAVIX	B-treatment
(	I-treatment
CLOPIDOGREL	I-treatment
)	I-treatment
75	O
MG	O
PO	O
QD	O
LIPITOR	B-treatment
(	I-treatment
ATORVASTATIN	I-treatment
)	I-treatment
40	O
MG	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
05/27/05	O
by	O
:	O

POTENTIALLY	O
SERIOUS	B-problem
INTERACTION	I-problem
:	O

NIACIN	B-treatment
,	O
VIT	O
.	O

B-3	O
and	O
ATORVASTATIN	B-treatment
CALCIUM	I-treatment

Reason	O
for	O
override	O
:	O

ok	O
PAD-WORD	O

DIET	O
:	O

House	O
/	O
Low	O
saturated	O
fat	O
low	O
cholesterol	O
&lt;	O
FDI	O
&gt;	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Follow	O
up	O
with	O
your	O
PCP	O
within	O
2	O
wks	O
,	O

ALLERGY	O
:	O

Morphine	B-treatment
,	O

LEUPROLIDE	B-treatment
ADMIT	O
DIAGNOSIS	O
:	O

Chest	B-problem
Pain	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Atypical	B-problem
chest	I-problem
pain	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

s	O
/	O
p	O
inferior	B-problem
STEMI	I-problem
(	O
2/17	O
)	O
with	O
stent	B-treatment
to	I-treatment
RCA	I-treatment
;	O
TTE	B-test
(	O
2/17	O
)	O
-	O
LVEF	B-test
55-60%	O
,	O
inferobasal	B-problem
HK	I-problem
;	O
cervical	B-problem
spinal	I-problem
stenosis	I-problem
;	O
hypothyroidism	B-problem
;	O
GERD	B-problem
;	O
endometriosis	B-problem
s	O
/	O
p	O
laparotomy	B-test
and	O
L	B-treatment
oophorectomy	I-treatment
.	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

none	O
PAD-WORD	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

ETT	B-test
-	O
MIBI	B-test
5/27/05	O
-	O
normal	O
,	O
no	O
e	O
/	O
o	O
ischemia	B-problem
.	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

45	O
yo	O
F	O
s	O
/	O
p	O
recent	B-problem
inferior	I-problem
STEMI	I-problem
(	O
2/17	O
)	O
w/	O
100%	O
RCA	O
stented	O
-&gt;	O
0%	O
,	O
and	O
residual	B-problem
LAD	I-problem
/	I-problem
Diag1/LCx	I-problem
/	I-problem
OM2	I-problem
disease	I-problem
.	O

Developed	O
burning	B-problem
chest	I-problem
pain	I-problem
before	O
bedtime	O
the	O
night	O
PTA	O
.	O

NO	O
associated	O
sxs	B-problem
/	O
radiation	B-problem
.	O

Slept	O
well	O
,	O
but	O
on	O
the	O
am	O
of	O
admission	O
had	O
same	B-problem
burning	I-problem
across	I-problem
chest	I-problem
(	O
&quot;	O
deeper	O
than	O
heartburn	B-problem
&quot;	O
)	O
so	O
went	O
to	O
her	O
MD	O
&apos;s	O
office	O
.	O

Transient	B-problem
diaphoresis	I-problem
in	O
MD	O
&apos;s	O
office	O
that	O
patient	O
attributed	O
to	O
heat	O
in	O
room	O
.	O

Patient	O
says	O
pain	B-problem
is	O
similar	O
in	O
location	O
and	O
quality	O
to	O
the	B-problem
pain	I-problem
she	O
had	O
with	O
her	B-problem
MI	I-problem
,	O
although	O
with	O
her	B-problem
MI	I-problem
the	B-problem
pain	I-problem
was	O
much	O
more	O
intense	O
(	O
20x	O
worse	O
)	O
.	O

This	O
is	O
1st	B-problem
pain	I-problem
since	O
MI	B-problem
(	O
though	O
patient	O
reports	O
chronic	B-problem
baseline	I-problem
chest	I-problem
tightness	I-problem
x8-10	O
years	O
of	O
unclear	O
etiology	O
)	O
.	O

CP	B-problem
/	O
burning	B-problem
lasted	O
several	O
hours	O
and	O
was	O
relieved	O
after	O
she	O
received	O
Maalox	B-treatment
,	O
lidocaine	B-treatment
,	O
and	O
NTG	B-treatment
in	O
the	O
ED	O
.	O

She	O
reports	O
compliance	O
with	O
her	B-treatment
ASA	I-treatment
+	O
plavix	B-treatment
.	O

She	O
is	O
active	O
at	O
baseline	O
,	O
participating	O
in	O
cardiac	B-treatment
rehab	I-treatment
for	O
2	O
hrs	O
/	O
week	O
and	O
running	O
up	O
and	O
down	O
stairs	O
at	O
home	O
without	O
CP	B-problem
/	O
SOB	B-problem
.	O

IN	O
ED	O
vitals	B-test
p86	B-test
bp	B-test
127/88	O
sat	B-test
100%	O
.	O

NAD	B-problem
.	O

No	O
JVD	B-problem
.	O

CTAB.	O
nl	O
s1s2	O
,	O
reg	O
,	O
no	O
m	B-problem
/	O
r.	B-problem
no	O
chest	B-problem
tenderness	I-problem
.	O

abd	O
soft	O
,	O
NT	B-problem
/	O
ND	B-problem
,	O
NABS.	O
ext	O
wwp	O
,	O
no	O
c	B-problem
/	O
c/e	B-problem
,	O
2+DP	B-test
&apos;s	O
b	O
/	O
l.	O

labs	O
:	O

A	O
set	O
:	O

trop	B-test
&lt;	I-test
assay	I-test
,	O
CK	B-test
67	O
,	O
MB	B-test
0.2	O
.	O

EKG	B-test
-	O
old	B-problem
TWI	I-problem
III	I-problem
.	O

A	O
/	O
P	B-test
:	O

45F	O
with	O
recent	B-problem
inferior	I-problem
STEMI	I-problem
s	O
/	O
p	O
stent	B-treatment
to	I-treatment
RCA	I-treatment
.	O

1.	O
CV	O
:	O

(	O
I	O
)	O
ROMI	B-test
negative	O
.	O

ETT	B-test
MIBI	B-test
4/14	O
without	O
e	O
/	O
o	O
ischemia	B-problem
.	O
?	O

GERD	B-problem
as	O
etiology	O
of	O
her	B-problem
chest	I-problem
burning	I-problem
.	O

cont	O
asa	B-treatment
,	O
statin	B-treatment
,	O
plavix	B-treatment
,	O
bblkr	B-treatment
.	O

(	O
P	O
)	O
Most	O
recent	O
echo	B-test
:	O

EF	B-test
55%	O
and	O
inf	B-problem
/	I-problem
post	I-problem
HK	I-problem
.	O

(	O
R	O
)	O
Patient	O
had	O
no	O
events	O
on	O
tele	B-test
.	O

2.	O
ENDO	O
:	O

continue	O
levoxyl	B-treatment
for	O
hypothyroidism	B-problem
,	O
synarel	B-treatment
for	O
endometriosis	B-problem
.	O

3.	O
MSK	O
:	O

cervical	B-problem
spondylosis	I-problem
,	O
tylenol	B-treatment
for	O
pain	B-problem
.	O

4.	O
GI	O
:	O

h	O
/	O
o	O
GERD-	B-problem
nexium	B-treatment
.	O

FULL	O
CODE	O
ADDITIONAL	O
COMMENTS	O
:	O

If	O
you	O
develop	O
recurrent	B-problem
chest	I-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
,	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
hospital	O
.	O

Continue	O
taking	O
all	O
of	O
your	B-treatment
regular	I-treatment
home	I-treatment
medications	I-treatment
.	O

Follow	O
up	O
with	O
Dr.	O
Koteskismanhout	O
in	O
July	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

SAGELYSS	O
,	O
TYTUMZE	O
V.	O
,	O
M.D.	O
(	O
FS69	O
)	O
05/27/05	O
05:33	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2012-05-24	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-06-19	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1954-07-01	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEUROSURGERY	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Joyce	O
V.	O
Seidel	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Right	B-problem
parietal	I-problem
wound	I-problem
dehiscence	I-problem
.	O

CSF	B-problem
leak	I-problem
.	O

Perforated	B-problem
diverticulitis	I-problem
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Lumbar	B-treatment
drain	I-treatment
placement	I-treatment
2012-05-24	O

Exploratory	B-test
laparotomy	I-test
2012-05-26	O

Abdominal	B-treatment
washtou	I-treatment
2012-05-26	O

Sigmoid	B-treatment
colectomy	I-treatment
and	O
Hartmans	B-treatment
pouch	I-treatment
2012-05-26	O

Lumbar	B-treatment
drain	I-treatment
placement	I-treatment
2012-05-29	O

CT-guided	B-treatment
aspiration	I-treatment
06-01	O
for	O
pelvic	B-problem
abscess	I-problem

Reveision	B-treatment
Right	I-treatment
craniotomy	I-treatment
06-03	O

revsion	B-treatment
of	I-treatment
bone	I-treatment
flap	I-treatment
06-03	O

Emergent	B-treatment
intubation	I-treatment
06-04	O

PICC	B-treatment
line	I-treatment
placement	I-treatment
2012-06-08	O

History	O
of	O
Present	O
Illness	O
:	O

57	O
yo	O
right	O
handed	O
male	O
with	O
seizure	B-problem
history	I-problem
since	O
1988	O
,	O
s/p	O
craniotomies	B-treatment
x	O
3	O
(	O
most	O
recently	O
05-05	O
)	O
for	O
oligodendroglioma	B-problem
.	O

The	O
patient	O
began	O
having	O
generalized	B-problem
tonic	I-problem
-	I-problem
clonic	I-problem
seizures	I-problem
in	O
1988	O
,	O
which	O
at	O
the	O
time	O
were	O
thought	O
to	O
be	O
related	O
to	O
asthma	B-treatment
medications	I-treatment
.	O

At	O
this	O
time	O
,	O
his	B-test
head	I-test
CT	I-test
was	O
negative	O
,	O
and	O
he	O
was	O
treated	O
with	O
Dilantin	B-treatment
and	O
Phenobarbital	B-treatment
.	O

However	O
,	O
he	O
continued	O
to	O
have	O
left	B-problem
arm	I-problem
focal	I-problem
motor	I-problem
seizures	I-problem
and	O
problems	B-problem
thinking	I-problem
.	O

In	O
2001-08-31	O
he	O
stopped	O
his	B-treatment
medication	I-treatment
and	O
had	O
a	B-problem
generalized	I-problem
tonic	I-problem
-	I-problem
clonic	I-problem
seizure	I-problem
in	O
12/94	O
.	O

He	O
was	O
diagnosed	O
by	O
biopsy	B-test
with	O
oligodendroglioma	B-problem
,	O
and	O
gross	B-treatment
total	I-treatment
resection	I-treatment
by	O
Dr.	O
Redner	O
in	O

95	O
revealed	O
a	B-problem
low-grade	I-problem
oligodendroglioma	I-problem
.	O

He	O
was	O
followed	O
by	O
Dr.	O
Gregory	O
Dumas	O
,	O
with	O
serial	B-test
MRI	I-test
's.	I-test

In	O
2011-05-02	O
,	O
he	O
was	O
requiring	O
more	B-treatment
ativan	I-treatment
to	O
control	O
his	B-problem
seizures	I-problem
,	O
and	O
was	O
increasingly	B-problem
disoriented	I-problem
and	O
forgetful	B-problem
with	O
headaches	B-problem
.	O

He	O
had	O
a	B-treatment
repeat	I-treatment
total	I-treatment
resection	I-treatment
in	O
4/04	O
by	O
Dr.	O
Peter	O
Hoadley	O
at	O
Hallmark	O
Health	O
System	O
which	O
revealed	O
anaplastic	B-problem
oligodendroglioma	I-problem
grade	I-problem
III	I-problem
.	O

He	O
had	O
radiation	B-treatment
following	O
the	B-treatment
resection	I-treatment
and	O
was	O
doing	O
well	O
on	O
monthly	B-treatment
Temodar	I-treatment
until	O
2012-04-23	O
when	O
he	O
had	O
a	B-problem
marked	I-problem
change	I-problem
in	I-problem
behavior	I-problem
,	O
his	O
balance	O
was	O
off	O
,	O
speech	B-problem
slurred	I-problem
,	O
and	O
he	O
had	O
difficulty	B-problem
using	I-problem
the	I-problem
computer	I-problem
.	O

A	B-test
head	I-test
MRI	I-test
on	O
2012-04-24	O
revealed	O
increasing	B-problem
tumor	I-problem
infiltration	I-problem
with	O
increased	B-problem
edema	I-problem
and	O
mass	B-problem
effect	I-problem
.	O

He	O
underwent	O
a	B-treatment
right	I-treatment
craniotomy	I-treatment
with	O
resection	B-treatment
and	O
gliadel	B-treatment
wafers	I-treatment
on	O
2012-05-02	O
at	O
Hallmark	O
Health	O
System	O
by	O
Dr.	O
Ackley	O
.	O

Came	O
for	O
neurosurgery	O
follow	O
up	O
on	O
05-21	O
,	O
and	O
had	O
been	O
having	O
clear	B-problem
fluid	I-problem
leaking	O
from	O
his	B-problem
incision	I-problem
,	O
as	O
well	O
as	O
frontal	B-problem
headache	I-problem
,	O
imbalance	B-problem
,	O
bumping	O
into	O
things	O
with	O
his	O
left	O
leg	O
and	O
worsening	B-problem
tremors	I-problem
.	O

He	O
was	O
admitted	O
for	O
Lumbar	B-treatment
drain	I-treatment
placement	I-treatment

Past	O
Medical	O
History	O
:	O

Right	B-problem
parietal	I-problem
oligodendroglioma	I-problem
,	O
as	O
above	O
status	O
post	O
craniotomy	B-treatment
x	O
3	O
(	O
'95	O
,	O
'04	O
,	O
'05	O
)	O

hernia	B-treatment
surgery	I-treatment
x	O
3	O

right	B-problem
hand	I-problem
ganglion	I-problem
cyst	I-problem
removed	O

asthma	B-problem
PAD-WORD	O

Social	O
History	O
:	O

Lives	O
w	O
wife	O
,	O
has	O
home	O
health	O
assistance	O
.	O

Employment	O
:	O
on	O
short	O
term	O
disability	O
,	O
has	O
boat	O
which	O
he	O
enjoys	O
as	O
hobby	O

Physical	O
Exam	O
:	O

RRR	O
PAD-WORD	O

CTA	O
PAD-WORD	O

Abdomen	O
soft	O
Nontender	B-problem
and	O
nondistended	B-problem

Alert	O
and	O
oriented	O
times	O
3	O

Speech	O
fluent	O
,	O
comprehension	O
intact	O

Pupils	O
equal	O
round	O
and	O
reactive	O
to	O
light	O
,	O
extraocular	O
movements	O
intact	O

Face	O
symmetric	O

Tongue	O
midline	O

No	O
pronator	B-problem
drift	I-problem

Strength	B-test
5/5	O
throughout	O

Normal	O
tone	O

2+	B-test
reflexes	I-test
throughout	O

Toes	O
downgoing	O
bilaterally	O

No	O
dysmetria	B-problem

Pertinent	O
Results	O
:	O

Admission	O
labs	O
:	O

2012-05-24	O
PAD-WORD	O

WBC	B-test
-	O
6.3	O
RBC	B-test
-	O
4.17	O
*	O
Hgb	B-test
-	O
13.7	O
*	O
Hct	B-test
-	O
40.2	O
MCV	B-test
-	O
96	O
MCH	B-test
-	O
32.7	O
*	O
MCHC	B-test
-	O
34.0	O
RDW	B-test
-	O
13.6	O
Plt	B-test
Ct	I-test
-	O
143	O
*	O
PT	B-test
-	O
11.9	O
PTT	B-test
-	O
21.1	O
*	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
0.9	O
Glucose	B-test
-	O
207	O
*	O
UreaN	B-test
-	O
17	O
Creat	B-test
-	O
0.9	O
Na	B-test
-	O
134	O
K	B-test
-	O
4.6	O
Cl	B-test
-	O
93	O
*	O
HCO3	B-test
-	O
35	O
*	O
AnGap	B-test
-	O
11	O
Calcium	B-test
-	O
8.3	O
*	O
Phos	B-test
-	O
1.8	O
*#	O
Mg	B-test
-	O
2.1	O

Discharge	O
labs	O
:	O

2012-06-18	O
PAD-WORD	O

WBC	B-test
-	O
6.5	O
RBC	B-test
-	O
3.20	O
*	O
Hgb	B-test
-	O
10.5	O
*	O
Hct	B-test
-	O
30.7	O
*	O
MCV	B-test
-	O
96	O
MCH	B-test
-	O
32.8	O
*	O
MCHC	B-test
-	O
34.2	O
RDW	B-test
-	O
14.3	O
Plt	B-test
Ct	I-test
-	O
227	O
PT	B-test
-	O
13.4	O
PTT	B-test
-	O
24.6	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.1	O
Glucose	B-test
-	O
117	O
*	O
UreaN	B-test
-	O
12	O
Creat	B-test
-	O
0.6	O
Na	B-test
-	O
140	O
K	B-test
-	O
4.2	O
Cl	B-test
-	O
102	O
HCO3	B-test
-	O
32	O
*	O
AnGap	B-test
-	O
10	O
Calcium	B-test
-	O
9.0	O
Phos	B-test
-	O
3.9	O
Mg	B-test
-	O
2.0	O

Pathology	O
:	O

Sigmoid	O
colon	O
:	O

Diverticular	B-problem
disease	I-problem
of	I-problem
the	I-problem
colon	I-problem
:	O

1.	O
Multiple	B-problem
diverticula	I-problem
.	O

2.	O
Rupture	B-problem
of	I-problem
diverticulum	I-problem
with	O
pericolic	B-problem
abscess	I-problem
.	O

CT	B-test
head	I-test
2012-06-11	O
:	O

IMPRESSION	O
:	O

1)	O
Overall	O
,	O
a	O
slight	O
decrease	O
in	O
the	B-problem
mass	I-problem
effect	I-problem
and	O
edema	B-problem
associated	O
with	O
the	O
postoperative	O
changes	O
.	O

2)	O
Slight	O
increase	O
in	O
epidural	B-problem
fluid	I-problem
collection	I-problem
adjacent	O
to	O
the	B-problem
craniotomy	I-problem
site	I-problem
.	O

CT	B-test
abdomen	I-test
2012-06-18	O
:	O

IMPRESSION	O
:	O

Small	B-problem
residual	I-problem
collection	I-problem
anterior	O
to	O
the	O
rectum	O
,	O
smaller	O
than	O
on	O
the	B-test
prior	I-test
study	I-test
,	O
and	O
without	O
substantial	B-problem
fluid	I-problem
components	I-problem
to	O
allow	O
drainage	B-treatment
.	O

WOUND	B-test
CULTURE	I-test
(	O
Final	O
2012-06-05	O
)	O
:	O

(	O
PELVIC	B-problem
ABSCESS	I-problem
)	O

Due	O
to	O
mixed	B-problem
bacterial	I-problem
types	I-problem
(	O
>=	O
3	O
colony	O
types	O
)	O
an	B-test
abbreviated	I-test
workup	I-test
is	O
performed	O
appropriate	O
to	O
the	O
isolates	O
recovered	O
from	O
the	O
site	O
(	O
including	O
a	B-test
screen	I-test
for	O
Pseudomonas	B-problem
aeruginosa	I-problem
,	O
Staphylococcus	B-problem
aureus	I-problem
and	O
beta	B-problem
streptococcus	I-problem
)	O
.	O

ENTEROCOCCUS	B-problem
SP.	I-problem

SPARSE	B-problem
GROWTH	I-problem
.	O

PSEUDOMONAS	B-problem
AERUGINOSA	I-problem
.	O

SPARSE	B-problem
GROWTH	I-problem
.	O

CORYNEBACTERIUM	B-problem
SPECIES	I-problem
(	I-problem
DIPHTHEROIDS	I-problem
)	I-problem
.	O

SPARSE	B-problem
GROWTH	I-problem
.	O

SENSITIVITIES	O
:	O

MIC	O
expressed	O
in	O

MCG/ML	O
PAD-WORD	O

_________________________________________________________	O
PAD-WORD	O

ENTEROCOCCUS	B-problem
SP	I-problem
.	O

|	O
PAD-WORD	O

PSEUDOMONAS	B-problem
AERUGINOSA	I-problem

|	O
PAD-WORD	O

|	O
PAD-WORD	O

AMPICILLIN------------	B-treatment
PAD-WORD	O

<=2	O
S	O

CEFEPIME--------------	B-treatment
PAD-WORD	O

2	O
S	O

CEFTAZIDIME-----------	B-treatment
PAD-WORD	O

4	O
S	O

CIPROFLOXACIN---------	B-treatment
PAD-WORD	O

<=0.25	O
S	O

GENTAMICIN------------	B-treatment
PAD-WORD	O

2	O
S	O

IMIPENEM--------------	B-treatment
PAD-WORD	O

8	O
I	O

LEVOFLOXACIN----------	B-treatment
PAD-WORD	O

1	O
S	O

MEROPENEM-------------	B-treatment
PAD-WORD	O

4	O
S	O

PENICILLIN------------	B-treatment
PAD-WORD	O

2	O
S	O

PIPERACILLIN----------	B-treatment
PAD-WORD	O

8	O
S	O

PIPERACILLIN/TAZO-----	B-treatment
PAD-WORD	O

8	O
S	O

TOBRAMYCIN------------	B-treatment
PAD-WORD	O

<=1	O
S	O

VANCOMYCIN------------	B-treatment
PAD-WORD	O

<=1	O
S	O

WOUND	B-test
CULTURE	I-test
(	O
Final	O
2012-06-05	O
)	O
:	O

(	O
from	O
OR	B-treatment
revision	I-treatment
craniotomy	I-treatment
)	O

STAPH	B-problem
AUREUS	I-problem
COAG	I-problem
+	O
.	O

SPARSE	B-problem
GROWTH	I-problem
.	O

Oxacillin	B-problem
RESISTANT	I-problem
Staphylococci	I-problem
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	B-problem
to	O
other	O
penicillins	B-treatment
,	O
cephalosporins	B-treatment
,	O
carbacephems	B-treatment
,	O
carbapenems	B-treatment
,	O
and	O
beta-lactamase	B-treatment
inhibitor	I-treatment
combinations	I-treatment
.	O

Rifampin	B-treatment
should	O
not	O
be	O
used	O
alone	O
for	O
therapy	B-treatment
.	O

Please	O
contact	O
the	O
Microbiology	O
Laboratory	O
(	O
2313-08-31	O
)	O
immediately	O
if	O
sensitivity	O
to	O
clindamycin	B-treatment
is	O
required	O
on	O
this	O
patient	O
's	O
isolate	O
.	O

SENSITIVITIES	O
:	O

MIC	O
expressed	O
in	O

MCG/ML	O
PAD-WORD	O

_________________________________________________________	O
PAD-WORD	O

STAPH	B-problem
AUREUS	I-problem
COAG	I-problem
+	O

|	O
PAD-WORD	O

ERYTHROMYCIN----------	B-treatment
PAD-WORD	O

=>8	O
R	O

GENTAMICIN------------	B-treatment
<=0.5	O
S	O

LEVOFLOXACIN----------	B-treatment
PAD-WORD	O

=>8	O
R	O

OXACILLIN-------------	B-treatment
PAD-WORD	O

=>4	O
R	O

PENICILLIN------------	B-treatment
=>0.5	O
R	O

RIFAMPIN--------------	B-treatment
<=0.5	O
S	O

TETRACYCLINE----------	B-treatment
PAD-WORD	O

<=1	O
S	O

VANCOMYCIN------------	B-treatment
PAD-WORD	O

<=1	O
S	O

Brief	O
Hospital	O
Course	O
:	O
patient	O
was	O
admitted	O
on	O
2012-05-24	O
after	O
having	O
drainage	B-problem
from	O
his	B-problem
incision	I-problem
for	O
the	O
last	O
couple	O
of	O
days	O
.	O

He	O
was	O
seen	O
in	O
the	O
brain	O
tumor	O
clinic	O
on	O
05-21	O
and	O
stitches	B-treatment
were	O
placed	O
in	O
the	B-problem
incision	I-problem
,	O
however	O
it	O
continued	O
to	O
leak	O
.	O

He	O
had	O
a	B-treatment
lumbar	I-treatment
drain	I-treatment
placed	O
.	O

He	O
c/o	O
of	O
abd	B-problem
pain	I-problem
and	O
distension	B-problem
on	O
05-25	O
he	O
had	O
a	B-test
kub	I-test
done	O
which	O
was	O
negative	O
.	O

on	O
05-26	O
he	O
continued	O
to	O
c/o	O
of	O
epigastric	B-problem
pain	I-problem
had	O
a	B-test
chest	I-test
x-ray	I-test
done	O
to	O
due	O
to	O
decreased	B-problem
lung	I-problem
sounds	I-problem
.	O

The	B-test
Chest	I-test
x-ray	I-test
showed	O
free	B-problem
air	I-problem
.	O

general	O
surgery	O
was	O
consulted	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
OR	O
for	O
exploratory	B-test
laproratomy	I-test
.	O

he	O
was	O
found	O
to	O
have	O
a	B-problem
perforated	I-problem
sigmoid	I-problem
diverticulum	I-problem
.	O

He	O
had	O
a	B-treatment
colostomy	I-treatment
and	O
partial	B-treatment
colectomy	I-treatment
.	O

patient	O
recovered	O
well	O
from	O
colocetomy	B-treatment
.	O

He	O
was	O
found	O
to	O
have	O
an	B-problem
abd	I-problem
abcess	I-problem
which	O
was	O
drained	O
via	O
CT	B-test
guidance	I-test
on	O
06-01	O
.	O

On	O
06-02	O
his	B-treatment
lumbar	I-treatment
drain	I-treatment
pulled	O
out	O
.	O

he	O
had	O
to	O
have	O
it	O
replaced	O
,	O
however	O
,	O
because	O
his	B-problem
head	I-problem
incision	I-problem
began	O
to	O
leak	O
again	O
.	O

On	O
06-03	O
he	O
was	O
taken	O
back	O
to	O
the	O
OR	O
for	O
debridement	B-treatment
of	O
his	B-problem
head	I-problem
wound	I-problem
with	O
removal	B-treatment
of	O
the	B-problem
remaining	I-problem
gliadel	I-problem
waffers	I-problem
.	O

He	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
,	O
postop	O
however	O
he	O
had	O
a	B-problem
grand	I-problem
mal	I-problem
seizure	I-problem
and	O
was	O
intubated	O
and	O
sent	O
to	O
the	O
ICU	O
.	O

ID	O
was	O
consulted	O
for	O
both	O
the	B-problem
abd	I-problem
abcess	I-problem
and	O
possible	O
meningitis	B-problem
given	O
the	B-problem
large	I-problem
amount	I-problem
of	I-problem
wbc	I-problem
in	O
the	B-test
csf	I-test
cultures	I-test
.	O

Patient	O
was	O
placed	O
on	O
vancomycin	B-treatment
1	O
gm	O
IV	O
q12	O
and	O
zosyn	B-treatment
.	O

He	O
was	O
kept	O
on	O
antibiotics	B-treatment
until	O
06-17	O
.	O

Neurologically	O
he	O
slowly	O
woke	O
up	O
after	O
the	B-problem
seizures	I-problem
and	O
was	O
extubated	O
on	O
06-03	O
.	O

He	O
was	O
transfered	O
to	O
the	O
step	O
down	O
unit	O
and	O
had	O
his	B-treatment
lumbar	I-treatment
drain	I-treatment
slowly	O
weaned	O
.	O

The	B-treatment
lumbar	I-treatment
drain	I-treatment
was	O
d/ced	O
on	O
06-14	O
.	O

He	O
had	O
a	B-test
head	I-test
Ct	I-test
which	O
remains	O
stable	O
and	O
head	B-problem
wound	I-problem
remain	O
dry	O
.	O

Neurologically	O
he	O
is	O
awake	O
and	O
alert	O
and	O
oriented	O
x	O
3	O
he	O
is	O
07-05	O
in	O
all	O
muscle	O
group	O
bilat	O
.	O

He	O
follows	O
commands	O
,	O
he	O
is	O
out	O
of	O
bed	O
ambulating	O
with	O
max	O
assist	O
.	O

PT	O
and	O
OT	O
are	O
recommending	O
rehab	B-treatment
.	O

He	O
will	O
follow	O
up	O
with	O
Dr	O
Fisher	O
the	O
general	O
surgeon	O
in	O
two	O
weeks	O
and	O
follow	O
up	O
in	O
the	O
brain	O
tumor	O
clinic	O
in	O
two	O
weeks	O
for	O
stitch	B-treatment
removal	I-treatment
.	O

H	O
ewas	O
switched	O
to	O
oral	B-treatment
CIpro	I-treatment
for	O
the	B-problem
pelvic	I-problem
abcess	I-problem
and	O
will	O
continue	O
it	O
until	O
he	O
has	O
his	O
followup	O
with	O
infectious	O
disease	O
in	O
2	O
weeks	O
.	O

Medications	O
on	O
Admission	O
:	O

Neurontin	B-treatment
,	O
Keppra	B-treatment
,	O
Lamictal	B-treatment
,	O
decadron	B-treatment
,	O
multivitamin	B-treatment
,	O
Murray	O
,	O
Calcium	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Heparin	B-treatment
Sodium	I-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

2.	O
Diphenhydramine	B-treatment
HCl	I-treatment
25	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Albuterol	B-treatment
-	I-treatment
Ipratropium	I-treatment
103-18	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
03-04	O
Puffs	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

4.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

5.	O
Fluticasone	B-treatment
-	I-treatment
Salmeterol	I-treatment
250-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

6.	O
Lamotrigine	B-treatment
100	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

7.	O
Levetiracetam	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

8.	O
Ibuprofen	B-treatment
400	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

9.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

10.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

11.	O
Ciprofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
2	O
weeks.	O
Tablet	O
(	O
s	O
)	O

12.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

13.	O
Lorazepam	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
.	O

14.	O
Dexamethasone	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
.	O

15.	O
Insulin	B-treatment
Regular	I-treatment
Human	I-treatment
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
ASDIR	O
(	O
AS	O
DIRECTED	O
)	O
:	O
51-150	O
0	O
Units	O

151-200	O
2	O
Units	O

201-250	O
4	O
Units	O

251-300	O
6	O
Units	O

301-350	O
8	O
Units	O

351-400	O
10	O
Units	O

>	O
400	O
Bessie	O
MD	O

16.	O
Hydralazine	B-treatment
HCl	I-treatment
20	O
mg	O
/	O
mL	O
Solution	O
Sig	O
:	O
0.5	O
syringe	O
Injection	O
Q4HR	O
(	O
)	O
as	O
needed	O
for	O
sbp	B-problem
>	O
150	O
.	O

Disp	O
:*	O
qs	O
syringe	O
*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Cerebrospinal	B-problem
fluid	I-problem
leak	I-problem

Chronic	O
steroid	O
use	O
wound	B-problem
infection	I-problem

Perforated	B-problem
sigmoid	I-problem
diverticulum	I-problem
status	O
post	O
exploratory	B-test
laparotomy	I-test

Status	O
post	O
sigmoid	B-treatment
colectomy	I-treatment
,	O
hartmans	B-treatment
pouch	I-treatment
and	O
washout	B-treatment

Post	B-problem
operative	I-problem
fever	I-problem
fever	B-problem
status	O
post	O
Reveision	B-treatment
Right	I-treatment
craniotomy	I-treatment
and	O
revsion	B-treatment
of	I-treatment
bone	I-treatment
flap	I-treatment
change	B-problem
in	I-problem
mental	I-problem
status	I-problem

Seizure	B-problem
PAD-WORD	O

Conant	B-problem
palsy	I-problem
with	O
Left	B-problem
sided	I-problem
weakness	I-problem

Respiratory	B-problem
failure	I-problem
requiring	O
intubation	B-treatment

Methicillin	B-problem
resistant	I-problem
staph	I-problem
aureus	I-problem
infection	I-problem
of	I-problem
central	I-problem
nervous	I-problem
system	I-problem

Pelvic	B-problem
abscess	I-problem
oligodendroglioma	B-problem

Asthma	B-problem
PAD-WORD	O

S/p	O
craniotomy	B-treatment
x	O
3	O

Hernia	B-treatment
Surgery	I-treatment
x	O
3	O

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Call	O
with	O
any	B-problem
spiking	I-problem
fevers	I-problem
,	O
leakage	B-problem
from	O
your	B-problem
head	I-problem
wound	I-problem
,	O
increase	B-problem
in	I-problem
headaches	I-problem
,	O
confusion	B-problem
,	O
blurry	B-problem
vision	I-problem
severe	B-problem
neck	I-problem
stiffness	I-problem
,	O
redness	B-problem
,	O
swelling	B-problem
,	O
or	O
discharge	B-problem
around	O
your	B-problem
wound	I-problem
site	I-problem

Call	O
your	O
general	O
surgeon	O
if	O
you	O
experience	O
increased	B-problem
abdominal	I-problem
pain	I-problem
,	O
vomiting	B-problem
,	O
decreased	B-problem
or	I-problem
increased	I-problem
ostomy	I-problem
output	I-problem
.	O

Followup	O
Instructions	O
:	O

1.	O
Dr.	O
Martha	O
Lopez	O
or	O
Dr.	O
Henson	O
in	O
infectious	O
disese	O
in	O
2	O
weeks	O
.	O

Call	O
for	O
an	O
appointment	O
(	O
724	O
)	O
875	O
5043	O

2.	O
Dr	O
Fisher	O
in	O
General	O
surgery	O
,	O
1	O
week	O
,	O
call	O
his	O
office	O
for	O
an	O
appointment	O
.	O

515-3442	O
PAD-WORD	O

3.	O
Follow	O
up	O
in	O
1	O
week	O
at	O
brain	O
tumor	O
clinic	O
.	O

Call	O
for	O
an	O
appointment	O
908-6508	O

Cherrie	O
Celeste	O
MD	O
44-924	O

Completed	O
by	O
:	O
Angie	O
Irene	O
MD	O
36-512	O
2012-06-19	O
@	O
0950	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Charles	O
Mcwilliams	O
on	O
:	O
Daniel	O
2012-07-05	O
3:09	O
PM	O

(	O
End	O
of	O
Report	O
)	O

456424011	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

4107358	O
PAD-WORD	O

541797	O
PAD-WORD	O

858595	O
PAD-WORD	O

4/7/1997	O
12:00:00	O
AM	O

CORONARY	B-problem
ARTERY	I-problem
DISEASE	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

VESSELS	O
,	O
TISTIE	O
D	O

UNIT	O
NUMBER	O
:	O

125-10-86	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

04/07/97	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

04/08/97	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

coronary	B-problem
artery	I-problem
disease	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Ischemic	B-problem
cardiomyopathy	I-problem
,	O
orthotopic	B-treatment
heart	I-treatment
transplantation	I-treatment
,	O
hyperlipidemia	B-problem
,	O
hypertension	B-problem
,	O
coronary	B-problem
graft	I-problem
disease	I-problem
,	O
medical	B-problem
noncompliance	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Cardiac	B-test
echocardiogram	I-test
.	O

OTHER	O
PROCEDURES	O
:	O

None	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Vessels	O
is	O
a	O
49-year-old	O
man	O
status	O
post	O
orthotopic	B-treatment
heart	I-treatment
transplantation	I-treatment
in	O
1991	O
at	O
Dautenorwe	O
Stuart	O
Erec	O
Hillpa	O
Of	O
Hospital	O
who	O
is	O
admitted	O
with	O
dyspnea	B-problem
and	O
severe	B-problem
heart	I-problem
failure	I-problem
.	O

Mr.	O
Vessels	O
&apos;s	O
postoperative	O
course	O
has	O
been	O
marked	O
by	O
CMV	B-problem
infection	I-problem
,	O
hypertension	B-problem
,	O
poorly	B-problem
controlled	I-problem
lipids	I-problem
,	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
,	O
and	O
chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
a	B-test
creatinine	I-test
of	O
1.8	O
or	O
so	O
.	O

Recently	O
he	O
had	O
documented	O
coronary	B-test
angiography	I-test
based	O
on	O
a	B-test
catheterization	I-test
performed	O
in	O
January	O
1996	O
with	O
moderate	B-problem
to	I-problem
diffuse	I-problem
atherosclerosis	I-problem
.	O

A	B-test
repeat	I-test
angiogram	I-test
performed	O
a	O
year	O
later	O
showed	O
marked	O
progression	O
of	O
coronary	B-problem
allograft	I-problem
disease	I-problem
.	O

A	B-test
biopsy	I-test
at	O
that	O
time	O
revealed	O
grade	B-problem
1B	I-problem
rejection	I-problem
with	O
endothelialitis	B-problem
and	O
eosinophils	B-problem
.	O

He	O
was	O
treated	O
with	O
pulsed	B-treatment
IV	I-treatment
steroids	I-treatment
and	O
Imuran	B-treatment
,	O
was	O
augmented	O
with	O
mycophenolate	B-treatment
Mofetil	I-treatment
.	O

Chest	B-test
x-ray	I-test
showed	O
cariogenic	B-problem
pulmonary	I-problem
edema	I-problem
and	O
he	O
was	O
faring	O
poorly	O
.	O

Prior	O
to	O
admission	O
he	O
was	O
seen	O
approximately	O
1	O
week	O
in	O
the	O
office	O
with	O
mild	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
.	O

An	B-test
echocardiogram	I-test
then	O
revealed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
40%	O
and	O
an	B-test
endomyocardial	I-test
biopsy	I-test
revealed	O
no	O
ejection	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
coronary	B-problem
allograft	I-problem
vasculopathy	I-problem
,	O
hyperlipidemia	B-problem
,	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
,	O
CMV	B-problem
infection	I-problem
,	O
hypertension	B-problem
,	O
depression	B-problem
,	O
and	O
tricuspid	B-problem
regurgitation	I-problem
.	O

Examination	B-test
revealed	O
a	O
tired	O
,	O
fatigued	O
man	O
with	O
cool	B-problem
extremities	I-problem
.	O

His	B-test
blood	I-test
pressure	I-test
is	O
130/80	O
and	O
heart	B-test
rate	I-test
was	O
100.	O
jugular	B-test
venous	I-test
pressure	I-test
was	O
increasing	O
.	O

Carotids	B-test
were	O
2+	O
.	O

Crackles	B-problem
were	O
increased	O
1/4	O
of	O
the	O
way	O
up	O
.	O

There	O
was	O
a	B-problem
left	I-problem
ventricular	I-problem
heave	I-problem
and	O
an	B-problem
S3	I-problem
galop	I-problem
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	B-problem
with	O
a	O
palpable	O
liver	O
edge	O
and	O
the	B-test
pulses	I-test
were	O
diminished	O
.	O

LABORATORY	O
DATA	O
:	O

Revealed	O
a	B-test
sodium	I-test
136	O
,	O
potassium	B-test
4.5	O
,	O
BUN	B-test
47	O
,	O
creatinine	B-test
2.4	O
,	O
glucose	B-test
136.	O
hematocrit	B-test
40%	O
.	O

The	B-test
electrocardiogram	I-test
revealed	O
poor	B-problem
R	I-problem
wave	I-problem
progression	I-problem
and	O
marked	B-problem
decrease	I-problem
in	I-problem
all	I-problem
volts	I-problem
.	O

chest	B-test
x-ray	I-test
revealed	O
prominent	B-problem
pulmonary	I-problem
vessels	I-problem
and	O
enlarged	B-problem
heart	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
via	O
the	O
emergency	O
room	O
where	O
a	B-test
bedside	I-test
echocardiogram	I-test
was	O
performed	O
.	O

The	B-test
echocardiogram	I-test
revealed	O
no	O
pericardial	B-problem
effusion	I-problem
,	O
an	B-test
ejection	I-test
fraction	I-test
of	O
30%	O
and	O
worsening	B-problem
systolic	I-problem
dysfunction	I-problem
.	O

Hydrocortisone	B-treatment
was	O
given	O
1	O
g	O
in	O
an	O
attempt	O
to	O
reverse	O
what	O
was	O
thought	O
to	O
be	O
aggressive	B-problem
coronary	I-problem
allograft	I-problem
vasculopathy	I-problem
.	O

The	O
patient	O
diuresed	O
and	O
responded	O
to	O
Lasix	B-treatment
100	O
mg	O
administered	O
in	O
the	O
emergency	O
room	O
and	O
was	O
admitted	O
to	O
a	O
monitored	O
bed	O
.	O

At	O
4:30	O
AM	O
the	O
following	O
morning	O
the	O
patient	O
was	O
found	O
in	O
cardiac	B-problem
arrest	I-problem
.	O

Despite	O
intravenous	B-treatment
fluids	I-treatment
,	O
intravenous	B-treatment
epinephrine	I-treatment
,	O
and	O
multiple	O
attempts	O
at	O
defibrillation	B-treatment
,	O
the	O
patient	O
was	O
unable	O
to	O
be	O
resuscitated	O
.	O

Upon	O
arrival	O
of	O
the	O
covering	O
access	O
physician	O
the	O
patient	O
was	O
being	O
ventilated	O
mechanically	O
and	O
CPR	B-treatment
was	O
being	O
performed	O
.	O

The	B-test
rhythm	I-test
revealed	O
sinus	B-problem
tachycardia	I-problem
with	O
no	O
palpable	O
or	O
measurable	B-test
blood	I-test
pressure	I-test
.	O

There	O
were	O
also	O
runs	O
of	O
ventricular	B-problem
tachycardia	I-problem
which	O
generated	O
into	O
ventricular	B-problem
fibrillation	I-problem
that	O
was	O
refractory	O
to	O
multiple	B-treatment
cardioversions	I-treatment
.	O

A	B-test
pericardiocentesis	I-test
was	O
attempted	O
with	O
no	O
yield	O
of	O
pericardial	O
fluid	O
.	O

A	B-treatment
transvenous	I-treatment
pacing	I-treatment
wire	I-treatment
was	O
attempted	O
and	O
a	O
pacing	O
rhythm	O
was	O
obtained	O
but	O
with	O
no	O
palpable	B-test
blood	I-test
pressure	I-test
.	O

In	O
total	O
,	O
the	O
patient	O
was	O
defibrillated	O
10	O
times	O
,	O
given	O
5	O
courses	O
of	O
intravenous	B-treatment
epinephrine	I-treatment
,	O
one	O
course	O
of	O
intravenous	B-treatment
Atropine	I-treatment
and	O
intravenous	B-treatment
calcium	I-treatment
x	O
1	O
in	O
addition	O
to	O
an	B-treatment
amp	I-treatment
of	I-treatment
bicarbonate	I-treatment
.	O

The	B-treatment
resuscitation	I-treatment
efforts	I-treatment
were	O
discontinued	O
at	O
4:15	O
AM	O
and	O
were	O
begun	O
at	O
3:38	O
AM	O
.	O

The	O
patient	O
was	O
pronounced	O
dead	O
.	O

Patient	O
&apos;s	O
mother	O
was	O
informed	O
by	O
Dr.	O
Vessels	O
.	O

An	B-test
autopsy	I-test
permission	O
was	O
granted	O
.	O

DOCTOR	O
&apos;S	O
DISCHARGE	O
ORDERS	O
:	O

None	O
.	O

AKA	O
MAM	O
,	O
M.D.	O

TR	O
:	O

ok	O
PAD-WORD	O

DD	O
:	O

05/14/97	O
PAD-WORD	O

TD	O
:	O

05/17/97	O
9:40	O
A	O

cc	O
:	O

AKA	O
G	O
MAM	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2016-11-02	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-11-15	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1938-06-17	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
SURGERY	O

ADDENDUM	O
:	O

The	O
patient	O
had	O
INR	B-test
of	O
3.2	O
that	O
came	O
back	O
on	O
date	O
of	O
discharge	O
.	O

Please	O
hold	O
dose	O
of	O
warfarin	B-treatment
on	O
the	O
night	O
of	O
the	O
16	O
,	O
and	O
please	O
recheck	O
INR	B-test
on	O
2016-11-16	O
and	O
dose	O
warfarin	B-treatment
appropriately	O
for	O
INR	B-test
of	O
2	O
to	O
2.5.	O

Dolly	O
K.	O
Reyes	O
,	O
M.D.	O

04-100	O
PAD-WORD	O

Dictated	O
By	O
:	O
Todd	O
N.	O
Brannon	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2016-11-15	O
11:54	O

T	O
:	O
2016-11-15	O
11:02	O

JOB	O
#:	O
75150	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Dolly	O
N	O
Wardlaw	O
on	O
:	O
TUE	O
2016-12-27	O
5:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

466217945	O
PAD-WORD	O

BH	O
PAD-WORD	O

0568574	O
PAD-WORD	O

158979	O
PAD-WORD	O

3/7/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

JESCOBEJESC	O
,	O
SON	O

UNIT	O
NUMBER	O
:	O

485-03-93	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

03/07/2002	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

03/13/2002	O
PAD-WORD	O

PRIMARY	O
DIAGNOSIS	O
:	O

Wound	B-problem
infection	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

None	O
.	O

PRINCIPAL	O
PROCEDURES	O
:	O

Incision	B-treatment
and	O
drainage	B-treatment
of	O
wound	B-problem
infection	I-problem
on	O
3/7/02	O
.	O

Abdominal	B-test
pelvic	I-test
CT	I-test
scan	I-test
on	O
3/10/02	O
.	O

Fistulogram	B-test
on	O
3/11/02	O
.	O

Intravenous	B-treatment
antibiotics	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
79-year-old	O
man	O
status	O
postradical	B-treatment
cystoprostatectomy	I-treatment
with	I-treatment
ileal	I-treatment
loop	I-treatment
for	O
locally	B-problem
invasive	I-problem
prostate	I-problem
cancer	I-problem
.	O

This	B-treatment
operation	I-treatment
was	O
performed	O
2/11/02	O
by	O
Dr.	O
Doje	O
Para	O
.	O

The	O
postoperative	O
course	O
was	O
complicated	O
by	O
atrial	B-problem
fibrillation	I-problem
with	O
transfer	O
to	O
the	O
Cardiac	O
Step-Down	O
Unit	O
.	O

This	O
transfer	O
occurred	O
around	O
postoperative	O
day	O
8	O
for	O
anticoagulation	B-treatment
and	O
amiodarone	B-treatment
load	I-treatment
.	O

The	B-treatment
anticoagulation	I-treatment
was	O
stopped	O
due	O
to	O
concern	O
for	O
postoperative	B-problem
bleeding	I-problem
.	O

The	O
patient	O
complained	O
of	O
fevers	B-problem
.	O

The	O
patient	O
presented	O
to	O
the	O
emergency	O
room	O
on	O
3/7/02	O
,	O
complaining	O
of	O
fevers	B-problem
since	O
Monday	O
3/2/02	O
.	O

He	O
developed	O
erythema	B-problem
around	O
the	B-problem
wound	I-problem
on	O
Wednesday	O
and	O
was	O
seen	O
by	O
Dr.	O
Para	O
,	O
who	O
started	O
Keflex	B-treatment
and	O
obtained	O
a	B-test
CT	I-test
scan	I-test
which	O
demonstrated	O
a	B-problem
fluid	I-problem
collection	I-problem
at	O
the	O
site	O
of	O
erythema	B-problem
.	O

The	B-problem
fevers	I-problem
continued	O
as	O
high	O
as	O
102.5	O
degrees	O
F	O
with	O
chills	B-problem
on	O
the	O
morning	O
of	O
admission	O
.	O

He	O
was	O
draining	O
pus	B-problem
from	O
the	B-problem
wound	I-problem
site	I-problem
with	O
subsequent	O
relief	O
of	O
discomfort	B-problem
at	O
the	O
site	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
,	O
atrial	B-problem
fibrillation	I-problem
,	O
gout	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Cystoprostatectomy	B-treatment
,	O
bilateral	B-treatment
inguinal	I-treatment
hernia	I-treatment
repair	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Keflex	B-treatment
500	O
mg	O
qid	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

On	O
presentation	O
,	O
temperature	B-test
99.3	O
degrees	O
F	O
,	O
other	B-test
vital	I-test
signs	I-test
were	O
within	O
normal	O
limits	O
.	O

He	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
non-toxic	B-problem
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
.	O

Pulmonary	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdomen	O
soft	O
and	O
there	O
was	O
wound	B-problem
erythema	I-problem
with	O
three	B-problem
areas	I-problem
of	I-problem
dehiscence	I-problem
draining	O
foul-smelling	B-problem
,	I-problem
purulent	I-problem
fluid	I-problem
.	O

The	O
fascia	O
appeared	O
intact	O
by	O
probing	B-test
.	O

The	B-treatment
stoma	I-treatment
was	O
pink	O
and	O
functional	O
.	O

The	B-problem
wound	I-problem
was	O
a	B-problem
midline	I-problem
incision	I-problem
for	O
his	B-treatment
radical	I-treatment
cystoprostatectomy	I-treatment
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
16.9	O
,	O
hematocrit	B-test
32.2	O
,	O
platelet	B-test
count	I-test
418	O
,	O
sodium	B-test
131	O
,	O
potassium	B-test
3.4	O
,	O
chloride	B-test
102	O
,	O
bicarbonate	B-test
21.4	O
,	O
BUN27	B-test
,	O
creatinine	B-test
1.4	O
,	O
glucose	B-test
150	O
.	O

RADIOLOGIC	O
STUDIES	O
:	O

CT	B-test
scan	I-test
3/5/02	O
:	O

A	B-problem
fluid	I-problem
collection	I-problem
external	I-problem
to	I-problem
the	I-problem
fascia	I-problem
consistent	O
with	O
site	O
of	O
erythema	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Urology	O
.	O

After	O
the	B-problem
wound	I-problem
was	O
further	O
opened	O
,	O
he	O
was	O
started	O
on	O
ampicillin	B-treatment
,	O
Gentamicin	B-treatment
,	O
and	O
Flagyl	B-treatment
antibiotics	I-treatment
and	O
he	O
was	O
placed	O
on	O
a	B-treatment
bid	I-treatment
dressing	I-treatment
change	I-treatment
and	O
packing	B-treatment
.	O

On	O
hospital	O
day	O
2	O
,	O
the	O
patient	O
had	O
no	O
complaints	O
.	O

He	O
was	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
and	O
good	O
urine	O
output	O
.	O

The	B-problem
wound	I-problem
erythema	I-problem
was	O
improving	O
and	O
the	B-problem
wound	I-problem
was	O
packed	O
twice	O
a	O
day	O
.	O

Wound	B-test
cultures	I-test
remained	O
negative	O
at	O
that	O
time	O
.	O

We	O
continued	O
his	B-treatment
ampicillin	I-treatment
,	O
Gentamicin	B-treatment
,	O
and	O
Flagyl	B-treatment
.	O

By	O
hospital	O
day	O
4	O
,	O
he	O
remained	O
afebrile	B-problem
throughout	O
his	O
hospital	O
course	O
.	O

The	B-test
wound	I-test
cultures	I-test
demonstrated	O
gram-positive	B-problem
cocci	I-problem
in	I-problem
clusters	I-problem
and	O
gram-negative	B-problem
rods	I-problem
.	O

Blood	B-test
cultures	I-test
remained	O
negative	O
.	O

The	O
patient	O
was	O
continued	O
on	O
antibiotics	B-treatment
and	O
we	O
obtained	O
a	B-test
CT	I-test
scan	I-test
to	O
check	O
for	O
an	B-problem
enterocutaneous	I-problem
fistula	I-problem
.	O

We	O
discontinued	O
his	B-treatment
Flagyl	I-treatment
on	O
that	O
day	O
.	O

We	O
contacted	O
the	O
patient	O
&apos;s	O
primary	O
care	O
physician	O
,	O
Dr.	O
Aslinke	O
______	O
,	O
regarding	O
his	B-treatment
cardiac	I-treatment
medication	I-treatment
management	I-treatment
.	O

We	O
agreed	O
that	O
he	O
should	O
resume	O
his	B-treatment
atenolol	I-treatment
.	O

He	O
was	O
started	O
on	O
2.5	O
mg	O
PO	O
qd	O
.	O

He	O
was	O
continued	O
on	O
his	B-treatment
dressing	I-treatment
changes	I-treatment
.	O

We	O
changed	O
the	B-treatment
dressings	I-treatment
tid	O
instead	O
of	O
bid	O
for	O
continued	B-problem
drainage	I-problem
.	O

The	B-test
CT	I-test
scan	I-test
that	O
was	O
obtained	O
on	O
3/10/02	O
demonstrated	O
no	O
connection	O
between	O
bowel	O
and	O
the	B-problem
wound	I-problem
.	O

The	B-problem
drainage	I-problem
had	O
been	O
decreasing	O
and	O
the	O
patient	O
continued	O
to	O
be	O
afebrile	B-problem
.	O

On	O
the	O
following	O
day	O
,	O
3/11/02	O
,	O
a	B-test
fistulogram	I-test
was	O
obtained	O
which	O
was	O
negative	O
for	O
a	B-problem
fistula	I-problem
from	I-problem
the	I-problem
bowel	I-problem
to	O
the	B-problem
wound	I-problem
.	O

The	O
patient	O
was	O
continued	O
on	O
ampicillin	B-treatment
and	O
Gentamicin	B-treatment
.	O

Her	O
remained	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
.	O

He	O
was	O
comfortable	O
and	O
erythema	B-problem
continued	O
to	O
decrease	O
with	O
improvemeent	O
in	O
the	O
appearance	O
of	O
the	B-problem
wound	I-problem
.	O

In	O
consultation	O
with	O
Infectious	O
Disease	O
,	O
it	O
was	O
agreed	O
to	O
discharge	O
the	O
patient	O
on	O
Augmentin	B-treatment
for	O
coverage	O
.	O

We	O
obtained	O
sensitivities	B-test
of	O
his	B-problem
wound	I-problem
bacteria	I-problem
.	O

His	B-treatment
intravenous	I-treatment
antibiotics	I-treatment
were	O
discontinued	O
.	O

He	O
remaineda	O
febrile	B-problem
with	O
daily	O
improvement	O
in	O
the	O
appearance	O
of	O
his	B-problem
wound	I-problem
.	O

On	O
hospital	O
day	O
7	O
,	O
the	O
patient	O
remained	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
.	O

His	B-problem
wound	I-problem
demonstrated	O
no	O
erythema	B-problem
with	O
moderate	B-problem
dark	I-problem
drainage	I-problem
.	O

The	O
patient	O
will	O
be	O
discharged	O
with	O
WH	O
and	O
continued	B-treatment
dressing	I-treatment
changes	I-treatment
bid	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
The	O
patient	O
will	O
be	O
sent	O
home	O
on	O
7	O
days	O
of	O
Augmentin	B-treatment
PO	I-treatment
.	O

2.	O
The	O
patient	O
will	O
have	O
follow-up	O
with	O
Dr.	O
Para	O
in	O
three	O
weeks	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Percocet	B-treatment
as	O
needed	O
for	O
pain	B-problem
.	O

Norvasc	B-treatment
2.5	O
mg	O
PO	O
qd	O
.	O

Augmentin	B-treatment
500/125	O
1	O
tab	O
PO	O
tid	O
x	O
7	O
days	O
.	O

LAKO	O
C	O
SCARVTWI	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O

DOJE	O
EED	O
PARA	O
,	O
M.D.	O

04/21/2002	O
10:49	O

_____________________________	O
DOJE	O
EED	O
PARA	O
,	O
M.D.	O

TR	O
:	O

yh	O
PAD-WORD	O

DD	O
:	O

03/13/2002	O
PAD-WORD	O

TD	O
:	O

03/13/2002	O
9:24	O
A	O
158979	O

cc	O
:	O

DOJE	O
EED	O
PARA	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2019-02-28	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-03-26	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1943-06-17	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Morphine	B-treatment
Sulfate	I-treatment
/	O
Codeine	B-treatment
/	O
Keflex	B-treatment
/	O
Sudafed	B-treatment

Attending	O
:	O
Willa	O
D	O
Garcia	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Fever	B-problem
/	O
+	O
BC	B-problem
w/	O
h/o	O
MV	B-problem
endocarditis	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Mitral	B-treatment
Valve	I-treatment
Replacement	I-treatment
with	O
31	B-treatment
mm	I-treatment
SJM	I-treatment
Biocor	I-treatment
Tissue	I-treatment
valve	I-treatment
/	I-treatment
della	I-treatment

Copeland	B-treatment
resection	I-treatment
on	O
2019-03-19	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Pizano	O
is	O
a	O
75	O
y/o	O
man	O
who	O
has	O
a	O
PMHx	O
significant	O
for	O
Enterococcus	B-problem
mitral	I-problem
valve	I-problem
endocarditis	I-problem
which	O
has	O
been	O
treated	O
since	O
09-19	O
.	O

He	O
has	O
had	O
2	O
6	O
week	O
courses	O
of	O
antibiotics	B-treatment
with	O
recurrent	B-problem
bacteremia	I-problem
.	O

He	O
had	O
a	B-test
TEE	I-test
on	O
2019-01-22	O
which	O
revealed	O
thickened	B-problem
mitral	I-problem
leaflets	I-problem
with	O
small	B-problem
vegetations	I-problem
on	I-problem
both	I-problem
anterior	I-problem
and	I-problem
posterior	I-problem
leaflets	I-problem
with	O
moderate	B-problem
to	I-problem
severe	I-problem
mitral	I-problem
regurgitation	I-problem
.	O

He	O
has	O
preserved	O
LV	O
systolic	O
function	O
with	O
mild	B-problem
TR	I-problem
and	O
AR	B-problem
and	O
LAE	B-problem
without	O
abscess	B-problem
.	O

He	O
had	O
a	B-test
repeat	I-test
TEE	I-test
on	O
02-19	O
which	O
revealed	O
4	B-problem
+	I-problem
MR	I-problem
.	O

Thomasine	O
was	O
tranferred	O
from	O
MWMC	O
(	O
where	O
he	O
was	O
admitted	O
on	O
02-15	O
with	O
fevers	B-problem
and	O
positive	B-problem
blood	I-problem
cultures	I-problem
)	O
to	O
IDMC	O
for	O
further	B-treatment
treatment	I-treatment
and	O
possibly	O
MVR	B-treatment
.	O

Past	O
Medical	O
History	O
:	O
h/o	O
Mitral	B-problem
Valve	I-problem
Endocarditis	I-problem

Hypertension	B-problem
PAD-WORD	O

h/o	O
CVA	B-problem

Spinal	B-problem
Stenosis	I-problem
s/p	O
Lumbar	B-treatment
Laminectomy	I-treatment
x	O
3	O

Parkinson	B-problem
's	I-problem
disease	I-problem

h/o	O
paranoid	B-problem
delusions	I-problem

MGUS	B-problem
vs	O
MM	B-problem

Social	O
History	O
:	O

Lives	O
in	O
nursing	O
home	O
.	O

Quit	O
smoking	O
3.5	O
years	O
ago	O
.	O

Denies	O
ETOH	O
.	O

Family	O
History	O
:	O

Non-contributory	O
PAD-WORD	O

Physical	O
Exam	O
:	O

Preop	O
PAD-WORD	O

General	O
:	O

Elderly	O
man	O
in	O
NAD	B-problem
,	O
VSS	O

HEENT	O
:	O

NC/AT	B-problem
,	O
PERRLA	O
,	O
EOMI	O
,	O
poor	B-problem
dentition	I-problem

Neck	O
:	O

Supple	O
,	O
FROM	O
,	O
-	O
thyromegaly	B-problem
,	O
-	O
lymphadenopathy	B-problem
,	O
Carotids	B-test
2	O
+	O

Bilat	O
w/out	O
bruits	B-problem

Lungs	O
:	O

CTAB	O
-	O
w/r/r	B-problem

Heart	O
:	O

RRR	O
,	O
+	O
S1S2	O
,	O
02-18	O
mumrmur	B-problem

Abd	O
:	O

Soft	O
NT/ND	B-problem
,	O
+	O
BS	O
without	O
masses	B-problem
or	O
hepatomegaly	B-problem
/	O
splenomegaly	B-problem

Ext	O
:	O

Warm	O
,	O
dry	O
-	O
c/c/e	B-problem
,	O
pulses	B-test
2+	O
throughout	O

Neuro	O
:	O

Non-focal	O
,	O
MAE	O

Skin	O
:	O
well-healed	B-problem
surgical	I-problem
scars	I-problem
on	I-problem
lower	I-problem
back	I-problem

Discharge	O
PAD-WORD	O

Gen	O
:	O

NAD	B-problem
/	O
VSS	O

Neuro	O
:	O

Alert	O
,	O
non	O
focal	O
exam	O

Pulm	O
:	O

CTA	O
bilat	O

Card	O
:	O

RRR	O
,	O
sternum	O
stable	O
,	O
incision	B-problem
clean	O
and	O
dry	O
,	O
no	O
erythema	B-problem
/	O
drainage	B-problem

Abdm	O
:	O
soft	O
,	O
NT	B-problem
/	O
ND	B-problem
/	O
NABS	B-problem

Ext	O
:	O
warm	O
well	O
perfused	O
,	O
no	O
C/C/E	B-problem

Pertinent	O
Results	O
:	O

2019-02-28	O
07:30	O
PM	O

GLUCOSE	B-test
-	O
94	O
UREA	B-test
N	I-test
-	O
21	O
*	O
CREAT	B-test
-	O
1.3	O
*	O
SODIUM	B-test
-	O
138	O
POTASSIUM	B-test
-	O
5.0	O
CHLORIDE	B-test
-	O
105	O
TOTAL	B-test
CO2	I-test
-	O
25	O
ANION	B-test
GAP	I-test
-	O
13	O

2019-02-28	O
07:30	O
PM	O

ALT	B-test
(	I-test
SGPT	I-test
)-	I-test
6	O
AST	B-test
(	I-test
SGOT	I-test
)-	I-test
20	O
LD	B-test
(	I-test
LDH	I-test
)-	I-test
255	O
*	O
ALK	B-test
PHOS	I-test
-	O
134	O
*	O
TOT	B-test
BILI	I-test
-	O
0.4	O

2019-02-28	O
07:30	O
PM	O

CALCIUM	B-test
-	O
9.3	O
PHOSPHATE	B-test
-	O
3.7	O
MAGNESIUM	B-test
-	O
2.3	O

2019-02-28	O
07:30	O
PM	O

WBC	B-test
-	O
4.9	O
RBC	B-test
-	O
4.27	O
*	O
HGB	B-test
-	O
11.3	O
*	O
HCT	B-test
-	O
35.1	O
*	O
MCV	B-test
-	O
82	O
MCH	B-test
-	O
26.4	O
*	O
MCHC	B-test
-	O
32.2	O
RDW	B-test
-	O
17.4	O
*	O

2019-02-28	O
07:30	O
PM	O

NEUTS	B-test
-	O
66.3	O
LYMPHS	B-test
-	O
25.0	O
MONOS	B-test
-	O
5.7	O
EOS	B-test
-	O
0.1	O
BASOS	B-test
-	O
2.9	O
*	O

2019-02-28	O
07:30	O
PM	O

PLT	B-test
COUNT	I-test
-	O
187	O

2019-02-28	O
07:30	O
PM	O

PT	B-test
-	O
13.1	O
PTT	B-test
-	O
30.1	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.1	O

2019-02-28	O
06:27	O
PM	O
URINE	B-test

COLOR	B-test
-	O
Amber	O
APPEAR	B-test
-	O
Clear	O
SP	B-test
Stickney	I-test
-	O
1.015	O

2019-03-23	O
05:31	O
AM	O
BLOOD	B-test

WBC	B-test
-	O
8.6	O
RBC	B-test
-	O
3.43	O
*	O
Hgb	B-test
-	O
9.9	O
*	O
Hct	B-test
-	O
28.7	O
*	O
MCV	B-test
-	O
84	O
MCH	B-test
-	O
28.9	O
MCHC	B-test
-	O
34.5	O
RDW	B-test
-	O
17.8	O
*	O
Plt	B-test
Ct	I-test
-	O
120	O
*	O

2019-03-25	O
01:53	O
AM	O
BLOOD	B-test

Glucose	B-test
-	O
95	O
UreaN	B-test
-	O
35	O
*	O
Creat	B-test
-	O
1.4	O
*	O
Na	B-test
-	O
136	O
K	B-test
-	O
4.9	O
Cl	B-test
-	O
105	O
HCO3	B-test
-	O
21	O
*	O
AnGap	B-test
-	O
15	O

2019-03-25	O
04:47	O
PM	O
BLOOD	B-test
PT	B-test
-	O
14.1	O
*	O
PTT	B-test
-	O
29.4	O
INR	B-test
(	I-test
PT	I-test
)-	O
1.3	O
*	O

Brief	O
Hospital	O
Course	O
:	O

As	O
mentioned	O
in	O
the	O
HPI	O
,	O
Mr.	O
Mcculley	O
was	O
transferred	O
from	O
MWMC	O
to	O
Nantucket	O
Cottage	O
Hospital	O
for	O
ongoing	O
care	O
(	O
?	O
MVR	B-treatment
).	O

And	O
Infectious	O
disease	O
consult	O
was	O
immediately	O
made	O
.	O

IV	B-treatment
Daptomycin	I-treatment
was	O
continued	O
via	O
PICC	B-treatment
line	I-treatment
which	O
was	O
inserted	O
on	O
02-20	O
at	O
MWMC	O
.	O

Mr	O
Stutts	O
had	O
an	B-test
extensive	I-test
preop	I-test
evaluation	I-test
including	O
cardiology	O
,	O
infectious	O
diseases	O
,	O
orthopedics	O
,	O
psychiatry	O
and	O
ethics	O
services	O
.	O

He	O
ultimately	O
was	O
brought	O
to	O
the	O
operating	O
room	O
on	O
03-19	O
.	O

At	O
that	O
time	O
he	O
had	O
a	B-treatment
Mitral	I-treatment
Valve	I-treatment
replacement	I-treatment
,	O
aortoomy	B-treatment
,	O
and	O
left	B-treatment
atrial	I-treatment
appendage	I-treatment
resection	I-treatment
.	O

His	B-treatment
bypass	I-treatment
time	I-treatment
was	O
103	O
minutes	O
/	O
crossclamp	B-treatment
89	O
mins	O
.	O

Please	O
see	O
OR	O
report	O
for	O
full	O
details	O
.	O

He	O
tolerated	O
the	B-treatment
surgery	I-treatment
well	O
and	O
was	O
transferred	O
from	O
the	O
OR	O
to	O
the	O
CSRU	O
on	O
Epinephrinne	B-treatment
and	O
Propofol	B-treatment
infusions	I-treatment
.	O

He	O
did	O
well	O
in	O
immediate	O
postoperative	O
period	O
.	O

Following	O
surgery	B-treatment
his	B-treatment
anesthesia	I-treatment
was	O
reversed	O
,	O
he	O
was	O
weaned	O
from	O
ventilator	B-treatment
and	O
successfully	O
extubated	O
.	O

His	B-treatment
iv	I-treatment
medications	I-treatment
were	O
also	O
weaned	O
to	O
off	O
.	O

On	O
POD1	O
His	B-treatment
PA	I-treatment
line	I-treatment
and	O
chest	B-treatment
tubes	I-treatment
were	O
removed	O
,	O
he	O
was	O
also	O
started	O
on	O
Beta	B-treatment
blockers	I-treatment
and	O
diuretics	B-treatment
.	O

On	O
POD2	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
and	O
was	O
transferred	O
from	O
the	O
ICU	O
to	O
F2	O
for	O
continued	O
postop	O
care	O
.	O

Over	O
the	O
next	O
several	O
days	O
with	O
the	O
assisstance	O
of	O
the	O
nursing	O
staff	O
and	O
physical	O
therapy	O
the	O
patients	O
activity	O
level	O
was	O
advanced	O
,	O
he	O
was	O
transitioned	O
to	O
all	B-treatment
oral	I-treatment
medications	I-treatment
with	O
the	O
exception	O
of	O
his	B-treatment
antibiotics	I-treatment
.	O

On	O
POD7	O
it	O
was	O
decided	O
that	O
the	O
pt	O
was	O
stable	O
and	O
ready	O
for	O
discharge	O
to	O
rehabilitation	O
.	O

It	O
should	O
be	O
noted	O
that	O
the	O
patient	O
did	O
have	O
episodes	O
of	O
postoperative	B-problem
atrial	I-problem
fibrillation	I-problem
,	O
he	O
was	O
seen	O
by	O
the	O

Electrophysiology	O
service	O
,	O
started	O
on	O
Procainamide	B-treatment
and	O
Coumadin	B-treatment
.	O

Medications	O
on	O
Admission	O
:	O

Aricept	B-treatment
10	O
mg	O
qd	O
,	O
Aspirin	B-treatment
81	O
mg	O
qd	O
,	O
Folic	B-treatment
acid	I-treatment
,	O
Gabapentin	B-treatment
200	O
mg	O
tid	O
,	O
Lopressor	B-treatment
12.5	O
mg	O
bid	O
,	O
Lisinopril	B-treatment
5	O
mg	O
qd	O
,	O
Daptomycin	B-treatment
420	O
mg	O
IV	O
qd	O
,	O
Protonix	B-treatment
40	O
mg	O
qd	O
,	O
Seroquel	B-treatment
50	O
mg	O
tid	O
,	O
Heparin	B-treatment
5000	O
units	O
SQ	O
tid	O
,	O
Colace	B-treatment
100	O
mg	O
bid	O
,	O
Lactulose	B-treatment
15	O
mg	O
bid	O
,	O
Comtan	B-treatment
200	O
mg	O
qd	O
,	O
Mirapex	B-treatment
1.5	O
mg	O
tid	O
,	O
Sinemet	B-treatment
50	O
/	O
200	O
mg	O
tid	O

Discharge	O
Medications	O
:	O

1.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
2	O
weeks	O
.	O

2.	O
Potassium	B-treatment
Chloride	I-treatment
20	O
mEq	O
Packet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Packet	O
PO	O
once	O
a	O
day	O
for	O
2	O
weeks	O
.	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

5.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Magnesium	B-treatment
Hydroxide	I-treatment
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

7.	O
Entacapone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

8.	O
Pramipexole	B-treatment
0.25	O
mg	O
Tablet	O
Sig	O
:	O
Six	O
(	O
6	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

9.	O
Carbidopa	B-treatment
-	I-treatment
Levodopa	I-treatment
50	O
-	O
200	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

10.	O
Quetiapine	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

11.	O
Procainamide	B-treatment
250	O
mg	O
Capsule	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Capsule	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
:	O
x	O
6	O
weeks	O
.	O

12.	O
Acetaminophen	B-treatment
-	I-treatment
Codeine	I-treatment
300-30	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

13.	O
Warfarin	B-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
as	O
directed	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

14.	O
Daptomycin	B-treatment
500	O
mg	O
Recon	O
Soln	O
Sig	O
:	O
Four	O
90y	O
(	O
480	O
)	O
mg	O
Intravenous	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
:	O
thru	O
05-02	O
.	O

Discharge	O
Disposition	O
:	O

Extended	B-treatment
Care	I-treatment

Discharge	O
Diagnosis	O
:	O
mitral	B-problem
valve	I-problem
endocarditis	I-problem
s/p	O
MV	B-treatment
replacement	I-treatment

HTN	B-problem
PAD-WORD	O

s/p	O
CVA	B-problem

Spinal	B-problem
stenosis	I-problem
s/p	O
Lumbar	B-treatment
Laminectomy	I-treatment

Parkingson	B-problem
's	I-problem

h/o	O
paranoid	B-problem
delusions	I-problem

MGUS	B-problem
vs	O
MM	B-problem

Discharge	O
Condition	O
:	O
good	O

Discharge	O
Instructions	O
:	O

May	O
take	O
shower	O
.	O

Wash	O
incisions	B-problem
with	O
warm	O
water	O
and	O
gentle	O
soap	O
.	O

Do	O
no	O
take	O
bath	O
or	O
swim	O
.	O

Do	O
not	O
apply	O
lotions	B-treatment
,	O
creams	B-treatment
,	O
ointments	B-treatment
or	O
powders	B-treatment
to	O
incision	B-problem
.	O

Do	O
not	O
drive	O
for	O
1	O
month	O
.	O

Do	O
not	O
lift	O
more	O
than	O
10	O
pounds	O
for	O
2	O
months	O
.	O

Please	O
contact	O
office	O
if	O
you	O
develop	O
a	B-problem
fever	I-problem
more	O
than	O
101.5	O
or	O
notice	O
drainage	B-problem
from	O
chest	B-problem
incision	I-problem
.	O

Followup	O
Instructions	O
:	O

Dr.	O
Portsche	O
in	O
4	O
weeks	O

Dr.	O
Bravo	O
(	O
PCP	O
)	O
in	O
1-2	O
weeks	O

Infectious	O
disease	O
Provider	O
:	O

Marsha	O
Harriet	O
,	O
MD	O

Phone	O
:	O
574-5036	O

Date	O
/	O
Time	O
:	O
2019-04-29	O
10:00	O

Jeffrey	O
Everett	O
MD	O
23-815	O

Completed	O
by	O
:	O
MARK	O
Carolyn	O
NP	O
80-AUO	O
2019-03-26	O
@	O
1033	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Millard	O
Fornataro	O
on	O
:	O
FRI	O
2019-03-29	O
4:45	O
PM	O

(	O
End	O
of	O
Report	O
)	O

468211586	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

9651828	O
PAD-WORD	O

14540	O
PAD-WORD	O

719527	O
PAD-WORD	O

1/4/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

RALNMOTTEFUH	O
,	O
AEEN	O

UNIT	O
NUMBER	O
:	O

363-79-23	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

01/04/96	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

01/10/96	O
PAD-WORD	O

FINAL	O
DIAGNOSIS	O
:	O

Cervical	B-problem
carcinoma	I-problem
;	O
bilateral	B-problem
ureteral	I-problem
obstruction	I-problem
secondary	O
to	O
the	B-problem
cancer	I-problem
.	O

Uremia	B-problem
.	O

Ileus	B-problem
.	O

OPERATION	O
:	O

Bilateral	B-treatment
ureteral	I-treatment
stent	I-treatment
placement	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
78-year-old	O
woman	O
had	O
stage	B-problem
IIIB	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
cervix	I-problem
and	O
she	O
has	O
known	B-problem
periaortic	I-problem
and	I-problem
splenic	I-problem
metastases	I-problem
.	O

She	O
was	O
discharged	O
from	O
the	O
hospital	O
about	O
18	O
days	O
prior	O
to	O
her	O
admission	O
,	O
following	O
a	O
month	O
long	O
stay	O
.	O

When	O
her	B-problem
cancer	I-problem
was	O
diagnosed	O
,	O
she	O
underwent	O
total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
and	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
and	O
pelvic	B-treatment
lymphadenectomy	I-treatment
.	O

She	O
had	O
extensive	B-problem
disease	I-problem
of	I-problem
the	I-problem
uterus	I-problem
,	I-problem
ovarian	I-problem
tubes	I-problem
,	I-problem
omentum	I-problem
and	I-problem
the	I-problem
periaortic	I-problem
lymph	I-problem
nodes	I-problem
.	O

Postoperatively	O
,	O
she	O
developed	O
ileus	B-problem
,	O
then	O
finally	O
she	O
recovered	O
and	O
she	O
was	O
discharged	O
to	O
the	O
nursing	O
home	O
.	O

She	O
was	O
readmitted	O
because	O
of	O
a	O
problem	O
with	O
uremia	B-problem
and	O
high	B-problem
BUN	I-problem
and	I-problem
creatinine	I-problem
when	O
she	O
seen	O
in	O
the	O
office	O
and	O
the	B-test
BUN	I-test
and	O
creatinine	B-test
was	O
ordered	O
.	O

The	B-test
BUN	I-test
was	O
70	O
and	O
creatinine	B-test
was	O
4.6	O
and	O
for	O
this	O
reason	O
she	O
had	O
ultrasound	B-test
of	I-test
the	I-test
kidney	I-test
which	O
showed	O
bilateral	B-problem
hydronephrosis	I-problem
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
ureteral	B-treatment
stent	I-treatment
placement	I-treatment
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
she	O
was	O
generally	O
stable	O
and	O
she	O
had	O
no	O
evidence	O
of	O
disease	B-problem
in	I-problem
the	I-problem
pelvis	I-problem
,	O
no	O
bleeding	B-problem
and	O
no	O
other	B-problem
abnormality	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Dr.	O
Jescdrig	O
was	O
called	O
and	O
a	O
consultation	O
was	O
done	O
and	O
he	O
placed	O
bilateral	B-treatment
ureteral	I-treatment
stents	I-treatment
in	I-treatment
her	I-treatment
kidneys	I-treatment
.	O

Postoperatively	O
,	O
she	O
diuresed	O
very	O
well	O
.	O

She	O
had	O
dropped	O
her	B-test
BUN	I-test
and	O
creatinine	B-test
to	O
normal	O
and	O
she	O
was	O
found	O
to	O
have	O
may	O
be	O
metastatic	B-problem
disease	I-problem
to	I-problem
her	I-problem
skin	I-problem
on	O
the	O
right	O
paraumbilical	O
area	O
.	O

Because	O
of	O
her	O
age	O
and	O
mental	O
condition	O
and	O
the	O
fact	O
that	O
she	O
had	O
cerebral	B-problem
atrophy	I-problem
,	O
the	O
decision	O
was	O
made	O
for	O
comfort	O
unless	O
she	O
has	O
any	B-problem
further	I-problem
problem	I-problem
and	O
no	O
further	O
chemotherapy	B-treatment
or	O
treatment	B-treatment
will	O
be	O
given	O
.	O

The	O
possibility	O
that	O
she	O
may	O
need	O
to	O
receive	O
radiation	B-treatment
therapy	I-treatment
to	O
this	O
area	O
to	O
prevent	O
her	O
from	O
getting	O
further	B-problem
obstruction	I-problem
was	O
also	O
brought	O
up	O
.	O

Her	O
family	O
felt	O
that	O
at	O
the	O
present	O
time	O
,	O
because	O
her	O
condition	O
was	O
no	O
good	O
,	O
they	O
would	O
like	O
to	O
just	O
take	O
her	O
home	O
so	O
that	O
she	O
could	O
enjoy	O
the	O
quality	O
of	O
life	O
.	O

Indeed	O
,	O
at	O
the	O
time	O
of	O
discharge	O
she	O
was	O
conscious	O
and	O
she	O
was	O
cooperative	O
and	O
she	O
was	O
able	O
to	O
communicate	O
very	O
nicely	O
with	O
everyone	O
including	O
her	O
family	O
,	O
except	O
for	O
the	B-problem
mental	I-problem
instability	I-problem
that	O
she	O
had	O
because	O
of	O
her	B-problem
cerebral	I-problem
atrophy	I-problem
due	O
to	O
senility	B-problem
.	O

FOLLOW-UP	O
:	O

She	O
will	O
be	O
followed	O
in	O
the	O
Centu	O
Fairgmer	O
Queen	O
Medical	O
Center	O
.	O

AZEL	O
U.	O
HIBBSKAYS	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

EARNRA	O
HAWNSPANTKOTE	O
,	O
M.D.	O

TR	O
:	O

yq	O
PAD-WORD	O

DD	O
:	O

01/26/96	O
PAD-WORD	O

TD	O
:	O

01/30/96	O
12:18	O
P	O

cc	O
:	O

AZEL	O
USANNE	O
HIBBSKAYS	O
,	O
M.D.	O
EARNRA	O
HAWNSPANTKOTE	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2016-03-22	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-04-04	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1940-06-17	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Morphine	B-treatment
PAD-WORD	O

Attending	O
:	O
Michael	O
I.	O
Miller	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
s/p	O
Fall	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
s/p	O
right	B-treatment
hip	I-treatment
ORIF	I-treatment

s/p	O
intubation	B-treatment

History	O
of	O
Present	O
Illness	O
:	O

75	O
yo	O
F	O
with	O
CAD	B-problem
s/p	O
MI	B-problem
x4	O
(	O
s/p	O
LAD	B-treatment
stent	I-treatment
'09	O
and	O
RCA	B-treatment
stent	I-treatment
x	O
2	O
in	O
'00	O
and	O
'04	O
)	O
,	O
CHF	B-problem
with	O
EF	B-test
55%	O
,	O
PAF	B-problem
,	O
Inducible	B-problem
Vtach	I-problem
s/p	O
AICD	B-treatment
placement	I-treatment
,	O
sick	B-problem
sinus	I-problem
syndrome	I-problem
s/p	O
pacer	B-treatment
and	O
COPD	B-problem
with	O
restrictive	B-problem
lung	I-problem
disease	I-problem
.	O

Per	O
daughter	O
,	O
pt	O
was	O
in	O
her	O
USOH	O
until	O
two	O
days	O
prior	O
to	O
admission	O
when	O
she	O
was	O
noted	O
to	O
have	O
a	B-problem
superficial	I-problem
ulcerations	I-problem
on	I-problem
her	I-problem
foot	I-problem
with	O
erythema	B-problem
.	O

Pt	O
was	O
taken	O
to	O
Bridgewater	O
Chelsea	O
Soldier	O
's	O
Home	O
Hospital	O
and	O
started	O
on	O
unasyn	B-treatment
IV	I-treatment
.	O

Pt	O
awoke	O
later	O
that	O
night	O
and	O
felt	O
unsteady	B-problem
on	I-problem
her	I-problem
feet	I-problem
and	O
sustained	O
a	O
mechanical	O
fall	O
.	O

Per	O
daughter	O
,	O
pt	O
did	O
not	O
note	O
chest	B-problem
pain	I-problem
,	O
tachycardia	B-problem
,	O
had	O
a	O
good	O
PO	O
intake	O
and	O
no	O
noted	B-problem
seizure	I-problem
activity	I-problem
.	O

Pt	O
was	O
in	O
severe	B-problem
"	I-problem
back	I-problem
pain	I-problem
"	I-problem
as	O
per	O
daughter	O
which	O
was	O
treated	O
with	O
dilaudid	B-treatment
.	O

CT	B-test
of	I-test
the	I-test
neck	I-test
revealed	O
a	O
possible	O
C1	B-problem
fracture	I-problem
and	O
the	B-test
X-ray	I-test
at	O
the	O
OSH	O
revealed	O
intratrochanteric	B-problem
fracture	I-problem
of	I-problem
the	I-problem
right	I-problem
femur	I-problem
.	O

Pt	O
was	O
subsequently	O
transferred	O
to	O
Hallmark	O
Health	O
System	O
for	O
orthopaedic	B-test
evaluation	I-test
.	O

In	O
Monica	O
at	O
Hallmark	O
Health	O
System	O
,	O
pt	O
was	O
seen	O
by	O
the	O
Trauma	O
service	O
where	O
a	B-test
CT	I-test
of	I-test
the	I-test
neck	I-test
revealed	O
no	O
fracture	B-problem
(	O
however	O
,	O
the	B-treatment
c-collar	I-treatment
was	O
maintained	O
secondary	O
to	O
pain	B-problem
)	O
.	O

The	O
orthopaedic	O
service	O
recommended	O
emergent	B-treatment
repair	I-treatment
of	O
the	B-problem
intratrochanteric	I-problem
fracture	I-problem
secondary	O
to	O
instability	B-problem
.	O

The	O
Monica	O
stay	O
was	O
complicated	O
by	O
runs	O
of	O
afib	B-problem
to	O
133	O
requiring	O
IV	B-treatment
lopressor	I-treatment
.	O

ROS	O
:	O

Pt	O
is	O
very	B-problem
SOB	I-problem
at	O
baseline	O
,	O
not	O
on	O
home	B-treatment
ox	I-treatment
,	O
no	O
CP	B-problem
at	O
rest	O
,	O
no	O
LE	B-problem
edema	I-problem
,	O
no	O
PND	B-problem
,	O
stable	B-problem
orthopnea	I-problem
(	O
2	O
pillows	O
)	O
.	O

Pt	O
ambulates	O
10	O
feet	O
with	O
significant	B-problem
fatigue	I-problem
as	O
per	O
daughter	O
.	O

(	O
?	O
dec	B-problem
in	I-problem
exercise	I-problem
tolerance	I-problem
)	O
.	O

CMED	O
CCU	O
change	O
include	O
discontinuation	O
of	O
coumadin	B-treatment
secondary	O
to	O
inc	O
risk	O
of	O
upper	B-problem
GI	I-problem
bleed	I-problem
.	O

Digoxin	B-treatment
,	O
Norvasc	B-treatment
and	O
Imdur	B-treatment
was	O
also	O
discontinued	O
.	O

HPI	O
:	O

75	O
yo	O
F	O
with	O
CAD	B-problem
s/p	O
stenting	B-treatment
,	O
VT	B-problem
,	O
SSS	B-problem
s/p	O
pacer	B-treatment
,	O
COPD	B-problem
,	O
presented	O
to	O
OSH	O
2016-03-21	O
with	O
foot	B-problem
ulceration	I-problem
.	O

Started	O
on	O
unasyn	B-treatment
,	O
in	O
hospital	O
suffered	O
mech.	O
fall	O
with	O
hip	B-problem
fx	I-problem
.	O

Transferred	O
to	O
Hallmark	O
Health	O
System	O
03-22	O
.	O

Medically	B-test
eval	I-test
not	O
high	B-treatment
risk	I-treatment
surgery	I-treatment
,	O
preop	B-treatment
beta	I-treatment
blocker	I-treatment
given	O
.	O

ORIF	B-treatment
with	O
repair	B-treatment
of	O
neck	B-problem
fracture	I-problem
2016-03-23	O
.	O

Expected	B-treatment
prolonged	I-treatment
extubation	I-treatment
course	I-treatment
given	O
COPD	B-problem
history	I-problem
,	O
as	O
with	O
colon	B-treatment
CA	I-treatment
resection	I-treatment
surgery	I-treatment
.	O

In	O
PM	O
extubated	O
,	O
transferred	O
to	O
floor	O
2016-03-23	O
.	O

Late	O
03-23	O
found	O
with	O
afib	B-problem
and	O
RVR	B-problem
,	O
given	O
beta	B-treatment
blocker	I-treatment
with	O
min.	O
response	O
,	O
started	O
dilt.	B-treatment
drip	I-treatment
.	O

Received	O
2	B-treatment
mg	I-treatment
dilaudid	I-treatment
for	O
pain	B-problem
o/n	O
.	O

This	O
AM	O
with	O
respiratory	B-problem
failure	I-problem
,	O
continued	B-problem
tachycardia	I-problem
on	O
dilt.	B-treatment
gtt	I-treatment
.	O

Transferred	O
to	O
unit	O
and	O
urgently	O
intubated	O
(	O
labs	B-test
below.	O
)	O

Of	O
note	O
,	O
a	B-treatment
NGT	I-treatment
by	O
Xray	B-test
was	O
not	O
in	O
correct	O
position	O
?	O
lungs	O
->	O
possibly	O
used	O
for	O
medication	B-treatment
administration	I-treatment
this	O
AM	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
CAD	B-problem
s/p	O
LAD	B-treatment
stent	I-treatment
in	O
'	O
98	O
+	O
RCA	B-treatment
stet	I-treatment
in	O
'	O
00	O
with	O
repeat	B-treatment
RCA	I-treatment
stent	I-treatment
in	O
'	O
04	O
.	O

Last	B-test
cath	I-test
in	O
9-04	O

2.	O
PAF	B-problem

3.	O
DM	B-problem

4.	O
Sick	B-problem
sinus	I-problem
syndrome	I-problem
s/p	O
pacer	B-treatment
placement	I-treatment
in	O
'	O
98	O

5.	O
Depression	B-problem

6.	O
COPD	B-problem
(	O
no	O
PFT	B-test
available	O
)	O

7.	O
Chronic	B-problem
restrictive	I-problem
lung	I-problem
disease	I-problem
(	O
no	O
PFT	B-test
available	O
)	O

8.	O
HTN	B-problem

9.	O
Hyperlipidemia	B-problem

10.	O
Obesity	B-problem

11.	O
s/p	O
TAH	B-treatment

12.	O
s/p	O
colonic	B-treatment
resection	I-treatment
secondary	O
to	O
perforation	B-problem
s/p	O
polypectomy	B-treatment

13.	O
Inducible	B-problem
Vtach	I-problem
on	O
EP	B-test
study	I-test
with	O
AICD	B-treatment
placement	I-treatment
11-01	O

14.	O
CHF	B-problem

15.	O
Upper	B-problem
GI	I-problem
bleed	I-problem

Physical	O
Exam	O
:	O

VS	B-test
:	O

HR	B-test
:	O
133	O

BP	B-test
:	O
110/80	O

Gen	O
:	O
sedated	B-treatment
but	O
A+O	O
x3	O

HEENT	O
:	O
cervical	B-treatment
collar	I-treatment
in	O
place	O

CV	O
:	O
tachycardia	B-problem

Chest	O
:	O
CTA	O
bilaterally	O

Abd	O
:	O
+	O
BS	O
,	O
soft	O
,	O
NT	B-problem
,	O
ND	B-problem
,	O
BS	O
+	O

Ext	O
:	O
no	O
peripheral	B-problem
edema	I-problem
,	O
R	B-problem
leg	I-problem
shortened	I-problem
and	I-problem
rotated	I-problem
,	O
+	O
cellulitis	B-problem

Pertinent	O
Results	O
:	O

2016-03-22	O
02:45	O
AM	O

WBC	B-test
-	O
12.7	O
*	O
RBC	B-test
-	O
4.32	O
HGB	B-test
-	O
10.5	O
*	O
HCT	B-test
-	O
33.2	O
*	O
MCV	B-test
-	O
77	O
*	O
MCH	B-test
-	O
24.2	O
*	O
MCHC	B-test
-	O
31.5	O
RDW	B-test
-	O
15.4	O

2016-03-22	O
02:45	O
AM	O

NEUTS	B-test
-	O
90.5	O
*	O
LYMPHS	B-test
-	O
5.1	O
*	O
MONOS	B-test
-	O
3.7	O
EOS	B-test
-	O
0.6	O
BASOS	B-test
-	O
0.2	O

2016-03-22	O
02:45	O
AM	O

HYPOCHROM	B-test
-	O
3+	O
POIKILOCY	B-test
-	O
1+	O
MICROCYT	B-test
-	O
2+	O

2016-03-22	O
02:45	O
AM	O

PLT	B-test
COUNT	I-test
-	O
324	O

2016-03-22	O
02:45	O
AM	O

PT	B-test
-	O
13.6	O
PTT	B-test
-	O
25.2	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.2	O

2016-03-22	O
02:45	O
AM	O

GLUCOSE	B-test
-	O
191	O
*	O
UREA	B-test
N	I-test
-	O
14	O
CREAT	B-test
-	O
0.6	O
SODIUM	B-test
-	O
141	O
POTASSIUM	B-test
-	O
3.5	O
CHLORIDE	B-test
-	O
101	O
TOTAL	B-test
CO2	I-test
-	O
28	O
ANION	B-test
GAP	I-test
-	O
16	O

2016-03-22	O
02:45	O
AM	O

CALCIUM	B-test
-	O
8.8	O
PHOSPHATE	B-test
-	O
4.4	O
MAGNESIUM	B-test
-	O
1.9	O

2016-03-22	O
11:25	O
AM	O
URINE	B-test

COLOR	B-test
-	O
Yellow	O
APPEAR	B-test
-	O
Clear	O
SP	B-test
Barajas	I-test
-	O
1.020	O

2016-03-22	O
11:25	O
AM	O
URINE	B-test

BLOOD	B-test
-	O
LG	B-test
NITRITE	I-test
-	O
NEG	O
PROTEIN	B-test
-	O
NEG	O
GLUCOSE	B-test
-	O
250	O
KETONE	B-test
-	O
NEG	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
NEG	O
PH	B-test
-	O
6.5	O

LEUK	B-test
-	O
NEG	O

2016-03-22	O
11:25	O
AM	O
URINE	B-test

RBC	B-test
-	O
0-2	O
WBC	B-test
-	O
04-02	O
BACTERIA	B-test
-	O
OCC	B-test
YEAST	I-test
-	O
NONE	O
EPI	B-test
-	O
0	O

2016-03-22	O
11:25	O
AM	O
URINE	B-test

HYALINE	B-test
-	O
3	O
*	O

2016-03-22	O
11:25	O
AM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
178	O
*	O

2016-03-22	O
11:25	O
AM	O

CK-MB	B-test
-	O
7	O

2016-03-22	O
04:45	O
PM	O

D-DIMER	B-test
-	O
1748	O
*	O

2016-03-22	O
04:45	O
PM	O

CK	B-test
(	I-test
CPK	I-test
)-	I-test
153	O
*	O

2016-03-22	O
04:45	O
PM	O

CK-MB	B-test
-	O
5	O
cTropnT	B-test
-<	O
0.01	O

'	O
00	O
TTE	B-test
:	O

EF	B-test
50-55%	O
;	O
mild	B-problem
to	I-problem
moderate	I-problem
MR	I-problem
,	O
left	O
atrium	O
is	O
moderately	B-problem
dilated	I-problem
,	O
trace	B-problem
AR	I-problem

10-02	O
:	O

Cardiac	B-test
catheterization	I-test
:	O
inferior	B-problem
,	I-problem
posterobasilar	I-problem
hypokinesis	I-problem
,	O
1	B-problem
+	I-problem
MR	I-problem
,	O
EF	B-test
48%	O
,	O
mid	O
RCA	O
50%	O
,	O
distal	O
RCA	O
40%	O
,	O
mid	O
LAD	O
50%	O
,	O
OM3	B-problem
diffusely	I-problem
diseased	I-problem
s/p	O
stenting	B-treatment
of	I-treatment
RCA	I-treatment
with	O
drug	B-treatment
eluting	I-treatment
stent	I-treatment
with	O
10%	B-test
residual	I-test
flow	I-test
.	O

2016-03-22	O
CXR	B-test
:	O
moderate	B-problem
cardiomegaly	I-problem
without	O
CHF	B-problem
,	O
no	O
effusions	B-problem
,	O
left	B-problem
retrocardiac	I-problem
opacity	I-problem
consistent	O
with	O
atelectasis	B-problem
vs.	O
consolidation	B-problem

2016-03-22	O
CT	B-test
c-spine	I-test
:	O

1)	O
No	O
evidence	O
of	O
fracture	B-problem
of	I-problem
the	I-problem
cervical	I-problem
spine	I-problem
.	O

No	O
definite	B-problem
fracture	I-problem
of	I-problem
C1	I-problem
is	O
identified	O
to	O
correlate	O
with	O
the	O
history	O
of	O
questioned	O
C1	B-problem
fracture	I-problem
from	O
outside	O
hospital	O
.	O

2)	O
Extensive	B-problem
degenerative	I-problem
change	I-problem
of	I-problem
the	I-problem
cervical	I-problem
spine	I-problem
."	O

2016-03-22	O
Femur	B-test
&	I-test
R	I-test
knee	I-test
X-ray	I-test
:	O

1)	O
Comminuted	B-problem
intertrochanteric	I-problem
fracture	I-problem
of	I-problem
the	I-problem
right	I-problem
femur	I-problem
,	O
with	O
avulsion	B-problem
of	I-problem
the	I-problem
lesser	I-problem
trochanter	I-problem
,	O
displacement	B-problem
and	O
angulation	B-problem
.	O

2)	O
No	O
other	B-problem
definite	I-problem
fractures	I-problem
identified.	O
degenerative	B-problem
changes	I-problem
of	I-problem
the	I-problem
lumbosacral	I-problem
spine	I-problem
."	O

2016-04-01	O
Flexion	B-test
extension	I-test
xrays	I-test
of	I-test
cervical	I-test
spine	I-test
:	O

Mild	O
degree	O
of	O
instability	B-problem
at	I-problem
level	I-problem
C3-C4	I-problem
as	O
described	O
.	O

Possibility	O
of	O
arch	B-problem
element	I-problem
in	I-problem
this	I-problem
region	I-problem
cannot	O
be	O
excluded	O
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

75	O
yo	O
F	O
s/p	O
MIx4	B-problem
,	O
numerous	B-test
cath	I-test
,	O
PAF	B-problem
,	O
Inducible	B-problem
VTach	I-problem
s/p	O
AICD	B-treatment
and	O
pacer	B-treatment
with	O
severe	B-problem
COPD	I-problem
/	O
restrictive	B-problem
lung	I-problem
disease	I-problem
s/p	O
fall	O
with	O
intertrochanteric	B-problem
fracture	I-problem
.	O

As	O
per	O
CMED	O
CCU	O
,	O
pt	O
requires	O
emergent	B-treatment
repair	I-treatment
of	O
intertrochanteric	B-problem
fracture	I-problem
to	O
preserve	O
neurovascular	O
function	O
.	O

Pt	O
is	O
a	O
moderate	O
risk	O
for	O
a	B-treatment
needed	I-treatment
emergent	I-treatment
non-cardiac	I-treatment
procedure	I-treatment
.	O

Pt	O
is	O
medically	O
cleared	O
for	O
procedure	B-treatment
,	O
likely	O
has	O
some	B-problem
mile	I-problem
rate	I-problem
related	I-problem
ischemia	I-problem
.	O

1.	O
Cards	O
:	O

---	O
Pre-op	B-treatment
B-blocker	I-treatment
with	O
goal	B-test
HR	I-test
<	O
70	O

---	O
No	O
real	O
utility	O
in	O
MIBI	B-treatment
/	O
cath	B-test
prior	O
to	O
procedure	B-treatment
gien	O
previous	B-test
caths	I-test
with	O
no	O
significant	B-problem
lesions	I-problem
to	O
be	O
intervened	O
on	O
.	O

---	O
V-Tach	B-problem
:	O
pt	O
has	O
AICD	B-treatment
in	O
place	O
,	O
however	O
b-blocker	B-treatment
should	O
contorl	O
Vtach	B-problem
for	O
now	O
.	O

---	O
B-blocker	B-treatment
IV	I-treatment
,	O
Dilt	B-treatment
PRN	O
for	O
PAF	B-problem

---	O
Hold	O
coumadin	B-treatment
for	O
afib	B-problem
given	O
hx	O
of	O
upper	B-problem
GIB	I-problem
and	O
surgery	B-treatment
in	O
AM	O

---	O
Continue	O
ASA	B-treatment
,	O
plavix	B-treatment

---	O
ROMI	B-problem
,	O
check	O
AM	O
ECG	B-test

2.	O
COPD	B-problem
/	O
Restrictive	B-problem
lung	I-problem
disease	I-problem
:	O

---	O
Nebs	B-treatment
/	O
MDI	B-treatment
PRN	O

---	O
no	O
need	O
for	O
steroids	B-treatment
now	O

---	O
expect	O
prolonged	B-problem
wean	I-problem
given	O
previous	O
history	O
of	O
prolonged	B-problem
wean	I-problem
s/p	O
colonic	B-treatment
resection	I-treatment

---	O
incentive	B-treatment
spirometry	I-treatment
for	O
atelectasis	B-problem

3.	O
Hip	B-problem
fracture	I-problem
:	O

---	O
pain	B-treatment
control	I-treatment
with	O
diluadid	B-treatment
,	O
tylenol	B-treatment

---	O
lovenox	B-treatment
tonight	O
x1	O
,	O
hold	O
AM	O
dose	O
per	O
CMED	O
CCU	O

---	O
Pt	O
to	O
OR	O
in	O
early	O
AM	O

4.	O
Anemia	B-problem
:	O

---	O
iron	B-test
studies	I-test

---	O
TSH	B-test

---	O
no	O
need	O
fortransfusion	B-treatment
currently	O
,	O
keep	O
Hct	B-test
>	O
30	O

5.	O
Hypokalemia	B-problem
:	O

---	O
60IV	B-treatment
K	I-treatment
now	O

---	O
continue	O
PO	B-treatment
K	I-treatment

---	O
check	O
lytes	B-test
in	O
PM	O

6.	O
Cellulitis	B-problem
:	O

---	O
continue	O
unasyn	B-treatment

---	O
hold	O
off	O
on	O
X-rays	B-test
for	O
now	O

7.	O
DM	B-problem
:	O

---	O
RISS	B-treatment
-	O
tight	O
glucose	B-treatment
control	I-treatment
pre-op	O

8.	O
PPx	B-treatment
:	O

---	O
Protonix	B-treatment
,	O
Lovenox	B-treatment
,	O
R	B-treatment
boot	I-treatment
as	O
per	O
CMED	O
CCU	O

9.	O
Diet	O
:	O

NPO	B-treatment
PAD-WORD	O

10.	O
Code	O
:	O

Full	O
-->	O
DNR	O
/	O
DNI	O

CMED	O
course	O
:	O

ORIF	B-treatment
with	O
repair	B-treatment
of	O
neck	B-problem
fracture	I-problem
2016-03-23	O
.	O

Had	O
expected	O
prolonged	B-problem
post-op	I-problem
extubation	I-problem
in	O
PACU	O
given	O
COPD	B-problem
history	I-problem
,	O
as	O
with	O
colon	B-treatment
CA	I-treatment
resection	I-treatment
surgery	I-treatment
.	O

In	O
PM	O
extubated	O
,	O
transferred	O
to	O
floor	O
2016-03-23	O
.	O

Late	O
03-23	O
found	O
with	O
afib	B-problem
and	O
RVR	B-problem
,	O
given	O
beta	B-treatment
blocker	I-treatment
with	O
min.	O
response	O
,	O
started	O
dilt.	B-treatment
drip	I-treatment
.	O

Received	O
2	B-treatment
mg	I-treatment
dilaudid	I-treatment
for	O
pain	B-problem
o/n	O
.	O

On	O
03-24	O
AM	O
p/w	O
with	O
respiratory	B-problem
failure	I-problem
,	O
continued	B-problem
tachycardia	I-problem
on	O
dilt.	B-treatment
gtt.	I-treatment

Transferred	O
to	O
unit	O
and	O
urgently	O
intubated	O
.	O

Of	O
note	O
,	O
there	O
was	O
a	O
question	O
of	O
misplaced	B-problem
NGT	I-problem
.	O

When	O
NGT	B-treatment
tube	I-treatment
was	O
pulled	O
out	O
,	O
it	O
was	O
noted	O
to	O
have	O
respiratory-like	O
secretions	O
.	O

Concern	O
for	O
aspiration	B-problem
of	O
mediations	B-treatment
to	O
lungs	O
.	O

However	O
,	O
evaluation	O
of	O
CXR	B-test
revealed	O
NGT	B-problem
coiled	I-problem
in	I-problem
esophagus	I-problem
.	O

Pt	B-problem
's	I-problem
respiratory	I-problem
distress	I-problem
is	O
most	O
likely	O
on	O
setting	O
of	O
aspiration	B-problem
pneumonia	I-problem
vs.	O
pneumonitis	B-problem
in	O
the	O
setting	O
of	O
depressed	B-problem
mental	I-problem
status	I-problem
secondary	O
to	O
post-operative	B-treatment
narcotics	I-treatment
.	O

Pt	O
was	O
pan-cultured	O
and	O
switched	O
from	O
unasyn	B-treatment
(	O
started	O
at	O
OSH	O
for	O
foot	B-problem
ulcer	I-problem
)	O
to	O
zosyn	B-treatment
.	O

Vanco	B-treatment
was	O
added	O
for	O
possible	O
nosocomial	B-problem
infection	I-problem
.	O

CTA	B-test
was	O
performed	O
which	O
was	O
negative	O
for	O
PE	B-problem
,	O
but	O
revealed	O
bilateral	B-problem
patchy	I-problem
ground	I-problem
glass	I-problem
opacities	I-problem
c/w	O
aspiration	B-problem
vs.	O
pneumonia	B-problem
vs.	O
edema	B-problem
.	O

Pt	O
was	O
weaned	O
down	O
on	O
ventilator	B-treatment
,	O
minimal	B-problem
secretions	I-problem
noted	O
.	O

On	O
03-27	O
,	O
pt	O
was	O
noted	O
to	O
have	O
depressed	B-problem
mental	I-problem
status	I-problem
off	O
all	B-treatment
sedating	I-treatment
medications	I-treatment
;	O
mental	O
status	O
improved	O
over	O
the	O
course	O
of	O
the	O
day	O
.	O

Pt	O
was	O
diuresed	O
.	O

Atrial	B-problem
fibrillation	I-problem
was	O
rate-controlled	O
on	O
dilt	B-treatment
drip	I-treatment
.	O

Dilt	B-treatment
drip	I-treatment
was	O
discontinued	O
and	O
metoprolol	B-treatment
titrated	O
up	O
.	O

Cardiac	B-test
enzymes	I-test
were	O
cycled	O
in	O
setting	O
of	O
rapid	B-problem
AF	I-problem
and	O
were	O
flat	O
.	O

Initially	O
,	O
pt	O
was	O
noted	O
to	O
be	O
dry	B-problem
with	O
low	B-problem
FeNa	I-problem
and	O
given	O
IVF	B-treatment
.	O

Then	O
,	O
noted	O
to	O
be	O
volume	B-problem
overloaded	I-problem
and	O
diuresed	O
with	O
lasix	B-treatment
.	O

Pt	O
had	O
depressed	B-problem
mental	I-problem
status	I-problem
on	O
transfer	O
to	O
CMED	O
in	O
setting	O
of	O
narcotics	B-treatment
.	O

She	O
was	O
then	O
started	O
on	O
propofol	B-treatment
while	O
intubated	B-treatment
.	O

Head	B-test
CT	I-test
was	O
negative	O
for	O
acute	B-problem
bleed	I-problem
,	O
mass	B-problem
effect	I-problem
,	O
or	O
stroke	B-problem
.	O

Mental	O
status	O
improved	O
during	O
times	O
when	O
propofol	B-treatment
was	O
held	O
.	O

On	O
03-27	O
,	O
pt	O
was	O
noted	O
to	O
have	O
significantly	B-problem
depressed	I-problem
M.S.	I-problem
off	O
propol	B-treatment
improved	O
off	O
sedation	B-treatment
.	O

All	B-treatment
sedating	I-treatment
medications	I-treatment
including	O
prn	B-treatment
narcotics	I-treatment
were	O
held	O
and	O
mental	O
status	O
cleared	O
somewhat	O
.	O

s/p	O
hip	B-treatment
fx	I-treatment
repair	I-treatment
:	O
started	O
on	O
lovenox	B-treatment
for	O
anti-coagulation	B-treatment
.	O

Given	O
standing	B-treatment
NSAID	I-treatment
,	O
tylenol	B-treatment
for	O
pain	B-treatment
control	I-treatment
.	O

opiates	B-treatment
used	O
very	O
sparingly	O
in	O
setting	O
of	O
MS	B-problem
change	I-problem

On	O
transfer	O
to	O
floor	O
team	O
from	O
CMED	O
active	O
issues	O
and	O
plan	O
included	O
:	O

Resp	B-problem
failure	I-problem
/	O
COPD	B-problem
:	O

Initially	O
got	O
steroids	B-treatment
upon	O
intubation	B-treatment
.	O

Off	O
for	O
days	O
now	O
.	O

Extubated	O
on	O
03-31	O
.	O

Still	O
tachypneic	B-problem
and	O
hypoxic	B-problem
on	O
room	O
air	O
.	O

Lung	O
sounds	O
fairly	O
clear	O
.	O

?	O
COPD	B-problem
vs	O
atelectasis	B-problem
as	O
cause	O
of	O
hypoxia	B-problem
.	O

On	O
Blake	O
,	O
Nancy	O
pe	O
less	O
likely	O

-	O
atrovent	B-treatment
standing	O
.	O

prn	O
albuterol	B-treatment
only	O
given	O
A	B-problem
fib	I-problem
with	O
RVR	B-problem

-	O
inhaled	B-treatment
steroids	I-treatment

-	O
obtaining	O
pcp	O
set	O
of	O
Reginald	O

Fever	B-problem
:	O

In	O
the	O
ICU	O
.	O

Had	O
received	O
unasyn	B-treatment
,	O
vanc	B-treatment
,	O
zosyn	B-treatment
during	O
hospital	O
course	O
for	O
cellulitis	B-problem
and	O
other	O
unclear	O
reasons	O
,	O
including	O
possible	O
vent	B-problem
associated	I-problem
pna	I-problem
.	O

No	O
true	O
source	O
found	O
.	O

Afebrile	B-problem
>	O
24	O
hours	O
off	O
abx	B-treatment
.	O

-	O
culture	B-test
if	O
spikes	O
.	O

No	O
abx	B-treatment
unless	O
source	O
found	O

a.fib	B-problem
with	O
RVR	B-problem
-	O
Has	O
ppm	B-treatment
,	O
so	O
can	O
have	O
lot	O
of	O
nodal	B-treatment
agents	I-treatment
.	O

Now	O
rate	O
controlled	O
on	O
metop	B-treatment
125	O
tid	O
and	O
dilt	B-treatment
.	O

30	O
QID	O
.	O

Titrate	O
prn	O
.	O

-	O
continue	O
nodal	B-treatment
agents	I-treatment

-	O
consider	O
anti	B-treatment
coag	I-treatment
for	O
cva	B-treatment
prevention	I-treatment
,	O
but	O
wait	O
until	O
ambulating	O
better	O

CAD	B-problem
:	O
on	O
asa	B-treatment
,	O
b	B-treatment
blocker	I-treatment
,	O
ace	B-treatment
.	O

No	O
statin	B-treatment
.	O

need	O
to	O
clear	O
with	O
family	O

Heme	O
-	O
anemic	B-problem
.	O

Unclear	O
baseline	O
.	O

Possible	O
anemia	B-problem
03-02	O
operative	B-problem
blood	I-problem
loss	I-problem
.	O

Follow	O
hct	B-test
daily	O
Goal	O
>	O
28	O

Neck	O
:	O
never	O
had	O
c	O
spine	O
cleared	O
by	O
neurosurg	O
.	O

Had	O
fall	O
pta	O
with	O
?	O
fx	B-problem
on	O
initial	B-test
CT	I-test
,	O
neg	O
fx	B-problem
on	O
f/u	B-test
ct	I-test
.	O

-	O
flex	B-test
/	I-test
ext	I-test
films	I-test
done	O

-	O
will	O
clear	O
with	O
neursurg	O
prior	O
to	O
removing	O
hard	B-treatment
collar	I-treatment

Overnight	O
on	O
pt	O
's	O
first	O
evening	O
on	O
the	O
floor	O
,	O
she	O
had	O
episode	O
of	O
desaturation	B-problem
with	O
inc	B-problem
O2	I-problem
requirement	I-problem
(	O
4L	O
->	O
6L	O
->	O
sating	B-test
91%	O
on	O
NRB	B-treatment
)	O
-	O
CXR	B-test
with	O
worsening	B-problem
-	O
non	O
responsive	O
to	O
lasix	B-treatment
.	O

Family	O
meeting	O
held	O
and	O
pt	O
made	O
clear	O
wishes	O
after	O
extubation	B-treatment
that	O
she	O
does	O
not	O
want	O
to	O
be	O
intubated	O
again	O
and	O
made	O
DNR	B-treatment
/	O
DNI	B-treatment
.	O

No	O
BIPAP	B-treatment
.	O

Now	O
pt	O
lethargic	B-problem
and	O
min	B-problem
responsive	I-problem
.	O

All	O
four	O
children	O
in	O
pts	O
room	O
and	O
agree	O
on	O
CMO	B-treatment
-	O
want	O
to	O
d/c	O
c-collar	B-treatment
and	O
start	O
morphine	B-treatment
ggt	I-treatment
.	O

Discussed	O
with	O
night	O
float	O
cover	O
Dr.	O
Dennis	O
COmmander	O
and	O
Dr.	O
Mike	O
French	O
.	O

Although	O
Dr.	O
Ray	O
will	O
be	O
covering	O
pt	O
today	O
,	O
Dr.	O
Stephanie	O
Wilson	O
spoke	O
with	O
family	O
this	O
morning	O
and	O
has	O
noted	O
that	O
pt	O
is	O
CMO	B-treatment
.	O

EP	O
was	O
called	O
to	O
deactivate	O
pt	O
dual	B-treatment
chamber	I-treatment
ICD	I-treatment
as	O
per	O
family	O
wishes	O
.	O

On	O
exam	B-test
,	O
pt	O
lethargic	B-problem
,	O
responsive	O
to	O
pain	B-problem
but	O
not	O
voice	O
,	O
with	O
NRB	B-treatment
in	O
place	O
;	O
obvious	B-problem
inc	I-problem
wob	I-problem
.	O

IV	B-treatment
in	I-treatment
R	I-treatment
foot	I-treatment
for	O
access	O
.	O

Family	O
at	O
bedside	O
.	O

afebrile	B-problem
;	O

BP	B-test
:	O
159-161-139-98	O
(	O
after	O
morphine	B-treatment
)/	O
69	O
HR	B-test
:	O
148	O
-->	O
88	O
;	O
rr	B-test
:	O
28-40	O
O2	B-test
:	O
94%	O
NRB	B-treatment

As	O
above	O
,	O
made	O
CMO	B-treatment
after	O
meeting	O
with	O
NF	O
team	O
and	O
family	O
and	O
reconfirmed	O
with	O
primary	O
medical	O
team	O
on	O
04-02	O
.	O

Start	O
morphine	B-treatment
ggt	I-treatment
and	O
titrate	O
to	O
comfort	O
.	O

D/c	O
'ed	O
all	B-test
lab	I-test
draws	I-test
/	O
vitals	B-test
.	O

Prn	B-treatment
nebs	I-treatment
for	O
comfort	O
.	O

Family	O
at	O
bedside	O
and	O
aware	O
and	O
in	O
agreement	O
of	O
plan	O
.	O

Morhpine	B-treatment
ggt	I-treatment
titrated	O
up	O
to	O
18	O
mg	O
/	O
hr	O
by	O
monday	O
morning	O
and	O
pt	O
expired	O
04-04	O
at	O
7:40	O
am	O
.	O

Medications	O
on	O
Admission	O
:	O

MEDICATION	O
:	O

1.	O
Coumadin	B-treatment
2	O
mg	O
once	O
daily	O
(	O
stopped	O
recently	O
due	O
to	O
risk	O
of	O
GI	B-problem
bleed	I-problem
)	O

2.	O
Zoloft	B-treatment
100	O
mg	O
once	O
daily	O

3.	O
Toprol	B-treatment
100	O
mg	O
BID	O

4.	O
Lasix	B-treatment
40	O
mg	O
BID	O

5.	O
AS	B-treatment
81	O
mg	O
once	O
daily	O

6.	O
Plavix	B-treatment
75	O
mg	O
once	O
daily	O

7.	O
KCl	B-treatment
40	O
mEq	O
once	O
daily	O

8.	O
Prandin	B-treatment
0.5	O
mg	O
once	O
daily	O

9.	O
Unasyn	B-treatment
3	O
gIV	O
Q8hours	O

ALLERGIES	O
:	O

Morphine	B-treatment
->	O
confusion	B-problem
/	O
delerium	B-problem
.	O

Discharge	O
Disposition	O
:	O

Expired	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O
n/a	O

Discharge	O
Condition	O
:	O
n/a	O

Discharge	O
Instructions	O
:	O
n/a	O

Followup	O
Instructions	O
:	O
n/a	O

Ruby	O
Eric	O
MD	O
73-490	O

Completed	O
by	O
:	O
Verna	O
Richard	O
MD	O
01-822	O
2016-04-04	O
@	O
2005	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brandon	O
Mangum	O
on	O
:	O
WED	O
2016-04-13	O
3:17	O
PM	O

(	O
End	O
of	O
Report	O
)	O

478767824	O
PAD-WORD	O

OMH	O
PAD-WORD	O

1644158	O
PAD-WORD	O

248222	O
PAD-WORD	O

4/27/1998	O
12:00:00	O
AM	O

ADULT	B-problem
RESPIRATORY	I-problem
DISTRESS	I-problem
SYNDROME	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

WYNDEALB	O
,	O
AUALE	O

UNIT	O
NUMBER	O
:	O

309-82-41	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

04/27/1998	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

05/02/1998	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

acute	B-problem
renal	I-problem
insufficiency	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
72	O
year	O
old	O
white	O
male	O
with	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
a	B-treatment
four	I-treatment
vessel	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
in	O
1983	O
,	O
pulmonary	B-problem
hypertension	I-problem
,	O
hepatitis	B-problem
C	I-problem
positive	O
cirrhosis	B-problem
history	O
with	O
history	O
of	O
portal	B-problem
hypertension	I-problem
and	O
status	O
post	O
an	B-problem
upper	I-problem
gastrointestinal	I-problem
bleed	I-problem
on	O
4-10-98	O
,	O
who	O
presents	O
from	O
Sondi	O
Memorial	O
for	O
work	B-test
up	I-test
of	O
pulmonary	B-problem
infiltrates	I-problem
,	O
acute	B-problem
renal	I-problem
failure	I-problem
and	O
pulmonary	B-problem
hypertension	I-problem
.	O

The	O
patient	O
presented	O
to	O
Sondi	O
Memorial	O
on	O
4-10-98	O
with	O
fatigue	B-problem
and	O
fall	O
,	O
found	O
to	O
have	O
a	B-test
hematocrit	I-test
of	O
29	O
,	O
baseline	O
37	O
.	O

The	O
patient	O
was	O
transfused	O
two	B-treatment
units	I-treatment
and	O
an	B-test
esophagogastroduodenoscopy	I-test
done	O
where	O
it	O
showed	O
gastritis	B-problem
,	O
candidal	B-problem
esophagitis	I-problem
and	O
portal	B-problem
hypertensive	I-problem
gastropathy	I-problem
without	O
varices	B-problem
.	O

A	B-test
colonoscopy	I-test
showed	O
anteriordysplasia	B-problem
,	O
no	O
bleeding	B-problem
was	O
seen	O
.	O

The	O
patient	O
was	O
discharged	O
after	O
one	O
week	O
on	O
iron	B-treatment
sulfate	I-treatment
.	O

On	O
4-24	O
,	O
the	O
patient	O
was	O
seen	O
again	O
at	O
Sondi	O
Memorial	O
when	O
he	O
experienced	O
at	O
home	O
a	O
fall	O
,	O
no	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
positive	O
substernal	B-problem
chest	I-problem
pain	I-problem
,	O
pleuritic	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
cough	B-problem
.	O

He	O
went	O
to	O
Sondi	O
Memorial	O
where	O
he	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
and	O
was	O
found	O
to	O
have	O
a	B-problem
left	I-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
/	O
pneumonia	B-problem
,	O
started	O
on	O
cefuroxime	B-treatment
.	O

His	O
respiratory	O
condition	O
continued	O
to	O
deteriorate	O
despite	O
aggressive	B-treatment
chest	I-treatment
physical	I-treatment
therapy	I-treatment
for	O
possible	O
blood	O
,	O
given	O
Lasix	B-treatment
for	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
became	O
hypotensive	B-problem
,	O
hypoxic	B-problem
and	O
intubated	B-treatment
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
expanding	B-problem
pulmonary	I-problem
infiltrates	I-problem
on	O
chest	B-test
x-ray	I-test
,	O
developed	O
acute	B-problem
renal	I-problem
insufficiency	I-problem
with	O
minimal	B-problem
urine	I-problem
output	I-problem
,	O
less	O
than	O
10	O
cc	O
an	O
hour	O
,	O
started	O
on	O
dopamine	B-treatment
for	O
hemodynamic	B-problem
instability	I-problem
.	O

An	B-test
echocardiogram	I-test
was	O
obtained	O
on	O
4-26	O
which	O
showed	O
concentric	B-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
with	O
normal	O
_____	O
left	O
ventricular	O
function	O
,	O
severe	B-problem
right	I-problem
ventricular	I-problem
dilatation	I-problem
with	O
septal	B-problem
hypokinesis	I-problem
and	I-problem
flattening	I-problem
with	O
a	O
question	O
of	O
right	B-problem
ventricular	I-problem
apical	I-problem
clot	I-problem
raised	O
with	O
mild	B-problem
aortic	I-problem
stenosis	I-problem
,	O
severe	B-problem
tricuspid	I-problem
regurgitation	I-problem
and	O
increased	B-problem
pulmonary	I-problem
artery	I-problem
pressure	I-problem
of	O
approximately	O
70	O
millimeters	O
,	O
consistent	O
with	O
fairly	B-problem
severe	I-problem
pulmonary	I-problem
hypertension	I-problem
.	O

Blood	B-test
cultures	I-test
x	O
two	O
sent	O
off	O
with	O
no	O
growth	B-problem
.	O

The	O
patient	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
with	O
flat	O
creatine	B-test
kinases	I-test
and	O
he	O
was	O
sent	O
to	O
Oaksgekesser/	O
Memorial	O
Hospital	O
for	O
further	B-test
work	I-test
up	I-test
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

At	O
the	O
Oaksgekesser/	O
Memorial	O
Hospital	O
he	O
was	O
quite	B-problem
hypotensive	I-problem
,	O
requiring	O
dopamine	B-treatment
at	O
1,000	O
,	O
Levo	B-treatment
at	O
12	O
.	O

His	B-test
chest	I-test
x-ray	I-test
showed	O
diffuse	B-problem
patchy	I-problem
infiltrates	I-problem
on	I-problem
left	I-problem
lung	I-problem
with	O
left	B-problem
upper	I-problem
lung	I-problem
patchy	I-problem
infiltrates	I-problem
and	O
right	B-problem
hemidiaphragm	I-problem
elevated	I-problem
,	O
consistent	O
with	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
from	O
possible	O
pneumonia	B-problem
.	O

A	B-test
urinalysis	I-test
was	O
obtained	O
which	O
showed	O
blood	B-problem
,	O
urine	B-problem
sediment	I-problem
was	O
active	B-problem
with	O
positive	O
dysmorphic	B-problem
cells	I-problem
,	O
red	B-problem
cell	I-problem
casts	I-problem
,	O
and	O
1+	B-problem
albumin	I-problem
with	O
mild	B-problem
protein	I-problem
uria	I-problem
.	O

The	O
patient	O
had	O
ANCA	B-test
,	O
anti-GBM	B-test
,	O
anti-streptolycin	B-test
,	O
ANA	B-test
,	O
UPEP	B-test
,	O
SPEP	B-test
,	O
renal	B-test
ultrasound	I-test
,	O
hepatitis	B-test
C	I-test
cryoglobulin	I-test
sent	O
out	O
.	O

He	O
had	O
a	B-test
bronchoscopy	I-test
immediately	O
done	O
which	O
showed	O
no	O
fresh	B-problem
blood	I-problem
,	O
just	O
old	B-problem
clot	I-problem
and	O
a	B-treatment
pulmonary	I-treatment
arterial	I-treatment
line	I-treatment
placed	O
in	O
the	O
right	O
internal	O
jugular	O
vein	O
.	O

Question	O
of	O
pulmonary-renal	B-problem
syndrome	I-problem
was	O
raised	O
.	O

The	O
patient	O
subsequently	O
deteriorated	O
over	O
time	O
,	O
was	O
started	O
on	O
CVVH	B-treatment
and	O
suffered	O
significant	B-problem
complications	I-problem
without	O
improvement	O
of	O
his	O
pulmonary	O
/	O
renal	O
situation	O
.	O

A	O
family	O
meeting	O
was	O
held	O
on	O
5-2-98	O
and	O
it	O
was	O
decided	O
that	O
the	O
patient	O
should	O
be	O
made	O
comfort	B-treatment
care	I-treatment
only	O
.	O

All	O
CVVH	B-treatment
and	O
the	B-treatment
ventilator	I-treatment
was	O
removed	O
and	O
the	O
patient	O
spontaneously	O
passed	O
away	O
on	O
5-2-98	O
,	O
at	O
4:55	O
p.m.	O

Family	O
and	O
primary	O
carephysician	O
informed	O
.	O

________________________	O
SONRIELA	O
RED	O
,	O
M.D.	O

TR	O
:	O

xbr	O
PAD-WORD	O

DD	O
:	O

07/12/1998	O
PAD-WORD	O

TD	O
:	O

07/27/1998	O
12:36	O

Pcc	O
:	O

Admission	O
Date	O
:	O

2011-10-17	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-10-31	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1955-09-01	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Cardiothor	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
56	O
year-old	O
gentleman	O
with	O
severe	B-problem
aortic	I-problem
stenosis	I-problem
,	O
reports	O
having	O
been	O
told	O
he	O
had	O
a	B-problem
heart	I-problem
murmur	I-problem
many	O
years	O
ago	O
but	O
just	O
recently	O
diagnosed	O
with	O
aortic	B-problem
stenosis	I-problem
.	O

He	O
has	O
had	O
mild	B-problem
dyspnea	I-problem
on	O
exertion	O
increasing	O
over	O
the	O
past	O
couple	O
of	O
months	O
prior	O
to	O
admission	O
.	O

An	B-test
echocardiogram	I-test
in	O
2011-09-05	O
revealed	O
a	B-test
left	I-test
ventricular	I-test
ejection	I-test
fraction	I-test
of	O
20	O
to	O
25%	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Cigarette	O
smoking	O
.	O

2.	O
Insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

3.	O
Proteinuria	B-problem
.	O

4.	O
Aortic	B-problem
stenosis	I-problem
.	O

5.	O
Cellulitis	B-problem
.	O

6.	O
Gangrene	B-problem
of	I-problem
his	I-problem
left	I-problem
second	I-problem
toe	I-problem
in	O
2010-06-06	O
followed	O
by	O
an	B-treatment
amputation	I-treatment
.	O

7.	O
Left	B-treatment
common	I-treatment
femoral	I-treatment
dorsalis	I-treatment
pedis	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

8.	O
Right	B-treatment
leg	I-treatment
bypass	I-treatment
graft	I-treatment
in	O
1999	O
.	O

9.	O
Right	B-treatment
below	I-treatment
the	I-treatment
knee	I-treatment
amputation	I-treatment
in	O
2008	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
states	O
he	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
po	O
q	O
day	O
.	O

2.	O
Vasotec	B-treatment
7.5	O
mg	O
po	O
q	O
day	O
.	O

3.	O
Humalog	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
with	O
meals	O
and	O
at	O
bedtime	O
.	O

4.	O
Humulin	B-treatment
Walters	I-treatment
insulin	I-treatment
24	O
units	O
subcutaneous	O
q	O
A.M.	O
and	O
8	O
to	O
16	O
in	O
the	O
evening	O
depending	O
upon	O
where	O
his	B-test
blood	I-test
sugar	I-test
has	O
been	O
.	O

Preoperative	B-test
laboratory	I-test
values	I-test
were	O
unremarkable	O
.	O

The	O
patient	O
underwent	O
cardiac	B-test
catheterization	I-test
on	O
2011-10-17	O
which	O
revealed	O
a	B-problem
20%	I-problem
left	I-problem
vein	I-problem
osteal	I-problem
lesion	I-problem
as	O
well	O
as	O
70%	B-problem
LAD	I-problem
lesion	I-problem
and	O
an	B-problem
80%	I-problem
right	I-problem
coronary	I-problem
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2011-10-18	O
where	O
he	O
underwent	O
an	B-treatment
aortic	I-treatment
valve	I-treatment
replacement	I-treatment
with	O
#23	B-treatment
mm	I-treatment
pericardial	I-treatment
valve	I-treatment
as	O
well	O
as	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
two	O
with	O
a	O
LIMA	O
to	O
the	O
LAD	O
and	O
saphenous	O
vein	O
to	O
the	O
acute	O
marginal	O
.	O

Postoperatively	O
the	O
patient	O
was	O
transported	O
to	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
on	O
Milrinone	B-treatment
,	O
Neo-Synephrine	B-treatment
and	O
Levophed	B-treatment
drip	I-treatment
.	O

The	O
patient	O
was	O
weaned	O
from	O
mechanical	B-treatment
ventilation	I-treatment
and	O
subsequently	O
extubated	O
on	O
the	O
night	O
of	O
surgery	B-treatment
.	O

He	O
remained	O
on	O
Levophed	B-treatment
,	O
Milrinone	B-treatment
and	O
Neo-Synephrine	B-treatment
drips	I-treatment
and	O
was	O
hemodynamically	O
stable	O
.	O

N.	O
Saez	O
clinic	O
consult	O
was	O
obtained	O
due	O
to	O
hyperglycemia	B-problem
and	O
the	O
need	O
for	O
insulin	B-treatment
drip	I-treatment
in	O
the	O
Intensive	O
Care	O
Unit	O
.	O

On	O
postoperative	O
day	O
the	B-treatment
Milrinone	I-treatment
was	O
weaned	O
down	O
.	O

The	B-treatment
Levophed	I-treatment
had	O
been	O
discontinued	O
as	O
the	B-treatment
Neo-Synephrine	I-treatment
and	O
the	O
patient	O
was	O
beginning	O
to	O
progress	O
hemodynamically	O
.	O

Upon	O
discontinuation	O
of	O
the	B-treatment
Milrinone	I-treatment
the	B-test
patient	I-test
's	I-test
SV02	I-test
had	O
dropped	O
significantly	O
in	O
the	O
low	O
50	O
s.	O

The	O
patient	O
had	O
decreased	B-problem
exercise	I-problem
tolerance	I-problem
and	O
therefore	O
was	O
placed	O
back	O
on	O
his	B-treatment
milrinone	I-treatment
to	O
keep	O
his	B-test
cardiac	I-test
index	I-test
greater	O
than	O
2.0	O
.	O

Over	O
the	O
next	O
couple	O
of	O
days	O
it	O
was	O
very	O
slowly	O
decreased	O
as	O
his	B-treatment
Ace	I-treatment
inhibitors	I-treatment
were	O
increased	O
orally	O
.	O

The	O
patient	O
ultimately	O
was	O
weaned	O
off	O
the	B-treatment
Milrinone	I-treatment
,	O
transitioned	O
to	O
Captopril	B-treatment
on	O
postoperative	O
day	O
five	O
and	O
remained	O
hemodynamically	O
stable	O
.	O

Once	O
the	O
patient	O
had	O
remained	O
off	O
of	O
inotropics	B-treatment
for	O
approximately	O
24	O
hours	O
,	O
he	O
had	O
been	O
given	O
diuretics	B-treatment
and	O
Ace	B-treatment
inhibitors	I-treatment
and	O
remained	O
hemodynamically	O
stable	O
he	O
was	O
transferred	O
from	O
the	O
Intensive	O
Care	O
Unit	O
to	O
the	O
Telemetry	O
floor	O
on	O
postoperative	O
day	O
six	O
.	O

A	B-test
physical	I-test
therapy	I-test
evaluation	I-test
was	O
obtained	O
for	O
assistance	O
and	O
mobility	O
.	O

Cardiac	B-treatment
rehabilitation	I-treatment
was	O
initiated	O
at	O
that	O
time	O
.	O

On	O
2011-10-24	O
postoperative	O
day	O
six	O
consultation	O
heart	O
failure	O
cardiology	O
service	O
was	O
obtained	O
.	O

It	O
was	O
their	O
recommendation	O
to	O
continue	O
Ace	B-treatment
inhibitors	I-treatment
,	O
to	O
continue	O
daily	B-test
weights	I-test
,	O
to	O
switch	O
the	O
patient	O
to	O
a	B-treatment
long	I-treatment
acting	I-treatment
beta-blocker	I-treatment
and	O
to	O
enroll	O
the	O
patient	O
in	O
postoperative	B-treatment
cardiac	I-treatment
rehabilitation	I-treatment
as	O
well	O
as	O
to	O
make	O
sure	O
the	O
patient	O
was	O
on	O
statin	B-treatment
drugs	I-treatment
.	O

These	O
measures	O
were	O
all	O
instituted	O
.	O

The	O
patient	O
continued	O
to	O
progress	O
from	O
cardiac	O
rehabilitation	O
and	O
physical	O
therapy	O
standpoint	O
while	O
on	O
the	O
floor	O
.	O

The	O
patient	O
remained	O
hemodynamically	O
stable	O
over	O
the	O
next	O
few	O
days	O
,	O
continued	O
to	O
increase	O
with	O
physical	B-treatment
therapy	I-treatment
and	O
ambulation	O
.	O

His	B-test
blood	I-test
sugars	I-test
were	O
followed	O
by	O
the	O
Cape	O
Cod	O
Hospital	O
Clinic	O
service	O
and	O
insulin	B-treatment
has	O
been	O
adjusted	O
accordingly	O
.	O

Today	O
,	O
2011-10-31	O
,	O
postoperative	O
day	O
13	O
the	O
patient	O
remains	O
stable	O
and	O
ready	O
for	O
discharge	O
to	O
home	O
.	O

The	O
patient	O
's	O
condition	O
today	O
is	O
as	O
follows	O
:	O

Temperature	B-test
96.9	O
F	O
,	O
pulse	B-test
84	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
blood	B-test
pressure	I-test
106/59	O
.	O

Most	B-test
recent	I-test
laboratory	I-test
values	I-test
are	O
from	O
2011-10-25	O
which	O
revealed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
8.4000	O
,	O
hematocrit	B-test
35	O
,	O
platelet	B-test
count	I-test
202,000.	O
Sodium	B-test
133	O
,	O
potassium	B-test
4.4	O
,	O
chloride	B-test
93	O
,	O
CO2	B-test
30	O
,	O
BUN	B-test
24	O
,	O
creatinine	B-test
0.7	O
,	O
glucose	B-test
198	O
.	O

The	B-test
patient	I-test
's	I-test
finger	I-test
stick	I-test
blood	I-test
glucose	I-test
levels	I-test
range	O
from	O
151	O
to	O
390	O
over	O
the	O
past	O
24	O
hours	O
and	O
his	B-treatment
insulin	I-treatment
scale	I-treatment
has	O
been	O
adjusted	O
upward	O
to	O
compensate	O
for	O
that	O
.	O

Neurologically	O
the	O
patient	O
is	O
grossly	O
intact	O
.	O

Pulmonary	B-test
exam	I-test
he	O
is	O
clear	O
upper	O
lobes	O
,	O
diminished	B-problem
bilateral	I-problem
bases	I-problem
left	O
greater	O
than	O
right	O
.	O

Coronary	B-test
exam	I-test
is	O
regular	O
rate	O
and	O
rhythm	O
.	O

His	O
abdomen	O
is	O
benign	O
.	O

His	O
sternum	O
is	O
stable.	O
His	B-problem
incision	I-problem
is	O
clean	O
and	O
dry	O
Steri	B-treatment
Strips	I-treatment
intact	O
.	O

His	O
extremities	O
are	O
warm	O
and	O
well	O
perfused	O
with	O
minimal	B-problem
edema	I-problem
of	I-problem
his	I-problem
left	I-problem
foot	I-problem
as	O
well	O
as	O
his	O
right	O
stump	O
.	O

He	O
is	O
able	O
to	O
apply	O
his	B-treatment
prosthesis	I-treatment
and	O
ambulate	O
as	O
well	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lasix	B-treatment
40	O
mg	O
po	O
bid	O
.	O

2.	O
Potassium	B-treatment
Chloride	I-treatment
20	O
milliequivalents	O
po	O
bid	O
.	O

3.	O
Colace	B-treatment
100	O
mg	O
po	O
bid	O
.	O

4.	O
Zantac	B-treatment
150	O
mg	O
po	O
bid	O
.	O

5.	O
Aspirin	B-treatment
325	O
mg	O
po	O
qd	O
.	O

6.	O
Captopril	B-treatment
25	O
mg	O
po	O
tid	O
.	O

7.	O
Digoxin	B-treatment
0.25	O
mg	O
po	O
q	O
day	O
.	O

8.	O
Atorvastatin	B-treatment
10	O
mg	O
po	O
q	O
day	O
.	O

9.	O
Toprol	B-treatment
XL	I-treatment
100	O
mg	O
po	O
q	O
day	O
.	O

10.	O
Bollin	B-treatment
insulin	I-treatment
18	O
units	O
subcutaneous	O
q	O
A.M.	O
,	O
Richard	B-treatment
insulin	I-treatment
14	O
units	O
subcutaneous	O
q	O
P.M.	O

11.	O
Sliding	B-treatment
scale	I-treatment
Humalog	I-treatment
regular	I-treatment
insulin	I-treatment
for	O
breakfast	O
is	O
blood	B-test
glucose	I-test
of	O
151	O
to	O
200	O
equal	O
4	O
units	O
,	O
201	O
to	O
250	O
equal	O
6	O
units	O
,	O
251	O
to	O
350	O
equal	O
12	O
units	O
,	O
greater	O
than	O
350	O
equals	O
15	O
units	O
.	O

For	O
lunch	O
blood	B-test
glucose	I-test
of	O
101	O
to	O
150	O
equals	O
4	O
units	O
,	O
151	O
to	O
200	O
equals	O
7	O
units	O
,	O
201	O
to	O
250	O
equals	O
8	O
units	O
,	O
251	O
to	O
350	O
equals	O
12	O
units	O
,	O
greater	O
than	O
350	O
equals	O
15	O
units	O
.	O

Dinner	O
blood	B-test
glucose	I-test
101	O
to	O
150	O
equals	O
2	O
units	O
,	O
151	O
to	O
200	O
equals	O
3	O
units	O
,	O
201	O
to	O
250	O
equals	O
6	O
units	O
,	O
251	O
to	O
350	O
equals	O
12	O
units	O
,	O
greater	O
than	O
350	O
equals	O
15	O
units	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Aortic	B-problem
stenosis	I-problem
.	O

2.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

3.	O
Type	B-problem
I	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

4.	O
Peripheral	B-problem
vascular	I-problem
disease	I-problem
.	O

FOLLOW	O
UP	O
:	O

Dr.	O
Lloyd	O
van	O
de	O
Clark	O
in	O
approximately	O
one	O
month	O
postoperative	O
.	O

Please	O
call	O
the	O
office	O
at	O
(	O
854	O
)	O
787-3243	O
for	O
an	O
appointment	O
.	O

The	O
patient	O
is	O
also	O
to	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
for	O
diabetes	B-treatment
management	I-treatment
.	O

He	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
East	O
here	O
at	O
the	O
Heart	O
Failure	O
Clinic	O
to	O
continue	O
follow	O
up	O
with	O
cardiac	B-treatment
rehabilitation	I-treatment
and	O
heart	B-treatment
failure	I-treatment
management	I-treatment
.	O

Brown	O
des	O
Stone	O
,	O
M.D.	O

07-760	O
PAD-WORD	O

Dictated	O
By	O
:	O
Anthony	O
O	O
Carreno	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2011-10-31	O
10:25	O

T	O
:	O
2011-10-31	O
10:45	O

JOB	O
#:	O
02527	O

Signed	O
electronically	O
by	O
:	O
DR.	O
John	O
della	O
Hopper	O
on	O
:	O
WED	O
2011-11-16	O
7:16	O
PM	O

(	O
End	O
of	O
Report	O
)	O

487110437	O
PAD-WORD	O

TGCHO	O
PAD-WORD	O

1128447	O
PAD-WORD	O

662727	O
PAD-WORD	O

10/15/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

FACTOR	O
,	O
REBEM	O

UNIT	O
NUMBER	O
:	O

333-33-75	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10/15/1999	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

10/18/1999	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Acute	B-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Hypertension	B-problem
.	O

Gout	B-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

Stent	B-treatment
placement	I-treatment
of	I-treatment
the	I-treatment
RCA	I-treatment
on	O
October	O
15	O
,	O
1999	O
.	O

OTHER	O
PROCEDURES	O
:	O

Right	B-test
heart	I-test
catheterization	I-test
and	O
coronary	B-test
angiography	I-test
on	O
October	O
15	O
,	O
1999	O
.	O

DOCTOR	O
&apos;	O
S	O
DISCHARGE	O
ORDERS	O
:	O

Aspirin	B-treatment
325	O
mg.	O
qday	O
.	O

Plavix	B-treatment
75	O
mg.	O
qday	O
for	O
four	O
weeks	O
.	O

Atenolol	B-treatment
50	O
mg.	O
qday	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Factor	O
is	O
a	O
76	O
year	O
old	O
white	O
male	O
with	O
acute	B-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
,	O
who	O
was	O
urgently	O
transferred	O
by	O
Dr.	O
Lenni	O
Factor	O
for	O
cardiac	B-test
catheterization	I-test
and	O
possible	O
angioplasty	B-treatment
.	O

His	O
only	O
cardiac	O
risk	O
factor	O
includes	O
hypertension	B-problem
.	O

The	O
night	O
of	O
Oct	O
14	O
,	O
1999	O
the	O
patient	O
developed	O
chest	B-problem
discomfort	I-problem
associated	O
with	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

On	O
October	O
15	O
,	O
1999	O
at	O
6	O
AM	O
the	O
patient	O
was	O
admitted	O
to	O
No	O
Verlmerver	O
Medical	O
Center	O
.	O

An	B-test
electrocardiogram	I-test
showed	O
acute	B-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

Due	O
to	O
unknown	O
duration	O
of	O
the	B-problem
chest	I-problem
pain	I-problem
the	O
patient	O
wastransferred	O
urgently	O
to	O
the	O
TGCHO	O
for	O
cardiac	B-test
catheterization	I-test
.	O

Shortly	O
after	O
Aggrastat	B-treatment
was	O
started	O
,	O
the	O
patient	O
became	O
pain	B-problem
free	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
and	O
gout	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Blood	B-test
pressure	I-test
115/77	O
.	O

The	B-test
heart	I-test
rate	I-test
64	O
.	O

JVP	B-test
6	O
cm	O
.	O

H20	O
.	O

Carotid	B-test
upstroke	I-test
was	O
normal	O
.	O

There	O
was	O
an	B-problem
S4	I-problem
.	O

The	O
lungs	O
were	O
clear	O
.	O

Abdomen	O
was	O
benign	O
.	O

Femoral	B-test
and	I-test
distal	I-test
pulses	I-test
were	O
full	O
.	O

There	O
was	O
no	O
pedaledema	B-problem
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
nonfocal	O
.	O

The	B-test
electrocardiogram	I-test
normal	O
sinus	O
rhythm	O
at	O
62	O
beats	O
per	O
minute	O
,	O
small	B-problem
Qwaves	I-problem
in	I-problem
3	I-problem
and	I-problem
F	I-problem
,	O
ST	B-problem
elevation	I-problem
in	I-problem
2	I-problem
,	I-problem
3	I-problem
,	I-problem
and	I-problem
F.	I-problem
ST	B-problem
Depression	I-problem
in	I-problem
1	I-problem
,	I-problem
L	I-problem
and	I-problem
V2	I-problem
and	I-problem
3	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Peak	B-test
CPK	I-test
1117	O
.	O

Total	B-test
cholesterol	I-test
142	O
.	O

LDL	B-test
56	O
.	O

HDL	B-test
30	O
.	O

Triglycerides	B-test
281	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
directly	O
admitted	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
.	O

Coronary	B-test
angiography	I-test
,	O
right	B-test
heart	I-test
catheterization	I-test
and	O
percutaneous	B-treatment
intervention	I-treatment
of	I-treatment
the	I-treatment
RCA	I-treatment
were	O
performed	O
from	O
the	O
right	O
groin	O
without	O
complications	B-problem
.	O

The	O
proximal	O
RCA	O
was	O
totally	B-problem
occluded	I-problem
with	O
good	O
left	O
to	O
right	O
collaterals	O
.	O

The	O
LAD	O
showed	O
a	B-problem
40%	I-problem
stenosis	I-problem
in	I-problem
the	I-problem
proximal	I-problem
segment	I-problem
.	O

The	O
circumflex	O
showed	O
mild	B-problem
atherosclerotic	I-problem
.	O

The	B-problem
RCA	I-problem
occlusion	I-problem
was	O
successfully	O
dilated	O
and	O
sent	O
using	O
a	B-treatment
3.0	I-treatment
X	I-treatment
23	I-treatment
mm	I-treatment
Duet	I-treatment
with	O
post	B-treatment
stent	I-treatment
dilatation	I-treatment
up	O
to	O
16	O
atmospheres	O
.	O

Following	O
intervention	B-treatment
right	B-test
heart	I-test
catheterization	I-test
was	O
performed	O
to	O
rule	O
out	O
RV	B-problem
infarct	I-problem
.	O

The	B-test
RA	I-test
was	O
5	O
.	O

PA	B-test
was	O
19/7	O
with	O
a	B-test
mean	I-test
of	O
13	O
.	O

PCW	B-test
was	O
11	O
.	O

Of	O
note	O
there	O
was	O
a	B-problem
clear	I-problem
A	I-problem
wave	I-problem
in	O
the	B-test
RV	I-test
tracing	I-test
,	O
suggestive	O
of	O
RV	B-problem
infarct	I-problem
.	O

The	O
next	O
day	O
the	O
patient	O
was	O
quite	B-problem
confused	I-problem
and	O
disoriented	B-problem
,	O
which	O
gradually	O
disappeared	O
.	O

An	B-test
echocardiogram	I-test
was	O
performed	O
to	O
evaluate	O
the	B-test
LV	I-test
function	I-test
,	O
which	O
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
53%	O
with	O
inferoposteriorakinesis	B-problem
/	O
hypokinesis	B-problem
.	O

The	O
next	O
day	O
the	O
patient	O
&apos;s	O
mental	O
status	O
came	O
back	O
to	O
baseline	O
and	O
he	O
remained	O
free	O
of	O
angina	B-problem
.	O

ASHEE	O
SHOULTSNER	O
,	O
M.D.	O

Electronically	O
Signed	O
ASHEE	O
SHOULTSNER	O
,	O
M.D.	O

11/07/1999	O
11:06	O

TR	O
:	O

ghu	O
PAD-WORD	O

DD	O
:	O

10/18/1999	O
PAD-WORD	O

TD	O
:	O

10/18/1999	O
10:59	O

Acc	O
:	O

ASHEE	O
SHOULTSNER	O
,	O
M.D.	O
Dr.	O
Lenni	O
Factor	O
No	O
Verlmerver	O
Medical	O
Center	O
Dr.	O
Tomedankell	O
Flowayles	O
No	O
Verlmerver	O
Medical	O
Center	O
STAT	O

Admission	O
Date	O
:	O

2017-02-04	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2017-03-04	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1958-07-29	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Betalactams	B-treatment
/	O
Levofloxacin	B-treatment

Attending	O
:	O
Cayla	O
R	O
Turner	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
respiratory	B-problem
distress	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
s/p	O
intracranial	B-treatment
pressure	I-treatment
bolt	I-treatment
placement	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

The	O
patient	O
is	O
a	O
58	O
-	O
year-old	O
man	O
with	O
history	O
of	O
IDDM	B-problem
,	O
PVD	B-problem
,	O
status	O
post	O
toe	B-treatment
amputations	I-treatment
,	O
diabetic	B-problem
neuropathy	I-problem
,	O
and	O
retinopathy	B-problem
recently	O
admitted	O
to	O
McLean	O
Hospital	O
from	O
2017-01-13	O
,	O
through	O
2017-01-18	O
,	O
with	O
a	O
diagnosis	O
of	O
right	B-problem
heel	I-problem
diabetic	I-problem
ulcer	I-problem
with	O
MSSA	B-problem
osteomyelitis	I-problem
of	I-problem
the	I-problem
calcaneus	I-problem
,	O
MSSA	B-problem
bacteremia	I-problem
,	O
acute	B-problem
interstitial	I-problem
nephritis	I-problem
secondary	O
to	O
oxacillin	B-treatment
,	O
and	O
RLL	B-problem
pna	I-problem
.	O

He	O
was	O
sent	O
home	O
with	O
a	B-treatment
PICC	I-treatment
line	I-treatment
and	O
IV	B-treatment
antibiotics	I-treatment
.	O

He	O
returned	O
to	O
the	O
Wing	O
Memorial	O
&	O
Medical	O
Center	O
intubated	B-treatment
from	O
an	O
outside	O
hospital	O
on	O
2017-02-04	O
,	O
for	O
respiratory	B-problem
failure	I-problem
and	O
was	O
sent	O
to	O
CMED	O
CSRU	O
.	O

Prior	O
to	O
his	O
re-admission	O
,	O
his	O
sister	O
had	O
noted	O
that	O
he	O
was	O
having	O
some	B-problem
shaking	I-problem
chills	I-problem
and	O
heavy	B-problem
breathing	I-problem
.	O

When	O
he	O
came	O
back	O
to	O
Faulkner	O
Hospital	O
Hospital	O
for	O
confusion	B-problem
and	O
diaphoresis	B-problem
,	O
his	B-test
initial	I-test
oxygen	I-test
sat	I-test
was	O
only	O
80%	O
with	O
a	B-test
fingerstick	I-test
of	O
29	O
.	O

He	O
was	O
given	O
D50	B-treatment
,	O
but	O
continued	O
to	O
have	O
progressive	B-problem
respiratory	I-problem
failure	I-problem
,	O
was	O
therefore	O
intubated	O
and	O
transferred	O
to	O
the	O
Austen	O
Riggs	O
Center	O
where	O
he	O
was	O
noted	O
to	O
have	O
multifocal	B-problem
pneumonia	I-problem
and	O
bacteremia	B-problem
with	O
enterobacter	B-problem
and	O
MSSA	B-problem
.	O

Past	O
Medical	O
History	O
:	O
diabetes	B-problem
type	I-problem
1	I-problem
since	O
age	O
24	O
after	O
pancreatic	B-problem
trauma	I-problem

diabetic	B-problem
retinopathy	I-problem

direct	B-problem
neuropathy	I-problem

PVD	B-problem
PAD-WORD	O

status	O
post	O
multiple	B-treatment
toe	I-treatment
amputations	I-treatment

recent	B-problem
right	I-problem
heel	I-problem
osteomyelitis	I-problem

recent	B-problem
MSSA	I-problem
bacteremia	I-problem

multifocal	B-problem
pneumonia	I-problem

acute	B-problem
interstitial	I-problem
nephritis	I-problem

cataract	B-treatment
surgery	I-treatment
.	O

Social	O
History	O
:	O
divorced	O
truck	O
driver	O

tobacco	O
:	O
16	O
pack	O
year	O
hx	O
;	O
quit	O
24	O
years	O
ago	O

ETOH	O
:	O
occasional	O
beer	O

Family	O
History	O
:	O

NC	O
PAD-WORD	O

Physical	O
Exam	O
:	O

On	O
transfer	O
to	O
the	O
floor	O
from	O
the	O
CMED	O
CSRU	O
on	O
2017-02-15	O
temp	B-test
:	O

97.4	O
HR	B-test
:	O

78	O
BP	B-test
:	O

141/64	O
RR	B-test
:	O

20	O
O2sat	B-test
:	O

94-95%	O
on	O
3L	B-treatment
NC	I-treatment

Gen	O
:	O
somnolent	B-problem
but	O
arousable	O
to	O
voice	O

HEENT	O
:	O

MM	O
moist	O
,	O
PERRLA	O

CV	O
:	O

RRR	O
,	O
no	O
m/r/g	B-problem

Lungs	O
:	O
crackles	B-problem
bibasilar	I-problem

Abd	O
:	O
soft	O
,	O
slightly	B-problem
distended	I-problem
,	O
nontender	B-problem
,	O
+BS	O

Ext	O
:	O

2+	B-problem
pitting	I-problem
edema	I-problem
B	I-problem
LE	I-problem
to	I-problem
knee	I-problem
,	O
nonpitting	B-problem
edema	I-problem
in	I-problem
B	I-problem
hands	I-problem
and	I-problem
arms	I-problem
.	O

1+	B-test
DP	I-test
pulses	I-test
bilaterally	I-test
.	O

Missing	B-problem
R	I-problem
1st	I-problem
toe	I-problem
and	I-problem
L	I-problem
2nd	I-problem
toe	I-problem
.	O

Wound	B-treatment
vac	I-treatment
in	O
place	O
on	O
R	O
foot	O
.	O

Access	O
:	O

L	B-treatment
PICC	I-treatment
(	O
2017-02-14	O
)	O
.	O

Neuro	O
:	O
arousable	O
.	O

States	O
he	O
is	O
at	O
home	O
,	O
name	O
is	O
"	O
Henry	O
"	O
and	O
year	O
is	O
1992	O
.	O

Not	O
answering	O
other	O
questions	O
.	O

Not	O
following	O
commands	O
but	O
moves	O
UE	O
's	O
to	O
try	O
to	O
pull	O
out	O
NG	B-treatment
tube	I-treatment
.	O

Pertinent	O
Results	O
:	O

CT	B-test
chest	I-test
2017-02-06	O

IMPRESSION	O
:	O

1.	O
Extensive	B-problem
bilateral	I-problem
diffuse	I-problem
ground	I-problem
glass	I-problem
and	O
more	O
confluent	O
areas	O
of	O
consolidation	B-problem
in	I-problem
both	I-problem
lungs	I-problem
consistent	O
with	O
the	B-test
recent	I-test
chest	I-test
x-ray	I-test
.	O

This	B-problem
non	I-problem
-	I-problem
specific	I-problem
pattern	I-problem
could	O
represent	O
diffuse	B-problem
pneumonia	I-problem
complicated	O
by	O
ARDS	B-problem
.	O

This	O
would	O
likely	O
less	O
represent	O
asymmetric	B-problem
pulmonary	I-problem
edema	I-problem
.	O

2.	O
Small	B-problem
bilateral	I-problem
pleural	I-problem
effusions	I-problem
.	O

Echo	B-test
2018-02-06	O

Conclusions	O
:	O

1.	O
No	O
spontaneous	B-problem
echo	I-problem
contrast	I-problem
or	O
thrombus	B-problem
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

No	O
atrial	B-problem
septal	I-problem
defect	I-problem
is	O
seen	O
by	O
2D	B-test
or	I-test
color	I-test
Doppler	I-test
.	O

2.	O
Left	B-test
ventricular	I-test
wall	I-test
thickness	I-test
,	O
cavity	B-test
size	I-test
,	O
and	O
systolic	B-test
function	I-test
are	O
normal	O
(	O
LVEF	B-test
>	O
55%	O
)	O
.	O

3.	O
Right	B-test
ventricular	I-test
chamber	I-test
size	I-test
and	O
free	B-test
wall	I-test
motion	I-test
are	O
normal	O
.	O

4.	O
The	O
ascending	O
,	O
transverse	O
and	O
descending	O
thoracic	O
aorta	O
are	O
normal	O
in	O
diameter	O
and	O
free	O
of	O
atherosclerotic	B-problem
plaque	I-problem
.	O

5.	O
The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
.	O

No	O
masses	B-problem
or	O
vegetations	B-problem
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

Trace	B-problem
aortic	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

6.	O
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

No	O
mass	B-problem
or	O
vegetation	B-problem
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

7.	O
No	O
vegetation	B-problem
/	O
mass	B-problem
is	O
seen	O
on	O
the	O
pulmonic	O
valve	O
.	O

8.	O
There	O
is	O
a	O
trivial	O
/	O
physiologic	B-problem
pericardial	I-problem
effusion	I-problem
.	O

Head	B-test
CT	I-test
2017-02-08	O

FINDINGS	O
:	O

No	O
intracranial	B-problem
hemorrhage	I-problem
is	O
identified	O
.	O

There	O
is	O
no	O
mass	B-problem
effect	I-problem
or	O
shift	B-problem
of	I-problem
the	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
.	O

No	O
major	B-problem
vascular	I-problem
territorial	I-problem
infarction	I-problem
is	O
identified	O
.	O

The	O
ventricles	O
and	O
sulci	O
are	O
normal	O
in	O
size	O
and	O
symmetrical	O
.	O

No	O
osseous	B-problem
lesions	I-problem
are	O
seen	O
.	O

IMPRESSION	O
:	O

No	O
intracranial	B-problem
hemorrhage	I-problem
or	O
CT	B-test
evidence	O
of	O
acute	B-problem
infarction	I-problem
.	O

EEG	B-test
2017-02-10	O

IMPRESSION	O
:	O

This	O
is	O
an	B-problem
abnormal	I-problem
EEG	I-problem
due	O
to	O
the	O
presence	O
of	O
a	B-problem
low	I-problem
voltage	I-problem
and	O
slow	B-problem
background	I-problem
consistent	O
with	O
a	B-problem
severe	I-problem
encephalopathy	I-problem
of	O
toxic	O
,	O
metabolic	O
,	O
or	O
anoxic	O
etiology	O
.	O

Note	O
that	O
with	O
the	O
documented	O
movements	O
of	O
the	O
patient	O
's	O
head	O
and	O
mouth	O
,	O
no	O
change	O
on	O
the	B-test
EEG	I-test
was	O
seen	O
.	O

No	O
evidence	O
of	O
ongoing	B-problem
seizures	I-problem
was	O
seen	O
.	O

Cultures	B-test
:	O

Urine	B-test
:	O

2017-02-04	O
and	O
2017-02-07	O
and	O
2017-02-11	O
:	O
yeast	B-problem

Sputum	B-test
2017-02-04	O

ENTEROBACTER	B-problem
CLOACAE	I-problem

IV	B-treatment
catheter	I-treatment
tip	I-treatment
2017-02-05:	O

STAPHYLOCOCCUS	B-problem
,	I-problem
COAGULASE	I-problem
NEGATIVE	I-problem
sensitive	O
to	O
vanc	B-treatment

Blood	B-test
:	O

2017-02-04	O
PAD-WORD	O

ENTEROBACTER	B-problem
CLOACAE	I-problem

ENTEROCOCCUS	B-problem
FAECIUM	I-problem
.	O

STAPHYLOCOCCUS	B-problem
,	I-problem
COAGULASE	I-problem
NEGATIVE	I-problem
.	O

ISOLATED	O
FROM	O
ONE	O
SET	O
ONLY	O
.	O

Stool	B-test
2017-02-07	O
:	O
c.	B-problem
diff	I-problem
negative	O

Brief	O
Hospital	O
Course	O
:	O

1)	O
Respiratory	B-problem
failure	I-problem
:	O

On	O
admission	O
,	O
this	O
was	O
felt	O
to	O
be	O
likely	O
03-15	O
worsening	B-problem
PNA	I-problem
.	O

Pt	O
remained	O
intubated	B-treatment
until	O
2017-02-14	O
.	O

He	O
had	O
difficulty	O
weaning	O
from	O
the	B-treatment
vent	I-treatment
due	O
to	O
difficulties	B-problem
with	I-problem
neurological	I-problem
status	I-problem
(	O
he	O
remained	O
drowsy	B-problem
and	O
unresponsive	B-problem
for	O
many	O
days	O
)	O
but	O
eventually	O
awoke	O
enough	O
and	O
was	O
extubated	O
without	O
difficulty	O
and	O
remained	O
stable	O
on	O
3L	B-treatment
NC	I-treatment
.	O

He	O
was	O
transferred	O
to	O
the	O
floor	O
but	O
a	O
few	O
days	O
later	O
began	O
to	O
show	O
signs	O
of	O
respiratory	B-problem
distress	I-problem
and	O
was	O
transferred	O
back	O
to	O
the	O
CMED	O
CSRU	O
for	O
reintubation	B-treatment
for	O
likely	O
aspiration	B-problem
event	I-problem
leading	O
to	O
worsening	B-problem
pneumonia	I-problem
as	O
well	O
as	O
some	O
component	O
of	O
pulm	B-problem
edema	I-problem
.	O

He	O
was	O
extubated	O
a	O
few	O
days	O
later	O
and	O
transferred	O
back	O
to	O
the	O
floor	O
where	O
his	O
pulm	O
status	O
improved	O
dramatically	O
with	O
lasix	B-treatment
and	O
continued	B-treatment
nebulizer	I-treatment
treatments	I-treatment
.	O

The	O
patient	O
was	O
prepared	O
for	O
discharge	O
on	O
05-29	O
,	O
when	O
he	O
was	O
sat	O
'	O
ing	O
in	O
the	O
high	O
90	O
's	O
on	O
room	O
air	O
.	O

However	O
,	O
on	O
2017-03-01	O
at	O
6	O
am	O
the	O
pt	O
was	O
found	O
with	O
labored	B-problem
respirations	I-problem
(	O
rr	B-test
=	O
24	O
)	O
and	O
SaO2	B-test
89%	O
,	O
which	O
improved	O
to	O
only	O
SaO290	B-test
-	O
91%	O
on	O
100%	O
NRB	B-treatment
.	O

ABG	B-test
(	O
7.42	O
/	O
38	O
/	O
88	O
)	O
was	O
performed	O
,	O
80	O
mg	O
lasix	B-treatment
was	O
given	O
and	O
the	O
patietn	O
had	O
foley	B-treatment
placed	O
and	O
had	O
good	O
urine	O
output	O
and	O
good	O
mentation	O
.	O

He	O
was	O
also	O
given	O
nebulizers	B-treatment
without	O
improvement	O
.	O

His	B-test
chest	I-test
radiograph	I-test
had	O
fluffy	B-problem
bilateral	I-problem
infiltrates	I-problem
.	O

Although	O
the	O
pt	O
was	O
w/o	O
fever	B-problem
,	O
he	O
had	O
chills	B-problem
.	O

He	O
was	O
readmitted	O
tot	O
he	O
CMED	O
CSRU	O
for	O
respiratory	B-problem
distress	I-problem
likely	O
secondary	O
to	O
a	B-problem
recurrent	I-problem
aspiration	I-problem
event	I-problem
.	O

He	O
was	O
continued	O
on	O
meropenem	B-treatment
,	O
started	O
on	O
BiPAP	B-treatment
and	O
aggressively	O
suctioned	O
in	O
an	O
attempt	O
to	O
avoid	O
intubation	B-treatment
.	O

On	O
03-02	O
at	O
10	O
am	O
,	O
the	O
patient	O
had	O
an	B-problem
acutechange	I-problem
in	I-problem
mental	I-problem
status	I-problem
with	O
bradycardia	B-problem
,	O
hypertension	B-problem
,	O
pinpoint	B-problem
pupils	I-problem
,	O
decerebrate	B-problem
posturing	I-problem
and	O
increased	B-problem
tone	I-problem
in	I-problem
bilateral	I-problem
upper	I-problem
extremities	I-problem
and	O
unresponsiveness	B-problem
.	O

The	O
patient	O
was	O
brought	O
to	O
CT	O
immediately	O
for	O
stat	B-test
scan	I-test
and	O
was	O
found	O
to	O
have	O
a	B-problem
massive	I-problem
occipital	I-problem
spontaneous	I-problem
hemorrhage	I-problem
into	I-problem
the	I-problem
L	I-problem
ventricle	I-problem
requiring	O
ventricular	B-treatment
drainage	I-treatment
.	O

Neurosurgery	O
was	O
immediately	O
called	O
for	O
an	B-treatment
EVD	I-treatment
and	O
anesthesia	O
was	O
called	O
STAT	O
to	O
the	O
bedside	O
for	O
intubation	B-treatment
at	O
10:45	O
am	O
in	O
order	O
to	O
assist	O
in	O
hyperventilation	B-treatment
.	O

After	O
endotracheal	B-treatment
intubation	I-treatment
,	O
MAPs	B-test
were	O
maintained	O
between	O
70	O
and	O
90	O
,	O
dilantin	B-treatment
was	O
dose	O
to	O
maintain	O
an	O
appropriate	O
level	O
.	O

L	B-treatment
frontal	I-treatment
ICP	I-treatment
bolt	I-treatment
was	O
placed	O
by	O
neurosurgery	O
under	O
sterile	O
conditions	O
on	O
antibiotics	B-treatment
.	O

Mannitol	B-treatment
75	O
mg	O
iv	O
x	O
1	O
then	O
50	O
gm	O
iv	O
tid	O
was	O
begun	O
to	O
maintain	O
serum	B-test
osm	I-test
>	O
320	O
and	O
Na	B-test
>	O
147	O
.	O

The	O
patient	O
was	O
hyperventilated	B-treatment
to	O
goal	B-test
PCO2	I-test
30-35	O
with	O
ICP	B-test
improvement	O
.	O

Serial	B-test
head	I-test
CT	I-test
studies	I-test
and	O
neurologic	B-test
exams	I-test
were	O
performed	O
but	O
the	O
patient	O
was	O
unchaged	O
,	O
unresponsive	B-problem
with	O
posturing	B-problem
and	O
no	B-problem
spontaneous	I-problem
movement	I-problem
despite	O
ICP	B-test
being	O
maintained	O
in	O
good	O
range	O
(	O
<	O
20	O
).	O

On	O
2017-03-03	O
,	O
a	O
family	O
meeting	O
resulted	O
in	O
the	O
patient	O
's	O
code	O
being	O
changed	O
to	O
comfort	B-treatment
measures	I-treatment
only	I-treatment
.	O

The	O
patient	O
was	O
terminally	O
extubated	O
on	O
a	B-treatment
morphine	I-treatment
drip	I-treatment
and	O
ativan	B-treatment
titrated	O
for	O
agonal	B-problem
breathing	I-problem
and	O
discomfort	B-problem
;	O
scopolamine	B-treatment
was	O
used	O
as	O
an	O
adjunct	O
to	O
control	O
secretions	B-problem
and	O
appeared	O
comfortable	O
when	O
he	O
died	O
at	O
12:27	O
pm	O
on	O
2017-03-04	O
.	O

The	O
family	O
refused	O
autopsy	B-test
or	O
post-mortem	B-test
examination	I-test
to	O
deduce	O
secondary	O
causes	O
of	O
death	O
.	O

2.	O
ID	O
-	O
Bacteremia	B-problem
and	O
PNA	B-problem
:	O

Pt	B-treatment
's	I-treatment
triple	I-treatment
lumen	I-treatment
catheter	I-treatment
was	O
found	O
to	O
be	O
growing	O
coag	B-problem
neg	I-problem
staph	I-problem
.	O
and	O
PICC	B-treatment
tip	I-treatment
and	O
sputum	B-test
growing	O
enterobacter	B-problem
cloacae	I-problem
.	O

The	B-treatment
PICC	I-treatment
was	O
d/c	O
'ed	O
and	O
pt	O
was	O
continued	O
on	O
vancomycin	B-treatment
(	O
for	O
course	O
of	O
6	O
weeks	O
)	O
and	O
meropenem	B-treatment
was	O
added	O
on	O
02-09	O
(	O
for	O
3	O
week	O
course	O
).	O

TEE	B-test
was	O
negative	O
.	O

Pt	O
finished	O
the	O
3	O
week	O
course	O
of	O
meropenem	B-treatment
while	O
in	O
house	O
and	O
was	O
discharged	O
to	O
rehab	O
on	O
day	O
34/42	O
of	O
the	B-treatment
vancomycin	I-treatment
.	O

3)	O
AIN	B-problem
:	O

Pt	O
received	O
oxacillin	B-treatment
during	O
his	O
prior	O
hospitalization	O
and	O
had	O
AIN	B-problem
from	O
this	B-treatment
medication	I-treatment
.	O

On	O
this	O
admission	O
he	O
was	O
continued	O
on	O
prednisone	B-treatment
taper	I-treatment
.	O

Fluoroquinolones	B-treatment
and	O
other	O
renal	O
toxins	O
were	O
avoided	O
.	O

Renal	O
function	O
gradually	O
improved	O
and	O
Cr	B-test
trended	O
down	O
from	O
peak	O
of	O
7.6	O
to	O
1.4	O
.	O

Before	O
the	O
patient	O
acutely	O
decompensated	O
as	O
above	O
,	O
the	O
plan	O
was	O
for	O
steroid	B-treatment
taper	I-treatment
:	O

60	O
mg	O
x	O
10	O
days	O
(	O
already	O
completed	O
)	O
,	O
40	O
mg	O
x	O
14	O
d	O
(	O
already	O
completed	O
)	O
,	O
20	O
mg	O
x	O
14	O
d	O
(	O
now	O
day	O
11-24	O
)	O
,	O
10	O
mg	O
x	O
10	O
d	O
,	O
5	O
mg	O
x	O
10	O
d	O
.	O

4)	O
Foot	B-problem
ulcer	I-problem
:	O
The	O
pt	O
was	O
followed	O
by	O
podiatry	O
and	O
had	O
several	B-treatment
further	I-treatment
debridement	I-treatment
of	O
his	B-problem
R	I-problem
heel	I-problem
wound	I-problem
.	O

on	O
abx	B-treatment
,	O
podiatry	O
following	O
,	O
changed	O
vac	B-treatment
q3	O
days	O
.	O

5)	O
Encephalopathy	B-problem
:	O
It	O
was	O
unclear	O
why	O
the	O
pt	O
's	O
mental	O
status	O
initially	O
did	O
not	O
improve	O
more	O
quickly	O
after	O
all	B-treatment
sedatives	I-treatment
were	O
removed	O
and	O
he	O
was	O
extubated	O
.	O

His	O
MS	O
waxed	O
and	O
waned	O
for	O
many	O
days	O
and	O
uremia	B-problem
vs.	O
failure	B-problem
to	I-problem
clear	I-problem
sedatives	I-problem
were	O
considered	O
(	O
although	O
pt	O
was	O
making	O
urine	O
and	O
LFT	B-test
's	I-test
are	O
wnl	O
).	O

The	O
pt	O
had	O
an	B-test
EEG	I-test
and	O
2	B-test
head	I-test
CT	I-test
's	I-test
which	O
did	O
not	O
show	O
anoxic	B-problem
brain	I-problem
injury	I-problem
or	O
bleeding	B-problem
.	O

He	O
gradually	O
improved	O
and	O
was	O
A&Ox3	O
and	O
near	O
baseline	O
before	O
Amesbury	O
Hospital	O
transferred	O
to	O
the	O
CMED	O
CSRU	O
in	O
respiratory	B-problem
distress	I-problem
.	O

6)	O
DM	B-problem
:	O

Pt	O
was	O
maintained	O
on	O
SSI	B-treatment
with	O
small	O
amount	O
of	O
standing	B-treatment
insulin	I-treatment
while	O
he	O
was	O
NPO	B-treatment
and	O
then	O
his	B-treatment
dose	I-treatment
was	O
gradually	O
increased	O
as	O
he	O
received	O
tube	B-treatment
feeds	I-treatment
.	O

7)	O
FEN	O
:	O

The	O
pt	O
had	O
an	B-treatment
NG	I-treatment
tube	I-treatment
placed	O
and	O
received	O
tube	B-treatment
feeds	I-treatment
for	O
the	O
majority	O
of	O
his	B-treatment
hospitalization	I-treatment
.	O

Upon	O
extubation	B-treatment
and	O
transfer	O
to	O
the	O
floor	O
he	O
pulled	O
out	O
the	B-treatment
NG	I-treatment
tube	I-treatment
time	O
several	O
times	O
and	O
required	O
restraints	B-treatment
.	O

Albumin	B-test
was	O
very	B-problem
low	I-problem
and	O
pt	O
had	O
significant	B-problem
edema	I-problem
likely	O
03-15	O
this	O
.	O

A	O
few	O
days	O
before	O
decompensating	O
,	O
his	O
mental	O
status	O
improved	O
to	O
the	O
degree	O
that	O
he	O
was	O
able	O
to	O
eat	O
normal	O
food	O
without	O
aspirating	O
.	O

8)	O
CV	O
:	O

Pump	O
/	O
HTN	B-problem
:	O
pt	O
had	O
episodes	O
of	O
both	O
hypertension	B-problem
and	O
hypotension	B-problem
during	O
his	O
stay	O
.	O

He	O
was	O
managed	O
with	O
Metoprolol	B-treatment
,	O
Hydralazine	B-treatment
,	O
and	O
Amlodipine	B-treatment
.	O

Near	O
discharge	O
his	B-test
BP	I-test
was	O
controlled	O
with	O
Metoprolol	B-treatment
only	O
.	O

9)	O
Hypernatremia	B-problem
-	O
While	O
in	O
the	O
CMED	O
CSRU	O
the	O
pt	O
developed	O
hypernatremia	B-problem
.	O

This	O
was	O
felt	O
to	O
be	O
likely	O
03-15	O
intravascular	B-problem
volume	I-problem
depletion	I-problem
since	O
the	B-test
pt	I-test
's	I-test
albumin	I-test
was	O
so	B-problem
low	I-problem
and	O
he	O
was	O
third	O
spacing	O
all	O
of	O
his	O
fluid	O
.	O

He	O
was	O
volume	O
resuscitated	O
and	O
managed	O
with	O
D5W	B-treatment
and	O
lasix	B-treatment
as	O
well	O
as	O
receving	O
FW	B-treatment
boluses	I-treatment
with	O
his	B-treatment
NG	I-treatment
tube	I-treatment
feeds	I-treatment
.	O

The	B-problem
hypernatremia	I-problem
fully	O
resolved	O
when	O
he	O
resumed	O
eating	O
on	O
his	O
own	O
and	O
had	O
access	O
to	O
free	O
water	O
.	O

10)	O
Anemia	B-problem
:	O

Pt	B-test
's	I-test
Hct	I-test
trended	O
down	O
slowly	O
throughout	O
his	O
hospitalization	O
.	O

Labs	B-test
were	O
consistent	O
with	O
anemia	B-problem
of	O
chronic	B-problem
disease	I-problem
.	O

He	O
was	O
transfused	O
3	B-treatment
units	I-treatment
pRBC	I-treatment
's	I-treatment
near	O
the	O
end	O
of	O
his	O
hospitalization	O
and	O
had	O
an	O
appropriate	O
bump	O
.	O

11)	O
CMED	O
CCU	O
:	O

When	O
the	O
pt	O
's	O
MS	O
improved	O
to	O
near	O
baseline	O
before	O
again	O
decompensating	O
,	O
he	O
became	O
extremely	B-problem
tearful	I-problem
and	O
expressed	O
feelings	O
of	O
depression	B-problem
after	O
being	O
in	O
the	O
hospital	O
for	O
so	O
long	O
.	O

He	O
expressed	O
interest	O
in	O
taking	O
an	B-treatment
anti-depressant	I-treatment
for	O
a	O
short	O
time	O
while	O
he	O
was	O
recovering	O
and	O
was	O
started	O
on	O
Celexa	B-treatment
.	O

Medications	O
on	O
Admission	O
:	O
vancomycin	B-treatment
1g	O
IV	O
q48	O

MVI	B-treatment
PAD-WORD	O

Neurontin	B-treatment
300	O
qd	O

RISS	B-treatment
PAD-WORD	O

Prednisone	B-treatment
taper	I-treatment
60	O
qd	O

Prilosec	B-treatment
20	O
qd	O

Metoprolol	B-treatment
25	O
bid	O

Lantus	B-treatment
480	O
qd	O

Calcium	B-treatment
Carbonate	I-treatment
tid	O
with	O
meals	O

Discharge	O
Medications	O
:	O
n/a	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O
subarachnoid	B-problem
hemorrhage	I-problem

Diabetes	B-problem
Mellitis	I-problem
(	O
Pancreatic	B-problem
Trauma	I-problem
)	O

Acute	B-problem
Interstitial	I-problem
Nephritis	I-problem
(	O
Oxacillin	B-treatment
)	O

Peripheral	B-problem
Neuropathy	I-problem

Peripheral	B-problem
Vascular	I-problem
Disease	I-problem

Digital	B-problem
Necrosis	I-problem

Multiple	B-treatment
Toe	I-treatment
Amputations	I-treatment

Diabetic	B-problem
Nephropathy	I-problem

Hypertension	B-problem
PAD-WORD	O

MSSA	B-problem
Bacteremia	I-problem

Enterococcal	B-problem
Bacteremia	I-problem

Enterbactor	B-problem
Cloacae	I-problem
Bacteremia	I-problem

Multifocal	B-problem
Pneumonia	I-problem

Respiratory	B-problem
Failure	I-problem

MSSA	B-problem
osteomyelitis	I-problem
of	I-problem
Calcaneous	I-problem

Toxic	B-problem
/	I-problem
Metabolic	I-problem
Encephalopathy	I-problem

Hypernatremia	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O

Deceased	O
PAD-WORD	O

Sims	O
Kenneth	O
Jason	O
MD	O
95-149	O

Completed	O
by	O
:	O
Michael	O
Sulzer	O
ROSENTHAL	O
MD	O
58-540	O
2017-05-24	O
@	O
2309	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Cheryl	O
James	O
on	O
:	O
Larry	O
2017-05-25	O
2:28	O
PM	O

(	O
End	O
of	O
Report	O
)	O

506243692_b	O
PAD-WORD	O

FIH	O
PAD-WORD	O

6305145	O
PAD-WORD	O

963632	O
PAD-WORD	O

439524	O
PAD-WORD	O

11/4/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

STATE	O
,	O
ELRO	O

UNIT	O
NUMBER	O
:	O

413-18-46	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

11/04/2000	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

11/09/2000	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pulmonary	B-problem
edema	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Congestive	B-problem
heart	I-problem
failure	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
mediastinal	B-problem
mass	I-problem
,	O
inferior	B-problem
myocardial	I-problem
infarction	I-problem
,	O
bronchiectasis	B-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

None	O
.	O

CLINICAL	O
INFECTIONS	O
:	O

None	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Cardiac	B-test
catheterization	I-test
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

VQ	B-test
scan	I-test
,	O
lower	B-test
extremities	I-test
noninvasive	I-test
Doppler	I-test
studies	I-test
and	O
overnight	B-test
oximetry	I-test
saturation	I-test
monitoring	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
State	O
is	O
an	O
81-year-old	O
man	O
with	O
a	O
history	O
of	O
restrictive	B-problem
and	I-problem
obstructive	I-problem
lung	I-problem
disease	I-problem
,	O
dilated	B-problem
cardiomyopathy	I-problem
,	O
inferior	B-problem
myocardial	I-problem
infarction	I-problem
,	O
and	O
anterior	B-problem
mediastinal	I-problem
masses	I-problem
admitted	O
with	O
acute	O
onset	O
of	O
pulmonary	B-problem
edema	I-problem
.	O

In	O
the	O
setting	O
of	O
inadvertently	O
decreasing	O
Lasix	B-treatment
from	O
80	O
mg.	O
po	O
40	O
mg.	O
a	O
day	O
Mr.	O
State	O
had	O
sudden	B-problem
onset	I-problem
dyspnea	I-problem
after	O
approximate	O
day	O
and	O
a	O
half	O
prodrome	B-problem
culminating	O
in	O
severe	B-problem
dyspnea	I-problem
.	O

Upon	O
arrival	O
in	O
the	O
Emergency	O
Room	O
Mr.	B-test
State	I-test
&apos;s	I-test
saturations	I-test
were	O
in	O
the	O
mid	O
80s	O
and	O
he	O
was	O
promptly	O
rendered	O
more	O
comfortable	O
with	O
high	B-treatment
flow	I-treatment
oxygen	I-treatment
,	O
morphine	B-treatment
,	O
and	O
nitrates	B-treatment
and	O
intravenous	B-treatment
Lasix	I-treatment
.	O

Chest	B-test
x-ray	I-test
was	O
relatively	O
unrevealing	O
for	O
interstitial	B-problem
or	I-problem
alveolar	I-problem
edema	I-problem
and	O
with	O
clinical	O
improvement	O
ensued	O
with	O
the	O
immediate	B-treatment
therapy	I-treatment
in	O
the	O
Emergency	O
Room	O
as	O
noted	O
.	O

The	O
patient	O
denied	O
angina	B-problem
,	O
syncope	B-problem
,	O
preceding	B-problem
worsening	I-problem
orthopnea	I-problem
,	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
,	O
palpitations	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
hematemesis	B-problem
or	O
melena	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
notable	O
for	O
an	B-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
,	O
restrictive	B-problem
and	I-problem
obstructive	I-problem
lung	I-problem
disease	I-problem
with	O
an	B-test
FEV1	I-test
of	O
.9	O
and	O
FVC	B-test
of	O
1.34	O
and	O
a	O
moderate	O
at	O
best	O
response	O
to	O
bronchodilators	B-treatment
,	O
and	O
a	O
negative	O
sestamibi	O
scan	O
in	O
May	O
,	O
1999	O
apart	O
from	O
a	B-problem
severe	I-problem
fixed	I-problem
inferolateral	I-problem
defect	I-problem
,	O
systolic	B-problem
dysfunction	I-problem
with	O
recent	B-test
echocardiography	I-test
revealing	O
an	B-test
LVID	I-test
of	O
62	O
mm.	O
and	O
ejection	B-test
fraction	I-test
of	O
28	O
percent	O
,	O
moderate	B-problem
mitral	I-problem
regurgitation	I-problem
and	O
mild-to-moderate	B-problem
aortic	I-problem
stenosis	I-problem
with	O
a	B-test
peak	I-test
gradient	I-test
of	O
33	O
and	O
a	B-test
mean	I-test
gradient	I-test
of	O
19	O
and	O
a	B-test
valve	I-test
area	I-test
of	O
1.4	O
cm.	O
squared	O
.	O

In	O
addition	O
,	O
Mr.	O
State	O
has	O
an	B-problem
anterior	I-problem
mediastinal	I-problem
mass	I-problem
2x2x1.7	O
cm.	O
by	O
recent	B-test
computerized	I-test
tomography	I-test
scan	I-test
without	O
surrounding	B-problem
or	I-problem
adjacent	I-problem
adenopathy	I-problem
or	O
parenchymal	B-problem
lung	I-problem
disease	I-problem
apart	O
from	O
bronchiectasis	B-problem
.	O

His	B-test
cardiomyopathy	I-test
work	I-test
up	I-test
entailed	O
a	O
negative	O
ANA	O
,	O
negative	O
SPEP	O
,	O
UPEP	B-test
and	O
Benz-Jones	B-test
proteins	I-test
,	O
normal	O
ferritin	O
,	O
thyroid	B-test
stimulating	I-test
hormone	I-test
and	O
a	B-test
recent	I-test
work	I-test
up	I-test
for	O
possible	O
bimomatous	B-problem
associated	O
myasthenia	B-problem
gravis	I-problem
that	O
was	O
negative	O
.	O

The	O
patient	O
lives	O
on	O
Quelene	O
with	O
his	O
wife	O
.	O

He	O
is	O
a	O
non-smoker	O
and	O
drinks	O
rare	O
alcohol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
a	O
very	O
pleasant	O
man	O
who	O
appeared	O
his	O
stated	O
age	O
.	O

Blood	B-test
pressure	I-test
was	O
155/60	O
,	O
heart	B-test
rate	I-test
70	O
with	O
occasional	B-problem
premature	I-problem
ventricular	I-problem
contractions	I-problem
,	O
respirations	B-test
14	O
.	O

Mr.	O
State	O
was	O
dyspneic	B-problem
speaking	O
in	O
short	O
sentences	O
initially	O
on	O
high	B-treatment
flow	I-treatment
oxygen	I-treatment
.	O

Jugular	B-test
venous	I-test
pressure	I-test
was	O
8	O
with	O
a	B-problem
brisk	I-problem
inspiratory	I-problem
descent	I-problem
.	O

There	O
was	O
no	O
thyromegaly	B-problem
.	O

Carotids	B-test
were	O
2+	O
.	O

Breath	O
sounds	O
were	O
decreased	B-problem
at	I-problem
the	I-problem
bases	I-problem
only	O
with	O
distant	B-problem
heart	I-problem
sounds	I-problem
and	O
a	B-problem
2	I-problem
out	I-problem
of	I-problem
6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
consistent	O
with	O
aortic	B-problem
stenosis	I-problem
with	O
Gallavardin	B-problem
like	I-problem
radiation	I-problem
to	I-problem
the	I-problem
apex	I-problem
.	O

Abdomen	O
:	O

soft	O
,	O
nontender	B-problem
with	O
hepatosplenomegaly	B-problem
,	O
or	O
hepatojugular	B-problem
reflex	I-problem
,	O
bruits	B-problem
or	O
pulsations	B-problem
.	O

There	O
was	O
no	O
rash	B-problem
and	O
no	O
edema	B-problem
and	O
the	B-test
neurological	I-test
examination	I-test
was	O
non-focal	O
.	O

LABORATORY	O
DATA	O
:	O

Notable	O
for	O
a	B-test
sodium	I-test
of	O
145	O
,	O
potassium	B-test
3.6	O
,	O
BUN	B-test
23	O
,	O
creatinine	B-test
1.3	O
,	O
glucose	B-test
104	O
,	O
hematocrit	B-test
42	O
,	O
white	B-test
count	I-test
8.7	O
,	O
platelet	B-test
count	I-test
235	O
and	O
a	B-test
PT	I-test
of	O
12.9	O
seconds	O
.	O

The	B-test
urinalysis	I-test
was	O
negative	O
.	O

The	B-test
Troponin	I-test
I	I-test
was	O
less	O
than	O
.4	O
and	O
the	B-test
creatine	I-test
kinase	I-test
was	O
114	O
.	O

Chest	B-test
x-ray	I-test
revealed	O
moderate	B-problem
cardiomegaly	I-problem
with	O
no	O
clear	B-problem
interstitial	I-problem
or	I-problem
alveolar	I-problem
pulmonary	I-problem
edema	I-problem
and	O
chronic	B-problem
atelectasis	I-problem
and	O
/	O
or	O
scarring	B-problem
at	I-problem
both	I-problem
lung	I-problem
bases	I-problem
.	O

The	B-test
electrocardiogram	I-test
revealed	O
normal	O
sinus	O
rhythm	O
with	O
premature	B-problem
atrial	I-problem
complexes	I-problem
and	O
right	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
with	O
left	B-problem
anterior	I-problem
hemiblock	I-problem
and	O
old	B-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Hospital	O
and	O
underwent	O
an	B-treatment
approximate	I-treatment
1.5	I-treatment
liter	I-treatment
diuresis	I-treatment
within	O
the	O
first	O
24	O
hours	O
with	O
improvement	O
in	O
his	B-problem
symptoms	I-problem
and	O
improvement	O
in	O
his	B-test
oxygen	I-test
saturations	I-test
.	O

After	O
a	O
long	O
discussion	O
with	O
the	O
patient	O
and	O
his	O
family	O
it	O
was	O
determined	O
that	O
a	B-test
cardiac	I-test
catheterization	I-test
would	O
be	O
prudent	O
.	O

Prior	O
to	O
catheterization	B-test
a	B-test
VQ	I-test
scan	I-test
was	O
performed	O
which	O
revealed	O
a	O
moderate	O
probability	O
for	O
PE	B-problem
with	O
a	B-problem
subsegmental	I-problem
defect	I-problem
in	I-problem
the	I-problem
lingular	I-problem
on	O
the	O
left	O
lung	O
.	O

Subsequent	B-test
lower	I-test
extremities	I-test
noninvasive	I-test
studies	I-test
and	O
D-dimer	B-test
test	I-test
were	O
both	O
negative	O
rendering	O
the	O
probability	O
of	O
acute	B-problem
pulmonary	I-problem
embolism	I-problem
less	O
than	O
2	O
percent	O
.	O

It	O
was	O
not	O
felt	O
that	O
the	O
patient	O
would	O
be	O
in	O
need	O
of	O
chronic	B-treatment
Coumadin	I-treatment
therapy	I-treatment
in	O
lieu	O
of	O
this	O
low	O
probability	O
findings	O
in	O
toto	O
.	O

Coronary	B-test
angiography	I-test
revealed	O
occlusion	B-problem
of	I-problem
the	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
proximally	I-problem
with	O
insignificant	B-problem
plaquing	I-problem
in	I-problem
the	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
artery	I-problem
and	O
circumflex	O
arteries	O
.	O

After	O
a	B-treatment
approximate	I-treatment
3	I-treatment
liter	I-treatment
total	I-treatment
diuresis	I-treatment
the	B-test
right	I-test
atrial	I-test
pressure	I-test
was	O
5	O
,	O
pulmonary	B-test
capillary	I-test
wedge	I-test
pressure	I-test
14	O
,	O
pulmonary	B-test
vacuolar	I-test
resistance	I-test
353	O
and	O
the	B-test
cardiac	I-test
output	I-test
depressed	O
at	O
2.95	O
liters	O
per	O
minute	O
,	O
or	O
a	B-test
cardiac	I-test
index	I-test
of	O
1.7	O
liters	O
per	O
minute	O
.	O

Based	O
upon	O
these	O
findings	O
it	O
was	O
felt	O
that	O
Mr.	O
State	O
most	O
likely	O
has	O
multi-factorial	B-problem
dyspnea	I-problem
owing	O
to	O
both	O
his	B-problem
ventilatory	I-problem
limitation	I-problem
and	O
to	O
a	B-problem
chronic	I-problem
low	I-problem
output	I-problem
state	I-problem
.	O

In	O
Hospital	O
he	O
was	O
seen	O
by	O
both	O
Speech	O
Therapy	O
,	O
physical	O
therapy	O
,	O
and	O
the	O
Uspend	O
Harmemewood	O
Medical	O
Center	O
Congestive	O
Heart	O
Failure	O
Nurse	O
Practitioner	O
Program	O
.	O

His	B-treatment
Isordil	I-treatment
was	O
increased	O
in	O
Hospital	O
and	O
blood	B-treatment
pressure	I-treatment
control	I-treatment
was	O
relative	O
episodic	O
with	O
systolic	B-test
pressures	I-test
ranging	O
between	O
100	O
and	O
160	O
.	O

Future	O
adjustments	O
will	O
be	O
made	O
at	O
home	O
pending	O
his	B-test
blood	I-test
pressure	I-test
measures	I-test
.	O

At	O
a	O
goal	O
weight	B-test
of	O
142	O
pounds	O
,	O
Mr.	B-test
State	I-test
&apos;s	I-test
filling	I-test
pressures	I-test
appeared	O
ideal	O
with	O
a	B-test
wedge	I-test
pressure	I-test
of	O
14	O
and	O
his	O
goal	O
weight	O
range	O
will	O
be	O
between	O
142	O
and	O
44	O
pounds	O
at	O
home	O
.	O

The	O
patient	O
will	O
be	O
followed	O
by	O
Dr.	O
State	O
within	O
a	O
week	O
of	O
discharge	O
and	O
by	O
Nieie	O
Naebrand	O
Freierm	O
of	O
the	O
Dyathenslycha	O
Medical	O
Center	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Imdur	B-treatment
120	O
mg.	O
PO	O
q.d.	O
Captopril	B-treatment
100mg.	O
PO	O
t.i.d.	O
Lasix	B-treatment
80	O
mg.	O
PO	O
q.d.	O
Potassium	B-treatment
chloride	I-treatment
40	O
mEq.	O
PO	O
q.d.	O
Coreg	B-treatment
12.5	O
mg.	O
b.i.d.	O
Cozaar	B-treatment
100	O
mg.	O
b.i.d.	O
Plavix	B-treatment
75	O
mg.	O
q.d.	O
Allopurinol	B-treatment
300	O
mg.	O
q.d.	O
Pulmacort	B-treatment
and	O
Serevent	B-treatment
inhalers	I-treatment
2	O
puffs	O
b.i.d.	O
Zocor	B-treatment
20	O
mg.	O
q.d.	O
Prilosec	B-treatment
20	O
mg.	O
q.d.	O
Colace	B-treatment
100	O
mg.	O
t.i.d.	O

FOLLOW	O
UP	O
:	O

The	O
patient	O
will	O
see	O
Dr.	O
State	O
,	O
as	O
noted	O
,	O
in	O
follow	O
up	O
.	O

AKA	O
G	O
STATE	O
,	O
M.D.	O
CARDIAC	O
TRANSPLANT	O
STEMSTRICTALLE	O
MEDICAL	O
CENTER	O
Electronically	O
Signed	O
AKA	O
G	O
STATE	O
,	O
M.D.	O
11/17/2000	O
12:46	O
_____________________________	O
??	O

TR	O
:	O

rij	O
PAD-WORD	O

DD	O
:	O

11/09/2000	O
PAD-WORD	O

TD	O
:	O

11/14/2000	O
1:09	O
P	O

cc	O
:	O

AKA	O
G	O
STATE	O
,	O
M.D.	O
AMAN	O
SCKOLLMINEVUILLE	O
,	O
M.D.	O
FA	O
HEN	O
KNOTTIPPSFYFE	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2012-03-01	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-03-13	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1985-11-02	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
26	O
-	O
year-old	O
female	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
nonischemic	B-problem
dilated	I-problem
cardiomyopathy	I-problem
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
15-20%	O
,	O
who	O
presents	O
with	O
a	O
one-week	O
history	O
of	O
progressive	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

She	O
reports	O
orthopnea	B-problem
with	O
an	B-problem
increasing	I-problem
pillow	I-problem
requirement	I-problem
of	O
2-4	O
with	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

Patient	O
also	O
reports	O
a	B-problem
6-pound	I-problem
weight	I-problem
gain	I-problem
over	O
the	O
last	O
four	O
days	O
with	O
associated	O
lower	B-problem
extremity	I-problem
edema	I-problem
.	O

She	O
also	O
reports	O
positional	B-problem
chest	I-problem
pain	I-problem
,	O
which	O
is	O
worse	O
with	O
lying	O
down	O
and	O
relieved	O
with	O
sitting	O
up	O
.	O

She	O
denies	O
any	B-problem
pain	I-problem
with	O
activity	O
.	O

She	O
also	O
reports	O
a	B-problem
cough	I-problem
productive	O
of	O
green	B-problem
sputum	I-problem
for	O
approximately	O
one	O
week	O
.	O

She	O
does	O
report	O
chills	B-problem
,	O
but	O
no	O
fevers	B-problem
.	O

In	O
the	O
Emergency	O
Department	O
,	O
she	O
was	O
started	O
on	O
a	B-treatment
nesiritide	I-treatment
drip	I-treatment
and	O
responded	O
well	O
with	O
2000	O
cc	O
urine	O
output	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Nonischemic	B-problem
dilated	I-problem
cardiomyopathy	I-problem
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
15-20%	O
.	O

2.	O
Status	O
post	O
cardiac	B-test
catheterization	I-test
in	O
2011-11-19	O
which	O
showed	O
normal	O
coronaries	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Toprol	B-treatment
.	O

2.	O
Lasix	B-treatment
.	O

3.	O
Digoxin	B-treatment
.	O

4.	O
Coumadin	B-treatment
.	O

5.	O
Flovent	B-treatment
.	O

6.	O
Albuterol	B-treatment
.	O

7.	O
Lisinopril	B-treatment
.	O

ALLERGIES	O
:	O

She	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
a	O
positive	O
tobacco	O
user	O
.	O

She	O
smoked	O
a	O
half	O
pack	O
a	O
day	O
for	O
eight	O
years	O
and	O
quit	O
in	O
2011-11-19	O
.	O

She	O
denies	O
any	O
alcohol	O
or	O
drug	O
use	O
.	O

She	O
has	O
a	O
5-year-old	O
son	O
.	O

FAMILY	O
HISTORY	O
:	O

There	O
is	O
no	O
family	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

VITALS	O
ON	O
ADMISSION	O
:	O

She	O
had	O
a	B-test
temperature	I-test
of	O
98.1	O
,	O
blood	B-test
pressure	I-test
of	O
130/99	O
,	O
pulse	B-test
of	O
111	O
,	O
respiratory	B-test
rate	I-test
of	O
16	O
.	O

She	O
was	O
saturating	O
100%	O
on	O
room	O
air	O
.	O

PHYSICAL	O
EXAM	O
:	O

General	O
:	O

She	O
is	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

She	O
is	O
obese	B-problem
.	O

She	O
is	O
slightly	B-problem
tachypneic	I-problem
.	O

HEENT	O
:	O

Pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

Her	O
oropharynx	O
is	O
clear	O
.	O

Mucous	O
membranes	O
are	O
moist	O
.	O

Neck	O
:	O

She	O
has	O
JVD	B-problem
to	O
angle	O
of	O
the	O
jaw	O
,	O
no	O
bruits	B-problem
.	O

Chest	O
:	O

She	O
has	O
got	O
bilateral	B-problem
basilar	I-problem
crackles	I-problem
,	O
no	O
wheezing	B-problem
.	O

Cardiac	B-test
examination	I-test
:	O

She	O
had	O
a	O
normal	O
S1	O
,	O
S2	O
with	O
a	B-problem
2/6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
at	I-problem
the	I-problem
left	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
.	O

She	O
had	O
a	O
positive	O
S4	B-problem
.	O

Her	O
abdomen	O
was	O
obese	B-problem
,	O
soft	O
,	O
nontender	B-problem
.	O

Extremities	O
:	O

2+	B-problem
edema	I-problem
to	I-problem
the	I-problem
knees	I-problem
.	O

LABORATORIES	O
ON	O
ADMISSION	O
:	O

She	O
had	O
a	B-test
white	I-test
count	I-test
of	O
9.3	O
,	O
hematocrit	B-test
of	O
37.7	O
,	O
platelets	B-test
of	O
293	O
.	O

She	O
had	O
a	B-test
CK	I-test
of	O
212	O
and	O
MB	B-test
of	O
21	O
,	O
and	O
a	B-test
troponin	I-test
of	O
0.56	O
.	O

She	O
had	O
a	B-test
Chem-7	I-test
which	O
was	O
normal	O
.	O

She	O
had	O
an	B-test
INR	I-test
of	O
1.5	O
on	O
her	B-treatment
Coumadin	I-treatment
.	O

Chest	B-test
x-ray	I-test
showed	O
right	B-problem
patchy	I-problem
opacity	I-problem
with	O
a	B-problem
right	I-problem
effusion	I-problem
.	O

EKG	B-test
showed	O
sinus	B-problem
tachycardia	I-problem
,	O
borderline	B-problem
left	I-problem
axis	I-problem
,	O
normal	O
intervals	O
,	O
LVH	B-problem
,	O
left	B-problem
atrial	I-problem
enlargement	I-problem
,	O
no	O
Q	B-problem
waves	I-problem
,	O
no	O
P-R	B-problem
depressions	I-problem
,	O
no	O
ST	B-problem
segment	I-problem
elevations	I-problem
or	O
depression	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
:	O

Patient	O
was	O
diuresed	O
effectively	O
with	O
nesiritide	B-treatment
and	O
Lasix	B-treatment
.	O

Patient	B-test
's	I-test
weight	I-test
on	O
admission	O
was	O
250	O
pounds	O
,	O
and	O
on	O
the	O
day	O
of	O
discharge	O
was	O
244	O
pounds	O
which	O
was	O
back	O
to	O
her	B-test
dry	I-test
weight	I-test
.	O

She	O
had	O
lost	O
the	O
6	O
pounds	O
that	O
she	O
reported	O
gaining	O
in	O
the	O
four	O
days	O
prior	O
to	O
her	O
hospitalization	O
.	O

Patient	O
was	O
continued	O
on	O
her	B-treatment
Toprol	I-treatment
,	O
her	B-treatment
lisinopril	I-treatment
,	O
and	O
her	B-treatment
digoxin	I-treatment
.	O

Patient	B-treatment
's	I-treatment
Coumadin	I-treatment
was	O
held	O
for	O
right	B-test
heart	I-test
catheterization	I-test
and	O
biopsy	B-test
,	O
and	O
then	O
EP	B-test
study	I-test
with	O
ICD	B-treatment
placement	I-treatment
.	O

Patient	O
did	O
have	O
Woodrow	O
Betty	O
,	O
SPEP	B-test
,	O
and	O
anticardiolipin	B-test
antibody	I-test
sent	O
for	O
further	B-test
workup	I-test
of	O
the	O
etiology	O
of	O
her	B-problem
cardiomyopathy	I-problem
.	O

The	O
Courtney	O
,	O
SPEP	B-test
,	O
and	O
anticardiolipin	B-test
antibody	I-test
were	O
all	O
negative	O
.	O

Her	B-test
CKs	I-test
did	O
trend	O
down	O
over	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
,	O
and	O
in	O
the	O
setting	O
of	O
her	O
known	O
clean	O
coronaries	O
on	O
cardiac	B-test
catheterization	I-test
in	O
2011-11-19	O
,	O
it	O
was	O
believed	O
that	O
a	B-problem
myocarditis	I-problem
might	O
be	O
the	O
cause	O
of	O
her	B-problem
elevated	I-problem
cardiac	I-problem
enzymes	I-problem
and	O
also	O
could	O
have	O
exacerbated	O
her	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
.	O

Patient	O
did	O
receive	O
a	B-test
right	I-test
heart	I-test
catheterization	I-test
,	O
which	O
showed	O
elevated	B-problem
wedge	I-problem
pressures	I-problem
and	O
biopsy	B-test
specimens	I-test
were	O
obtained	O
of	O
the	O
right	O
ventricle	O
.	O

The	O
results	O
of	O
these	B-test
biopsies	I-test
are	O
still	O
pending	O
in	O
pathology	O
.	O

Post	O
right	B-test
heart	I-test
catheterization	I-test
and	O
right	B-test
ventricular	I-test
biopsy	I-test
,	O
the	O
patient	O
was	O
sent	O
to	O
the	O
CCU	O
for	O
a	B-treatment
Swan	I-treatment
-	I-treatment
guided	I-treatment
therapy	I-treatment
in	O
the	O
setting	O
of	O
her	B-problem
elevated	I-problem
wedge	I-problem
pressures	I-problem
and	O
low	B-problem
cardiac	I-problem
output	I-problem
.	O

In	O
the	O
CCU	O
,	O
she	O
was	O
put	O
on	O
milrinone	B-treatment
with	O
good	O
results	O
.	O

Patient	O
was	O
also	O
seen	O
by	O
the	O
Pulmonary	O
service	O
here	O
and	O
had	O
pulmonary	B-test
function	I-test
tests	I-test
done	O
as	O
part	O
of	O
a	B-test
pretransplant	I-test
workup	I-test
.	O

There	O
is	O
no	O
pulmonary	O
process	O
to	O
exclude	O
her	O
from	O
the	O
transplant	O
list	O
as	O
noted	O
by	O
the	O
Pulmonary	O
service	O
.	O

Patient	O
did	O
receive	O
an	B-treatment
ICD	I-treatment
during	O
this	O
hospital	O
admission	O
without	O
complication	B-problem
.	O

Patient	O
was	O
in	O
bigeminy	B-problem
during	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
,	O
and	O
did	O
have	O
frequent	O
runs	O
of	O
ectopy	B-problem
as	O
noted	O
on	O
telemetry	B-test
.	O

2.	O
Her	B-problem
right	I-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
:	O

Patient	O
did	O
report	O
a	B-problem
cough	I-problem
productive	O
of	O
green	B-problem
sputum	I-problem
on	O
admission	O
.	O

She	O
received	O
a	O
full	O
course	O
of	O
azithromycin	B-treatment
for	O
this	O
with	O
resolution	O
of	O
her	B-problem
cough	I-problem
and	O
sputum	B-problem
production	I-problem
.	O

On	O
discharge	O
,	O
the	O
patient	O
was	O
restarted	O
on	O
her	B-treatment
Coumadin	I-treatment
,	O
which	O
was	O
held	O
for	O
her	B-test
right	I-test
heart	I-test
catheterization	I-test
,	O
and	O
her	B-test
biopsy	I-test
,	O
and	O
her	B-treatment
ICD	I-treatment
placement	I-treatment
.	O

She	O
was	O
also	O
continued	O
on	O
all	B-treatment
her	I-treatment
heart	I-treatment
failure	I-treatment
medications	I-treatment
including	O
her	B-treatment
Toprol	I-treatment
,	O
her	B-treatment
lisinopril	I-treatment
,	O
her	B-treatment
digoxin	I-treatment
,	O
and	O
her	B-treatment
Lasix	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Nonischemic	B-problem
dilated	I-problem
cardiomyopathy	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Digoxin	B-treatment
375	O
mcg	O
and	O
250	O
mcg	O
alternating	O
doses	O
each	O
day	O
.	O

2.	O
Lisinopril	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

3.	O
Toprol	B-treatment
XL	I-treatment
75	O
mg	O
p.o.	O
q.d.	O

4.	O
Flovent	B-treatment
110	O
mcg	O
two	O
puffs	O
b.i.d.	O

5.	O
Albuterol	B-treatment
1-2	O
puffs	O
q.6h.	O
prn	O
.	O

6.	O
Coumadin	B-treatment
10	O
mg	O
p.o.	O
q.h.s.	O

7.	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

8.	O
Keflex	B-treatment
500	O
mg	O
x6	O
doses	O
.	O

FOLLOW-UP	O
INSTRUCTIONS	O
:	O

The	O
patient	O
will	O
follow	O
up	O
in	O
EP	O
Clinic	O
on	O
2012-03-19	O
.	O

She	O
will	O
also	O
be	O
seen	O
in	O
the	O
Heart	O
Failure	O
Clinic	O
on	O
2012-03-28	O
.	O

Patient	O
will	O
also	O
followup	O
with	O
her	O
primary	O
care	O
provider	O
,	O
Dr.	O
Sandra	O
Lamar	O
for	O
check	O
of	O
her	B-test
INR	I-test
in	O
one	O
week	O
's	O
time	O
.	O

Felix	O
Weiss	O
,	O
M.D.	O

95-771	O
PAD-WORD	O

Dictated	O
By	O
:	O
Randy	O
EB	O
Brooks	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2012-03-13	O
12:25	O

T	O
:	O
2012-03-13	O
14:00	O

JOB	O
#:	O
15824	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Felix	O
Willis	O
on	O
:	O
FRI	O
2012-06-22	O
12:49	O
PM	O

(	O
End	O
of	O
Report	O
)	O

513119146	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

2186824	O
PAD-WORD	O

425597	O
PAD-WORD	O

704384	O
PAD-WORD	O

4/16/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

FALMDREPSGREND	O
,	O
LINE	O

MRN	O
:	O

2186824	O
PAD-WORD	O

Age	O
:	O

40y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

04/16/2001	O
03:46	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
FALMDREPSGREND	O
,	O
LINE	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
04/16/2001	O
03:46	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
PAIN	B-problem
/	O
ASSAULT	O
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
TO	O
OBSERVATION	O
AT	O
PH	O
UNIVERSITY	O
OF	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
SHUFFCUCH	O
,	O
SEYSHARMSE	O
N	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
VERTEBRAL	B-problem
FRACTURES	I-problem
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
639-873-2993	O
.	O

PCP	O
Name	O
:	O

RALLSVERSGACH	O
,	O
DWAINCO	O

Provider	O
Number	O
:	O

91361	O
PAD-WORD	O

Admission	O
Date	O
:	O

2014-01-20	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-01-21	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1928-01-02	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Michael	O
V.	O
Hamlett	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Hypoxia	B-problem
PAD-WORD	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
none	O

History	O
of	O
Present	O
Illness	O
:	O

CC	O
:	O
dyspnea	B-problem

HPI	O
:	O

86	O
yo	O
man	O
with	O
h/o	O
CVA	B-problem
,	O
CHF	B-problem
,	O
recent	O
episodes	O
of	O
aspiration	B-problem
pneumonia	I-problem
,	O
who	O
p/w	O
dyspnea	B-problem
from	O
his	O
NH	O
.	O

Per	O
the	O
pt	O
's	O
daughter	O
,	O
the	O
patient	O
has	O
had	O
2-3	O
episodes	O
of	O
asp	B-problem
pna	I-problem
in	O
the	O
last	O
2	O
months	O
,	O
for	O
which	O
he	O
has	O
received	O
IV	B-treatment
abx	I-treatment
at	O
the	O
NH	O
with	O
apparent	O
resolution	O
of	O
symptoms	B-problem
.	O

The	O
daughter	O
says	O
that	O
on	O
the	O
day	O
PTA	O
,	O
when	O
she	O
visited	O
the	O
patient	O
at	O
the	O
NH	O
,	O
he	O
was	O
"	O
having	O
a	O
good	O
day	O
,"	O
more	O
interactive	O
than	O
usual	O
and	O
in	O
good	O
spirits	O
.	O

She	O
was	O
called	O
at	O
430	O
am	O
today	O
from	O
the	O
NH	O
with	O
the	O
news	O
that	O
the	O
pt	O
was	O
not	O
doing	O
well	O
,	O
and	O
she	O
came	O
to	O
the	O
Deanna	O
to	O
meet	O
up	O
with	O
her	O
father	O
.	O

Of	O
note	O
,	O
the	O
patient	O
's	O
daughter	O
and	O
son-in-law	O
confirm	O
his	O
desire	O
to	O
be	O
DNR/DNI	B-treatment
,	O
stating	O
that	O
they	O
want	O
him	O
to	O
be	O
comfortable	O
.	O

However	O
,	O
when	O
asked	O
if	O
she	O
thinks	O
he	O
would	O
want	O
comfort	B-treatment
measures	I-treatment
even	O
if	O
it	O
meant	O
that	O
his	O
respiratory	O
status	O
would	O
worsen	O
,	O
the	O
pt	O
's	O
daughter	O
says	O
that	O
he	O
would	O
not	O
.	O

In	O
particular	O
,	O
she	O
feels	O
that	O
the	O
pt	O
would	O
not	O
want	O
a	B-treatment
morphine	I-treatment
drip	I-treatment
if	O
it	O
would	O
negatively	O
impact	O
his	O
respiratory	O
function	O
.	O

ROS	O
:	O
patient	O
unable	O
to	O
communicate	O
at	O
current	O
time	O

Past	O
Medical	O
History	O
:	O

PMH	O
:	O

-	O
DM2	B-problem
,	O
with	O
mild	B-problem
background	I-problem
diabetic	I-problem
retinopathy	I-problem

-	O
CVA	B-problem
x	O
2	O
,	O
1970	O
and	O
1996	O

-	O
HTN	B-problem

-	O
CAD	B-problem

-	O
CHF	B-problem
,	O
LVEF	B-test
unknown	O

-	O
PVD	B-problem
,	O
s/p	O
femoral-popliteal	B-treatment
bypass	I-treatment

-	O
renal	B-problem
cell	I-problem
ca	I-problem
,	O
s/p	O
left	B-treatment
nephrectomy	I-treatment
1992	O

-	O
BPH	B-problem

-	O
dementia	B-problem
,	O
since	O
2000	O
,	O
baseline	B-test
MMSE	I-test
21/29	O

-	O
s/p	O
fall	O
with	O
right	B-problem
hip	I-problem
fx	I-problem
and	O
ORIF	B-treatment

-	O
moderate	B-problem
R	I-problem
sided	I-problem
macular	I-problem
degeneration	I-problem

-	O
Depression	B-problem

-	O
s/p	O
right	B-treatment
inguinal	I-treatment
hernia	I-treatment
repair	I-treatment

Social	O
History	O
:	O

Social	O
hx	O
:	O
came	O
to	O
the	O
States	O
10	O
yrs	O
ago	O
with	O
his	O
wife	O
.	O

Robert	O
a	O
daughter	O
who	O
lives	O
in	O
Wareham	O
.	O

Used	O
to	O
work	O
as	O
an	O
engineer	O
at	O
an	O
automobile	O
plant	O
.	O

World	O
War	O
II	O
veteran	O
.	O

Currently	O
living	O
at	O
Beth	O
Israel	O
Deaconess	O
Hospital-Needham	O
Rehab	O
.	O

Asian-speaking	O
only	O
.	O

Family	O
History	O
:	O
noncontributory	O

Physical	O
Exam	O
:	O

Vitals	O
:	O

T	B-test
102.8	O

HR	B-test
113	O

BP	B-test
157/85	O

RR	B-test
35	O

Sat	B-test
97%	O
on	O
BIPAP	B-treatment

10-23	O
PAD-WORD	O

Gen	O
:	O
frail	B-problem
,	O
elderly	O
caucasian	O
man	O
lying	O
in	O
stretcher	O
,	O
HOB	O
at	O
45	O
degrees	O
,	O
breathing	O
in	O
moderate	B-problem
distress	I-problem
with	O
accessory	B-problem
muscle	I-problem
use	I-problem

HEENT	O
:	O

BIPAP	B-treatment
mask	I-treatment
in	O
place	O
with	O
no	O
apparent	B-problem
leak	I-problem
,	O
eyes	O
closed	O
,	O
mouth	O
open	O
,	O
no	O
rhinorhea	B-problem
or	O
oral	B-problem
discharge	I-problem
visible	O

Neck	O
:	O

JVP	B-test
flat	O

CV	O
:	O
difficult	O
to	O
assess	O
heart	O
sounds	O
over	O
respiratory	O
sounds	O
,	O
but	O
appears	O
to	O
have	O
RRR	O
,	O
nl	O
s1	O
s2	O
,	O
no	O
murmurs	B-problem

Lungs	O
:	O

R	O
lower	O
01-20	O
with	O
coarse	B-problem
BS	I-problem
and	O
rales	B-problem
;	O
L	O
side	O
clear	O
;	O
no	O
wheezing	B-problem

Abd	O
:	O
thin	O
,	O
nd	B-problem
,	O
nt	B-problem
,	O
soft	O
,	O
no	O
masses	B-problem
palpable	O

Ext	O
:	O
thin	O
,	O
no	O
edema	B-problem
,	O
multiple	B-problem
old	I-problem
well-healed	I-problem
scars	I-problem
on	I-problem
R	I-problem
leg	I-problem

Skin	O
:	O
warm	O
and	O
dry	O
,	O
no	O
rash	B-problem
or	O
breakdown	B-problem
noted	O
though	O
could	O
not	O
examine	O
sacrum	O

Neuro	O
:	O
reactive	O
to	O
pain	B-test
,	O
otherwise	O

Pertinent	O
Results	O
:	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
10.9	O
RBC	B-test
-	O
4.63	O
Hgb	B-test
-	O
13.6	O
*	O
Hct	B-test
-	O
40.3	O
#	O
MCV	B-test
-	O
87	O
MCH	B-test
-	O
29.3	O
MCHC	B-test
-	O
33.7	O
RDW	B-test
-	O
14.0	O
Plt	B-test
Ct	I-test
-	O
393	O
#	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
Neuts	B-test
-	O
82.6	O
*	O
Lymphs	B-test
-	O
14.5	O
*	O
Monos	B-test
-	O
2.2	O
Eos	B-test
-	O
0.2	O
Baso	B-test
-	O
0.4	O

2014-01-20	O
02:08	O
PM	O
BLOOD	B-test
PT	B-test
-	O
13.2	O
PTT	B-test
-	O
27.4	O
INR	B-test
(	I-test
PT	I-test
)-	I-test
1.2	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
Plt	B-test
Ct	I-test
-	O
393	O
#	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
334	O
*	O
UreaN	B-test
-	O
22	O
*	O
Creat	B-test
-	O
0.9	O
Na	B-test
-	O
144	O
K	B-test
-	O
5.0	O
Cl	B-test
-	O
108	O
HCO3	B-test
-	O
25	O
AnGap	B-test
-	O
16	O

2014-01-20	O
02:08	O
PM	O
BLOOD	B-test
CK	B-test
(	I-test
CPK	I-test
)-	I-test
275	O
*	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
15	O
AST	B-test
-	O
22	O
LD	B-test
(	I-test
LDH	I-test
)-	I-test
254	O
*	O
CK	B-test
(	I-test
CPK	I-test
)-	I-test
398	O
*	O
AlkPhos	B-test
-	O
125	O
*	O
TotBili	B-test
-	O
0.5	O

2014-01-20	O
02:08	O
PM	O
BLOOD	B-test
CK-MB	B-test
-	O
9	O
cTropnT	B-test
-	O
0.08	O
*	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
cTropnT	B-test
-	O
0.05	O
*	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
CK-MB	B-test
-	O
7	O

2014-01-20	O
05:30	O
AM	O
BLOOD	B-test
Albumin	B-test
-	O
3.2	O
*	O
Calcium	B-test
-	O
9.3	O
Phos	B-test
-	O
4.2	O
Mg	B-test
-	O
1.8	O

ABG	B-test
s:	I-test

2014-01-20	O
10:46	O
PM	O
BLOOD	B-test
Type	O
-	O
ART	B-test
pO2	B-test
-	O
148	O
*	O
pCO2	B-test
-	O
129	O
*	O
pH	B-test
-	O
7.03	O
*	O
calHCO3	B-test
-	O
37	O
*	O
Base	B-test
XS	I-test
-	O
-1	O

2014-01-20	O
11:49	O
AM	O
BLOOD	B-test
Type	O
-	O
ART	B-test
PEEP	B-treatment
-	O
5	O
FiO2	B-treatment
-	O
60	O
pO2	B-test
-	O
75	O
*	O
pCO2	B-test
-	O
56	O
*	O
pH	B-test
-	O
7.29	O
*	O
calHCO3	B-test
-	O
28	O
Base	B-test
XS	I-test
-	O
0	O
Intubat	O
-	O
NOT	O
INTUBA	O
Comment	O
-	O
BIPAP	B-treatment

2014-01-20	O
10:46	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
114	O
*	O
Lactate	B-test
-	O
1.8	O
K	B-test
-	O
4.8	O

2014-01-20	O
11:49	O
AM	O
BLOOD	B-test
Lactate	B-test
-	O
3.0	O
*	O
K	B-test
-	O
5.1	O

2014-01-20	O
11:49	O
AM	O
BLOOD	B-test
freeCa	B-test
-	O
1.19	O

CXR	B-test
:	O

IMPRESSION	O
:	O

Focal	B-problem
consolidation	I-problem
in	I-problem
the	I-problem
medial	I-problem
aspect	I-problem
of	O
the	O
right	O
lower	O
lung	O

Brief	O
Hospital	O
Course	O
:	O

This	O
86	O
yo	O
man	O
with	O
h/o	O
CVA	B-problem
,	O
CHF	B-problem
,	O
recent	O
episodes	O
of	O
aspiration	B-problem
pneumonia	I-problem
,	O
presented	O
with	O
dyspnea	B-problem
from	O
his	O
NH	O
,	O
likely	O
from	O
new	O
RLL	B-problem
pneumonia	I-problem
.	O

He	O
was	O
started	O
on	O
Zosyn	B-treatment
and	O
Vanco	B-treatment
for	O
his	B-problem
presumed	I-problem
aspiration	I-problem
,	O
"	B-problem
hospital	I-problem
"	I-problem
aquired	I-problem
PNA	I-problem
.	O

PE	B-problem
was	O
considered	O
but	O
less	O
likely	O
given	O
his	B-problem
fevers	I-problem
and	O
clear	B-problem
pneumonia	I-problem
on	O
CXR	B-test
.	O

He	O
was	O
supported	O
on	O
BIPAP	B-treatment
for	O
his	O
respiratory	O
status	O
.	O

An	B-test
ABG	I-test
was	O
attempted	O
in	O
the	O
Deanna	O
however	O
it	O
was	O
limited	O
by	O
pt	B-problem
discomfort	I-problem
.	O

ABG	B-test
on	O
arrival	O
to	O
the	O
ICU	O
was	O
7.29/56/75	O
.	O

He	O
was	O
continued	O
on	O
BIPAP	B-treatment
.	O

Blood	B-test
cultures	I-test
and	O
sputum	B-test
cultures	I-test
were	O
sent	O
.	O

Over	O
the	O
course	O
of	O
the	O
day	O
he	O
continued	O
to	O
decline	O
.	O

He	O
was	O
given	O
some	B-treatment
prn	I-treatment
Morphine	I-treatment
for	O
comfort	O
.	O

In	O
the	O
evening	O
of	O
the	O
day	O
of	O
admission	O
he	O
was	O
noted	O
to	O
be	O
increasingly	B-problem
somnolent	I-problem
.	O

A	B-test
repeat	I-test
ABG	I-test
was	O
performed	O
which	O
was	O
7.03/129/148	O
.	O

His	O
family	O
was	O
notified	O
that	O
he	O
was	O
doing	O
worse	O
and	O
came	O
in	O
to	O
visit	O
him	O
.	O

It	O
was	O
his	O
family	O
's	O
wish	O
that	O
he	O
be	O
made	O
comfortable	O
.	O

Based	O
upon	O
this	O
wish	O
the	B-treatment
BIPAP	I-treatment
was	O
removed	O
and	O
he	O
was	O
placed	O
on	O
nasal	B-treatment
cannula	I-treatment
.	O

He	O
was	O
written	O
for	O
a	B-treatment
morphine	I-treatment
drip	I-treatment
however	O
he	O
expired	O
before	O
this	O
could	O
be	O
initiated	O
.	O

Secondary	O
issues	O

Elevated	B-problem
lactate	I-problem
:	O

This	O
was	O
concerning	O
for	O
early	B-problem
sepsis	I-problem
given	O
RLL	B-problem
PNA	I-problem
.	O

His	B-test
blood	I-test
pressures	I-test
remained	O
elevated	B-problem
and	O
he	O
was	O
hydrated	O
with	O
NS	B-treatment
conservatively	O
,	O
given	O
h/o	O
CHF	B-problem
and	O
dyspnea	B-problem
.	O

DM2	B-problem
:	O

He	O
was	O
covered	O
with	O
a	B-treatment
Insulin	I-treatment
drip	I-treatment
while	O
unstable	O

CV	O
:	O

CAD	B-problem
:	O

He	O
was	O
not	O
taking	O
any	B-treatment
PO	I-treatment
medications	I-treatment
per	O
Hunt	O
Center	O
Rehab	O
so	O
all	B-treatment
medications	I-treatment
were	O
held	O
.	O

Medications	O
on	O
Admission	O
:	O

Meds	O
:	O

-	O
Paxil	B-treatment

-	O
Terazosin	B-treatment

-	O
Glucophage	B-treatment

-	O
Glyburide	B-treatment

-	O
Atenolol	B-treatment

-	O
Imdur	B-treatment

Discharge	O
Disposition	O
:	O

Expired	O
PAD-WORD	O

Discharge	O
Diagnosis	O
:	O

Pneumonia	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O
expired	O

Discharge	O
Instructions	O
:	O

N/A	O
PAD-WORD	O

Followup	O
Instructions	O
:	O

N/A	O
PAD-WORD	O

Daniel	O
Monica	O
MD	O
55-804	O

Completed	O
by	O
:	O
Sheri	O
John	O
MD	O
30-456	O
2014-01-21	O
@	O
0659	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Meredith	O
Davis	O
on	O
:	O
Sandra	O
2014-03-13	O
1:53	O
PM	O

(	O
End	O
of	O
Report	O
)	O

525602122	O
EH	O

25951463	O
PAD-WORD	O

363878	O
PAD-WORD	O

12/05/1997	O
12:00:00	O
AM	O

BILATERAL	B-problem
LUNG	I-problem
NODULES	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

12/05/1997	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

12/07/1997	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
50	O
year-old	O
female	O
with	O
a	O
history	O
of	O
bilateral	B-problem
lung	I-problem
nodules	I-problem
dating	O
back	O
to	O
the	O
July	O
of	O
1995	O
discovered	O
on	O
a	B-test
work-up	I-test
for	O
an	B-problem
adrenal	I-problem
abnormality	I-problem
.	O

Diffuse	B-problem
adenopathy	I-problem
was	O
noted	O
at	O
that	O
time	O
and	O
an	O
attempt	O
was	O
made	O
at	O
axillary	B-test
node	I-test
biopsy	I-test
which	O
was	O
aborted	O
secondary	O
to	O
positioning	O
difficulty	O
and	O
difficult	B-problem
intubation	I-problem
.	O

She	O
was	O
since	O
then	O
lost	O
to	O
follow-up	B-test
with	O
a	O
recently	O
re-establish	O
primary	O
care	O
practitioner	O
contact	O
.	O

Follow-up	B-test
chest	I-test
CT	I-test
on	O
October	O
26	O
,	O
1997	O
at	O
the	O
Ver	O
Medical	O
Center	O
showed	O
multiple	B-problem
pulmonary	I-problem
nodules	I-problem
in	O
abundant	O
number	O
,	O
very	B-problem
small	I-problem
nodes	I-problem
seen	O
in	O
the	O
mediastinum	O
but	O
no	O
hilar	B-problem
adenopathy	I-problem
,	O
no	O
hepatosplenomegaly	B-problem
or	O
adrenal	B-problem
mass	I-problem
was	O
noted	O
.	O

Chest	B-test
x-ray	I-test
on	O
August	O
6	O
,	O
1997	O
revealed	O
multiple	B-problem
pulmonary	I-problem
nodules	I-problem
increasing	O
in	O
size	O
since	O
July	O
22	O
,	O
1995	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

She	O
denies	O
any	B-problem
hypertension	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
myocardial	B-problem
infarction	I-problem
or	O
diabetes	B-problem
mellitus	I-problem
.	O

She	O
is	O
status	O
post	O
an	B-treatment
open	I-treatment
cholecystectomy	I-treatment
in	O
1968	O
,	O
status	O
post	O
hysterectomy	B-treatment
and	O
axillary	B-test
node	I-test
biopsy	I-test
which	O
failed	O
.	O

She	O
has	O
a	O
history	O
of	O
hiatal	B-problem
hernia	I-problem
and	O
umbilical	B-treatment
hernia	I-treatment
repair	I-treatment
.	O

She	O
also	O
has	O
a	O
history	O
of	O
an	B-problem
adrenal	I-problem
disorder	I-problem
treated	O
with	O
Prednisone	B-treatment
in	O
the	O
past	O
,	O
but	O
not	O
currently	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1)	O
Spironolactone	B-treatment
50	O
mg	O
p.o.	O
b.i.d.	O

2)	O
Advil	B-treatment
p.r.n.	O

3)	O
Topical	B-treatment
steroids	I-treatment
for	O
eczema	B-problem
p.r.n.	O

ALLERGIES	O
:	O

The	O
patient	O
had	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
quit	O
smoking	O
approximately	O
fourteen	O
years	O
ago	O
after	O
a	O
four	O
pack	O
per	O
year	O
history	O
.	O

She	O
is	O
a	O
single	O
female	O
who	O
lives	O
in	O
Mifayston	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Blood	B-test
pressure	I-test
140/80	O
,	O
heart	B-test
rate	I-test
86	O
.	O

She	O
is	O
a	O
pleasant	O
,	O
obese	O
,	O
black	O
female	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

There	O
is	O
no	O
lymphadenopathy	B-problem
.	O

Her	O
skin	O
is	O
intact	O
without	O
lesions	B-problem
.	O

Her	B-test
HEENT	I-test
examination	I-test
is	O
benign	O
.	O

Her	O
neck	O
is	O
slightly	B-problem
tender	I-problem
with	O
a	B-problem
firm	I-problem
thyroid	I-problem
,	O
but	O
no	O
masses	B-problem
or	O
bruits	B-problem
.	O

Her	O
lungs	O
have	O
decreased	B-problem
sounds	I-problem
bilaterally	I-problem
in	I-problem
the	I-problem
upper	I-problem
lung	I-problem
fields	I-problem
.	O

Her	O
heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
.	O

She	O
has	O
a	B-problem
well	I-problem
healed	I-problem
umbilical	I-problem
hernia	I-problem
scar	I-problem
for	I-problem
approximately	I-problem
2	I-problem
1/2	I-problem
cm	I-problem
.	O

She	O
has	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
on	I-problem
her	I-problem
extremities	I-problem
.	O

LABORATORY	O
:	O

Pulmonary	B-test
function	I-test
tests	I-test
on	O
September	O
27	O
,	O
1997	O
revealed	O
an	B-test
FVC	I-test
of	O
2.7	O
which	O
is	O
112%	O
and	O
FEV1	B-test
of	O
2.23	O
which	O
is	O
123%	O
.	O

Her	O
admission	O
laboratory	O
data	O
includes	O
serum	B-test
chemistries	I-test
with	O
a	B-test
sodium	I-test
of	O
144	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
101	O
,	O
bicarbonate	B-test
28	O
,	O
BUN	B-test
10	O
,	O
creatinine	B-test
0.9	O
and	O
glucose	B-test
of	O
93	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
is	O
7.65	O
,	O
hematocrit	B-test
of	O
42	O
and	O
platelets	B-test
of	O
345	O
.	O

Her	B-test
urinalysis	I-test
shows	O
2+	B-problem
bacteria	I-problem
and	O
2+	B-problem
squamous	I-problem
epithelium	I-problem
with	O
greater	B-problem
than	I-problem
10,000	I-problem
mixed	I-problem
bacteria	I-problem
.	O

Chest	B-test
x-ray	I-test
on	O
August	O
6	O
,	O
1997	O
revealed	O
multiple	B-problem
pulmonary	I-problem
nodules	I-problem
increased	O
in	O
size	O
as	O
previously	O
mentioned	O
.	O

PT	B-test
was	O
11.7	O
,	O
PTT	B-test
26.7	O
and	O
INR	B-test
of	O
0.9	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
December	O
5	O
,	O
1997	O
and	O
underwent	O
left	B-treatment
lung	I-treatment
wedge	I-treatment
thoracoscopic	I-treatment
resection	I-treatment
and	O
bronchoscopy	B-treatment
.	O

She	O
was	O
transferred	O
to	O
the	O
Post	O
Anesthesia	O
Care	O
Unit	O
postoperatively	O
in	O
stable	O
condition	O
.	O

Her	B-treatment
chest	I-treatment
tube	I-treatment
was	O
pulled	O
on	O
postoperative	O
day	O
number	O
one	O
and	O
the	O
patient	O
did	O
quite	O
well	O
and	O
remained	O
inhouse	O
for	O
observation	B-test
until	O
December	O
7	O
,	O
1997	O
and	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1)	O
Lac-Hydrin	B-treatment
12%	O
topically	O
b.i.d.	O

2)	O
Colace	B-treatment
100	O
mg	O
p.o.	O
t.i.d.	O

3)	O
Tylenol	B-treatment
#	I-treatment
3	I-treatment
tablets	O
rather	O
than	O
Percocet	B-treatment
,	O
1-2	O
tablets	O
p.o.	O
q.4-6h.	O
p.r.n.	O
pain	B-problem
.	O

4)	O
Spironolactone	B-treatment
50	O
mg	O
p.o.	O
b.i.d.	O

DIET	O
:	O

No	O
restrictions	O
.	O

ACTIVITY	O
:	O

No	O
restrictions	O
.	O

FOLLOW-UP	O
:	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Prus	O
and	O
she	O
should	O
call	O
for	O
an	O
appointment	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
stay	O
with	O
her	O
family	O
until	O
returning	O
home	O
and	O
will	O
be	O
screened	O
for	O
house	O
safety	O
upon	O
moving	O
from	O
the	O
family	O
&apos;s	O
house	O
.	O

Dictated	O
By	O
:	O

BURLTIS	O
SHOULDER	O
,	O
M.D.	O
UU24	O

Attending	O
:	O

LASHAUND	O
PRUS	O
,	O
M.D.	O
HY9	O
ZG840/5307	O

Batch	O
:	O

47331	O
PAD-WORD	O

Index	O
No.	O
HRMNNB82LK	O

D	O
:	O

12/07/97	O
PAD-WORD	O

T	O
:	O

12/09/97	O
PAD-WORD	O

﻿Admission	O
Date	O
:	O

2016-03-30	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-04-03	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1951-08-19	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CCU	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
64-year-old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-problem
,	O
hypercholesterolemia	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
and	O
dilated	B-problem
cardiomyopathy	I-problem
(	O
with	O
a	B-test
transthoracic	I-test
echocardiogram	I-test
in	O
2016-01-13	O
showing	O
an	B-test
ejection	I-test
fraction	I-test
of	O
40%	O
,	O
posterior	B-problem
and	I-problem
inferior	I-problem
apical	I-problem
akinesis	I-problem
,	O
and	O
large	B-problem
left	I-problem
ventricular	I-problem
thrombus	I-problem
).	O

The	O
patient	O
was	O
admitted	O
from	O
2016-01-21	O
to	O
2016-02-03	O
;	O
at	O
which	O
time	O
she	O
was	O
ruled	O
out	O
for	O
a	B-problem
myocardial	I-problem
infarction	I-problem
.	O

She	O
had	O
a	B-test
cardiac	I-test
catheterization	I-test
which	O
revealed	O
3-vessel	B-problem
disease	I-problem
with	O
normal	O
left	O
main	O
,	O
mid	O
left	O
anterior	O
descending	O
artery	O
60%	O
,	O
diffuse	B-problem
90%	I-problem
mid	I-problem
distal	I-problem
stenosis	I-problem
at	O
the	O
origin	O
of	O
the	O
diagonal	O
,	O
serial	O
70%	O
and	O
90%	B-problem
left	I-problem
circumflex	I-problem
lesions	I-problem
,	O
and	O
90%	O
first	O
obtuse	O
marginal	O
,	O
and	O
mid	O
right	O
coronary	O
artery	O
60%	O
.	O

During	O
initial	B-test
evaluation	I-test
for	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
,	O
80%	O
to	O
90%	O
of	O
the	B-problem
right	I-problem
coronary	I-problem
artery	I-problem
stenosis	I-problem
was	O
found	O
;	O
for	O
which	O
she	O
underwent	O
a	B-treatment
right	I-treatment
internal	I-treatment
carotid	I-treatment
artery	I-treatment
stent	I-treatment
.	O

She	O
was	O
discharged	O
on	O
Coumadin	B-treatment
for	O
a	O
goal	O
INR	B-test
of	O
2.5	O
to	O
3	O
.	O

She	O
was	O
then	O
admitted	O
again	O
on	O
2016-03-30	O
for	O
an	B-treatment
elective	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

At	O
surgery	B-treatment
,	O
the	O
descending	O
aorta	O
was	O
noted	O
to	O
be	O
calcified	B-problem
,	O
and	O
an	B-test
intraoperative	I-test
transesophageal	I-test
echocardiogram	I-test
revealed	O
an	B-problem
irregular	I-problem
intra-aortic	I-problem
pedunculated	I-problem
lesion	I-problem
.	O

Given	O
the	B-problem
elevated	I-problem
stroke	I-problem
risk	I-problem
of	O
aortic	B-treatment
cross-clamping	I-treatment
in	O
the	O
setting	O
of	O
this	O
finding	O
,	O
the	O
plan	O
for	O
a	B-treatment
bypass	I-treatment
graft	I-treatment
was	O
aborted	O
.	O

The	O
patient	O
was	O
then	O
transferred	O
to	O
the	O
Coronary	O
Care	O
Unit	O
Service	O
for	O
medical	O
management	O
in	O
anticipation	O
of	O
possible	O
percutaneous	B-treatment
coronary	I-treatment
intervention	I-treatment
later	O
in	O
the	O
admission	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Diabetes	B-problem
mellitus	I-problem
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

4.	O
Asthma	B-problem
.	O

5.	O
Chronic	B-problem
low	I-problem
back	I-problem
pain	I-problem
.	O

6.	O
Cholelithiasis	B-problem
.	O

7.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
(	O
as	O
noted	O
previously	O
).	O

8.	O
Dilated	B-problem
cardiomyopathy	I-problem
(	O
also	O
as	O
noted	O
above	O
).	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Dopamine	B-treatment
drip	I-treatment
at	O
3	O
.	O

2.	O
Insulin	B-treatment
drip	I-treatment
at	O
2	O
.	O

3.	O
Regular	B-treatment
10	O
units	O
intravenously	O
q.6h.	O
as	O
needed	O
.	O

4.	O
Percocet	B-treatment
as	O
needed	O
.	O

5.	O
Sucralfate	B-treatment
1	O
g	O
via	O
nasogastric	O
tube	O
q.6h.	O

6.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

7.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
twice	O
per	O
day	O
.	O

8.	O
Flonase	B-treatment
2	O
puffs	O
twice	O
per	O
day	O
.	O

9.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

10.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

11.	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Social	O
history	O
is	O
positive	O
for	O
smoking	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Physical	B-test
examination	I-test
revealed	O
temperature	B-test
was	O
99.3	O
,	O
heart	B-test
rate	I-test
was	O
66	O
in	O
a	O
normal	O
sinus	O
rhythm	O
,	O
blood	B-test
pressure	I-test
was	O
132/51	O
,	O
respiratory	B-test
rate	I-test
was	O
22	O
,	O
and	O
oxygen	B-test
saturation	I-test
was	O
100%	O
on	O
3	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
.	O

Swan	B-test
showed	O
a	B-test
PA	I-test
of	O
29/11	O
,	O
SVR	B-test
of	O
14/9	O
,	O
cardiac	B-test
output	I-test
of	O
3.86	O
,	O
cardiac	B-test
index	I-test
of	O
2.14	O
.	O

Urine	B-test
output	I-test
of	O
30	O
cc	O
to	O
100	O
cc	O
per	O
hour	O
over	O
the	O
last	O
four	O
hours	O
.	O

Chest	B-treatment
tube	I-treatment
showed	O
30	O
cc	O
per	O
hour	O
over	O
the	O
last	O
four	O
hours	O
.	O

In	O
general	O
,	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

In	O
no	O
apparent	B-problem
distress	I-problem
and	O
denied	O
pain	B-problem
.	O

Head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
and	I-test
throat	I-test
examination	I-test
was	O
without	O
bruits	B-problem
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
anteriorly	O
.	O

Heart	O
was	O
regular	O
in	O
rate	B-test
and	O
rhythm	B-test
.	O

Normal	O
first	B-test
heart	I-test
sounds	I-test
and	O
second	B-test
heart	I-test
sounds	I-test
.	O

No	O
audible	B-problem
murmurs	I-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
with	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
were	O
without	O
edema	B-problem
.	O

Neurologic	B-test
examination	I-test
was	O
nonfocal	O
.	O

Lines	B-treatment
included	O
a	B-treatment
right	I-treatment
antecubital	I-treatment
peripheral	I-treatment
intravenous	I-treatment
.	O

Chest	B-treatment
tube	I-treatment
was	O
in	O
place	O
in	O
left	O
internal	O
jugular	O
an	B-treatment
pulmonary	I-treatment
artery	I-treatment
catheter	I-treatment
.	O

PERTINENT	O
LABORATORY	O
VALUES	O
ON	O
PRESENTATION	O
:	O

Laboratories	B-test
revealed	O
white	B-test
blood	I-test
cell	I-test
count	I-test
was	O
12.7	O
,	O
hematocrit	B-test
was	O
32.4	O
,	O
platelets	B-test
were	O
140	O
,	O
and	O
mean	B-test
cell	I-test
volume	I-test
was	O
80	O
.	O

Patient	O
was	O
4.4	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
was	O
14	O
,	O
creatinine	B-test
was	O
0.6	O
,	O
and	O
glucose	B-test
was	O
147	O
.	O

INR	B-test
was	O
1.2	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
was	O
23.7	O
,	O
and	O
prothrombin	B-test
time	I-test
was	O
13.4	O
.	O

Free	B-test
calcium	I-test
was	O
0.95	O
on	O
03-30	O
.	O

Phosphate	B-test
was	O
3.6	O
and	O
magnesium	B-test
was	O
2.2	O
.	O

Arterial	B-test
blood	I-test
gas	I-test
at	O
3	O
a.m.	O
demonstrated	O
7.4/45/125	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
is	O
a	O
64-year-old	O
female	O
with	O
3-vessel	B-problem
disease	I-problem
who	O
was	O
admitted	O
to	O
the	O
Coronary	O
Care	O
Unit	O
Service	O
for	O
Western	O
Mass	O
.	O

Hospital	O
medical	O
optimization	O
and	O
management	O
following	O
an	B-treatment
aborted	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
when	O
a	B-problem
mobile	I-problem
aortic	I-problem
atheroma	I-problem
was	O
noted	O
.	O

The	O
patient	O
was	O
continued	O
on	O
aspirin	B-treatment
,	O
Plavix	B-treatment
,	O
and	O
statin	B-treatment
.	O

Once	O
the	O
patient	O
was	O
titrated	O
off	O
dopamine	B-treatment
,	O
the	B-treatment
beta	I-treatment
blocker	I-treatment
and	O
ACE	B-treatment
inhibitor	I-treatment
were	O
restarted	O
.	O

With	O
regard	O
to	O
the	B-problem
left	I-problem
ventricular	I-problem
thrombus	I-problem
,	O
her	O
goal	O
INR	B-test
remained	O
2.5	O
to	O
3	O
;	O
and	O
the	O
goal	O
was	O
to	O
start	O
heparin	B-treatment
once	O
the	O
patient	O
was	O
stable	O
from	O
a	B-treatment
thoracotomy	I-treatment
and	O
chest	B-treatment
tube	I-treatment

standpoint	O
.	O

The	O
patient	O
remained	O
comfortable	O
.	O

By	O
04-01	O
,	O
on	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
was	O
doing	O
well	O
and	O
the	B-treatment
chest	I-treatment
tube	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
still	O
had	O
transcutaneous	B-treatment
pacing	I-treatment
wires	I-treatment
in	O
place	O
.	O

Likewise	O
,	O
on	O
04-01	O
,	O
the	O
patient	O
was	O
weaned	O
off	O
surgery	B-treatment
without	O
difficulty	O
.	O

Thus	O
,	O
the	B-treatment
beta	I-treatment
blocker	I-treatment
and	O
ACE	B-treatment
inhibitor	I-treatment
were	O
started	O
to	O
be	O
titrated	O
up	O
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
started	O
on	O
Wellbutrin	B-treatment
for	O
smoking	O
cessation	O
.	O

At	O
this	O
point	O
,	O
it	O
was	O
determined	O
that	O
the	O
patient	O
would	O
not	O
receive	O
percutaneous	B-treatment
coronary	I-treatment
intervention	I-treatment
on	O
this	O
admission	O
and	O
would	O
likely	O
be	O
discharged	O
to	O
the	O
floor	O
for	O
stabilization	O
with	O
followup	O
.	O

The	O
patient	O
did	O
well	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
04-02	O
.	O

After	O
evaluation	B-test
and	O
a	O
discussion	O
with	O
Dr.	O
Gunter	O
,	O
it	O
was	O
determined	O
that	O
the	O
patient	O
no	O
longer	O
needed	O
anticoagulation	B-treatment
since	O
there	O
was	O
no	O
aortic	B-problem
thrombus	I-problem
but	O
only	O
an	B-problem
aortic	I-problem
plaque	I-problem
,	O
and	O
there	O
was	O
no	O
anterior/apical	B-problem
akinesis	I-problem
noted	O
.	O

At	O
this	O
point	O
,	O
the	B-problem
left	I-problem
ventricular	I-problem
thrombus	I-problem
(	O
for	O
which	O
she	O
was	O
initially	O
started	O
therapy	B-treatment
for	O
)	O
was	O
no	O
longer	O
present	O
.	O

The	O
patient	O
was	O
noted	O
to	O
have	O
a	B-problem
slight	I-problem
hematocrit	I-problem
drop	I-problem
and	O
was	O
transfused	O
one	B-treatment
unit	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
for	O
a	O
goal	O
hematocrit	B-test
of	O
greater	O
than	O
30	O
.	O

By	O
04-03	O
,	O
captopril	B-treatment
and	O
atenolol	B-treatment
were	O
started	O
,	O
and	O
the	B-treatment
patient	I-treatment
's	I-treatment
leg	I-treatment
bandage	I-treatment
from	O
the	B-treatment
vein	I-treatment
harvest	I-treatment
was	O
removed	O
.	O

The	O
patient	O
continued	O
to	O
do	O
well	O
on	O
the	B-treatment
medical	I-treatment
regimen	I-treatment
and	O
was	O
without	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
or	O
any	B-problem
other	I-problem
symptoms	I-problem
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Thus	O
,	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
INSTRUCTIONS/FOLLOWUP	O
:	O

The	O
patient	O
was	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
(	O
Dr.	O
Desmet	O
)	O
,	O
as	O
well	O
as	O

with	O
Dr.	O
Gunter	O
for	O
an	B-treatment
eventual	I-treatment
percutaneous	I-treatment
coronary	I-treatment
intervention	I-treatment
,	O
and	O
her	O
surgeon	O
(	O
Dr.	O
Halcomb	O
)	O
following	O
her	B-treatment
thoracotomy	I-treatment
.	O

DISCHARGE	O
DIAGNOSES:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
;	O
3-vessel	B-problem
disease	I-problem
.	O

2.	O
Status	B-treatment
post	I-treatment
aborted	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
due	O
to	O
mobile	B-problem
aortic	I-problem
atheroma	I-problem
.	O

3.	O
Diabetes	B-problem
.	O

4.	O
Hypertension	B-problem
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Condition	O
on	O
discharge	O
was	O
stable	O
and	O
asymptomatic	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Aspirin	B-treatment
325	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

2.	O
Docusate	B-treatment
100	O
mg	O
p.o.	O
twice	O
per	O
day	O
.	O

3.	O
Fluticasone	B-treatment
2	O
puffs	O
inhaled	O
twice	O
per	O
day	O
.	O

4.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

5.	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

6.	O
Pravastatin	B-treatment
20	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

7.	O
Bupropion	B-treatment
100	O
mg	O
p.o.	O
twice	O
per	O
day	O
(	O
for	O
smoking	O
cessation	O
).	O

8.	O
Atenolol	B-treatment
25	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

9.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
once	O
per	O
day	O
.	O

Miriam	O
C	O
Hebert	O
,	O
M.D.	O

05-383	O
PAD-WORD	O

Dictated	O
By	O
:	O
Barbara	O
B.	O
Phillips	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D:	O
2016-06-15	O

21:48	O
PAD-WORD	O

T:	O
2016-06-19	O

10:46	O
PAD-WORD	O

JOB	O
#:	O

26532	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kevin	O
Sineath	O
on	O
:	O
Andrea	O
2016-06-30	O
1:09	O
PM	O

(	O
End	O
of	O
Report	O
)	O

534644131	O
PAD-WORD	O

FIH	O
PAD-WORD	O

9393835	O
PAD-WORD	O

24529/65a4	O
PAD-WORD	O

204379	O
PAD-WORD	O

4/28/1993	O
12:00:00	O
AM	O

RIGHT	B-problem
THYROID	I-problem
PAPILLARY	I-problem
CARCINOMA	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

4/28/93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

5/15/93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
thyroid	I-problem
papillary	I-problem
carcinoma	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Pulmonary	B-problem
and	I-problem
right	I-problem
iliac	I-problem
bone	I-problem
metastases	I-problem
.	O

2.	O
Eosinophilia	B-problem
.	O

3.	O
Chronic	B-problem
leg	I-problem
edema	I-problem
.	O

4.	O
Atrial	B-problem
fibrillation	I-problem
.	O

5.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

6.	O
Left	B-problem
subclavian	I-problem
vein	I-problem
thrombosis	I-problem
.	O

7.	O
Urinary	B-problem
tract	I-problem
infection	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
74	O
year	O
old	O
female	O
with	O
metastatic	B-problem
papillary	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
thyroid	I-problem
who	O
presented	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
on	O
4/28/93	O
with	O
progressive	B-problem
weakness	I-problem
,	O
weight	B-problem
loss	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
was	O
in	O
a	O
good	O
state	O
of	O
health	O
until	O
January	O
of	O
1993	O
when	O
she	O
developed	O
a	B-problem
serious	I-problem
upper	I-problem
respiratory	I-problem
tract	I-problem
infection	I-problem
associated	O
with	O
weakness	B-problem
and	O
fatigue	B-problem
.	O

She	O
had	O
also	O
reported	O
a	B-problem
weight	I-problem
loss	I-problem
of	I-problem
15	I-problem
pounds	I-problem
over	O
the	O
past	O
two	O
months	O
.	O

Although	O
her	B-problem
upper	I-problem
respiratory	I-problem
tract	I-problem
infection	I-problem
seemed	O
to	O
be	O
resolving	O
,	O
her	B-problem
weakness	I-problem
persisted	O
.	O

A	B-test
work	I-test
up	I-test
begun	O
by	O
her	O
internist	O
,	O
Dr.	O
Brain	O
,	O
revealed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
49,000	O
with	O
50%	B-test
eosinophils	I-test
.	O

She	O
was	O
admitted	O
to	O
Box	O
Memorial	O
Hospital	O
Nursing	O
Home	O
for	O
further	B-test
evaluation	I-test
.	O

Data	O
collected	O
there	O
included	O
a	B-test
chest	I-test
x-ray	I-test
which	O
was	O
unremarkable	O
.	O

The	B-test
liver	I-test
function	I-test
tests	I-test
showed	O
an	B-test
alkaline	I-test
phosphatase	I-test
of	O
303	O
,	O
LDH	B-test
310	O
,	O
SGOT	B-test
66	O
,	O
albumin	B-test
2.5	O
.	O

A	B-test
peripheral	I-test
blood	I-test
smear	I-test
showed	O
mature	O
eosinophils	O
in	O
increased	B-problem
numbers	I-problem
.	O

Chromosomal	B-test
studies	I-test
were	O
negative	O
.	O

A	B-test
bone	I-test
scan	I-test
showed	O
increased	B-problem
uptake	I-problem
at	I-problem
the	I-problem
manubrium	I-problem
at	O
the	O
site	O
of	O
an	B-problem
old	I-problem
fracture	I-problem
,	O
as	O
well	O
as	O
in	O
the	O
right	O
supraclavicular	O
area	O
.	O

A	B-test
thyroid	I-test
ultrasound	I-test
showed	O
an	B-problem
inferior	I-problem
thyroid	I-problem
mass	I-problem
.	O

This	O
was	O
followed	O
by	O
an	B-test
abdominal	I-test
CT	I-test
which	O
showed	O
an	B-problem
enlarged	I-problem
spleen	I-problem
,	O
a	B-problem
lytic	I-problem
lesion	I-problem
on	I-problem
the	I-problem
right	I-problem
iliac	I-problem
bone	I-problem
and	O
a	B-problem
benign	I-problem
renal	I-problem
cyst	I-problem
.	O

Biopsy	B-test
of	I-test
the	I-test
lytic	I-test
lesion	I-test
was	O
consistent	O
with	O
metastases	B-problem
papillary	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
thyroid	I-problem
.	O

An	B-test
upper	I-test
gastrointestinal	I-test
was	O
unremarkable	O
.	O

The	B-test
small	I-test
bowel	I-test
follow	I-test
through	I-test
was	O
within	O
normal	O
limits	O
.	O

A	B-test
thyroid	I-test
scan	I-test
revealed	O
decreased	B-problem
function	I-problem
and	O
displacement	B-problem
of	I-problem
the	I-problem
thyroid	I-problem
by	O
a	B-problem
cold	I-problem
mass	I-problem
located	O
inferiorly	O
with	O
calcifications	B-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
.	O

A	B-test
chest	I-test
CT	I-test
also	O
revealed	O
a	B-problem
small	I-problem
pulmonary	I-problem
nodule	I-problem
with	O
a	B-problem
necrotic	I-problem
mass	I-problem
involving	O
the	O
right	O
lung	O
posteriorly	O
.	O

The	O
patient	O
was	O
subsequently	O
referred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
under	O
the	O
service	O
of	O
Dr.	O
Brain	O
.	O

She	O
continued	O
to	O
have	O
profound	B-problem
weakness	I-problem
,	O
a	B-problem
decreased	I-problem
appetite	I-problem
and	O
weight	B-problem
loss	I-problem
.	O

She	O
also	O
developed	O
lower	B-problem
extremity	I-problem
edema	I-problem
as	O
well	O
as	O
left	B-problem
upper	I-problem
extremity	I-problem
swelling	I-problem
associated	O
with	O
increased	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
on	O
exertion	O
.	O

A	B-test
needle	I-test
biopsy	I-test
of	I-test
the	I-test
right	I-test
thyroid	I-test
nodule	I-test
showed	O
papillary	B-problem
thyroid	I-problem
carcinoma	I-problem
.	O

The	O
patient	O
reports	O
no	O
history	O
of	O
radiation	B-problem
exposure	I-problem
,	O
no	O
family	O
history	O
of	O
thyroid	B-problem
carcinoma	I-problem
,	O
no	O
recent	O
travels	O
or	O
exposure	B-problem
to	I-problem
tuberculosis	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
a	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
with	O
good	O
heart	B-treatment
rate	I-treatment
control	I-treatment
on	O
Digoxin	B-treatment
.	O

She	O
reports	O
no	O
prior	O
surgical	O
history	O
.	O

The	O
patient	O
also	O
reports	O
no	O
known	B-problem
drug	I-problem
allergy	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
alone	O
in	O
Leschle	O
Drive	O
,	O
Sonpo	O
,	O
and	O
does	O
not	O
report	O
a	O
smoking	O
or	O
alcohol	O
history	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lanoxin	B-treatment
,	O
0.25	O
mg	O
po	O
qd	O
;	O
Lasix	B-treatment
,	O
20	O
mg	O
po	O
qd	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
a	O
pleasant	O
,	O
elderly	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Her	B-test
vital	I-test
signs	I-test
showed	O
a	B-test
blood	I-test
pressure	I-test
of	O
126/72	O
,	O
pulse	B-test
84	O
,	O
respirations	B-test
22	O
,	O
temperature	B-test
98.6	O
.	O

She	O
had	O
a	B-problem
3	I-problem
x	I-problem
4	I-problem
cm	I-problem
firm	I-problem
,	I-problem
nontender	I-problem
right	I-problem
thyroid	I-problem
mass	I-problem
that	O
seemed	O
to	O
be	O
fixed	O
to	O
the	O
trachea	O
.	O

She	O
had	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
or	O
bruits	B-problem
.	O

The	O
lungs	O
exhibited	O
right	B-problem
basilar	I-problem
dullness	I-problem
one	O
quarter	O
of	O
the	O
way	O
up	O
.	O

She	O
had	O
no	O
definite	B-problem
S3	I-problem
.	O

The	O
liver	O
edge	O
was	O
palpable	O
to	O
6	O
cm	O
below	O
the	O
right	O
costal	O
margin	O
.	O

Her	O
spleen	O
could	O
not	O
be	O
palpated	O
.	O

She	O
had	O
4+	B-problem
edema	I-problem
to	I-problem
the	I-problem
knees	I-problem
bilaterally	I-problem
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
the	B-test
white	I-test
blood	I-test
count	I-test
was	O
67.3	O
with	O
a	B-test
differential	I-test
of	O
21%	B-test
polys	I-test
,	O
16%	B-test
bands	I-test
,	O
3%	B-test
lymphocytes	I-test
,	O
2%	B-test
monocytes	I-test
,	O
57%	B-test
eosinophils	I-test
and	O
1%	B-test
myelocytes	I-test
.	O

Her	B-test
hematocrit	I-test
was	O
38.8	O
,	O
hemoglobin	B-test
13.7	O
,	O
platelet	B-test
count	I-test
155,000	O
,	O
PT	B-test
12.7/10.1	O
,	O
PTT	B-test
33.9	O
,	O
erythrocyte	B-test
sedimentation	I-test
rate	I-test
18	O
,	O
calcium	B-test
7.5	O
,	O
phosphorus	B-test
3.5	O
,	O
sodium	B-test
136	O
,	O
potassium	B-test
3.7	O
,	O
BUN	B-test
15	O
,	O
total	B-test
protein	I-test
5.9	O
,	O
albumin	B-test
2.3	O
,	O
globulin	B-test
3.6	O
,	O
alkaline	B-test
phosphatase	I-test
379	O
,	O
SGOT	B-test
37	O
,	O
Digoxin	B-test
level	I-test
0.7	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Dr.	O
Shatermivaet	O
S	O
Brain	O
on	O
4/28/93	O
with	O
a	O
history	O
of	O
papillary	B-problem
carcinoma	I-problem
of	I-problem
the	I-problem
thyroid	I-problem
with	O
bone	B-problem
involvement	I-problem
and	O
possible	O
lung	B-problem
involvement	I-problem
.	O

Work	B-test
up	I-test
was	O
begun	O
for	O
the	O
possible	O
myeloproliferative	B-problem
/	I-problem
myelodysplastic	I-problem
disorder	I-problem
associated	O
with	O
the	B-problem
hyper-eosinophilic	I-problem
syndrome	I-problem
.	O

Accordingly	O
,	O
an	O
Oncology	O
consult	O
was	O
called	O
on	O
4/29/93	O
and	O
a	B-test
bone	I-test
marrow	I-test
aspirate	I-test
biopsy	I-test
was	O
performed	O
.	O

This	O
revealed	O
maturation	O
of	O
leukocytes	O
to	O
all	O
stages	O
with	O
markedly	B-problem
increased	I-problem
eosinophilic	I-problem
proliferation	I-problem
.	O

A	B-test
lung	I-test
biopsy	I-test
was	O
performed	O
on	O
4/30/93	O
without	O
definitive	O
results	O
.	O

During	O
this	O
time	O
the	O
patient	O
&apos;s	O
coagulation	O
status	O
had	O
improved	O
with	O
Vitamin	B-treatment
K	I-treatment
therapy	I-treatment
with	O
PTs	B-test
normalizing	O
.	O

ANCA	O
serum	O
results	O
were	O
negative	O
.	O

ANA	O
results	O
were	O
also	O
nonsuggestive	O
.	O

The	O
patient	O
continued	O
to	O
suffer	O
from	O
edema	B-problem
of	I-problem
the	I-problem
left	I-problem
upper	I-problem
extremity	I-problem
and	O
a	O
Vascular	O
Radiology	O
consult	O
revealed	O
a	B-problem
thrombosis	I-problem
of	I-problem
the	I-problem
left	I-problem
subclavian	I-problem
vein	I-problem
extending	O
into	O
the	O
axillary	O
vein	O
.	O

There	O
was	O
some	B-problem
thrombosis	I-problem
of	I-problem
the	I-problem
left	I-problem
internal	I-problem
jugular	I-problem
vein	I-problem
as	O
well	O
.	O

A	B-test
head	I-test
CT	I-test
was	O
performed	O
and	O
was	O
completely	O
negative	O
for	O
any	B-problem
metastatic	I-problem
process	I-problem
involving	O
the	O
brain	O
.	O

Thus	O
,	O
a	B-treatment
heparin	I-treatment
sliding	I-treatment
scale	I-treatment
was	O
begun	O
.	O

Meanwhile	O
,	O
the	B-problem
patient	I-problem
&apos;s	I-problem
eosinophilia	I-problem
was	O
treated	O
with	O
a	B-treatment
trial	I-treatment
of	I-treatment
prednisone	I-treatment
.	O

She	O
also	O
developed	O
a	B-problem
mild	I-problem
urinary	I-problem
tract	I-problem
infection	I-problem
which	O
responded	O
to	O
Bactrim	B-treatment
,	O
but	O
which	O
was	O
subsequently	O
stopped	O
because	O
of	O
diarrhea	B-problem
.	O

The	O
conclusions	O
at	O
this	O
time	O
of	O
the	O
thyroid	O
cytologist	O
,	O
as	O
well	O
as	O
the	O
bone	O
pathologist	O
,	O
were	O
that	O
the	O
findings	O
were	O
diagnostic	O
of	O
papillary	B-problem
thyroid	I-problem
carcinoma	I-problem
with	O
pulmonary	B-problem
metastases	I-problem
.	O

Dr.	O
Trial	O
was	O
subsequently	O
consulted	O
on	O
5/5	O
for	O
surgical	B-treatment
intervention	I-treatment
.	O

On	O
5/6/93	O
the	O
patient	O
underwent	O
a	B-treatment
right	I-treatment
thyroidectomy	I-treatment
with	O
sacrifice	O
of	O
the	O
right	O
recurrent	O
laryngeal	O
nerve	O
as	O
well	O
as	O
the	O
right	O
sternothyroid	O
muscle	O
and	O
lower	O
parathyroid	O
gland	O
.	O

She	O
underwent	O
autotransplantation	B-treatment
of	I-treatment
the	I-treatment
right	I-treatment
upper	I-treatment
parathyroid	I-treatment
gland	I-treatment
,	O
as	O
well	O
as	O
repair	B-treatment
of	O
a	B-treatment
right	I-treatment
posterior	I-treatment
membranous	I-treatment
tracheotomy	I-treatment
.	O

She	O
was	O
received	O
in	O
the	O
Respiratory	O
Intensive	O
Care	O
Unit	O
immediately	O
postoperatively	O
in	O
stable	O
condition	O
.	O

Her	B-test
rate	I-test
was	O
well	O
controlled	O
on	O
Digoxin	B-treatment
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
5/7	O
.	O

On	O
the	O
ward	O
she	O
continued	O
a	B-treatment
gentle	I-treatment
diuresis	I-treatment
as	O
well	O
as	O
Solu-Medrol	B-treatment
therapy	I-treatment
.	O

Calcium	B-test
levels	I-test
remained	O
7.2	O
to	O
7.5	O
postoperatively	O
.	O

She	O
continued	O
to	O
improve	O
with	O
a	B-problem
slight	I-problem
hoarseness	I-problem
in	I-problem
her	I-problem
voice	I-problem
that	O
was	O
expected	O
.	O

She	O
continued	O
to	O
exhibit	O
asymptomatic	B-problem
atrial	I-problem
fibrillation	I-problem
.	O

Anticoagulation	B-treatment
was	O
begun	O
on	O
the	O
third	O
postoperative	O
day	O
with	O
Coumadin	B-treatment
.	O

She	O
was	O
effectively	B-treatment
anticoagulated	I-treatment
with	O
a	B-test
PT	I-test
in	O
the	O
range	O
between	O
15	O
and	O
17	O
over	O
a	O
control	O
of	O
10	O
.	O

She	O
also	O
received	O
a	O
Radiation	O
Therapy	O
consult	O
for	O
local	B-treatment
control	I-treatment
of	O
her	B-problem
invasive	I-problem
carcinoma	I-problem
.	O

She	O
did	O
well	O
on	O
the	O
ward	O
and	O
was	O
discharged	O
on	O
her	O
ninth	O
postoperative	O
day	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Metastatic	B-problem
papillary	I-problem
thyroid	I-problem
carcinoma	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Coumadin	B-treatment
,	O
5	O
mg	O
po	O
alternating	O
with	O
2.5	O
mg	O
po	O
;	O
prednisolone	B-treatment
,	O
30	O
mg	O
po	O
bid	O
;	O
hydrochlorothiazide	B-treatment
,	O
50	O
mg	O
po	O
bid	O
;	O
potassium	B-treatment
chloride	I-treatment
,	O
40	O
mEq	O
po	O
bid	O
;	O
Augmentin	B-treatment
,	O
500	O
mg	O
po	O
tid	O
;	O
Digoxin	B-treatment
,	O
0.125	O
mg	O
po	O
qd	O
;	O
Tylenol	B-treatment
,	O
650	O
mg	O
po	O
q4h	O
prn	O
;	O
Carafate	B-treatment
,	O
1	O
gram	O
po	O
bid	O
;	O
Synthroid	B-treatment
,	O
0.125	O
mg	O
po	O
qd	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
home	O
with	O
Terchestlumnesamp	O
Medical	O
Center	O
referral	O
for	O
weekly	B-test
blood	I-test
tests	I-test
,	O
potassium	B-test
and	O
PT	B-test
.	O

The	O
patient	O
is	O
also	O
to	O
keep	O
her	B-treatment
left	I-treatment
arm	I-treatment
elevated	I-treatment
and	O
to	O
remain	O
on	O
a	B-treatment
low	I-treatment
sodium	I-treatment
diet	I-treatment
.	O

She	O
will	O
be	O
maintained	O
on	O
a	B-test
PT	I-test
between	O
15	O
and	O
17	O
with	O
Coumadin	B-treatment
.	O

Arrangements	O
will	O
be	O
made	O
for	O
radiation	B-treatment
therapy	I-treatment
to	I-treatment
the	I-treatment
right	I-treatment
neck	I-treatment
and	I-treatment
right	I-treatment
iliac	I-treatment
crest	I-treatment
.	O

The	O
prognosis	O
for	O
rehabilitation	O
potential	O
is	O
guarded	O
.	O

LENNI	O
BRAIN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

ERTCA	O
TRIAL	O
,	O
M.D.	O

TR	O
:	O

ak	O
/	O
bmot	O

DD	O
:	O

05/15/93	O
PAD-WORD	O

TD	O
:	O

05/15/93	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Trial	O
,	O
Ertca	O
Dirk	O
,	O
Dr.	O
Lenni	O
Brain	O

Admission	O
Date	O
:	O

2015-09-30	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-10-02	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1958-01-16	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICAL	O
ICU	O

CHIEF	O
COMPLAINT	O
:	O

Change	B-problem
in	I-problem
mental	I-problem
status	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
57-year-old	O
nursing	O
home	O
resident	O
female	O
,	O
who	O
had	O
been	O
in	O
her	O
usual	O
state	O
of	O

health	O
until	O
about	O
three	O
weeks	O
ago	O
when	O
the	O
daughter	O
noted	O
she	O
was	O
sleeping	O
more	O
.	O

Per	O
record	O
,	O
she	O
has	O
had	O
multiple	O
episodes	O
in	O
the	O
last	O
week	O
of	O
changes	B-problem
in	I-problem
mental	I-problem
status	I-problem
.	O

EMTs	O
called	O
many	O
times	O
.	O

The	O
patient	O
would	O
awake	O
prior	O
to	O
arrival	O
and	O
not	O
need	O
transfer	O
.	O

The	O
patient	O
was	O
seen	O
at	O
the	O
Leonard	O
Morse/Metrowest	O
Medical	O
Center	O
on	O
09-28	O
.	O

No	O
localizing	O
etiology	O
of	O
delta	B-problem
MS	I-problem
.	O

That	O
evening	O
she	O
was	O
unresponsive	B-problem
and	O
the	O
patient	O
was	O
brought	O
to	O
Amesbury	O
Hospital	O
Hospital	O
.	O

There	O
her	B-test
oxygen	I-test
she	O
was	O
sating	O
65%	O
on	O
room	O
air	O
,	O
increased	O
to	O
98%	O
with	O
a	B-treatment
nonrebreather	I-treatment
mask	I-treatment
.	O

There	O
an	B-test
ABG	I-test
was	O
done	O
which	O
showed	O
an	B-test
ABG	I-test
of	O
7.42	O
,	O
62	O
,	O
and	O
55	O
.	O

She	O
had	O
a	B-test
head	I-test
CT	I-test
that	O
was	O
negative	O
.	O

Chest	B-test
x-ray	I-test
that	O
was	O
questionable	O
left	B-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
.	O

Lumbar	B-test
puncture	I-test
was	O
performed	O
and	O
the	B-test
micro	I-test
cultures	I-test
are	O
still	O
pending	O
.	O

She	O
was	O
seen	O
by	O
Psychiatry	O
at	O
the	O
outside	O
hospital	O
,	O
but	O
noted	O
there	O
was	O
no	O
psychoses	B-problem
,	O
but	O
delirium	B-problem
.	O

The	O
patient	O
's	O
mental	O
status	O
waxed	O
and	O
waned	O
there	O
.	O

She	O
also	O
had	O
a	B-test
K	I-test
of	O
6.0	O
and	O
given	O
30	O
of	O
Kayexalate	B-treatment
,	O
5	O
of	O
Haldol	B-treatment
,	O
2	O
mg	O
of	O
Ativan	B-treatment
given	O
for	O

agitation	B-problem
,	O
and	O
2	O
mg	O
of	O
ceftriaxone	B-treatment
was	O
given	O
for	O
a	B-test
temperature	I-test
of	O
101.3	O
with	O
a	O
concern	O
for	O
meningitis	B-problem
as	O
a	B-test
LP	I-test
was	O
done	O
prior	O
.	O

Patient	O
was	O
transferred	O
to	O
the	O
Kindred	O
Hospital	O
Melendez	O
the	O
patient	O
's	O
primary	O
care	O
provider	O
was	O
here	O
.	O

She	O
is	O
currently	O
being	O
seen	O
by	O
Addison	O
Gilbert	O
Hospital	O
Group	O
.	O

On	O
arrival	O
to	O
Mass.	O
Eye	O
&	O
Ear	O
Infirmary	O
,	O
she	O
was	O
unresponsive	B-problem
with	O
an	B-test
oxygen	I-test
saturation	I-test
of	O
72%	O
on	O
6	B-treatment
liters	I-treatment
.	O

She	O
was	O
placed	O
on	O
50%	B-treatment
vent	I-treatment
mask	I-treatment
,	O
which	O
improved	O
her	B-test
oxygenation	I-test
to	O
97%	O
.	O

Patient	O
was	O
placed	O
on	O
BiPAP	B-treatment
.	O

Original	B-test
ABG	I-test
here	O
before	O
BiPAP	B-treatment
was	O
7.19	O
,	O
102	O
,	O
and	O
92	O
.	O

After	O
being	O
placed	O
on	O
BiPAP	B-treatment
,	O
her	B-test
blood	I-test
pressure	I-test
decreased	B-problem
to	O
the	O
80s	O
.	O

She	O
responded	O
to	O
1	O
liter	O
of	O
IV	B-treatment
fluids	I-treatment
,	O
normal	B-treatment
saline	I-treatment
and	O
blood	B-test
pressure	I-test
remained	O
stable	O
.	O

Patient	O
had	O
peripheral	B-treatment
IV	I-treatment
x1	O
placed	O
and	O
right	B-treatment
femoral	I-treatment
line	I-treatment
placed	O
in	O
the	O
Matthew	O
.	O

When	O
laying	O
flat	O
,	O
her	B-test
sats	I-test
decreased	B-problem
to	O
50%	O
on	O
30%	O
FIO2	B-treatment
,	O
PEEP	B-treatment
of	O
10	O
,	O
and	O
pressure	B-treatment
support	I-treatment
of	O
5	O
.	O

Her	B-test
ABG	I-test
at	O
the	O
time	O
was	O
7.24	O
,	O
91	O
,	O
and	O
38	O
.	O

Once	O
the	O
patient	O
sat	O
up	O
,	O
her	B-test
sats	I-test
improved	O
and	O
her	O
airway	O
was	O
no	O
longer	O
obstructed	O
.	O

After	O
a	O
history	O
on	O
BiPAP	B-treatment
about	O
a	O
half	O
an	O
hour	O
,	O
her	B-test
ABG	I-test
was	O
7.29	O
,	O
79	O
,	O
and	O
106	O
on	O
30%	O
pressure	B-treatment
support	I-treatment
of	O
5	O
and	O
PEEP	B-treatment
of	O
10	O
.	O

Patient	O
was	O
intermittently	O
awaking	O
.	O

She	O
denied	O
any	O
pain	B-problem
and	O
was	O
not	O
answering	O
questions	O
at	O
the	O
time	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Obstructive-sleep	B-problem
apnea	I-problem
?	O

2.	O
Morbid	B-problem
obesity	I-problem
.	O

3.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
,	O
unknown	O
EF	B-test
.	O

4.	O
Hypertension	B-problem
.	O

5.	O
Diabetes	B-problem
mellitus	I-problem
.	O

6.	O
Depression	B-problem
.	O

7.	O
Nursing	O
home	O
resident	O
.	O

8.	O
Dyspnea	B-problem
on	O
exertion	O
.	O

9.	O
History	O
of	O
fibroids	B-problem
.	O

10.	O
Hypercholesterolemia	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
a	O
nursing	O
home	O
resident	O
.	O

Does	O
not	O
ambulate	O
.	O

Denies	O
alcohol	O
or	O
tobacco	O
use	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
FROM	O
NURSING	O
HOME	O
:	O

1.	O
Lasix	B-treatment
40	O
q.d.	O

2.	O
Senna	B-treatment
two	O
tablets	O
q.6h.	O

3.	O
Metoprolol	B-treatment
25	O
mg	O
b.i.d.	O

4.	O
Metformin	B-treatment
1,000	O
mg	O
b.i.d.	O

5.	O
Colace	B-treatment
.	O

6.	O
Niferex	B-treatment
one	O
tablet	O
b.i.d.	O

7.	O
Cozaar	B-treatment
25	O
mg	O
q.d.	O

8.	O
Ranitidine	B-treatment
150	O
mg	O
p.o.	O
q.d.	O

9.	O
Peroxetine	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

10.	O
Insulin	B-treatment
:	O

NPH	B-treatment
70	O
units	O
q.a.m.	O
,	O
50	O
units	O
q.p.m.	O
,	O
regular	B-treatment
insulin-sliding	I-treatment
scale	I-treatment
.	O

11.	O
SubQ	B-treatment
Heparin	I-treatment
5,000	O
q.8h.	O

12.	O
Lactulose	B-treatment
.	O

13.	O
Multivitamins	B-treatment
.	O

14.	O
Albuterol	B-treatment
inhalers	I-treatment
prn	O
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
:	O

Shortness	B-problem
of	I-problem
breath	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Heart	B-test
rate	I-test
108	O
,	O
blood	B-test
pressure	I-test
140/82	O
,	O
oxygen	B-test
saturation	I-test
96%	O
,	O
respiratory	B-test
rate	I-test
of	O
22	O
on	O
BiPAP	B-treatment
5/10/30%	O
.	O

In	O
general	O
,	O
sleepy	B-problem
but	O
arousable	O
.	O

Arousable	O
intermittently	O
to	O
voice	B-test
.	O

HEENT	O
:	O

Pupils	B-test
3	O
mm	O
reactive	O
.	O

Neck	O
:	O

Obese	B-problem
,	O
unable	O
to	O
assess	O
lymphadenopathy	B-problem
or	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

Lungs	O
:	O

Poor	B-problem
effort	I-problem
,	O
no	O
wheezes	B-problem
,	O
rales	B-problem
,	O
or	O
rhonchi	B-problem
.	O

Cardiovascular	O
:	O

Distant	B-problem
heart	I-problem
sounds	I-problem
,	O
tachycardia	B-problem
,	O
regular	O
rhythm	B-test
.	O

Abdomen	O
is	O
obese	B-problem
,	O
nontender	B-problem
,	O
decreased	B-problem
bowel	I-problem
sounds	I-problem
.	O

Extremities	O
:	O

Obese	B-problem
,	O
no	O
edema	B-problem
,	O
2+	O
pulses	B-test
.	O

Neurologic	O
:	O

Responding	O
to	O
commands	O
.	O

Moving	O
all	O
extremities	O
well	O
.	O

Toes	O
are	O
downgoing	O
.	O

PERTINENT	O
LABORATORIES	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
12.8	O
(	O
79%	O
polys	B-test
,	O
13%	O
lymphocytes	B-test
,	O
8	O
monocytes	B-test
,	O
nucleated	B-test
RBCs	I-test
1%	O
),hematocrit	B-test
31.7	O
.	O

Potassium	B-test
5.2	O
,	O
creatinine	B-test
1.3	O
,	O
BUN	B-test
35	O
,	O
glucose	B-test
152	O
,	O
D	B-test
dimer	I-test
1636	O
,	O
INR	B-test
1.3	O
.	O

Urinalysis	B-test
:	O

Moderate	B-test
leukocytes	I-test
,	O
06-09	O
RBCs	B-test
,	O
21-50	O
lymphocytes	B-test
,	O
many	B-problem
bacteria	I-problem
,	O
06-09	O
epithelial	B-test
cells	I-test
.	O

Tox	B-test
screen	I-test
negative	O
.	O

Urine	B-test
cultures	I-test
pending	O
.	O

LABORATORIES	O
AT	O
OUTSIDE	O
HOSPITAL	O
:	O

White	B-test
count	I-test
11.8	O
(	O
90%	O
polys	B-test
,	O
4%	O
lymphocytes	B-test
,	O
5%	O
monocytes	B-test
,	O
1%	O
basophils	B-test
,	O
3%	O
nucleated	B-test
RBCs	I-test
).	O

Potassium	B-test
6.6	O
,	O
creatinine	B-test
1.4	O
,	O
alkaline	B-test
phosphatase	I-test
302	O
,	O
T	B-test
bilirubin	I-test
0.6	O
,	O
AST	B-test
25	O
,	O
ALT	B-test
84	O
,	O
CK	B-test
of	O
15	O
,	O
troponin	B-test
0.01	O
.	O

Chest	B-test
x-ray	I-test
:	O

Left	B-problem
lower	I-problem
lobe	I-problem
basal	I-problem
opacity	I-problem
.	O

EKG	B-test
:	O

Sinus	B-problem
tachycardia	I-problem
at	O
106	O
beats	B-test
per	I-test
minute	I-test
,	O
left	B-problem
axis	I-problem
deviation	I-problem
,	O
T-wave	B-problem
inversions	I-problem
in	I-problem
leads	I-problem
I	I-problem
and	I-problem
aVL	I-problem
that	O
are	O
old	O
.	O

No	O
QRS	B-problem
widening	I-problem
and	O
no	O
peak	B-problem
T	I-problem
waves	I-problem
.	O

This	O
is	O
in	O
comparison	O
to	O
2015-09-27	O
EKG	B-test
.	O

Chest	B-test
x-ray	I-test
rotated	O
low	B-problem
lung	I-problem
volumes	I-problem
,	O
hazy	B-problem
opacities	I-problem
at	I-problem
bases	I-problem
.	O

Echocardiogram	B-test
in	O
2010	O
:	O

Mild-to-moderate	B-problem
MR	I-problem
,	O
TR	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Hypercarbic	B-problem
respiratory	I-problem
failure	I-problem
issues	I-problem
:	O

The	O
patient	O
presented	O
with	O
changes	B-problem
in	I-problem
mental	I-problem
status	I-problem
,	O
pCO2	B-test
of	O
100	O
,	O
pH	B-test
of	O
7.19	O
,	O
decreasing	B-problem
sats	I-problem
on	O
arrival	O
likely	O
element	O
of	O
obstructive-sleep	B-problem
apnea	I-problem
.	O

She	O
was	O
monitored	O
overnight	O
.	O

She	O
had	O
admitted	O
to	O
the	O
CMED	O
and	O
had	O
multiple	O
episodes	O
of	O
apnea	B-problem
throughout	O
the	O
night	O
.	O

She	O
was	O
placed	O
on	O
pressure	B-treatment
support	I-treatment
,	O
which	O
improved	O
her	B-test
saturations	I-test
and	O
decreased	O
her	B-problem
hypercarbia	I-problem
.	O

Patient	O
improved	O
that	O
her	B-test
mental	I-test
status	I-test
with	O
improvement	O
of	O
her	B-test
oxygenation	I-test
and	O
ventilation	O
as	O
well	O
as	O
for	O
correction	O
of	O
her	B-problem
respiratory	I-problem
acidosis	I-problem
.	O

Patient	O
was	O
eventually	O
placed	O
on	O
BiPAP	B-treatment
on	O
hospital	O
day	O
three	O
,	O
on	O
the	O
date	O
prior	O
to	O
discharge	O
of	O
BiPAP	B-treatment
settings	O
of	O
12/8/5	B-treatment
liters	I-treatment
of	I-treatment
oxygen	I-treatment
with	O
saturations	B-test
of	O
96%	O
with	O
a	B-test
gas	I-test
of	O
7.38	O
,	O
67	O
,	O
and	O
91	O
with	O
an	O
aim	O
of	O
a	O
goal	O
pCO2	B-test
of	O
67	O
.	O

She	O
only	O
had	O
one	O
episode	O
of	O
apnea	B-problem
on	O
the	O
day	O
prior	O
to	O
discharge	O
.	O

2.	O
Delta	B-problem
MS/mental	I-problem
status	I-problem
issues	I-problem
:	O

Most	O
likely	O
her	B-problem
waxing	I-problem
and	I-problem
waning	I-problem
mental	I-problem
status	I-problem
and	O
hypercarbia/hypoxia	B-problem
compounded	O
by	O
infection	B-problem
of	I-problem
pneumonia	I-problem
and	O
UTI	B-problem
.	O

With	O
improvements	O
of	O
her	B-test
ventilation	I-test
and	O
oxygenation	B-test
and	O
treatment	B-treatment
with	O
levofloxacin	B-treatment
of	O
her	B-problem
UTI	I-problem
and	O
pneumonia	B-problem
,	O
her	O
mental	O
status	O
greatly	O
improved	O
on	O
hospital	O
day	O
two	O
without	O
further	B-problem
waxing	I-problem
and	I-problem
waning	I-problem
.	O

Her	O
daughters	O
came	O
by	O
and	O
visited	O
her	O
,	O
and	O
reported	O
that	O
she	O
was	O
at	O
her	O
baseline	O
mental	O
status	O
on	O
the	O
day	O
prior	O
to	O
discharge	O
.	O

B12	B-test
,	O
folate	B-test
,	O
RPR	B-test
were	O
all	O
sent	O
that	O
were	O
unremarkable	O
as	O
causes	O
for	O
delta	B-problem
MS	I-problem
.	O

We	O
are	O
awaiting	O
results	O
of	O
the	B-test
lumbar	I-test
puncture	I-test
from	O
the	O
outside	O
hospital	O
,	O
but	O
on	O
hospital	O
day	O
two	O
.	O

Those	B-test
cultures	I-test
are	O
still	O
pending	O
at	O
the	O
time	O
.	O

Patient	O
was	O
also	O
given	O
multivites	B-treatment
.	O

3.	O
Fever	B-problem
issues	I-problem
:	O

The	O
patient	O
initially	O
presented	O
with	O
T	B-test
max	I-test
of	O
101.3	O
at	O
outside	O
hospital	O
with	O
increasing	B-problem
white	I-problem
blood	I-problem
cell	I-problem
counts	I-problem
and	O
a	O
positive	O
urinalysis	B-problem
.	O

A	B-test
chest	I-test
x-ray	I-test
with	O
bilateral	B-problem
patchy	I-problem
infiltrates	I-problem
likely	O
pneumonia	B-problem
and	O
UTI	B-problem
.	O

Upon	O
calling	O
the	O
outside	O
hospital	O
,	O
the	O
urine	O
was	O
growing	O
out	O
Klebsiella	B-problem
,	O
and	O
patient	O
was	O
given	O
a	O
10	O
day	O
course	O
of	O
levofloxacin	B-treatment
to	O
cover	O
both	O
the	B-problem
pneumonia	I-problem
and	O
UTI	B-problem
.	O

Blood	B-test
cultures	I-test
and	O
urine	B-test
cultures	I-test
are	O
still	O
pending	O
at	O
this	O
hospital	O
visit	O
and	O
the	O
CSF	B-test
fluid	I-test
from	O
Whitter	O
Rehabilitation	O
Hospital	O
needs	O
to	O
be	O
further	O
evaluated	O
.	O

Patient	O
on	O
the	O
day	O
of	O
discharge	O
was	O
afebrile	B-problem
with	O
a	B-problem
decreasing	I-problem
white	I-problem
count	I-problem
x48	O
hours	O
.	O

4.	O
Acute	B-problem
renal	I-problem
failure	I-problem
issues	I-problem
:	O

Creatinine	B-test
initially	O
presented	O
at	O
1.3	O
.	O

Patient	O
is	O
known	O
to	O
have	O
a	O
baseline	O
of	O
1.0	O
,	O
most	O
likely	O
hypovolemia	B-problem
and	O
prerenal	O
.	O

A	B-test
FENa	I-test
was	O
sent	O
,	O
was	O
0.3%	O
.	O

Patient	O
was	O
gently	O
hydrated	O
and	O
IV	B-treatment
fluids	I-treatment
started	O
up	O
on	O
a	B-treatment
p.o.	I-treatment
diet	I-treatment
regimen	I-treatment
.	O

On	O
hospital	O
day	O
two	O
,	O
her	B-test
creatinine	I-test
returned	O
to	O
0.8	O
,	O
and	O
she	O
remained	O
with	O
a	B-test
creatinine	I-test
of	O
0.8	O
for	O
the	O
remainder	O
of	O
her	O
hospital	O
stay	O
.	O

Patient's	B-test
K	I-test
was	O
followed	O
,	O
and	O
trended	O
back	O
down	O
to	O
normal	O
on	O
the	O
day	O
of	O
discharge	O
at	O
3.9	O
.	O

5.	O
Elevated	B-problem
transaminases	I-problem
:	O

Patient	O
had	O
no	O
right	B-problem
upper	I-problem
quadrant	I-problem
pain	I-problem
.	O

Stewart	B-test
sign	I-test
was	O
negative	O
.	O

A	B-test
right	I-test
upper	I-test
quadrant	I-test
ultrasound	I-test
was	O
performed	O
that	O
showed	O
no	O
hepatic	B-problem
or	I-problem
biliary	I-problem
pathology	I-problem
likely	O
due	O
to	O
acute	B-problem
phase	I-problem
stress	I-problem
changes	I-problem
given	O
the	O
fact	O
that	O
she	O
had	O
no	O
clinical	B-problem
symptoms	I-problem
.	O

There	O
is	O
no	O
need	O
to	O
followup	O
these	B-test
transaminases	I-test
.	O

6.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
history	O
:	O

Patient	O
was	O
stable	O
without	O
evidence	O
of	O
CHF	B-problem
on	O
chest	B-test
x-ray	I-test
.	O

Followed	O
her	B-test
sats	I-test
likely	O
due	O
to	O
obstructive-sleep	B-problem
apnea	I-problem
and	O
hypoventilation	B-problem
.	O

Patient	O
was	O
restarted	O
on	O
her	B-treatment
beta	I-treatment
blocker	I-treatment
and	O
.......-	O
receptor	B-treatment
blocker	I-treatment
on	O
hospital	O
day	O
two	O
given	O
that	O
her	B-test
creatinine	I-test
had	O
stabilized	O
.	O

Patient	O
had	O
no	O
further	B-problem
cardiac	I-problem
issues	I-problem
at	O
this	O
time	O
.	O

She	O
was	O
on	O
telemetry	B-test
without	O
any	O
episodes	O
of	O
any	B-problem
rhythm	I-problem
abnormalities	I-problem
.	O

7.	O
CMED	O
CCU	O
:	O

The	O
patient	O
had	O
some	B-problem
vaginal	I-problem
bleeding	I-problem
x2	O
days	O
.	O

Patient	O
had	O
a	O
history	O
of	O
fibroids	B-problem
during	O
this	O
hospitalization	O
.	O

Followed	O
her	B-test
examination	I-test
.	O

Her	B-test
hematocrit	I-test
remained	O
stable	O
throughout	O
this	O
course	O
.	O

Patient	O
is	O
strongly	O
encouraged	O
to	O
followup	O
with	O
her	O
outside	O
primary	O
care	O
provider	O
to	O
followup	O
for	O
the	B-problem
vaginal	I-problem
bleeding	I-problem
given	O
her	O
history	O
of	O
fibroids	B-problem
and	O
question	O
metaplasia	B-problem
of	I-problem
the	I-problem
endometrium	I-problem
.	O

8.	O
Heme	O
:	O

Her	B-test
hematocrit	I-test
remained	O
stable	O
.	O

She	O
had	O
a	O
history	O
of	O
nucleated	B-problem
RBCs	I-problem
likely	O
secondary	O
to	O
stress	B-problem
and	O
hypoxia	B-problem
during	O
this	O
admission	O
.	O

Hemolysis	B-test
laboratories	I-test
were	O
negative	O
.	O

Patient	O
was	O
restarted	O
on	O
her	B-treatment
iron	I-treatment
supplementation	I-treatment
.	O

Reticulocyte	B-test
count	I-test
was	O
performed	O
that	O
was	O
negative	O
.	O

9.	O
FEN	O
:	O

She	O
was	O
NPO	B-treatment
with	O
a	B-problem
decrease	I-problem
in	I-problem
her	I-problem
mental	I-problem
status	I-problem
.	O

We	O
slowly	O
advanced	O
her	O
diet	O
as	O
her	O
mental	O
status	O
improved	O
and	O
repleted	O
her	B-test
electrolytes	I-test
,	O
and	O
started	O
on	O
her	B-treatment
p.o.	I-treatment
medications	I-treatment
on	O
hospital	O
day	O
two	O
.	O

10.	O
Diabetes	B-problem
:	O

Patient	O
had	O
q.i.d.	O
fingersticks	B-test
with	O
a	B-treatment
Humalog	I-treatment
sliding	I-treatment
scale	I-treatment
and	O
NPH	B-treatment
doses	I-treatment
were	O
cut	O
in	O
half	O
while	O
she	O
was	O
NPO	B-treatment
,	O
and	O
they	O
were	O
brought	O
back	O
to	O
her	B-treatment
normal	I-treatment
doses	I-treatment
on	O
the	O
day	O
of	O
discharge	O
with	O
a	O
full	O
diet	O
.	O

11.	O
Code	O
status	O
:	O

Full	O
.	O

Two	O
daughters	O
came	O
by	O
and	O
requested	O
to	O
be	O
health	O
care	O
proxies	O
as	O
patient	O
approved	O
.	O

Documentation	O
is	O
in	O
her	O
medical	O
chart	O
.	O

12.	O
Prophylaxis	B-treatment
:	O

The	O
patient	O
was	O
on	O
subQ	B-treatment
Heparin	I-treatment
for	O
DVT	B-problem
and	O
ranitidine	B-treatment
for	O
GI	B-treatment
prophylaxis	I-treatment
.	O

DISPOSITION:	O
PAD-WORD	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
today	O
to	O
Lahey	O
Clinic	O
-	O
North	O
Shore	O
Hospital	O
for	O
long-term	B-treatment
pulmonary	I-treatment
........	I-treatment
therapy	I-treatment
and	O
further	O
evaluation	B-test
of	O
her	B-problem
obstructive-sleep	I-problem
apnea	I-problem
.	O

DISCHARGE	O
CONDITION	O
:	O

Patient	O
was	O
stable	O
with	O
complete	O
clearance	O
of	O
her	O
mental	O
status	O
,	O
advancement	O
of	O
her	O
diet	O
,	O

blood	B-test
pressure	I-test
,	O
and	O
heart	B-test
rate	I-test
remained	O
stable	O
,	O
and	O
her	B-test
oxygen	I-test
saturations	I-test
were	O
well	O
above	O
90%	O
during	O
the	O
daytime	O
on	O
2	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
and	O
at	O
night	O
on	O
the	B-treatment
BiPAP	I-treatment
settings	O

described	O
above	O
.	O

Physical	O
Therapy	O
consult	O
is	O
pending	O
today	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
NPH	B-treatment
70	O
units	O
q.a.m.	O
,	O
50	O
units	O
q.p.m.	O

2.	O
Humalog	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

3.	O
SubQ	B-treatment
Heparin	I-treatment
5,000	O
units	O
t.i.d.	O

4.	O
Ranitidine	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O

5.	O
Multivitamin	B-treatment
x1	O
.	O

6.	O
Losartan	B-treatment
25	O
mg	O
p.o.	O
q.d.	O

7.	O
Iron	B-treatment
supplementation	I-treatment
150	O
mg	O
p.o.	O
q.d.	O

8.	O
Levofloxacin	B-treatment
day	O
four	O
of	O
10	O
to	O
be	O
completed	O
for	O
a	O
full	O
10-day	O
course	O
,	O
500	O
mg	O
p.o.	O
q.d.	O

9.	O
Metoprolol	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O

10.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

Mark	O
Nibbe	O
,	O
M.D.	O

87-896	O
PAD-WORD	O

Dictated	O
By	O
:	O
Jeffrey	O
N.	O
Elvington	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O

2015-10-02	O
08:19	O

T	O
:	O

2015-10-02	O
08:20	O

JOB	O
#	O
:	O

15790	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Mark	O
Nibbe	O
on	O
:	O
TUE	O
2015-10-06	O
9:46	O
PM	O

(	O
End	O
of	O
Report	O
)	O

537167143	O
PAD-WORD	O

FIH	O
PAD-WORD	O

1543338	O
PAD-WORD	O

75053/sqyo	O
PAD-WORD	O

326247	O
PAD-WORD	O

12/3/1993	O
12:00:00	O
AM	O

PAPILLARY	B-problem
ADENOCARCINOMA	I-problem
OF	I-problem
THE	I-problem
LUNG	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12-3-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

12-10-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Papillary	B-problem
adenocarcinoma	I-problem
of	I-problem
the	I-problem
lung	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

A	B-test
flexible	I-test
bronchoscopy	I-test
and	O
extrapleural-pleural	B-treatment
lobectomy	I-treatment
on	O
12-4-93	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
year	O
old	O
white	O
male	O
with	O
a	O
history	O
of	O
emphysema	B-problem
who	O
presents	O
for	O
admission	O
with	O
a	O
diagnosis	O
of	O
broncho-alveolar	B-problem
carcinoma	I-problem
and	O
is	O
scheduled	O
for	O
flexible	B-test
bronchoscopy	I-test
,	O
mediastinoscopy	B-test
and	O
thoracotomy	B-treatment
with	O
questionable	O
pneumonectomy	B-treatment
by	O
Dr.	O
An	O
on	O
12-4-93	O
.	O

The	O
patient	O
is	O
a	O
native	O
of	O
Nahuter	O
with	O
a	O
70+	O
pack	O
year	O
smoking	O
history	O
(	O
2	O
1/2-3	O
pack	O
per	O
day	O
x	O
35	O
years	O
)	O
whose	O
symptoms	O
began	O
last	O
12/92	O
when	O
he	O
had	O
a	B-problem
persistent	I-problem
cough	I-problem
and	O
fever	B-problem
.	O

In	O
six	O
months	O
,	O
he	O
was	O
hospitalized	O
for	O
pneumonia	B-problem
x	O
four	O
.	O

He	O
has	O
had	O
worsening	B-problem
dyspnea	I-problem
and	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
,	O
though	O
denies	O
orthopnea	B-problem
.	O

No	O
hemoptysis	B-problem
,	O
no	O
fevers	B-problem
,	O
chills	B-problem
,	O
sweats	B-problem
,	O
when	O
pneumonia	B-problem
resolved	O
.	O

The	O
patient	O
also	O
noticed	O
a	B-problem
loss	I-problem
of	I-problem
weight	I-problem
of	O
approximately	O
25	O
pounds	O
over	O
a	O
few	O
months	O
with	O
increased	B-problem
fatigue	I-problem
and	O
lower	B-problem
extremity	I-problem
weakness	I-problem
.	O

A	B-problem
&quot;	I-problem
spot	I-problem
&quot;	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
on	O
chest	B-test
X-ray	I-test
was	O
noted	O
in	O
October	O
of	O
1993	O
,	O
after	O
his	B-problem
pneumonia	I-problem
cleared	O
.	O

A	B-test
follow	I-test
up	I-test
chest	I-test
computerized	I-test
tomography	I-test
scan	I-test
led	O
to	O
a	B-test
tissue	I-test
biopsy	I-test
via	O
flexible	B-test
bronchoscopy	I-test
in	O
07/93	O
.	O

Tissue	O
returned	O
well	B-problem
differentiated	I-problem
adenocarcinoma	I-problem
.	O

The	O
patient	O
was	O
told	O
nothing	O
could	O
be	O
done	O
until	O
he	O
was	O
referred	O
to	O
Dr.	O
An	O
.	O

His	O
appetite	O
has	O
been	O
good	O
and	O
he	O
has	O
only	O
complained	O
of	O
occasional	B-problem
sharp	I-problem
pain	I-problem
under	I-problem
his	I-problem
rib	I-problem
cage	I-problem
,	O
right	O
greater	O
than	O
left	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
Percodan	B-treatment
,	O
which	O
gives	O
him	O
itchiness	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Triamcinolone	B-treatment
,	O
one	O
tablet	O
PO	O
b.i.d.	O
,	O
dosage	O
unknown	O
,	O
Xanax	B-treatment
one	O
tablet	O
PO	O
t.i.d.	O
,	O
prn	O
anxiety	B-problem
,	O
dosage	O
unknown	O
,	O
MS	B-treatment
Contin	I-treatment
prn	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Distant	B-problem
peptic	I-problem
ulcer	I-problem
disease	I-problem
,	O
thumb	B-problem
and	I-problem
middle	I-problem
finger	I-problem
lost	I-problem
secondary	O
to	O
lawnmower	O
accident	O
at	O
age	O
five	O
years	O
,	O
no	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
status	O
post	O
partial	B-treatment
gastrectomy	I-treatment
for	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
in	O
1965	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	B-test
review	I-test
of	I-test
systems	I-test
was	O
notable	O
for	O
anxiety	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
he	O
is	O
a	O
cachectic	O
white	O
male	O
looking	O
older	O
than	O
his	O
stated	O
age	O
,	O
who	O
is	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
was	O
within	O
normal	O
limits	O
.	O

The	O
neck	O
showed	O
a	B-problem
1	I-problem
x	I-problem
1	I-problem
centimeter	I-problem
submaxillary	I-problem
right	I-problem
lymph	I-problem
node	I-problem
.	O

It	O
was	O
otherwise	O
supple	O
,	O
with	O
no	O
thyromegaly	B-problem
.	O

His	O
chest	O
and	O
axillae	O
showed	O
no	O
supraclavicular	B-problem
or	I-problem
axillary	I-problem
adenopathy	I-problem
.	O

The	O
lung	O
sounds	O
were	O
rhonchorous	B-problem
,	O
otherwise	O
clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
.	O

Cardiovascular	B-test
exam	I-test
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
Sl	O
and	O
S2	O
,	O
no	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
.	O

Abdomen	O
:	O

scaphoid	O
,	O
positive	O
bowel	O
sounds	O
,	O
no	O
palpable	B-problem
masses	I-problem
,	O
with	O
a	B-problem
parasagittal	I-problem
scar	I-problem
right	O
of	O
the	O
midline	O
.	O

Extremities	O
:	O

Pulses	B-test
were	O
2+	O
and	O
symmetrical	O
,	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

Admission	B-test
sodium	I-test
of	O
136	O
,	O
potassium	B-test
3.8	O
,	O
chloride	B-test
99	O
,	O
bicarbonate	B-test
27.3	O
,	O
BUN	B-test
and	O
creatinine	B-test
of	O
13	O
and	O
0.6	O
,	O
glucose	B-test
86	O
,	O
calcium	B-test
9.3	O
,	O
liver	B-test
function	I-test
tests	I-test
notable	O
for	O
an	O
albumin	B-test
of	O
2.5	O
,	O
globulin	B-test
4.5	O
.	O

The	B-test
complete	I-test
blood	I-test
count	I-test
on	I-test
admission	I-test
showed	O
a	B-test
white	I-test
blood	I-test
count	I-test
of	O
14.5	O
,	O
hematocrit	B-test
31.0	O
,	O
hemoglobin	B-test
10.3	O
and	O
platelet	B-test
count	I-test
478,000	O
.	O

The	B-test
arterial	I-test
blood	I-test
gases	I-test
on	O
room	O
air	O
were	O
7.46/70/41	O
.	O

The	B-test
pulmonary	I-test
function	I-test
tests	I-test
revealed	O
an	B-test
FEV1	I-test
of	O
1.51	O
,	O
FVC	B-test
2.72	O
,	O
and	O
FEV1/FVC	B-test
ratio	I-test
of	O
56%	O
.	O

DLCO	B-test
was	O
2	O
,	O
or	O
19%	O
of	O
predicted	O
.	O

HOSPITAL	O
COURSE	O
:	O

A	B-test
quantitative	I-test
V	I-test
/	I-test
Q	I-test
scan	I-test
was	O
also	O
done	O
preoperatively	O
and	O
Pulmonary	O
consult	O
was	O
obtained	O
preoperatively	O
.	O

Pulmonary	O
recommended	O
that	O
he	O
just	O
be	O
started	O
on	O
Albuterol	B-treatment
and	O
Atrovent	B-treatment
metered	I-treatment
dose	I-treatment
inhalers	I-treatment
,	O
2	O
puffs	O
q6h	O
,	O
prior	O
to	O
surgery	B-treatment
.	O

The	O
patient	O
underwent	O
his	B-treatment
procedure	I-treatment
on	O
12-4-93	O
,	O
without	O
complications	B-problem
.	O

Findings	O
included	O
thickened	B-problem
pleura	I-problem
with	O
multiple	B-problem
adhesions	I-problem
and	O
an	B-problem
abscess	I-problem
near	I-problem
the	I-problem
margin	I-problem
major	I-problem
fissure	I-problem
.	O

He	O
had	O
a	B-problem
firm	I-problem
nodule	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Respiratory	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
and	O
had	O
an	O
uneventful	O
stay	O
there	O
.	O

He	O
had	O
oxygen	B-test
saturations	I-test
of	O
99%	O
with	O
an	B-test
Fi02	I-test
of	O
40%	O
and	O
had	O
no	O
complaints	O
.	O

He	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
number	O
one	O
and	O
tolerated	O
his	O
PO&apos;s	O
well	O
.	O

His	B-test
left	I-test
lower	I-test
lobe	I-test
micro	I-test
results	O
revealed	O
alpha	B-problem
hemolytic	I-problem
Streptococcus	I-problem
on	O
culture	B-test
and	O
he	O
was	O
then	O
switched	O
to	O
penicillin	B-treatment
and	O
Gentamicin	B-treatment
after	O
being	O
started	O
on	O
triples	O
of	O
Flagyl	B-treatment
,	O
Ampicillin	B-treatment
,	O
and	O
Gentamicin	B-treatment
.	O

He	O
had	O
low	B-problem
grade	I-problem
temperatures	I-problem
,	O
though	O
did	O
not	O
spike	O
a	B-problem
high	I-problem
temperature	I-problem
during	O
his	O
hospital	O
course	O
.	O

His	O
hospital	O
course	O
was	O
otherwise	O
uneventful	O
and	O
the	O
patient	O
was	O
discharged	O
in	O
stable	O
condition	O
on	O
postoperative	O
day	O
,	O
afebrile	B-problem
.	O

The	B-test
chest	I-test
X-ray	I-test
on	O
the	O
morning	O
of	O
discharge	O
was	O
unchanged	O
from	O
the	O
previous	O
day	O
,	O
with	O
slight	B-problem
increase	I-problem
in	I-problem
left	I-problem
pleural	I-problem
fluid	I-problem
.	O

He	O
had	O
completed	O
six	O
days	O
of	O
penicillin	B-treatment
and	O
Gentamicin	B-treatment
and	O
was	O
discharged	O
on	O
Ciprofloxacin	B-treatment
and	O
Flagyl	B-treatment
for	O
the	O
next	O
seven	O
days	O
.	O

He	O
stayed	O
at	O
the	O
local	O
Comfort	O
Inn	O
before	O
his	O
return	O
back	O
to	O
Aujer	O
Cin	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Tylenol	B-treatment
#	I-treatment
3	I-treatment
,	O
Xanax	B-treatment
,	O
Ciprofloxacin	B-treatment
,	O
Flagyl	B-treatment
.	O

TVI	O
POST	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

REG	O
V.	O
POST	O
,	O
M.D.	O

TR	O
:	O

xr	O
/	O
bmot	O

DD	O
:	O

1-4-94	O
PAD-WORD	O

TD	O
:	O

01/05/94	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2009-03-27	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2009-04-03	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1960-03-06	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

GYNECOLOGY	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49-year-old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
who	O
was	O
sent	O
from	O
her	O
primary	O
care	O
physician	O
's	O
office	O
secondary	O
to	O
lower	B-problem
abdominal	I-problem
pain	I-problem
.	O

The	O
patient	O
is	O
status	O
post	O
uterine	B-treatment
artery	I-treatment
embolization	I-treatment
on	O
2009-01-07	O
secondary	O
to	O
fibroids	B-problem
.	O

She	O
has	O
had	O
continuing	B-problem
vaginal	I-problem
discharge	I-problem
,	O
and	O
was	O
diagnosed	O
with	O
bacterial	B-problem
vaginosis	I-problem
one	O
day	O
prior	O
to	O
admission	O
,	O
and	O
was	O
given	O
a	O
prescription	O
for	O
Flagyl	B-treatment
.	O

She	O
noted	O
increasing	B-problem
abdominal	I-problem
pain	I-problem
two	O
days	O
prior	O
to	O
admission	O
,	O
which	O
became	O
more	O
severe	O
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

She	O
went	O
to	O
her	O
primary	O
care	O
physician	O
's	O
office	O
on	O
the	O
day	O
of	O
admission	O
complaining	O
of	O
abdominal	B-problem
pain	I-problem
,	O
which	O
she	O
stated	O
was	O
constant	O
but	O
intermittently	O
sharper	O
at	O
times	O
.	O

The	O
location	O
was	O
variable	O
.	O

She	O
also	O
complained	O
of	O
some	B-problem
loose	I-problem
stools	I-problem
on	O
the	O
day	O
of	O
admission	O
,	O
no	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

Her	B-test
temperature	I-test
was	O
100.4	O
in	O
the	O
office	O
,	O
and	O
she	O
had	O
no	O
chills	B-problem
.	O

She	O
was	O
sent	O
for	O
a	B-test
CT	I-test
scan	I-test
of	I-test
her	I-test
abdomen	I-test
,	O
which	O
revealed	O
fluid	B-problem
and	O
question	O
of	O
gas	B-problem
in	I-problem
the	I-problem
endometrial	I-problem
cavity	I-problem
,	O
and	O
she	O
was	O
sent	O
to	O
Pinewood	O
,	O
Norfolk	O
for	O
treatment	B-treatment
and	O
admission	B-treatment
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

Cesarean	B-treatment
section	I-treatment
x	O
2	O
,	O
spontaneous	B-problem
abortion	I-problem
x	O
1	O
.	O

PAST	O
GYNECOLOGIC	O
HISTORY	O
:	O

Last	O
menstrual	O
period	O
2009-02-21	O
.	O

Some	B-problem
spotting	I-problem
on	O
the	O
day	O
prior	O
to	O
admission	O
,	O
but	O
not	O
a	O
normal	O
period	O
.	O

Periods	O
regular	O
.	O

Lupron	B-treatment
x	O
three	O
months	O
prior	O
to	O
embolization	B-treatment
.	O

Fibroid	B-problem
uterus	I-problem
status	O
post	O
embolization	B-treatment
on	O
2009-01-07	O
.	O

Dilatation	B-treatment
and	I-treatment
curettage	I-treatment
x	O
1	O
for	O
SAB	B-problem
.	O

History	O
of	O
herpes	B-problem
simplex	I-problem
virus	I-problem
,	O
last	O
outbreak	O
in	O
2000	O
.	O

No	O
history	O
of	O
abnormal	B-problem
Pap	I-problem
smears	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Cesarean	B-treatment
section	I-treatment
x	O
2	O
,	O
dilatation	B-treatment
and	I-treatment
curettage	I-treatment
x	O
1	O
,	O
neck	B-treatment
fusion	I-treatment
after	O
motor	O
vehicle	O
accident	O
,	O
shoulder	B-treatment
surgery	I-treatment
after	O
motor	O
vehicle	O
accident	O
.	O

MEDICATIONS	O
:	O

Flagyl	B-treatment
.	O

ALLERGIES	O
:	O

None	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
smoking	O
,	O
alcohol	O
or	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
100.4	O
,	O
pulse	B-test
108	O
,	O
respirations	B-test
20	O
,	O
blood	B-test
pressure	I-test
110/70	O
,	O
oxygen	B-test
saturation	I-test
100%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
she	O
was	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Her	O
abdomen	O
was	O
notable	O
for	O
voluntary	B-problem
guarding	I-problem
but	O
no	O
involuntary	B-problem
guarding	I-problem
or	O
rebound	B-problem
,	O
mild	B-problem
right	I-problem
lower	I-problem
quadrant	I-problem
tenderness	I-problem
greater	O
than	O
left	O
lower	O
quadrant	O
,	O
nondistended	B-problem
.	O

Her	B-test
pelvic	I-test
examination	I-test
was	O
notable	O
for	O
some	B-problem
brownish	I-problem
discharge	I-problem
.	O

Her	O
uterus	O
and	O
adnexa	O
were	O
difficult	O
to	O
assess	O
secondary	O
to	O
voluntary	B-problem
tensing	I-problem
of	I-problem
her	I-problem
abdomen	I-problem
.	O

ASSESSMENT	O
:	O

This	O
is	O
a	O
49-year-old	O
gravida	O
III	O
,	O
para	O
II	O
,	O
status	B-treatment
post	I-treatment
uterine	I-treatment
artery	I-treatment
embolization	I-treatment
on	O
2009-01-07	O
due	O
to	O
uterine	B-problem
fibroids	I-problem
,	O
with	O
continued	B-problem
abdominal	I-problem
pain	I-problem
and	O
CT	B-test
scan	I-test
revealing	O
fluid	B-problem
and	I-problem
gas	I-problem
in	I-problem
the	I-problem
endometrial	I-problem
cavity	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
was	O
initially	O
started	O
on	O
intravenous	B-treatment
ampicillin	I-treatment
,	O
gentamicin	B-treatment
and	O
clindamycin	B-treatment
.	O

Her	B-test
initial	I-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
11.3	O
,	O
with	O
a	O
normal	O
differential	O
.	O

Her	B-test
sedimentation	I-test
rate	I-test
was	O
elevated	B-problem
at	O
110	O
.	O

Her	B-test
electrolytes	I-test
were	O
within	O
normal	O
limits	O
.	O

She	O
was	O
maintained	O
on	O
intravenous	B-treatment
antibiotics	I-treatment
.	O

On	O
hospital	O
day	O
number	O
three	O
,	O
her	B-test
blood	I-test
cultures	I-test
came	O
back	O
positive	B-problem
in	O
the	B-test
anaerobic	I-test
culture	I-test
for	O
gram-positive	B-problem
cocci	I-problem
in	I-problem
pairs	I-problem
and	I-problem
clusters	I-problem
.	O

Further	B-test
identification	I-test
revealed	O
staphylococcus	B-problem
coag-negative	I-problem
,	O
which	O
was	O
sensitive	O
to	O
gentamicin	B-treatment
and	O
clindamycin	B-treatment
.	O

She	O
was	O
continued	O
on	O
her	B-treatment
antibiotics	I-treatment
,	O
and	O
was	O
afebrile	B-problem
until	O
hospital	O
day	O
number	O
five	O
,	O
when	O
she	O
had	O
a	B-problem
temperature	I-problem
spike	I-problem
to	O
102.3	O
.	O

Repeat	B-test
blood	I-test
cultures	I-test
were	O
sent	O
.	O

Her	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
was	O
12.8	O
,	O
with	O
a	O
normal	O
differential	O
.	O

At	O
this	O
time	O
,	O
an	O
Infectious	O
Disease	O
consult	O
was	O
obtained	O
,	O
and	O
the	O
recommendation	O
was	O
to	O
discontinue	O
the	B-treatment
ampicillin	I-treatment
,	O
gentamicin	B-treatment
and	O
clindamycin	B-treatment
,	O
and	O
start	O
her	O
on	O
intravenous	B-treatment
Unasyn	I-treatment
.	O

She	O
underwent	O
a	B-test
pelvic	I-test
ultrasound	I-test
and	O
an	B-test
abdomen	I-test
and	I-test
pelvis	I-test
CT	I-test
,	O
which	O
revealed	O
continued	B-problem
air	I-problem
in	I-problem
the	I-problem
endometrial	I-problem
cavity	I-problem
vs.	O
in	O
the	B-problem
fundal	I-problem
fibroid	I-problem
.	O

Discussion	O
was	O
had	O
at	O
this	O
time	O
with	O
the	O
patient	O
regarding	O
whether	O
or	O
not	O
this	O
represented	O
an	B-problem
infected	I-problem
abscess	I-problem
vs.	O
post-surgical	B-problem
change	I-problem
.	O

Extensive	O
discussion	O
was	O
held	O
,	O
and	O
second	O
opinion	O
was	O
obtained	O
regarding	O
the	O
need	O
for	O

possible	O
drainage	B-treatment
of	O
the	B-problem
abscess	I-problem
vs.	O
hysterectomy	B-treatment
.	O

The	O
patient	O
requested	O
an	O
outside	O
second	O
opinion	O
,	O
as	O
she	O
was	O
reluctant	O
to	O
undergo	O
hysterectomy	B-treatment
at	O
this	O
time	O
.	O

She	O
was	O
discharged	O
to	O
home	O
on	O
hospital	O
day	O
number	O
eight	O
,	O
on	O
oral	B-treatment
antibiotics	I-treatment
.	O

The	O
patient	O
was	O
to	O
have	O
a	B-test
repeat	I-test
CT	I-test
scan	I-test
in	O
one	O
week	O
.	O

She	O
was	O
also	O
to	O
obtain	O
a	O
second	O
opinion	O
regarding	O
the	O
question	O
of	O
possible	O
surgical	B-treatment
management	I-treatment
.	O

Claude	O
U	O
Bolanos	O
,	O
M.D.	O

95-182	O
PAD-WORD	O

Dictated	O
By	O
:	O
William	O
MP	O
Lajoie	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2009-04-02	O
22:09	O

T	O
:	O
2009-04-03	O
01:26	O

JOB	O
#:	O

61261	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Suzanne	O
Simpson	O
on	O
:	O
FRI	O
2009-04-24	O
12:48	O
PM	O

(	O
End	O
of	O
Report	O
)	O

551969782	O
PAD-WORD	O

HLGMC	O
PAD-WORD	O

2743471	O
PAD-WORD	O

05215/8895	O
PAD-WORD	O

3/26/1993	O
12:00:00	O
AM	O

POST-INFARCTION	B-problem
UNSTABLE	I-problem
ANGINA	I-problem
PECTORIS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

3-26-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

4-3-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Post-infarction	B-problem
unstable	I-problem
angina	I-problem
pectoris	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Inferior	B-problem
wall	I-problem
myocardial	I-problem
infarction	I-problem
,	O
ventricular	B-problem
fibrillation	I-problem
arrest	I-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
paroxysmal	B-problem
atrial	I-problem
tachycardia	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
psychosis	B-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

3-27-93	O
,	O
cardiac	B-test
catheterization	I-test
and	O
coronary	B-test
and	I-test
left	I-test
ventricular	I-test
angiography	I-test
;	O
4-2-93	O
,	O
exercise	B-test
tolerance	I-test
test	I-test
with	I-test
Thallium	I-test
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Vasotec	B-treatment
5	O
mg	O
PO	O
b.i.d.	O
,	O
Isordil	B-treatment
10	O
mg	O
PO	O
q.i.d.	O
,	O
Ticlopidine	B-treatment
50	O
mg	O
PO	O
b.i.d.	O
,	O
Metoprolol	B-treatment
50	O
mg	O
PO	O
b.i.d.	O
,	O
Ciprofloxacin	B-treatment
500	O
mg	O
PO	O
q12h	O
x	O
seven	O
days	O
,	O
nitroglycerin	B-treatment
0.3	O
mg	O
sublingually	O
prn	O
chest	B-problem
pain	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
73	O
year	O
old	O
female	O
who	O
was	O
transferred	O
for	O
cardiac	B-test
catheterization	I-test
after	O
ventricular	B-problem
fibrillation	I-problem
arrest	I-problem
in	O
the	O
setting	O
of	O
an	B-problem
acute	I-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
and	O
a	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

The	O
patient	O
was	O
admitted	O
on	O
3-16-93	O
to	O
Diy	O
Hospital	O
for	O
an	B-problem
E.	I-problem
coli	I-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

The	O
patient	O
was	O
readmitted	O
on	O
3-20-93	O
because	O
of	O
fever	B-problem
,	O
chills	B-problem
and	O
a	O
sudden	O
onset	O
of	O
ventricular	B-problem
fibrillation	I-problem
arrest	I-problem
,	O
successfully	O
cardioverted	O
back	O
to	O
rapid	B-problem
atrial	I-problem
fibrillation	I-problem
and	O
finally	O
to	O
sinus	O
rhythm	O
,	O
where	O
an	B-test
electrocardiogram	I-test
then	O
showed	O
ST	B-problem
elevation	I-problem
in	I-problem
inferior	I-problem
leads	I-problem
.	O

Peak	B-test
CPK	I-test
was	O
2494	O
with	O
18%	B-test
MB	I-test
's	I-test
.	O

She	O
required	O
intubation	B-treatment
for	O
mild	B-problem
to	I-problem
moderate	I-problem
congestive	I-problem
heart	I-problem
failure	I-problem
,	O
treated	O
with	O
diuretics	B-treatment
,	O
intravenous	B-treatment
nitroglycerin	I-treatment
and	O
heparin	B-treatment
.	O

She	O
had	O
post-infarction	B-problem
angina	I-problem
,	O
was	O
transferred	O
here	O
for	O
angiography	B-test
and	O
possible	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
blood	B-test
pressure	I-test
is	O
130/80	O
,	O
pulse	B-test
74	O
and	O
regular	O
,	O
respirations	B-test
14	O
.	O

Her	O
chest	O
demonstrated	O
bibasilar	B-problem
crackles	I-problem
.	O

Cardiovascular	O
exam	O
:	O

the	B-test
jugular	I-test
venous	I-test
pressure	I-test
was	O
seven	O
centimeters	O
,	O
carotid	B-test
upstroke	I-test
normal	O
.	O

The	B-test
heart	I-test
exam	I-test
revealed	O
a	O
normal	O
Sl	O
and	O
S2	O
was	O
normally	O
split	O
.	O

There	O
was	O
an	B-problem
S4	I-problem
,	O
no	O
S3	B-problem
,	O
grade	B-problem
II/VI	I-problem
apical	I-problem
murmur	I-problem
in	I-problem
systole	I-problem
,	O
no	O
rubs	B-problem
.	O

The	O
abdomen	O
was	O
benign	O
,	O
unremarkable	O
.	O

Extremities	O
:	O

no	O
calf	B-problem
tenderness	I-problem
or	O
peripheral	B-problem
edema	I-problem
.	O

Peripheral	B-test
pulses	I-test
were	O
2+	O
and	O
symmetrical	O
bilaterally	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
3-27-93	O
,	O
patient	O
underwent	O
cardiac	B-test
catheterization	I-test
,	O
coronary	B-test
and	I-test
left	I-test
ventricular	I-test
angiography	I-test
without	O
complications	B-problem
.	O

Review	O
of	O
these	B-test
angiograms	I-test
demonstrated	O
a	O
dominant	O
right	O
coronary	O
artery	O
with	O
a	B-problem
focal	I-problem
50%	I-problem
stenosis	I-problem
in	I-problem
the	I-problem
mid-portion	I-problem
.	O

The	O
left	O
main	O
coronary	O
artery	O
was	O
clear	O
.	O

The	O
left	O
anterior	O
descending	O
had	O
moderate	B-problem
plaques	I-problem
with	O
a	B-problem
50%	I-problem
proximal	I-problem
stenosis	I-problem
of	I-problem
the	I-problem
right	I-problem
anterior	I-problem
oblique	I-problem
caudal	I-problem
view	O
.	O

The	O
proximal	O
diagonal	O
D1	O
had	O
a	B-problem
50%	I-problem
stenosis	I-problem
.	O

The	O
circumflex	O
had	O
a	B-problem
long	I-problem
30%	I-problem
stenosis	I-problem
proximally	O
and	O
an	B-problem
80%	I-problem
stenosis	I-problem
at	O
the	O
origin	O
of	O
the	O
second	O
major	O
marginal	O
artery	O
.	O

The	B-test
left	I-test
ventricular	I-test
angiogram	I-test
showed	O
akinesis	B-problem
of	I-problem
the	I-problem
posterobasal	I-problem
walls	I-problem
,	O
severe	B-problem
hypokinesis	I-problem
of	I-problem
the	I-problem
diaphragmatic	I-problem
wall	I-problem
and	O
trace	B-problem
mitral	I-problem
regurgitation	I-problem
.	O

The	O
patient	O
was	O
maintained	O
on	O
heparin	B-treatment
anticoagulation	I-treatment
.	O

An	B-test
exercise	I-test
tolerance	I-test
test	I-test
with	I-test
Thallium	I-test
was	O
to	O
be	O
performed	O
in	O
order	O
to	O
assess	O
myocardial	O
viability	O
in	O
the	B-problem
infarct	I-problem
zone	I-problem
.	O

The	B-problem
right	I-problem
coronary	I-problem
artery	I-problem
lesion	I-problem
was	O
complex	O
and	O
there	O
was	O
severe	B-problem
stenosis	I-problem
in	I-problem
the	I-problem
obtuse	I-problem
marginal	I-problem
1	I-problem
.	O

The	O
patient	O
had	O
no	O
further	B-problem
angina	I-problem
.	O

On	O
4-2-93	O
,	O
she	O
underwent	O
a	B-test
Persantine	I-test
Thallium	I-test
study	I-test
.	O

This	O
showed	O
no	O
diagnostic	B-problem
electrocardiogram	I-problem
changes	I-problem
for	O
ischemia	B-problem
and	O
no	O
angina	B-problem
pectoris	I-problem
.	O

The	B-test
thallium	I-test
images	I-test
showed	O
a	B-problem
large	I-problem
region	I-problem
of	I-problem
persistently	I-problem
reduced	I-problem
blood	I-problem
flow	I-problem
involving	O
the	O
apex	O
and	O
inferoposterior	O
segments	O
of	O
the	O
left	O
ventricular	O
wall	O
.	O

This	O
was	O
consistent	O
with	O
scar	B-problem
.	O

There	O
was	O
no	O
definite	B-problem
perfusion	I-problem
abnormality	I-problem
in	I-problem
the	I-problem
circumflex	I-problem
zone	I-problem
.	O

In	O
view	O
of	O
these	O
findings	O
,	O
it	O
was	O
elected	O
to	O
discharge	O
her	O
on	O
her	O
present	O
medical	O
program	O
.	O

The	O
patient	O
is	O
to	O
return	O
to	O
the	O
follow	O
up	O
care	O
of	O
Dr.	O
Ko	O
Kollciem	O
at	O
the	O
Diy	O
Hospital	O
.	O

CHPO	O
E.	O
JESCOBEA	O
,	O
M.D.	O

TR	O
:	O

sq	O
/	O
bmot	O

DD	O
:	O

06-13-93	O
PAD-WORD	O

TD	O
:	O

06/15/93	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Ko	O
Kollciem	O
,	O
Retchard	O
Healthcare	O
to	O
Dr.	O
Wall	O

Admission	O
Date	O
:	O

2013-09-06	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-09-18	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1927-08-07	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

NEUROLOGIC	O
MEDICINE	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Large	B-problem
left	I-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
stroke	I-problem
along	O
with	O
posterior	B-problem
cerebral	I-problem
artery	I-problem
strokes	I-problem
bilaterally	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
86	O
year	O
old	O
woman	O
who	O
has	O
a	O
history	O
of	O
atrial	B-problem
fibrillation	I-problem
,	O
peripheral	B-problem
vascular	I-problem
disease	I-problem
,	O
and	O
a	O
history	O
of	O
atrial	B-problem
emboli	I-problem
who	O
was	O
admitted	O
on	O
2013-09-06	O
,	O
to	O
the	O
Neurologic	O
Intensive	O
Care	O
Unit	O
service	O
after	O
collapsing	O
at	O
home	O
at	O
8:30	O
p.m	O
.	O

She	O
was	O
found	O
to	O
have	O
right	B-problem
sided	I-problem
weakness	I-problem
and	O
was	O
noted	O
by	O
her	O
husband	O
to	O
have	O
vomited	O
.	O

She	O
was	O
found	O
comatose	B-problem
at	O
home	O
by	O
EMS	O
and	O
was	O
brought	O
to	O
the	O
Emergency	O
Department	O
.	O

On	O
arrival	O
to	O
the	O
Emergency	O
Department	O
,	O
she	O
was	O
noted	O
to	O
have	O
a	B-test
temperature	I-test
of	O
98.2	O
,	O
blood	B-test
pressure	I-test
164/110	O
,	O
respiratory	B-test
rate	I-test
28	O
,	O
and	O
heart	B-test
rate	I-test
of	O
74	O
.	O

She	O
was	O
found	O
to	O
be	O
responsive	B-problem
only	I-problem
to	I-problem
painful	I-problem
stimuli	I-problem
at	O
this	O
time	O
.	O

She	O
was	O
intubated	O
for	O
airway	B-treatment
protection	I-treatment
and	O
received	O
multiple	B-treatment
medications	I-treatment
prior	O
to	O
her	B-test
initial	I-test
neurologic	I-test
examination	I-test
.	O

She	O
was	O
also	O
noted	O
to	O
have	O
a	B-problem
cold	I-problem
distal	I-problem
left	I-problem
upper	I-problem
extremity	I-problem
which	O
was	O
operated	O
on	O
and	O
she	O
is	O
now	O
status	O
post	O
left	B-treatment
brachial	I-treatment
artery	I-treatment
embolectomy	I-treatment
.	O

Throughout	O
her	O
course	O
on	O
the	O
Intensive	O
Care	O
Unit	O
service	O
,	O
she	O
has	O
remained	O
unresponsive	B-problem
with	O
imaging	B-test
studies	I-test
consistent	O
with	O
a	O
large	O
left	O
middle	O
cerebral	O
artery	O
and	O
posterior	B-problem
cerebral	I-problem
artery	I-problem
distribution	I-problem
cerebral	I-problem
infarction	I-problem
with	O
mass	B-problem
effect	I-problem
and	O
midline	B-problem
shift	I-problem
.	O

There	O
is	O
evidence	O
of	O
bilateral	B-problem
occipital	I-problem
and	I-problem
cerebellar	I-problem
infarctions	I-problem
as	O
well	O
.	O

Discussion	O
with	O
the	O
patient	O
's	O
family	O
by	O
the	O
Intensive	O
Care	O
Unit	O
service	O
has	O
resulted	O
in	O
focusing	O
on	O
her	B-treatment
comfort	I-treatment
care	I-treatment
.	O

This	O
decision	O
was	O
made	O
after	O
an	O
extensive	O
discussion	O
with	O
her	O
husband	O
and	O
family	O
as	O
the	O
likelihood	O
of	O
significant	O
meaningful	O
recovery	O
is	O
extremely	O
low	O
.	O

Based	O
on	O
this	O
,	O
she	O
is	O
transferred	O
to	O
the	O
Neurology	O
service	O
for	O
focus	O
on	O
comfort	B-treatment
care	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Breast	B-problem
cancer	I-problem
,	O
status	O
post	O
lumpectomy	B-treatment
.	O

2.	O
Mitral	B-treatment
commissurectomy	I-treatment
.	O

3.	O
Atrial	B-problem
fibrillation	I-problem
.	O

4.	O
Peripheral	B-problem
vascular	I-problem
disease	I-problem
.	O

5.	O
Arterial	B-problem
emboli	I-problem
,	I-problem
left	I-problem
femoral	I-problem
artery	I-problem
.	O

6.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Lopressor	B-treatment
intravenous	I-treatment
q	O
6	O
hours	O
.	O

2.	O
Morphine	B-treatment
Sulfate	I-treatment
1	O
mg	O
intravenous	O
p.r.n.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
,	O
Sulfa	B-treatment
and	O
Quinidine	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
lived	O
with	O
her	O
husband	O
caring	O
for	O
him	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
the	O
date	O
of	O
transfer	O
,	O
temperature	B-test
98.5	O
,	O
heart	B-test
rate	I-test
80	O
and	O
irregular	B-problem
,	O
blood	B-test
pressure	I-test
140/60	O
,	O
oxygen	B-test
saturation	I-test
100%	O
in	O
room	O
air	O
.	O

in	O
general	O
,	O
the	O
patient	O
is	O
minimally	B-problem
responsive	I-problem
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Head	O
and	O
neck	O
-	O
normocephalic	O
,	O
supple	O
,	O
no	O
lymphadenopathy	B-problem
.	O

Cardiovascular	O
-	O
irregular	B-problem
rhythm	I-problem
,	O
normal	O
rate	O
.	O

Pulmonary	O
-	O
Good	O
air	O
movement	O
,	O
but	O
occasional	B-problem
rhonchi	I-problem
.	O

Abdomen	O
reveals	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
-	O
no	O
edema	B-problem
.	O

Neurologic	O
-	O
The	O
patient	O
is	O
unresponsive	B-problem
to	O
verbal	B-test
stimuli	I-test
,	O
withdrawals	O
the	O
left	O
extremities	O
to	O
noxious	B-test
stimulation	I-test
.	O

The	O
right	O
side	O
does	O
not	O
move	O
.	O

Tone	O
is	O
increased	O
on	O
the	O
right	O
.	O

Toes	O
are	O
upgoing	O
on	O
the	O
right	O
.	O

Cranial	O
nerves	O
-	O
The	O
pupils	O
are	O
equal	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

There	O
is	O
a	B-problem
left	I-problem
gaze	I-problem
preference	I-problem
.	O

The	O
fundi	O
Belmont	O
difficult	O
to	O
visualize	O
but	O
there	O
is	O
no	O
evidence	O
of	O
papilledema	B-problem
.	O

Reflexes	B-test
are	O
down	B-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
.	O

Normal	O
reflexes	O
on	O
the	O
left	O
side	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
11.5	O
,	O
hematocrit	B-test
31.0	O
,	O
platelet	B-test
count	I-test
290,000	O
.	O

INR	B-test
3.0	O
.	O

Potassium	B-test
was	O
3.0	O
,	O
glucose	B-test
131	O
.	O

MR	B-test
studies	I-test
revealed	O
a	B-problem
large	I-problem
left	I-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
infarction	I-problem
with	O
multiple	B-problem
smaller	I-problem
posterior	I-problem
circulation	I-problem
infarctions	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
's	O
course	O
up	O
to	O
the	O
date	O
of	O
transfer	O
to	O
Neurology	O
has	O
been	O
outlined	O
above	O
.	O

Briefly	O
,	O
she	O
is	O
an	O
86	O
year	O
old	O
woman	O
who	O
has	O
suffered	O
multiple	B-problem
cardioembolic	I-problem
cerebral	I-problem
infarctions	I-problem
in	I-problem
multiple	I-problem
arterial	I-problem
territories	I-problem
.	O

She	O
has	O
remained	O
unresponsive	B-problem
throughout	O
the	O
hospitalization	O
and	O
currently	O
only	O
withdraws	O
to	O
pain	B-problem
.	O

After	O
extensive	O
discussion	O
with	O
her	O
family	O
,	O
her	O
care	O
was	O
focused	O
on	O
comfort	O
.	O

A	B-treatment
low	I-treatment
dose	I-treatment
Morphine	I-treatment
drip	I-treatment
was	O
initiated	O
after	O
further	O
serious	O
discussion	O
with	O
her	O
husband	O
and	O
nieces	O
and	O
nephews	O
.	O

The	O
patient	O
passed	O
away	O
peacefully	O
on	O
2013-09-18	O
.	O

The	O
family	O
did	O
not	O
want	O
postmortem	B-test
examination	I-test
.	O

Michael	O
P	O
Galuszka	O
,	O
M.D.	O

46-348	O
PAD-WORD	O

Dictated	O
By	O
:	O
Melissa	O
U	O
Sangi	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-11-11	O
18:47	O

T	O
:	O
2013-11-11	O
19:46	O

JOB	O
#:	O

93375	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ryann	O
W.	O
U.	O
Galuszka	O
on	O
:	O
TUE	O
2013-11-19	O
12:45	O
PM	O

(	O
End	O
of	O
Report	O
)	O

559197012_a	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4469096	O
PAD-WORD	O

80486/8ays	O
PAD-WORD	O

271958	O
PAD-WORD	O

9/2/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

9-2-94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

9-18-94	O
PAD-WORD	O

ADMISSION	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Non-insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
history	O
of	O
gastric	B-problem
ulcer	I-problem
,	O
and	O
history	O
of	O
ETOH	O
abuse	O
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

September	O
11	O
,	O
1994	O
,	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
surgery	I-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Coumadin	B-treatment
5	O
mg	O
PO	O
q.day	O
,	O
Digoxin	B-treatment
0.25	O
mg	O
PO	O
q.day	O
,	O
Metoprolol	B-treatment
25	O
mg	O
PO	O
b.i.d.	O
,	O
Baby	B-treatment
aspirin	I-treatment
80	O
mg	O
PO	O
q.day	O
.	O

The	O
patient	O
will	O
be	O
followed	O
by	O
the	O
Anticoagulation	O
Clinic	O
for	O
prothrombin	B-test
time	I-test
level	I-test
evaluations	I-test
and	O
appropriate	B-treatment
Coumadin	I-treatment
doses	I-treatment
.	O

IDENTIFYING	O
DATA	O
:	O

The	O
patient	O
is	O
a	O
66	O
year	O
old	O
Portuguese	O
speaking	O
gentleman	O
with	O
a	O
history	O
of	O
hypertension	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
increasing	B-problem
cholesterol	I-problem
,	O
and	O
history	O
of	O
tobacco	O
use	O
,	O
who	O
is	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
September	O
of	O
1993	O
and	O
February	O
of	O
1993	O
,	O
who	O
presented	O
with	O
new	O
onset	O
of	O
left	B-problem
chest	I-problem
pain	I-problem
and	O
arm	B-problem
pain	I-problem
for	O
two	O
days	O
.	O

Apparently	O
,	O
patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
two	O
days	O
prior	O
to	O
admission	O
when	O
he	O
noted	O
new	O
onset	O
of	O
chest	B-problem
pain	I-problem
and	O
arm	B-problem
pain	I-problem
,	O
confined	O
to	O
his	O
left	O
side	O
.	O

The	B-problem
chest	I-problem
pain	I-problem
was	O
considered	O
mild	O
but	O
persistent	O
with	O
episodes	O
lasting	O
twenty	O
minutes	O
.	O

He	O
came	O
to	O
the	O
emergency	O
room	O
with	O
chest	B-problem
pain	I-problem
on	O
July	O
22	O
,	O
1994	O
,	O
relieved	O
with	O
sublingual	B-treatment
nitroglycerin	I-treatment
.	O

No	O
history	O
of	O
nausea	B-problem
and	O
vomiting	B-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

Denies	O
fevers	B-problem
,	O
pleuritic	B-problem
chest	I-problem
pain	I-problem
or	O
cough	B-problem
.	O

The	B-test
electrocardiogram	I-test
showed	O
pseudonormalization	B-problem
of	I-problem
T	I-problem
waves	I-problem
in	O
V1	O
through	O
V6	O
and	O
Q	B-problem
waves	I-problem
in	I-problem
V1	I-problem
through	O
V3	O
.	O

The	O
patient	O
&apos;s	O
past	O
cardiac	O
history	O
is	O
significant	O
for	O
an	B-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
in	O
September	O
of	O
1993	O
and	O
a	B-problem
non-Q	I-problem
wave	I-problem
myocardial	I-problem
infarction	I-problem
in	O
February	O
of	O
1993	O
.	O

The	O
patient	O
in	O
September	O
of	O
1993	O
had	O
3-4	B-problem
millimeter	I-problem
ST	I-problem
segment	I-problem
elevation	I-problem
in	I-problem
V1	I-problem
through	O
V4	O
and	O
depression	B-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
and	I-problem
AVF	I-problem
.	O

At	O
the	O
time	O
,	O
patient	O
had	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
as	O
well	O
and	O
patient	O
had	O
cardiac	B-test
catheterization	I-test
at	O
the	O
time	O
which	O
showed	O
95%	O
left	O
anterior	O
descending	O
,	O
which	O
was	O
percutaneous	O
transluminal	O
coronary	O
angioplastied	O
and	O
had	O
intra-aortic	B-treatment
balloon	I-treatment
pump	I-treatment
placement	I-treatment
.	O

He	O
had	O
a	B-test
CPK	I-test
of	O
over	O
5000	O
with	O
MB	B-test
fraction	I-test
of	O
26.7	O
.	O

The	B-test
echocardiogram	I-test
showed	O
a	B-test
44%	I-test
ejection	I-test
fraction	I-test
with	O
anterior	B-problem
akinesis	I-problem
and	O
septal	B-problem
hypokinesis	I-problem
.	O

He	O
had	O
a	B-problem
positive	I-problem
exercise	I-problem
tolerance	I-problem
test	I-problem
with	O
Thallium	O
and	O
repeat	B-test
cardiac	I-test
catheterization	I-test
showed	O
left	O
anterior	O
descending	O
being	O
patent	O
and	O
distal	B-problem
posterior	I-problem
descending	I-problem
artery	I-problem
lesion	I-problem
with	O
circumflex	B-problem
lesion	I-problem
after	I-problem
the	I-problem
obtuse	I-problem
marginal	I-problem
1	I-problem
.	O

In	O
February	O
of	O
1993	O
,	O
patient	O
again	O
presented	O
with	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
ruled	O
in	O
for	O
a	B-problem
non-Q	I-problem
wave	I-problem
myocardial	I-problem
infarction	I-problem
with	O
CPK	B-test
peak	I-test
of	O
219	O
and	O
MB	B-test
of	O
20.9	O
.	O

Repeat	B-test
cardiac	I-test
catheterization	I-test
showed	O
re-stenosis	B-problem
of	I-problem
proximal	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
that	O
had	O
been	O
percutaneous	O
transluminal	O
coronary	O
angioplastied	O
and	O
a	B-problem
lesion	I-problem
in	I-problem
the	I-problem
first	I-problem
obtuse	I-problem
marginal	I-problem
and	O
a	B-problem
moderate	I-problem
to	I-problem
severe	I-problem
left	I-problem
circumflex	I-problem
lesion	I-problem
after	O
the	O
third	O
obtuse	O
marginal	O
.	O

He	O
also	O
had	O
an	B-problem
akinetic	I-problem
anterolateral	I-problem
and	I-problem
apical	I-problem
ventricle	I-problem
.	O

CARDIAC	O
RISK	O
FACTORS	O
:	O

Again	O
,	O
patient	O
&apos;s	O
cardiac	O
risk	O
factors	O
include	O
hypertension	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
increasing	B-problem
cholesterol	I-problem
and	O
a	O
positive	O
family	O
history	O
and	O
tobacco	O
use	O
.	O

In	O
the	O
past	O
,	O
patient	O
had	O
been	O
noted	O
to	O
be	O
non-compliant	B-problem
with	O
cardiac	B-treatment
medications	I-treatment
and	O
continues	O
to	O
smoke	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
hypertension	B-problem
,	O
non-insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
diet-controlled	O
,	O
status	O
post	O
myocardial	B-problem
infarctions	I-problem
x	O
two	O
as	O
mentioned	O
above	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
status	O
post	O
appendectomy	B-treatment
.	O

Lower	B-problem
gastrointestinal	I-problem
bleed	I-problem
in	O
February	O
of	O
1993	O
which	O
was	O
not	O
worked	O
up	O
due	O
to	O
patient	O
deferment	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
penicillin	B-treatment
,	O
develops	O
a	B-problem
rash	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Metoprolol	B-treatment
50	O
mg	O
PO	O
b.i.d.	O
,	O
Isordil	B-treatment
20	O
mg	O
PO	O
t.i.d.	O
,	O
Ecotrin	B-treatment
aspirin	I-treatment
q.day	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
smokes	O
one	O
pack	O
per	O
day	O
.	O

He	O
used	O
to	O
be	O
a	O
heavy	O
drinker	O
in	O
the	O
past	O
,	O
no	O
drugs	O
.	O

The	O
patient	O
lives	O
in	O
Hou	O
with	O
wife	O
and	O
daughter	O
.	O

He	O
is	O
a	O
retired	O
taxi	O
driver	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
physical	I-test
examination	I-test
revealed	O
him	O
to	O
be	O
afebrile	B-problem
,	O
blood	B-test
pressure	I-test
of	O
130/80	O
with	O
a	B-test
pulse	I-test
rate	I-test
of	O
56	O
and	O
respirations	B-test
of	O
24	O
.	O

In	O
general	O
,	O
he	O
is	O
a	O
well	O
developed	O
,	O
well	O
nourished	O
man	O
breathing	O
easily	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Skin	O
:	O

multiple	B-problem
stigmata	I-problem
of	O
burns	B-problem
on	I-problem
the	I-problem
left	I-problem
arm	I-problem
and	I-problem
chest	I-problem
.	O

On	O
head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
,	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
fundus	O
was	O
sharp	O
,	O
oral	O
mucosa	O
was	O
clear	O
.	O

Neck	O
:	O

no	O
jugular	B-problem
venous	I-problem
distention	I-problem
at	O
five	O
centimeters	O
,	O
neck	O
was	O
supple	O
,	O
full	O
range	O
of	O
movement	O
,	O
no	O
bruits	B-problem
,	O
no	O
adenopathy	B-problem
.	O

Lungs	O
had	O
bibasilar	B-problem
rales	I-problem
1/4	O
of	O
the	O
way	O
up	O
bilaterally	O
,	O
otherwise	O
clear	O
.	O

Cardiovascular	O
exam	O
:	O

II	B-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
at	I-problem
left	I-problem
sternal	I-problem
border	I-problem
,	O
positive	O
S3	B-problem
,	O
question	O
of	O
S4	B-problem
,	O
otherwise	O
point	O
of	O
maximal	B-test
impulse	I-test
was	O
laterally	B-problem
displaced	I-problem
.	O

Abdomen	O
:	O

surgical	B-problem
midline	I-problem
incision	I-problem
and	O
previous	B-treatment
surgery	I-treatment
for	O
history	O
of	O
gastric	B-problem
ulcer	I-problem
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
mildly	B-problem
obese	I-problem
with	O
liver	O
edge	O
two	O
centimeters	O
below	O
the	O
right	O
costal	O
margin	O
.	O

Extremities	O
:	O

no	O
evidence	O
of	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

The	B-test
rectal	I-test
examination	I-test
was	O
trace	B-problem
guaiac	I-problem
positive	I-problem
.	O

The	O
patient	O
had	O
pulses	B-test
distally	I-test
,	O
1+	B-test
femorals	I-test
,	O
1+	B-test
dorsalis	I-test
pedis	I-test
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
otherwise	O
nonfocal	O
with	O
mentioned	O
left	O
upper	O
extremity	O
3/5	O
strength	O
with	O
pain	B-problem
and	O
5/5	O
on	O
the	O
left	O
lower	O
extremity	O
.	O

LABORATORY	O
DATA	O
:	O

Admission	B-test
hematocrit	I-test
44	O
,	O
BUN	B-test
and	O
creatinine	B-test
of	O
13	O
and	O
0.9	O
,	O
prothrombin	B-test
time	I-test
and	O
partial	B-test
thromboplastin	I-test
time	I-test
normal	O
.	O

The	O
patient	O
had	O
a	B-test
chest	I-test
X-ray	I-test
which	O
showed	O
mild	B-problem
pulmonary	I-problem
edema	I-problem
.	O

The	B-test
electrocardiogram	I-test
showed	O
Q	B-problem
waves	I-problem
in	I-problem
V1	I-problem
through	O
V6	O
,	O
T	B-problem
wave	I-problem
pseudonormalization	I-problem
in	I-problem
V1	I-problem
through	O
V6	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
rule	O
out	O
myocardial	B-problem
infarction	I-problem
.	O

The	O
patient	O
ruled	O
in	O
for	O
myocardial	B-problem
infarction	I-problem
with	O
CPK	B-test
maximum	O
on	O
hospital	O
day	O
number	O
one	O
peak	B-test
of	O
186	O
and	O
iso	B-test
of	O
23.8	O
and	O
index	B-test
of	O
12.8	O
on	O
September	O
2	O
,	O
1994	O
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
Dr.	O
Signs	O
for	O
Dr.	O
Churlaunt	O
of	O
Cardiology	O
.	O

The	O
patient	O
received	O
the	B-treatment
appropriate	I-treatment
protocol	I-treatment
for	O
myocardial	B-problem
infarction	I-problem
,	O
intravenous	B-treatment
heparin	I-treatment
,	O
aspirin	B-treatment
,	O
and	O
beta	B-treatment
blockers	I-treatment
for	O
rate	B-treatment
and	I-treatment
blood	I-treatment
pressure	I-treatment
control	I-treatment
.	O

The	O
patient	O
on	O
the	O
date	O
of	O
September	O
5	O
,	O
1994	O
had	O
cardiac	B-test
catheterization	I-test
which	O
showed	O
normal	O
resting	O
hemodynamics	O
.	O

The	O
patient	O
has	O
a	O
small	O
non-dominant	O
right	O
coronary	O
artery	O
,	O
left	O
anterior	O
descending	O
showed	O
severe	B-problem
proximal	I-problem
lesion	I-problem
with	O
more	B-problem
distal	I-problem
lesions	I-problem
of	I-problem
diagonal	I-problem
one	I-problem
.	O

The	O
left	O
circumflex	O
was	O
dominant	O
with	O
severe	B-problem
disease	I-problem
of	I-problem
obtuse	I-problem
marginal	I-problem
one	I-problem
,	O
with	O
moderate	B-problem
mid-circumflex	I-problem
stenosis	I-problem
and	O
moderate	B-problem
posterior	I-problem
descending	I-problem
artery	I-problem
lesion	I-problem
.	O

The	B-test
left	I-test
ventriculography	I-test
shows	O
anterior	B-problem
akinesis	I-problem
and	O
apical	B-problem
severe	I-problem
hypokinesis	I-problem
with	O
a	B-problem
moderately	I-problem
depressed	I-problem
ejection	I-problem
fraction	I-problem
,	O
cardiac	B-test
output	I-test
of	O
3.9	O
,	O
index	B-test
of	O
2.0	O
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
Cardiac	O
Surgery	O
for	O
evaluation	B-test
of	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

The	O
patient	O
had	O
stable	B-test
hematocrit	I-test
of	O
38%	O
on	O
intravenous	B-treatment
heparin	I-treatment
.	O

The	B-test
carotid	I-test
noninvasives	I-test
preoperatively	O
were	O
negative	O
.	O

Dental	B-test
consult	I-test
was	O
negative	O
.	O

On	O
the	O
date	O
of	O
September	O
11	O
,	O
1994	O
,	O
patient	O
underwent	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
with	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
posterior	I-treatment
descending	I-treatment
artery	I-treatment
,	O
circumflex	B-treatment
and	I-treatment
diagonal	I-treatment
and	I-treatment
left	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
to	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
.	O

The	O
patient	O
had	O
a	O
bypass	O
time	O
of	O
one	O
hour	O
and	O
fifty	O
minutes	O
with	O
good	O
urine	O
output	O
and	O
pre-bypass	B-test
cardiac	I-test
output	I-test
of	O
4.0	O
,	O
post-chest	B-test
closure	I-test
5.3	O
,	O
arrived	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
on	O
Nipride	B-treatment
,	O
Lidocaine	B-treatment
of	O
1	O
and	O
Fentanyl/	B-treatment
Versed	B-treatment
of	O
10	O
.	O

The	B-test
postoperative	I-test
hematocrit	I-test
was	O
26%	O
.	O

The	O
patient	O
had	O
a	O
routine	O
postoperative	O
course	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
with	O
a	B-test
postoperative	I-test
BUN	I-test
and	O
creatinine	B-test
of	O
11	O
and	O
1.2	O
with	O
good	O
urine	O
output	O
of	O
over	O
100	O
an	O
hour	O
and	O
patient	O
received	O
two	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
and	O
platelets	B-treatment
for	O
increasing	B-problem
chest	I-problem
tube	I-problem
drainage	I-problem
.	O

The	O
patient	O
on	O
the	O
date	O
of	O
postoperative	O
day	O
number	O
one	O
,	O
September	O
13	O
,	O
1994	O
,	O
was	O
transferred	O
from	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
up	O
to	O
the	O
FIH	O
18	O
floor	O
.	O

The	O
patient	O
&apos;s	O
only	O
post-Surgical	O
Intensive	O
Care	O
Unit	O
course	O
was	O
remarkable	O
for	O
hypertension	B-problem
requiring	O
Nipride	B-treatment
and	O
bleeding	B-problem
which	O
was	O
controlled	O
with	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
,	O
platelets	B-treatment
.	O

The	O
patient	O
had	O
a	B-test
stable	I-test
hematocrit	I-test
of	O
30%	O
with	O
CPK	B-test
&apos;s	I-test
postoperatively	O
maximum	B-test
MB	I-test
fraction	I-test
of	O
78	O
.	O

On	O
postoperative	O
day	O
number	O
three	O
,	O
patient	O
went	O
into	O
atrial	B-problem
fibrillation	I-problem
,	O
which	O
was	O
treated	O
appropriately	O
with	O
metoprolol	B-treatment
and	O
digoxin	B-treatment
and	O
converted	O
back	O
to	O
sinus	O
rhythm	O
.	O

The	O
patient	O
continued	O
to	O
need	O
diuresis	B-treatment
.	O

The	B-treatment
postoperative	I-treatment
medications	I-treatment
up	O
on	O
FIH	O
were	O
Coumadin	B-treatment
,	O
baby	B-treatment
aspirin	I-treatment
,	O
Isordil	B-treatment
10	O
PO	O
t.i.d.	O
,	O
Digoxin	B-treatment
.25	O
q.day	O
,	O
metoprolol	B-treatment
25	O
PO	O
b.i.d.	O
______________	O

Chest	B-treatment
tubes	I-treatment
and	O
wires	B-treatment
were	O
all	O
discontinued	O
according	O
to	O
protocol	B-treatment
on	O
postoperative	O
day	O
number	O
four	O
.	O

The	B-treatment
Isordil	I-treatment
was	O
also	O
discontinued	O
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
incisions	I-problem
sternal	O
and	O
right	O
leg	O
were	O
clean	O
and	O
healing	O
well	O
,	O
normal	O
sinus	O
rhythm	O
at	O
70-80	O
,	O
with	O
blood	B-test
pressure	I-test
98-110/60	O
and	O
patient	O
was	O
doing	O
well	O
,	O
recovering	O
,	O
ambulating	O
,	O
tolerating	O
regular	O
diet	O
and	O
last	B-test
hematocrit	I-test
prior	O
to	O
discharge	O
was	O
39%	O
with	O
a	B-test
BUN	I-test
and	O
creatinine	B-test
of	O
15	O
and	O
1.0	O
,	O
prothrombin	B-test
time	I-test
level	I-test
of	O
13.8	O
,	O
chest	B-test
X-ray	I-test
prior	O
to	O
discharge	O
showed	O
small	B-problem
bilateral	I-problem
effusions	I-problem
with	O
mild	B-problem
cardiomegaly	I-problem
and	O
subsegmental	B-problem
atelectasis	I-problem
bibasilar	I-problem
and	O
electrocardiogram	B-test
showed	O
normal	O
sinus	O
rhythm	O
with	O
left	B-problem
atrial	I-problem
enlargement	I-problem
and	O
no	O
acute	B-problem
ischemic	I-problem
changes	I-problem
on	O
electrocardiogram	B-test
.	O

Note	O
:	O

patient	O
needs	O
anticoagulation	B-treatment
for	O
large	B-treatment
saphenous	I-treatment
vein	I-treatment
graft	I-treatment
to	O
prevent	O
any	O
possibility	O
of	O
thrombosis	B-problem
.	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
and	O
will	O
follow	O
up	O
with	O
his	O
cardiologist	O
and	O
will	O
follow	O
up	O
with	O
Dr.	O
Hemp	O
and	O
Dr.	O
Signs	O
.	O

A	O
NECESSARY	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

G	O
HEMP	O
,	O
M.D.	O

TR	O
:	O

ee	O
/	O
bmot	O

DD	O
:	O

9-18-94	O
PAD-WORD	O

TD	O
:	O

09/19/94	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Signs	O

﻿Admission	O
Date	O
:	O

2010-07-15	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-07-18	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1978-01-25	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

KULAND	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
32-year-old	O
white	O
female	O
with	O
history	O
of	O
diabetes	B-problem
type	I-problem
1	I-problem
and	O
migraines	B-problem
who	O
presented	O
with	O
complaints	O
of	O
nausea	B-problem
,	O
diarrhea	B-problem
and	O
vomiting	B-problem
for	O
24	O
hours	O
.	O

Patient	O
states	O
she	O
was	O
unable	O
to	O
take	O
her	B-treatment
usual	I-treatment
insulin	I-treatment
regimen	I-treatment
because	O
she	O
was	O
vomiting	B-problem
.	O

The	O
patient	O
denied	O
any	O
fevers	B-problem
,	O
chills	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
or	O
dysuria	B-problem
but	O
does	O
state	O
she	O
had	O
her	B-problem
usual	I-problem
migraine	I-problem
headache	I-problem
the	O
night	O
prior	O
to	O
admission	O
.	O

The	B-test
patient	I-test
's	I-test
arterial	I-test
blood	I-test
gases	I-test
in	O
the	O
Emergency	O
Department	O
were	O
7.19	O
,	O
22	O
and	O
109	O
with	O
a	B-test
bicarbonate	I-test
of	O
9	O
and	O
a	B-test
fingerstick	I-test
of	O
greater	O
than	O
500	O
.	O

Patient	O
was	O
given	O
two	B-treatment
boluses	I-treatment
of	I-treatment
15	I-treatment
units	I-treatment
of	I-treatment
regular	I-treatment
insulin	I-treatment
and	O
was	O
started	O
on	O
an	B-treatment
insulin	I-treatment
drip	I-treatment
of	O
one	O
unit	O
per	O
hour	O
and	O
given	O
a	B-treatment
total	I-treatment
of	I-treatment
five	I-treatment
liters	I-treatment
of	I-treatment
normal	I-treatment
saline	I-treatment
.	O

Her	B-test
fingersticks	I-test
decreased	O
with	O
the	B-treatment
insulin	I-treatment
drip	I-treatment
and	O
the	B-treatment
intravenous	I-treatment
fluids	I-treatment
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Intensive	O
Care	O
Unit	O
for	O
an	B-treatment
insulin	I-treatment
drip	I-treatment
and	O
frequent	B-test
blood	I-test
sugar	I-test
monitoring	I-test
and	O
Chem-7	B-test
monitoring	I-test
.	O

The	O
patient	O
did	O
well	O
overnight	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
.	O

Her	B-test
anion	I-test
gap	I-test
closed	O
and	O
her	B-test
fingersticks	I-test
were	O
less	O
than	O
200	O
.	O

Her	B-treatment
NPH	I-treatment
and	O
a	B-treatment
regular	I-treatment
sliding	I-treatment
scale	I-treatment
were	O
started	O
and	O
her	B-treatment
drip	I-treatment
was	O
discontinued	O
.	O

The	O
patient	O
denied	O
any	B-problem
more	I-problem
gastrointestinal	I-problem
symptoms	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
diabetes	B-problem
,	O
diagnosed	O
at	O
age	O
14	O
.	O

Multiple	O
episodes	O
of	O
diabetic	B-problem
ketoacidosis	I-problem
in	O
the	O
past	O
,	O
migraine	B-problem
headaches	I-problem
and	O
attention	B-problem
deficit	I-problem
disorder	I-problem
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Included	O
Wellbutrin	B-treatment
,	O
Imitrex	B-treatment
,	O
Tylenol	B-treatment
,	O
Humalog	B-treatment
sliding	I-treatment
scale	I-treatment
and	O
NPH	B-treatment
insulin	I-treatment
two	O
units	O
in	O
the	O
morning	O
,	O
7	O
units	O
at	O
noon	O
and	O
13	O
units	O
at	O
bedtime	O
.	O

ALLERGIES	O
:	O

Patient	O
has	O
allergies	B-problem
to	O
penicillin	B-treatment
.	O

She	O
gets	O
hives	B-problem
.	O

Bactrim	B-treatment
,	O
she	O
gets	O
hives	B-problem
.	O

Percocet	B-treatment
and	O
erythromycin	B-treatment
,	O
she	O
gets	O
gastrointestinal	B-problem
upset	I-problem
and	O
Keflex	B-treatment
she	O
gets	O
hives	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
mother	O
and	O
father	O
.	O

She	O
had	O
a	O
recent	O
pregnancy	O
with	O
a	O
five	O
month	O
stay	O
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
.	O

Patient	O
had	O
a	B-treatment
cesarean	I-treatment
section	I-treatment
at	O
eight	O
months	O
.	O

The	O
baby	O
is	O
now	O
healthy	O
,	O
about	O
four	O
months	O
old	O
.	O

Tobacco	O
history	O
,	O
three	O
cigarettes	O
a	O
week	O
.	O

Denies	O
alcohol	O
or	O
drugs	O
.	O

FAMILY	O
HISTORY	O
:	O

Hypertension	B-problem
.	O

PHYSICAL	O
EXAM	O
ON	O
ADMISSION	O
:	O

Includes	O
a	B-test
temperature	I-test
of	O
99.9	O
.	O

Pulse	B-test
of	O
94	O
.	O

Blood	B-test
pressure	I-test
of	O
138/49	O
.	O

Patient	O
was	O
generally	B-problem
ill-appearing	I-problem
and	O
nauseated	B-problem
,	O
but	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
exam	O
:	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Oropharynx	O
clear	O
.	O

Dry	O
mucous	O
membranes	O
.	O

Neck	O
supple	O
,	O
no	O
lymphadenopathy	B-problem
.	O

Chest	O
clear	O
to	O
auscultation	B-test
.	O

Heart	O
regular	O
.	O

Abdomen	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
:	O

No	O
edema	B-problem
.	O

Neurological	B-test
exam	I-test
:	O

Alert	O
and	O
oriented	O
times	O
three	O
.	O

Cranial	B-test
nerves	I-test
II	I-test
through	I-test
XII	I-test
are	O
intact	O
,	O
nonfocal	O
,	O
moving	O
all	O
extremities	O
.	O

LABORATORY	O
ON	O
ADMISSION	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
of	O
22.8	O
,	O
hematocrit	B-test
of	O
42.1	O
.	O

Sodium	B-test
of	O
136	O
,	O
chloride	B-test
96	O
,	O
bicarbonate	B-test
8	O
,	O
BUN	B-test
25	O
,	O
creatinine	B-test
1.2	O
,	O
glucose	B-test
720	O
.	O

Arterial	B-test
blood	I-test
gases	I-test
showed	O
a	B-test
pH	I-test
of	O
7.19	O
,	O
pCO2	B-test
of	O
22	O
and	O
PO2	B-test
of	O
102	O
and	O
a	B-test
potassium	I-test
of	O
3.9	O
.	O

Chest	B-test
x-ray	I-test
was	O
negative	O
for	O
infiltrate	B-problem
.	O

Electrocardiogram	B-test
was	O
normal	O
sinus	O
rhythm	O
with	O
a	B-problem
T	I-problem
wave	I-problem
inversion	I-problem
in	I-problem
V2	I-problem
,	O
but	O
no	O
ST	B-problem
segment	I-problem
elevations	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

As	O
above	O
,	O
and	O
once	O
transferred	O
to	O
the	O
floor	O
,	O
patient	O
had	O
fingersticks	B-test
monitored	O
every	O
four	O
hours	O
with	O
a	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

Patient	O
reached	O
goal	O
of	O
fingersticks	B-test
between	O
50	O
and	O
300	O
,	O
which	O
is	O
what	O
she	O
maintains	O
at	O
home	O
.	O

Sliding	B-treatment
scale	I-treatment
was	O
adjusted	O
as	O
necessary	O
.	O

Patient	O
was	O
continued	O
on	O
intravenous	B-treatment
fluids	I-treatment
until	O
taking	O
good	O
po	O
.	O

Infectious	O
Disease	O
:	O

The	O
patient	O
had	O
an	B-problem
elevated	I-problem
white	I-problem
count	I-problem
upon	O
admission	O
,	O
however	O
,	O
white	B-test
count	I-test
came	O
down	O
to	O
7.1	O
and	O
prior	O
to	O
discharge	O
,	O
patient	O
was	O
afebrile	B-problem
and	O
no	O
clear	O
etiology	O
for	O
elevated	B-problem
white	I-problem
blood	I-problem
cell	I-problem
on	O
admission	O
,	O
questionably	O
secondary	O
to	O
short	B-problem
gastrointestinal	I-problem
infection	I-problem
,	O
however	O
,	O
patient	O
is	O
completely	O
symptom	O
free	O
upon	O
discharge	O
.	O

Fluid	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	B-test
patient	I-test
's	I-test
electrolytes	I-test
were	O
repleted	O
as	O
necessary	O
.	O

Potassium	B-treatment
was	O
given	O
with	O
her	B-treatment
intravenous	I-treatment
fluids	I-treatment
and	O
phosphate	B-treatment
will	O
be	O
repleted	O
as	O
patient	O
increases	O
her	O
po	O
intake	O
.	O

CONDITION	O
OF	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Diabetic	B-problem
ketoacidosis	I-problem
.	O

2.	O
Viral	B-problem
gastroenteritis	I-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Includes	O
her	B-treatment
regular	I-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
and	O
her	B-treatment
NPH	I-treatment
fixed	O
scale	O
of	O
7	O
units	O
in	O
the	O
morning	O
,	O
2	O
units	O
at	O
noon	O
and	O
13	O
units	O
at	O
bedtime	O
.	O

Patient	O
was	O
instructed	O
to	O
decrease	O
her	B-treatment
evening	I-treatment
dose	I-treatment
if	O
she	O
does	O
not	O
continue	O
to	O
take	O
good	O
po	O
.	O

Patient	O
will	O
also	O
continue	O
on	O
her	B-treatment
Wellbutrin	I-treatment
and	O
Imitrex	B-treatment
as	O
needed	O
for	O
migraines	B-problem
.	O

FOLLOW-UP	O
PLANS	O
:	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
her	O
endocrinologist	O
at	O
the	O
Mahoney	O
,	O
as	O
well	O
as	O
her	O
primary	O
care	O
physician	O
.	O

Diane	O
Sands	O
,	O
M.D.	O

11-089	O
PAD-WORD	O

Dictated	O
By	O
:	O
Pamela	O
F.	O
Williams	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2010-07-20	O
21:01	O

T	O
:	O
2010-07-20	O
21:01	O

JOB	O
#:	O

65230	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Timothy	O
Clemons	O
on	O
:	O
MON	O
2010-07-26	O
11:01	O
AM	O

(	O
End	O
of	O
Report	O
)	O

559197012_b	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4469096	O
PAD-WORD	O

64024/p16e	O
PAD-WORD	O

909222	O
PAD-WORD	O

10/24/1993	O
12:00:00	O
AM	O

NON-Q	B-problem
WAVE	I-problem
MYOCARDIAL	I-problem
INFARCTION	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10-24-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

11-2-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Non-Q	B-problem
wave	I-problem
myocardial	I-problem
infarction	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Status	O
post	O
anterior	B-problem
myocardial	I-problem
infarction	I-problem
in	O
05-93	O
,	O
status	O
post	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
of	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
in	O
05-93	O
,	O
hypertension	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Coronary	B-treatment
angiography	I-treatment
,	O
exercise	B-test
tolerance	I-test
test	I-test
with	I-test
Thallium	I-test
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Metoprolol	B-treatment
50	O
mg	O
PO	O
bid	O
,	O
Isordil	B-treatment
20	O
mg	O
PO	O
tid	O
,	O
enteric	B-treatment
coated	I-treatment
aspirin	I-treatment
1	O
PO	O
qd	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65	O
year	O
old	O
Portuguese	O
male	O
with	O
a	O
history	O
of	O
an	B-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
i	O
May	O
1993	O
and	O
is	O
status	O
post	O
a	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
of	I-treatment
the	I-treatment
LAD	I-treatment
who	O
presented	O
on	O
10-24-93	O
with	O
crushing	B-problem
substernal	I-problem
chest	I-problem
pain	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

He	O
had	O
no	O
prior	O
cardiac	O
history	O
until	O
May	O
1993	O
when	O
on	O
5-24	O
he	O
had	O
crushing	B-problem
chest	I-problem
pain	I-problem
which	O
radiated	O
to	O
his	O
left	O
arm	O
.	O

He	O
was	O
found	O
at	O
that	O
time	O
to	O
have	O
3-4	B-problem
mm	I-problem
ST	I-problem
segment	I-problem
elevations	I-problem
in	I-problem
V1	I-problem
through	O
V4	O
at	O
Pre	O
Health	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
and	O
had	O
4-7	B-problem
mm	I-problem
ST	I-problem
segment	I-problem
elevations	I-problem
across	I-problem
the	I-problem
precordium	I-problem
with	O
Q&apos;s	B-problem
in	I-problem
V1	I-problem
and	I-problem
V2	I-problem
,	O
2	B-problem
mm	I-problem
ST	I-problem
elevation	I-problem
in	I-problem
AVL	I-problem
,	O
and	O
1-2	B-problem
mm	I-problem
reciprocal	I-problem
ST	I-problem
depression	I-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
and	I-problem
F.	I-problem

On	O
physical	B-test
examination	I-test
at	O
that	O
time	O
he	O
had	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
and	O
therefore	O
lysis	B-treatment
was	O
deferred	O
and	O
he	O
was	O
taken	O
directly	O
to	O
the	O
cardiac	O
catheterization	O
lab	O
.	O

The	O
cardiac	O
catheterization	O
results	O
at	O
that	O
time	O
revealed	O
a	B-test
right	I-test
atrial	I-test
pressure	I-test
of	O
7	O
,	O
pulmonary	B-test
artery	I-test
pressure	I-test
of	O
29/16	O
,	O
RV	B-test
33/8	O
,	O
pulmonary	B-test
capillary	I-test
wedge	I-test
pressure	I-test
of	O
16	O
.	O

He	O
had	O
a	B-problem
95%	I-problem
proximal	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
lesion	I-problem
which	O
was	O
PTCA	O
&apos;d	O
to	O
a	O
residual	O
of	O
30%	O
and	O
an	B-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
was	O
placed	O
.	O

He	O
also	O
had	O
some	B-problem
mild	I-problem
to	I-problem
moderate	I-problem
disease	I-problem
at	O
the	O
OM1	O
noted	O
at	O
that	O
time	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Cardiac	O
Care	O
Unit	O
where	O
he	O
had	O
a	B-test
peak	I-test
CPK	I-test
of	O
5,042	O
and	O
26.7%	O
MB&apos;s	B-test
.	O

His	B-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
was	O
weaned	O
without	O
problems	B-problem
.	O

He	O
had	O
hypotension	B-problem
with	O
beta	B-treatment
blockers	I-treatment
and	O
therefore	O
they	O
were	O
not	O
started	O
.	O

On	O
day	O
six	O
,	O
an	B-test
echocardiogram	I-test
showed	O
an	B-test
ejection	I-test
fraction	I-test
of	O
44%	O
with	O
anterior	B-problem
akinesis	I-problem
and	O
septal	B-problem
hypokinesis	I-problem
.	O

On	O
day	O
nine	O
,	O
he	O
had	O
a	B-test
low	I-test
level	I-test
exercise	I-test
tolerance	I-test
test	I-test
with	I-test
Thallium	I-test
which	O
was	O
positive	O
for	O
2.5	B-problem
mm	I-problem
horizontal	I-problem
depressions	I-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
and	I-problem
AVF	I-problem
,	O
and	O
1.5	B-problem
mm	I-problem
downsloping	I-problem
ST	I-problem
depressions	I-problem
in	I-problem
V5	I-problem
and	I-problem
V6	I-problem
,	O
as	O
well	O
as	O
some	B-problem
anteroseptal	I-problem
redistribution	I-problem
on	O
Thallium	B-treatment
.	O

Therefore	O
,	O
he	O
went	O
to	O
repeat	B-test
cardiac	I-test
catheterization	I-test
which	O
revealed	O
that	O
the	O
left	O
anterior	O
descending	O
site	O
was	O
patent	O
and	O
revealed	O
a	B-problem
distal	I-problem
PDA	I-problem
lesion	I-problem
and	O
a	B-problem
circumflex	I-problem
lesion	I-problem
after	O
the	O
OM	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
and	O
is	O
supposed	O
to	O
follow	O
up	O
with	O
Dr.	O
Shuffburle	O
of	O
Gastroenterology	O
for	O
work	B-test
up	I-test
of	O
his	B-problem
bright	I-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
and	O
is	O
supposed	O
to	O
follow	O
up	O
with	O
Dr.	O
Amesin	O
of	O
Cardiology	O
and	O
Dr.	O
Shuffpasc	O
of	O
Dingclearf	O
Alllirefaith	O
Memorial	O
Hospital	O
.	O

However	O
,	O
he	O
did	O
not	O
keep	O
any	O
of	O
these	O
appointments	O
.	O

He	O
went	O
home	O
and	O
did	O
not	O
take	O
any	O
of	O
his	B-treatment
medications	I-treatment
and	O
smoked	O
and	O
drank	O
heavily	O
throughout	O
the	O
several	O
months	O
.	O

On	O
the	O
a.m.	O
of	O
10-24-93	O
,	O
the	O
patient	O
developed	O
crushing	B-problem
substernal	I-problem
chest	I-problem
pain	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

He	O
came	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
Emergency	O
Ward	O
where	O
he	O
was	O
noted	O
to	O
be	O
ashen	B-problem
and	O
diaphoretic	B-problem
.	O

He	O
was	O
treated	O
with	O
oxygen	B-treatment
,	O
aspirin	B-treatment
,	O
five	B-treatment
sublingual	I-treatment
nitroglycerins	I-treatment
,	O
heparin	B-treatment
,	O
and	O
was	O
eventually	O
made	O
pain	O
free	O
with	O
that	B-treatment
regimen	I-treatment
.	O

CARDIAC	O
RISK	O
FACTORS	O
:	O

His	O
cardiac	O
risk	O
factors	O
included	O
hypertension	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
hypercholesterolemia	B-problem
,	O
cigarette	O
smoking	O
,	O
and	O
a	O
positive	O
family	O
history	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

His	O
past	O
medical	O
history	O
included	O
hypertension	B-problem
and	O
non-insulin	B-problem
diabetes	I-problem
mellitus	I-problem
which	O
is	O
diet	O
controlled	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

His	O
past	O
surgical	O
history	O
had	O
included	O
gastric	B-treatment
ulcer	I-treatment
surgery	I-treatment
and	O
appendectomy	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

On	O
admission	O
,	O
he	O
was	O
on	O
Isordil	B-treatment
10	O
tid	O
and	O
enteric	B-treatment
coated	I-treatment
aspirin	I-treatment
,	O
but	O
he	O
was	O
not	O
taking	O
either	O
of	O
these	B-treatment
medications	I-treatment
.	O

HABITS	O
:	O

The	O
patient	O
smokes	O
one	O
pack	O
per	O
day	O
and	O
has	O
a	O
history	O
of	O
heavy	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
physical	I-test
examination	I-test
on	I-test
admission	I-test
revealed	O
a	B-test
blood	I-test
pressure	I-test
of	O
110/70	O
,	O
a	B-test
heart	I-test
rate	I-test
of	O
66	O
,	O
respirations	B-test
of	O
24	O
,	O
temperature	B-test
of	O
98	O
.	O

The	B-test
HEENT	I-test
exam	I-test
revealed	O
the	O
extra	O
ocular	O
movements	O
intact	O
.	O

The	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
.	O

The	O
oropharynx	O
was	O
clear	O
and	O
the	O
fundi	O
were	O
normal	O
.	O

There	O
were	O
no	O
hypertensive	B-problem
or	I-problem
diabetic	I-problem
changes	I-problem
.	O

The	O
neck	O
was	O
suppled	O
,	O
with	O
no	O
lymphadenopathy	B-problem
and	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

The	B-test
carotids	I-test
were	O
1+	O
without	O
bruits	B-problem
.	O

The	O
heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
S4	O
,	O
S1	O
,	O
S2	O
,	O
with	O
a	B-problem
I	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
left	I-problem
lower	I-problem
sternal	I-problem
border	I-problem
.	O

The	O
lungs	O
were	O
clear	O
,	O
except	O
for	O
a	B-problem
few	I-problem
dry	I-problem
crackles	I-problem
bibasilarly	I-problem
.	O

The	O
abdomen	O
revealed	O
a	B-problem
midline	I-problem
scar	I-problem
and	O
a	B-problem
right	I-problem
lower	I-problem
quadrant	I-problem
scar	I-problem
,	O
and	O
it	O
was	O
soft	O
and	O
nontender	B-problem
wit	O
positive	O
bowel	O
sounds	O
.	O

The	O
liver	O
edge	O
was	O
2	O
cm	O
below	O
the	O
right	O
costal	O
margin	O
,	O
but	O
smooth	O
and	O
nontender	B-problem
.	O

There	O
was	O
no	O
splenomegaly	B-problem
.	O

The	B-test
femoral	I-test
pulses	I-test
were	O
diminished	B-problem
.	O

He	O
had	O
bilateral	B-problem
intertrigo	I-problem
in	I-problem
his	I-problem
femoral	I-problem
region	I-problem
as	O
well	O
as	O
his	O
axillae	O
.	O

The	O
extremities	O
revealed	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

The	B-test
pulses	I-test
were	O
1+	O
bilaterally	O
.	O

The	B-test
skin	I-test
exam	I-test
revealed	O
changes	O
consistent	O
with	O
vitiligo	B-problem
.	O

The	B-test
rectal	I-test
examination	I-test
was	O
guaiac	B-test
negative	O
.	O

LABORATORY	O
DATA	O
:	O

The	O
laboratory	O
data	O
revealed	O
normal	O
electrolytes	O
,	O
BUN	O
and	O
creatinine	O
,	O
normal	O
liver	O
function	O
tests	O
,	O
a	B-test
first	I-test
CPK	I-test
of	O
140	O
,	O
and	O
a	B-test
hematocrit	I-test
of	O
43.1	O
.	O

The	B-test
portable	I-test
chest	I-test
X-ray	I-test
showed	O
clear	O
lungs	O
,	O
slight	B-problem
enlarged	I-problem
heart	I-problem
,	O
and	O
a	B-problem
mildly	I-problem
elevated	I-problem
hemidiaphragm	I-problem
.	O

The	B-test
electrocardiogram	I-test
was	O
normal	O
sinus	O
rhythm	O
at	O
81	O
,	O
with	O
normal	O
intervals	O
and	O
normal	O
axis	O
,	O
had	O
poor	B-problem
R-wave	I-problem
progression	I-problem
consistent	O
with	O
an	B-problem
old	I-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
,	O
had	O
flipped	B-problem
T-waves	I-problem
in	I-problem
V1	I-problem
through	O
V5	O
,	O
which	O
were	O
of	O
no	O
significant	B-problem
change	I-problem
since	O
his	B-test
last	I-test
EKG	I-test
on	O
5-25-93	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Step	O
Down	O
Unit	O
for	O
a	O
rule	O
out	O
MI	B-treatment
protocol	I-treatment
.	O

He	O
was	O
treated	O
with	O
aspirin	B-treatment
,	O
heparin	B-treatment
,	O
and	O
intravenous	B-treatment
nitroglycerin	I-treatment
.	O

No	O
beta	B-treatment
blockers	I-treatment
was	O
started	O
because	O
of	O
his	O
history	O
of	O
hypertension	B-problem
with	O
beta	B-treatment
blockers	I-treatment
and	O
because	O
his	B-test
blood	I-test
pressure	I-test
of	O
only	O
110/70	O
.	O

The	O
patient	O
ruled	O
in	O
for	O
myocardial	B-problem
infarction	I-problem
with	O
a	B-test
peak	I-test
CPK	I-test
of	O
219	O
and	O
20.9%	B-test
MB	I-test
fraction	I-test
.	O

This	O
was	O
a	B-problem
non-Q	I-problem
wave	I-problem
myocardial	I-problem
infarction	I-problem
as	O
there	O
were	O
no	O
diagnostic	B-problem
electrocardiogram	I-problem
changes	I-problem
.	O

on	O
10-27-93	O
,	O
the	O
patient	O
went	O
to	O
the	O
cath	O
lab	O
which	O
revealed	O
a	O
small	O
nondominant	O
right	O
coronary	O
artery	O
without	O
any	B-problem
lesions	I-problem
,	O
a	B-problem
restenosis	I-problem
of	I-problem
the	I-problem
proximal	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
lesion	I-problem
that	O
had	O
been	O
PTCA	B-treatment
&apos;d	I-treatment
,	O
a	B-problem
lesion	I-problem
in	I-problem
the	I-problem
first	I-problem
OM	I-problem
,	O
and	O
a	B-problem
moderately	I-problem
severe	I-problem
left	I-problem
circumflex	I-problem
lesion	I-problem
after	I-problem
the	I-problem
OM3	I-problem
.	O

The	B-test
left	I-test
ventriculogram	I-test
revealed	O
an	B-problem
akinetic	I-problem
anterolateral	I-problem
and	I-problem
apical	I-problem
ventricle	I-problem
.	O

Given	O
the	O
results	O
of	O
this	B-test
cardiac	I-test
catheterization	I-test
,	O
which	O
were	O
not	O
significantly	O
changed	O
from	O
his	B-test
previous	I-test
cardiac	I-test
catheterization	I-test
prior	O
to	O
the	B-treatment
PTCA	I-treatment
,	O
it	O
was	O
elected	O
to	O
attempt	O
to	O
medically	O
manage	O
the	O
patient	O
.	O

He	O
was	O
ambulated	O
progressively	O
on	O
the	O
floor	O
.	O

A	B-treatment
beta	I-treatment
blocker	I-treatment
was	O
started	O
with	O
Metoprolol	B-treatment
initially	O
at	O
25	O
mg	O
PO	O
bid	O
and	O
eventually	O
increased	O
to	O
50	O
mg	O
PO	O
bid	O
.	O

The	O
patient	O
ambulated	O
extensively	O
on	O
the	O
FIH	O
20	O
floor	O
each	O
day	O
without	O
any	O
episodes	O
of	O
chest	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

On	O
11-2-93	O
,	O
the	O
patient	O
underwent	O
a	B-test
low	I-test
level	I-test
treadmill	I-test
exercise	I-test
test	I-test
with	O
Thallium	B-test
imaging	I-test
.	O

This	B-test
treadmill	I-test
test	I-test
was	O
done	O
on	O
medications	B-treatment
,	O
including	O
beta	B-treatment
blockers	I-treatment
,	O
in	O
hopes	O
to	O
assess	O
an	O
amount	O
of	O
ischemia	B-problem
on	O
treatment	B-treatment
.	O

The	O
patient	O
was	O
able	O
to	O
exercise	O
for	O
approximately	O
nine	O
minutes	O
on	O
a	B-treatment
modified	I-treatment
Bruce	I-treatment
protocol	I-treatment
,	O
however	O
,	O
he	O
did	O
not	O
reach	O
his	O
predicted	O
maximal	O
heart	O
rate	O
while	O
he	O
was	O
on	O
the	B-treatment
beta	I-treatment
blockade	I-treatment
.	O

There	O
were	O
no	O
diagnostic	B-problem
electrocardiogram	I-problem
changes	I-problem
during	O
the	B-test
treadmill	I-test
exercise	I-test
test	I-test
,	O
although	O
he	O
did	O
have	O
0.5	B-problem
to	I-problem
1	I-problem
mm	I-problem
ST	I-problem
depression	I-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
and	I-problem
AVF	I-problem
.	O

The	B-test
study	I-test
was	O
halted	O
for	O
shortness	B-problem
of	I-problem
breath	I-problem
and	O
there	O
was	O
no	O
chest	B-problem
pain	I-problem
.	O

Thallium	B-test
images	I-test
revealed	O
a	B-problem
moderate	I-problem
sized	I-problem
region	I-problem
of	I-problem
ischemic	I-problem
but	I-problem
viable	I-problem
myocardium	I-problem
involving	O
the	O
anteroseptal	O
and	O
lateral	O
segments	O
of	O
the	O
left	O
ventricle	O
.	O

There	O
was	O
also	O
some	O
evidence	O
of	O
left	B-problem
ventricular	I-problem
dysfunction	I-problem
during	O
the	B-test
test	I-test
.	O

These	B-test
images	I-test
were	O
essentially	O
unchanged	O
compared	O
with	O
the	B-test
previous	I-test
Thallium	I-test
images	I-test
in	O
May	O
1993	O
.	O

After	O
extensive	O
discussion	O
between	O
myself	O
,	O
Dr.	O
Amesin	O
,	O
and	O
Dr.	O
Scgach	O
,	O
it	O
was	O
elected	O
to	O
discharge	O
the	O
patient	O
to	O
home	O
with	O
medical	B-treatment
management	I-treatment
.	O

The	O
patient	O
was	O
extremely	O
reluctant	O
to	O
undergo	O
surgery	B-treatment
,	O
although	O
he	O
understands	O
that	O
this	O
may	O
become	O
necessary	O
in	O
the	O
future	O
.	O

Dr.	O
Amesin	O
had	O
a	O
long	O
discussion	O
with	O
the	O
patient	O
&apos;s	O
daughters	O
revolving	O
primarily	O
around	O
issues	O
of	O
the	O
patient	O
&apos;s	O
compliance	O
.	O

Previously	O
he	O
had	O
not	O
taken	O
any	O
of	O
his	B-treatment
medicines	I-treatment
and	O
smoked	O
heavily	O
on	O
the	O
outside	O
and	O
not	O
kept	O
any	O
of	O
his	O
appointments	O
.	O

The	O
importance	O
of	O
quitting	O
smoking	O
as	O
well	O
as	O
continuing	O
to	O
follow	O
his	B-treatment
medical	I-treatment
regimen	I-treatment
was	O
emphasized	O
to	O
the	O
daughter	O
and	O
to	O
the	O
patient	O
.	O

She	O
will	O
be	O
actively	O
involved	O
in	O
encouraging	O
the	O
patient	O
to	O
comply	O
with	O
this	B-treatment
medical	I-treatment
regimen	I-treatment
and	O
also	O
to	O
follow	O
up	O
with	O
Dr.	O
Amesin	O
as	O
well	O
as	O
Dr.	O
Lfsquarc	O
on	O
the	O
outside	O
.	O

The	O
patient	O
remained	O
guaiac	B-test
negative	O
throughout	O
the	O
entire	O
hospitalization	O
.	O

Despite	O
being	O
on	O
heparin	B-treatment
for	O
a	O
short	O
time	O
,	O
his	B-test
hematocrit	I-test
remained	O
very	O
stable	O
with	O
only	O
a	B-problem
small	I-problem
dip	I-problem
after	O
the	B-treatment
catheterization	I-treatment
was	O
done	O
.	O

He	O
will	O
need	O
to	O
be	O
followed	O
up	O
as	O
an	O
out	O
patient	O
for	O
guaiac	B-problem
positive	I-problem
stools	I-problem
and	O
possibly	O
worked	O
up	O
for	O
this	O
in	O
the	O
future	O
.	O

CAGHALA	O
UINTEELE	O
,	O
M.D.	O

TR	O
:	O

yf	O
/	O
bmot	O

DD	O
:	O

11-3-93	O
PAD-WORD	O

TD	O
:	O

11/04/93	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Telshey	O
Swatlleebtik	O
Dr.	O
Eri	O
Lfsquarc	O

Admission	O
Date	O
:	O

2013-09-05	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-09-12	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1934-08-29	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Mary	O
N	O
Major	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

change	B-problem
in	I-problem
mental	I-problem
status	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

HPI	O
:	O
This	O
is	O
a	O
79	O
y/o	O
M	O
with	O
h/o	O
of	O
HTN	B-problem
,	O
DM	B-problem
,	O
recent	B-problem
CVA	I-problem
Theresa	O
,	O
chronic	B-problem
respiratory	I-problem
failure	I-problem
on	O
vent	B-treatment
,	O
trached	B-treatment
,	O
ESRD	B-problem
on	O
HD	B-treatment
who	O
was	O
sent	O
from	O
rehab	O
facility	O
for	O
worsening	B-problem
mental	I-problem
status	I-problem
.	O

Per	O
refferal	O
notes	O
,	O
he	O
went	O
to	O
hemodyalisis	B-treatment
today	O
in	O
the	O
morning	O
.	O

1	O
L	O
was	O
removed	O
.	O

At	O
about	O
2:30	O
pm	O
,	O
he	O
was	O
found	O
to	O
have	O
worsening	B-problem
mental	I-problem
status	I-problem
.	O

In	O
that	O
setting	O
he	O
was	O
hypotensive	B-problem
down	O
to	O
the	O
92/45	O
,	O
and	O
was	O
given	O
1	B-treatment
L	I-treatment
NS	I-treatment
.	O

Fs	B-test
was	O
also	O
checked	O
179	O
.	O

At	O
that	O
time	O
,	O
it	O
seems	O
that	O
he	O
had	O
been	O
on	O
T	B-treatment
peace	I-treatment
since	O
4	O
am	O
today	O
.	O

At	O
2:30	O
he	O
was	O
also	O
found	O
with	O
sats	B-test
in	O
the	O
90%	O
.	O

ABG	B-test
done	O
7.1	O
,	O
89/72	O
-	O
he	O
was	O
placed	O
on	O
AC	B-treatment
600	O
/	O
0.4	O
and	O
6	O
PEEP	B-treatment
-	O
sats	B-test
up	O
to	O
94%	O
.	O

Given	O
persistent	B-problem
lethargy	I-problem
,	O
patient	O
was	O
sent	O
to	O
Falkener	O
Amanda	O
.	O

Of	O
note	O
,	O
after	O
interview	O
with	O
HCP	O
,	O
at	O
around	O
07-23	O
,	O
patient	O
started	O
having	O
episodes	O
of	O
dizziness	B-problem
,	O
and	O
had	O
unstable	B-problem
gait	I-problem
.	O

he	O
was	O
taken	O
to	O
Williams	O
ICU	O
until	O
08-09	O
when	O
he	O
was	O
discharged	O
to	O
Waltham/Weston	O
Hospital	O
Rehab	O
.	O

he	O
had	O
a	B-treatment
peg	I-treatment
tube	I-treatment
and	O
tracheostomy	B-treatment
prior	O
to	O
d/c	O
.	O

He	O
had	O
been	O
chronicallyl	B-problem
vent	I-problem
dependent	I-problem
.	O

His	O
companion	O
states	O
that	O
they	O
have	O
been	O
trying	O
to	O
wean	O
him	O
down	O
at	O
rehab	O
.	O

his	O
basline	O
mental	O
staus	O
apparently	O
responds	O
with	O
his	O
head	O
shaking	O
,	O
and	O
also	O
try	O
to	O
write	O
sentences	O
.	O

In	O
the	O
Amanda	O
:	O
VS	B-test
T	B-test
103	O
rectal	O
BP90/44	B-test
HR	B-test
:	O
84	O
RR	B-test
16	O
Sats	B-test
:	O
98	O
+	B-problem
guiac	I-problem
stool	I-problem
.	O

He	O
received	O
tylenol	B-treatment
,	O
levofloxacin	B-treatment
500	O
mg	O
IV	O
,	O
Flagyl	B-treatment
500	O
mg	O
and	O
Vancomycin	B-treatment
and	O
I	B-treatment
L	I-treatment
NS	I-treatment
.	O

ROS	O
:	O
difficult	O
to	O
obtain	O
2x2	O
to	O
patient	O
mental	O
status	O
baselin	O

Past	O
Medical	O
History	O
:	O

CVA	B-problem
Theresa	O
/	O
2006	O

HTN	B-problem
PAD-WORD	O

DM	B-problem
PAD-WORD	O

CRI	B-problem
on	O
HD	B-treatment
since	O
Theresa	O
(	O
Tu,	O
Thurs,	O
Sat	O
)	O

Neuropathy	B-problem
right	I-problem
leg	I-problem

s/p	O
cCY	B-treatment

Social	O
History	O
:	O

Uset	O
to	O
be	O
truck	O
driver	O
.	O

Retired	O
15	O
years	O
ago	O
.	O

He	O
has	O
1	O
son	O
,	O
two	O
grandson	O
.	O

smoking	O
(-),	O
alcohol	O
-	O

Family	O
History	O
:	O

brother	O
died	O
cerebral	B-problem
aneurysm	I-problem

Brother	O
Sabina	B-problem
cancer	I-problem

brother	O
prostate	B-problem
cancer	I-problem

father	O
Randall	O

Physical	O
Exam	O
:	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O
T	B-test
:	O
99	O
P	B-test
:	O
84	O
BP	B-test
:	O
145/62	O
AC	B-treatment
:	O
600	O
,	O
x	O
12	O
/	O
0.5	O
/	O
5	O
SaO2	B-test
:	O
100%	O

General	O
:	O
Awake	O
,	O
alert	O
,	O
responding	O
to	O
voice	O
.	O

HEENT	O
:	O
PEERLA	O
,	O
no	O
JVD	B-problem
.	O
+	O
tracheostomy	B-treatment

Pulmonary	O
:	O
clear	O
anteriorly	O
.	O

decrease	B-problem
breath	I-problem
sounds	I-problem
bases	I-problem
.	O

Cardiac	O
:	O
RRR	O
,	O
nl	O
.	O
S1S2	O
,	O
soft	B-problem
holosytolic	I-problem
murmur	I-problem
apex	I-problem

Abdomen	O
:	O
soft	O
,	O
NT/ND	B-problem
,	O
normoactive	O
bowel	O
sounds	O
,	O
no	O
masses	B-problem
or	O
organomegaly	B-problem
noted	O
.	O

+	O
g	B-treatment
tube	I-treatment

Extremities	O
:	O
Left	B-treatment
arm	I-treatment
AVF	I-treatment

1+	B-problem
trace	I-problem
edemalymphadenopathy	I-problem
noted	O
.	O

Skin	O
:	O
no	O
rashes	B-problem
,	O
small	B-problem
decubit	I-problem
in	I-problem
the	I-problem
back	I-problem
.	O

Neurologic	O
:	O
alert	O
,	O
awake	O
,	O
partially	O
interacting	O
and	O
responding	O
to	O
comands	O
.	O

decreased	B-problem
reflexes	I-problem
Lower	I-problem
extremities	I-problem
.	O

bilaterally	O
.	O

spastic	O
right	O

upper	O
extremity	O
.	O

Pertinent	O
Results	O
:	O

141	O
103	O
53	O
167	O

AGap	B-test
=	O
14	O

------------->	O
PAD-WORD	O

5.7	O
30	O
3.6	O

CK	B-test
:	O
29	O
MB	B-test
:	O
Notdone	O
Trop	B-test
-*	O
T	O
*:	O
0.44	O

Comments	O
:	O
Notified	O
Glenn	O
Shives	O
2013-09-05	O
6:50	O
p	O

Ctropnt	B-test
>	O
0.10	O
Ng	O
/	O
Ml	O
Suggests	O
Acute	B-problem
Mi	I-problem

Ca	B-test
:	O
8.6	O
Mg	B-test
:	O
2.4	O
P	B-test
:	O
5.0	O

Other	O
Blood	O
Chemistry	O
:	O

proBNP	B-test
:	O
11065	O

WBC	B-test
15.2	O
Plat	B-test
395	O

HCT	B-test
:	O
28.4	O

N	B-test
:	O
89.8	O
Band	B-test
:	O
0	O
L	B-test
:	O
5.8	O
M	B-test
:	O
4.1	O
E	B-test
:	O
0.3	O
Bas	B-test
:	O
0.1	O
PT	B-test
:	O
12.1	O
PTT	B-test
:	O
37.5	O
INR	B-test
:	O
1.0	O

2013-09-05	O
PAD-WORD	O

5:04	O
p	O

Green	O
Top	O

K	B-test
:	O
5.5	O
Lactate	B-test
:	O
1.3	O

Brief	O
Hospital	O
Course	O
:	O

Assessment	O
and	O
Plan	O
:	O

This	O
is	O
a	O
79	O
y/o	O
M	O
with	O
h/o	O
HTN	B-problem
,	O
DM	B-problem
,	O
recent	B-problem
CVA	I-problem
,	O
chronic	B-problem
ventilatory	I-problem
failure	I-problem
,	O
CRI	B-problem
on	O
HD	B-treatment
who	O
presents	O
with	O
change	B-problem
in	I-problem
MS	I-problem
and	O
febrile	B-problem
in	O
the	O
Amanda	O
,	O
admitted	O
to	O
CMED	O
.	O

#	O
Altered	B-problem
mental	I-problem
status	I-problem
:	O
Ct	B-test
scan	I-test
with	O
no	O
evidence	O
of	O
new	B-problem
intracraneal	I-problem
bleeding	I-problem
.	O

Patient	O
febrile	B-problem
in	O
the	O
Amanda	O
.	O

High	B-problem
WBC	I-problem
.	O

It	O
was	O
thought	O
that	O
it	O
could	O
have	O
been	O
a	O
combination	O
of	O
hypotension	B-problem
,	O
hypercapnia	B-problem
and	O
infection	B-problem
.	O

He	O
was	O
initially	O
started	O
on	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
.	O

Despite	O
having	O
a	B-problem
profund	I-problem
limitation	I-problem
communicating	I-problem
given	O
his	B-problem
neurological	I-problem
status	I-problem
,	O
his	B-problem
mental	I-problem
changes	I-problem
seemed	O
to	O
improved	O
initially	O
.	O

However	O
later	O
on	O
during	O
his	O
course	O
,	O
his	O
mental	O
status	O
deteriorated	O
,	O
being	O
even	O
less	B-problem
responsive	I-problem
.	O

#	O
ID	O
:	O

Patient	O
febrile	B-problem
and	O
with	O
a	B-problem
high	I-problem
WBC	I-problem
on	O
admission	O
.	O

After	O
starting	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
-	O
cefepime	B-treatment
-	O
vancomycin	B-treatment
and	O
flagyl	B-treatment
(	O
for	O
initial	O
concern	O
of	O
aspiration	B-problem
pneumonia	I-problem
),	O
he	O
responded	O
clinically	O
.	O

Urine	B-test
cx	I-test
from	O
Rehab	O
showed	O
gram	B-problem
negative	I-problem
rods	I-problem
>	B-problem
100	I-problem
K	I-problem
enterobacter	I-problem
cloacae	I-problem
.	O

Urine	B-test
Cx	I-test
in	O
house	O
grew	O
Citrobacter	B-problem
Freundi	I-problem
and	O
his	B-test
sputum	I-test
grew	O
Acinetobacter	B-problem
Baummani	I-problem
.	O

Since	O
there	O
was	O
no	O
more	O
evidence	O
of	O
gram	B-problem
positive	I-problem
infections	I-problem
,	O
vancomycin	B-treatment
was	O
discontinued	O
and	O
cefepime	B-treatment
was	O
kept	O
.	O

#	O
Fevers	B-problem
:	O
in	O
the	O
Amanda	O
,	O
high	B-problem
WBC	I-problem
,	O
possible	O
pneumonia	B-problem
.	O

Also	O
possible	O
source	O
sinus	B-problem
infections	I-problem
given	O
findings	O
on	O
intial	B-test
CT	I-test
(	O
see	O
summary	O
in	O
significant	O
studies	O
).	O
He	O
did	O
not	O
spike	O
any	O
fevers	B-problem
after	O
being	O
transfer	O
to	O
the	O
CMED	O
from	O
the	O
Amanda	O
.	O

#	O
Resp	O
:	O
Patient	O
was	O
intermitentely	O
switched	O
from	O
AC	B-treatment
to	O
Pressure	B-treatment
support	I-treatment
trials	I-treatment
.	O

However	O
,	O
after	O
Patient	O
did	O
well	O
.	O

Then	O
trach	B-treatment
mask	I-treatment
trials	I-treatment
were	O
done	O
.	O

He	O
tolerated	O
this	O
well	O
,	O
although	O
he	O
required	O
PS	B-treatment
overnight	O
.	O

#	O
ESRD	B-problem
on	O
hemodyalisis	B-treatment
:	O
Renal	O
service	O
was	O
consulted	O
and	O
HD	B-treatment
was	O
continued	O
.	O

#	O
CV	O
:	O

Rhythm	B-test
:	O
NSR	O
,	O
not	O
tachycardic	B-problem
.	O

Pump	B-test
:	O
With	O
trace	O
of	O
lower	B-problem
extremity	I-problem
edema	I-problem
.	O

X	B-test
ray	I-test
suggested	O
some	B-problem
pulmonary	I-problem
edema	I-problem
on	O
admission	O
.	O

Despite	O
this	O
findings	O
,	O
he	O
was	O
supported	O
with	O
40%	B-treatment
FIO2	I-treatment
most	O
of	O
the	O
time	O
.	O

CAD	B-problem
:	O
On	O
admission	O
Ck	B-test
low	O
normal	O
,	O
MB	B-test
not	O
done	O
.	O

Troponin	B-test
0.44.	O

It	O
was	O
more	O
likely	O
due	O
to	O
CRI	B-problem
.	O

Second	O
set	O
12	O
hours	O
apart	O
,	O
showed	O
no	O
changes	B-problem
.	O

s/p	O
stroke	B-problem
:	O
continue	O
aspirin	B-treatment
,	O
statin	B-treatment
,	O
plavix	B-treatment

#	O
Hypotension	B-problem
:	O
per	O
referral	O
form	O
.	O

Intially	O
concern	O
for	O
sepsis	B-problem
in	O
the	O
setting	O
of	O
fevers	B-problem
and	O
high	B-problem
blood	I-problem
count	I-problem
.	O

His	B-treatment
BP	I-treatment
medications	I-treatment
were	O
held	O
on	O
admission	O
.	O

Patient	O
did	O
not	O
require	O
pressors	B-treatment
.	O

His	B-test
blood	I-test
pressure	I-test
remained	O
stable	O
and	O
BP	B-treatment
meds	I-treatment
were	O
restarted	O
.	O

#	O
FEN	O
:	O

Tube	B-treatment
feedings	I-treatment
were	O
started	O
thorugh	O
peg	B-treatment
tube	I-treatment
.	O

On	O
2013-09-08	O
,	O
patient	O
pulled	O
out	O
peg	B-treatment
tube	I-treatment
.	O

Temporary	B-treatment
foley	I-treatment
was	O
placed	O
and	O
on	O
2013-09-11	O
,	O

On	O
2013-09-12	O
after	O
deterioration	B-problem
of	I-problem
his	I-problem
mental	I-problem
status	I-problem
and	I-problem
also	I-problem
of	I-problem
his	I-problem
blood	I-problem
pressure	I-problem
,	O
goals	O
of	O
care	O
were	O
discussed	O
with	O
his	O
HCP	O
.	O

It	O
was	O
decided	O
to	O
direct	O
goals	O
of	O
care	O
towards	O
confort	B-treatment
care	I-treatment
.	O

Patient	O
passed	O
away	O
accompanied	O
by	O
his	O
significant	O
other	O
.	O

Medications	O
on	O
Admission	O
:	O

Novolin	B-treatment
16	O
U	O
q	O
12h	O

Aranesp	B-treatment
40	O
mcg	O
sc	O

Prozac	B-treatment
liquid	I-treatment
20	O
mg	O
q	O
am	O

Heparin	B-treatment
3000	O
U	O
tu	O
,	O
thursday	O
saturday	O

Norvasc	B-treatment
10	O
mg	O
daily	O
GT	O

Tylenol	B-treatment
PRN	O

Reglan	B-treatment
5	O
mg	O
q	O
6h	O
,	O

fergon	B-treatment
300	O
mg	O
BID	O

Plavix	B-treatment
75	O
mg	O
GT	O

nephrocaps	B-treatment
1	O
daily	O

novolin	B-treatment
Sliding	I-treatment
scale	I-treatment

heparin	B-treatment
sc	O
5000	O
q	O
8h	O

Protonix	B-treatment
40	O
mg	O
daily	O
GT	O

Combivent	B-treatment
2	O
puff	O
qid	O
inh	O

zocor	B-treatment
10	O
mg	O
Tab	O
/	O
day	O
GT	O

aspirin	B-treatment
325	O
mg	O
tab	O

Ferrlecit	B-treatment
Sodium	I-treatment
ferric	I-treatment
gluconate	I-treatment
Mo-We	O
Fr	O
IV	O

Discharge	O
Medications	O
:	O

n/a	O
PAD-WORD	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

1.	O
Change	B-problem
in	I-problem
Mental	I-problem
status	I-problem

2.	O
Urinary	B-problem
tract	I-problem
Infection	I-problem

3.	O
Chronic	B-problem
respiratory	I-problem
failure	I-problem

Secondary	O
:	O

1.	O
Hypertension	B-problem

2.	O
Diabetes	B-problem
Mellitus	I-problem

3.	O
End	B-problem
stage	I-problem
renal	I-problem
disease	I-problem
on	O
HD	B-treatment

Discharge	O
Condition	O
:	O

expired	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

n/a	O
PAD-WORD	O

Followup	O
Instructions	O
:	O

n/a	O
PAD-WORD	O

Z.	O
Mcbride	O
WEISS	O
MD	O
51-615	O

Completed	O
by	O
:	O
Martha	O
Fairley	O
MD	O
53-063	O
2013-11-12	O
@	O
2057	O

Signed	O
electronically	O
by	O
:	O
DR.	O
V	O
Osterman	O
WEISS	O
on	O
:	O
WED	O
2013-11-13	O
8:40	O
AM	O

(	O
End	O
of	O
Report	O
)	O

570922581	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

93618376	O
PAD-WORD	O

016906	O
PAD-WORD	O

1/11/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/11/1996	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/19/1996	O
PAD-WORD	O

IDENTIFICATION	O
:	O

Ms.	O
Less	O
was	O
initially	O
admitted	O
to	O
the	O
Vascular	O
Surgery	O
Service	O
for	O
Dr.	O
Scosthuang	O
and	O
was	O
recently	O
transferred	O
to	O
the	O
Neurosurgery	O
Service	O
under	O
the	O
care	O
of	O
Dr.	O
Pae	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Less	O
is	O
a	O
79	O
year	O
old	O
white	O
female	O
with	O
history	O
of	O
non	B-problem
small	I-problem
cell	I-problem
lung	I-problem
cancer	I-problem
diagnosed	O
in	O
02/95	O
.	O

She	O
underwent	O
a	B-treatment
resection	I-treatment
for	O
stage	B-problem
I	I-problem
in	O
10/95	O
and	O
treated	O
with	O
XRT	B-treatment
.	O

She	O
presented	O
to	O
the	O
hospital	O
with	O
a	B-problem
numb	I-problem
right	I-problem
leg	I-problem
this	O
morning	O
and	O
underwent	O
an	B-treatment
emergent	I-treatment
embolectomy	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
1990	O
,	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
and	O
hypertension	B-problem
.	O

MEDICATIONS	O
:	O

Medications	B-treatment
on	I-treatment
admission	I-treatment
were	O
Coumadin	B-treatment
,	O
Digoxin	B-treatment
Synthroid	B-treatment
,	O
Lopressor	B-treatment
and	O
Zantac	B-treatment
.	O

On	O
1/14/96	O
,	O
she	O
had	O
a	B-treatment
dialysis	I-treatment
catheter	I-treatment
.	O

On	O
1/18/96	O
,	O
she	O
had	O
an	B-problem
acute	I-problem
change	I-problem
in	I-problem
mental	I-problem
status	I-problem
and	O
underwent	O
an	B-test
emergent	I-test
head	I-test
CT	I-test
scan	I-test
which	O
showed	O
a	B-problem
massive	I-problem
subarachnoid	I-problem
hemorrhage	I-problem
with	O
bleeding	B-problem
in	I-problem
the	I-problem
subarachnoid	I-problem
space	I-problem
,	O
and	O
throughout	O
the	O
ventricles	O
.	O

She	O
also	O
had	O
significant	B-problem
hydrocephalus	I-problem
.	O

Follow	B-test
up	I-test
CT	I-test
scan	I-test
showed	O
worsening	O
of	O
her	B-problem
hydrocephalus	I-problem
and	O
she	O
had	O
a	B-treatment
ventriculostomy	I-treatment
placed	O
in	O
the	O
Intensive	O
Care	O
Unit	O
.	O

She	O
failed	O
to	O
improve	O
following	O
placement	O
of	O
the	B-treatment
ventriculostomy	I-treatment
and	O
her	O
poor	O
prognosis	O
was	O
discussed	O
with	O
the	O
family	O
.	O

The	O
family	O
at	O
that	O
point	O
considering	O
the	O
multiple	O
system	O
involvement	O
of	O
her	B-problem
diseases	I-problem
,	O
decided	O
to	O
make	O
the	O
patient	O
DNR	B-treatment
and	O
withdraw	O
care	B-treatment
.	O

The	O
patient	O
expired	O
on	O
1/19/96	O
at	O
11:35	O
p.m.	O

The	O
medical	O
examiner	O
was	O
called	O
and	O
the	O
case	O
was	O
discussed	O
,	O
and	O
he	O
declined	O
autopsy	B-test
of	O
the	O
case	O
.	O

The	O
family	O
was	O
informed	O
and	O
all	O
questions	O
were	O
answered	O
.	O

Dictated	O
By	O
:	O

RORIEZAILA	O
FERNE	O
KOTEKAYSKOTEKAYSCOA	O
,	O
M.D.	O
AV9	O

Attending	O
:	O

NAREA	O
L.	O
RUDESTHIR	O
,	O
M.D.	O
XS62	O
RS286/0162	O

Batch	O
:	O

2998	O
PAD-WORD	O

Index	O
No.	O
WLDOVN4PV4	O

D	O
:	O

01/19/96	O
PAD-WORD	O

T	O
:	O

01/19/96	O
PAD-WORD	O

420033129	O
YC	O

87142319	O
PAD-WORD	O

129591	O
PAD-WORD	O

12/12/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

12/12/1996	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

12/16/1996	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

STATUS	O
POST	O
TOTAL	B-treatment
ABDOMINAL	I-treatment
HYSTERECTOMY	I-treatment
AND	O
BILATERAL	B-treatment
SALPINGO-OOPHORECTOMY	I-treatment
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1)	O
MENORRHAGIA	B-problem
.	O

2)	O
PELVIC	B-problem
PAIN	I-problem
.	O

3)	O
ENDOMETRIOSIS	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

TAH-BSO	B-treatment
.	O

HISTORY	O
/	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

The	O
patient	O
is	O
a	O
42	O
year	O
old	O
gravida	O
II	O
,	O
para	O
I	O
female	O
with	O
a	O
long	O
history	O
of	O
menorrhagia	B-problem
and	O
pelvic	B-problem
pain	I-problem
.	O

She	O
also	O
has	O
a	O
history	O
of	O
endometriosis	B-problem
that	O
is	O
symptomatic	B-problem
.	O

She	O
used	O
Danocrine	B-treatment
for	O
approximately	O
nine	O
months	O
and	O
was	O
pain	B-problem
free	O
,	O
but	O
was	O
unable	O
to	O
tolerate	O
the	B-problem
side	I-problem
effects	I-problem
.	O

She	O
is	O
status	O
post	O
several	B-test
laparoscopies	I-test
in	O
the	O
past	O
with	O
which	O
she	O
was	O
diagnosed	O
with	O
endometriosis	B-problem
.	O

She	O
has	O
recently	O
been	O
on	O
Depo-Provera	B-treatment
and	O
has	O
had	O
episodes	O
of	O
break-through	B-problem
bleeding	I-problem
for	O
six	O
weeks	O
at	O
a	O
time	O
.	O

She	O
desired	O
surgical	B-treatment
therapy	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
12/12/96	O
she	O
had	O
an	B-treatment
uncomplicated	I-treatment
total	I-treatment
abdominal	I-treatment
hysterectomy	I-treatment
and	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
.	O

Estimated	B-problem
blood	I-problem
loss	I-problem
was	O
100	O
cc	O
and	O
she	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
.	O

On	O
postop	O
day	O
number	O
one	O
she	O
was	O
afebrile	B-problem
and	O
doing	O
well	O
with	O
a	B-treatment
PCA	I-treatment
for	O
pain	B-treatment
control	I-treatment
.	O

On	O
postop	O
day	O
number	O
two	O
she	O
was	O
also	O
afebrile	B-problem
and	O
had	O
not	O
passed	O
any	B-problem
flatus	I-problem
yet	O
.	O

She	O
was	O
ambulating	O
frequently	O
.	O

Her	B-test
hematocrit	I-test
was	O
34.2	O
and	O
stable	O
from	O
her	O
preoperative	O
value	O
.	O

On	O
postop	O
day	O
number	O
three	O
her	O
abdomen	O
was	O
noted	O
to	O
be	O
distended	B-problem
with	O
a	B-test
few	I-test
bowel	I-test
sounds	I-test
and	O
she	O
still	O
had	O
not	O
passed	O
gas	B-problem
.	O

The	O
patient	O
decreased	O
the	O
amount	O
of	O
Demerol	B-treatment
she	O
was	O
using	O
and	O
supplemented	O
with	O
Tylenol	B-treatment
and	O
continued	O
her	O
frequent	O
ambulation	O
.	O

On	O
postop	O
day	O
number	O
four	O
she	O
had	O
passed	O
flatus	B-problem
and	O
was	O
feeling	O
much	O
better	O
.	O

She	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
on	O
the	B-treatment
following	I-treatment
medications	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Demerol	B-treatment
for	O
pain	B-problem
.	O

Motrin	B-treatment
for	O
pain	B-problem
.	O

Colace	B-treatment
stool	I-treatment
softener	I-treatment
.	O

DISPOSITION	O
:	O

The	O
patient	O
should	O
follow-up	O
with	O
Dr.	O
Side	O
in	O
two	O
weeks	O
.	O

Dictated	O
By	O
:	O

IEDEARC	O
SIDE	O
,	O
M.D.	O
LB28	O

Attending	O
:	O

MITERY	O
D.	O
LOSS	O
,	O
M.D.	O
CB51	O
II795/2112	O

Batch	O
:	O

42100	O
PAD-WORD	O

Index	O
No.	O
ZMFX3O4G1	O

D	O
:	O

01/04/97	O
PAD-WORD	O

T	O
:	O

01/06/97	O
PAD-WORD	O

CC	O
:	O

1.	O
MITERY	O
D.	O
LOSS	O
,	O
M.D.	O
NT11	O

[	O
report	O
_	O
end	O
]	O

573620996	O
PAD-WORD	O

FIH	O
PAD-WORD	O

7728564	O
PAD-WORD	O

87294/8g15	O
PAD-WORD	O

879796	O
PAD-WORD	O

6/26/1994	O
12:00:00	O
AM	O

MIXED	B-problem
MESODERMAL	I-problem
CANCER	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

06/26/94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

06/30/94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

mixed	B-problem
mesodermal	I-problem
cancer	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

(	O
1	O
)	O
status	O
post	O
hysterectomy	B-treatment
and	O
bilateral	B-treatment
oophorectomy	I-treatment
.	O

(	O
2	O
)	O
abdominal	B-problem
wall	I-problem
hernia	I-problem
.	O

(	O
3	O
)	O
hypertension	B-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

On	O
June	O
26	O
,	O
1994	O
tumor	B-treatment
debulking	I-treatment
,	O
pelvic	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
,	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
abdominal	B-treatment
wall	I-treatment
hernia	I-treatment
repair	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
81	O
year	O
old	O
female	O
,	O
G2	O
,	O
P2	O
,	O
who	O
status	O
post	O
total	B-treatment
abdominal	I-treatment
hysterectomy-bilateral	I-treatment
salpingo-oophorectomy	I-treatment
one	O
years	O
ago	O
for	O
a	B-problem
mixed	I-problem
mesodermal	I-problem
cancer	I-problem
who	O
presents	O
with	O
vaginal	B-problem
apex	I-problem
recurrence	I-problem
.	O

She	O
had	O
a	O
normal	O
pelvic	O
examination	O
and	O
CT	B-test
scan	I-test
in	O
February	O
of	O
1993	O
but	O
one	O
month	O
prior	O
to	O
this	O
admission	O
starting	O
bleeding	B-problem
per	I-problem
vagina	I-problem
.	O

An	B-test
examination	I-test
revealed	O
an	B-problem
apicovaginal	I-problem
lesion	I-problem
consistent	O
with	O
recurrent	B-problem
tumor	I-problem
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
was	O
performed	O
which	O
showed	O
a	B-problem
central	I-problem
recurrence	I-problem
and	O
biopsy	B-test
of	O
this	B-problem
lesion	I-problem
was	O
positive	O
.	O

She	O
presents	O
now	O
for	O
excision	B-treatment
of	O
her	B-problem
local	I-problem
cancer	I-problem
recurrence	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
as	O
above	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Halcion	B-treatment
0.25	O
mg.	O
P.O.	O
q.h.s.	O
,	O

Valium	B-treatment
5	O
mg.	O
P.O.	O
p.r.n	O
and	O
methyclothiazide	B-treatment
5	O
mg.	O
q.d.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Her	B-test
temperature	I-test
is	O
97.9	O
,	O
blood	B-test
pressure	I-test
160/80	O
,	O
heart	B-test
rate	I-test
92	O
,	O
her	B-test
HEENT	I-test
examination	I-test
reveals	O
anicteric	B-problem
sclerae	I-problem
and	O
her	O
left	O
eye	O
has	O
slightly	B-problem
relaxed	I-problem
inferoorbital	I-problem
wall	I-problem
.	O

Her	O
chest	O
is	O
clear	O
to	O
auscultation	B-test
.	O

Her	O
heart	O
has	O
regular	O
rate	O
and	O
rhythm	O
with	O
I	B-problem
/	I-problem
VI	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
at	I-problem
the	I-problem
base	I-problem
.	O

Abdomen	O
is	O
obese	B-problem
,	O
soft	O
,	O
non-tender	B-problem
,	O
and	O
without	O
palpable	B-problem
masses	I-problem
.	O

Extremities	O
two	B-test
plus	I-test
pulses	I-test
bilaterally	I-test
and	O
nonpitting	B-problem
edema	I-problem
up	I-problem
to	I-problem
the	I-problem
knees	I-problem
in	O
both	O
legs	O
.	O

Neurologic	O
examination	O
:	O

is	O
unremarkable	O
.	O

LABORATORY	O
DATA	O
:	O

sodium	B-test
142	O
,	O
potassium	B-test
3.3	O
,	O
chloride	B-test
98	O
,	O
bicarbonate	B-test
34	O
,	O
BUN	B-test
and	O
creatinine	B-test
14/0.9	O
.	O

Her	B-test
alkaline	I-test
phosphatase	I-test
is	O
77	O
,	O
white	B-test
blood	I-test
count	I-test
12.5	O
,	O
hematocrit	B-test
42.6	O
,	O
platelet	B-test
count	I-test
268	O
.	O

IN	O
SUMMARY	O
:	O

This	O
is	O
a	O
patient	O
with	O
recurrence	O
of	O
a	B-problem
mixed	I-problem
mesodermal	I-problem
cancer	I-problem
at	I-problem
the	I-problem
vaginal	I-problem
apex	I-problem
who	O
presents	O
for	O
local	B-treatment
excision	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
GYN	O
/	O
Oncology	O
Service	O
under	O
the	O
care	O
of	O
Dr.	O
Top	O
on	O
June	O
26	O
,	O
1994	O
.	O

On	O
that	O
day	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
an	B-test
exam	I-test
under	O
anesthesia	B-treatment
,	O
an	B-test
exploratory	I-test
laparotomy	I-test
with	O
lysis	B-treatment
of	O
adhesions	B-problem
,	O
tumor	B-treatment
debulking	I-treatment
and	O
bilateral	B-treatment
pelvic	I-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
.	O

An	B-problem
abdominal	I-problem
wall	I-problem
hernia	I-problem
was	O
also	O
repaired	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
without	O
any	B-problem
complications	I-problem
.	O

Her	O
postoperative	O
course	O
was	O
unremarkable	O
.	O

Her	B-treatment
vaginal	I-treatment
pack	I-treatment
was	O
removed	O
on	O
the	O
second	O
postoperative	O
day	O
as	O
well	O
as	O
the	B-treatment
Foley	I-treatment
catheter	I-treatment
.	O

By	O
postoperative	O
day	O
three	O
she	O
had	O
return	O
of	O
normal	O
bowel	O
function	O
and	O
was	O
able	O
to	O
tolerate	O
a	O
regular	O
diet	O
without	O
any	B-problem
difficulty	I-problem
.	O

Her	B-treatment
Jackson-Pratt	I-treatment
drain	I-treatment
was	O
removed	O
on	O
June	O
30	O
,	O
1994	O
,	O
postoperative	O
day	O
four	O
.	O

On	O
that	O
day	O
she	O
was	O
feeling	O
well	O
enough	O
,	O
eating	O
well	O
,	O
and	O
voiding	O
without	O
difficulty	B-problem
.	O

As	O
a	O
result	O
she	O
was	O
able	O
to	O
be	O
discharged	O
home	O
on	O
June	O
30	O
,	O
1994	O
.	O

FOLLOW-UP	O
:	O

She	O
will	O
follow	O
up	O
with	O
Dr.	O
Top	O
in	O
his	O
office	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Her	B-treatment
only	I-treatment
additional	I-treatment
medication	I-treatment
on	O
discharge	O
is	O
Percocet	B-treatment
as	O
needed	O
for	O
pain	B-problem
.	O

In	O
addition	O
Dr.	O
Blincarour	O
from	O
Radiation	O
Oncology	O
saw	O
the	O
patient	O
and	O
recommended	O
pelvic	B-treatment
radiation	I-treatment
therapy	I-treatment
.	O

She	O
wishes	O
to	O
get	O
her	B-treatment
radiation	I-treatment
in	O
O	O
and	O
has	O
spoken	O
to	O
her	O
primary	O
care	O
physician	O
regarding	O
this	O
.	O

Of	O
note	O
the	O
pelvic	O
lymph	O
nodes	O
which	O
were	O
dissected	O
were	O
positive	O
for	O
tumor	B-problem
by	O
frozen	B-test
section	I-test
analysis	I-test
.	O

The	B-test
permanent	I-test
pathology	I-test
sections	I-test
are	O
still	O
pending	O
.	O

DOLL	O
GRENDBLY	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

SLAINEAEE	O
S.	O
NIET	O
TOP	O
,	O
M.D.	O

TR	O
:	O

egi	O
/	O
bmot	O

DD	O
:	O

06/30/94	O
PAD-WORD	O

TD	O
:	O

07/01/94	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Top	O
Dr.	O
Grendbly	O

Admission	O
Date	O
:	O

2009-06-23	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2009-07-12	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1926-02-07	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMI	O
;	O
then	O
to	O
Medcine	O
;	O
then	O
transferred	O
to	O
CCU	O

CHIEF	O
COMPLAINT	O
:	O

Renal	B-problem
failure	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
83-year-old	O
male	O
with	O
a	O
history	O
of	O
diabetes	B-problem
mellitus	I-problem
,	O
steroid-treated	B-problem
polymyalgia	I-problem
rheumatica	I-problem
,	O
hypertension	B-problem
,	O
benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
,	O
and	O
high	B-problem
cholesterol	I-problem
who	O
presented	O
for	O
a	B-test
lower	I-test
extremity	I-test
peripheral	I-test
angiography	I-test
for	O
bilateral	B-problem
foot	I-problem
ulcers	I-problem
,	O
and	O
he	O
was	O
found	O
to	O
an	B-problem
evaluated	I-problem
blood	I-problem
urea	I-problem
nitrogen	I-problem
,	I-problem
and	I-problem
creatinine	I-problem
,	I-problem
and	I-problem
potassium	I-problem
.	O

The	O
patient	O
notes	O
he	O
developed	O
worsening	B-problem
foot	I-problem
pain	I-problem
and	O
ulcers	B-problem
four	O
months	O
ago	O
.	O

Due	O
to	O
his	B-problem
worsening	I-problem
blood	I-problem
glucose	I-problem
,	O
he	O
was	O
started	O
on	O
insulin	B-treatment
.	O

His	B-problem
foot	I-problem
ulcers	I-problem
continued	O
to	O
develop	O
,	O
and	O
the	O
patient	O
complained	O
of	O
pain	B-problem
in	I-problem
his	I-problem
feet	I-problem
;	O
primarily	O
at	O
night	O
.	O

The	O
patient	O
was	O
referred	O
to	O
for	O
Vascular	O
consultation	O
because	O
of	O
the	B-problem
ulcerations	I-problem
and	O
pain	B-problem
and	O
scheduled	O
for	O
a	O
lower	O

extremity	B-test
angiography	I-test
on	O
the	O
day	O
of	O
admission	O
,	O
but	O
due	O
to	O
his	B-problem
renal	I-problem
failure	I-problem
the	O
procedure	O
was	O
cancelled	O
.	O

The	O
patient	O
showed	O
peaked	B-problem
T	I-problem
waves	I-problem
on	O
electrocardiogram	B-test
,	O
and	O
he	O
was	O
transferred	O
to	O
Medicine	O
.	O

The	O
patient	O
denied	O
any	O
oliguria	B-problem
,	O
hematuria	B-problem
,	O
dysuria	B-problem
,	O
foamy	B-problem
urine	I-problem
,	O
flank	B-problem
pain	I-problem
,	O
abdominal	B-problem
pain	I-problem
,	O
or	O
urinary	B-problem
hesitancy	I-problem
.	O

He	O
has	O
complained	O
of	O
fatigue	B-problem
,	O
anorexia	B-problem
,	O
and	O
a	B-problem
10-pound	I-problem
weight	I-problem
loss	I-problem
in	O
the	O
last	O
four	O
months	O
.	O

He	O
gets	O
short	B-problem
of	I-problem
breath	I-problem
with	O
one	O
flight	O
of	O
stairs	O
.	O

He	O
denies	O
any	B-problem
fevers	I-problem
,	O
chills	B-problem
,	O
recent	B-problem
infections	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
orthopnea	B-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
diarrhea	B-problem
,	O
hematemesis	B-problem
,	O
melena	B-problem
,	O
or	O
hematochezia	B-problem
.	O

The	O
patient	O
also	O
notes	O
he	O
has	O
had	O
hoarseness	B-problem
for	O
the	O
last	O
two	O
to	O
three	O
weeks	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Diabetes	B-problem
mellitus	I-problem
times	O
four	O
years	O
;	O
recently	O
started	O
insulin	B-treatment
and	O
metformin	B-treatment
due	O
to	O
his	B-treatment
concurrent	I-treatment
steroid	I-treatment
use	I-treatment
.	O

Last	O
hemoglobin	B-test
A1c	I-test
was	O
11.4	O
.	O

2.	O
Polymyalgia	B-problem
rheumatica	I-problem
diagnosed	O
four	O
years	O
ago	O
;	O
on	O
steroids	B-treatment
.	O

3.	O
Benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
,	O
status	O
post	O
transurethral	B-treatment
resection	I-treatment
of	I-treatment
prostate	I-treatment
.	O

4.	O
Hypertension	B-problem
.	O

5.	O
High	B-problem
cholesterol	I-problem
.	O

6.	O
Lower	B-problem
extremity	I-problem
edema	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Methylprednisolone	B-treatment
4	O
mg	O
q.	O
a.m.	O
and	O
2	O
mg	O
p.o.	O
q.h.s.	O
,	O
spironolactone	B-treatment
50	O
mg	O
p.o.	O
q.d.	O
,	O
metformin	B-treatment
1500	O
mg	O
p.o.	O
q.h.s.	O
,	O
Pravastatin	B-treatment
10	O
mg	O
p.o.	O
q.h.s.	O
,	O
lisinopril	B-treatment
20	O
mg	O
p.o.	O
q.	O
a.m.	O
,	O
Lasix	B-treatment
80	O
mg	O
p.o.	O
q.	O
a.m.	O
,	O
Tylenol	B-treatment
as	O
needed	O
,	O
insulin	B-treatment
regular	I-treatment
22	O
units	O
in	O
the	O
morning	O
and	O
12	O
units	O
at	O
night	O
(	O
lispro	B-treatment
regular	I-treatment
).	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Type	B-problem
1	I-problem
diabetes	I-problem
in	O
twin	O
brother	O
,	O
type	B-problem
2	I-problem
diabetes	I-problem
in	O
mother	O
and	O
brother	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
a	O
former	O
smoker	O
;	O
he	O
quit	O
50	O
years	O
ago	O
.	O

He	O
drinks	O
one	O
glass	O
of	O
wine	O
per	O
night	O
.	O

He	O
is	O
married	O
and	O
lives	O
with	O
his	O
wife	O
.	O

John	O
was	O
in	O
the	O
Army	O
during	O
World	O
War	O
II	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

On	O
admission	O
,	O
temperature	B-test
was	O
98.1	O
,	O
blood	B-test
pressure	I-test
was	O
140/70	O
,	O
pulse	B-test
was	O
95	O
,	O
respiratory	B-test
rate	I-test
was	O
18	O
,	O
oxygen	B-test
saturation	I-test
was	O
98%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
the	O
patient	O
was	O
a	O
thin	O
white	O
male	O
,	O
lying	O
in	O
bed	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
with	O
a	B-problem
hoarse	I-problem
voice	I-problem
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
revealed	O
pupils	O
were	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Extraocular	O
movements	O
were	O
intact	O
.	O

Sclerae	O
were	O
anicteric	B-problem
.	O

Mucous	O
membranes	O
were	O
moist	O
.	O

Neck	O
revealed	O
no	O
lymphadenopathy	B-problem
.	O

No	O
thyromegaly	B-problem
.	O

No	O
jugular	B-problem
venous	I-problem
distention	I-problem
.	O

Cardiovascular	B-test
examination	I-test
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

Normal	O
first	O
heart	O
sound	O
and	O
second	O
heart	O
sound	O
.	O

A	B-problem
2/6	I-problem
systolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	O
with	O
faint	B-problem
lower	I-problem
lobe	I-problem
crackles	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

Back	O
revealed	O
no	O
costovertebral	B-problem
angle	I-problem
tenderness	I-problem
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nontender	B-problem
.	O

No	O
rebound	B-problem
or	O
guarding	B-problem
.	O

No	O
hepatosplenomegaly	B-problem
.	O

Extremities	O
revealed	O
2+	B-test
femoral	I-test
pulses	I-test
bilaterally	I-test
,	O
1+	B-test
dorsalis	I-test
pedis	I-test
pulses	I-test
bilaterally	I-test
.	O

No	O
lower	B-problem
extremity	I-problem
edema	I-problem
.	O

Left	O
foot	O
with	O
a	B-problem
dry	I-problem
crusted	I-problem
ulcer	I-problem
over	O
the	O
medial	O
aspect	O
of	O
the	O
first	O
metatarsal	O
head	O
and	O
the	O
lateral	O
posterior	O
heel	O
.	O

On	O
the	B-problem
right	I-problem
foot	I-problem
dry	I-problem
crusted	I-problem
ulcer	I-problem
over	O
the	O
medial	O
aspect	O
of	O
the	O
first	O
metatarsal	O
head	O
and	O
medial	O
posterior	O
heel	O
.	O

Neurologic	B-test
examination	I-test
was	O
grossly	O
intact	O
.	O

PERTINENT	O
LABORATORY	O
DATA	O
ON	O
PRESENTATION	O
:	O

On	O
admission	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
was	O
11	O
,	O
hematocrit	B-test
was	O
30	O
,	O
platelets	B-test
were	O
269	O
.	O

Sodium	B-test
was	O
139	O
,	O
potassium	B-test
was	O
6.1	O
,	O
chloride	B-test
was	O
102	O
,	O
bicarbonate	B-test
was	O
18	O
,	O
blood	B-test
urea	I-test
nitrogen	I-test
was	O
100	O
,	O
creatinine	B-test
was	O
2.3	O
,	O
and	O
blood	B-test
glucose	I-test
was	O
189	O
.	O

FENa	B-test
was	O
0.37	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

Renal	B-test
ultrasound	I-test
was	O
normal	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
is	O
an	O
83	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
diabetes	B-problem
,	O
steroid-treated	B-problem
polymyalgia	I-problem
rheumatica	I-problem
,	O
hypertension	B-problem
,	O
benign	B-problem
prostatic	I-problem
hypertrophy	I-problem
,	O
and	O
high	B-problem
cholesterol	I-problem
without	O
presented	O
to	O
the	O
hospital	O
for	O
lower	B-test
extremity	I-test
angiograph	I-test
;	O
however	O
,	O
that	O
was	O
deferred	O
due	O
to	O
new	B-problem
onset	I-problem
renal	I-problem
failure	I-problem
.	O

1.	O
RENAL	B-problem
FAILURE	I-problem
:	O

The	O
patient	O
was	O
initially	O
thought	O
to	O
be	O
prerenal	B-problem
,	O
and	O
his	O
renal	O
status	O
improved	O
after	O
hydration	B-treatment
and	O
increased	B-treatment
oral	I-treatment
intake	I-treatment
.	O

He	O
did	O
have	O
a	B-test
magnetic	I-test
resonance	I-test
angiography	I-test
of	I-test
his	I-test
kidneys	I-test
which	O
showed	O
mild	B-problem
right-sided	I-problem
renal	I-problem
artery	I-problem
stenosis	I-problem
.	O

His	O
renal	O
function	O
fluctuated	O
throughout	O
his	O
hospital	O
stay	O
,	O
and	O
when	O
he	O
was	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
he	O
did	O
have	O
decreased	B-problem
urine	I-problem
output	I-problem
in	O
the	O
setting	O
of	O
cardiogenic	B-problem
shock	I-problem
.	O

2.	O
CARDIOVASCULAR	O
:	O

The	O
patient	O
with	O
severe	B-problem
peripheral	I-problem
vascular	I-problem
disease	I-problem
.	O

During	O
his	O
hospital	O
stay	O
,	O
he	O
developed	O
some	B-problem
nonsustained	I-problem
ventricular	I-problem
tachycardia	I-problem
.	O

He	O
also	O
became	O
hypotensive	B-problem
on	O
07-02	O
in	O
the	O
setting	O
of	O
infection	B-problem
.	O

The	O
patient	O
had	O
a	B-treatment
central	I-treatment
line	I-treatment
placed	O
and	O
went	O
into	O
sustained	B-problem
ventricular	I-problem
tachycardia	I-problem
that	O
was	O
treated	O
with	O
lidocaine	B-treatment
.	O

After	O
being	O
treated	O
with	O
lidocaine	B-treatment
,	O
the	O
patient	O
became	O
apneic	B-problem
requiring	O
intubation	B-treatment
and	O
transfer	O
to	O
the	O
Coronary	O
Care	O
Unit	O
.	O

His	B-problem
nonsustained	I-problem
ventricular	I-problem
tachycardia	I-problem
was	O
treated	O
with	O
a	B-treatment
lidocaine	I-treatment
drip	I-treatment
.	O

It	O
was	O
found	O
that	O
he	O
had	O
elevated	B-problem
troponins	I-problem
and	O
likely	O
an	B-problem
ischemic	I-problem
event	I-problem
on	O
the	O
07-02	O
.	O

A	B-test
repeat	I-test
echocardiogram	I-test
showed	O
a	B-problem
decreased	I-problem
ejection	I-problem
fraction	I-problem
from	O
prior	O
.	O

He	O
had	O
a	B-test
cardiac	I-test
catheterization	I-test
which	O
revealed	O
3-vessel	B-problem
disease	I-problem
.	O

Cardiothoracic	O
Surgery	O
was	O
consulted	O
,	O
and	O
due	O
to	O
the	B-problem
patient	I-problem
's	I-problem
acute	I-problem
illness	I-problem
,	O
they	O
wanted	O
to	O
re-evaluate	O
after	O
the	O
patient	O
was	O
extubated	O
.	O

The	O
patient	O
continued	O
to	O
have	O
intermittent	O
episodes	O
of	O
ventricular	B-problem
tachycardia	I-problem
.	O

He	O
was	O
continued	O
on	O
lidocaine	B-treatment
and	O
eventually	O
changed	O
over	O
to	O
amiodarone	B-treatment
.	O

He	O
was	O
noted	O
to	O
be	O
cardiogenic	B-problem
shock	I-problem
requiring	O
pressors	B-treatment
.	O

Of	O
note	O
,	O
he	O
likely	O
suffered	O
a	B-problem
second	I-problem
ischemic	I-problem
event	I-problem
during	O
his	O
Coronary	O
Care	O
Unit	O
stay	O
.	O

The	O
patient	O
did	O
have	O
a	B-test
Swan-Ganz	I-test
catheter	I-test
in	O
place	O
and	O
had	O
a	B-problem
low	I-problem
cardiac	I-problem
output	I-problem
.	O

The	O
patient	O
's	O
family	O
eventually	O
decided	O
to	O
withdraw	O
care	O
,	O
and	O
the	O
patient	O
was	O
extubated	O
and	O
passed	O
away	O
on	O
2009-07-12	O
.	O

2.	O
INFECTIOUS	O
DISEASE	O
:	O

The	O
patient	O
was	O
initially	O
treated	O
with	O
levofloxacin	B-treatment
for	O
a	B-problem
left	I-problem
lower	I-problem
lobe	I-problem
infiltrate	I-problem
and	O
a	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

He	O
then	O
developed	O
positive	B-problem
blood	I-problem
cultures	I-problem
with	O
Staphylococcus	B-problem
aureus	I-problem
sensitive	O
to	O
levofloxacin	B-treatment
,	O
and	O
that	O
was	O
continued	O
.	O

When	O
the	O
patient	O
became	O
hypotensive	B-problem
and	O
required	O
intubation	B-treatment
and	O
pressors	B-treatment
,	O
his	B-treatment
antibiotics	I-treatment
were	O
broadened	O
,	O
and	O
he	O
was	O
put	O
on	O
stress-dose	B-treatment
steroids	I-treatment
.	O

He	O
was	O
found	O
to	O
have	O
bilateral	B-problem
Staphylococcus	I-problem
pneumonia	I-problem
.	O

3.	O
PULMONARY	O
:	O

The	O
patient	O
required	O
intubation	B-treatment
in	O
the	O
setting	O
of	O
hypotension	B-problem
and	O
ventricular	B-problem
tachycardia	I-problem
.	O

He	O
was	O
actually	O
extubated	O
on	O
07-09	O
,	O
but	O
then	O
reintubated	O
one	O
hour	O
later	O
due	O
to	O
hypoxia	B-problem
.	O

He	O
was	O
also	O
found	O
to	O
have	O
a	B-problem
bilateral	I-problem
Staphylococcus	I-problem
pneumonia	I-problem
.	O

DISCHARGE	O
DISPOSITION	O
:	O

On	O
07-12	O
,	O
after	O
and	O
extensive	O
family	O
meeting	O
,	O
the	O
family	O
decided	O
to	O
extubate	O
the	O
patient	O
and	O
make	O
him	O
comfortable	O
,	O
and	O
he	O
passed	O
away	O
at	O
5:20	O
on	O
2009-07-12	O
.	O

Hattie	O
L	O
Breaux	O
,	O
M.D.	O

33-679	O
PAD-WORD	O

Dictated	O
By	O
:	O
Larry	O
W.	O
Nagy	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2009-12-03	O
09:18	O

T	O
:	O
2009-12-08	O
10:47	O

JOB	O
#:	O

32151	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Stephanie	O
Francis	O
on	O
:	O
TUE	O
2009-12-08	O
4:59	O
PM	O

(	O
End	O
of	O
Report	O
)	O

599923748	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

0079427	O
PAD-WORD	O

25598/1879	O
PAD-WORD	O

538465	O
PAD-WORD	O

5/8/1995	O
12:00:00	O
AM	O

RIGHT	B-problem
OCCIPITAL	I-problem
,	I-problem
CEREBRAL	I-problem
INFARCTION	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

05/08/95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

05/14/95	O
PAD-WORD	O

DATE	O
OF	O
BIRTH	O
:	O

April	O
1	O
,	O
1923	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
occipital	I-problem
,	I-problem
cerebral	I-problem
infarction	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Old	B-problem
inferior	I-problem
wall	I-problem
myocardial	I-problem
infarction	I-problem
in	O
1984	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Head	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
and	O
magnetic	B-test
resonance	I-test
imaging	I-test
angiogram	I-test
with	I-test
and	I-test
without	I-test
gadolinium	I-test
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

Head	B-test
computerized	I-test
tomography	I-test
scan	I-test
,	O
echocardiogram	B-test
,	O
transcranial	B-test
Dopplers	I-test
,	O
carotid	B-test
noninvasives	I-test
,	O
Holter	B-test
electrocardiogram	I-test
,	O
electroencephalogram	B-test
,	O
and	O
visual	B-test
field	I-test
testing	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
72-year-old	O
right-handed	O
gentleman	O
with	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
1984	O
.	O

Also	O
with	O
a	O
history	O
of	O
noninsulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
now	O
presenting	O
with	O
acute	B-problem
blurry	I-problem
vision	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
,	O
which	O
is	O
homonymous	O
.	O

The	O
patient	O
woke	O
up	O
as	O
usual	O
on	O
May	O
8	O
,	O
1995	O
.	O

At	O
8	O
a.m.	O
the	O
patient	O
was	O
looking	O
at	O
his	O
wife	O
with	O
the	O
background	O
outside	O
a	O
large	O
window	O
.	O

The	O
patient	O
had	O
sudden	O
onset	O
of	O
blurred	B-problem
vision	I-problem
,	O
where	O
the	O
right	O
side	O
of	O
his	O
wife	O
&apos;s	O
face	O
looked	O
blurred	O
.	O

The	O
patient	O
did	O
not	O
notice	O
change	B-problem
of	I-problem
vision	I-problem
in	O
the	O
background	O
.	O

The	B-problem
blurred	I-problem
vision	I-problem
was	O
homonymous	O
,	O
which	O
he	O
had	O
blurred	O
in	O
each	O
eye	O
in	O
the	O
left	O
visual	O
field	O
.	O

The	B-problem
same	I-problem
blurred	I-problem
vision	I-problem
was	O
also	O
noticed	O
later	O
when	O
the	O
patient	O
was	O
watching	O
television	O
and	O
also	O
when	O
he	O
was	O
reading	O
.	O

The	O
patient	O
was	O
seen	O
at	O
the	O
Ochtuheihugh	O
Put	O
University	O
Medical	O
Center	O
and	O
then	O
he	O
was	O
referred	O
to	O
the	O
Purckecation	O
Balpoingdelt	O
Pabarnes-	O
Campa	O
Memorial	O
Hospital	O
.	O

At	O
8	O
p.m.	O
the	O
patient	O
seen	O
at	O
the	O
Purckecation	O
Balpoingdelt	O
Pabarnes-	O
Campa	O
Memorial	O
Hospital	O
and	O
was	O
examined	O
and	O
assessed	O
.	O

The	O
patient	O
was	O
referred	O
to	O
Ph	O
University	O
Of	O
Medical	O
Center	O
for	O
rule	O
out	O
transient	B-problem
ischemic	I-problem
attack	I-problem
and	O
rule	O
out	O
stroke	B-problem
.	O

The	O
patient	O
denies	O
any	B-problem
nausea	I-problem
,	O
vomiting	B-problem
,	O
ataxia	B-problem
,	O
motor	B-problem
deficits	I-problem
,	O
speech	B-problem
deficits	I-problem
or	O
sensory	B-problem
deficits	I-problem
.	O

The	O
patient	O
lightly	O
bumped	O
his	O
head	O
on	O
the	O
top	O
three	O
times	O
on	O
the	O
previous	O
night	O
and	O
the	O
patient	O
had	O
frontal	B-problem
headaches	I-problem
and	O
a	B-problem
tight	I-problem
neck	I-problem
.	O

One	O
hour	O
after	O
he	O
had	O
physical	O
activity	O
on	O
the	O
previously	O
night	O
as	O
well	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
denies	O
any	B-problem
drug	I-problem
allergies	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

is	O
significant	O
for	O
a	B-problem
myocardial	I-problem
infarction	I-problem
in	O
1984	O
.	O

The	O
patient	O
has	O
been	O
on	O
cardiac	B-treatment
medications	I-treatment
since	O
and	O
has	O
had	O
no	O
new	B-problem
episodes	I-problem
.	O

The	O
patient	O
has	O
been	O
diagnosed	O
with	O
diabetes	B-problem
mellitus	I-problem
since	O
1991	O
and	O
has	O
been	O
maintained	O
on	O
Glipizide	B-treatment
.	O

In	O
1992	O
,	O
the	O
patient	O
has	O
been	O
diagnosed	O
with	O
bladder	B-problem
papilloma	I-problem
and	O
has	O
been	O
cystoscoped	O
seven	O
times	O
.	O

The	O
most	O
recent	O
was	O
done	O
on	O
May	O
4	O
,	O
1995	O
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
has	O
a	O
family	O
history	O
of	O
prostate	B-problem
cancer	I-problem
and	O
stroke	B-problem
but	O
no	O
history	O
of	O
migraines	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
stopped	O
smoking	O
10	O
years	O
ago	O
and	O
works	O
as	O
a	O
lawyer	O
20	O
hours	O
per	O
week	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lopressor	B-treatment
25	O
mg	O
PO	O
b.i.d.	O
,	O
Cardizem	B-treatment
30	O
mg	O
po	O
q.i.d.	O
,	O
Zantac	B-treatment
150	O
mg	O
po	O
qd	O
,	O
Isordil	B-treatment
60	O
mg	O
po	O
q	O
a.m.	O
,	O
60	O
mg	O
po	O
q	O
noon	O
,	O
30	O
mg	O
po	O
q	O
p.m.	O
and	O
30	O
mg	O
po	O
q	O
hs	O
,	O
Glipizide	B-treatment
po	O
5	O
mg	O
q	O
a.m.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
was	O
unremarkable	O
.	O

The	O
neck	O
was	O
supple	O
and	O
no	O
goiter	B-problem
was	O
noticed	O
,	O
no	O
bruit	B-problem
was	O
noticed	O
.	O

The	O
lungs	O
were	O
clear	O
.	O

The	O
heart	O
had	O
normal	O
rate	O
and	O
rhythm	O
,	O
with	O
normal	O
Sl	O
and	O
S2	O
and	O
no	O
significant	B-problem
heart	I-problem
murmur	I-problem
was	O
heard	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
flat	O
,	O
nontender	B-problem
,	O
with	O
normal	O
bowel	O
sounds	O
and	O
no	O
hepatosplenomegaly	B-problem
was	O
noticed	O
.	O

No	O
mass	B-problem
was	O
noticed	O
.	O

Capillary	B-test
refill	I-test
was	O
normal	O
and	O
there	O
was	O
no	O
edema	B-problem
.	O

The	O
calves	O
were	O
nontender	B-problem
.	O

On	O
neurological	B-test
examination	I-test
,	O
the	O
patient	O
was	O
alert	O
,	O
oriented	O
to	O
time	O
,	O
place	O
and	O
person	O
.	O

The	O
memory	O
was	O
intact	O
for	O
retention	O
and	O
long-term	O
memory	O
.	O

Fort	O
short-term	O
memory	O
the	O
patient	O
was	O
able	O
to	O
recall	O
one	O
object	O
out	O
of	O
thee	O
at	O
five	O
minute	O
,	O
two	O
out	O
of	O
three	O
with	O
clues	O
and	O
three	O
out	O
of	O
three	O
with	O
multiple	O
choice	O
.	O

The	O
reading	O
,	O
writing	O
,	O
drawing	O
clock	O
and	O
copying	O
cubes	O
were	O
all	O
intact	O
.	O

The	O
speech	O
was	O
fluent	O
and	O
repetition	O
was	O
normal	O
.	O

The	O
pattern	O
recognition	O
was	O
intact	O
.	O

Insight	O
,	O
abstract	O
thinking	O
and	O
______________	O
test	O
were	O
all	O
intact	O
.	O

The	O
patient	O
had	O
mild	O
errors	O
in	O
sequential	O
substracting	O
sevens	O
from	O
100	O
test	O
.	O

The	O
patient	O
was	O
able	O
to	O
follow	O
complex	O
commands	O
of	O
three	O
parts	O
involving	O
right	O
and	O
left	O
side	O
.	O

For	O
cranial	O
nerves	O
the	O
patient	O
had	O
minimal	B-problem
blurred	I-problem
vision	I-problem
in	I-problem
left	I-problem
upper	I-problem
quadrant	I-problem
.	O

The	O
optic	O
fundi	O
was	O
normal	O
.	O

The	B-test
extra	I-test
ocular	I-test
movements	I-test
were	O
full	O
with	O
mild	B-problem
terminal	I-problem
nystagmus	I-problem
,	O
2-3	O
beats	O
,	O
in	O
the	O
right	O
lateral	O
gaze	O
.	O

The	B-test
light	I-test
reflex	I-test
was	O
slightly	B-problem
slow	I-problem
but	O
equal	O
and	O
intact	O
direct	O
and	O
indirectly	O
.	O

The	O
pupils	O
were	O
bilaterally	O
4.5	O
mm	O
and	O
had	O
been	O
dilated	O
at	O
the	O
Purckecation	O
Balpoingdelt	O
Pabarnes-	O
Campa	O
Memorial	O
Hospital	O
.	O

The	O
pupils	O
were	O
round	O
and	O
regular	O
.	O

The	O
nasolabial	O
fold	O
,	O
the	O
wrinkling	O
of	O
forehead	O
and	O
the	O
eye	O
closure	O
were	O
all	O
symmetric	O
and	O
normal	O
.	O

The	O
patient	O
had	O
conduction	B-problem
hearing	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
,	O
which	O
had	O
been	O
old	O
.	O

The	O
tongue	O
was	O
midline	O
and	O
uvula	O
was	O
midline	O
as	O
well	O
.	O

The	O
gag	O
reflex	O
was	O
intact	O
.	O

The	O
sternocleidomastoid	O
and	O
the	O
trapezius	O
muscles	O
were	O
both	O
intact	O
.	O

The	B-test
motor	I-test
examination	I-test
,	O
the	O
tone	O
and	O
bulk	O
were	O
normal	O
.	O

The	O
patient	O
had	O
no	O
pronator	B-problem
drift	I-problem
.	O

The	O
patient	O
had	O
mild	B-problem
weakness	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
with	O
the	B-test
strength	I-test
of	O
5	O
minus	O
on	O
the	O
upper	O
and	O
lower	O
extremities	O
,	O
distally	O
and	O
proximally	O
.	O

The	O
coordination	O
was	O
intact	O
for	O
finger-nose-finger	B-test
test	I-test
,	O
rapid	O
alternating	O
hand	O
movements	O
.	O

The	B-test
heel-shin-test	I-test
was	O
slightly	B-problem
clumsy	I-problem
bilaterally	I-problem
but	O
the	O
knee	O
tapping	O
was	O
normal	O
bilaterally	O
.	O

Sensory	B-test
examination	I-test
:	O

The	O
patient	O
had	O
decreased	B-problem
vibratory	I-problem
sense	I-problem
in	I-problem
the	I-problem
distal	I-problem
lower	I-problem
extremities	I-problem
,	O
worse	O
on	O
the	O
left	O
side	O
.	O

The	O
touch	O
,	O
pain	O
,	O
and	O
position	O
sense	O
were	O
all	O
intact	O
.	O

The	O
patient	O
had	O
reflexes	O
of	O
two-plus	O
bilaterally	O
in	O
the	O
radials	O
,	O
the	O
biceps	O
,	O
the	O
triceps	O
and	O
the	O
knee	O
jerk	O
.	O

The	O
ankle	O
jerks	O
were	O
one-plus	O
bilaterally	O
.	O

The	B-test
Babinski	I-test
&apos;s	I-test
were	O
negative	O
bilaterally	O
.	O

The	B-test
cross	I-test
extension	I-test
reflex	I-test
was	O
positive	O
on	O
the	O
left	O
.	O

The	O
gait	O
was	O
intact	O
and	O
the	O
tandem	O
gait	O
was	O
intact	O
as	O
well	O
.	O

LABORATORY	O
DATA	O
:	O

Complete	B-test
blood	I-test
count	I-test
:	O

white	B-test
blood	I-test
cells	I-test
7	O
,	O
hematocrit	B-test
42.7%	O
,	O
hemoglobin	B-test
14.3	O
,	O
platelets	B-test
161	O
.	O

Differential	O
:	O

69%	B-test
polys	I-test
,	O
60%	B-test
lymphs	I-test
,	O
10%	B-test
monos	I-test
,	O
5%	B-test
eos	I-test
.	O

Prothrombin	B-test
time	I-test
11.7	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
30.4	O
.	O

Urinalysis	O
:	O

over	B-test
100	I-test
red	I-test
blood	I-test
cells	I-test
per	O
high	O
powered	O
field	O
,	O
20-50	B-test
white	I-test
blood	I-test
cells	I-test
per	O
high	O
powered	O
field	O
.	O

Sodium	B-test
139	O
,	O
potassium	B-test
4.7	O
,	O
chloride	B-test
106	O
,	O
bicarbonate	B-test
21.6	O
,	O
BUN	B-test
22	O
,	O
creatinine	B-test
1.6	O
,	O
glucose	B-test
107	O
,	O
amylase	B-test
120	O
,	O
calcium	B-test
8.7	O
,	O
phosphorus	B-test
3.3	O
,	O
magnesium	B-test
1.9	O
,	O
total	B-test
protein	I-test
7.5	O
,	O
albumin	B-test
3.9	O
,	O
globulin	B-test
3.6	O
,	O
uric	B-test
acid	I-test
5.6	O
,	O
alkaline	B-test
phosphatase	I-test
43	O
,	O
GOT	B-test
42	O
,	O
LDH	B-test
549	O
with	O
hemolyzed	B-test
sample	I-test
.	O

Chest	B-test
x-ray	I-test
revealed	O
no	O
pneumonia	B-problem
,	O
no	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

Electrocardiogram	B-test
revealed	O
Q-waves	B-problem
in	I-problem
leads	I-problem
II	I-problem
,	I-problem
III	I-problem
and	I-problem
AVF	I-problem
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
revealed	O
right	B-problem
lower	I-problem
occipital	I-problem
low-density	I-problem
area	I-problem
.	O

Head	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
and	O
magnetic	B-test
resonance	I-test
imaging	I-test
angiogram	I-test
obtained	O
on	O
May	O
11	O
,	O
1995	O
,	O
revealed	O
subacute	B-problem
right	I-problem
lateral	I-problem
occipital	I-problem
lobe	I-problem
infarction	I-problem
and	O
decreased	B-problem
flow	I-problem
related	I-problem
enhancement	I-problem
in	I-problem
the	I-problem
left	I-problem
posterior	I-problem
communicating	I-problem
artery	I-problem
with	O
respect	O
to	O
that	O
on	O
the	O
right	O
.	O

The	O
right	O
suggested	O
decreased	B-problem
flow	I-problem
.	O

Carotid	B-test
noninvasives	I-test
revealed	O
minimal	B-problem
carotid	I-problem
disease	I-problem
.	O

Transcranial	B-test
Dopplers	I-test
:	O

normal	O
posterior	O
and	O
anterior	O
circulation	O
.	O

Holter	B-test
electrocardiogram	I-test
:	O

no	O
significant	B-problem
arrhythmias	I-problem
.	O

Electroencephalogram	B-test
:	O

normal	O
study	O
.	O

Visual	B-test
field	I-test
testing	I-test
:	O

small	B-problem
wedge-shaped	I-problem
visual	I-problem
field	I-problem
defect	I-problem
in	I-problem
right	I-problem
eye	I-problem
,	O
suggesting	O
retinal	B-problem
lesion	I-problem
.	O

Echocardiogram	B-test
revealing	O
segmental	B-problem
left	I-problem
ventricular	I-problem
dysfunction	I-problem
involving	O
inferoseptal	O
,	O
inferior	O
and	O
posterior	O
segments	O
at	O
the	O
base	O
and	O
mid	O
ventricular	O
level	O
.	O

Overall	B-test
left	I-test
ventricle	I-test
systolic	I-test
function	I-test
moderately	B-problem
impaired	I-problem
with	O
and	B-test
estimated	I-test
ejection	I-test
fraction	I-test
of	O
35%	O
.	O

Otherwise	O
,	O
there	O
was	O
pulmonary	B-problem
insufficiency	I-problem
,	O
tricuspid	B-problem
insufficiency	I-problem
,	O
mitral	B-problem
insufficiency	I-problem
and	O
aortic	B-problem
insufficiency	I-problem
.	O

There	O
were	O
no	O
clots	B-problem
seen	O
on	O
the	B-test
echocardiogram	I-test
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
a	B-problem
right	I-problem
occipital	I-problem
cerebral	I-problem
infarction	I-problem
.	O

The	O
patient	O
was	O
started	O
on	O
intravenous	B-treatment
heparin	I-treatment
and	O
had	O
the	B-test
studies	I-test
as	O
described	O
above	O
for	O
rule	O
out	O
source	O
of	O
embolic	B-problem
strokes	I-problem
including	O
carotid	B-test
noninvasives	I-test
,	O
transcranial	B-test
Dopplers	I-test
,	O
Holter	B-test
electrocardiogram	I-test
and	O
echocardiogram	B-test
.	O

The	O
patient	O
also	O
had	O
serial	B-test
electrocardiogram	I-test
,	O
which	O
showed	O
no	O
change	O
.	O

The	O
patient	O
also	O
had	O
serial	B-test
creatinine	I-test
kinase	I-test
with	I-test
MB	I-test
fractions	I-test
studied	O
,	O
which	O
revealed	O
MB	B-test
fraction	I-test
too	B-problem
low	I-problem
to	O
be	O
tested	O
.	O

The	O
patient	O
also	O
experienced	O
a	O
feeling	O
of	O
moving	O
back	O
and	O
forth	O
when	O
lying	O
down	O
with	O
neck	O
extended	O
during	O
the	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
study	I-test
and	O
also	O
in	O
bed	O
.	O

This	B-problem
moving	I-problem
sense	I-problem
,	O
with	O
normal	O
electroencephalogram	O
,	O
was	O
thought	O
to	O
be	O
a	B-problem
mild	I-problem
vestibular	I-problem
dysfunction	I-problem
or	O
from	O
the	O
acute	O
episode	O
of	O
the	B-problem
stroke	I-problem
.	O

The	O
patient	O
will	O
have	O
these	B-problem
symptoms	I-problem
only	O
when	O
the	O
eyes	O
are	O
closed	O
.	O

Our	O
opinion	O
was	O
not	O
to	O
intervene	O
or	O
have	O
any	B-test
further	I-test
studies	I-test
for	O
acute	O
period	O
and	O
to	O
continued	O
to	O
observe	O
.	O

The	O
patient	O
did	O
have	O
a	B-problem
hypotensive	I-problem
episode	I-problem
and	O
the	B-test
systolic	I-test
blood	I-test
pressure	I-test
was	O
80	O
,	O
after	O
the	O
patient	O
received	O
his	B-treatment
regular	I-treatment
cardiac	I-treatment
medications	I-treatment
.	O

The	O
patient	O
had	O
been	O
off	O
his	B-treatment
regular	I-treatment
medications	I-treatment
since	O
during	O
the	O
admission	O
and	O
will	O
be	O
discharged	O
off	O
his	B-treatment
medications	I-treatment
.	O

Otherwise	O
,	O
there	O
were	O
no	O
further	O
episodes	O
of	O
blurred	B-problem
vision	I-problem
.	O

The	O
patient	O
was	O
stable	O
with	O
an	O
unchanged	O
neurological	B-test
and	I-test
physical	I-test
examination	I-test
and	O
was	O
discharged	O
on	O
aspirin	B-treatment
325	O
mg	O
po	O
qd	O
,	O
on	O
May	O
14	O
,	O
1995	O
.	O

The	O
patient	O
will	O
be	O
randomized	O
on	O
the	O
Wars	O
study	O
early	O
next	O
week	O
by	O
the	O
Stroke	O
Service	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
stable	O
with	O
the	B-test
physical	I-test
examination	I-test
as	O
described	O
above	O
.	O

DISCHARGE	O
ORDERS	O
:	O

Medications	B-treatment
-	O
aspirin	B-treatment
325	O
mg	O
po	O
qd	O
,	O
Glipizide	B-treatment
25	O
mg	O
po	O
qd	O
.	O

The	O
patient	O
will	O
be	O
discharged	O
home	O
without	O
his	B-treatment
regular	I-treatment
cardiac	I-treatment
medications	I-treatment
.	O

The	O
patient	O
will	O
be	O
followed	O
by	O
Dr.	O
Ketyvi	O
Liftjesc	O
of	O
the	O
Neurology	O
Service	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
May	O
17	O
,	O
1995	O
,	O
for	O
randomization	O
on	O
the	O
Wars	O
study	O
.	O

The	O
patient	O
will	O
be	O
also	O
followed	O
by	O
Dr.	O
Joseet	O
Gelineau	O
of	O
the	O
Neurology	O
Service	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
.	O

The	O
patient	O
will	O
also	O
be	O
followed	O
by	O
Dr.	O
Margmimaui	O
Gelineau	O
,	O
his	O
primary	O
care	O
physician	O
at	O
Ochtuheihugh	O
Put	O
University	O
Medical	O
Center	O
within	O
one	O
week	O
after	O
discharge	O
.	O

The	O
patient	O
will	O
also	O
be	O
followed	O
by	O
his	O
regular	O
Urologist	O
at	O
Ochtuheihugh	O
Put	O
University	O
Medical	O
Center	O
within	O
one	O
week	O
after	O
discharge	O
for	O
his	B-problem
continuing	I-problem
hematuria	I-problem
.	O

JOSEET	O
GELINEAU	O
,	O
M.D.	O

TR	O
:	O

lj	O
/	O
bmot	O

DD	O
:	O

05/13/95	O
PAD-WORD	O

TD	O
:	O

05/17/95	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Besti	O
Kotebreun	O
,	O
Neurology	O
Service	O
Dr.	O
Margmimaui	O
Gelineau	O
,	O
Ochtuheihugh	O
Put	O
University	O
Medical	O
Center	O

Admission	O
Date	O
:	O

2013-08-05	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-08-15	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1949-01-18	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

In	O
brief	O
,	O
the	O
patient	O
is	O
a	O
64	O
-	O
year-old	O
male	O
with	O
a	O
significant	O
history	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
three	B-problem
myocardial	I-problem
infarctions	I-problem
and	O
also	O
status	O
post	O
five	B-treatment
vessel	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
in	O
'	O
89	O
and	O
status	O
post	O
multiple	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasties	I-treatment
who	O
recently	O
had	O
a	B-test
catheterization	I-test
done	O
in	O
Mississippi	O
and	O
stent	B-treatment
placed	O
in	O
2013-03-24	O
.	O

The	O
patient	O
did	O
well	O
until	O
approximately	O
three	O
to	O
four	O
weeks	O
prior	O
to	O
presentation	O
when	O
he	O
began	O
to	O
experience	O
increased	B-problem
dyspnea	I-problem
on	O
exertion	O
.	O

One	O
week	O
prior	O
to	O
presentation	O
,	O
he	O
had	O
chest	B-problem
pain	I-problem
leading	O
to	O
a	B-test
repeat	I-test
catheterization	I-test
at	O
Springfield	O
on	O
07-30	O
which	O
showed	O
narrowing	B-problem
of	O
the	B-treatment
stent	I-treatment
and	O
an	B-test
ejection	I-test
fraction	I-test
of	O
approximately	O
20%	O
.	O

No	O
intervention	B-treatment
was	O
done	O
at	O
that	O
point	O
.	O

On	O
the	O
evening	O
prior	O
to	O
admission	O
,	O
the	O
patient	O
was	O
awoken	O
with	O
chest	B-problem
pressure	I-problem
radiating	O
to	O
the	O
neck	O
anginal	O

equivalent	O
which	O
was	O
relieved	O
by	O
sublingual	B-treatment
nitroglycerin	I-treatment
.	O

This	O
episode	O
happened	O
three	O
times	O
that	O
night	O
and	O
finally	O
on	O
the	O
fourth	O
re-awakening	O
,	O
the	O
patient	O
presented	O
to	O
the	O
Emergency	O
Department	O
at	O
Springfield	O
and	O
was	O
transferred	O
to	O
the	O
Faulkner	O
Hospital	O
for	O
coronary	B-treatment
revascularization	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem

2.	O
Myocardial	B-problem
infarction	I-problem
x3	I-problem

3.	O
Coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment

4.	O
Systemic	B-problem
lupus	I-problem
erythematosus	I-problem
in	O
remission	O

HOME	O
MEDICATIONS	O
:	O

1.	O
Coreg	B-treatment
6.25	O
mg	O
po	O
bid	O

2.	O
Lasix	B-treatment
25	O
mg	O
po	O
qd	O

3.	O
Imdur	B-treatment
30	O
mg	O
po	O
qd	O

4.	O
K-Dur	B-treatment
10	O
milliequivalents	O
po	O
qd	O

5.	O
Zestril	B-treatment
2.5	O
mg	O
po	O
bid	O

6.	O
Multivitamin	B-treatment

7.	O
Folate	B-treatment

ALLERGIES	O
:	O

He	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAM	O
:	O

VITAL	O
SIGNS	O
:	O

He	O
was	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O

HEART	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
2	I-problem
out	I-problem
of	I-problem
6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
heard	O
loudest	O
at	O
the	O
apex	O
.	O

LUNGS	O
:	O

Clear	O
to	O
auscultation	B-test
.	O

ABDOMEN	O
:	O

Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

EXTREMITIES	O
:	O

No	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O
edema	B-problem
.	O

Palpable	O
DP	O
s	O
bilaterally	O
.	O

PERTINENT	O
LABS	O
:	O

His	B-test
hematocrit	I-test
was	O
44	O
.	O

White	B-test
count	I-test
was	O
8	O
.	O

Potassium	B-test
was	O
3.9	O
.	O

BUN	B-test
and	O
creatinine	B-test
was	O
18	O
and	O
0.9	O
.	O

His	B-test
troponin	I-test
was	O
29.7	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
medically	O
managed	O
initially	O
and	O
then	O
underwent	O
on	O
2013-08-09	O
,	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
x2	O
and	O
a	B-treatment
mitral	I-treatment
valve	I-treatment
annuloplasty	I-treatment
with	O
placement	B-treatment
of	I-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
.	O

He	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
in	O
relatively	O
stable	O
condition	O
.	O

On	O
postoperative	O
day	O
#1	O
,	O
his	B-treatment
balloon	I-treatment
pump	I-treatment
was	O
weaned	O
and	O
the	O
patient	O
was	O
transferred	O
at	O
2	B-treatment
units	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

He	O
also	O
began	O
to	O
wean	O
off	O
the	B-treatment
ventilator	I-treatment
.	O

On	O
postoperative	O
day	O
#1	O
in	O
the	O
evening	O
,	O
the	O
patient	O
was	O
noted	O
to	O
go	O
into	O
atrial	B-problem
fibrillation	I-problem
,	O
for	O
which	O
he	O
was	O
controlled	O
and	O
started	O
on	O
amiodarone	B-treatment
,	O
after	O
which	O
he	O
converted	O
again	O
to	O
normal	O
sinus	O
rhythm	O
.	O

He	O
was	O
extubated	O
during	O
postoperative	O
day	O
#1	O
.	O

On	O
postoperative	O
day	O
#2	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
relatively	O
stable	O
.	O

His	B-treatment
balloon	I-treatment
pump	I-treatment
had	O
already	O
been	O
removed	O
and	O
on	O
postoperative	O
day	O
#3	O
,	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
Lopressor	B-treatment
and	O
amiodarone	B-treatment
in	O
normal	O
sinus	O
rhythm	O
.	O

On	O
the	O
floor	O
,	O
the	O
patient	O
was	O
noted	O
to	O
do	O
extremely	O
well	O
.	O

Physical	O
therapy	O
was	O
consulted	O
and	O
the	O
patient	O
was	O
ambulating	O
extremely	O
well	O
with	O
minimal	O
assistance	O
.	O

On	O
postoperative	O
day	O
#4	O
,	O
he	O
remained	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
on	O
Lopressor	B-treatment
at	O
25	O
mg	O
po	O
bid	O
and	O
an	B-treatment
amiodarone	I-treatment
dose	I-treatment
.	O

His	B-treatment
left	I-treatment
chest	I-treatment
tube	I-treatment
was	O
discontinued	O
at	O
this	O
time	O
and	O
his	B-treatment
right	I-treatment
chest	I-treatment
tube	I-treatment
was	O
removed	O
the	O
following	O
day	O
on	O

postoperative	O
day	O
#5	O
.	O

Currently	O
,	O
the	O
patient	O
is	O
postoperative	O
day	O
#6	O
.	O

He	O
remains	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
and	O
the	O
patient	O
is	O
ambulating	O
to	O
a	O
level	O
5	O
with	O
physical	B-treatment
therapy	I-treatment
and	O
wishes	O
to	O
be	O
discharged	O
home	O
today	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem

2.	O
Mitral	B-problem
valve	I-problem
regurgitation	I-problem
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
x2	O
and	O
mitral	B-treatment
valve	I-treatment
annuloplasty	I-treatment

SECONDARY	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem

2.	O
Myocardial	B-problem
infarction	I-problem
x3	O

3.	O
Coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lopressor	B-treatment
25	O
mg	O
po	O
bid	O

2.	O
Amiodarone	B-treatment
taper	I-treatment
400	O
mg	O
po	O
tid	O
x4	O
days	O
,	O
then	O
bid	O
x7	O
days	O
,	O
qd	O
x7	O
days	O
,	O
then	O
200	O
mg	O
po	O
qd	O

3.	O
Lasix	B-treatment
20	O
mg	O
po	O
qd	O

4.	O
K-Dur	B-treatment
20	O
milliequivalents	O
po	O
qd	O

5.	O
Aspirin	B-treatment
81	O
mg	O
po	O
qd	O

6.	O
Percocet	B-treatment
1	O
to	O
2	O
po	O
q	O
4	O
to	O
6	O
hours	O
prn	O

7.	O
Colace	B-treatment
100	O
mg	O
po	O
bid	O

8.	O
Percocet	B-treatment

9.	O
Protonix	B-treatment
20	O
mg	O
po	O
qd	O

DIGrimmE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
should	O
follow	O
up	O
with	O
Dr.	O
von	O
Diamond	O
in	O
approximately	O
three	O
weeks	O
.	O

The	O
patient	O
should	O
also	O
follow	O
up	O
with	O
his	O
primary	O
care	O
doctor	O
,	O
Dr.	O
Beals	O
,	O
in	O
approximately	O
three	O
weeks	O
.	O

Briley	O
von	O
der	O
Ross	O
,	O
M.D.	O

67-576	O
PAD-WORD	O

Dictated	O
By	O
:	O
Julie	O
H.	O
Bullock	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-08-15	O
07:55	O

T	O
:	O
2013-08-15	O
09:01	O

JOB	O
#:	O

15357	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Santos	O
von	O
der	O
Ross	O
on	O
:	O
WED	O
2013-08-21	O
2:56	O
PM	O

(	O
End	O
of	O
Report	O
)	O

600720722	O
SC	O

86426538	O
PAD-WORD	O

5408181	O
PAD-WORD	O

9/17/2005	O
12:00:00	O
AM	O

pp	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

09/17/2005	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

09/20/2005	O
PAD-WORD	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

CRASSBELBKOTE	O
,	O
NEE	O
537-39-30-6	O
T83	O

Room	O
:	O

EIZ0-059	O
PAD-WORD	O

Service	O
:	O

OBS	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

09/20/05	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

HO	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

GIENGPRATLSHUFF	O
,	O
QUASARZELL	O
KATECHEL	O
,	O
M.D.	O
,	O
PH.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

QH	O
2/6wks	O
,	O

ALLERGY	O
:	O

NKA	B-problem
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

pp	B-problem
/	O
pps	B-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
pp	B-problem

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
pp	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	B-treatment
PAD-WORD	O

Secondary	O
Anesthesia	O
:	O

Local	O
Procedures	O
:	O

PPS	B-problem
,	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

bilateral	B-treatment
tubal	I-treatment
ligation	I-treatment

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T3	O
P0	O
A0	O
L3	O

Estimated	O
EDC	O
:	O

Maternal	O
transfer	O
:	O

No	O
PAD-WORD	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

JOAS	O
,	O
CENI	O
,	O
C.N.M.	O
(	O
FJ992	O
)	O
09/19/05	O
09:50	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2015-11-22	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-11-27	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1942-03-04	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
CCU-GREEN	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
73	O
year	O
old	O
male	O
with	O
a	O
recent	O
history	O
of	O
paroxysmal	B-problem
atrial	I-problem
fibrillation	I-problem
and	O
hypercholesterolemia	B-problem
who	O
presented	O
to	O
the	O
Emergency	O
Department	O
with	O
the	O
chief	O
complaint	O
of	O
syncope	B-problem
.	O

The	O
patient	O
was	O
discharged	O
from	O
The	O
Hospital	O
for	O
Orthopedics	O
with	O
the	O
diagnosis	O
of	O
pulmonary	B-problem
embolism	I-problem
about	O
six	O
months	O
prior	O
to	O
the	O
current	O
admission	O
and	O
was	O
started	O
on	O
Warfarin	B-treatment
.	O

One	O
month	O
prior	O
to	O
this	O
admission	O
,	O
the	O
patient	O
reports	O
not	O
feeling	O
well	O
with	O
worsening	B-problem
gastric	I-problem
distress	I-problem
.	O

A	O
few	O
weeks	O
prior	O
to	O
admission	O
,	O
he	O
fell	O
down	O
on	O
his	O
back	O
and	O
started	O
taking	O
ibuprofen	B-treatment
1000	O
mg	O
once	O
a	O
day	O
for	O
pain	B-problem
and	O
Vioxx	B-treatment
in	O
addition	O
to	O
his	B-treatment
aspirin	I-treatment
and	O
Coumadin	B-treatment
regimen	I-treatment
.	O

The	O
night	O
prior	O
to	O
admission	O
,	O
he	O
was	O
found	O
by	O
his	O
wife	O
on	O
the	O
bathroom	O
floor	O
in	O
a	O
pool	O
of	O
urine	O
,	O
unresponsive	B-problem
without	O
any	O
body	O
movements	O
,	O
post-ictal	B-problem
state	I-problem
.	O

EMS	O
was	O
activated	O
,	O
however	O
,	O
the	O
patient	O
refused	O
to	O
go	O
to	O
the	O
hospital	O
.	O

A	O
similar	O
episode	O
happened	O
at	O
2	O
a.m.	O
the	O
same	O
night	O
and	O
at	O
07:45	O
on	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
lost	O
consciousness	O
once	O
again	O
when	O
he	O
was	O
trying	O
to	O
sit	O
up	O
.	O

He	O
was	O
then	O
transferred	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
.	O

The	O
patient	O
reports	O
some	B-problem
nausea	I-problem
and	O
epigastric	B-problem
pressure	I-problem
which	O
is	O
post-prandial	O
.	O

He	O
denies	O
any	O
emesis	B-problem
,	O
melena	B-problem
,	O
diarrhea	B-problem
or	O
constipation	B-problem
.	O

He	O
describes	O
the	O
room	O
spinning	O
with	O
attempts	O
to	O
sit	O
upright	O
.	O

No	O
history	O
of	O
previous	O
episodes	O
was	O
noted	O
.	O

Denies	O
incontinence	B-problem
.	O

He	O
does	O
have	O
diaphoresis	B-problem
and	O
weakness	B-problem
with	O
orthostatic	O
changes	O
.	O

In	O
the	O
Emergency	O
Department	O
,	O
stool	B-test
guaiac	I-test
was	O
trace	B-problem
positive	I-problem
.	O

Hematocrit	B-test
was	O
24.8	O
,	O
with	O
a	O
baseline	O
of	O
46	O
.	O

Gastric	B-treatment
lavage	I-treatment
was	O
grossly	O
positive	O
for	O
coffee	B-problem
ground	I-problem
material	I-problem
.	O

His	B-test
INR	I-test
was	O
found	O
to	O
be	O
4.4	O
.	O

He	O
was	O
given	O
Vitamin	B-treatment
K	I-treatment
10	O
mg	O
subcutaneously	O
,	O
2.5	O
liters	O
of	O
normal	B-treatment
saline	I-treatment
,	O
two	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
and	O
two	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
and	O
transferred	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
further	O
management	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hyperthyroid	B-problem
disease	I-problem
status	O
post	O
radioactive	B-treatment
iodine	I-treatment
ablation	I-treatment
,	O
now	O
hypothyroid	B-problem
on	O
Levoxyl	B-treatment
.	O

2.	O
History	O
of	O
pulmonary	B-problem
embolism	I-problem
,	O
etiology	O
unknown	O
.	O

It	O
was	O
thought	O
to	O
be	O
induced	O
by	O
frequent	O
flying	O
to	O
California	O
.	O

The	O
patient	O
was	O
started	O
on	O
Coumadin	B-treatment
five	O
months	O
prior	O
to	O
this	O
admission	O
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

Well	O
controlled	O
on	O
Lipitor	B-treatment
.	O

Last	B-test
total	I-test
cholesterol	I-test
was	O
168	O
in	O
2015-08-24	O
.	O

4.	O
Paroxysmal	B-problem
atrial	I-problem
fibrillation	I-problem
in	O
the	O
setting	O
of	O
pulmonary	B-problem
embolism	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

1.	O
Only	O
significant	O
for	O
a	B-treatment
right	I-treatment
inguinal	I-treatment
hernia	I-treatment
repair	I-treatment
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
.	O

OUTPATIENT	O
MEDICATIONS	O
:	O

1.	O
Lipitor	B-treatment
10	O
mg	O
three	O
times	O
a	O
week	O
.	O

2.	O
Aspirin	B-treatment
81	O
.	O

3.	O
Propranolol	B-treatment
10	O
mg	O
three	O
times	O
a	O
day	O
.	O

4.	O
Coumadin	B-treatment
6.25	O
mg	O
once	O
a	O
day	O
.	O

5.	O
Levoxyl	B-treatment
100	O
mEq	O
q.	O
day	O
.	O

6.	O
Ambien	B-treatment
p.r.n.	O

7.	O
Vitamins	B-treatment
.	O

8.	O
Vioxx	B-treatment
times	O
three	O
weeks	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
quit	O
smoking	O
20	O
years	O
ago	O
;	O
ethanol	O
one	O
glass	O
of	O
wine	O
a	O
day	O
.	O

He	O
is	O
a	O
retired	O
elementary	O
school	O
principal	O
and	O
now	O
works	O
in	O
Johnson	O
management	O
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
mother	O
who	O
has	O
hypertension	B-problem
and	O
stroke	B-problem
at	O
the	O
age	O
of	O
70	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	B-test
was	O
100.3	O
F.	O
;	O
heart	B-test
rate	I-test
was	O
115	O
.	O

In	O
general	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Alert	O
and	O
oriented	O
times	O
three	O
.	O

HEENT	O
:	O

Extraocular	O
movements	O
are	O
intact	O
.	O

Pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	B-test
and	O
accommodation	B-test
bilaterally	O
.	O

Oropharynx	O
clear	O
.	O

Mucosal	O
membranes	O
are	O
moist	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
S1	O
,	O
S2	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Pulmonary	O
clear	O
to	O
auscultation	B-test
anteriorly	O
.	O

Abdomen	O
soft	O
,	O
mildly	B-problem
distended	I-problem
,	O
nontender	B-problem
,	O
positive	O
bowel	O
sounds	O
.	O

Extremities	O
with	O
no	O
edema	B-problem
,	O
one	O
to	O
two	O
pulses	O
in	O
all	O
four	O
extremities	O
.	O

LABORATORY	O
:	O

Sodium	B-test
141	O
,	O
potassium	B-test
4.4	O
,	O
chloride	B-test
108	O
,	O
bicarbonate	B-test
23	O
,	O
BUN	B-test
57	O
,	O
creatinine	B-test
0.7	O
,	O
glucose	B-test
115	O
.	O

White	B-test
blood	I-test
cell	I-test
count	I-test
11.0	O
,	O
differential	B-test
with	O
76	O
neutrophils	B-test
,	O
2	O
monos	B-test
,	O
21	O
lymphocytes	B-test
,	O
and	O
no	O
eosinophils	B-test
.	O

Hematocrit	B-test
24.8	O
,	O
platelets	B-test
223	O
,	O
INR	B-test
2.4	O
,	O
CK	B-test
234	O
.	O

CT	B-test
scan	I-test
of	I-test
the	I-test
head	I-test
showed	O
no	O
hemorrhage	B-problem
or	O
edema	B-problem
.	O

EKG	B-test
showed	O
normal	O
sinus	O
rhythm	O
at	O
90	O
with	O
normal	O
intervals	O
and	O
ST	B-problem
wave	I-problem
inversions	I-problem
and	O
early	B-problem
R	I-problem
wave	I-problem
progression	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
transferred	O
to	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
further	O
management	O
for	O
acute	B-problem
GI	I-problem
bleed	I-problem
.	O

1.	O
Gastrointestinal	B-problem
bleed	I-problem
:	O

The	O
patient	O
continued	O
to	O
receive	O
blood	B-treatment
transfusions	I-treatment
on	O
the	O
floor	O
and	O
serial	B-test
hematocrits	I-test
with	O
serial	B-test
INR	I-test
checks	I-test
were	O
drawn	O
.	O

As	O
he	O
was	O
receiving	O
his	O
third	O
unit	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
the	O
patient	O
became	O
tachycardic	B-problem
and	O
short	B-problem
of	I-problem
breath	I-problem
.	O

His	B-test
temperature	I-test
raised	O
from	O
98.6	O
F.	O
,	O
to	O
101.0	O
F.	O

He	O
was	O
shown	O
to	O
have	O
rigors	B-problem
.	O

The	B-treatment
transfusion	I-treatment
was	O
stopped	O
and	O
the	O
patient	O
was	O
given	O
Tylenol	B-treatment
1	O
mg	O
with	O
epinephrine	B-treatment
,	O
100	O
mg	O
of	O
hydrocortisone	B-treatment
,	O
25	O
mg	O
of	O
Benadryl	B-treatment
and	O
Demerol	B-treatment
15	I-treatment
as	O
well	O
as	O
Pepcid	B-treatment
.	O

He	O
had	O
emesis	B-problem
times	O
three	O
of	O
75	O
cc	O
of	O
coffee	B-problem
ground	I-problem
material	I-problem
.	O

The	O
patient	O
also	O
desaturated	O
to	O
the	O
low	O
80	O
s	O
and	O
was	O
started	O
on	O
a	B-treatment
non-rebreather	I-treatment
mask	I-treatment
.	O

His	B-test
saturations	I-test
improved	O
quickly	O
on	O
100%	B-treatment
non-rebreather	I-treatment
mask	I-treatment
within	O
15	O
to	O
20	O
minutes	O
.	O

Shortly	O
after	O
his	O
mental	O
status	O
changed	O
;	O
he	O
became	O
disoriented	B-problem
and	O
euphoric	B-problem
and	O
continued	O
to	O
be	O
in	O
this	O
state	O
for	O
two	O
more	O
hours	O
.	O

After	O
that	O
period	O
of	O
time	O
,	O
his	O
mental	O
status	O
gradually	O
improved	O
and	O
he	O
continued	O
to	O
receive	O
his	B-treatment
blood	I-treatment
transfusions	I-treatment
requiring	O
a	O
total	O
of	O
ten	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
and	O
four	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
to	O
reach	O
a	B-test
hematocrit	I-test
of	O
30.0	O
,	O
which	O
remained	O
stable	O
for	O
the	O
duration	O
of	O
his	O
stay	O
.	O

On	O
admission	O
,	O
the	O
patient	O
was	O
started	O
on	O
high	B-treatment
dose	I-treatment
proton	I-treatment
pump	I-treatment
inhibitors	I-treatment
for	O
prophylaxis	B-treatment
.	O

On	O
Wednesday	O
,	O
11-25	O
,	O
an	B-test
esophagogastroduodenoscopy	I-test
was	O
performed	O
and	O
was	O
significant	O
for	O
the	O
following	O
findings	O
:	O

Medium	B-problem
hiatal	I-problem
hernia	I-problem
,	O
Barrett's	B-problem
esophagus	I-problem
,	O
erosion	B-problem
of	I-problem
the	I-problem
gastroesophageal	I-problem
junction	I-problem
,	O
granularity	B-problem
,	O
erythema	B-problem
and	O
congestion	B-problem
of	I-problem
the	I-problem
antrum	I-problem
in	O
the	O
pre-pyloric	O
region	O
compatible	O
with	O
gastritis	B-problem
.	O

Erosions	B-problem
in	I-problem
the	I-problem
antrum	I-problem
and	I-problem
pre-pyloric	I-problem
region	I-problem
,	O
granularity	B-problem
,	O
erythema	B-problem
and	O
congestion	B-problem
of	I-problem
the	I-problem
anterior	I-problem
bulb	I-problem
and	I-problem
posterior	I-problem
bulb	I-problem
compatible	O
with	O
duodenitis	B-problem
.	O

It	O
was	O
recommended	O
by	O
Gastroenterology	O
that	O
the	O
patient	O
is	O
to	O
stay	O
off	O
aspirin	B-treatment
for	O
at	O
least	O
four	O
to	O
six	O
weeks	O
at	O
discharge	O
to	O
prevent	O
further	B-problem
bleeding	I-problem
.	O

2.	O
Cardiovascular	O
:	O

During	O
transfusion	B-problem
reaction	I-problem
episode	I-problem
,	O
the	O
patient	O
had	O
an	O
episode	O
of	O
tachycardia	B-problem
ranging	O
from	O
134	O
to	O
158	O
,	O
for	O
one	O
to	O
two	O
hours	O
.	O

EKG	B-test
during	O
this	O
episode	O
was	O
taken	O
and	O
showed	O
sinus	B-problem
tachycardia	I-problem
;	O
however	O
,	O
serial	B-test
enzymes	I-test
were	O
significant	O
for	O
CK	B-test
peaking	O
at	O
1075	O
,	O
MB	B-test
peaking	O
at	O
114	O
and	O
MB	B-test
index	I-test
peaking	O
at	O
10.8	O
,	O
consistent	O
with	O
myocardial	B-problem
damage	I-problem
.	O

The	O
day	O
following	O
this	O
episode	O
,	O
EKG	B-test
showed	O
loss	B-problem
of	I-problem
R	I-problem
wave	I-problem
progression	I-problem
in	O
anterior	O
leads	O
and	O
Q	B-problem
waves	I-problem
in	I-problem
leads	I-problem
III	I-problem
and	O
AVF	B-problem
consistent	O
with	O
anteroseptal	B-problem
myocardial	I-problem
infarction	I-problem
.	O

The	B-test
patient	I-test
's	I-test
blood	I-test
pressures	I-test
remained	O
stable	O
during	O
his	O
stay	O
.	O

He	O
had	O
no	O
episodes	O
of	O
arrhythmia	B-problem
on	O
Telemetry	B-test
.	O

Cardiology	O
consultation	O
was	O
obtained	O
.	O

The	B-problem
myocardial	I-problem
infarction	I-problem
was	O
attributed	O
to	O
demand	B-problem
ischemia	I-problem
secondary	O
to	O
acute	B-problem
hematocrit	I-problem
drop	I-problem
exacerbated	O
by	O
tachycardia	B-problem
secondary	O
to	O
blood	B-problem
transfusion	I-problem
reaction	I-problem
.	O

Further	B-test
Cardiologic	I-test
work-up	I-test
was	O
suggested	O
as	O
an	O
outpatient	O
at	O
four	O
to	O
six	O
weeks	O
post	O
discharge	O
.	O

The	O
patient	O
was	O
started	O
on	O
Lopressor	B-treatment
,	O
Lipitor	B-treatment
and	O
Lisinopril	B-treatment
.	O

3.	O
After	O
ten	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
and	O
four	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
transfusions	I-treatment
,	O
the	B-test
patient	I-test
's	I-test
hematocrit	I-test
remained	O
stable	O
at	O
above	O
30	O
.	O

His	B-test
INR	I-test
decreased	O
to	O
1.3	O
at	O
the	O
time	O
of	O
discharge	O
.	O

He	O
required	O
no	O
blood	B-treatment
transfusions	I-treatment
for	O
four	O
days	O
prior	O
to	O
discharge	O
.	O

4.	O
History	O
of	O
pulmonary	B-problem
embolism	I-problem
likely	O
secondary	O
to	O
frequent	O
flying	O
.	O

The	O
need	O
for	O
further	B-treatment
anti-coagulation	I-treatment
was	O
discussed	O
with	O
the	O
patient	O
's	O
attending	O
,	O
Dr.	O
Coleman	O
,	O
and	O
it	O
was	O
decided	O
not	O
to	O
continue	O
anti-coagulation	B-treatment
due	O
to	O
increased	O
risk	B-problem
of	I-problem
gastrointestinal	I-problem
bleeding	I-problem
.	O

The	O
patient	O
remained	O
symptom	O
free	O
during	O
his	O
stay	O
in	O
the	O
hospital	O
,	O
saturating	O
well	O
in	O
room	O
air	O
.	O

5.	O
Endocrine	O
:	O

The	O
patient	O
was	O
restarted	O
on	O
Levothyroxine	B-treatment
soon	O
after	O
admission	O
.	O

His	B-test
hemoglobin	I-test
A1C	I-test
was	O
sent	O
and	O
it	O
was	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

6.	O
Single	B-problem
mental	I-problem
status	I-problem
change	I-problem
times	O
two	O
hours	O
during	O
episode	O
of	O
blood	B-problem
transfusion	I-problem
reaction	I-problem
.	O

Was	O
most	O
likely	O
due	O
to	O
multiple	B-treatment
drugs	I-treatment
administered	O
during	O
the	O
episode	O
including	O
Demerol	B-treatment
.	O

After	O
this	O
episode	O
,	O
the	O
patient	O
's	O
mental	O
status	O
remained	O
clear	O
for	O
the	O
rest	O
of	O
the	O
duration	O
of	O
his	O
stay	O
.	O

7.	O
Prophylaxis	B-treatment
:	O

The	O
patient	O
was	O
sent	O
home	O
on	O
proton	B-treatment
pump	I-treatment
inhibitors	I-treatment
.	O

His	B-test
Helicobacter	I-test
pylori	I-test
serology	I-test
was	O
sent	O
and	O
was	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Good	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
the	B-treatment
following	I-treatment
medications	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Metoprolol	B-treatment
37.5	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

3.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Pantoprazole	B-treatment
40	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Levothyroxine	B-treatment
100	O
micrograms	O
p.o.	O
q.	O
day	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
The	O
patient	O
was	O
to	O
arrange	O
his	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
,	O
Bryan	O
Smith	O
.	O

2.	O
To	O
follow-up	O
with	O
his	O
Cardiologist	O
,	O
Dr.	O
Delores	O
Padilla	O
within	O
one	O
to	O
two	O
weeks	O
of	O
discharge	O
.	O

Tammy	O
Thompson	O
,	O
M.D.	O

40-318	O
PAD-WORD	O

Dictated	O
By	O
:	O
Randolph	O
Q	O
Barber	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-11-26	O
15:15	O

T	O
:	O
2015-11-26	O
16:10	O

JOB	O
#:	O

90402	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Tammy	O
Thompson	O
on	O
:	O
FRI	O
2015-11-27	O
8:46	O
PM	O

(	O
End	O
of	O
Report	O
)	O

625433852	O
PAD-WORD	O

FIH	O
PAD-WORD	O

3767370	O
PAD-WORD	O

25103/5cy1	O
PAD-WORD	O

160996	O
PAD-WORD	O

10/1/1994	O
12:00:00	O
AM	O

METASTATIC	B-problem
CANCER	I-problem
TO	I-problem
THE	I-problem
LIVER	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10-01-94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

10-10-94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Metastatic	B-problem
cancer	I-problem
to	I-problem
the	I-problem
liver	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

diabetes	B-problem
mellitus	I-problem
,	O
peripheral	B-problem
neuropathy	I-problem
,	O
rectal	B-problem
carcinoma	I-problem
,	O
premature	B-problem
ventricular	I-problem
contractions	I-problem
,	O
right	B-problem
hemidiaphragmatic	I-problem
paralysis	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

10-02-94	O
left	B-treatment
hepatectomy	I-treatment
,	O
10-01-94	O
celiac	B-test
and	I-test
superior	I-test
mesenteric	I-test
angiogram	I-test
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
60	O
year	O
old	O
diabetic	O
who	O
underwent	O
an	B-treatment
APR	I-treatment
in	O
1989	O
for	O
rectal	B-problem
carcinoma	I-problem
and	O
has	O
been	O
doing	O
following	O
radiation	B-treatment
therapy	I-treatment
and	O
5FU	B-treatment
.	O

He	O
recently	O
developed	O
fatigue	B-problem
and	O
dyspnea	B-problem
and	O
workup	B-test
disclosed	O
a	B-problem
large	I-problem
liver	I-problem
mass	I-problem
which	O
was	O
biopsied	O
and	O
revealed	O
to	O
be	O
poorly	B-problem
differentiated	I-problem
neoplasm	I-problem
most	O
consistent	O
with	O
metastatic	B-problem
rectal	I-problem
discontinued	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

remarkable	O
for	O
diabetes	B-problem
mellitus	I-problem
,	O
premature	B-problem
ventricular	I-problem
contractions	I-problem
,	O
rectal	B-problem
carcinoma	I-problem
,	O
diabetic	B-problem
neuropathy	I-problem
both	O
peripherally	O
and	O
involving	O
the	O
right	O
diaphragm	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Diabeta	B-treatment
10	O
mg.	O
po.	O
bid	O
.	O

Serax	B-treatment
20	O
mg.	O
po.	O
qhs	O
.	O

Sudafed	B-treatment
30	O
mg.	O
po.	O
bid	O
.	O

Theo-dur	B-treatment
300	O
mg.	O
po.	O
bid	O
.	O

Betoptic	B-treatment
0.5%	O
one	O
drop	O
OU	O
bid	O
,	O
Propene	B-treatment
0.1%	O
one	O
drop	O
OU	O
bid	O
,	O
Pred-Forte	B-treatment
1%	O
one	O
drop	O
OS	O
bid	O
,	O
Percocet	B-treatment
two	O
tabs.	O
po.	O
q4hours	O
prn	O
.	O

Proventil	B-treatment
2	O
puffs	O
q6hours	O
prn	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

includes	O
and	O
abdominoperineal	B-treatment
resection	I-treatment
in	O
1989	O
.	O

ALLERGIES	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem

PHYSICAL	O
EXAMINATION	O
:	O

demonstrated	O
an	O
obese	O
man	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

The	B-test
blood	I-test
pressure	I-test
140/75	O
,	O
pulse	B-test
90	O
and	O
irregular	B-problem
,	O
respirations	B-test
20	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
and	I-test
neck	I-test
examinations	I-test
were	O
unremarkable	O
.	O

Cardiac	B-test
examination	I-test
was	O
remarkable	O
for	O
frequent	B-problem
ectopic	I-problem
beats	I-problem
.	O

The	B-test
lung	I-test
examination	I-test
was	O
clear	O
but	O
breath	B-test
sounds	I-test
were	O
more	O
pronounced	O
on	O
the	O
left	O
than	O
the	O
right	O
.	O

Abdomen	O
:	O

soft	O
,	O
obese	B-problem
with	O
mild	B-problem
epigastric	I-problem
and	I-problem
right	I-problem
upper	I-problem
quadrant	I-problem
tenderness	I-problem
.	O

An	B-treatment
intact	I-treatment
colostomy	I-treatment
was	O
present	O
.	O

No	O
masses	B-problem
could	O
be	O
palpated	O
secondary	O
to	O
the	B-problem
patient	I-problem
&apos;s	I-problem
extreme	I-problem
obesity	I-problem
.	O

Extremities	O
:	O

unremarkable	O
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
remarkable	O
for	O
a	B-problem
peripheral	I-problem
neuropathy	I-problem
including	O
decreased	B-problem
sensation	I-problem
in	I-problem
the	I-problem
lower	I-problem
extremities	I-problem
with	O
decreased	B-problem
strength	I-problem
in	I-problem
the	I-problem
upper	I-problem
and	I-problem
lower	I-problem
extremities	I-problem
most	O
pronounced	O
in	O
the	O
legs	O
and	O
feet	O
.	O

A	B-test
chest	I-test
X-ray	I-test
demonstrated	O
right	B-problem
hemidiaphragmatic	I-problem
elevation	I-problem
.	O

The	B-test
electrocardiogram	I-test
was	O
remarkable	O
for	O
trigeminy	B-problem
at	O
91	O
per	O
minute	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
underwent	O
celiac	B-test
and	I-test
superior	I-test
mesenteric	I-test
artery	I-test
angiography	I-test
which	O
demonstrated	O
a	O
patent	O
celiac	O
and	O
superior	O
mesenteric	O
artery	O
with	O
normal	O
branching	O
pattern	O
.	O

His	B-test
preoperative	I-test
workup	I-test
was	O
completed	O
and	O
included	O
a	O
normal	O
white	O
count	O
,	O
hematocrit	B-test
42	O
.	O

normal	O
electrolytes	O
,	O
normal	O
coags	O
and	O
normal	O
renal	O
function	O
.	O

On	O
10-02-94	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
exploratory	B-test
laparotomy	I-test
and	O
left	B-treatment
hepatectomy	I-treatment
and	O
cholecystectomy	B-treatment
by	O
Dr.	O
Duhenile	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
with	O
a	B-problem
2000	I-problem
cc.	I-problem
blood	I-problem
loss	I-problem
and	O
was	O
autotransfused	O
two	O
units	O
of	O
blood	B-treatment
.	O

In	O
the	O
postoperative	O
course	O
Mr.	O
Fyfe	O
did	O
surprisingly	O
well	O
given	O
his	B-problem
underlying	I-problem
medical	I-problem
condition	I-problem
.	O
,	O

He	O
did	O
require	O
two	O
units	O
of	O
transfused	B-treatment
blood	I-treatment
but	O
otherwise	O
did	O
quite	O
well	O
and	O
was	O
extubated	O
on	O
the	O
night	O
of	O
surgery	O
.	O

He	O
remained	O
in	O
the	O
Intensive	O
Care	O
Unit	O
for	O
two	O
days	O
but	O
was	O
hemodynamically	O
stable	O
throughout	O
.	O

He	O
continued	O
to	O
manifest	O
occasional	B-problem
premature	I-problem
ventricular	I-problem
contractions	I-problem
,	O
but	O
these	O
were	O
unchanged	O
from	O
preoperatively	O
and	O
the	O
patient	O
otherwise	O
did	O
well	O
.	O

His	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
discontinued	O
and	O
he	O
was	O
begun	O
on	O
clear	B-treatment
liquids	I-treatment
and	O
subsequently	O
advanced	O
to	O
a	O
regular	O
diet	O
without	O
difficulty	O
.	O

Both	O
of	O
his	B-treatment
Jackson-Pratt	I-treatment
drains	I-treatment
were	O
removed	O
without	O
incident	O
.	O

By	O
postoperative	O
day	O
#	O
7	O
,	O
Mr.	O
Fyfe	O
was	O
tolerating	O
a	B-treatment
regular	I-treatment
ADA	I-treatment
1800	I-treatment
kilocalorie	I-treatment
diet	I-treatment
without	O
difficulty	O
with	O
all	O
of	O
his	B-treatment
tubes	I-treatment
and	O
drains	B-treatment
removed	O
.	O

His	B-problem
wound	I-problem
was	O
noted	O
to	O
be	O
healing	O
well	O
and	O
his	B-treatment
colostomy	I-treatment
functioning	O
appropriately	O
without	O
significant	O
difficulty	O
.	O

He	O
is	O
being	O
transferred	O
back	O
to	O
the	O
Per	O
Naplesspecrycet	O
Hospital	O
in	O
stable	O
condition	O
on	O
the	B-treatment
same	I-treatment
medications	I-treatment
which	O
he	O
was	O
on	O
preoperatively	O
.	O

These	O
include	O
Diabeta	B-treatment
10	O
mg.	O
po.	O
bid	O
.	O

Serax	B-treatment
20	O
mg.	O
po.	O
qhs	O
.	O

Sudafed	B-treatment
30	O
po.	O
bid	O
.	O

Theo-dur	B-treatment
300	O
mg.	O
po.	O
bid	O
.	O

Betoptic	B-treatment
0.5%	O
one	O
drop	O
OU	O
bid	O
,	O
Propene	B-treatment
0.1%	O
one	O
drop	O
OU	O
bid	O
.	O

Pred-Forte	B-treatment
1%	O
one	O
drop	O
OS	O
bid	O
.	O

Percocet	B-treatment
two	O
tabs	O
po.	O
q4h	O
prn	O
.	O

Proventil	B-treatment
2	O
puffs	O
q6hours	O
prn	O
..	O

The	O
patient	O
will	O
followup	O
with	O
Dr.	O
Fede	O
Duhenile	O
in	O
two	O
weeks	O
in	O
Dr.	O
Duhenile	O
&apos;s	O
office	O
.	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

FEDE	O
A.	O
DUHENILE	O
,	O
M.D.	O

TR	O
:	O

eb	O
/	O
bmot	O

DD	O
:	O

10-10-94	O
PAD-WORD	O

TD	O
:	O

10/09/94	O
PAD-WORD	O

CC	O
:	O

STAT	O
PAD-WORD	O

﻿Admission	O
Date	O
:	O

2012-05-08	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-05-18	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2012-05-08	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

Neonatology	O
PAD-WORD	O

HISTORY	O
:	O

Baby	O
Barbara	O
Stead	O
is	O
a	O
term	O
infant	O
admitted	O
with	O
increasing	B-problem
head	I-problem
circumference	I-problem
and	O
bruising	B-problem
.	O

He	O
was	O
born	O
to	O
a	O
31-year-old	O
G1	O
P0	O
now	O
1	O
mother	O
with	O
unremarkable	O
prenatal	O
screens	O
as	O
follows	O
:	O

O	B-test
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
rubella	B-test
immune	I-test

PREGNANCY	O
HISTORY	O
:	O

Estimated	O
date	O
of	O
delivery	O
was	O
2012-05-14	O
for	O
estimated	O
gestational	O
age	O
of	O
39-1/7	O
weeks	O
.	O

Pregnancy	O
was	O
complicated	O
by	O
oligohydramnios	B-problem
with	O
an	B-test
AFI	I-test
of	O
3.5	O
and	O
by	O
multiple	B-test
evaluations	I-test
for	O
decreased	B-problem
fetal	I-problem
movement	I-problem
.	O

There	O
was	O
spontaneous	B-problem
onset	I-problem
of	I-problem
labor	I-problem
progressing	O
through	O
vacuum	B-treatment
assisted	I-treatment
vaginal	I-treatment
delivery	I-treatment
under	O
epidural	B-treatment
anesthesia	I-treatment
.	O

clear	O
amniotic	O
fluid	O
,	O
no	O
antepartum	B-problem
maternal	I-problem
fever	I-problem
or	O
fetal	B-problem
tachycardia	I-problem
,	O
no	O
antepartum	B-treatment
antibiotic	I-treatment
prophylaxis	I-treatment
.	O

Baby	O
was	O
vigorous	O
at	O
delivery	O
,	O
was	O
bulb	B-treatment
suction	I-treatment
,	O
dried	O
,	O
and	O
had	O
free	B-treatment
flow	I-treatment
oxygen	I-treatment
administered	O
briefly	O
.	O

Apgars	B-test
were	O
nine	O
and	O
nine	O
.	O

In	O
the	O
Newborn	O
Nursery	O
,	O
he	O
initially	O
had	O
a	B-problem
caput	I-problem
which	O
increased	O
in	O
the	O
amount	O
of	O
swelling	B-problem
and	O
bruising	B-problem
in	O
the	O
subsequent	O
24	O
hours	O
.	O

He	O
was	O
then	O
referred	O
to	O
the	O
CMED	O
CCU	O
for	O
assessment	B-test
and	O
management	B-treatment
of	O
the	B-problem
increased	I-problem
bleeding	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
UPON	O
ADMISSION	O
TO	O
THE	O
CMED	O
CCU	O
:	O

Birth	B-test
weight	I-test
was	O
3850	O
grams	O
.	O

Head	B-test
circumference	I-test
was	O
41	O
cm	O
.	O

HEENT	B-test
was	O
significant	O
for	O
swelling	B-problem
of	I-problem
the	I-problem
scalp	I-problem
tissue	I-problem
in	O
generalized	O
distribution	O
with	O
ecchymosis	B-problem
extending	O
from	O
the	O
occiput	O
to	O
the	O
posterior	O
auricular	O
area	O
and	O
dorsal	O
aspect	O
of	O
the	O
neck	O
to	O
the	O
mid	O
cervical	O
level	O
.	O

Ears	O
were	O
displaced	O
forward	O
.	O

Eyes	O
were	O
normal	O
.	O

Neck	O
and	O
mouth	O
were	O
normal	O
.	O

No	O
nasal	B-problem
flaring	I-problem
.	O

Chest	O
:	O

No	O
retractions	B-problem
,	O
good	O
breath	O
sounds	O
bilaterally	O
,	O
no	O
crackles	B-problem
.	O

Cardiovascular	O
:	O

Regular	O
,	O
rate	O
,	O
and	O
rhythm	O
.	O

Femoral	B-test
pulses	I-test
normal	O
,	O
S1	O
,	O
S2	O
were	O
normal	O
.	O

There	O
was	O
a	B-problem
1/6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
in	O
the	O
upper	O
left	O
sternal	O
border	O
without	O
radiation	B-problem
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
no	O
organomegaly	B-problem
,	O
no	O
masses	B-problem
.	O

Bowel	B-test
sounds	I-test
are	O
active	O
and	O
patent	O
.	O

CNS	O
active	O
,	O
responsive	O
to	O
stimulation	B-test
.	O

Pupils	O
are	O
reactive	O
to	O
light	O
.	O

Tone	B-test
is	O
normal	O
,	O
moving	O
all	O
limbs	O
symmetrically	O
,	O
irritable	B-problem
with	O
palpation	B-test
of	I-test
the	I-test
scalp	I-test
.	O

Suck	B-test
,	O
root	B-test
,	O
gag	B-test
,	O
grasp	B-test
,	O
and	O
morrow	B-test
were	O
normal	O
.	O

Skin	O
:	O

Pale	O
as	O
above	O
,	O
nonicteric	B-problem
.	O

Musculoskeletal	O
:	O

Normal	O
spine	O
,	O
hip	O
,	O
clavicles	O
,	O
small	B-problem
mass	I-problem
at	O
the	O
site	O
of	O
previous	B-treatment
right	I-treatment
quadriceps	I-treatment
intramuscular	I-treatment
injection	I-treatment
.	O

An	B-test
initial	I-test
head	I-test
CT	I-test
scan	I-test
had	O
revealed	O
extracranial	B-problem
soft	I-problem
tissue	I-problem
swelling	I-problem
most	O
prominently	O
at	O
the	O
right	O
frontal-parietal-occipital	O
area	O
extending	O
to	O
the	O
left	O
and	O
to	O
the	O
upper	O
cervical	O
region	O
.	O

Ventricles	O
were	O
symmetrical	O
and	O
not	O
compressed	O
.	O

No	O
gross	B-problem
intraparenchymal	I-problem
hemorrhage	I-problem
.	O

But	O
upon	O
further	O
radiology	O
attending	O
Stoughton	O
,	O
there	O
was	O
a	B-problem
small	I-problem
bilateral	I-problem
occipital	I-problem
subdural	I-problem
hemorrhage	I-problem
noted	O
.	O

The	B-test
initial	I-test
hematocrit	I-test
was	O
21.2	O
,	O
platelets	B-test
186	O
.	O

PT	B-test
was	O
14.6	O
,	O
PTT	B-test
77	O
with	O
an	B-test
INR	I-test
of	O
1.4	O
.	O

Fibrinogen	B-test
was	O
192	O
.	O

D-dimer	B-test
was	O
negative	O
.	O

ASSESSMENT	O
:	O

This	O
is	O
a	O
term	O
infant	O
with	O
significant	B-problem
subgaleal	I-problem
hematoma	I-problem
with	O
apparent	O
extension	O
over	O
the	O
past	O
six	O
hours	O
.	O

There	O
was	O
also	O
elevation	B-problem
of	O
the	B-test
PTT	I-test
suggesting	O
possible	O
inborn	B-problem
coagulopathy	I-problem
.	O

There	O
is	O
also	O
critical	B-problem
anemia	I-problem
secondary	O
to	O
the	B-problem
subgaleal	I-problem
hemorrhage	I-problem
.	O

He	O
was	O
admitted	O
to	O
the	O
CMED	O
CCU	O
for	O
further	B-treatment
management	I-treatment
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

1.	O
Respiratory	O
:	O

Patient	O
has	O
been	O
on	O
room	O
air	O
maintaining	O
sats	B-test
above	O
95%	O
.	O

No	O
apnea	B-problem
or	O
bradycardia	B-problem
.	O

2.	O
Cardiovascular	O
:	O

There	O
was	O
an	B-problem
initial	I-problem
murmur	I-problem
on	O
admission	O
likely	O
secondary	O
to	O
severe	B-problem
anemia	I-problem
which	O
has	O
since	O
resolved	O
.	O

He	O
remained	O
hemodynamically	O
stable	O
throughout	O
this	O
admission	O
.	O

3.	O
FEN	O
:	O

Patient	O
was	O
restarted	O
on	O
po	O
feeds	O
as	O
of	O
day	O
of	O
life	O
three	O
after	O
the	B-problem
bleeding	I-problem
had	O
stabilized	O
.	O

He	O
has	O
been	O
taking	O
breast	O
milk	O
or	O
Enfamil	O
20	O
po	O
adlib	O
.	O

His	B-test
admission	I-test
weight	I-test
was	O
3850	O
grams	O
.	O

His	B-test
weight	I-test
on	I-test
discharge	I-test
was	O
4055	O
.	O

4.	O
GI	O
:	O

Given	O
the	O
significant	O
amount	O
of	O
bleeding	B-problem
,	O
baby	O
was	O
started	O
prophylactically	O
on	O
phototherapy	B-treatment
.	O

His	B-test
bilirubin	I-test
peaked	O
on	O
day	O
of	O
life	O
three	O
at	O
5.4	O
with	O
a	B-test
subsequent	I-test
bilirubin	I-test
of	O
4.6	O
at	O
which	O
time	O
phototherapy	B-treatment
was	O
discontinued	O
.	O

5.	O
Hematology	O
:	O

Given	O
the	O
rapid	O
extension	O
of	O
the	B-problem
subgaleal	I-problem
bleed	I-problem
,	O
coagulopathy	B-test
workup	I-test
was	O
initiated	O
revealing	O
an	B-problem
elevated	I-problem
PTT	I-problem
level	I-problem
of	O
77	O
as	O
well	O
as	O
factor	B-test
8	I-test
level	I-test
that	O
was	O
below	O
detection	O
in	O
the	O
presence	O
of	O
normal	O
factors	O
5	O
,	O
9	O
,	O
10	O
,	O
and	O
11	O
.	O

He	O
was	O
started	O
on	O
a	B-treatment
50	I-treatment
units	I-treatment
/	I-treatment
kg	I-treatment
bolus	I-treatment
of	I-treatment
factor	I-treatment
8	I-treatment
followed	O
by	O
continuous	B-treatment
factor	I-treatment
8	I-treatment
infusions	I-treatment
at	O
50	O
units	O
/	O
kg	O
/	O
day	O
divided	O
until	O
hourly	O
infusion	O
rates	O
at	O
05-10	O
.	O

Subsequent	B-test
factor	I-test
8	I-test
levels	I-test
varied	O
with	O
an	B-test
initial	I-test
factor	I-test
8	I-test
level	I-test
of	O
18	O
after	O
the	B-treatment
bolus	I-treatment
with	O
which	O
he	O
received	O
another	O
bolus	O
of	O
factor	B-treatment
8	I-treatment
of	O
50	O
units	O
/	O
kg	O
and	O
increased	B-treatment
factor	I-treatment
8	I-treatment
infusion	I-treatment
rate	I-treatment
to	O
65	O
units	O
/	O
kg	O
/	O
day	O
.	O

As	O
of	O
05-17	O
,	O
he	O
was	O
switched	O
over	O
to	O
bolus	B-treatment
infusion	I-treatment
in	O
preparation	O
of	O
continued	B-treatment
home	I-treatment
factor	I-treatment
8	I-treatment
administration	I-treatment
.	O

His	B-test
peak	I-test
level	I-test
after	O
a	O
bolus	O
of	O
75	O
units	O
/	O
kg	O
of	O
factor	B-treatment
8	I-treatment
was	O
131	O
.	O

A	B-test
trough	I-test
level	I-test
at	O
20	O
hours	O
after	O
the	B-treatment
bolus	I-treatment
on	O
day	O
of	O
discharge	O
was	O
29	O
.	O

He	O
will	O
continue	O
to	O
receive	O
factor	B-treatment
8	I-treatment
bolus	I-treatment
q	O
day	O
for	O
a	O
total	O
of	O
2-3	O
weeks	O
in	O
light	O
of	O
the	B-problem
intracranial	I-problem
hemorrhage	I-problem
,	O
and	O
will	O
be	O
followed	O
by	O
Hematology	O
visiting	O
nurse	O
Michael	O
Edwards	O
level	O
checks	O
at	O
home	O
.	O

Currently	O
,	O
the	B-treatment
infusion	I-treatment
of	O
factor	B-treatment
8	I-treatment
are	O
going	O
through	O
a	B-treatment
jugular	I-treatment
Broviac	I-treatment
which	O
was	O
placed	O
on	O
05-15	O
for	O
administration	O
of	O
factor	B-treatment
.	O

His	B-test
last	I-test
PTT	I-test
on	O
05-16	O
was	O
68.3	O
.	O

The	B-test
last	I-test
hematocrit	I-test
was	O
on	O
05-16	O
of	O
54.5	O
.	O

6.	O
Neurology	O
:	O

Baby	O
Mary	O
Stead	O
initially	O
presented	O
with	O
significant	B-problem
subgaleal	I-problem
bleed	I-problem
as	O
well	O
as	O
a	B-problem
small	I-problem
subdural	I-problem
hemorrhage	I-problem
.	O

A	B-test
repeat	I-test
head	I-test
CT	I-test
scan	I-test
on	O
05-15	O
had	O
shown	O
the	O
resolution	O
of	O
the	B-problem
subdural	I-problem
hematoma	I-problem
and	O
significant	O
improvement	O
of	O
the	B-problem
subgaleal	I-problem
bleed	I-problem
.	O

His	B-test
head	I-test
ultrasound	I-test
on	O
05-14	O
reveals	O
no	O
interventricular	B-problem
hemorrhage	I-problem
.	O

He	O
had	O
remained	O
neurologically	O
stable	O
.	O

His	B-test
head	I-test
circumference	I-test
on	O
05-18	O
was	O
36.5	O
cm	O
with	O
a	B-test
maximum	I-test
head	I-test
circumference	I-test
on	O

admission	O
of	O
40.5	O
cm	O
.	O

7.	O
Social	O
:	O

Both	O
parents	O
are	O
very	O
involved	O
in	O
the	O
care	O
of	O
Baby	O
Norman	O
Stead	O
.	O

They	O
have	O
been	O
informed	O
up	O
to	O
date	O
on	O
his	O
needs	O
,	O
discharge	O
from	O
the	O
hospital	O
.	O

Teaching	O
has	O
been	O
completed	O
on	O
the	O
care	O
of	O
the	B-treatment
Boviak	I-treatment
as	O
well	O
as	O
administration	O
of	O
factor	B-treatment
8	I-treatment
.	O

8.	O
Sensory	O
:	O

Audiology	O
:	O

Hearing	B-test
screen	I-test
was	O
performed	O
automated	O
auditory	O
brain	O
stem	O
responses	O
and	O
Baby	O
David	O
Stead	O

passed	O
bilaterally	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Baby	O
Julian	O
Stead	O
had	O
been	O
stable	O
with	O
improvement	O
of	O
the	B-problem
subgaleal	I-problem
bleed	I-problem
and	O
good	O
peak	O
and	O
trough	O
factor	O
8	O
levels	O
after	O
the	B-treatment
bolus	I-treatment
infusion	I-treatment
.	O

DISPOSITION	O
:	O

Baby	O
Corine	O
Stead	O
is	O
to	O
be	O
discharged	O
home	O
with	O
parents	O
with	O
close	O
Hematology	O
VNA	O
followup	O
.	O

NAME	O
OF	O
PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Pearly	O
Reilly	O
,	O
208-4200	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

1.	O
Feeds	O
at	O
discharge	O
:	O

Breast	O
milk	O
Enfamil	O
20	O
po	O
adlib	O
as	O
tolerated	O
.	O

2.	O
Medications	O
:	O

Factor	B-treatment
8	I-treatment
boluses	I-treatment
at	O
75	O
units	O
/	O
kg	O
/	O
day	O
.	O

3.	O
Car	B-test
seat	I-test
position	I-test
screening	I-test
passed	O
.	O

4.	O
State	B-test
Newborn	I-test
Screen	I-test
sent	O
.	O

5.	O
Immunizations	O
:	O

Received	O
hepatitis	B-treatment
B	I-treatment
vaccination	I-treatment
on	O
05-16	O
.	O

FOLLOW-UP	O
APPOINTMENT	O
:	O

Scheduled	O
for	O
05-21	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Factor	B-problem
8	I-problem
deficiency	I-problem
.	O

2.	O
Subgaleal	B-problem
hemorrhage	I-problem
,	O
resolved	O
.	O

3.	O
Small	B-problem
occipital	I-problem
subdural	I-problem
hemorrhage	I-problem
,	O
resolved	O

Reviewed	O
By	O
:	O
Mavis	O
W.	O
Mobley,	O
M.D.	O

21-114	O
PAD-WORD	O

Dictated	O
By	O
:	O
William	O
A.	O
Hunter	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2012-05-18	O
13:58	O

T	O
:	O
2012-05-18	O
14:22	O

JOB	O
#:	O

93716	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
George	O
Sherwood	O
on	O
:	O
MON	O
2012-05-21	O
11:57	O
AM	O

(	O
End	O
of	O
Report	O
)	O

649917202	O
DH	O

8205558	O
PAD-WORD	O

997074	O
PAD-WORD	O

322941	O
PAD-WORD	O

3/25/2001	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

DULDKOTE	O
,	O
EI	O
N	O

UNIT	O
NUMBER	O
:	O

904-33-96	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

03/25/2001	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

03/26/2001	O
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

Right	B-problem
shoulder	I-problem
instability	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
30-year-old	O
right	O
hand	O
dominant	O
gentleman	O
who	O
pleasant	O
Software	O
Engineer	O
.	O

In	O
1989	O
the	O
patient	O
was	O
dunking	O
a	O
basketball	O
and	O
injured	O
his	O
right	O
shoulder	O
with	O
abduction	B-problem
external	I-problem
rotation	I-problem
injury	I-problem
.	O

He	O
has	O
had	O
persistent	B-problem
pain	I-problem
over	O
the	O
years	O
which	O
has	O
worsened	O
in	O
the	O
past	O
several	O
months	O
including	O
inability	B-problem
to	I-problem
sleep	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
unremarkable	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Knee	B-treatment
surgery	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

None	O
.	O

SOCIAL	O
HISTORY	O
:	O

Occasional	O
alcohol	O
,	O
does	O
not	O
smoke	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

In	O
Clinic	O
his	B-test
cervical	I-test
spine	I-test
examination	I-test
was	O
benign	O
.	O

Shoulder	B-test
elevation	I-test
is	O
170	O
degrees	O
with	O
70	O
degrees	O
of	O
external	O
rotation	O
and	O
internal	O
rotation	O
of	O
the	O
right	O
shoulder	O
to	O
T9	O
vertebra	O
versus	O
T7	O
on	O
the	O
left	O
.	O

Rotator	O
cuff	O
measures	O
4-5	O
on	O
the	O
right	O
and	O
5	O
out	O
of	O
5	O
on	O
the	O
left	O
.	O

Mild	B-problem
pain	I-problem
with	O
resistive	B-test
test	I-test
and	O
his	B-test
Pigott	I-test
sign	I-test
is	O
mildly	O
positive	O
on	O
the	O
right	O
,	O
negative	O
on	O
the	O
left	O
.	O

There	O
is	O
1	O
cm.	O
sulcus	O
sign	O
bilaterally	O
.	O

Laxity	B-problem
is	O
noted	O
as	O
well	O
as	O
markedly	B-problem
positive	I-problem
apprehension	I-problem
sign	I-problem
on	I-problem
the	I-problem
right	I-problem
.	O

Biceps	O
are	O
normal	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Hospital	O
and	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
an	B-treatment
open	I-treatment
Bankart	I-treatment
procedure	I-treatment
with	O
biceps	B-treatment
tenodesis	I-treatment
(	O
Please	O
see	O
the	O
operative	O
note	O
for	O
full	O
details	O
)	O
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
very	O
well	O
and	O
was	O
neurovascularly	O
intact	O
.	O

His	B-problem
wound	I-problem
was	O
intact	O
,	O
clean	O
and	O
dry	O
and	O
it	O
was	O
covered	O
with	O
perioperative	B-treatment
antibiotics	I-treatment
.	O

He	O
was	O
discharged	O
to	O
home	O
on	O
Percocet	B-treatment
.	O

He	O
was	O
given	O
strict	O
instructions	O
to	O
limit	O
his	O
external	O
rotation	O
no	O
more	O
than	O
30	O
degrees	O
.	O

He	O
was	O
seen	O
by	O
physical	O
therapy	O
prior	O
to	O
discharge	O
.	O

FOLLOW	O
UP	O
:	O

He	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Rach	O
Breutznedeaisscarvwierst	O
in	O
Clinic	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Percocet	B-treatment
1-2	O
tablets	O
PO	O
q.4-6	O
hours	O
prn	O
pain	B-problem
.	O

MA	O
ANSHI	O
PIERNREUKOTEFILLE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
RACH	O
HY	O
BREUTZNEDEAISSCARVWIERST	O
,	O
M.D.	O
05/20/2001	O
18:29	O

_____________________________	O
RACH	O
HY	O
BREUTZNEDEAISSCARVWIERST	O
,	O
M.D.	O

TR	O
:	O

wlk	O
PAD-WORD	O

DD	O
:	O

03/26/2001	O
PAD-WORD	O

TD	O
:	O

03/31/2001	O
10:13	O
A	O

cc	O
:	O

RACH	O
HY	O
BREUTZNEDEAISSCARVWIERST	O
,	O
M.D.	O

﻿Admission	O
Date	O
:	O

1989-03-20	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-12-31	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1931-12-09	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

This	O
is	O
an	O
addendum	O
to	O
the	O
discharge	O
summary	O
that	O
was	O
dictated	O
earlier	O
this	O
morning	O
.	O

Continuing	O
throughout	O
his	O
course	O
he	O
had	O
multiple	B-problem
infectious	I-problem
disease	I-problem
issues	I-problem
.	O

He	O
developed	O
zoster	B-problem
for	O
which	O
he	O
received	O
a	B-treatment
course	I-treatment
of	I-treatment
acyclovir	I-treatment
.	O

His	B-test
cultures	I-test
came	O
back	O
as	O
noted	O
with	O
Klebsiella	B-problem
ultimately	O
in	O
his	B-problem
chest	I-problem
wound	I-problem
,	O
MRSA	B-problem
in	O
his	O
sputum	O
.	O

He	O
had	O
multiple	B-problem
sources	I-problem
of	I-problem
yeast	I-problem
.	O

Currently	O
his	B-problem
only	I-problem
yeast	I-problem
source	I-problem
is	O
urine	O
.	O

Negative	O
blood	O
cultures	O
at	O
this	O
point	O
.	O

Also	O
in	O
the	O
course	O
of	O
the	O
month	O
that	O
he	O
was	O
in	O
the	O
ICU	O
he	O
had	O
a	B-treatment
left	I-treatment
chest	I-treatment
tube	I-treatment
placed	O
for	O
fluid	B-problem
and	O
then	O
a	B-treatment
right	I-treatment
chest	I-treatment
tube	I-treatment
placed	O
ultimately	O
for	O
fluid	B-problem
.	O

He	O
received	O
O.T.	O
and	O
P.T.	O
consults	O
.	O

He	O
developed	O
another	O
round	O
of	O
acute	B-problem
renal	I-problem
failure	I-problem
with	O
ATN	B-problem
and	O
casts	B-problem
in	I-problem
his	I-problem
urine	I-problem
.	O

On	O
11-18	O
a	O
DNR	O
order	O
was	O
put	O
into	O
place	O
.	O

He	O
also	O
started	O
treatment	B-treatment
for	O
gallstones	B-problem
with	O
cholestasis	B-problem
on	O
the	O
medication	O
ursodiol	B-treatment
.	O

He	O
received	O
a	O
course	O
of	O
cefepime	B-treatment
also	O
.	O

He	O
continued	O
to	O
have	O
multiple	B-treatment
dressing	I-treatment
changes	I-treatment
after	O
his	B-treatment
split	I-treatment
thickness	I-treatment
skin	I-treatment
grafts	I-treatment
,	O
which	O
he	O
does	O
to	O
this	O
day	O
.	O

In	O
early	O
November	O
he	O
started	O
dialysis	B-treatment
after	O
a	B-treatment
PermCath	I-treatment
was	O
placed	O
.	O

His	B-treatment
Dobbhoff	I-treatment
tube	I-treatment
was	O
removed	O
.	O

He	O
was	O
able	O
to	O
use	O
a	B-treatment
Passy-Muir	I-treatment
valve	I-treatment
intermittently	O
for	O
his	B-treatment
trach	I-treatment
.	O

On	O
12-23	O
he	O
went	O
back	O
to	O
the	O
operating	O
room	O
for	O
open	B-problem
jejunostomy	I-problem
tube	I-problem
dehiscence	I-problem
site	I-problem
.	O

His	B-treatment
J	I-treatment
tube	I-treatment
is	O
now	O
functioning	O
.	O

This	O
was	O
repaired	O
and	O
stay	B-treatment
sutures	I-treatment
are	O
in	O
place	O
.	O

This	O
was	O
done	O
on	O
11-23	O
.	O

On	O
11-24	O
he	O
received	O
a	B-treatment
permanent	I-treatment
DDD	I-treatment
pacemaker	I-treatment
with	O
a	B-treatment
lead	I-treatment
that	O
was	O
externally	O
placed	O
on	O
his	O
chest	O
wall	O
due	O
to	O
his	O
healing	O
and	O
infected	B-problem
chest	I-problem
wound	I-problem
.	O

From	O
the	O
point	O
of	O
discharge	O
today	O
on	O
12-31	O
his	B-test
most	I-test
recent	I-test
labs	I-test
are	O
as	O
follows	O
.	O

White	B-test
count	I-test
13.9	O
,	O
hematocrit	B-test
35.9	O
,	O
platelet	B-test
count	I-test
81,000	O
.	O

Sodium	B-test
139	O
,	O
K	B-test
4.8	O
,	O
chloride	B-test
109	O
,	O
CO2	B-test
31	O
,	O
BUN	B-test
33	O
,	O
creatinine	B-test
2.2	O
,	O
blood	B-test
sugar	I-test
164	O
.	O

Albumin	B-test
2.5	O
.	O

Vancomycin	B-test
level	I-test
was	O
21	O
.	O

To	O
go	O
by	O
systems	O
,	O
currently	O
he	O
is	O
neurologically	O
alert	O
and	O
follows	O
commands	O
.	O

He	O
occasionally	O
gets	O
agitated	B-problem
.	O

From	O
a	O
cardiac	O
point	O
of	O
view	O
,	O
he	O
is	O
in	O
sinus	O
rhythm	O
today	O
.	O

He	O
does	O
have	O
his	B-treatment
pacing	I-treatment
lead	I-treatment
with	O
his	B-treatment
external	I-treatment
pacemaker	I-treatment
DDD	I-treatment
available	O
to	O
him	O
and	O
is	O
being	O
followed	O
by	O
the	O
EP	O
service	O
and	O
Dr.	O
Janet	O
Gutkin	O
for	O
further	O
outpatient	O
treatment	O
of	O
this	O

in	O
the	O
future	O
.	O

From	O
a	O
respiratory	O
point	O
of	O
view	O
,	O
he	O
is	O
on	O
CPAP	B-treatment
and	O
pressure	B-treatment
support	I-treatment
at	O
5	O
and	O
5	O
at	O
40%	O
.	O

He	O
does	O
use	O
the	B-treatment
Passy-Muir	I-treatment
valve	I-treatment
intermittently	O
for	O
his	B-treatment
trach	I-treatment
.	O

He	O
is	O
on	O
a	B-treatment
trach	I-treatment
collar	I-treatment
this	O
week	O
during	O
the	O
day	O
only	O
and	O
rested	O
on	O
the	B-treatment
ventilator	I-treatment
at	O

night	O
.	O

Abdominally	O
,	O
he	O
does	O
have	O
his	B-problem
midabdominal	I-problem
incision	I-problem
with	O
good	O
approximated	O
margins	O
and	O
stay	B-treatment
sutures	I-treatment
in	O
place	O
.	O

From	O
a	O
GI	O
point	O
of	O
view	O
,	O
he	O
is	O
receiving	O
Promote	B-treatment
tube	I-treatment
feeds	I-treatment
through	O
his	B-treatment
jejunostomy	I-treatment
tube	I-treatment
.	O

His	B-problem
chest	I-problem
incision	I-problem
is	O
granulating	O
in	O
well	O
.	O

He	O
currently	O
receives	O
saline	B-treatment
washes	I-treatment
and	O
Adaptic	B-treatment
dressing	I-treatment
changes	I-treatment
twice	O
a	O
day	O
.	O

From	O
a	O
CMED	O
CCU	O
point	O
of	O
view	O
,	O
he	O
gets	O
straight	B-treatment
cathed	I-treatment
every	O
other	O
day	O
.	O

He	O
has	O
a	B-treatment
left	I-treatment
subclavian	I-treatment
PermCath	I-treatment
access	O
for	O
his	B-treatment
dialysis	I-treatment
which	O
takes	O
place	O
on	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
.	O

Hematology	O
.	O

He	O
is	O
HITT	B-test
negative	O
.	O

He	O
has	O
received	O
no	O
transfusions	B-treatment
in	O
the	O
past	O
week	O
or	O
so	O
.	O

His	B-test
hematocrit	I-test
has	O
been	O
stable	O
in	O
the	O
mid-30s	O
.	O

He	O
has	O
a	B-treatment
PICC	I-treatment
line	I-treatment
in	O
place	O
for	O
his	B-treatment
antibiotics	I-treatment
which	O
are	O
as	O
follows	O
.	O

The	B-treatment
PICC	I-treatment
line	I-treatment
was	O
placed	O
on	O
12-29	O
.	O

His	B-treatment
antibiotics	I-treatment
currently	O
are	O
vancomycin	B-treatment
,	O
ceftazidime	B-treatment
,	O
fluconazole	B-treatment
and	O
caspofungin	B-treatment
.	O

I	O
will	O
give	O
doses	O
and	O
administration	O
information	O
in	O
his	O
list	O
of	O
discharge	B-treatment
medications	I-treatment
.	O

In	O
addition	O
,	O
his	B-test
albumin	I-test
today	O
is	O
2.5	O
.	O

He	O
is	O
being	O
covered	O
by	O
regular	B-treatment
insulin	I-treatment
sliding	I-treatment
scale	I-treatment
.	O

Exam	B-test
today	O
shows	O
he	O
is	O
neurologically	O
alert	O
.	O

Heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

He	O
had	O
coarse	B-problem
respiratory	I-problem
sounds	I-problem
.	O

Abdomen	O
was	O
soft	O
.	O

His	B-treatment
graft	I-treatment
is	O
granulating	O
in	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Docusate	B-treatment
sodium	I-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

2.	O
Ursodiol	B-treatment
300	O
mg	O
p.o.	O
b.i.d.	O

3.	O
Ascorbic	B-treatment
acid	I-treatment
500	O
mg	O
p.o.	O
q.d.	O

4.	O
Zinc	B-treatment
sulfate	I-treatment
220	O
mg	O
p.o.	O
q.d.	O

5.	O
Lansoprazole	B-treatment
oral	I-treatment
solution	I-treatment
30	O
mg	O
per	O
gastric	O
tube	O
q.d.	O

6.	O
Caspofungin	B-treatment
acetate	I-treatment
50	O
mg	O
IV	O
q.d.	O
,	O
day	O
23	O
of	O
treatment	B-treatment
and	O
patient	O
should	O
remain	O
on	O
it	O
indefinitely	O
.	O

7.	O
Nephrocaps	B-treatment
one	O
cap	O
p.o.	O
q.d.	O

If	O
on	O
dialysis,	B-treatment
please	O
take	O
after	O
dialysis	B-treatment
treatment	I-treatment
.	O

8.	O
Metoclopramide	B-treatment
5	O
mg	O
p.o.	O
b.i.d.	O
,	O
take	O
30	O
minutes	O
before	O
meals	O
.	O

9.	O
Fluconazole	B-treatment
200	O
mg	O
p.o.	O
q.h.d.	O

Patient	O
should	O
remain	O
on	O
this	O
medication	B-treatment
.	O

10.	O
Magnesium	B-treatment
sulfate	I-treatment
2	O
gm	O
in	O
100	O
ml	O
of	O
D5W	B-treatment
IV	O
as	O
needed	O
for	O
repletion	O
p.r.n.	O

11.	O
Miconazole	B-treatment
powder	I-treatment
2%	O
one	O
application	O
t.p.	O
t.i.d.	O
p.r.n.	O

12.	O
Acetaminophen	B-treatment
325	O
mg	O
to	O
650	O
mg	O
p.o.	O
q.four	O
to	O
six	O
hours	O
p.r.n.	O

13.	O
Albuterol	B-treatment
one	O
to	O
two	O
puffs	O
inhaled	O
q.	O
six	O
hours	O
p.r.n.	O

14.	O
Bisacodyl	B-treatment
10	O
mg	O
per	O
rectum	O
h.s.	O
as	O
needed	O
p.r.n.	O

15.	O
Hydralazine	B-treatment
hydrochloride	I-treatment
10	O
mg	O
IV	O
q.	O
six	O
hours	O
p.r.n.	O
systolic	B-test
blood	I-test
pressure	I-test
greater	O
than	O
140	O
.	O

16.	O
Vancomycin	B-treatment
1	O
gm	O
IV	O
as	O
needed	O
for	O
vancomycin	B-test
level	I-test
less	O
than	O
15	O
.	O

This	O
is	O
day	O
23	O
of	O
treatment	B-treatment
for	O
an	O
approximate	O
six	O
week	O
course	O
.	O

17.	O
Ceftazidime	B-treatment
1	O
gm	O
IV	O
q.h.d.	O
after	O
dialysis	B-treatment
.	O

18.	O
Alteplase	B-treatment
for	O
catheter	O
clearance	O
2	O
mg	O
IV	O
once	O
times	O
one	O
dose	O
for	O
indwelling	B-treatment
PermCath	I-treatment
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Status	O
post	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
and	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
times	O
four	O
.	O

2.	O
Status	O
post	O
sternal	B-treatment
debridement	I-treatment
.	O

3.	O
Status	O
post	O
skin	B-treatment
graft	I-treatment
to	O
chest	B-problem
incision	I-problem
.	O

4.	O
Status	O
post	O
open	B-treatment
jejunostomy	I-treatment
tube	I-treatment
placement	I-treatment
,	O
open	B-treatment
left	I-treatment
subclavian	I-treatment
PermCath	I-treatment
placement	I-treatment
.	O

5.	O
Status	O
post	O
DDD	B-treatment
pacer	I-treatment
placement	I-treatment
with	O
external	B-treatment
generator	I-treatment
.	O

6.	O
Status	O
post	O
abdominal	B-treatment
repair	I-treatment
of	O
wound	B-problem
dehiscence	I-problem
of	I-problem
jejunostomy	I-problem
site	I-problem
.	O

7.	O
Status	O
post	O
percutaneous	B-treatment
tracheostomy	I-treatment
.	O

8.	O
Status	O
post	O
acute	B-problem
renal	I-problem
failure	I-problem
.	O

9.	O
Status	O
post	O
myocardial	B-problem
infarction	I-problem
.	O

10.	O
Hypertension	B-problem
.	O

11.	O
Hypercholesterolemia	B-problem
.	O

12.	O
Asthma	B-problem
.	O

13.	O
Peptic	B-problem
ulcer	I-problem
disease	I-problem
status	O
post	O
gastrectomy	B-treatment
30	O
years	O
ago	O
.	O

14.	O
Colon	B-problem
cancer	I-problem
status	O
post	O
colectomy	B-treatment
with	O
XRT	B-treatment
four	O
years	O
ago	O
.	O

15.	O
Peripheral	B-problem
vascular	I-problem
disease	I-problem
with	O
history	O
of	O
bilateral	B-problem
lower	I-problem
extremity	I-problem
claudication	I-problem
.	O

16.	O
COPD	B-problem
with	O
asbestosis	B-problem
on	O
chest	B-test
CT	I-test
scan	I-test
.	O

The	O
patient	O
is	O
discharged	O
on	O
Thursday	O
,	O
12-31	O
,	O
to	O
a	O
rehabilitation	O
facility	O
,	O
on	O
postoperative	O
day	O
93	O
,	O
in	O
stable	O
condition	O
,	O
from	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
.	O

Perry	O
G.	O
Ozuna	O
,	O
M.D.	O

83-390	O
PAD-WORD	O

Dictated	O
By	O
:	O
Keith	O
E.	O
Shafer	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-12-31	O
11:12	O

T	O
:	O
2015-12-31	O
11:19	O

JOB	O
#:	O

04648	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kelsey	O
MOORMAN	O
on	O
:	O
FRI	O
2016-01-08	O
9:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

649953363_c	O
PAD-WORD	O

FIH	O
PAD-WORD	O

8723483	O
PAD-WORD	O

824333	O
PAD-WORD	O

005999	O
PAD-WORD	O

5/12/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

UPH	O
,	O
JIM	O

UNIT	O
NUMBER	O
:	O

089-44-01	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

05/12/2000	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

05/20/2000	O
PAD-WORD	O

REASON	O
FOR	O
ADMISSION	O
:	O

Small	B-problem
cell	I-problem
lung	I-problem
cancer	I-problem
.	O

Chemotherapy	B-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Provided	O
in	O
the	O
house	O
staff	O
note	O
from	O
the	O
admission	O
date	O
.	O

Briefly	O
this	O
is	O
a	O
Hispanic	O
patient	O
with	O
history	O
of	O
advanced	B-problem
lung	I-problem
cancer	I-problem
,	O
small	O
cell	O
in	O
histology	O
.	O

The	O
patient	O
presented	O
with	O
almost	B-problem
a	I-problem
stridor	I-problem
and	O
a	B-problem
large	I-problem
mediastinal	I-problem
mass	I-problem
with	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

He	O
was	O
transferred	O
to	O
the	O
Oncology	O
Service	O
after	O
discussions	O
about	O
the	O
utility	O
of	O
chemotherapy	B-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

In	O
the	O
Oncology	O
Floor	O
he	O
received	O
Carboplatin	B-treatment
and	O
Etoposide	B-treatment
to	O
which	O
he	O
reacted	O
well	O
.	O

There	O
were	O
no	O
major	O
issues	O
and	O
he	O
was	O
discharged	O
home	O
on	O
5/20/00	O
.	O

________________________	O
PAD-WORD	O

MAREN	O
TLANDFLENT	O
,	O
M.D.	O

Electronically	O
Signed	O

MAREN	O
STEA	O
TLANDFLENT	O
,	O
M.D.	O

07/15/2000	O
21:36	O

TR	O
:	O

se	O
PAD-WORD	O

DD	O
:	O

07/06/2000	O
PAD-WORD	O

TD	O
:	O

07/11/2000	O
12:44	O
P	O

cc	O
:	O

MAREN	O
STEA	O
TLANDFLENT	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2011-06-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-06-13	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1976-04-17	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
CSRU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
35-year-old	O
gentleman	O
with	O
HIV	B-problem
on	O
HAART	B-treatment
with	O
last	B-test
CD4	I-test
count	I-test
of	O
268	O
and	O
undetectable	O
viral	B-test
load	I-test
who	O
was	O
referred	O
to	O
the	O
emergency	O
room	O
via	O
his	O
PCP	O
for	O
progressive	B-problem
throat	I-problem
pain	I-problem
and	O
edema	B-problem
.	O

His	B-problem
throat	I-problem
pain	I-problem
began	O
2	O
to	O
3	O
days	O
prior	O
to	O
admission	O
,	O
initially	O
treated	O
with	O
ibuprofen	B-treatment
,	O
seen	O
in	O
an	O
outside	O
hospital	O
emergency	O
room	O
day	O
prior	O
to	O
admission	O
where	O
he	O
received	O
IV	B-treatment
penicillin	I-treatment
and	O
was	O
sent	O
home	O
.	O

In	O
clinic	O
today	O
,	O
the	O
patient	O
desaturated	O
to	O
low	O
90	O
s	O
with	O
ambulation	O
and	O
also	O
had	O
complaints	O
of	O
progressive	B-problem
swelling	I-problem
"	O
like	O
my	O
throat	O
is	O
going	O
to	O
close	O
up	O
"	O
with	O
increasing	B-problem
drooling	I-problem
,	O
unable	O
to	O
swallow	O
the	B-treatment
HIV	I-treatment
medications	I-treatment
.	O

Also	O
noted	O
to	O
have	O
low-grade	B-problem
temperature	I-problem
of	O
99	O
to	O
100	O
degrees	O
with	O
productive	B-problem
cough	I-problem
and	O
yellow	B-problem
sputum	I-problem
times	O
1	O
day	O
with	O

right	B-problem
ear	I-problem
pain	I-problem
.	O

No	O
subjective	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
.	O

The	O
patient	O
describes	O
whole	B-problem
body	I-problem
numbness	I-problem
.	O

He	O
currently	O
notes	O
improvement	O
in	O
his	B-problem
throat	I-problem
pain	I-problem
after	O
some	B-treatment
Decadron	I-treatment
and	O
clindamycin	B-treatment
.	O

He	O
was	O
seen	O
by	O
CMED	O
CSRU	O
in	O
the	O
emergency	O
room	O
and	O
the	B-test
exam	I-test
was	O
consistent	O
with	O
supraglottitis	B-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	B-test
of	I-test
systems	I-test
was	O
negative	O
for	O
history	O
of	O
opportunistic	B-problem
infections	I-problem
or	O
prior	O
hospitalizations	O
.	O

Of	O
note	O
,	O
his	B-test
CD4	I-test
count	I-test
was	O
less	O
than	O
200	O
last	O
winter	O
.	O

He	O
believes	O
he	O
is	O
up-to-date	O
on	O
all	O
his	B-treatment
vaccines	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

HIV	B-problem
times	O
13	O
years	O
.	O

Last	B-test
CD4	I-test
count	I-test
of	O
268	O
,	O
viral	B-test
load	I-test
undetectable	O
,	O
followed	O
at	O
the	O
Boston	O
Regional	O
Medical	O
Centerr	O
Clinic	O
by	O
Dr.	O
Taylor	O
.	O

History	O
of	O
anal	B-problem
warts	I-problem
and	O
rectal	B-problem
abscesses	I-problem
and	O
fistula	B-problem
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
diabetes	B-problem
.	O

Negative	O
for	O
CAD	B-problem
.	O

Mother	O
with	O
throat	B-problem
cancer	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Works	O
in	O
a	O
restaurant	O
.	O

Lives	O
with	O
his	O
partner	O
.	O

Negative	O
Barbara	O
.	O

Positive	O
occasional	O
alcohol	O
use	O
,	O
occasional	O
pot	O
and	O
crystal	O
meth	O
,	O
but	O
negative	O
IV	O
drug	O
use	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Atazanavir	B-treatment
300	O
mg	O
q.d.	O

2.	O
Ritonavir	B-treatment
100	O
mg	O
q.d.	O

3.	O
Tenofovir	B-treatment
300	O
mg	O
q.d.	O

4.	O
Didanosine	B-treatment
250	O
mg	O
q.d.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	B-test
Signs	I-test
:	O

Temperature	B-test
100.1	O
degrees	O
,	O
blood	B-test
pressure	I-test
134/79	O
,	O
pulse	B-test
100	O
,	O
respiratory	B-test
rate	I-test
17	O
,	O
and	O
saturations	B-test
95	O
percent	O
on	O
room	O
air	O
.	O

General	O
:	O

He	O
is	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
times	O
3	O
and	O
pleasant	O
.	O

HEENT	O
:	O
Positive	O
hoarse	B-problem
whisper	I-problem
.	O

Positive	O
drooling	B-problem
.	O

Negative	O
trismus	B-problem
or	O
stridor	B-problem
.	O

Bilateral	B-problem
tonsillar	I-problem
hypertrophy	I-problem
.	O

No	O
white	B-problem
exudate	I-problem
.	O

Right	O
external	O
auditory	O
canal	O
was	O
occluded	B-problem
bycerumen	I-problem
and	O
left	O
external	O
auditory	O
canal	O
clear	O
with	O
tympanic	O
membrane	O
intact	O
.	O

Positive	O
anterior	B-problem
cervical	I-problem
lymphadenopathy	I-problem
.	O

Cardiovascular	O
:	O

Regular	O
and	O
tachycardic	B-problem
.	O

Normal	O
S1	O
and	O
S2	O
.	O

Lungs	O
:	O

Bilateral	B-problem
coarse	I-problem
breath	I-problem
sounds	I-problem
.	O

Negative	O
rhonchi	B-problem
,	O
rales	B-problem
,	O
or	O
wheezes	B-problem
.	O

Abdomen	O
:	O

Soft	O
and	O
nontender	B-problem
.	O

Extremities	O
:	O

Warm	O
,	O
well	O
perfused	O
.	O

No	O
edema	B-problem
.	O

Neuro	O
Exam	O
:	O

Cranial	O
nerves	O
II	O
through	O
XII	O
are	O
intact	O
.	O

Muscles	O
are	O
05-04	O
in	O
all	O
extremities	O
with	O
good	O
sensation	O
to	O
light	O
touch	O
.	O

LABORATORY	O
DATA	O
ON	O
ADMISSION	O
:	O

White	B-test
count	I-test
18.3	O
,	O
neutrophils	B-test
89	O
percent	O
,	O
hematocrit	B-test
41	O
,	O
platelets	B-test
261	O
,	O
INR	B-test
1.2	O
,	O
and	O
chem-7	B-test
otherwise	O
normal	O
.	O

Chest	B-test
x-ray	I-test
was	O
negative	O
for	O
effusions	B-problem
,	O
pneumonia	B-problem
,	O
or	O
pneumothorax	B-problem
.	O

Neck	O
with	O
soft	B-problem
tissue	I-problem
prominence	I-problem
of	I-problem
the	I-problem
epiglottitis	I-problem
and	I-problem
uvula	I-problem
consistent	O
with	O
epiglottitis	B-problem
.	O

Fiberoptic	B-test
scope	I-test
showed	O
swelling	B-problem
of	I-problem
the	I-problem
right	I-problem
epiglottitis	I-problem
extending	O
down	O
to	O
the	O
right	O
aryepiglottic	O
fold	O
obscuring	O
view	O
of	O
the	O
right	O
vocal	O
cord	O
.	O

Left	O
vocal	O
cord	O
with	O
glottic	O
airway	O
visible	O
but	O
narrow	B-problem
.	O

Positive	O
edema	B-problem
of	I-problem
the	I-problem
left	I-problem
supraglottitis	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

This	O
is	O
a	O
35-year-old	O
gentleman	O
with	O
HIV	B-problem
on	O
HAART	B-treatment
,	O
last	B-test
CD4	I-test
count	I-test
268	O
with	O
undetectable	O
viral	B-test
load	I-test
who	O
was	O
initially	O
admitted	O
to	O
the	O
CMED	O
CSRU	O
for	O
supraglottitis	B-problem
with	O
significant	B-problem
edema	I-problem
.	O

PROBLEM	O
LIST	O
:	O

1.	O
Epiglottitis	B-problem
/	O
supraglottitis	B-problem
.	O

The	O
patient	O
was	O
observed	O
in	O
the	O
CMED	O
CSRU	O
for	O
48	O
hours	O
and	O
noted	O
to	O
have	O
decrease	O
in	O
swelling	B-problem
on	O
serial	B-test
exams	I-test
.	O

He	O
was	O
followed	O
by	O
the	O
CMED	O
CSRU	O
Service	O
and	O
was	O
started	O
on	O
IV	B-treatment
Decadron	I-treatment
initially	O
in	O
addition	O
to	O
IV	B-treatment
Unasyn	I-treatment
,	O
which	O
he	O
tolerated	O
well	O
.	O

His	B-problem
edema	I-problem
was	O
improving	O
and	O
was	O
starting	O
to	O
tolerate	O
p.o.	O

His	O
airway	O
and	O
symptoms	B-problem
continued	O
to	O
improve	O
and	O
remained	O
stable	O
.	O

The	O
patient	O
was	O
stable	O
for	O
transfer	O
to	O
the	O
floor	O
,	O
was	O
treated	O
with	O
over	O
72	O
hours	O
of	O
IV	B-treatment
Unasyn	I-treatment
,	O
and	O
then	O
transitioned	O
to	O
oral	O
regimen	O
of	O
Augmentin	B-treatment
to	O
be	O
continued	O
as	O
an	O
outpatient	O
.	O

Eventually	O
,	O
his	B-treatment
IV	I-treatment
steroids	I-treatment
were	O
transitioned	O
to	O
a	B-treatment
p.o.	I-treatment
steroid	I-treatment
taper	I-treatment
,	O
which	O
he	O
tolerated	O
well	O
,	O
and	O
was	O
discharged	O
on	O
a	B-treatment
steroid	I-treatment
taper	I-treatment
also	O
with	O
CMED	O
CSRU	O
follow-up	O
as	O
an	O
outpatient	O
.	O

His	O
oxygenation	O
and	O
symptoms	B-problem
remained	O
stable	O
and	O
again	O
tolerated	O
p.o.	O
without	O
difficulty	O
.	O

Eventually	O
,	O
as	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
,	O
his	O
airway	O
remained	O
stable	O
,	O
and	O
he	O
was	O
tolerating	O
PO	O
s,	O
he	O
was	O
transitioned	O
to	O
the	O
floor	O
where	O
he	O
remained	O
otherwise	O
stable	O
and	O
asymptomatic	B-problem
.	O

His	O
voice	O
improved	O
during	O
the	O
course	O
of	O
his	O
stay	O
and	O
was	O
talking	O
clearly	O
by	O
the	O
time	O
of	O
discharge	O
.	O

He	O
remained	O
afebrile	B-problem
during	O
the	O
course	O
of	O
his	O
stay	O
after	O
transfer	O
to	O
the	O
floor	O
and	O
per	O
CMED	O
CSRU	O
was	O
to	O
be	O
discharged	O
on	O
a	O
2-week	O
course	O
of	O
Augmentin	B-treatment
with	O
follow-up	O
with	O
Dr.	O
Thibodeau	O
in	O
2	O
weeks	O
'	O
time	O
in	O
addition	O
to	O
a	B-treatment
Medrol	I-treatment
Dosepak	I-treatment
.	O

1.	O
HIV	B-problem
.	O

Once	O
,	O
the	O
patient	O
was	O
tolerating	O
p.o.	O
,	O
the	O
patient	O
was	O
restarted	O
on	O
his	B-treatment
HAART	I-treatment
regimen	I-treatment
and	O
remained	O
stable	O
from	O
that	O
perspective	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Good	O
.	O

The	O
patient	O
ambulating	O
without	O
difficulty	O
,	O
tolerating	O
p.o.	O
,	O
stable	O
oxygen	O
saturation	O
,	O
and	O
stable	O
voice	O
by	O
the	O
time	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Epiglottitis	B-problem
/	O
supraglottitis	B-problem
.	O

HIV	B-problem
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Menthol	B-treatment
-	I-treatment
Cetylpyridinium	I-treatment
lozenges	I-treatment
1	O
as	O
needed	O
.	O

2.	O
Tenofovir	B-treatment
300	O
mg	O
p.o.	O
q.d.	O

3.	O
Didanosine	B-treatment
250	O
mg	O
p.o.	O
q.d.	O

4.	O
Atazanavir	B-treatment
300	O
mg	O
p.o.	O
q.d.	O

5.	O
Ritonavir	B-treatment
100	O
mg	O
p.o.	O
q.d.	O

6.	O
Calcium	B-treatment
carbonate	I-treatment
500	O
mg	O
p.o.	O
q.d.	O

7.	O
Methylprednisolone	B-treatment
4	O
mg	O
tablets	O
per	O
taper	O
regimen	O
.	O

The	O
patient	O
was	O
to	O
take	O
one	O
4	O
mg	O
tablet	O
dinner	O
and	O
at	O
bedtime	O
the	O
day	O
of	O
discharge	O
,	O
then	O
the	O
next	O
day	O
take	O
one	O
4	O
mg	O
tablet	O
in	O
the	O
morning	O
,	O
lunch	O
time	O
,	O
and	O
with	O
dinner	O
and	O
then	O
at	O
bedtime	O
,	O
then	O
the	O
third	O
day	O
to	O
take	O
4	O
mg	O
tablet	O
in	O
the	O
morning	O
,	O
lunch	O
,	O
and	O
bedtime	O
,	O
the	O
fourth	O
day	O
to	O
take	O
one	O
tablet	O
in	O
the	O
morning	O
and	O
dinner	O
,	O
and	O
in	O
the	O
last	O
day	O
take	O
one	O
4	O
mg	O
tablet	O
in	O
the	O
morning	O
.	O

He	O
was	O
also	O
discharged	O
on	O
Augmentin	B-treatment
XR	I-treatment
1000	O
mg	O
/	O
62.5	O
mg	O
sustained	O
release	O
1	O
tablet	O
q.	O
12h	O
.	O
for	O
2	O
weeks	O
.	O

FOLLOW-UP	O
:	O

The	O
patient	O
was	O
to	O
follow	O
up	O
with	O
his	O
PCP	O
A.	O
L.	O
.	O
Taylor	O
in	O
7	O
to	O
10	O
days	O
,	O
and	O
the	O
patient	O
was	O
to	O
call	O
Dr.	O
Thibodeau	O
,	O
CMED	O
CSRU	O
doctor	O
to	O
follow	O
up	O
in	O
2	O
weeks	O
'	O
time	O
.	O

Teddy	O
Stephen	O
,	O
Louisiana	O
32870	O

Dictated	O
By	O
:	O
Judy	O
J	O
Johnston	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2011-07-12	O
15:55:31	O

T	O
:	O
2011-07-13	O
11:14:52	O

Job	O
#:	O

79962	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ruth	O
Gibson	O
on	O
:	O
MON	O
2011-07-18	O
7:48	O
AM	O

(	O
End	O
of	O
Report	O
)	O

649953363_e	O
PAD-WORD	O

FIH	O
PAD-WORD	O

8723483	O
PAD-WORD	O

249112	O
PAD-WORD	O

912397	O
PAD-WORD	O

12/19/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

UPH	O
,	O
JIM	O

MRN	O
:	O

8723483	O
PAD-WORD	O

Age	O
:	O

57y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

12/19/2000	O
02:48	O
PM	O

Provider	O
:	O

Asha	O
Vengloan	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O
PAD-WORD	O

Discharge	O
Date	O
/	O
Time	O
:	O

12/19/00	O
6:13:06	O
PM	O

Discharge	O
Status	O
:	O

Discharged	O
PAD-WORD	O

Patient	O
States	O
Complaint	O
:	O

SOB	B-problem
PAD-WORD	O

Diagnosis	O
:	O

COPD	B-problem
exacerbation	I-problem
(	I-problem
emphysema	I-problem
)	I-problem

Treatment	O
Rendered	O
:	O

Prednisone	B-treatment
,	O
nebulizers	B-treatment
.	O

Chest	B-test
x-ray	I-test
shows	O
question	O
of	O
a	B-problem
pulmonary	I-problem
nodule	I-problem
in	I-problem
the	I-problem
right	I-problem
lower	I-problem
lobe	I-problem
which	O
may	O
be	O
cancer	B-problem
.	O

Discharge	O
Medications	O
:	O

Prednisone	B-treatment
60	O
mg	O
daily	O
for	O
4	O
days	O
.	O

Continue	O
inhalers	B-treatment
as	O
prescribed	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Call	O
Dr.	O
Linketerf	O
tomorrow	O
and	O
make	O
an	O
appointment	O
for	O
follow-up	O
on	O
the	B-problem
lung	I-problem
nodule	I-problem
.	O

THIS	O
IS	O
VERY	O
IMPORTANT	O
.	O

This	O
report	O
was	O
created	O
by	O
Vengloan	O
,	O
Asha	O
12/19/2000	O
06:15	O
PM	O

Admission	O
Date	O
:	O

2014-12-03	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-12-18	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1962-09-23	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

Medicine	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
52	O
-	O
year-old	O
female	O
with	O
no	O
known	B-problem
cardiopulmonary	I-problem
history	I-problem
who	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
dyspnea	B-problem
on	O
exertion	O
as	O
well	O
as	O
exertional	B-problem
chest	I-problem
tightness	I-problem
which	O
was	O
acute-on-chronic	O
.	O

The	O
patient	O
stated	O
her	B-problem
symptoms	I-problem
began	O
in	O
2011	O
and	O
have	O
increased	O
in	O
intensity	O
and	O
frequency	O
every	O
since	O
then	O
.	O

She	O
reports	O
dyspnea	B-problem
on	O
exertion	O
and	O
chest	B-problem
tightness	I-problem
daily	O
which	O
worsened	O
significantly	O
one	O
day	O
prior	O
to	O
admission	O
.	O

Says	O
that	O
she	O
could	O
not	O
walk	O
a	O
few	O
yards	O
without	O
developing	O
symptoms	B-problem
.	O

She	O
describes	O
the	B-problem
chest	I-problem
tightness	I-problem
as	O
substernal	O
and	O
epigastric	O
.	O

She	O
denied	O
any	B-problem
associated	I-problem
nausea	I-problem
,	O
vomiting	B-problem
,	O
diaphoresis	B-problem
,	O
lightheadedness	B-problem
,	O
or	O
dizziness	B-problem
.	O

She	O
does	O
have	O
radiation	B-problem
of	I-problem
the	I-problem
pain	I-problem
to	O
her	O
neck	O
and	O
jaw	O
bilaterally	O
.	O

She	O
also	O
describes	O
a	B-problem
fast	I-problem
heart	I-problem
rate	I-problem
and	O
palpitations	B-problem
.	O

She	O
stated	O
her	B-problem
symptoms	I-problem
improved	O
with	O
rest	O
,	O
and	O
she	O
denied	O
any	B-problem
symptoms	I-problem
beginning	O
when	O
she	O
was	O
at	O
rest	O
.	O

The	O
patient	O
reports	O
a	B-test
previous	I-test
workup	I-test
which	O
included	O
a	O
negative	O
exercise	O
treadmill	O
test	O
,	O
a	O
normal	O
MIBI	O
in	O
2011-04-10	O
,	O
and	O
a	O
normal	O
echocardiogram	O
in	O
2012	O
(	O
except	O
some	B-problem
borderline	I-problem
mild	I-problem
pulmonary	I-problem
hypertension	I-problem
)	O
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
55%	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	B-test
of	I-test
systems	I-test
was	O
significant	O
for	O
menopausal	B-problem
symptoms	I-problem
(	O
for	O
which	O
she	O
has	O
attempted	O
hormone	B-treatment
replacement	I-treatment
therapy	I-treatment
,	O
discontinued	O
in	O
2014	O
).	O

She	O
also	O
reports	O
difficulty	B-problem
sleeping	I-problem
,	O
daytime	B-problem
sleepiness	I-problem
.	O

She	O
sleeps	O
on	O
elevated	B-treatment
pillows	I-treatment
secondary	O
to	O
her	B-problem
gastroesophageal	I-problem
reflux	I-problem
disease	I-problem
.	O

Occasional	B-problem
paroxysmal	I-problem
nocturnal	I-problem
dyspnea	I-problem
in	O
the	O
past	O
but	O
none	O
recently	O
.	O

Occasional	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
,	O
left	O
greater	O
than	O
right	O
.	O

No	O
abdominal	B-problem
or	I-problem
urinary	I-problem
complaints	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

2.	O
Grave's	B-problem
,	O
status	O
post	O
radiation	B-treatment
resulting	O
in	O
hypothyroidism	B-problem
.	O

3.	O
Migraines	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Synthroid	B-treatment
,	O
Prilosec	B-treatment
20	O
mg	O
p.o.	O
,	O
Fioricet	B-treatment
,	O
Celebrex	B-treatment
.	O

ALLERGIES	O
:	O

PENICILLIN	B-treatment
causes	O
a	B-problem
rash	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

Diabetes	B-problem
,	O
Grave's	B-problem
disease	I-problem
,	O
but	O
no	O
history	O
of	O
cardiopulmonary	B-problem
disease	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
her	O
husband	O
,	O
and	O
they	O
have	O
no	O
children	O
.	O

She	O
denies	O
any	O
tobacco	O
or	O
alcohol	O
history	O
.	O

She	O
does	O
use	O
herbal	B-treatment
remedies	I-treatment
including	O
Primrose	B-treatment
oil	I-treatment
,	O
Siberian	B-treatment
ginseng	I-treatment
,	O
and	O
has	O
a	O
history	O
of	O
use	O
of	O
wallerian	B-treatment
root	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Vital	B-test
signs	I-test
were	O
temperature	B-test
of	O
98.4	O
,	O
heart	B-test
rate	I-test
74	O
,	O
blood	B-test
pressure	I-test
130/91	O
,	O
respiratory	B-test
rate	I-test
21	O
,	O
satting	O
98%	O
on	O
room	O
air	O
.	O

HEENT	O
revealed	O
pupils	O
were	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
.	O

The	O
oropharynx	O
was	O
clear	O
.	O

Neck	O
was	O
supple	O
,	O
no	O
lymphadenopathy	B-problem
,	O
no	O
thyromegaly	B-problem
,	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
,	O
and	O
no	O
bruits	B-problem
.	O

Lungs	O
had	O
scant	B-problem
crackles	I-problem
at	I-problem
the	I-problem
left	I-problem
base	I-problem
and	I-problem
middle	I-problem
field	I-problem
;	O
otherwise	O
clear	O
.	O

Cardiovascular	O
had	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

No	O
murmurs	B-problem
.	O

No	O
fourth	O
heart	O
sound	O
or	O
third	O
heart	O
sound	O
.	O

No	O
parasternal	B-problem
heave	I-problem
.	O

Gastrointestinal	O
revealed	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
.	O

No	O
hepatosplenomegaly	B-problem
.	O

No	O
masses	B-problem
.	O

No	O
bruits	B-problem
.	O

Normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
had	O
no	O
edema	B-problem
,	O
2+	B-test
distal	I-test
pedis	I-test
.	O

Neurologically	O
,	O
grossly	O
nonfocal	O
.	O

LABORATORY	O
DATA	O
ON	O
PRESENTATION	O
:	O

At	O
the	O
time	O
of	O
admission	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
11.1	O
,	O
hematocrit	B-test
37.7	O
,	O
platelets	B-test
326	O
.	O

Sodium	B-test
140	O
,	O
potassium	B-test
4	O
,	O
chloride	B-test
105	O
,	O
bicarbonate	B-test
28	O
,	O
BUN	B-test
17	O
,	O
creatinine	B-test
0.8	O
,	O
glucose	B-test
76	O
.	O

Creatine	B-test
kinase	I-test
100	O
,	O
MB	B-test
4	O
,	O
troponin	B-test
of	O
less	O
than	O
0.3	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

Electrocardiogram	B-test
revealed	O
left	B-problem
atrial	I-problem
hypertrophy	I-problem
,	O
right	B-problem
ventricular	I-problem
hypertrophy	I-problem
,	O
and	O
poor	B-problem
R	I-problem
wave	I-problem
progression	I-problem
which	O
were	O
new	O
.	O

Also	O
,	O
T	B-problem
wave	I-problem
inversions	I-problem
in	I-problem
II	I-problem
,	I-problem
III	I-problem
,	I-problem
aVF	I-problem
,	I-problem
V1	I-problem
through	I-problem
V5	I-problem
;	O
new	B-problem
evolving	I-problem
right	I-problem
bundle-branch	I-problem
block	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
is	O
a	O
52	O
-	O
year-old	O
female	O
with	O
no	O
known	O
history	O
of	O
cardiac	B-problem
disease	I-problem
presenting	O
with	O
dyspnea	B-problem
on	O
exertion	O
and	O
chest	B-problem
tightness	I-problem
,	O
who	O
was	O
admitted	O
for	O
evaluation	B-test
and	O
management	B-treatment
of	O
her	B-problem
symptoms	I-problem
.	O

1.	O
CARDIOVASCULAR	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
complaints	O
of	O
dyspnea	B-problem
on	O
exertion	O
and	O
chest	B-problem
pressure	I-problem
which	O
could	O
be	O
consistent	O
with	O
angina	B-problem
.	O

However	O
,	O
given	O
the	O
long	O
duration	O
of	O
the	B-problem
symptoms	I-problem
and	O
negative	O
workup	O
in	O
the	O
past	O
,	O
it	O
was	O
thought	O
to	O
be	O
unlikely	O
.	O

However	O
,	O
the	O
patient	O
was	O
started	O
on	O
an	B-treatment
aspirin	I-treatment
as	O
well	O
as	O
a	B-treatment
beta	I-treatment
blocker	I-treatment
,	O
and	O
a	B-test
rule	I-test
out	I-test
myocardial	I-test
infarction	I-test
protocol	I-test
was	O
initiated	O
.	O

A	B-test
stress	I-test
thallium	I-test
was	O
planned	O
for	O
the	O
day	O
following	O
admission	O
.	O

However	O
,	O
on	O
the	O
night	O
of	O
admission	O
the	O
patient	O
was	O
found	O
lying	O
in	O
her	O
bed	O
diaphoretic	B-problem
and	O
obtunded	B-problem
,	O
and	O
a	O
code	O
was	O
called	O
.	O

Further	B-test
examination	I-test
revealed	O
a	O
strong	O
palpable	O
pulse	O
with	O
a	B-test
systolic	I-test
blood	I-test
pressure	I-test
in	O
the	O
130	O
s	O
and	O
a	B-test
heart	I-test
rate	I-test
in	O
the	O
80	O
s.	O

Over	O
the	O
course	O
of	O
the	O
next	O
few	O
minutes	O
the	O
patient	O
became	O
increasingly	O
more	O
responsive	O
.	O

She	O
was	O
treated	O
with	O
a	B-treatment
fluid	I-treatment
bolus	I-treatment
.	O

The	O
patient	O
quickly	O
responded	O
to	O
a	B-treatment
fluid	I-treatment
bolus	I-treatment
and	O
became	O
interactive	O
.	O

She	O
reported	O
that	O
she	O
was	O
sitting	O
on	O
the	O
commode	O
urinating	O
and	O
began	O
to	O
feel	O
nauseous	B-problem
and	O
presyncopal	B-problem
.	O

She	O
was	O
able	O
to	O
get	O
to	O
bed	O
at	O
which	O
point	O
she	O
passed	O
out	O
.	O

She	O
denied	O
any	B-problem
chest	I-problem
pain	I-problem
or	O
pressure	B-problem
,	O
and	O
no	O
shortness	B-problem
of	I-problem
breath	I-problem
during	O
this	O
event	O
.	O

A	B-test
rhythm	I-test
check	I-test
obtained	O
during	O
the	O
time	O
of	O
this	O
event	O
demonstrated	O
a	B-problem
pause	I-problem
of	I-problem
six	I-problem
seconds	I-problem
followed	O
by	O
a	B-problem
junctional	I-problem
escape	I-problem
rhythm	I-problem
.	O

An	B-test
electrocardiogram	I-test
obtained	O
after	O
the	O
code	O
demonstrated	O
no	O
acute	B-problem
changes	I-problem
.	O

Her	B-problem
acute	I-problem
bradycardic	I-problem
event	I-problem
was	O
felt	O
likely	O
secondary	O
to	O
her	B-treatment
new	I-treatment
beta	I-treatment
blocker	I-treatment
in	O
conjunction	O
with	O
a	B-problem
vagal	I-problem
response	I-problem
.	O

It	O
was	O
determined	O
to	O
stop	O
the	B-treatment
beta	I-treatment
blocker	I-treatment
,	O
and	O
atropine	B-treatment
was	O
placed	O
at	O
the	O
bedside	O
.	O

On	O
the	O
following	O
day	O
the	O
patient	O
underwent	O
an	B-test
echocardiogram	I-test
which	O
demonstrated	O
dilated	B-problem
right	I-problem
ventricle	I-problem
secondary	O
to	O
chronic	B-problem
dysfunction	I-problem
and	O
a	B-test
pulmonary	I-test
artery	I-test
pressure	I-test
of	O
greater	O
than	O
100	O
.	O

Her	B-test
stress	I-test
test	I-test
was	O
cancelled	O
.	O

A	B-test
CT	I-test
angiogram	I-test
was	O
ordered	O
to	O
evaluate	O
for	O
chronic	B-problem
thromboembolic	I-problem
disease	I-problem
as	O
a	O
potential	O
cause	O
of	O
her	B-problem
pulmonary	I-problem
hypertension	I-problem
.	O

She	O
was	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
with	O
three	O
sets	O
of	O
normal	O
enzymes	O
and	O
continued	O
to	O
be	O
monitored	O
on	O
telemetry	B-test
.	O

A	O
Pulmonary	O
consultation	O
was	O
obtained	O
to	O
evaluate	O
for	O
possible	O
etiology	O
of	O
the	B-problem
patient	I-problem
's	I-problem
hypotension	I-problem
.	O

There	O
was	O
little	O
evidence	O
to	O
suggest	O
any	B-problem
cardiac	I-problem
disease	I-problem
,	O
and	O
given	O
the	B-problem
patient	I-problem
's	I-problem
Grave's	I-problem
disease	I-problem
an	B-problem
autoimmune	I-problem
process	I-problem
was	O
felt	O
to	O
be	O
possible	O
.	O

In	O
addition	O
,	O
consideration	O
was	O
given	O
to	O
sarcoidosis	B-problem
,	O
human	B-problem
immunodeficiency	I-problem
virus	I-problem
,	O
and	O
drug-induced	O
given	O
her	O
history	O
of	O
herbal	B-treatment
medication	I-treatment
use	O
.	O

It	O
was	O
recommended	O
that	O
the	O
patient	O
begin	O
anticoagulation	B-treatment
given	O
the	O
severity	O
of	O
her	B-problem
pulmonary	I-problem
hypertension	I-problem
.	O

It	O
was	O
also	O
planned	O
to	O
undergo	O
a	B-test
right	I-test
heart	I-test
catheterization	I-test
with	O
a	B-test
vasodilation	I-test
trial	I-test
by	O
the	O
catheterization	O
laboratory	O
.	O

A	B-test
right	I-test
heart	I-test
catheterization	I-test
was	O
performed	O
on	O
2014-12-05	O
.	O

A	B-test
pharmacologic	I-test
pulmonary	I-test
vasodilator	I-test
challenge	I-test
was	O
performed	O
with	O
a	O
positive	O
response	O
.	O

In	O
addition	O
,	O
a	B-test
CT	I-test
angiogram	I-test
of	I-test
the	I-test
chest	I-test
with	O
pulmonary	B-test
embolism	I-test
protocol	I-test
showed	O
no	O
intravascular	B-problem
filling	I-problem
defect	I-problem
but	O
did	O
show	O
a	B-problem
right	I-problem
upper	I-problem
lobe	I-problem
ground-glass	I-problem
and	O
scattered	B-problem
adenopathy	I-problem
.	O

Therefore	O
,	O
in	O
the	O
end	O
left	B-problem
atrial	I-problem
hypertension	I-problem
was	O
essentially	O
ruled	O
out	O
as	O
a	O
primary	O
cause	O
.	O

Chronic	B-problem
pulmonary	I-problem
embolus	I-problem
was	O
less	O
likely	O
given	O
her	O
negative	O
CT	O
angiogram	O
.	O

Chronic	B-problem
lung	I-problem
disease	I-problem
was	O
unlikely	O
given	O
the	O
patient	O
's	O
normal	O
pulmonary	O
function	O
tests	O
and	O
DLCO	B-test
in	O
2012	O
as	O
well	O
as	O
a	O
normal	O
CT	O
angiogram	O
.	O

Collagen	B-problem
vascular	I-problem
disease	I-problem
could	O
not	O
be	O
definitively	O
ruled	O
out	O
;	O
however	O
,	O
given	O
the	O
patient	O
's	O
lack	O
of	O
connective	B-problem
tissue	I-problem
disorder	I-problem
stigmata	I-problem
it	O
was	O
thought	O
to	O
be	O
less	O
likely	O
,	O
and	O
the	B-test
patient	I-test
's	I-test
human	I-test
immunodeficiency	I-test
virus	I-test
test	I-test
was	O
negative	O
.	O

Therefore	O
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
was	O
most	O
likely	O
experiencing	O
a	B-problem
primary	I-problem
pulmonary	I-problem
hypertension	I-problem
.	O

Consideration	O
was	O
given	O
to	O
treating	O
the	O
patient	O
with	O
a	O
course	O
of	O
calcium	B-treatment
channel	I-treatment
blocker	I-treatment
;	O
however	O
,	O
given	O
the	O
patient	O
's	O
poor	O
response	O
to	O
Lopressor	B-treatment
,	O
it	O
was	O
determined	O
that	O
this	O
would	O
not	O
be	O
optimal	O
treatment	O
for	O
the	B-problem
patient	I-problem
's	I-problem
pulmonary	I-problem
hypertension	I-problem
.	O

Therefore	O
,	O
her	O
insurance	O
company	O
was	O
contacted	O
regarding	O
the	O
potential	O
of	O
Flolan	B-treatment
as	O
a	O
treatment	O
.	O

Plans	O
were	O
made	O
for	O
placement	O
of	O
a	B-treatment
Hickman	I-treatment
catheter	I-treatment
and	O
initiation	O
of	O
Flolan	B-treatment
treatment	I-treatment
.	O

However	O
,	O
on	O
12-07	O
,	O
the	O
patient	O
once	O
again	O
experienced	O
an	O
episode	O
of	O
unresponsiveness	B-problem
.	O

Upon	O
arrival	O
by	O
the	O
physician	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
,	O
and	O
oriented	O
with	O
a	B-test
pulse	I-test
in	O
the	O
80	O
s,	O
with	O
pressure	B-test
in	O
the	O
80	O
s,	O
and	O
satting	O
100%	O
on	O
room	O
air	O
.	O

She	O
described	O
this	O
episode	O
as	O
an	B-problem
uncomfortable	I-problem
feeling	I-problem
in	I-problem
her	I-problem
chest	I-problem
.	O

The	O
patient	O
was	O
treated	O
with	O
2	O
liters	O
of	O
intravenous	B-treatment
fluids	I-treatment
with	O
a	O
bump	O
in	O
her	B-test
systolic	I-test
blood	I-test
pressure	I-test
to	O
the	O
90	O
s.	O

Review	O
of	O
telemetry	B-test
revealed	O
an	O
8	O
to	O
9	O
beat	O
episode	O
of	O
nonsustained	B-problem
ventricular	I-problem
tachycardia	I-problem
followed	O
by	O
an	O
episode	O
of	O
bradycardia	B-problem
to	O
60	O
beats	O
per	O
minute	O
.	O

The	O
etiology	O
of	O
these	B-problem
cardiovascular	I-problem
episodes	I-problem
was	O
unclear	O
,	O
but	O
was	O
felt	O
likely	O
secondary	O
to	O
the	B-problem
patient	I-problem
's	I-problem
tenuous	I-problem
cardiovascular	I-problem
status	I-problem
given	O
the	O
fact	O
that	O
she	O
had	O
clear	B-problem
pulmonary	I-problem
hypertension	I-problem
,	O
was	O
very	B-problem
preload	I-problem
dependent	I-problem
,	O
and	O
had	O
an	O
intact	O
left	O
ventricular	O
function	O
but	O
with	O
cardiac	B-problem
output	I-problem
limited	I-problem
due	O
to	O
left	B-problem
ventricular	I-problem
compression	I-problem
by	O
a	B-problem
dilated	I-problem
left	I-problem
ventricle	I-problem
.	O

Given	O
the	B-problem
patient	I-problem
's	I-problem
persistent	I-problem
hypotensive	I-problem
episodes	I-problem
,	O
and	O
decreased	B-problem
urine	I-problem
output	I-problem
,	O
she	O
was	O
transferred	O
back	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
management	O
prior	O
to	O
initiation	O
of	O
Flolan	B-treatment
therapy	I-treatment
.	O

On	O
12-08	O
,	O
the	B-treatment
Hickman	I-treatment
catheter	I-treatment
was	O
placed	O
in	O
preparation	O
of	O
Flolan	B-treatment
administration	O
.	O

During	O
the	O
Mass.	O
Mental	O
Health	O
Center	O
Medical	O
Intensive	O
Care	O
Unit	O
stay	O
,	O
the	O
patient	O
was	O
found	O
to	O
exquisitely	B-problem
preload	I-problem
dependent	I-problem
and	O
responded	O
well	O
to	O
aggressive	B-treatment
fluids	I-treatment
as	O
needed	O
to	O
maintain	O
her	B-test
blood	I-test
pressure	I-test
with	O
a	B-test
systolic	I-test
of	O
greater	O
than	O
90	O
.	O

She	O
had	O
no	O
further	O
episodes	O
of	O
bradycardia	B-problem
during	O
her	O
Medical	O
Intensive	O
Care	O
Unit	O
stay	O
.	O

In	O
addition	O
,	O
the	B-test
patient	I-test
's	I-test
urine	I-test
output	I-test
improved	O
dramatically	O
with	O
hydration	B-treatment
therapy	I-treatment
,	O
suggesting	O
her	B-problem
low	I-problem
urine	I-problem
output	I-problem
was	O
secondary	O
to	O
decreased	B-problem
cardiac	I-problem
output	I-problem
secondary	O
to	O
low	B-problem
preload	I-problem
.	O

The	O
patient	O
continued	O
to	O
be	O
followed	O
by	O
the	O
Electrophysiology	O
Service	O
,	O
who	O
determined	O
that	O
the	O
patient	O
was	O
demonstrating	O
severe	B-problem
vasal	I-problem
sensitivity	I-problem
with	O
bradycardia	B-problem
necessitating	O
pacemaker	B-treatment
placement	I-treatment
.	O

This	O
was	O
to	O
be	O
deferred	O
until	O
after	O
the	O
patient	O
had	O
her	B-treatment
Hickman	I-treatment
in	O
place	O
.	O

Because	O
the	B-test
patient	I-test
's	I-test
pulmonary	I-test
pressures	I-test
responded	O
so	O
well	O
to	O
adenosine	B-treatment
during	O
right	B-test
heart	I-test
catheterization	I-test
,	O
it	O
was	O
thought	O
that	O
the	O
patient	O
would	O
be	O
a	O
good	O
candidate	O
for	O
Flolan	B-treatment
therapy	I-treatment
.	O

Flolan	B-treatment
was	O
initiated	O
on	O
12-08	O
at	O
5	O
nanograms	O
per	O
kilogram	O
per	O
minute	O
.	O

The	O
patient	O
was	O
monitored	O
for	O
symptoms	B-problem
of	O
Flolan	B-treatment
therapy	I-treatment
including	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
first	B-problem
bite	I-problem
jaw	I-problem
claudication	I-problem
,	O
or	O
hypotension	B-problem
.	O

Over	O
the	O
course	O
of	O
the	O
hospital	O
stay	O
the	B-treatment
patient	I-treatment
's	I-treatment
Flolan	I-treatment
dose	I-treatment
was	O
titrated	O
to	O
receive	O
maximum	O
benefit	O
without	O
precipitating	O
symptoms	O
of	O
Flolan	B-problem
overdose	I-problem
.	O

The	O
patient	O
was	O
felt	O
to	O
be	O
stable	O
on	O
her	B-treatment
current	I-treatment
Flolan	I-treatment
dose	I-treatment
and	O
was	O
therefore	O
transferred	O
back	O
to	O
the	O
floor	O
.	O

A	B-test
high	I-test
resolution	I-test
CT	I-test
was	O
requested	O
to	O
further	O
evaluate	O
for	O
possible	O
secondary	O
cause	O
of	O
her	B-problem
primary	I-problem
pulmonary	I-problem
hypertension	I-problem
;	O
however	O
,	O
the	O
patient	O
refused	O
it	O
at	O
this	O
time	O
.	O

Plans	O
for	O
placement	O
of	O
a	B-treatment
pacemaker	I-treatment
were	O
initiated	O
.	O

However	O
,	O
on	O
the	O
night	O
prior	O
to	O
the	O
planned	O
surgical	O
date	O
the	O
patient	O
suffered	O
an	O
episode	O
of	O
bleeding	B-problem
from	O
her	B-treatment
Hickman	I-treatment
catheter	I-treatment
site	O
.	O

Surgery	O
was	O
notified	O
and	O
pressure	B-treatment
was	O
applied	O
;	O
however	O
,	O
it	O
did	O
not	O
stop	O
oozing	O
.	O

A	B-treatment
surgicel	I-treatment
dressing	I-treatment
was	O
placed	O
and	O
prolonged	B-treatment
pressure	I-treatment
resulted	O
in	O
resolution	O
of	O
the	B-problem
bleeding	I-problem
.	O

In	O
addition	O
,	O
an	B-treatment
extra	I-treatment
stitch	I-treatment
was	O
placed	O
in	O
an	O
effort	O
to	O
stop	O
the	B-problem
bleeding	I-problem
.	O

Following	O
this	O
episode	O
the	O
patient	O
felt	O
like	O
she	O
was	O
"	O
too	B-problem
stressed	I-problem
"	O
for	O
pacemaker	B-treatment
placement	I-treatment
.	O

Therefore	O
,	O
she	O
was	O
monitored	O
over	O
the	O
next	O
few	O
days	O
for	O
any	B-problem
further	I-problem
bleeding	I-problem
events	I-problem
.	O

Over	O
the	O
course	O
of	O
the	O
next	O
few	O
days	O
the	O
patient	O
became	O
more	O
accustomed	O
to	O
her	B-treatment
Flolan	I-treatment
,	O
and	O
Flolan	B-treatment
teaching	O
was	O
continued	O
.	O

She	O
continued	O
to	O
have	O
occasional	O
episodes	O
of	O
dizziness	B-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
and	O
hypotension	B-problem
whenever	O
the	O
alarm	O
sounded	O
suggesting	O
that	O
the	B-treatment
Flolan	I-treatment
bag	I-treatment
needed	O
to	O
be	O
changed	O
.	O

However	O
,	O
over	O
the	O
course	O
of	O
the	O
hospital	O
stay	O
these	O
decreased	O
both	O
in	O
frequency	O
and	O
severity	O
.	O

On	O
12-15	O
,	O
the	O
patient	O
went	O
for	O
placement	O
of	O
a	B-treatment
pacemaker	I-treatment
.	O

She	O
had	O
dual-mode	B-treatment
,	I-treatment
dual-pacing	I-treatment
,	I-treatment
dual-sensing	I-treatment
pacemaker	I-treatment
placed	O
with	O
a	B-test
lower	I-test
rate	I-test
at	O
60	O
ppm	O
,	O
and	O
upper	B-test
rate	I-test
of	O
120	O
ppm	O
with	O
a	B-test
paced	I-test
AV	I-test
of	O
150	O
msec	O
.	O

The	O
patient	O
recovered	O
well	O
from	O
her	B-treatment
surgery	I-treatment
for	O
pacemaker	B-treatment
placement	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
was	O
tolerating	O
her	B-treatment
Flolan	I-treatment
therapy	I-treatment
well	O
.	O

She	O
had	O
received	O
a	O
full	O
course	O
of	O
Flolan	B-treatment
teaching	I-treatment
and	O
reported	O
that	O
she	O
and	O
her	O
husband	O
felt	O
comfortable	O
with	O
the	O
administration	O
of	O
the	B-treatment
medication	I-treatment
at	O
home	O
.	O

She	O
was	O
set	O
up	O
with	O
a	B-treatment
primary	I-treatment
pulmonary	I-treatment
hypertension	I-treatment
support	I-treatment
group	I-treatment
,	O
and	O
home	B-treatment
services	I-treatment
were	O
arranged	O
to	O
help	O
her	O
in	O
the	O
initiation	O
of	O
Flolan	B-treatment
therapy	I-treatment
.	O

Following	O
pacemaker	B-treatment
placement	I-treatment
the	O
patient	O
had	O
no	O
further	O
episodes	O
of	O
bradycardia	B-problem
on	O
telemetry	B-test
,	O
and	O
therefore	O
she	O
was	O
discharged	O
in	O
satisfactory	O
condition	O
.	O

2.	O
INFECTIOUS	O
DISEASE	O
:	O

The	O
patient	O
had	O
no	O
signs	O
or	O
symptoms	O
of	O
infection	B-problem
at	O
the	O
time	O
of	O
admission	O
.	O

However	O
,	O
she	O
was	O
noted	O
to	O
have	O
a	B-problem
relatively	I-problem
elevated	I-problem
white	I-problem
blood	I-problem
cell	I-problem
count	I-problem
that	O
remained	O
stable	O
over	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
.	O

However	O
,	O
near	O
the	O
end	O
of	O
her	O
hospitalization	O
the	O
patient	O
began	O
describing	O
increased	B-problem
urinary	I-problem
frequency	I-problem
which	O
persisted	O
once	O
her	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
removed	O
.	O

A	B-test
urinalysis	I-test
was	O
positive	B-problem
and	O
urine	B-test
culture	I-test
grew	O
enterococcus	B-problem
which	O
was	O
pan	O
sensitive	O
.	O

Therefore	O
,	O
the	O
patient	O
was	O
started	O
on	O
levofloxacin	B-treatment
therapy	I-treatment
to	O
complete	O
a	O
10	O
-	O
day	O
course	O
.	O

Following	O
initiation	O
of	O
the	B-treatment
antibiotic	I-treatment
the	B-test
patient	I-test
's	I-test
white	I-test
blood	I-test
cell	I-test
count	I-test
quickly	O
came	O
down	O
,	O
and	O
she	O
remained	O
afebrile	B-problem
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
still	O
had	O
a	B-problem
mildly	I-problem
elevated	I-problem
white	I-problem
blood	I-problem
cell	I-problem
count	I-problem
but	O
was	O
asymptomatic	B-problem
with	O
a	O
normal	O
temperature	O
.	O

She	O
will	O
complete	O
two	O
more	O
days	O
of	O
Levaquin	B-treatment
therapy	I-treatment
as	O
an	O
outpatient	O
.	O

3.	O
RENAL	O
:	O

The	B-test
patient	I-test
's	I-test
BUN	I-test
and	O
creatinine	B-test
were	O
followed	O
over	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
.	O

These	O
remained	O
stable	O
and	O
within	O
normal	O
limits	O
.	O

It	O
was	O
felt	O
that	O
the	B-problem
decreased	I-problem
urine	I-problem
output	I-problem
was	O
secondary	O
to	O
her	B-problem
preload	I-problem
dependence	I-problem
,	O
and	O
that	O
her	B-test
urine	I-test
output	I-test
increased	O
significantly	O
when	O
she	O
was	O
adequately	O
hydrated	O
in	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
.	O

4.	O
GASTROINTESTINAL	O
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
.	O

She	O
was	O
continued	O
on	O
Protonix	B-treatment
over	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
and	O
had	O
no	O
further	B-problem
gastrointestinal	I-problem
issues	I-problem
.	O

5.	O
HEMATOLOGY	O
:	O

The	B-test
patient	I-test
's	I-test
hematocrit	I-test
remained	O
stable	O
over	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
.	O

Despite	O
bleeding	B-problem
from	O
the	B-treatment
Hickman	I-treatment
site	I-treatment
,	O
she	O
did	O
not	O
require	O
any	B-treatment
transfusion	I-treatment
therapy	I-treatment
.	O

6.	O
FLUIDS	O
/	O
ELECTROLYTES	O
/	O
NUTRITION	O
:	O

The	O
patient	O
tolerated	O
a	O
regular	O
diet	O
throughout	O
the	O
course	O
of	O
her	O
hospital	O
stay	O
.	O

Her	B-test
electrolytes	I-test
were	O
checked	O
on	O
a	O
daily	O
basis	O
and	O
remained	O
within	O
normal	O
limits	O
,	O
being	O
replaced	O
as	O
needed	O
.	O

She	O
was	O
discharged	O
to	O
home	O
on	O
a	O
regular	O
diet	O
.	O

7.	O
ENDOCRINE	O
:	O

The	O
patient	O
with	O
a	O
history	O
of	O
hypothyroidism	B-problem
.	O

She	O
was	O
continued	O
on	O
her	B-treatment
regular	I-treatment
Synthroid	I-treatment
dose	I-treatment
.	O

She	O
will	O
need	O
a	B-test
TSH	I-test
and	O
T4	B-test
checked	O
as	O
an	O
outpatient	O
.	O

8.	O
CODE	O
STATUS	O
:	O

The	O
patient	O
is	O
a	B-treatment
full	I-treatment
code	I-treatment
.	O

9.	O
FLOLAN	B-treatment
ADMINISTRATION	I-treatment
:	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
was	O
tolerating	O
a	B-treatment
Flolan	I-treatment
dose	I-treatment
of	O
5	O
nanograms	O
per	O
kilogram	O
per	O
minute	O
.	O

A	O
Physical	O
Therapy	O
consultation	O
was	O
obtained	O
to	O
initiate	O
a	B-test
6	I-test
-	I-test
minute	I-test
walk	I-test
test	I-test
.	O

On	O
room	O
air	O
,	O
the	B-test
patient	I-test
's	I-test
oxygen	I-test
saturation	I-test
was	O
95%	O
and	O
dropped	O
to	O
88%	O
following	O
a	O
6	O
-	O
minute	O
walk	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
appropriate	O
Flolan	B-treatment
teaching	I-treatment
and	O
supplies	O
.	O

She	O
was	O
to	O
follow	O
up	O
with	O
Dr.	O
Savage	O
in	O
the	O
Clinic	O
the	O
following	O
week	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

She	O
was	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

She	O
has	O
follow	O
up	O
with	O
Dr.	O
Schwartz	O
in	O
the	O
Clinic	O
on	O
Monday	O
,	O
12-22	O
,	O
at	O
2:30	O
p.m.	O
to	O
check	O
her	B-test
INR	I-test
and	O
digoxin	B-test
level	I-test
.	O

She	O
also	O
has	O
follow	O
up	O
with	O
Dr.	O
Savage	O
in	O
the	O
Pulmonary	O
Clinic	O
on	O
12-25	O
at	O
12:15	O
p.m.	O
for	O
management	B-treatment
of	O
her	B-problem
pulmonary	I-problem
hypertension	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Coumadin	B-treatment
2	O
mg	O
p.o.	O
q.6h.	O

2.	O
Tylenol	B-treatment
No.	I-treatment
3	I-treatment
one	O
to	O
two	O
tablets	O
p.o.	O
q.4h.	O
p.r.n.	O
for	O
pain	B-problem
.	O

3.	O
Digoxin	B-treatment
0.125	O
mg	O
p.o.	O
q.d.	O

4.	O
Levofloxacin	B-treatment
500	O
mg	O
p.o.	O
t.i.d.	O
times	O
two	O
days	O
.	O

5.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

6.	O
Tylenol	B-treatment
650	O
mg	O
p.o.	O
q.4-6h.	O
p.r.n.	O
for	O
fever	B-problem
or	O
pain	B-problem
.	O

7.	O
Synthroid	B-treatment
125	O
mcg	O
p.o.	O
q.d.	O

8.	O
Colace	B-treatment
100	O
mg	O
p.o.	O
q.d.	O

9.	O
Lactulose	B-treatment
30	O
cc	O
p.o.	O
q.6h.	O
p.r.n.	O
for	O
constipation	B-problem
.	O

10.	O
Flolan	B-treatment
5	O
nanograms	O
per	O
kilograms	O
per	O
minute	O
,	O
continuous	O
infusion	O
.	O

11.	O
Oxygen	B-treatment
per	O
nasal	B-treatment
cannula	I-treatment
as	O
needed	O
.	O

Alan	O
Q.	O
Steckelberg	O
,	O
M.D.	O

54-745	O
PAD-WORD	O

Dictated	O
By	O
:	O
Roy	O
C	O
Ali	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-12-18	O
18:32	O

T	O
:	O
2014-12-21	O
10:44	O

JOB	O
#:	O

60351	O
PAD-WORD	O

(	O
cclist	O
)	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Melody	O
PARKS	O
on	O
:	O
TUE	O
2014-12-23	O
6:28	O
AM	O

(	O
End	O
of	O
Report	O
)	O

656225945	O
YC	O

76593195	O
PAD-WORD	O

2774375	O
PAD-WORD	O

01/19/2003	O
12:00:00	O
AM	O

cellulitis	B-problem
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

01/19/2003	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/24/2003	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

MONG	O
,	O
RISHRIELI	O

156-02-38-0	O
P22	O

Room	O
:	O

15L-305	O
PAD-WORD	O

Service	O
:	O

MED	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/24/03	O
AT	O
02:00	O
PM	O

CONTINGENT	O
UPON	O

Attending	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

SHONESGANS	O
,	O
AH	O
B.	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

LEVOFLOXACIN	B-treatment
500	O
MG	O
PO	O
QD	O
X	O
14	O
Days	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Administer	O
iron	B-treatment
products	I-treatment
a	O
minimum	O
of	O
2	O
hours	O
before	O
or	O
after	O
a	B-treatment
levofloxacin	I-treatment
or	O
ciprofloxacin	B-treatment
dose	I-treatment
dose	O
If	O
on	O
tube	B-treatment
feeds	I-treatment
,	O
please	O
cycle	O
(	O
hold	O
1	O
hr	O
before	O
to	O
2	O
hr	O
after	O
)	O
Take	O
2	O
hours	O
before	O
or	O
2	O
hours	O
after	O
dairy	O
products	O
.	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Ica	O
Gachcienne	O
-	O
in	O
PCP	O
office	O
01/26/03	O
,	O

ALLERGY	O
:	O

Penicillins	B-treatment
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

Cellulitis	B-problem
PAD-WORD	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
cellulitis	B-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
cellulitis	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

None	O
PAD-WORD	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

CT	B-test
of	I-test
neck	I-test
with	I-test
contrast	I-test

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

Pt	O
is	O
22	O
y	O
/	O
o	O
female	O
with	O
hx	O
of	O
HIV	B-problem
and	O
CD4	B-test
ct	I-test
of	O
297	O
who	O
presented	O
to	O
ED	O
on	O
01/14	O
with	O
sebaceous	B-problem
cyst	I-problem
that	O
was	O
infected	B-problem
.	O

Cyst	B-problem
was	O
drained	O
and	O
pt	O
was	O
sent	O
home	O
with	O
Duracef	B-treatment
.	O

She	O
did	O
not	O
fill	O
script	B-treatment
for	O
2	O
days	O
and	O
even	O
then	O
was	O
not	B-problem
compliant	I-problem
with	O
her	B-treatment
meds	I-treatment
.	O

She	O
now	O
returns	O
to	O
ED	O
with	O
pain	B-problem
and	O
erythema	B-problem
from	I-problem
the	I-problem
midline	I-problem
posterior	I-problem
neck	I-problem
to	O
her	O
submental	O
area	O
and	O
2-3	O
d	O
of	O
intermittent	B-problem
fevers	I-problem
and	O
chills	B-problem
.	O
+	O
nausea	B-problem
.	O

No	O
dysphagia	B-problem
,	O
trouble	O
hearing	O
.	O

PMH	O
:	O

HIV	B-problem
,	O
viral	B-test
load	I-test
954	O
,	O
7/03	O
-	O
H.	B-problem
Pylori	I-problem
pos.	O
,	O
asthma	B-problem

FHX	O
/	O
SHX	O
:	O

Lives	O
with	O
boyfriend	O
in	O
apt	O
.	O

Smokes	O
2-3	O
cig	O
/	O
day	O
,	O
occ	O
etoh	O
,	O
and	O
no	O
drugs	O
except	O
marijuana	O
Exam	B-test
:	O

98.6	O
54	O
119/59	O
18	O
100%	O
RA	O
.	O

Exam	B-test
sig.	O
for	O
erthyema	B-problem
as	O
described	O
previously	O
and	O
tenderness	B-problem
to	O
minimal	B-test
palpation	I-test
.	O

Data	O
:	O

Neck	B-test
CT	I-test
neg	O
for	O
abcess	B-problem
.	O

Pt	O
with	O
WBC	B-test
of	O
15.4	O
with	O
70%	B-test
seg	I-test
.	O

Plan	O
:	O

(1)	O
ID	O
-	O
Pt	O
received	O
Clinda	B-treatment
and	O
Ancef	B-treatment
in	O
ED	O
.	O

Will	O
cont	O
Ancef	B-treatment
1q8	O
overnight	O
and	O
trans	O
to	O
Keflex	B-treatment
.	O

CD4	B-test
ct	I-test
.	O

Bacitracin	B-treatment
oint	I-treatment
.	O

Percocet	B-treatment
and	O
morphine	B-treatment
sulfate	I-treatment
for	O
pain	B-problem
.	O

(2)	O
GI	O
-	O
Nexium	B-treatment

(3)	O
FEN	O
-	O
NS	B-treatment
overnight	O

(4)	O
Pulm	O
-	O
Albuterol	B-treatment
inhalers	I-treatment
prn	O
Patient	O
seems	O
to	O
be	O
improving	O
and	O
afebrile	B-problem
and	O
resting	O
comfortably	O
.	O

The	B-problem
erythematous	I-problem
region	I-problem
is	O
retreating	O
and	O
the	B-problem
wound	I-problem
cleaned	O
.	O

She	O
is	O
ready	O
to	O
be	O
sent	O
home	O
with	O
antibiotics	B-treatment
.	O

Repeat	B-test
CT	I-test
was	O
neg.	O
for	O
abcess	B-problem
or	O
fascitis	B-problem
.	O

ADDITIONAL	O
COMMENTS	O
:	O

1	O
-	O
be	O
sure	O
to	O
finish	O
all	O
antibiotic	B-treatment
even	O
if	O
pain	B-problem
subsides	O
adn	O
inflammation	B-problem
goes	O
down	O
.	O

2	O
-	O
clean	O
wound	B-problem

3	O
-	O
Follow	O
up	O
with	O
PCP	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

1	O
-	O
Fill	O
Rx	O
for	O
antibiotics	B-treatment
today	O
and	O
take	O
until	O
finished	O
even	O
if	O
neck	B-problem
pain	I-problem
subsides	O
x	O
14	O
days	O

2	O
-	O
Clean	O
wound	B-problem

3	O
-	O
Return	O
to	O
ED	O
or	O
call	O
PCP	O
if	O
neck	B-problem
inflammation	I-problem
and	O
red	B-problem
swollen	I-problem
area	I-problem
does	O
not	O
continue	O
to	O
get	O
better	O
or	O
if	O
temperature	B-problem
returns	O
.	O

4	O
-	O
Visit	O
PCP	O
on	O
Monday	O
at	O
2:30	O
No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

DRIN	O
,	O
FONDT	O
L.	O
,	O
M.D.	O
(	O
CR90	O
)	O
01/24/03	O
12:48	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2014-08-07	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-08-09	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1958-03-14	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEUROSURG	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
56	O
-	O
year-old	O
man	O
without	O
any	O
significant	O
past	O
medical	O
history	O
who	O
presented	O
to	O
the	O
emergency	O
room	O
after	O
the	O
sudden	O
onset	O
of	O
headache	B-problem
while	O
he	O
was	O
riding	O
a	O
bicycle	O
.	O

He	O
characterized	O
this	B-problem
headache	I-problem
as	O
the	B-problem
worst	I-problem
headache	I-problem
of	O
his	O
life	O
and	O
had	O
associated	O
nausea	B-problem
and	O
vomiting	B-problem
times	O
one	O
.	O

He	O
also	O
complained	O
of	O
dizziness	B-problem
at	O
the	O
time	O
of	O
headache	B-problem
onset	O
.	O

He	O
presented	O
to	O
the	O
Edith	O
Nourse	O
Rogers	O
Memorial	O
VA	O
Hospital	O
emergency	O
room	O
,	O
where	O
an	B-test
initial	I-test
head	I-test
CT	I-test
scan	I-test
was	O
read	O
as	O
negative	O
.	O

However	O
,	O
a	B-test
lumbar	I-test
puncture	I-test
was	O
done	O
,	O
in	O
which	O
tube	O
1	O
showed	O
4800	B-test
red	I-test
blood	I-test
cells	I-test
and	O
tube	O
4	O
showed	O
4000	B-test
red	I-test
blood	I-test
cells	I-test
.	O

The	O
patient	O
was	O
sent	O
for	O
an	B-test
MRI	I-test
of	I-test
the	I-test
head	I-test
,	O
which	O
raised	O
the	O
question	O
of	O
a	B-problem
right	I-problem
posterior	I-problem
cerebral	I-problem
artery	I-problem
aneurysm	I-problem
.	O

The	B-test
CT	I-test
scan	I-test
was	O
revealed	O
and	O
,	O
on	O
second	O
analysis	O
,	O
it	O
was	O
thought	O
that	O
it	O
was	O
suspicious	O
for	O
a	B-problem
subarachnoid	I-problem
hemorrhage	I-problem
in	I-problem
the	I-problem
suprasellar	I-problem
cistern	I-problem
.	O

The	O
patient	O
was	O
then	O
admitted	O
for	O
further	B-test
evaluation	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
was	O
significant	O
for	O
left	B-treatment
shoulder	I-treatment
surgery	I-treatment
in	O
2014-03-06	O
for	O
repair	B-treatment
of	O
a	B-problem
"	I-problem
minor	I-problem
rotator	I-problem
cuff	I-problem
tear	I-problem
"	O
and	O
removal	B-treatment
of	O
osteophytes	B-problem
.	O

Otherwise	O
,	O
the	O
past	O
medical	O
history	O
was	O
insignificant	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
was	O
on	O
no	O
medications	B-treatment
.	O

ALLERGIES	O
:	O

There	O
were	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

FAMILY	O
HISTORY	O
:	O

The	O
father	O
had	O
leukemia	B-problem
and	O
the	O
mother	O
had	O
gastrointestinal	B-problem
cancer	I-problem
.	O

There	O
was	O
no	O
family	O
history	O
of	O
aneurysms	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
was	O
a	O
nonsmoker	O
and	O
used	O
no	O
ethanol	O
.	O

He	O
was	O
married	O
,	O
with	O
children	O
,	O
and	O
was	O
a	O
church	O
minister	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
,	O
the	O
patient	O
was	O
resting	O
comfortably	O
when	O
seen	O
,	O
slightly	B-problem
sleepy	I-problem
at	O
first	O
but	O
readily	O
arousable	O
,	O
awake	O
,	O
alert	O
,	O
oriented	O
and	O
conversant	O
.	O

Of	O
note	O
,	O
the	O
patient	O
had	O
been	O
given	O
2	O
mg	O
of	O
Ativan	B-treatment
before	O
the	B-test
examination	I-test
.	O

The	O
face	O
was	O
symmetric	O
.	O

The	O
tongue	O
was	O
midline	O
.	O

The	O
neck	O
was	O
supple	O
with	O
full	O
range	O
of	O
motion	O
.	O

There	O
was	O
no	O
rigidity	B-problem
,	O
but	O
the	O
neck	O
was	O
slightly	B-problem
painful	I-problem
at	O
extreme	B-test
flexion	I-test
.	O

The	B-test
general	I-test
examination	I-test
was	O
essentially	O
unremarkable	O
,	O
as	O
per	O
previous	O
notes	O
.	O

On	O
examination	B-test
of	I-test
the	I-test
extremities	I-test
,	O
the	O
patient	O
moved	O
all	O
extremities	O
and	O
had	O
strength	O
of	O
5/5	O
in	O
all	O
of	O
the	O
muscle	O

groups	O
tested	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
.	O

The	B-test
sensory	I-test
examination	I-test
was	O
intact	O
to	O
light	B-test
touch	I-test
.	O

There	O
was	O
a	B-problem
very	I-problem
slight	I-problem
inward	I-problem
pronator	I-problem
drift	I-problem
of	I-problem
the	I-problem
left	I-problem
hand	I-problem
.	O

Finger	B-test
-	I-test
nose	I-test
-	I-test
finger	I-test
testing	I-test
and	O
heel	B-test
-	I-test
to	I-test
-	I-test
shin	I-test
testing	I-test
were	O
normal	O
.	O

Rapid	O
alternating	O
movement	O
was	O
normal	O
.	O

The	O
toes	O
were	O
downgoing	O
bilaterally	O
.	O

Gait	O
was	O
reported	O
to	O
be	O
normal	O
,	O
as	O
per	O
the	O
emergency	O
room	O
staff	O
.	O

There	O
was	O
no	O
ataxia	B-problem
noted	O
.	O

LABORATORY	O
:	O

Laboratory	B-test
values	I-test
were	O
as	O
per	O
the	O
History	O
of	O
Present	O
Illness	O
.	O

RADIOLOGY	O
:	O

Neurological	B-test
imaging	I-test
data	O
was	O
as	O
per	O
the	O
History	O
of	O
Present	O
Illness	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
surgical	O
intensive	O
care	O
unit	O
,	O
where	O
a	B-test
continued	I-test
cerebral	I-test
angiogram	I-test
was	O
done	O
that	O
was	O
essentially	O
normal	O
,	O
without	O
evidence	O
of	O
any	B-problem
obvious	I-problem
aneurysm	I-problem
.	O

The	O
patient	O
was	O
observed	O
for	O
two	O
days	O
with	O
a	B-test
repeat	I-test
CT	I-test
scan	I-test
showing	O
no	O
changes	B-problem
from	O
the	B-test
previous	I-test
examination	I-test
.	O

The	B-problem
headache	I-problem
stabilized	O
after	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
.	O

The	O
patient	O
continued	O
to	O
do	O
well	O
and	O
the	O
decision	O
was	O
made	O
to	O
discharge	O
him	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
was	O
discharged	O
with	O
strict	O
instructions	O
to	O
return	O
to	O
the	O
emergency	O
room	O
,	O
should	O
there	O
be	O
an	O
exacerbation	O
of	O
symptoms	B-problem
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Ruled	O
out	O
subarachnoid	B-problem
hemorrhage	I-problem
.	O

Michael	O
Lawrence	O
,	O
M.D.	O

41-707	O
PAD-WORD	O

Dictated	O
By	O
:	O
Lena	O
D.	O
Mannie	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-08-09	O
14:04	O

T	O
:	O
2014-08-09	O
15:27	O

JOB	O
#:	O

45402	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Michael	O
Jackson	O
on	O
:	O
FRI	O
2014-09-05	O
11:39	O
AM	O

(	O
End	O
of	O
Report	O
)	O

662179752	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

9175227	O
PAD-WORD	O

22849/871n	O
PAD-WORD	O

818603	O
PAD-WORD	O

7/30/1993	O
12:00:00	O
AM	O

CORONARY	B-problem
ARTERY	I-problem
DISEASE	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

07-30-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

08-10-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Congestive	B-problem
heart	I-problem
failure	I-problem
.	O

2.	O
Ventricular	B-problem
ectopy	I-problem
.	O

3.	O
Pulmonary	B-problem
hypertension	I-problem
.	O

4.	O
Cardiomegaly	B-problem
.	O

5.	O
Sinus	B-problem
tachycardia	I-problem
.	O

6.	O
Diabetes	B-problem
mellitus	I-problem
.	O

7.	O
Paraphimosis	B-problem
.	O

8.	O
Right	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
.	O

9.	O
Pericarditis	B-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

Heparin	B-treatment
,	O
consisting	O
of	O
thrombocytopenia	B-problem
;	O
Pronestyl	B-treatment
,	O
consisting	O
of	O
nausea	B-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

08/02/93	O
:	O

coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
x	I-treatment
3	I-treatment
.	O

08/02/93	O
:	O

left	O
internal	O
mammary	O
artery	O
to	O
anterior	O
descending	O
artery	O
x	O
1	O
.	O

08/02/93	O
:	O

Insertion	B-treatment
of	I-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
.	O

07/30/93	O
:	O

bilateral	B-test
cardiac	I-test
catheterization	I-test
.	O

07/30/93	O
:	O

Left	B-test
ventriculography	I-test
.	O

07/30/93	O
:	O

bilateral	B-test
coronary	I-test
angiography	I-test
.	O

08/02/93	O
:	O

Signal	B-test
average	I-test
EKG	I-test
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Digoxin	B-treatment
,	O
.25	O
mg	O
PO	O
QD	O
;	O
Ecotrin	B-treatment
,	O
325	O
mg	O
QD	O
;	O
Coumadin	B-treatment
,	O
2.5	O
mg	O
PO	O
QD	O
;	O
Lisinopril	B-treatment
,	O
2.5	O
mg	O
PO	O
QD	O
;	O
Micronase	B-treatment
,	O
5	O
mg	O
PO	O
BID	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
year	O
old	O
patient	O
of	O
Dr.	O
Laymie	O
Fournier	O
and	O
Dr.	O
Leebjescobe	O
in	O
Co	O
In	O
Saorlirv	O
Frea	O
,	O
West	O
Virginia	O
who	O
was	O
well	O
until	O
a	O
bout	O
of	O
double	B-problem
pneumonia	I-problem
in	O
May	O
1992	O
,	O
at	O
which	O
time	O
he	O
was	O
hospitalized	O
at	O
Centdick	O
Naco	O
Hospital	O
Medical	O
Center	O
.	O

He	O
also	O
has	O
a	O
history	O
of	O
hypertension	B-problem
and	O
diabetes	B-problem
mellitus	I-problem
.	O

He	O
had	O
a	O
transient	O
episode	O
of	O
headache	B-problem
and	O
disorientation	B-problem
at	O
that	O
time	O
.	O

A	B-test
CT	I-test
and	O
MRI	B-test
scan	I-test
corroborated	O
multiple	B-problem
cerebral	I-problem
infarcts	I-problem
.	O

He	O
was	O
started	O
on	O
aspirin	B-treatment
.	O

He	O
has	O
a	O
family	O
history	O
of	O
hypertension	B-problem
as	O
well	O
.	O

He	O
was	O
also	O
placed	O
on	O
Vasotec	B-treatment
.	O

A	B-test
Holter	I-test
monitor	I-test
showed	O
ventricular	B-problem
ectopy	I-problem
.	O

A	B-test
thallium	I-test
stress	I-test
test	I-test
showed	O
tachycardia	B-problem
and	O
severe	B-problem
dyspnea	I-problem
as	O
well	O
as	O
a	B-problem
fall	I-problem
in	I-problem
blood	I-problem
pressure	I-problem
with	O
low	O
level	O
exercise	O
.	O

An	B-test
echocardiogram	I-test
showed	O
global	B-problem
hypokinesis	I-problem
.	O

Accordingly	O
he	O
was	O
referred	O
for	O
further	B-test
evaluation	I-test
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Blood	B-test
pressure	I-test
140/100	O
,	O
phosphorus	B-test
94	O
,	O
weight	B-test
181	O
lb	O
.	O

Head	O
,	O
neck	O
:	O

unremarkable	O
.	O

Lungs	O
clear	O
.	O

Carotids	O
normal	O
.	O

Cardiac	O
:	O

Loud	B-problem
S4	I-problem
and	O
a	B-problem
II	I-problem
/	I-problem
VI	I-problem
regurgitant	I-problem
murmur	I-problem
.	O

Abdomen	O
was	O
benign	O
.	O

Peripheral	B-test
pulses	I-test
intact	O
.	O

Neurological	O
:	O

Nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

Sodium	B-test
140	O
,	O
potassium	B-test
4.0	O
,	O
chloride	B-test
104	O
,	O
CO2	B-test
28	O
,	O
BUN	B-test
14	O
,	O
creatinine	B-test
1.1	O
,	O
glucose	B-test
243	O
.	O

Cholesterol	B-test
197	O
,	O
triglycerides	B-test
118	O
,	O
HDL	B-test
31	O
,	O
LDL	B-test
142	O
,	O
total	B-test
protein	I-test
6.2	O
,	O
bilirubin	B-test
1.0	O
,	O
alkaline	B-test
phosphatase	I-test
72	O
,	O
SGOT	B-test
23	O
.	O

Hematocrit	B-test
on	O
admission	O
was	O
43%	O
with	O
a	B-test
white	I-test
blood	I-test
count	I-test
of	O
6600	O
.	O

MCV	B-test
was	O
85	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
,	O
where	O
he	O
was	O
noted	O
initially	O
to	O
have	O
a	B-test
pulmonary	I-test
wedge	I-test
pressure	I-test
of	O
45	O
with	O
a	B-test
pulmonary	I-test
artery	I-test
pressure	I-test
of	O
82/40	O
.	O

This	O
lowered	O
with	O
IV	B-treatment
nitroglycerin	I-treatment
.	O

Selective	B-test
coronary	I-test
angiography	I-test
showed	O
an	B-problem
occluded	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
in	I-problem
its	I-problem
midportion	I-problem
.	O

He	O
had	O
an	O
80%	O
distal	O
left	O
main	O
,	O
a	O
90%	O
proximal	O
circumflex	O
,	O
and	O
multiple	B-problem
significant	I-problem
lesions	I-problem
in	I-problem
the	I-problem
LAD	I-problem
.	O

His	O
left	O
ventricle	O
ejection	O
showed	O
diffuse	B-problem
hypokinesis	I-problem
.	O

The	O
situation	O
was	O
reviewed	O
with	O
his	O
wife	O
,	O
Sligh	O
.	O

She	O
noted	O
that	O
he	O
was	O
actively	O
working	O
full	O
time	O
and	O
was	O
a	O
sales	O
representative	O
at	O
the	O
Leigh	O
and	O
lives	O
at	O
home	O
with	O
her	O
and	O
his	O
daughter	O
,	O
age	O
18	O
.	O

It	O
was	O
felt	O
that	O
,	O
because	O
of	O
the	O
evidence	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
and	O
the	B-problem
critical	I-problem
left	I-problem
main	I-problem
lesion	I-problem
,	O
he	O
should	O
be	O
admitted	O
for	O
further	B-test
evaluation	I-test
.	O

Indeed	O
,	O
he	O
was	O
treated	O
with	O
diuretics	B-treatment
and	O
nitrates	B-treatment
along	O
with	O
cessation	O
of	O
his	B-treatment
aspirin	I-treatment
,	O
and	O
he	O
was	O
put	O
on	O
IV	B-treatment
Heparin	I-treatment
.	O

He	O
stabilized	O
over	O
the	O
weekend	O
.	O

He	O
was	O
noted	O
to	O
have	O
some	B-problem
ventricular	I-problem
ectopy	I-problem
on	O
Holter	B-test
monitor	I-test
.	O

He	O
developed	O
epigastric	B-problem
pain	I-problem
on	O
07/31	O
which	O
previously	O
had	O
been	O
ignored	O
but	O
in	O
retrospect	O
was	O
probably	O
his	B-problem
anginal	I-problem
equivalent	I-problem
.	O

He	O
also	O
had	O
multifocal	B-problem
ventricular	I-problem
ectopy	I-problem
at	O
that	O
time	O
.	O

He	O
had	O
some	B-problem
further	I-problem
anterolateral	I-problem
ST	I-problem
segment	I-problem
changes	I-problem
.	O

Therefore	O
,	O
he	O
did	O
have	O
unstable	B-problem
angina	I-problem
with	O
his	B-problem
critical	I-problem
coronary	I-problem
anatomy	I-problem
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Electrophysiology	O
service	O
,	O
Dr.	O
Slusslashgodle	O
,	O
who	O
said	O
that	O
he	O
had	O
no	O
indication	O
for	O
patch	B-treatment
placement	I-treatment
at	O
the	O
time	O
of	O
surgery	B-treatment
.	O

On	O
08/02/93	O
,	O
an	B-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
was	O
placed	O
;	O
then	O
,	O
Dr.	O
Thorebreutz	O
took	O
him	O
to	O
the	O
operating	O
room	O
,	O
where	O
he	O
had	O
quadruple	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

He	O
had	O
a	B-treatment
left	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
graft	I-treatment
of	I-treatment
the	I-treatment
LAD	I-treatment
,	O
a	O
single	O
saphenous	O
vein	O
to	O
the	O
right	O
coronary	O
artery	O
with	O
280	O
cc	O
per	O
minute	O
flow	O
,	O
and	O
a	B-treatment
saphenous	I-treatment
vein	I-treatment
snake	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
diagonal	I-treatment
and	O
circumflex	O
with	O
150	O
cc	O
per	O
minute	O
flow	O
.	O

A	B-problem
paraphimosis	I-problem
was	O
noted	O
and	O
treated	O
by	O
Dr.	O
Ryna	O
Jescdrig	O
.	O

After	O
surgery	B-treatment
he	O
had	O
a	B-problem
ongoing	I-problem
sinus	I-problem
tachycardia	I-problem
.	O

He	O
was	O
able	O
to	O
be	O
rapidly	O
weaned	O
and	O
extubated	O
.	O

He	O
had	O
good	O
hemodynamics	O
.	O

He	O
had	O
occasional	B-problem
atrial	I-problem
and	I-problem
ventricular	I-problem
premature	I-problem
beats	I-problem
.	O

His	B-treatment
intra-aortic	I-treatment
balloon	I-treatment
pump	I-treatment
was	O
weaned	O
the	O
following	O
day	O
and	O
he	O
was	O
transferred	O
out	O
of	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
.	O

He	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Nutrition	O
Service	O
,	O
who	O
followed	O
him	O
for	O
dietary	O
management	O
of	O
his	B-problem
diabetes	I-problem
mellitus	I-problem
.	O

On	O
08/05	O
it	O
was	O
noted	O
that	O
his	B-test
platelet	I-test
count	I-test
had	O
fallen	O
from	O
171,000	O
to	O
54,000	O
;	O
this	O
was	O
thought	O
to	O
be	O
associated	O
with	O
intravenous	B-treatment
Heparin	I-treatment
and	O
indeed	O
,	O
when	O
Heparin	B-treatment
was	O
discontinued	O
,	O
since	O
it	O
had	O
been	O
restarted	O
after	O
surgery	O
,	O
his	B-test
platelet	I-test
count	I-test
rebounded	O
to	O
normal	O
.	O

Therefore	O
,	O
he	O
does	O
have	O
a	B-problem
thrombocytopenic	I-problem
reaction	I-problem
to	O
Heparin	B-treatment
.	O

He	O
remained	O
in	O
normal	O
sinus	O
rhythm	O
.	O

He	O
did	O
have	O
runs	O
of	O
nonsustained	B-problem
ventricular	I-problem
tachycardia	I-problem
,	O
which	O
were	O
clinically	O
stable	O
.	O

He	O
had	O
a	B-problem
right	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
.	O

He	O
is	O
at	O
increased	O
risk	O
for	O
future	O
events	O
because	O
of	O
his	B-problem
low	I-problem
left	I-problem
ventricular	I-problem
ejection	I-problem
fraction	I-problem
,	O
but	O
he	O
is	O
clinically	O
stable	O
on	O
ACE	B-treatment
inhibitors	I-treatment
,	O
Digoxin	B-treatment
,	O
Coumadin	B-treatment
,	O
and	O
aspirin	B-treatment
.	O

Therefore	O
he	O
was	O
able	O
to	O
be	O
discharged	O
home	O
.	O

He	O
understands	O
that	O
he	O
does	O
have	O
significant	B-problem
left	I-problem
ventricle	I-problem
dysfunction	I-problem
and	O
requires	O
monitoring	B-test
of	I-test
his	I-test
prothrombin	I-test
times	I-test
and	I-test
his	I-test
arrhythmias	I-test
;	O
these	O
will	O
be	O
done	O
in	O
Grovea	O
Co	O
Terburgperv	O
Portnew	O
.	O

ACHASTHA	O
N.	O
DAIZSMAELLILLE	O
,	O
M.D.	O

TR	O
:	O

ssx	O
/	O
bmot	O

DD	O
:	O

08-09-93	O
PAD-WORD	O

TD	O
:	O

08/10/93	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Thorebreutz	O
,	O
E	O
2	O

Admission	O
Date	O
:	O

2015-09-20	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-09-30	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1961-09-28	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

NEUROLOGY	O
PAD-WORD	O

Allergies	O
:	O

Lamictal	B-treatment
/	O
Keflex	B-treatment
/	O
Navane	B-treatment
/	O
Inderal	B-treatment
/	O
Depakote	B-treatment

Attending	O
:	O
Cindy	O
U.	O
Kelly	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

transfer	O
from	O
OSH	O
,	O
seizure	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Lumbar	B-test
puncture	I-test

History	O
of	O
Present	O
Illness	O
:	O

Ms.	O
Swanson	O
is	O
a	O
53	O
yo	O
woman	O
with	O
PMH	O
significant	O
for	O
seizure	B-problem
disorder	I-problem
,	O
brain	B-problem
injury	I-problem
,	O
and	O
?	O
atypical	B-problem
multiple	I-problem
sclerosis	I-problem
who	O
presents	O
with	O
right	B-problem
face	I-problem
twitch	I-problem
and	O
right	B-problem
arm	I-problem
shaking	I-problem
.	O

History	O
is	O
obtained	O
from	O
her	O
sister	O
,	O
William	O
from	O
Lawrence	O
General	O
Hospital	O
,	O
and	O
from	O
her	O
primary	O
neurologist	O
,	O
Dr.	O
Brian	O
.	O

She	O
lives	O
in	O
an	O
assisted	O
living	O
,	O
and	O
was	O
noted	O
yesterday	O
to	O
have	O
generalized	B-problem
tonic-clonic	I-problem
activity	I-problem
beginning	O
on	O
the	O
right	O
side	O
and	O
lasting	O
90	O
minutes	O
.	O

EMS	O
gave	O
her	O
valium	B-treatment
5	O
mg	O
pr	O
at	O
the	O
facility	O
and	O
brought	O
her	O
to	O
Barnstable	O
County	O
Hospital	O
.	O

She	O
persisted	O
with	O
right	B-problem
sided	I-problem
seizure	I-problem
activity	I-problem
there	O
and	O
was	O
given	O
valium	B-treatment
10	O
mg	O
and	O
ativan	B-treatment
1	O
mg	O
,	O
as	O
well	O
as	O
loaded	O
with	O
dilantin	B-treatment
1000	O
mg	O
.	O

She	O
was	O
transferred	O
to	O
the	O
Providence	O
Behavioral	O
Health	O
Hospital	O
CMED	O
.	O

Here	O
she	O
was	O
given	O
an	B-treatment
additional	I-treatment
valium	I-treatment
5	O
mg	O
x	O
2	O
and	O
ativan	B-treatment
1	O
mg	O
x	O
3	O
for	O
persistent	B-problem
twitching	I-problem
in	I-problem
her	I-problem
face	I-problem
and	I-problem
right	I-problem
hand	I-problem
.	O

Since	O
the	B-treatment
ativan	I-treatment
,	O
her	B-problem
facial	I-problem
twitching	I-problem
has	O
apparently	O
improved	O
,	O
but	O
she	O
continues	O
to	O
have	O
hand	B-problem
twitches	I-problem
.	O

She	O
also	O
had	O
an	B-test
EEG	I-test
,	O
which	O
showed	O
left	B-problem
sided	I-problem
slowing	I-problem
on	O
preliminary	O
read	O
.	O

Apparently	O
she	O
has	O
a	O
long	O
history	O
of	O
seizure	B-problem
disorder	I-problem
,	O
possibly	O
from	O
a	O
history	O
of	O
traumatic	B-problem
brain	I-problem
injury	I-problem
(	O
though	O
per	O
Dr.	O
Paula	O
,	O

records	O
from	O
that	O
hospitalization	O
indicate	O
she	O
may	O
have	O
only	O
had	O
a	B-problem
very	I-problem
mild	I-problem
injury	I-problem
)	O
and	O
has	O
been	O
managed	O
on	O
dilantin	B-treatment
and	O
keppra	B-treatment
.	O

Since	O
she	O
has	O
seen	O
Dr.	O
Ollie	O
,	O
she	O
has	O
had	O
at	O
least	O
two	O
episodes	O
of	O
status	B-problem
epilepticus	I-problem
and	O
one	B-problem
generalized	I-problem
seizure	I-problem
,	O
as	O
well	O
as	O
some	B-problem
less	I-problem
significant	I-problem
seizures	I-problem
which	O
are	O
characterized	O
by	O
left	B-problem
gaze	I-problem
preference	I-problem
and	O
left	B-problem
sided	I-problem
tonic-clonic	I-problem
activity	I-problem
.	O

Her	B-test
dilantin	I-test
levels	I-test
had	O
been	O
somewhat	O
difficult	O
to	O
control	O
.	O

He	O
tried	O
adding	O
lamictal	B-treatment
,	O
but	O
this	O
caused	O
a	B-problem
rash	I-problem
.	O

At	O
the	O
time	O
of	O
her	O
last	O
visit	O
(	O
2015-03-18	O
)	O
Dr.	O
Bradley	O
had	O
discussed	O
the	O
addition	O
of	O
a	B-treatment
third	I-treatment
Castelluccio	I-treatment
,	O
possibly	O
zonegran	B-treatment
(	O
less	O
likely	O
topamax	B-treatment
),	O
to	O
the	B-treatment
dilantin	I-treatment
200	O
mg	O
bid	O
and	O
keppra	B-treatment
1500	O
mg	O
bid	O
.	O

Her	O
sister	O
had	O
wanted	O
to	O
keep	O
the	O
current	O
course	O
because	O
she	O
felt	O
she	O
was	O
doing	O
well	O
where	O
she	O
was	O
living	O
and	O
did	O
not	O
want	O
to	O
upset	O
that	O
.	O

However	O
,	O
she	O
had	O
several	B-test
dilantin	I-test
levels	I-test
drawn	O
since	O
her	O
last	O
visit	O
,	O
with	O
15.4	O
in	O
05	O
-	O
23.5	O
in	O
Theresa	O
,	O
and	O
3.09	O
-	O
18	O
.	O

Her	O
sister	O
reports	O
that	O
the	B-treatment
medication	I-treatment
dose	I-treatment
had	O
been	O
changed	O
to	O
200	O
mg	O
qam	O
and	O
100	O
mg	O
qpm	O
in	O
Theresa	O
,	O
and	O
a	O
review	O
of	O
her	O
Union	O
Hospital	O
-	O
North	O
Shore	O
Medical	O
Center	O
records	O
indicates	O
that	O
this	O
may	O
have	O
occurred	O
in	O
an	O
urgent	O
care	O
appointment	O
secondary	O
to	O
slurred	B-problem
speech	I-problem
and	O
a	O
recent	O
fall	O
and	O
a	B-problem
non-trough	I-problem
level	I-problem
of	O
15.9	O
.	O

According	O
to	O
her	O
sister	O
,	O
the	O
patient	O
has	O
no	B-problem
short-term	I-problem
memory	I-problem
.	O

She	O
has	O
been	O
living	O
in	O
an	O
assisted	O
living	O
facility	O
and	O
frequently	O
calls	O
her	O
even	O
right	O
after	O
she	O
has	O
left	O
without	O
remembering	O
her	O
visit	O
.	O

The	O
patient	O
walks	O
with	O
a	B-treatment
walker	I-treatment
at	O
baseline	O
and	O
goes	O
out	O
for	O
dinner	O
and	O
shopping	O
with	O
her	O
sister	O
.	O

Ms.	O
Swanson	O
also	O
carries	O
a	O
diagnosis	O
of	O
"	O
atypical	B-problem
MS	I-problem
",	O
which	O
she	O
brought	O
with	O
her	O
to	O
Dr.	O
Billie	O
.	O

According	O
to	O
Dr.	O
Nicole	O
,	O
she	O
has	O
had	O
stable	B-problem
deficits	I-problem
for	O
many	O
years	O
without	O
any	B-problem
flare-like	I-problem
episodes	I-problem
.	O

She	O
had	O
an	B-test
MRI	I-test
in	O
2014	O
that	O
showed	O
multiple	B-problem
plaque-like	I-problem
lesions	I-problem
,	O
but	O
these	O
were	O
entirely	O
stable	O
since	O
2010	O
.	O

She	O
is	O
not	O
undergoing	O
any	B-treatment
treatment	I-treatment
.	O

Reportedly	O
she	O
has	O
been	O
evaluated	O
at	O
Shriner's	O
Hospital	O
for	O
Crippled	O
Children	O
,	O
HealthSouth	O
Braintree	O
Rehab	O
Hospital	O
,	O
and	O
possibly	O
St.	O
Elizabeth's	O
Medical	O
Center	O
of	O
Boston	O
.	O

She	O
has	O
not	O
had	O
an	B-test
LP	I-test
as	O
far	O
as	O
Dr.	O
Ginger	O
knows	O
.	O

Past	O
Medical	O
History	O
:	O

h/o	O
head	B-problem
trauma	I-problem

atypical	B-problem
MS	I-problem

seizures	B-problem
PAD-WORD	O

depression	B-problem
PAD-WORD	O

hypercholesterolemia	B-problem
PAD-WORD	O

Social	O
History	O
:	O

lives	O
in	O
assisted	O
living	O
.	O

Sister	O
Andrew	O
is	O
HCP	O

Family	O
History	O
:	O

not	O
elicited	O

Physical	O
Exam	O
:	O

ICU	O
exam	O
:	O

VS	B-test
:	O
T99.5	O
,	O
BP	B-test
126/72	O
,	O
HR	B-test
99	O
,	O
RR	B-test
15	O
,	O
SaO2	B-test
99%	O
/	O
RA	O

Genl	O
:	O
lying	O
in	O
bed	O
,	O
right	O
hand	O
moving	O
rhythmically	O
,	O
NGT	B-treatment
in	O
place	O

MS	O
:	O
not	B-problem
following	I-problem
commands	I-problem
,	O
withdraws	O
to	O
noxious	B-test
stimuli	I-test
,	O
making	O
incomprehensible	B-problem
vocalizations	I-problem

CN	O
:	O
PERRL	O
,	O
corneal	O
reflex	O
intact	O
,	O
nasal	O
tickle	O
intact	O
,	O
face	O
symmetric	O
.	O

Motor	O
:	O
moving	O
right	O
hand	O
rhythmically	O
with	O
occasional	B-problem
right	I-problem
face	I-problem
twitching	I-problem
as	O
well	O
.	O

Moves	O
all	O
extremities	O
to	O
stimuli	B-test
,	O
L	O
>	O
R	O

Sensation	O
:	O
intact	O
to	O
noxious	B-test
stimuli	I-test
in	O
all	O
four	O
extremities	O

Reflexes	O
:	O
3+	O
throughout	O
,	O
both	O
toes	O
upgoing	O

Recent	O
exam	O
:	O

Afebrile	B-problem
,	O
VSS	O

Following	O
commands	O
,	O
oriented	O
to	O
name	O
,	O
place	O
.	O

Able	O
to	O
carry	O
on	O
simple	O
conversation	O
.	O

No	O
dysarthria	B-problem
,	O
speech	O
fluent	O
.	O

CN	O
:	O
PEERL	O
,	O
EOM	O
full	O
,	O
tongue	O
midline	O

Motor	O
:	O
moves	O
all	O
extremities	O
with	O
some	O
strength,	O
improved	O
bilaterally	O

Reflexes	O
:	O
as	O
above	O

Pertinent	O
Results	O
:	O

Admission	O
labs	O
:	O

2015-09-20	O
03:54	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
11.4	O
*#	O
RBC	B-test
-	O
3.96	O
*	O
Hgb	B-test
-	O
12.1	O
Hct	B-test
-	O
35.1	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
30.6	O
MCHC	B-test
-	O
34.6	O
RDW	B-test
-	O
13.1	O
Plt	B-test
Ct	I-test
-	O
152	O

2015-09-28	O
07:50	O
AM	O
BLOOD	B-test
Neuts	B-test
-	O
83.3	O
*	O
Lymphs	B-test
-	O
10.1	O
*	O
Monos	B-test
-	O
5.3	O
Eos	B-test
-	O
1.1	O
Baso	B-test
-	O
0.2	O

2015-09-20	O
03:54	O
AM	O
BLOOD	B-test
PT	B-test
-	O
12.3	O
PTT	B-test
-	O
26.7	O
INR(PT)	B-test
-	O
1.1	O

2015-09-20	O
03:54	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
97	O
UreaN	B-test
-	O
12	O
Creat	B-test
-	O
0.4	O
Na	B-test
-	O
137	O
K	B-test
-	O
3.8	O
Cl	B-test
-	O
101	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
14	O

2015-09-20	O
03:54	O
AM	O
BLOOD	B-test
Albumin	B-test
-	O
4.0	O
Calcium	B-test
-	O
8.0	O
*	O
Phos	B-test
-	O
2.9	O
Mg	B-test
-	O
2.0	O

2015-09-20	O
03:54	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
14	O
AST	B-test
-	O
18	O
AlkPhos	B-test
-	O
92	O
TotBili	B-test
-	O
0.3	O

2015-09-20	O
03:54	O
AM	O
BLOOD	B-test
Phenyto	B-test
-	O
18.4	O

Discharge	O
labs	O
:	O

2015-09-29	O
07:25	O
AM	O
BLOOD	B-test
Phenyto	B-test
-	O
5.1	O
*	O

U/A	O
:	O

2015-09-22	O
03:04	O
PM	O
URINE	B-test
Color	B-test
-	O
Straw	O
Appear	B-test
-	O
Clear	O
Sp	O
Dixon	B-test
-	O
1.010	O

2015-09-22	O
03:04	O
PM	O
URINE	B-test
Blood	B-test
-	O
SM	O
Nitrite	B-test
-	O
NEG	O
Protein	B-test
-	O
NEG	O
Glucose	B-test
-	O
NEG	O
Ketone	B-test
-	O
15	O
Bilirub	B-test
-	O
NEG	O
Urobiln	B-test
-	O
NEG	O
pH	B-test
-	O
5.0	O
Leuks	B-test
-	O
MOD	O

2015-09-22	O
03:04	O
PM	O
URINE	B-test
RBC	B-test
-	O
6	O
*	O
WBC	B-test
-	O
29	O
*	O
Bacteri	B-test
-	O
OCC	B-test
Yeast	I-test
-	O
NONE	O
Epi	B-test
-	O
<	O
1	O

2015-09-28	O
03:04	O
PM	O
URINE	B-test
Color	B-test
-	O
Yellow	O
Appear	B-test
-	O
Clear	O
Sp	B-test
Brown	I-test
-	O
1.015	O

2015-09-28	O
03:04	O
PM	O
URINE	B-test
Blood	B-test
-	O
LG	B-test
Nitrite	I-test
-	O
NEG	O
Protein	B-test
-	O
TR	O
Glucose	B-test
-	O
NEG	O
Ketone	B-test
-	O
NEG	O
Bilirub	B-test
-	O
NEG	O
Urobiln	B-test
-	O
0.2	O
pH	B-test
-	O
6.5	O
Leuks	B-test
-	O
NEG	O

2015-09-28	O
03:04	O
PM	O
URINE	B-test
RBC	B-test
-	O
01-04	O
*	O
WBC	B-test
-	O
04-19	O
Bacteri	B-test
-	O
FEW	O
Yeast	B-test
-	O
NONE	O
Epi	B-test
-	O
0-2	O

CSF	O
:	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
WBC	B-test
-	O
6	O
RBC	B-test
-	O
2	O
*	O
Polys	B-test
-	O
0	O
Lymphs	B-test
-	O
92	O
Monos	B-test
-	O
8	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
WBC	B-test
-	O
6	O
RBC	B-test
-	O
0	O
Polys	B-test
-	O
0	O
Lymphs	B-test
-	O
95	O
Monos	B-test
-	O
5	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
TotProt	B-test
-	O
56	O
*	O
Glucose	B-test
-	O
77	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
ANGIOTENSIN	B-test
1	I-test
CONVERTING	I-test
ENZYME	I-test
-	O
PND	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
VDRL	B-test
-	O
PND	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
Ernest	B-test
VIRUS	I-test
(	I-test
JCV	I-test
)	I-test
DNA	I-test
DETECTION	I-test
BY	I-test
POLYMERASE	I-test
CHAIN	I-test
REACTION	I-test
(	I-test
PCR	I-test
)-	O
PND	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
VARICELLA	B-test
DNA	I-test
(	I-test
PCR	I-test
)-	O
PND	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
HERPES	B-test
SIMPLEX	I-test
VIRUS	I-test
PCR	I-test
-	O
PND	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	O
EBV	B-test
-	I-test
PCR	I-test
-	O
PND	O

2015-09-25	O
02:20	O
PM	O
CEREBROSPINAL	B-test
FLUID	I-test
(	I-test
CSF	I-test
)	I-test
CYTOMEGALOVIRUS	B-test
-	I-test
PCR	I-test
-	O
negative	O

Other	O
:	O

cryptococcus	B-problem
:	O
negative	O

CSF	B-test
negative	O

blood	B-test
cx	I-test
NGTD	O

urine	B-test
cx	I-test
lactobacillus	B-problem

CSF	B-test
cytology	I-test
:	O
NEGATIVE	O
FOR	O
MALIGNANT	B-problem
CELLS	I-problem
.	O

Reactive	B-problem
lymphoid	I-problem
cells	I-problem
.	O

immunotyping	B-test
negative	O
.	O

CXR	B-test
09-28	O
:	O
No	O
evidence	O
for	O
pneumonia	B-problem
.	O

No	O
change	O
since	O
prior	B-test
study	I-test
of	O
2015-09-24	O
.	O

CT	B-test
HEAD	I-test
FINDINGS	O
:	O
There	O
is	O
moderately	B-problem
severe	I-problem
,	I-problem
confluent	I-problem
periventricular	I-problem
white	I-problem
matter	I-problem
hypodensity	I-problem
surrounding	O
the	O
frontal	O
horns	O
,	O
posterior	O
horns	O
,	O
and	O
more	O
superiorly	O
,	O
involving	O
the	O
centra	O
semiovale	O
.	O

These	O
findings	O
are	O
unchanged	O
from	O
prior	B-test
studies	I-test
,	O
and	O
may	O
relate	O
to	O
the	B-problem
"	I-problem
atypical	I-problem
"	I-problem
demyelinating	I-problem
process	I-problem
,	O
suggested	O
in	O
the	O
indication	O
on	O
the	B-test
prior	I-test
MRI	I-test
;	O
however	O
,	O
they	O
are	O
non-specific	O
.	O

There	O
is	O
no	O
evidence	O
of	O
acute	B-problem
intra	I-problem
-	I-problem
or	I-problem
extra	I-problem
-	I-problem
axial	I-problem
hemorrhage	I-problem
.	O

There	O
is	O
no	O
shift	B-problem
of	I-problem
normally	I-problem
midline	I-problem
structures	I-problem
.	O

The	O
ventricles	O
are	O
mildly	B-problem
prominent	I-problem
,	O
but	O
are	O
unchanged	O
from	O
the	B-test
prior	I-test
study	I-test
.	O

There	O
is	O
no	O
interval	B-problem
loss	I-problem
of	I-problem
focal	I-problem
gray	I-problem
-	I-problem
white	I-problem
matter	I-problem
differentiation	I-problem
to	O
suggest	O
acute	B-problem
infarction	I-problem
,	O
though	O
CT	B-test
is	O
not	O
sensitive	O
in	O
the	O
early	O
stages	O
.	O

No	O
focal	B-problem
masses	I-problem
is	O
seen	O
.	O

IMPRESSION	O
:	O

1)	O
No	O
intracranial	B-problem
hemorrhage	I-problem
or	O
mass	B-problem
effect	I-problem
;	O
no	O
significant	B-problem
interval	I-problem
change	I-problem
from	O
CT	B-test
of	O
2015-07-20	O
.	O

2)	O
Diffuse	B-problem
,	I-problem
confluent	I-problem
periventricular	I-problem
white	I-problem
matter	I-problem
hypodensity	I-problem
,	O
which	O
may	O
relate	O
to	O
an	B-problem
underlying	I-problem
demyelinating	I-problem
process	I-problem
(	O
as	O
suggested	O
in	O
the	O
indication	O
provided	O
for	O
the	B-test
prior	I-test
MRI	I-test
).	O

The	B-problem
markedly	I-problem
low	I-problem
-	I-problem
attenation	I-problem
(	O
14-15	O
HU	O
)	O
centered	O
within	O
this	O
process	O
suggests	O
either	O
irreversible	B-problem
demyelination	I-problem
with	O
cavitation	B-problem
("	I-problem
black	I-problem
hole	I-problem
"),	O
or	O
lacunar	B-problem
infarction	I-problem
on	I-problem
a	I-problem
vascular	I-problem
basis	I-problem
.	O

Generalized	O
and	O
marked	B-problem
callosal	I-problem
atrophy	I-problem
(	O
on	O
the	B-test
MR	I-test
)	O
also	O
suggest	O
advanced	B-problem
,	I-problem
irreversible	I-problem
disease	I-problem
.	O

3)	O
No	O
mass	B-problem
is	O
appreciated	O
on	O
this	B-test
limited	I-test
non-contrast	I-test
study	I-test
;	O
if	O
clinically	O
concerned	O
,	O
an	B-test
MRI	I-test
with	I-test
gadolinium	I-test
is	O
recommended	O
.	O

MRI	B-test
:	O
There	O
is	O
a	O
similar	O
configuration	O
of	O
increased	B-problem
T2	I-problem
signal	I-problem
in	O
the	O
periventricular	O
white	O
matter	O
of	O
both	O
cerebral	O
hemispheres	O
,	O
suggesting	O
demyelinating	B-problem
disease	I-problem
.	O

As	O
previously	O
noted	O
,	O
there	O
is	O
associated	B-problem
volume	I-problem
loss	I-problem
,	O
thinning	B-problem
of	I-problem
the	I-problem
corpus	I-problem
callosum	I-problem
,	O
and	O
slight	B-problem
widening	I-problem
of	I-problem
the	I-problem
ventricles	I-problem
.	O

On	O
post-contrast	B-test
images	I-test
,	O
there	O
is	O
a	O
probably	O
stable	O
appearance	O
of	O
a	B-problem
5	I-problem
mm	I-problem
linear	I-problem
,	I-problem
focal	I-problem
area	I-problem
of	I-problem
enhancement	I-problem
in	I-problem
the	I-problem
left	I-problem
centrum	I-problem
semiovale	I-problem
,	O
of	O
uncertain	O
etiology	O
.	O

Also	O
ehancing	O
is	O
3	B-problem
mm	I-problem
linear	I-problem
lesion	I-problem
in	I-problem
the	I-problem
left	I-problem
hippocampal	I-problem
cortex	I-problem
anteriorly	I-problem
,	O
not	O
seen	O
on	O
the	O
08-20	O
MR	B-test
,	O
but	O
that	B-test
study	I-test
was	O
very	O
motion	O
-	O
degraded	O
.	O

The	O
hippocampus	O
would	O
be	O
a	O
most	O
unusual	O
site	O
for	O
involvement	O
by	O
multiple	B-problem
sclerosis	I-problem
.	O

There	O
is	O
no	O
apparent	B-problem
mass	I-problem
lesion	I-problem
or	O
mass	B-problem
effect	I-problem
.	O

No	O
changes	B-problem
in	I-problem
the	I-problem
overall	I-problem
morphology	I-problem
of	O
the	O
brain	O
are	O
identified	O
.	O

The	O
surrounding	O
osseous	O
and	O
soft	O
tissue	O
structures	O
are	O
unremarkable	O
.	O

The	O
major	O
vascular	O
flow	O
patterns	O
are	O
normal	O
.	O

IMPRESSION	O
:	O

1.	O
Stable	O
appearance	O
of	O
confluent	O
areas	O
of	O
increased	B-problem
T2	I-problem
signal	I-problem
in	I-problem
the	I-problem
periventricular	I-problem
white	I-problem
matter	I-problem
,	O
consistent	O
with	O
severe	B-problem
demyelinating	I-problem
disease	I-problem
.	O

2.	O
Enhancing	B-problem
lesions	I-problem
in	I-problem
the	I-problem
left	I-problem
centrum	I-problem
semiovale	I-problem
and	O
also	O
left	O
hippocampal	O
cortex	O
.	O

This	B-problem
former	I-problem
lesion	I-problem
was	O
evident	O
on	O
MR	B-test
dating	O
back	O
to	O
2014-08-15	O
,	O
though	O
is	O
more	O
prominent	O
at	O
this	O
time	O
,	O
likely	O
due	O
to	O
less	O
motion	O
degradation	O
of	O
the	B-test
current	I-test
scan	I-test
.	O

Etiology	O
of	O
these	B-problem
enhancing	I-problem
lesions	I-problem
is	O
uncertain	O
,	O
but	O
could	O
be	O
atypical	B-problem
manifestations	I-problem
of	I-problem
demyelination	I-problem
.	O

EEG	B-test
:	O

ABNORMALITY	O
#1:	O
Throughout	O
the	O
recording	O
there	O
were	O
frequent	O
bursts	O
of	O
generalized	B-problem
theta	I-problem
and	I-problem
delta	I-problem
slowing	I-problem
.	O

Facial	B-problem
twitching	I-problem
was	O
described	O
by	O
the	O
technologist	O
and	O
seen	O
on	O
the	B-test
video	I-test
.	O

This	O
is	O
primarily	O
right-sided	B-problem
,	I-problem
facial	I-problem
movement	I-problem
clinically	O
and	O
did	O
not	O
appear	O
to	O
involve	O
the	O
forehead	O
or	O
CMED	O
CSRU	O
.	O

There	O
were	O
no	O
clear	O
EEG	B-test
correlate	O
.	O

ABNORMALITY	O
#2:	O
The	B-test
background	I-test
voltages	I-test
were	O
occasionally	B-problem
lower	I-problem
on	O
the	O
left	O
side	O
,	O
and	O
there	O
were	O
additional	B-problem
bursts	I-problem
of	I-problem
delta	I-problem
slowing	I-problem
seen	O
broadly	O
on	O
the	O
left	O
side	O
alone	O
.	O

ABNORMALITY	O
#3:	O
The	O
background	O
rhythms	O
were	O
dominated	O
by	O
much	B-problem
faster	I-problem
beta	I-problem
rhythm	I-problem
.	O

They	O
appeared	O
to	O
reach	O
an	O
8	O
Hz	O
frequency	O
on	O
the	O
right	O
at	O
times	O
,	O
though	O
the	O
background	O
was	O
disorganized	O
and	O
slow	O
on	O
both	O
sides	O
for	O

much	O
of	O
the	O
recording	O
.	O

It	O
was	O
of	O
much	O
lower	O
voltage	O
on	O
the	O
left	O
.	O

HYPERVENTILATION	B-treatment
:	O
Could	O
not	O
be	O
performed	O
.	O

INTERMITTENT	B-test
PHOTIC	I-test
STIMULATION	I-test
:	O
Could	O
not	O
be	O
performed	O
.	O

SLEEP	O
:	O
No	O
normal	O
waking	O
or	O
sleeping	O
morphologies	O
were	O
seen	O
.	O

CARDIAC	B-test
MONITOR	I-test
:	O
Showed	O
a	O
generally	O
regular	O
rhythm	O
.	O

IMPRESSION	O
:	O
Abnormal	B-problem
portable	I-problem
EEG	I-problem
due	O
to	O
the	B-problem
bursts	I-problem
of	I-problem
generalized	I-problem
slowing	I-problem
and	O
additional	B-problem
left-sided	I-problem
slowing	I-problem
and	O
voltage	B-problem
dimunition	I-problem
,	O
along	O
with	O
some	B-problem
slowing	I-problem
of	I-problem
the	I-problem
background	I-problem
.	O

The	O
generalized	O
and	O
background	O
features	O
indicate	O
a	B-problem
wide-spread	I-problem
encephalopathy	I-problem
.	O

The	B-problem
left	I-problem
sided	I-problem
slowing	I-problem
and	O
voltage	B-problem
reduction	I-problem
surpassed	O
an	B-problem
additional	I-problem
dysfunction	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
,	O
possibly	O
wide-spread	B-problem
cortical	I-problem
dysfunction	I-problem
.	O

There	O
is	O
a	O
possibility	O
of	O
a	B-problem
structural	I-problem
lesion	I-problem
on	I-problem
the	I-problem
left	I-problem
,	O
but	O
the	B-problem
encephalopathy	I-problem
dominated	O
the	O
overall	O
picture	O
.	O

There	O
were	O
no	O
clear	B-problem
epileptiform	I-problem
discharges	I-problem
.	O

No	O
EEG	O
correlate	O
was	O
established	O
for	O
the	B-problem
facial	I-problem
twitching	I-problem
.	O

The	O
lack	O
of	O
EEG	O
correlate	O
to	O
the	B-problem
facial	I-problem
twitching	I-problem
does	O
not	O
exclude	O
a	O
central	O
cause	O
(	O
and	O
,	O
indeed	O
,	O
this	O
appeared	O
most	O
likely	O
based	O
on	O
the	O
clinical	O
and	O
video	B-test
observations	I-test
).	O

Brief	O
Hospital	O
Course	O
:	O

53	O
yo	O
woman	O
with	O
h/o	O
seizure	B-problem
disorder	I-problem
,	O
demyelinating	B-problem
disease	I-problem
,	O
and	O
brain	B-problem
injury	I-problem
,	O
presents	O
with	O
prolonged	B-problem
seizure	I-problem
,	O
now	O
unresponsive	B-problem
with	O
persistent	B-problem
twitching	I-problem
of	I-problem
right	I-problem
arm	I-problem
and	I-problem
face	I-problem
.	O

This	O
is	O
most	O
consistent	O
with	O
complex	B-problem
partial	I-problem
seizures	I-problem
with	O
a	O
focus	O
in	O
the	O
left	O
hemisphere	O
,	O
most	O
likely	O
the	O
motor	O
strip	O
.	O

In	O
the	O
past	O
,	O
her	B-problem
seizures	I-problem
were	O
on	O
the	O
left	O
side	O
,	O
which	O
implies	O
that	O
she	O
now	O
has	O
a	O
new	O
focus	O
.	O

It	O
is	O
possible	O
that	O
this	O
is	O
secondary	O
to	O
her	B-problem
underlying	I-problem
demyelinating	I-problem
disease	I-problem
,	O
but	O
per	O
report	O
this	O
has	O
not	O
been	O
very	O
active	O
.	O

Other	O
possibilities	O
include	O
infection	B-problem
,	O
including	O
her	B-problem
UTI	I-problem
.	O

It	O
is	O
likely	O
that	O
these	B-problem
seizures	I-problem
began	O
due	O
to	O
subtherapeutic	B-problem
dilantin	I-problem
levels	I-problem
on	O
her	B-treatment
new	I-treatment
dose	I-treatment
of	O
200	O
mg	O
/	O
100	O
mg	O
.	O

Her	B-treatment
seizure	I-treatment
management	I-treatment
is	O
difficult	O
,	O
given	O
the	B-treatment
higher	I-treatment
doses	I-treatment
were	O
causing	O
her	O
to	O
fall	O
and	O
slur	O
her	O
speech	O
.	O

Discussed	O
with	O
Dr.	O
Joaquin	O
the	O
addition	O
of	O
an	B-treatment
alternate	I-treatment
Castelluccio	I-treatment
with	O
the	O
possibility	O
of	O
tapering	O
down	O
the	B-treatment
dilantin	I-treatment
in	O
the	O
future	O
,	O
and	O
he	O
agreed	O
that	O
she	O
may	O
benefit	O
from	O
zonegran	B-treatment
.	O

Cannot	O
use	O
lamictal	B-treatment
or	O
depakote	B-treatment
due	O
to	O
reactions	B-problem
.	O

Topamax	B-treatment
is	O
another	O
possibility	O
,	O
but	O
not	O
ideal	O
in	O
a	O
patient	O
with	O
preexisting	B-problem
cognitive	I-problem
deficits	I-problem
.	O

She	O
was	O
started	O
on	O
zonegran	B-treatment
at	O
50	O
mg	O
daily	O
with	O
plans	O
to	O
increase	O
by	O
50	O
mg	O
every	O
other	O
week	O
to	O
a	O
goal	O
dose	O
of	O
200	O
mg	O
/	O
day	O
;	O
she	O
was	O
on	O
100	O
mg	O
daily	O
at	O
discharge	O
and	O
should	O
have	O
her	O
dose	O
increased	O
on	O
10-12	O
and	O
again	O
on	O
10-26	O
.	O

She	O
was	O
continued	O
on	O
keppra	B-treatment
and	O
dilantin	B-treatment
with	O
trough	B-test
checked	O
frequently	O
and	O
adjustment	O
as	O
needed	O
.	O

Ativan	B-treatment
was	O
used	O
for	O
breakthrough	B-problem
seizures	I-problem
(	O
facial	B-problem
twitching	I-problem
).	O

MRI/MRA	B-test
showed	O
new	B-problem
temporal	I-problem
lesions	I-problem
,	O
but	O
it	O
is	O
unclear	O
if	O
these	O
are	O
the	O
cause	O
or	O
effect	O
of	O
her	B-problem
seizures	I-problem
.	O

She	O
will	O
need	O
to	O
have	O
a	B-test
repeat	I-test
MRI	I-test
in	O
several	O
months	O
for	O
further	B-test
evaluation	I-test
.	O

LP	B-test
was	O
done	O
and	O
had	O
no	O
changes	O
to	O
suggest	O
a	O
different	O
etiology	O
(	O
ie	O
negative	O
cytology	O
and	O
negative	O
immunophenotyping	O
).	O

Oligoclonal	B-test
bands	I-test
were	O
not	O
assessed	O
as	O
there	O
was	O
not	O
enough	O
CSF	B-test
per	O
the	O
laboratory	O
.	O

She	O
will	O
need	O
repeated	B-test
dilantin	I-test
troughs	I-test
with	O
one	O
time	O
dose	O
when	O
trough	O
is	O
subtherapeutic	O
.	O

Pending	O
tests	O
:	O

ANGIOTENSIN	B-test
1	I-test
CONVERTING	I-test
ENZYME	I-test

EBV-PCR	B-test
PAD-WORD	O

HERPES	B-test
SIMPLEX	I-test
VIRUS	I-test
PCR	I-test

Ernest	B-test
VIRUS	I-test
(	I-test
JCV	I-test
)	I-test
DNA	B-test
PCR	I-test

LYME	B-test
,	O
TOTAL	B-test
EIA	I-test
WITH	O
REFLEX	B-test
TO	I-test
CSF	I-test
RATIO	I-test

VARICELLA	B-test
DNA	I-test
(	I-test
PCR	I-test
)	I-test

VDRL	B-test
PAD-WORD	O

2.	O
atypical	B-problem
MS	I-problem
:	O
discussed	O
with	O
her	O
outpt	O
neurologist	O
(	O
Dr.	O
Ford	O
in	O
Boston	O
Medical	O
Center	O
);	O
no	O
current	O
role	O
for	O
MS	B-treatment
medications	I-treatment
.	O

MRI	B-test
was	O
performed	O
and	O
showed	O
new	B-problem
lesions	I-problem
vs	O
sz	B-problem
effects	I-problem
in	I-problem
the	I-problem
left	I-problem
temporal	I-problem
lobe	I-problem
.	O

She	O
also	O
had	O
a	B-problem
new	I-problem
lesion	I-problem
on	O
her	B-test
last	I-test
MRI	I-test
in	O
the	O
centrum	O
semiovale	O
.	O

LP	B-test
was	O
done	O
to	O
evaluate	O
for	O
malignancy	B-problem
,	O
and	O
no	O
malignant	B-problem
cells	I-problem
were	O
seen	O
.	O

Immunotyping	B-test
was	O
negative	O
as	O
well	O
(	O
per	O
verbal	O
report	O
).	O

Unfortunately	O
,	O
oligoclonal	B-test
bands	I-test
could	O
not	O
be	O
sent	O
from	O
the	O
CSF	O
(	O
lab	O
sent	O
CSF	O
for	O
other	B-test
studies	I-test
and	O
there	O
was	O
not	O
enough	O
left	O
over	O
for	O
OCB	B-test
s).	I-test

This	O
was	O
relayed	O
to	O
the	O
family	O
(	O
Kirk	O
).	O

Given	O
that	O
she	O
does	O
have	O
new	B-problem
lesions	I-problem
on	O
MRI	B-test
,	O
if	O
OCB	B-test
s	I-test
were	O
sent	O
this	O
would	O
have	O
weighed	O
in	O
in	O
her	O
dx	O
of	O
MS	B-problem
,	O
and	O
it's	O
possible	O
she	O
could	O
benefit	O
from	O
MS	B-treatment
therapy	I-treatment
.	O

This	O
was	O
relayed	O
to	O
the	O
family	O
,	O
and	O
they	O
will	O
readdress	O
this	O
with	O
Dr.	O
Ford	O
(	O
MS	O
Hoyos	O
).	O

The	O
family	O
is	O
confident	O
in	O
any	O
decision	O
Dr.	O
Ford	O
would	O
make	O
re	O
:	O
therapy	B-treatment
for	O
her	B-problem
MS	I-problem
.	O

3.	O
fevers	B-problem
on	O
admission	O
:	O
Pt	O
w/	O
positive	B-problem
U/A	I-problem
,	O
treated	O
with	O
bactrim	B-treatment
x	O
3	O
days	O
with	O
defervescence	O
.	O

4.	O
depression	B-problem
:	O
continue	O
escitalopram	B-treatment
;	O
assess	O
need	O
to	O
change	O
medication	B-treatment
as	O
an	O
outpatient	O
.	O

5.	O
FEN	O
:	O
NGT	B-treatment
was	O
placed	O
given	O
her	B-problem
altered	I-problem
mental	I-problem
status	I-problem
,	O
and	O
she	O
has	O
been	O
unable	O
to	O
pass	O
a	B-test
swallow	I-test
evaluation	I-test
,	O
but	O
has	O
improved	O
.	O

This	O
should	O
be	O
repeated	O
in	O
several	O
days	O
as	O
her	O
mental	O
status	O
continues	O
to	O
clear	O
.	O

Commun	O
:	O
Sister	O
Andrew	O
is	O
HCP	O
.	O
(	O
780	O
)	O
970-0261	O

Dispo	O
:	O
PT/OT	O
worked	O
with	O
patient	O
during	O
admission	O

Medications	O
on	O
Admission	O
:	O

Dilantin	B-treatment
200/100	O

Keppra	B-treatment
1500	O
mg	O
bid	O

Lexapro	B-treatment
20	O
mg	O
q	O
day	O

Folate	B-treatment
1	O
mg	O
q	O
day	O

Calcium	B-treatment
1	O
tab	O
bid	O

Discharge	O
Medications	O
:	O

1.	O
Zonisamide	B-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
DAILY	O
(	O
Daily	O
):	O
Increase	O
by	O
50	O
mg	O
every	O
other	O
week	O
(	O
next	O
increase	O
2015-10-12	O
).	O

2.	O
Phenytoin	B-treatment
50	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

3.	O
Phenytoin	B-treatment
50	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
QPM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)).	O

4.	O
Phenytoin	B-treatment
50	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
EVERY	O
OTHER	O
DAY	O
(	O
Every	O
Other	O
Day	O
).	O

5.	O
Levetiracetam	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Escitalopram	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

7.	O
Folic	B-treatment
Acid	I-treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

8.	O
Lansoprazole	B-treatment
30	O
mg	O
Tablet	O
,	O
Rapid	O
Dissolve	O
,	O
DR	O
Turner	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Rapid	O
Dissolve	O
,	O
DR	O
Hughes	O
DAILY	O
(	O
Daily	O
).	O

9.	O
Docusate	B-treatment
Sodium	I-treatment
150	O
mg	O
/	O
15	O
mL	O
Liquid	O
Sig	O
:	O
One	O
Hundred	O
(	O
100	O
)	O
mg	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

10.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

11.	O
Bisacodyl	B-treatment
10	O
mg	O
Suppository	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Suppository	O
Rectal	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
constipation	B-problem
.	O

12.	O
Heparin	B-treatment
(	I-treatment
Porcine	I-treatment
)	O
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
5000	O
(	O
5000	O
)	O
units	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

L.F.	O
Quigley	O
Memorial	O
Hospital	O
&	O
Rehab	O
Center	O
-	O
Berkshire	O
Medical	O
Center	O

Discharge	O
Diagnosis	O
:	O

Seizure	B-problem
PAD-WORD	O

History	O
of	O
atypical	B-problem
multiple	I-problem
sclerosis	I-problem

Memory	B-problem
loss	I-problem

Status	O
post	O
brain	B-problem
injury	I-problem

Urinary	B-problem
tract	I-problem
infection	I-problem

Discharge	O
Condition	O
:	O

Stable	O
,	O
much	O
improved	O
from	O
admission	O
,	O
and	O
almost	O
at	O
baseline	O
.	O

Discharge	O
Instructions	O
:	O

Take	O
all	B-treatment
medications	I-treatment
as	O
prescribed	O
.	O

Please	O
increase	O
zonegran	B-treatment
dose	I-treatment
by	O
50	O
every	O
other	O
week	O
until	O
it	O
reaches	O
200	O
mg	O
daily	O
,	O
with	O
first	O
dose	O
change	O
10-12	O
to	O
150	O
mg	O
daily	O
and	O
second	O
dose	O
change	O
10-26	O
to	O
200	O
mg	O
daily	O
.	O

Follow	O
up	O
with	O
Dr.	O
Pilcher	O
,	O
Dr.	O
Donnie	O
,	O
and	O
Dr.	O
Harris	O
upon	O
discharge	O
.	O

Call	O
the	O
doctor	O
or	O
go	O
to	O
the	O
emergency	O
room	O
with	O
increased	B-problem
seizure	I-problem
frequency	I-problem
,	O
unresponsiveness	B-problem
,	O
new	B-problem
weakness	I-problem
or	O
numbness	B-problem
,	O
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
a	B-test
repeat	I-test
MRI	I-test
in	O
several	O
months	O
to	O
evaluate	O
new	B-problem
lesions	I-problem
in	I-problem
the	I-problem
brain	I-problem
.	O

Follow	O
up	O
with	O
:	O

Dr.	O
Harris	O
(	O
859-847-5149	O
)	O
on	O
2015-10-05	O
at	O
915	O
am	O
.	O

Dr.	O
Alejandro	O
((	O
211	O
)	O
394-5801	O
)	O
on	O
2015-10-20	O
at	O
145	O
pm	O
.	O

Dr.	O
Sheets	O
((	O
506	O
)	O
858	O
7552)	O
on	O
2015-10-26	O
at	O
10	O
am	O
.	O

Wayne	O
Deloris	O
MD	O
55-122	O

Completed	O
by	O
:	O
Meghan	O
Mark	O
MD	O
99-323	O
2015-09-30	O
@	O
1502	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Sheila	O
SHEEN	O
on	O
:	O
WED	O
2015-09-30	O
4:59	O
PM	O

(	O
End	O
of	O
Report	O
)	O

669952543	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

98431395	O
PAD-WORD	O

329475	O
PAD-WORD	O

2/8/1990	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/08/1990	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

Discharge	O
Date	O
:	O

02/13/1990	O
PAD-WORD	O

ADMISSION	O
DIAGNOSIS	O
:	O

VULVAR	B-problem
CANCER	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
43-year-old	O
gravida	O
II	O
para	O
II	O
white	O
female	O
referred	O
by	O
Dr.	O
Ca	O
Shuff	O
for	O
evaluation	B-test
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
good	O
health	O
until	O
December	O
when	O
she	O
was	O
seen	O
emergently	O
for	O
treatment	B-treatment
of	O
a	B-problem
perforated	I-problem
colon	I-problem
cancer	I-problem
.	O

That	O
area	O
was	O
resected	O
with	O
no	O
evidence	O
of	O
metastatic	B-problem
disease	I-problem
.	O

She	O
has	O
had	O
subsequent	B-test
CEA&apos;s	I-test
and	O
scans	B-test
which	O
were	O
negative	O
.	O

A	B-problem
tumor	I-problem
was	O
noted	O
on	O
her	O
vulva	O
which	O
was	O
biopsied	O
and	O
revealed	O
squamous	B-problem
cell	I-problem
carcinoma	I-problem
in	I-problem
situ	I-problem
.	O

ALLERGIES	O
:	O

NO	O
KNOWN	B-problem
DRUG	I-problem
ALLERGIES	I-problem
.	O

MEDICATIONS	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

As	O
above	O
with	O
colostomy	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
included	O
HEENT	B-test
exam	I-test
which	O
was	O
normal	O
.	O

Chest	O
was	O
clear	O
.	O

Heart	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdomen	O
was	O
soft	O
and	O
nontender	B-problem
.	O

Vulva	O
and	O
right	O
labia	O
replaced	O
by	O
reddish	B-problem
lesion	I-problem
,	O
somewhat	O
raised	O
in	O
the	O
center	O
extending	O
from	O
adjacent	O
to	O
the	O
cuterus	O
to	O
the	O
posterior	O
forchette	O
.	O

Otherwise	O
,	O
her	B-test
pelvic	I-test
exam	I-test
was	O
negative	O
.	O

IMPRESSION	O
:	O

STAGE	B-problem
II	I-problem
SQUAMOUS	I-problem
CELL	I-problem
CARCINOMA	I-problem
OF	I-problem
THE	I-problem
VULVA	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
plan	O
was	O
for	O
right	B-treatment
radical	I-treatment
vulvectomy	I-treatment
.	O

1.	O
Vulvectomy	B-treatment
:	O

The	O
patient	O
on	O
2/8/90	O
underwent	O
a	B-treatment
right	I-treatment
radical	I-treatment
vulvectomy	I-treatment
with	O
excellent	O
results	O
and	O
negative	O
margins	O
on	O
frozen	B-test
section	I-test
.	O

Her	O
postoperative	O
course	O
was	O
unremarkble	O
.	O

She	O
was	O
kept	O
on	O
bedrest	B-treatment
for	O
two	O
days	O
and	O
then	O
was	O
ambulating	O
and	O
voiding	O
well	O
without	O
trouble	O
on	O
postoperative	O
day	O
number	O
three	O
when	O
the	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
discontinued	O
.	O

She	O
has	O
been	O
doing	O
Betadine	B-treatment
paint	I-treatment
and	O
blow	O
drying	O
the	O
area	O
several	O
times	O
a	O
day	O
and	O
after	O
each	O
bowel	O
movement	O
and	O
urine	O
without	O
incident	O
.	O

DISPOSITION	O
:	O

The	O
discharge	O
is	O
to	O
home	O
.	O

The	O
patient	O
will	O
follow-up	O
with	O
Dr.	O
Friednantflirt	O
.	O

She	O
will	O
have	O
AH	O
for	O
support	O
.	O

________________________________	O
YT844/9769	O
LAKO	O
SCARVTWI	O
,	O
M.D.	O
TH0	O

D	O
:	O

02/12/90	O
PAD-WORD	O

Batch	O
:	O

7753	O
PAD-WORD	O

Report	O
:	O

Y6201H2	O
PAD-WORD	O

T	O
:	O

02/13/90	O
PAD-WORD	O

Dicatated	O
By	O
:	O

RORIEZAILA	O
KOTEKAYSKOTEKAYSCOA	O
,	O
M.D.	O
SE85	O

Admission	O
Date	O
:	O

2014-04-17	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-04-25	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1953-07-04	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CARDIOTHORACIC	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Christopher	O
Q	O
Thompson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Chest	B-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2014-04-18	O
Off	B-treatment
Pump	I-treatment
Coronary	I-treatment
Artery	I-treatment
Bypass	I-treatment
Grafting	I-treatment
utilizing	O
the	O
left	O
internal	O
mammary	O
artery	O
to	O
left	O
anterior	O
descending	O
artery	O
,	O
free	O
right	O
internal	O
mammary	O
to	O
obtuse	O
marginal	O
and	O
vein	B-treatment
graft	I-treatment
to	I-treatment
diagonal	I-treatment
.	O

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
a	O
60	O
year	O
old	O
male	O
with	O
new	B-problem
onset	I-problem
chest	I-problem
pain	I-problem
.	O

Nuclear	B-test
myocardial	I-test
perfusion	I-test
study	I-test
was	O
notable	O
for	O
a	B-problem
moderate	I-problem
fixed	I-problem
defect	I-problem
within	I-problem
the	I-problem
inferior	I-problem
wall	I-problem
and	O
cardiac	O
apex	O
.	O

His	B-test
ejection	I-test
fraction	I-test
however	O
appeared	O
preserved	O
at	O
73%	O
with	O
mild	B-problem
inferior	I-problem
wall	I-problem
hypokinesis	I-problem
.	O

Subsequent	B-test
cardiac	I-test
catheterization	I-test
at	O
Nantucket	O
Cottage	O
Hospital	O
Hospital	O
on	O
2014-04-16	O
was	O
significant	O
for	O
severe	B-problem
two	I-problem
vessel	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
.	O

Angiography	B-test
revealed	O
a	B-problem
right	I-problem
dominant	I-problem
system	I-problem
with	O
a	B-problem
40%	I-problem
lesion	I-problem
in	I-problem
the	I-problem
distal	I-problem
left	I-problem
main,	I-problem
several	B-problem
tight	I-problem
lesions	I-problem
in	I-problem
the	I-problem
proximal	I-problem
and	I-problem
mid	I-problem
left	I-problem
anterior	I-problem
descending	I-problem
artery	I-problem
,	O
and	O
a	B-problem
90%	I-problem
stenosis	I-problem
in	I-problem
the	I-problem
proximal	I-problem
circumflex	I-problem
.	O

The	O
right	O
coronary	O
artery	O
had	O
mild	B-problem
diffuse	I-problem
plaquing	I-problem
but	O
no	O
evidence	O
of	O
focal	B-problem
stenosis	I-problem
.	O

Based	O
upon	O
the	O
above	O
results	O
,	O
he	O
was	O
transferred	O
to	O
the	O
Mediplex	O
Rehab	O
Hospital	O
for	O
surgical	B-treatment
revascularization	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

Asthma	B-problem
PAD-WORD	O

Benign	B-problem
Prostatic	I-problem
Hypertrophy	I-problem

History	O
of	O
Nephrolithiasis	B-problem

Hemorrhoids	B-problem
PAD-WORD	O

Social	O
History	O
:	O

Denies	O
tobacco	O
history	O
.	O

Admits	O
to	O
03-08	O
ETOH	O
drinks	O
per	O
week	O
.	O

He	O
works	O
as	O
an	O
accountant	O
.	O

Family	O
History	O
:	O

Mother	O
suffer	O
MI	B-problem
in	O
her	O
50	O
's,	O
died	O
at	O
age	O
59	O
.	O

Father	O
died	O
from	O
MI	B-problem
at	O
age	O
72	O
.	O

Physical	O
Exam	O
:	O

Vitals	B-test
:	O
T	B-test
98.9	O
,	O
BP	B-test
148/70	O
,	O
HR	B-test
57	O
,	O
RR	B-test
20	O
,	O
SAT	B-test
95	O
on	O
room	O
air	O

General	O
:	O
well	O
developed	O
male	O
in	O
no	O
acute	B-problem
distress	I-problem

HEENT	O
:	O
oropharynx	O
benign	O
,	O

Neck	O
:	O
supple	O
,	O
no	O
JVD	B-problem
,	O

Heart	O
:	O
regular	O
rate	O
,	O
normal	O
s1s2	O
,	O
no	O
murmur	B-problem
or	O
rub	B-problem

Lungs	O
:	O
clear	O
bilaterally	O

Abdomen	O
:	O
soft	O
,	O
nontender	B-problem
,	O
normoactive	O
bowel	O
sounds	O

Ext	O
:	O
warm	O
,	O
no	O
edema	B-problem
,	O
no	O
varicosities	B-problem

Pulses	B-test
:	O
2+	O
distally	O
,	O
no	O
carotid	B-problem
or	I-problem
femoral	I-problem
bruits	I-problem

Neuro	O
:	O
nonfocal	O

Pertinent	O
Results	O
:	O

2014-04-17	O
03:58	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
6.3	O
RBC	B-test
-	O
4.60	O
Hgb	B-test
-	O
15.4	O
Hct	B-test
-	O
42.9	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
33.4	O
*	O
MCHC	B-test
-	O
35.8	O
*	O
RDW	B-test
-	O
12.8	O
Plt	B-test
Ct	I-test
-	O
168	O

2014-04-17	O
03:58	O
PM	O
BLOOD	B-test
PT	B-test
-	O
13.2	O
*	O
PTT	B-test
-	O
30.3	O
INR(PT)	B-test
-	O
1.2	O
*	O

2014-04-17	O
03:58	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
92	O
UreaN	B-test
-	O
15	O
Creat	B-test
-	O
1.3	O
*	O
Na	B-test
-	O
142	O
K	B-test
-	O
4.5	O
Cl	B-test
-	O
104	O
HCO3	B-test
-	O
26	O
AnGap	B-test
-	O
17	O

2014-04-17	O
03:58	O
PM	O
BLOOD	B-test
ALT	B-test
-	O
18	O
AST	B-test
-	O
20	O
AlkPhos	B-test
-	O
53	O
Amylase	B-test
-	O
98	O
TotBili	B-test
-	O
0.6	O

2014-04-17	O
03:58	O
PM	O
BLOOD	B-test
%HbA1c	B-test
-	O
5.8	O
[Hgb]	B-test
-	O
DONE	O
[A1c]	B-test
-	O
DONE	O

2014-04-22	O
07:10	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
6.5	O
RBC	B-test
-	O
2.89	O
*	O
Hgb	B-test
-	O
9.3	O
*	O
Hct	B-test
-	O
26.4	O
*	O
MCV	B-test
-	O
92	O
MCH	B-test
-	O
32.3	O
*	O
MCHC	B-test
-	O
35.2	O
*	O
RDW	B-test
-	O
13.8	O
Plt	B-test
Ct	I-test
-	O
155	O

2014-04-22	O
07:10	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
97	O
UreaN	B-test
-	O
11	O
Creat	B-test
-	O
1.3	O
*	O
Na	B-test
-	O
142	O
K	B-test
-	O
4.4	O
Cl	B-test
-	O
103	O
HCO3	B-test
-	O
34	O
*	O
AnGap	B-test
-	O
9	O

2014-04-22	O
07:10	O
AM	O
BLOOD	B-test
Mg	B-test
-	O
2.0	O

2014-04-22	O
Chest	B-test
x-ray	I-test
:	O
No	O
evidence	O
of	O
pneumothorax	B-problem
.	O

Persistent	B-problem
bibasilar	I-problem
atelectasis	I-problem
and	O
tiny	B-problem
pleural	I-problem
effusions	I-problem
.	O

Stable	B-problem
postoperative	I-problem
cardiac	I-problem
and	I-problem
mediastinal	I-problem
widening	I-problem
.	O

2014-04-24	O
06:35	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
6.7	O
RBC	B-test
-	O
2.96	O
*	O
Hgb	B-test
-	O
9.1	O
*	O
Hct	B-test
-	O
28.0	O
*	O
MCV	B-test
-	O
94	O
MCH	B-test
-	O
30.9	O
MCHC	B-test
-	O
32.7	O
RDW	B-test
-	O
13.6	O
Plt	B-test
Ct	I-test
-	O
234	O
#	O

2014-04-25	O
06:45	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
93	O
UreaN	B-test
-	O
13	O
Creat	B-test
-	O
1.4	O
*	O
Na	B-test
-	O
141	O
K	B-test
-	O
4.6	O
Cl	B-test
-	O
102	O
HCO3	B-test
-	O
31	O
AnGap	B-test
-	O
13	O

2014-04-24	O
06:35	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
96	O
UreaN	B-test
-	O
13	O
Creat	B-test
-	O
1.4	O
*	O
Na	B-test
-	O
143	O
K	B-test
-	O
4.8	O
Cl	B-test
-	O
104	O
HCO3	B-test
-	O
33	O
*	O
AnGap	B-test
-	O
11	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Chester	O
was	O
admitted	O
to	O
the	O
cardiac	O
surgical	O
service	O
and	O
underwent	O
routine	B-test
preoperative	I-test
evaluation	I-test
.	O

He	O
remained	O
pain	B-problem
free	O
on	O
medical	B-treatment
therapy	I-treatment
.	O

Workup	B-test
was	O
unremarkable	O
and	O
he	O
was	O
cleared	O
for	O
surgery	B-treatment
.	O

On	O
04-18	O
,	O
Dr.	O
Oneill	O
performed	O
off	B-treatment
pump	I-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

For	O
surgical	O
details	O
,	O
please	O
see	O
seperate	O
dictated	O
operative	O
note	O
.	O

Following	O
the	B-treatment
operation	I-treatment
,	O
he	O
was	O
brought	O
to	O
the	O
CSRU	O
for	O
invasive	B-test
monitoring	I-test
.	O

Within	O
24	O
hours	O
,	O
he	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	O
without	O
incident	O
.	O

Given	O
hypotension	B-problem
and	O
bradycardia	B-problem
,	O
he	O
was	O
slow	B-problem
to	I-problem
wean	I-problem
from	O
Neosynephrine	B-treatment
.	O

Low	B-treatment
dose	I-treatment
beta	I-treatment
blockade	I-treatment
was	O
eventually	O
resumed	O
.	O

Chest	B-treatment
tubes	I-treatment
and	O
pacing	B-treatment
wires	I-treatment
were	O
removed	O
without	O
complication	B-problem
.	O

On	O
postoperative	O
day	O
three	O
,	O
he	O
transferred	O
to	O
the	O
SDU	O
.	O

He	O
maintained	O
a	O
normal	O
sinus	O
rhythm	O
without	O
atrial	B-problem
or	I-problem
ventricular	I-problem
arrhythmias	I-problem
.	O

He	O
remained	O
in	O
sinus	B-problem
bradycardia	I-problem
(	O
rate	O
50-60	O
)	O
and	O
tolerated	O
low	B-treatment
dose	I-treatment
beta	I-treatment
blockade	I-treatment
.	O

On	O
POD	O
#6	O
his	B-test
creatinine	I-test
became	O
slightly	B-problem
elevated	I-problem
at	O
1.4	O
,	O
his	B-treatment
lasix	I-treatment
was	O
discontinued	O
and	O
the	O
following	O
day	O
his	B-test
creatinine	I-test
was	O
stable	O
at	O
1.4	O
.	O

He	O
continued	O
to	O
progress	O
and	O
was	O
eventually	O
cleared	O
for	O
discharge	O
to	O
home	O
on	O
postoperative	O
day	O
7	O
.	O

His	B-test
discharge	I-test
chest	I-test
x-ray	I-test
showed	O
persistent	B-problem
bibasilar	I-problem
atelectasis	I-problem
with	O
only	O
tiny	B-problem
pleural	I-problem
effusions	I-problem
.	O

Of	O
note	O
,	O
he	O
will	O
need	O
to	O
remain	O
on	O
Plavix	B-treatment
for	O
three	O
months	O
postop	O
given	O
the	B-treatment
off	I-treatment
pump	I-treatment
procedure	I-treatment
.	O

In	O
addition	O
,	O
he	O
will	O
need	O
to	O
remain	O
on	O
Imdur	B-treatment
given	O
use	O
of	O
his	O
right	O
internal	O
mammary	O
artery	O
as	O
a	B-treatment
"	I-treatment
free	I-treatment
"	I-treatment
arterial	I-treatment
graft	I-treatment
in	O
preventing	O

vasospasm	B-problem
.	O

Medications	O
on	O
Admission	O
:	O

Lopressor	B-treatment
?	O
dose	O

Aspirin	B-treatment
325	O
qd	O

Zocor	B-treatment
40	O
qd	O

IV	B-treatment
Heparin	I-treatment

Discharge	O
Medications	O
:	O

1.	O
Furosemide	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
5	O
days	O
.	O

Disp	O
:*	O
5	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Potassium	B-treatment
Chloride	I-treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
once	O
a	O
day	O
for	O
5	O
days	O
.	O

Disp	O
:*	O
10	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Aspirin	B-treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Oxycodone	B-treatment
-	I-treatment
Acetaminophen	I-treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Simvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Fluticasone	B-treatment
-	I-treatment
Salmeterol	I-treatment
250-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
1	O
Disk	O
with	O
Device	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Isosorbide	B-treatment
Mononitrate	I-treatment
30	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Clopidogrel	B-treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Metoprolol	B-treatment
Succinate	I-treatment
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig	O
:	O
0.5	O
(	O
half	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
-	O
s/p	O
Off	B-treatment
Pump	I-treatment
CABG	I-treatment

Sinus	B-problem
Bradycardia	I-problem

Asthma	B-problem
PAD-WORD	O

BPH	B-problem
PAD-WORD	O

Nephrolithiasis	B-problem
PAD-WORD	O

Discharge	O
Condition	O
:	O

Good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Follow	O
medications	B-treatment
on	O
discharge	O
instructions	O
.	O

Do	O
not	O
drive	O
for	O
4	O
weeks	O
.	O

Do	O
not	O
lift	O
more	O
than	O
10	O
lbs	O
for	O
2	O
months	O
.	O

Shower	O
daily	O
,	O
let	O
water	O
flow	O
over	O
wounds	B-problem
,	O
pat	O
dry	O
with	O
a	O
towel	O
.	O

Do	O
not	O
use	O
creams	O
,	O
lotions	O
,	O
or	O
powders	O
on	O
wounds	B-problem
.	O

Call	O
our	O
office	O
for	O
sternal	B-problem
drainage	I-problem
,	O
temp	B-problem
.>	O
101.5	O

Followup	O
Instructions	O
:	O

Make	O
an	O
appointment	O
with	O
Dr.	O
Aguirre	O
for	O
1-2	O
weeks	O
.	O

Make	O
an	O
appointment	O
with	O
Dr.	O
Keller	O
for	O
4-5	O
weeks	O
.	O

Alice	O
Jordan	O
MD	O
62-102	O

Completed	O
by	O
:	O
Kitty	O
Pamela	O
NP	O
80-BXH	O
2014-04-25	O
@	O
0955	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Bessie	O
R.	O
Conners	O
on	O
:	O
WED	O
2014-05-21	O
9:31	O
AM	O

(	O
End	O
of	O
Report	O
)	O

676650879	O
RWH	O

8529404	O
PAD-WORD	O

689059	O
PAD-WORD	O

5100093	O
PAD-WORD	O

10/16/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O

DOUETNOUNBREUNKOLL	O
,	O
STENRESLYSE	O

MRN	O
:	O

8529404	O
PAD-WORD	O

Age	O
:	O

55y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

10/16/2005	O
10:38	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
DOUETNOUNBREUNKOLL	O
,	O
STENRESLYSE	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
10/16/2005	O
10:38	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
RLQ	B-problem
PAIN	I-problem
.	O

Following	O
evaluation	B-test
and	O
treatment	B-treatment
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
admitted	O
as	O
an	O
inpatient	O
to	O
Ro	O
Woodma	O
Healthcare	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
DALEJESC	O
,	O
OIE	O
and	O
the	O
preliminary	O
admitting	O
diagnosis	O
is	O
CHOLECYSTITIS	B-problem
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

BREUTZFREIERM	O
,	O
VIENNEE	O

Provider	O
Number	O
:	O

98704	O
PAD-WORD	O

﻿Admission	O
Date	O
:	O

2014-07-30	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-08-04	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1930-08-11	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Penicillins	B-treatment
PAD-WORD	O

Attending	O
:	O
William	O
Q.	O
Williams	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

dyspnea	B-problem
PAD-WORD	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
an	O
83	O
y/o	O
female	O
with	O
moderate	B-problem
AS	I-problem
,	O
s/p	O
MVR	B-treatment
27	O
years	O
ago	O
,	O
s/p	O
PPM	B-treatment
,	O
DM	B-problem
,	O
CHF	B-problem
,	O
p/w	O
dsypnea	B-problem
and	O
increased	B-problem
work	I-problem
of	I-problem
breathing	I-problem
x	O
4-5	O
days	O
.	O

Per	O
family	O
,	O
the	O
patient	O
has	O
had	O
worsening	B-problem
CHF/volume	I-problem
overload	I-problem
over	O
the	O
last	O
several	O
weeks	O
,	O
requiring	O
supplemental	B-treatment
O2	I-treatment
at	O
rehab	O
.	O

Over	O
the	O
last	O
few	O
days	O
,	O
she	O
has	O
been	O
noted	O
to	O
be	O
more	B-problem
short	I-problem
of	I-problem
breath	I-problem
and	O
having	O
sats	B-test
to	O
60%	O
on	O
RA	O
.	O

Her	B-treatment
lasix	I-treatment
was	O
increased	O
to	O
60	O
mg	O
bid	O
.	O

Beginning	O
today	O
,	O
she	O
was	O
noted	O
to	O
be	O
in	O
hypoxic	B-problem
respiratory	I-problem
distress	I-problem
,	O
87-91%	O
on	O
2L/NC	B-treatment
.	O

She	O
was	O
increased	O
to	O
5L	O
,	O
with	O
her	B-test
sats	I-test
going	O
up	O
to	O
97%	O
.	O

She	O
was	O
also	O
noted	O
to	O
be	O
more	B-problem
confused	I-problem
over	O
the	O
last	O
few	O
days	O
and	O
especially	O
today	O
.	O

She	O
was	O
given	O
lasix	B-treatment
and	O
2	B-treatment
mg	I-treatment
IV	I-treatment
morphine	I-treatment
at	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
Rehab	O
,	O
and	O
sent	O
to	O
Nantucket	O
Cottage	O
Hospital	O
for	O
further	B-test
evaluation	I-test
.	O

En	O
route	O
,	O
she	O
was	O
given	O
additional	B-treatment
lasix	I-treatment
of	O
60	O
mg	O
IV	O
and	O
nitro	B-treatment
spray	I-treatment
x	O
2	O
.	O

In	O
the	O
Deanna	O
,	O
her	B-test
VS	I-test
were	O
Tc	B-test
97.2	O
,	O
BP	B-test
146/25	O
,	O
HR	B-test
70	O
,	O
RR	B-test
27	O
,	O
SaO2	B-test
95%/NRB	B-treatment
.	O

Foley	B-treatment
was	O
placed	O
in	O
Deanna	O
.	O

She	O
was	O
given	O
40	O
mg	O
IV	B-treatment
lasix	I-treatment
and	O
325	O
mg	O
ASA	B-treatment
.	O

She	O
was	O
placed	O
on	O
BiPAP	B-treatment
for	O
comfort	O
at	O
30%	O
FiO2	B-treatment
,	O
5	O
PEEP	B-treatment
,	O
12	O
PS	B-treatment
.	O

Admitted	O
to	O
the	O
CMED	O
CSRU	O
for	O
further	B-treatment
management	I-treatment
.	O

Per	O
family	O
,	O
besides	O
the	B-problem
dyspnea	I-problem
and	O
SOB	B-problem
,	O
the	O
patient	O
has	O
had	O
no	O
other	B-problem
symptoms	I-problem
,	O
including	O
f/c/s	B-problem
,	O
CP	B-problem
,	O
palpitations	B-problem
,	O
abd	B-problem
pain	I-problem
,	O
n/v/diarrhea	B-problem
.	O

She	O
has	O
had	O
decreased	B-problem
appetite	I-problem
over	O
the	O
last	O
few	O
days	O
in	O
the	O
context	O
of	O
increasing	B-problem
confusion	I-problem
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Moderate	B-problem
AS	I-problem

2.	O
s/p	O
MVR	B-treatment

3.	O
s/p	O
PPM	B-treatment

4.	O
A	B-problem
fib	I-problem

5.	O
DM	B-problem
2	I-problem
on	O
insulin	B-treatment

6.	O
Hypercholesterolemia	B-problem

7.	O
Gout	B-problem

8.	O
Depression	B-problem

9.	O
?	O
Pulmonary	B-problem
fibrosis	I-problem

10.	O
CHF/CAD	B-problem
,	O
last	B-test
EF	I-test
55%	O
4/06	O

Social	O
History	O
:	O

Lives	O
at	O
Salem	O
Hospital	O
-	O
North	O
Shore	O
Medical	O
Center	O
Rehab	O
.	O

Prior	O
h/o	O
heavy	O
tobacco	O
use	O
.	O

Ambulates	O
at	O
baseline	O
.	O

Family	O
History	O
:	O

Mother	O
with	O
h/o	O
emphysema	B-problem
,	O
CAD	B-problem

Physical	O
Exam	O
:	O

General	O
:	O
Asleep	O
,	O
easily	O
arousable	O
.	O

On	O
BiPAP	B-treatment
,	O
NAD	B-problem

HEENT	O
:	O
NC/AT	O
,	O
PERRL	O
,	O
EOMI	O
.	O

MMM	O
,	O
OP	O
clear	O

Neck	O
:	O
+	O
elevated	B-problem
JVD	I-problem
to	O
earlobe	O
,	O
supple	O

Chest	O
:	O
decreased	B-problem
BS	I-problem
at	O
bases	O
with	O
few	B-problem
crackles	I-problem
b/l	I-problem

CV	O
:	O
RRR	O
3/6	O
HSM	B-problem
,	O
loudest	O
at	O
LUSB	O

Abd	O
:	O
soft	O
,	O
NT/ND	B-problem
,	O
NABS	O

Ext	O
:	O
2	O
+	O
pitting	B-problem
edema	I-problem
b/l	I-problem
,	O
warm	O
with	O
faint	O
DP	O

Pertinent	O
Results	O
:	O

2014-07-30	O
01:30PM	O

WBC	B-test
-	O
9.6	O
RBC	B-test
-	O
4.02	O
*	O
HGB	B-test
-	O
11.4	O
*	O
HCT	B-test
-	O
36.3	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
28.4	O
MCHC	B-test
-	O
31.4	O
RDW	B-test
-	O
17.8	O
*	O

2014-07-30	O
01:30PM	O

NEUTS	B-test
-	O
87.0	O
*	O
LYMPHS	B-test
-	O
6.7	O
*	O
MONOS	B-test
-	O
5.0	O
EOS	B-test
-	O
0.9	O
BASOS	B-test
-	O
0.4	O

2014-07-30	O
01:30PM	O

PLT	B-test
COUNT	I-test
-	O
161	O

2014-07-30	O
01:30PM	O

PT	B-test
-	O
23.2	O
*	O
INR	B-test
(	O
PT	O
)	O
-	O
2.3	O
*	O

2014-07-30	O
01:30PM	O

cTropnT	B-test
-	O
0.08	O
*	O

2014-07-30	O
01:30PM	O

CK	B-test
(	I-test
CPK	I-test
)	I-test
-	O
37	O

2014-07-30	O
01:30PM	O

cTropnT	B-test
-	O
0.08	O
*	O

2014-07-30	O
01:30PM	O

CK-MB	B-test
-	O
NotDone	O
proBNP	B-test
-	O
5313	O
*	O

2014-07-30	O
01:30PM	O

GLUCOSE	B-test
-	O
173	O
*	O
UREA	B-test
N	I-test
-	O
52	O
*	O
CREAT	B-test
-	O
1.5	O
*	O
SODIUM	B-test
-	O
145	O
POTASSIUM	B-test
-	O
4.8	O
CHLORIDE	B-test
-	O
100	O
TOTAL	B-test
CO2	I-test
-	O
40	O
*	O
ANION	B-test
GAP	I-test
-	O
10	O

2014-07-30	O
01:45PM	O

TYPE	O
-	O
ART	B-test
PO2	I-test
-	O
249	O
*	O
PCO2	B-test
-	O
99	O
*	O
PH	B-test
-	O
7.28	O
*	O
TOTAL	B-test
CO2	I-test
-	O
49	O
*	O
BASE	B-test
XS	I-test
-	O
15	O
INTUBATED	O
-	O
NOT	O
INTUBA	O

2014-07-30	O
06:20PM	O

TYPE	O
-	O
ART	B-test
TEMP	I-test
-	O
37.0	O
O2-90	O
O2	B-treatment
FLOW	I-treatment
-	O
5	O
PO2	B-test
-	O
63	O
*	O
PCO2	B-test
-	O
81	O
*	O
PH	B-test
-	O
7.39	O
TOTAL	B-test
CO2	I-test
-	O
51	O
*	O
BASE	B-test
XS	I-test
-	O
19	O
AADO2	B-test
-	O
513	O
REQ	B-test
O2	I-test
-	O
84	O

INTUBATED	O
-	O
NOT	O
INTUBA	O
COMMENTS	O
-	O
NASAL	O
Harper	O

Echo	B-test
:	O
The	O
left	O
atrium	O
is	O
mildly	B-problem
dilated	I-problem
.	O

There	O
is	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

The	B-test
left	I-test
ventricular	I-test
cavity	I-test
size	I-test
is	O
normal	O
.	O

Overall	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
normal	O
(	O
LVEF	B-test
70%	O
).	O

There	O
is	O
no	O
ventricular	B-problem
septal	I-problem
defect	I-problem
.	O

The	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied	B-problem
.	O

The	O
right	O
ventricular	O
cavity	O
is	O
dilated	B-problem
.	O

Right	B-test
ventricular	I-test
systolic	I-test
function	I-test
appears	O
depressed	B-problem
.	O

The	O
aortic	O
arch	O
is	O
mildly	B-problem
dilated	I-problem
.	O

There	O
are	O
focal	B-problem
calcifications	I-problem
in	I-problem
the	I-problem
aortic	I-problem
arch	I-problem
.	O

There	O
are	O
three	B-problem
aortic	I-problem
valve	I-problem
leaflets	I-problem
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	B-problem
thickened	I-problem
.	O

There	O
is	O
at	O
least	O
moderate	B-problem
aortic	I-problem
valve	I-problem
stenosis	I-problem
.	O

A	B-treatment
bileaflet	I-treatment
mitral	I-treatment
valve	I-treatment
prosthesis	I-treatment
is	O
present	O
.	O

The	B-test
gradients	I-test
are	O
higher	O
than	O
expected	O
for	O
this	O
type	O
of	O
prosthesis	B-treatment
.	O

The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

There	O
is	O
moderate	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

The	B-test
end-diastolic	I-test
pulmonic	I-test
regurgitation	I-test
velocity	I-test
is	O
increased	B-problem
suggesting	O
pulmonary	B-problem
artery	I-problem
diastolic	I-problem
hypertension	I-problem
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

Compared	O
with	O
the	O
findings	O
of	O
the	B-test
prior	I-test
study	I-test
(	O
images	O
reviewed	O
)	O
of	O
2013-06-18	O
,	O
the	B-test
pressure	I-test
gradient	I-test
across	O
the	B-treatment
mitral	I-treatment
valve	I-treatment
prosthesis	I-treatment
is	O
increased	B-problem
.	O

IMPRESSION	O
:	O
AP	B-test
chest	I-test
compared	O
to	O
07-30	O
through	O
26	O
:	O
Mild	B-problem
pulmonary	I-problem
edema	I-problem
is	O
unchanged	O
.	O

Bilateral	B-problem
pleural	I-problem
effusion	I-problem
small	O
on	O
the	O
right	O
and	O
moderate	O
on	O
the	O
left	O
is	O
stable	O
.	O

Severe	B-problem
cardiomegaly	I-problem
and	O
left	B-problem
lower	I-problem
lobe	I-problem
atelectasis	I-problem
unchanged	O
.	O

No	O
pneumothorax	B-problem
.	O

Transvenous	B-treatment
right	I-treatment
ventricular	I-treatment
pacer	I-treatment
lead	I-treatment
in	O
standard	O
placement	O
.	O

ECG	B-test
:	O
Ventricular	O
paced	O
rhythm	O
.	O

Compared	O
to	O
the	B-test
previous	I-test
tracing	I-test
of	O
2014-07-30	O
no	O
significant	O
change	O
.	O

Intervals	O
Axes	O

Rate	B-test
PR	B-test
QRS	B-test
QT/QTc	B-test
P	B-test
QRS	B-test
T	B-test
70	O
0	O
160	O
466/486.42	O
0	O
-71	O
112	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
-	O
83yo	O
F	O
with	O
valvular	B-problem
disorder	I-problem
,	O
AF	B-problem
,	O
and	O
h/o	O
CAD	B-problem
a/w	O
hypercarbic	B-problem
respiratory	I-problem
failure	I-problem
.	O

#	O
Respiratory	B-problem
failure	I-problem
-	O
She	O
was	O
admitted	O
to	O
the	O
CMED	O
CSRU	O
for	O
her	B-problem
repiratory	I-problem
failure	I-problem
which	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
CHF	B-problem
.	O

Pt	O
was	O
diuresed	O
with	O
iv	B-treatment
lasix	I-treatment
/	O
acetazolamide	B-treatment
and	O
given	O
iv	B-treatment
morphine	I-treatment
/	O
prn	O
for	O
respiratory	B-problem
distress	I-problem
and	O
BIPAP	B-treatment
was	O
tried	O
.	O

However	O
,	O
hypercarbia	B-problem
(	O
04-11	O
metabolic	B-problem
alkalosis	I-problem
)	O
remained	O
in	O
the	O
90s	O
.	O

Pt	O
was	O
mentating	O
okay	O
,	O
having	O
conversations	O
with	O
intermittent	B-problem
somnolence	I-problem
despite	O
hypercarbia	B-problem
.	O

TTE	B-test
showed	O
preserved	O
EF	O
with	O
moderate	B-problem
AS	I-problem
and	O
moderate	B-problem
MS	I-problem
and	O
mod	B-problem
pulm	I-problem
HTN	I-problem
.	O

Cardiology	O
was	O
consulted	O
and	O
thought	O
MS	B-problem
Harold	O
Holcomb	O
to	O
her	B-problem
pulm	I-problem
edema	I-problem
and	O
pulm	B-problem
HTN	I-problem
.	O

Cardiology	O
recommended	O
d/cing	O
digoxin	B-treatment
and	O
starting	O
amiodarone	B-treatment
.	O

Family	O
declined	O
valvuloplasty	B-treatment
.	O

For	O
possible	O
COPD	B-problem
,	O
pt	O
was	O
started	O
on	O
steroids	B-treatment
and	O
nebs	B-treatment
on	O
08-03	O
.	O

Pt	O
is	O
currently	O
satting	B-test
90s	O
on	O
1	O
L	O
NC	B-treatment
while	O
sitting	O
in	O
a	O
chair	O
but	O
needs	O
more	B-treatment
O2	I-treatment
when	O
supine	O
.	O

Pt	O
is	O
a	O
mouth	O
breather	O
and	O
occasionally	O
needs	O
a	B-treatment
face	I-treatment
mask	I-treatment
.	O

Pt	O
will	O
need	O
I/Os	B-test
monitored	O
to	O
goal	O
even	O
to	O
slightly	O
negative	O
as	O
she	O
was	O
diursed	O
4.8	O
L	O
during	O
her	O
CMED	O
stay	O
.	O

Depending	O
on	O
her	B-test
I/O	I-test
,	O
lasix	B-treatment
and	O
acetazolamide	B-treatment
can	O
be	O
decreased	O
or	O
discontinued	O
.	O

If	O
she	O
were	O
to	O
decompensate	O
at	O
the	O
rehab	O
,	O
goals	O
of	O
care	O
will	O
need	O
to	O
be	O
readdressed	O
.	O

#	O
h/o	O
CAD	B-problem
-	O
There	O
were	O
new	O
changes	O
on	O
EKG	B-test
but	O
pt	O
was	O
ruled	O
out	O
with	O
3	O
sets	O
of	O
negative	O
cardiac	O
enzymes	O
.	O

Pt	O
was	O
continued	O
on	O
BB	B-treatment
,	O
ASA	B-treatment
,	O
and	O
nitrates	B-treatment
.	O

#	O
Acid	O
/	O
base	O
status	O
-	O
Respiratory	B-problem
acidosis	I-problem
with	O
metabolic	O
compensation	O
.	O

Appears	O
to	O
be	O
chronic	O
in	O
nature	O
given	O
degree	O
of	O
metabolic	O
compensation	O
with	O
acute	O
component	O
earlier	O
today	O
.	O

Pt	O
failed	O
BIPAP	B-treatment
and	O
pCO2	B-test
remained	O
in	O
the	O
90s	O
but	O
maintaining	O
mentation	O
.	O

#	O
Renal	B-problem
insufficiency	I-problem
-	O
baseline	B-test
Cr	I-test
unknown	O
,	O
may	O
have	O
CRI	B-problem
from	O
DM	B-problem
.	O

Creatinine	B-test
stayed	O
stable	O
from	O
1.3-1.5	O
.	O

Will	O
need	O
to	O
renally	O
dose	O
all	B-treatment
medications	I-treatment
.	O

#	O
A	B-problem
fib	I-problem
-	O
continued	O
BB	B-treatment
.	O

Per	O
cardiology	O
consult	O
recs	O
,	O
discontinued	O
digoxin	B-treatment
and	O
started	O
amiodarone	B-treatment
.	O

Due	O
to	O
elevated	B-problem
INR	I-problem
,	O
coumadin	B-treatment
was	O
held	O
.	O

Pt	O
is	O
also	O
paced	O
.	O

Pt	O
needs	O
to	O
be	O
on	O
amiodarone	B-treatment
400mg	O
BID	O
x	O
7	O
days	O
(	O
loading	O
dose	O
)	O
and	O
then	O
400mg	O
daily	O
for	O
maintenance	O
.	O

#	O
DM	B-problem
-	O
insulin	B-treatment
standing	O
+	O
HISS	O
,	O
FS	O
qid	O

#	O
Depression	B-problem
-	O
continued	B-treatment
home	I-treatment
regimen	I-treatment

#	O
F/E/N	O
-	O
NPO	O
initially	O
while	O
on	O
BIPAP	B-treatment
and	O
now	O
low	B-treatment
sodium	I-treatment
cardiac	I-treatment
diet	I-treatment
.	O

#	O
PPx	O
-	O
supratherpeutic	B-problem
INR	I-problem

#	O
Access	O
-	O
PIV	B-treatment

#	O
Code	O
-	O
DNR/DNI	O
.	O

No	O
pressors	B-treatment
or	O
central	B-treatment
line	I-treatment
per	O
HCP	O
.	O

If	O
she	O
were	O
to	O
decompensate	O
at	O
the	O
rehab	O
,	O
goals	O
of	O
care	O
will	O
need	O
to	O
be	O
readressed	O
.	O

#	O
Communication	O
-	O
Evelyn	O
Matos	O
(	O
niece	O
)	O
492	O
-	O
9977	O
,	O
cell	O
(	O
921	O
)	O
815	O
-	O
7040	O

Medications	O
on	O
Admission	O
:	O

Coumadin	B-treatment
2.5	O
mg	O
/	O
3	O
mg	O

Insulin	B-treatment
-	O
Humulin	B-treatment
N	I-treatment
36	O
U	O
daily	O
/	O
14	O
U	O
qhs	O

Lasix	B-treatment
40	O
mg	O
bid	O

Venlafaxine	B-treatment
XR	O
75	O
mg	O
qd	O

Sorbitol	B-treatment
PAD-WORD	O

Metoprolol	B-treatment
25	O
mg	O
bid	O

Imdur	B-treatment
30	O
mg	O
qd	O

Hydralazine	B-treatment
50	O
mg	O
bid	O

Digoxin	B-treatment
0.125	O
qd	O

Oscal	B-treatment
250	O
mg	O
+	O
D	O

Tylenol	B-treatment
prn	O

Morphine	B-treatment
sulfate	I-treatment
4	O
mg	O
q2	O
hrs	O
prn	O

Discharge	O
Medications	O
:	O

1.	O
NPH	B-treatment

18	O
units	O
qam	O
and	O
7	O
units	O
qhs	O

2.	O
Humalog	B-treatment

Per	O
sliding	O
scale	O
q	O
breakfast	O
,	O
lunch	O
,	O
and	O
dinner	O

3.	O
Venlafaxine	B-treatment
37.5	O
mg	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24	O
hr	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(	O
Daily	O
).	O

4.	O
Aspirin	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

5.	O
Isosorbide	B-treatment
Mononitrate	I-treatment
30	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Albuterol	B-treatment
Sulfate	I-treatment
0.083	O
%	O
(	O
0.83	O
mg	O
/	O
mL	O
)	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

8.	O
Ipratropium	B-treatment
Bromide	I-treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

9.	O
Albuterol	B-treatment
Sulfate	I-treatment
0.083	O
%	O
(	O
0.83	O
mg	O
/	O
mL	O
)	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q2H	O
(	O
every	O
2	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Prednisone	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
4	O
days	O
.	O

11.	O
Furosemide	B-treatment
10	O
mg	O
/	O
mL	O
Solution	O
Sig	O
:	O
Forty	O
(	O
40	O
)	O
mg	O
Injection	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

12.	O
Acetazolamide	B-treatment
Sodium	I-treatment
500	O
mg	O
Recon	O
Soln	O
Sig	O
:	O
Two	O
Hundred	O
Fifty	O
(	O
250	O
)	O
Recon	O
Soln	O
Injection	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

13.	O
Morphine	B-treatment
2	O
mg	O
/	O
mL	O
Syringe	O
Sig	O
:	O
1-2	O
mg	O
Injection	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

14.	O
Amiodarone	B-treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

15.	O
Amiodarone	B-treatment
400	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
after	O
finishing	O
400mg	O
BID	O
x	O
6	O
days	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Whidden	O
Memorial	O
Hospital	O
for	O
the	O
Aged	O
-	O
LTC	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnoses	O
:	O

Diastolic	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem

Aortic	B-problem
stenosis	I-problem

Mitral	B-problem
stenosis	I-problem

Possible	O
chronic	B-problem
obstructive	I-problem
lung	I-problem
disease	I-problem

Secondary	O
diagnoses	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem

Chronic	B-problem
kidney	I-problem
disease	I-problem

Depression	B-problem
PAD-WORD	O

Diabetes	B-problem
mellitus	I-problem

Discharge	O
Condition	O
:	O

Stable	O
,	O
satting	O
98%	O
on	O
1L	B-treatment
via	I-treatment
NC	I-treatment
,	O
sitting	O
up	O
in	O
a	O
chair	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
your	O
doctor	O
at	O
the	O
rehabilitation	O
if	O
you	O
develop	O
any	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
or	O
any	B-problem
other	I-problem
concerning	I-problem
symptoms	I-problem
.	O

Please	O
take	O
medications	B-treatment
as	O
instructed	O
.	O

Keep	O
all	O
your	O
follow-up	O
appointments	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
David	O
Phone	O
:	O
912-6800-0569	O
Date	O
/	O
Time	O
:	O
2014-08-11	O
1:00	O

Jim	O
Stanley	O
MD	O
78-708	O

Completed	O
by	O
:	O
Junko	O
Alpha	O
MD	O
22-842	O
2014-08-04	O
@	O
1725	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jane	O
B.	O
Hardy	O
on	O
:	O
Sandra	O
2014-08-07	O
11:10	O
AM	O

(	O
End	O
of	O
Report	O
)	O

677051476	O
PAD-WORD	O

FIH	O
PAD-WORD	O

4871976	O
PAD-WORD	O

46286/a787	O
PAD-WORD	O

826393	O
PAD-WORD	O

1/11/1992	O
12:00:00	O
AM	O

GASTRIC	B-problem
CARCINOMA	I-problem

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

01-11-92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

01-22-92	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Gastric	B-problem
carcinoma	I-problem

ASSOCIATED	O
DIAGNOSIS	O
:	O

hypothyroidism	B-problem
following	O
near	B-treatment
total	I-treatment
thyroidectomy	I-treatment
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

On	O
1/12/92	O
near	B-treatment
total	I-treatment
gastrectomy	I-treatment
with	O
retrocolic	B-treatment
Bill-Roth	I-treatment
II	I-treatment
gastrojejunostomy	I-treatment
,	O
portal	B-treatment
node	I-treatment
dissection	I-treatment
,	O
repair	B-treatment
of	O
ventral	B-problem
hernia	I-problem
,	O
and	O
needle	B-treatment
jejunostomy	I-treatment
tube	I-treatment
placement	I-treatment
.	O

OTHER	O
PROCEDURES	O
:	O

None	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Tikrhalt	O
is	O
an	O
86	O
year	O
old	O
female	O
,	O
previously	O
healthy	O
,	O
who	O
presents	O
with	O
a	O
3	O
month	O
history	O
of	O
dysphagia	B-problem
.	O

A	B-test
subsequent	I-test
workup	I-test
including	O
upper	B-test
gastrointestinal	I-test
series	I-test
and	O
abdominal	B-test
computerized	I-test
tomography	I-test
scan	I-test
suggested	O
the	O
presence	O
of	O
a	B-problem
gastric	I-problem
mass	I-problem
.	O

Endoscopy	B-test
with	O
biopsy	B-test
revealed	O
gastric	B-problem
carcinoma	I-problem
,	O
poorly	O
differentiated	O
,	O
within	O
the	O
body	O
of	O
the	O
stomach	O
along	O
the	O
greater	O
curvature	O
.	O

She	O
was	O
subsequently	O
referred	O
to	O
Dr.	O
Ko	O
for	O
a	O
possible	O
resection	B-treatment
of	O
this	B-problem
carcinoma	I-problem
.	O

She	O
reports	O
a	B-problem
10	I-problem
pound	I-problem
weight	I-problem
loss	I-problem
over	O
the	O
past	O
several	O
months	O
.	O

She	O
denies	O
any	B-problem
abdominal	I-problem
pain	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
an	B-treatment
appendectomy	I-treatment
in	O
the	O
distant	O
past	O
,	O
cholecystectomy	B-treatment
in	O
the	O
past	O
,	O
history	O
of	O
of	O
Cesarean	B-treatment
section	I-treatment
in	O
the	O
past	O
and	O
a	O
history	O
of	O
near	B-treatment
total	I-treatment
thyroidectomy	I-treatment
for	O
nodular	B-problem
goiter	I-problem
in	O
the	O
past	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Her	B-treatment
only	I-treatment
medication	I-treatment
is	O
Thyrolar	B-treatment
for	O
her	B-problem
relative	I-problem
hypothyroidism	I-problem
following	O
resection	B-treatment
.	O

There	O
is	O
a	O
question	O
of	O
an	B-problem
allergy	I-problem
to	O
Tylenol	B-treatment
.	O

She	O
denies	O
any	O
history	O
of	O
hypertension	B-problem
,	O
diabetes	B-problem
mellitus	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
or	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
.	O

Interestingly	O
,	O
she	O
reports	O
that	O
both	O
her	O
mother	O
and	O
father	O
died	O
of	O
stomach	B-problem
carcinoma	I-problem
.	O

She	O
is	O
a	O
former	O
smoker	O
,	O
and	O
drinks	O
alcohol	O
occasionally	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
she	O
is	O
an	O
elderly	O
but	O
spry	O
white	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Her	O
sclera	O
were	O
nonicteric	B-problem
.	O

Her	O
oropharynx	O
was	O
clear	O
.	O

Her	O
neck	O
was	O
supple	O
without	O
masses	B-problem
or	O
bruits	B-problem
noted	O
.	O

Her	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
.	O

Her	B-test
cardiac	I-test
examination	I-test
was	O
unremarkable	O
.	O

Examination	B-test
of	I-test
her	I-test
abdomen	I-test
revealed	O
a	B-problem
flat	I-problem
nontender	I-problem
abdomen	I-problem
without	O
palpable	B-problem
masses	I-problem
.	O

There	O
were	O
multiple	B-problem
well	I-problem
healed	I-problem
surgical	I-problem
scars	I-problem
.	O

She	O
was	O
guaiac	B-test
negative	O
.	O

There	O
was	O
no	O
cva	B-problem
tenderness	I-problem
or	O
spinal	B-problem
tenderness	I-problem
noted	O
.	O

Her	B-test
pulses	I-test
were	O
intact	O
throughout	O
.	O

LABORATORY	O
DATA	O
:	O

Sodium	B-test
139	O
,	O
potassium	B-test
3.7	O
and	O
BUN	B-test
of	O
19	O
.	O

Her	B-test
hematocrit	I-test
was	O
37.2	O
with	O
a	B-test
white	I-test
blood	I-test
count	I-test
of	O
6.6	O
.	O

Her	B-test
Bilirubin	I-test
direct	I-test
and	O
total	B-test
were	O
0.1	O
and	O
0.3	O
respectively	O
.	O

Her	B-test
alkaline	I-test
phosphatase	I-test
was	O
134	O
.	O

Her	B-test
electrocardiogram	I-test
demonstrated	O
normal	O
sinus	O
rhythm	O
without	O
acute	B-problem
ischemic	I-problem
changes	I-problem
.	O

Chest	B-test
X-Ray	I-test
was	O
unremarkable	O
.	O

The	B-test
assessment	I-test
at	O
the	O
time	O
of	O
admission	O
was	O
that	O
of	O
an	O
86	O
year	O
old	O
female	O
with	O
poorly	B-problem
differentiated	I-problem
gastric	I-problem
adenocarcinoma	I-problem
,	O
admitted	O
for	O
resection	B-treatment
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Service	O
of	O
Dr.	O
Fede	O
A.	O
Duhenile	O
.	O

On	O
1/12/92	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	B-treatment
neart	I-treatment
total	I-treatment
gastrectomy	I-treatment
with	O
a	B-treatment
retrocolic	I-treatment
Bill-Roth	I-treatment
II	I-treatment
gastrojejunostomy	I-treatment
reconstruction	I-treatment
.	O

In	O
addition	O
a	B-problem
small	I-problem
ventral	I-problem
hernia	I-problem
was	O
noted	O
upon	O
abdominal	B-test
exploration	I-test
within	O
a	B-treatment
previous	I-treatment
surgical	I-treatment
incision	I-treatment
.	O

This	O
was	O
repaired	B-treatment
.	O

A	B-treatment
needle	I-treatment
jejunostomy	I-treatment
catheter	I-treatment
was	O
placed	O
at	O
the	O
time	O
of	O
her	B-treatment
operation	I-treatment
to	O
facilitate	O
postoperative	B-treatment
nutrition	I-treatment
.	O

With	O
regards	O
to	O
the	B-problem
cancer	I-problem
,	O
there	O
was	O
a	B-problem
large	I-problem
mass	I-problem
along	O
the	O
greater	O
curvature	O
in	O
the	O
body	O
of	O
the	O
stomach	O
,	O
and	O
several	O
perigastric	O
lymph	O
nodes	O
which	O
were	O
taken	O
with	O
the	B-test
specimen	I-test
.	O

In	O
addition	O
,	O
there	O
were	O
at	O
least	O
two	O
lymph	O
nodes	O
within	O
the	O
porta	O
hepatis	O
which	O
were	O
dissected	B-treatment
free	I-treatment
and	O
taken	O
en	O
bloc	O
with	O
the	B-test
specimen	I-test
.	O

The	O
remainder	O
of	O
her	O
abdomen	O
was	O
unremarkable	O
without	O
evidence	O
of	O
metastatic	B-problem
spread	I-problem
elsewhere	O
,	O
including	O
the	O
liver	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
taken	O
to	O
the	O
recovery	O
room	O
in	O
good	O
condition	O
.	O

The	O
patient	O
's	O
postoperative	O
course	O
was	O
for	O
the	O
most	O
part	O
unremarkable	O
.	O

Her	B-problem
wounds	I-problem
healed	O
well	O
without	O
incident	O
and	O
the	B-treatment
needle	I-treatment
jejunostomy	I-treatment
tube	I-treatment
was	O
utilized	O
on	O
the	O
first	O
postoperative	O
day	O
right	O
up	O
until	O
the	O
time	O
of	O
discharge	O
,	O
infusing	O
Vivonex	B-treatment
T.E.N.	I-treatment

The	O
patient	O
tolerated	O
this	O
without	O
difficulty	B-problem
.	O

The	B-treatment
patient	I-treatment
's	I-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
removed	O
on	O
the	O
3rd	O
postoperative	O
day	O
,	O
and	O
with	O
the	O
passage	O
of	O
flatus	O
and	O
good	O
bowel	O
sounds	O
noted	O
,	O
she	O
was	O
started	O
on	O
a	B-treatment
liquid	I-treatment
diet	I-treatment
which	O
was	O
advanced	O
slowly	O
.	O

She	O
was	O
seen	O
by	O
the	O
dietician	O
and	O
was	O
advised	O
with	O
regard	O
to	O
needing	O
numerous	O
small	O
meals	O
during	O
the	O
day	O
rather	O
than	O
3	O
larger	O
meals	O
as	O
she	O
previously	O
was	O
used	O
to	O
.	O

Her	O
ambulation	O
and	O
mobilization	O
increased	O
gradually	O
and	O
by	O
the	O
time	O
of	O
discharge	O
she	O
was	O
walking	O
in	O
the	O
halls	O
without	O
assistance	O
.	O

As	O
mentioned	O
,	O
her	B-problem
wounds	I-problem
healed	O
well	O
without	O
incident	O
and	O
the	B-treatment
staples	I-treatment
were	O
removed	O
on	O
the	O
10th	O
postoperative	O
day	O
just	O
prior	O
to	O
discharge	O
.	O

She	O
had	O
some	B-problem
difficulties	I-problem
with	O
confusion	B-problem
in	O
the	O
early	O
postoperative	O
period	O
which	O
were	O
attributable	O
to	O
her	O
advanced	O
age	O
and	O
a	B-problem
sundowning	I-problem
effect	I-problem
.	O

These	O
problems	O
resolved	O
by	O
the	O
4th	O
or	O
5th	O
postoperative	O
day	O
and	O
she	O
remained	O
lucid	O
and	O
alert	O
for	O
the	O
remainder	O
of	O
her	O
hospital	O
stay	O
.	O

Surgical	O
pathology	O
report	O
was	O
completed	O
prior	O
to	O
discharge	O
which	O
revealed	O
poorly	B-problem
differentiated	I-problem
adenocarcinoma	I-problem
ulcerating	O
and	O
extending	O
through	O
the	O
wall	O
into	O
the	O
serosa	O
of	O
the	O
stomach	O
.	O

Metastatic	B-problem
carcinoma	I-problem
was	O
present	O
in	O
3	O
of	O
3	O
lymph	O
nodes	O
.	O

The	O
gastric	O
resection	O
margins	O
were	O
free	O
of	O
carcinoma	B-problem
.	O

The	O
patient	O
was	O
set	O
for	O
discharge	O
on	O
the	O
11th	O
postoperative	O
day	O
doing	O
well	O
.	O

On	O
the	O
day	O
prior	O
to	O
discharge	O
she	O
complained	O
of	O
some	B-problem
dysuria	I-problem
,	O
a	B-test
urine	I-test
specimen	I-test
was	O
obtained	O
,	O
which	O
showed	O
numerous	B-problem
white	I-problem
cells	I-problem
consistent	O
with	O
a	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

She	O
was	O
started	O
empirically	O
on	O
Bactrim	B-treatment
,	O
while	O
culture	B-test
and	O
sensitivity	B-test
results	O
were	O
pending	O
and	O
remained	O
pending	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

She	O
will	O
be	O
discharged	O
to	O
home	O
and	O
will	O
be	O
seen	O
in	O
follow-up	O
by	O
her	O
regular	O
physicians	O
as	O
well	O
as	O
Dr.	O
Ko	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Bactrim	B-treatment
,	I-treatment
single	I-treatment
strength	I-treatment
,	O
one	O
p.o.	O
b.i.d.	O
times	O
10	O
days	O
,	O
initiated	O
9/27/92	O
,	O
Synthroid	B-treatment
0.1	O
mg	O
p.o.	O
q.day	O
,	O
Ferrous	B-treatment
Gluconate	I-treatment
300	O
mg	O
p.o.	O
t.i.d.	O
and	O
Folate	B-treatment
1	O
mg	O
p.o.	O
q.	O
day	O
.	O

She	O
will	O
be	O
seen	O
by	O
Visiting	O
Nurses	O
Association	O
to	O
help	O
with	O
general	O
aspects	O
of	O
daily	O
living	O
as	O
well	O
as	O
adequate	O
diet	O
planning	O
following	O
her	B-treatment
gastric	I-treatment
resection	I-treatment
.	O

TOMEDANKELL	O
FLOWAYLES	O
,	O
M.D.	O

TR	O
:	O

cdw	O
/	O
bmot	O

DD	O
:	O

01-21-92	O
PAD-WORD	O

TD	O
:	O

01/22/92	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Ko	O

Admission	O
Date	O
:	O

2019-04-06	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-04-15	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1938-02-19	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O
ORTHOPAEDICS	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Woodrow	O
Y	O
Williams	O
,	O
M.D.	O

Addendum	O
:	O

On	O
2019-04-12	O
he	O
was	O
transfused	O
with	O
2	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
due	O
to	O
post-operative	B-problem
anemia	I-problem
.	O

Mr.	O
Minton	O
did	O
not	O
get	O
his	B-treatment
IVIG	I-treatment
until	O
2019-04-14	O
.	O

The	B-treatment
infusion	I-treatment
was	O
completed	O
without	O
incidence	O
.	O

He	O
remained	O
stable	O
with	O
his	B-test
vital	I-test
signs	I-test
and	O
lab	B-test
data	I-test
within	O
normal	O
limits	O
.	O

Chief	O
Complaint	O
:	O

see	O
below	O

Pertinent	O
Results	O
:	O

2019-04-15	O
09:25	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
3.8	O
*	O
RBC	B-test
-	O
2.88	O
*	O
Hgb	B-test
-	O
8.9	O
*	O
Hct	B-test
-	O
25.9	O
*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
30.9	O
MCHC	B-test
-	O
34.3	O
RDW	B-test
-	O
16.4	O
*	O
Plt	B-test
Ct	I-test
-	O
194	O

2019-04-14	O
08:50	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
6.5	O
RBC	B-test
-	O
3.02	O
*	O
Hgb	B-test
-	O
9.4	O
*	O
Hct	B-test
-	O
27.1*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
31.0	O
MCHC	B-test
-	O
34.6	O
RDW	B-test
-	O
16.3	O
*	O
Plt	B-test
Ct	I-test
-	O
169	O

2019-04-13	O
08:40	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
6.7	O
RBC	B-test
-	O
3.07	O
*	O
Hgb	B-test
-	O
9.3	O
*	O
Hct	B-test
-	O
27.1	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
30.4	O
MCHC	B-test
-	O
34.5	O
RDW	B-test
-	O
16.2	O
*	O
Plt	B-test
Ct	I-test
-	O
144	O
*	O

2019-04-12	O
08:00	O
PM	O
BLOOD	B-test
Hct	I-test
-	O
26.5	O
*	O

2019-04-12	O
06:35	O
AM	O
BLOOD	B-test
Hct	I-test
-	O
23.6	O
*	O

2019-04-11	O
12:55	O
PM	O
BLOOD	B-test
Hct	I-test
-	O
27.1	O
*	O

2019-04-11	O
09:50	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
4.8	O
RBC	B-test
-	O
3.02	O
*	O
Hgb	B-test
-	O
9.5	O
*	O
Hct	B-test
-	O
26.7	O
*	O
MCV	B-test
-	O
89	O
MCH	B-test
-	O
31.4	O
MCHC	B-test
-	O
35.5	O
*	O
RDW	B-test
-	O
15.2	O
Plt	B-test
Ct	I-test
-	O
103	O
*	O

2019-04-11	O
06:27	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
4.4	O
RBC	B-test
-	O
3.03	O
*	O
Hgb	B-test
-	O
9.5	O
*	O
Hct	B-test
-	O
26.7	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
31.2	O
MCHC	B-test
-	O
35.4	O
*	O
RDW	B-test
-	O
14.7	O
Plt	B-test
Ct	I-test
-	O
94	O
*	O

2019-04-10	O
06:30	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
4.6	O
RBC	B-test
-	O
2.81	O
*	O
Hgb	B-test
-	O
8.9	O
*	O
Hct	B-test
-	O
24.8	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
31.7	O
MCHC	B-test
-	O
36.0	O
*	O
RDW	B-test
-	O
15.2	O
Plt	B-test
Ct	I-test
-	O
95	O
*	O

2019-04-09	O
06:45	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
5.0	O
RBC	B-test
-	O
3.33	O
*	O
Hgb	B-test
-	O
10.4	O
*	O
Hct	B-test
-	O
29.2	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
31.2	O
MCHC	B-test
-	O
35.5	O
*	O
RDW	B-test
-	O
15.0	O
Plt	B-test
Ct	I-test
-	O
72	O
*	O

2019-04-08	O
12:27	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
4.9	O
RBC	B-test
-	O
3.11	O
*	O
Hgb	B-test
-	O
9.9	O
*	O
Hct	B-test
-	O
27.1	O
*	O
MCV	B-test
-	O
87	O
MCH	B-test
-	O
32.0	O
MCHC	B-test
-	O
36.6	O
*	O
RDW	B-test
-	O
15.5	O
Plt	B-test
Ct	I-test
-	O
107	O
*	O

2019-04-07	O
04:53	O
PM	O
BLOOD	B-test
WBC	I-test
-	O
4.4	O
RBC	B-test
-	O
2.92	O
*	O
Hgb	B-test
-	O
9.6	O
*#	O
Hct	B-test
-	O
25.8	O
*	O
MCV	B-test
-	O
88	O
MCH	B-test
-	O
32.8	O
*	O
MCHC	B-test
-	O
37.1	O
*	O
RDW	B-test
-	O
14.9	O
Plt	B-test
Ct	I-test
-	O
81	O
*	O

2019-04-07	O
11:00	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
4.4	O
RBC	B-test
-	O
2.34	O
*#	O
Hgb	B-test
-	O
7.5	O
*	O
Hct	B-test
-	O
21.2	O
*#	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
32.1	O
*	O
MCHC	B-test
-	O
35.4	O
*	O
RDW	B-test
-	O
14.5	O
Plt	B-test
Ct	I-test
-	O
94	O
*	O

2019-04-07	O
06:00	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
3.2	O
*#	O
RBC	B-test
-	O
3.14	O
*	O
Hgb	B-test
-	O
10.0	O
*	O
Hct	B-test
-	O
28.9	O
*	O
MCV	B-test
-	O
92	O
MCH	B-test
-	O
32.0	O
MCHC	B-test
-	O
34.8	O
RDW	B-test
-	O
14.1	O
Plt	B-test
Ct	I-test
-	O
82	O
*#	O

2019-04-06	O
10:40	O
AM	O
BLOOD	B-test
WBC	I-test
-	O
2.1	O
*	O
RBC	B-test
-	O
3.51	O
*	O
Hgb	B-test
-	O
10.9	O
*	O
Hct	B-test
-	O
31.7	O
*	O
MCV	B-test
-	O
90	O
MCH	B-test
-	O
31.1	O
MCHC	B-test
-	O
34.5	O
RDW	B-test
-	O
14.3	O
Plt	B-test
Ct	I-test
-	O
50	O
*	O

2019-04-15	O
09:25	O
AM	O
BLOOD	B-test
Plt	I-test
Ct	I-test
-	O
194	O

2019-04-14	O
08:50	O
AM	O
BLOOD	B-test
Plt	I-test
Ct	I-test
-	O
169	O

2019-04-14	O
08:50	O
AM	O
BLOOD	B-test
PT	I-test
-	O
12.0	O
INR(PT)	B-test
-	O
1.0	O

2019-04-15	O
09:25	O
AM	O
BLOOD	B-test
Glucose	I-test
-	O
134	O
*	O
UreaN	B-test
-	O
19	O
Creat	B-test
-	O
0.8	O
Na	B-test
-	O
135	O
K	B-test
-	O
3.5	O
Cl	B-test
-	O
100	O
HCO3	B-test
-	O
28	O
AnGap	B-test
-	O
11	O

Discharge	O
Medications	O
:	O

1.	O
Cholecalciferol	B-treatment
(	I-treatment
Vitamin	I-treatment
D3	I-treatment
)	I-treatment
400	O
unit	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

3.	O
Lorazepam	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
anxiety	B-problem
.	O

4.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
).	O

5.	O
Lisinopril	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

7.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

8.	O
Enoxaparin	B-treatment
30	O
mg	O
/	O
0.3	O
mL	O
Syringe	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Subcutaneous	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
4	O
weeks	O
.	O

9.	O
Oxycodone	B-treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
.	O

11.	O
Magnesium	B-treatment
Hydroxide	I-treatment
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

12.	O
Trazodone	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
)	O
as	O
needed	O
for	O
insomnia	B-problem
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Lemuel	O
Shattuck	O
Hospital	O
-	O
Malden	O

Michelle	O
Franklin	O
MD	O
31-164	O

Completed	O
by	O
:	O
Celia	O
Gloria	O
NP	O
80-CCZ	O
2019-04-15	O
@	O
1049	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Michelle	O
K.	O
Partin	O
on	O
:	O
WED	O
2019-04-17	O
1:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

693519617	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

2328487	O
PAD-WORD	O

769151	O
PAD-WORD	O

388371	O
PAD-WORD	O

12/16/1997	O
12:00:00	O
AM	O

END-STAGE	B-problem
RENAL	I-problem
DISEASE	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

LESS	O
,	O
LIESEANALE	O

UNIT	O
NUMBER	O
:	O

589-25-50	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12/16/97	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

01/16/98	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

End-stage	B-problem
renal	I-problem
disease	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Right	B-treatment
nephrectomy	I-treatment
.	O

2.	O
Cadaveric	B-treatment
renal	I-treatment
transplant	I-treatment
.	O

3.	O
Acute	B-problem
thrombosis	I-problem
.	O

4.	O
Transplant	B-treatment
nephrectomy	I-treatment
.	O

5.	O
Pulmonary	B-problem
emboli	I-problem
.	O

6.	O
Hypertension	B-problem
.	O

7.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

8.	O
Chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
.	O

9.	O
Hypercoagulable	B-problem
state	I-problem
.	O

10.	O
Perforated	B-problem
viscus	I-problem
.	O

11.	O
Abdominal	B-problem
abscesses	I-problem
.	O

12.	O
Sepsis	B-problem
.	O

13.	O
Respiratory	B-problem
failure	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
a	O
53-year-old	O
male	O
with	O
a	O
longstanding	O
history	O
of	O
renal	B-problem
disease	I-problem
with	O
multiple	B-problem
complications	I-problem
and	O
problems	B-problem
related	O
to	O
vascular	O
access	O
and	O
hypercoagulable	B-problem
state	I-problem
.	O

These	O
culminated	O
in	O
an	B-treatment
attempted	I-treatment
cadaveric	I-treatment
kidney	I-treatment
transplant	I-treatment
undertaken	O
on	O
12/16/97	O
,	O
which	O
was	O
complicated	O
by	O
thrombosis	B-problem
and	O
necrosis	B-problem
of	I-problem
the	I-problem
cadaveric	I-problem
renal	I-problem
vein	I-problem
within	O
24	O
hours	O
.	O

This	O
required	O
a	B-treatment
transplant	I-treatment
nephrectomy	I-treatment
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
&apos;s	O
course	O
was	O
subsequently	O
characterized	O
by	O
recurrent	B-problem
pneumonias	I-problem
,	O
possibly	O
due	O
to	O
aspiration	B-problem
,	O
and	O
by	O
hemodynamic	B-problem
instability	I-problem
.	O

He	O
was	O
transferred	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
from	O
the	O
Transplant	O
Service	O
for	O
ventilatory	B-treatment
management	I-treatment
in	O
the	O
setting	O
of	O
hypotension	B-problem
.	O

On	O
transfer	O
,	O
the	O
patient	O
was	O
not	O
sedated	B-treatment
,	O
but	O
was	O
unresponsive	B-problem
and	O
extremely	B-problem
dyssynchronous	I-problem
with	O
the	B-treatment
ventilator	I-treatment
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
substantial	B-problem
auto	I-problem
PEEP	I-problem
with	O
an	B-problem
elevated	I-problem
dead	I-problem
space	I-problem
.	O

A	B-test
pulmonary	I-test
arteriogram	I-test
on	O
01/03/98	O
demonstrated	O
multiple	B-problem
pulmonary	I-problem
emboli	I-problem
,	O
likely	O
less	O
than	O
one	O
week	O
old	O
,	O
possibly	O
introduced	O
at	O
the	O
time	O
of	O
the	B-problem
renal	I-problem
vein	I-problem
thrombosis	I-problem
of	O
12/19/97	O
.	O

An	B-treatment
inferior	I-treatment
vena	I-treatment
cava	I-treatment
filter	I-treatment
was	O
placed	O
;	O
lower	B-test
extremity	I-test
noninvasive	I-test
studies	I-test
were	O
negative	O
.	O

The	O
patient	O
required	O
high	B-treatment
pressures	I-treatment
to	O
ventilate	O
adequately	O
,	O
possibly	O
related	O
to	O
an	B-problem
abdominal	I-problem
compartment	I-problem
syndrome	I-problem
.	O

The	O
patient	O
had	O
undergone	O
two	B-treatment
abdominal	I-treatment
procedures	I-treatment
following	O
explantation	O
.	O

The	O
physiology	O
at	O
the	O
time	O
of	O
transfer	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
was	O
consistent	O
with	O
a	B-problem
septic	I-problem
process	I-problem
.	O

CT	B-test
scan	I-test
demonstrated	O
retroperitoneal	B-problem
collection	I-problem
containing	O
both	O
free	B-problem
air	I-problem
and	O
extravasated	B-problem
contrast	I-problem
material	I-problem
.	O

For	O
the	O
concern	O
of	O
a	B-problem
perforated	I-problem
viscus	I-problem
,	O
the	O
patient	O
was	O
taken	O
to	O
exploratory	B-test
laparotomy	I-test
on	O
01/06/98	O
,	O
during	O
which	O
the	O
bowel	O
was	O
run	O
without	O
evidence	O
of	O
perforation	B-problem
.	O

The	O
patient	O
remained	O
unstable	B-problem
.	O

He	O
was	O
taken	O
to	O
fluoroscopy	B-test
,	O
where	O
oral	B-test
contrast	I-test
was	O
demonstrated	O
to	O
be	O
extravasating	O
through	O
a	O
posterior	O
duodenum	O
.	O

For	O
this	O
reason	O
,	O
he	O
was	O
taken	O
again	O
to	O
the	O
operating	O
room	O
on	O
01/08/98	O
,	O
at	O
which	O
time	O
a	B-treatment
gastrojejunostomy	I-treatment
was	O
performed	O
with	O
stapling	B-treatment
across	I-treatment
the	I-treatment
gastroduodenal	I-treatment
junction	I-treatment
,	O
introduction	O
of	O
five	B-treatment
Jackson-Pratt	I-treatment
drains	I-treatment
into	O
the	B-problem
retroperitoneal	I-problem
mass	I-problem
,	O
cholecystotomy	B-treatment
tube	I-treatment
,	O
gastrostomy	B-treatment
tube	I-treatment
,	O
and	O
jejunostomy	B-treatment
tube	I-treatment
.	O

The	O
patient	O
had	O
an	B-problem
extensive	I-problem
estimated	I-problem
blood	I-problem
loss	I-problem
requiring	O
multiple	B-treatment
blood	I-treatment
products	I-treatment
and	O
fluid	B-treatment
resuscitation	I-treatment
therapy	I-treatment
.	O

Accompanying	O
this	O
during	O
this	O
period	O
were	O
elevations	B-problem
in	O
liver	B-test
function	I-test
studies	I-test
and	O
amylase	B-test
and	O
lipase	B-test
consistent	O
with	O
pancreatic	B-problem
inflammation	I-problem
.	O

The	O
patient	O
was	O
aggressively	O
treated	O
with	O
fluid	B-treatment
resuscitation	I-treatment
and	O
pressors	B-treatment
for	O
his	B-problem
septic	I-problem
physiology	I-problem
.	O

There	O
was	O
no	O
evidence	O
of	O
cardiac	B-problem
tamponade	I-problem
or	O
specific	B-problem
underlying	I-problem
coronary	I-problem
dysfunction	I-problem
.	O

He	O
was	O
treated	O
with	O
appropriate	B-treatment
antibiotics	I-treatment
for	O
his	B-problem
Serratia	I-problem
pneumonia	I-problem
,	O
as	O
well	O
as	O
for	O
his	B-problem
abdominal	I-problem
process	I-problem
.	O

The	O
patient	O
was	O
felt	O
to	O
have	O
an	B-problem
underlying	I-problem
hypercoagulable	I-problem
state	I-problem
,	O
thought	O
to	O
be	O
the	O
source	O
for	O
the	B-problem
repeated	I-problem
clots	I-problem
.	O

Because	O
of	O
the	B-problem
bleeding	I-problem
problems	I-problem
,	O
however	O
,	O
it	O
was	O
felt	O
that	O
full	B-treatment
heparinization	I-treatment
would	O
not	O
be	O
prudent	O
,	O
and	O
the	O
patient	O
was	O
treated	O
with	O
pneumo-boots	B-treatment
and	O
subcutaneous	B-treatment
heparin	I-treatment
.	O

Attention	O
was	O
paid	O
to	O
a	O
variety	O
of	O
metabolic	B-problem
and	I-problem
electrolyte	I-problem
abnormalities	I-problem
,	O
which	O
were	O
corrected	O
appropriately	O
.	O

Nonetheless	O
,	O
Mr.	O
Less	O
continued	O
to	O
remain	O
critically	B-problem
ill	I-problem
with	O
only	O
very	O
transient	O
mild	O
improvement	O
with	O
drainage	B-treatment
of	O
additional	B-problem
retroperitoneal	I-problem
fluid	I-problem
.	O

He	O
remained	O
pressor	B-problem
dependent	I-problem
,	O
as	O
well	O
as	O
dependent	B-problem
upon	O
mechanical	B-treatment
ventilatory	I-treatment
assistance	I-treatment
.	O

His	O
course	O
was	O
complicated	O
by	O
atrial	B-problem
fibrillation	I-problem
requiring	O
cardioversion	B-treatment
.	O

He	O
had	O
an	B-problem
ongoing	I-problem
requirement	I-problem
for	O
high	B-treatment
volume	I-treatment
resuscitation	I-treatment
and	O
was	O
persistently	B-problem
acidotic	I-problem
despite	O
CV-VVH	B-treatment
in	O
the	O
face	O
of	O
bicarbonate	B-treatment
replenishment	I-treatment
.	O

The	O
patient	O
also	O
appeared	O
to	O
have	O
stool	O
from	O
his	B-problem
Jackson-Pratt	I-problem
site	I-problem
and	O
right	B-problem
oblique	I-problem
incision	I-problem
.	O

Bloody	B-problem
drainage	I-problem
from	O
his	B-problem
increasingly	I-problem
distended	I-problem
abdomen	I-problem
was	O
noted	O
.	O

Extensive	O
discussions	O
were	O
carried	O
out	O
with	O
Mrs.	O
Less	O
condition	O
was	O
irretrievable	O
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
had	O
continued	O
massive	B-problem
retroperitoneal	I-problem
contamination	I-problem
and	O
probable	O
multiple	B-problem
enteric	I-problem
fistulae	I-problem
from	O
an	B-problem
ischemic	I-problem
bowel	I-problem
.	O

Dr.	O
Cantsleddjesc	O
felt	O
that	O
no	O
surgical	B-treatment
approach	I-treatment
to	O
this	B-problem
problem	I-problem
or	O
further	B-treatment
intervention	I-treatment
or	O
radiologic	B-treatment
procedures	I-treatment
would	O
be	O
helpful	O
.	O

All	O
physicians	O
and	O
the	O
family	O
were	O
in	O
agreement	O
that	O
the	O
most	O
appropriate	O
approach	O
was	O
to	O
institute	O
comfort	B-treatment
measures	I-treatment
.	O

This	O
was	O
done	O
,	O
and	O
the	O
patient	O
appeared	O
to	O
be	O
comfortable	O
at	O
the	O
time	O
of	O
death	O
with	O
his	O
family	O
at	O
his	O
side	O
on	O
1/16/98	O
.	O

I	O
L.	O
STERPSKOLK	O
,	O
M.D.	O

TR	O
:	O

vcp	O
PAD-WORD	O

DD	O
:	O

05/25/98	O
PAD-WORD	O

TD	O
:	O

05/30/98	O
8:30	O
A	O

cc	O
:	O

LE	O
FREIERM	O
,	O
JR	O
,	O
M.D.	O
KIVERL	O
NA	O
CANTSLEDDJESC	O
,	O
M.D.	O
I	O
LYNIN	O
STERPSKOLK	O
,	O
M.D.	O
ETI	O
CHAELKA	O
MULKEVI	O
,	O
M.D.	O

cc	O
:	O

Dr.	O
Less	O

Admission	O
Date	O
:	O

2013-03-27	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-04-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1954-08-12	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O
NEUROSURGERY	O

Allergies	O
:	O

Shellfish	O
PAD-WORD	O

Attending	O
:	O
Sam	O
K.	O
Laudato	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

s/p	O
MVC	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

none	O
PAD-WORD	O

History	O
of	O
Present	O
Illness	O
:	O

58	O
yo	O
female	O
s/p	O
high	O
speed	O
MVC	O
.	O

She	O
lost	O
contaol	O
of	O
her	O
car	O
,	O
she	O
hit	O
the	O
Barnes	O
rails	O
then	O
the	O
car	O
stopped	O
.	O

Another	O
car	O
was	O
coming	O
behind	O
her	O
did	O
not	O
see	O
her	O
car	O
,	O
hit	O
again	O
,	O
the	O
person	O
checked	O
the	O
car	O
,	O
she	O
was	O
not	O
inside	O
.	O

+LOC	B-problem
,	O
GCS:14	B-test
.	O

She	O
ejected	O
.	O

She	O
brought	O
by	O
EMS	O
to	O
Nantucket	O
Cottage	O
Hospital	O
for	O
furher	B-test
evaluation	I-test
.	O

Past	O
Medical	O
History	O
:	O

1.	O
EtOH	O
addiction	O
in	O
past	O

2.	O
h/o	O
depression	B-problem

3.	O
?	O
h/o	O
hypomania	B-problem

4.	O
L5-S1	B-problem
spondylolisthesis	I-problem

all	O
:	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem

Social	O
History	O
:	O

divorced	O
twice	O
.	O

smokes	O
1ppd	O
for	O
many	O
years	O
,	O
no	O
EtOH	O
or	O
illicit	O
drug	O
use	O
.	O

Family	O
History	O
:	O

brother	O
who	O
was	O
alcoholic	O

Physical	O
Exam	O
:	O

O	O
:	O
T	B-test
:	O
100.1	O
BP	B-test
:	O
162/84	O
HR	B-test
:	O
80	O
RR	B-test
:	O
20	O
O2Sats	B-test
:	O
100	O

Gen	O
:	O
lying	O
in	O
strecther	O
,	O
NAD	B-problem
,	O
shaking	B-problem
om	I-problem
bilateral	I-problem
lower	I-problem
extremities	I-problem
.	O

HEENT	O
:	O
Neck	O
Supple	O
,	O
right	O
CMED	O
CCU	O
ecchymotic	B-problem
and	O
edematous	B-problem
,	O
c-collor	B-treatment
in	O
place	O
.	O

Lungs	O
:	O
CTA	O
bilaterally	O
.	O

Cardiac	O
:	O
RRR	O
.	O

S1/S2	O
.	O

Abd	O
:	O
Soft	O
,	O
NT	B-problem
,	O
BS+	O

Extrem	O
:	O
Cool	O
,	O
No	O
C/C/E	B-problem
.	O

Neuro	O
:	O

Mental	O
status	O
:	O
Awake	O
and	O
alert	O
,	O
cooperative	O
with	O
exam	B-test
,	O
normal	O
affect	O
.	O

Orientation	O
:	O
Oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
date	O
.	O

Language	O
:	O
Speech	O
fluent	O
with	O
good	O
comprehension	O
and	O
repetition	O
.	O

Naming	O
intact	O
.	O

No	O
dysarthria	B-problem
or	O
paraphasic	B-problem
errors	I-problem
.	O

Cranial	O
Nerves	O
:	O

I:	O
Not	O
tested	O

II:	O
Pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
,	O
3to	O
2	O
mm	O
bilaterally	O
.	O

Visual	O
fields	O
are	O
full	O
to	O
confrontation	B-test
.	O

III	O
,	O
IV	O
,	O
VI:	O
Extraocular	O
movements	O
intact	O
bilaterally	O
without	O
nystagmus	B-problem
.	O

V	O
,	O
VII:	O
Facial	O
strength	O
and	O
sensation	O
intact	O
and	O
symmetric	O
.	O

VIII:	O
Hearing	O
intact	O
to	O
finger	B-test
rub	I-test
bilaterally	O
.	O

IX	O
,	O
X:	O
Palatal	O
elevation	O
symmetrical	O
.	O

XI:	O
Sternocleidomastoid	O
and	O
trapezius	O
normal	O
bilaterally	O
.	O

XII:	O
Tongue	O
midline	O
without	O
fasciculations	B-problem
.	O

Motor	O
:	O
Normal	O
bulk	O
and	O
tone	O
bilaterally	O
.	O

No	O
abnormal	B-problem
movements	I-problem
,	O
tremors	B-problem
.	O

Strength	B-test
full	O
power	O
05-31	O
execept	O
Right	O
Dubord	O
03-31	O
.	O

No	O
pronator	B-problem
drift	I-problem

Sensation	B-test
:	O
Intact	O
to	O
light	B-test
touch	I-test
,	O
propioception	B-test
,	O
pinprick	B-test
execept	O
decreased	B-problem
sensation	I-problem
L5-S1	I-problem
distrubution	I-problem
.	O

Reflexes	B-test
:	O

Right	O
:	O
B	B-test
-	O
2	O
;	O
T	B-test
-	O
2	O
;	O
Br	B-test
-	O
2	O
;	O
Pa	B-test
-	O
2	O
;	O
Ac	B-test
-	O
2	O

Left	O
:	O
B	B-test
-	O
2	O
;	O
T	B-test
-	O
2	O
;	O
Br	B-test
-	O
2	O
;	O
Pa	B-test
-	O
2	O
;	O
Ac	B-test
-	O
2	O

Toes	O
downgoing	O
bilaterally	O

Coordination	O
:	O
normal	O
finger-nose-finger	B-test

Pertinent	O
Results	O
:	O

2013-03-27	O
12:59	O
AM	O
URINE	B-test
COLOR	I-test
-	O
Yellow	O
APPEAR	B-test
-	O
Clear	O
SP	B-test
Stickney	I-test
-	O
1.032	O

2013-03-27	O
12:59	O
AM	O
URINE	B-test
BLOOD	I-test
-	O
NEG	O
NITRITE	B-test
-	O
NEG	O
PROTEIN	B-test
-	O
TR	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
50	O
BILIRUBIN	B-test
-	O
NEG	O
UROBILNGN	B-test
-	O
1	O
PH	B-test
-	O
7.0	O
LEUK	B-test
-	O
NEG	O

2013-03-27	O
12:59	O
AM	O
URINE	B-test
RBC-	I-test
0-2	O
WBC	B-test
-	O
0	O
BACTERIA	B-test
-	O
NONE	O
YEAST	B-test
-	O
NONE	O
EPI	B-test
-	O
0-2	O

2013-03-27	O
12:59	O
AM	O
WBC	B-test
-	O
5.0	O
RBC	B-test
-	O
4.23	O
HGB	B-test
-	O
13.4	O
HCT	B-test
-	O
38.5	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
31.8	O
MCHC	B-test
-	O
34.9	O
RDW	B-test
-	O
12.7	O

2013-03-27	O
12:59	O
AM	O
PLT	B-test
COUNT	I-test
-	O
213	O

2013-03-27	O
12:59	O
AM	O
URINE	B-test
bnzodzpn	I-test
-	O
NEG	O
barbitrt	B-test
-	O
NEG	O
opiates	B-test
-	O
NEG	O
cocaine	B-test
-	O
NEG	O
amphetmn	B-test
-	O
POS	O
mthdone	B-test
-	O
NEG	O

2013-03-27	O
01:09	O
AM	O
HGB	B-test
-	O
13.4	O
calcHCT	B-test
-	O
40	O
O2	B-test
SAT	I-test
-	O
95	O
CARBOXYHB	B-test
-	O
1.2	O
MET	B-test
HGB	I-test
-	O
0.2	O

2013-03-27	O
12:59	O
AM	O
UREA	B-test
N	I-test
-	O
21	O
*	O
CREAT	B-test
-	O
0.8	O

2013-03-27	O
02:25	O
AM	O
PT	B-test
-	O
13.2	O
*	O
PTT	B-test
-	O
22.9	O
INR(PT)	B-test
-	O
1.2	O
*	O

Brief	O
Hospital	O
Course	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Nantucket	O
Cottage	O
Hospital	O
on	O
2013-03-27	O
following	O
a	O
motor	O
vehicle	O
crash	O
as	O
described	O
previously	O
.	O

Chest	B-test
and	I-test
pelvis	I-test
X-rays	I-test
were	O
negative	O
for	O
fractures	B-problem
.	O

A	B-test
CT	I-test
of	I-test
her	I-test
head	I-test
demonstrated	O
intraparenchymal	B-problem
and	I-problem
extraaxial	I-problem
blood	I-problem
(	I-problem
mostly	I-problem
subarachnoid	I-problem
)	I-problem
in	I-problem
bilateral	I-problem
cerebral	I-problem
hemispheres	I-problem
,	O
right	O
greater	O
than	O
left	O
,	O
in	O
a	O
pattern	O
indicating	O
contrecoup	B-problem
injury	I-problem
.	O

A	B-test
CT	I-test
of	I-test
her	I-test
C-spine	I-test
revealed	O
a	O
possible	O
fracture	B-problem
of	I-problem
right	I-problem
C7	I-problem
pedicle	I-problem
.	O

A	B-test
CT	I-test
of	I-test
her	I-test
chest	I-test
revealed	O
bliateral	B-problem
lung	I-problem
nodules	I-problem
and	O
a	B-problem
right	I-problem
thyroid	I-problem
nodule	I-problem
.	O

A	B-test
CT	I-test
of	I-test
her	I-test
sinues	I-test
revealed	O
no	O
fractures	B-problem
.	O

X-rays	B-test
of	I-test
her	I-test
right	I-test
lower	I-test
extremity	I-test
were	O
negative	O
for	O
any	B-problem
acute	I-problem
injury	I-problem
.	O

A	O
neurosurgery	O
consult	O
was	O
obtained	O
.	O

Our	O
recommendations	O
were	O
to	O
load	O
her	O
with	O
Dilantin	B-treatment
and	O
then	O
continue	O
at	O
100	O
mg	O
PO	O
TID	O
.	O

The	O
orthopedics	O
spine	O
service	O
saw	O
her	O
and	O
put	O
her	O
in	O
a	B-treatment
C-collar	I-treatment
.	O

She	O
was	O
admitted	O
to	O
the	O
trauma	O
ICU	O
.	O

A	B-test
repeat	I-test
head	I-test
CT	I-test
12	O
hours	O
after	O
the	O
first	O
was	O
largely	O
unchanged	O
.	O

She	O
was	O
transferred	O
to	O
step	O
down	O
.	O

She	O
was	O
having	O
some	B-problem
pain	I-problem
issues	I-problem
and	O
morphine	B-treatment
was	O
making	O
her	O
"	O
jittery	B-problem
."	O

On	O
HD	O
2	O
she	O
was	O
switched	O
to	O
Fioricet	B-treatment
,	O
which	O
helped	O
with	O
her	B-problem
headaches	I-problem
.	O

A	B-test
repeact	I-test
head	I-test
CT	I-test
was	O
unchanged	O
.	O

An	B-test
MRI	I-test
of	I-test
her	I-test
C-spine	I-test
was	O
done	O
to	O
evaluate	O
for	O
ligamentous	B-problem
injury	I-problem
,	O
but	O
this	O
was	O
extremely	B-test
limited	I-test
examination	I-test
due	O
to	O
patient	O
motion	O
and	O
the	O
signal	O
in	O
the	O
spinal	O
cord	O
could	O
not	O
be	O
adequately	O
assessed	O
for	O
edema	B-problem
.	O

As	O
per	O
CMED	O
CSRU	O
spine	O
,	O
the	O
patient	O
was	O
instructed	O
to	O
follow-up	O
in	O
2	O
weeks	O
for	O
repeat	B-test
X-rays	I-test
.	O

On	O
discharge	O
she	O
was	O
awake	O
,	O
alert	O
and	O
orientated	O
X3	O
with	O
c/o	O
mild	B-problem
headache	I-problem
.	O

She	O
had	O
full	B-test
strength	I-test
motor	I-test
exam	I-test
,	O
no	O
pronator	B-problem
drift	I-problem
and	O
PERRLA	O
with	O
full	O
EOM	O
s.	O

She	O
was	O
ambulating	O
without	O
difficulties	B-problem
.	O

On	O
04-01	O
she	O
was	O
seen	O
by	O
physical	B-treatment
therapy	I-treatment
was	O
thought	O
to	O
benefit	O
from	O
acute	B-treatment
rehabilitation	I-treatment
.	O

She	O
had	O
a	B-test
head	I-test
CT	I-test
prior	O
to	O
discharge	O
that	O
showed	O
resolution	O
of	O
the	B-problem
subarachnoid	I-problem
hemorrhage	I-problem
.	O

Follow-up	O
in	O
1	O
month	O
with	O
neurosurgery	O
for	O
a	B-test
repeat	I-test
head	I-test
CT	I-test
was	O
arranged	O
.	O

She	O
was	O
discharged	O
on	O
fioricet	B-treatment
and	O
dilantin	B-treatment
.	O

She	O
was	O
counseled	O
to	O
follow-up	O
with	O
her	O
PCP	O
F	O
6-12	O
months	O
regading	O
the	B-problem
right	I-problem
thyroid	I-problem
nodule	I-problem
and	O
the	B-problem
bilateral	I-problem
small	I-problem
lung	I-problem
nodules	I-problem
seen	O
on	O
her	B-test
chest	I-test
CT	I-test
.	O

Medications	O
on	O
Admission	O
:	O

1.	O
celexa	B-treatment

2.	O
premarin	B-treatment

3.	O
trazodone	B-treatment

4.	O
6-MP	B-treatment

5.	O
Prednisone	B-treatment

Discharge	O
Medications	O
:	O

1.	O
Phenytoin	B-treatment
Sodium	I-treatment
Extended	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
1	O
months	O
.	O

Disp	O
:*	O
90	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Acetaminophen	B-treatment
-	O
Caff	B-treatment
-	O
Butalbital	B-treatment
504-61-78	O
mg	O
Capsule	O
Sig	O
:	O
01-28	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
1	O
months	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Citalopram	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

4.	O
Metoprolol	B-treatment
Tartrate	I-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

5.	O
Hydromorphone	B-treatment
2	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Docusate	B-treatment
Sodium	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
Use	O
while	O
taking	O
narcotics	B-treatment
.	O

7.	O
Phenytoin	B-treatment
Sodium	I-treatment
Extended	I-treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
90	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

St.	O
Anne's	O
Hospital	O
-	O
Burlington	O

Discharge	O
Diagnosis	O
:	O

Head	B-problem
trauma	I-problem
with	O
subarachnoid	B-problem
hemorrhage	I-problem

C7	B-problem
fracture	I-problem

Discharge	O
Condition	O
:	O

neurologically	O
stable	O

Discharge	O
Instructions	O
:	O

Call	O
for	O
severe	B-problem
headache	I-problem
or	O
any	B-problem
other	I-problem
problems	I-problem
.	O

Please	O
take	O
Fioricet	B-treatment
as	O
directed	O
for	O
headaches	B-problem
.	O

Please	O
do	O
not	O
drive	O
while	O
on	O
this	B-treatment
medication	I-treatment
.	O

Please	O
continue	O
to	O
wear	O
your	B-treatment
C-collar	I-treatment
at	O
all	O
times	O
.	O

Please	O
continue	O
Dilantin	B-treatment
as	O
directed	O
for	O
seizure	B-treatment
prophylaxis	I-treatment
.	O

Followup	O
Instructions	O
:	O

Follow	O
up	O
with	O
Dr.	O
Kelley	O
in	O
4	O
weeks	O
with	O
head	B-test
CT	I-test
-	O
call	O
716	O
3268	O

Please	O
also	O
follow-up	O
with	O
Dr.	O
Obrecht	O
of	O
CMED	O
CCU	O
spine	O
in	O
2	O
weeks	O
for	O
flexion	B-test
/	I-test
extension	I-test
X-rays	I-test
((	O
228	O
)	O
411-7660	O
)	O

Please	O
follow-up	O
with	O
your	O
PCP	O
N	O
6-12	O
months	O
reguading	O
the	B-problem
right	I-problem
thyroid	I-problem
nodule	I-problem
and	O
the	B-problem
bilateral	I-problem
small	I-problem
lung	I-problem
nodules	I-problem
seen	O
on	O
your	B-test
chest	I-test
CT	I-test
.	O

Vernia	O
Diana	O
MD	O
76-016	O

Completed	O
by	O
:	O
Sonya	O
Ramona	O
NP	O
80-AKY	O
2013-04-01	O
@	O
1453	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Shirley	O
Bennett	O
on	O
:	O
Sandra	O
2013-05-02	O
4:53	O
PM	O

(	O
End	O
of	O
Report	O
)	O

694467643	O
PAD-WORD	O

FIH	O
PAD-WORD	O

7327698	O
PAD-WORD	O

47130/04v4	O
PAD-WORD	O

120605	O
PAD-WORD	O

06/29/1992	O
12:00:00	O
AM	O

HEPATOCELLULAR	B-problem
CARCINOMA	I-problem
,	O
AND	O
HEPATITIS	B-problem
C	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

06/29/92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

07/27/92	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Hepatocellular	B-problem
carcinoma	I-problem
,	O
and	O
hepatitis	B-problem
C	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Liver	B-treatment
transplant	I-treatment
.	O

Native	B-treatment
hepatectomy	I-treatment
.	O

Re-exploration	B-test
for	O
bleeding	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Villesatelkscurb	O
is	O
a	O
fifty	O
year	O
old	O
black	O
gentleman	O
with	O
a	O
long	O
history	O
of	O
hepatitis	B-problem
C	I-problem
,	O
believed	O
to	O
be	O
contracted	O
during	O
transfusions	B-treatment
in	O
a	B-problem
previous	I-problem
trauma	I-problem
.	O

The	O
patient	O
had	O
recently	O
prior	O
to	O
this	O
admission	O
,	O
had	O
a	B-problem
rise	I-problem
in	I-problem
his	I-problem
alpha	I-problem
feta	I-problem
protein	I-problem
and	O
a	B-test
biopsy	I-test
of	I-test
his	I-test
liver	I-test
had	O
shown	O
hepatocellular	B-problem
carcinoma	I-problem
.	O

The	O
patient	O
was	O
admitted	O
for	O
liver	B-test
transplant	I-test
workup	I-test
and	O
to	O
await	O
liver	B-treatment
transplant	I-treatment
.	O

PAST	O
MEDICAL	O
and	O

SURGICAL	O
HISTORY	O
:	O

Significant	O
for	O
motor	O
vehicle	O
accident	O
in	O
1966	O
,	O
requiring	O
exploratory	B-test
laparotomy	I-test
and	O
splenectomy	B-treatment
,	O
tonsillectomy	B-treatment
as	O
a	O
child	O
,	O
pneumonia	B-problem
in	O
the	O
past	O
,	O
hepatitis	B-problem
C	I-problem
and	O
recent	O
diagnosis	O
of	O
hepatocellular	B-problem
carcinoma	I-problem
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

On	O
admission	O
medications	B-treatment
included	O
Lasix	B-treatment
and	O
iron	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Significant	O
for	O
normal	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
throat	O
exam	O
with	O
no	O
scleral	B-problem
icterus	I-problem
.	O

Heart	O
regular	O
rate	O
and	O
rhythm	O
,	O
his	O
lungs	O
were	O
clear	O
.	O

He	O
had	O
no	O
appreciable	B-problem
ascites	I-problem
.	O

He	O
did	O
have	O
clubbing	B-problem
and	O
palmar	B-problem
erythema	I-problem
with	O
bilateral	B-problem
ankle	I-problem
edema	I-problem
.	O

He	O
was	O
Neurologically	O
intact	O
.	O

LABORATORY	O
DATA	O
:	O

bilirubin	B-test
to	O
be	O
.6	O
.	O

SGOT	B-test
of	O
80	O
.	O

HOSPITAL	O
COURSE	O
:	O

Preoperatively	O
,	O
the	O
patient	O
underwent	O
chemo-embolization	B-treatment
for	O
his	B-problem
hepatocellular	I-problem
carcinoma	I-problem
.	O

The	O
remainder	O
of	O
his	O
preoperative	O
course	O
was	O
benign	O
.	O

On	O
July	O
15	O
,	O
1992	O
,	O
a	O
liver	O
became	O
available	O
,	O
and	O
the	O
patient	O
underwent	O
hepatectomy	B-treatment
and	O
orthotopic	B-treatment
liver	I-treatment
transplant	I-treatment
.	O

His	B-treatment
operation	I-treatment
was	O
complicated	O
by	O
severe	B-problem
coagulopathy	I-problem
requiring	O
fifty-nine	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
64	O
units	O
of	O
FFP	B-treatment
and	O
34	O
units	O
of	O
platelets	B-treatment
.	O

Postoperatively	O
,	O
the	O
patient	O
continued	O
to	O
have	O
a	B-problem
coagulopathy	I-problem
requiring	O
re-exploration	B-test
on	O
postoperatively	O
day	O
2	O
,	O
with	O
findings	O
only	O
of	O
hematoma	B-problem
and	O
no	O
active	B-problem
bleeding	I-problem
.	O

Initially	O
,	O
the	O
patient	O
did	O
well	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
mentally	O
alert	O
,	O
and	O
oriented	O
,	O
however	O
,	O
he	O
continued	O
to	O
be	O
coagulopathic	B-problem
and	O
was	O
requiring	O
large	B-treatment
amounts	I-treatment
of	I-treatment
blood	I-treatment
and	O
FFP	B-treatment
transfusions	I-treatment
,	O
with	O
a	B-problem
resultant	I-problem
pulmonary	I-problem
edema	I-problem
.	O

He	O
developed	O
renal	B-problem
failure	I-problem
felt	O
to	O
be	O
ATN	B-problem
secondary	O
to	O
ischemia	B-problem
of	I-problem
his	I-problem
kidneys	I-problem
.	O

The	O
patient	O
remained	O
intubated	B-treatment
in	O
the	O
Intensive	O
Care	O
Unit	O
for	O
twelve	O
days	O
prior	O
to	O
his	O
death	O
.	O

He	O
had	O
daily	B-treatment
transfusions	I-treatment
of	O
FFP	B-treatment
and	O
blood	B-treatment
,	O
and	O
continued	O
coagulopathy	B-problem
.	O

He	O
also	O
developed	O
thrombocytopenia	B-problem
,	O
requiring	O
persistent	B-treatment
platelet	I-treatment
transfusions	I-treatment
on	O
a	O
daily	O
basis	O
.	O

His	B-treatment
immunosuppression	I-treatment
was	O
OKT3	B-treatment
and	O
Solu	B-treatment
Medrol	I-treatment
,	O
and	O
he	O
underwent	O
hemodialysis	B-treatment
and	O
ultra	B-treatment
filtration	I-treatment
to	O
remove	O
fluid	O
.	O

While	O
in	O
the	O
ICU	O
he	O
developed	O
seizures	B-problem
,	O
requiring	O
large	B-treatment
amounts	I-treatment
of	I-treatment
intravenous	I-treatment
Valium	I-treatment
to	O
break	O
his	B-problem
seizures	I-problem
,	O
and	O
he	O
was	O
maintained	O
on	O
Tegretol	B-treatment
and	O
Dilantin	B-treatment
.	O

However	O
,	O
he	O
became	O
progressively	O
more	O
mentally	B-problem
obtunded	I-problem
.	O

During	O
the	B-problem
seizure	I-problem
,	O
he	O
bit	O
his	O
tongue	O
,	O
resulting	O
in	O
a	B-problem
large	I-problem
bleed	I-problem
from	I-problem
his	I-problem
tongue	I-problem
,	O
which	O
was	O
sutured	B-treatment
by	O
the	O
ENT	O
Service	O
,	O
however	O
,	O
his	B-problem
continued	I-problem
coagulopathy	I-problem
resulted	O
in	O
bleeding	B-problem
from	I-problem
his	I-problem
nasopharynx	I-problem
,	O
which	O
could	O
never	O
be	O
identified	O
,	O
and	O
also	O
upper	B-problem
gastrointestinal	I-problem
bleeding	I-problem
.	O

Endoscopy	B-test
never	O
revealed	O
specific	O
sources	O
of	O
bleeding	B-problem
,	O
although	O
he	O
appeared	O
to	O
have	O
a	B-problem
diffuse	I-problem
duodenitis	I-problem
.	O

He	O
was	O
started	O
on	O
Pitressin	B-treatment
to	O
try	O
to	O
control	O
the	B-problem
gastrointestinal	I-problem
bleeding	I-problem
,	O
but	O
he	O
continued	O
to	O
have	O
severe	B-problem
bleeding	I-problem
,	O
and	O
became	O
progressively	B-problem
hypotensive	I-problem
,	O
with	O
eventual	B-problem
bradycardia	I-problem
and	O
cardiac	B-problem
arrest	I-problem
.	O

He	O
was	O
pronounced	O
dead	O
at	O
3:49	O
PM	O
on	O
July	O
15	O
,	O
1992	O
.	O

STA	O
TITCHEGRIESESC	O
,	O
M.D.	O
DICTATING	O
FOR	O
;	O
KIVERL	O
NA	O
CANTSLEDDJESC	O
,	O
M.D.	O

TR	O
:	O

wj	O
/	O
bmot	O

DD	O
:	O

07/28/92	O
PAD-WORD	O

TD	O
:	O

07/28/92	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2015-08-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-08-15	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1954-12-08	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CT	O
CMED	O
CSRU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Bruno	O
is	O
a	O
60	O
year	O
old	O
gentleman	O
who	O
initially	O
presented	O
with	O
hematemesis	B-problem
,	O
hemoptysis	B-problem
and	O
on	O
work-up	B-test
was	O
found	O
to	O
have	O
a	B-problem
left	I-problem
lower	I-problem
lobe	I-problem
mass	I-problem
.	O

He	O
previously	O
underwent	O
bronchoscopy	B-test
with	I-test
washings	I-test
which	O
showed	O
to	O
be	O
negative	O
for	O
malignant	B-problem
cells	I-problem
and	O
showed	O
atypical	B-problem
bronchial	I-problem
epithelial	I-problem
cells	I-problem
,	O
likely	O
to	O
be	O
reactive	B-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Rectal	B-problem
fissure	I-problem
.	O

2.	O
Lumpectomy	B-treatment
of	O
the	B-problem
left	I-problem
breast	I-problem
nodule	I-problem
.	O

3.	O
Knee	B-treatment
surgery	I-treatment
.	O

4.	O
Hand	B-treatment
surgery	I-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
:	O

The	O
patient	O
had	O
no	O
home	B-treatment
medications	I-treatment
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	B-test
review	I-test
of	I-test
systems	I-test
was	O
essentially	O
negative	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
showed	O
a	O
gentleman	O
in	O
no	O
acute	B-problem
distress	I-problem
;	O
afebrile	B-problem
.	O

Chest	O
was	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
has	O
a	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdomen	O
is	O
benign	O
,	O
no	O
mass	B-problem
.	O

Extremities	O
were	O
well	O
perfused	O
and	O
warm	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
the	O
day	O
of	O
admission	O
.	O

He	O
underwent	O
a	B-treatment
left	I-treatment
bronchoscopy	I-treatment
and	O
lower	B-treatment
lobectomy	I-treatment
of	I-treatment
the	I-treatment
left	I-treatment
side	I-treatment
.	O

The	B-treatment
operation	I-treatment
was	O
subsequently	O
complicated	O
by	O
a	B-problem
postoperative	I-problem
bleeding	I-problem
.	O

The	O
patient	O
had	O
to	O
be	O
taken	O
back	O
to	O
the	O
Operating	O
Room	O
where	O
a	B-treatment
repair	I-treatment
of	I-treatment
the	I-treatment
left	I-treatment
pulmonary	I-treatment
artery	I-treatment
was	O
performed	O
.	O

The	O
patient	O
was	O
then	O
transferred	O
to	O
the	O
CSRU	O
,	O
intubated	O
,	O
in	O
stable	O
condition	O
.	O

Vascular	O
Surgery	O
Service	O
was	O
also	O
consulted	O
.	O

During	O
the	B-treatment
operation	I-treatment
,	O
the	O
patient	O
received	O
13	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
four	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
and	O
one	O
unit	O
of	O
platelets	B-treatment
with	O
an	B-problem
estimated	I-problem
blood	I-problem
loss	I-problem
of	O
1500	O
cc	O
.	O

The	O
patient	O
remained	O
to	O
be	O
stable	O
on	O
the	O
floor	O
with	O
subsequent	O
monitoring	O
of	O
hematocrit	B-test
within	O
a	O
normal	O
stable	O
range	O
.	O

He	O
is	O
successfully	O
extubated	O
on	O
08-12	O
and	O
hypertension	B-problem
transferred	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
where	O
the	O
Pain	O
Service	O
is	O
managing	O
his	B-treatment
epidural	I-treatment
with	O
very	O
good	O
effect	O
and	O
he	O
is	O
tolerating	O
a	O
regular	O
p.o.	O
diet	O
and	O
is	O
making	O
adequate	O
amount	O
of	O
urine	O
.	O

His	O
recovery	O
was	O
essentially	O
unremarkable	O
.	O

His	B-treatment
epidural	I-treatment
was	O
successfully	O
discontinued	O
and	O
he	O
is	O
discharged	O
to	O
home	O
on	O
08-15	O
with	O
instructions	O
to	O
follow-up	O
with	O
Dr.	O
Cordova	O
in	O
the	O
office	O
within	O
the	O
next	O
one	O
to	O
two	O
weeks	O
.	O

He	O
is	O
discharged	O
to	O
home	O
with	O
pain	B-treatment
medication	I-treatment
which	O
is	O
percocet	B-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
without	O
service	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Left	B-problem
lung	I-problem
mass	I-problem
status	O
post	O
resection	B-treatment
.	O

Harriet	O
D.	O
Buffington	O
,	O
M.D.	O
51-721	O

Dictated	O
By	O
:	O
Steven	O
L.	O
Ibarra	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-08-17	O
10:50	O

T	O
:	O
2015-08-21	O
16:28	O

JOB	O
#:	O
00413	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Natasha	O
Toth	O
on	O
:	O
TUE	O
2015-10-06	O
5:11	O
PM	O

(	O
End	O
of	O
Report	O
)	O

704319103	O
PUMC	O

6340505	O
PAD-WORD	O

274938	O
PAD-WORD	O

7752547	O
PAD-WORD	O

10/14/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

A	O
,	O
MIFER	O

MRN	O
:	O

6340505	O
PAD-WORD	O

Age	O
:	O

41y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

10/14/2004	O
03:51	O
PM	O

Provider	O
:	O

KOTEJESCZUK	O
,	O
M.D.	O
STOCKADALELEEFNATHE	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O
PAD-WORD	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/14/2004	O
21:17	O

Discharge	O
Status	O
:	O

Discharged	O
PAD-WORD	O

Condition	O
on	O
Discharge	O
:	O

Stable	O
PAD-WORD	O

Patient	O
States	O
Complaint	O
:	O

CP	B-problem
Standardized	I-problem

Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
chest	B-problem
pain	I-problem
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

lt	B-problem
arm/	I-problem
chest	I-problem
pain	I-problem

Treatment	O
Rendered	O
:	O

ekg	B-test
=	O
normal	O
,	O
cxr	B-test
normal	O
,	O
ddimer	B-test
/	O
cardiac	B-test
enzymes	I-test
negative	O

Discharge	O
Medications	O
:	O

ibuprofen	B-treatment
as	O
needed	O

Follow	O
up	O
Service	O
:	O

call	O
dr	O
koorskote	O
&apos;s	O
office	O
tomorrow	O

PCP	O
Name	O
:	O

KOORSKOTE	O
,	O
SHARA	O
G	O

Provider	O
Number	O
:	O

00708	O
PAD-WORD	O

This	O
report	O
was	O
created	O
by	O
STOCKADALELEEFNATHE	O
,	O
LISHE	O
,	O
M.D.	O
10/14/2004	O
09:35	O
PM	O

Admission	O
Date	O
:	O

2016-02-15	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-02-21	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2016-02-15	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEONATOLOGY	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
infant	O
is	O
a	O
32	O
and	O
03-05	O
week	O
male	O
,	O
twin	O
A	O
,	O
who	O
was	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
for	O
management	B-treatment
of	O
prematurity	B-problem
.	O

The	O
infant	O
was	O
born	O
to	O
a	O
38	O
year	O
old	O
,	O
gravida	O
V	O
,	O
para	O
III	O
,	O
woman	O
.	O

Serologies	B-test
:	O

A	O
positive	O
,	O
antibody	B-test
negative	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
rubella	B-test
immune	O
,	O
GBS	B-test
unknown	O
.	O

Pregnancy	B-problem
notable	O
for:	O

1.	O
Gestational	O
carrier	O
for	O
brother	O
and	O
his	O
wife	O
(	O
donor	O
eggs	O
).	O

2.	O
IVF	B-treatment
with	O
diamniotic	O
,	O
dichorionic	O
twins	O
.	O

3.	O
At	O
29-30	O
week	O
gestation	O
concern	O
for	O
fetal	B-problem
decelerations	I-problem
of	O
twin	O
A	O
,	O
admitted	O
to	O
Cambridge	O
Health	O
Alliance	O
,	O
completed	O
a	O
course	O
of	O
Betamethasone	B-treatment
,	O
discharged	O
to	O
home	O
.	O

4.	O
Elevated	B-problem
one	I-problem
hour	I-problem
glucose	I-problem
tolerance	I-problem
test	I-problem
,	O
normal	O
three	O
hour	O
glucose	O
tolerance	O
test	O
.	O

5.	O
Declined	O
triple	B-test
screen	I-test
and	O
amniocentesis	B-test
.	O

Gestational	O
carrier	O
for	O
brother	O
and	O
sister-in-law	O
as	O
noted	O
above	O
.	O

Presented	O
with	O
spontaneous	B-problem
,	I-problem
premature	I-problem
rupture	I-problem
of	I-problem
membranes	I-problem
.	O

No	O
maternal	B-problem
fever	I-problem
.	O

Clear	O
fluid	O
.	O

Delivery	B-treatment
by	I-treatment
cesarean	I-treatment
section	I-treatment
secondary	O
to	O
twin	B-problem
B	I-problem
breech	I-problem
presentation	I-problem
.	O

Apgars	B-test
eight	O
at	O
one	O
minute	O
and	O
eight	O
at	O
five	O
minutes	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Birth	B-test
weight	I-test
1865	O
grams	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Respiratory	O
-	O
The	O
infant	O
has	O
remained	O
in	O
room	O
air	O
throughout	O
this	O
hospitalization	O
with	O
respiratory	B-test
rates	I-test
40	O
s	O
to	O
50	O
s,	O
oxygen	B-test
saturation	I-test
greater	O
than	O
94%	O
.	O

One	B-problem
apnea	I-problem
and	I-problem
bradycardia	I-problem
event	I-problem
which	O
was	O
self	O
resolved	O
on	O
day	O
of	O
life	O
four	O
.	O

2.	O
Cardiovascular	O
-	O
The	O
infant	O
was	O
noted	O
on	O
CR-monitor	B-test
to	O
have	O
premature	B-problem
ventricular	I-problem
contractions	I-problem
which	O
resolved	O
spontaneously	O
.	O

A	B-test
twelve	I-test
lead	I-test
electrocardiogram	I-test
was	O
recommended	O
if	O
this	O
persists	O
.	O

No	O
murmur	B-problem
.	O

Heart	B-test
rates	I-test
140	O
s	O
to	O
150	O
s.	O

Mean	B-test
blood	I-test
pressure	I-test
has	O
been	O
46	O
to	O
54	O
.	O

3.	O
Fluid	O
,	O
electrolytes	O
and	O
nutrition	O
-	O
The	O
infant	O
was	O
started	O
on	O
enteral	B-treatment
feedings	I-treatment
on	O
day	O
of	O
life	O
one	O
and	O
advanced	O
to	O
full	B-treatment
volume	I-treatment
feedings	I-treatment
by	O
day	O
of	O
life	O
four	O
.	O

The	O
infant	O
was	O
initially	O
started	O
on	O
80	O
cc	O
/	O
kg	O
/	O
day	O
of	O
intravenous	B-treatment
fluid	I-treatment
D10W	I-treatment
and	O
advanced	O
to	O
150	O
cc	O
/	O
kg	O
/	O
day	O
by	O
day	O
of	O
life	O
four	O
.	O

The	O
infant	O
tolerated	O
feeding	O
advancement	O
without	O
difficulty	O
.	O

The	O
infant	O
did	O
not	O
receive	O
parenteral	B-treatment
nutrition	I-treatment
.	O

The	B-test
most	I-test
recent	I-test
electrolytes	I-test
on	O
day	O
of	O
life	O
two	O
showed	O
a	B-test
sodium	I-test
of	O
145	O
,	O
chloride	B-test
111	O
,	O
potassium	B-test
3.8	O
,	O
bicarbonate	B-test
21	O
.	O

The	O
infant	O
is	O
currently	O
receiving	O
breast	O
milk	O
22	O
calories	O
per	O
ounce	O
or	O
premature	O
Enfamil	O
22	O
calories	O
per	O
ounce	O
,	O
150	O
cc	O
/	O
kg	O
/	O
day	O
p.o.	O
and	O
gavage	B-treatment
.	O

The	B-test
most	I-test
recent	I-test
weight	I-test
today	O
is	O
1810	O
grams	O
which	O
was	O
no	O
change	O
from	O
the	O
previous	O
day	O
.	O

4.	O
Gastrointestinal	O
-	O
The	O
infant	O
was	O
started	O
on	O
single	B-treatment
phototherapy	I-treatment
on	O
day	O
of	O
life	O
two	O
for	O
a	B-test
maximum	I-test
bilirubin	I-test
level	I-test
of	O
9.1	O
with	O
a	B-test
direct	I-test
of	O
0.3	O
.	O

Phototherapy	B-treatment
was	O
discontinued	O
on	O
day	O
of	O
life	O
five	O
and	O
the	B-test
rebound	I-test
bilirubin	I-test
level	I-test
on	O
day	O
of	O
life	O
six	O
is	O
7.7	O
with	O
a	B-test
direct	I-test
of	O
0.2	O
.	O

5.	O
Hematology	O
-	O
The	B-test
most	I-test
recent	I-test
hematocrit	I-test
on	O
day	O
of	O
life	O
two	O
was	O
45.8%	O
.	O

Hematocrit	B-test
on	I-test
admission	I-test
was	O
54.0%	O
.	O

The	O
infant	O
has	O
not	O
received	O
any	B-treatment
blood	I-treatment
transfusions	I-treatment
this	O
hospitalization	O
.	O

6.	O
Infectious	O
disease	O
-	O
The	O
infant	O
received	O
48	O
hours	O
of	O
Ampicillin	B-treatment
and	O
Gentamicin	B-treatment
for	O
rule	O
out	O
sepsis	B-problem
.	O

The	B-test
complete	I-test
blood	I-test
count	I-test
on	I-test
admission	I-test
showed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
8.0	O
,	O
hematocrit	B-test
54.0%	O
,	O
platelet	B-test
count	I-test
190,000	O
,	O
11	O

neutrophils	B-test
,	O
0	O
bands	B-test
.	O

A	B-test
repeat	I-test
complete	I-test
blood	I-test
count	I-test
on	O
day	O
of	O
life	O
two	O
showed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
6.3	O
,	O
hematocrit	B-test
45.8%	O
,	O
platelet	B-test
count	I-test
199,000	O
,	O
37	O
neutrophils	B-test
,	O
0	O
bands	B-test
,	O
53	O
lymphocytes	B-test
.	O

Blood	B-test
cultures	I-test
remained	O
negative	O
to	O
date	O
.	O

7.	O
Neurology	O
-	O
Normal	O
neurologic	O
examination	O
.	O

The	O
infant	O
does	O
not	O
meet	O
criteria	O
for	O
head	B-test
ultrasound	I-test
.	O

8.	O
Sensory	O
-	O
Hearing	B-test
screening	I-test
is	O
recommended	O
prior	O
to	O
discharge	O
.	O

9.	O
Psychosocial	O
-	O
As	O
noted	O
above	O
,	O
paternal	O
aunt	O
was	O
the	O
gestational	O
carrier	O
.	O

The	O
infants	O
are	O
legally	O
under	O
the	O
parents	O
'	O
names	O
and	O
they	O
are	O
involved	O
with	O
the	B-treatment
infant	I-treatment
's	I-treatment
care	I-treatment
.	O

The	O
gestational	O
carrier	O
is	O
not	O
involved	O
.	O

Noted	O
in	O
the	O
chart	O
are	O
legal	O
documents	O
.	O

The	O
contact	O
social	O
worker	O
can	O
be	O
reached	O
at	O
(	O
756	O
)	O
599-4849	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

32	O
and	O
4/7	O
weeks	O
,	O
now	O
day	O
of	O
life	O
six	O
,	O
stable	O
in	O
room	O
air	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
nursery	O
at	O
VA	O
Hospital	O
Jamaica	O
Plain	O
Hospital	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
James	O
Ramos	O
,	O
telephone	O
(	O
346	O
)	O
741	O
2728	O
.	O

FEEDINGS	O
AT	O
DISCHARGE	O
:	O

150	O
cc	O
/	O
kg	O
/	O
day	O
of	O
breast	O
milk	O
22	O
calories	O
or	O
premature	O
Enfamil	O
22	O
calories	O
per	O
ounce	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

None	O
.	O

CAR	B-test
SEAT	I-test
POSITION	I-test
SCREENING	I-test
:	O

Recommended	O
prior	O
to	O
discharge	O
.	O

STATE	B-test
NEWBORN	I-test
SCREEN	I-test
:	O

Screens	B-test
have	O
been	O
sent	O
and	O
results	O
are	O
pending	O
.	O

IMMUNIZATIONS	B-treatment
:	O

The	O
infant	O
has	O
not	O
received	O
any	B-treatment
immunizations	I-treatment
this	O
hospitalization	O
.	O

IMMUNIZATIONS	O
RECOMMENDED	O
:	O

Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
.	O

2.	O
Born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
two	O
of	O
the	O
following	O
:	O

a.	O
Day	O
Care	O
during	O
RSV	O
season	O
.	O

b.	O
A	O
smoker	O
in	O
the	O
household	O
,	O

c.	O
neuromuscular	B-problem
disease	I-problem
,	O

d.	O
airway	B-problem
abnormalities	I-problem
or	O

e.	O
a	O
school	O
age	O
sibling	O
.	O

3.	O
With	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-problem
32	I-problem
and	I-problem
4/7	I-problem
weeks	I-problem
,	O
Twin	O
#1	O
.	O

2.	O
Rule	O
out	O
sepsis	B-problem
,	O
ruled	O
out	O
.	O

3.	O
Apnea	B-problem
of	I-problem
prematurity	I-problem
.	O

4.	O
Indirect	B-problem
hyperbilirubinemia	I-problem
.	O

Gregory	O
R	O
Godfrey	O
,	O
M.D.	O
28-526	O

Dictated	O
By	O
:	O
Crystal	O
K.	O
Carter	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2016-02-21	O
09:53	O

T	O
:	O
2016-02-21	O
10:12	O

JOB	O
#:	O
02200	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Cynthia	O
Short	O
on	O
:	O
MON	O
2016-02-22	O
8:16	O
AM	O

(	O
End	O
of	O
Report	O
)	O

708632336	O
YC	O

32343989	O
PAD-WORD	O

0527629	O
PAD-WORD	O

10/14/2004	O
12:00:00	O
AM	O

PELVIC	B-problem
MASS	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

10/14/2004	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

10/17/2004	O
PAD-WORD	O

ATTENDING	O
:	O

NAEELV	O
CRUTCH	O
MD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pelvic	B-problem
mass	I-problem
,	O
benign	B-problem
mucinous	I-problem
cystadenoma	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Total	B-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
right	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
,	O
appendectomy	B-treatment
,	O
omental	B-test
biopsy	I-test
,	O
and	O
pelvic	B-treatment
washings	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
56-year-old	O
menopausal	O
female	O
G3	O
,	O
P3	O
who	O
presented	O
initially	O
for	O
evaluation	B-test
of	O
a	B-problem
pelvic	I-problem
mass	I-problem
while	O
recently	O
vacationing	O
in	O
An	O
Saintcafield	O
Terland	O
.	O

She	O
had	O
a	B-test
physical	I-test
over	O
there	O
,	O
and	O
the	B-test
evaluation	I-test
included	O
an	B-test
ultrasound	I-test
which	O
showed	O
an	B-problem
ovarian	I-problem
mass	I-problem
.	O

She	O
was	O
seen	O
in	O
the	O
emergency	O
room	O
here	O
on	O
08/31/04	O
where	O
they	O
performed	O
an	B-test
abdominal	I-test
CT	I-test
that	O
showed	O
a	B-problem
14	I-problem
x	I-problem
14	I-problem
x	I-problem
10	I-problem
cm	I-problem
pelvic	I-problem
mass	I-problem
with	O
multiple	B-problem
enlarged	I-problem
lymph	I-problem
nodes	I-problem
.	O

The	O
patient	O
was	O
thus	O
sent	O
to	O
GYN	O
for	O
further	B-test
workup	I-test
and	O
is	O
now	O
here	O
for	O
surgical	B-treatment
management	I-treatment
of	O
pelvic	B-problem
mass	I-problem
.	O

Her	B-test
CA-125	I-test
is	O
9	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Tubal	B-treatment
ligation	I-treatment
.	O

PAST	O
OBSTETRICAL	O
HISTORY	O
:	O

G3	O
,	O
P3	O
,	O
spontaneous	B-treatment
vaginal	I-treatment
delivery	I-treatment
x3	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Denies	O
tobacco	O
,	O
alcohol	O
or	O
drug	O
use	O
.	O

Married	O
,	O
lives	O
with	O
husband	O
,	O
denies	O
domestic	O
violence	O
.	O

FAMILY	O
HISTORY	O
:	O

No	O
history	O
of	O
GYN	B-problem
,	O
cancers	B-problem
,	O
or	O
breast	B-problem
cancer	I-problem
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Negative	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
hospital	O
day	O
#	O
1	O
where	O
she	O
underwent	O
an	B-treatment
uncomplicated	I-treatment
total	I-treatment
abdominal	I-treatment
hysterectomy	I-treatment
,	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
,	O
right	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
,	O
appendectomy	B-treatment
,	O
omental	B-test
biopsy	I-test
,	O
pelvic	B-treatment
washings	I-treatment
,	O
and	O
Pap	B-treatment
of	I-treatment
the	I-treatment
diaphragm	I-treatment
.	O

An	B-problem
estimated	I-problem
blood	I-problem
loss	I-problem
was	O
100	O
cc	O
.	O

At	O
the	O
time	O
of	O
surgery	B-treatment
,	O
frozen	B-test
section	I-test
revealed	O
benign	B-problem
mucinous	I-problem
cystadenoma	I-problem
.	O

By	O
postoperative	O
day	O
#3	O
,	O
the	O
patient	O
was	O
tolerating	O
p.o.&apos;	O
s	O
,	O
tolerating	O
oral	B-treatment
pain	I-treatment
medications	I-treatment
,	O
ambulating	O
,	O
passing	O
flatus	O
,	O
and	O
having	O
a	O
bowel	O
movement	O
.	O

She	O
was	O
voiding	O
without	O
difficulty	O
.	O

Her	B-test
hematocrit	I-test
preoperatively	O
was	O
36	O
and	O
postoperatively	O
was	O
33	O
and	O
then	O
32	O
.	O

The	O
patient	O
did	O
have	O
some	B-problem
tachycardia	I-problem
postoperatively	I-problem
;	O
however	O
,	O
her	B-test
hematocrit	I-test
remained	O
stable	O
.	O

She	O
was	O
asymptomatic	B-problem
,	O
and	O
her	B-test
EKG	I-test
was	O
within	O
normal	O
limits	O
.	O

Her	B-problem
tachycardia	I-problem
improved	O
.	O

Throughout	O
this	O
time	O
,	O
she	O
had	O
normal	O
vital	O
signs	O
with	O
a	O
normal	O
O2	O
saturation	O
.	O

DISPOSITION	O
AND	O
DISCHARGE	O
MEDICATIONS	O
:	O

She	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
with	O
prescriptions	O
for	O
Colace	B-treatment
,	O
Motrin	B-treatment
and	O
Percocet	B-treatment
as	O
needed	O
.	O

FOLLOW	O
UP	O
:	O

She	O
will	O
follow	O
up	O
with	O
Dr.	O
Crutch	O
in	O
two	O
weeks	O
.	O

She	O
was	O
again	O
discharged	O
home	O
in	O
stable	O
condition	O
.	O

eScription	O
document	O
:	O

2-8707232	O
WEBCtug	O
Tel	O

Dictated	O
By	O
:	O

JAQUENATHE	O
,	O
MYA	O

Attending	O
:	O

CRUTCH	O
,	O
NAEELV	O
Dictation	O
ID	O
8975259	O

D	O
:	O

10/17/04	O
PAD-WORD	O

T	O
:	O

10/17/04	O
PAD-WORD	O

Admission	O
Date	O
:	O

2013-01-03	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-01-09	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1954-07-20	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
58	O
-	O
year-old	O
woman	O
who	O
was	O
transferred	O
from	O
Shaugnessy-Kaplan	O
Rehab	O
Hospital	O
Hospital	O
for	O
cardiac	B-test
catheterization	I-test
.	O

The	O
patient	O
had	O
a	O
long	O
history	O
of	O
hypertension	B-problem
,	O
hypercholesterolemia	B-problem
,	O
tobacco	O
abuse	O
,	O
and	O
family	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
who	O
was	O
in	O
the	O
usual	O
state	O
of	O
health	O
until	O
Saturday	O
previous	O
to	O
admission	O
when	O
she	O
experienced	O
bilateral	B-problem
arm	I-problem
and	I-problem
chest	I-problem
discomfort	I-problem
while	O
carrying	O
groceries	O
.	O

Her	B-problem
symptoms	I-problem
resolved	O
with	O
rest	B-treatment
.	O

The	B-problem
same	I-problem
symptoms	I-problem
occurred	O
again	O
the	O
same	O
evening	O
with	O
exertion	O
and	O
then	O
were	O
again	O
relieved	O
with	O
rest	B-treatment
.	O

The	O
patient	O
presented	O
to	O
the	O
outside	O
hospital	O
Emergency	O
Room	O
where	O
she	O
was	O
started	O
on	O
Aspirin	B-treatment
,	O
Lovenox	B-treatment
and	O
beta	B-treatment
blocker	I-treatment
.	O

She	O
ruled	O
out	O
for	O
myocardial	B-problem
infarction	I-problem
by	O
CPK	B-test
and	O
troponin	B-test
and	O
had	O
non	B-problem
diagnostic	I-problem
EKG	I-problem
changes	I-problem
.	O

She	O
is	O
being	O
transferred	O
to	O
Arbour-Fuller	O
Hospital	O
for	O
cardiac	B-test
catheterization	I-test
.	O

Results	O
of	O
the	B-test
catheterization	I-test
indicated	O
the	O
patient	O
had	O
three	B-problem
vessel	I-problem
disease	I-problem
and	O
was	O
a	O
candidate	O
for	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

The	O
patient	O
went	O
to	O
the	O
operating	O
room	O
,	O
was	O
admitted	O
to	O
go	O
to	O
the	O
operating	O
room	O
on	O
2013-01-04	O
.	O

Her	O
risk	O
factors	O
:	O
Hypertension	B-problem
,	O
tobacco	O
abuse	O
(	O
one	O
pack	O
per	O
day	O
times	O
45	O
years	O
),	O
family	O
history	O
(	O
father	O
diagnosed	O
with	O
coronary	B-problem
artery	I-problem
disease	I-problem
in	O
his	O
50	O
's,	O
patient	O
's	O
mother	O
had	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
patient	O
's	O
brother	O
has	O
coronary	B-problem
artery	I-problem
disease	I-problem
).	O

Hypercholesterolemia	B-problem
(	O
total	B-test
cholesterol	I-test
on	O
admission	O
300	O
's	O
several	O
years	O
ago	O
).	O

The	O
patient	O
denies	O
any	O
history	O
of	O
diabetes	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Status	O
post	O
CVA	B-problem
times	O
two	O
in	O
2010	O
,	O
arthritis	B-problem
,	O
hypertension	B-problem
,	O
hypercholesterolemia	B-problem
,	O
status	O
post	O
remote	B-problem
pneumonia	I-problem
,	O
status	O
post	O
remote	B-problem
pleurisy	I-problem
,	O
psoriasis	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Status	O
post	O
tubal	B-treatment
ligation	I-treatment
.	O

MEDICATIONS	O
:	O

At	O
home	O
,	O
Aggrenox	B-treatment
250	O
mg	O
po	O
q	O
day	O
.	O

ALLERGIES	O
:	O

Sulfa	B-treatment
causes	O
rash	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
alone	O
and	O
works	O
full	O
time	O
doing	O
secretarial	O
work	O
.	O

She	O
has	O
a	O
son	O
who	O
is	O
mentally	B-problem
handicapped	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
vital	B-test
signs	I-test
,	O
heart	B-test
rate	I-test
71	O
,	O
blood	B-test
pressure	I-test
134/75	O
,	O
respiratory	B-test
rate	I-test
20	O
.	O

Neck	O
,	O
no	O
jugulovenous	B-problem
distension	I-problem
,	O
carotids	B-problem
,	O
no	O
bruit	B-problem
in	I-problem
either	I-problem
right	I-problem
or	I-problem
left	I-problem
carotid	I-problem
artery	I-problem
.	O

Lungs	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Heart	O
,	O
S1	B-test
and	O
S2	B-test
appreciated	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
soft	O
,	O
non	B-problem
distended	I-problem
,	O
nontender	B-problem
.	O

There	O
is	O
ecchymosis	B-problem
in	I-problem
mid	I-problem
abdomen	I-problem
,	O
left	O
of	O
midline	O
,	O
likely	O
secondary	O
to	O
Lovenox	B-treatment
injections	I-treatment
.	O

Extremities	O
,	O
no	O
bruit	B-problem
at	I-problem
the	I-problem
left	I-problem
or	I-problem
right	I-problem
femoral	I-problem
arteries	I-problem
.	O

DP	B-test
and	I-test
PT	I-test
pulses	I-test
are	O
2+	O
bilaterally	O
.	O

There	O
is	O
no	O
pedal	B-problem
edema	I-problem
but	O
there	O
is	O
evidence	O
of	O
some	B-problem
psoriasis	I-problem
of	I-problem
the	I-problem
lower	I-problem
extremities	I-problem
,	O
right	O
greater	O
than	O
left	O
.	O

LABORATORY	O
DATA	O
:	O

Cardiac	B-test
catheterization	I-test
performed	O
on	O
2013-01-03	O
:	O
Three	B-problem
vessel	I-problem
disease	I-problem
in	I-problem
the	I-problem
right	I-problem
dominant	I-problem
system	I-problem
.	O

Left	O
main	O
coronary	O
artery	O
with	O
short	O
vessel	O
without	O
significant	B-problem
lesions	I-problem
.	O

The	B-problem
LAD	I-problem
diffusely	I-problem
diseased	I-problem
proximal	I-problem
section	I-problem
up	O
to	O
50%	O
with	O
focal	O
70%	B-problem
mid	I-problem
segment	I-problem
lesion	I-problem
.	O

D1	O
was	O
mildly	B-problem
diseased	I-problem
diffusely	I-problem
.	O

Left	O
circumflex	O
had	O
80%	B-problem
stenosis	I-problem
in	I-problem
a	I-problem
large	I-problem
OM1	I-problem
branch	I-problem
.	O

The	O
right	O
coronary	O
artery	O
was	O
diffusely	B-problem
diseased	I-problem
in	I-problem
the	I-problem
mid	I-problem
segment	I-problem
with	O
serial	B-problem
80-90%	I-problem
stenosis	I-problem
.	O

Limited	B-test
hemodynamics	I-test
showed	O
elevated	B-problem
LV	I-problem
and	I-problem
diastolic	I-problem
pressure	I-problem
(	O
21	O
mmHg	O
).	O

Left	B-test
ventriculogram	I-test
demonstrates	O
a	B-problem
mild	I-problem
mitral	I-problem
regurgitation	I-problem
and	O
left	B-test
ventricular	I-test
ejection	I-test
fraction	I-test
of	O
58%	O
with	O
normal	O
regional	B-test
wall	I-test
motion	I-test
.	O

HOWeaver	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Edith	O
Nourse	O
Rogers	O
Memorial	O
VA	O
Hospital	O
and	O
brought	O
to	O
the	O
operating	O
room	O
on	O
2013-01-04	O
by	O
Dr.	O
van	O
der	O
Talbot	O
where	O
she	O
received	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
three	O
.	O

She	O
had	O
an	B-treatment
anastomosis	I-treatment
between	I-treatment
the	I-treatment
left	I-treatment
internal	I-treatment
mammary	I-treatment
artery	I-treatment
and	I-treatment
the	I-treatment
left	I-treatment
anterior	I-treatment
descending	I-treatment
artery	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
RCA	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
OM	I-treatment
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
transported	O
to	O
the	O
cardiac	O
surgery	O
recovery	O
room	O
.	O

The	O
patient	O
was	O
extubated	O
on	O
arrival	O
in	O
the	O
cardiac	O
surgery	O
recovery	O
room	O
but	O
was	O
on	O
no	O
drips	B-treatment
.	O

The	O
patient	O
's	O
postoperative	O
course	O
was	O
uncomplicated	O
and	O
she	O
was	O
extubated	O
on	O
the	O
first	O
postoperative	O
day	O
.	O

On	O
the	O
first	O
postoperative	O
day	O
her	O
diet	O
was	O
advanced	O
as	O
tolerated	O
and	O
she	O
was	O
transferred	O
to	O
the	O
patient	O
care	O
floor	O
.	O

On	O
postoperative	O
day	O
#2	O
her	B-treatment
Foley	I-treatment
catheter	I-treatment
and	O
chest	B-treatment
tubes	I-treatment
were	O
discontinued	O
.	O

By	O
postoperative	O
day	O
#3	O
she	O
began	O
ambulating	O
with	O
some	B-problem
great	I-problem
hesitancy	I-problem
.	O

Foley	B-treatment
catheter	I-treatment
was	O
removed	O
.	O

By	O
postoperative	O
day	O
#5	O
she	O
was	O
ambulating	O
at	O
level	O
IV	O
,	O
was	O
tolerating	O
po	O
,	O
was	O
able	O
to	O
void	O
and	O
felt	O
comfortable	O
to	O
go	O
to	O
rehab	B-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

Discharged	O
to	O
rehab	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
three	O
on	O
2013-01-04	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Toprol	B-treatment
75	O
mg	O
po	O
bid	O
,	O
Furosemide	B-treatment
20	O
mg	O
po	O
bid	O
times	O
one	O
week	O
,	O
potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
po	O
bid	O
while	O
on	O
Lasix	B-treatment
,	O
Colace	B-treatment
100	O
mg	O
po	O
bid	O
while	O
on	O
Percocet	B-treatment
,	O
enteric	B-treatment
coated	I-treatment
Aspirin	I-treatment
325	O
mg	O
po	O
q	O
day	O
,	O
Indocin	B-treatment
25	O
mg	O
po	O
bid	O
,	O
Sarna	B-treatment
cream	I-treatment
applied	O
to	O
affected	O
area	O
prn	O
,	O
Percocet	B-treatment
1-2	O
tabs	O
po	O
q	O
4-6	O
hours	O
prn	O
,	O
Ibuprofen	B-treatment
400	O
mg	O
po	O
q	O
6	O
hours	O
prn	O
,	O
Tylenol	B-treatment
650	O
mg	O
po	O
q	O
4-6	O
hours	O
prn	O
,	O
Ativan	B-treatment
0.5	O
mg	O
po	O
q	O
8	O
hours	O
prn	O
.	O

FOAnterP	O
:	O

The	O
patient	O
will	O
follow-up	O
in	O
the	O
wound	O
care	O
clinic	O
in	O
two	O
weeks	O
.	O

The	O
patient	O
will	O
also	O
follow-up	O
with	O
Dr.	O
Fairchild	O
,	O
her	O
primary	O
care	O
physician	O
in	O
three	O
weeks	O
.	O

The	O
patient	O
will	O
follow-up	O
with	O
Dr.	O
vel	O
Diaz	O
in	O
3-4	O
weeks	O
.	O

Briley	O
von	O
der	O
Ross,	O
M.D.	O
67-576	O

Dictated	O
By	O
:	O
Emily	O
O	O
Ennis	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-01-08	O
16:46	O

T	O
:	O
2013-01-08	O
17:08	O

JOB	O
#:	O
67252	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Santos	O
von	O
der	O
Ross	O
on	O
:	O
Elizabeth	O
2013-02-21	O
3:05	O
PM	O

(	O
End	O
of	O
Report	O
)	O

712282401	O
PAD-WORD	O

OMH	O
PAD-WORD	O

5834580	O
PAD-WORD	O

96137	O
PAD-WORD	O

10/24/1996	O
12:00:00	O
AM	O

RIGHT	B-problem
MIDDLE	I-problem
CEREBRAL	I-problem
ARTERY	I-problem
INFARCT	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

FINGER	O
,	O
ASHA	O

UNIT	O
NUMBER	O
:	O

424-76-57	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10/24/96	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

Halloween	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
infarct	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Urinary	B-problem
tract	I-problem
infection	I-problem
.	O

CLINICAL	O
INFECTIONS	O
:	O

Urinary	B-problem
tract	I-problem
infection	I-problem
,	O
E.	B-problem
Coli	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

MRI	B-test
/	O
MRA	B-test
.	O

OTHER	O
PROCEDURES	O
:	O

Echocardiogram	B-test
,	O
neurovascular	B-test
ultrasound	I-test
.	O

HISTORY	O
:	O

Patient	O
is	O
a	O
73-year-old	O
retired	O
cook	O
with	O
a	O
history	O
of	O
cervical	B-problem
myelopathy	I-problem
,	O
who	O
is	O
admitted	O
for	O
new	B-problem
left	I-problem
hemiparesis	I-problem
.	O

He	O
had	O
undergone	O
C-spine	B-treatment
surgery	I-treatment
for	O
spinal	B-problem
stenosis	I-problem
with	O
a	O
question	O
of	O
myelopathy	B-problem
and	O
radiculopathy	B-problem
in	O
1992	O
with	O
residual	B-problem
spastic	I-problem
paresis	I-problem
and	O
monoparesis	B-problem
of	I-problem
the	I-problem
left	I-problem
upper	I-problem
extremity	I-problem
,	O
but	O
was	O
ambulatory	O
until	O
a	O
day	O
prior	O
to	O
admission	O
.	O

At	O
his	O
baseline	O
,	O
he	O
was	O
able	O
to	O
perform	O
limited	O
tasks	O
with	O
his	O
left	O
upper	O
extremity	O
,	O
and	O
was	O
clearly	O
able	O
to	O
move	O
his	O
hand	O
and	O
able	O
to	O
ambulate	O
.	O

He	O
also	O
at	O
baseline	O
has	O
had	O
urinary	B-problem
and	I-problem
fecal	I-problem
urgencies	I-problem
/	O
incontinence	B-problem
.	O

His	O
history	O
is	O
now	O
that	O
he	O
has	O
had	O
a	O
week	O
of	O
progressive	B-problem
left	I-problem
upper	I-problem
extremity	I-problem
weakness	I-problem
,	O
to	O
the	O
point	O
of	O
being	O
unable	O
to	O
move	O
the	O
left	O
hand	O
and	O
one	O
day	O
of	O
being	O
unable	O
to	O
walk	O
secondary	O
to	O
left	B-problem
leg	I-problem
weakness	I-problem
with	O
a	O
marked	O
tendency	O
to	O
fall	O
leftward	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
anemia	B-problem
,	O
hypercholesterolemia	B-problem
,	O
narcolepsy	B-problem
for	O
the	O
past	O
6	O
years	O
on	O
Dexedrine	B-treatment
,	O
impotence	B-problem
with	O
decreased	B-problem
testosterone	I-problem
,	O
status	O
post	O
implant	B-treatment
,	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
,	O
status	O
post	O
duodenal	B-treatment
resection	I-treatment
,	O
cervical	B-problem
stenosis	I-problem
,	O
status	O
post	O
decompression	B-treatment
&apos;92	O
,	O
hernia	B-problem
,	O
status	O
post	O
herniorrhaphy	B-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	B-treatment
ON	O
ADMISSION	O
:	O

Dexedrine	B-treatment
5	O
mg	O
per	O
day	O
and	O
Motrin	B-treatment
600	O
mg	O
tid	O
.	O

PHYSICAL	B-test
EXAMINATION	I-test
:	O

On	O
admission	O
,	O
older	O
,	O
black	O
gentleman	O
in	O
no	O
acute	B-problem
distress	I-problem
with	O
left	B-test
upper	I-test
extremity	I-test
flex	I-test
across	O
his	O
chest	O
.	O

His	B-test
temperatureis	I-test
98.9	O
.	O

His	B-test
pressure	I-test
is	O
150/90	O
.	O

Rate	B-test
76	O
.	O

Respirations	B-test
16	O
.	O

He	O
was	O
edentulous	B-problem
.	O

He	O
had	O
mild	B-problem
copper	I-problem
wiring	I-problem
.	O

He	O
has	O
a	B-problem
I	I-problem
/	I-problem
VI	I-problem
systolic	I-problem
murmur	I-problem
at	I-problem
the	I-problem
right	I-problem
upper	I-problem
sternal	I-problem
border	I-problem
.	O

Heart	B-test
sounds	I-test
were	O
normal	O
and	O
regular	O
.	O

Breath	B-test
sounds	I-test
were	O
equal	O
bilaterally	O
with	O
course	B-problem
rhonchi	I-problem
.	O

He	O
had	O
a	B-problem
midline	I-problem
abdominal	I-problem
scar	I-problem
and	O
a	B-problem
reducible	I-problem
umbilical	I-problem
hernia	I-problem
.	O

Abdomen	O
was	O
otherwise	O
soft	O
and	O
nontender	B-problem
.	O

He	O
had	O
2+	B-test
carotids	I-test
,	O
no	O
bruits	B-problem
.	O

He	O
had	O
gynecomastia	B-problem
.	O

Rectal	O
was	O
guaiac	O
negative	O
with	O
brown	O
stool	O
,	O
good	O
tone	O
but	O
unable	O
to	O
squeeze	O
.	O

Extremities	O
:	O

1+	B-test
right	I-test
posterior	I-test
tibialis	I-test
,	O
2+	B-test
left	I-test
posterior	I-test
tibialis	I-test
,	O
no	O
edema	B-problem
,	O
ichthyotic	B-problem
changes	I-problem
were	O
present	O
.	O

He	O
had	O
0	O
left	O
wrist	O
flexion	O
or	O
extension	O
while	O
his	O
left	O
proximal	O
muscles	O
were	O
4	O
including	O
his	O
biceps	O
and	O
triceps	O
.	O

His	O
right	O
arm	O
muscles	O
were	O
also	O
in	O
the	O
range	O
of	O
4/5.	O

His	B-test
hip	I-test
flexion	I-test
was	O
4+	O
on	O
the	O
right	O
and	O
4-	O
on	O
the	O
left	O
;	O
extension	B-test
5	O
on	O
the	O
right	O
,	O
4+	O
on	O
the	O
left	O
;	O
knee	B-test
flexion	I-test
evidently	O
trace	O
on	O
the	O
right	O
and	O
4-	O
on	O
the	O
left	O
with	O
knee	B-test
extension	I-test
5-	O
on	O
the	O
left	O
,	O
5	O
on	O
the	O
right	O
;	O
knee	B-test
flexion	I-test
4-	O
on	O
the	O
left	O
,	O
trace	O
on	O
the	O
right	O
;	O
ankle	B-test
dorsi	I-test
flexion	I-test
4-	O
on	O
the	O
left	O
,	O
trace	O
on	O
the	O
right	O
.	O

Reflexes	B-test
4+	O
overall	O
in	O
the	O
upper	O
extremities	O
and	O
3+	O
overall	O
in	O
the	O
lower	O
extremities	O
,	O
an	O
upgoing	O
left	O
toe	O
and	O
a	O
down	O
going	O
right	O
toe	O
.	O

His	O
tone	O
was	O
increased	O
on	O
the	O
left	O
side	O
and	O
he	O
had	O
diminished	O
pin	O
prick	O
and	O
light	O
touch	O
in	O
his	O
left	O
upper	O
extremity	O
and	O
slightly	O
in	O
his	O
left	O
lower	O
extremity	O
with	O
a	O
similar	O
finding	O
for	O
vibratory	O
sense	O
,	O
but	O
in	O
an	O
unreliable	O
pattern	O
.	O

He	O
occasionally	O
had	O
extinction	O
in	O
his	O
left	O
upper	O
,	O
greater	O
than	O
lower	O
extremity	O
,	O
but	O
this	O
was	O
fluctuating	O
.	O

Mental	O
state	O
:	O

He	O
was	O
awake	O
,	O
occasionally	O
sleepy	O
but	O
easily	O
aroused	O
,	O
oriented	O
to	O
self	O
,	O
Oaksgekesser/	O
Memorial	O
Hospital	O
and	O
the	O
date	O
.	O

He	O
was	O
mildly	B-problem
perseverative	I-problem
and	O
inattentive	B-problem
.	O

Coordination	O
:	O

his	O
fine	O
finger	O
movements	O
and	O
rapid	O
alternating	O
movements	O
were	O
within	O
normal	O
limits	O
.	O

He	O
was	O
unable	O
to	O
stand	O
without	O
extensive	O
assistance	O
.	O

LABORATORY	B-test
DATA	I-test
:	O

Sodium	B-test
141	O
,	O
potassium	B-test
3.6	O
,	O
BUN	B-test
14	O
,	O
creatinine	B-test
1.1	O
,	O
hematocrit	B-test
37%	O
,	O
platelets	B-test
177	O
,	O
white	B-test
blood	I-test
count	I-test
4.1	O
.	O

Chest	B-test
x-ray	I-test
showed	O
degenerative	B-problem
joint	I-problem
disease	I-problem
,	O
an	B-problem
ill	I-problem
defined	I-problem
left	I-problem
hemi-diaphragm	I-problem
without	O
air	B-problem
space	I-problem
disease	I-problem
.	O

On	O
the	O
lateral	O
view	O
,	O
surgical	B-treatment
clips	I-treatment
in	I-treatment
the	I-treatment
abdomen	I-treatment
.	O

EKG	B-test
showed	O
normal	O
sinus	O
rhythm	O
,	O
no	O
ST	B-problem
or	I-problem
T	I-problem
wave	I-problem
changes	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	B-treatment
:	O

Mr.	O
Finger	O
was	O
admitted	O
for	O
what	O
appeared	O
to	O
be	O
a	B-problem
stroke	I-problem
syndrome	I-problem
involving	O
his	O
left	O
middle	O
cerebral	O
artery	O
territory	O
.	O

He	O
underwent	O
neurovascular	B-test
doppler	I-test
studies	I-test
which	O
showed	O
no	O
significant	O
change	O
in	O
either	O
common	O
carotid	O
or	O
in	O
the	O
left	O
common	O
internal	O
ophthalmic	O
system	O
.	O

However	O
,	O
there	O
were	O
hemodynamic	B-problem
changes	I-problem
which	O
raised	O
the	O
question	O
of	O
right	B-problem
siphon	I-problem
disease	I-problem
.	O

He	O
had	O
normal	O
cervical	O
vertebral	O
arteries	O
.	O

Transcranial	B-test
dopplers	I-test
showed	O
no	O
abnormalities	B-problem
in	I-problem
the	I-problem
ophthalmic	I-problem
siphon	I-problem
systems	I-problem
,	O
distal	O
vertebrals	O
,	O
or	O
proximal	O
basilar	O
artery	O
.	O

The	O
proximal	O
,	O
middle	O
,	O
anterior	O
and	O
posterior	O
cerebral	O
arteries	O
,	O
however	O
,	O
could	O
not	O
be	O
insinuated	O
.	O

Over	O
the	O
course	O
of	O
the	O
first	O
hospital	O
day	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
exam	I-test
deteriorated	O
in	O
a	O
manner	O
that	O
appeared	O
to	O
be	O
blood	O
pressure	O
dependent	O
.	O

He	O
had	O
been	O
started	O
on	O
Heparin	B-treatment
from	O
the	O
time	O
of	O
his	O
admission	O
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
had	O
showed	O
multiple	B-problem
lacunes	I-problem
,	O
right	O
greater	O
than	O
left	O
,	O
and	O
the	O
deep	O
gray	O
and	O
white	O
matters	O
suspicious	O
for	O
proximal	B-problem
middle	I-problem
cerebral	I-problem
artery	I-problem
stem	I-problem
occlusion	I-problem
or	O
stenosis	B-problem
.	O

MRI	B-test
/	O
MRA	B-test
was	O
performed	O
with	O
diffusion	O
weighted	O
images	O
,	O
showing	O
subcortical	B-problem
white	I-problem
matter	I-problem
and	O
basal	B-problem
ganglia	I-problem
infarcts	I-problem
,	O
but	O
preserved	O
middle	O
cerebral	O
artery	O
territory	O
cortex	O
.	O

Because	O
of	O
his	B-test
blood	I-test
pressure	I-test
,	O
dependence	O
of	O
his	O
left	O
sided	O
extremities	O
,	O
the	O
lower	O
leg	O
specifically	O
,	O
he	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
where	O
he	O
underwent	O
hypertensive	B-treatment
therapy	I-treatment
for	O
several	O
days	O
.	O

His	B-test
systolic	I-test
blood	I-test
pressure	I-test
goal	O
was	O
initially	O
170-190	O
,	O
which	O
he	O
was	O
able	O
to	O
achieve	O
spontaneously	O
for	O
the	O
most	O
part	O
.	O

However	O
,	O
due	O
to	O
the	O
absence	O
of	O
clear	O
benefit	O
at	O
this	O
level	O
,	O
and	O
further	B-problem
deterioration	I-problem
in	I-problem
his	I-problem
left	I-problem
sided	I-problem
strength	I-problem
,	O
this	O
goal	O
was	O
increased	O
and	O
Neo-Synephrine	B-treatment
was	O
added	O
to	O
his	O
regimen	O
to	O
achieve	O
mean	B-test
arterial	I-test
pressures	I-test
in	O
the	O
110-120	O
range	O
.	O

This	O
strategy	O
and	O
its	O
incumbent	O
risks	O
,	O
particularly	O
in	O
a	O
patient	O
on	O
Heparin	B-treatment
,	O
were	O
discussed	O
at	O
length	O
with	O
both	O
the	O
patient	O
and	O
his	O
family	O
,	O
who	O
were	O
very	O
clear	O
in	O
wanting	O
to	O
proceed	O
with	O
all	O
possible	O
efforts	O
to	O
save	O
the	O
use	O
of	O
his	O
left	O
leg	O
.	O

While	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
his	O
strength	O
deteriorated	O
from	O
being	O
able	O
to	O
hold	O
his	O
left	O
leg	O
off	O
the	O
bed	O
up	O
to	O
several	O
inches	O
to	O
loosing	O
virtually	O
all	O
distal	O
extremity	O
strength	O
,	O
and	O
having	O
a	O
2-3/5	O
power	O
in	O
his	O
proximal	O
left	O
leg	O
groups	O
.	O

He	O
also	O
,	O
as	O
Neo-Synephrinewas	B-treatment
tapered	O
,	O
developed	O
mild	B-problem
sensory	I-problem
findings	I-problem
,	O
in	O
particular	O
diminished	B-problem
large	I-problem
fiber	I-problem
sensibility	I-problem
in	I-problem
his	I-problem
left	I-problem
hand	I-problem
,	O
although	O
he	O
at	O
times	O
,	O
including	O
near	O
the	O
end	O
of	O
his	O
Intensive	O
Care	O
Unit	O
stay	O
had	O
a	B-problem
right	I-problem
gaze	I-problem
preference	I-problem
.	O

In	O
terms	O
of	O
exploring	O
his	O
visual	O
space	O
,	O
he	O
was	O
able	O
to	O
look	O
to	O
the	O
left	O
,	O
and	O
it	O
was	O
not	O
possible	O
to	O
elicit	O
clear	O
evidence	O
for	O
a	B-problem
field	I-problem
deficit	I-problem
.	O

He	O
was	O
followed	O
by	O
speech	O
and	O
swallowing	O
service	O
,	O
who	O
assisted	O
in	O
the	B-treatment
management	I-treatment
of	I-treatment
po	I-treatment
intake	I-treatment
which	O
gradually	O
improved	O
,	O
although	O
he	O
clearly	O
had	O
problems	O
with	O
manipulation	O
of	O
food	O
in	O
the	O
left	O
side	O
of	O
his	O
mouth	O
and	O
would	O
tend	O
to	O
accumulate	O
a	O
pouch	O
of	O
food	O
in	O
his	O
left	O
cheek	O
.	O

I	O
should	O
mention	O
that	O
his	B-treatment
blood	I-treatment
pressure	I-treatment
therapy	I-treatment
was	O
at	O
times	O
limited	O
by	O
a	B-problem
severe	I-problem
headache	I-problem
,	O
although	O
he	O
also	O
had	O
this	O
off	O
the	B-treatment
pressor	I-treatment
.	O

He	O
had	O
several	B-test
repeat	I-test
imaging	I-test
studies	I-test
during	O
his	O
Intensive	O
Care	O
Unit	O
stay	O
which	O
showed	O
further	B-problem
demarcation	I-problem
,	O
but	O
not	O
extension	B-problem
of	I-problem
his	I-problem
prior	I-problem
infarct	I-problem
,	O
both	O
on	O
computerized	B-test
tomography	I-test
scan	I-test
and	O
DWI	B-test
images	I-test
.	O

Additionally	O
,	O
he	O
had	O
a	B-test
perfusion	I-test
,	I-test
diffusion	I-test
MR	I-test
study	I-test
earlier	O
on	O
,	O
which	O
suggested	O
the	O
presence	O
of	O
viable	B-problem
penumbra	I-problem
,	O
including	O
the	O
overlying	O
cortex	O
.	O

He	O
was	O
transferred	O
to	O
the	O
regular	O
neurology	O
floor	O
once	O
it	O
became	O
clear	O
that	O
he	O
was	O
not	O
receiving	O
any	O
significant	O
benefit	O
from	O
hypertensive	B-treatment
therapy	I-treatment
.	O

At	O
this	O
time	O
,	O
his	B-test
neurologic	I-test
exam	I-test
is	O
notable	O
for	O
hemiplegia	B-problem
of	I-problem
his	I-problem
left	I-problem
arm	I-problem
,	O
severe	B-problem
hemiparesis	I-problem
of	I-problem
his	I-problem
left	I-problem
leg	I-problem
,	O
mild	B-problem
large	I-problem
fiber	I-problem
sensory	I-problem
loss	I-problem
in	I-problem
his	I-problem
left	I-problem
arm	I-problem
,	O
and	O
otherwise	O
fairly	O
intact	O
mental	O
status	O
,	O
cranial	O
nerve	O
function	O
,	O
and	O
right	O
sided	O
motor	O
and	O
sensory	O
function	O
.	O

We	O
anticipate	O
that	O
he	O
represents	O
a	O
good	O
rehab	O
potential	O
.	O

He	O
will	O
be	O
discharged	O
to	O
rehab	O
on	O
a	O
regimen	O
of	O
Coumadin	B-treatment
5	O
mg	O
po	O
today	O
then	O
daily	O
for	O
an	O
INR	B-test
goal	O
of	O
2-3	O
,	O
Ofloxacin	B-treatment
400	O
mg	O
po	O
bid	O
to	O
be	O
discontinued	O
on	O
11/05/96	O
,	O
Dexedrine	B-treatment
5	O
mg	O
po	O
qd	O
,	O
Omeprazole	B-treatment
20mg	O
po	O
qd	O
,	O
Erythromycin	B-treatment
eye	I-treatment
ointment	I-treatment
OU	O
bid	O
,	O
Heparin	B-treatment
at	O
its	O
present	O
rate	O
adjusting	O
per	O
partial	B-test
thromboplastin	I-test
time	I-test
bid	O
,	O
and	O
discontinuing	O
when	O
the	B-treatment
Coumadin	I-treatment
is	O
therapeutic	O
,	O
Tylenol	B-treatment
650	O
mg	O
po	O
q4	O
prn	O
,	O
Colace	B-treatment
100	O
mg	O
po	O
bid	O
.	O

Follow	O
up	O
will	O
be	O
with	O
Dr.	O
Tvi	O
Fine	O
of	O
Neurology	O
,	O
and	O
Dr.	O
Doll	O
Grendbly	O
of	O
internal	O
medicine	O
and	O
primary	O
care	O
,	O
shortly	O
after	O
discharge	O
from	O
rehab	O
.	O

BETHTATCHA	O
W	O
R	O
NEW	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

TVI	O
SHANEL	O
WASHING	O
,	O
M.D	O
,	O
PhD	O
.	O

TR	O
:	O

tu	O
PAD-WORD	O

DD	O
:	O

Halloween	O
PAD-WORD	O

TD	O
:	O

10/31/96	O
2:55	O

Pcc	O
:	O

LASDAJENA	O
WASHING	O
,	O
M.D.	O
TELSHEY	O
KO	O
SWATLLEEBTIK	O
,	O
JR	O
,	O
M.D.	O
TVI	O
SHANEL	O
WASHING	O
,	O
M.D.	O
,	O
Ph.D.	O
DOLL	O
MAO	O
GRENDBLY	O
,	O
M.D.	O
BETHTATCHA	O
W	O
R	O
NIQUE	O
DOUETMONES	O
,	O
III	O
,	O
M.D.	O
STAT	O

﻿Admission	O
Date	O
:	O

2014-07-24	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-08-09	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1946-08-07	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

BLUE	O
GENERAL	O
SURGERY	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Gonzalez	O
is	O
a	O
patient	O
with	O
a	O
prior	O
medical	O
history	O
including	O
hypothyroidism	B-problem
,	O
iron-deficiency	B-problem
anemia	I-problem
,	O
osteoporosis	B-problem
,	O
increased	B-problem
cholesterol	I-problem
,	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
,	O
chronic	B-problem
constipation	I-problem
,	O
and	O
status	O
post	O
appendectomy	B-treatment
as	O
well	O
as	O
status	O
post	O
hysterectomy	B-treatment
and	O
bilateral	B-treatment
salpingo-oophorectomy	I-treatment
.	O

She	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
for	O
evaluation	B-test
and	O
treatment	B-treatment
of	O
adenocarcinoma	B-problem
involving	O
the	O
transverse	O
colon	O
and	O
gallbladder	O
.	O

At	O
the	O
outside	O
hospital	O
the	O
patient	O
had	O
already	O
seemed	O
some	B-test
workup	I-test
for	O
a	O
couple	O
weeks	O
duration	O
of	O
bilateral	B-problem
upper	I-problem
quadrant	I-problem
pain	I-problem
which	O
occasionally	O
radiated	O
to	O
her	O
back	O
.	O

She	O
was	O
also	O
complaining	O
of	O
fatigue	B-problem
for	O
two	O
weeks	O
but	O
a	O
good	O
appetite	O
and	O
the	O
patient	O
denied	O
weight	B-problem
loss	I-problem
,	O
melena	B-problem
,	O
or	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
.	O

A	B-test
CAT	I-test
scan	I-test
of	I-test
the	I-test
abdomen	I-test
showed	O
air-fluid	B-problem
levels	I-problem
in	I-problem
the	I-problem
gallbladder	I-problem
.	O

It	O
also	O
showed	O
a	B-problem
thickened	I-problem
gallbladder	I-problem
wall	I-problem
as	O
well	O
as	O
a	B-problem
dilated	I-problem
common	I-problem
bile	I-problem
duct	I-problem
.	O

Incidentally	O
,	O
it	O
also	O
showed	O
diverticulosis	B-problem
.	O

A	B-test
HIDA	I-test
scan	I-test
at	O
the	O
other	O
hospital	O
did	O
not	O
show	O
filling	B-problem
of	I-problem
the	I-problem
gallbladder	I-problem
indicating	O
some	O
sort	O
of	O

cystic	B-problem
duct	I-problem
obstruction	I-problem
.	O

The	B-test
first	I-test
imaging	I-test
study	I-test
that	O
was	O
done	O
at	O
Hahnemann	O
General	O
Hospital	O
was	O
a	B-test
MRCP	I-test
which	O
revealed	O
an	B-problem
enhanced	I-problem
thickened	I-problem
gallbladder	I-problem
wall	I-problem
consistent	O
with	O
chronic	B-problem
cholecystitis	I-problem
.	O

A	O
differential	O
according	O
to	O
the	B-test
imaging	I-test
included	O
a	B-problem
fistula	I-problem
with	O
adjacent	B-problem
inflammatory	I-problem
change	I-problem
but	O
also	O
carcinoma	B-problem
or	O
adenomatosis	B-problem
.	O

In	O
addition,	O
also	O
the	B-test
MRCP	I-test
showed	O
a	B-problem
mass	I-problem
near	O
the	O
region	O
of	O
the	O
neck	O
of	O
the	O
gallbladder	O
.	O

Of	O
note	O
,	O
at	O
the	O
outside	O
hospital	O
,	O
an	B-test
endoscopy	I-test
and	O
colonoscopy	B-test
were	O
performed	O
.	O

The	B-test
colonoscopy	I-test
showed	O
two	B-problem
polyps	I-problem
and	O
also	O
a	O
region	O
in	O
the	O
transverse	O
colon	O
that	O
was	O
biopsied	O
.	O

This	B-test
biopsy	I-test
came	O
back	O
as	O
positive	O
for	O
adenocarcinoma	B-problem
.	O

The	O
diagnosis	O
of	O
adenocarcinoma	B-problem
was	O
already	O
established	O
prior	O
to	O
her	O
admission	O
at	O
this	O
hospital	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
scheduled	O
for	O
an	O
operative	O
date	O
on	O
2014-07-29	O
and	O
over	O
the	O
next	O
few	O
days	O
she	O
was	O

given	O
a	B-treatment
low-residual	I-treatment
diet	I-treatment
.	O

She	O
had	O
her	O
belly	O
cleaned	O
with	O
Hibiclens	B-treatment
one	O
a	O
day	O
and	O
once	O
an	B-test
adequate	I-test
preoperative	I-test
evaluation	I-test
was	O
performed	O
,	O
she	O
was	O
given	O
a	B-treatment
bowel	I-treatment
prep	I-treatment
on	O
Monday	O
afternoon	O
and	O
evening	O
in	O
preparation	O
for	O
an	O

exploratory	B-test
laparotomy	I-test
on	O
Tuesday	O
,	O
2014-07-29	O
.	O

On	O
the	O
morning	O
of	O
2014-07-29	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
and	O
underwent	O
a	B-treatment
cholecystectomy	I-treatment
,	O
partial	B-treatment
hepatectomy	I-treatment
,	O
partial	B-treatment
lymph	I-treatment
node	I-treatment
dissection	I-treatment
,	O
a	B-treatment
colocolostomy	I-treatment
,	O
partial	B-treatment
colectomy	I-treatment
,	O
and	O
in	O
addition	O
a	B-treatment
gastrostomy	I-treatment
and	O
a	B-treatment
feeding	I-treatment
jejunostomy	I-treatment
were	O
also	O
put	O
in	O
place	O
.	O

Please	O
refer	O
to	O
the	O
previously	O
dictated	O
operative	O
notes	O
for	O
the	O
details	O
of	O
this	B-treatment
surgery	I-treatment
.	O

Briefly	O
,	O
the	B-treatment
surgery	I-treatment
on	O
2014-07-29	O
revealed	O
a	B-problem
carcinoma	I-problem
of	I-problem
the	I-problem
gallbladder	I-problem
with	O
a	B-problem
cholecystocolonic	I-problem
fistula	I-problem
which	O
crossed	O
into	O
the	O
liver	O
as	O
well	O
as	O
metastatic	B-problem
adenopathy	I-problem
around	I-problem
the	I-problem
portal	I-problem
nodes	I-problem
as	O
well	O
as	O
retroperitoneal	B-problem
nodes	I-problem
around	I-problem
the	I-problem
inferior	I-problem
vena	I-problem
cava	I-problem
and	I-problem
the	I-problem
hepatic	I-problem
artery	I-problem
.	O

In	O
addition	O
to	O
the	B-treatment
gastrostomy	I-treatment
and	O
feeding	B-treatment
jejunostomy	I-treatment
tube	I-treatment
,	O
two	B-treatment
Belmont-Gardner	I-treatment
drains	I-treatment
were	O
placed	O
.	O

The	B-problem
patient	I-problem
's	I-problem
pain	I-problem
postoperatively	O
was	O
controlled	O
with	O
an	B-treatment
epidural	I-treatment
catheter	I-treatment
.	O

However	O
,	O
the	B-treatment
epidural	I-treatment
had	O
the	O
consequence	O
of	O
causing	O
a	O
bit	O
of	O
a	B-problem
hypotension	I-problem
in	O
the	O
patient	O
and	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Surgical	O
ICU	O
for	O
the	O
first	O
postoperative	O
day	O
.	O

In	O
addition	O
,	O
the	O
patient	O
had	O
low	B-problem
hematocrits	I-problem
which	O
required	O
a	B-treatment
transfusion	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

In	O
addition	O
,	O
on	O
postoperative	O
day	O
number	O
two	O
,	O
the	O
patient	O
was	O
transferred	O
out	O
to	O
the	O
floor	O
and	O
she	O
was	O
doing	O
better	O
in	O
terms	O
of	O
pain	B-treatment
control	I-treatment
on	O
a	B-treatment
Dilaudid	I-treatment
PCA	I-treatment
machine	I-treatment
.	O

On	O
postoperative	O
day	O
number	O
two	O
,	O
interestingly	O
,	O
the	O
patient	O
was	O
complaining	O
of	O
sensitivity	B-problem
to	I-problem
light	I-problem
from	O
an	O
unknown	O
etiology	O
.	O

The	O
patient	O
's	O
postoperative	O
course	O
was	O
unremarkable	O
aside	O
from	O
the	B-problem
photophobia	I-problem
.	O

On	O
postoperative	O
day	O
number	O
two	O
,	O
an	O
Oncology	O
consult	O
with	O
Dr.	O
Natalie	O
Mcalister	O
was	O
obtained	O
and	O

follow-up	O
appointments	O
were	O
scheduled	O
with	O
him	O
as	O
an	O
outpatient	O
.	O

Following	O
that	O
,	O
the	O
patient	O
was	O
slowly	O
advanced	O
to	O
clear	B-treatment
liquids	I-treatment
and	O
to	O
a	O
regular	O
diet	O
once	O
her	O
bowels	O
began	O
working	O
when	O
she	O
began	O
having	O
flatus	O
.	O

Her	O
bowel	O
function	O
was	O
slow	O
to	O
develop	O
and	O
she	O
needed	O
to	O
remain	O
n.p.o.	B-treatment
until	O
postoperative	O
day	O
number	O
six	O
.	O

The	O
patient	O
was	O
also	O
given	O
supplemental	B-treatment
tube	I-treatment
feedings	I-treatment
to	O
supplement	O
her	O
calories	O
and	O
caloric	O
intake	O
.	O

On	O
postoperative	O
day	O
number	O
seven	O
,	O
the	O
patient	O
was	O
tolerating	O
her	B-treatment
clear	I-treatment
liquid	I-treatment
diet	I-treatment
and	O
her	B-treatment
tube	I-treatment
feeds	I-treatment
.	O

She	O
was	O
started	O
on	O
p.o.	B-treatment
medicines	I-treatment
and	O
her	B-treatment
first	I-treatment
Belmont-Gardner	I-treatment
drain	I-treatment
was	O
pulled	O
due	O
to	O
scant	O
output	O
.	O

By	O
2014-08-09	O
,	O
the	O
patient	O
was	O
tolerating	O
a	O
full	O
solid	O
diet	O
as	O
well	O
as	O
her	B-treatment
tube	I-treatment
feeds	I-treatment
.	O

Between	O
the	O
two	O
of	O
those	O
,	O
her	O
caloric	O
intake	O
was	O
sufficient	O
for	O
her	O
to	O
sustain	O
herself	O
.	O

She	O
was	O
discharged	O
to	O
home	O
with	O
services	O
including	O
tube	B-treatment
feedings	I-treatment
for	O
her	O
home	O
care	O
.	O

Therefore	O
,	O
she	O
was	O
discharged	O
on	O
2014-08-09	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Metastatic	B-problem
gallbladder	I-problem
cancer	I-problem
.	O

2.	O
Status	O
post	O
cholecystectomy	B-treatment
.	O

3.	O
Status	O
post	O
transverse	B-treatment
colectomy	I-treatment
with	O
anastomosis	B-problem
.	O

4.	O
G	B-treatment
tube	I-treatment
placement	I-treatment
.	O

5.	O
Feeding	B-treatment
jejunostomy	I-treatment
.	O

6.	O
Hypothyroidism	B-problem
.	O

7.	O
Blood	B-problem
loss	I-problem
requiring	O
transfusion	B-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Levothyroxine	B-treatment
100	O
micrograms	O
orally	O
once	O
a	O
day	O
.	O

2.	O
Pantoprazole	B-treatment
one	O
tablet	O
once	O
a	O
day	O
.	O

3.	O
Ambien	B-treatment
10	O
mg	O
orally	O
before	O
bed	O
.	O

4.	O
Tylenol	B-treatment
#	O
3	O
one	O
tablet	O
every	O
four	O
hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

5.	O
Reglan	B-treatment
10	O
mg	O
four	O
times	O
a	O
day	O
before	O
meals	O
and	O
at	O
bedtime	O
.	O

6.	O
Colace	B-treatment
100	O
mg	O
twice	O
a	O
day	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Follow-up	O
with	O
the	O
Visiting	O
Nurses	O
Association	O
to	O
arrange	O
assistance	O
with	O
her	B-treatment
tube	I-treatment
feeding	I-treatment
and	O

her	O
activities	O
of	O
daily	O
living	O
.	O

The	O
patient	O
is	O
also	O
scheduled	O
for	O
an	O
appointment	O
with	O
Dr.	O
Patterson	O
approximately	O
two	O
weeks	O
after	O
her	O
discharge	O
from	O
the	O
hospital	O
.	O

Heather	O
FISCHER	O
,	O
M.D.	O

91-657	O
PAD-WORD	O

Dictated	O
By	O
:	O
Raymond	O
Q.	O
Martinez	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-08-16	O
01:23	O

T	O
:	O
2014-08-16	O
13:25	O

JOB	O
#:	O

23786	O
PAD-WORD	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brian	O
S	O
Heath	O
on	O
:	O
Danielle	O
2014-08-28	O
2:52	O
PM	O

(	O
End	O
of	O
Report	O
)	O

736743101	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

2427050	O
PAD-WORD	O

19324/7383	O
PAD-WORD	O

418074	O
PAD-WORD	O

4/17/1995	O
12:00:00	O
AM	O

NECROTIZING	B-problem
PANCREATITIS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

4/17/95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

07/16/95	O
PAD-WORD	O

DATE	O
OF	O
BIRTH	O
:	O

7/2/1928	O
.	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Necrotizing	B-problem
pancreatitis	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Wegener	B-problem
&apos;s	I-problem
granulomatosis	I-problem
.	O

2.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
anterior	B-problem
myocardial	I-problem
infarction	I-problem
in	O
1993	O
.	O

3.	O
Left	B-problem
ventricular	I-problem
aneurysm	I-problem
.	O

4.	O
Dementia	B-problem
.	O

5.	O
Gallstone	B-problem
pancreatitis	I-problem
.	O

6.	O
Fungal	B-problem
cystitis	I-problem
.	O

7.	O
Intra-abdominal	B-problem
infection	I-problem
.	O

8.	O
Total	B-problem
parenteral	I-problem
nutrition	I-problem
dependent	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Exploratory	B-test
laparotomy	I-test
,	O
left	B-treatment
colectomy	I-treatment
,	O
end-transverse	B-treatment
colostomy	I-treatment
,	O
drainage	B-treatment
of	O
pancreatic	B-problem
necrosis	I-problem
.	O

Date	O
of	O
operation	O
:	O

4/28/95	O
.	O

HISTORY	O
AND	O
REASON	O
FOR	O
ADMISSION	O
:	O

Mr.	O
Mass	O
was	O
a	O
56	O
year	O
old	O
white	O
male	O
who	O
was	O
transferred	O
from	O
Vassdiysey	O
Medical	O
Center	O
for	O
rule	O
out	O
pancreatic	B-problem
pseudocyst	I-problem
.	O

Mr.	O
Mass	O
had	O
a	O
past	O
medical	O
history	O
which	O
included	O
Wegener	B-problem
&apos;s	I-problem
granulomatosis	I-problem
,	O
history	O
of	O
an	B-problem
anterior	I-problem
myocardial	I-problem
infarction	I-problem
,	O
and	O
gallstone	B-problem
pancreatitis	I-problem
.	O

He	O
was	O
admitted	O
to	O
Vassdiysey	O
Medical	O
Center	O
with	O
severe	B-problem
recurrent	I-problem
pancreatitis	I-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
and	O
abdominal	B-problem
pain	I-problem
.	O

His	B-test
amylase	I-test
on	O
admission	O
there	O
was	O
1,961	O
.	O

The	O
patient	O
had	O
two	O
recent	O
admissions	O
for	O
pancreatitis	B-problem
in	O
January	O
1994	O
,	O
and	O
August	O
1994	O
.	O

On	O
his	O
current	O
admission	O
,	O
the	O
patient	O
was	O
admitted	O
to	O
Free	O
Medical	O
Center	O
.	O

His	B-test
amylase	I-test
decreased	O
to	O
51	O
,	O
and	O
the	O
increased	O
back	O
to	O
151	O
on	O
hospital	O
day	O
#10	O
.	O

At	O
that	O
time	O
,	O
he	O
spiked	O
a	B-test
temperature	I-test
to	O
103	O
.	O

He	O
also	O
became	O
increasingly	B-problem
confused	I-problem
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
done	O
on	O
4/16/95	O
showed	O
a	B-problem
large	I-problem
&quot;	I-problem
pseudocyst	I-problem
&quot;	I-problem
.	O

He	O
was	O
transferred	O
to	O
Ph	O
University	O
Of	O
Medical	O
Center	O
for	O
further	B-test
surgical	I-test
evaluation	I-test
.&apos;	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
As	O
above	O
.	O

2.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
anterior	B-problem
myocardial	I-problem
infarction	I-problem
,	O
in	O
1993	O
.	O

Ejection	B-test
fraction	I-test
was	O
felt	O
to	O
be	O
35%	O
in	O
1993	O
.	O

Recent	B-test
echocardiogram	I-test
suggests	O
ejection	B-test
fraction	I-test
of	O
15%	O
.	O

3.	O
Wegener	B-problem
&apos;s	I-problem
granulomatosis	I-problem
,	O
with	O
associated	B-problem
chronic	I-problem
renal	I-problem
insufficiency	I-problem
.	O

4.	O
Mild	B-problem
dementia	I-problem
.	O

MEDICATIONS	O
:	O

Vitamin	B-treatment
K	I-treatment
,	O
10	O
mg.	O
,	O
IM	O
,	O
q-week	O
.	O

2.	O
Pepcid	B-treatment
,	O
20	O
mg.	O
,	O
intravenously	O
,	O
q12h.	O

3.	O
Digoxin	B-treatment
,	O
0.125	O
mg.	O
,	O
intravenously	O
,	O
qD	O
.	O

4.	O
Imipenem	B-treatment
,	O
500	O
mg.	O
,	O
intravenously	O
,	O
q6h.	O

5.	O
Nitropaste	B-treatment
,	O
one-half	O
inch	O
to	O
chest	O
wall	O
,	O
q6h.	O

6.	O
Vasotec	B-treatment
.	O

7.	O
Alterajel	B-treatment
.	O

8.	O
Lasix	B-treatment
,	O
20	O
mg.	O
,	O
po	O
,	O
qD	O
.	O

9.	O
Haldol	B-treatment
.	O

10.	O
Demerol	B-treatment
,	O
prn	O
.	O

ALLERGIES	O
:	O

Ativan	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

In	O
general	O
,	O
confused	O
white	O
man	O
,	O
in	O
mild	B-problem
distress	I-problem
.	O

Vital	O
signs	O
:	O

Temperature	B-test
was	O
102	O
,	O
heart	B-test
rate	I-test
was	O
110	O
,	O
respiratory	B-test
rate	I-test
was	O
22	O
,	O
blood	B-test
pressure	I-test
was	O
113/63	O
.	O

His	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
throat	O
was	O
benign	O
.	O

His	O
neck	O
was	O
supple	O
.	O

Lungs	O
:	O

Rales	B-problem
at	I-problem
the	I-problem
right	I-problem
base	I-problem
,	O
bilateral	B-problem
decreased	I-problem
breath	I-problem
sounds	I-problem
at	I-problem
the	I-problem
bases	I-problem
.	O

Cor	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
and	O
S2	O
,	O
no	O
extra	B-problem
heart	I-problem
sounds	I-problem
,	O
abdomen	B-problem
distended	I-problem
with	O
an	B-problem
epigastric	I-problem
mass	I-problem
noted	O
,	O
mildly	B-problem
tender	I-problem
to	O
palpation	B-test
,	O
no	O
guarding	B-problem
.	O

Bowel	O
sounds	O
were	O
present	O
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
count	I-test
was	O
14.4	O
,	O
hematocrit	B-test
was	O
36.2	O
,	O
platelet	B-test
count	I-test
was	O
217	O
,	O
sodium	B-test
was	O
135	O
,	O
potassium	B-test
was	O
3.3	O
,	O
chloride	B-test
was	O
99	O
,	O
bicarbonate	B-test
was	O
25	O
,	O
BUN	B-test
was	O
40	O
,	O
creatinine	B-test
was	O
1.9	O
,	O
glucose	B-test
was	O
124	O
,	O
urinalysis	B-test
was	O
negative	O
,	O
PT	B-test
was	O
12.2	O
,	O
PTT	B-test
was	O
24.5	O
,	O
calcium	B-test
was	O
7.8	O
,	O
phosphorus	B-test
was	O
3.7	O
,	O
albumin	B-test
was	O
2.3	O
,	O
total	B-test
bilirubin	I-test
was	O
1.3	O
,	O
alkaline	B-test
phosphatase	I-test
was	O
202	O
,	O
SGPT	B-test
was	O
32	O
,	O
SGOT	B-test
was	O
64	O
,	O
LDH	B-test
was	O
998	O
,	O
amylase	B-test
was	O
150	O
.	O

EKG	B-test
revealed	O
sinus	B-problem
tachycardia	I-problem
at	O
107	O
beats	O
per	O
minute	O
.	O

Evidence	O
of	O
old	B-problem
left	I-problem
anterior	I-problem
septal	I-problem
infarct	I-problem
.	O

Chest	B-test
X-ray	I-test
:	O

Large	B-problem
left	I-problem
ventricle	I-problem
,	O
bilateral	B-problem
atelectasis	I-problem
or	O
effusion	B-problem
.	O

Abdominal	B-test
computerized	I-test
tomography	I-test
scan	I-test
:	O

Pancreatitis	B-problem
,	O
fluid	B-problem
collection	I-problem
in	I-problem
the	I-problem
lesser	I-problem
sac	I-problem
.	O

A	B-problem
perisplenic	I-problem
effusion	I-problem
was	O
noted	O
which	O
appeared	O
to	O
communicate	O
with	O
the	B-problem
lesser	I-problem
sac	I-problem
collection	I-problem
.	O

Gallbladder	O
was	O
visualized	O
with	O
stones	B-problem
.	O

IN	O
SUMMARY	O
,	O
the	O
patient	O
was	O
considered	O
to	O
have	O
severe	B-problem
necrotizing	I-problem
pancreatitis	I-problem
,	O
with	O
severe	B-problem
cardiac	I-problem
disease	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
,	O
placed	O
on	O
intravenous	B-treatment
fluids	I-treatment
.	O

He	O
was	O
continued	O
on	O
his	B-treatment
imipenem	I-treatment
,	I-treatment
intravenously	I-treatment
.	O

The	O
patient	O
was	O
started	O
on	O
total	B-treatment
parenteral	I-treatment
nutrition	I-treatment
.	O

On	O
4/17/95	O
,	O
GI	O
Interventional	O
Radiology	O
performed	O
drainage	B-treatment
of	O
the	B-problem
peripancreatic	I-problem
fluid	I-problem
collection	I-problem
.	O

Approximately	O
one	O
liter	O
of	O
brownish	B-problem
fluid	I-problem
was	O
obtained	O
and	O
sent	O
for	O
culture	B-test
.	O

The	B-treatment
drainage	I-treatment
catheter	I-treatment
was	O
left	O
in	O
a	B-problem
pseudocyst	I-problem
.	O

The	O
patient	O
was	O
evaluated	O
by	O
Cardiology	O
.	O

A	B-test
Persantine	I-test
Thallium	I-test
study	I-test
demonstrated	O
a	B-problem
large	I-problem
infarct	I-problem
,	O
involving	O
the	O
posteroseptal	O
,	O
anteroseptal	O
areas	O
.	O

Left	B-problem
ventricular	I-problem
aneurysm	I-problem
was	O
also	O
noted	O
;	O
however	O
,	O
no	O
ischemia	B-problem
was	O
seen	O
.	O

An	B-test
echocardiogram	I-test
was	O
done	O
.	O

The	B-test
echocardiogram	I-test
showed	O
terrible	B-problem
left	I-problem
ventricular	I-problem
function	I-problem
,	O
with	O
left	B-problem
ventricular	I-problem
aneurysm	I-problem
.	O

The	O
right	O
ventricle	O
appeared	O
to	O
be	O
acceptable	O
.	O

The	B-treatment
percutaneous	I-treatment
drainage	I-treatment
catheter	I-treatment
continued	O
to	O
have	O
high	O
output	O
.	O

The	O
fluid	O
was	O
sent	O
for	O
amylase	B-test
,	O
which	O
came	O
back	O
53,230	O
.	O

On	O
4/28/95	O
,	O
the	O
patient	O
had	O
new	O
onset	O
of	O
abdominal	B-problem
pain	I-problem
.	O

His	B-test
white	I-test
count	I-test
had	O
bumped	O
from	O
8.3	O
on	O
admission	O
to	O
18.5	O
,	O
on	O
4/27	O
.	O

A	B-test
computerized	I-test
tomography	I-test
scan	I-test
of	I-test
the	I-test
abdomen	I-test
was	O
performed	O
.	O

Approximately	O
100	O
cc.&apos;s	O
of	O
thick	B-problem
brownish	I-problem
material	I-problem
was	O
aspirated	O
through	O
the	B-treatment
indwelling	I-treatment
catheter	I-treatment
.	O

The	B-test
computerized	I-test
tomography	I-test
scan	I-test
showed	O
the	B-treatment
catheter	I-treatment
tip	I-treatment
in	O
good	O
position	O
.	O

Because	O
of	O
the	B-problem
patient	I-problem
&apos;s	I-problem
deteriorating	I-problem
state	I-problem
,	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
on	O
4/28/95	O
.	O

An	B-test
exploratory	I-test
laparotomy	I-test
was	O
performed	O
.	O

The	O
splenic	O
flexure	O
had	O
a	B-problem
purulent	I-problem
exudative	I-problem
process	I-problem
along	I-problem
the	I-problem
antimesenteric	I-problem
surface	I-problem
.	O

Thus	O
,	O
the	O
splenic	O
flexure	O
and	O
a	O
portion	O
of	O
the	O
descending	O
colon	O
were	O
resected	B-treatment
.	O

The	O
patient	O
underwent	O
a	B-treatment
left	I-treatment
colectomy	I-treatment
with	O
end	B-treatment
transverse	I-treatment
colostomy	I-treatment
,	O
and	O
oversewing	B-treatment
of	I-treatment
the	I-treatment
descending	I-treatment
colon	I-treatment
.	O

Drainage	B-treatment
of	O
the	B-problem
pancreatic	I-problem
necrosis	I-problem
was	O
also	O
done	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
fairly	O
well	O
,	O
and	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
.	O

In	O
the	O
Intensive	O
Care	O
Unit	O
,	O
the	O
patient	O
had	O
a	O
prolonged	O
course	O
.	O

The	O
patient	O
was	O
then	O
extubated	O
on	O
postoperative	O
day	O
#2	O
,	O
but	O
remained	O
pressor-dependent	B-problem
.	O

He	O
remained	O
on	O
imipenem	B-treatment
,	O
and	O
Vancomycin	B-treatment
was	O
also	O
started	O
.	O

Thereafter	O
,	O
the	O
patient	O
had	O
a	B-problem
long	I-problem
and	I-problem
complicated	I-problem
postoperative	I-problem
course	I-problem
.	O

He	O
was	O
eventually	O
transferred	O
to	O
the	O
floor	O
,	O
where	O
he	O
remained	O
meta-stable	O
.	O

He	O
had	O
repeated	O
episodes	O
of	O
hypotension	B-problem
to	O
80-90	B-test
systolic/40-50	I-test
diastolic	I-test
.	O

These	O
resolved	O
without	O
incident	O
.	O

He	O
also	O
had	O
repeated	B-problem
temperature	I-problem
spikes	I-problem
.	O

After	O
repeated	B-test
work	I-test
ups	I-test
,	O
it	O
was	O
felt	O
that	O
these	O
were	O
probably	O
due	O
to	O
remaining	B-problem
infection	I-problem
in	I-problem
the	I-problem
peripancreatic	I-problem
area	I-problem
.	O

His	B-treatment
drainage	I-treatment
tube	I-treatment
from	I-treatment
the	I-treatment
peripancreatic	I-treatment
area	I-treatment
was	O
gradually	O
advanced	O
,	O
and	O
eventually	O
discontinued	O
.	O

Mr.	O
Mass	O
was	O
placed	O
on	O
multiple	O
courses	O
of	O
antibiotics	B-treatment
.	O

Most	O
recently	O
,	O
he	O
was	O
on	O
a	O
28	O
day	O
course	O
of	O
Vancomycin	B-treatment
,	O
ofloxacin	B-treatment
,	O
and	O
Flagyl	B-treatment
,	O
for	O
blood	B-test
cultures	I-test
that	O
were	O
positive	O
for	O
gram	B-problem
positive	I-problem
cocci	I-problem
and	O
enteric	B-problem
and	I-problem
non-enteric	I-problem
gram	I-problem
negative	I-problem
rods	I-problem
.	O

This	B-treatment
28	I-treatment
day	I-treatment
course	I-treatment
was	O
completed	O
on	O
07/15/95	O
.	O

The	O
patient	O
was	O
also	O
treated	O
initially	O
with	O
amphotericin-B	B-treatment
and	O
then	O
with	O
fluconazole	B-treatment
for	O
a	B-test
computerized	I-test
tomography	I-test
guided	I-test
aspirate	I-test
of	O
a	B-problem
small	I-problem
fluid	I-problem
collection	I-problem
around	I-problem
his	I-problem
pancreas	I-problem
,	O
which	O
grew	O
Candida	B-problem
albicans	I-problem
.	O

The	O
patient	O
also	O
had	O
several	O
episodes	O
of	O
fungal	B-problem
cystitis	I-problem
with	O
Torulopsis	B-problem
glabrata	I-problem
,	O
going	O
from	O
his	B-test
urine	I-test
.	O

He	O
was	O
treated	O
with	O
amphotericin-B	B-treatment
bladder	I-treatment
washes	I-treatment
for	O
this	O
.	O

Mr.	O
Mass	O
was	O
initially	O
anticoagulated	B-treatment
for	O
his	B-problem
left	I-problem
ventricular	I-problem
aneurysm	I-problem
.	O

He	O
remained	O
stable	O
from	O
a	O
cardiac	O
fashion	O
.	O

He	O
did	O
have	O
problems	B-problem
with	O
po	O
intake	O
.	O

He	O
had	O
repeated	O
bouts	O
of	O
small-volume	B-problem
emesis	I-problem
that	O
may	O
have	O
been	O
secondary	O
to	O
reflux	B-problem
.	O

He	O
was	O
treated	O
with	O
a	O
variety	O
of	O
anti-emetics	B-treatment
,	O
most	O
recently	O
Granisetron	B-treatment
,	O
with	O
only	O
mild	O
success	O
.	O

He	O
remained	O
total	B-problem
parenteral	I-problem
nutrition-dependent	I-problem
throughout	O
his	O
hospital	O
course	O
.	O

By	O
the	O
end	O
of	O
June	O
,	O
it	O
became	O
clear	O
that	O
Mr.	O
Mass	O
would	O
require	O
aggressive	B-treatment
surgical	I-treatment
intervention	I-treatment
in	O
order	O
to	O
eradicate	O
his	B-problem
intra-abdominal	I-problem
bursts	I-problem
of	I-problem
intermittent	I-problem
sepsis	I-problem
;	O
however	O
,	O
long	O
discussions	O
with	O
the	O
patient	O
and	O
his	O
wife	O
,	O
who	O
was	O
his	O
health-care	O
proxy	O
,	O
revealed	O
that	O
they	O
felt	O
that	O
no	O
further	B-treatment
aggressive	I-treatment
intervention	I-treatment
be	O
attempted	O
.	O

The	O
patient	O
had	O
been	O
made	O
a	O
do	O
not	O
resuscitate	O
do	O
not	O
intubate	O
patient	O
earlier	O
in	O
his	O
hospital	O
stay	O
.	O

Multiple	O
discussions	O
were	O
held	O
between	O
Dr.	O
Mass	O
,	O
the	O
rest	O
of	O
the	O
surgical	O
team	O
,	O
and	O
the	O
patient	O
&apos;s	O
wife	O
,	O
with	O
this	O
same	O
result	O
.	O

After	O
discussion	O
with	O
the	O
patient	O
&apos;s	O
primary	O
doctor	O
,	O
Dr.	O
Douet	O
at	O
Vassdiysey	O
Medical	O
Center	O
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
and	O
his	O
family	O
would	O
be	O
best	O
served	O
if	O
the	O
patient	O
were	O
transferred	O
to	O
Vassdiysey	O
Medical	O
Center	O
.	O

Of	O
note	O
,	O
given	O
the	O
patient	O
&apos;s	O
do	O
not	O
resuscitate	O
status	O
and	O
the	B-problem
risk	I-problem
for	I-problem
bleeding	I-problem
,	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
Coumadin	I-treatment
was	O
stopped	O
without	O
incident	O
several	O
weeks	O
before	O
transfer	O
.	O

DOCTORS	O
DISCHARGE	O
INSTRUCTIONS	O
:	O

MEDICATIONS	O
:	O

1.	O
Heparin	B-treatment
,	O
5,000	O
units	O
,	O
sc.	O
,	O
b.i.d.	O

2.	O
Lisinopril	B-treatment
,	O
20	O
mg.	O
,	O
po	O
,	O
qD	O
.	O

3.	O
Isordil	B-treatment
,	O
10	O
mg.	O
,	O
po	O
,	O
t.i.d.	O

4.	O
Nitropaste	B-treatment
,	O
1	O
inch	O
to	O
chest	O
wall	O
,	O
q8h.	O

5.	O
Carafate	B-treatment
,	O
one	O
gram	O
,	O
po	O
or	O
per	O
nasogastric	B-treatment
tube	I-treatment
,	O
q.i.d.	O
,	O
Cardizem	B-treatment
,	O
30	O
mg.	O
,	O
po	O
,	O
q6h	O
,	O
digoxin	B-treatment
,	O
0.25	O
mg.	O
,	O
po	O
or	O
intravenously	O
,	O
qD	O
,	O
fluconazole	B-treatment
,	O
200	O
mg.	O
,	O
qD	O
,	O
for	O
five	O
more	O
days	O
,	O
after	O
transfer	O
,	O
for	O
a	O
total	O
of	O
a	O
14	O
day	O
course	O
,	O
total	B-treatment
parenteral	I-treatment
nutrition	I-treatment
to	O
meet	O
the	O
patient	O
&apos;s	O
nutritional	O
needs	O
.	O

The	O
patient	O
has	O
an	B-treatment
ostomy	I-treatment
appliance	I-treatment
around	O
the	O
former	O
site	O
of	O
his	B-treatment
pancreatic	I-treatment
fistula	I-treatment
drain	I-treatment
.	O

This	O
area	O
has	O
continued	O
to	O
drain	O
and	O
it	O
is	O
felt	O
that	O
it	O
could	O
be	O
best	O
managed	O
by	O
an	B-treatment
ostomy	I-treatment
appliance	I-treatment
and	O
stoma	B-treatment
care	I-treatment
.	O

The	O
patient	O
is	O
also	O
treated	O
with	O
shots	B-treatment
of	I-treatment
morphine	I-treatment
for	O
intermittent	B-problem
pain	I-problem
.	O

I	O
DRAIN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

LIASUN	O
L.	O
MASS	O
,	O
M.D.	O

TR	O
:	O

aet	O
/	O
bmot	O

DD	O
:	O

07/16/95	O
PAD-WORD	O

TD	O
:	O

07/15/95	O
PAD-WORD	O

CC	O
:	O

STAT	O
discharge	O
summary	O
.	O

Copies	O
to	O
Dr.	O
Liasun	O
Mass	O
,	O
Dr.	O
Tomedankell	O
New	O
of	O
Cardiology	O
,	O
and	O
Dr.	O
Scosthuang	O
of	O
Vassdiysey	O
Medical	O
Center	O
.	O

Please	O
have	O
a	O
copy	O
in	O
the	O
chart	O
;	O
the	O
patient	O
will	O
be	O
leaving	O
on	O
the	O
morning	O
of	O
07/16/95	O
.	O

Admission	O
Date	O
:	O

2014-03-22	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-03-28	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1983-03-15	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

ORT	O
PAD-WORD	O

ADDENDUM	O
:	O

Mr.	O
Olander	O
had	O
acute	B-problem
blood	I-problem
loss	I-problem
anemia	I-problem
from	O
the	O
combination	O
of	O
the	B-problem
gunshot	I-problem
wound	I-problem
to	I-problem
the	I-problem
right	I-problem
distal	I-problem
femur	I-problem
as	O
well	O
as	O
requirements	O
for	O
urgent	B-treatment
open	I-treatment
reduction	I-treatment
,	O
internal	B-treatment
fixation	I-treatment
.	O

His	B-test
hematocrit	I-test
dropped	O
down	O
to	O
the	O
level	O
of	O
20	O
.	O

Although	O
he	O
remained	O
hemodynamically	O
stable	O
,	O
we	O
elected	O
to	O
move	O
ahead	O
and	O
transfuse	O
him	O
with	O
nonautologous	B-treatment
PRBC	I-treatment
.	O

Bertha	O
Patrick	O
,	O
MD	O
20AAQ	O

Dictated	O
By	O
:	O
Rose	O
D.	O
Bordelon	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-04-11	O
13:18:08	O

T	O
:	O
2014-04-12	O
09:36:49	O

Job	O
#:	O
32074	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Josefa	O
V.	O
Wynn	O
on	O
:	O
WED	O
2014-04-16	O
2:19	O
PM	O

(	O
End	O
of	O
Report	O
)	O

745232329	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

9543139	O
PAD-WORD	O

96458/7hv1	O
PAD-WORD	O

139846	O
PAD-WORD	O

9/14/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

9/14/93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

9/15/93	O
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

left	B-treatment
axillary	I-treatment
node	I-treatment
dissection	I-treatment
,	O
status	O
post	O
breast	B-problem
carcinoma	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
a	O
49	O
year	O
old	O
previously	O
healthy	O
female	O
,	O
who	O
was	O
diagnosed	O
in	O
June	O
,	O
1992	O
,	O
with	O
a	B-problem
breast	I-problem
carcinoma	I-problem
,	O
after	O
she	O
presented	O
with	O
some	B-problem
breast	I-problem
discomfort	I-problem
on	I-problem
the	I-problem
left	I-problem
side	I-problem
.	O

She	O
underwent	O
a	B-treatment
wide	I-treatment
resection	I-treatment
of	O
a	B-problem
left	I-problem
breast	I-problem
mass	I-problem
by	O
Dr.	O
Ausguall	O
on	O
8/17/93	O
.	O

Pathology	B-test
of	O
this	B-treatment
resection	I-treatment
revealed	O
a	B-problem
Grade	I-problem
III	I-problem
/	I-problem
III	I-problem
infiltrating	I-problem
ductal	I-problem
carcinoma	I-problem
.	O

She	O
now	O
presents	O
for	O
left	B-treatment
axillary	I-treatment
node	I-treatment
dissection	I-treatment
,	O
to	O
complete	O
her	O
staging	O
.	O

She	O
has	O
no	O
complaints	O
at	O
the	O
time	O
of	O
presentation	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

noncontributory	O
,	O
her	O
last	O
menstrual	O
period	O
was	O
regular	O
,	O
and	O
last	O
week	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

:w	O
PAD-WORD	O

:q	O
PAD-WORD	O

none	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Noncontributory	O
.	O

ALLERGIES	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Denies	O
cigarette	O
,	O
or	O
alcohol	O
use	O
,	O
she	O
is	O
married	O
and	O
has	O
one	O
child	O
.	O

FAMILY	O
HISTORY	O
:	O

Is	O
negative	O
,	O
there	O
is	O
no	O
breast	B-problem
carcinoma	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Patient	O
is	O
a	O
pleasant	O
female	O
,	O
in	O
no	O
apparent	B-problem
distress	I-problem
.	O

Her	B-test
vital	I-test
signs	I-test
are	O
stable	O
,	O
she	O
is	O
afebrile	B-problem
.	O

head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
throat	O
:	O

reveals	O
no	O
adenopathy	B-problem
,	O
extra	O
ocular	O
movements	O
intact	O
,	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Throat	O
:	O

benign	O
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
first	O
and	O
second	O
heart	O
sounds	O
,	O
no	O
murmur	B-problem
,	O
rub	B-problem
or	O
gallop	B-problem
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
and	O
percussion	B-test
.	O

Abdomen	O
:	O

soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
,	O
positive	O
bowel	O
sounds	O
,	O
there	O
is	O
no	O
hepatosplenomegaly	B-problem
.	O

Chest	O
:	O

reveals	O
a	B-problem
well	I-problem
healed	I-problem
incision	I-problem
in	I-problem
the	I-problem
left	I-problem
side	I-problem
,	O
there	O
are	O
no	O
axillary	O
lymph	O
nodes	O
palpable	O
on	O
both	O
sides	O
.	O

Extremities	O
:	O

reveal	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

Motor	O
:	O

5/5	O
throughout	O
.	O

Sensory	O
:	O

intact	O
.	O

LABORATORY	O
DATA	O
:	O

sodium	B-test
140	O
,	O
potassium	B-test
4.4	O
,	O
BUN	B-test
and	O
creatinine	B-test
14/.9	O
,	O
glucose	B-test
95	O
,	O
prothrombin	B-test
time	I-test
10.0	O
,	O
with	O
a	O
control	O
of	O
10.2	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
26.9	O
,	O
urinalysis	B-test
negative	O
,	O
white	B-test
blood	I-test
count	I-test
5.8	O
,	O
hematocrit	B-test
37.5	O
,	O
hemoglobin	B-test
13.4	O
,	O
platelet	B-test
count	I-test
274,000	O
.	O

The	B-test
electrocardiogram	I-test
reveals	O
normal	O
sinus	O
rhythm	O
at	O
66	O
beats	O
per	O
minute	O
,	O
with	O
no	O
ST	B-problem
changes	I-problem
,	O
there	O
is	O
R	B-problem
wave	I-problem
progression	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
9/14/93	O
,	O
and	O
underwent	O
on	O
that	O
same	O
day	O
,	O
a	B-treatment
left	I-treatment
axillary	I-treatment
lymph	I-treatment
nodes	I-treatment
dissection	I-treatment
,	O
by	O
Dr.	O
Ausguall	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
,	O
there	O
were	O
no	O
complications	B-problem
.	O

Postoperative	O
course	O
was	O
unremarkable	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
on	O
9/15/93	O
.	O

At	O
that	O
time	O
her	B-treatment
JP	I-treatment
was	O
still	O
in	O
place	O
.	O

DISPOSITION	O
:	O

Patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Ausguall	O
,	O
in	O
about	O
4-5	O
days	O
,	O
at	O
which	O
time	O
the	B-treatment
JP	I-treatment
drain	I-treatment
will	O
be	O
removed	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Percocet	B-treatment
1-2	O
tablets	O
PO	O
q3-4	O
prn	O
.	O

BESTI	O
KOTEBREUN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

WILFTAM	O
AUSGUALL	O
,	O
M.D.	O

TR	O
:	O

th	O
/	O
bmot	O

DD	O
:	O

9/14/93	O
PAD-WORD	O

TD	O
:	O

09/15/93	O
PAD-WORD	O

CC	O
:	O

Dr.	O
Ausguall	O

Admission	O
Date	O
:	O

2019-02-01	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2019-02-09	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1940-04-28	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	O
Drugs	B-treatment

Attending	O
:	O
Nicholas	O
E.	O
E.	O
Collard	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Abdominal	B-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Intubation	B-treatment
PAD-WORD	O

ERCP	B-test
with	O
stent	B-treatment

Blood	B-treatment
transfusion	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

Pt	O
is	O
a	O
78	O
yo	O
male	O
with	O
h/o	O
A	B-problem
fib	I-problem
,	O
s/p	O
multiple	B-problem
CVA	I-problem
s,	I-problem
CHF	B-problem
,	O
HTN	B-problem
,	O
DM2	B-problem
admitted	O
to	O
Mediplex	O
Rehab	O
Hospital	O
Robert	O
on	O
02-01	O
with	O
abdominal	B-problem
pain	I-problem
and	O
n/v	B-problem
since	O
that	O
morning	O
.	O

Pt	B-test
's	I-test
vitals	I-test
on	O
admission	O
wer	O
significant	O
for	O
T	B-test
104	O
,	O
SBP	B-test
100	O
s,	O
HR	B-test
in	O
the	O
120	O
s.	O

RUQ	B-test
U/s	I-test
demonstrated	O
multiple	B-problem
small	I-problem
gallstones	I-problem
with	O
sludges	B-problem
without	O
evidence	O
of	O
pericholecystic	B-problem
fluid	I-problem
or	O
significant	B-problem
dilatation	I-problem
of	I-problem
the	I-problem
gallbladder	I-problem
.	O

Surgery	O
was	O
consulted	O
for	O
concern	O
of	O
cholangitis	B-problem
with	O
probable	O
sepsis	B-problem
.	O

Pt	O
was	O
admitted	O
to	O
the	O
CMED	O
CCU	O
,	O
intubated	B-treatment
overnight	O
for	O
ERCP	B-test
procedure	I-test
and	O
fluid	B-treatment
resuscitation	I-treatment
.	O

The	O
patient	O
was	O
placed	O
on	O
zosyn	B-treatment
.	O

Pt	B-test
's	I-test
INR	I-test
was	O
eleveted	B-problem
as	O
he	O
was	O
on	O
home	B-treatment
coumadin	I-treatment
.	O

He	O
was	O
given	O
4	B-treatment
units	I-treatment
FFP	I-treatment
in	O
anticipation	O
of	O
ERCP	B-test
the	O
following	O
day	O
.	O

On	O
02-02	O
ERCP	B-test
demonstrated	O
a	B-problem
large	I-problem
filling	I-problem
defect	I-problem
in	I-problem
the	I-problem
distal	I-problem
duct	I-problem
representing	O
a	B-problem
stone	I-problem
with	O
CBD	B-problem
dilatation	I-problem
.	O

A	B-treatment
biliary	I-treatment
stent	I-treatment
was	O
placed	O
after	O
the	B-treatment
removal	I-treatment
of	O
the	B-problem
stone	I-problem
.	O

Pt	O
was	O
extubated	O
the	O
next	O
day	O
.	O

He	O
was	O
then	O
transferred	O
to	O
the	O
medicine	O
service	O
.	O

Past	O
Medical	O
History	O
:	O

1)	O
Atrial	B-problem
fibrillation	I-problem

2)	O
s/p	O
MVR	B-treatment
(	I-treatment
mechanical	I-treatment
)	I-treatment

3)	O
CHF	B-problem
EF	B-test
15%	O

4)	O
HTN	B-problem

5)	O
multiple	B-problem
CVA	I-problem
s	I-problem
(	O
last	O
1998	O
)	O

6)	O
Hypercholesterolemia	B-problem

7)	O
Type	B-problem
II	I-problem
DM	I-problem

8)	O
Multiple	B-problem
prior	I-problem
UTI	I-problem

Social	O
History	O
:	O

Lives	O
in	O
Danvers	O
with	O
wife	O
,	O
denies	O
Timothy	O
or	O
alcohol	O
.	O

Family	O
History	O
:	O

NC	O
PAD-WORD	O

Physical	O
Exam	O
:	O

upon	O
tx	O
to	O
medicine	O
service	O

T	B-test
:	O
99.0	O
;	O
BP	B-test
142/61	O
;	O
Pulse	B-test
65	O
;	O
Resp	B-test
20	O
;	O
O2	B-test
sat	I-test
96%	O
RA	O

Gen	O
-	O
Alert	O
,	O
no	O
acute	B-problem
distress	I-problem

HEENT	O
-	O
mucous	B-problem
membranes	I-problem
slightly	I-problem
dry	I-problem

Neck	O
-	O
no	O
JVD	B-problem
,	O
no	O
cervical	B-problem
lymphadenopathy	I-problem

Chest	O
-	O
CTA	O
b/l	O
with	O
good	O
air	O
entry	O

CV	O
-	O
Normal	O
S1/S2	O
,	O
irreg	B-problem
irreg	I-problem

Abd	O
-	O
Soft	O
,	O
nontender	B-problem
,	O
mild	B-problem
distension	I-problem
,	O
normoactive	O
bowel	O
sounds	O

Extr	O
-	O
No	O
edema	B-problem
.	O

2+	O
DP	B-test
pulses	I-test
bilaterally	O

Neur	O
:	O
A	O
&	O
O	O
X3	O
,	O
dysarthric	B-problem
speech	I-problem
,	O

CN	O
:	O
mild	B-problem
left	I-problem
facial	I-problem
droop	I-problem
,	O
o/w	O
appears	O
intact	O
;	O
4/5	O
strength	O
on	O
flex	O
at	O
elbows	O
b/l	O
,	O
legs	O
06-22	O
strength	O
,	O
DTR	O
s	O
intact	O
,	O
sensation	O
intact	O

Skin	O
-	O
No	O
rash	B-problem

Pertinent	O
Results	O
:	O

ERCP	O
report	O
:	O
Four	B-test
fluoroscopic	I-test
images	I-test
and	O
ERCP	B-test
are	O
provided	O
.	O

A	B-problem
large	I-problem
filling	I-problem
defect	I-problem
is	O
seen	O
in	O
the	O
distal	O
duct	O
representing	O
a	B-problem
stone	I-problem
.	O

The	O
common	O
duct	O
is	O
dilated	B-problem
.	O

Subsequent	B-treatment
biliary	I-treatment
stent	I-treatment
was	O
placed	O
after	O
the	B-treatment
removal	I-treatment
of	O
the	B-problem
stone	I-problem
.	O

Blood	B-test
cultures	I-test
:	O

2019-02-01	O
(	O
4	O
of	O
4	O
bottles	O
)	O
E.coli	B-problem

CXR	B-test
:	O
Pulmonary	B-problem
edema	I-problem
.	O

ECHO	B-test
:	O

The	O
left	O
atrium	O
is	O
markedly	B-problem
dilated	I-problem
.	O

There	O
is	O
mild	B-problem
symmetric	I-problem
left	I-problem
ventricular	I-problem
hypertrophy	I-problem
.	O

The	O
left	O
ventricular	O
cavity	O
is	O
moderately	B-problem
dilated	I-problem
.	O

There	O
is	O
moderate	B-problem
global	I-problem
left	I-problem
ventricular	I-problem
hypokinesis	I-problem
.	O

Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
moderately	B-problem
depressed	I-problem
.	O

Right	B-test
ventricular	I-test
chamber	I-test
size	I-test
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

Right	B-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
normal	O
.	O

[	O
Intrinsic	B-test
right	I-test
ventricular	I-test
systolic	I-test
function	I-test
is	O
likely	O
more	B-problem
depressed	I-problem
given	O
the	O
severity	O
of	O
tricuspid	B-problem
regurgitation	I-problem
.]	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	B-problem
thickened	I-problem
.	O

There	O
is	O
no	O
aortic	B-problem
valve	I-problem
stenosis	I-problem
.	O

Mild	B-problem
(	I-problem
1+	I-problem
)	I-problem
aortic	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

A	B-treatment
bileaflet	I-treatment
mitral	I-treatment
valve	I-treatment
prosthesis	I-treatment
is	O
present	O
.	O

The	B-test
transmitral	I-test
gradient	I-test
is	O
normal	O
for	O
this	B-treatment
prosthesis	I-treatment
.	O

No	O
mitral	B-problem
regurgitation	I-problem
is	O
seen	O
.	O

Mild	B-problem
(	I-problem
1+	I-problem
)	I-problem
mitral	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

[	O
Due	O
to	O
acoustic	O
shadowing	O
,	O
the	O
severity	O
of	O
mitral	B-problem
regurgitation	I-problem
may	O
be	O
significantly	O
UNDERestimated	O
.]	O

The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	B-problem
thickened	I-problem
.	O

Moderate	B-problem
[	I-problem
2+	I-problem
]	I-problem
tricuspid	I-problem
regurgitation	I-problem
is	O
seen	O
.	O

There	O
is	O
mild	B-problem
pulmonary	I-problem
artery	I-problem
systolic	I-problem
hypertension	I-problem
.	O

There	O
is	O
no	O
pericardial	B-problem
effusion	I-problem
.	O

Labs	O
on	O
admission	O
:	O

2019-02-01	O
03:20	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
11.7	O
*#	O
RBC	B-test
-	O
4.72	O
Hgb	B-test
-	O
14.1	O
Hct	B-test
-	O
42.7	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
29.9	O
MCHC	B-test
-	O
33.1	O
RDW	B-test
-	O
14.9	O
Plt	B-test
Ct	I-test
-	O
91	O
*	O

2019-02-01	O
03:20	O
PM	O
BLOOD	B-test
Neuts	B-test
-	O
94.6	O
*	O
Bands	B-test
-	O
0	O
Lymphs	B-test
-	O
2.7	O
*	O
Monos	B-test
-	O
1.9	O
*	O
Eos	B-test
-	O
0.4	O
Baso	B-test
-	O
0.4	O

2019-02-01	O
03:20	O
PM	O
BLOOD	B-test
PT	B-test
-	O
28.0	O
*	O
PTT	B-test
-	O
26.7	O
INR(PT)	B-test
-	O
2.9	O
*	O

2019-02-01	O
03:20	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
202	O
*	O
UreaN	B-test
-	O
31	O
*	O
Creat	B-test
-	O
1.3	O
*	O
Na	B-test
-	O
141	O
K	B-test
-	O
4.0	O
Cl	B-test
-	O
102	O
HCO3	B-test
-	O
27	O
AnGap	B-test
-	O
16	O

2019-02-01	O
03:20	O
PM	O
BLOOD	B-test
ALT	B-test
-	O
167	O
*	O
AST	B-test
-	O
218	O
*	O
AlkPhos	B-test
-	O
108	O
Amylase	B-test
-	O
117	O
*	O
TotBili	B-test
-	O
3.6	O
*	O

2019-02-02	O
03:54	O
PM	O
BLOOD	B-test
Lipase	B-test
-	O
992	O
*	O

2019-02-01	O
03:20	O
PM	O
BLOOD	B-test
Albumin	B-test
-	O
4.8	O
Calcium	B-test
-	O
9.4	O
Phos	B-test
-	O
1.9	O
*	O
Mg	B-test
-	O
2.0	O

2019-02-01	O
04:15	O
PM	O
BLOOD	B-test
Digoxin	B-test
-	O
0.3	O
*	O

2019-02-01	O
11:43	O
PM	O
BLOOD	B-test
Type	I-test
-	O
ART	O
Temp	B-test
-	O
38.3	O
PEEP	B-treatment
-	O
5	O
pO2	B-test
-	O
115	O
*	O
pCO2	B-test
-	O
36	O
pH	B-test
-	O
7.33	O
*	O
calTCO2	B-test
-	O
20	O
*	O
Base	B-test
XS	I-test
-	O
-6	O
Intubat	O
-	O
INTUBATED	B-treatment

2019-02-01	O
04:06	O
PM	O
BLOOD	B-test
Lactate	B-test
-	O
3.4	O
*	O

2019-02-01	O
08:00	O
PM	O
BLOOD	B-test
Lactate	B-test
-	O
6.4	O
*	O

Labs	O
on	O
discharge	O
:	O

2019-02-06	O
06:30	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
7.4	O
RBC	B-test
-	O
3.82	O
*	O
Hgb	B-test
-	O
11.3	O
*	O
Hct	B-test
-	O
34.7	O
*	O
MCV	B-test
-	O
91	O
MCH	B-test
-	O
29.5	O
MCHC	B-test
-	O
32.5	O
RDW	B-test
-	O
15.1	O
Plt	B-test
Ct	I-test
-	O
92	O
*	O

2019-02-09	O
04:45	O
AM	O
BLOOD	B-test
PT	B-test
-	O
19.6	O
*	O
PTT	B-test
-	O
74.9	O
*	O
INR(PT)	B-test
-	O
1.9	O
*	O

2019-02-07	O
09:00	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
124	O
*	O
UreaN	B-test
-	O
26	O
*	O
Creat	B-test
-	O
1.2	O
Na	B-test
-	O
140	O
K	B-test
-	O
3.7	O
Cl	B-test
-	O
102	O
HCO3	B-test
-	O
29	O
AnGap	B-test
-	O
13	O

2019-02-07	O
09:00	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
62	O
*	O
AST	B-test
-	O
45	O
*	O
AlkPhos	B-test
-	O
105	O
TotBili	B-test
-	O
2.2	O
*	O

2019-02-04	O
02:40	O
AM	O
BLOOD	B-test
Lipase	B-test
-	O
74	O
*	O

2019-02-07	O
09:00	O
AM	O
BLOOD	B-test
Mg	B-test
-	O
2.0	O

2019-02-04	O
02:50	O
AM	O
BLOOD	B-test
Lactate	B-test
-	O
1.0	O

Brief	O
Hospital	O
Course	O
:	O

Pt	O
is	O
a	O
78	O
yo	O
male	O
with	O
atrial	B-problem
fibrillation	I-problem
,	O
s/p	O
multiple	B-problem
CVA	I-problem
s,	I-problem
CHF	B-problem
,	O
HTN	B-problem
,	O
DM2	B-problem
transferred	O
from	O
the	O
CMED	O
CCU	O
s/p	O
intervention	B-treatment
for	O
cholangitis	B-problem
.	O

1)	O
Acute	B-problem
cholangitis	I-problem
:	O
Pt	O
was	O
admitted	O
to	O
the	O
ICU	O
,	O
intubated	O
,	O
and	O
ERCP	B-test
performed	O
,	O
likely	O
stone	B-problem
obstructing	O
CBD	O
.	O

Stent	B-treatment
was	O
placed	O
and	O
patient	O
was	O
treated	O
with	O
antibiotics	B-treatment
(	O
Zosyn	B-treatment
-	O
>	O
Ciprofloxacin	B-treatment
).	O

Per	O
ERCP	O
fellow	O
,	O
plan	O
is	O
for	O
patient	O
to	O
return	O
in	O
four	O
weeks	O
to	O
see	O
Dr.	O
Suzanne	O
Davis	O
,	O
at	O
which	O
time	O
he	O
will	O
likely	O
have	O
repeat	B-test
cholangiogram	I-test
and	O
removal	B-treatment
of	O
stent	B-treatment
and	O
stone	B-problem
.	O

If	O
this	O
is	O
still	O
problematic	O
,	O
pt	O
may	O
also	O
need	O
a	B-treatment
sphincterotomy	I-treatment
.	O

Dr.Demby	O
secretary	O
will	O
contact	O
patient	O
at	O
home	O
the	O
week	O
after	O
discharge	O
to	O
schedule	O
this	O
for	O
the	O
end	O
of	O
January	O
.	O

Pt	O
is	O
to	O
continue	O
ciprofloxacin	B-treatment
for	O
a	O
complete	O
14	O
day	O
course	O
.	O

2)	O
Mechanical	B-treatment
mitral	I-treatment
valve	I-treatment
:	O
Anticoagulation	B-treatment
was	O
reversed	O
for	O
ERCP	B-test
.	O

After	O
this	O
he	O
was	O
anticoagulated	O
with	O
heparin	B-treatment
drip	I-treatment
.	O

INR	B-test
was	O
1.9	O
on	O
discharge	O
.	O

He	O
was	O
given	O
sc	B-treatment
lovenox	I-treatment
x	O
1	O
and	O
will	O
continue	O
this	O
the	O
day	O
after	O
discharge	O
bid	O
for	O
one	O
day	O
.	O

VNA	O
will	O
check	O
his	B-test
INR	I-test
at	O
home	O
and	O
page	O
his	O
PCP	O
with	O
the	O
results	O
.	O

3)	O
Atrial	B-problem
fibrillation	I-problem
:	O
Rate	O
controlled	O
and	O
on	O
warfarin	B-treatment
.	O

While	O
in	O
the	O
hospital	O
he	O
had	O
several	O
episodes	O
of	O
pauses	B-problem
,	O
none	O
longer	O
than	O
2.5	O
seconds	O
.	O

His	B-treatment
digoxin	I-treatment
was	O
held	O
and	O
his	B-treatment
metoprolol	I-treatment
was	O
titrated	O
down	O
from	O
his	B-treatment
home	I-treatment
dose	I-treatment
.	O

Once	O
the	B-treatment
digoxin	I-treatment
was	O
no	O
longer	O
having	O
effect	O
,	O
metoprolol	B-treatment
was	O
titrated	O
back	O
to	O
home	O
dose	O
.	O

4)	O
CHF	B-problem
:	O
Pt	O
was	O
oxygen	B-problem
dependent	I-problem
for	O
most	O
of	O
the	O
hospital	O
course	O
,	O
CXR	B-test
was	O
consistent	O
with	O
pulmonary	B-problem
edema	I-problem
.	O

He	O
was	O
diuresed	O
with	O
lasix	B-treatment
with	O
good	O
effect	O
.	O

Volume	B-problem
overload	I-problem
likely	O
ocurred	O
in	O
the	O
setting	O
of	O
IV	B-treatment
fluids	I-treatment
given	O
in	O
the	O
ICU	O
.	O

Did	O
not	O
require	O
lasix	B-treatment
on	O
discharge	O
.	O

5)	O
E.	B-problem
coli	I-problem
bacteremia	I-problem
/	O
sepsis	B-problem
:	O
Source	O
of	O
acute	B-problem
cholangitis	I-problem
as	O
above	O
.	O

Pt	O
required	O
3	O
day	O
stay	O
in	O
the	O
surgical	O
ICU	O
and	O
intubation	B-treatment
as	O
above	O
.	O

6)	O
Intubation	B-treatment
:	O
Pt	O
was	O
97%	O
on	O
room	O
air	O
on	O
arrival	O
to	O
Cindy	O
,	O
developed	O
rapid	B-problem
ventricular	I-problem
reponse	I-problem
to	O
a	B-problem
fib	I-problem
which	O
was	O
treated	O
,	O
but	O
after	O
that	O
period	O
of	O
time	O
required	O
oxygen	B-treatment
,	O
presumably	O
for	O
pulmonary	B-problem
edema	I-problem
.	O

In	O
the	O
Lori	O
pt	O
was	O
given	O
3L	B-treatment
NS	I-treatment
as	O
well	O
as	O
1	O
unit	O
of	O
FFP	B-treatment
,	O
and	O
oxygen	B-problem
requirements	I-problem
contimued	O
to	O
climb	O
.	O

In	O
the	O
CMED	O
CCU	O
pt	O
was	O
intubated	O
for	O
ERCP	B-test
procedure	I-test
.	O

He	O
was	O
extubated	O
the	O
next	O
morning	O
.	O

Medications	O
on	O
Admission	O
:	O

Lisinopril	B-treatment
2.5	O
qday	O
,	O
Buspiron	B-treatment
20	O
mg	O
po	O
qday	O
,	O
Digoxin	B-treatment
,	O
Doxasozin	B-treatment
8	O
mg	O
qhs	O
,	O
Glyburide	B-treatment
2.5	O
mg	O
qday	O
,	O
metoprolol	B-treatment
bid	O
,	O
atorvastatin	B-treatment
20	O
mg	O
qday	O
,	O
warfarin	B-treatment
5	O
mg	O
qday	O

Discharge	O
Medications	O
:	O

1.	O
Ciprofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
6	O
days	O
.	O

Disp	O
:*	O
12	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Medications	B-treatment

Continue	O
all	B-treatment
other	I-treatment
home	I-treatment
medications	I-treatment
EXCEPT	O
do	O
not	O
take	O
digoxin	B-treatment
.	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnosis	O
:	O

acute	B-problem
cholangitis	I-problem

Secondary	O
diagnosis	O
:	O

anticoagulation	B-treatment
with	O
a	B-treatment
mechanical	I-treatment
valve	I-treatment

Atrial	B-problem
fibrillation	I-problem

Diabetes	B-problem
Mellitus	I-problem

Congestive	B-problem
heart	I-problem
failure	I-problem

Discharge	O
Condition	O
:	O

stable	O
,	O
will	O
work	O
with	O
home	O
PT	O

Discharge	O
Instructions	O
:	O

Please	O
continue	O
Ciprofloxacin	B-treatment
antibiotic	I-treatment
until	O
2019-02-14	O
.	O

Dr.	O
Mcfarlane	O
is	O
the	O
doctor	O
who	O
performed	O
the	B-treatment
procedure	I-treatment
to	O
place	O
a	B-treatment
stent	I-treatment
in	I-treatment
your	I-treatment
bile	I-treatment
duct	I-treatment
(	O
a	O
tube	O
that	O
drains	O
the	O
liver	O
).	O

His	O
nurse	O
is	O
going	O
to	O
contact	O
you	O
at	O
home	O
to	O
schedule	O
a	O
time	O
for	O
a	B-treatment
repeat	I-treatment
procedure	I-treatment
to	O
remove	O
that	B-treatment
stent	I-treatment
.	O

You	O
will	O
have	O
your	O
blood	O
drawn	O
tomorrow	O
(	O
2019-02-10	O
)	O
by	O
VNA	O
.	O

It	O
will	O
be	O
called	O
in	O
to	O
Dr.	O
Hamasaki	O
office	O
and	O
he	O
will	O
call	O
you	O
to	O
see	O
how	O
to	O
change	O
your	B-treatment
coumadin	I-treatment
.	O

You	O
will	O
also	O
take	O
lovenox	B-treatment
subcutaneous	I-treatment
injections	I-treatment
tomorrow	O
,	O
2019-02-10	O
.	O

You	O
will	O
take	O
one	O
if	O
the	O
morning	O
and	O
one	O
at	O
night	O
.	O

Continue	O
all	O
of	O
your	B-treatment
medications	I-treatment
except	O
for	O
digoxin	B-treatment
.	O

Followup	O
Instructions	O
:	O

Dr.	O
Mcfarlane	O
is	O
the	O
doctor	O
who	O
performed	O
the	B-treatment
procedure	I-treatment
to	O
place	O
a	B-treatment
stent	I-treatment
in	I-treatment
your	I-treatment
bile	I-treatment
duct	I-treatment
(	O
a	O
tube	O
that	O
drains	O
the	O
liver	O
).	O

His	O
nurse	O
is	O
going	O
to	O
contact	O
you	O
at	O
home	O
to	O
schedule	O
a	O
time	O
for	O
a	B-treatment
repeat	I-treatment
procedure	I-treatment
to	O
remove	O
that	B-treatment
stent	I-treatment
.	O

Before	O
you	O
have	O
the	B-treatment
procedure	I-treatment
with	O
Dr.	O
Morris	O
you	O
will	O
need	O
to	O
talk	O
to	O
Dr.	O
Moya	O
to	O
see	O
if	O
you	O
need	O
to	O
stop	O
your	B-treatment
coumadin	I-treatment
/	O
warfarin	B-treatment
for	O
a	O
few	O
days	O
.	O

Shirley	O
Anthony	O
MD	O
56-333	O

Completed	O
by	O
:	O
Donald	O
Beverly	O
MD	O
74-194	O
2019-02-09	O
@	O
1644	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Shirley	O
V	O
Usher	O
on	O
:	O
SAT	O
2019-02-09	O
5:32	O
PM	O

(	O
End	O
of	O
Report	O
)	O

747495092	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

91057356	O
PAD-WORD	O

183023	O
PAD-WORD	O

7/3/1998	O
12:00:00	O
AM	O

AMPULLARY	B-problem
ADENOCARCINOMA	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

07/03/1998	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

07/10/1998	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

AMPULLARY	B-problem
ADENOCARCINOMA	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
50	O
year	O
old	O
man	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
two	O
weeks	O
prior	O
to	O
admission	O
when	O
the	O
patient	O
developed	O
epigastric	B-problem
pain	I-problem
after	O
meals	O
.	O

The	O
next	O
morning	O
,	O
the	O
patient	O
felt	O
dizzy	B-problem
and	O
went	O
to	O
his	O
private	O
medical	O
doctor	O
at	O
Eifro	O
Medical	O
Center	O
,	O
and	O
was	O
found	O
to	O
have	O
elevated	B-problem
bilirubins	I-problem
,	I-problem
alkaline	I-problem
phosphatase	I-problem
,	I-problem
and	I-problem
transaminases	I-problem
.	O

The	O
patient	O
reported	O
fatigue	B-problem
and	O
nausea	B-problem
,	O
as	O
well	O
as	O
noted	O
coca	B-problem
cola	I-problem
colored	I-problem
urine	I-problem
.	O

The	O
patient	O
has	O
been	O
constipated	B-problem
with	O
hard	B-problem
stool	I-problem
,	O
but	O
no	O
bright	B-problem
red	I-problem
blood	I-problem
per	I-problem
rectum	I-problem
.	O

The	O
patient	O
also	O
reported	O
an	B-problem
18	I-problem
lb	I-problem
weight	I-problem
loss	I-problem
over	O
the	O
last	O
4-5	O
months	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
only	O
for	O
history	O
of	O
hypertension	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

Serax	B-treatment
p.r.n.	O
insomnia	B-problem
;	O
iron	B-treatment
;	O
MVI	B-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

VITAL	O
SIGNS	O
:	O

BP	B-test
120/80	O
,	O
temp	B-test
96	O
,	O
pulse	B-test
78	O
,	O
respiratory	B-test
rate	I-test
18	O
.	O

GENERAL	O
:	O

No	O
acute	B-problem
distress	I-problem
.	O

SKIN	O
:	O

The	O
skin	O
is	O
jaundiced	B-problem
.	O

NODES	O
:	O

No	O
lymph	O
nodes	O
palpated	O
.	O

HEENT	O
:	O

Notable	O
for	O
scleral	B-problem
icterus	I-problem
.	O

LUNGS	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	I-test
,	O
no	O
wheezes	B-problem
,	O
rales	B-problem
,	O
or	O
rhonchi	B-problem
.	O

HEART	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-problem
.	O

ABDOMEN	O
:	O

Soft	O
,	O
bowel	O
sounds	O
present	O
,	O
tenderness	B-problem
present	O
in	O
epigastrium	O
to	O
moderate	B-test
palpation	I-test
.	O

There	O
was	O
no	O
rebound	B-problem
and	O
no	O
hepatosplenomegaly	B-problem
.	O

No	O
incisional	B-problem
scars	I-problem
.	O

EXTREMITIES	O
:	O

Warm	O
,	O
with	O
no	O
edema	B-problem
and	O
palpable	O
pulses	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

Na	B-test
134	O
,	O
K	B-test
4.2	O
,	O
Cl	B-test
98	O
,	O
bicarb	B-test
26	O
,	O
BUN	B-test
11	O
,	O
creatinine	B-test
0.5	O
,	O
glucose	B-test
119	O
.	O

CBC	B-test
-	O
White	B-test
count	I-test
7.5	O
,	O
hematocrit	B-test
28.5	O
,	O
platelets	B-test
452	O
.	O

PT	B-test
16.2	O
,	O
PTT	B-test
34.7	O
,	O
INR	B-test
1.8	O
.	O

LDH	B-test
254	O
,	O
amylase	B-test
727	O
,	O
lipase	B-test
8600	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
preoperatively	O
for	O
surgery	B-treatment
on	O
7/4/98	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
workup	I-test
up	I-test
until	O
that	O
time	O
included	O
a	O
diagnosis	O
of	O
periampullary	B-problem
adenocarcinoma	I-problem
,	O
which	O
was	O
proven	O
by	O
EGD	B-test
directed	I-test
biopsy	I-test
,	O
and	O
a	B-problem
left	I-problem
renal	I-problem
mass	I-problem
,	O
which	O
was	O
biopsied	O
and	O
found	O
to	O
be	O
an	B-problem
oncocytoma	I-problem
.	O

On	O
7/4/98	O
,	O
the	O
patient	O
underwent	O
a	B-treatment
Whipple	I-treatment
procedure	I-treatment
,	O
which	O
proceeded	O
without	O
complications	B-problem
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
extremely	O
well	O
and	O
was	O
extubated	O
the	O
following	O
morning	O
.	O

The	B-treatment
NG	I-treatment
tube	I-treatment
was	O
D/C&apos;d	O
on	O
postoperative	O
day	O
#2	O
.	O

The	O
patient	O
was	O
to	O
be	O
transferred	O
to	O
the	O
floor	O
on	O
postoperative	O
day	O
#2	O
,	O
however	O
,	O
due	O
to	O
the	O
lack	O
of	O
beds	O
,	O
he	O
remained	O
in	O
the	O
ICU	O
until	O
postoperative	O
day	O
#3	O
.	O

On	O
postoperative	O
day	O
#4	O
,	O
the	O
patient	O
began	O
tolerating	O
clear	B-treatment
liquids	I-treatment
and	O
his	O
diet	O
was	O
advanced	O
as	O
tolerated	O
by	O
postoperative	O
day	O
#6	O
and	O
7	O
.	O

The	O
patient	O
was	O
out	O
of	O
bed	O
,	O
doing	O
fine	O
,	O
and	O
tolerating	O
a	O
regular	O
diet	O
on	O
7/10/98	O
.	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
with	O
services	O
and	O
in	O
stable	O
condition	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Sandostatin	B-treatment
100	O
mcg	O
subcu.	O
b.i.d.	O
;	O
Percocet	B-treatment
1-2	O
tabs	O
q.3-4h.	O
p.r.n.	O
pain	B-problem
;	O
Axid	B-treatment
150	O
mg	O
p.o.	O
b.i.d.	O
;	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

DISCHARGE	O
FOLLOW-UP	O
:	O

The	O
patient	O
has	O
been	O
instructed	O
to	O
follow-up	O
with	O
Dr.	O
Red	O
in	O
one	O
week	O
and	O
in	O
the	O
Urology	O
Clinic	O
in	O
three	O
weeks	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
home	O
on	O
7/10/98	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
condition	O
.	O

Dictated	O
By	O
:	O

MALICHARLEAR	O
KROENER	O
,	O
M.D.	O
EB85	O

Attending	O
:	O

LEAND	O
L.	O
KROENER	O
,	O
M.D.	O
QW18	O
FO508/6558	O

Batch	O
:	O

54270	O
PAD-WORD	O

Index	O
No.	O
YCCYST5DG2	O

D	O
:	O

07/10/98	O
PAD-WORD	O

T	O
:	O

07/12/98	O
PAD-WORD	O

CC	O
:	O

1.	O
LEAND	O
L.	O
KROENER	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2012-06-20	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-06-29	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1958-02-28	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

FICU	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
54	O
year-old	O
female	O
with	O
a	O
history	O
of	O
breast	B-problem
cancer	I-problem
with	O
known	B-problem
brain	I-problem
mets	I-problem
,	O
history	O
of	O
PE	B-problem
,	O
recent	B-treatment
radiation	I-treatment
therapy	I-treatment
and	O
steroids	B-treatment
who	O
presented	O
in	O
2012-04-23	O
with	O
myopathy	B-problem
presumed	O
secondary	O
to	O
sterids	B-treatment
,	O
which	O
have	O
been	O
given	O
for	O
her	B-problem
brain	I-problem
mets	I-problem
.	O

She	O
was	O
later	O
sent	O
to	O
rehab	O
,	O
but	O
returned	O
early	O
in	O
April	O
with	O
increased	B-problem
cough	I-problem
with	O
exertion	O
with	O
fever	B-problem
to	O
101	O
.	O

She	O
was	O
treated	O
with	O
Levaquin	B-treatment
given	O
her	B-test
temperatures	I-test
and	O
differential	O
diagnosis	O
of	O
increased	B-problem
PE	I-problem
burden	I-problem
load	I-problem
,	O
infections	B-problem
or	O
pneumonia	B-problem
and	O
questionable	O
lymphangitic	B-problem
spread	I-problem
of	O
her	B-problem
cancer	I-problem
.	O

The	O
patient	O
did	O
not	O
experience	O
improvement	O
in	O
her	B-problem
symptoms	I-problem
and	O
was	O
readmitted	O
on	O
06-11	O
with	O
continued	B-problem
dyspnea	I-problem
and	O
fevers	B-problem
.	O

Review	O
of	O
CTA	B-test
showed	O
no	O
PE	B-problem
,	O
but	O
there	O
was	O
ground	B-problem
glass	I-problem
opacities	I-problem
on	O
CT	B-test
,	O
so	O
PCP	B-problem
was	O
considered	O
highly	O
unlikely	O
given	O
her	O
recent	O
history	O
of	O
steroid	B-treatment
use	I-treatment
.	O

Her	B-test
induced	I-test
sputum	I-test
was	O
negative	O
and	O
BOL	B-test
was	O
done	O
and	O
also	O
negative	O
.	O

Sputum	B-test
cultures	I-test
were	O
negative	O
.	O

She	O
was	O
given	O
Bactrim	B-treatment
and	O
she	O
had	O
improvement	O
in	O
the	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
after	O
her	B-treatment
Bactrim	I-treatment
was	O
started	O
and	O
improved	O
room	O
air	O
sats	O
and	O
was	O
sent	O
home	O
on	O
Bactrim	B-treatment
.	O

She	O
then	O
continued	O
to	O
do	O
poorly	O
and	O
then	O
returned	O
on	O
06-19	O
.	O

She	O
presented	O
on	O
clinic	O
on	O
06-20	O
with	O
hypotension	B-problem
for	O
which	O
she	O
was	O
given	O
intravenous	B-treatment
fluids	I-treatment
.	O

She	O
spiked	O
a	B-problem
fever	I-problem
to	O
103	O
with	O
blood	B-test
pressures	I-test
hypertensive	B-problem
into	O
the	B-test
systolic	I-test
80	O
s	O
and	O
with	O
rigors	B-problem
.	O

Chest	B-test
x-ray	I-test
showed	O
a	O
question	O
of	O
left	B-problem
lung	I-problem
opacity	I-problem
.	O

The	O
patient	O
was	O
given	O
Vancomycin	B-treatment
and	O
a	O
gram	O
of	O
intravenous	B-treatment
fluids	I-treatment
.	O

Today	O
,	O
the	O
patient	O
was	O
found	O
in	O
the	O
bathroom	O
and	O
became	O
hypoxic	B-problem
with	O
saturations	B-test
in	O
the	O
80	O
s	O
and	O
was	O
responsive	O
to	O
oxygen	B-treatment
,	O
but	O
was	O
still	O
tachypneic	B-problem
without	O
improvement	O
and	O
was	O
placed	O
on	O
nonrebreather	B-treatment
.	O

Currently	O
the	O
patient	O
is	O
admitted	O
to	O
the	O
Intensive	O
Care	O
Unit	O
for	O
further	B-treatment
medical	I-treatment
care	I-treatment
.	O

Currently	O
the	O
patient	O
is	O
short	B-problem
of	I-problem
breath	I-problem
without	O
chest	B-problem
pain	I-problem
or	O
dysphagia	B-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Breast	B-problem
cancer	I-problem
left	I-problem
side	I-problem
diagnosed	O
in	O
1982	O
status	O
post	O
1995	O
mastectomy	B-treatment
with	O
5	O
out	O
of	O
9	O
positive	B-problem
lymph	I-problem
nodes	I-problem
.	O

She	O
was	O
treated	O
with	O
chemotherapy	B-treatment
and	O
bone	B-treatment
marrow	I-treatment
transplant	I-treatment
and	O
then	O
later	O
with	O
Tamoxifen	B-treatment
from	O
2004	O
to	O
2001	O
.	O

In	O
2011	O
she	O
had	O
mediastinal	B-problem
lymphadenopathy	I-problem
treated	O
with	O
Taxol	B-treatment
and	O
changed	O
to	O
Navelbine	B-treatment
on	O
03-28	O
.	O

She	O
had	O
diagnosed	O
brain	B-problem
mets	I-problem
in	O
2012-03-25	O
right	O
side	O
cerebella	O
and	O
parietal	O
for	O
which	O
she	O
was	O
treated	O
with	O
chemotherapy	B-treatment
,	O
radiation	B-treatment
therapy	I-treatment
and	O
Decadron	B-treatment
.	O

2.	O
History	O
of	O
pulmonary	B-problem
embolism	I-problem
in	O
2012-04-23	O
treated	O
with	O
only	O
aspirin	B-treatment
secondary	O
to	O
brain	B-problem
mets	I-problem
.	O

3.	O
Asthma	B-problem
.	O

4.	O
Gastritis	B-problem
.	O

5.	O
Questionable	O
history	O
of	O
_______________.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Protonix	B-treatment
40	O
mg	O
q	O
day	O
.	O

2.	O
Megace	B-treatment
400	O
q	O
day	O
.	O

3.	O
Colace	B-treatment
200	O
b.i.d.	O

4.	O
Aspirin	B-treatment
.	O

5.	O
Heparin	B-treatment
subq.	O

6.	O
Prednisone	B-treatment
40	O
q	O
day	O
.	O

7.	O
___________	O
30	O
q	O
day	O
.	O

8.	O
Clindamycin	B-treatment
900	O
q	O
8	O
.	O

9.	O
Levaquin	B-treatment
500	O
q	O
day	O
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
an	O
emergency	O
room	O
physician	O
at	O
the	O
Pauline	O
.	O

She	O
is	O
married	O
with	O
three	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	B-test
on	O
transfer	O
to	O
the	O
Intensive	O
Care	O
Unit	O
she	O
is	O
febrile	B-problem
with	O
a	B-problem
low	I-problem
grade	I-problem
temperature	I-problem
of	O
100.1	O
,	O
tachycardic	B-problem
to	O
110	O
,	O
hypotensive	B-problem
85/49	O
,	O
tachypneic	B-problem
into	O
the	O
50	O
s	O
and	O
60	O
s,	O
95%	O
on	O
nonrebreather	B-treatment
.	O

In	O
general	O
,	O
she	O
is	O
extremely	B-problem
tachypneic	I-problem
,	O
difficulty	B-problem
in	I-problem
speaking	I-problem
words	I-problem
.	O

Her	O
heart	O
is	O
regular	O
without	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
,	O
slightly	B-problem
tachycardic	I-problem
.	O

Her	B-test
pulmonary	I-test
examination	I-test
shows	O
she	O
has	O
bronchial	O
breath	O
sounds	O
with	O
dry	B-problem
crackles	I-problem
at	I-problem
the	I-problem
bases	I-problem
.	O

Abdominal	B-test
examination	I-test
was	O
benign	O
.	O

Extremities	O
no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

She	O
is	O
alert	O
and	O
following	O
commands	O
.	O

LABORATORY	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
3.2	O
,	O
hematocrit	B-test
26.6	O
,	O
platelets	B-test
130	O
,	O
chemistry	B-test
is	O
131	O
,	O
potassium	B-test
3.0	O
,	O
chloride	B-test
105	O
,	O
bicarb	B-test
17	O
,	O
BUN	B-test
10	O
,	O
creatinine	B-test
0.5	O
,	O
glucose	B-test
105	O
.	O

Calcium	B-test
7.3	O
,	O
phos	B-test
1.8	O
,	O
magnesium	B-test
1.5	O
.	O

She	O
had	O
a	B-test
gas	I-test
showing	O
7.36	O
,	O
31	O
,	O
96	O
.	O

She	O
had	O
a	B-test
CT	I-test
from	O
the	O
29th	O
of	O
her	O
abdomen	O
and	O
pelvis	O
showing	O
marked	B-problem
increased	I-problem
consolidations	I-problem
at	I-problem
the	I-problem
left	I-problem
lung	I-problem
base	I-problem
and	O
question	O
of	O
new	B-problem
left	I-problem
sided	I-problem
pleural	I-problem
effusion	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Pulmonary	O
:	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
for	O
respiratory	B-problem
distress	I-problem
and	O
febrile	B-problem
hypotension	I-problem
with	O
a	O
question	O
of	O
a	B-problem
new	I-problem
infiltrate	I-problem
on	O
her	B-test
chest	I-test
x-ray	I-test
.	O

The	O
exact	O
etiology	O
of	O
the	B-problem
patient	I-problem
's	I-problem
respiratory	I-problem
distress	I-problem
was	O
presumed	O
to	O
be	O
questionable	O
multifactorial	O
.	O

There	O
was	O
concern	O
about	O
possible	O
pneumonia	B-problem
.	O

Also	O
she	O
had	O
a	O
history	O
of	O
PE	B-problem
and	O
also	O
there	O
was	O
concern	O
about	O
possible	O
lymphangitic	B-problem
spread	I-problem
of	O
her	B-problem
breast	I-problem
CA	I-problem
.	O

Given	O
her	B-problem
fevers	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
the	O
patient	O
was	O
treated	O
with	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
initially	O
started	O
on	O
Ceptaz	B-treatment
,	O
Levaquin	B-treatment
and	O
__________	O
and	O
Clindamycin	B-treatment
.	O

Lab	O
two	B-treatment
antibiotics	I-treatment
were	O
added	O
considering	O
the	O
patient	O
was	O
thought	O
to	O
be	O
a	O
relatively	O
high	O
risk	O
for	O
PCP	B-problem
Douglas	O
.	O

The	O
patient	O
was	O
initially	O
trialed	O
on	O
BiPAP	B-treatment
,	O
but	O
the	O
patient	O
was	O
increasingly	B-problem
dyspneic	I-problem
,	O
increased	B-problem
respiratory	I-problem
stress	I-problem
and	O
ultimately	O
needed	O
to	O
be	O
intubated	O
on	O
06-22	O
.	O

Earlier	O
during	O
her	O
Intensive	O
Care	O
Unit	O
course	O
she	O
underwent	O
bronchoscopy	B-test
,	O
which	O
was	O
sent	O
for	O
cytology	B-test
and	O
multiple	B-problem
bacterial	I-problem
pathogens	I-problem
all	O
of	O
which	O
were	O
negative	O
.	O

Ultimately	O
her	O
Intensive	O
Care	O
Unit	O
course	O
continued	O
and	O
she	O
began	O
to	O
defervesce	O
and	O
her	B-test
bacterial	I-test
studies	I-test
particulaly	O
from	O
BAL	B-test
lavage	I-test
were	O
found	O
to	O
be	O
negative	O
.	O

The	O
patient	O
had	O
multiple	B-treatment
antibiotics	I-treatment
withdrawn	O
.	O

Clindamycin	B-treatment
and	O
_______________	O
was	O
discontinued	O
early	O
in	O
hospital	O
course	O
.	O

Her	B-test
PCP	I-test
was	O
thought	O
to	O
be	O
negative	O
.	O

In	O
addition	O
,	O
Vancomycin	B-treatment
,	O
Levaquin	B-treatment
were	O
also	O
discontinued	O
.	O

She	O
was	O
later	O
continued	O
on	O
Ceftazidine	B-treatment
and	O
Clindamycin	B-treatment
for	O
possible	O
gram	B-problem
negative	I-problem
infection	I-problem
and	O
also	O
for	O
possible	O
post	B-problem
obstructive	I-problem
picture	I-problem
that	O
she	O
would	O
be	O
at	O
risk	O
for	O
given	O
her	O
pulmonary	O
anatomy	O
.	O

As	O
the	O
Hubbard	O
Regional	O
Hospital	O
hospital	O
course	O
went	O
on	O
the	O
patient	O
's	O
respiratory	O
did	O
not	O
show	O
mild	O
improvement	O
on	O
the	B-treatment
ventilator	I-treatment
.	O

She	O
was	O
able	O
to	O
oxygenate	O
originally	O
.	O

Unfortunately	O
her	O
mental	O
status	O
failed	O
to	O
improve	O
despite	O
having	O
been	O
off	O
all	B-treatment
sedative	I-treatment
medications	I-treatment
for	O
several	O
days	O
.	O

Later	O
in	O
her	O
Intensive	O
Care	O
Unit	O
course	O
family	O
meetings	O
took	O
place	O
and	O
given	O
the	O
patient	O
's	O
overall	O
poor	O
prognosis	O
with	O
decreased	B-problem
mental	I-problem
status	I-problem
it	O
was	O
decided	O
that	O
the	O
patient	O
would	O
become	O
CMO	B-treatment
.	O

Subsequently	O
she	O
was	O
extubated	O
on	O
06-28	O
.	O

The	O
patient	O
continues	O
to	O
actually	O
ventilate	O
well	O
off	O
of	O
the	O
respiratory	O
.	O

However	O
,	O
she	O
is	O
CMO	B-treatment
and	O
will	O
not	O
be	O
intubated	O
for	O
respiratory	B-problem
distress	I-problem
.	O

2.	O
Cardiovascular	O
:	O

The	O
patient	O
was	O
initially	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
thought	O
to	O
be	O
exhibiting	O
septic	B-problem
physiology	I-problem
,	O
respiratory	B-problem
distress	I-problem
and	O
hypotensive	B-problem
.	O

She	O
required	O
aggressive	B-treatment
intravenous	I-treatment
fluids	I-treatment
and	O
later	O
required	O
pressor	B-treatment
support	I-treatment
with	O
neo-synephrine	B-treatment
.	O

Later	O
during	O
her	O
Intensive	O
Care	O
Unit	O
course	O
she	O
was	O
felt	O
to	O
be	O
somewhat	B-problem
overloaded	I-problem
and	O
intravenous	B-treatment
fluids	I-treatment
were	O
cut	O
back	O
.	O

It	O
was	O
quite	O
difficult	O
weaning	O
her	O
off	O
of	O
neo-synephrine	B-treatment
.	O

She	O
was	O
also	O
given	O
stress	B-treatment
dose	I-treatment
steroids	I-treatment
.	O

Later	O
in	O
her	O
hospital	O
course	O
she	O
also	O
had	O
an	B-test
echocardiogram	I-test
for	O
question	O
of	O
new	O
ECG	O
findings	O
in	O
her	O
inferior	O
leads	O
.	O

Her	B-test
echocardiogram	I-test
,	O
however	O
,	O
was	O
essentially	O
normal	O
with	O
an	B-test
ejection	I-test
fraction	I-test
of	O
55%	O
without	O
any	B-problem
gross	I-problem
wall	I-problem
motion	I-problem
abnormalities	I-problem
or	O
valvular	B-problem
pathology	I-problem
.	O

As	O
mentioned	O
above	O
the	O
patient	O
's	O
hemodynamic	O
status	O
was	O
tenuous	B-problem
throughout	O
her	O
hospital	O
course	O
as	O
it	O
was	O
difficult	O
to	O
wean	O
the	O
patient	O
off	O
of	O
neo-synephrine	B-treatment
.	O

By	O
06-28	O
,	O
however	O
,	O
the	O
patient	O
had	O
been	O
off	O
of	O
neo-synephrine	B-treatment
,	O
but	O
at	O
this	O
time	O
as	O
mentioned	O
above	O
the	O
patient	O
was	O
deemed	O
to	O
be	O
CMO	B-treatment
per	O
discussion	O
with	O
physicians	O
and	O
her	O
husband	O
/	O
health	O
care	O
proxy	O
.	O

3.	O
Hematology	O
:	O

Patient	O
with	O
a	O
history	O
of	O
known	B-problem
malignancy	I-problem
and	O
also	O
a	O
history	O
of	O
pulmonary	B-problem
embolisms	I-problem
from	O
2012-04-23	O
.	O

Earlier	O
in	O
her	O
Intensive	O
Care	O
Unit	O
course	O
the	O
team	O
was	O
concerned	O
about	O
possible	O
pulmonary	B-problem
embolisms	I-problem
as	O
a	O
possible	O
source	O
of	O
the	B-problem
patient	I-problem
's	I-problem
respiratory	I-problem
decompensation	I-problem
.	O

However	O
,	O
the	O
patient	O
also	O
had	O
brain	B-problem
metastasis	I-problem
and	O
at	O
this	O
point	O
anticoagulation	B-treatment
was	O
thought	O
to	O
be	O
a	O
contraindication	O
given	O
risk	O
for	O
hemorrhage	B-problem
into	O
these	B-problem
tumors	I-problem
.	O

She	O
did	O
have	O
lower	B-test
extremity	I-test
doppler	I-test
ultrasounds	I-test
,	O
which	O
were	O
negative	O
.	O

4.	O
Infectious	O
disease	O
:	O

As	O
mentioned	O
above	O
patient	O
initially	O
hypotension	B-problem
,	O
febrile	B-problem
and	O
in	O
respiratory	B-problem
distress	I-problem
presumed	O
to	O
be	O
septic	B-problem
source	I-problem
likely	O
pulmonary	O
.	O

Initially	O
the	O
patient	O
was	O
treated	O
with	O
broad	B-treatment
spectrum	I-treatment
antibiotics	I-treatment
including	O
Vancomycin	B-treatment
,	O
Ceptaz	B-treatment
,	O
Levaquin	B-treatment
,	O
Clindamycin	B-treatment
and	O
_________.	O

All	O
of	O
her	B-test
cultures	I-test
are	O
negative	O
to	O
date	O
.	O

She	O
was	O
negative	O
for	O
PCP	B-problem
and	O
subsequently	O
_____________	O
was	O
continued	O
and	O
Clindamycin	B-treatment
was	O
changed	O
for	O
anaerobic	B-treatment
coverage	I-treatment
.	O

In	O
addition	O
her	B-treatment
Vancomycin	I-treatment
and	O
Levaquin	B-treatment
were	O
also	O
discontinued	O
.	O

The	O
patient	O
remained	O
afebrile	B-problem
during	O
the	O
majority	O
of	O
her	O
hospital	O
course	O
.	O

By	O
virtue	O
of	O
discussions	O
on	O
06-28	O
the	O
patient	O
was	O
deemed	O
to	O
be	O
CMO	B-treatment
and	O
all	B-treatment
antibiotics	I-treatment
were	O
withdrawn	O
at	O
this	O
point	O
.	O

5.	O
Gastroenterology	O
:	O

The	O
patient	O
had	O
an	B-test
abdominal	I-test
CT	I-test
earlier	O
in	O
her	O
Intensive	O
Care	O
Unit	O
course	O
,	O
which	O
was	O
essentially	O
negative	O
for	O
an	B-problem
intraabdominal	I-problem
pathology	I-problem
.	O

She	O
was	O
initially	O
supported	O
with	O
tube	B-treatment
feeds	I-treatment
during	O
her	O
Intensive	O
Care	O
Unit	O
course	O
,	O
but	O
at	O
this	O
point	O
the	O
patient	O
is	O
CMO	B-treatment
and	O
tube	B-treatment
feeds	I-treatment
have	O
been	O
subsequently	O
discontinued	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
's	O
attending	O
physician	O
was	O
in	O
constant	O
communication	O
with	O
the	O
patient	O
's	O
health	O
care	O
proxy	O
her	O
husband	O
.	O

As	O
her	O
Intensive	O
Care	O
Unit	O
course	O
continued	O
and	O
the	O
patient	O
showed	O
minimal	O
signs	O
of	O
meaningful	O
improvement	O
,	O
continued	O
discussions	O
were	O
had	O
with	O
the	O
family	O
about	O
possibly	O
changing	O
code	O
status	O
.	O

Ultimately	O
it	O
was	O
decided	O
by	O
06-28	O
that	O
the	O
patient	O
had	O
shown	O
minimal	O
improvement	O
and	O
minimal	O
evidence	O
of	O
improvement	O
status	O
,	O
it	O
was	O
decided	O
at	O
this	O
point	O
for	O
the	O
patient	O
to	O
be	O
extubated	O
and	O
to	O
move	O
toward	O
CMO	B-treatment
care	I-treatment
.	O

Subsequently	O
all	B-treatment
antibiotics	I-treatment
,	O
blood	B-test
draws	I-test
and	O
supportive	B-treatment
blood	I-treatment
pressure	I-treatment
medications	I-treatment
were	O
withdrawn	O
.	O

Currently	O
she	O
is	O
comfortable	O
with	O
morphine	B-treatment
and	O
Ativan	B-treatment
prn.	O

Currently	O
plans	O
are	O
in	O
the	O
making	O
for	O
arranging	O
for	O
the	O
patient	O
to	O
have	O
home	B-treatment
hospice	I-treatment
care	I-treatment
.	O

Please	O
see	O
discharge	O
addendum	O
for	O
further	O
developments	O
in	O
the	O
patient	O
's	O
care	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Metastatic	B-problem
breast	I-problem
cancer	I-problem
end	I-problem
stage	I-problem
.	O

2.	O
Respiratory	B-problem
failure	I-problem
unclear	O
etiology	O
,	O
presumed	O
secondary	O
to	O
possible	O
pneumonia	B-problem
,	O
questionable	O
lymphangitic	B-problem
spread	I-problem
.	O

3.	O
Sepsis	B-problem
presumed	O
pulmonary	O
source	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Grim	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Morphine	B-treatment
prn	O
.	O

2.	O
Ativan	B-treatment
prn	O
.	O

3.	O
Tylenol	B-treatment
prn	O
.	O

4.	O
Albuterol	B-treatment
and	O
Atrovent	B-treatment
nebs	I-treatment
prn	O
.	O

Rice	O
S.F.	O
Thrash	O
,	O
M.D.	O
15-419	O

Dictated	O
By	O
:	O
Brett	O
E.X.	O
Im	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2012-06-29	O
01:15	O

T	O
:	O
2012-06-29	O
05:47	O

JOB	O
#:	O
44693	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Vicki	O
Baker	O
on	O
:	O
TUE	O
2012-07-03	O
8:23	O
AM	O

(	O
End	O
of	O
Report	O
)	O

763970014	O
PAD-WORD	O

CMC	O
PAD-WORD	O

85905567	O
PAD-WORD	O

04/21/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

04/21/1994	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

04/29/1994	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSIS	O
:	O

LEFT	B-problem
PARIETAL	I-problem
GLIOBLASTOMA	I-problem
MULTIFORME	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Patient	O
is	O
an	O
88	O
year	O
old	O
female	O
with	O
fatigue	B-problem
and	O
decreased	B-problem
short	I-problem
term	I-problem
memory	I-problem
for	O
the	O
past	O
six	O
months	O
.	O

The	O
past	O
six	O
weeks	O
,	O
she	O
has	O
also	O
been	O
complaining	O
of	O
hot	B-problem
sensation	I-problem
and	O
tingling	B-problem
sensation	I-problem
in	I-problem
the	I-problem
hands	I-problem
bilaterally	I-problem
.	O

For	O
the	O
past	O
five	O
weeks	O
,	O
the	O
patient	O
has	O
experienced	O
dragging	B-problem
of	I-problem
the	I-problem
right	I-problem
leg	I-problem
with	O
weakness	B-problem
throughout	O
that	O
side	O
.	O

Head	B-test
CT	I-test
was	O
done	O
which	O
patient	O
reported	O
demonstrated	O
three	B-problem
lesions	I-problem
in	I-problem
the	I-problem
left	I-problem
parietal	I-problem
region	I-problem
of	O
the	O
brain	O
.	O

Bone	B-test
scan	I-test
,	O
CT	B-test
of	I-test
the	I-test
abdomen	I-test
,	O
chest	B-test
X-Ray	I-test
,	O
and	O
mammogram	B-test
were	O
all	O
negative	O
.	O

Patient	O
noted	O
the	B-problem
foot	I-problem
dragging	I-problem
to	O
have	O
worsened	O
over	O
the	O
past	O
few	O
weeks	O
but	O
improved	O
since	O
on	O
Decadron	B-treatment
the	O
past	O
week	O
before	O
admission	O
.	O

Patient	O
is	O
now	O
admitted	O
for	O
elective	B-test
left	I-test
parietal	I-test
stereotactic	I-test
biopsy	I-test
of	O
the	B-problem
tumor	I-problem
.	O

PAST	O
MEDICAL	O
/	O
SURGICAL	O
HISTORY	O
:	O

Significant	O
for	O
a	O
history	O
of	O
hypertension	B-problem
,	O
basal	B-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
nose	I-problem
six	O
years	O
ago	O
,	O
cataracts	B-problem
,	O
and	O
a	B-treatment
hysterectomy	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

CURRENT	O
MEDICATIONS	O
:	O

Hydrochlorothiazide	B-treatment
25	O
mg	O
q.d.	O
and	O
Decadron	B-treatment
25	O
mg	O
b.i.d.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
demonstrated	O
a	O
well-developed	O
,	O
well-nourished	O
female	O
in	O
no	O
apparent	B-problem
distress	I-problem
dragging	O
her	O
right	O
foot	O
.	O

HEENT	O
:	O

Head	O
was	O
atraumatic	B-problem
and	O
normocephalic	O
with	O
pupils	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

LUNGS	O
:	O

Clear	O
to	O
auscultation	B-test
.	O

HEART	O
:	O

Examination	B-test
demonstrated	O
a	O
regular	O
rate	O
and	O
rhythm	O
without	O
any	B-problem
murmurs	I-problem
noted	O
.	O

ABDOMEN	O
:	O

Benign	O
with	O
a	B-problem
hysterectomy	I-problem
scar	I-problem
which	O
was	O
well	O
healed	O
.	O

NEUROLOGICAL	O
:	O

Examination	B-test
showed	O
that	O
the	O
patient	O
was	O
noted	O
to	O
be	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
short	O
term	O
memory	O
was	O
deficient	B-problem
,	O
patient	O
remembered	O
zero	O
out	O
of	O
three	O
things	O
to	O
remember	O
at	O
one	O
minute	O
,	O
speech	O
was	O
noted	O
to	O
be	O
fluent	O
,	O
and	O
cranial	O
nerves	O
II-XII	O
were	O
intact	O
.	O

On	O
motor	B-test
examination	I-test
,	O
patient	O
was	O
noted	O
to	O
be	O
of	O
normal	O
motor	O
function	O
throughout	O
except	O
for	O
a	B-problem
slight	I-problem
weakness	I-problem
of	I-problem
the	I-problem
right	I-problem
dorsi	I-problem
flexion	I-problem
and	I-problem
plantar	I-problem
flexion	I-problem
,	O
both	O
noted	O
to	O
be	O
about	O
4/5	O
and	O
sensory	B-test
examination	I-test
was	O
intact	O
throughout	O
.	O

Patient	O
's	O
gait	O
was	O
noted	O
to	O
have	O
a	B-problem
right	I-problem
foot	I-problem
drag	I-problem
as	O
well	O
as	O
right	B-problem
foot	I-problem
drop	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
April	O
21	O
where	O
patient	O
underwent	O
a	B-test
left	I-test
parietal	I-test
stereotactic	I-test
guided	I-test
brain	I-test
biopsy	I-test
.	O

Patient	O
tolerated	O
the	B-test
procedure	I-test
well	O
without	O
any	B-problem
complications	I-problem
and	O
was	O
taken	O
to	O
the	O
Recovery	O
Room	O
awake	O
and	O
stable	O
then	O
subsequently	O
transferred	O
to	O
the	O
floor	O
.	O

Patient	O
did	O
well	O
post-operatively	O
,	O
continued	O
to	O
have	O
a	B-problem
right	I-problem
sided	I-problem
deficit	I-problem
,	O
and	O
Physical	O
Therapy	O
and	O
Occupational	O
Therapy	O
visited	O
the	O
patient	O
,	O
worked	O
with	O
the	O
patient	O
,	O
and	O
determined	O
that	O
patient	O
needed	O
rehabilitation	B-treatment
with	O
Physical	O
Therapy	O
.	O

The	O
patient	O
was	O
evaluated	O
by	O
Doing	O
and	O
was	O
subsequently	O
accepted	O
into	O
that	O
program	O
.	O

Patient	O
is	O
now	O
discharged	O
to	O
Harl	O
Wa	O
Healthcare	O
Network	O
on	O
April	O
29	O
,	O
1994	O
in	O
stable	O
condition	O
.	O

DISPOSITION	O
:	O

She	O
is	O
to	O
receive	O
rehabilitation	B-treatment
to	O
increase	O
her	O
mobility	O
and	O
strength	O
,	O
rehabilitation	B-treatment
potential	O
is	O
good	O
,	O
and	O
she	O
is	O
to	O
receive	O
the	O
following	O
medications	O
at	O
that	O
facility	O
:	O

Decadron	B-treatment
3	O
mg	O
p.o.	O
q.6h.	O
times	O
one	O
week	O
then	O
2	O
mg	O
p.o.q.6h.	O
thereafter	O
,	O
Colace	B-treatment
100	O
mg	O
b.i.d.	O
,	O
Heparin	B-treatment
5000	O
units	O
subcutaneously	O
b.i.d.	O
until	O
ambulating	O
well	O
,	O
Hydrochlorothiazide	B-treatment
25mg	O
q.d.	O
,	O
Dilantin	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O
,	O
Zantac	B-treatment
150	O
mg	O
b.i.d.	O
,	O
and	O
Percocet	B-treatment
p.r.n.	O

Patient	O
is	O
to	O
be	O
subsequently	O
followed	O
up	O
by	O
Dr.	O
Memory	O
.	O

Pathology	O
of	O
the	B-test
biopsy	I-test
demonstrated	O
glioblastoma	B-problem
multiforme	I-problem
,	I-problem
grade	I-problem
IIi/III	I-problem
.	O

Radiation	O
Oncology	O
saw	O
the	O
patient	O
while	O
in	O
the	O
hospital	O
and	O
is	O
to	O
follow	O
her	O
over	O
at	O
Colning	O
.	O

Dictated	O
By	O
:	O

TELSHEY	O
MEMORY	O
,	O
M.D.	O

Attending	O
:	O

BESTI	O
T.	O
DROP	O
,	O
M.D.	O
ND32	O
UZ561/2906	O

Batch	O
:	O

349	O
PAD-WORD	O

Index	O
No.	O
WZGE1	O
XNHQ	O

D	O
:	O

04/29/94	O
PAD-WORD	O

T	O
:	O

04/29/94	O
PAD-WORD	O

Admission	O
Date	O
:	O

2016-09-05	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-09-14	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1940-08-17	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CSU	O
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

Chest	B-problem
pain	I-problem
and	O
back	B-problem
pain	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Hohlt	O
is	O
a	O
76	O
-	O
year-old	O
man	O
with	O
a	O
history	O
of	O
hypertension	B-problem
,	O
hyperlipidemia	B-problem
and	O
prior	B-problem
myocardial	I-problem
infarction	I-problem
with	O
a	B-treatment
percutaneous	I-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
of	I-treatment
the	I-treatment
right	I-treatment
coronary	I-treatment
artery	I-treatment
in	O
2005	O
at	O
the	O
Cambridge	O
Health	O
Alliance	O
.	O

He	O
states	O
that	O
he	O
has	O
experienced	O
pain	B-problem
and	O
tightness	B-problem
in	I-problem
his	I-problem
back	I-problem
radiating	O
into	O
both	O
shoulders	O
starting	O
on	O
2016-09-02	O
.	O

The	O
patient	O
denies	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
dizziness	B-problem
,	O
diaphoresis	B-problem
,	O
or	O
nausea	B-problem
.	O

The	B-problem
pain	I-problem
lasted	O
for	O
30	O
seconds	O
following	O
pushing	O
a	O
wheelbarrow	O
and	O
resolved	O
with	O
rest	O
.	O

The	O
patient	O
denied	O
any	O
prior	O
episodes	O
of	O
pain	B-problem
or	O
any	O
since	O
2005	O
following	O
the	O
initial	O
episode	O
of	O
pain	B-problem
.	O

The	O
patient	O
informs	O
his	O
primary	O
care	O
provider	O
who	O
referred	O
him	O
to	O
the	O
emergency	O
room	O
.	O

He	O
then	O
presented	O
to	O
Mass.	O
Mental	O
Health	O
Center	O
where	O
he	O
was	O
ruled	O
out	O
for	O
an	B-problem
myocardial	I-problem
infarction	I-problem
by	O
enzymes	B-test
and	O
electrocardiograms	B-test
.	O

The	O
patient	O
also	O
underwent	O
a	O
negative	O
evaluation	O
for	O
dissecting	B-problem
aortic	I-problem
aneurysm	I-problem
.	O

On	O
2016-09-03	O
,	O
the	O
patient	O
began	O
experiencing	O
continuing	B-problem
chest	I-problem
pain	I-problem
of	O
increasing	O
intensity	O
.	O

He	O
was	O
treated	O
with	O
nitroglycerin	B-treatment
paste	I-treatment
and	O
IV	B-treatment
Integrelin	I-treatment
as	O
well	O
as	O
Plavix	B-treatment
.	O

At	O
that	O
time	O
,	O
he	O
ruled	O
in	O
for	O
an	B-problem
NST	I-problem
EMI	I-problem
with	O
a	B-test
peak	I-test
CK	I-test
of	O
412	O
and	O
a	B-test
troponin	I-test
of	O
6.23	O
.	O

Electrocardiograms	B-test
progressed	O
to	O
inverted	B-problem
T	I-problem
waves	I-problem
in	I-problem
V5	I-problem
and	I-problem
V6	I-problem
.	O

The	O
patient	O
is	O
now	O
transferred	O
to	O
Cambridge	O
Health	O
Alliance	O
for	O
cardiac	B-test
catheterization	I-test
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-problem
,	O
hyperlipidemia	B-problem
,	O
IMI	B-problem
in	O
2005	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Partial	B-treatment
thyroidectomy	I-treatment
,	O
herniorrhaphy	B-treatment
,	O
percutaneous	B-treatment
transluminal	I-treatment
coronary	I-treatment
angioplasty	I-treatment
of	I-treatment
the	I-treatment
RCA	I-treatment
in	O
2005	O
,	O
left	B-treatment
knee	I-treatment
surgery	I-treatment
as	O
well	O
as	O
tonsil	B-treatment
and	I-treatment
adenoid	I-treatment
surgery	I-treatment
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Flomax	B-treatment
0.4	O
q.d.	O

2.	O
Aspirin	B-treatment
325	O
q.d.	O

3.	O
Lipitor	B-treatment
10	O
q.d.	O

4.	O
Naproxen	B-treatment
p.r.n.	O
as	O
well	O
as	O
several	B-treatment
vitamins	I-treatment
and	O
supplements	B-treatment
.	O

5.	O
Zestoretic	B-treatment
with	O
an	O
unknown	O
dose	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Captopril	B-treatment
25	O
t.i.d.	O

2.	O
Protonix	B-treatment
q.d.	O
40	O
.	O

3.	O
Nitroglycerin	B-treatment
paste	I-treatment
1	O
inch	O
q.	O
6	O
hours	O
.	O

4.	O
Lopressor	B-treatment
25	O
b.i.d.	O

5.	O
Plavix	B-treatment
75	O
q.d.	O

6.	O
Lovenox	B-treatment
90	O
b.i.d.	O

7.	O
Aspirin	B-treatment
325	O
q.d.	O

8.	O
Lipitor	B-treatment
10	O
q.d.	O

SOCIAL	O
HISTORY	O
:	O

Married	O
,	O
retired	O
accountant	O
with	O
six	O
children	O
.	O

He	O
denies	O
any	O
tobacco	O
use	O
,	O
2	O
to	O
3	O
alcohol	O
drinks	O
per	O
week	O
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
died	O
in	O
his	O
80	O
's	O
of	O
pacemaker	B-problem
failure	I-problem
,	O
also	O
had	O
a	B-problem
myocardial	I-problem
infarction	I-problem
in	O
his	O
70	O
's.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Heart	B-test
rate	I-test
is	O
55	O
,	O
blood	B-test
pressure	I-test
is	O
129/79	O
,	O
Respiratory	B-test
rate	I-test
is	O
22	O
,	O
O2	B-test
sat	I-test
is	O
96	O
percent	O
on	O
2	B-treatment
liters	I-treatment
.	O

In	O
general	O
,	O
well-appearing	O
man	O
,	O
lying	O
on	O
a	O
stretcher	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Neck	O
:	O

2	B-test
plus	I-test
carotids	I-test
with	O
no	O
jugular	B-problem
venous	I-problem
distention	I-problem
and	O
no	O
bruits	B-problem
and	O
no	O
thyromegaly	B-problem
.	O

Lungs	O
:	O

Fine	B-problem
crackles	I-problem
in	I-problem
the	I-problem
bases	I-problem
,	O
otherwise	O
clear	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
and	O
S2	O
with	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	O
:	O
Soft	O
and	O
nontender	B-problem
and	O
nondistended	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
and	O
no	O
bruits	B-problem
.	O

Pulses	B-test
are	O
2	O
plus	O
femoral	O
bilaterally	O
,	O
2	O
plus	O
dorsalis	O
pedis	O
as	O
well	O
as	O
posterior	O
tibial	O
bilaterally	O
.	O

No	O
edema	B-problem
.	O

Neurological	O
:	O

Alert	O
and	O
oriented	O
times	O
3	O
.	O

Chest	B-test
CT	I-test
done	O
at	O
the	O
outside	O
hospital	O
showed	O
no	O
gallstones	B-problem
.	O

Left	O
kidney	O
with	O
a	B-problem
small	I-problem
cyst	I-problem
splenic	I-problem
lesion	I-problem
and	O
no	O
triple	B-problem
A	I-problem
.	O

Electrocardiogram	B-test
has	O
sinus	O
rhythm	O
with	O
Q	B-problem
wave	I-problem
in	I-problem
2	I-problem
,	I-problem
3	I-problem
,	I-problem
and	I-problem
F	I-problem
,	O
flattened	B-problem
T	I-problem
waves	I-problem
in	I-problem
the	I-problem
lateral	I-problem
leads	I-problem
,	O
sinus	O
rhythm	O
at	O
a	O
rate	O
of	O
56	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
is	O
8.3	O
,	O
hematocrit	B-test
42.7	O
,	O
platelets	B-test
180	O
,	O
INR	B-test
was	O
1.1	O
,	O
sodium	B-test
135	O
,	O
potassium	B-test
4.0	O
,	O
chloride	B-test
99	O
,	O
CO2	B-test
33	O
,	O
BUN	B-test
13	O
,	O
creatinine	B-test
1.0	O
,	O
glucose	B-test
96	O
.	O

While	O
on	O
transfer	O
,	O
the	O
patient	O
underwent	O
cardiac	B-test
catheterization	I-test
.	O

Please	O
see	O
cathed	O
report	O
for	O
full	O
details	O
.	O

In	O
summary	O
,	O
the	B-test
catheterization	I-test
showed	O
left	O
main	O
with	O
no	O
obstructive	B-problem
disease	I-problem
,	O
LAD	O
with	O
70	B-problem
percent	I-problem
serial	I-problem
lesion	I-problem
,	O
left	O
circumflex	O
with	O
70	O
percent	O
proximal	O
,	O
OM1	O
and	O
OM2	O
both	O
70	B-problem
percent	I-problem
lesions	I-problem
,	O
RCA	O
with	O
nonobstructive	B-problem
disease	I-problem
and	O
ejection	O

fraction	B-test
of	O
25	O
percent	O
.	O

The	O
patient	O
was	O
referred	O
to	O
CT	O
surgery	O
who	O
was	O
seen	O
and	O
accepted	O
for	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
.	O

On	O
09-06	O
,	O
he	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
,	O
please	O
see	O
the	O
Operating	O
Room	O
report	O
for	O
full	O
details	O
.	O

In	O
summary	O
,	O
he	O
had	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
4	O
with	O
a	B-treatment
LIMA	I-treatment
to	I-treatment
the	I-treatment
LAD	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
OM1	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
OM2	I-treatment
and	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
of	I-treatment
the	I-treatment
diagonal	I-treatment
.	O

His	O
bypass	O
time	O
was	O
105	O
minutes	O
with	O
a	O
cross	O
clamp	O
time	O
of	O
87	O
minutes	O
.	O

He	O
tolerated	O
the	B-treatment
operation	I-treatment
well	O
and	O
was	O
transferred	O
from	O
the	O
Operating	O
Room	O
to	O
the	O
cardiothoracic	O
ICU	O
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
he	O
was	O
AV	B-treatment
paced	I-treatment
at	O
a	O
rate	O
of	O
88	O
beats	O
per	O
minute	O
.	O

He	O
had	O
Propofol	B-treatment
at	O
30	O
mc	O
per	O
kg	O
per	O
minute	O
and	O
Neo-Synephrine	B-treatment
to	O
maintain	O
his	B-test
blood	I-test
pressure	I-test
.	O

The	O
patient	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
.	O

His	B-treatment
anesthesia	I-treatment
was	O
reversed	O
.	O

He	O
was	O
weaned	O
from	O
the	B-treatment
ventilator	I-treatment
and	O
successfully	O
extubated	O
.	O

He	O
remained	O
hemodynamically	O
stable	O
throughout	O
the	O
remainder	O
of	O
his	O
operative	O
day	O
.	O

On	O
postoperative	O
day	O
1	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
on	O
a	B-treatment
Neo-Synephrine	I-treatment
drip	I-treatment
to	O
maintain	O
an	O
adequate	O
blood	O

pressure	O
.	O

He	O
remained	O
in	O
the	O
Intensive	O
Care	O
Unit	O
as	O
he	O
was	O
unable	O
to	O
be	O
weaned	O
off	O
of	O
his	B-treatment
Neo-Synephrine	I-treatment
drip	I-treatment
.	O

On	O
postoperative	O
day	O
1	O
,	O
his	B-treatment
Swan-Ganz	I-treatment
catheter	I-treatment
was	O
removed	O
as	O
well	O
.	O

On	O
postoperative	O
day	O
2	O
,	O
another	O
attempt	O
was	O
made	O
to	O
wean	O
the	O
patient	O
off	O
of	O
Neo-Synephrine	B-treatment
unsuccessfully	O
.	O

His	B-treatment
chest	I-treatment
tubes	I-treatment
were	O
removed	O
.	O

However	O
,	O
because	O
he	O
could	O
not	O
be	O
weaned	O
from	O
the	B-treatment
Neo-Synephrine	I-treatment
,	O
he	O
again	O
remained	O
in	O
the	O
Intensive	O
Care	O
Unit	O
.	O

On	O
postoperative	O
day	O
3	O
,	O
an	O
additional	O
attempt	O
was	O
made	O
to	O
wean	O
the	O
patient	O
from	O
his	B-treatment
Neo-Synephrine	I-treatment
unsuccessfully	O
.	O

The	O
patient	O
also	O
received	O
a	B-treatment
unit	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
in	O
an	O
additional	O
attempt	O
to	O
wean	O
from	O
Neo-Synephrine	B-treatment
.	O

This	O
also	O
did	O
not	O
help	O
in	O
the	O
attempt	O
to	O
wean	O
from	O
Neo-Synephrine	B-treatment
.	O

His	B-treatment
Foley	I-treatment
catheter	I-treatment
was	O
removed	O
and	O
he	O
remained	O
again	O
in	O
the	O
ICU	O
.	O

On	O
postoperative	O
day	O
4	O
,	O
additional	O
attempts	O
were	O
made	O
to	O
wean	O
the	O
patient	O
off	O
of	O
his	B-treatment
Neo-Synephrine	I-treatment
,	O
however	O
,	O
he	O
continued	O
to	O
drop	O
his	B-test
blood	I-test
pressure	I-test
whenever	O
an	O
attempt	O
was	O
made	O
.	O

Other	O
than	O
that	O
,	O
the	O
patient	O
remained	O
completely	O
stable	O
.	O

On	O
postoperative	O
day	O
5	O
,	O
the	O
patient	O
was	O
finally	O
weaned	O
off	O
of	O
his	B-treatment
Neo-Synephrine	I-treatment
and	O
diuresis	B-treatment
was	O
begun	O
.	O

He	O
remained	O
in	O
the	O
Intensive	O
Care	O
Unit	O
for	O
an	O
additional	O
day	O
to	O
monitor	O
his	O
hemodynamics	O
.	O

On	O
postoperative	O
day	O
6	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
and	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
for	O
continuing	B-treatment
postoperative	I-treatment
care	I-treatment
and	O
cardiac	B-treatment
rehabilitation	I-treatment
.	O

Over	O
the	O
next	O
two	O
days	O
,	O
the	O
patient	O
had	O
an	O
uneventful	O
hospitalization	O
.	O

His	O
activity	O
level	O
was	O
increased	O
with	O
the	O
assistance	O
of	O
physical	O
therapy	O
department	O
and	O
the	O
nursing	O
staff	O
.	O

On	O
postoperative	O
day	O
7	O
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
would	O
be	O
stable	O
and	O
ready	O
to	O
be	O
discharged	O
to	O
home	O
on	O
the	O
following	O
day	O
.	O

At	O
the	O
time	O
of	O
this	O
dictation	O
,	O
the	B-test
patient	I-test
's	I-test
physical	I-test
examination	I-test
is	O
as	O
follows	O
:	O
Vital	B-test
signs	I-test
were	O
temperature	B-test
99	O
,	O
heart	B-test
rate	I-test
84	O
in	O
sinus	O
rhythm	O
,	O
blood	B-test
pressure	I-test
was	O
114/63	O
,	O
Respiratory	B-test
rate	I-test
was	O
18	O
,	O
O2	B-test
sat	I-test
was	O
94	O
percent	O
on	O
room	O
air	O
.	O

Weight	B-test
preoperatively	O
was	O
88.5	O
kilos	O
,	O
at	O
discharge	O
was	O
90.4	O
kilos	O
.	O

LABORATORY	O
DATA	O
:	O

White	B-test
blood	I-test
cell	I-test
count	I-test
8.8	O
,	O
hematocrit	B-test
29.7	O
,	O
platelets	B-test
367	O
,	O
sodium	B-test
139	O
,	O
potassium	B-test
4.7	O
,	O
chloride	B-test
102	O
,	O
CO2	B-test
27	O
,	O
BUN	B-test
17	O
,	O
creatinine	B-test
1.1	O
,	O
glucose	B-test
95	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Neurological	O
:	O
Alert	O
and	O
oriented	O
times	O
3	O
.	O

Moves	O
all	O
extremities	O
and	O
follows	O
commands	O
.	O

Respiratory	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Cardiovascular	O
:	O
Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
and	O
S2	O
.	O

No	O
murmurs	B-problem
.	O

Sternum	O
is	O
stable	O
,	O
incision	B-problem
with	O
staples	B-treatment
,	O
opened	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

Abdomen	O
:	O
Soft	O
and	O
nontender	B-problem
,	O
nondistended	B-problem
with	O
positive	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

Warm	O
and	O
well	O
profuse	O
with	O
1	B-problem
to	I-problem
2	I-problem
plus	I-problem
edema	I-problem
.	O

Right	B-problem
saphenous	I-problem
vein	I-problem
graft	I-problem
site	I-problem
with	O
Steri-strips	B-treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O

The	O
patient	O
's	O
condition	O
at	O
discharge	O
is	O
good	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
grafting	I-treatment
times	O
4	O
with	O
LIMA	B-treatment
to	I-treatment
the	I-treatment
LAD	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
OM1	I-treatment
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
OM2	I-treatment
and	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	I-treatment
the	I-treatment
diagonal	I-treatment
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

4.	O
Status	O
post	O
partial	B-treatment
thyroidectomy	I-treatment
.	O

5.	O
Status	O
post	O
hernia	B-treatment
repair	I-treatment
.	O

6.	O
Status	O
post	O
left	B-treatment
knee	I-treatment
surgery	I-treatment
.	O

7.	O
Status	O
post	O
tonsil	B-treatment
and	I-treatment
adenoid	I-treatment
surgery	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Atorvastatin	B-treatment
10	O
mg	O
q.d.	O

2.	O
Plavix	B-treatment
75	O
mg	O
q.d.	O
times	O
3	O
months	O
.	O

3.	O
Aspirin	B-treatment
325	O
mg	O
q.d.	O

4.	O
Lasix	B-treatment
20	O
mg	O
q.d.	O
times	O
two	O
weeks	O
.	O

5.	O
Potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
q.d.	O
times	O
two	O
weeks	O
.	O

6.	O
Metoprolol	B-treatment
12.5	O
mg	O
b.i.d.	O

7.	O
Percocet	B-treatment
1	O
to	O
2	O
tabs	O
q.	O
4	O
hours	O
p.r.n.	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
home	O
with	O
visiting	O
nurses	O
.	O

He	O
is	O
to	O
have	O
follow	O
up	O
in	O
the	O
wound	O
clinic	O
in	O
two	O
weeks	O
and	O
follow	O
up	O
with	O
Dr.	O
Brewster	O
in	O
two	O
to	O
three	O
weeks	O
and	O
follow	O
up	O
with	O
Dr.	O
Rota	O
in	O
4	O
weeks	O
.	O

Herbert	O
Jesus	O
,	O
Georgia	O
01835	O

Dictated	O
By	O
:	O
Scott	O
OK	O
Astarita	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2016-09-14	O
12:52:27	O

T	O
:	O
2016-09-14	O
13:28:05	O

Job	O
#:	O
15604	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Gomez	O
on	O
:	O
FRI	O
2016-09-16	O
7:05	O
AM	O

(	O
End	O
of	O
Report	O
)	O

766212923	O
ELMVH	O

70097548	O
PAD-WORD	O

1264110	O
PAD-WORD	O

11/9/2003	O
12:00:00	O
AM	O

GASTROINTESTINAL	B-problem
BLEEDING	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

11/09/2003	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

11/16/2003	O
PAD-WORD	O

ATTENDING	O
:	O

GROSRIANNE	O
SISANDLEE	O
JERGJESC	O
M.D.	O

SERVICE	O
:	O

GMS	O
1	O
Medical	O
Service	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

GI	B-problem
bleed	I-problem
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

HOSPITAL	O
COURSE	O
:	O

Patient	O
&apos;s	O
hospital	O
course	O
is	O
as	O
follows	O
:	O

Patient	O
is	O
an	O
84-year-old	O
male	O
who	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
with	O
a	B-problem
low	I-problem
hematocrit	I-problem
of	O
21	O
and	O
with	O
guaiac-positive	B-problem
stool	I-problem
.	O

The	O
day	O
prior	O
to	O
admission	O
,	O
he	O
experienced	O
dyspnea	B-problem
on	O
exertion	O
,	O
and	O
on	O
the	O
day	O
of	O
admission	O
he	O
collapsed	O
and	O
complained	O
of	O
substantial	B-problem
weakness	I-problem
.	O

He	O
denied	O
any	B-problem
melana	I-problem
,	O
any	B-problem
hematemesis	I-problem
,	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

He	O
was	O
taken	O
to	O
an	O
outside	O
hospital	O
at	O
the	O
time	O
at	O
which	O
time	O
it	O
was	O
found	O
that	O
his	B-test
hematocrit	I-test
was	O
21	O
,	O
blood	B-test
pressure	I-test
90/60	O
,	O
and	O
his	B-test
INR	I-test
was	O
3.3	O
.	O

Of	O
note	O
,	O
he	O
is	O
anti-coagulated	B-treatment
for	O
an	B-treatment
artificial	I-treatment
heart	I-treatment
valve	I-treatment
.	O

He	O
was	O
at	O
that	O
point	O
given	O
1	B-treatment
unit	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

On	O
further	O
questioning	O
,	O
the	O
patient	O
reported	O
that	O
he	O
started	O
to	O
feel	O
&quot;	O
different	O
&quot;	O
several	O
days	O
ago	O
with	O
slowing	B-problem
and	I-problem
difficult	I-problem
ambulation	I-problem
progressing	O
to	O
complete	O
inability	O
to	O
ambulate	O
.	O

He	O
was	O
also	O
short	B-problem
of	I-problem
breath	I-problem
with	O
ambulation	O
,	O
but	O
he	O
does	O
have	O
baseline	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
with	O
exertion	O
.	O

He	O
denied	O
any	B-problem
chest	I-problem
pain	I-problem
,	O
dysuria	B-problem
,	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
fevers	B-problem
,	O
chills	B-problem
or	O
any	O
history	O
of	O
myocardial	B-problem
infarction	I-problem
.	O

Patient	O
was	O
last	O
admitted	O
to	O
Padrugmoff	O
Hospital	O
with	O
a	B-test
hematocrit	I-test
of	O
24.5	O
,	O
and	O
was	O
asymptomatic	B-problem
prior	O
to	O
admission	O
.	O

At	O
that	O
time	O
,	O
he	O
had	O
guaiac-positive	B-problem
and	O
had	O
a	B-test
small	I-test
bowel	I-test
follow	I-test
through	I-test
which	O
was	O
negative	O
.	O

He	O
was	O
transfused	O
4	B-treatment
units	I-treatment
during	O
that	O
admission	O
and	O
discharged	O
with	O
a	B-test
hematocrit	I-test
of	O
34	O
on	O
vitamin	B-treatment
C	I-treatment
and	O
iron	B-treatment
sulfate	I-treatment
.	O

EXAM	O
ON	O
ARRIVAL	O
IN	O
THE	O
LO	O
HOSPITAL	O
EMERGENCY	O
ROOM	O
:	O

On	O
arrival	O
at	O
the	O
Lo	O
Hospital	O
Emergency	O
Room	O
:	O

He	O
was	O
found	O
to	O
have	O
a	B-test
temperature	I-test
of	O
97.4	O
,	O
heart	B-test
rate	I-test
65	O
,	O
pressure	B-test
107/52	O
,	O
respiratory	B-test
rate	I-test
22	O
and	O
saturating	B-test
100%	O
on	O
2	O
L	O
of	O
a	B-treatment
nasal	I-treatment
cannula	I-treatment
.	O

General	B-test
exam	I-test
at	O
the	O
time	O
was	O
notable	O
for	O
pale	B-problem
mucous	I-problem
membranes	I-problem
,	O
left	B-problem
lateral	I-problem
eye	I-problem
deviation	I-problem
,	O
clear	O
lungs	O
,	O
2/6	B-problem
holosystolic	I-problem
murmur	I-problem
,	O
best	O
heard	O
at	O
the	O
apex	O
,	O
abdomen	O
was	O
mildly	B-problem
distended	I-problem
but	O
was	O
soft	O
and	O
nontender	B-problem
and	O
his	O
extremities	O
were	O
without	O
edema	B-problem
and	O
skin	O
without	O
any	B-problem
rashes	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
as	O
follows	O
:	O

History	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
with	O
status	O
post	O
two-vessel	B-treatment
CABG	I-treatment
in	O
1986	O
,	O
also	O
he	O
was	O
treated	O
for	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
hypertension	B-problem
,	O
aortic	B-treatment
valve	I-treatment
replacement	I-treatment
,	O
and	O
mitral	B-treatment
valve	I-treatment
replacement	I-treatment
with	O
St.	B-treatment
Jude	I-treatment
&apos;s	I-treatment
valve	I-treatment
in	O
09/2001	O
,	O
atrial	B-problem
fibrillation	I-problem
,	O
history	O
of	O
prior	B-problem
GI	I-problem
bleed	I-problem
requiring	O
blood	B-treatment
transfusions	I-treatment
during	O
which	O
he	O
also	O
had	O
a	B-test
colonoscopy	I-test
on	O
05/2003	O
which	O
demonstrated	O
no	O
neoplasia	B-problem
and	O
scattered	B-problem
diverticuli	I-problem
.	O

The	O
patient	O
also	O
,	O
following	O
his	B-problem
first	I-problem
GI	I-problem
bleed	I-problem
,	O
had	O
an	B-test
EEG	I-test
done	O
in	O
07/2003	O
which	O
showed	O
gastritis	B-problem
with	O
oozing	B-problem
and	O
evidence	O
of	O
a	B-problem
recent	I-problem
bleed	I-problem
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
:	O

Included	O
Lasix	B-treatment
,	O
Lopressor	B-treatment
,	O
Coumadin	B-treatment
,	O
Diovan	B-treatment
,	O
torsemide	B-treatment
,	O
Flomax	B-treatment
,	O
Protonix	B-treatment
,	O
Senekot	B-treatment
,	O
potassium	B-treatment
,	O
vitamin	B-treatment
C	I-treatment
,	O
iron	B-treatment
,	O
and	O
a	B-treatment
multivitamin	I-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

Notable	O
for	O
no	O
tobacco	O
,	O
no	O
alcohol	O
.	O

He	O
has	O
a	O
wife	O
with	O
Alzheimer	B-problem
&apos;s	I-problem
who	O
lives	O
in	O
a	O
skilled-nursing	O
facility	O
.	O

LABORATORY	O
DATA	O
:	O

Notable	O
for	O
a	B-test
BUN	I-test
and	O
creatinine	B-test
of	O
78	O
,	O
1.7	O
;	O
for	O
a	B-test
sodium	I-test
,	O
potassium	B-test
139	O
and	O
3.6	O
;	O
chloride	B-test
and	O
bicarb	B-test
108	O
,	O
21	O
.	O

White	B-test
count	I-test
7	O
,	O
hematocrit	B-test
24.2	O
,	O
platelet	B-test
count	I-test
was	O
183	O
.	O

His	B-test
INR	I-test
was	O
also	O
3.4	O
.	O

PTT	B-test
was	O
55	O
.	O

His	B-test
EKG	I-test
was	O
notable	O
for	O
right	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
,	O
left	B-problem
axis	I-problem
deviation	I-problem
,	O
but	O
was	O
in	O
sinus	O
rhythm	O
.	O

His	B-test
UA	I-test
had	O
10-17	B-problem
white	I-problem
blood	I-problem
cells	I-problem
;	O
trace	B-problem
leukocyte	I-problem
esterase	I-problem
hyaline	B-problem
casts	I-problem
numbering	O
60-70	O
.	O

His	B-test
chest	I-test
x-ray	I-test
was	O
notable	O
for	O
clear	O
lungs	O
with	O
no	O
edema	B-problem
or	O
infiltrates	B-problem
and	O
small	B-problem
bilateral	I-problem
effusions	I-problem
.	O

OTHER	O
NOTALBE	O
LABS	O
:	O

Patient	O
was	O
found	O
to	O
have	O
a	B-test
troponin	I-test
of	O
0.71	O
on	O
admission	O
with	O
a	B-test
CK	I-test
of	O
46	O
and	O
CKMB	B-test
of	O
3.4	O
.	O

ASSESSMENT	O
:	O

At	O
that	O
time	O
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
was	O
likely	O
having	O
a	B-problem
repeat	I-problem
GI	I-problem
bleed	I-problem
and	O
while	O
he	O
was	O
hemodynamically	O
stable	O
,	O
he	O
had	O
evidently	O
lost	O
a	O
substantial	O
amount	O
of	O
blood	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
GI	O
:	O

Patient	O
was	O
transfused	O
2	B-treatment
units	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
overnight	O
,	O
the	O
first	O
night	O
after	O
admission	O
and	O
his	B-test
hematocrit	I-test
bumped	O
up	O
appropriately	O
.	O

He	O
remained	O
hemodynamically	O
stable	O
throughout	O
his	O
admission	O
.	O

He	O
was	O
continued	O
on	O
a	B-treatment
proton	I-treatment
pump	I-treatment
inhibitor	I-treatment
and	O
on	O
iron	B-treatment
sulfate	I-treatment
and	O
vitamin	B-treatment
C	I-treatment
.	O

His	B-treatment
Coumadin	I-treatment
was	O
held	O
at	O
the	O
time	O
given	O
the	B-problem
bleeding	I-problem
,	O
even	O
though	O
it	O
was	O
important	O
to	O
keep	O
his	B-test
INR	I-test
2.5-3.5	O
,	O
given	O
his	B-treatment
artificial	I-treatment
valve	I-treatment
it	O
was	O
felt	O
that	O
the	O
risk	O
of	O
continued	B-problem
bleeding	I-problem
was	O
to	O
great	O
to	O
continue	O
the	B-treatment
Coumadin	I-treatment
.	O

He	O
was	O
subsequently	O
seen	O
by	O
the	O
GI	O
team	O
who	O
performed	O
an	B-test
upper	I-test
endoscopy	I-test
which	O
demonstrated	O
the	O
following	O
:	O

In	O
the	O
esophagus	O
,	O
there	O
was	O
a	B-problem
small	I-problem
hiatal	I-problem
hernia	I-problem
and	O
in	O
the	O
stomach	O
there	O
is	O
evidence	O
of	O
erosive	B-problem
gastritis	I-problem
of	I-problem
the	I-problem
body	I-problem
of	O
the	O
stomach	O
and	O
the	O
antrum	O
,	O
the	O
mucous	O
appeared	O
edematous	B-problem
.	O

A	B-problem
small	I-problem
polyp	I-problem
was	O
found	O
in	O
the	O
fundus	O
which	O
stigmata	B-problem
of	O
old	B-problem
bleeding	I-problem
;	O
an	B-treatment
Endoclip	I-treatment
was	O
applied	O
to	O
this	O
.	O

Another	B-problem
polyp	I-problem
was	O
found	O
in	O
the	O
antrum	O
and	O
cold	B-test
biopsies	I-test
were	O
obtained	O
there	O
.	O

In	O
the	O
duodenum	O
,	O
a	B-problem
small	I-problem
AVM	I-problem
was	O
noted	O
in	O
the	O
second	O
portion	O
of	O
the	O
duodenum	O
and	O
was	O
cauterized	O
.	O

The	B-test
biopsy	I-test
subsequently	O
demonstrated	O
a	B-problem
hyperplastic	I-problem
polyp	I-problem
with	O
acute	B-problem
and	I-problem
chronic	I-problem
inflammation	I-problem
and	O
erosion	B-problem
and	O
reactive	B-problem
epithelial	I-problem
changes	I-problem
but	O
no	O
dysplasia	B-problem
.	O

Also	O
of	O
note	O
,	O
prior	O
to	O
the	B-test
upper	I-test
endoscopy	I-test
,	O
the	O
patient	O
received	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
to	O
reverse	O
his	B-treatment
anticoagulation	I-treatment
.	O

Patient	O
remained	O
hemodynamically	O
stable	O
during	O
and	O
after	O
the	B-test
upper	I-test
endoscopy	I-test
and	O
his	B-test
hematocrit	I-test
remained	O
above	O
30	O
following	O
this	O
until	O
the	O
point	O
of	O
discharge	O
.	O

His	B-test
last	I-test
recorded	I-test
hematocrit	I-test
on	O
discharge	O
was	O
31.3	O
.	O

His	B-test
last	I-test
BUN	I-test
and	O
creatinine	B-test
were	O
42	O
and	O
1.5	O
with	O
an	B-test
INR	I-test
of	O
2.5	O
.	O

Consideration	O
was	O
given	O
to	O
performing	O
a	B-test
repeat	I-test
colonoscopy	I-test
.	O

This	O
was	O
discussed	O
with	O
the	O
GI	O
Service	O
who	O
felt	O
that	O
this	O
was	O
not	O
necessary	O
given	O
the	B-test
recent	I-test
colonoscopy	I-test
that	O
he	O
had	O
had	O
in	O
05/2003	O
.	O

2.	O
Cardiovascular	O
:	O

A	O
:	O

Ischemia	B-problem
:	O

Patient	B-problem
&apos;s	I-problem
troponin	I-problem
bump	I-problem
was	O
found	O
to	O
be	O
likely	O
to	O
demand	B-problem
ischemia	I-problem
in	O
the	O
setting	O
of	O
his	B-problem
GI	I-problem
bleed	I-problem
,	O
it	O
was	O
not	O
felt	O
that	O
he	O
was	O
having	O
acute	B-problem
coronary	I-problem
syndrome	I-problem
.	O

On	O
discharge	O
,	O
he	O
was	O
continued	O
on	O
his	B-treatment
aspirin	I-treatment
,	O
simvastatin	B-treatment
and	O
his	B-treatment
Lopressor	I-treatment
which	O
was	O
initially	O
held	O
,	O
and	O
subsequently	O
restarted	O
.	O

B	O
:	O

Rhythm	O
:	O

Patient	O
continued	O
to	O
be	O
in	O
A-fib.	B-problem
throughout	O
the	O
admission	O
and	O
was	O
restarted	O
on	O
his	B-treatment
Coumadin	I-treatment
concurrently	O
with	O
heparin	B-treatment
.	O

Heparin	B-treatment
was	O
subsequently	O
DCd	O
once	O
his	B-test
INR	I-test
reached	O
a	O
therapeutic	O
level	O
between	O
2.5-3.5	O
.	O

His	B-test
last	I-test
reported	I-test
INR	I-test
on	O
discharge	O
was	O
2.5	O
.	O

C	O
:	O

Valves	O
:	O

Patient	O
had	O
,	O
as	O
noted	O
above	O
,	O
his	B-treatment
anticoagulation	I-treatment
was	O
initially	O
reversed	O
despite	O
his	O
having	O
artificial	B-treatment
valves	I-treatment
.	O

However	O
,	O
his	B-treatment
Coumadin	I-treatment
was	O
subsequently	O
restarted	O
and	O
he	O
achieved	O
therapeutic	O
INR	B-test
levels	I-test
before	O
discharge	O
.	O

D	O
:	O

Pump	O
:	O

Patient	O
,	O
during	O
this	O
hospital	O
course	O
,	O
became	O
hypervolemic	B-problem
likely	O
due	O
to	O
his	B-treatment
diuretics	I-treatment
being	O
held	O
and	O
due	O
to	O
his	O
receiving	O
blood	B-treatment
products	I-treatment
.	O

He	O
was	O
diuresed	O
initially	O
with	O
one	O
dose	O
of	O
Lasix	B-treatment
and	O
subsequently	O
with	O
one	O
dose	O
of	O
torsemide	B-treatment
after	O
it	O
was	O
discovered	O
that	O
he	O
developed	O
thrombocytopenia	B-problem
on	O
a	O
prior	O
admission	O
in	O
reaction	O
to	O
Lasix	B-treatment
.	O

He	O
subsequently	O
was	O
diuresed	O
to	O
a	O
euvolemic	O
state	O
.	O

Of	O
note	O
,	O
he	O
did	O
not	O
become	O
thrombocytopenic	B-problem
on	O
this	O
admission	O
.	O

DISPOSITION	O
:	O

Was	O
discharged	O
on	O
11/16/2003	O
in	O
stable	O
condition	O
with	O
the	B-test
last	I-test
recorded	I-test
hematocrit	I-test
of	O
31.3	O
.	O

He	O
was	O
asked	O
to	O
continue	O
on	O
his	B-treatment
Nexium	I-treatment
,	O
iron	B-treatment
and	O
vitamin	B-treatment
C	I-treatment
and	O
was	O
continued	O
on	O
his	B-treatment
other	I-treatment
home	I-treatment
medications	I-treatment
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

His	B-treatment
final	I-treatment
medications	I-treatment
on	O
discharge	O
were	O
as	O
follows	O
:	O

Aspirin	B-treatment
325	O
,	O
he	O
was	O
restarted	O
on	O
a	B-treatment
PPI	I-treatment
,	O
also	O
on	O
iron	B-treatment
,	O
vitamin	B-treatment
C	I-treatment
,	O
Lopressor	B-treatment
12.5	O
b.i.d	O
.	O

Of	O
note	O
,	O
this	O
was	O
at	O
a	O
decreased	O
dose	O
compared	O
to	O
that	O
which	O
he	O
came	O
in	O
on	O
,	O
Coumadin	B-treatment
7.5	O
,	O
mg	O
,	O
torsemide	B-treatment
100	O
q.d.	O
,	O
sucralfate	B-treatment
,	O
simvastatin	B-treatment
,	O
Diovan	B-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

He	O
was	O
discharged	O
in	O
stable	O
condition	O
with	O
instructions	O
to	O
follow	O
up	O
with	O
his	O
PCP	O
as	O
well	O
as	O
to	O
follow	O
up	O
with	O
the	O
Anticoagulation	O
Clinic	O
and	O
Dr.	O
Gilbert	O
.	O

eScription	O
document	O
:	O

4-9918752	O
IEEHttd	O
Tel	O

Dictated	O
By	O
:	O

NETPEAKE	O
,	O
SHIRLH	O

Attending	O
:	O

JERGJESC	O
,	O
GROSRIANNE	O
SISANDLEE	O
Dictation	O
ID	O
4535172	O

D	O
:	O

12/22/03	O
PAD-WORD	O

T	O
:	O

12/22/03	O
PAD-WORD	O

Admission	O
Date	O
:	O

2013-04-25	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-05-11	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1963-05-10	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
CSRU	O

CHIEF	O
COMPLAINT	O
:	O

Cardiac	B-problem
arrest	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49	O
year	O
old	O
man	O
who	O
was	O
admitted	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
status	O
post	O
cardiac	B-problem
arrest	I-problem
.	O

History	O
was	O
obtained	O
per	O
the	O
Emergency	O
Department	O
report	O
as	O
well	O
as	O
from	O
the	O
patient	O
's	O
family	O
.	O

Information	O
was	O
very	O
limited	O
regarding	O
the	O
circumstances	O
of	O
his	B-problem
cardiac	I-problem
arrest	I-problem
.	O

Reportedly	O
,	O
the	O
patient	O
was	O
at	O
a	O
local	O
restaurant	O
where	O
he	O
was	O
noted	O
to	O
be	O
unresponsive	B-problem
.	O

EMS	O
was	O
called	O
and	O
reported	O
to	O
arrive	O
on	O
scene	O
within	O
three	O
minutes	O
.	O

The	O
patient	O
was	O
asystolic	B-problem
but	O
regained	O
a	O
perfusing	O
rhythm	O
after	O
2	O
mg	O
of	O
Epinephrine	B-treatment
and	O
2	O
mg	O
of	O
Atropine	B-treatment
.	O

He	O
was	O
intubated	O
in	O
the	O
field	O
and	O
brought	O
to	O
the	O
Emergency	O
Department	O
.	O

He	O
remained	O
unresponsive	B-problem
despite	O
the	O
administration	O
of	O
Narcan	B-treatment
.	O

CT	B-test
examinations	I-test
of	I-test
the	I-test
head	I-test
,	I-test
chest	I-test
,	I-test
abdomen	I-test
and	I-test
pelvis	I-test
were	O
all	O
unremarkable	O
.	O

Initial	B-test
chest	I-test
x-ray	I-test
showed	O
a	B-problem
left	I-problem
retrocardiac	I-problem
opacity	I-problem
and	O
prominent	B-problem
interstitium	I-problem
though	O
his	O
lung	O
volumes	O
were	O
low	B-problem
.	O

Subsequent	B-test
chest	I-test
x-ray	I-test
showed	O
right	B-treatment
main	I-treatment
stem	I-treatment
intubation	I-treatment
with	O
left	B-problem
lung	I-problem
collapse	I-problem
which	O
had	O
corrected	O
with	O
withdrawal	B-treatment
of	I-treatment
the	I-treatment
endotracheal	I-treatment
tube	I-treatment
.	O

The	O
patient	O
was	O
then	O
transferred	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
induced	B-treatment
hypothermia	I-treatment
given	O
his	O
hemodynamic	O
stability	O
,	O
ongoing	B-problem
unresponsiveness	I-problem
and	O
recent	B-problem
out	I-problem
of	I-problem
hospital	I-problem
cardiac	I-problem
arrest	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Hypertension	B-problem
.	O

2)	O
Chronic	B-problem
low	I-problem
back	I-problem
pain	I-problem
,	O
s/p	O
lumbar	B-treatment
discectomy	I-treatment
x	O
2	O
.	O

3)	O
Cirrhosis	B-problem
.	O

4)	O
h/o	O
stab	B-problem
wound	I-problem
complicated	O
by	O
pneumothorax	B-problem
.	O

5)	O
h/o	O
lower	B-problem
extremity	I-problem
cellulitis	I-problem
.	O

6)	O
s/p	O
cholecystectomy	B-treatment
.	O

7)	O
Peripheral	B-problem
neuropathy	I-problem
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

According	O
to	O
his	O
pharmacy	O
,	O
he	O
was	O
on	O
:	O

1.	O
OxyContin	B-treatment
40	O
mg	O
p.o.	O
q	O
12hours	O
.	O

2.	O
Percocet	B-treatment
.	O

3.	O
Nortriptyline	B-treatment
.	O

4.	O
Neurontin	B-treatment
1800	O
mg	O
four	O
times	O
a	O
day	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
divorced	O
.	O

His	O
son	O
is	O
a	O
policeman	O
working	O
in	O
Ludlow	O
.	O

He	O
drinks	O
greater	O
than	O
one	O
case	O
of	O
beer	O
per	O
day	O
.	O

He	O
has	O
a	O
history	O
of	O
abuse	O
of	O
Percocet	B-treatment
according	O
to	O
his	O
brother	O
.	O

James	O
is	O
currently	O
homeless	O
.	O

He	O
was	O
recently	O
arrested	O
for	O
altering	O
a	O
prescription	O
according	O
to	O
his	O
pharmacy	O
.	O

He	O
had	O
recently	O
filled	O
a	O
prescription	O
for	O
560	O
tablets	O
of	O
Percocet	B-treatment
as	O
well	O
as	O
60	O
tablets	O
of	O
OxyContin	B-treatment
early	O
last	O
month	O
.	O

FAMILY	O
HISTORY	O
:	O

Negative	O
for	O
any	O
history	O
of	O
sudden	B-problem
death	I-problem
or	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
temperature	B-test
was	O
96.2	O
,	O
blood	B-test
pressure	I-test
150/80	O
,	O
heart	B-test
rate	I-test
92	O
,	O
respiratory	B-test
rate	I-test
16	O
.	O

In	O
general	O
,	O
he	O
was	O
unarousible	B-problem
,	O
intubated	B-treatment
,	O
not	O
on	O
any	B-treatment
sedation	I-treatment
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
-	O
His	O
pupils	O
were	O
equal	O
and	O
three	O
millimeters	O
.	O

They	O
were	O
minimally	B-problem
reactive	I-problem
.	O

His	O
sclerae	O
were	O
anicteric	B-problem
.	O

The	B-test
cardiac	I-test
examination	I-test
was	O
unremarkable	O
without	O
murmurs	B-problem
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

His	O
abdomen	O
had	O
normal	O
bowel	O
sounds	O
,	O
soft	O
and	O
nontender	B-problem
.	O

Extremities	O
had	O
multiple	B-problem
bilateral	I-problem
lower	I-problem
extremity	I-problem
excoriations	I-problem
.	O

Neurologic	B-test
examination	I-test
-	O
he	O
was	O
unarousible	B-problem
and	O
without	O
sedation	B-treatment
.	O

He	O
had	O
no	B-problem
spontaneous	I-problem
movements	I-problem
.	O

Flaccid	B-problem
.	O

Extremities	O
-	O
Babinski	B-test
reflex	I-test
was	O
equivocal	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

At	O
the	O
time	O
of	O
admission	O
,	O
laboratories	B-test
were	O
remarkable	O
for	O
a	B-test
partial	I-test
thromboplastin	I-test
time	I-test
of	O
31.7	O
,	O
INR	B-test
1.4	O
,	O
potassium	B-test
3.2	O
,	O
glucose	B-test
182	O
,	O
lactate	B-test
was	O
initially	O
6.6	O
.	O

Urine	B-test
toxicology	I-test
screen	I-test
was	O
negative	O
.	O

Serum	B-test
toxicology	I-test
screen	I-test
was	O
positive	O
for	O
TCA	B-treatment
s.	I-treatment

Tylenol	B-test
level	I-test
was	O
15	O
.	O

Alcohol	B-test
level	I-test
was	O
199	O
.	O

Initial	B-test
blood	I-test
gas	I-test
was	O
7.31/46/500/77	O
.	O

HOSPITAL	O
COURSE	O
:	O

Cardiac	B-problem
arrest	I-problem
-	O
His	B-problem
arrest	I-problem
was	O
of	O
unknown	O
etiology	O
at	O
the	O
time	O
of	O
admission	O
.	O

No	O
further	O
history	O
was	O
ever	O
gained	O
about	O
his	B-problem
cardiac	I-problem
arrest	I-problem
throughout	O
his	O
hospitalization	O
.	O

CT	B-test
angiogram	I-test
had	O
been	O
negative	O
for	O
pulmonary	B-problem
embolism	I-problem
.	O

The	O
patient	O
had	O
an	B-test
echocardiogram	I-test
on	O
2013-04-26	O
,	O
which	O
showed	O
a	O
normal	O
ejection	O
fraction	O
and	O
trivial	B-problem
mitral	I-problem
regurgitation	I-problem
;	O
otherwise	O
no	O
obvious	B-problem
abnormalities	I-problem
were	O
seen	O
.	O

Given	O
the	O
patient	O
had	O
an	B-problem
out	I-problem
of	I-problem
hospital	I-problem
arrest	I-problem
,	O
remained	O
unresponsive	B-problem
despite	O
hemodynamic	O
stability	O
,	O
he	O
was	O
treated	O
with	O
induced	B-treatment
hypothermia	I-treatment
and	O
with	O
cold	B-treatment
packs	I-treatment
and	O
a	B-treatment
cooling	I-treatment
blanket	I-treatment
were	O
placed	O
with	O
goals	O
of	O
reducing	O
his	B-test
core	I-test
body	I-test
temperature	I-test
to	O
32	O
degrees	O
Celsius	O
for	O
a	O
period	O
of	O
twelve	O
hours	O
at	O
which	O
point	O
he	O
would	O
be	O
rewarmed	O
over	O
the	O
subsequent	O
six	O
hours	O
.	O

This	O
was	O
done	O
,	O
however	O
,	O
as	O
in	O
problem	O
number	O
two	O
below	O
,	O
we	O
were	O
not	O
successful	O
in	O
any	O
neurologic	O
recovery	O
.	O

Neurology	O
-	O
The	O
patient	O
remained	O
unresponsive	B-problem
after	O
the	B-treatment
induced	I-treatment
hypothermia	I-treatment
,	O
the	O
patient	O
was	O
noticed	O
to	O
develop	O
myoclonic	B-problem
jerks	I-problem
and	O
occasional	O
fluttering	O
of	O
his	O
eyelids	O
.	O

Electroencephalogram	B-test
revealed	O
the	O
patient	O
was	O
experiencing	O
persistent	B-problem
seizure	I-problem
activity	I-problem
.	O

Neurology	O
was	O
consulted	O
and	O
the	O
patient	O
was	O
treated	O
very	O
aggressively	O
,	O
loaded	O
with	O
multiple	B-treatment
drugs	I-treatment
,	O
including	O
Ativan	B-treatment
and	O
Propofol	B-treatment
drips	I-treatment
.	O

The	O
patient	O
continued	O
to	O
demonstrate	O
seizure	B-problem
activity	I-problem
despite	O
this	O
.	O

He	O
was	O
loaded	O
with	O
Dilantin	B-treatment
and	O
ultimately	O
was	O
treated	O
with	O
a	B-treatment
Pentobarb	I-treatment
coma	I-treatment
.	O

After	O
multiple	O
attempts	O
of	O
weaning	O
the	B-treatment
Pentobarb	I-treatment
,	O
the	O
patient	O
was	O
continually	O
reverting	O
to	O
status	B-problem
epilepticus	I-problem
which	O
was	O
never	O
able	O
to	O
be	O
suppressed	O
.	O

Infectious	O
disease	O
-	O
Over	O
the	O
course	O
of	O
his	O
hospital	O
stay	O
,	O
the	B-test
patient	I-test
's	I-test
white	I-test
blood	I-test
cell	I-test
count	I-test
rose	O
to	O
a	O
peak	O
of	O
17	O
.	O

Multiple	B-test
cultures	I-test
were	O
done	O
and	O
the	O
patient	O
was	O
ultimately	O
found	O
to	O
have	O
methicillin	B-problem
resistant	I-problem
Staphylococcus	I-problem
aureus	I-problem
bacteremia	I-problem
,	O
pneumonia	B-problem
,	O
and	O
urinary	B-problem
tract	I-problem
infection	I-problem
.	O

For	O
all	O
these	B-problem
infections	I-problem
,	O
the	O
patient	O
was	O
treated	O
with	O
Vancomycin	B-treatment
and	O
he	O
was	O
also	O
on	O
Levofloxacin	B-treatment
and	O
Flagyl	B-treatment
for	O
presumed	O
aspiration	B-problem
pneumonia	I-problem
at	O
the	O
time	O
of	O
his	O
admission	O
.	O

Blood	B-test
cultures	I-test
cleared	O
by	O
2013-05-03	O
.	O

Sputum	B-test
culture	I-test
as	O
late	O
as	O
2013-05-10	O
,	O
however	O
was	O
still	O
positive	O
for	O
coagulase	B-problem
positive	I-problem
Staphylococcus	I-problem
which	O
was	O
methicillin	B-problem
resistant	I-problem
Staphylococcus	I-problem
aureus	I-problem
.	O

The	O
patient	O
remained	O
gravely	B-problem
ill	I-problem
throughout	O
his	O
hospital	O
stay	O
and	O
had	O
multiple	O
meetings	O
were	O
held	O
with	O
his	O
family	O
with	O
his	O
son	O
being	O
his	O
next	O
of	O
kin	O
.	O

Ultimately	O
it	O
was	O
decided	O
that	O
the	O
patient	O
's	O
wishes	O
would	O
be	O
to	O
not	O
be	O
maintained	O
in	O
a	O
vegetative	O
state	O
and	O
given	O
his	O
poor	O
prognosis	O
ultimately	O
the	O
decision	O
was	O
made	O
to	O
pursue	O
comfort	B-treatment
measures	I-treatment
only	O
.	O

With	O
these	O
goals	O
of	O
care	O
,	O
the	O
patient	O
expired	O
on	O
2013-05-11	O
.	O

The	O
family	O
did	O
consent	O
to	O
a	B-test
postmortem	I-test
examination	I-test
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Cardiac	B-problem
arrest	I-problem
.	O

Anoxic	B-problem
brain	I-problem
injury	I-problem

Status	B-problem
epilepticus	I-problem

Methicillin	B-problem
resistant	I-problem
Staphylococcus	I-problem
aureus	I-problem
pneumonia	I-problem
.	O

MRSA	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

MRSA	B-problem
Bacteremia	I-problem
.	O

Steven	O
Welch	O
,	O
Montana	O
61528	O

Dictated	O
By	O
:	O
Julie	O
DD	O
George	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2013-12-24	O
13:55:05	O

T	O
:	O
2013-12-24	O
20:47:07	O

Job	O
#:	O
52892	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Patricia	O
Henley	O
on	O
:	O
Maxine	O
2014-01-02	O
10:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

768768524	O
PAD-WORD	O

PRGH	O
PAD-WORD	O

91287406	O
PAD-WORD	O

057469	O
PAD-WORD	O

6/19/1998	O
12:00:00	O
AM	O

RESPIRATORY	B-problem
DISTRESS	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

06/19/1998	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

08/01/1998	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSES	O
:	O

1	O
)	O
THROMBOTIC	B-problem
THROMBOCYTOPENIC	I-problem
PURPURA	I-problem
.	O

2	O
)	O
BRONCHIOLITIS	B-problem
OBLITERANS	I-problem
ORGANIZING	I-problem
PNEUMONIA	I-problem
.	O

3	O
)	O
RENAL	B-problem
FAILURE	I-problem
REQUIRING	O
CHRONIC	B-treatment
DIALYSIS	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
63	O
year-old	O
woman	O
transferred	O
from	O
Pre	O
Health	O
on	O
June	O
19	O
,	O
1998	O
to	O
the	O
Verg	O
Medical	O
Center	O
Intensive	O
Care	O
Unit	O
for	O
evaluation	B-test
of	O
thrombotic	B-problem
thrombocytopenic	I-problem
purpura	I-problem
and	O
bronchiolitis	B-problem
obliterans	I-problem
organizing	I-problem
pneumonia	I-problem
.	O

On	O
May	O
12	O
,	O
1998	O
,	O
the	O
patient	O
presented	O
to	O
Pre	O
Health	O
with	O
fever	B-problem
,	O
cough	B-problem
,	O
dyspnea	B-problem
and	O
a	B-test
chest	I-test
x-ray	I-test
revealing	O
a	B-problem
patchy	I-problem
infiltrate	I-problem
in	I-problem
the	I-problem
right	I-problem
lung	I-problem
.	O

She	O
was	O
treated	O
with	O
Clindamycin	B-treatment
and	O
Erythromycin	B-treatment
which	O
were	O
changed	O
to	O
Trovan	B-treatment
and	O
then	O
transferred	O
to	O
A	O
Hospital	O
.	O

On	O
May	O
27	O
,	O
1998	O
,	O
the	O
patient	O
desaturated	O
to	O
40%	O
with	O
a	B-test
temperature	I-test
of	O
100.5	O
degrees	O
.	O

Her	B-test
oxygen	I-test
saturations	I-test
improved	O
to	O
only	O
92%	O
on	O
100%	B-treatment
face	I-treatment
mask	I-treatment
and	O
she	O
was	O
admitted	O
to	O
Pre	O
Health	O
Intensive	O
Care	O
Unit	O
.	O

Chest	B-test
x-ray	I-test
there	O
revealed	O
bilateral	B-problem
pulmonary	I-problem
infiltrates	I-problem
with	O
increasing	B-problem
pleural	I-problem
effusion	I-problem
.	O

A	B-test
VQ	I-test
scan	I-test
was	O
high	O
probability	O
,	O
but	O
no	O
pulmonary	B-test
angiogram	I-test
was	O
done	O
and	O
an	B-test
echocardiogram	I-test
revealed	O
a	O
normal	O
left	O
ventricle	O
with	O
no	O
wall	B-problem
motion	I-problem
abnormality	I-problem
and	O
an	B-test
ejection	I-test
fraction	I-test
of	O
75%	O
.	O

On	O
May	O
24	O
,	O
1998	O
,	O
the	O
patient	O
had	O
a	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
chest	I-test
which	O
revealed	O
diffuse	B-problem
alveolar	I-problem
infiltrates	I-problem
at	I-problem
the	I-problem
right	I-problem
base	I-problem
,	O
mediastinal	B-problem
lymphadenopathy	I-problem
and	O
bilateral	B-problem
pleural	I-problem
effusions	I-problem
.	O

At	O
this	O
point	O
,	O
a	O
diagnosis	O
of	O
lupus	B-problem
was	O
considered	O
and	O
her	B-test
ANA	I-test
was	O
1:640	O
and	O
her	B-test
rheumatoid	I-test
factor	I-test
and	O
ANCA	B-test
were	O
negative	O
.	O

She	O
was	O
started	O
on	O
a	B-treatment
steroid	I-treatment
trial	I-treatment
at	O
that	O
point	O
.	O

Her	O
pleural	O
fluid	O
was	O
tapped	O
and	O
it	O
was	O
negative	O
for	O
malignancy	B-problem
.	O

On	O
June	O
11	O
,	O
1998	O
,	O
the	O
patient	O
had	O
a	B-test
video	I-test
assisted	I-test
thoracoscopic	I-test
study	I-test
of	I-test
the	I-test
right	I-test
lung	I-test
which	O
revealed	O
chronic	B-problem
interstitial	I-problem
pneumonitis	I-problem
with	O
a	B-problem
bronchiolitis	I-problem
obliterans	I-problem
organizing	I-problem
pneumonia-like	I-problem
reaction	I-problem
and	O
a	B-treatment
chest	I-treatment
tube	I-treatment
was	O
placed	O
.	O

The	O
patient	O
was	O
then	O
started	O
on	O
40	O
mg	O
of	O
Prednisone	B-treatment
q.	O
day	O
.	O

From	O
May	O
27	O
,	O
1998	O
through	O
June	O
19	O
,	O
1998	O
,	O
the	O
patient	O
had	O
a	O
decline	O
in	O
her	B-test
platelets	I-test
from	O
394	O
to	O
28	O
with	O
a	O
stable	O
hematocrit	O
of	O
32	O
to	O
33	O
and	O
a	B-problem
rise	I-problem
in	O
creatinine	B-test
from	O
1.0	O
to	O
3.8	O
.	O

On	O
June	O
19	O
,	O
1998	O
,	O
she	O
was	O
transferred	O
to	O
the	O
Verg	O
Medical	O
Center	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
evaluation	B-test
of	O
possible	O
thrombotic	B-problem
thrombocytopenic	I-problem
purpura	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1	O
)	O
Cerebrovascular	B-problem
accident	I-problem
in	O
1995	O
in	O
the	O
pontine	O
region	O
secondary	O
to	O
hypertension	B-problem
.	O

2	O
)	O
Hypertension	B-problem
.	O

3	O
)	O
Status	O
post	O
hysterectomy	B-treatment
.	O

4	O
)	O
Status	O
post	O
appendectomy	B-treatment
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1	O
)	O
Albuterol	B-treatment
inhaler	I-treatment
4	O
puffs	O
q.i.d.	O

2	O
)	O
Lasix	B-treatment
p.r.n.	O

3	O
)	O
Prednisone	B-treatment
40	O
mg	O
p.o.	O
q.	O
day	O
.	O

4	O
)	O
Inderal	B-treatment
40	O
mg	O
p.o.	O
q.i.d.	O

5	O
)	O
Thiamine	B-treatment
.	O

6	O
)	O
Lasix	B-treatment
p.r.n.	O

7	O
)	O
Atrovent	B-treatment
inhaler	I-treatment
4	O
puffs	O
q.i.d.	O

8	O
)	O
Folic	B-treatment
acid	I-treatment
.	O

9	O
)	O
Premarin	B-treatment
0.625	O
mg	O
p.o.	O
q.	O
day	O
.	O

10	O
)	O
Omeprazole	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

11	O
)	O
Insulin	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
had	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
divorced	O
.	O

She	O
has	O
two	O
children	O
.	O

She	O
recently	O
retired	O
as	O
a	O
clerical	O
worker	O
.	O

She	O
denies	O
any	O
tobacco	O
.	O

She	O
has	O
only	O
social	O
alcohol	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
died	O
at	O
age	O
56	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

Mother	O
died	O
at	O
age	O
68	O
of	O
pancreatic	B-problem
carcinoma	I-problem
.	O

Brother	O
has	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

There	O
is	O
no	O
family	O
history	O
of	O
hematologic	B-problem
problems	I-problem
.	O

LABORATORY	O
:	O

Laboratory	B-test
studies	I-test
on	O
admission	O
were	O
notable	O
for	O
a	B-test
sodium	I-test
of	O
131	O
,	O
potassium	B-test
6.2	O
,	O
BUN	B-test
111	O
,	O
creatinine	B-test
3.9	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
23	O
,	O
hematocrit	B-test
27	O
with	O
2+	B-problem
schistocytes	I-problem
and	O
2+	B-problem
spherocytes	I-problem
on	O
the	B-test
smear	I-test
,	O
platelet	B-test
count	I-test
92	O
and	O
LDH	B-test
496	O
.	O

HOSPITAL	O
COURSE	O
:	O

1	O
)	O
Bronchiolitis	B-problem
obliterans	I-problem
organizing	I-problem
pneumonia	I-problem
:	O

The	B-test
video	I-test
assisted	I-test
thoracoscopic	I-test
study	I-test
at	O
the	O
outside	O
hospital	O
was	O
consistent	O
with	O
bronchiolitis	B-problem
obliterans	I-problem
organizing	I-problem
pneumonia	I-problem
.	O

The	O
patient	O
was	O
continued	O
on	O
steroids	B-treatment
throughout	O
the	O
course	O
of	O
her	O
stay	O
.	O

This	O
was	O
changed	O
to	O
Solu-Medrol	B-treatment
part	O
way	O
through	O
the	O
course	O
due	O
to	O
her	B-problem
hematologic	I-problem
problems	I-problem
,	O
see	O
below	O
.	O

By	O
discharge	O
,	O
she	O
was	O
returned	O
to	O
40	O
mg	O
of	O
Prednisone	B-treatment
q.	O
day	O
times	O
one	O
month	O
to	O
be	O
followed	O
by	O
a	B-treatment
slow	I-treatment
taper	I-treatment
.	O

The	B-problem
patient	I-problem
&apos;s	I-problem
bronchiolitis	I-problem
obliterans	I-problem
organizing	I-problem
pneumonia	I-problem
appeared	O
to	O
improve	O
slowly	O
throughout	O
her	O
hospital	O
course	O
,	O
however	O
on	O
July	O
12	O
,	O
1998	O
,	O
after	O
starting	O
dialysis	B-treatment
(	O
see	O
below	O
)	O
,	O
the	O
patient	O
desaturated	O
and	O
required	O
supplemental	B-treatment
oxygen	I-treatment
.	O

Repeat	B-test
chest	I-test
x-rays	I-test
and	O
chest	B-test
CT	I-test
scans	I-test
appeared	O
consistent	O
with	O
pulmonary	B-problem
edema	I-problem
from	O
volume	B-problem
overload	I-problem
given	O
her	B-problem
renal	I-problem
failure	I-problem
and	O
eventually	O
,	O
the	O
patient	O
&apos;s	O
pulmonary	O
status	O
did	O
improve	O
after	O
significant	B-treatment
volume	I-treatment
removal	I-treatment
with	O
dialysis	B-treatment
for	O
several	O
weeks	O
.	O

At	O
the	O
time	O
of	O
her	O
discharge	O
,	O
the	O
patient	O
was	O
still	O
requiring	O
two	O
liters	O
of	O
supplemental	B-treatment
oxygen	I-treatment
to	O
maintain	O
her	B-test
oxygen	I-test
saturations	I-test
in	O
the	O
mid	O
90%	O
.	O

2	O
)	O
Thrombotic	B-problem
thrombocytopenic	I-problem
purpura	I-problem
:	O

The	O
patient	O
was	O
initially	O
admitted	O
with	O
platelet	B-test
count	I-test
of	O
28	O
,	O
hematocrit	B-test
of	O
32	O
,	O
LDH	B-test
of	O
496	O
with	O
2+	B-problem
schistocytes	I-problem
and	O
2+	B-problem
spherocytes	I-problem
on	O
her	B-test
smear	I-test
.	O

This	O
was	O
felt	O
to	O
be	O
consistent	O
with	O
thrombotic	B-problem
thrombocytopenic	I-problem
purpura	I-problem
and	O
on	O
June	O
20	O
,	O
1998	O
,	O
she	O
was	O
started	O
on	O
daily	B-treatment
plasma	I-treatment
exchange	I-treatment
which	O
continued	O
through	O
July	O
27	O
,	O
1999	O
.	O

She	O
was	O
also	O
changed	O
to	O
intravenous	B-treatment
Solu-Medrol	I-treatment
50	O
mg	O
q.	O
day	O
which	O
was	O
changed	O
back	O
to	O
40	O
mg	O
of	O
Prednisone	B-treatment
prior	O
to	O
discharge	O
.	O

Her	B-test
platelet	I-test
count	I-test
initially	O
rose	O
to	O
a	O
maximum	O
of	O
159	O
on	O
July	O
3	O
,	O
1998	O
,	O
then	O
they	O
steadily	O
fell	O
to	O
a	O
low	O
of	O
60	O
on	O
July	O
20	O
,	O
1999	O
.	O

Her	B-test
LDH	I-test
which	O
peaked	O
at	O
1255	O
decreased	O
to	O
the	O
mid	O
200s	O
,	O
but	O
remained	O
elevated	B-problem
.	O

She	O
continued	O
to	O
have	O
a	B-problem
few	I-problem
schistocytes	I-problem
on	O
her	B-test
smear	I-test
,	O
but	O
it	O
was	O
much	O
decreased	O
.	O

The	O
patient	O
also	O
required	O
red	B-treatment
blood	I-treatment
cell	I-treatment
transfusions	I-treatment
,	O
approximately	O
two	O
units	O
every	O
seven	O
to	O
ten	O
days	O
to	O
maintain	O
her	B-test
hematocrit	I-test
.	O

Eventually	O
,	O
her	B-treatment
plasma	I-treatment
exchange	I-treatment
was	O
tapered	O
to	O
a	O
smaller	O
and	O
smaller	O
dose	O
each	O
day	O
and	O
then	O
discontinued	O
altogether	O
after	O
July	O
27	O
,	O
1999	O
.	O

After	O
this	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
platelet	I-test
count	I-test
rose	O
to	O
a	O
maximum	O
of	O
177	O
on	O
discharge	O
.	O

It	O
is	O
felt	O
that	O
the	B-problem
patient	I-problem
&apos;s	I-problem
thrombotic	I-problem
thrombocytopenic	I-problem
purpura	I-problem
has	O
resolved	O
.	O

She	O
will	O
continue	O
on	O
her	B-treatment
Prednisone	I-treatment
for	O
one	O
month	O
as	O
above	O
for	O
the	B-problem
bronchiolitis	I-problem
obliterans	I-problem
organizing	I-problem
pneumonia	I-problem
with	O
a	B-treatment
very	I-treatment
slow	I-treatment
taper	I-treatment
.	O

3	O
)	O
Renal	O
:	O

The	O
patient	O
presented	O
in	O
acute	B-problem
renal	I-problem
failure	I-problem
with	O
a	B-test
BUN	I-test
of	O
101	O
and	O
a	B-test
creatinine	I-test
of	O
3.7	O
.	O

Throughout	O
the	O
month	O
of	O
June	O
,	O
she	O
had	O
a	B-problem
rising	I-problem
Potassium	I-problem
phosphate	I-problem
and	O
increasing	B-problem
volume	I-problem
overload	I-problem
with	O
decreasing	O
response	O
to	O
diuretics	B-treatment
and	O
she	O
was	O
finally	O
initiated	O
on	O
dialysis	B-treatment
with	O
ultrafiltration	B-treatment
on	O
July	O
12	O
,	O
1998	O
.	O

The	O
opinion	O
of	O
the	O
Renal	O
consult	O
was	O
that	O
this	O
was	O
permanent	B-problem
and	I-problem
non-reversible	I-problem
renal	I-problem
failure	I-problem
since	O
it	O
did	O
not	O
improve	O
with	O
dialysis	B-treatment
and	O
the	O
patient	O
will	O
continue	O
on	O
dialysis	B-treatment
three	O
times	O
per	O
week	O
.	O

She	O
required	O
approximately	O
five	O
liters	O
of	O
ultrafiltration	B-treatment
fluid	I-treatment
removal	I-treatment
at	O
each	O
dialysis	O
session	O
due	O
to	O
her	B-problem
significant	I-problem
volume	I-problem
overload	I-problem
.	O

During	O
the	O
course	O
of	O
her	B-treatment
dialysis	I-treatment
,	O
she	O
had	O
a	O
great	O
improvement	O
in	O
her	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
and	O
her	B-test
oxygen	I-test
saturation	I-test
.	O

4	O
)	O
Infectious	O
disease	O
:	O

The	O
patient	O
had	O
multiple	B-problem
line	I-problem
infections	I-problem
during	O
her	O
admission	O
including	O
a	B-problem
confirmed	I-problem
coag.	I-problem
negative	I-problem
Staphylococcus	I-problem
line	I-problem
infection	I-problem
with	O
positive	B-problem
blood	I-problem
cultures	I-problem
on	O
June	O
23	O
,	O
1998	O
,	O
July	O
4	O
,	O
1998	O
,	O
July	O
8	O
,	O
1998	O
and	O
July	O
9	O
,	O
1998	O
.	O

The	O
patient	O
eventually	O
had	O
a	B-treatment
left	I-treatment
subclavian	I-treatment
Tesio	I-treatment
catheter	I-treatment
placed	O
and	O
a	B-treatment
right	I-treatment
brachial	I-treatment
PICC	I-treatment
line	I-treatment
placed	O
on	O
July	O
10	O
,	O
1998	O
which	O
remained	O
patent	O
and	O
uninfected	B-problem
.	O

She	O
received	O
a	B-treatment
full	I-treatment
three	I-treatment
week	I-treatment
course	I-treatment
of	I-treatment
Vancomycin	I-treatment
and	O
also	O
received	O
a	B-treatment
three	I-treatment
week	I-treatment
course	I-treatment
of	I-treatment
Ceftazidime	I-treatment
.	O

In	O
addition	O
,	O
she	O
had	O
a	B-problem
fungal	I-problem
urinary	I-problem
tract	I-problem
infection	I-problem
treated	O
with	O
Amphojel	B-treatment
bladder	I-treatment
irrigation	I-treatment
,	O
which	O
was	O
followed	O
by	O
a	B-problem
Klebsiella	I-problem
urinary	I-problem
tract	I-problem
infection	I-problem
for	O
which	O
she	O
received	O
Levofloxacin	B-treatment
times	O
fourteen	O
days	O
.	O

She	O
also	O
received	O
a	B-treatment
fourteen	I-treatment
day	I-treatment
course	I-treatment
of	I-treatment
Acyclovir	I-treatment
which	O
was	O
begun	O
on	O
June	O
21	O
,	O
1998	O
for	O
perianal	B-problem
lesions	I-problem
consistent	O
with	O
herpes	B-problem
simplex	I-problem
virus	I-problem
.	O

She	O
was	O
also	O
on	O
Fluconazole	B-treatment
for	O
some	B-problem
oral	I-problem
thrush	I-problem
which	O
was	O
inadvertently	O
continued	O
for	O
a	O
total	O
of	O
thirty	O
days	O
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
Bactrim	B-treatment
one	I-treatment
double	I-treatment
strength	I-treatment
tablet	O
q.o.d.	O
as	O
prophylaxis	O
for	O
Pneumocystis	B-problem
carinii	I-problem
pneumonia	I-problem
while	O
on	O
her	B-treatment
high	I-treatment
dose	I-treatment
steroids	I-treatment
.	O

5	O
)	O
Rheumatology	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
a	O
question	O
of	O
lupus	B-problem
given	O
her	B-test
ANA	I-test
of	O
1:640	O
although	O
her	B-test
rheumatoid	I-test
factor	I-test
and	O
ANCA	B-test
were	O
negative	O
.	O

Unfortunately	O
throughout	O
her	O
admission	O
,	O
we	O
were	O
unable	O
to	O
test	O
any	B-test
more	I-test
titers	I-test
since	O
she	O
was	O
receiving	O
daily	B-treatment
plasma	I-treatment
exchange	I-treatment
.	O

A	B-test
repeat	I-test
ANA	I-test
,	O
rheumatoid	B-test
factor	I-test
and	O
ANCA	B-test
may	O
be	O
repeated	O
as	O
an	O
outpatient	O
.	O

FOLLOW-UP	O
:	O

1	O
)	O
The	O
patient	O
will	O
follow-up	O
with	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Tamarg	O
Study	O
,	O
in	O
Arvus	O
after	O
she	O
is	O
discharged	O
from	O
rehabilitation	B-treatment
.	O

2	O
)	O
The	O
patient	O
is	O
being	O
discharged	O
to	O
A	O
Hospital	O
where	O
she	O
will	O
receive	O
onsite	B-treatment
hemodialysis	I-treatment
three	O
times	O
per	O
week	O
on	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
.	O

The	O
nephrologist	O
who	O
will	O
follow	O
her	O
there	O
is	O
Dr.	O
Study	O
.	O

3	O
)	O
The	O
patient	O
will	O
continue	O
to	O
have	O
her	B-test
CBC	I-test
,	O
LDH	B-test
,	O
bilirubin	B-test
,	O
chem-7	B-test
and	O
magnesium	B-test
and	O
calcium	B-test
checked	O
with	O
each	B-treatment
dialysis	I-treatment
and	O
the	O
results	O
will	O
be	O
faxed	O
to	O
Dr.	O
Ian	O
Zineisfreierm	O
,	O
the	O
hematology	O
attending	O
at	O
fax	O
number	O
751-329-8840	O
.	O

4	O
)	O
The	O
patient	O
will	O
eventually	O
need	O
a	B-treatment
permanent	I-treatment
dialysis	I-treatment
fistula	I-treatment
.	O

The	B-treatment
left	I-treatment
subclavian	I-treatment
Tesio	I-treatment
which	O
she	O
has	O
in	O
place	O
will	O
last	O
for	O
several	O
months	O
in	O
the	O
mean	O
time	O
.	O

She	O
would	O
like	O
to	O
arrange	O
to	O
have	O
her	B-treatment
fistula	I-treatment
placed	O
at	O
Pre	O
Health	O
and	O
the	O
vascular	O
surgeons	O
there	O
should	O
be	O
contacted	O
regarding	O
this	O
.	O

5	O
)	O
The	O
patient	O
will	O
need	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cell	I-treatment
transfusions	I-treatment
with	O
dialysis	B-treatment
when	O
her	B-test
hematocrit	I-test
falls	O
below	O
26	O
.	O

6	O
)	O
The	O
patient	O
will	O
continue	O
her	B-treatment
Prednisone	I-treatment
at	O
40	O
mg	O
p.o.	O
q.	O
day	O
times	O
one	O
month	O
(	O
this	O
was	O
started	O
on	O
July	O
27	O
,	O
1999	O
)	O
and	O
then	O
she	O
will	O
begin	O
a	B-treatment
slow	I-treatment
taper	I-treatment
as	O
guided	O
by	O
Pulmonary	O
.	O

7	O
)	O
The	O
patient	O
has	O
a	O
follow-up	O
appointment	O
in	O
the	O
Pulmonary	O
Clinic	O
with	O
Dr.	O
Cedwi	O
Stone	O
at	O
336-2931	O
on	O
August	O
30	O
,	O
1999	O
at	O
1:40	O
PM	O
.	O

8	O
)	O
The	O
patient	O
has	O
a	O
follow-up	O
appointment	O
with	O
Dr.	O
Ian	O
Zineisfreierm	O
at	O
the	O
We	O
Erthunt	O
Hospital	O
at	O
180-0455	O
on	O
August	O
15	O
,	O
1999	O
at	O
12:30	O
PM	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1	O
)	O
Calcitriol	B-treatment
0.25	O
mcg	O
p.o.	O
q.	O
day	O
.	O

2	O
)	O
TUMS	B-treatment
1250	O
mg	O
p.o.	O
t.i.d.	O

3	O
)	O
Premarin	B-treatment
0.625	O
mg	O
p.o.	O
q.	O
day	O
.	O

4	O
)	O
Colace	B-treatment
100	O
mg	O
p.o.	O
b.i.d.	O

5	O
)	O
Humulin	B-treatment
sliding	I-treatment
scale	I-treatment
q.a.c.	O
and	O
q.h.s.	O

6	O
)	O
Labetalol	B-treatment
400	O
mg	O
p.o.	O
t.i.d.	O

7	O
)	O
Omeprazole	B-treatment
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

8	O
)	O
Serax	B-treatment
15	O
mg	O
p.o.	O
q.h.s.	O
p.r.n.	O
insomnia	B-problem
.	O

9	O
)	O
Prednisone	B-treatment
40	O
mg	O
p.o.	O
q.	O
day	O
times	O
thirty	O
days	O
beginning	O
on	O
July	O
27	O
,	O
1999	O
to	O
be	O
followed	O
by	O
a	B-treatment
slow	I-treatment
taper	I-treatment
as	O
directed	O
by	O
the	O
pulmonologist	O
.	O

10	O
)	O
Metamucil	B-treatment
one	O
packet	O
p.o.	O
q.	O
day	O
.	O

11	O
)	O
Amlodipine	B-treatment
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

12	O
)	O
Bactrim	B-treatment
Double	I-treatment
Strength	I-treatment
one	O
tablet	O
p.o.	O
q.o.d.	O

13	O
)	O
Nephrocaps	B-treatment
one	O
tablet	O
p.o.	O
q.	O
day	O
.	O

14	O
)	O
Epogen	B-treatment
1,000	O
units	O
subcutaneously	O
three	O
times	O
per	O
week	O
.	O

15	O
)	O
Iron	B-treatment
sulfate	I-treatment
300	O
mg	O
p.o.	O
t.i.d.	O

Dictated	O
By	O
:	O

CHELA	O
FYFENEIGH	O
,	O
M.D.	O
NY5	O

Attending	O
:	O

LENNI	O
E.	O
NECESSARY	O
,	O
M.D.	O
BE1	O
IZ845/6789	O

Batch	O
:	O

7665	O
PAD-WORD	O

Index	O
No.	O
YQGKGG4LST	O

D	O
:	O

08/01/98	O
PAD-WORD	O

T	O
:	O

08/01/98	O
PAD-WORD	O

CC	O
:	O

CEDWI	O
STONE	O
,	O
MD	O
,	O
BMH	O
PULMONARY	O
CLINIC	O
TAMARG	O
STUDY	O
,	O
MD	O
,	O
Port	O
O	O
,	O
PHONE	O
912-434-8561	O
A	O
HOSPITAL	O
,	O
Sburgbuff	O

﻿Admission	O
Date	O
:	O

2016-03-18	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2016-04-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1929-07-27	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

SURGERY	B-treatment
PAD-WORD	O

Allergies	O
:	O

Tetracycline	B-treatment
PAD-WORD	O

Attending	O
:	O
Samuel	O
A.	O
Brown	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Transfer	O
from	O
Lewis	O
to	O
Hallmark	O
Health	O
System	O
CMED	O
CSRU	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

s/p	O
I&D	B-treatment
(	O
03-17	O
)	O

s/p	O
Debridement	B-treatment
(	O
03-18	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Morton	O
is	O
a	O
86	O
yo	O
male	O
transferred	O
from	O
Kindred	O
Park	O
View	O
Specialty	O
Hospital	O
of	O
Springfield-Sample	O
.	O

He	O
developed	O
right	B-problem
foot	I-problem
pain	I-problem
the	O
Sunday	O
prior	O
to	O
admission	O
and	O
was	O
seen	O
by	O
his	O
Podiatrist	O
,	O
who	O
diagnosed	O
him	O
with	O
gout	B-problem
.	O

He	O
was	O
given	O
colchicine	B-treatment
and	O
prednisone	B-treatment
.	O

Mr.	O
Morton	O
then	O
developed	O
more	B-problem
pain	I-problem
and	O
warmth	B-problem
to	I-problem
his	I-problem
right	I-problem
foot	I-problem
later	O
in	O
the	O
week	O
and	O
presented	O
to	O
the	O
Youville	O
Hospital	O
-	O
Woody	O
Monica	O
.	O

At	O
this	O
hospital	O
he	O
underwent	O
an	B-treatment
I&D	I-treatment
(	O
03-17	O
)	O
of	O
a	B-problem
right	I-problem
foot	I-problem
infection	I-problem
and	O
subsequently	O
underwent	O

re-exploration	B-test
(	O
03-18	O
)	O
for	O
developing	B-problem
necrotizing	I-problem
fascitis	I-problem
.	O

He	O
was	O
transferred	O
to	O
Hallmark	O
Health	O
System	O
for	O
further	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

PMH	O
:	O
Prostate	B-problem
Ca	I-problem
,	O
Glaucoma	B-problem

PSH	O
:	O
RIH	B-treatment
repair	I-treatment
,	O
s/p	O
TURP	B-treatment
,	O
s/p	O
thyroid	B-treatment
excision	I-treatment

Social	O
History	O
:	O

EtOH	O
PAD-WORD	O

Physical	O
Exam	O
:	O

98.9	O
,	O
93	O
,	O
137/78	O
,	O
16	O
,	O
98%	O

GEN	O
:	O
NAD	O

HEENT	O
:	O
EOMI	O
,	O
anicteric,	B-problem
OP	O
pink	O

NECK	O
:	O
no	O
masses	B-problem
,	O
supple	O

CV	O
:	O
RRR	O
,	O
no	O
m/r	B-problem

RESP	O
:	O
clear	O

GI	O
:	O
soft/NT/ND	B-problem

EXT	O
:	O
R	O
foot	O
with	O
erythema	B-problem
/	O
swelling	B-problem
;	O
muscle	O
and	O
tendons	O
exposed	O
,	O
with	O
necrotic	B-problem
edges	I-problem
,	O
some	B-problem
fibrinous	I-problem
exudate	I-problem

NEURO	O
:	O
AxOx3	O

Pertinent	O
Results	O
:	O

MRI	B-test
RLE	I-test
03-21	O

"	O
1.	B-problem
7	I-problem
cm	I-problem
linear	I-problem
fluid	I-problem
collection	I-problem
running	O
between	O
the	O
anterior	O
and	O
lateral	O
muscle	O
compartments	O
,	O
extending	O
from	O
a	O
large	O
area	O
of	O
soft	B-problem
tissue	I-problem
loss	I-problem
seen	O
in	O
the	O
distal	O
lateral	O
foreleg	O
to	O
roughly	O
the	O
mid	O
tibia	O
/	O
fibula	O
,	O
18	O
cm	O
distal	O
to	O
the	O
knee	O
joint	O
line	O
.	O

The	B-problem
collection	I-problem
is	O
largest	O
at	O
its	O
most	O
proximal	O
extent	O
,	O
measuring	O
1.4	O
x	O
0.7	O
cm	O
in	O
the	O
transverse	O
dimension	O
.	O

2.	O
Non-specific	B-problem
myositis	I-problem
involving	O
multiple	O
muscle	O
groups	O
in	O
the	O
foreleg	O
,	O
most	O
severe	O
in	O
the	O
anterior	O
,	O
lateral	O
,	O
and	O
posterior	O
deep	O
compartments	O
.	O

3.	O
Tendinosis	B-problem
of	O
the	O
posterior	O
tibialis	O
and	O
peroneus	O
brevis	O
tendons	O
.	O

No	O
tendon	B-problem
tear	I-problem
.	O

4.	O
No	O
evidence	O
of	O
abnormal	B-problem
bone	I-problem
marrow	I-problem
signal	I-problem
intensity	I-problem
or	O
intraosseous	B-problem
abscess	I-problem
."	O

RLE	B-test
Angio	I-test
03-21	O

"	O
1.	O
Mild	B-problem
but	I-problem
multifocal	I-problem
atherosclerotic	I-problem
disease	I-problem
involving	O
the	O
infrarenal	O
aorta	O
and	O
iliac	O
arteries	O
,	O
with	O
no	O
significant	B-problem
pressure	I-problem
gradient	I-problem
associated	O
.	O

2.	O
Significant	B-problem
segmental	I-problem
stenosis	I-problem
(	O
approx.	O
5-6	O
cm	O
long	O
)	O
in	O
the	O
mid	O
right	O
superficial	O
femoral	O
artery	O
.	O

3.	O
High	B-problem
bifurcation	I-problem
of	I-problem
the	I-problem
popliteal	I-problem
artery	I-problem
at	O
the	O
knee	O
level	O
.	O

4.	O
In	O
the	O
proximal	O
calf	O
,	O
severe	B-problem
stenosis	I-problem
or	O
occlusion	B-problem
of	I-problem
the	I-problem
two	I-problem
terminal	I-problem
branches	I-problem
arising	O
from	O
this	O
popliteal	O
bifurcation	O
(	O
likely	O
the	O
anterior	O
tibial	O
and	O
the	O
peroneal	O
arteries	O
).	O

Two	B-problem
significant	I-problem
focal	I-problem
stenoses	I-problem
of	I-problem
the	I-problem
distal	I-problem
right	I-problem
anterior	I-problem
tibial	I-problem
artery	I-problem
.	O

Right	O
posterior	O
tibial	O
artery	O
completely	B-problem
occluded	I-problem
.	O

5.	O
Patent	O
medial	O
and	O
lateral	O
plantar	O
arteries	O
,	O
filled	O
through	O
collaterals	O
arising	O
mostly	O
from	O
the	O
peroneal	O
artery	O
.	O

Dorsalis	O
pedis	O
artery	O
not	O
seen	O
."	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Morton	O
was	O
admitted	O
to	O
the	O
TSICU	O
.	O

He	O
was	O
placed	O
on	O
Penicillin	B-treatment
G	I-treatment
,	O
Clindamycin	B-treatment
,	O
for	O
empiric	B-treatment
coverage	I-treatment
of	O
his	B-problem
wound	I-problem
,	O
with	O
Group	B-problem
A	I-problem
strep	I-problem
growth	I-problem
from	O
the	B-test
New	I-test
England	I-test
Baptist	I-test
Hospital-Bryce	I-test
cultures	I-test
.	O

He	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
HD#2	O
.	O

He	O
continued	O
to	O
undergo	O
BID	B-treatment
dressing	I-treatment
changes	I-treatment
.	O

Plastic	O
surgery	O
was	O
asked	O
to	O
evaluate	O
the	O
patient	O
.	O

Per	O
their	O
recommendations	O
,	O
silvadine	B-treatment
was	O
applied	O
to	O
the	O
tendons	O
to	O
prevent	O
dessication	B-problem
.	O

Vascular	O
surgery	O
was	O
also	O
asked	O
to	O
evaluate	O
the	O
patient	O
's	O
right	O
lower	O
extremity	O
blood	O
flow	O
.	O

An	B-test
angiogram	I-test
on	O
HD#4	O
showed	O
severe	B-problem
tibial	I-problem
disease	I-problem
and	O
moderate	B-problem
SFA	I-problem
disease	I-problem
,	O
no	O
DP	O
artery	O
was	O
seen	O
.	O

The	O
vascular	O
team	O
recommended	O
a	B-treatment
femoral-peroneal	I-treatment
bypass	I-treatment
for	O
revascularization	B-treatment
and	O
performed	O
this	B-treatment
operation	I-treatment
on	O
HD#5	O
.	O

He	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
,	O
please	O
see	O
Dr.	O
Allgood	O
Operative	O
Note	O
for	O
detail	O
.	O

On	O
POD#1	O
,	O
Mr.	O
Morton	O
received	O
2	O
units	O
of	O
pRBCs	B-treatment
for	O
post-op	B-problem
anemia	I-problem
(	O
Hct	B-test
25	O
).	O

Mr.	O
Morton	O
continued	O
to	O
be	O
followed	O
by	O
Infectious	O
Disease	O
,	O
whose	O
recommendations	O
were	O
to	O
complete	O
a	O
01-28	O
week	O
course	O
of	O
Penicillin	B-treatment
G	I-treatment
and	O
Clindamycin	B-treatment
after	O
the	O
foot	O
was	O
completely	O
debrided	O
and	O
the	B-treatment
skin	I-treatment
flaps	I-treatment
completed	O
.	O

His	B-problem
wound	I-problem
continued	O
to	O
heal	O
well	O
and	O
by	O
POD	O
#6	O
a	B-treatment
VAC	I-treatment
dressing	I-treatment
was	O
placed	O
.	O

He	O
received	O
a	B-treatment
PICC	I-treatment
on	O
POD#7	O
for	O
his	B-treatment
long-term	I-treatment
antibiotic	I-treatment
therapy	I-treatment
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
Mr.	O
Morton	O
had	O
good	O
pain	O
control	O
,	O
was	O
tolerating	O
a	O
regular	O
diet	O
,	O
had	O
a	B-problem
well-healing	I-problem
wound	I-problem
treated	O
with	O
a	B-treatment
VAC	I-treatment
dressing	I-treatment
,	O
and	O
was	O
to	O
continue	O
his	B-treatment
IV	I-treatment
PCN	I-treatment
G	I-treatment
and	O
Clindamycin	B-treatment
.	O

He	O
was	O
discharged	O
to	O
a	O
rehab	O
facility	O
in	O
fair	O
condition	O
.	O

Medications	O
on	O
Admission	O
:	O

Timolol	B-treatment
.5%	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Right	B-problem
lower	I-problem
extremity	I-problem
necrosing	I-problem
fascitis	I-problem
history	O
of	O
prostate	B-problem
cancer	I-problem
s/p	O
TURP	B-treatment
glaucoma	B-problem

Discharge	O
Condition	O
:	O

Fair	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

If	O
you	O
have	O
any	B-problem
fevers/chills	I-problem
,	O
nausea/vomiting	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
foot	B-problem
pain	I-problem
,	O
please	O
seek	O
medical	O
attention	O
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Mallard	O
in	O
one	O
week	O
,	O
call	O
421-3721	O
for	O
an	O
appointment	O
.	O

Follow	O
up	O
with	O
Dr.	O
Adner	O
in	O
2	O
weeks	O
,	O
call	O
763-9180	O
for	O
an	O
appointment	O
.	O

Mark	O
William	O
MD	O
19-081	O

Completed	O
by	O
:	O
Shane	O
Gabrielle	O
MD	O
73-971	O
2016-04-01	O
@	O
0836	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Robert	O
Howell	O
on:	O
WED	O
2016-05-18	O
5:18	O
PM	O

(	O
End	O
of	O
Report	O
)	O

770828516	O
PAD-WORD	O

OMH	O
PAD-WORD	O

9357991	O
PAD-WORD	O

58511/2j86	O
PAD-WORD	O

12/28/1995	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

12/28/95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

New	O
Years	O
Eve	O

ADDENDUM	O
:	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Mevacor	B-treatment
20	O
mg	O
p.o.	O
q.d.	O
;	O
Colace	B-treatment
100	O
t.i.d.	O
;	O
Carafate	B-treatment
1	O
gram	O
q.i.d.	O
;	O
Serax	B-treatment
15	O
mg	O
p.o.	O
q.6.h.	O
to	O
hold	O
for	O
somnolence	B-problem
;	O
thiamine	B-treatment
100	O
mg	O
IM	O
q.d.	O
,	O
folate	B-treatment
1	O
mg	O
q.d.	O
,	O
Multivitamin	B-treatment
1	O
q.d.	O
,	O
Percocet	B-treatment
1-2	O
tabs	O
p.o.	O
q.4.h.	O
p.r.n.	O
pain	B-problem
,	O
Dulcolax	B-treatment
2	O
tabs	O
p.o.	O
q.d.	O
,	O
p.r.n.	O
no	B-problem
stool	I-problem
x	O
48	O
hours	O
;	O
Tylenol	B-treatment
650	O
p.o.	O
q.4.h.	O
p.r.n.	O
and	O
heparin	B-treatment
7500	O
units	O
subcu.	O
b.i.d.	O

STA	O
TITCHEGRIESESC	O
,	O
M.D.	O

TR	O
:	O

kk	O
/	O
bmot	O

DD	O
:	O

12-30-95	O
PAD-WORD	O

TD	O
:	O

01/02/96	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2009-11-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2009-11-12	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1948-10-16	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CCU	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
61	O
-	O
year-old	O
white	O
male	O
with	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
5-vessel	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
on	O
2009-09-11	O
,	O
who	O
presents	O
for	O
elective	B-test
right	I-test
heart	I-test
catheterization	I-test
and	O
pericardiocentesis	B-treatment
.	O

The	O
patient	O
did	O
well	O
after	O
his	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

On	O
10-14	O
,	O
the	O
patient	O
had	O
a	B-test
transthoracic	I-test
echocardiogram	I-test
which	O
revealed	O
a	B-problem
new	I-problem
,	I-problem
moderate-to-large	I-problem
sized	I-problem
pericardial	I-problem
effusion	I-problem
.	O

The	O
patient	O
was	O
asymptomatic	B-problem
at	O
this	O
time	O
,	O
and	O
the	O
decision	O
was	O
made	O
to	O
monitor	O
him	O
and	O
to	O
start	O
him	O
on	O
Lasix	B-treatment
.	O

The	O
patient	O
had	O
follow-up	B-test
transthoracic	I-test
echocardiogram	I-test
on	O
11-04	O
which	O
revealed	O
a	B-problem
slightly	I-problem
large	I-problem
effusion	I-problem
.	O

A	O
few	O
days	O
later	O
,	O
on	O
11-07	O
,	O
the	O
patient	O
began	O
to	O
develop	O
dyspnea	B-problem
on	O
exertion	O
with	O
normal	O
activity	O
.	O

He	O
also	O
noted	O
a	B-problem
new	I-problem
two	I-problem
to	I-problem
three-pillow	I-problem
orthopnea	I-problem
and	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
.	O

On	O
11-08	O
,	O
he	O
had	O
an	O
episode	O
of	O
acute	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
with	O
chest	B-problem
pressure	I-problem
which	O
he	O
describes	O
as	O
different	O
from	O
his	B-problem
typical	I-problem
angina	I-problem
with	O
minimal	O
exertion	O
.	O

The	O
patient	O
spoke	O
with	O
his	O
cardiologist	O
who	O
referred	O
him	O
for	O
pericardiocentesis	B-treatment
for	O
persistent	B-problem
and	I-problem
symptomatic	I-problem
pericardial	I-problem
effusion	I-problem
.	O

On	O
right	B-test
heart	I-test
catheterization	I-test
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
elevated	B-problem
right-sided	I-problem
and	I-problem
left-sided	I-problem
filling	I-problem
pressures	I-problem
with	O
a	B-test
pulmonary	I-test
capillary	I-test
wedge	I-test
pressure	I-test
of	O
19	O
and	O
a	B-test
right	I-test
atrial	I-test
pressure	I-test
of	O
16	O
.	O

After	O
600	O
cc	O
of	O
serosanguineous	B-problem
pericardial	I-problem
fluid	I-problem
was	O
removed	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
a	B-test
pulmonary	I-test
capillary	I-test
wedge	I-test
pressure	I-test
of	O
9	O
and	O
a	B-test
right	I-test
atrial	I-test
pressure	I-test
of	O
2	O
;	O
indicating	O
resolution	O
of	O
tamponade	B-problem
physiology	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
5-vessel	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
on	O
2009-09-11	O
.	O

Left	O
internal	O
mammary	O
artery	O
to	O
left	O
anterior	O
descending	O
artery	O
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	O
left	O
anterior	O
descending	O
artery	O
to	O
diagonal	O
,	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	O
right	O
posterior	O
descending	O
artery	O
,	O
and	O
saphenous	B-treatment
vein	I-treatment
graft	I-treatment
to	O
first	O
obtuse	O
marginal	O
.	O

2.	O
Type	B-problem
1	I-problem
diabetes	I-problem
mellitus	I-problem
for	O
50	O
years	O
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

4.	O
Hypertension	B-problem
.	O

5.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
with	O
a	B-test
baseline	I-test
creatinine	I-test
of	O
1.1	O
to	O
1.4	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
a	O
positive	O
tobacco	O
history	O
,	O
but	O
he	O
quit	O
smoking	O
over	O
20	O
years	O
ago	O
.	O

He	O
is	O
married	O
and	O
lives	O
in	O
Burbank	O
Hospital	O
.	O

He	O
has	O
retired	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Atenolol	B-treatment
50	O
mg	O
p.o.	O
q.d.	O
,	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.d.	O
,	O
baby	B-treatment
aspirin	I-treatment
81	O
mg	O
p.o.	O
q.d.	O
,	O
iron	B-treatment
sulfate	I-treatment
81	O
mg	O
p.o.	O
q.d.	O
,	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
q.d.	O
,	O
Accupril	B-treatment
40	O
mg	O
p.o.	O
q.d.	O
,	O
hydrochlorothiazide	B-treatment
12.5	O
mg	O
p.o.	O
q.d.	O
,	O
NPH	B-treatment
insulin	I-treatment
18	O
units	O
q.a.m.	O
and	O
10	O
units	O
q.p.m.	O
,	O
Humalog	B-treatment
sliding-scale	I-treatment
q.a.m.	O
and	O
q.p.m.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

The	O
patient	O
had	O
a	B-test
temperature	I-test
of	O
100.9	O
.	O

He	O
had	O
a	B-test
blood	I-test
pressure	I-test
of	O
148	O
to	O
162/45	O
to	O
54	O
.	O

He	O
had	O
a	B-test
heart	I-test
rate	I-test
of	O
85	O
to	O
87	O
,	O
breathing	O
at	O
17	O
to	O
23	O
,	O
satting	O
100%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
he	O
was	O
alert	O
and	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

His	O
neck	O
was	O
supple	O
without	O
any	B-problem
jugular	I-problem
venous	I-problem
distention	I-problem
.	O

HEENT	B-test
examination	I-test
revealed	O
his	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

His	O
extraocular	O
movements	O
were	O
intact	O
.	O

His	O
sclerae	O
were	O
anicteric	B-problem
.	O

His	O
mucous	O
membranes	O
were	O
moist	O
.	O

His	O
oropharynx	O
was	O
benign	O
.	O

Cardiovascular	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
,	O
heart	B-problem
sounds	I-problem
muffled	I-problem
,	O
no	O
murmurs	B-problem
.	O

Respiratory	O
revealed	O
bibasilar	B-problem
rales	I-problem
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
and	O
nondistended	B-problem
,	O
positive	O
bowel	O
sounds	O
.	O

Extremities	O
revealed	O
trace	B-problem
lower	I-problem
extremity	I-problem
edema	I-problem
,	O
right	O
greater	O
than	O
left	O
,	O
2+	B-test
dorsalis	I-test
pedis	I-test
and	I-test
posterior	I-test
tibialis	I-test
pulses	I-test
.	O

He	O
had	O
2+	B-test
femoral	I-test
pulses	I-test
bilaterally	O
.	O

No	O
hematomas	B-problem
were	O
noted	O
,	O
but	O
a	B-problem
soft	I-problem
right	I-problem
femoral	I-problem
bruit	I-problem
was	O
heard	O
.	O

LABORATORY	O
DATA	O
ON	O
PRESENTATION	O
:	O

The	O
patient	O
had	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
9.5	O
,	O
a	B-test
hematocrit	I-test
of	O
34.5	O
,	O
a	B-test
platelet	I-test
count	I-test
of	O
194	O
.	O

His	B-test
Chem-7	I-test
revealed	O
sodium	B-test
of	O
132	O
,	O
potassium	B-test
of	O
43	O
,	O
chloride	B-test
of	O
97	O
,	O
bicarbonate	B-test
of	O
28	O
,	O
BUN	B-test
of	O
25	O
,	O
creatinine	B-test
of	O
1.3	O
,	O
glucose	B-test
of	O
220	O
.	O

He	O
had	O
an	B-test
INR	I-test
of	O
1.1	O
.	O

A	B-test
calcium	I-test
of	O
8.4	O
,	O
phosphate	B-test
of	O
2.5	O
,	O
magnesium	B-test
of	O
1.9	O
.	O

Pericardial	B-test
fluid	I-test
analysis	I-test
was	O
consistent	O
with	O
an	B-problem
exudative	I-problem
etiology	I-problem
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

The	O
patient	O
had	O
an	B-test
electrocardiogram	I-test
with	O
normal	O
sinus	O
rhythm	O
at	O
70	O
,	O
normal	O
axis	O
,	O
normal	O
intervals	O
,	O
low	B-problem
voltage	I-problem
in	I-problem
the	I-problem
limb	I-problem
leads	I-problem
.	O

Chest	B-test
x-ray	I-test
on	O
admission	O
revealed	O
a	B-problem
large	I-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

The	O
patient	O
had	O
an	B-test
echocardiogram	I-test
on	O
11-10	O
which	O
revealed	O
the	O
following	O
:	O

Global	B-test
left	I-test
ventricular	I-test
systolic	I-test
function	I-test
appeared	O
grossly	O
preserved	O
.	O

Due	O
to	O
technical	O
quality	O
a	B-problem
focal	I-problem
wall	I-problem
motion	I-problem
abnormality	I-problem
could	O
not	O
be	O
fully	O
excluded	O
.	O

The	O
aortic	O
valve	O
leaflets	O
were	O
mildly	B-problem
thickened	I-problem
.	O

The	O
mitral	O
valve	O
leaflets	O
were	O
mildly	B-problem
thickened	I-problem
.	O

There	O
was	O
a	B-problem
large	I-problem
pericardial	I-problem
effusion	I-problem
(	O
up	O
to	O
greater	O
than	O
6	O
cm	O
wide	O
anterior	O
to	O
the	O
right	O
ventricle	O
).	O

The	O
right	O
ventricle	O
was	O
compressed	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Coronary	O
Care	O
Unit	O
after	O
his	B-treatment
therapeutic	I-treatment
pericardiocentesis	I-treatment
.	O

He	O
was	O
hemodynamically	O
stable	O
and	O
without	O
any	O
complaints	O
.	O

He	O
was	O
continued	O
on	O
his	B-treatment
home	I-treatment
cardiac	I-treatment
regimen	I-treatment
,	O
but	O
was	O
started	O
on	O
indomethacin	B-treatment
for	O
post	B-problem
pericardiotomy	I-problem
syndrome	I-problem
.	O

Over	O
the	O
course	O
of	O
the	O
night	O
the	O
patient	O
drained	O
an	O
additional	O
400	O
cc	O
of	O
serosanguineous	B-problem
fluid	I-problem
from	O
his	B-treatment
pericardial	I-treatment
drain	I-treatment
pouch	I-treatment
.	O

By	O
the	O
next	O
morning	O
,	O
the	O
degree	O
of	O
drainage	B-problem
had	O
decreased	O
considerably	O
with	O
only	O
60	O
cc	O
drained	O
over	O
six	O
hours	O
.	O

The	O
patient	O
had	O
a	B-test
repeat	I-test
transthoracic	I-test
echocardiogram	I-test
prior	O
to	O
drain	B-treatment
removal	I-treatment
which	O
revealed	O
the	O
following	O
:	O

A	B-problem
trivial	I-problem
/	I-problem
physiologic	I-problem
pericardial	I-problem
effusion	I-problem
one	O
day	O
post	O
pericardiocentesis	B-treatment
with	O
no	O
change	O
from	O
the	B-test
study	I-test
immediately	O
post	O
pericardiocentesis	B-treatment
.	O

The	B-treatment
pericardial	I-treatment
drain	I-treatment
was	O
removed	O
without	O
any	B-problem
difficulty	I-problem
.	O

The	B-treatment
pericardial	I-treatment
fluid	I-treatment
bag	I-treatment
was	O
removed	O
without	O
any	B-problem
difficulty	I-problem
with	O
the	O
decision	O
to	O
monitor	O
the	O
patient	O
overnight	O
and	O
repeat	O
the	B-test
echocardiogram	I-test
prior	O
to	O
discharge	O
.	O

The	O
patient	O
had	O
an	B-problem
enlarged	I-problem
left	I-problem
pleural	I-problem
effusion	I-problem
which	O
was	O
noted	O
to	O
layer	O
on	O
a	B-test
lateral	I-test
decubitus	I-test
film	I-test
.	O

We	O
decided	O
to	O
perform	O
a	B-treatment
therapeutic	I-treatment
thoracentesis	I-treatment
.	O

The	O
patient	O
was	O
prepped	O
and	O
draped	O
in	O
a	O
sterile	O
fashion	O
,	O
and	O
1150	O
cc	O
of	O
fluid	B-problem
were	O
drained	B-treatment
.	O

A	B-test
chest	I-test
x-ray	I-test
was	O
obtained	O
post	O
thoracentesis	B-treatment
which	O
revealed	O
a	O
significant	O
decrease	O
in	O
the	O
size	O
of	O
the	B-problem
left	I-problem
pleural	I-problem
effusion	I-problem
.	O

No	O
evidence	O
of	O
pneumothorax	B-problem
.	O

On	O
the	O
morning	O
of	O
admission	O
the	O
patient	O
had	O
a	B-test
markedly	I-test
improved	I-test
lung	I-test
examination	I-test
with	O
increased	O
air	O
movement	O
in	O
the	O
left	O
base	O
.	O

He	O
denied	O
any	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
and	O
had	O
oxygen	B-test
saturations	I-test
in	O
the	O
90	O
s	O
on	O
room	O
air	O
.	O

He	O
had	O
a	B-test
repeat	I-test
echocardiogram	I-test
which	O
revealed	O
a	B-problem
trivial	I-problem
/	I-problem
physiologic	I-problem
pericardial	I-problem
effusion	I-problem
.	O

The	O
patient	O
was	O
without	O
any	O
complaints	O
and	O
remained	O
stable	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Condition	O
on	O
discharge	O
was	O
stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
was	O
to	O
be	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Post	B-problem
pericardiotomy	I-problem
syndrome	I-problem
.	O

2.	O
Status	O
post	O
pericardiocentesis	B-treatment
.	O

3.	O
Status	O
post	O
thoracentesis	B-treatment
.	O

4.	O
Type	B-problem
1	I-problem
diabetes	I-problem
mellitus	I-problem
for	O
50	O
years	O
.	O

5.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
.	O

6.	O
Hypercholesterolemia	B-problem
.	O

7.	O
Hypertension	B-problem
.	O

8.	O
Chronic	B-problem
renal	I-problem
insufficiency	I-problem
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O
(	O
Discharge	O
medications	O
include	O
)	O

1.	O
Indomethacin	B-treatment
25	O
mg	O
p.o.	O
t.i.d.	O
for	O
seven	O
days.	O

2.	O
Atenolol	B-treatment
50	O
mg	O
p.o.	O
q.d.	O

3.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.d.	O

4.	O
Baby	B-treatment
aspirin	I-treatment
81	O
mg	O
p.o.	O
q.d.	O

5.	O
Iron	B-treatment
sulfate	I-treatment
81	O
mg	O
p.o.	O
q.d.	O

6.	O
Accupril	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

7.	O
Hydrochlorothiazide	B-treatment
12.5	O
mg	O
p.o.	O
q.d.	O

8.	O
NPH	B-treatment
insulin	I-treatment
18	O
units	O
q.a.m.	O
and	O
10	O
units	O
q.p.m.	O

9.	O
Humalog	B-treatment
sliding-scale	I-treatment
q.a.m.	O
and	O
q.p.m.	O

DISCHARGE	O
FOLLOWUP	O
:	O

The	O
patient	O
was	O
to	O
follow	O
up	O
with	O
his	O
primary	O
cardiologist	O
,	O
Dr.	O
Thomas	O
,	O
within	O
one	O
week	O
.	O

David	O
Archibald	O
,	O
M.D.	O
11-989	O

Dictated	O
By	O
:	O
Dorothy	O
Y.	O
Madore	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2009-11-12	O
12:02	O

T	O
:	O
2009-11-12	O
17:44	O

JOB	O
#:	O
33199	O

(	O
cclist	O
)	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Susan	O
O.	O
G.	O
Aviles	O
on	O
:	O
Robert	O
2010-01-14	O
7:23	O
PM	O

(	O
End	O
of	O
Report	O
)	O

782836641	O
DH	O

9369592	O
PAD-WORD	O

01111	O
PAD-WORD	O

974771	O
PAD-WORD	O

3/15/2002	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

XIEACASS	O
BETHCONRI	O
BALLOON	O

UNIT	O
NUMBER	O
:	O

242-36-71	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

20020315	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

20020318	O
PAD-WORD	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	B-treatment
Delivery	I-treatment
With	O
First	B-problem
Degree	I-problem
Laceration	I-problem

ASSOCIATED	O
DIAGNOSES	O
:	O

Advanced	B-problem
Maternal	I-problem
Age	I-problem
;	O
Depression	B-problem
,	O
history	O
of	O
;	O
Hepatitis	B-problem
C	I-problem
Antibody	I-problem
Positive	I-problem
;	O
Polyneuropathy	B-problem
,	O
history	O
of	O
;	O
Problems	O
With	O
Abuse	O
,	O
history	O
of	O
;	O
Rh	O
Nonsensitization	O
;	O
Stopped	O
Smoking	O
This	O
Pregnancy	O
,	O
history	O
of	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	B-treatment
Vertex	I-treatment
Vaginal	I-treatment
Delivery	I-treatment

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O
PAD-WORD	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O
PAD-WORD	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Active	B-problem
Labor	I-problem

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	B-test
NORMAL	O
66	O
HEENT	O
NORMAL	O
MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
COR	O
NORMAL	O
ABDOMEN	O
NORMAL	O
EXTREM	O
NORMAL	O
SKIN	B-problem
mottled	I-problem
on	I-problem
both	I-problem
lower	I-problem
extremities	I-problem
.	O

NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
NORMAL	O
CERVIX	O
NORMAL	O
OS	O
NORMAL	O
ADNEXAE	O
NORMAL	O
UTERUS	O
NORMAL	O
UTERINE	B-test
SIZE	I-test
IN	O
WEEKS	O
15	O
HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
42	O
year	O
old	O
Gravida	O
3	O
Para	O
2002	O
was	O
admitted	O
to	O
the	O
Naliheall	O
County	O
Memorial	O
Hospital	O
Obstetrical	O
service	O
on	O
03/15/2002	O
at	O
10:04	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

active	B-problem
labor	I-problem
.	O

She	O
delivered	O
a	O
2809	O
gram	O
male	O
infant	O
on	O
03/16/2002	O
at	O
02:50	O
am	O
with	O
apgar	B-test
scores	I-test
of	O
7	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
38.0	O
weeks	O
gestation	O
via	O
spontaneous	B-treatment
vertex	I-treatment
vaginal	I-treatment
delivery	I-treatment
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

.	O
Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

depression	B-problem
.	O

She	O
was	O
discharged	O
on	O
03/18/2002	O
at	O
12:45	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ORDERS	O
(	O
medications	O
instructions	O
to	O
patient	O
,	O
follow-up	O
care)	O
:	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
Under	O
Care	O
Of	O
Shingle	O
Geabell	O
Hospital	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Dh	O
Ob	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O
PAD-WORD	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

No	O
PAD-WORD	O

POSTPARTUM	B-treatment
RH	I-treatment
IMMUNE	I-treatment
GLOBULIN	I-treatment
:	O

Given	O
PAD-WORD	O

POSTPARTUM	B-treatment
MEASLES	I-treatment
/	I-treatment
MUMPS/RUBELLA	I-treatment
VACCINE	I-treatment
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	B-treatment
And	O
Folate	B-treatment
(	O
Stuart	B-treatment
Prenatal	I-treatment
With	O
Folate	B-treatment
)	O
;	O
Fluoxetine	B-treatment
(	I-treatment
Prozac	I-treatment
)	I-treatment

Electronically	O
Signed	O
:	O

Polle	O
,	O
Nella	O
O	O
03/18/2002	O
9:01:18	O
PM	O

Admission	O
Date	O
:	O

2015-04-16	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-04-24	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1937-04-06	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

SURGERY	O
PAD-WORD	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-problem
Allergies	I-problem
to	I-problem
Drugs	I-problem

Attending	O
:	O
Mattie	O
R.	O
A.	O
Hamilton	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Altered	B-problem
mental	I-problem
status	I-problem

Diaphoresis	B-problem
PAD-WORD	O

Abdominal	B-problem
pain	I-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Lap	B-treatment
converted	O
to	O
open	B-treatment
cholecystectomy	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

This	O
78	O
year	O
old	O
Mexican	O
speaking	O
female	O
presented	O
to	O
the	O
emergency	O
department	O
on	O
2015-04-16	O
.	O

Her	O
family	O
memebers	O
stated	O
that	O
she	O
was	O
found	O
at	O
home	O
with	O
altered	B-problem
mental	I-problem
status	I-problem
and	O
diaphoresis	B-problem
.	O

She	O
is	O
diabetic	B-problem
.	O

Mental	O
status	O
improved	O
after	O
binasal	B-treatment
cannula	I-treatment
oxygen	I-treatment
applied	O
,	O
at	O
which	O
time	O
she	O
localized	O
right	B-problem
upper	I-problem
quadrant	I-problem
pain	I-problem
.	O

She	O
developed	O
leukocytosis	B-problem
and	O
transaminasemia	B-problem
.	O

Past	O
Medical	O
History	O
:	O

DM	B-problem
on	O
insulin	B-treatment

HTN	B-problem
PAD-WORD	O

gerd	B-problem
PAD-WORD	O

pvd	B-problem
PAD-WORD	O

osteo-arthritis	B-problem
PAD-WORD	O

osteoporosis	B-problem
PAD-WORD	O

anemia	B-problem
PAD-WORD	O

cholelithiasis	B-problem
PAD-WORD	O

left	B-problem
humeral	I-problem
fracture	I-problem

b/l	B-problem
cataracts	I-problem
s/p	O
surgery	B-treatment

s/p	O
uterine	B-treatment
myomectomy	I-treatment

Social	O
History	O
:	O

distant	O
tobacco	O

drinks	O
often	O
-	O
including	O
vodka	O

walks	O
without	O
cane	B-treatment

trained	O
engineer	O
in	O
Papua	O
New	O
Guinea	O

Has	O
brother	O
,	O
nephew	O
and	O
daughter	O
in	O
law	O
near	O
by	O
.	O

Family	O
History	O
:	O

denies	O
cad	B-problem

Physical	O
Exam	O
:	O

T	B-test
:	O
99.2	O
HR	B-test
97	O
BP	B-test
131/68	O
RR	B-test
:	O
20	O
Spo2	B-test
100%	O
on	O
RA	O

Constitutional	O
:	O
alert	O
&	O
oriented	O
x	O
3	O
.	O

Head	O
/	O
eyes	O
:	O
EOMI	O
,	O
PERRL	O

Chest	O
/	O
respiratory	O
:	O
clear	O
to	O
auscultation	O
bilaterally	O

Cardiovascular	O
:	O
Regular	O
rate	O
&	O
rhythm	O
+	O
S1/S2	O
.	O

No	O
Mumur	B-problem
/	O
regurgiation	B-problem
/	O
gallop	B-problem

GI	O
/	O
Abdomen	O
:	O
soft	O
.	O

+	O
Haskell	B-test
sign	I-test
,	O
right	B-problem
upper	I-problem
quadrant	I-problem
tenderness	I-problem
.	O

Nondistended	B-problem
.	O

No	O
rebounding	B-problem

Musculoskeletal	O
:	O
5/5	O
strength	O
all	O
extremities	O

Skin	O
:	O
no	O
C/C/E	B-problem

Neuro	O
:	O
CN	O
II-XII	O
intact	O
,	O
no	O
dysdiadokinesis	B-problem
.	O

decreased	B-problem
Babinski	I-problem
's	I-problem

Pertinent	O
Results	O
:	O

2015-04-16	O
07:10	O
PM	O
BLOOD	B-test
Albumin	B-test
-	O
3.8	O
Calcium	B-test
-	O
9.0	O
Phos	B-test
-	O
2.6	O
*#	O
Mg	B-test
-	O
1.9	O

2015-04-16	O
07:10	O
PM	O
BLOOD	B-test
ALT	B-test
-	O
295	O
*	O
AST	B-test
-	O
56	O
*	O
CK(CPK)	B-test
-	O
60	O
AlkPhos	B-test
-	O
208	O
*	O
Amylase	B-test
-	O
23	O
TotBili	B-test
-	O
1.6	O
*	O

2015-04-16	O
07:10	O
PM	O
BLOOD	B-test
Glucose	B-test
-	O
280	O
*	O
UreaN	B-test
-	O
18	O
Creat	B-test
-	O
1.0	O
Na	B-test
-	O
135	O
K	B-test
-	O
4.2	O
Cl	B-test
-	O
98	O
HCO3	B-test
-	O
22	O
AnGap	B-test
-	O
19	O

2015-04-16	O
07:10	O
PM	O
BLOOD	B-test
WBC	B-test
-	O
18.4	O
*#	O
RBC	B-test
-	O
4.27	O
Hgb	B-test
-	O
11.9	O
*	O
Hct	B-test
-	O
34.8	O
*	O
MCV	B-test
-	O
82	O
MCH	B-test
-	O
27.9	O
MCHC	B-test
-	O
34.1	O
RDW	B-test
-	O
15.0	O
Plt	B-test
Ct	I-test
-	O
317	O

2015-04-24	O
06:35	O
AM	O
BLOOD	B-test
ALT	B-test
-	O
82	O
*	O
AST	B-test
-	O
62	O
*	O
AlkPhos	B-test
-	O
145	O
*	O
Amylase	B-test
-	O
51	O
TotBili	B-test
-	O
0.4	O

2015-04-24	O
06:35	O
AM	O
BLOOD	B-test
Glucose	B-test
-	O
134	O
*	O
UreaN	B-test
-	O
8	O
Creat	B-test
-	O
0.6	O
Na	B-test
-	O
144	O
K	B-test
-	O
3.7	O
Cl	B-test
-	O
106	O
HCO3	B-test
-	O
31	O
AnGap	B-test
-	O
11	O

2015-04-24	O
06:35	O
AM	O
BLOOD	B-test
WBC	B-test
-	O
10.5	O
RBC	B-test
-	O
3.49	O
*	O
Hgb	B-test
-	O
9.6	O
*	O
Hct	B-test
-	O
28.0	O
*	O
MCV	B-test
-	O
80	O
*	O
MCH	B-test
-	O
27.5	O
MCHC	B-test
-	O
34.3	O
RDW	B-test
-	O
15.8	O
*	O
Plt	B-test
Ct	I-test
-	O
504	O
*	O

GB	B-test
US	I-test
2015-04-16	O

IMPRESSION	O
:	O

1.	O
Distended	B-problem
gallbladder	I-problem
with	O
impacted	B-problem
1.6	I-problem
cm	I-problem
gallstone	I-problem
,	O
focal	B-problem
wall	I-problem
thickening	I-problem
,	O
and	O
positive	B-problem
sonAllan	I-problem
Stephens	I-problem
sign	I-problem
-	O
findings	O
consistent	O
with	O
acute	B-problem
cholecystitis	I-problem
.	O

2.	O
Right	B-problem
renal	I-problem
cysts	I-problem
-	O
lower	B-problem
pole	I-problem
cyst	I-problem
is	O
unchanged	O
from	O
prior	B-test
exam	I-test
of	O
2010-10-25	O
and	O
upper	B-problem
pole	I-problem
exophytic	I-problem
cyst	I-problem
was	O
not	O
previously	O
seen	O
sonStacy	O
.	O

ERCP	B-test
report	O
2015-04-21	O

IMPRESSION	O
:	O

1.	O
Successful	O
removal	B-treatment
of	O
CBD	B-problem
stone	I-problem
and	O
placement	O
of	O
plastic	B-treatment
biliary	I-treatment
stent	I-treatment
for	O
confirmed	B-problem
cystic	I-problem
duct	I-problem
leak	I-problem
.	O

Brief	O
Hospital	O
Course	O
:	O

Ms	O
Malek	O
was	O
admitted	O
on	O
2015-04-16	O
due	O
to	O
altered	B-problem
mental	I-problem
status	I-problem
and	O
acute	B-problem
right	I-problem
upper	I-problem
quadrant	I-problem
abdominal	I-problem
pain	I-problem
.	O

Gallbladder	B-test
ultra	I-test
sound	I-test
revealed	O
a	B-problem
distended	I-problem
1.6	I-problem
cm	I-problem
non	I-problem
mobile	I-problem
stone	I-problem
in	I-problem
the	I-problem
neck	I-problem
.	O

HD	O
#	O
01-20	O
She	O
was	O
monitored	O
closely	O
in	O
the	O
CMED	O
.	O

On	O
2015-04-17	O
she	O
was	O
taken	O
to	O
the	O
OR	O
for	O
lap	B-treatment
converted	O
to	O
open	B-treatment
cholecystectomy	I-treatment
.	O

She	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
,	O
see	O
op	O
report	O
for	O
details	O
.	O

She	O
was	O
extubated	B-treatment
and	O
recovered	O
well	O
in	O
PACU	O
.	O

She	O
remained	O
NPO	B-treatment
with	O
IV	B-treatment
fluids	I-treatment
,	O
foley	B-treatment
catheter	I-treatment
and	O
Dilaudid	B-treatment
IV	I-treatment
for	O
pain	B-treatment
control	I-treatment
,	O
Unasyn	B-treatment
for	O
antibiotic	B-treatment
coverage	I-treatment
.	O

She	O
returned	O
to	O
CMED	O
for	O
further	B-test
monitoring	I-test
.	O

She	O
was	O
noted	O
to	O
have	O
low	B-problem
urine	I-problem
output	I-problem
at	O
times	O
.	O

She	O
responded	O
well	O
to	O
fluid	B-treatment
bolusing	I-treatment
.	O

POD#1	O
she	O
was	O
transferred	O
to	O
CC6	O
for	O
further	O
recovery	O
.	O

She	O
remained	O
afebrile	B-problem
,	O
she	O
was	O
given	O
ice	O
chips	O
.	O

Physical	O
therapy	O
was	O
consulted	O
for	O
strength	O
and	O
mobility	O
.	O

POD#2	O
her	B-problem
pain	I-problem
was	O
somewhat	O
uncontrolled	O
,	O
she	O
was	O
placed	O
on	O
Dilaudid	B-treatment
PCA	I-treatment
with	O
fair	O
effect	O
.	O

Urine	B-test
output	I-test
remained	O
adequate	O
.	O

She	O
was	O
monitored	O
on	O
telemetry	B-test
for	O
mild	B-problem
tachycardia	I-problem
and	O
recieved	O
IV	B-treatment
beta	I-treatment
blockers	I-treatment
.	O

She	O
ambulated	O
with	O
assistance	O
.	O

POD#3	O
she	O
was	O
advanced	O
to	O
sips	B-treatment
and	I-treatment
clears	I-treatment
,	O
foley	B-treatment
catheter	I-treatment
was	O
discontinued	O
.	O

POD#4	O
,	O
bilious	B-problem
drainage	I-problem
was	O
noted	O
in	O
her	B-treatment
JP	I-treatment
.	O

She	O
had	O
worsening	B-problem
abdominal	I-problem
pain	I-problem
on	O
exam	B-test
.	O

She	O
was	O
held	O
NPO	B-treatment
.	O

She	O
was	O
taken	O
to	O
ERCP	B-test
where	O
sphincterotomy	B-treatment
was	O
performed	O
and	O
biliary	B-treatment
stent	I-treatment
was	O
placed	O
.	O

She	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
returned	O
to	O
CC6	O
post-procedure	O
.	O

JP	B-treatment
remained	O
intact	O
with	O
serosainguinous	B-problem
drainage	I-problem
.	O

POD#5	O
she	O
c/o	O
difficulty	B-problem
voiding	I-problem
,	O
pt	O
was	O
straight	B-treatment
cathed	I-treatment
after	O
bladder	B-test
scan	I-test
was	O
obtained	O
and	O
revealed	O
>	O
600	O
ccs	O
urine	O
.	O

POD#	O
05-25	O
she	O
continued	O
with	O
intermittent	O
complaints	O
of	O
urinary	B-problem
retention	I-problem
.	O

However	O
she	O
was	O
able	O
to	O
void	O
.	O

Renal	B-test
function	I-test
remained	O
normal	O
.	O

She	O
did	O
not	O
require	O
further	B-treatment
straight	I-treatment
catheterization	I-treatment
.	O

She	O
was	O
advanced	O
to	O
clear	B-treatment
liquids	I-treatment
again	O
without	O
nausea	B-problem
or	O
vomiting	B-problem
.	O

Her	B-problem
pain	I-problem
was	O
well	O
controlled	O
by	O
Tylenol	B-treatment
.	O

Her	O
home	O
regimen	O
of	O
lantus	B-treatment
was	O
resumed	O
for	O
elevated	B-problem
blood	I-problem
glucose	I-problem
.	O

POD#6	O
,	O
her	O
diet	O
was	O
advanced	O
to	O
regular	O
.	O

She	O
required	O
disimpaction	B-treatment
and	O
had	O
hard	B-problem
stool	I-problem
in	I-problem
the	I-problem
rectum	I-problem
.	O

She	O
was	O
initiated	O
on	O
a	B-treatment
bowel	I-treatment
regimen	I-treatment
and	O
had	O
no	O
further	O
incidents	O
of	O
diarrhea	B-problem
or	O
constipation	B-problem
.	O

POD#7	O
she	O
was	O
discharged	O
to	O
rehab	O
in	O
stable	O
condition	O
.	O

Appropriate	O
follow	O
up	O
appointments	O
are	O
recommended	O
as	O
well	O
as	O
prescriptions	B-treatment
.	O

She	O
should	O
return	O
in	O
6	O
weeks	O
for	O
removal	B-treatment
of	O
biliary	B-treatment
stent	I-treatment
.	O

Medications	O
on	O
Admission	O
:	O

Tramadol	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day)	O
.	O

2.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

3.	O
Nortriptyline	B-treatment
25	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

4.	O
Atenolol	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

5.	O
Buspirone	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Clonazepam	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Cholecalciferol	B-treatment
(	I-treatment
Vitamin	I-treatment
D3	I-treatment
)	I-treatment
400	O
unit	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

8.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

9.	O
Docusate	B-treatment
Sodium	I-treatment
50	O
mg	O
/	O
5	O
mL	O
Liquid	O
Sig	O
:	O
Ten	O
(	O
10	O
)	O
mL	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

10.	O
Hexavitamin	B-treatment
Tablet	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
).	O

11.	O
Dicyclomine	B-treatment
10	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

12.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

15.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

16.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

17.	O
Ibuprofen	B-treatment
600	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

18.	O
Insulin	B-treatment
sliding	I-treatment
scale	I-treatment
Insulin	B-treatment
SC	I-treatment
Sliding	I-treatment
Scale	I-treatment
Q6H	B-treatment
Regular	I-treatment
Glucose	I-treatment
Insulin	I-treatment
Dose	I-treatment
0-60	O
mg	O
/	O
dL	O
01-20	O
amp	O
D50	O
61-120	O
mg	O
/	O
dL	O
0	O
Units	O
121-140	O
mg	O
/	O
dL	O
3	O
Units	O
141-160	O
mg/dL	O
5	O
Units	O
161-180	O
mg/dL	O
7	O

Units	O
181-200	O
mg	O
/	O
dL	O
9	O
Units	O
201-220	O
mg	O
/	O
dL	O
11	O
Units	O
221-240	O
mg	O
/	O
dL	O
13	O
Units	O
241-260	O
mg	O
/	O
dL	O
15	O
Units	O
261-280	O
mg	O
/	O
dL	O
17	O
Units	O
281-300	O
mg	O
/	O
dL	O
19	O
Units	O
301-320	O
mg	O
/	O
dL	O
21	O
Units	O
>	O
320	O
mg	O
/	O
dL	O
Notify	O
M.D.	O

19.	O
Lantus	B-treatment
30	O
units	O
Lantus	B-treatment
insulin	I-treatment
with	O
breakfast	O

Discharge	O
Medications	O
:	O

1.	O
Tramadol	B-treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

2.	O
Senna	B-treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

3.	O
Nortriptyline	B-treatment
25	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

4.	O
Atenolol	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

5.	O
Buspirone	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Clonazepam	B-treatment
0.5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Cholecalciferol	B-treatment
(	I-treatment
Vitamin	I-treatment
D3	I-treatment
)	I-treatment
400	O
unit	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

8.	O
Pantoprazole	B-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

9.	O
Docusate	B-treatment
Sodium	I-treatment
50	O
mg	O
/	O
5	O
mL	O
Liquid	O
Sig	O
:	O
Ten	O
(	O
10	O
)	O
mL	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

10.	O
Hexavitamin	B-treatment
Tablet	I-treatment
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
).	O

11.	O
Dicyclomine	B-treatment
10	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

12.	O
Atorvastatin	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

13.	O
Amoxicillin-Pot	B-treatment
Clavulanate	I-treatment
875-125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
4	O
days	O
.	O

14.	O
Heparin	B-treatment
(	I-treatment
Porcine	I-treatment
)	I-treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
injection	O
Injection	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

15.	O
Bisacodyl	B-treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

16.	O
Acetaminophen	B-treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

17.	O
Ibuprofen	B-treatment
600	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-problem
.	O

18.	O
Insulin	B-treatment
sliding	I-treatment
scale	I-treatment

Insulin	B-treatment
SC	I-treatment
Sliding	I-treatment
Scale	I-treatment

Q6H	O
PAD-WORD	O

Regular	O
PAD-WORD	O

Glucose	B-treatment
Insulin	I-treatment
Dose	I-treatment

0-60	O
mg	O
/	O
dL	O
01-20	O
amp	O
D50	O

61-120	O
mg	O
/	O
dL	O
0	O
Units	O

121-140	O
mg	O
/	O
dL	O
3	O
Units	O

141-160	O
mg	O
/	O
dL	O
5	O
Units	O

161-180	O
mg	O
/	O
dL	O
7	O
Units	O

181-200	O
mg	O
/	O
dL	O
9	O
Units	O

201-220	O
mg	O
/	O
dL	O
11	O
Units	O

221-240	O
mg	O
/	O
dL	O
13	O
Units	O

241-260	O
mg	O
/	O
dL	O
15	O
Units	O

261-280	O
mg	O
/	O
dL	O
17	O
Units	O

281-300	O
mg	O
/	O
dL	O
19	O
Units	O

301-320	O
mg	O
/	O
dL	O
21	O
Units	O

>	O
320	O
mg	O
/	O
dL	O
Notify	O
M.D.	O

30	O
units	O
Lantus	B-treatment
insulin	I-treatment
with	O
breakfast	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
-	O
Everett	O

Discharge	O
Diagnosis	O
:	O

Acute	B-problem
Cholecystitis	I-problem

Gangrenous	B-problem
cholecystitis	I-problem
with	O
perforation	B-problem

Discharge	O
Condition	O
:	O

good	O
PAD-WORD	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
your	O
surgeon	O
if	O
you	O
develop	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
fever	B-problem
greater	O
than	O
101.5	O
,	O
foul	B-problem
smelling	I-problem
or	I-problem
colorful	I-problem
drainage	I-problem
from	O
your	B-problem
incisions	I-problem
,	O
redness	B-problem
or	O
swelling	B-problem
,	O
severe	B-problem
abdominal	I-problem
pain	I-problem
or	O
distention	B-problem
,	O
persistent	B-problem
nausea	I-problem
or	O
vomiting	B-problem
,	O
inability	B-problem
to	I-problem
eat	I-problem
or	I-problem
drink	I-problem
,	O
or	O
any	B-problem
other	I-problem
symptoms	I-problem
which	O
are	O
concerning	O
to	O
you	O
.	O

No	O
tub	O
baths	O
or	O
swimming	O
.	O

You	O
may	O
shower	O
.	O

If	O
there	O
is	O
clear	B-problem
drainage	I-problem
from	O
your	B-problem
incisions	I-problem
,	O
cover	O
with	O
a	B-treatment
dry	I-treatment
dressing	I-treatment
.	O

Leave	O
white	B-treatment
strips	I-treatment
above	O
your	B-problem
incisions	I-problem
in	O
place	O
,	O
allow	O
them	O
to	O
fall	O
off	O
on	O
their	O
own	O
.	O

Activity	O
:	O
No	O
heavy	O
lifting	O
of	O
items	O
11-02	O
pounds	O
until	O
the	O
follow	O
up	O
appointment	O
with	O
your	O
doctor	O
.	O

Medications	O
:	O
Resume	O
your	B-treatment
home	I-treatment
medications	I-treatment
.	O

You	O
should	O
take	O
a	B-treatment
stool	I-treatment
softener	I-treatment
,	O
Colace	B-treatment
100	O
mg	O
twice	O
daily	O
as	O
needed	O
for	O
constipation	B-problem
.	O

You	O
will	O
be	O
given	O
pain	B-treatment
medication	I-treatment
which	O
may	O
make	O
you	O
drowsy	B-problem
.	O

No	O
driving	O
while	O
taking	O
pain	B-treatment
medicine	I-treatment
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Gregory	O
X	O
Wingard	O
,	O
M.D.	O
Phone	O
:(	O
855	O
)	O
651-4418	O

Date	O
/	O
Time	O
:	O
2015-06-03	O
9:30	O

Please	O
call	O
(	O
808	O
)	O
246-1373	O
and	O
schedule	O
an	O
appointment	O
to	O
see	O
Dr.	O
Lewis	O
in	O
2	O
weeks	O
.	O

You	O
will	O
be	O
contacted	O
by	O
the	O
gastrointestinal	O
doctors	O
Pat	O
Barrow	O
the	B-treatment
removal	I-treatment
of	O
your	B-treatment
biliary	I-treatment
stent	I-treatment
in	O
6	O
weeks	O
.	O

Joe	O
Kari	O
MD	O
09-697	O

Completed	O
by	O
:	O
Carol	O
Robert	O
NP	O
80-CIY	O
2015-04-24	O
@	O
1506	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marion	O
SCHNEIDER	O
on	O
:	O
FRI	O
2015-04-24	O
5:11	O
PM	O

(	O
End	O
of	O
Report	O
)	O

791411240	O
PAD-WORD	O

PRGH	O
PAD-WORD	O

80504780	O
PAD-WORD	O

383201	O
PAD-WORD	O

9/16/2000	O
12:00:00	O
AM	O

RUPTURED	B-problem
AORTIC	I-problem
ANEURISM	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

09/16/2000	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

11/03/2000	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

RUPTURED	B-problem
PARATHYROID	I-problem
ADENOMA	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Shuffa	O
is	O
a	O
73-year-old	O
Portuguese	O
speaking	O
woman	O
who	O
was	O
transferred	O
via	O
Med	O
Flight	O
to	O
Verg	O
Medical	O
Center	O
.	O

She	O
arrived	O
intubated	B-treatment
and	O
was	O
hemodynamically	O
stable	O
despite	O
concerns	O
of	O
a	B-problem
dissecting	I-problem
aortic	I-problem
arch	I-problem
aneurysm	I-problem
.	O

She	O
initially	O
presented	O
to	O
Brottlake	O
Medical	O
Center	O
on	O
9/15/00	O
complaining	O
of	O
acute	B-problem
onset	I-problem
dysphasia	I-problem
to	O
liquids	O
and	O
solids	O
.	O

While	O
she	O
was	O
in	O
Brottlake	O
Medical	O
Center	O
,	O
she	O
developed	O
new	B-problem
onset	I-problem
stridor	I-problem
,	O
and	O
an	O
ENT	O
consult	O
was	O
obtained	O
.	O

They	O
attempted	O
a	B-treatment
fiberoptic	I-treatment
intubation	I-treatment
with	O
a	B-treatment
#	I-treatment
6	I-treatment
endotracheal	I-treatment
tube	I-treatment
and	O
found	O
a	B-problem
5	I-problem
mm	I-problem
severely	I-problem
compressed	I-problem
airway	I-problem
.	O

She	O
was	O
also	O
found	O
to	O
have	O
a	B-problem
differential	I-problem
systolic	I-problem
blood	I-problem
pressure	I-problem
and	O
ecchymosis	B-problem
on	I-problem
her	I-problem
anterior	I-problem
chest	I-problem
.	O

Given	O
these	O
findings	O
,	O
she	O
underwent	O
a	B-test
CT	I-test
scan	I-test
which	O
showed	O
a	B-problem
retrotracheal	I-problem
mass	I-problem
that	O
appeared	O
to	O
obliterate	O
the	O
esophagus	O
.	O

This	O
raised	O
concerns	O
for	O
a	B-problem
hemorrhage	I-problem
,	O
and	O
she	O
was	O
transferred	O
to	O
Verg	O
Medical	O
Center	O
emergently	O
.	O

At	O
the	O
Ingree	O
and	O
Ot	O
of	O
Weamanshy	O
Medical	O
Center	O
,	O
she	O
underwent	O
an	B-test
emergent	I-test
CT	I-test
scan	I-test
with	O
IV	B-test
contrast	I-test
.	O

This	O
revealed	O
no	O
extravasation	B-problem
of	I-problem
contrast	I-problem
and	O
no	O
aortic	B-problem
aneurysm	I-problem
.	O

However	O
,	O
it	O
did	O
show	O
an	B-problem
anterior	I-problem
mediastinal	I-problem
mass	I-problem
compressing	O
the	O
trachea	O
with	O
a	O
density	O
consistent	O
with	O
a	B-problem
hematoma	I-problem
.	O

She	O
was	O
admitted	O
to	O
the	O
Thoracic	O
Surgery	O
Service	O
under	O
the	O
care	O
of	O
Dr.	O
Sccrookes	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Severe	B-problem
hypertension	I-problem
,	O
angina	B-problem
,	O
GERD	B-problem
,	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
,	O
status	O
post	O
Billroth	B-treatment
II	I-treatment
,	O
ovarian	B-problem
cancer	I-problem
,	O
status	O
post	O
TAH-BSO	B-treatment
in	O
1987	O
with	O
a	O
negative	O
second	O
look	O
laparotomy	O
in	O
1988	O
,	O
chronic	B-problem
anemia	I-problem
,	O
chronic	B-problem
left	I-problem
ear	I-problem
infection	I-problem
.	O

MEDICATIONS	O
PRIOR	O
TO	O
ADMISSION	O
:	O

Celexa	B-treatment
10	O
mg	O
p.o.	O
q.d.;	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
q.d.;	O
Capoten	B-treatment
50	O
mg	O
p.o.	O
b.i.d.;	O
Pepcid	B-treatment
20	O
mg	O
p.o.	O
q.d.;	O
Cardizem	B-treatment
180	O
mg	O
p.o.	O
q.d.;	O
Xanax	B-treatment
0.5	O
mg	O
tabs	O
.	O

On	O
transfer	O
,	O
she	O
was	O
on	O
her	B-treatment
preadmission	I-treatment
medications	I-treatment
plus	O
Unasyn	B-treatment
and	O
Tigan	B-treatment
250	O
mg	O
p.o.	O
q.6h.	O
p.r.n.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
divorced	O
and	O
retired	O
.	O

She	O
lives	O
with	O
her	O
daughter	O
,	O
and	O
denies	O
any	O
tobacco	O
or	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
intubated	B-treatment
.	O

VITAL	O
SIGNS	O
:	O

Temperature	B-test
98.6	O
,	O
66	O
.	O

Right	B-test
arm	I-test
was	O
180/80	O
,	O
left	B-test
188/72	O
,	O
and	O
A-line	B-test
was	O
151/61	O
.	O

Tidal	B-treatment
volume	I-treatment
is	O
700	O
with	O
a	B-treatment
rate	I-treatment
of	O
10	O
,	O
10	O
of	O
pressure	B-treatment
support	I-treatment
,	O
and	O
10	O
of	O
PEEP	B-treatment
,	O
and	O
100%	B-treatment
FiO2	I-treatment
,	O
satting	O
100%	O
.	O

GENERAL	O
:	O

She	O
was	O
sedated	B-treatment
and	O
spontaneously	O
moving	O
all	O
four	O
extremities	O
.	O

NECK	O
:	O

Edematous	B-problem
.	O

Trachea	O
was	O
midline	O
.	O

She	O
had	O
bilateral	B-problem
crepitus	I-problem
in	I-problem
the	I-problem
anterior	I-problem
neck	I-problem
.	O

The	O
superior	O
clavicular	O
area	O
showed	O
no	O
signs	O
of	O
central	B-treatment
line	I-treatment
access	I-treatment
attempts	O
.	O

She	O
had	O
a	B-problem
3	I-problem
cm	I-problem
mobile	I-problem
gelatinous	I-problem
well-circumscribed	I-problem
mass	I-problem
in	I-problem
the	I-problem
right	I-problem
supraclavicular	I-problem
region	I-problem
.	O

Her	O
anterior	O
neck	O
and	O
chest	O
had	O
a	B-problem
1	I-problem
cm	I-problem
to	I-problem
2	I-problem
cm	I-problem
area	I-problem
of	I-problem
ecchymosis	I-problem
.	O

LUNGS	O
:	O

She	O
had	O
bilateral	B-problem
expiratory	I-problem
wheezes	I-problem
.	O

ABDOMEN	O
:	O

Soft	O
with	O
good	O
bowel	O
sounds	O
.	O

It	O
was	O
nontender	B-problem
.	O

It	O
was	O
obese	B-problem
with	O
a	B-problem
large	I-problem
midline	I-problem
defect	I-problem
consistent	O
with	O
a	B-problem
ventral	I-problem
hernia	I-problem
,	O
as	O
well	O
as	O
a	B-problem
smaller	I-problem
anterior	I-problem
defect	I-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
quadrant	I-problem
.	O

Both	O
were	O
easily	O
reducible	O
.	O

PULSE	O
:	O

On	O
the	O
right	O
side	O
,	O
2+	B-test
femoral	I-test
,	O
popliteal	B-test
,	O
DP	B-test
,	O
PT	B-test
,	O
and	O
radial	B-test
;	O
on	O
the	O
left	O
side	O
,	O
2+	B-test
femoral	I-test
,	O
popliteal	B-test
,	O
DP	B-test
,	O
PT	B-test
,	O
and	O
radial	B-test
.	O

LABORATORY	O
DATA	O
:	O

CBC	B-test
was	O
8.7	O
,	O
25.3	O
,	O
and	O
184	O
.	O

Coags	B-test
12.2	O
,	O
24.8	O
,	O
and	O
1.0	O
.	O

Her	B-test
gas	I-test
was	O
7.47/40/332	O
.	O

Electrolytes	B-test
were	O
143	O
,	O
3.4	O
,	O
105	O
,	O
28	O
,	O
24	O
,	O
3	O
,	O
and	O
131	O
.	O

EKG	B-test
showed	O
normal	O
sinus	O
rhythm	O
with	O
left	B-problem
ventricular	I-problem
hypertrophy	I-problem
and	O
incomplete	B-problem
left	I-problem
bundle	I-problem
branch	I-problem
block	I-problem
.	O

CT	B-test
scan	I-test
showed	O
an	B-problem
anterior	I-problem
mediastinal	I-problem
mass	I-problem
compressing	O
the	O
trachea	O
with	O
air	O
.	O

It	O
was	O
consistent	O
with	O
a	B-problem
hematoma	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

Ms.	O
Shuffa	O
underwent	O
an	B-test
EGD	I-test
and	O
flexible	B-test
bronchoscopy	I-test
on	O
9/16/00	O
shortly	O
after	O
she	O
arrived	O
.	O

This	O
showed	O
tracheal	B-problem
compressions	I-problem
but	O
no	O
other	B-problem
lesions	I-problem
that	O
were	O
obvious	O
at	O
the	O
time	O
.	O

She	O
was	O
hemodynamically	O
stable	O
and	O
remained	O
on	O
the	B-treatment
ventilator	I-treatment
.	O

The	O
differential	O
diagnoses	O
at	O
this	O
point	O
consisted	O
of	O
hematoma	B-problem
vs.	O
neoplasm	B-problem
vs.	O
an	B-problem
abscess	I-problem
vs.	O
a	B-problem
thyroid	I-problem
tumor	I-problem
.	O

On	O
9/22/00	O
,	O
she	O
underwent	O
a	B-test
cervical	I-test
mediastinoscopy	I-test
.	O

A	B-test
biopsy	I-test
of	O
this	B-problem
mass	I-problem
was	O
consistent	O
with	O
hematoma	B-problem
.	O

The	O
operative	O
report	O
shows	O
that	O
there	O
was	O
an	B-problem
abnormal	I-problem
area	I-problem
below	I-problem
the	I-problem
trachea	I-problem
to	O
the	O
left	O
which	O
represented	O
a	O
cavity	O
between	O
the	O
esophagus	O
,	O
trachea	O
,	O
aorta	O
,	O
and	O
spine	O
that	O
was	O
full	O
of	O
clot	B-problem
.	O

There	O
was	O
no	O
active	B-problem
bleeding	I-problem
at	O
the	O
time	O
.	O

Over	O
the	O
next	O
several	O
days	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
on	O
the	B-treatment
ventilator	I-treatment
.	O

She	O
had	O
an	B-problem
elevated	I-problem
calcium	I-problem
level	I-problem
that	O
raised	O
the	O
suspicion	O
that	O
this	B-problem
mass	I-problem
could	O
be	O
a	B-problem
hematoma	I-problem
coming	O
from	O
a	B-problem
ruptured	I-problem
parathyroid	I-problem
adenoma	I-problem
.	O

The	B-test
ionized	I-test
calcium	I-test
was	O
elevated	B-problem
as	O
was	O
the	B-test
parathormone	I-test
level	I-test
.	O

Given	O
these	O
findings	O
,	O
she	O
underwent	O
a	B-test
Sestamibi	I-test
scan	I-test
.	O

The	B-test
Sestamibi	I-test
scan	I-test
showed	O
findings	O
that	O
were	O
consistent	O
with	O
a	B-problem
parathyroid	I-problem
adenoma	I-problem
in	I-problem
the	I-problem
right	I-problem
lobe	I-problem
of	O
the	O
thyroid	O
.	O

At	O
this	O
time	O
,	O
it	O
was	O
believed	O
that	O
her	B-problem
clot	I-problem
was	O
due	O
to	O
a	B-problem
rupture	I-problem
of	O
this	B-problem
parathyroid	I-problem
adenoma	I-problem
.	O

Dr.	O
Ear	O
brought	O
the	O
patient	O
to	O
the	O
operating	O
room	O
on	O
10/5/00	O
.	O

She	O
underwent	O
a	B-test
parathyroid	I-test
exploration	I-test
with	O
resection	B-treatment
of	O
a	B-problem
ruptured	I-problem
ectopic	I-problem
right	I-problem
upper	I-problem
parathyroid	I-problem
adenoma	I-problem
,	O
a	B-test
biopsy	I-test
of	I-test
a	I-test
normal	I-test
left	I-test
and	I-test
right	I-test
lower	I-test
parathyroids	I-test
,	O
resection	B-treatment
of	I-treatment
a	I-treatment
left	I-treatment
upper	I-treatment
parathyroid	I-treatment
,	O
and	O
tracheostomy	B-treatment
.	O

She	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
was	O
transferred	O
back	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
with	O
her	B-treatment
new	I-treatment
tracheostomy	I-treatment
working	O
well	O
.	O

Her	O
postoperative	O
course	O
was	O
complicated	O
by	O
serosanguineous	B-problem
pleural	I-problem
effusion	I-problem
on	I-problem
the	I-problem
left	I-problem
.	O

This	O
required	O
a	B-treatment
chest	I-treatment
tube	I-treatment
.	O

Her	B-test
hematocrit	I-test
continued	O
to	O
drop	O
over	O
the	O
next	O
couple	O
of	O
days	O
despite	O
normal	O
platelet	O
count	O
,	O
normal	O
coags	O
,	O
and	O
no	O
obvious	O
source	O
of	O
bleeding	B-problem
.	O

It	O
was	O
believed	O
that	O
she	O
was	O
continuing	O
to	O
bleed	B-problem
in	I-problem
her	I-problem
chest	I-problem
.	O

However	O
,	O
we	O
are	O
not	O
quite	O
sure	O
why	O
this	O
was	O
occurring	O
.	O

She	O
underwent	O
an	B-test
extensive	I-test
workup	I-test
by	O
Hematology	O
that	O
revealed	O
a	B-problem
bleeding	I-problem
diatheses	I-problem
of	O
unknown	O
etiology	O
.	O

It	O
turns	O
out	O
that	O
several	O
people	O
in	O
her	O
family	O
have	O
a	B-problem
similar	I-problem
bleeding	I-problem
diathesis	I-problem
of	O
unknown	O
etiology	O
.	O

In	O
conclusion	O
,	O
by	O
systems	O
:	O

1.	O
Neuro	O
.	O

The	O
patient	O
became	O
intermittently	B-problem
agitated	I-problem
.	O

We	O
have	O
been	O
giving	O
her	B-treatment
Haldol	I-treatment
at	O
bedtime	O
as	O
well	O
as	O
Ativan	B-treatment
p.r.n.	O
throughout	O
the	O
day	O
.	O

She	O
responds	O
well	O
to	O
this	O
.	O

She	O
speaks	O
some	O
English	O
and	O
seems	O
to	O
understand	O
more	O
than	O
she	O
speaks	O
.	O

She	O
has	O
a	O
family	O
member	O
who	O
is	O
present	O
for	O
approximately	O
12	O
hours	O
each	O
day	O
.	O

She	O
has	O
been	O
very	O
helpful	O
in	O
translating	O
and	O
seems	O
to	O
say	O
that	O
Ms.	O
Shuffa	O
is	O
in	O
good	O
spirits	O
.	O

2.	O
Cardiac	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
blood	I-test
pressure	I-test
has	O
been	O
ranging	O
from	O
approximately	O
140	O
to	O
160	O
systolic	O
.	O

This	O
is	O
on	O
a	O
current	O
regimen	O
of	O
Lopressor	B-treatment
25	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
t.i.d.	O
as	O
well	O
as	O
Diltiazem	B-treatment
60	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
t.i.d.	O
,	O
and	O
lisinopril	B-treatment
10	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
q.d.	O
She	O
occasionally	O
gets	O
hypertensive	B-problem
when	O
she	O
is	O
agitated	B-problem
.	O

For	O
this	O
,	O
we	O
have	O
given	O
her	O
10	O
mg	O
of	O
hydralazine	B-treatment
.	O

Her	B-test
blood	I-test
pressure	I-test
responds	O
well	O
to	O
this	O
.	O

Otherwise	O
,	O
she	O
is	O
in	O
normal	O
sinus	O
rhythm	O
and	O
has	O
been	O
hemodynamically	O
stable	O
throughout	O
her	O
hospitalization	O
.	O

The	O
patient	O
developed	O
a	B-problem
left	I-problem
femoral	I-problem
artery	I-problem
pseudoaneurysm	I-problem
after	O
placement	B-treatment
of	I-treatment
a	I-treatment
Greenfield	I-treatment
filter	I-treatment
.	O

This	O
has	O
been	O
followed	O
by	O
the	O
Vascular	O
Surgery	O
Service	O
here	O
at	O
the	O
Ingree	O
and	O
Ot	O
of	O
Weamanshy	O
Medical	O
Center	O
.	O

Dr.	O
Lenni	O
Lung	O
has	O
been	O
consulted	O
.	O

The	B-problem
aneurysm	I-problem
at	O
the	O
time	O
of	O
discharge	O
is	O
approximately	O
2.5	O
cm	O
.	O

They	O
elected	O
not	O
to	O
inject	O
it	O
with	O
thrombin	B-treatment
.	O

They	O
asked	O
that	O
the	O
patient	O
follow-up	O
with	O
Dr.	O
Ear	O
in	O
approximately	O
three	O
to	O
four	O
weeks	O
so	O
that	O
this	B-problem
aneurysm	I-problem
can	O
be	O
assessed	O
.	O

They	O
have	O
opted	O
for	O
conservative	O
management	O
given	O
the	O
size	O
.	O

3.	O
Respiratory	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
remained	O
on	O
CPAP	B-treatment
with	O
a	B-treatment
PEEP	I-treatment
of	O
7.5	O
and	O
a	B-treatment
pressure	I-treatment
support	I-treatment
of	O
9	O
.	O

She	O
seems	O
to	O
be	O
tolerating	O
this	O
well	O
as	O
she	O
has	O
an	B-test
O2	I-test
sat	I-test
of	O
100%	O
on	O
40%	B-treatment
FIO2	I-treatment
.	O

Her	B-test
chest	I-test
x-ray	I-test
shows	O
a	B-problem
left	I-problem
lower	I-problem
lobe	I-problem
hematoma	I-problem
that	O
had	O
greatly	O
improved	O
in	O
the	O
last	O
few	O
days	O
.	O

Her	O
right	O
lung	O
field	O
is	O
clear	O
.	O

Her	B-treatment
tracheostomy	I-treatment
is	O
functioning	O
well	O
,	O
and	O
we	O
have	O
had	O
no	O
problems	B-problem
with	O
it	O
.	O

She	O
will	O
obviously	O
need	O
to	O
be	O
weaned	O
as	O
tolerated	O
.	O

We	O
had	O
her	O
down	O
to	O
a	B-treatment
low	I-treatment
pressure	I-treatment
support	I-treatment
of	O
7	O
in	O
the	O
last	O
week	O
.	O

With	O
the	B-treatment
pressure	I-treatment
support	I-treatment
at	O
7	O
,	O
she	O
became	O
tachypneic	B-problem
and	O
had	O
to	O
be	O
brought	O
back	O
up	O
to	O
10	O
.	O

Her	B-test
oxygen	I-test
saturation	I-test
has	O
always	O
been	O
good	O
.	O

4.	O
GI	O
.	O

The	O
patient	O
is	O
getting	O
tube	B-treatment
feeds	I-treatment
via	O
her	B-treatment
NG	I-treatment
tube	I-treatment
of	O
full	B-treatment
strength	I-treatment
Jevity	I-treatment
of	O
75	O
cc	O
per	O
hour	O
.	O

This	O
is	O
her	O
goal	O
.	O

She	O
tolerates	O
them	O
very	O
well	O
and	O
has	O
approximately	O
200	O
cc	O
to	O
300	O
cc	O
of	O
stool	O
per	O
day	O
.	O

Last	O
week	O
,	O
she	O
had	O
copious	B-problem
amounts	I-problem
of	I-problem
stool	I-problem
in	O
the	O
range	O
of	O
500	O
cc	O
to	O
1000	O
cc	O
of	O
liquid	O
stool	O
per	O
day	O
.	O

Stool	B-test
cultures	I-test
have	O
been	O
sent	O
numerous	O
times	O
as	O
well	O
as	O
analysis	B-test
for	O
C.	B-problem
difficile	I-problem
toxin	I-problem
.	O

These	O
have	O
all	O
been	O
negative	O
.	O

We	O
believe	O
the	O
this	O
was	O
an	B-problem
osmotic	I-problem
diarrhea	I-problem
.	O

Since	O
her	B-treatment
tube	I-treatment
feeds	I-treatment
have	O
been	O
changed	O
from	O
full	B-treatment
strength	I-treatment
Nephro	I-treatment
to	O
Jevity	B-treatment
,	O
her	B-problem
diarrhea	I-problem
has	O
resolved	O
.	O

She	O
has	O
been	O
taking	O
Zantac	B-treatment
,	O
and	O
the	B-test
pH	I-test
of	I-test
her	I-test
NG	I-test
tube	I-test
residuals	I-test
have	O
been	O
in	O
the	O
5	O
to	O
8	O
range	O
.	O

5.	O
GU	O
.	O

The	O
patient	O
has	O
had	O
hypernatremia	B-problem
.	O

She	O
is	O
approximately	O
10	O
kg	O
up	O
her	O
overall	O
body	O
weight	O
.	O

We	O
believe	O
her	O
to	O
still	O
be	O
total	B-problem
body	I-problem
overloaded	I-problem
.	O

Over	O
the	O
last	O
several	O
days	O
,	O
we	O
have	O
been	O
giving	O
her	O
approximately	O
500	O
cc	O
to	O
1000	O
cc	O
of	O
free	B-treatment
water	I-treatment
through	O
her	B-treatment
NG	I-treatment
tube	I-treatment
.	O

We	O
also	O
have	O
been	O
diuresing	O
her	O
with	O
Bumex	B-treatment
.	O

This	O
seems	O
to	O
trend	O
her	B-test
sodium	I-test
down	O
.	O

This	O
will	O
need	O
to	O
be	O
monitored	O
closely	O
.	O

Her	B-test
BUN	I-test
and	O
creatinine	B-test
have	O
been	O
normal	O
,	O
and	O
she	O
has	O
always	O
made	O
good	O
urine	O
.	O

6.	O
Heme	O
.	O

As	O
stated	O
before	O
,	O
the	O
patient	O
continued	O
to	O
ooze	O
into	O
her	O
pleural	O
space	O
well	O
after	O
her	B-treatment
definitive	I-treatment
operation	I-treatment
.	O

She	O
had	O
an	B-test
extensive	I-test
workup	I-test
by	O
Hematology	O
which	O
revealed	O
a	B-problem
bleeding	I-problem
diathesis	I-problem
of	O
unknown	O
origin	O
.	O

Before	O
we	O
removed	O
her	B-treatment
chest	I-treatment
tube	I-treatment
,	O
we	O
had	O
to	O
give	O
her	B-treatment
platelets	I-treatment
.	O

She	O
had	O
no	O
problems	B-problem
with	O
this	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
her	B-test
hematocrit	I-test
is	O
stable	O
in	O
the	O
28	O
to	O
33	O
range	O
.	O

I	O
stress	O
that	O
she	O
cannot	O
be	O
anticoagulated	B-treatment
.	O

We	O
have	O
given	O
her	B-treatment
Lovenox	I-treatment
in	O
the	O
past	O
,	O
and	O
she	O
continues	O
to	O
bleed	O
.	O

Therefore	O
,	O
she	O
is	O
on	O
no	O
DVT	B-treatment
prophylaxis	I-treatment
.	O

She	O
does	O
have	O
a	B-problem
left	I-problem
iliac	I-problem
deep	I-problem
vein	I-problem
thrombosis	I-problem
.	O

She	O
has	O
a	B-treatment
Greenfield	I-treatment
filter	I-treatment
in	O
place	O
,	O
and	O
this	O
is	O
her	O
only	O
DVT	B-treatment
prophylaxis	I-treatment
.	O

7.	O
ID	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
has	O
a	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
.	O

She	O
is	O
growing	O
Enterobacter	B-problem
cloacae	I-problem
that	O
is	O
sensitive	O
only	O
to	O
Macrodantin	B-treatment
from	O
her	B-test
urine	I-test
cultures	I-test
.	O

Interestingly	O
enough	O
,	O
she	O
also	O
has	O
Enterobacter	B-problem
cloacae	I-problem
growing	O
out	O
of	O
her	O
sputum	O
.	O

This	O
is	O
also	O
sensitive	O
only	O
to	O
Macrodantin	B-treatment
.	O

We	O
do	O
not	O
believe	O
that	O
she	O
has	O
any	B-problem
respiratory	I-problem
process	I-problem
going	O
on	O
at	O
the	O
time	O
.	O

She	O
is	O
just	O
begun	O
on	O
Macrodantin	B-treatment
at	O
the	O
day	O
of	O
discharge	O
and	O
should	O
continue	O
100	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
q.i.d.	O
for	O
a	O
ten	O
day	O
course	O
.	O

Her	B-treatment
Foley	I-treatment
was	O
changed	O
the	O
day	O
before	O
discharge	O
.	O

8.	O
Tubes	B-treatment
,	O
lines	B-treatment
,	O
and	O
drains	B-treatment
.	O

The	O
patient	O
has	O
a	B-treatment
tracheostomy	I-treatment
,	O
NG	B-treatment
tube	I-treatment
,	O
and	O
a	B-treatment
Foley	I-treatment
catheter	I-treatment
.	O

Her	B-treatment
central	I-treatment
line	I-treatment
,	O
which	O
was	O
left	B-treatment
subclavian	I-treatment
quad	I-treatment
lumen	I-treatment
,	O
was	O
removed	O
on	O
the	O
day	O
of	O
discharge	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Albuterol	B-treatment
nebulizers	I-treatment
2.5	O
mg	O
q.4h.	O
and	O
Atrovent	B-treatment
nebulizers	I-treatment
0.5	O
mg	O
q.4h.	O
,	O
please	O
alternate	O
albuterol	B-treatment
and	O
Atrovent	B-treatment
;	O
Rocaltrol	B-treatment
0.25	O
mcg	O
per	O
NG	B-treatment
tube	I-treatment
q.d.;	O
calcium	B-treatment
carbonate	I-treatment
1250	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
q.i.d.;	O
vitamin	B-treatment
B12	I-treatment
1000	O
mcg	O
IM	O
q.	O
month	O
,	O
next	O
dose	O
is	O
due	O
Nov	O
18	O
;	O
diltiazem	B-treatment
60	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
t.i.d.;	O
ferrous	B-treatment
sulfate	I-treatment
300	O
mg	O
per	O
NG	B-treatment
t.i.d.;	O
Haldol	B-treatment
5	O
mg	O
IV	O
q.h.s.;	O
hydralazine	B-treatment
10	O
mg	O
IV	O
q.6h.	O
p.r.n.	O
hypertension	B-problem
;	O
lisinopril	B-treatment
10	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
q.d.;	O
Ativan	B-treatment
1	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
q.h.s.;	O
Lopressor	B-treatment
25	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
t.i.d.;	O
Zantac	B-treatment
150	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
b.i.d.;	O
multivitamin	B-treatment
10	O
ml	O
per	O
NG	B-treatment
tube	I-treatment
q.d.;	O
Macrodantin	B-treatment
100	O
mg	O
per	O
NG	B-treatment
tube	I-treatment
q.i.d.	O
x	O
10	O
days	O
beginning	O
on	O
11/3/00	O
.	O

CONDITION	O
:	O

Stable	O
,	O
with	O
active	B-problem
problems	I-problem
being	O
respiratory	B-problem
failure	I-problem
,	O
urinary	B-problem
tract	I-problem
infection	I-problem
,	O
and	O
bleeding	B-problem
diathesis	I-problem
.	O

DISCHARGE	O
LABS	O
:	O

On	O
the	O
day	O
of	O
discharge	O
,	O
sodium	B-test
145	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
109	O
,	O
bicarb	B-test
31	O
,	O
creatinine	B-test
0.7	O
,	O
BUN	B-test
43	O
,	O
glucose	B-test
116	O
.	O

CBC	B-test
14.9	O
,	O
29.2	O
(	O
which	O
is	O
stable	O
)	O
,	O
and	O
398	O
.	O

PT	B-test
12	O
,	O
PTT	B-test
27	O
,	O
and	O
INR	B-test
1.0	O
.	O

Magnesium	B-test
of	O
1.9	O
.	O

Calcium	B-test
8.1	O
.	O

COMPLICATIONS	O
:	O

None	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
being	O
discharged	O
to	O
an	O
acute	O
rehab	O
facility	O
.	O

She	O
should	O
follow-up	O
with	O
Dr.	O
Ryna	O
Jescdrig	O
as	O
well	O
as	O
Dr.	O
Lenni	O
Lung	O
in	O
the	O
Vascular	O
Surgery	O
Department	O
in	O
approximately	O
three	O
to	O
four	O
weeks	O
.	O

Please	O
call	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
at	O
Verg	O
Medical	O
Center	O
for	O
any	O
further	O
details	O
that	O
may	O
be	O
needed	O
.	O

You	O
can	O
also	O
page	O
Sta	O
Lung	O
,	O
M.D.	O
as	O
I	O
am	O
the	O
dictating	O
physician	O
who	O
has	O
been	O
taking	O
care	O
of	O
Ms.	O
Shuffa	O
for	O
quite	O
some	O
time	O
now	O
.	O

I	O
would	O
be	O
happy	O
to	O
answer	O
any	O
questions	O
.	O

My	O
pager	O
number	O
at	O
Verg	O
Medical	O
Center	O
is	O
number	O
54930	O
.	O

Dictated	O
By	O
:	O

STA	O
LUNG	O
,	O
M.D.	O
HU53	O

Attending	O
:	O

RYNA	O
R.	O
JESCDRIG	O
,	O
M.D.	O
GN3	O
QE555/1531	O

Batch	O
:	O

77428	O
PAD-WORD	O

Index	O
No.	O
DXXJ8U8529	O

D	O
:	O

11/03/00	O
PAD-WORD	O

T	O
:	O

11/03/00	O
PAD-WORD	O

Admission	O
Date	O
:	O

2015-01-19	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-01-22	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1948-02-29	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

CCU	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
ADDENDUM	O
:	O
The	O
patient	O
during	O
her	O
admission	O
from	O
2015-01-19	O
to	O
2015-01-22	O
during	O
that	O
admission	O
she	O
had	O
an	B-test
echocardiogram	I-test
which	O
revealed	O
essentially	O
an	B-test
ejection	I-test
fraction	I-test
of	O
40%	O
with	O
a	B-problem
patent	I-problem
foramen	I-problem
ovale	I-problem
mildly	B-problem
dilated	I-problem
left	I-problem
atrium	I-problem
.	O

It	O
also	O
showed	O
intraseptal	B-problem
and	I-problem
inferior	I-problem
akinesis	I-problem
.	O

Additionally	O
because	O
of	O
her	O
history	O
of	O
contrast	B-problem
allergy	I-problem
,	O
she	O
was	O
given	O
Solu-Medrol	B-treatment
40	O
milligrams	O
IV	O
prior	O
to	O
the	B-treatment
procedure	I-treatment
.	O

She	O
did	O
not	O
have	O
any	B-problem
untoward	I-problem
affects	I-problem
or	O
allergic	B-problem
reactions	I-problem
to	O
the	B-treatment
procedure	I-treatment
.	O

Barbara	O
Gallant	O
,	O
M.D.	O

66-480	O
PAD-WORD	O

Dictated	O
By	O
:	O
Troy	O
X.	O
Hall	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-03-12	O
18:30	O

T	O
:	O
2015-03-16	O
11:19	O

JOB	O
#:	O
24204	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Barbara	O
Rogers	O
on	O
:	O
WED	O
2015-03-25	O
9:51	O
AM	O

(	O
End	O
of	O
Report	O
)	O

801499036	O
PAD-WORD	O

FIH	O
PAD-WORD	O

3380885	O
PAD-WORD	O

04891/6516	O
PAD-WORD	O

412982	O
PAD-WORD	O

06/06/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

06-06-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

06-07-93	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
68	O
year	O
old	O
male	O
status	O
post	O
three	O
and	O
a	O
half	O
cycles	O
of	O
adjuvant	B-treatment
EAP	I-treatment
chemotherapy	I-treatment
.	O

He	O
had	O
a	O
good	O
response	O
to	O
preoperative	B-treatment
therapy	I-treatment
and	O
negative	O
nodes	O
,	O
and	O
is	O
admitted	O
for	O
the	O
final	O
portion	O
of	O
his	B-treatment
postoperative	I-treatment
cycles	I-treatment
.	O

His	B-treatment
chemotherapy	I-treatment
the	O
week	O
before	O
was	O
decreased	O
because	O
the	B-test
white	I-test
blood	I-test
count	I-test
dropped	O
to	O
2.8	O
.	O

In	O
the	O
interim	O
,	O
the	B-test
white	I-test
blood	I-test
count	I-test
rose	O
again	O
to	O
4.2	O
with	O
a	B-test
hematocrit	I-test
of	O
30.5	O
,	O
platelet	B-test
count	I-test
of	O
196	O
thousand	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-test
examination	I-test
on	O
admission	O
,	O
the	B-test
blood	I-test
pressure	I-test
was	O
146/80	O
,	O
weight	B-test
146	O
,	O
temperature	B-test
98.6	O
,	O
and	O
pulse	B-test
of	O
92	O
.	O

The	O
skin	O
was	O
normal	O
.	O

The	O
neck	O
was	O
supple	O
.	O

The	B-test
cardiac	I-test
examination	I-test
demonstrated	O
single	O
S1	O
,	O
S2	O
,	O
no	O
murmurs	B-problem
.	O

The	O
lungs	O
were	O
clear	O
.	O

The	B-test
abdominal	I-test
examination	I-test
was	O
within	O
normal	O
limits	O
.	O

The	O
extremities	O
were	O
normal	O
.	O

The	B-test
neurological	I-test
examination	I-test
was	O
nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

The	B-test
creatinine	I-test
was	O
1.3	O
and	O
dropping	O
to	O
1.1	O
.	O

The	B-test
bilirubin	I-test
was	O
0.2	O
,	O
SGOT	B-test
20	O
,	O
magnesium	B-test
of	O
1.4	O
.	O

The	B-test
white	I-test
blood	I-test
count	I-test
was	O
4.0	O
,	O
platelet	B-test
count	I-test
190	O
,	O
with	O
62%	O
polys	B-test
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
treated	O
with	O
Adriamycin	B-treatment
25	O
mg	O
,	O
Cis-platinum	B-treatment
40	O
mg	O
,	O
preceded	O
by	O
Mannitol	B-treatment
12.5	O
grams	O
intravenous	O
bolus	O
,	O
and	O
Zofran	B-treatment
11	O
mg	O
on	O
two	O
occasions	O
given	O
as	O
an	B-treatment
antiemetic	I-treatment
.	O

The	B-treatment
chemotherapy	I-treatment
was	O
well	O
tolerated	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

1.	O
Intravenous	B-treatment
chemotherapy	I-treatment
,	O

2.	O
adenocarcinoma	B-problem
of	I-problem
the	I-problem
distal	I-problem
esophagus	I-problem
,	O

3.	O
mild	B-problem
hypomagnesemia	I-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

Intravenous	B-treatment
antibiotics	I-treatment
chemotherapy	I-treatment
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Slow-Mag	B-treatment
2	O
tablets	O
PO	O
bid	O
,	O
Ativan	B-treatment
1	O
mg	O
sublingually	O
q4h	O
prn	O
nausea	B-problem
.	O

GUABENFRANDA	O
D.	O
PO	O
,	O
M.D.	O

TR	O
:	O

ff	O
/	O
bmot	O

DD	O
:	O

06-07-93	O
PAD-WORD	O

TD	O
:	O

06/09/93	O
PAD-WORD	O

CC	O
:	O

Admission	O
Date	O
:	O

2012-09-26	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2012-10-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2012-09-26	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

NEONATOLOGY	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
5235	O
-	O
gram	O
full-term	O
male	O
infant	O
of	O
a	O
diabetic	O
mother	O
born	O
by	O
repeat	B-treatment
cesarean	I-treatment
section	I-treatment
to	O
a	O
29-year-old	O
gravida	O
1	O
,	O
para	O
2	O
,	O
woman	O
.	O

Prenatal	B-test
screens	I-test
benign	O
.	O

Group	B-test
B	I-test
strep	I-test
status	I-test
negative	O
.	O

Pregnancy	O
complicated	O
by	O
insulin-dependent	B-problem
gestational	I-problem
diabetes	I-problem
.	O

Apgar	B-test
scores	I-test
were	O
8	O
at	O
1	O
minute	O
and	O
9	O
at	O
5	O
minutes	O
.	O

The	O
infant	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
for	O
a	B-test
dextrose	I-test
stick	I-test
of	O
20	O
in	O
the	O
delivery	O
room	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Birth	B-test
weight	I-test
was	O
5235	O
grams	O
,	O
length	B-test
was	O
56	O
cm	O
,	O
and	O
head	B-test
circumference	I-test
was	O
37.5	O
cm	O
.	O

Anterior	O
fontanel	O
open	O
and	O
flat	O
.	O

The	O
palate	O
was	O
intact	O
.	O

Nares	O
were	O
patent	O
.	O

Bilateral	B-test
breath	I-test
sounds	I-test
were	O
clear	O
and	O
equal	O
.	O

No	O
grunting	B-problem
,	O
flaring	B-problem
,	O
or	O
retracting	B-problem
.	O

No	O
murmurs	B-problem
.	O

A	O
regular	O
rate	O
and	O
rhythm	O
.	O

Pink	O
and	O
well	O
perfused	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
nondistended	B-problem
.	O

There	O
was	O
no	O
hepatosplenomegaly	B-problem
.	O

There	O
was	O
a	O
3-vessel	O
cord	O
.	O

The	O
spine	O
was	O
intact	O
.	O

The	O
anus	O
was	O
patent	O
.	O

Normal	O
male	O
genitalia	O
.	O

Tone	O
was	O
appropriate	O
for	O
gestational	O
age	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
BY	O
ISSUES-SYSTEM	O
:	O

RESPIRATORY	O
:	O

The	O
infant	O
has	O
remained	O
on	O
room	O
air	O
throughout	O
his	O
hospitalization	O
with	O
oxygen	B-test
saturations	I-test
of	O
greater	O
than	O
95	O
percent	O
.	O

Respiratory	B-test
rates	I-test
have	O
been	O
40	O
s	O
to	O
60	O
s.	O

The	O
infant	O
has	O
had	O
two	B-problem
spontaneous	I-problem
desaturations	I-problem
which	O
quickly	O
self-resolved	O
on	O
day	O
of	O
life	O
one	O
.	O

No	O
other	O
issues	O
.	O

No	O
apnea	B-problem
or	O
bradycardia	B-problem
.	O

CARDIOVASCULAR	O
:	O

The	O
infant	O
has	O
remained	O
hemodynamically	O
stable	O
with	O
heart	B-test
rates	I-test
in	O
the	O
120	O
s	O
to	O
140	O
s	O
and	O
mean	B-test
blood	I-test
pressures	I-test
of	O
57	O
to	O
60	O
.	O

FLUIDS	O
,	O
ELECTROLYTES	O
AND	O
NUTRITION	O
:	O

The	O
infant	O
was	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
for	O
treatment	B-treatment
of	O
hypoglycemia	B-problem
.	O

The	O
infant	O
was	O
started	O
on	O
enteral	B-treatment
feedings	I-treatment
of	O
Enfamil	B-treatment
20	I-treatment
calories	I-treatment
per	I-treatment
ounce	I-treatment
by	O
mouth	O
ad	O
lib	O
and	O
maintained	O
glucoses	B-test
in	O
the	O
middle	O
to	O
high	O
40	O
s	O
taking	O
by	B-treatment
mouth	I-treatment
feedings	I-treatment
every	O
two	O
to	O
three	O
hours	O
by	O
mouth	O
ad	O
lib	O
.	O

On	O
day	O
of	O
life	O
one	O
,	O
the	O
infant	O
had	O
a	B-test
dextrose	I-test
stick	I-test
of	O
34	O
.	O

At	O
that	O
time	O
,	O
an	B-treatment
intravenous	I-treatment
of	O
D-10-W	B-treatment
was	O
started	O
at	O
80	O
cc	O
/	O
kilogram	O
per	O
day	O
.	O

On	O
day	O
of	O
life	O
two	O
,	O
the	O
infant	O
began	O
to	O
wean	O
off	O
intravenous	B-treatment
fluids	I-treatment
,	O
and	O
this	O
was	O
completed	O
by	O
day	O
of	O
life	O
four	O
.	O

Calories	O
were	O
increased	O
to	O
Similac	B-treatment
24	I-treatment
calories	I-treatment
per	I-treatment
ounce	I-treatment
.	O

Before	O
discharge	O
to	O
the	O
Newborn	O
Nursery	O
,	O
the	O
infant	O
was	O
taking	O
Similac	B-treatment
22	I-treatment
calories	I-treatment
per	I-treatment
ounce	I-treatment
by	O
mouth	O
ad	O
lib	O
and	O
maintaining	O
dextrose	B-test
sticks	I-test
in	O
the	O
60	O
s.	O

Weight	B-test
on	O
discharge	O
was	O
5200	O
grams	O
.	O

GASTROINTESTINAL	O
:	O

No	O
issues	O
.	O

HEMATOLOGY	O
:	O

No	O
issues	O
.	O

NEUROLOGY	O
:	O

Normal	O
neurologic	O
examination	O
.	O

SCREENS	O
:	O

A	B-test
hearing	I-test
screen	I-test
was	O
performed	O
with	O
automated	B-test
auditory	I-test
brain	I-test
stem	I-test
responses	I-test
and	O
the	O
infant	O
passed	O
on	O
both	O
ears	O
.	O

PSYCHOSOCIAL	O
:	O

The	O
parents	O
are	O
involved	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
on	O
room	O
air	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
Newborn	O
Nursery	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Tamatha	O
-	O
Cape	O
Cod	O
Hospital	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Feedings	O
at	O
discharge	O
:	O

Similac	B-treatment
22	I-treatment
calories	I-treatment
per	I-treatment
ounce	I-treatment
by	O
mouth	O
ad	O
lib	O
with	O
a	O
goal	O
of	O
decreasing	O
to	O
20	B-treatment
calories	I-treatment
per	I-treatment
ounce	I-treatment
for	O
dextrose	B-test
sticks	I-test
of	O
greater	O
than	O
60	O
.	O

2.	O
Medications	B-treatment
:	O

None	O
.	O

3.	O
A	B-test
state	I-test
newborn	I-test
screen	I-test
was	O
sent	O
on	O
day	O
of	O
life	O
three	O
;	O
the	O
results	O
are	O
pending	O
.	O

4.	O
Received	O
hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
on	O
2012-09-30	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Large	B-problem
for	I-problem
gestational	I-problem
age	I-problem
.	O

2.	O
Infant	O
of	O
a	O
diabetic	O
mother	O
.	O

3.	O
Hypoglycemia	B-problem
.	O

Reviewed	O
By	O
:	O

Mary	O
Karina	O
,	O
Oregon	O
30621	O

Dictated	O
By	O
:	O
James	O
H.	O
Acosta	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2012-10-02	O
15:46:05	O

T	O
:	O
2012-10-02	O
17:14:44	O

Job	O
#:	O
07783	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Stripling	O
on	O
:	O
Maxine	O
2012-10-25	O
8:30	O
PM	O

(	O
End	O
of	O
Report	O
)	O

811533262	O
SC	O

77894566	O
PAD-WORD	O

9188280	O
PAD-WORD	O

6/30/2006	O
12:00:00	O
AM	O

Primary	B-treatment
c	I-treatment
/	I-treatment
s	I-treatment
for	O
breech	B-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

06/30/2006	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

07/04/2006	O
PAD-WORD	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

OBEFYFE	O
,	O
TREE	O

373-78-78-7	O
O38	O

Room	O
:	O

DEALPERSANDERSWAUKE	O
MISSJEANES	O
MACOMTOMA	O
GLANDSTATE	O
MEDICAL	O
CENTER	O

Service	O
:	O

OBS	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

Independence	O
Day	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Attending	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

PO	O
,	O
IEDEARC	O
J	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

IBUPROFEN	B-treatment
400-600	O
MG	O
PO	O
Q6H	O
PRN	O
Pain	B-problem

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O

OXYCODONE	B-treatment
5-10	O
MG	O
PO	O
Q3H	O
PRN	O
Pain	B-problem

Instructions	O
:	O

If	O
pt	O
received	O
post	B-treatment
partum	I-treatment
spinal	I-treatment
morphine	I-treatment
,	O
DO	O
NOT	O
administer	O
Oxycodone	B-treatment
for	O
18	O
hours	O
after	O
morphine	B-treatment
administration	I-treatment
.	O

PRENATAL	B-treatment
MULTIVITAMINS	I-treatment
(	I-treatment
STUARTNATAL	I-treatment
)	I-treatment
1	O

TAB	O
PO	O
DAILY	O
DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

PH	O
Po	O
6	O
wks	O
,	O

ALLERGY	O
:	O

Penicillins	B-treatment
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

Breech	B-problem
failed	I-problem
version	I-problem
Pregnancy	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Primary	B-treatment
c	I-treatment
/	I-treatment
s	I-treatment
for	O
breech	B-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

scheduled	B-treatment
c	I-treatment
/	I-treatment
s	I-treatment
for	O
breech	B-problem

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Vaginal	B-treatment
delivery	I-treatment
:	O

Undelivered	B-problem
PAD-WORD	O

Cesarean	O
Status	O
:	O

Primary	O
PAD-WORD	O

Urgency	O
:	O

Scheduled	O
PAD-WORD	O

Indications	O
:	O

Breech	B-problem
,	O

Uterine	B-treatment
incision	I-treatment
type	I-treatment
:	O

Transverse	O
PAD-WORD	O

Placenta	O
:	O

Delivery	O
:	O

Manual	O
PAD-WORD	O

Condition	O
:	O

Normal	O
PAD-WORD	O

Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

PO	O
,	O
IEDEARC	O
J	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O
PAD-WORD	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G1	O
T0	O
P0	O
A0	O
L0	O

Estimated	O
EDC	O
:	O

07/09/06	O
PAD-WORD	O

Maternal	O
transfer	O
:	O

No	O
PAD-WORD	O

Initial	B-test
newborn	I-test
exam	I-test
:	O

No	O
observed	B-problem
abnormalities	I-problem

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

PO	O
,	O
IEDEARC	O
J	O
,	O
M.D.	O
(	O
NH10	O
)	O
06/30/06	O
09:55	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

1191042	O
PAD-WORD	O

Admission	O
Date	O
:	O

2015-04-21	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-04-29	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2015-04-21	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
PAD-WORD	O

HISTORY	O
:	O

Baby	O
Daniel	O
Holman	O
was	O
born	O
at	O
39	O
and	O
3/7	O
weeks	O
gestation	O
(	O
EDC	O
2015-04-25	O
).	O

His	O
mother	O
is	O
a	O
31-year-old	O
female	O
gravida	O
2	O
,	O
para	O
1	O
,	O
now	O
2	O
.	O

Prenatal	B-test
screens	I-test
:	O
blood	B-test
type	I-test
A	O
positive	O
,	O
antibody	B-test
negative	O
,	O
rubella	B-test
immune	O
,	O
RPR	B-test
nonreactive	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
GBS	B-test
unknown	O
.	O

He	O
was	O
born	O
by	O
repeat	B-treatment
C-section	I-treatment
.	O

There	O
was	O
artificial	B-treatment
rupture	I-treatment
of	I-treatment
membranes	I-treatment
was	O
performed	O
at	O
the	B-treatment
delivery	I-treatment
.	O

Amniotic	O
fluid	O
was	O
clear	O
.	O

Mother	O
received	O
epidural	B-treatment
and	O
spinal	B-treatment
anesthesia	I-treatment
.	O

Baby	O
was	O
vigorous	O
at	O
birth	O
and	O
received	O
routine	O
DR	O
Johnson	O
.	O

Apgars	B-test
were	O
9	O
and	O
9	O
at	O
1	O
and	O
5	O
minutes	O
.	O

He	O
was	O
transferred	O
to	O
the	O
newborn	O
nursery	O
for	O
further	B-treatment
care	I-treatment
.	O

In	O
the	O
newborn	O
nursery	O
he	O
was	O
started	O
on	O
PO	B-treatment
feedings	I-treatment
on	O
demand	O
.	O

He	O
was	O
noted	O
to	O
be	O
large	B-problem
for	I-problem
gestational	I-problem
age	I-problem
with	O
a	B-test
weight	I-test
of	O
4525	O
grams	O
.	O

His	B-test
d-sticks	I-test
were	O
greater	O
than	O
80	O
.	O

At	O
5	O
hours	O
of	O
life	O
he	O
was	O
noted	O
to	O
have	O
grunting	B-problem
and	O
flaring	B-problem
and	O
E.C.	O
Bovell	O
consult	O
was	O
done	O
.	O

He	O
was	O
in	O
mild	B-problem
respiratory	I-problem
distress	I-problem
and	O
a	O
diagnosis	O
of	O
transient	B-problem
tachypnea	I-problem
of	I-problem
the	I-problem
newborn	I-problem
was	O
made	O
.	O

He	O
was	O
observed	O
in	O
the	O
nursery	O
for	O
progression	B-problem
of	I-problem
symptoms	I-problem
.	O

At	O
16	O
hours	O
of	O
life	O
he	O
was	O
noted	O
to	O
have	O
increased	B-problem
work	I-problem
of	I-problem
breathing	I-problem
with	O
tachypnea	B-problem
,	O
flaring	B-problem
and	O
grunting	B-problem
.	O

He	O
was	O
also	O
noted	O
to	O
have	O
axillary	B-test
temperature	I-test
of	O
100.4	O
and	O
a	B-test
rectal	I-test
temperature	I-test
of	O
100.9	O
.	O

At	O
this	O
point	O
CMED	O
was	O
consulted	O
again	O
and	O
he	O
was	O
transferred	O
to	O
the	O
CMED	O
triage	O
for	O
further	B-treatment
care	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Birth	B-test
weight	I-test
of	O
4525	O
grams	O
which	O
is	O
greater	O
than	O
90th	O
percentile	O
;	O
length	B-test
54	O
cm	O
which	O
is	O
greater	O
than	O
90th	O
percentile	O
;	O
head	B-test
circumference	I-test
37	O
cm	O
which	O
is	O
greater	O
than	O
90th	O
percentile	O
.	O

D-sticks	B-test
of	O
117	O
.	O

Large	B-problem
for	I-problem
gestational	I-problem
age	I-problem
appearance	I-problem
of	O
an	O
infant	O
with	O
tachypnea	B-problem
,	O
grunting	B-problem
and	O
flaring	B-problem
.	O

HEENT	O
:	O
Anterior	O
fontanel	O
open	O
and	O
flat	O
.	O

Bilateral	B-test
red	I-test
reflexes	I-test
.	O

Patent	O
nares	O
.	O

Mild	B-problem
flaring	I-problem
.	O

Neck	O
supple	O
.	O

Clavicles	O
stable	O
.	O

RESPIRATORY	O
:	O
Tachypneic	B-problem
with	O
mild	B-problem
retractions	I-problem
,	O
increased	B-problem
work	I-problem
of	I-problem
breathing	I-problem
,	O
clear	O
and	O
equal	O
breath	O
sounds	O
.	O

CARDIOVASCULAR	O
:	O
Normal	O
rate	O
and	O
rhythm	O
.	O

Normal	O
S1	O
and	O
S2	O
without	O
murmur	B-problem
.	O

Brachial	B-test
pulses	I-test
equal	O
femoral	B-test
pulses	I-test
and	O
are	O
2+	O
.	O

ABDOMEN	O
:	O
Soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

No	O
hepatosplenomegaly	B-problem
.	O

Patent	O
anus	O
.	O

Umbilical	O
stump	O
dry	O
.	O

GENITALIA	O
:	O
Normal	O
male	O
.	O

Testes	O
distended	O
bilaterally	O
.	O

NEUROLOGIC	O
:	O
Alert	O
and	O
crying	O
.	O

Normal	O
tone	O
and	O
neonatal	B-test
reflexes	I-test
.	O

EXTREMITIES	O
:	O
Warm	O
and	O
pink	O
.	O

Moves	O
all	O
extremities	O
well	O
.	O

Hips	O
stable	O
.	O

Skin	O
pink	O
and	O
capillary	B-test
refill	I-test
less	O
than	O
2	O
seconds	O
.	O

Spine	O
straight	O
and	O
no	O
abnormalities	B-problem
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

RESPIRATORY	O
:	O
The	O
infant	O
was	O
placed	O
on	O
CPAP	B-treatment
on	O
admission	O
to	O
the	O
CMED	O
and	O
remained	O
on	O
CPAP	B-treatment
until	O
day	O
of	O
life	O
2	O
at	O
which	O
time	O
he	O
weaned	O
to	O
nasal	B-treatment
cannula	I-treatment
and	O
then	O
subsequently	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
3	O
.	O

He	O
has	O
remained	O
on	O
room	O
air	O
since	O
that	O
time	O
and	O
has	O
had	O
no	O
issues	O
with	O
apnea	B-problem
or	O
desaturation	B-problem
since	O
being	O
on	O
room	O
air	O
.	O

Initial	B-test
chest	I-test
x-ray	I-test
in	O
the	O
CMED	O
showed	O
haziness	B-problem
in	I-problem
the	I-problem
left	I-problem
lower	I-problem
lobe	I-problem
and	O
patchy	B-problem
areas	I-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
consistent	O
with	O
concerns	O
for	O
pneumonia	B-problem
.	O

The	O
infant	O
was	O
treated	O
for	O
pneumonia	B-problem
from	O
admission	O
to	O
the	O
CMED	O
.	O

CARDIOVASCULAR	O
:	O
The	O
infant	O
has	O
maintained	O
stable	O
cardiovascular	O
status	O
with	O
normal	O
heart	O
rates	O
and	O
blood	B-test
pressures	I-test
and	O
no	O
murmurs	B-problem
.	O

FLUIDS	O
,	O
ELECTROLYTES	O
AND	O
NUTRITION	O
:	O
The	O
infant	O
was	O
started	O
on	O
IV	B-treatment
fluids	I-treatment
on	O
admission	O
to	O
the	O
CMED	O
.	O

Electrolytes	B-test
were	O
measured	O
on	O
day	O
of	O
life	O
2	O
and	O
were	O
stable	O
at	O
that	O
time	O
.	O

No	O
further	B-test
electrolytes	I-test
have	O
been	O
measured	O
.	O

Enteral	B-treatment
feedings	I-treatment
were	O
initiated	O
on	O
day	O
of	O
life	O
3	O
and	O
the	O
infant	O
has	O
been	O
ad	B-treatment
lib	I-treatment
PO	I-treatment
feeding	I-treatment
on	O
demand	O
since	O
that	O
time	O
.	O

His	B-test
discharge	I-test
weight	I-test
is	O
4180	O
grams	O
.	O

GASTROINTESTINAL	O
:	O

Bilirubin	B-test
level	I-test
was	O
peaked	O
on	O
day	O
of	O
life	O
4	O
to	O
10.9/0.3	O
.	O

He	O
has	O
required	O
no	O
phototherapy	B-treatment
.	O

HEMATOLOGY	O
:	O
Hematocrit	B-test
was	O
done	O
on	O
admission	O
to	O
the	O
CMED	O
.	O

Hematocrit	B-test
was	O
41	O
,	O
platelet	B-test
count	I-test
of	O
404,000	O
.	O

No	O
further	O
hematocrit	B-test
or	O
platelets	B-test
have	O
been	O
measured	O
.	O

Blood	B-test
typing	I-test
has	O
been	O
done	O
on	O
this	O
infant	O
.	O

The	B-test
baby	I-test
's	I-test
blood	I-test
type	I-test
is	O
B	O
negative	O
,	O
antibody	B-test
negative	O
.	O

INFECTIOUS	O
DISEASE	O
:	O
CBC	B-test
and	O
blood	B-test
culture	I-test
were	O
screened	O
on	O
admission	O
.	O

CBC	B-test
was	O
benign	O
with	O
22,000	O
whites	B-test
,	O
80	O
poly	B-test
's,	I-test
0	O
bands	B-test
,	O
15	O
lymphs	B-test
.	O

Ampicillin	B-treatment
and	O
gentamycin	B-treatment
were	O
initiated	O
on	O
admission	O
and	O
an	B-test
LP	I-test
was	O
done	O
due	O
to	O
the	O
clinical	O
issues	O
of	O
respiratory	B-problem
distress	I-problem
and	O
fever	B-problem
on	O
admission	O
to	O
the	O
CMED	O
.	O

CSF	B-test
showed	O
white	B-test
count	I-test
of	O
7	O
,	O
reds	B-test
4	O
,	O
protein	B-test
119	O
,	O
glucose	B-test
69	O
.	O

The	O
infant	O
was	O
treated	O
for	O
7	O
days	O
of	O
presumed	O
pneumonia	B-problem
with	O
ampicillin	B-treatment
and	O
gentamycin	B-treatment
.	O

Antibiotics	B-treatment
were	O
discontinued	O
on	O
the	O
evening	O
of	O
2015-04-28	O
.	O

NEUROLOGY	O
:	O
The	O
infant	O
has	O
maintained	O
a	O
normal	O
neurologic	O
examination	O
.	O

SENSORY	O
:	O
Hearing	B-test
screen	I-test
was	O
performed	O
with	O
automated	B-test
auditory	I-test
brain	I-test
stem	I-test
responses	I-test
and	O
the	O
results	O
was	O
the	O
infant	O
passing	O
in	O
both	O
ears	O
.	O

PSYCHOSOCIAL	O
:	O
A	O
Arbour	O
Hospital	O
social	O
worker	O
has	O
been	O
involved	O
with	O
the	O
family	O
.	O

The	O
contact	O
social	O
worker	O
can	O
be	O
reached	O
at	O
(	O
374	O
)	O
419-2007	O
.	O

There	O
are	O
no	O
active	B-problem
ongoing	I-problem
issues	I-problem
at	O
this	O
time	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Good	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

Home	O
with	O
the	O
parents	O
.	O

NAME	O
OF	O
PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Gene	O
Hardy	O
from	O
Webster	O
Pediatrics	O
.	O

Telephone	O
No.	O
:	O
(	O
309	O
)	O
642-6861	O
fax	O
(	O
515	O
)	O
568-6798	O
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Ad	B-treatment
lib	I-treatment
PO	I-treatment
feedings	I-treatment
of	O
Similac	B-treatment
20	I-treatment
cal	I-treatment
/	I-treatment
oz	I-treatment
with	I-treatment
iron	I-treatment
.	O

2.	O
Medications	B-treatment
:	O
None	O
.	O

3.	O
State	B-test
newborn	I-test
screen	I-test
was	O
sent	O
on	O
2015-04-24	O
and	O
results	O
are	O
pending	O
.	O

4.	O
Immunizations	B-treatment
received	O
:	O
Hepatitis	B-treatment
B	I-treatment
vaccine	I-treatment
was	O
given	O
on	O
2015-04-25	O
.	O

5.	O
Immunizations	B-treatment
Recommended	O
:	O

6.	O
Synagis	B-treatment
RSV	I-treatment
prophylaxis	I-treatment
should	O
be	O
considered	O
from	O
November	O
through	O
March	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
.	O

A.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
gestation	O
.	O

B.	O
Born	O
between	O
32	O
and	O
35	O
weeks	O
gestation	O
with	O
two	O
of	O
the	O
following	O
:	O

daycare	O
during	O
the	O
RSV	O
season	O
a	O
smoker	O
in	O
the	O
household	O
,	O
neuromuscular	B-problem
disease	I-problem
,	O
airway	B-problem
abnormalities	I-problem
,	O
or	O
school	O
age	O
siblings	O

C.	O
with	O
chronic	B-problem
lung	I-problem
disease	I-problem
.	O

7.	O
Influenza	B-treatment
immunization	I-treatment
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
,	O
immunization	B-treatment
against	O
influenza	B-problem
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
caregivers	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Presumed	O
pneumonia	B-problem
,	O
treated	O
.	O

2.	O
Large	B-problem
for	I-problem
gestational	I-problem
age	I-problem
term	O
male	O
.	O

3.	O
Respiratory	B-problem
distress	I-problem
,	O
resolved	O
.	O

4.	O
Mild	B-problem
hyperbilirubinemia	I-problem
,	O
resolving	O
.	O

Claudia	O
Ernest	O
,	O
MD	O
50AAD	O

Dictated	O
By	O
:	O
Stan	O
C.	O
Haaz	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-04-28	O
23:50:08	O

T	O
:	O
2015-04-29	O
02:50:40	O

Job	O
#:	O
76623	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Maria	O
L	O
Ulabarro	O
on	O
:	O
WED	O
2015-04-29	O
2:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

825280108	O
PUMC	O

2717701	O
PAD-WORD	O

366967	O
PAD-WORD	O

8348653	O
PAD-WORD	O

9/9/2003	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

GUYNLORDSMANTDOUET	O
,	O
ARYRISTE	O
T	O

UNIT	O
NUMBER	O
:	O

566-45-49	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

09/09/2003	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

09/12/2003	O
PAD-WORD	O

PRINCIPLE	O
DIAGNOSIS	O
:	O

Infrarenal	B-problem
abdominal	I-problem
aortic	I-problem
aneurysm	I-problem
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

1.	O
Hypertension	B-problem
;	O

2.	O
Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
;	O

3.	O
Osteoarthritis	B-problem
.	O

PRINCIPLE	O
PROCEDURE	O
:	O

Endovascular	B-treatment
repair	I-treatment
of	O
abdominal	B-problem
aortic	I-problem
aneurysm	I-problem
with	O
bifurcated	B-treatment
device	I-treatment
on	O
September	O
9	O
,	O
2003	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
84	O
year	O
old	O
male	O
,	O
with	O
a	O
history	O
of	O
hypertension	B-problem
,	O
who	O
was	O
discovered	O
to	O
have	O
an	B-problem
asymptomatic	I-problem
7	I-problem
cm	I-problem
abdominal	I-problem
aortic	I-problem
aneurysm	I-problem
on	O
CT	B-test
scan	I-test
obtained	O
in	O
the	O
emergency	O
room	O
back	O
in	O
May	O
.	O

At	O
that	O
time	O
he	O
had	O
presented	O
with	O
abdominal	B-problem
pain	I-problem
,	O
and	O
was	O
found	O
to	O
have	O
acute	B-problem
cholecystectomy	I-problem
.	O

He	O
underwent	O
an	B-treatment
uncomplicated	I-treatment
laparoscopic	I-treatment
cholecystectomy	I-treatment
.	O

He	O
presents	O
at	O
this	O
time	O
for	O
endovascular	B-treatment
repair	I-treatment
of	O
this	B-problem
abdominal	I-problem
aortic	I-problem
aneurysm	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-problem
;	O

2.	O
Gastroesophageal	B-problem
reflux	I-problem
disease	I-problem
;	O

3.	O
H.	B-problem
pylori	I-problem
positive	I-problem
,	O
status	O
post	O
therapy	B-treatment
;	O

4.	O
Osteoarthritis	B-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

1.	O
Craniotomy	B-treatment
for	O
meningoma	B-problem
,	O
February	O
,	O
1994	O
;	O

2.	O
Laparoscopic	B-treatment
cholecystectomy	I-treatment
in	O
May	O
,	O
2002	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Aspirin	B-treatment
81	O
mg	O
PO	O
qd	O
;	O

2.	O
Atenolol	B-treatment
25	O
mg	O
PO	O
qd	O
;	O

3.	O
Protonics	B-treatment
40	O
mg	O
PO	O
qd	O
.	O

ALLERGIES	O
:	O

No	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
quit	O
smoking	O
30	O
years	O
ago	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Blood	B-test
pressure	I-test
152/74	O
,	O
pulse	B-test
60	O
,	O
respirations	B-test
16	O
.	O

He	O
is	O
71	O
inches	O
tall	O
,	O
196	O
lbs	O
.	O

He	O
has	O
no	O
carotid	B-problem
bruits	I-problem
.	O

Lungs	O
were	O
clear	O
bilaterally	O
.	O

Heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
,	O
without	O
murmur	B-problem
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-problem
with	O
a	B-problem
pulsatile	I-problem
mass	I-problem
in	I-problem
the	I-problem
epigastrium	I-problem
.	O

Extremities	O
reveals	O
a	B-test
2+	I-test
femoral	I-test
and	I-test
pedal	I-test
pulses	I-test
bilaterally	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
Vascular	O
Surgery	O
Service	O
as	O
a	O
same	O
day	O
admission	O
,	O
and	O
taken	O
to	O
the	O
operating	O
room	O
for	O
an	B-treatment
uncomplicated	I-treatment
endovascular	I-treatment
repair	I-treatment
of	O
his	B-problem
abdominal	I-problem
aortic	I-problem
aneurysm	I-problem
,	O
and	O
Anurx	B-treatment
modular	I-treatment
bifurcated	I-treatment
graft	I-treatment
was	O
placed	O
,	O
and	O
both	O
common	O
femoral	O
arteries	O
were	O
repaired	O
in	O
the	O
usual	O
fashion	O
.	O

He	O
had	O
pulsatile	B-test
pulse	I-test
volume	I-test
recordings	I-test
,	O
in	O
both	O
lower	O
extremities	O
,	O
and	O
both	O
renal	O
arteries	O
were	O
noted	O
to	O
be	O
patent	O
,	O
as	O
were	O
both	O
internal	O
iliac	O
arteries	O
.	O

His	B-test
angiogram	I-test
in	O
the	O
operating	O
room	O
,	O
revealed	O
no	O
evidence	O
of	O
an	B-problem
endo	I-problem
leak	I-problem
.	O

Postoperatively	O
,	O
his	O
course	O
was	O
relatively	O
uncomplicated	O
.	O

He	O
did	O
have	O
an	O
episode	O
of	O
a	B-problem
prolonged	I-problem
sinus	I-problem
pause	I-problem
in	O
the	O
recovery	O
room	O
,	O
which	O
resulted	O
in	O
transient	B-problem
loss	I-problem
of	I-problem
consciousness	I-problem
.	O

He	O
responded	O
to	O
a	B-treatment
Neo-Synephrine	I-treatment
bolus	I-treatment
,	O
and	O
had	O
no	O
further	B-problem
complications	I-problem
from	O
this	O
standpoint	O
.	O

Dr.	O
Rosean	O
Fletcher	O
,	O
of	O
the	O
Cardiology	O
Department	O
was	O
consulted	O
,	O
and	O
it	O
was	O
his	O
opinion	O
that	O
the	B-problem
sinus	I-problem
pause	I-problem
was	O
related	O
to	O
increased	B-problem
vagal	I-problem
tone	I-problem
postoperatively	O
,	O
perhaps	O
secondary	O
to	O
the	B-treatment
epidural	I-treatment
,	O
as	O
well	O
as	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
Atenolol	I-treatment
use	I-treatment
.	O

His	B-treatment
Atenolol	I-treatment
was	O
held	O
,	O
and	O
he	O
had	O
no	O
further	B-problem
pauses	I-problem
during	O
his	O
stay	O
.	O

His	B-test
postoperative	I-test
CT	I-test
scan	I-test
showed	O
no	O
evidence	O
of	O
endo	B-problem
leak	I-problem
,	O
or	O
graft	B-problem
kinking	I-problem
.	O

He	O
maintained	O
good	O
peripheral	O
pulses	O
and	O
warm	O
feet	O
postoperatively	O
.	O

However	O
,	O
he	O
did	O
develop	O
significant	B-problem
ecchymosis	I-problem
in	I-problem
both	I-problem
groins	I-problem
,	O
extending	O
down	O
into	O
his	O
scrotum	O
.	O

There	O
was	O
no	O
evidence	O
of	O
significant	B-problem
groin	I-problem
hematomas	I-problem
.	O

He	O
tolerated	O
a	O
regular	O
diet	O
.	O

His	B-problem
pain	I-problem
was	O
adequately	O
controlled	O
with	O
oral	B-treatment
medications	I-treatment
.	O

Accordingly	O
,	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
postoperative	O
day	O
2	O
.	O

He	O
will	O
be	O
visited	O
by	O
LDAMC	O
for	O
blood	B-test
pressure	I-test
and	O
incision	B-test
checks	I-test
.	O

He	O
will	O
follow	O
up	O
with	O
Dr.	O
Dye	O
in	O
the	O
Clinic	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Admission	B-treatment
medications	I-treatment
.	O

YERTREY	O
TANELI	O
SUMCHIRDKAYSMAVVEINDREPS	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
ALEN	O
LAA	O
CREDKOTE	O
,	O
M.D.	O

09/30/2003	O
13:34	O

_____________________________	O
ALEN	O
LAA	O
CREDKOTE	O
,	O
M.D.	O

TR	O
:	O

ruw	O
PAD-WORD	O

DD	O
:	O

09/11/2003	O
PAD-WORD	O

TD	O
:	O

09/12/2003	O
2:23	O
P	O
366967	O

cc	O
:	O

ALEN	O
LAA	O
CREDKOTE	O
,	O
M.D.	O
,	O
ROSEAN	O
FLETCHER	O
,	O
M.D.	O
,	O
VIENNEE	O
BACK	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2011-11-18	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2011-11-22	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1950-04-21	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CCU	O
PAD-WORD	O

REASON	O
FOR	O
ADMISSION	O
:	O

Acute	B-problem
inferior	I-problem
myocardial	I-problem
infarction	I-problem
and	O
right	B-problem
ventricular	I-problem
infarction	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
61	O
-	O
year-old	O
Caucasian-speaking	O
woman	O
with	O
a	O
history	O
of	O
hypercholesterolemia	B-problem
and	O
tobacco	O
use	O
who	O
developed	O
waxing	B-problem
and	I-problem
waning	I-problem
left	I-problem
substernal	I-problem
chest	I-problem
pain	I-problem
with	O
radiation	B-problem
to	I-problem
the	I-problem
left	I-problem
shoulder	I-problem
on	O
2011-11-17	O
which	O
lasted	O
that	O
entire	O
day	O
.	O

Upon	O
waking	O
on	O
the	O
morning	O
of	O
admission	O
,	O
she	O
had	O
10/10	O
chest	B-problem
pain	I-problem
associated	O
with	O
nausea	B-problem
.	O

She	O
presented	O
to	O
Charlton	O
Memorial	O
Hospital	O
Hospital	O
Emergency	O
Department	O
with	O
inferior	B-problem
ST	I-problem
elevations	I-problem
;	O
at	O
which	O
time	O
she	O
became	O
acutely	B-problem
hypotensive	I-problem
to	O
a	B-test
systolic	I-test
blood	I-test
pressure	I-test
of	O
70	O
to	O
80	O
after	O
receiving	O
one	O
ublingual	B-treatment
nitroglycerin	I-treatment
.	O

She	O
then	O
became	O
bradycardic	B-problem
which	O
responded	O
to	O
atropine	B-treatment
and	O
intravenous	B-treatment
fluids	I-treatment
.	O

In	O
addition	O
,	O
she	O
was	O
given	O
aspirin	B-treatment
,	O
Plavix	B-treatment
,	O
heparin	B-treatment
,	O
and	O
morphine	B-treatment
.	O

Immediately	O
prior	O
to	O
transfer	O
to	O
Worcester	O
State	O
Hospital	O
,	O
she	O
went	O
into	O
ventricular	B-problem
fibrillation	I-problem
arrest	I-problem
at	O
12:30	O
p.m.	O
,	O
at	O
which	O
time	O
she	O
was	O
intubated	B-treatment
and	O
defibrillated	B-treatment
back	O
to	O
sinus	O
rhythm	O
after	O
five	B-treatment
shocks	I-treatment
.	O

She	O
received	O
an	B-treatment
amiodarone	I-treatment
bolus	I-treatment
of	O
150	O
mg	O
intravenously	O
and	O
was	O
continued	O
on	O
an	B-treatment
amiodarone	I-treatment
drip	I-treatment
while	O
CMED	O
CSRU-flighted	O
to	O
Boston	O
Regional	O
Medical	O
Centerr	O
where	O
she	O
underwent	O
a	B-test
catheterization	I-test
.	O

The	B-test
cardiac	I-test
catheterization	I-test
revealed	O
a	B-problem
total	I-problem
occlusion	I-problem
of	I-problem
the	I-problem
proximal	I-problem
right	I-problem
coronary	I-problem
artery	I-problem
and	O
diffuse	B-problem
right	I-problem
coronary	I-problem
artery	I-problem
disease	I-problem
.	O

She	O
received	O
three	B-treatment
stents	I-treatment
to	I-treatment
the	I-treatment
right	I-treatment
coronary	I-treatment
artery	I-treatment
which	O
was	O
complicated	O
by	O
a	B-problem
proximal	I-problem
dissection	I-problem
.	O

She	O
had	O
good	O
post	B-test
percutaneous	I-test
coronary	I-test
intervention	I-test
angiographic	I-test
results	I-test
.	O

Incidentally	O
,	O
an	B-test
aortogram	I-test
during	O
the	B-test
catheterization	I-test
revealed	O
a	B-problem
Debakey	I-problem
class	I-problem
I	I-problem
aortic	I-problem
ascending	I-problem
aneurysm	I-problem
,	O
and	O
the	O
patient	O
had	O
a	B-test
pulmonary	I-test
capillary	I-test
wedge	I-test
pressure	I-test
of	O
20	O
at	O
the	O
time	O
of	O
catheterization	B-test
.	O

She	O
was	O
transferred	O
to	O
the	O
Coronary	O
Care	O
Unit	O
in	O
stable	O
condition	O
and	O
still	O
intubated	B-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypercholesterolemia	B-problem
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

"	O
Flumaran	B-treatment
"	O
for	O
circulatory	B-problem
problems	I-problem
.	O

She	O
receives	O
this	B-treatment
medication	I-treatment
by	O
mail	O
from	O
her	O
relatives	O
in	O
Jill	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
TO	O
CORONARY	O
CARE	O
0408398	O
.	O

Amiodarone	B-treatment
drip	I-treatment
.	O

2.	O
Integrilin	B-treatment
drip	I-treatment
.	O

3.	O
Intravenous	B-treatment
fluids	I-treatment
.	O

ALLERGIES	O
:	O

A	O
question	O
of	O
a	B-treatment
SULFA	I-treatment
allergy	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
alone	O
in	O
Woburn	O
.	O

She	O
came	O
from	O
Czech	O
Republic	O
14	O
years	O
ago	O
.	O

She	O
works	O
as	O
a	O
nursing	O
assistant	O
in	O
a	O
nursing	O
home	O
.	O

She	O
smokes	O
approximately	O
one	O
and	O
a	O
half	O
packs	O
of	O
cigarettes	O
per	O
day	O
for	O
the	O
last	O
30	O
years	O
.	O

FAMILY	O
HISTORY	O
:	O

Family	O
history	O
is	O
not	O
significant	O
for	O
any	O
early	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Examination	B-test
on	O
admission	O
to	O
the	O
Coronary	O
Care	O
Unit	O
revealed	O
blood	B-test
pressure	I-test
was	O
100/57	O
,	O
with	O
a	B-test
mean	I-test
arterial	I-test
pressure	I-test
of	O
75	O
,	O
heart	B-test
rate	I-test
was	O
sinus	O
rhythm	O
at	O
75	O
,	O
temperature	B-test
was	O
97.6	O
,	O
oxygen	B-test
saturation	I-test
was	O
99%	O
on	O
assist	B-treatment
control	I-treatment
with	O
a	B-treatment
tidal	I-treatment
volume	I-treatment
of	O
600	O
on	O
60%	O
FIO2	B-treatment
,	O
5	O
of	O
positive	B-treatment
end-expiratory	I-treatment
pressure	I-treatment
.	O

In	O
general	O
,	O
she	O
was	O
sedated	B-treatment
at	O
the	O
time	O
,	O
responsive	O
to	O
stimuli	O
,	O
and	O
was	O
following	O
commands	O
.	O

She	O
had	O
moist	O
mucous	O
membranes	O
.	O

Her	B-test
carotids	I-test
were	O
2+	O
bilaterally	O
.	O

Her	O
lungs	O
were	O
clear	O
to	O
auscultation	B-test
anteriorly	O
.	O

Her	O
heart	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-problem
faint	I-problem
second	I-problem
heart	I-problem
sound	I-problem
and	O
second	O
heart	O
sound	O
.	O

No	O
audible	B-problem
extra	I-problem
heart	I-problem
sounds	I-problem
.	O

Her	O
abdomen	O
was	O
obese	B-problem
and	O
had	O
positive	O
bowel	O
sounds	O
.	O

It	O
was	O
soft	O
and	O
nontender	B-problem
.	O

She	O
had	O
peripheral	B-problem
edema	I-problem
with	O
2+	B-test
peripheral	I-test
pulses	I-test
bilaterally	I-test
.	O

PERTINENT	O
LABORATORY	O
DATA	O
ON	O
PRESENTATION	O
:	O

Her	B-test
laboratories	I-test
at	O
the	O
time	O
of	O
transfer	O
to	O
Saint	O
Vincent	O
Hospital	O
revealed	O
white	B-test
blood	I-test
cell	I-test
count	I-test
was	O
11.5	O
,	O
hematocrit	B-test
was	O
42	O
on	O
admission	O
,	O
platelets	B-test
were	O
242	O
.	O

Chemistry-7	B-test
was	O
unremarkable	O
.	O

Creatine	B-test
kinase	I-test
on	O
admission	O
was	O
309	O
,	O
with	O
a	B-test
MB	I-test
of	O
19.6	O
,	O
an	B-test
index	I-test
of	O
6.3	O
,	O
and	O
an	B-test
initial	I-test
troponin	I-test
of	O
0.73	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

A	B-test
chest	I-test
x-ray	I-test
revealed	O
an	B-problem
enlarged	I-problem
mediastinum	I-problem
with	O
clear	O
lung	O
fields	O
bilaterally	O
.	O

Initial	B-test
electrocardiogram	I-test
showed	O
a	O
normal	O
sinus	O
rhythm	O
at	O
65	O
,	O
normal	O
axis	O
,	O
2-mm	B-problem
ST	I-problem
elevations	I-problem
in	I-problem
lead	I-problem
III	I-problem
,	O
1-mm	B-problem
ST	I-problem
elevations	I-problem
in	I-problem
aVF	I-problem
and	I-problem
V1	I-problem
,	O
1-mm	B-problem
ST	I-problem
depressions	I-problem
in	I-problem
I	I-problem
and	I-problem
aVL	I-problem
;	O
consistent	O
with	O
an	B-problem
inferior	I-problem
and	I-problem
right	I-problem
ventricular	I-problem
infarction	I-problem
.	O

Right-sided	B-test
electrocardiograms	I-test
showed	O
1-mm	B-problem
ST	I-problem
elevations	I-problem
in	I-problem
V4	I-problem
;	O
consistent	O
with	O
a	B-problem
right	I-problem
ventricular	I-problem
infarct	I-problem
.	O

Electrocardiogram	B-test
status	O
post	O
percutaneous	B-treatment
coronary	I-treatment
intervention	I-treatment
revealed	O
a	O
normal	O
sinus	O
rhythm	O
at	O
84	O
,	O
with	O
a	O

normal	O
axis	O
,	O
and	O
normalizing	O
of	O
the	B-problem
inferior	I-problem
ST	I-problem
segments	I-problem
,	O
with	O
Q	O
waves	O
evolving	O
in	O
leads	O
III	O
and	O
aVF	O
.	O

An	B-test
echocardiogram	I-test
status	O
post	O
percutaneous	B-treatment
coronary	I-treatment
intervention	I-treatment
revealed	O
an	B-problem
akinetic	I-problem
inferior	I-problem
wall	I-problem
and	I-problem
right	I-problem
ventricle	I-problem
,	O
mild	B-problem
mitral	I-problem
regurgitation	I-problem
,	O
and	O
ascending	O
aorta	O
measuring	O
5	O
cm	O
.	O

There	O
was	O
no	O
effusion	B-problem
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
CARDIOVASCULAR	O
SYSTEM	O
:	O

On	O
the	O
night	O
of	O
admission	O
,	O
the	O
patient	O
experienced	O
post	B-problem
catheterization	I-problem
hypotension	I-problem
which	O
required	O
intravenous	B-treatment
fluids	I-treatment
and	O
dopamine	B-treatment
.	O

Electrocardiogram	B-test
the	O
following	O
morning	O
revealed	O
normalization	O
of	O
her	O
ST	O
segments	O
with	O
evolution	B-problem
of	I-problem
Q	I-problem
waves	I-problem
.	O

Her	B-treatment
dopamine	I-treatment
was	O
weaned	O
off	O
the	O
following	O
day	O
,	O
and	O
her	B-treatment
heparin	I-treatment
was	O
discontinued	O
secondary	O
to	O
a	B-problem
right	I-problem
groin	I-problem
hematoma	I-problem
which	O
had	O
developed	O
after	O
the	B-treatment
sheath	I-treatment
had	O
been	O
pulled	O
out	O
by	O
the	O
fellow	O
.	O

Her	B-test
creatine	I-test
kinases	I-test
climbed	O
;	O
reaching	O
a	O
peak	O
of	O
3523	O
,	O
which	O
was	O
down	O
to	O
1500	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Also	O
noted	O
on	O
the	O
day	O
of	O
11-20	O
,	O
the	O
patient	O
self-extubated	O
herself	O
.	O

For	O
her	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
catheterization	B-test
,	O
she	O
was	O
given	O
Integrilin	B-treatment
for	O
18	O
hours	O
.	O

She	O
was	O
continued	O
on	O
aspirin	B-treatment
,	O
Plavix	B-treatment
,	O
and	O
Lipitor	B-treatment
.	O

For	O
her	O
rhythm	O
,	O
amiodarone	B-treatment
was	O
discontinued	O
as	O
she	O
was	O
maintained	O
in	O
sinus	O
rhythm	O
after	O
moving	O
to	O
the	O
floor	O
.	O

For	O
pump	O
,	O
once	O
transferred	O
out	O
of	O
the	O
Coronary	O
Care	O
Unit	O
on	O
2011-11-20	O
,	O
a	B-treatment
beta	I-treatment
blocker	I-treatment
was	O
begun	O
at	O
12.5	O
mg	O
of	O
Lopressor	B-treatment
p.o.	O
b.i.d.	O
which	O
was	O
titrated	O
to	O
25	O
mg	O
at	O
the	O
time	O
of	O
discharge	O
.	O

Also	O
,	O
at	O
the	O
time	O
of	O
discharge	O
,	O
for	O
increased	B-treatment
afterload	I-treatment
reduction	I-treatment
,	O
she	O
was	O
started	O
on	O
lisinopril	B-treatment
5	O
mg	O
p.o.	O
q.d.	O

On	O
2011-11-21	O
,	O
the	O
patient	O
experienced	O
atypical	B-problem
chest	I-problem
pain	I-problem
which	O
was	O
made	O
worse	O
with	O
inspiration	O
and	O
movement	O
.	O

It	O
was	O
not	O
associated	O
with	O
any	B-problem
nausea	I-problem
or	O
vomiting	B-problem
.	O

It	O
did	O
not	O
radiate	O
.	O

It	O
was	O
felt	O
to	O
be	O
pain	B-problem
secondary	O
to	O
her	B-problem
self-extubation	I-problem
and	O
noncardiac	B-problem
chest	I-problem
pain	I-problem
.	O

An	B-test
electrocardiogram	I-test
was	O
checked	O
which	O
revealed	O
no	O
ST	B-problem
changes	I-problem
,	O
and	O
there	O
was	O
no	O
increase	O
in	O
her	O
downward	O
trending	O
creatine	B-test
phosphokinases	I-test
.	O

No	O
further	B-treatment
intervention	I-treatment
was	O
done	O
.	O

The	O
patient	O
was	O
treated	O
with	O
Tylenol	B-treatment
orally	I-treatment
as	O
well	O
as	O
Ativan	B-treatment
for	O
anxiety	B-problem
that	O
she	O
had	O
about	O
going	O
home	O
.	O

She	O
was	O
pain	B-problem
free	O
on	O
the	O
day	O
of	O
discharge	O
.	O

Regarding	O
her	B-problem
aortic	I-problem
ascending	I-problem
aneurysm	I-problem
,	O
Cardiothoracic	O
Surgery	O
was	O
consulted	O
regarding	O
further	B-test
workup	I-test
.	O

At	O
their	O
request	O
,	O
a	B-test
CT	I-test
scan	I-test
of	I-test
the	I-test
chest	I-test
with	O
contrast	B-test
was	O
performed	O
on	O
the	O
day	O
of	O
discharge	O
.	O

Dr.	O
Streeter	O
from	O
Cardiothoracic	O
Surgery	O
will	O
follow	O
up	O
with	O
the	O
patient	O
for	O
further	B-treatment
management	I-treatment
in	O
approximately	O
one	O
month	O
as	O
an	O
outpatient	O
.	O

His	O
office	O
will	O
contact	O
her	O
to	O
make	O
that	O
appointment	O
.	O

2.	O
PULMONARY	O
SYSTEM	O
:	O

As	O
stated	O
above	O
,	O
the	O
patient	O
self-extubated	O
herself	O
.	O

She	O
complained	O
of	O
a	B-problem
sore	I-problem
throat	I-problem
which	O
was	O
likely	O
the	O
etiology	O
of	O
her	B-problem
atypical	I-problem
chest	I-problem
complaints	I-problem
.	O

This	O
resolved	O
with	O
Tylenol	B-treatment
and	O
as	O
needed	O
doses	O
of	O
oxycodone	B-treatment
.	O

Her	O
lungs	O
remained	O
clear	O
to	O
auscultation	B-test
bilaterally	O
throughout	O
the	O
remainder	O
of	O
her	O
hospital	O
course	O
.	O

At	O
the	O
time	O
of	O
this	O
dictation	O
,	O
the	B-test
CT	I-test
of	I-test
her	I-test
chest	I-test
was	O
still	O
pending	O
.	O

The	O
official	O
result	O
was	O
not	O
yet	O
in	O
.	O

3.	O
FLUIDS	O
/	O
ELECTROLYTES	O
/	O
NUTRITION	O
:	O

The	B-test
patient	I-test
's	I-test
electrolytes	I-test
sere	O
managed	O
daily	O
and	O
repleted	O
on	O
an	O
as	O
needed	O
basis	O
.	O

She	O
did	O
receive	O
intravenous	B-treatment
K-Phos	I-treatment
for	O
a	B-problem
low	I-problem
phosphorous	I-problem
of	O
1.5	O
.	O

Her	B-test
phosphorous	I-test
rose	O
appropriately	O
to	O
3.6	O
at	O
the	O
time	O
of	O
discharge	O
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

1.	O
The	O
patient	O
has	O
an	O
appointment	O
to	O
initiate	O
primary	O
care	O
,	O
as	O
she	O
no	O
longer	O
had	O
a	O
primary	O
care	O
physician	O
.	O

Claire	O
was	O
to	O
see	O
Dr.	O
Michael	O
Majerowski	O
at	O
the	O
Sturdy	O
Memorial	O
Clinic	O
on	O
the	O
east	O
campus	O
,	O
on	O
Bissonette	O
Six	O
,	O
in	O
the	O
South	O
Suite	O
,	O
on	O
31-05-03	O
at	O
11:30	O
a.m.	O

2.	O
In	O
addition	O
,	O
as	O
stated	O
above	O
,	O
Dr.Hastings	O
office	O
from	O
Cardiothoracic	O
Surgery	O
will	O
be	O
in	O
contact	O
with	O
Ms.	O
Williams	O
to	O
arrange	O
followup	O
for	O
her	B-problem
ascending	I-problem
aortic	I-problem
aneurysm	I-problem
in	O
approximately	O
one	O
month	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Lisinopril	B-treatment
5	O
mg	O
p.o.	O
q.d.	O

2.	O
Lopressor	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O

3.	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
q.d.	O

4.	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.d.	O

5.	O
Protonix	B-treatment
40	O
mg	O
p.o.	O
q.d.	O

6.	O
Enteric-coated	B-treatment
aspirin	I-treatment
325	O
mg	O
p.o.	O
q.d.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Condition	O
on	O
discharge	O
was	O
stable	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Inferior	B-problem
myocardial	I-problem
infarction	I-problem
and	O
right	B-problem
ventricular	I-problem
infarction	I-problem
.	O

Status	O
post	O
cardiac	B-test
catheterization	I-test
and	O
stents	B-treatment
times	O
three	O
of	O
the	O
right	O
coronary	O
artery	O
.	O

2.	O
Hypertension	B-problem
.	O

3.	O
Hypercholesterolemia	B-problem
.	O

Rosemary	O
D	O
Mccluskey	O
,	O
M.D.	O
39-696	O

Dictated	O
By	O
:	O
Harriet	O
E.	O
Evans	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2011-11-22	O
14:09	O

T	O
:	O
2011-11-23	O
11:59	O

JOB	O
#:	O
15087	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Sandra	O
BURGER	O
on	O
:	O
WED	O
2011-11-30	O
9:46	O
AM	O

(	O
End	O
of	O
Report	O
)	O

846470157	O
PAD-WORD	O

FIH	O
PAD-WORD	O

2831385	O
PAD-WORD	O

45917/em77	O
PAD-WORD	O

071794	O
PAD-WORD	O

5/13/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

5-13-92	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

5-22-92	O
PAD-WORD	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
75	O
year	O
old	O
righthanded	O
Caucasian	O
female	O
who	O
was	O
admitted	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
because	O
of	O
left	B-problem
facial	I-problem
droop	I-problem
and	O
hand	B-problem
weakness	I-problem
after	O
glaucoma	B-treatment
laser	I-treatment
surgery	I-treatment
.	O

She	O
was	O
transferred	O
to	O
the	O
Sas	O
General	O
Hospital	O
for	O
further	B-test
evaluation	I-test
of	O
some	B-problem
weakness	I-problem
in	O
the	O
setting	O
of	O
multiple	B-problem
medical	I-problem
problems	I-problem
.	O

The	O
patient	O
had	O
o.d.	B-treatment
glaucoma	I-treatment
surgery	I-treatment
,	O
1400	O
hours	O
,	O
on	O
May	O
12th	O
,	O
1992	O
.	O

Soon	O
after	O
surgery	B-treatment
,	O
the	O
patient	O
noted	O
her	O
left	O
lower	O
face	O
and	O
hand	O
were	O
weak	B-problem
.	O

She	O
was	O
brought	O
to	O
the	O
emergency	O
room	O
where	O
she	O
was	O
evaluated	O
and	O
determined	O
to	O
have	O
had	O
a	B-problem
cerebrovascular	I-problem
accident	I-problem
.	O

She	O
has	O
absolutely	O
no	O
neurologic	B-problem
disease	I-problem
in	O
past	O
.	O

The	B-test
review	I-test
of	I-test
systems	I-test
is	O
negative	O
.	O

However	O
,	O
two	O
days	O
prior	O
to	O
admission	O
,	O
one	O
family	O
member	O
noted	O
that	O
the	O
patient	O
had	O
a	B-problem
transient	I-problem
left	I-problem
facial	I-problem
droop	I-problem
.	O

A	B-test
potassium	I-test
three	O
days	O
prior	O
to	O
surgery	B-treatment
was	O
2.8	O
,	O
the	B-test
level	I-test
being	O
normalized	O
with	O
p.o.	B-treatment
kay	I-treatment
ciel	I-treatment
prior	O
to	O
admission	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
MI	B-problem
in	O
1989	O
,	O
no	O
angina	B-problem
before	O
or	O
after	O
.	O

She	O
had	O
a	O
normal	O
exercise	O
thallium	O
test	O
in	O
08/89	O
,	O
per	O
Ona	O
Hospital	O
.	O

The	O
phone	O
no.	O
at	O
the	O
Ona	O
Hospital	O
is	O
337-4296	O
,	O
936	O
area	O
code	O
.	O

#	O
2.	O
History	O
of	O
M.	B-problem
kansasaii	I-problem
with	O
workup	B-test
by	O
Dr.	O
Screen	O
at	O
Sas	O
General	O
Hospital	O
proceeding	O
currently	O
.	O

#	O
3.	O
History	O
of	O
breast	B-problem
cancer	I-problem
.	O

In	O
December	O
1990	O
she	O
had	O
a	B-treatment
lumpectomy	I-treatment
,	I-treatment
from	I-treatment
left	I-treatment
breast	I-treatment
,	O
and	O
XRT	B-treatment
x	O
35	O
.	O

No	O
axillary	B-treatment
dissection	I-treatment
was	O
done	O
because	O
she	O
was	O
status	O
post	O
MI	B-problem
.	O

She	O
received	O
Tamoxifen	B-treatment
briefly	O
.	O

Mammogram	B-test
was	O
normal	O
7/92	O
,	O
and	O
5/92	O
.	O

She	O
is	O
allergic	B-problem
to	O
Amoxicillin	B-treatment
,	O
having	O
developed	O
a	B-problem
rash	I-problem
,	O
does	O
not	O
smoke	O
,	O
does	O
not	O
drink	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Dyazide	B-treatment
one	O
p.o.	O
q.d.	O
Propanolol	B-treatment
5	O
mg.	O
p.o.	O
t.i.d.	O
Isordil	B-treatment
5	O
mg.	O
p.o.	O
t.i.d.	O
Glaucoma	B-treatment
drops	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

blood	B-test
pressure	I-test
118/75	O
,	O
pulse	B-test
88	O
,	O
respirations	B-test
20	O
,	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

Head	B-test
and	I-test
neck	I-test
exam	I-test
was	O
unremarkable	O
,	O
except	O
for	O
the	O
right	O
eye	O
being	O
patched	O
over	O
.	O

Lungs	O
were	O
clear	O
.	O

Breasts	O
were	O
unremarkable	O
.	O

Back	O
was	O
nontender	B-problem
.	O

Heart	O
exam	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
jugular	B-test
venous	I-test
pressure	I-test
was	O
normal	O
,	O
no	O
carotid	B-problem
bruit	I-problem
was	O
noted	O
;	O
murmur	B-problem
,	O
rub	B-problem
,	O
gallop	B-problem
,	O
click	B-problem
and	O
ectopy	B-problem
were	O
absent	O
.	O

Abdomen	O
was	O
benign	O
.	O

Rectal	B-test
tone	I-test
was	O
normal	O
,	O
guaiac	B-test
negative	O
stool	O
.	O

Extremities	O
:	O

without	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
or	O
stigmata	B-problem
of	O
subacute	B-problem
bacterial	I-problem
endocarditis	I-problem
.	O

Normal	O
pulses	O
were	O
palpated	O
.	O

Neurologic	O
exam	O
:	O

the	O
patient	O
was	O
alert	O
and	O
oriented	O
x	O
4	O
.	O

Extensive	B-test
mental	I-test
status	I-test
testing	I-test
was	O
normal	O
,	O
except	O
for	O
recalling	O
only	O
one	O
out	O
of	O
three	O
objects	O
at	O
five	O
minutes	O
.	O

There	O
was	O
a	O
touch	O
an	B-problem
anosognosia	I-problem
.	O

Cranial	O
nerve	O
exam	O
:	O

visual	O
fields	O
were	O
full	O
o.s.	O
,	O
visual	B-test
acuity	I-test
was	O
20/70	O
o.s.	O

Pupil	B-test
o.s.	I-test
reacted	O
to	O
light	O
.	O

EOMs	O
with	O
full	O
range	O
of	O
movement	O
,	O
no	O
nystagmus	B-problem
.	O

VIIth	O
cranial	O
nerve	O
:	O

inferior	B-problem
left	I-problem
weak	I-problem
.	O

No	O
gag	B-problem
was	O
present	O
.	O

Otherwise	O
normal	O
CN	O
&apos;s	O
.	O

DTRs	B-test
showed	O
a	O
mild	O
decrease	O
in	O
left	B-problem
biceps	I-problem
and	I-problem
brachioradialis	I-problem
reflexes	I-problem
,	O
otherwise	O
normal	O
tone	O
,	O
symmetrical	O
reflexes	O
,	O
downgoing	O
toes	O
.	O

Motor	O
exam	O
:	O

5+	O
throughout	O
,	O
except	O
left	O
hand	O
intrinsic	O
muscles	O
were	O
4+	O
,	O
3+	O
in	O
the	O
middle	O
digits	O
.	O

No	O
atrophy	B-problem
was	O
noted	O
.	O

Sensory	B-test
exam	I-test
showed	O
some	O
leftsided	B-problem
errors	I-problem
with	O
pinprick	O
and	O
proprioception	O
.	O

Cerebellar	O
exam	O
:	O

finger	B-test
/	I-test
to/nose	I-test
was	O
with	O
mild	B-problem
dysmetria	I-problem
,	O
exaggerated	O
on	O
tracking	O
;	O
rapid	O
alternating	O
movements	O
normal	O
,	O
heel-to-shin	B-test
was	O
good	O
with	O
few	B-problem
errors	I-problem
.	O

LABORATORY	O
DATA	O
:	O

Chest	B-test
xray	I-test
showed	O
expanded	O
lungs	O
with	O
biapical	B-problem
pulmonary	I-problem
opacities	I-problem
.	O

EKG	B-test
:	O

left	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
.	O

Urinalysis	B-test
was	O
unremarkable	O
.	O

BUN	B-test
27	O
,	O
with	O
a	B-test
creatinine	I-test
of	O
.9	O
,	O
glucose	B-test
was	O
182	O
,	O
but	O
otherwise	O
electrolytes	B-test
were	O
normal	O
.	O

Her	B-test
admitting	I-test
hematocrit	I-test
was	O
45%	O
,	O
white	B-test
count	I-test
7,700	O
,	O
with	O
an	B-test
MCV	I-test
of	O
92	O
,	O
platelets	B-test
were	O
normal	O
at	O
263,000	O
.	O

Albumin	B-test
2.5	O
.	O

HOSPITAL	O
COURSE	O
:	O

#	O
1.	O
cerebrovascular	B-problem
accident	I-problem
.	O

The	O
patient	O
suffered	O
some	B-problem
mild	I-problem
weakness	I-problem
which	O
was	O
attributed	O
to	O
stenosis	B-problem
of	I-problem
the	I-problem
distal	I-problem
right	I-problem
internal	I-problem
carotid	I-problem
artery	I-problem
.	O

This	O
was	O
determined	O
by	O
head	B-test
CT	I-test
,	O
head	B-test
MRI	I-test
,	O
head	B-test
MRA	I-test
,	O
carotid	B-test
noninvasive	I-test
studies	I-test
,	O
transcranial	B-test
Dopplers	I-test
.	O

The	O
possibility	O
of	O
a	O
cardiac	O
origin	O
was	O
evaluated	O
by	O
echocardiogram	B-test
and	O
Holter	B-test
monitor	I-test
.	O

Her	B-test
echocardiogram	I-test
curiously	O
showed	O
a	O
normal	O
left	O
ventricular	O
size	O
and	O
systolic	O
function	O
,	O
a	B-problem
patent	I-problem
foramen	I-problem
ovale	I-problem
,	O
with	O
a	B-problem
trace	I-problem
right	I-problem
to	I-problem
left	I-problem
shunt	I-problem
,	O
as	O
determined	O
by	O
bubble	B-test
study	I-test
,	O
trace	B-problem
MR	I-problem
was	O
present	O
.	O

Previous	B-test
echoes	I-test
have	O
shown	O
MVP	B-problem
at	O
the	O
Ona	O
Hospital	O
.	O

Her	B-test
Holter	I-test
showed	O
up	O
to	O
12	O
beats	O
of	O
SVT	B-problem
,	O
but	O
was	O
otherwise	O
unremarkable	O
.	O

The	O
patient	O
had	O
a	O
normal	O
B12	O
,	O
negative	O
syphilis	O
serologies	O
and	O
normal	O
thyroid	O
function	O
during	O
this	O
hospitalization	O
.	O

She	O
was	O
anticoagulated	O
with	O
heparin	B-treatment
and	O
after	O
several	O
days	O
Coumadin	B-treatment
was	O
started	O
.	O

Her	B-treatment
exact	I-treatment
Coumadin	I-treatment
dose	I-treatment
is	O
undetermined	O
at	O
this	O
point	O
,	O
however	O
it	O
looks	O
like	O
it	O
will	O
be	O
something	O
around	O
5	O
mg	O
a	O
day	O
.	O

Her	B-test
pro	I-test
time	I-test
and	O
PTT	B-test
have	O
normalized	O
at	O
the	O
time	O
of	O
discharge	O
.	O

She	O
needs	O
to	O
be	O
given	O
5	O
mg	O
of	O
Coumadin	B-treatment
tonight	O
,	O
5/22/92	O
.	O

In	O
addition	O
heparin	B-treatment
should	O
be	O
started	O
to	O
drip	O
on	O
arrival	O
at	O
400	O
units	O
an	O
hour	O
.	O

It	O
is	O
discontinued	O
at	O
the	O
time	O
of	O
transport	O
.	O

The	O
patient	O
has	O
received	O
physical	B-treatment
therapy	I-treatment
and	O
occupational	B-treatment
therapy	I-treatment
and	O
her	O
recovery	O
is	O
near	O
complete	O
.	O

During	O
evaluation	B-test
of	I-test
her	I-test
neurologic	I-test
status	I-test
,	O
it	O
was	O
determined	O
that	O
for	O
several	O
months	O
prior	O
to	O
admission	O
,	O
the	O
patient	O
has	O
been	O
too	B-problem
unsteady	I-problem
to	I-problem
ambulate	I-problem
.	O

On	B-test
our	I-test
exam	I-test
she	O
is	O
found	O
to	O
have	O
a	O
significant	O
amount	O
of	O
ataxia	B-problem
,	O
especially	O
in	O
the	O
midline	O
and	O
the	O
exact	O
cause	O
of	O
this	O
is	O
unknown	O
.	O

There	O
are	O
multiple	O
possible	O
contributions	O
and	O
this	O
is	O
where	O
her	O
need	O
for	O
careful	B-test
internal	I-test
medical	I-test
evaluation	I-test
has	O
arisen	O
.	O

At	O
the	O
time	O
we	O
were	O
to	O
embark	O
on	O
this	B-test
evaluation	I-test
,	O
the	O
patient	O
&apos;s	O
family	O
strongly	O
requested	O
that	O
she	O
be	O
transferred	O
to	O
the	O
Sas	O
General	O
Hospital	O
.	O

What	O
follows	O
is	O
a	O
summary	O
of	O
her	B-problem
medical	I-problem
problems	I-problem
and	O
their	O
possible	O
relationship	O
to	O
her	B-problem
ataxia	I-problem
.	O

Her	B-problem
ataxia	I-problem
is	O
likely	O
due	O
to	O
some	O
cerebellar	O
function	O
,	O
though	O
this	O
is	O
not	O
certain	O
.	O

Moreover	O
her	B-test
MRI	I-test
did	O
not	O
show	O
any	B-problem
discrete	I-problem
cerebellar	I-problem
lesions	I-problem
.	O

Our	O
leading	O
theory	O
at	O
this	O
point	O
is	O
that	O
her	B-problem
cerebellar	I-problem
dysfunction	I-problem
relates	O
to	O
perineoplastic	B-problem
syndrome	I-problem
,	O
relating	O
to	O
her	O
history	O
of	O
breast	B-problem
Ca	I-problem
.	O

As	O
I	O
mentioned	O
above	O
,	O
her	B-test
evaluation	I-test
was	O
limited	O
by	O
her	O
cardiologic	O
status	O
at	O
the	O
time	O
.	O

While	O
mammogram	B-test
and	O
CA-15.3	B-test
and	O
breast	B-test
exam	I-test
are	O
all	O
normal	O
,	O
the	O
idea	O
of	O
a	B-problem
perineoplastic	I-problem
syndrome	I-problem
with	O
or	O
without	O
concomitant	B-problem
breast	I-problem
Ca	I-problem
has	O
reared	O
its	O
head	O
.	O

Two	O
possible	O
markers	O
are	O
anti-Hu	B-problem
syndrome	I-problem
and	O
anti-Yo	B-test
antibody	I-test
.	O

These	B-test
tests	I-test
were	O
sent	O
on	O
the	O
18th	O
and	O
are	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

The	B-test
results	I-test
can	O
be	O
obtained	O
by	O
paging	O
me	O
,	O
Do	O
A.	O
Joasscchird	O
,	O
M.D.	O
at	O
834-364-2251	O
.	O

I	O
will	O
be	O
happy	O
to	O
furnish	O
the	B-test
results	I-test
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
MI	B-problem
in	O
1989	O
.	O

Echocardiogram	B-test
no	O
longer	O
shows	O
wall	B-problem
motion	I-problem
abnormalities	I-problem
.	O

EKG	B-test
,	O
when	O
the	O
patient	O
goes	O
out	O
of	O
left	B-problem
bundle	I-problem
branch	I-problem
block	I-problem
transiently	O
shows	O
an	B-problem
anterolateral	I-problem
Q/wave	I-problem
inversion	I-problem
.	O

We	O
would	O
like	O
to	O
discontinue	O
her	B-treatment
Isordil	I-treatment
to	O
improve	O
upon	O
some	B-problem
orthostatic	I-problem
hypotension	I-problem
,	O
but	O
we	O
are	O
not	O
certain	O
whether	O
her	O
heart	O
will	O
tolerate	O
this	O
.	O

Persantine	B-test
thallium	I-test
is	O
scheduled	O
at	O
this	O
time	O
,	O
but	O
is	O
yet	O
to	O
be	O
performed	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
orthostatic	B-problem
hypotension	I-problem
x	O
many	O
years	O
.	O

It	O
has	O
been	O
evaluated	O
in	O
the	O
past	O
without	O
success	O
.	O

During	O
her	O
hospitalization	O
,	O
we	O
confirmed	O
the	O
presence	O
of	O
this	O
,	O
even	O
when	O
she	O
was	O
hydrated	O
with	O
saline	B-treatment
,	O
to	O
a	B-test
fractional	I-test
excretion	I-test
of	I-test
sodium	I-test
of	O
2%	O
.	O

Studies	B-test
of	I-test
her	I-test
autonomic	I-test
system	I-test
did	O
not	O
document	O
any	B-problem
dysautonomia	I-problem
.	O

Studies	B-test
of	I-test
skin	I-test
galvanic	I-test
conduction	I-test
were	O
normal	O
and	O
her	B-test
RR	I-test
interval	I-test
evaluation	I-test
was	O
not	O
abnormal	B-problem
.	O

This	O
is	O
a	B-problem
chronic	I-problem
problem	I-problem
but	O
may	O
be	O
contributing	O
to	O
her	B-problem
current	I-problem
weakness	I-problem
and	O
inability	B-problem
to	I-problem
walk	I-problem
.	O

Florinef	B-treatment
is	O
to	O
be	O
considered	O
,	O
however	O
stopping	O
the	B-treatment
Isordil	I-treatment
is	O
one	O
goal	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
bronchiectasis	B-problem
from	O
a	B-problem
childhood	I-problem
pneumonia	I-problem
.	O

In	O
addition	O
there	O
is	O
a	O
distant	O
history	O
of	O
M.	B-problem
kansasaii	I-problem
infection	I-problem
.	O

This	O
has	O
been	O
evaluated	O
by	O
Dr.	O
Screen	O
at	O
Sas	O
General	O
Hospital	O
and	O
probably	O
relates	O
to	O
her	B-test
lung	I-test
xray	I-test
.	O

CT	B-test
at	O
the	O
Ona	O
Hospital	O
in	O
1989	O
showed	O
similar	O
findings	O
.	O

A	B-test
chest	I-test
CT	I-test
was	O
to	O
be	O
performed	O
and	O
may	O
be	O
yielding	O
.	O

A	B-test
PPD	I-test
was	O
placed	O
and	O
is	O
to	O
be	O
read	O
on	O
Saturday	O
,	O
4	O
26th	O
.	O

The	O
left	O
volar	O
forearm	O
has	O
the	B-test
PPD	I-test
just	O
proximal	O
to	O
the	O
wrist	O
crease	O
and	O
a	B-test
candida	I-test
albicans	I-test
placed	O
just	O
distal	O
to	O
the	O
antecubital	O
fossa	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
in	O
1990	O
,	O
for	O
which	O
she	O
received	O
6	O
months	O
of	O
Coumadin	B-treatment
.	O

Dopplers	B-test
of	I-test
her	I-test
lower	I-test
extremities	I-test
were	O
negative	O
on	O
this	O
admission	O
.	O

It	O
is	O
doubtful	O
that	O
she	O
has	O
chronic	B-problem
PE	I-problem
,	O
but	O
this	O
is	O
one	O
consideration	O
.	O

It	O
is	O
likely	O
that	O
she	O
has	O
pulmonary	B-problem
hypertension	I-problem
from	O
her	B-problem
lung	I-problem
disease	I-problem
,	O
and	O
so	O
this	O
is	O
a	O
consideration	O
.	O

The	O
patient	O
had	O
mild	B-problem
hyponatremia	I-problem
during	O
this	O
hospitalization	O
with	O
a	B-test
sodium	I-test
as	O
low	O
as	O
131	O
.	O

We	O
think	O
this	O
is	O
likely	O
due	O
to	O
an	B-problem
SIADH	I-problem
as	O
she	O
is	O
euvolemic	O
.	O

This	O
can	O
be	O
evaluated	O
further	O
and	O
is	O
not	O
a	O
problem	O
at	O
this	O
time	O
.	O

The	O
patient	O
has	O
glaucoma	B-problem
.	O

Her	B-treatment
medications	I-treatment
are	O
as	O
listed	O
below	O
.	O

Her	O
ophthalmologist	O
is	O
aware	O
of	O
transfer	O
.	O

His	O
name	O
is	O
Ettrent	O
Can	O
and	O
he	O
can	O
be	O
reached	O
at	O
678-233-5033	O
,	O
b	O
549	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
:	O

Propanolol	B-treatment
5	O
mg.	O
p.o.	O
t.i.d.	O
[	O
hold	O
for	O
SBP	B-test
less	O
than	O
110	O
]	O
,	O
Isosorbide	B-treatment
5	O
mg.	O
p.o.	O
t.i.d.	O
,	O
hold	O
for	O
SBP	B-test
less	O
than	O
110	O
,	O
Colace	B-treatment
100	O
mg.	O
p.o.	O
b.i.d.	O
Pilocarpine	B-treatment
4%	O
one	O
drop	O
q.i.d.	O
O.D.	O
Pilocarpine	B-treatment
2%	O
one	O
drop	O
b.i.d.	O
O.S.	O
Betasan	B-treatment
0.5%	O
one	O
drop	O
b.i.d.	O
O.D.	O
.	O

Bacitracin	B-treatment
ointment	I-treatment
one	O
drop	O
O.D.	O
q.h.s.	O
Ciprofloxacin	B-treatment
500	O
mg.	O
one	O
p.o.	O
b.i.d.	O
x	O
four	O
more	O
days	O
[	O
until	O
5/25/92	O
]	O
,	O
for	O
recently	B-problem
discovered	I-problem
siderobacter	I-problem
UTI	I-problem
.	O

Coumadin	B-treatment
5	O
mg.	O
p.o.	O
q.h.s.	O

She	O
needs	O
her	B-treatment
dose	I-treatment
on	O
5/22/92	O
.	O

Heparin	B-treatment
i.v.	I-treatment
drip	I-treatment
at	O
400	O
units	O
per	O
hour	O
,	O
on	O
her	O
arrival	O
.	O

In	O
addition	O
the	O
patient	O
requires	O
occupational	B-treatment
therapy	I-treatment
and	O
physical	B-treatment
therapy	I-treatment
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Amoxicillin	B-problem
rash	I-problem
.	O

Small	B-problem
stroke	I-problem
,	O
nearly	O
recovered	O
,	O
likely	O
embolic	B-problem
from	I-problem
carotid	I-problem
artery	I-problem
.	O

Glaucoma	B-problem
,	O
under	O
therapy	B-treatment
,	O
status	O
post	O
laser	B-treatment
surgery	I-treatment
O.D.	I-treatment

Orthostatic	B-problem
hypotension	I-problem
.	O

Ataxia	B-problem
with	O
gait	B-problem
abnormality	I-problem
.	O

History	O
of	O
breast	B-problem
cancer	I-problem
.	O

History	O
of	O
atypical	B-problem
mycobacterial	I-problem
colonization	I-problem
.	O

History	O
of	O
DVT	B-problem
.	O

Hyponatremia	B-problem
.	O

Coronary	B-problem
artery	I-problem
disease	I-problem
with	O
MI	B-problem
in	O
1989	O
.	O

DO	O
JOASSCCHIRD	O
,	O
M.D.	O

TR	O
:	O

zg	O
/	O
bmot	O

DD	O
:	O

5-22-92	O
PAD-WORD	O

TD	O
:	O

05/22/92	O
PAD-WORD	O

CC	O
:	O

MAVIC	O
WORD	O
,	O
M.D.	O
and	O
TOMEDANKELL	O
EAR	O
M.D.	O
,	O
DEPT	O
OF	O
NEUROLOGY	O
.	O

LYNA	O
CAN	O
,	O
M.D.	O
DIVISION	O
OF	O
PULMONARY	O
MEDICINE	O
,	O
JEANES	O
CLINIC	O
,	O
Apem	O
and	O
ETTRENT	O
CAN	O
,	O
C	O
/	O
O	O
Valtawnprinceel	O
Community	O
Memorial	O
Hospital	O

Admission	O
Date	O
:	O

2013-10-27	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2013-11-03	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1971-05-13	O
PAD-WORD	O

Sex	O
:	O

F	O
PAD-WORD	O

Service	O
:	O

MEDICINE	B-treatment
PAD-WORD	O

Allergies	O
:	O

Morphine	B-treatment
/	O
Latex	B-treatment

Attending	O
:	O
Everett	O
J.	O
Decardo	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

GIB	B-problem
,	O
hematemesis	B-problem

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

EGD	B-test
with	O
esophageal	B-treatment
varices	I-treatment
sclerosis	I-treatment

History	O
of	O
Present	O
Illness	O
:	O

42	O
year	O
old	O
female	O
with	O
h/o	O
cholangiocarcinoma	B-problem
dx	O
in	O
2009	O
s/p	O
resection	B-treatment
,	O
with	O
recent	B-test
CT	I-test
showing	O
met	B-problem
cholangiocarcinoma	I-problem
in	O
9/2004	O
.	O

Pt	O
was	O
recently	O
admitted	O
for	O
fever	B-problem
due	O
to	O
cholangitis	B-problem
on	O
10-18	O
and	O
had	O
chemo	B-treatment
(	O
CDDP	B-treatment
and	O
Gemcitabine	B-treatment
)	O
on	O
Monday	O
,	O
10-21	O
.	O

Since	O
chemo	B-treatment
pt	O
has	O
intermittent	B-problem
nausea	I-problem
adequately	O
controlled	O
by	O
zofran	B-treatment
and	O
compazine	B-treatment
.	O

Pt	O
was	O
doing	O
well	O
till	O
night	O
of	O
admission	O
when	O
she	O
developed	O
nausea	B-problem
/	O
vomitting	B-problem
and	O
sizable	O
amount	O
of	O
hemoptysis	B-problem
and	O
clots	B-problem
.	O

Has	O
low	B-problem
grade	I-problem
fever	I-problem
since	O
chemo	B-treatment
but	O
otherwise	O
ROS	B-test
was	O
neg	O
for	O
shaking	B-problem
chills	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
SOB	B-problem
,	O
coughing	B-problem
,	O
constipation	B-problem
,	O
diarrhea	B-problem
,	O
tarry	B-problem
stools	I-problem
,	O
abd	B-problem
pain	I-problem
.	O

Pt	O
has	O
reported	O
gaining	O
30	O
lbs	O
since	O
08-31	O
due	O
to	O
ascites	B-problem
.	O

In	O
Monica	O
:	O
vitals	B-test
:	O
T	B-test
98.8	O
P	B-test
98	O
BP	B-test
136/68	O
R	B-test
29	O
Sat	B-test
98%	O
RAPt	O
had	O
NG	B-treatment
lavage	I-treatment
which	O
evantually	O
cleared	O
up	O
,	O
also	O
was	O
transfused	O
1U	B-treatment
PRBC	I-treatment
,	O
GI	O
consult	O
called	O
,	O
also	O
got	O
zofran	B-treatment
and	O
iv	B-treatment
protonix	I-treatment
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Ca	O
Hx-Klatskin	B-problem
tumor	I-problem
originally	O
diagnosed	O
2010-08-28	O
after	O
presenting	O
with	O
painless	B-problem
jaundice	I-problem
.	O

2010-10-01	O
pt	O
underwent	O
ex.	B-test
lap	I-test
with	O
en	B-treatment
bloc	I-treatment
resection	I-treatment
of	I-treatment
L	I-treatment
liver	I-treatment
lobe	I-treatment
,	I-treatment
biliary	I-treatment
tree	I-treatment
,	I-treatment
and	I-treatment
portal	I-treatment
vein	I-treatment
.	O

Reconstructed	B-treatment
portal	I-treatment
vein	I-treatment
followed	O
by	O
Roux-en-Y	B-treatment
hepaticojejunostomy	I-treatment
.	O

Per	O
notes	O
,	O
pathology	B-test
demonstrated	O
biliary	B-problem
ductal	I-problem
adenocarcinoma	I-problem
(	O
T3N0M0	B-problem
)	O
stage	O
Margit	O
.	O

Since	O
presentation	O
,	O
patient	O
had	O
multiple	O
episodes	O
of	O
cholangitis	B-problem
(	O
08-06	O
in	O
past	O
3	O
years	O
with	O
last	O
on	O
10-18	O
),	O
always	O
short	O
lived	O
and	O
treated	O
with	O
antimicrobial	B-treatment
therapy	I-treatment
.	O

She	O
has	O
been	O
on	O
ciprofloxacin	B-treatment
proph	I-treatment
for	O
about	O
1	O
year	O
.	O

Followed	O
with	O
yearly	B-test
abdominal	I-test
CT	I-test
without	O
radiographic	B-problem
progression	I-problem
.	O

CAT	B-test
scan	I-test
was	O
performed	O
on	O
2013-09-20	O
at	O
Kindred	O
Park	O
View	O
Specialty	O
Hospital	O
of	O
Springfield	O
,	O
which	O
revealed	O
that	O
she	O
had	O
a	B-problem
recurrence	I-problem
of	I-problem
the	I-problem
tumor	I-problem
with	O
occlusion	B-problem
of	I-problem
her	I-problem
portal	I-problem
vein	I-problem
occluding	B-problem
bile	I-problem
ducts	I-problem
,	O
hepatic	B-problem
artery	I-problem
nearly	I-problem
completely	I-problem
occluded	I-problem
,	O
and	O
much	B-problem
ascites	I-problem
and	O
was	O
started	O
on	O
diuretics	B-treatment
.	O

She	O
was	O
was	O
seen	O
at	O
Hallmark	O
Health	O
System	O
heme	O
/	O
on	O
clinic	O
10-09	O
and	O
had	O
repeat	B-test
CT	I-test
scan	I-test
which	O
revealed	O
metastatic	B-problem
cholangiocarcinoma	I-problem
with	O
mets	B-problem
to	I-problem
the	I-problem
ovaries	I-problem
,	O
with	O
tremendous	B-problem
increase	I-problem
in	I-problem
metastatic	I-problem
disease	I-problem
.	O

There	O
was	O
there	O
was	O
obstructive	B-problem
uropathy	I-problem
on	I-problem
the	I-problem
right	I-problem
side	I-problem
,	O
as	O
well	O
as	O
questionable	O
gastric	B-problem
outlet	I-problem
obstruction	I-problem
and	O
peritoneal	B-problem
carcinomatosis	I-problem
.	O

2.	O
cholecystectomy	B-treatment
at	O
age	O
25	O

3.	O
MVA-multiple	B-treatment
orthopedic	I-treatment
procedures	I-treatment

4.	O
Strabismus	B-problem

Social	O
History	O
:	O

She	O
is	O
a	O
nurse	O
Damian	O
Mary	O
Lane	O
Hospital	O
.	O

She	O
denies	O
any	O
alcohol	O
,	O
drugs	O
or	O
tobacco	O
.	O

She	O
lives	O
in	O
Tobey	O
Hospital	O
with	O
her	O
mom	O
.	O

She	O
is	O
single	O
,	O
no	O
children	O
.	O

Family	O
History	O
:	O

Her	O
maternal	O
grandmother	O
had	O
breast	B-problem
cancer	I-problem
in	O
her	O
80	O
s	O
and	O
her	O
dad	O
's	O
grandmother	O
had	O
stomach	B-problem
cancer	I-problem
and	O
died	O
in	O
her	O
50	O
s.	O

On	O
her	O
mom	O
's	O
side	O
is	O
an	B-problem
extensive	I-problem
family	I-problem
cardiac	I-problem
history	I-problem
.	O

Physical	O
Exam	O
:	O

VITAL	B-test
:	O
afebrile	B-problem
,	O
96	O
,	O
108/51	O
,	O
O2sat99%RA	B-test

GENERAL	O
:	O
pleasant	O
female	O
in	O
no	O
apparent	B-problem
distress	I-problem
,	O
jaundiced	B-problem
skin	I-problem
.	O

HEENT	O
:	O
sclera	B-problem
icteric	I-problem
,	O
OP	O
clear	O
,	O
EOMI	O
,	O
PERRL	O
.	O

NECK	O
:	O
Supple	O
.	O

NODES	O
:	O
No	O
supraclavicular	B-problem
,	I-problem
submandibular	I-problem
,	I-problem
axillary	I-problem
or	I-problem
inguinal	I-problem
lymphadenopathy	I-problem
.	O

LUNGS	O
:	O
Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

HEART	O
:	O
Regular	O
rate	O
,	O
s1	O
s2	O
.	O

ABDOMEN	O
:	O
soft	O
and	O
distended	B-problem
,	O
but	O
no	O
actual	B-problem
tenderness	I-problem
.	O

Guaiac	B-test
neg	O
by	O
Monica	O

BACK	O
:	O
No	O
CVA	B-problem
tenderness	I-problem
.	O

EXTREMITIES	O
:	O
No	O
clubbing	B-problem
,	O
cyanosis	B-problem
,	O
but	O
+	O
edema	B-problem
.	O

Pertinent	O
Results	O
:	O

2013-10-27	O
01:30	O
AM	O

GLUCOSE	B-test
-	O
112	O
*	O
UREA	B-test
N	I-test
-	O
14	O
CREAT	B-test
-	O
0.8	O
SODIUM	B-test
-	O
133	O
POTASSIUM	B-test
-	O
4.0	O
CHLORIDE	B-test
-	O
97	O
TOTAL	B-test
CO2	I-test
-	O
23	O
ANION	B-test
GAP	I-test
-	O
17	O

2013-10-27	O
01:30	O
AM	O

ALT(SGPT)	B-test
-	O
149	O
*	O
AST(SGOT)	B-test
-	O
83	O
*	O
ALK	B-test
PHOS	I-test
-	O
663	O
*	O
AMYLASE	B-test
-	O
37	O
TOT	B-test
BILI	I-test
-	O
8.2	O
*	O

2013-10-27	O
01:30	O
AM	O

LIPASE	B-test
-	O
42	O

2013-10-27	O
01:30	O
AM	O

IRON	B-test
-	O
52	O

2013-10-27	O
01:30	O
AM	O

calTIBC	B-test
-	O
230	O
*	O
FERRITIN	B-test
-	O
197	O
*	O
TRF	B-test
-	O
177	O
*	O

2013-10-27	O
01:30	O
AM	O

WBC	B-test
-	O
3.0	O
*	O
RBC	B-test
-	O
2.25	O
*	O
HGB	B-test
-	O
7.2	O
*	O
HCT	B-test
-	O
20.9	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
31.8	O
MCHC	B-test
-	O
34.3	O
RDW	B-test
-	O
14.7	O

2013-10-27	O
01:30	O
AM	O

NEUTS	B-test
-	O
79.7	O
*	O
BANDS	B-test
-	O
0	O
LYMPHS	B-test
-	O
13.3	O
*	O
MONOS	B-test
-	O
4.6	O
EOS	B-test
-	O
2.2	O
BASOS	B-test
-	O
0.2	O

2013-10-27	O
01:30	O
AM	O

HYPOCHROM	B-test
-	O
1+	O
ANISOCYT	B-test
-	O
NORMAL	O
POIKILOCY	B-test
-	O
1+	O
MACROCYT	B-test
-	O
NORMAL	O
MICROCYT	B-test
-	O
NORMAL	O
POLYCHROM	B-test
-	O
NORMAL	O
OVALOCYT	B-test
-	O
1+	O

2013-10-27	O
01:30	O
AM	O

PLT	B-test
COUNT	I-test
-	O
88	O
*	O

2013-10-27	O
01:30	O
AM	O

PT	B-test
-	O
13.4	O
PTT	B-test
-	O
25.9	O
INR(PT)	B-test
-	O
1.1	O

2013-10-27	O
01:30	O
AM	O

RET	B-test
AUT	I-test
-	O
0.3	O
*	O

2013-10-27	O
01:30	O
AM	O
URINE	B-test

COLOR	B-test
-	O
Amber	O
APPEAR	B-test
-	O
SlHazy	O
SP	B-test
Barajas	I-test
-	O
1.025	O

2013-10-27	O
01:30	O
AM	O
URINE	B-test

BLOOD	B-test
-	O
NEG	O
NITRITE	B-test
-	O
POS	O
PROTEIN	B-test
-	O
30	O
GLUCOSE	B-test
-	O
NEG	O
KETONE	B-test
-	O
TR	O
BILIRUBIN	B-test
-	O
LG	O
UROBILNGN	B-test
-	O
0.2	O
PH	B-test
-	O
5.5	O
LEUK	B-test
-	O
NEG	O

2013-10-27	O
01:30	O
AM	O
URINE	B-test

RBC	B-test
-	O
0-2	O
WBC	B-test
-	O
0-2	O
BACTERIA	B-test
-	O
MOD	O
YEAST	B-test
-	O
NONE	O
EPI	B-test
-	O
03-01	O
RENAL	B-test
EPI	I-test
-	O
0-2	O

2013-10-27	O
01:30	O
AM	O
URINE	B-test

HYALINE	B-test
-	O
0-2	O

CT	B-test
abd	I-test
on	O
2013-10-17	O
showed	O
:	O

1.	O
Recurrent	B-problem
cholangiocarcinoma	I-problem
,	O
with	O
intrahepatic	B-problem
bile	I-problem
duct	I-problem
dilatation	I-problem
and	O
gastric	B-problem
outlet	I-problem
obstruction	I-problem
;	O
exact	O
extent	O
of	O
disease	B-problem
is	O
unclear	O
,	O
but	O
likely	O
extensive	O
.	O

No	O
evidence	O
of	O
portal	B-problem
hypertension	I-problem
is	O
seen	O
.	O

2.	O
Large	B-problem
,	I-problem
cystic	I-problem
,	I-problem
multiseptated	I-problem
mass	I-problem
arising	O
from	O
the	O
adnexa	O
,	O
worrisome	O
for	O
second	B-problem
primary	I-problem
malignancy	I-problem
.	O

3.	O
Ascites	B-problem
,	O
and	O
intraperitoneal	B-problem
carcinomatosis	I-problem
,	O
which	O
can	O
arise	O
from	O
either	O
of	O
the	O
two	O
processes	O
described	O
above	O
.	O

4.	O
Hiatal	B-problem
hernia	I-problem
.	O

2013-11-03	O
07:30	O
AM	O

BLOOD	B-test
WBC	B-test
-	O
2.2	O
*	O
RBC	B-test
-	O
3.09	O
*	O
Hgb	B-test
-	O
9.6	O
*	O
Hct	B-test
-	O
28.7	O
*	O
MCV	B-test
-	O
93	O
MCH	B-test
-	O
31.2	O
MCHC	B-test
-	O
33.6	O
RDW	B-test
-	O
17.0	O
*	O
Plt	B-test
Ct	I-test
-	O
89	O
*	O

2013-10-31	O
06:00	O
AM	O

BLOOD	B-test
Neuts	I-test
-	O
89.7	O
*	O
Bands	B-test
-	O
0	O
Lymphs	B-test
-	O
6.9	O
*	O
Monos	B-test
-	O
2.6	O
Eos	B-test
-	O
0.2	O
Baso	B-test
-	O
0.7	O

2013-11-03	O
07:30	O
AM	O

BLOOD	B-test
PT	I-test
-	O
15.2	O
*	O
PTT	B-test
-	O
29.7	O
INR(PT)	B-test
-	O
1.5	O

2013-11-03	O
07:30	O
AM	O

BLOOD	B-test
Glucose	B-test
-	O
117	O
*	O
UreaN	B-test
-	O
11	O
Creat	B-test
-	O
0.9	O
Na	B-test
-	O
135	O
K	B-test
-	O
3.5	O
Cl	B-test
-	O
97	O
HCO3	B-test
-	O
28	O
AnGap	B-test
-	O
14	O

2013-11-03	O
07:30	O
AM	O

BLOOD	B-test
AlkPhos	B-test
-	O
431	O
*	O
TotBili	B-test
-	O
7.8	O
*	O

2013-11-03	O
07:30	O
AM	O

BLOOD	B-test
Calcium	B-test
-	O
8.3	O
*	O
Phos	B-test
-	O
3.5	O
Mg	B-test
-	O
1.9	O

2013-10-27	O
01:30	O
AM	O

BLOOD	B-test
calTIBC	B-test
-	O
230	O
*	O
Ferritn	B-test
-	O
197	O
*	O
TRF	B-test
-	O
177	O
*	O

Brief	O
Hospital	O
Course	O
:	O

1)	O
GI	O
-	O
In	O
the	O
Monica	O
pt	O
had	O
Hct	B-test
of	O
20	O
and	O
bloody	B-problem
NG	I-problem
lavage	I-problem
which	O
did	O
not	O
clear	O
.	O

She	O
was	O
transfused	O
1U	B-treatment
PRBC	I-treatment
,	O
GI	O
consult	O
called	O
,	O
also	O
got	O
zofran	B-treatment
and	O
iv	B-treatment
protonix	I-treatment
and	O
admitted	O
to	O
the	O
FICU	O
.	O

On	O
arrival	O
to	O
unit	O
pt	O
had	O
EGD	B-test
which	O
revealed	O
grade	B-problem
III	I-problem
esophageal	I-problem
varices	I-problem
with	O
signs	O
of	O
old	B-problem
bleeding	I-problem
.	O

She	O
was	O
started	O
on	O
octreotide	B-treatment
and	O
nadolol	B-treatment
to	O
control	O
portal	B-problem
htn	I-problem
.	O

Pt	O
was	O
stable	O
and	O
had	O
appropriate	O
Hct	B-problem
bump	I-problem
to	O
25	O
after	O
2U	B-treatment
PRBC	I-treatment
's.	I-treatment

She	O
also	O
had	O
climbing	B-problem
bilirubin	I-problem
and	O
low	B-problem
grade	I-problem
temp	I-problem
and	O
was	O
started	O
on	O
Zosyn	B-treatment
for	O
suspected	O
biliary	B-problem
obstruction	I-problem
and	O
ascending	B-problem
cholangitis	I-problem
coverage	O
.	O

She	O
was	O
rescoped	O
on	O
10-28	O
and	O
varices	B-problem
were	O
sclerosed	O
(	O
no	O
banding	B-treatment
due	O
to	O
latex	B-problem
allergy	I-problem
)	O
and	O
diuretics	B-treatment
of	O
lasix	B-treatment
and	O
aldactone	B-treatment
were	O
readded	O
for	O
ascites	B-problem
since	O
BP	B-test
stable	O
.	O

10-29	O
she	O
was	O
transfused	O
another	O
3U	B-treatment
PRBC	I-treatment
's	I-treatment
with	O
hct	B-problem
bump	I-problem
to	O
31.9	O
and	O
antibiotic	B-treatment
coverage	I-treatment
broadend	O
to	O
Unasyn	B-treatment
,	O
Ceftriaxone	B-treatment
,	O
Flagyl	B-treatment
because	O
she	O
continued	O
to	O
spike	O
,	O
and	O
for	O
SBP	B-treatment
prophylaxis	I-treatment
.	O

Preprocedure	O
of	O
PTC	B-test
on	O
10-30	O
she	O
was	O
transfused	O
1	B-treatment
unit	I-treatment
PRBC	I-treatment
's,	I-treatment
2	B-treatment
platelets	I-treatment
and	O
2U	B-treatment
FFP	I-treatment
and	O
procedure	B-test
went	O
without	O
complication	B-problem
.	O

ON	O
transfer	O
to	O
the	O
floor	O
she	O
remained	O
hemodynamically	O
stable	O
with	O
stable	O
Hct	O
and	O
declining	B-problem
bilirubin	I-problem
.	O

She	O
remained	O
afebrile	B-problem
so	O
on	O
11-02	O
antibiotic	B-treatment
regimen	I-treatment
was	O
weaned	O
to	O
only	O
levofloxacin	B-treatment
.	O

Liver	O
teams	O
recommended	O
to	O
repeat	B-test
EGD	I-test
with	O
non	B-treatment
latex	I-treatment
banding	I-treatment
in	O
7-10	O
days	O
.	O

She	O
also	O
went	O
home	O
on	O
naldolol	B-treatment
20	O
mg	O
qd	O
for	O
portal	B-problem
htn	I-problem
,	O
and	O
her	B-treatment
home	I-treatment
doses	I-treatment
of	O
diuretics	B-treatment
to	O
control	O
her	B-problem
ascites	I-problem
.	O

2.	O
US	B-test
finding	O
-	O
Pt	O
was	O
incidentally	O
found	O
to	O
have	O
R	B-problem
hydronephrosis	I-problem
and	O
a	B-problem
R	I-problem
adenexal	I-problem
mass	I-problem
on	O
her	B-test
US	I-test
.	O

The	B-problem
hydronephrosis	I-problem
was	O
likely	O
caused	O
by	O
blockage	B-problem
by	O
her	B-problem
tumor	I-problem
.	O

Given	O
her	O
disease	O
prognosis	O
and	O
the	O
fact	O
that	O
her	O
other	O
kidney	O
is	O
functioning	O
well	O
,	O
no	O
intervention	B-treatment
was	O
done	O
.	O

Also	O
the	B-problem
adenexal	I-problem
mass	I-problem
may	O
represent	O
a	B-problem
second	I-problem
primary	I-problem
maligancy	I-problem
.	O

This	O
was	O
seen	O
on	O
a	B-test
prior	I-test
CT	I-test
scan	I-test
and	O
her	O
oncologist	O
is	O
aware	O
.	O

Again	O
given	O
the	B-problem
patient	I-problem
's	I-problem
poor	I-problem
disease	I-problem
prognosis	I-problem
,	O
there	O
was	O
no	O
intervention	B-treatment
made	O
at	O
this	O
time	O
.	O

Medications	O
on	O
Admission	O
:	O

MEDICATIONS	O
:	O
She	O
is	O
on	O
Lasix	B-treatment
40	O
mg	O
p.o.	O
b.i.d.	O
,	O
Aldactone	B-treatment
25	O
mg	O
p.o.	O
b.i.d.	O
,	O
Prilosec	B-treatment
20	O
mg	O
p.o.	O
daily	O
,	O
ciprofloxacin	B-treatment
250	O
mg	O
p.o.	O
daily	O
,	O
this	O
is	O
for	O
prophylaxis	B-treatment
for	O
cholangitis	B-problem
and	O
iron	B-treatment
.	O

Discharge	O
Medications	O
:	O

1.	O
Pantoprazole	B-treatment
Sodium	I-treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

Disp	O
:*	O
60	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Furosemide	B-treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Spironolactone	B-treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Levofloxacin	B-treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Ursodiol	B-treatment
300	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
90	O
Capsule	O
(s)*	O
Refills	O
:*	O
2	O
*	O

6.	O
Prochlorperazine	B-treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Nystatin	B-treatment
100,000	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
mL	O
PO	O
four	O
times	O
a	O
day	O
:	O
Swish	O
and	O
swallow	O
.	O

Disp	O
:*	O
qs	O
mL	O
*	O
Refills	O
:*	O
2	O
*	O

8.	O
Nadolol	B-treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Outpatient	O
Lab	O
Work	O

Please	O
have	O
CBC	B-test
and	O
alkaline	B-test
phosphatase	I-test
and	O
total	B-test
bilirubin	I-test
checked	O
on	O
Monday	O
11-04	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Cholangiocarcinoma	B-problem
PAD-WORD	O

Biliary	B-problem
obstruction	I-problem

Grade	B-problem
III	I-problem
esophageal	I-problem
varices	I-problem

Discharge	O
Condition	O
:	O

Stable	O
.	O

Discharge	O
Instructions	O
:	O

Call	O
your	O
primary	O
care	O
doctor	O
,	O
oncologist	O
,	O
or	O
return	O
to	O
the	O
Emergency	O
Room	O
if	O
you	O
have	O
increasing	B-problem
nausea	I-problem
,	O
vomiting	B-problem
,	O
leg	B-problem
swelling	I-problem
,	O
confusion	B-problem
,	O
or	O
pain	B-problem
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
at	O
all	O
scheduled	O
appointments	O
including	O
Wednesday	O
in	O
IR	O
clinic	O
.	O

Call	O
the	O
IR	O
clinic	O
on	O
Monday	O
to	O
confirm	O
your	O
appointment	O
:	O
(	O
236	O
)	O
672	O
0628	O
.	O

Ask	O
to	O
speak	O
with	O
May	O
Chen	O
,	O
PA.	O

Call	O
your	O
primary	O
care	O
doctor	O
Joanne	O
Dennen	O
for	O
follow	O
up	O
appointments	O
.	O

You	O
will	O
have	O
a	B-treatment
banding	I-treatment
procedure	I-treatment
in	O
9	O
days	O
.	O

Please	O
call	O
the	O
GI	O
clinic	O
and	O
arrange	O
to	O
see	O
Dr.	O
Langton	O
for	O
an	O
appointment	O
:	O
232-2590	O
.	O

Ronald	O
Donna	O
MD	O
19-658	O

Completed	O
by	O
:	O
Neal	O
Robert	O
MD	O
12-904	O
2013-11-04	O
@	O
1405	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Wilson	O
J.	O
Sanchez	O
on	O
:	O
WED	O
2013-11-13	O
9:05	O
AM	O

(	O
End	O
of	O
Report	O
)	O

858462183	O
PAD-WORD	O

SH	O
PAD-WORD	O

20464340	O
PAD-WORD	O

11/3/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

11/03/1993	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

11/07/1993	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

1.	O
MYELODYSPLASTIC	B-problem
SYNDROME	I-problem
WITH	O
SYMPTOMATIC	B-problem
ANEMIA	I-problem

OTHER	O
DIAGNOSES	O
:	O

2.	O
RHEUMATOID	B-problem
ARTHRITIS	I-problem

3.	O
DIABETES	B-problem
MELLITUS	I-problem

4.	O
HISTORY	O
OF	O
MULTIPLE	B-problem
FOCAL	I-problem
ATRIAL	I-problem
TACHYCARDIA	I-problem

5.	O
CONGESTIVE	B-problem
HEART	I-problem
FAILURE	I-problem
WITH	O
DILATED	B-problem
CARDIOMYOPATHY	I-problem
,	O
EJECTION	B-test
FRACTION	I-test
OF	O
30%	O

6.	O
CORONARY	B-problem
ARTERY	I-problem
DISEASE	I-problem

7.	O
CHRONIC	B-problem
BRONCHIECTASIS	I-problem
ON	O
HOME	B-treatment
O2	I-treatment

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
69-year-old	O
male	O
with	O
multiple	B-problem
medical	I-problem
problems	I-problem
and	O
known	B-problem
transfusion	I-problem
dependent	I-problem
secondary	O
to	O
myelodysplastic	B-problem
syndrome	I-problem
admitted	O
with	O
decreased	B-problem
hematocrit	I-problem
.	O

The	O
patient	O
has	O
had	O
multiple	O
previous	O
admissions	O
for	O
cardiac	B-problem
and	I-problem
pulmonary	I-problem
disease	I-problem
.	O

He	O
has	O
had	O
chronic	B-problem
anemia	I-problem
since	O
1990	O
,	O
but	O
a	B-test
bone	I-test
marrow	I-test
biopsy	I-test
in	O
07-92	O
,	O
was	O
consistent	O
with	O
myelodysplastic	B-problem
syndrome	I-problem
.	O

Over	O
the	O
past	O
several	O
months	O
,	O
the	O
patient	O
has	O
had	O
increasing	B-problem
transfusing	I-problem
requirements	I-problem
.	O

His	B-treatment
transfusions	I-treatment
have	O
been	O
complicated	O
by	O
fluid	B-problem
overload	I-problem
and	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
secondary	O
to	O
ischemia	B-problem
cardiomyopathy	I-problem
.	O

His	O
last	O
admission	O
was	O
9-14-93	O
,	O
for	O
a	B-treatment
transfusion	I-treatment
without	O
complications	B-problem
,	O
and	O
prior	O
to	O
admission	O
the	O
patient	O
reports	O
having	O
several	O
days	O
of	O
increasing	B-problem
weakness	I-problem
,	O
dizziness	B-problem
and	O
fatigue	B-problem
.	O

His	O
wife	O
says	O
his	O
hands	O
and	O
lips	O
have	O
been	O
blue	O
.	O

Apparently	O
,	O
he	O
had	O
had	O
a	B-problem
low	I-problem
hematocrit	I-problem
as	O
an	O
outpatient	O
and	O
was	O
checked	O
two	O
weeks	O
prior	O
to	O
admission	O
but	O
was	O
not	O
given	O
transfusion	B-treatment
because	O
the	O
patient	O
did	O
not	O
want	O
to	O
come	O
in	O
at	O
that	O
time	O
.	O

Aside	O
from	O
the	O
above	O
,	O
the	O
patient	O
had	O
felt	O
that	O
baseline	O
without	O
fever	B-problem
and	O
chills	B-problem
or	O
change	B-problem
in	I-problem
chronic	I-problem
cough	I-problem
.	O

He	O
had	O
no	O
increase	O
in	O
his	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
symptoms	I-problem
,	O
no	O
chest	B-problem
pain	I-problem
,	O
and	O
no	O
hemoptysis	B-problem
or	O
changed	O
in	O
arthritis	B-problem
.	O

The	O
patient	O
did	O
report	O
taking	O
a	B-treatment
po	I-treatment
antibiotic	I-treatment
(	I-treatment
Ciprofloxacin	I-treatment
)	I-treatment
for	O
right	B-problem
great	I-problem
toe	I-problem
infection	I-problem
(	O
question	O
of	O
cellulitis	B-problem
vs.	O
paronychia	B-problem
)	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Myelodysplastic	B-problem
syndrome	I-problem
.	O

2.	O
Coronary	B-problem
artery	I-problem
disease	I-problem
/	O
ischemiccardiomyopathy	B-problem
with	O
ejection	B-test
fraction	I-test
of	O
30%	O
.	O

3.	O
History	O
of	O
MAT	B-problem
for	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
/	O
chronic	B-problem
bronchi	I-problem
ectasis	I-problem
,	O
on	O
home	B-treatment
oxygen	I-treatment
.	O

4.	O
Non	B-problem
insulin	I-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

5.	O
Rheumatoid	B-problem
arthritis	I-problem
.	O

6.	O
History	O
of	O
alcohol	O
abuse	O
.	O

7.	O
History	O
of	O
peptic	B-problem
ulcer	I-problem
disease	I-problem
.	O

8.	O
Cataracts	B-problem
,	O
status	O
post	O
bilateral	B-treatment
repair	I-treatment
.	O

9.	O
C3	B-problem
radiculopathy	I-problem
.	O

10.	O
Psoriasis	B-problem
.	O

11.	O
History	O
of	O
hemoptysis	B-problem
,	O
on	O
Coumadin	B-treatment
.	O

12.	O
Status	O
post	O
TURP	B-treatment
.	O

ALLERGIES	O
:	O

Quinine	B-treatment
,	O
Quinidine	B-treatment
,	O
Bactrim	B-treatment
,	O
Plaquenil	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
a	O
50	O
pack	O
year	O
history	O
of	O
tobacco	O
and	O
quit	O
10	O
years	O
ago	O
;	O
also	O
,	O
a	O
history	O
of	O
ethanol	O
abuse	O
.	O

Still	O
drinks	O
occasionally	O
.	O

The	O
patient	O
lives	O
with	O
his	O
wife	O
and	O
is	O
a	O
retired	O
sardine	O
packer	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Temperature	B-test
98.8	O
;	O
heart	B-test
rate	I-test
88-120	O
and	O
irregular	B-problem
;	O
blood	B-test
pressure	I-test
118/78	O
;	O
O2	B-test
saturation	I-test
96%	O
on	O
2	B-treatment
liters	I-treatment
.	O

HEENT	O
:	O

Bilateral	B-problem
cataracts	I-problem
;	O
neck	O
appeared	O
to	O
be	O
somewhat	B-problem
asymmetric	I-problem
thyroid	I-problem
with	O
small	B-problem
nodule	I-problem
barely	O
palpable	O
on	O
the	O
left	O
lobe	O
with	O
the	O
thyroid	O
,	O
otherwise	O
negative	O
.	O

No	O
lymphadenopathy	B-problem
was	O
palpated	O
.	O

Lungs	O
:	O

Rales	B-problem
1/3	O
of	O
the	O
way	O
upbilaterally	O
.	O

Cardiovascular	B-test
examination	I-test
revealed	O
jugular	B-problem
venous	I-problem
distention	I-problem
at	O
12	O
cm	O
,	O
no	O
carotid	B-problem
bruits	I-problem
,	O
heart	B-test
rate	I-test
was	O
tachycardic	B-problem
and	O
regular	O
,	O
normal	O
S1	O
and	O
S2	O
,	O
palpable	B-problem
S4	I-problem
,	O
no	O
murmur	B-problem
was	O
auscultated	O
.	O

Abdominal	O
examination	O
:	O

Obese	B-problem
,	O
soft	O
,	O
non-tender	B-problem
,	O
bowel	O
sounds	O
were	O
present	O
.	O

Rectal	O
examination	O
:	O

Heme	B-test
negative	O
.	O

Extremities	O
:	O

Joint	B-problem
deformities	I-problem
consistent	O
with	O
rheumatoid	B-problem
arthritis	I-problem
,	O
right	O
MTP	O
/	O
toe	O
with	O
minimal	B-problem
erythema	I-problem
.	O

Skin	O
examination	O
:	O

Diffuse	B-problem
psoriasis	I-problem
over	I-problem
trunk	I-problem
and	I-problem
arms	I-problem
.	O

Neurological	B-test
examination	I-test
was	O
non-focal	O
.	O

LABORATORY	O
DATA	O
:	O

SMA-7	B-test
was	O
unremarkable	O
aside	O
form	O
a	B-test
creatinine	I-test
of	O
1.6	O
and	O
a	B-test
glucose	I-test
of	O
207	O
;	O
otherwise	O
,	O
was	O
within	O
normal	O
limits	O
.	O

Hematocrit	B-test
was	O
22.4	O
;	O
white	B-test
count	I-test
.59	O
;	O
platelets	B-test
84.	O

The	O
patient	O
had	O
an	B-problem
absolute	I-problem
neutropenia	I-problem
with	O
a	B-test
ANC	I-test
of	O
318	O
;	O
differential	B-test
revealed	O
48	O
segs	B-test
,	O
6	O
bands	B-test
,	O
40	O
lymphs	B-test
,	O
4	O
monos	B-test
.	O

Digoxin	B-test
level	I-test
was	O
1.4	O
.	O

Theo-Dur	B-test
level	I-test
was	O
15	O
.	O

PT	B-test
was	O
12.5	O
;	O
PTT	B-test
27.0	O
.	O

Urinalysis	B-test
was	O
within	O
normal	O
limits	O
.	O

Chest	B-test
x-ray	I-test
showed	O
enlarged	B-problem
heart	I-problem
with	O
mild	B-problem
pulmonary	I-problem
vascular	I-problem
redistribution	I-problem
,	O
no	O
gross	B-problem
congestive	I-problem
heart	I-problem
failure	I-problem
was	O
noted	O
.	O

EKG	B-test
showed	O
question	O
of	O
MAT	B-problem
vs.	O
atrial	B-problem
fibrillation	I-problem
with	O
a	B-test
ventricular	I-test
response	I-test
of	O
118	O
,	O
axis	B-test
was	O
0	O
degrees	O
.	O

There	O
was	O
ST	B-problem
scooping	I-problem
in	O
the	O
lateral	O
leads	O
consistent	O
with	O
Dig	B-treatment
vs.	O
a	O
question	O
of	O
chronic	B-problem
ischemia	I-problem
changes	I-problem
.	O

There	O
was	O
no	O
significant	B-problem
change	I-problem
from	O
his	B-test
baseline	I-test
EKG	I-test
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
placed	O
in	O
isolation	B-treatment
on	O
neutropenic	B-treatment
precautions	I-treatment
.	O

He	O
was	O
transfused	O
with	O
1/2	B-treatment
units	I-treatment
of	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
and	O
given	O
Lasix	B-treatment
periodically	O
to	O
prevent	O
him	O
from	O
going	O
into	O
congestive	B-problem
heart	I-problem
failure	I-problem
has	O
he	O
had	O
on	O
his	B-treatment
prior	I-treatment
transfusion	I-treatment
.	O

Because	O
his	O
need	O
for	O
multiple	B-treatment
transfusionsm	I-treatment
he	O
was	O
transfused	O
with	O
radiated	B-treatment
Leuco	I-treatment
four	O
units	O
.	O

The	O
patient	O
had	O
a	O
good	O
bump	O
in	O
his	B-test
hematocrit	I-test
,	O
more	O
than	O
expected	O
from	O
22	O
to	O
high	O
20	O
&apos;s	O
range	O
next	O
day	O
after	O
3	O
1/2	O
units	O
,	O
but	O
later	O
that	O
evening	O
had	O
a	B-problem
drop	I-problem
in	O
his	B-test
hematocrit	I-test
so	O
was	O
given	O
4	O
more	O
1/2	O
units	O
at	O
this	O
point	O
for	O
a	O
total	O
of	O
4	B-treatment
units	I-treatment
packed	I-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

He	O
again	O
did	O
not	O
bump	O
his	B-test
hematocrit	I-test
sufficiently	O
and	O
remained	O
in	O
the	O
high	O
20	O
&apos;s	O
after	O
a	O
total	O
of	O
4	O
units	O
,	O
so	O
he	O
was	O
given	O
2	O
more	O
total	O
units	O
in	O
1/2	O
units	O
segments	O
the	O
following	O
day	O
.	O

His	B-test
hematocrit	I-test
subsequently	O
bumped	O
to	O
greater	O
than	O
30	O
and	O
was	O
discharged	O
with	O
hematocrit	B-test
of	O
32	O
on	O
11-7-93	O
.	O

The	O
patient	O
remained	O
asymptomatic	B-problem
from	O
a	B-problem
CHF	I-problem
stand	I-problem
point	I-problem
and	O
felt	O
much	O
better	O
after	O
the	B-treatment
transfusions	I-treatment
.	O

It	O
is	O
unclear	O
why	O
the	O
patient	O
did	O
not	O
bump	O
his	B-test
hematocrit	I-test
more	O
but	O
he	O
did	O
not	O
appear	O
to	O
be	O
hemolyzing	O
from	O
laboratory	O
data	O
,	O
that	O
is	O
his	B-test
LDH	I-test
was	O
within	O
normal	O
limits	O
.	O

In	O
addition	O
,	O
multiple	O
stools	O
were	O
guaiaced	O
and	O
were	O
all	O
guaiac	B-test
negative	O
.	O

The	O
patient	O
was	O
discharged	O
with	O
follow-up	O
with	O
his	O
Hematologist	O
,	O
Dr.	O
Eci	O
Area	O
and	O
Rheumatologist	O
,	O
Dr.	O
Taange	O
Peter	O
,	O
and	O
Cardiologist	O
,	O
Dr.	O
Peter	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Prednisone	B-treatment
10	O
mg	O
po	O
q	O
day	O
,	O
Verapamil	B-treatment
80	O
mg	O
po	O
t.i.d.	O
,	O
Digoxin	B-treatment
0.25	O
mg	O
po	O
q	O
day	O
,	O
Isordil	B-treatment
20	O
mg	O
po	O
t.i.d.	O
,	O
Theo-Dur	B-treatment
200	O
mg	O
po	O
b.i.d.	O
,	O
Lasix	B-treatment
80mg	O
q	O
am	O
,	O
40	O
mg	O
po	O
q	O
pm	O
,	O
Enalapril	B-treatment
2.5	O
mg	O
po	O
b.i.d.	O
,	O
Pepcid	B-treatment
20	O
mg	O
po	O
b.i.d.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

FOLLOW	O
UP	O
CARE	O
:	O

Follow-up	O
with	O
his	O
various	O
doctors	O
as	O
noted	O
above	O
.	O

Dictated	O
By	O
:	O

CAGHALA	O
UINTEELE	O
,	O
M.D.	O
HE27	O

Attending	O
:	O

TAANGE	O
Q.	O
PETER	O
,	O
M.D.	O
LX12	O
JL816/3429	O

Batch	O
:	O

2749	O
PAD-WORD	O

Index	O
No.	O

BHNZEG2MVV	O
PAD-WORD	O

D	O
:	O

12/03/93	O
PAD-WORD	O

T	O
:	O

12/05/93	O
PAD-WORD	O

CC	O
:	O

1.	O
DR.	O
ECI	O
AREA	O
,	O
HEMOTOLOGY	O
FELLOW	O
AT	O
RWSTMMCO	O

2.	O
DR.	O
PETER	O
,	O
CARDIOLOGY	O

Admission	O
Date:	O

2014-03-31	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2014-04-01	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

2014-03-31	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

CMED	O
PAD-WORD	O

HISTORY	O
:	O

Baby	O
Alfonso	O
Carroll	O
is	O
a	O
full	O
term	O
infant	O
born	O
at	O
3.325	O
kg	O
to	O
a	O
35-year-old	O
G2	O
,	O
P1	O
,	O
now	O
2	O
mother	O
.	O

Prenatal	B-test
screens	I-test
-	O
blood	B-test
type	I-test
O	O
positive	O
,	O
antibody	B-test
screen	I-test
negative	O
,	O
hepatitis	B-test
B	I-test
surface	I-test
antigen	I-test
negative	O
,	O
RPR	B-test
nonreactive	O
,	O
rubella	B-test
immune	O
.	O

GBS	B-problem
negative	O
.	O

Maternal	O
history	O
notable	O
for	O
hypothyroidism	B-problem
on	O
Levoxyl	B-treatment
.	O

Primary	B-treatment
cesarean	I-treatment
section	I-treatment
with	O
previous	O
pregnancy	O
for	O
arrest	B-problem
of	I-problem
descent	I-problem
.	O

Other	B-treatment
meds	I-treatment
:	O
Paxil	B-treatment
.	O

This	O
pregnancy	O
is	O
complicated	O
by	O
a	B-problem
cyst	I-problem
noted	O
on	O
the	O
umbilical	O
cord	O
on	O
fetal	B-test
ultrasound	I-test
study	I-test
at	O
18	O
weeks	O
gestation	O
.	O

Mother	O
presented	O
in	O
spontaneous	O
labor	O
.	O

No	O
perineal	B-problem
sepsis	I-problem
risk	I-problem
factors	I-problem
.	O

No	O
maternal	B-problem
fever	I-problem
.	O

No	O
prolonged	B-problem
rupture	I-problem
of	I-problem
membranes	I-problem
.	O

Clear	O
amniotic	O
fluid	O
.	O

Anesthesia	B-treatment
by	O
epidural	B-treatment
.	O

Vaginal	O
delivery	O
.	O

Apgars	B-test
were	O
8	O
and	O
9	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Weight	B-test
3.325	O
kg	O
,	O
length	B-test
was	O
20	O
inches	O
i.e.	O
51	O
cm	O
,	O
head	B-test
circumference	I-test
34.5	O
cm	O
.	O

Nondysmorphic	B-problem
infant	O
.	O

Active	O
,	O
pink	O
newborn	O
in	O
no	O
distress	B-problem
on	O
radiate	B-treatment
warmer	I-treatment
.	O

Anterior	O
fontanel	O
soft	O
and	O
flat	O
.	O

Palate	O
and	O
clavicles	O
intact	O
.	O

Neck	O
supple	O
.	O

Lungs	O
clear	O
to	O
apex	O
and	O
equal	O
.	O

CARDIOVASCULAR	O
:	O

Regular	O
rate	O
and	O
rhythm	O
.	O

No	O
murmurs	B-problem
.	O

2+	B-test
femoral	I-test
pulses	I-test
.	O

ABDOMEN	O
:	O
Soft	O
.	O

Positive	O
bowel	O
sounds	O
.	O

Umbilical	O
cord	O
with	O
Braintree	O
jelly	B-problem
cysts	I-problem
but	O
also	O
with	O
pink	B-problem
tubular	I-problem
discoloration	I-problem
at	I-problem
base	I-problem
.	O

Umbilical	O
ring	O
intact	O
.	O

Normal	O
male	O
.	O

Testes	O
down	O
bilaterally	O
.	O

Patent	O
anus	O
.	O

No	O
sacral	B-problem
anomalies	I-problem
.	O

EXTREMITIES	O
:	O
Pink	O
and	O
well	O
perfused	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

RESPIRATORY	O
:	O
He	O
has	O
been	O
stable	O
in	O
room	O
air	O
throughout	O
hospital	O
course	O
.	O

CARDIOVASCULAR	O
:	O
No	O
cardiovascular	B-problem
issues	I-problem
.	O

FLUIDS	O
,	O
ELECTROLYTES	O
AND	O
NUTRITION	O
:	O
Infant	O
initiated	O
on	O
60	O
cc	O
per	O
kg	O
per	O
day	O
of	O
D10W	B-treatment
.	O

D-sticks	B-test
have	O
been	O
stable	O
.	O
Infant	O
is	O
allowed	O
to	O
ad	O
lib	O
breast	O
feed	O
which	O
he	O
is	O
doing	O
vigorously	O
.	O

GASTROINTESTINAL	O
:	O
Infant	O
is	O
ad	O
lib	O
feeding	O
.	O

An	B-test
abdominal	I-test
ultrasound	I-test
was	O
performed	O
.	O

Initial	O
impression	O
included	O
omphalocele	B-problem
with	O
further	B-test
imaging	I-test
of	I-test
the	I-test
bowel	I-test
to	O
be	O
done	O
.	O

Surgery	O
was	O
consulted	O
and	O
Dr.	O
Boston	O
took	O
patient	O
to	O
OR	O
for	O
exploration	B-test
of	I-test
cord	I-test
on	O
04-01	O
.	O

Urachal	B-problem
duct	I-problem
remnanr	I-problem
found	O
,	O
removed	O
and	O
bladder	O
repaired	O
.	O

Post	O
op	O
course	O
unremrakable	O
.	O

PAtient	O
began	O
feeding	O
first	O
post	O
op	O
day	O
and	O
has	O
done	O
well	O
.	O

HEMATOLOGY	O
:	O
Hematocrit	B-test
on	O
admission	O
was	O
52.8	O
.	O

The	O
infant	O
does	O
not	O
require	O
a	B-treatment
new	I-treatment
blood	I-treatment
transfusion	I-treatment
.	O

INFECTIOUS	O
DISEASE	O
:	O
CBC	B-test
and	O
blood	B-test
culture	I-test
obtained	O
on	O
admission	O
.	O

Initial	B-test
CBC	I-test
had	O
a	B-test
white	I-test
count	I-test
of	O
20	O
,	O
platelet	B-test
count	I-test
of	O
386	O
,	O
63	O
polys	B-test
,	O
2	O
bands	B-test
,	O
23	O
lymphs	B-test
.	O

Blood	B-test
cultures	I-test
remained	O
negative	O
at	O
this	O
time	O
.	O

Infant	O
has	O
not	O
received	O
any	B-treatment
antibiotics	I-treatment
.	O

NEUROLOGIC	O
:	O
Infant	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
.	O

SENSORY	O
:	O
Hearing	B-test
screen	I-test
has	O
not	O
yet	O
been	O
performed	O
but	O
should	O
be	O
done	O
prior	O
to	O
discharge	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
Massachusetts	O
General	O
Hospital	O
.	O

NAME	O
OF	O
PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Joan	O
Derringer	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Urachal	B-problem
duct	I-problem
remnant	I-problem
.	O

CARE	O
RECOMMENDATIONS	O
:	O

1.	O
Dressing	B-treatment
to	O
remain	O
in	O
place	O
for	O
10	O
days	O
unless	O
signs	O
of	O
bleeding	B-problem
,	O
infection	B-problem
or	O
is	O
soiled	O
.	O

2.	O
F/U	O
with	O
primary	O
pediatricians	O
in	O
3-4	O
days	O
or	O
earlier	O
as	O
needed	O
.	O

3.	O
F/U	O
appt	O
with	O
Dr	O
Boston	O
,	O
Massachusetts	O
General	O
Hospital	O
Surgery	O
in	O
approx	O
4	O
weeks	O
.	O

Mother	O
has	O
Dr	O
Fishman's	O
contact	O
information	O
.	O

Emma	O
Nicolas	O
,	O
MD	O
79-770	O

Dictated	O
By	O
:	O
Jerry	O
E	O
Ross	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2014-04-01	O
01:57:51	O

T	O
:	O
2014-04-01	O
02:59:13	O

Job	O
#:	O
96281	O

Signed	O
electronically	O
by	O
:	O
DR.	O
James	O
GRAY	O
on	O
:	O
Roger	O
2014-04-03	O
3:20	O
PM	O

(	O
End	O
of	O
Report	O
)	O

860059421	O
PAD-WORD	O

SH	O
PAD-WORD	O

17511921	O
PAD-WORD	O

6/10/1999	O
12:00:00	O
AM	O

GASTROINTESTINAL	B-problem
BLEED	I-problem

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

06/10/1999	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

06/26/1999	O
PAD-WORD	O

DISCHARGE	O
DIAGNOSIS	O
:	O

SEPSIS	B-problem
.	O

SIGNIFICANT	O
PROBLEMS	O
:	O

1	O
)	O
GASTROINTESTINAL	B-problem
BLEED	I-problem
.	O

2	O
)	O
HEPATIC	B-problem
ENCEPHALOPATHY	I-problem
.	O

3	O
)	O
END	B-problem
STAGE	I-problem
RENAL	I-problem
DISEASE	I-problem
ON	O
DIALYSIS	B-treatment
.	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Vinktlandfreierm	O
was	O
admitted	O
from	O
Owaleharbo	O
Tanaminer	O
Hospital	O
to	O
which	O
he	O
had	O
been	O
discharged	O
approximately	O
four	O
days	O
prior	O
to	O
admission	O
.	O

He	O
was	O
noted	O
to	O
have	O
dark	B-problem
stools	I-problem
per	I-problem
rectum	I-problem
and	O
to	O
be	O
somewhat	B-problem
fluid	I-problem
overloaded	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
admitted	O
and	O
found	O
to	O
have	O
a	O
significant	O
hematocrit	B-problem
drop	I-problem
from	O
33.8	O
to	O
24.3	O
.	O

He	O
was	O
found	O
operation	O
be	O
short	B-problem
of	I-problem
breath	I-problem
and	O
was	O
taken	O
to	O
dialysis	B-treatment
for	O
apparent	B-problem
fluid	I-problem
overload	I-problem
.	O

His	B-problem
gastrointestinal	I-problem
bleeding	I-problem
issues	I-problem
were	O
investigated	O
with	O
an	B-test
upper	I-test
endoscopy	I-test
which	O
revealed	O
multiple	O
superficial	O
gastric	B-problem
ulcerations	I-problem
consistent	O
with	O
an	B-problem
non-steroidal	I-problem
anti-inflammatory	I-problem
drugs	I-problem
gastropathy	I-problem
.	O

He	O
had	O
been	O
discharged	O
on	O
one	B-treatment
aspirin	I-treatment
a	O
day	O
with	O
20	O
of	O
Prilosec	B-treatment
b.i.d.	O

The	B-treatment
aspirin	I-treatment
was	O
discontinued	O
and	O
he	O
had	O
no	O
further	O
problems	O
with	O
gastrointestinal	B-problem
bleeding	I-problem
and	O
a	O
stable	O
hematocrit	B-test
the	O
rest	O
of	O
his	O
hospitalization	O
.	O

During	O
the	O
course	O
of	O
his	O
hospitalization	O
,	O
he	O
became	O
increasingly	B-problem
lethargic	I-problem
.	O

An	B-test
extensive	I-test
work-up	I-test
was	O
done	O
for	O
any	B-problem
metabolic	I-problem
abnormalities	I-problem
which	O
was	O
unrevealing	O
.	O

He	O
responded	O
somewhat	O
to	O
lactulose	B-treatment
for	O
hepatic	B-problem
encephalopathy	I-problem
.	O

He	O
had	O
one	B-problem
positive	I-problem
blood	I-problem
culture	I-problem
for	O
Vancomycin	B-problem
resistant	I-problem
enterococcus	I-problem
.	O

In	O
the	O
few	O
days	O
prior	O
to	O
his	O
demise	O
,	O
he	O
was	O
intermittently	O
somewhat	B-problem
lethargic	I-problem
buton	O
the	O
morning	O
of	O
June	O
25	O
,	O
1999	O
,	O
his	B-test
white	I-test
count	I-test
was	O
noted	O
to	O
have	O
increased	O
from	O
8	O
to	O
13,000	O
.	O

That	O
day	O
,	O
he	O
was	O
found	O
to	O
be	O
acutely	B-problem
short	I-problem
of	I-problem
breath	I-problem
with	O
a	B-test
respiratory	I-test
rate	I-test
of	O
40	O
and	O
oxygen	B-test
saturations	I-test
in	O
the	O
mid	O
seventies	O
.	O

He	O
was	O
put	O
on	O
100%	B-treatment
nonrebreather	I-treatment
and	O
his	B-test
oxygen	I-test
saturations	I-test
improved	O
to	O
the	O
low	O
nineties	O
.	O

Nasal	B-treatment
trumpet	I-treatment
suction	I-treatment
was	O
done	O
and	O
he	O
was	O
found	O
to	O
have	O
food	O
like	O
material	O
that	O
was	O
easily	O
suctioned	O
out	O
.	O

He	O
was	O
also	O
found	O
to	O
havesome	O
pieces	O
of	O
toast	O
in	O
his	O
mouth	O
.	O

Blood	B-test
gases	I-test
were	O
done	O
and	O
he	O
was	O
found	O
to	O
have	O
a	B-test
pH	I-test
of	O
7.2	O
with	O
a	B-test
pCO2	I-test
of	O
21	O
.	O

Fingerstick	B-test
glucose	I-test
revealed	O
a	B-test
sugar	I-test
of	O
12	O
.	O

A	B-test
stat	I-test
panel	I-test
7	I-test
confirmed	O
that	O
the	B-test
sugar	I-test
was	O
23	O
and	O
that	O
he	O
had	O
a	B-test
new	I-test
anion	I-test
gap	I-test
of	O
40	O
.	O

Repeat	B-test
blood	I-test
gas	I-test
was	O
done	O
which	O
was	O
almost	O
identical	O
to	O
the	O
first	O
.	O

The	O
family	O
was	O
called	O
and	O
came	O
in	O
to	O
see	O
the	O
patient	O
.	O

An	O
extensive	O
family	O
meeting	O
was	O
held	O
and	O
the	O
family	O
agreed	O
that	O
it	O
did	O
not	O
make	O
sense	O
to	O
intubate	O
the	O
patient	O
and	O
send	O
him	O
to	O
the	O
Intensive	O
Care	O
Unit	O
.	O

In	O
the	O
acute	O
setting	O
,	O
he	O
had	O
been	O
started	O
on	O
levofloxacin	B-treatment
,	O
Flagyl	B-treatment
,	O
and	O
Vancomycin	B-treatment
.	O

These	B-treatment
antibiotics	I-treatment
were	O
continued	O
but	O
the	O
family	O
decided	O
that	O
they	O
wanted	O
us	O
to	O
emphasize	O
the	O
comfort	O
of	O
the	O
patient	O
and	O
pursue	O
no	O
further	B-treatment
invasive	I-treatment
measures	I-treatment
.	O

The	O
patient	O
was	O
made	O
do	O
not	O
resuscitate	O
/	O
do	O
not	O
intubate	O
.	O

At	O
2:30	O
on	O
June	O
26	O
,	O
1999	O
,	O
I	O
was	O
called	O
to	O
see	O
the	O
patient	O
who	O
had	O
expired	O
.	O

DISPOSITION	O
:	O

The	O
family	O
was	O
notified	O
and	O
came	O
in	O
to	O
see	O
the	O
patient	O
.	O

The	O
family	O
declined	O
an	B-test
autopsy	I-test
saying	O
that	O
they	O
felt	O
that	O
the	O
patient	O
had	O
been	O
through	O
enough	O
.	O

The	O
patient	O
&apos;s	O
attending	O
physician	O
,	O
Dr.	O
Erm	O
Neidwierst	O
,	O
was	O
notified	O
as	O
well	O
.	O

Dictated	O
By	O
:	O

CONRELLIE	O
KOTERUDES	O
,	O
M.D.	O
UK0	O

Attending	O
:	O

ERM	O
K.	O
NEIDWIERST	O
,	O
M.D.	O
QQ62	O
OC499/5391	O

Batch	O
:	O

15168	O
PAD-WORD	O

Index	O
No.	O

VKRPJQ81J6	O
PAD-WORD	O

D	O
:	O

06/26/99	O
PAD-WORD	O

T	O
:	O

06/29/99	O
PAD-WORD	O

Admission	O
Date	O
:	O

2010-08-30	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2010-08-31	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1977-03-27	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

MEDICINE	B-treatment
PAD-WORD	O

CHIEF	O
COMPLAINT	O
:	O

Delta	O
MS	O
Rachel	O
Rohrer	O
.	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
33	O
-	O
year-old	O
Asian-Caucasian	O
male	O
with	O
a	O
history	O
of	O
Type	B-problem
1	I-problem
diabetes	I-problem
,	O
asthma	B-problem
,	O
alcohol	O
abuse	O
,	O
and	O
personality	B-problem
disorder	I-problem
/	O
depression	B-problem
admitted	O
on	O
2010-08-28	O
for	O
persistent	B-problem
hypoglycemia	I-problem
.	O

The	O
patient	O
complained	O
of	O
diaphoresis	B-problem
,	O
confusion	B-problem
,	O
dizziness	B-problem
,	O
lightheadedness	B-problem
after	O
drinking	O
a	O
24	O
ounce	O
beer	O
and	O
taking	O
at	O
least	O
an	O
extra	O
15	O
units	O
of	O
NPH	B-treatment
insulin	I-treatment
the	O
evening	O
of	O
2010-08-27	O
(	O
later	O
reported	O
over	O
70	O
U	O
insulin	B-treatment
administered	O
from	O
2.30	O
PM	O
until	O
time	O
of	O
presentation	O
)	O
followed	O
by	O
not	O
eating	O
dinner	O
.	O

His	B-problem
symptoms	I-problem
mildly	O
improved	O
after	O
eating	O
a	O
candy	O
bar	O
.	O

The	O
EMS	O
was	O
called	O
and	O
found	O
his	B-test
blood	I-test
sugar	I-test
at	O
the	O
time	O
to	O
be	O
61	O
and	O
noted	O
to	O
be	O
41	O
in	O
the	O
Emergency	O
Department	O
.	O

He	O
denied	O
any	B-problem
seizure	I-problem
activity	I-problem
,	O
loss	B-problem
of	I-problem
consciousness	I-problem
,	O
incontinence	B-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
fevers	B-problem
,	O
or	O
chills	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
change	B-problem
in	I-problem
urinary	I-problem
or	I-problem
bowel	I-problem
habits	I-problem
,	O
or	O
suicidal	B-problem
ideation	I-problem
.	O

He	O
has	O
been	O
depressed	B-problem
recently	O
regarding	O
stress	O
with	O
his	O
home	O
life	O
and	O
on	O
the	O
night	O
of	O
his	B-treatment
extra	I-treatment
insulin	I-treatment
doses	I-treatment
,	O
his	O
wife	O
had	O
just	O
kicked	O
him	O
out	O
of	O
the	O
house	O
.	O

He	O
has	O
had	O
four	O
past	O
hospitalizations	O
for	O
attempted	B-problem
suicide	I-problem
with	O
insulin	B-problem
overdosing	I-problem
,	O
usually	O
denied	O
.	O

The	O
wife	O
also	O
states	O
that	O
he	O
drinks	O
more	O
than	O
he	O
states	O
.	O

In	O
the	O
Emergency	O
Department	O
,	O
he	O
received	O
3.5	O
amps	O
of	O
D50	B-treatment
and	O
then	O
D5	B-treatment
normal	I-treatment
saline	I-treatment
and	O
D10	B-treatment
normal	I-treatment
saline	I-treatment
with	O
blood	B-test
sugars	I-test
that	O
were	O
slow	B-problem
to	I-problem
increase	I-problem
leading	O
the	O
ICU	O
team	O
to	O
suspect	O
that	O
the	O
patient	O
had	O
taken	O
more	O
insulin	B-treatment
than	O
he	O
admitted	O
.	O

He	O
also	O
had	O
a	O
very	O
positive	O
tox	B-test
screen	I-test
for	O
alcohol	O
.	O

His	B-test
fingersticks	I-test
are	O
currently	O
in	O
the	O
200	O
s	O
and	O
his	O
normal	O
blood	O
glucose	O
at	O
home	O
ranges	O
between	O
90-200	O
per	O
the	O
patient	O
.	O

The	O
patient	O
also	O
now	O
complains	O
of	O
increased	B-problem
right	I-problem
upper	I-problem
quadrant	I-problem
/	I-problem
right	I-problem
rib	I-problem
cage	I-problem
pain	I-problem
and	O
new	B-problem
headache	I-problem
.	O

He	O
also	O
complains	O
of	O
chronic	B-problem
photophobia	I-problem
which	O
is	O
unchanged	O
.	O

He	O
denied	O
visual	B-problem
changes	I-problem
,	O
lightheadedness	B-problem
of	O
dizziness	B-problem
currently	O
,	O
neck	B-problem
stiffness	I-problem
,	O
or	O
pain	B-problem
in	I-problem
any	I-problem
other	I-problem
area	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Insulin-dependent	B-problem
diabetes	I-problem
.	O

-	O
followed	O
by	O
Johannes	O
/	O
Brink	O

2.	O
Depression	B-problem
.	O

3.	O
Asthma	B-problem
.	O

4.	O
Alcohol	O
abuse	O
.	O

5.	O
Hypercholesterolemia	B-problem
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
FROM	O
THE	O
INTENSIVE	O
CARE	O
4999801	O
.	O

Humalog	B-treatment
sliding	I-treatment
scale	I-treatment
insulin	I-treatment
.	O

2.	O
NPH	B-treatment
12	O
units	O
q.a.m.	O
,	O
7	O
units	O
q.p.m.	O
with	O
normal	B-treatment
home	I-treatment
dose	I-treatment
being	O
30	O
units	O
q.a.m.	O
and	O
15	O
units	O
q.p.m.	O

3.	O
Thiamine	B-treatment
.	O

4.	O
Folate	B-treatment
.	O

5.	O
Multivitamin	B-treatment
.	O

6.	O
Fluticasone	B-treatment
.	O

7.	O
Albuterol	B-treatment
inhaler	I-treatment
p.r.n.	O

8.	O
Neutra-Phos	B-treatment
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

Half	O
pack	O
per	O
day	O
of	O
tobacco	O
times	O
20	O
years	O
,	O
alcohol	O
about	O
two	O
24	O
ounce	O
beers	O
per	O
week	O
.	O

Drugs	O
:	O

Denied	O
IV	O
drug	O
abuse	O
.	O

He	O
lives	O
with	O
his	O
wife	O
who	O
has	O
a	O
baby	O
with	O
another	O
boyfriend	O
of	O
two	O
years	O
.	O

He	O
recently	O
came	O
out	O
as	O
bisexual	O
to	O
his	O
wife	O
.	O

The	O
wife	O
and	O
the	O
patient	O
have	O
two	O
children	O
together	O
.	O

He	O
was	O
fired	O
as	O
a	O
Federal	O
Express	O
worker	O
recently	O
and	O
his	O
wife	O
kicked	O
the	O
patient	O
out	O
of	O
his	O
home	O
on	O
2010-08-27	O
.	O

FAMILY	O
HISTORY	O
:	O

Grandmother	O
with	O
diabetes	B-problem
.	O

Mother	O
with	O
asthma	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
TRANSFER	O
:	O
Vital	B-test
signs	I-test
:	O

T	B-test
maximum	I-test
98.6	O
,	O
blood	B-test
pressure	I-test
90s-130s	O
/	O
80s-90s	O
,	O
heart	B-test
rate	I-test
70s	O
to	O
80s	O
,	O
respirations	B-test
18	O
,	O
oxygen	B-test
saturation	I-test
98%	O
on	O
room	O
air	O
.	O

General	O
:	O

The	O
patient	O
was	O
a	O
soft-spoken	O
male	O
resting	O
in	O
his	O
bed	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

HEENT	O
:	O

The	O
pupils	O
were	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Extraocular	O
muscles	O
were	O
intact	O
.	O

Sclerae	O
were	O
anicteric	B-problem
.	O

Moist	O
mucous	O
membranes	O
,	O
clear	O
oropharynx	O
.	O

Neck	O
:	O

Supple	O
,	O
no	O
masses	B-problem
,	O
no	O
lymphadenopathy	B-problem
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
,	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

Normal	O
S1	O
,	O
S2	O
.	O

Pulmonary	O
:	O

Clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Abdomen	O
:	O

Normoactive	O
bowel	O
sounds	O
,	O
soft	O
,	O
mildly	B-problem
tender	I-problem
at	I-problem
right	I-problem
upper	I-problem
quadrant	I-problem
just	O
inferior	O
to	O
the	O
lower	O
ribs	O
,	O
no	O
epigastric	B-problem
tenderness	I-problem
.	O

Extremities	O
:	O
Warm	O
and	O
well	O
perfuse	O
.	O

Normal	O
peripheral	O
pulses	O
.	O

Neurologic	O
:	O

Cranial	O
nerves	O
II	O
through	O
XII	O
were	O
intact	O
.	O

Normal	O
sensation	O
.	O

Normal	O
motor	O
strength	O
bilaterally	O
.	O

Psychiatric	O
:	O

Depressed	B-problem
affect	I-problem
.	O

Denied	O
suicidal	B-problem
ideation	I-problem
.	O

LABORATORY	O
/	O
RADIOLOGIC	O
DATA	O
:	O

CBC	B-test
with	O
a	B-test
white	I-test
count	I-test
of	O
6.2	O
,	O
hemoglobin	B-test
13.3	O
,	O
hematocrit	B-test
39.4	O
,	O
platelet	B-test
307,000	O
.	O

Sodium	B-test
142	O
,	O
potassium	B-test
4.1	O
,	O
chloride	B-test
104	O
,	O
bicarbonate	B-test
30	O
,	O
BUN	B-test
7	O
,	O
creatinine	B-test
0.7	O
,	O
glucose	B-test
41	O
.	O

Calcium	B-test
9.6	O
,	O
magnesium	B-test
2.2	O
,	O
phosphorus	B-test
7.4	O
,	O
vitamin	B-test
B12	I-test
level	I-test
320	O
,	O
folate	B-test
9.5	O
,	O
TSH	B-test
1.4	O
,	O
acetone	B-test
negative	O
.	O

Serum	B-test
tox	I-test
screen	I-test
,	O
alcohol	O
32	O
mg	O
per	O
deciliter	O
,	O
negative	O
for	O
aspirin	B-treatment
,	O
benzos	B-treatment
,	O
barbiturates	B-treatment
,	O
and	O
TCA	B-treatment
.	O

Urine	B-test
tox	I-test
screen	I-test
negative	O
for	O
benzos	B-treatment
,	O
barbiturates	B-treatment
,	O
opiates	B-treatment
,	O
cocaine	B-treatment
,	O
amphetamines	B-treatment
,	O
and	O
methadone	B-treatment
.	O

Telemetry	B-test
was	O
notable	O
for	O
episodes	O
of	O
sinus	B-problem
tachycardia	I-problem
to	O
120s	O
to	O
140s	O
only	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
HYPOGLYCEMIA	B-problem
:	O

The	O
patient	O
had	O
been	O
initially	O
very	B-problem
hypoglycemic	I-problem
on	O
admission	O
secondary	O
to	O
overdosing	B-problem
on	I-problem
insulin	I-problem
;	O
however	O
,	O
with	O
glucose	B-treatment
repletion	I-treatment
both	O
in	O
the	O
Emergency	O
Department	O
and	O
in	O
the	O
ICU	O
,	O
this	O
resolved	O
and	O
the	O
patient	O
also	O
began	O
to	O
eat	O
.	O

We	O
checked	O
fingerstick	B-test
glucoses	I-test
q.i.d.	O
and	O
at	O
3:00	O
a.m.	O

His	B-test
glucose	I-test
on	O
the	O
morning	O
of	O
discharge	O
was	O
about	O
60	O
so	O
we	O
opted	O
to	O
decrease	O
his	B-treatment
p.m.	I-treatment
NPH	I-treatment
dose	I-treatment
slightly	O
for	O
discharge	O
and	O
continue	O
covering	O
him	O
with	O
sliding	B-treatment
scale	I-treatment
insulin	I-treatment
.	O

He	O
should	O
also	O
continue	O
having	O
a	O
snack	O
at	O
midnight	O
if	O
able	O
.	O

It	O
is	O
likely	O
that	O
he	O
required	O
a	O
much	O
greater	O
amount	O
of	O
insulin	B-treatment
as	O
an	O
outpatient	O
due	O
to	O
poor	B-problem
compliance	I-problem
with	O
Richard	B-treatment
Natalie	I-treatment
diet	I-treatment
.	O

2.	O
ALCOHOL	O
ABUSE	O
:	O

It	O
is	O
likely	O
that	O
the	O
patient	O
continues	O
to	O
drink	O
more	O
than	O
he	O
admits	O
.	O

He	O
did	O
have	O
past	O
alcoholism	O
consisting	O
of	O
a	O
half	O
a	O
pint	O
of	O
brandy	O
per	O
day	O
for	O
three	O
years	O
but	O
supposedly	O
had	O
quit	O
in	O
2009-09-03	O
.	O

He	O
had	O
been	O
on	O
a	B-treatment
diazepam	I-treatment
CIWA	I-treatment
scale	I-treatment
prophylaxis	I-treatment
against	O
DT	B-problem
s;	I-problem
however	O
,	O
he	O
had	O
a	B-test
very	I-test
low	I-test
CIWA	I-test
scale	I-test
during	O
his	O
entire	O
admission	O
and	O
did	O
not	O
need	O
any	B-treatment
benzodiazepines	I-treatment
.	O

This	O
alcohol	O
abuse	O
may	O
be	O
further	O
addressed	O
as	O
an	O
inpatient	O
on	O
the	O
Psychiatry	O
Quincy	O
Medical	O
Center	O
.	O

We	O
had	O
also	O
requested	O
a	O
Social	O
Work	O
consult	O
regarding	O
this	O
.	O

3.	O
DEPRESSION	B-problem
vs.	O
Borderline	B-problem
personality	I-problem
disorder	I-problem
:	O

The	O
patient	O
has	O
had	O
several	O
admissions	O
in	O
the	O
past	O
for	O
attempted	B-problem
suicide	I-problem
with	O
overdose	B-problem
of	O
his	B-treatment
insulin	I-treatment
and	O
though	O
he	O
denied	O
at	O
this	O
time	O
attempting	O
to	O
end	O
his	O
life	O
,	O
it	O
appears	O
that	O
the	O
social	O
situation	O
of	O
increased	B-problem
stressors	I-problem
corresponding	O
to	O
this	O
time	O
suggest	O
that	O
this	O
is	O
not	O
the	O
truth	O
.	O

He	O
received	O
a	O
one-to-one	B-treatment
sitter	I-treatment
during	O
his	O
admission	O
and	O
will	O
be	O
transferred	O
to	O
the	O
Psychiatry	O
HealthSouth	O
New	O
England	O
Rehab	O
Hospital	O
to	O
ensure	O
the	O
patient	O
's	O
safety	O
and	O
initiate	O
further	B-treatment
antidepressant	I-treatment
treatment	I-treatment
.	O

He	O
will	O
need	O
close	O
follow-up	O
regarding	O
his	B-problem
depression	I-problem
as	O
an	O
outpatient	O
,	O
although	O
apparently	O
this	O
has	O
been	O
set	O
up	O
for	O
him	O
in	O
the	O
past	O
and	O
he	O
had	O
not	O
followed	O
through	O
.	O

4.	O
HISTORY	O
OF	O
HIGH	B-problem
BLOOD	I-problem
PRESSURE	I-problem
:	O

His	B-test
blood	I-test
pressure	I-test
was	O
fairly	O
low	O
with	O
a	O
maximum	O
of	O
130s	O
systolic	O
during	O
his	O
admission	O
,	O
thus	O
we	O
did	O
not	O
continue	O
his	B-treatment
lisinopril	I-treatment
which	O
he	O
had	O
been	O
on	O
in	O
the	O
past	O
.	O

5.	O
RIGHT	B-problem
UPPER	I-problem
QUADRANT	I-problem
PAIN	I-problem
:	O

We	O
obtained	O
a	B-test
right	I-test
upper	I-test
quadrant	I-test
ultrasound	I-test
as	O
well	O
as	O
LFTs	B-test
,	O
amylase	B-test
,	O
and	O
lipase	B-test
which	O
were	O
all	O
normal	O
.	O

He	O
had	O
no	O
evidence	O
of	O
cholecystitis	B-problem
or	O
gallstones	B-problem
or	O
any	B-problem
abnormalities	I-problem
with	I-problem
the	I-problem
liver	I-problem
or	I-problem
kidneys	I-problem
.	O

it	O
is	O
possible	O
that	O
he	O
has	O
had	O
a	B-problem
muscle	I-problem
strain	I-problem
or	O
other	B-problem
musculoskeletal	I-problem
cause	I-problem
.	O

6.	O
PROPHYLAXIS	B-treatment
:	O

He	O
was	O
put	O
on	O
Pepcid	B-treatment
for	O
GI	B-treatment
prophylaxis	I-treatment
.	O

7.	O
FLUIDS	O
,	O
ELECTROLYTES	O
,	O
AND	O
NUTRITION	O
:	O

He	O
complied	O
with	O
Linda	B-treatment
Chad	I-treatment
diet	I-treatment
while	O
hospitalized	O
.	O

The	O
patient	O
was	O
hyperphosphatemic	B-problem
secondary	O
to	O
overadministration	O
of	O
Neutra-Phos	B-treatment
during	O
his	O
ICU	O
stay	O
.	O

He	O
was	O
given	O
two	O
doses	O
of	O
calcium	B-treatment
carbonate	I-treatment
1	O
gram	O
,	O
and	O
will	O
most	O
likely	O
normalize	O
secondary	O
to	O
both	O
calcium	O
binding	O
and	O
urinary	O
excretion	O
.	O

He	O
has	O
been	O
asymptomatic	B-problem
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Depression	B-problem
.	O

2.	O
Insulin-dependent	B-problem
diabetes	I-problem
mellitus	I-problem
.	O

3.	O
Asthma	B-problem
.	O

4.	O
Alcohol	O
abuse	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Insulin	B-treatment
NPH	I-treatment
10	O
units	O
q.a.m.	O
,	O
5	O
units	O
q.p.m.	O

2.	O
Humalog	B-treatment
sliding	I-treatment
scale	I-treatment
insulin	I-treatment
for	O
fingerstick	B-test
blood	I-test
glucose	I-test
151-200	O
2	O
units	O
;	O
201-250	O
4	O
units	O
;	O
251-300	O
6	O
units	O
;	O
301-350	O
8	O
units	O
;	O
351-400	O
10	O
units	O
;	O
greater	O
than	O
400	O
12	O
units	O
.	O

3.	O
Multivitamin	B-treatment
.	O

4.	O
Fluticasone	B-treatment
.	O

5.	O
Albuterol	B-treatment
p.r.n.	O

6.	O
Pepcid	B-treatment
20	O
mg	O
p.o.	O
q.d.	O

FOLLOW-UP	O
PLANS	O
:	O

The	O
patient	O
will	O
be	O
transferred	O
to	O
the	O
Inpatient	O
Psychiatry	O
Unit	O
on	O
Springfield	O
Municipal	O
Hospital	O
IV	O
for	O
further	B-test
evaluation	I-test
and	O
treatment	B-treatment
of	O
his	B-problem
depression	I-problem
and	O
possible	O
suicidal	B-problem
ideation	I-problem
.	O

He	O
will	O
follow-up	O
with	O
his	O
primary	O
care	O
doctor	O
,	O
Dr.	O
Gillis	O
,	O
after	O
discharge	O
,	O
Johannes	O
for	O
Diabetes	B-treatment
management	I-treatment
,	O
and	O
Psychiatry	O
for	O
further	B-treatment
management	I-treatment
of	O
his	B-problem
impulsive	I-problem
behaviors	I-problem
.	O

Patty	O
K.	O
Wagner	O
,	O
M.D.	O
01-820	O

Dictated	O
By	O
:	O
Cora	O
C.	O
Haskett	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2010-08-31	O
09:08	O

T	O
:	O
2010-09-10	O
08:23	O

JOB	O
#:	O
34336	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Elizabeth	O
Gabriele	O
on	O
:	O
FRI	O
2010-09-10	O
3:04	O
PM	O

(	O
End	O
of	O
Report	O
)	O

866196074	O
RWH	O

6639378	O
PAD-WORD	O

578141	O
PAD-WORD	O

0325706	O
PAD-WORD	O

3/10/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KNOLESA	O
,	O
VIA	O

MRN	O
:	O

6639378	O
PAD-WORD	O

Age	O
:	O

39y	O
PAD-WORD	O

REGISTRATION	O
DATE	O
:	O

03/10/2003	O
06:42	O
PM	O

Provider	O
:	O

Inachelle	O
Breutzbreunbreuncotfalke	O

PRELMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O
PAD-WORD	O

Discharge	O
Date	O
/	O
Time	O
:	O

03/10/2003	O
23:26	O

Discharge	O
Status	O
:	O

Discharged	O
PAD-WORD	O

Condition	O
on	O
Discharge	O
:	O

Stable	O
PAD-WORD	O

Patient	O
States	O
Complaint	O
:	O

INCREASED	O
ACID	B-problem
REFLUX	I-problem

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
abdominal	B-problem
pain	I-problem
(	O
Spanish	O
)	O
.	O

Diagnosis	O
:	O

GERD	B-problem
PAD-WORD	O

Treatment	O
Rendered	O
:	O

h	O
,	O
p,	B-test
labs	B-test
,	O
mylanta	B-treatment
/	O
viscous	B-treatment
lidocaine	I-treatment

Discharge	O
Medications	O
:	O

mylanta	B-treatment
15	O
cc	O
mixed	O
with	O
Viscous	B-treatment
lidocaine	I-treatment
every	O
8	O
hours	O
if	O
needed	O
for	O
severe	O
pain	B-problem
only	O
can	O
use	O
mylanta	B-treatment
without	O
lidocaine	B-treatment
more	O
frequently	O
bland	B-treatment
diet	I-treatment
,	O
no	O
caffeine	O
,	O
chilli	O
,	O
or	O
alcohol	O
...	O

Follow	O
up	O
Service	O
:	O

call	O
your	O
PCP	O
to	O
schedule	O
your	O
GI	O
follow	O
up	O
date	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

return	O
to	O
ED	O
if	O
worsening	B-problem
pain	I-problem
,	O
black	B-problem
stools	I-problem
,	O
blood	B-problem
in	I-problem
stool	I-problem

PCP	O
Name	O
:	O

LEEBKAYSHAUPKERTH	O
,	O
MAENZET	O
N	O

Provider	O
Number	O
:	O

31710	O
PAD-WORD	O

This	O
report	O
was	O
created	O
by	O
Breutzbreunbreuncotfalke	O
,	O
Inachelle	O
03/10/2003	O
11:28	O
PM	O

Admission	O
Date	O
:	O

2015-06-10	O
PAD-WORD	O

Discharge	O
Date	O
:	O

2015-06-11	O
PAD-WORD	O

Date	O
of	O
Birth	O
:	O

1970-12-08	O
PAD-WORD	O

Sex	O
:	O

M	O
PAD-WORD	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
44	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
9/02	O
,	O
status	O
post	O
stent	B-treatment
proximal	B-problem
and	I-problem
mid-RCA	I-problem
lesion	I-problem
and	O
OM	B-problem
lesion	I-problem
.	O

He	O
had	O
a	B-test
Myoview	I-test
on	O
05-04	O
which	O
showed	O
fixed	B-problem
inferior	I-problem
wall	I-problem
defect	I-problem
but	O
no	O
evidence	O
of	O
ischemia	B-problem
.	O

He	O
has	O
been	O
getting	O
short	B-problem
of	I-problem
breath	I-problem
with	O
exertion	O
times	O
one	O
month	O
and	O
also	O
has	O
occasional	B-problem
chest	I-problem
tightness	I-problem
.	O

He	O
denies	O
orthopnea	B-problem
,	O
edema	B-problem
,	O
paroxysmal	B-problem
nocturnal	I-problem
dyspnea	I-problem
,	O
diaphoresis	B-problem
,	O
claudication	B-problem
.	O

He	O
also	O
has	O
history	O
of	O
hypertension	B-problem
,	O
high	B-problem
cholesterol	I-problem
and	O
noninsulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
.	O

He	O
underwent	O
cardiac	B-test
catheterization	I-test
today	O
which	O
revealed	O
OM	O
,	O
no	O
obstructive	B-problem
disease	I-problem
,	O
left	B-problem
anterior	I-problem
descending	I-problem
minimal	I-problem
disease	I-problem
,	O
left	B-problem
circumflex	I-problem
40%	I-problem
mid-stenosis	I-problem
.	O

Right	B-problem
coronary	I-problem
artery	I-problem
100%	I-problem
mid-stenosis	I-problem
.	O

Echo	B-test
in	O
9/02	O
showed	O
LVF	B-test
of	O
75%	O
with	O
moderate	B-problem
dilatation	I-problem
of	I-problem
the	I-problem
descending	I-problem
aorta	I-problem
.	O

He	O
is	O
now	O
preop	O
for	O
a	B-treatment
coronary	I-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Noninsulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
,	O
hypertension	B-problem
,	O
high	B-problem
cholesterol	I-problem
,	O
coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
myocardial	B-problem
infarction	I-problem
in	O
9/02	O
.	O

Status	O
post	O
stent	B-treatment
.	O

MEDICATIONS	O
:	O

1.	O
Folic	B-treatment
Acid	I-treatment
.	O

2.	O
Metformin	B-treatment
.	O

3.	O
Norvasc	B-treatment
.	O

4.	O
Aspirin	B-treatment
.	O

5.	O
Lopressor	B-treatment
.	O

6.	O
Lipitor	B-treatment
.	O

7.	O
Diovan	B-treatment
.	O

8.	O
Hydrochlorothiazide	B-treatment
.	O

ALLERGIES	O
:	O

Penicillin	B-treatment
,	O
sulfa	B-treatment
and	O
Codeine	B-treatment
.	O

FAMILY	O
HISTORY	O
:	O

Strong	B-problem
coronary	I-problem
artery	I-problem
disease	I-problem
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
tobacco	O
,	O
no	O
alcohol	O
,	O
lives	O
with	O
wife	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
in	O
no	O
acute	B-problem
distress	I-problem
,	O
vital	B-test
signs	I-test
stable	O
.	O

Normocephalic	B-problem
,	O
atraumatic	B-problem
.	O

Pupils	O
are	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Extraocular	O
movements	O
intact	O
.	O

Oropharynx	O
clear	O
.	O

Neck	O
supple	O
.	O

Full	O
range	O
of	O
motion	O
,	O
no	O
lymphadenopathy	B-problem
.	O

No	O
thyromegaly	B-problem
.	O

Carotids	B-test
2+	O
bilaterally	O
without	O
bruits	B-problem
.	O

Lungs	O
clear	O
to	O
auscultation	B-test
bilaterally	O
.	O

Cardiac	O
:	O

Regular	O
rate	O
and	O
rhythm	O
.	O

No	O
murmurs	B-problem
,	O
rubs	B-problem
or	O
gallops	B-problem
.	O

Abdomen	B-problem
obese	I-problem
,	O
soft	O
,	O
nontender	B-problem
without	O
masses	B-problem
,	O
no	O
hepatosplenomegaly	B-problem
,	O
positive	O
bowel	O
sounds	O
without	O
cyanosis	B-problem
,	O
clubbing	B-problem
or	O
edema	B-problem
.	O

Pulses	B-test
2+	O
bilaterally	O
throughout	O
.	O

Neurological	O
:	O

Nonfocal	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
on	O
2015-06-10	O
and	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2015-06-11	O
where	O
coronary	B-treatment
artery	I-treatment
bypass	I-treatment
graft	I-treatment
times	O
four	O
was	O
performed	O
.	O

He	O
initially	O
required	O
nitroglycerin	B-treatment
drip	I-treatment
.	O

He	O
had	O
chest	B-treatment
tube	I-treatment
and	O
pacing	B-treatment
wires	I-treatment
in	O
place	O
.	O

Received	O
perioperative	B-treatment
Vancomycin	I-treatment
.	O

Postoperative	O
day	O
one	O
the	B-test
chest	I-test
x-ray	I-test
showed	O
a	B-problem
collapsed	I-problem
left	I-problem
upper	I-problem
lobe	I-problem
.	O

PEEP	B-treatment
was	O
increased	O
and	O
a	B-test
chest	I-test
x-ray	I-test
checked	O
the	O
following	O
morning	O
.	O

The	O
patient	O
subsequently	O
did	O
well	O
,	O
chest	B-treatment
tubes	I-treatment
were	O
removed	O
at	O
the	O
appropriate	O
time	O
,	O
pacing	B-treatment
wires	I-treatment
removed	O
at	O
the	O
appropriate	O
time	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
the	O
regular	O
cardiothoracic	O
floor	O
where	O
his	B-treatment
anti-hypertensives	I-treatment
were	O
manipulated	O
to	O
improve	O
his	B-test
heart	I-test
rate	I-test
and	O
blood	B-test
pressure	I-test
.	O

The	O
patient	O
did	O
well	O
on	O
the	O
floor	O
,	O
was	O
seen	O
by	O
physical	O
therapy	O
who	O
quickly	O
cleared	O
him	O
to	O
go	O
home	O
on	O
2015-06-15	O
and	O
the	O
patient	O
was	O
in	O
good	O
condition	O
.	O

Being	O
discharged	O
to	O
home	O
.	O

The	O
patient	O
may	O
shower	O
but	O
should	O
not	O
take	O
baths	O
.	O

Should	O
avoid	O
strenuous	O
activity	O
.	O

Should	O
not	O
drive	O
while	O
on	O
pain	B-treatment
medication	I-treatment
.	O

He	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Ellis	O
in	O
four	O
weeks	O
,	O
Dr.	O
Joseph	O
Overstreet	O
in	O
one	O
to	O
two	O
weeks	O
.	O

Dr.	O
Iola	O
Alexander	O
in	O
2	O
to	O
3	O
weeks	O
.	O

He	O
is	O
on	O
Lopressor	B-treatment
100	O
mg	O
twice	O
a	O
day	O
.	O

Metformin	B-treatment
500	O
mg	O
twice	O
a	O
day	O
.	O

Lasix	B-treatment
20	O
mg	O
twice	O
a	O
day	O
times	O
seven	O
days	O
.	O

Potassium	B-treatment
20	O
mEq	O
twice	O
a	O
day	O
times	O
seven	O
days	O
.	O

Potassium	B-treatment
chloride	I-treatment
20	O
mEq	O
times	O
seven	O
days	O
,	O
Plavix	B-treatment
75	O
mg	O
p.o.	O
q	O
day	O
,	O
Isosorbide	B-treatment
60	O
mg	O
q	O
day	O
,	O
Percocet	B-treatment
p.r.n.	O
,	O
Entericoated	B-treatment
aspirin	I-treatment
325	O
mg	O
q	O
day	O
.	O

Colace	B-treatment
100	O
mg	O
twice	O
a	O
day	O
p.r.n.	O

Lipitor	B-treatment
20	O
mg	O
p.o.	O
q	O
day	O
.	O

Folate	B-treatment
1	O
mg	O
q	O
day	O
.	O

DR.	O
Edwards	O
,	O
Brittany	O
92-534	O

Dictated	O
By	O
:	O
William	O
H	O
Centeno	O
,	O
M.D.	O

MEDQUIST36	O
PAD-WORD	O

D	O
:	O
2015-06-15	O
15:23	O

T	O
:	O
2015-06-15	O
16:16	O

JOB	O
#:	O
83178	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Timothy	O
BZ	O
Holmes	O
on	O
:	O
TUE	O
2015-06-16	O
4:15	O
PM	O

(	O
End	O
of	O
Report	O
)	O

892163777	O
PAD-WORD	O

TGCHO	O
PAD-WORD	O

3997057	O
PAD-WORD	O

299593	O
PAD-WORD	O

8/5/1998	O
12:00:00	O
AM	O

RULE	O
OUT	O
FOR	O
MYOCARDIAL	B-problem
INFARCTION	I-problem

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

FYFEREOSKOTE	O
,	O
CILLMA	O
M	O

UNIT	O
NUMBER	O
:	O

333-10-08	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

08/05/98	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

08/07/98	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Rule	O
out	O
for	O
myocardial	B-problem
infarction	I-problem

ASSOCIATED	O
DIAGNOSIS	O
:	O

1	O
)	O
aortic	B-problem
insufficiency	I-problem
;	O
2	O
)	O
Parkinson	B-problem
's	I-problem
Disease	I-problem
;	O
3	O
)	O
a	O
history	O
of	O
colon	B-problem
carcinoma	I-problem
;	O
4	O
)	O
congestive	B-problem
heart	I-problem
failure	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

An	B-test
exercise	I-test
tolerance	I-test
test	I-test
with	O
imaging	B-test
.	O

CHIEF	O
COMPLAINT	O
:	O

Right	B-problem
sided	I-problem
chest	I-problem
pain	I-problem
by	O
several	O
hours	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Miss	O
Siehjesc	O
is	O
an	O
85-year-old	O
woman	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
Parkinson	B-problem
's	I-problem
Disease	I-problem
of	O
ten	O
years	O
duration	O
,	O
supraventricular	B-problem
tachycardia	I-problem
,	O
and	O
a	O
history	O
of	O
colon	B-problem
carcinoma	I-problem
,	O
who	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
11:30	O
on	O
the	O
morning	O
of	O
admission	O
when	O
she	O
felt	O
the	O
acute	O
on	O
set	O
of	O
5	O
out	O
of	O
10	O
right	B-problem
sided	I-problem
chest	I-problem
pain	I-problem
with	O
radiation	B-problem
to	I-problem
her	I-problem
sternum	I-problem
but	O
not	O
to	O
her	O
neck	O
or	O
arms	O
or	O
back	O
.	O

It	O
was	O
not	O
relieved	O
by	O
2	B-treatment
sublingual	I-treatment
nitroglycerins	I-treatment
.	O

She	O
did	O
state	O
that	O
she	O
experienced	O
some	B-problem
shortness	I-problem
of	I-problem
breath	I-problem
(	O
her	O
usual	O
anginal	O
equivalent	O
)	O
and	O
believes	O
she	O
did	O
experience	O
some	B-problem
lightheadedness	I-problem
as	O
well	O
,	O
but	O
denies	O
blacking	O
out	O
or	O
falling	O
.	O

While	O
the	B-problem
pain	I-problem
was	O
initially	O
intermittent	O
,	O
it	O
became	O
steady	O
at	O
about	O
1:00	O
p.m.	O
at	O
which	O
time	O
she	O
presented	O
to	O
the	O
Tecal	O
Galecounxopt	O
Community	O
Hospital	O
Emergency	O
Room	O
and	O
following	O
this	O
experience	O
a	O
spontaneous	O
remission	O
of	O
her	B-problem
right	I-problem
sided	I-problem
pain	I-problem
.	O

Since	O
that	O
time	O
she	O
has	O
experience	O
occasional	O
episodes	O
of	O
the	B-problem
same	I-problem
focal	I-problem
chest	I-problem
pain	I-problem
but	O
finds	O
that	O
it	O
spontaneously	O
remits	O
.	O

It	O
is	O
made	O
better	O
by	O
direct	B-treatment
pressure	I-treatment
to	I-treatment
the	I-treatment
point	I-treatment
and	O
she	O
recalls	O
no	O
factors	O
which	O
worsened	O
it	O
.	O

She	O
is	O
admitted	O
to	O
rule	O
out	O
myocardial	B-problem
infarction	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1	O
)	O
Parkinson	B-problem
's	I-problem
Disease	I-problem
;	O

2	O
)	O
hypertension	B-problem
;	O

3	O
)	O
aorticsclerosis	B-problem
;	O

4	O
)	O
history	O
of	O
colon	B-problem
carcinoma	I-problem
;	O

5	O
)	O
severe	B-problem
kyphosis	I-problem
.	O

ALLERGIES	O
:	O

Codeine	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1	O
)	O
Lasix	B-treatment
20	O
mg.	O
PO	O
q.d.	O

2	O
)	O
Sinemet	B-treatment
25/100	O
1	O
t.i.d.	O

3	O
)	O
Cogentin	B-treatment
0.5	O
mg.	O
1	O
tabs	O
PO	O
q.a.m.	O
and	O
1	O
q.noon	O
as	O
well	O
as	O
1	O
q.h.s.	O

4	O
)	O
Eldepryl	B-treatment
5	O
mg.	O
PO	O
b.i.d.	O

5	O
)	O
Enteric	B-treatment
coated	I-treatment
aspirin	I-treatment
325	O
mg.	O
PO	O
q.d.	O

6	O
)	O
Potassium	B-treatment
chloride	I-treatment
10	O
mEq.	O
PO	O
q.d.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
smoked	O
one	O
pack	O
of	O
cigarettes	O
per	O
day	O
from	O
age	O
16	O
to	O
50	O
.	O

She	O
quit	O
35	O
years	O
ago	O
.	O

She	O
takes	O
one	O
sip	O
of	O
wine	O
on	O
Fridays	O
.	O

She	O
denies	O
any	O
history	O
of	O
elicit	O
drug	O
use	O
.	O

She	O
did	O
not	O
work	O
after	O
the	O
age	O
of	O
approximately	O
65	O
.	O

The	O
patient	O
is	O
now	O
widowed	O
.	O

She	O
lives	O
with	O
her	O
single	O
daughter	O
.	O

She	O
does	O
have	O
one	O
son	O
who	O
died	O
at	O
the	O
age	O
of	O
21	O
years	O
old	O
.	O

FAMILY	O
HISTORY	O
:	O

Is	O
significant	O
for	O
a	O
father	O
who	O
had	O
a	B-problem
stroke	I-problem
and	O
also	O
suffered	O
from	O
hypertension	B-problem
.	O

She	O
denies	O
any	O
family	O
history	O
of	O
diabetes	B-problem
mellitus	I-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
vital	I-test
signs	I-test
showed	O
a	B-test
temperature	I-test
of	O
96.8	O
,	O
heart	B-test
rate	I-test
80	O
,	O
blood	B-test
pressure	I-test
180/78	O
,	O
respiratory	B-test
rate	I-test
18	O
,	O
and	O
she	O
was	O
satting	B-test
95	O
percent	O
on	O
two	B-treatment
liters	I-treatment
nasal	I-treatment
cannula	I-treatment
.	O

In	O
general	O
the	O
patient	O
was	O
resting	O
comfortably	O
in	O
bed	O
with	O
a	B-problem
visible	I-problem
tremor	I-problem
of	I-problem
her	I-problem
right	I-problem
hand	I-problem
and	I-problem
foot	I-problem
.	O

The	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
,	O
normocephalic	O
,	O
atraumatic	B-problem
,	O
pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
extraocular	O
muscles	O
intact	O
,	O
sclera	B-problem
anicteric	I-problem
.	O

Neck	O
:	O

supple	O
,	O
no	O
bruits	B-problem
,	O
nodes	B-problem
or	O
thyromegaly	B-problem
.	O

Thorax	O
:	O

crackles	B-problem
at	I-problem
both	I-problem
bases	I-problem
,	O
kyphotic	B-problem
,	O
no	O
costovertebral	B-problem
angle	I-problem
tenderness	I-problem
.	O

Cardiovascular	O
exam	O
:	O

regular	O
rate	O
and	O
rhythm	O
with	O
1	B-problem
out	I-problem
of	I-problem
6	I-problem
systolic	I-problem
ejection	I-problem
murmur	I-problem
.	O

Abdomen	O
:	O

soft	O
,	O
well	B-problem
healed	I-problem
scar	I-problem
,	O
positive	O
bowel	O
sounds	O
,	O
no	O
tenderness	B-problem
or	O
organomegaly	B-problem
noted	O
.	O

Extremities	O
:	O

without	O
clubbing	B-problem
,	O
claudication	B-problem
,	O
or	O
edema	B-problem
.	O

Rectal	O
:	O

negative	O
per	O
the	O
emergency	O
room	O
.	O

Neurologically	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
x3	O
.	O

Tremors	B-problem
of	I-problem
the	I-problem
right	I-problem
hand	I-problem
and	I-problem
foot	I-problem
at	O
rest	O
.	O

Equivocal	B-problem
cogwheeling	I-problem
on	I-problem
the	I-problem
right	I-problem
,	O
normal	O
tone	O
on	O
the	O
left	O
.	O

LABORATORY	O
DATA	O
:	O

The	B-test
patient	I-test
's	I-test
SMA	I-test
7	I-test
was	O
notable	O
for	O
a	B-test
BUN	I-test
of	O
28	O
,	O
creatinine	B-test
1.3	O
,	O
and	O
a	B-test
glucose	I-test
of	O
102	O
.	O

Extended	O
chemistries	B-test
were	O
within	O
normal	O
limits	O
with	O
a	B-test
creatine	I-test
kinase	I-test
of	O
122	O
and	O
no	O
measured	B-test
methylene	I-test
blue	I-test
fraction	I-test
given	O
the	O
low	O
value	O
.	O

The	B-test
complete	I-test
blood	I-test
count	I-test
was	O
notable	O
for	O
a	B-test
white	I-test
count	I-test
of	O
5.3,000	O
,	O
hematocrit	B-test
39	O
1/2	O
and	O
platelet	B-test
count	I-test
of	O
180,000	O
and	O
normal	O
coags	O
were	O
measured	O
.	O

RADIOLOGY	O
:	O

Portable	B-test
chest	I-test
x-ray	I-test
was	O
without	O
evidence	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
or	O
pneumonia	B-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
proceeded	O
to	O
rule	O
out	O
formyocardial	B-problem
infarction	I-problem
by	O
enzymes	B-test
.	O

Additionally	O
,	O
the	O
patient	O
underwent	O
a	B-test
exercise	I-test
stress	I-test
test	I-test
on	O
8/6/98	O
with	O
a	B-test
heart	I-test
rate	I-test
proceeding	O
from	O
76	O
to	O
93	O
beats	O
per	O
minute	O
.	O

There	O
were	O
no	O
electrocardiogram	B-problem
changes	I-problem
noted	O
and	O
there	O
were	O
no	O
arrhythmias	B-problem
noted	O
as	O
well	O
.	O

During	O
the	B-test
test	I-test
the	O
patient	O
experienced	O
no	O
chest	B-problem
pressure	I-problem
or	O
pain	B-problem
or	O
dyspnea	B-problem
and	O
nuclear	B-test
medical	I-test
imaging	I-test
was	O
without	O
evidence	O
of	O
ischemia	B-problem
.	O

The	O
patient	O
was	O
in	O
this	O
fashion	O
discharged	O
from	O
the	O
service	O
to	O
continue	O
on	O
her	B-treatment
current	I-treatment
medications	I-treatment
and	O
to	O
call	O
in	O
oneweek	O
to	O
follow	O
up	O
with	O
Dr.	O
Sterpbreutzsterp	O
and	O
Cardiology	O
.	O

The	O
patient	O
already	O
had	O
a	O
follow	O
up	O
appointment	O
with	O
Dr.	O
Sterpbreutzsterp	O
in	O
three	O
weeks	O
,	O
and	O
was	O
instructed	O
to	O
keep	O
that	O
appointment	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1)	O
Lasix	B-treatment
20	O
mg.	O
PO	O
q.d.	O

2)	O
Sinemet	B-treatment
25/100	O
PO	O
t.i.d.	O

3)	O
Cogentin	B-treatment
0.5	O
mg.	O
2	O
tabs	O
q.a.m.	O
,	O
1	O
q.lunch	O
time	O
,	O
1	O
q.bed	O
time	O
.	O

4)	O
Eldepryl	B-treatment
5	O
mg.	O
PO	O
q.d.	O

5)	O
Enteric	B-treatment
coated	I-treatment
aspirin	I-treatment
325	O
mg.	O
PO	O
q.d.	O

6)	O
Potassium	B-treatment
chloride	I-treatment
10	O
mEq.	O
PO	O
q.d.	O

7)	O
Metoprolol	B-treatment
25	O
mg.	O
PO	O
b.i.d.	O

DOCTOR	O
'	O
S	O
DISCHARGE	O
ORDERS	O
:	O

The	O
patient	O
will	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Stoa	O
Sterpbreutzsterp	O
as	O
has	O
already	O
been	O
scheduled	O
three	O
weeks	O
after	O
the	O
discharge	O
date	O
.	O

NILA	O
H.	O
LEFT	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

STOA	O
STERPBREUTZSTERP	O
,	O
M.D.	O

TR	O
:	O

fgz	O
PAD-WORD	O

DD	O
:	O

10/12/98	O
PAD-WORD	O

TD	O
:	O

10/17/98	O
11:52	O

Acc	O
:	O

NILA	O
H	O
LEFT	O
,	O
M.D.	O
STOA	O
STERPBREUTZSTERP	O
,	O
M.D.	O

895872725	O
ELMVH	O

99080881	O
PAD-WORD	O

979718	O
PAD-WORD	O

5/25/2002	O
12:00:00	O
AM	O

Chest	B-problem
pain	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

05/25/2002	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

05/27/2002	O
PAD-WORD	O

******	O
DISCHARGE	O
ORDERS	O
******	O

FYFEWIERST	O
,	O
MIER	O

799-99-77-2	O
X12	O

Room	O
:	O

33C-139	O
PAD-WORD	O

Service	O
:	O

CAR	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

05/27/02	O
AT	O
04:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

SAGELYSS	O
,	O
TYTUMZE	O
VACHOLLE	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
PAD-WORD	O

DISCHARGE	O
MEDICATIONS	O
:	O

LOPRESSOR	B-treatment
(	I-treatment
METOPROLOL	I-treatment
TARTRATE	I-treatment
)	I-treatment
12.5	O
MG	O
PO	O
BID	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

ENALAPRIL	B-treatment
MALEATE	I-treatment
20	O

MG	O
PO	O
BID	O
DIET	O
:	O

House	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O

Activity	O
-	O
As	O
tolerated	O

RETURN	O
TO	O
WORK	O
:	O

After	O
Appt	O
with	O
local	O
physician	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Hashimoto	O
,	O
No	O
Known	B-problem
Allergies	I-problem

ADMIT	O
DIAGNOSIS	O
:	O

chest	B-problem
pressure	I-problem
;	O
r	O
/	O
o	O
mi	B-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Chest	B-problem
pain	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

Chest	B-problem
pain	I-problem
;	O
R	O
/	O
o	O

MI	B-problem
PAD-WORD	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Echocardiogram	B-test
MRA	B-test
Kidney	I-test

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

51	O
yo	O
F	O
h	O
/	O
o	O
HTN	B-problem
,	O
hyperchol	B-problem
,	O
p	O
/	O
w	O
SS	B-problem
chest	I-problem
pressure	I-problem
x	O
3	O
days	O
.	O

USOH	O
until	O
3	O
day	O
PTa	O
,	O
dev	O
new	B-problem
SS	I-problem
chest	I-problem
pressure	I-problem
sometimes	O
rad	O
to	O
back	O
and	O
L	O
neck	O
/	O
jaw	O
.	O

Not	O
assoc	O
with	O
exertion	O
(	O
pt	O
has	O
active	O
lifestyle	O
)	O
.	O

Pressure	B-problem
lasted	O
for	O
hours	O
at	O
a	O
time	O
.	O

Variably	O
assoc	O
with	O
SOB	B-problem
,	O
nausea	B-problem
,	O
palpitations	B-problem
,	O
tremulousness	B-problem
,	O
diaphoresis	B-problem
.	O

Pt	O
has	O
HTN	B-problem
,	O
measured	O
BP	B-test
home	O
200/100	O
.	O

Reported	O
to	O
a	O
local	O
ED	O
was	O
found	O
to	O
have	O
BP	B-test
up	O
to	O
200/100	O
.	O

Put	O
on	O
NTG	B-treatment
drip	I-treatment
without	O
relief	O
.	O

Pain	B-problem
2/10	O
persisted	O
,	O
relieved	O
by	O
MSO4	B-treatment
.	O

At	O
ELMVH	O
ED	O
,	O
BP	B-test
160/87	O
.	O

Now	O
adm	O
for	O
r	O
/	O
o	O
MI	B-problem
,	O
eval	B-test
of	O
?	O
demand	B-problem
ischemia	I-problem
,	O
plus	O
w	B-test
/	I-test
u	I-test
of	O
HTN	B-problem
urgency	I-problem
(	O
which	O
may	O
be	O
very	O
new	O
in	O
onset	O
)	O
.	O

PE	B-test
T97.5	B-test
P59	B-test
BP	B-test
(	O
l	O
)	O
180/86	O
(	O
r	O
)	O
186/98	O
RR20	B-test
98%	O
2L	B-treatment
.	O

Exam	B-test
only	O
notable	O
for	O
II	B-problem
/	I-problem
VI	I-problem
systolic	I-problem
murmur	I-problem
.	O

Labs	B-test
only	O
notable	O
for	O
CK	B-test
54	O
(	O
nl	O
)	O
,	O
Trop	B-test
0.03	O
,	O
Hct	B-test
35.6	O
MCV	B-test
79	O
.	O

EKG	B-test
LBBB	B-problem
NSR	O
.	O

CXR	B-test
negative	O
.	O

Plan	O
ROMI	B-test
protocol	I-test
.	O

CP	B-treatment
protocol	I-treatment
.	O

Captopril	B-treatment
and	O
nitropaste	B-treatment
to	O
control	O
pressure	B-problem
.	O

MSO4	B-treatment
for	O
CP	B-problem
.	O

Echo	B-test
,	O
MRA	B-test
(	O
r	O
/	O
o	O
dissection	B-problem
)	O
,	O
urine	B-test
catecholamines	I-test
and	O
VMA	B-test
.	O

Guaiac	B-test
all	I-test
stools	I-test
,	O
check	O
iron	B-test
studies	I-test
.	O

HOSPITAL	O
COURSE	O

1.	O
Chest	B-problem
Pain	I-problem

-	O
Pt	O
placed	O
on	O
captopril	B-treatment
25	O
tid	O
,	O
lopressor	B-treatment
12.5	O
BID	O
and	O
NTG	B-treatment
paste	I-treatment
SS	O
,	O
achieving	O
normal	O
BP	O
w	O
/	O
in	O
5	O
hrs	O
of	O
adm	O
to	O
floor	O
.	O

Her	B-problem
CPress	I-problem
dissappeared	O
over	O
the	O
same	O
timeframe	O
.	O

-	O
pt	O
r&apos;d	O
/	O
o	O
for	O
mi	B-problem
by	O
CPK	B-test
(	O
54-&gt;	O
38-&gt;	O
33	O
)	O
and	O
TPN	B-test
(	O
0.03	O
)	O
,	O
and	O
stable	O
EKG	O
.	O

2.	O
Hypertension	B-problem

-	O
controlled	O
on	O
captopril	B-treatment
+	O
lopressor	B-treatment
to	O
110-130s	O
;	O
NTG	B-treatment
paste	I-treatment
causing	O
30	O
pt	O
drop	O
so	O
d	O
/	O
c&apos;d	O
.	O

-	O
MRA	B-test
kidney	I-test
:	O

no	O
stenosis	B-problem
;	O
no	O
parenchymal	B-problem
lesions	I-problem

-	O
CXR	B-test
:	O

no	O
obvious	B-problem
mediastinal	I-problem
widening	I-problem
,	O
but	O
no	O
comp	B-test
arison	I-test
film	I-test
;	O
wnl	O

-	O
echo	B-test
:	O

prelim	O
:	O

EF	B-test
55-60	O
,	O
?	O
septal	B-problem
flattening	I-problem
,	O
mild	B-problem
TR	I-problem
and	O
MR	B-problem
,	O
trace	B-problem
effusion	I-problem
-24h	B-test
urine	I-test
study	I-test
:	O

pending	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Satisfactory	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

MEED	O
,	O
CILE	O
PRILARA	O
,	O
M.D.	O
,	O
PH.D.	O
(	O
RG185	O
)	O
05/27/02	O
05:35	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

901751538	O
PAD-WORD	O

CTMC	O
PAD-WORD	O

71624078	O
PAD-WORD	O

425615	O
PAD-WORD	O

2/3/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

02/03/1992	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

02/07/1992	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

STERNAL	B-problem
WOUND	I-problem
INFECTION	I-problem
.	O

SECONDARY	O
DIAGNOSES	O
:	O

STATUS	O
POST	O
ORTHOTOPIC	B-treatment
CARDIAC	I-treatment
TRANSPLANT	I-treatment
.	O

INSULIN	B-problem
DEPENDENT	I-problem
DIABETES	I-problem
MELLITUS	I-problem
.	O

DILATED	B-problem
CARDIOMYOPATHY	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
48-year-old	O
white	O
man	O
who	O
is	O
20	O
days	O
status	O
post	O
orthotopic	B-treatment
cardiac	I-treatment
transplant	I-treatment
who	O
was	O
readmitted	O
for	O
sternal	B-problem
wound	I-problem
infection	I-problem
.	O

He	O
has	O
insulin	B-problem
dependent	I-problem
diabetes	I-problem
mellitus	I-problem
and	O
a	O
history	O
of	O
a	B-problem
dilated	I-problem
cardiomyopathy	I-problem
.	O

He	O
had	O
progressive	O
symptoms	O
of	O
congestive	B-problem
heart	I-problem
failure	I-problem
which	O
led	O
to	O
his	B-test
evaluation	I-test
of	O
his	B-treatment
cardiac	I-treatment
transplant	I-treatment
in	O
March	O
of	O
1991	O
.	O

Preoperatively	O
,	O
he	O
had	O
a	B-problem
severely	I-problem
dilated	I-problem
left	I-problem
ventricle	I-problem
with	O
markedly	B-problem
diminished	I-problem
function	I-problem
.	O

His	O
post	O
transplant	O
course	O
was	O
initially	O
complicated	O
by	O
hyperglycemia	B-problem
and	O
seizure	B-problem
on	O
postoperative	O
day	O
number	O
one	O
.	O

He	O
was	O
,	O
however	O
,	O
extubted	O
without	O
difficulty	O
and	O
after	O
that	O
did	O
quite	O
well	O
.	O

He	O
had	O
a	B-test
predischarge	I-test
biopsy	I-test
.	O

He	O
felt	O
well	O
at	O
home	O
without	O
fevers	B-problem
,	O
chills	B-problem
or	O
rigors	B-problem
.	O

There	O
were	O
no	O
rashes	B-problem
.	O

He	O
had	O
no	O
chest	B-problem
pain	I-problem
or	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

When	O
he	O
was	O
seen	O
on	O
2/3	O
in	O
the	O
Transplant	O
Clinic	O
,	O
his	B-problem
incision	I-problem
was	O
noted	O
to	O
be	O
more	B-problem
erythematous	I-problem
.	O

He	O
was	O
referred	O
to	O
the	O
Surgical	O
Clinic	O
where	O
the	B-problem
wound	I-problem
was	O
opened	O
and	O
the	O
patient	O
was	O
admitted	O
for	O
intravenous	B-treatment
antibiotics	I-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
revealed	O
a	O
middle	O
aged	O
man	O
in	O
no	O
distress	B-problem
.	O

Blood	B-test
pressure	I-test
was	O
152/88	O
.	O

Heart	B-test
rate	I-test
90	O
.	O

Respiratory	B-test
rate	I-test
14	O
.	O

HEENT	B-test
exam	I-test
was	O
within	O
normal	O
limits	O
.	O

Neck	O
was	O
without	O
bruits	B-problem
.	O

Lungs	O
were	O
clear	O
bilaterally	O
.	O

Cardiac	B-test
exam	I-test
showed	O
a	O
normal	O
PMI	O
,	O
regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
S1	O
,	O
physiologically	B-problem
split	I-problem
S2	I-problem
.	O

There	O
was	O
an	B-problem
S4	I-problem
.	O

There	O
were	O
no	O
murmurs	B-problem
or	O
rubs	B-problem
.	O

Abdomen	O
was	O
benign	O
.	O

Extremities	O
were	O
2+	B-problem
pedal	I-problem
edema	I-problem
to	O
the	O
knees	O
.	O

Examination	B-test
of	O
the	B-problem
sternal	I-problem
wound	I-problem
showed	O
an	O
opened	O
area	O
in	O
the	O
mid	O
region	O
of	O
the	B-problem
wound	I-problem
with	O
serosanguineous	B-problem
drainage	I-problem
and	O
a	B-problem
scant	I-problem
amount	I-problem
of	I-problem
thick	I-problem
,	I-problem
yellow	I-problem
pus	I-problem
.	O

There	O
was	O
no	O
induration	B-problem
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
revealed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
9.46	O
with	O
89%	O
polys	B-test
,	O
2%	O
bands	B-test
,	O
7%	O
lymphocytes	B-test
,	O
2%	O
monocytes	B-test
.	O

Cyclosporin	B-test
A	I-test
level	I-test
on	O
admission	O
was	O
179	O
.	O

Microscopic	B-test
exam	I-test
showed	O
4+	B-problem
Staph	I-problem
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
pancultured	O
.	O

He	O
was	O
treated	O
with	O
vancomycin	B-treatment
and	O
ceftazidime	B-treatment
while	O
awaiting	O
wound	B-test
cultures	I-test
.	O

He	O
had	O
dressing	B-treatment
changes	I-treatment
twice	O
a	O
day	O
.	O

Surgery	O
was	O
consulted	O
and	O
followed	O
him	O
while	O
he	O
was	O
in	O
house	O
.	O

Cyclosporin	B-test
levels	I-test
were	O
followed	O
and	O
his	B-test
sugars	I-test
were	O
followed	O
with	O
a	B-treatment
sliding	I-treatment
scale	I-treatment
.	O

During	O
the	O
first	O
two	O
days	O
,	O
he	O
required	O
14	B-treatment
and	I-treatment
22	I-treatment
units	I-treatment
of	I-treatment
additional	I-treatment
coverage	I-treatment
.	O

However	O
,	O
by	O
day	O
three	O
he	O
required	O
no	O
additional	B-treatment
insulin	I-treatment
coverage	I-treatment
.	O

On	O
the	O
day	O
prior	O
to	O
discharge	O
,	O
his	B-treatment
intravenous	I-treatment
antibiotics	I-treatment
were	O
discontinued	O
and	O
he	O
was	O
begun	O
on	O
tetracycline	B-treatment
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
.	O

MEDICATIONS	O
:	O

On	O
discharge	O
included	O
tetracycline	B-treatment
,	O
250	O
mg	O
po	O
q.i.d.	O
;	O
cyclosporin	B-treatment
,	O
325	O
mg	O
po	O
b.i.d.	O
;	O
prednisone	B-treatment
,	O
30	O
mg	O
po	O
q	O
day	O
;	O
Bactrim	B-treatment
DS	I-treatment
,	O
one	O
po	O
q.o.d.	O
;	O
diltiazem	B-treatment
,	O
30	O
mg	O
po	O
q.i.d.	O
;	O
Mycostatin	B-treatment
,	O
15	O
cc	O
swish	O
and	O
swallow	O
q.i.d.	O
;	O
Lasix	B-treatment
,	O
40	O
mg	O
po	O
q	O
day	O
;	O
Colace	B-treatment
,	O
100	O
mg	O
po	O
q.i.d.	O
;	O
Carafate	B-treatment
,	O
1	O
gram	O
po	O
q.i.d.	O
;	O
Imuran	B-treatment
,	O
50	O
mg	O
po	O
t.i.d.	O
;	O
NPH	B-treatment
insulin	I-treatment
,	O
44	O
units	O
and	O
10	O
units	O
of	O
regular	O
q	O
a.m.	O
;	O
NPH	B-treatment
,	O
22	O
units	O
and	O
8	O
units	O
of	O
regular	O
q	O
p.m.	O

PM296/2413	O
RI	O
SEEN	O
,	O
M.D.	O
MC0	O

D	O
:	O

02/26/92	O
PAD-WORD	O

Batch	O
:	O

4373	O
PAD-WORD	O

Report	O
:	O

O8919E48	O
PAD-WORD	O

T	O
:	O

02/27/92	O
PAD-WORD	O

Dicatated	O
By	O
:	O

SUSHA	O
I.	O
RHIM	O
,	O
M.D.	O

917563546	O
ELMVH	O

73397283	O
PAD-WORD	O

7646550	O
PAD-WORD	O

1/23/2003	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

01/23/2003	O
PAD-WORD	O

Date	O
of	O
Discharge	O
:	O

01/23/2003	O
PAD-WORD	O

ATTENDING	O
:	O

DOTA	O
SPACE	O
M.D.	O

ADMITTING	O
DIAGNOSIS	O
:	O

Lumbar	B-problem
spinal	I-problem
stenosis	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

L2	B-treatment
to	I-treatment
L5	I-treatment
laminectomy	I-treatment
,	O
L2	B-treatment
through	I-treatment
L5	I-treatment
posterior	I-treatment
fusion	I-treatment
with	O
segmental	B-treatment
instrumentation	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
50-year-old	O
female	O
with	O
history	O
of	O
low	B-problem
back	I-problem
pain	I-problem
radiating	B-problem
to	I-problem
both	I-problem
legs	I-problem
.	O

She	O
had	O
increasing	B-problem
symptoms	I-problem
overtime	O
,	O
not	O
controlled	O
by	O
conservative	B-treatment
management	I-treatment
.	O

She	O
therefore	O
elected	O
to	O
undergo	O
surgical	B-treatment
treatment	I-treatment
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Her	O
past	O
medical	O
history	O
is	O
notable	O
for	O
bilateral	B-problem
lower	I-problem
extremity	I-problem
venous	I-problem
insufficiency	I-problem
with	O
edema	B-problem
,	O
hypertension	B-problem
.	O

She	O
takes	O
lisinopril	B-treatment
/	O
hydrochlorothiazide	B-treatment
20/25	O
mg	O
p.o.	O
q.d.	O
,	O
Vioxx	B-treatment
50	O
mg	O
p.o.	O
q.d.	O
,	O
Lipitor	B-treatment
10	O
mg	O
p.o.	O
q.d.	O
,	O
Nortriptyline	B-treatment
25	O
mg	O
p.o.	O
q.h.s.	O
,	O
Neurontin	B-treatment
300	O
mg	O
p.o.	O
t.i.d.	O

ALLERGIES	O
:	O

She	O
has	O
nausea	B-problem
with	O
Codeine	B-treatment
otherwise	O
no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Past	O
surgical	O
history	O
is	O
notable	O
of	O
D	B-test
and	O
C	B-test
in	O
1980	O
and	O
cyst	B-treatment
excision	I-treatment
.	O

HABITS	O
:	O

She	O
denies	O
smoking	O
or	O
alcohol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	B-test
,	O
her	O
lungs	O
were	O
clear	O
.	O

She	O
had	O
a	O
regular	O
heart	O
rate	O
and	O
rhythm	O
.	O

She	O
had	O
2+	B-test
bilateral	I-test
DP	I-test
and	O
radial	B-test
pulses	I-test
.	O

She	O
has	O
mild	B-problem
swelling	I-problem
in	I-problem
both	I-problem
lower	I-problem
extremities	I-problem
.	O

She	O
has	O
pain	B-problem
with	O
straight	O
leg	O
raise	O
,	O
left	O
greater	O
than	O
right	O
and	O
5/5	O
strength	O
in	O
right	O
quads	O
compared	O
to	O
4/5	O
on	O
the	O
left	O
.	O

Please	O
see	O
Dr.	O
Uph	O
&apos;s	O
office	O
note	O
for	O
further	O
details	O
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
01/16/2003	O
for	O
decompression	B-treatment
at	I-treatment
L2	I-treatment
,	I-treatment
L5	I-treatment
and	O
laminectomy	B-treatment
with	O
posterior	B-treatment
instrumented	I-treatment
fusion	I-treatment
at	I-treatment
L3	I-treatment
to	I-treatment
L5	I-treatment
.	O

She	O
tolerated	O
the	B-treatment
surgery	I-treatment
well	O
.	O

She	O
was	O
transferred	O
to	O
recovery	O
room	O
in	O
stable	O
condition	O
.	O

She	O
received	O
blood	B-treatment
transfusions	I-treatment
intraoperatively	O
and	O
postoperatively	O
in	O
addition	O
to	O
autologous	B-treatment
blood	I-treatment
.	O

Her	B-test
hematocrit	I-test
was	O
stable	O
postoperatively	O
.	O

Her	B-test
neurologic	I-test
exam	I-test
was	O
stable	O
postoperatively	O
with	O
5/5	O
bilaterally	O
,	O
tibial	O
,	O
EHL	O
,	O
FHL	O
,	O
gastroc	O
soleus	O
,	O
and	O
intact	O
quadriceps	O
.	O

She	O
has	O
intact	O
sensation	O
L3	O
to	O
S1	O
and	O
bilateral	O
lower	O
extremities	O
.	O

She	O
was	O
fitted	O
for	O
Verholl	B-treatment
Aet	I-treatment
over	I-treatment
leg	I-treatment
brace	I-treatment
and	O
mobilized	O
out	O
of	O
the	O
bed	O
in	O
the	B-treatment
brace	I-treatment
with	O
physical	B-treatment
therapy	I-treatment
.	O

Her	B-problem
wounds	I-problem
were	O
stable	O
without	O
any	B-problem
erythema	I-problem
or	O
drainage	B-problem
.	O

She	O
reported	O
nausea	B-problem
on	O
pain	B-treatment
medications	I-treatment
.	O

Her	B-treatment
pain	I-treatment
medications	I-treatment
were	O
changed	O
around	O
until	O
an	O
acceptable	O
regime	O
was	O
accomplished	O
.	O

She	O
is	O
stable	O
for	O
discharge	O
to	O
rehab	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

She	O
should	O
continue	O
to	O
wear	O
the	B-treatment
brace	I-treatment
when	O
out	O
of	O
bed	O
and	O
there	O
should	O
be	O
no	O
heavy	O
lifting	O
,	O
twisting	O
or	O
bending	O
activities	O
.	O

She	O
will	O
need	O
to	O
follow	O
up	O
with	O
Dr.	O
Uph	O
on	O
02/21/03	O
at	O
9:30	O
a.m.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Tylenol	B-treatment
650	O
mg	O
p.o.	O
q.4h.	O
p.r.n.	O
,	O
Benadryl	B-treatment
25	O
mg	O
p.o.	O
q.h.s.	O
p.r.n.	O
,	O
Colace	B-treatment
100	O
mg	O
p.o.	O
q.i.d.	O
,	O
Nortriptyline	B-treatment
25	O
mg	O
p.o.	O
q.h.s.	O
,	O
Simvastatin	B-treatment
10	O
mg	O
p.o.	O
q.h.s.	O
,	O
Metamucil	B-treatment
one	O
packet	O
p.o.	O
b.i.d.	O
p.r.n.	O
,	O
Neurontin	B-treatment
300	O
mg	O
p.o.	O
t.i.d.	O
,	O
Levsinex	B-treatment
0.375	O
mg	O
p.o.	O
q.12h.	O
,	O
Lisinopril	B-treatment
/	O
hydrochlorothiazide	B-treatment
20/25	O
mg	O
p.o.	O
q.d.	O
,	O
hydrocortisone	B-treatment
topical	I-treatment
ointment	I-treatment
to	O
affected	B-problem
areas	I-problem
,	O
MS	B-treatment
Contin	I-treatment
30	O
mg	O
p.o.	O
b.i.d.	O
,	O
MSIR	B-treatment
15	O
to	O
30	O
mg	O
p.o.	O
q.4h.	O
p.r.n.	O
pain	B-problem
.	O

The	O
patient	O
should	O
continue	O
to	O
have	O
dry	B-treatment
sterile	I-treatment
dressings	I-treatment
to	O
her	B-problem
back	I-problem
and	I-problem
iliac	I-problem
crest	I-problem
wounds	I-problem
until	O
follow	O
up	O
with	O
Dr.	O
Uph	O
.	O

Should	O
there	O
be	O
any	B-problem
wound	I-problem
erythema	I-problem
or	O
drainage	B-problem
,	O
please	O
contact	O
Dr.	O
Uph	O
&apos;s	O
office	O
immediately	O
.	O

eScription	O
document	O
:	O

2-7712488	O
ZNHKjeu	O
Tel	O

Dictated	O
By	O
:	O

MAULPLACKAGNELEEB	O
,	O
INACHELLE	O

Attending	O
:	O

SPACE	O
,	O
DOTA	O
Dictation	O
ID	O
3624752	O

D	O
:	O

01/23/03	O
PAD-WORD	O

T	O
:	O

01/23/03	O
PAD-WORD	O

948986258	O
YC	O

28079279	O
PAD-WORD	O

1027681	O
PAD-WORD	O

04/06/2005	O
12:00:00	O
AM	O

abdominal	B-problem
fluid	I-problem
collection	I-problem

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

04/06/2005	O
PAD-WORD	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

04/12/2005	O
PAD-WORD	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

LILEY	O
,	O
PEANTSALL	O
885-17-29-8	O
M12	O

Room	O
:	O

5Y-704	O
PAD-WORD	O

Service	O
:	O

GGI	O
PAD-WORD	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

04/12/05	O
AT	O
01:00	O
PM	O

CONTINGENT	O
UPON	O

HO	B-test
evaluation	I-test

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O
PAD-WORD	O

Attending	O
:	O

LILEY	O
,	O
BER	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O
w/	O
services	O

DISCHARGE	O
MEDICATIONS	O
:	O

MOTRIN	B-treatment
(	I-treatment
IBUPROFEN	I-treatment
)	I-treatment
600	O
MG	O
PO	O
Q6H	O
PRN	O
Pain	B-problem
,	O
Headache	B-problem
,	O
Temperature	B-test
greater	O
than	O
:	O

100	O
PAD-WORD	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
FLAGYL	B-treatment
(	I-treatment
METRONIDAZOLE	I-treatment
)	I-treatment
500	O
MG	O
PO	O
Q8H	O
X	O
10	O
Days	O
Starting	O
Today	O
(	O
04/12	O
)	O

Instructions	O
:	O

Take	O
for	O
10	O
days	O
or	O
until	O
drains	B-treatment
come	O
out	O
;	O
whichever	O
is	O
of	O
longer	O
duration	O
.	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
OXYCODONE	B-treatment
10	O
MG	O
PO	O
Q4H	O
PRN	O
Pain	B-problem
LEVOFLOXACIN	B-treatment
500	O
MG	O
PO	O
QD	O
X	O
10	O
Days	O
Starting	O
Today	O
(	O
04/12	O
)	O

Instructions	O
:	O

Take	O
for	O
10	O
days	O
or	O
until	O
drains	B-treatment
come	O
out	O
;	O
whichever	O
is	O
of	O
longer	O
duration	O
.	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Administer	O
iron	B-treatment
products	I-treatment
a	O
minimum	O
of	O
2	O
hours	O
before	O
or	O
after	O
a	B-treatment
levofloxacin	I-treatment
or	O
ciprofloxacin	B-treatment
dose	I-treatment
dose	O
If	O
on	O
tube	B-treatment
feeds	I-treatment
,	O
please	O
cycle	O
(	O
hold	O
1	O
hr	O
before	O
to	O
2	O
hr	O
after	O
)	O

Take	O
2	O
hours	O
before	O
or	O
2	O
hours	O
after	O
dairy	O
products	O
.	O

MAALOX-TABLETS	B-treatment
QUICK	I-treatment
DISSOLVE	I-treatment
/	I-treatment
CHEWABLE	I-treatment
2	O
TAB	O
PO	O
Q6H	O
PROTONIX	B-treatment
(	I-treatment
PANTOPRAZOLE	I-treatment
)	I-treatment
40	O
MG	O
PO	O
QD	O

DIET	O
:	O

House	B-treatment
/	I-treatment
Low	I-treatment
Residue	I-treatment
&lt;	O
FDI	O
&gt;	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Liley	O
,	O
call	O
ASAP	O
to	O
schedule	O
1-2	O
weeks	O
,	O
Your	O
primary	O
care	O
physician	O
1-2	O
weeks	O
,	O
Interventional	O
Radiology	O
,	O
call	O
329-125-0028	O
to	O
schedule	O
an	O
appointment	O
when	O
drain	B-test
outputs	I-test
are	O
less	O
than	O
10cc	O
/	O
day	O
.	O
,	O

ALLERGY	O
:	O

NKA	B-problem
PAD-WORD	O

ADMIT	O
DIAGNOSIS	O
:	O

abdominal	B-problem
fluid	I-problem
collection	I-problem

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
abdominal	B-problem
fluid	I-problem
collection	I-problem

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
liver	B-problem
hemangioma	I-problem
,	O
bph	B-problem
,	O
gout	B-problem
,	O
meningioma	B-problem
,	O
gerd	B-problem
,	O
episodic	B-problem
vertigo	I-problem
,	O
s	O
/	O
p	O
r	B-treatment
colectomy	I-treatment
,	O
subtotal	B-treatment
colectomy	I-treatment

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

NONE	O
PAD-WORD	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

IR	B-treatment
drainage	I-treatment
X2	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

HPI	O
This	O
is	O
a	O
60	O
yo	O
gentleman	O
who	O
previously	O
had	O
an	B-treatment
ileocolic	I-treatment
resection	I-treatment
for	O
a	B-problem
right	I-problem
colon	I-problem
cancer	I-problem
,	O
and	O
was	O
found	O
to	O
have	O
recurrent	B-problem
disease	I-problem
on	O
colonoscopy	B-test
.	O

He	O
was	O
also	O
found	O
to	O
have	O
a	B-problem
malignant	I-problem
lesion	I-problem
in	I-problem
his	I-problem
descending	I-problem
colon	I-problem
.	O

He	O
had	O
a	B-treatment
subtotal	I-treatment
colectomy	I-treatment
on	O
03/22/05	O
which	O
was	O
uncomplicated	O
.	O

Postop	O
he	O
has	O
had	O
numerous	O
visits	O
to	O
the	O
ED	O
for	O
co	O
fevers	B-problem
,	O
sweats	B-problem
,	O
and	O
SOB	B-problem
.	O

CTS	B-test
chest	I-test
was	O
negative	O
for	O
PE	B-problem
,	O
however	O
it	O
did	O
reveal	O
pulmonary	B-problem
nodules	I-problem
in	I-problem
his	I-problem
RML	I-problem
which	O
need	O
fu	B-test
imaging	I-test
in	O
3	O
months	O
.	O

He	O
also	O
had	O
bl	B-problem
atelectasis	I-problem
on	O
cxr	B-test
.	O

CT	B-test
of	I-test
the	I-test
abdomen	I-test
showed	O
a	B-problem
collection	I-problem
in	I-problem
the	I-problem
RLQ	I-problem
which	O
appears	O
to	O
be	O
amenable	O
to	O
IR	B-treatment
drainage	I-treatment
.	O

He	O
also	O
has	O
had	O
urine	B-test
and	I-test
blood	I-test
cultures	I-test
sent	O
from	O
the	O
ED	O
on	O
04/05	O
and	O
was	O
empirically	O
started	O
on	O
avalox	B-treatment
last	O
pm	O
.	O

PMH	O
GERD	B-problem
,	O
HTN	B-problem
,	O
Gout	B-problem
,	O
Meningioma	B-problem
,	O
liver	B-problem
hemangioma	I-problem
,	O
episodic	B-problem
vertigo	I-problem
,	O
colon	B-problem
cancer	I-problem
.	O

MEDS	B-treatment
PAD-WORD	O

Protonix	B-treatment
40	O
qd	O
,	O
Colchicine	B-treatment
6	O
mg	O
bid	O
,	O
Meclizine	B-treatment
25	O
mg	O
qid	O
prn	O
,	O
glucosamine	B-treatment
and	O
oxycodone	B-treatment
prn	O
,	O
tessalon	B-treatment
prn	O
.	O

ALL	O
NKDA	B-problem
SH	O
No	O
smoking	O
PE	O

GEN	O
-	O
NAD	B-problem

HEENT	O
--	O
perrla	O
,	O
eomi	O
,	O
mmm	O
,	O
tongue	O
midline	O
,	O
op	O
clear	O
,	O
no	O
masses	B-problem

NECK	O
--	O
no	O
jvd	B-problem
/	O
lad/	B-problem
;	O
trachea	O
midline	O
CARD	O
-	O
RRR	O
,	O
S1/S2	O
,	O
no	O
m	B-problem
/	O
r/g	B-problem

PULM	O
-	O
CTAB	O
no	O
w	B-problem
/	I-problem
r	I-problem
/	I-problem
r	I-problem
ABD	O
-nt	B-problem
/	O
nd	B-problem
;	O
incision	B-problem
c	O
/	O
d	O
/	O
I	O
;	O
discrete	B-problem
3x3	I-problem
cm	I-problem
slightly	I-problem
firm	I-problem
protuberant	I-problem
mass	I-problem
to	I-problem
the	I-problem
R	I-problem
of	I-problem
umbilicus	I-problem
;	O
no	O
rebound	B-problem
,	O
no	O
guarding	B-problem
.	O

BACK	O
-	O
no	O
flank	B-problem
tenderness	I-problem

RECTAL	O
--	O
deferred	O

EXT	O
-	O
WWP	O
;	O
no	O
edema	B-problem

On	O
04/06/05	O
Mr.	O
Liley	O
was	O
admitted	O
to	O
Dr.	O
Liley	O
&apos;s	O
service	O
.	O

At	O
that	O
time	O
he	O
was	O
made	O
NPO	B-treatment
with	O
IVF	B-treatment
,	O
placed	O
on	O
Ampicillin	B-treatment
/	O
Levofloxacin	B-treatment
/	O
Flagyl	B-treatment
and	O
underwent	O
IR	B-treatment
placement	I-treatment
of	I-treatment
a	I-treatment
drainage	I-treatment
catheter	I-treatment
for	O
his	B-problem
abdominopelvic	I-problem
fluid	I-problem
collection	I-problem
.	O

Overnight	O
he	O
spiked	O
a	B-problem
fever	I-problem
to	O
103	O
and	O
his	B-test
WBC	I-test
climbed	O
from	O
11	O
to	O
13	O
.	O

As	O
a	O
result	O
,	O
IR	O
reviewed	O
the	B-test
patient	I-test
&apos;s	I-test
post-procedure	I-test
imaging	I-test
and	O
felt	O
that	O
the	B-treatment
catheter	I-treatment
was	O
not	O
adequately	O
draining	O
the	B-problem
patient	I-problem
&apos;s	I-problem
fluid	I-problem
collection	I-problem
.	O

On	O
04/07	O
they	O
took	O
the	O
patient	O
back	O
to	O
the	O
IR	O
suite	O
and	O
placed	O
a	B-treatment
second	I-treatment
catheter	I-treatment
.	O

The	O
location	O
of	O
the	B-treatment
second	I-treatment
catheter	I-treatment
was	O
confirmed	O
that	O
evening	O
by	O
a	B-test
follow-up	I-test
scan	I-test
which	O
revealed	O
good	O
placement	O
.	O

The	O
following	O
day	O
the	O
patient	O
defervesced	O
.	O

Neurologic	O
:	O

The	B-problem
patient	I-problem
&apos;s	I-problem
pain	I-problem
from	O
his	B-treatment
catheters	I-treatment
was	O
controlled	O
with	O
Oxycodone	B-treatment
and	O
Motrin	B-treatment
.	O

CV	O
:	O

No	O
active	O
issues	O
.	O

R	O
:	O

The	O
patient	O
received	O
chest	B-treatment
PT	I-treatment
and	O
was	O
encouraged	O
to	O
ambulate	O
frequently	O
.	O

GI	O
:	O

After	O
catheter	B-treatment
placement	I-treatment
,	O
the	O
patient	O
was	O
started	O
on	O
sips	B-treatment
.	O

He	O
tolerated	O
this	O
well	O
.	O

He	O
was	O
advanced	O
to	O
clears	B-treatment
which	O
he	O
tolerated	O
and	O
was	O
restarted	O
on	O
a	B-treatment
low	I-treatment
residue	I-treatment
diet	I-treatment
.	O

His	O
bowel	O
function	O
resumed	O
and	O
in	O
fact	O
he	O
had	O
loose	O
stool	O
.	O

He	O
had	O
3	B-test
specimens	I-test
sent	O
for	O
C.	B-problem
difficile	I-problem
which	O
were	O
negative	O
.	O

GU	O
:	O

The	O
patient	O
&apos;s	O
electrolytes	O
and	O
fluids	O
were	O
monitored	O
closely	O
during	O
his	O
admission	O
.	O

Heme	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
WBC	I-test
trended	O
down	O
to	O
10.7	O
at	O
discharge	O
from	O
a	O
peak	O
of	O
13	O
on	O
04/07	O
.	O

His	B-test
hematocrit	I-test
remained	O
stable	O
.	O

He	O
received	O
DVT	B-treatment
prophylaxis	I-treatment
with	O
SC	B-treatment
Heparin	I-treatment
.	O

ID	O
:	O

Blood	B-test
cultures	I-test
04/05	O
revealed	O
Bacteroides	B-problem
fragilis	I-problem
;	O
04/06	O
Fluid	B-test
collection	I-test
drainage	I-test
from	I-test
IR	I-test
revealed	O

1)	O
4+	B-problem
alpha	I-problem
hemolytic	I-problem
Strep	I-problem
,	O

2)	O
2+	B-problem
E.	I-problem
coli	I-problem
sensitive	O
to	O
Ampicillin	B-treatment
and	O
Levofloxacin	B-treatment
,	O

3)	O
3+	B-problem
Enterococci	I-problem
sensitive	O
to	O
Ampicillin	B-treatment
and	O
Levofloxacin	B-treatment
,	O

4)	O
Bacteroides	B-problem
fragilis	I-problem
and	O
Clostridium	B-problem
perfringens	I-problem
.	O

Blood	B-test
cultures	I-test
from	O
04/07	O
showed	O
NGTD	B-problem
.	O

Cdiff	B-test
from	O
04/08	O
,	O
04/09	O
,	O
04/10	O
were	O
negative	O
.	O

Mr.	O
Liley	O
was	O
discharged	O
in	O
stable	O
condition	O
,	O
ambulating	O
and	O
voiding	O
independently	O
,	O
and	O
with	O
adequate	B-treatment
pain	I-treatment
control	I-treatment
.	O

LDAMC	O
services	O
were	O
set-up	O
for	O
care	B-treatment
of	O
his	B-treatment
IR	I-treatment
drains	I-treatment
.	O

He	O
was	O
given	O
explicit	O
instructions	O
to	O
follow-up	O
in	O
clinic	O
with	O
Dr.	O
Liley	O
in	O
1-2	O
weeks	O
.	O

ADDENDUM	O
:	O

An	B-test
abscessogram	I-test
was	O
performed	O
on	O
04/12/05	O
and	O
revealed	O
no	O
fistula	B-problem
.	O

ADDITIONAL	O
COMMENTS	O
:	O

-	O
Seek	O
medical	O
attention	O
for	O
fevers	B-problem
(	O
temp	B-test
&gt;	O
101.5	O
)	O
,	O
worsening	B-problem
pain	I-problem
,	O
drainage	B-problem
or	O
excessive	B-problem
bleeding	I-problem
from	O
incision	B-problem
,	O
chest	B-problem
pain	I-problem
,	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
or	O
any	B-problem
other	I-problem
symptoms	I-problem
of	O
concern	O
.	O

-	O
Follow	O
up	O
with	O
your	O
surgeon	O
in	O
1-2	O
weeks	O
for	O
wound	B-test
check	I-test
.	O

-	O
Please	O
do	O
not	O
drive	O
or	O
consume	O
alcohol	O
while	O
taking	O
pain	B-treatment
medications	I-treatment
.	O

-	O
Resume	O
home	B-treatment
medications	I-treatment
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
PAD-WORD	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

ALIKES	O
,	O
NATO	O
T.	O
,	O
M.D.	O
(	O
FG980	O
)	O

04/12/05	O
11:30	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

957770228	O
PAD-WORD	O

FIH	O
PAD-WORD	O

0408267	O
PAD-WORD	O

46769/5v7d	O
PAD-WORD	O

237890	O
PAD-WORD	O

2/5/1994	O
12:00:00	O
AM	O

TRACHEOESOPHAGEAL	B-problem
FISTULA	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

2-5-94	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

4-2-94	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Tracheoesophageal	B-problem
fistula	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Diabetes	B-problem
mellitus	I-problem
,	O
pneumonia	B-problem
,	O
sepsis	B-problem
,	O
respiratory	B-problem
failure	I-problem
,	O
pleural	B-problem
effusion	I-problem
,	O
postoperative	B-problem
encephalopathy	I-problem
,	O
postoperative	B-problem
myocardial	I-problem
infarction	I-problem
,	O
and	O
thrombocytopenia	B-problem
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

February	O
6	O
,	O
1994	O
,	O
rigid	B-test
bronchoscopy	I-test
with	O
biopsy	B-test
and	O
upper	B-test
gastrointestinal	I-test
endoscopy	I-test
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

On	O
February	O
10	O
,	O
1994	O
,	O
flexible	B-test
bronchoscopy	I-test
,	O
flexible	B-test
esophagoscopy	I-test
,	O
rigid	B-test
bronchoscopy	I-test
,	O
transhiatal	B-treatment
esophagectomy	I-treatment
(	I-treatment
partial	I-treatment
)	I-treatment
,	O
substernal	B-treatment
gastric	I-treatment
interposition	I-treatment
and	O
jejunostomy	B-treatment
.	O

Multiple	B-test
bronchoscopies	I-test
,	O
chest	B-treatment
tube	I-treatment
insertion	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
a	O
71	O
year	O
old	O
white	O
female	O
with	O
a	O
history	O
of	O
carcinoid	B-problem
lung	I-problem
cancer	I-problem
who	O
presented	O
for	O
evaluation	B-test
of	O
a	B-problem
tracheoesophageal	I-problem
fistula	I-problem
.	O

The	O
patient	O
was	O
initially	O
diagnosed	O
in	O
1978	O
with	O
atypical	B-problem
small	I-problem
cell	I-problem
carcinoma	I-problem
of	I-problem
the	I-problem
lung	I-problem
and	O
treated	O
with	O
chemotherapy	B-treatment
and	O
radiation	B-treatment
therapy	I-treatment
until	O
1980	O
.	O

She	O
did	O
well	O
for	O
approximately	O
twelve	O
years	O
until	O
she	O
was	O
diagnosed	O
with	O
carcinoid	B-problem
cancer	I-problem
of	I-problem
the	I-problem
same	I-problem
right	I-problem
upper	I-problem
lobe	I-problem
.	O

This	O
may	O
have	O
been	O
the	B-problem
initial	I-problem
primary	I-problem
cancer	I-problem
although	O
it	O
is	O
unclear	O
at	O
present	O
.	O

Bronchoscopy	B-test
at	O
that	O
time	O
showed	O
an	B-problem
endobronchial	I-problem
tumor	I-problem
of	I-problem
the	I-problem
right	I-problem
upper	I-problem
lobe	I-problem
bronchus	I-problem
and	O
it	O
was	O
felt	O
to	O
be	O
unresectable	O
.	O

She	O
underwent	O
four	B-treatment
treatments	I-treatment
of	O
brachytherapy	B-treatment
in	O
March	O
through	O
May	O
of	O
1993	O
.	O

She	O
had	O
been	O
doing	O
reasonably	O
well	O
until	O
December	O
of	O
1993	O
when	O
she	O
presented	O
with	O
persistent	B-problem
and	I-problem
worsening	I-problem
cough	I-problem
and	O
near	B-problem
strangulation	I-problem
on	O
attempts	O
at	O
eating	O
solids	O
or	O
drinking	O
liquids	O
.	O

A	B-test
bronchoscopy	I-test
showed	O
a	B-problem
tracheoesophageal	I-problem
fistula	I-problem
with	O
an	O
opening	O
into	O
the	O
trachea	O
above	O
the	O
carina	O
and	O
no	O
tumor	B-problem
in	I-problem
the	I-problem
right	I-problem
upper	I-problem
lobe	I-problem
.	O

She	O
has	O
been	O
on	O
total	B-treatment
parenteral	I-treatment
nutrition	I-treatment
and	O
has	O
been	O
nothing	B-treatment
by	I-treatment
mouth	I-treatment
since	O
then	O
.	O

A	B-test
barium	I-test
swallow	I-test
prior	O
to	O
admission	O
showed	O
the	O
presence	O
of	O
a	B-problem
tracheoesophageal	I-problem
fistula	I-problem
with	O
entrance	O
into	O
the	O
right	O
mainstem	O
bronchus	O
below	O
the	O
carina	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Bronchitis	B-problem
,	O
asthma	B-problem
,	O
carcinoid	B-problem
cancer	I-problem
,	O
no	O
history	O
of	O
coronary	B-problem
artery	I-problem
disease	I-problem
or	O
cerebrovascular	B-problem
accident	I-problem
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
status	O
post	O
appendectomy	B-treatment
,	O
hysterectomy	B-treatment
and	O
right	B-treatment
salpingo-oophorectomy	I-treatment
,	O
bladder	B-treatment
suspension	I-treatment
and	O
a	B-treatment
tumor	I-treatment
removal	I-treatment
from	I-treatment
the	I-treatment
right	I-treatment
neck	I-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Cefuroxime	B-treatment
1.5	O
grams	O
intravenously	O
q8h	O
,	O
Solu-Medrol	B-treatment
62.5	O
mg	O
intravenously	O
q8h	O
,	O
Ventolin	B-treatment
metered	I-treatment
dose	I-treatment
inhaler	I-treatment
,	O
2	O
puffs	O
PO	O
q.i.d.	O
,	O
Pepcid	B-treatment
20	O
mg	O
intravenously	O
b.i.d.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-problem
to	O
penicillin	B-treatment
,	O
morphine	B-treatment
,	O
codeine	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
a	O
pleasant	O
white	O
female	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

She	O
is	O
afebrile	B-problem
with	O
stable	O
vital	O
signs	O
.	O

The	B-test
head	I-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
,	I-test
throat	I-test
examination	I-test
was	O
unremarkable	O
.	O

Neck	O
shows	O
a	B-problem
well	I-problem
healed	I-problem
low	I-problem
collar	I-problem
incision	I-problem
without	O
adenopathy	B-problem
or	O
bruit	B-problem
.	O

The	O
lungs	O
showed	O
mild	B-problem
inspiratory	I-problem
wheeze	I-problem
and	O
moderate	B-problem
expiratory	I-problem
wheezes	I-problem
.	O

Breath	O
sounds	O
are	O
present	O
bilaterally	O
.	O

Cardiovascular	O
exam	O
:	O

regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-problem
,	O
nondistended	B-problem
.	O

Extremities	O
:	O

no	O
clubbing	B-problem
,	O
cyanosis	B-problem
or	O
edema	B-problem
.	O

The	B-test
rectal	I-test
examination	I-test
is	O
guaiac	B-test
negative	O
with	O
a	O
minimal	O
amount	O
of	O
stool	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
February	O
5	O
,	O
1994	O
and	O
had	O
a	B-treatment
central	I-treatment
venous	I-treatment
line	I-treatment
placed	O
in	O
her	O
right	O
subclavian	O
.	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
February	O
6	O
,	O
1994	O
where	O
she	O
underwent	O
rigid	B-test
and	I-test
flexible	I-test
bronchoscopy	I-test
and	O
upper	B-test
gastrointestinal	I-test
endoscopy	I-test
.	O

Findings	O
included	O
necrotic	B-problem
debris	I-problem
in	I-problem
the	I-problem
distal	I-problem
trachea	I-problem
at	O
the	O
carina	O
and	O
right	O
mainstem	O
bronchus	O
.	O

Esophageal	O
mucosa	O
was	O
visible	O
through	O
the	O
trachea	O
.	O

Her	B-treatment
steroids	I-treatment
were	O
weaned	O
and	O
the	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
February	O
10	O
,	O
1994	O
where	O
she	O
underwent	O
once	O
again	O
flexible	B-test
bronchoscopy	I-test
and	O
flexible	B-test
esophagoscopy	I-test
,	O
as	O
well	O
as	O
rigid	B-test
bronchoscopy	I-test
.	O

She	O
then	O
had	O
a	B-treatment
transhiatal	I-treatment
esophagectomy	I-treatment
which	O
was	O
partial	O
,	O
and	O
a	B-treatment
substernal	I-treatment
gastric	I-treatment
interposition	I-treatment
as	O
well	O
as	O
a	B-treatment
jejunostomy	I-treatment
.	O

The	B-test
pathology	I-test
report	I-test
suggested	O
that	O
the	O
area	O
was	O
involved	O
with	O
radiation	B-problem
esophagitis	I-problem
and	O
focal	B-problem
ulceration	I-problem
.	O

She	O
remained	O
ventilator	B-problem
dependent	I-problem
postoperatively	O
and	O
was	O
taken	O
to	O
the	O
Respiratory	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
was	O
maintained	O
on	O
triple	B-treatment
antibiotics	I-treatment
which	O
included	O
Vancomycin	B-treatment
,	O
ceftazidime	B-treatment
and	O
Gentamicin	B-treatment
.	O

On	O
postoperative	O
day	O
two	O
,	O
she	O
had	O
an	B-test
electroencephalogram	I-test
which	O
showed	O
no	O
evidence	O
of	O
seizure	B-problem
activity	I-problem
but	O
some	B-problem
generalized	I-problem
slowing	I-problem
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Neurology	O
Service	O
for	O
her	B-problem
apparent	I-problem
postoperative	I-problem
encephalopathy	I-problem
and	O
episodes	O
of	O
shaking	B-problem
.	O

An	B-test
endoscopy	I-test
was	O
also	O
performed	O
on	O
postoperative	O
day	O
two	O
which	O
showed	O
clean	O
anastomosis	B-treatment
.	O

She	O
received	O
multiple	B-test
bronchoscopies	I-test
for	O
pulmonary	B-treatment
toilet	I-treatment
.	O

The	O
patient	O
was	O
maintained	O
on	O
tube	B-treatment
feedings	I-treatment
and	O
the	B-treatment
ventilator	I-treatment
.	O

A	B-test
repeat	I-test
echocardiogram	I-test
on	O
February	O
18	O
showed	O
no	O
significant	B-problem
change	I-problem
of	O
her	B-test
previous	I-test
echocardiogram	I-test
on	O
February	O
11	O
,	O
which	O
showed	O
only	O
a	B-problem
small	I-problem
pericardial	I-problem
effusion	I-problem
.	O

A	B-test
pelvic	I-test
and	I-test
abdominal	I-test
computerized	I-test
tomography	I-test
scan	I-test
on	O
February	O
18	O
also	O
showed	O
no	O
evidence	O
of	O
a	B-problem
focal	I-problem
collection	I-problem
or	O
abscess	B-problem
.	O

She	O
remained	O
intermittently	B-problem
febrile	I-problem
despite	O
numerous	B-treatment
antibiotics	I-treatment
.	O

Her	B-test
chest	I-test
X-ray	I-test
showed	O
bilateral	B-problem
air	I-problem
space	I-problem
disease	I-problem
,	O
consistent	O
with	O
pneumonia	B-problem
or	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
.	O

She	O
suffered	O
an	O
episode	O
of	O
renal	B-problem
failure	I-problem
which	O
was	O
felt	O
attributable	O
to	O
aminoglycoside	B-problem
toxicity	I-problem
.	O

Her	B-treatment
steroids	I-treatment
were	O
weaned	O
.	O

Because	O
of	O
her	B-treatment
prolonged	I-treatment
intubation	I-treatment
and	O
inability	B-problem
to	I-problem
wean	I-problem
,	O
on	O
February	O
24	O
,	O
1994	O
,	O
she	O
had	O
a	B-treatment
tracheostomy	I-treatment
placed	O
.	O

She	O
remained	O
in	O
a	B-problem
coma	I-problem
.	O

The	B-test
blood	I-test
cultures	I-test
on	O
February	O
26	O
,	O
1994	O
grew	O
out	O
Staphylococcus	B-problem
and	O
she	O
was	O
treated	O
for	O
septicemia	B-problem
.	O

Her	B-test
sputum	I-test
grew	O
out	O
Pseudomonas	B-problem
aeruginosa	I-problem
as	O
well	O
.	O

The	B-test
urine	I-test
contained	O
yeast	B-problem
and	O
she	O
was	O
treated	O
with	O
amphotericin	B-treatment
.	O

On	O
March	O
3	O
,	O
1994	O
,	O
a	B-test
repeat	I-test
chest	I-test
and	I-test
abdominal	I-test
and	I-test
pelvis	I-test
computerized	I-test
tomography	I-test
scan	I-test
showed	O
no	O
evidence	O
of	O
fluid	B-problem
collections	I-problem
.	O

There	O
was	O
a	B-problem
large	I-problem
left	I-problem
pleural	I-problem
effusion	I-problem
however	O
.	O

This	O
was	O
drained	O
with	O
a	B-treatment
left	I-treatment
chest	I-treatment
tube	I-treatment
.	O

Her	B-test
sputum	I-test
then	O
grew	O
out	O
Klebsiella	B-problem
and	O
she	O
was	O
treated	O
with	O
amikacin	B-treatment
and	O
imipenem	B-treatment
.	O

She	O
developed	O
a	B-problem
right	I-problem
pleural	I-problem
effusion	I-problem
and	O
had	O
a	B-treatment
right	I-treatment
chest	I-treatment
tube	I-treatment
placed	O
.	O

On	O
March	O
13	O
,	O
1994	O
,	O
she	O
regained	O
some	O
level	O
of	O
consciousness	O
.	O

She	O
was	O
able	O
to	O
fix	O
and	O
follow	O
with	O
her	O
eyes	O
,	O
respond	O
to	O
commands	O
.	O

On	O
March	O
14	O
,	O
1994	O
,	O
her	O
right	O
lung	O
was	O
pleurodesed	O
.	O

Attempts	O
were	O
made	O
to	O
facilitate	O
her	B-treatment
wean	I-treatment
by	O
resting	O
her	O
overnight	O
with	O
a	O
combination	O
of	O
propafol	B-treatment
and	O
Fentanyl	B-treatment
.	O

This	O
was	O
tried	O
for	O
approximately	O
seven	O
days	O
with	O
no	O
real	O
progress	O
made	O
toward	O
facilitating	O
her	B-treatment
vent	I-treatment
wean	I-treatment
.	O

She	O
continued	O
to	O
require	O
pressor	B-treatment
support	I-treatment
in	O
the	O
high	O
30	O
&apos;s	O
.	O

She	O
also	O
fell	O
into	O
a	B-problem
coma	I-problem
once	O
again	O
.	O

On	O
March	O
31	O
,	O
1994	O
,	O
her	B-problem
pressor	I-problem
support	I-problem
requirement	I-problem
increased	O
and	O
she	O
continued	O
to	O
have	O
tachypneic	B-problem
episodes	I-problem
.	O

On	O
April	O
2	O
,	O
1994	O
,	O
she	O
had	O
several	O
episodes	O
of	O
bradycardia	B-problem
and	O
asystole	B-problem
,	O
which	O
responded	O
only	O
to	O
manual	B-treatment
ventilation	I-treatment
.	O

Discussions	O
were	O
held	O
with	O
the	O
patient	O
&apos;s	O
family	O
with	O
regard	O
to	O
her	O
previously	O
expressed	O
wishes	O
not	O
to	O
be	O
maintained	O
on	O
artificial	B-treatment
life	I-treatment
support	I-treatment
for	O
extended	O
period	O
of	O
time	O
with	O
little	O
or	O
no	O
hope	O
for	O
recovery	O
.	O

She	O
had	O
expressed	O
these	O
wishes	O
in	O
writing	O
on	O
several	O
legal	O
forms	O
from	O
the	O
state	O
of	O
Jose	O
Pineston	O
,	O
as	O
well	O
as	O
in	O
discussions	O
with	O
her	O
loved	O
ones	O
.	O

Decision	O
was	O
made	O
in	O
conjunction	O
with	O
the	O
family	O
and	O
Dr.	O
Caslighlourdes	O
to	O
terminate	O
artificial	B-treatment
respiratory	I-treatment
support	I-treatment
.	O

The	O
patient	O
was	O
removed	O
from	O
the	B-treatment
ventilator	I-treatment
and	O
placed	O
on	O
a	B-treatment
T-piece	I-treatment
in	I-treatment
her	I-treatment
trachea	I-treatment
only	O
and	O
was	O
made	O
comfortable	O
with	O
narcotics	B-treatment
.	O

Her	O
respirations	O
ceased	O
and	O
she	O
died	O
at	O
10:15	O
a.m.	O
on	O
April	O
2	O
,	O
1994	O
.	O

DISPOSITION	O
/	O
PLAN	O
ON	O
DISCHARGE	O
:	O

The	O
family	O
will	O
return	O
the	O
body	O
to	O
Sa	O
for	O
burial	O
.	O

They	O
have	O
declined	O
a	B-test
post-mortem	I-test
examination	I-test
.	O

CA	O
SHUFF	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

RIEMIND	O
CASLIGHLOURDES	O
,	O
M.D.	O

TR	O
:	O

yu	O
/	O
bmot	O

DD	O
:	O

4-2-94	O
PAD-WORD	O

TD	O
:	O

04/03/94	O
PAD-WORD	O

CC	O
:	O

963005114	O
PAD-WORD	O

FIH	O
PAD-WORD	O

1704696	O
PAD-WORD	O

04773/k096	O
PAD-WORD	O

064394	O
PAD-WORD	O

5/3/1993	O
12:00:00	O
AM	O

ADULT	B-problem
RESPIRATORY	I-problem
DISTRESS	I-problem
SYNDROME	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

5-3-93	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

5-12-93	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Urinary	B-problem
tract	I-problem
infection	I-problem
,	O
tracheostomy	B-treatment
status	O
,	O
diabetes	B-problem
mellitus	I-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Stain	O
was	O
transferred	O
from	O
the	O
Oreiewlefell	O
Merkane	O
I	O
Penaltbridgesgreat	O
University	O
Medical	O
Center	O
for	O
progressive	B-problem
respiratory	I-problem
failure	I-problem
and	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
superimposed	O
on	O
a	O
history	O
of	O
chronic	B-problem
obstructive	I-problem
pulmonary	I-problem
disease	I-problem
,	O
perhaps	O
asthma	B-problem
,	O
and	O
ulcerative	B-problem
colitis	I-problem
.	O

His	O
only	O
positive	O
result	O
was	O
a	B-test
sputum	I-test
culture	I-test
for	O
Pseudomonas	B-problem
and	O
this	O
came	O
after	O
he	O
had	O
already	O
been	O
on	O
antibiotics	B-treatment
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-test
physical	I-test
examination	I-test
on	O
transfer	O
showed	O
an	O
alert	O
male	O
with	O
temperature	B-test
100	O
degrees	O
,	O
blood	B-test
pressure	I-test
120/64	O
,	O
heart	B-test
rate	I-test
80	O
.	O

He	O
was	O
intubated	B-treatment
with	O
pressor	B-treatment
support	I-treatment
of	O
25	O
,	O
and	O
PEEP	B-treatment
of	O
12.5	O
with	O
70%	O
FIO2	B-treatment
.	O

Tracheostomy	B-treatment
tube	I-treatment
was	O
in	O
good	O
position	O
.	O

There	O
was	O
an	B-problem
audible	I-problem
air	I-problem
leak	I-problem
.	O

His	O
chest	O
showed	O
bilateral	B-problem
rhonchi	I-problem
.	O

The	O
abdomen	O
was	O
distended	B-problem
with	O
active	O
bowel	O
sounds	O
.	O

The	B-test
rectal	I-test
examination	I-test
was	O
unremarkable	O
.	O

Extremities	O
showed	O
trace	B-problem
pulmonary	I-problem
edema	I-problem
.	O

LABORATORY	O
DATA	O
:	O

A	B-test
chest	I-test
X-ray	I-test
showed	O
diffuse	B-problem
bilateral	I-problem
alveolar	I-problem
infiltrates	I-problem
,	O
greater	O
in	O
the	O
lower	O
lung	O
fields	O
than	O
in	O
the	O
upper	O
.	O

The	B-test
EKG	I-test
showed	O
normal	O
sinus	O
rhythm	O
at	O
83	O
,	O
with	O
an	O
11	O
degree	O
axis	O
,	O
non-specific	B-problem
ST-T	I-problem
wave	I-problem
changes	I-problem
.	O

The	B-test
sputum	I-test
Gram	I-test
stain	I-test
showed	O
a	B-problem
few	I-problem
polys	I-problem
and	O
no	O
organisms	B-problem
.	O

The	B-test
blood	I-test
gas	I-test
showed	O
a	B-test
pO2	I-test
of	O
56	O
,	O
pCO2	B-test
of	O
48	O
and	O
pH	B-test
of	O
7.47	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
Dr.	O
Wire	O
who	O
felt	O
that	O
manipulation	B-treatment
of	I-treatment
the	I-treatment
tracheal	I-treatment
tube	I-treatment
was	O
the	O
best	O
approach	O
to	O
the	B-problem
air	I-problem
leak	I-problem
since	O
it	O
was	O
a	B-treatment
new	I-treatment
trach	I-treatment
and	O
he	O
was	O
requiring	O
such	O
high	B-treatment
ventilator	I-treatment
support	I-treatment
that	O
it	O
was	O
risky	O
to	O
change	O
it	O
.	O

He	O
also	O
felt	O
that	O
lung	B-test
biopsy	I-test
at	O
this	O
time	O
was	O
rather	O
risky	O
.	O

The	O
patient	O
was	O
therefore	O
completely	B-test
cultured	I-test
again	O
and	O
begun	O
on	O
antibiotic	B-treatment
coverage	I-treatment
which	O
would	O
take	O
care	O
of	O
the	B-problem
Pseudomonas	I-problem
he	O
was	O
known	O
to	O
have	O
.	O

The	B-treatment
steroids	I-treatment
were	O
tapered	O
.	O

He	O
was	O
also	O
begun	O
on	O
anti-Candida	B-treatment
regimen	I-treatment
for	O
his	B-problem
urinary	I-problem
tract	I-problem
infection	I-problem
with	O
yeast	B-problem
being	O
seen	O
.	O

Because	O
of	O
the	O
story	O
of	O
hemoptysis	B-problem
,	O
he	O
also	O
underwent	O
an	B-test
exotic	I-test
bleeding	I-test
work	I-test
up	I-test
for	O
such	O
things	O
as	O
Wegner	B-problem
&apos;s	I-problem
and	O
Goodpasture	B-problem
&apos;s	I-problem
.	O

These	O
results	O
were	O
all	O
negative	O
.	O

He	O
continued	O
to	O
require	O
very	B-treatment
high	I-treatment
FIO2	I-treatment
.	O

He	O
was	O
found	O
to	O
have	O
a	B-problem
DVT	I-problem
by	O
ultrasound	B-test
.	O

He	O
underwent	O
a	B-treatment
trial	I-treatment
of	I-treatment
TPA	I-treatment
followed	O
by	O
heparin	B-treatment
.	O

This	O
produced	O
substantially	B-problem
further	I-problem
hemoptysis	I-problem
and	O
the	O
need	O
for	O
transfusion	B-treatment
.	O

He	O
stabilized	O
from	O
this	O
,	O
but	O
on	O
the	O
fifth	O
while	O
continuing	O
to	O
have	O
extremely	B-problem
ventilator	I-problem
requirement	I-problem
.	O

In	O
consultation	O
with	O
his	O
family	O
,	O
it	O
was	O
decided	O
that	O
enough	O
support	O
had	O
been	O
done	O
.	O

At	O
that	O
time	O
,	O
therefore	O
,	O
ventilator	B-treatment
support	I-treatment
was	O
withdrawn	O
under	O
the	B-treatment
comfort	I-treatment
measures	I-treatment
of	O
morphine	B-treatment
.	O

STAIN	O
J.	O
A	O
,	O
M.D.	O

TR	O
:	O

sj	O
/	O
bmot	O

DD	O
:	O

6-4-93	O
PAD-WORD	O

TD	O
:	O

06/05/93	O
PAD-WORD	O

CC	O
:	O

972977292	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

9149486	O
PAD-WORD	O

13382	O
PAD-WORD	O

713336	O
PAD-WORD	O

10/14/1996	O
12:00:00	O
AM	O

LEFT	B-problem
ANTERIOR	I-problem
TEMPORAL	I-problem
INTRAPARENCHYMAL	I-problem
HEMORRHAGE	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

CALL	O
,	O
GRANRIVERN	O
S	O

UNIT	O
NUMBER	O
:	O

585-28-96	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

10/14/96	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

10/27/96	O
date	O
of	O
birth	O
;	O
September	O
30	O
,	O
1917	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Left	B-problem
anterior	I-problem
temporal	I-problem
intraparenchymal	I-problem
hemorrhage	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

atrial	B-problem
fibrillation	I-problem
,	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
,	O
pulmonary	B-problem
embolus	I-problem
,	O
right	B-problem
frontal	I-problem
infarct	I-problem
,	O
hypertension	B-problem
,	O
and	O
question	O
progressive	B-problem
supranuclear	I-problem
palsy	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

magnetic	B-test
resonance	I-test
imaging	I-test
of	I-test
the	I-test
brain	I-test
on	O
10/18/96	O
.	O

THER	O
PROCEDURES	O
:	O

arterial	B-test
catheterization	I-test
on	O
10/14/96	O
,	O
head	B-test
CT	I-test
scan	I-test
on	O
10/14/96	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Granrivern	O
Call	O
is	O
a	O
79-year-old	O
right	O
handed	O
white	O
male	O
with	O
a	O
history	O
of	O
questionable	O
progressive	B-problem
supranuclear	I-problem
palsy	I-problem
,	O
atrial	B-problem
fibrillation	I-problem
,	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
,	O
and	O
pulmonary	B-problem
embolus	I-problem
who	O
presents	O
with	O
a	B-problem
change	I-problem
in	I-problem
mental	I-problem
status	I-problem
and	O
a	O
fall	O
at	O
home	O
.	O

His	O
family	O
stated	O
that	O
he	O
had	O
a	B-problem
progressive	I-problem
mental	I-problem
decline	I-problem
over	O
the	O
past	O
three	O
years	O
and	O
was	O
initially	O
diagnosed	O
with	O
Parkinson	B-problem
&apos;s	I-problem
disease	I-problem
or	O
features	B-problem
consistent	O
with	O
Parkinsonism	B-problem
.	O

This	O
was	O
poorly	O
responsive	O
to	O
Eldopa	B-treatment
.	O

He	O
was	O
later	O
seen	O
by	O
Dr.	O
Flo	O
Cuchkote	O
at	O
the	O
Ph	O
University	O
Of	O
Medical	O
Center	O
and	O
diagnosed	O
with	O
progressive	B-problem
supranuclear	I-problem
palsy	I-problem
.	O

Over	O
the	O
five	O
to	O
six	O
weeks	O
prior	O
to	O
admission	O
he	O
had	O
a	B-problem
drop	I-problem
off	I-problem
in	I-problem
his	I-problem
mental	I-problem
functioning	I-problem
with	O
more	O
frequent	O
episodes	O
of	O
confusion	B-problem
and	O
disorientation	B-problem
and	O
requiring	O
more	O
assistance	B-treatment
with	O
his	O
activities	O
of	O
daily	O
living	O
.	O

He	O
also	O
developed	O
a	B-problem
urinary	I-problem
incontinence	I-problem
.	O

He	O
had	O
had	O
two	O
falls	O
to	O
his	O
wife	O
&apos;s	O
recollection	O
,	O
both	O
times	O
slipping	O
off	O
the	O
edge	O
of	O
a	O
chair	O
backwards	O
.	O

On	O
the	O
morning	O
of	O
admission	O
at	O
8	O
o&apos;clock	O
,	O
he	O
was	O
noted	O
to	O
be	O
moving	O
his	O
mouth	O
less	O
and	O
speaking	O
&quot;	O
gibberish	O
&quot;	O
.	O

He	O
was	O
later	O
sitting	O
in	O
a	O
chair	O
making	O
multiple	O
attempts	O
to	O
get	O
up	O
,	O
which	O
he	O
subsequently	O
did	O
and	O
promptly	O
fell	O
directly	O
on	O
his	O
face	O
at	O
approximately	O
11:30	O
a.m.	O

There	O
was	O
no	O
definite	B-problem
clonic	I-problem
activity	I-problem
.	O

There	O
was	O
no	O
known	B-problem
incontinence	I-problem
.	O

He	O
was	O
taken	O
to	O
an	O
outside	O
hospital	O
and	O
nasally	O
intubated	O
and	O
then	O
transferred	O
to	O
the	O
Ph	O
University	O
Of	O
Medical	O
Center	O
Emergency	O
Room	O
where	O
he	O
was	O
orally	O
intubated	O
.	O

A	B-test
trauma	I-test
evaluation	I-test
was	O
negative	O
and	O
thus	O
he	O
was	O
transferred	O
to	O
the	O
Neurology	O
Service	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Coumadin	B-treatment
4	O
mgs	O
po	O
qhs	O
,	O
Vasotec	B-treatment
5	O
mgs	O
po	O
qd	O
,	O
Lasix	B-treatment
prn	O
,	O
Digoxin	B-treatment
0.25	O
mgs	O
poqd	O
,	O
Proscar	B-treatment
and	O
Sinemet	B-treatment
.	O

ALLERGIES	O
:	O

no	O
known	B-problem
drug	I-problem
allergies	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
atrial	B-problem
fibrillation	I-problem
on	O
coumadin	B-treatment
,	O

2)	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
and	O
pulmonary	B-problem
embolus	I-problem
;	O
the	O
wife	O
states	O
since	O
he	O
was	O
in	O
the	O
infantry	O
in	O
World	O
War	O
II	O
.	O

3)	O
Question	O
progressive	B-problem
supranuclear	I-problem
palsy	I-problem
.	O

4)	O
old	B-problem
right	I-problem
frontal	I-problem
infarct	I-problem
.	O

5)	O
hypertension	B-problem
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lives	O
with	O
his	O
wife	O
who	O
is	O
his	O
primary	O
care	O
giver	O
.	O

He	O
is	O
a	O
former	O
professor	O
at	O
Montana	O
.	O

Tobacco	O
;	O
he	O
has	O
some	O
distant	O
history	O
of	O
some	O
very	O
minimal	O
use	O
.	O

Alcohol	O
;	O
he	O
has	O
no	O
recent	O
use	O
.	O

He	O
was	O
a	O
previous	O
drinker	O
of	O
one	O
&quot;	O
old	O
fashioned	O
&quot;	O
every	O
night	O
.	O

FAMILY	O
HISTORY	O
:	O

He	O
has	O
a	O
father	O
who	O
had	O
dementia	B-problem
.	O

There	O
was	O
no	O
history	O
of	O
strokes	B-problem
or	O
bleeding	B-problem
disorders	I-problem
in	O
the	O
family	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

vital	B-test
signs	I-test
in	O
the	O
emergency	O
room	O
were	O
210/100	O
for	O
blood	B-test
pressure	I-test
,	O
heart	B-test
rate	I-test
70	O
and	O
irregular	B-problem
.	O

He	O
was	O
afebrile	B-problem
.	O

In	O
general	O
he	O
was	O
an	O
intubated	O
elderly	O
frail	O
appearing	O
white	O
male	O
with	O
blood	B-problem
about	I-problem
his	I-problem
face	I-problem
.	O

head	B-test
,	I-test
eyes	I-test
,	I-test
ears	I-test
,	I-test
nose	I-test
and	I-test
throat	I-test
examination	I-test
;	O
abrasions	B-problem
about	I-problem
his	I-problem
forehead	I-problem
,	O
there	O
was	O
some	B-problem
minimal	I-problem
swelling	I-problem
associated	O
.	O

His	O
neck	O
was	O
rigid	B-problem
;	O
1+	B-test
carotids	I-test
without	O
bruits	B-problem
.	O

oropharynx	O
was	O
intubated	B-treatment
with	O
blood	B-problem
as	O
well	O
.	O

Lungs	O
;	O
clear	O
to	O
auscultation	B-test
bilaterally	I-test
.	O

Cardiovascular	B-test
examination	I-test
;	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-problem
,	O
rubs	B-problem
,	O
or	O
gallops	B-problem
.	O

Abdominal	B-test
examination	I-test
;	O
soft	O
,	O
non-tender	B-problem
,	O
non-distended	B-problem
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

no	O
clubbing	B-problem
,	O
cyanosis	B-problem
,	O
or	O
edema	B-problem
.	O

Neurologically	O
;	O
he	O
opens	O
his	O
eyes	O
to	O
voice	O
.	O

He	O
does	O
not	O
regard	O
the	O
examiner	O
.	O

He	O
had	O
no	B-problem
blink	I-problem
to	O
threat	B-test
.	O

His	O
pupils	O
were	O
three	O
down	O
to	O
two	O
on	O
the	O
right	O
and	O
five	O
down	O
to	O
four	O
on	O
the	O
left	O
.	O

According	O
to	O
the	O
family	O
this	B-problem
iansicoria	I-problem
was	O
old	O
.	O

He	O
had	O
intact	O
corneals	O
bilaterally	O
and	O
intact	O
horizontal	O
dull	O
movements	O
bilaterally	O
.	O

He	O
had	O
left	O
greater	O
than	O
right	O
nasal	O
stimulation	O
to	O
grimace	O
.	O

He	O
had	O
no	O
gag	B-problem
to	O
tube	B-treatment
manipulation	I-treatment
.	O

Motor	B-test
examination	I-test
he	O
had	O
a	B-problem
weak	I-problem
withdrawal	I-problem
to	O
nail	B-test
bed	I-test
pressure	I-test
in	O
both	O
hands	O
.	O

He	O
triple	O
flexed	O
his	O
bilateral	O
lower	O
extremities	O
to	O
pain	B-problem
.	O

His	B-test
deep	I-test
tendon	I-test
reflexes	I-test
were	O
2+	O
at	O
the	O
right	O
brachial	O
radialis	O
and	O
right	O
patella	O
;	O
everywhere	O
else	O
his	B-test
reflexes	I-test
were	O
1	O
.	O

His	O
toes	O
were	O
down	O
going	O
.	O

SUMMARY	O
OF	O
LABORATORY	O
AND	O
RADIOLOGICAL	O
EXAMINATIONS	O
:	O

sodium	B-test
141	O
,	O
potassium	B-test
3.5	O
,	O
chloride	B-test
107	O
,	O
bicarbonates	B-test
23.8	O
,	O
BUN	B-test
23	O
,	O
creatinine	B-test
1.1	O
,	O
glucose	B-test
165	O
,	O
PO2	B-test
377	O
,	O
PCO2	B-test
32	O
,	O
PH	B-test
7.50	O
,	O
asomus	B-test
298	O
,	O
toxic	B-test
screen	I-test
negative	O
,	O
white	B-test
blood	I-test
cell	I-test
count	I-test
11.1	O
,	O
hematocrit	B-test
39.6	O
,	O
platelet	B-test
count	I-test
137	O
,	O
prothrombin	B-test
time	I-test
25.2	O
,	O
INR	B-test
4.3	O
,	O
partial	B-test
thromboplastin	I-test
time	I-test
34.7	O
,	O
urinalysis	B-test
1+	B-problem
albumin,	I-problem
0-5	B-problem
high	I-problem
link	I-problem
caths	I-problem
,	O
cervical	B-test
spine	I-test
negative	O
,	O
pelvis	B-test
negative	O
,	O
lumbar	B-test
spine	I-test
;	O
negative	O
,	O
thoracic	B-test
spine	I-test
negative	O
.	O

chest	B-test
x-ray	I-test
clear	O
.	O

electrocardiogram	B-test
showed	O
2	O
mm	O
of	O
ST	B-problem
depressions	I-problem
in	I-problem
V4-6	I-problem
.	O

Head	B-test
CT	I-test
scan	I-test
showed	O
a	B-problem
2	I-problem
x	I-problem
2	I-problem
x	I-problem
2	I-problem
left	I-problem
anterior	I-problem
temporal	I-problem
hemorrhage	I-problem
with	O
minimal	B-problem
surrounding	I-problem
edema	I-problem
.	O

There	O
was	O
also	O
evidence	O
of	O
an	B-problem
old	I-problem
right	I-problem
frontal	I-problem
infarction	I-problem
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

1)	O
NEUROLOGY	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Neurology	O
Intensive	O
Care	O
Unit	O
for	O
intensive	B-test
monitoring	I-test
due	O
to	O
his	B-problem
frail	I-problem
condition	I-problem
.	O

He	O
had	O
an	B-test
electroencephalogram	I-test
performed	O
on	O
his	O
initial	O
admittance	O
to	O
the	O
Intensive	O
Care	O
Unit	O
which	O
did	O
not	O
show	O
any	O
evidence	O
of	O
seizure	B-problem
activity	I-problem
.	O

It	O
did	O
,	O
however	O
,	O
show	O
diffuse	B-problem
slowing	I-problem
.	O

He	O
was	O
given	O
1.5	O
grams	O
of	O
Dilantin	B-treatment
in	O
the	O
emergency	O
room	O
as	O
well	O
as	O
2	O
mgs	O
of	O
intravenous	B-treatment
Ativan	I-treatment
which	O
did	O
little	O
to	O
stop	O
his	B-problem
rhythmic	I-problem
blinking	I-problem
that	O
he	O
showed	O
from	O
time	O
to	O
time	O
on	O
examination	B-test
.	O

His	B-problem
hypertension	I-problem
;	O
his	B-problem
high	I-problem
blood	I-problem
pressure	I-problem
was	O
controlled	O
with	O
intravenous	B-treatment
nitroglycerine	I-treatment
in	O
the	O
early	O
going	O
and	O
then	O
he	O
was	O
switched	O
to	O
an	B-treatment
oral	I-treatment
regimen	I-treatment
for	O
better	O
control	O
after	O
he	O
was	O
removed	O
from	O
the	O
Intensive	O
Care	O
Unit	O
.	O

He	O
continued	O
to	O
do	O
well	O
over	O
the	O
next	O
few	O
days	O
and	O
was	O
quite	O
surprisingly	O
intact	O
on	O
both	O
sides	O
of	O
his	O
body	O
in	O
terms	O
of	O
his	O
ability	O
to	O
move	O
.	O

He	O
did	O
consistently	O
have	O
more	O
movement	O
on	O
the	O
left	O
side	O
of	O
his	O
body	O
than	O
on	O
the	O
right	O
,	O
but	O
he	O
gradually	O
became	O
more	O
awake	O
and	O
alert	O
and	O
communicative	O
and	O
his	B-treatment
endotracheal	I-treatment
tube	I-treatment
was	O
removed	O
on	O
the	O
second	O
day	O
of	O
admission	O
.	O

His	O
diagnosis	O
of	O
progressive	B-problem
supranuclear	I-problem
palsy	I-problem
was	O
placed	O
under	O
question	O
on	O
further	B-test
examination	I-test
of	I-test
his	I-test
eye	I-test
movement	I-test
since	O
he	O
was	O
able	O
to	O
have	O
excellent	O
superior	O
gaze	O
especially	O
with	O
the	B-test
bells	I-test
phenomenon	I-test
which	O
would	O
not	O
be	O
seen	O
with	O
progressive	B-problem
supranuclear	I-problem
palsy	I-problem
.	O

It	O
was	O
felt	O
that	O
his	B-problem
dementing	I-problem
illness	I-problem
and	O
rigidity	B-problem
was	O
most	O
likely	O
due	O
to	O
some	O
type	O
of	O
cortico-basal	B-problem
ganglia	I-problem
degeneration	I-problem
process	I-problem
,	O
but	O
this	O
was	O
not	O
clarified	O
during	O
this	O
admission	O
.	O

It	O
was	O
not	O
felt	O
likely	O
to	O
be	O
due	O
to	O
Parkinson	B-problem
&apos;s	I-problem
disease	I-problem
,	O
as	O
he	O
had	O
no	O
significant	O
response	O
to	O
Eldopa	B-treatment
in	O
the	O
past	O
and	O
the	O
patient	O
had	O
no	O
evidence	O
of	O
tremor	B-problem
,	O
although	O
he	O
was	O
quite	B-problem
rigid	I-problem
and	O
bradykinetic	B-problem
.	O

He	O
had	O
an	B-test
magnetic	I-test
resonance	I-test
imaging	I-test
performed	O
on	O
October	O
18	O
,	O
1996	O
.	O

This	O
showed	O
the	B-problem
unchanged	I-problem
left	I-problem
temporal	I-problem
parenchymal	I-problem
interparenchymal	I-problem
hematoma	I-problem
and	O
the	B-problem
old	I-problem
embolic	I-problem
right	I-problem
frontal	I-problem
infarct	I-problem
,	O
but	O
there	O
were	O
no	O
new	B-problem
lesions	I-problem
and	O
no	O
evidence	O
of	O
his	B-test
susceptibility	I-test
studies	I-test
to	O
suggest	O
old	B-problem
bleeds	I-problem
which	O
might	O
have	O
been	O
consistent	O
with	O
amylase	B-problem
angiopathy	I-problem
.	O

In	O
addition	O
,	O
he	O
gadolinium	B-test
scan	I-test
did	O
not	O
show	O
enhancement	B-problem
at	O
the	O
area	O
of	O
his	B-problem
hemorrhage	I-problem
,	O
so	O
tumor	B-problem
was	O
felt	O
to	O
be	O
unlikely	O
.	O

However	O
,	O
this	O
issue	O
will	O
need	O
to	O
be	O
re-evaluated	O
in	O
six	O
months	O
time	O
once	O
the	B-problem
hematoma	I-problem
is	O
less	O
prominent	O
to	O
see	O
if	O
there	O
is	O
possibly	O
an	B-problem
underlying	I-problem
tumor	I-problem
or	O
arterial	B-problem
venous	I-problem
malformation	I-problem
that	O
could	O
be	O
currently	O
compressed	O
by	O
the	O
area	O
of	O
hemorrhage	B-problem
.	O

The	O
etiology	O
of	O
his	B-problem
bleed	I-problem
was	O
felt	O
to	O
be	O
most	O
likely	O
secondary	O
to	O
hypertension	B-problem
,	O
but	O
these	O
other	O
causes	O
could	O
also	O
not	O
be	O
ruled	O
out	O
.	O

2)	O
CARDIOVASCULAR	O
:	O

His	B-test
electrocardiogram	I-test
was	O
concerning	O
for	O
ischemia	B-problem
.	O

He	O
was	O
on	O
intravenous	B-treatment
TNG	I-treatment
and	O
was	O
supratherapeutic	B-problem
on	O
his	B-treatment
anti-coagulation	I-treatment
.	O

He	O
did	O
have	O
a	B-problem
slight	I-problem
elevation	I-problem
of	O
his	B-test
TPK	I-test
with	O
an	O
additional	O
value	O
of	O
198	O
with	O
a	B-test
MB	I-test
fraction	I-test
of	O
5.7	O
,	O
which	O
makes	O
for	O
a	O
percentage	O
of	O
2.9	O
.	O

That	O
was	O
at	O
the	O
highest	O
percentage	O
that	O
he	O
had	O
and	O
after	O
this	O
his	O
percentage	O
came	O
down	O
to	O
1.6	O
,	O
1.0	O
on	O
subsequent	B-test
CKMBs	I-test
and	O
was	O
felt	O
that	O
he	O
had	O
a	B-problem
very	I-problem
small	I-problem
&quot;	I-problem
leaflet	I-problem
&quot;	I-problem
.	O

He	O
remained	O
chest	B-problem
pain	I-problem
free	O
throughout	O
his	O
admission	O
.	O

3)	O
PULMONARY	O
:	O

After	O
his	B-treatment
initial	I-treatment
intubation	I-treatment
he	O
remained	O
quite	O
stable	O
.	O

He	O
was	O
found	O
to	O
be	O
at	O
a	B-problem
large	I-problem
aspiration	I-problem
risk	I-problem
given	O
his	B-problem
decreased	I-problem
mental	I-problem
status	I-problem
and	O
the	O
lack	O
of	O
presence	O
of	O
a	B-test
gag	I-test
reflex	I-test
.	O

However	O
,	O
he	O
was	O
given	O
aggressive	B-treatment
pulmonary	I-treatment
toilets	I-treatment
including	O
chest	B-treatment
physical	I-treatment
therapy	I-treatment
and	O
aspiration	B-treatment
precautions	I-treatment
and	O
the	O
patient	O
did	O
not	O
develop	O
any	B-problem
pulmonary	I-problem
symptoms	I-problem
during	O
his	O
admission	O
.	O

4)	O
HEMATOLOGY	O
:	O

He	O
had	O
his	B-test
prothrombin	I-test
time	I-test
reversed	O
with	O
Vitamin	B-treatment
K	I-treatment
2	O
mgs	O
on	O
admission	O
subcutaneously	O
as	O
well	O
as	O
two	O
units	O
of	O
fresh	B-treatment
frozen	I-treatment
plasma	I-treatment
given	O
in	O
the	O
emergency	O
room	O
.	O

His	O
anticoagulation	O
status	O
had	O
to	O
be	O
monitored	O
very	O
closely	O
due	O
to	O
his	O
history	O
of	O
deep	B-problem
venous	I-problem
thrombosis	I-problem
and	O
pulmonary	B-problem
embolus	I-problem
as	O
well	O
as	O
atrial	B-problem
fibrillation	I-problem
,	O
but	O
he	O
could	O
not	O
be	O
placed	O
on	O
a	O
high	O
amount	O
of	O
anticoagulation	B-treatment
because	O
of	O
the	B-problem
new	I-problem
intraparenchymal	I-problem
bleed	I-problem
.	O

It	O
was	O
decided	O
that	O
his	O
goal	O
INR	B-test
was	O
to	O
be	O
2.0	O
.	O

He	O
did	O
drop	O
below	O
1.5	O
at	O
one	O
time	O
,	O
at	O
which	O
time	O
he	O
was	O
placed	O
on	O
heparin	B-treatment
intravenous	I-treatment
to	O
carry	O
him	O
through	O
that	O
period	O
,	O
but	O
his	B-test
discharge	I-test
INR	I-test
was	O
around	O
2	O
and	O
he	O
was	O
off	O
of	O
heparin	B-treatment
at	O
that	O
time	O
.	O

It	O
was	O
decided	O
that	O
he	O
would	O
have	O
very	O
close	O
monitoring	B-test
of	O
his	O
anticoagulation	O
status	O
in	O
the	O
future	O
to	O
prevent	O
further	B-problem
problems	I-problem
.	O

5)	O
GASTROINTESTINAL	O
:	O

He	O
was	O
evaluated	O
by	O
the	O
speech	O
and	O
swallow	O
pathology	O
group	O
at	O
the	O
Ph	O
University	O
Of	O
Medical	O
Center	O
and	O
it	O
was	O
decided	O
that	O
he	O
was	O
able	O
to	O
swallow	O
on	O
his	O
own	O
with	O
a	B-treatment
soft	I-treatment
solid	I-treatment
diet	I-treatment
with	O
supervision	O
.	O

Thus	O
,	O
his	B-treatment
nasogastric	I-treatment
tube	I-treatment
was	O
discontinued	O
on	O
October	O
19	O
,	O
1996	O
and	O
he	O
tolerated	O
feeding	O
quite	O
well	O
.	O

In	O
discussions	O
with	O
the	O
family	O
,	O
given	O
his	O
age	O
and	O
number	O
of	O
medical	B-problem
problems	I-problem
,	O
it	O
was	O
decided	O
that	O
the	O
patient	O
should	O
be	O
do	O
not	O
resuscitate	O
should	O
he	O
have	O
a	B-problem
terminal	I-problem
cardiac	I-problem
event	I-problem
during	O
his	O
admission	O
or	O
during	O
future	O
admissions	O
.	O

However	O
,	O
he	O
was	O
still	O
an	B-treatment
intubation	I-treatment
candidate	O
if	O
it	O
were	O
felt	O
to	O
be	O
a	B-treatment
short	I-treatment
term	I-treatment
procedure	I-treatment
.	O

The	O
family	O
realizes	O
that	O
the	O
long	O
term	O
outlook	O
for	O
this	O
patient	O
is	O
not	O
very	O
good	O
,	O
but	O
they	O
would	O
like	O
to	O
currently	O
continue	O
to	O
provide	O
him	O
with	O
all	B-treatment
support	I-treatment
necessary	I-treatment
,	O
short	O
of	O
resuscitation	B-treatment
measures	I-treatment
or	O
heroic	B-treatment
measures	I-treatment
should	O
he	O
have	O
a	B-problem
cardiopulmonary	I-problem
arrest	I-problem
.	O

DISPOSITION	O
/	O
PLAN	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DOCTOR	O
&apos;S	O
DISCHARGE	O
ORDERS	O
:	O

The	O
patient	O
was	O
to	O
be	O
discharged	O
to	O
a	O
rehabilitation	O
hospital	O
,	O
the	O
location	O
of	O
which	O
was	O
undetermined	O
at	O
this	O
time	O
of	O
this	O
discharge	O
summary	O
.	O

The	O
patient	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Ria	O
in	O
clinic	O
on	O
one	O
month	O
time	O
and	O
the	O
family	O
is	O
to	O
call	O
me	O
if	O
there	O
were	O
any	O
questions	O
in	O
the	O
interim	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Dilantin	B-treatment
100	O
mgs	O
po	O
tid	O
,	O
Carafate	B-treatment
1	O
gram	O
po	O
qid	O
,	O
Digoxin	B-treatment
0.25	O
mgs	O
po	O
qd	O
,	O
Isordil	B-treatment
20	O
mgs	O
po	O
tid	O
,	O
Captopril	B-treatment
25	O
mgs	O
po	O
tid	O
,	O
Lopressor	B-treatment
50	O
mgs	O
po	O
bid	O
,	O
Colace	B-treatment
100	O
mgs	O
po	O
tid	O
,	O
and	O
Coumadin	B-treatment
2	O
mgs	O
po	O
qhs	O
.	O

TI	O
CALL	O
,	O
M.D.	O

TR	O
:	O

fcz	O
PAD-WORD	O

DD	O
:	O

10/21/96	O
PAD-WORD	O

TD	O
:	O

10/21/96	O
2:07	O
A	O

cc	O
:	O

TI	O
SHEMAU	O
CALL	O
,	O
M.D.	O
ASHA	O
E	O
VENGLOAN	O
,	O
M.D.	O
LYDELL	O
R	O
WORCE	O
,	O
M.D.	O
/	O
STAT	O

988183518	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

7961198	O
PAD-WORD	O

290757	O
PAD-WORD	O

137082	O
PAD-WORD	O

1/25/1997	O
12:00:00	O
AM	O

CRYPTOGENIC	B-problem
CIRRHOSIS	I-problem
.	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

BOEHKOTE	O
,	O
SONA	O
S	O

UNIT	O
NUMBER	O
:	O

457-95-71	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

01/25/97	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

01/30/97	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Cryptogenic	B-problem
cirrhosis	I-problem
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Variceal	B-problem
bleeding	I-problem
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Variceal	B-treatment
banding	I-treatment
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
70-year-old	O
female	O
with	O
cryptogenic	B-problem
cirrhosis	I-problem
.	O

She	O
has	O
a	O
history	O
of	O
esophageal	B-problem
varices	I-problem
and	O
a	O
history	O
of	O
an	B-problem
Upper	I-problem
GI	I-problem
bleed	I-problem
.	O

She	O
has	O
had	O
one	O
pervious	O
episode	O
of	O
variceal	B-problem
bleeding	I-problem
with	O
an	O
unclear	O
date	O
.	O

However	O
she	O
is	O
followed	O
by	O
a	O
Dr.	O
Joasscchird	O
at	O
Vaila	O
Medical	O
Center	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
one	O
day	O
prior	O
to	O
admission	O
when	O
she	O
felt	O
increasing	B-problem
fatigue	I-problem
,	O
nausea	B-problem
and	O
vomiting	B-problem
productive	O
of	O
bright	B-problem
red	I-problem
blood	I-problem
and	O
coffee	B-problem
ground	I-problem
emesis	I-problem
.	O

She	O
also	O
had	O
some	B-problem
black	I-problem
,	I-problem
tarry	I-problem
stool	I-problem
in	O
her	B-treatment
colostomy	I-treatment
bag	I-treatment
.	O

At	O
Vaila	O
Medical	O
Center	O
,	O
she	O
had	O
a	B-test
hematocrit	I-test
of	O
25	O
and	O
was	O
transfused	O
2	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
.	O

She	O
had	O
an	B-test
upper	I-test
endoscopy	I-test
at	O
Va	O
Sit	O
Namar	O
Healthcare	O
showing	O
an	O
esophagus	O
filled	O
with	O
clots	B-problem
and	O
small	O
amount	O
of	O
bleeding	B-problem
varices	I-problem
,	O
clot	B-problem
in	I-problem
the	I-problem
stomach	I-problem
with	O
antral	B-problem
gastritis	I-problem
,	O
and	O
a	O
normal	O
duodenum	O
.	O

She	O
was	O
started	O
on	O
Pitressin	B-treatment
,	O
a	B-treatment
Blakemore	I-treatment
tube	I-treatment
was	O
inserted	O
.	O

She	O
was	O
transferred	O
to	O
the	O
Ph	O
University	O
Of	O
Medical	O
Center	O
Intensive	O
Care	O
Unit	O
where	O
on	O
January	O
25	O
in	O
the	O
morning	O
her	B-test
hematocrit	I-test
was	O
found	O
to	O
be	O
27.4	O
.	O

She	O
was	O
transfused	O
another	O
2	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
over	O
the	O
course	O
of	O
the	O
day	O
and	O
her	B-test
hematocrit	I-test
improved	O
to	O
29.4	O
and	O
then	O
31.2	O
.	O

The	O
GI	O
service	O
was	O
consulted	O
and	O
an	B-test
upper	I-test
endoscopy	I-test
study	I-test
showed	O
grade	B-problem
III	I-problem
varices	I-problem
with	O
no	O
active	B-problem
bleeding	I-problem
and	O
a	B-problem
clean	I-problem
base	I-problem
gastric	I-problem
ulcer	I-problem
possibly	O
secondary	O
to	O
the	B-treatment
Blakemore	I-treatment
tube	I-treatment
.	O

Her	B-problem
varices	I-problem
had	O
stigmata	B-problem
of	O
recent	B-problem
bleeding	I-problem
,	O
were	O
banded	B-treatment
successfully	O
.	O

after	O
the	B-treatment
procedure	I-treatment
and	O
2	O
more	O
units	O
of	O
packed	B-treatment
red	I-treatment
blood	I-treatment
cells	I-treatment
,	O
the	O
patient	O
was	O
hemodynamically	O
stable	O
and	O
hematocrit	B-test
was	O
stable	O
at	O
31.2	O
.	O

At	O
that	O
time	O
she	O
was	O
transferred	O
from	O
the	O
Intensive	O
Care	O
Unit	O
to	O
Coden	O
2	O
for	O
the	O
Lemgarson	O
Hospital	O
service	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Cryptogenic	B-problem
cirrhosis	I-problem
with	O
an	B-test
unclear	I-test
work	I-test
up	I-test
.	O

Diverticular	B-problem
bleed	I-problem
requiring	O
colostomy	B-treatment
on	O
May	O
96	O
.	O

Spinal	B-problem
stenosis	I-problem
.	O

Hysterectomy	B-treatment
at	O
the	O
age	O
of	O
32	O
.	O

No	O
coronary	B-problem
disease	I-problem
,	O
no	O
diabetes	B-problem
and	O
no	O
hypertension	B-problem
.	O

She	O
had	O
medications	B-treatment
on	O
transfer	O
which	O
included	O
Synthroid	B-treatment
0.15	O
mg	O
QD	O
,	O
Zoloft	B-treatment
50	O
mg	O
QD	O
,	O
Inderal	B-treatment
10	O
mg	O
BID	O
,	O
Prilosec	B-treatment
20	O
mg	O
QD	O
,	O
Neomycin	B-treatment
500	O
TID	O
,	O
Feosol	B-treatment
3	O
mg	O
and	O
Darvocet	B-treatment
PRN	O
.	O

She	O
has	O
allergies	B-problem
to	O
Morphine	B-treatment
,	O
Percocet	B-treatment
,	O
Codeine	B-treatment
,	O
Penicillin	B-treatment
,	O
Xanax	B-treatment
and	O
Toradol	B-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
does	O
not	O
smoke	O
tobacco	O
.	O

She	O
uses	O
only	O
occasional	O
alcohol	O
and	O
she	O
is	O
not	O
sexually	O
active	O
.	O

Her	O
husband	O
died	O
of	O
lung	B-problem
cancer	I-problem
.	O

She	O
lives	O
alone	O
in	O
Burg	O
Chi	O
Sternafre	O
,	O
Massachusetts	O
.	O

Her	O
friends	O
check	O
up	O
on	O
her	O
.	O

She	O
does	O
not	O
have	O
a	O
home	O
health	O
aide	O
.	O

She	O
has	O
3	O
kids	O
who	O
live	O
far	O
away	O
.	O

She	O
is	O
able	O
at	O
baseline	O
to	O
walk	O
one	O
flight	O
of	O
stairs	O
,	O
2	O
floor	O
apartment	O
.	O

FAMILY	O
HISTORY	O
:	O

Non	O
contributory	O
and	O
unavailable	O
as	O
she	O
is	O
adopted	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
an	O
obese	O
,	O
elderly	O
woman	O
in	O
no	O
acute	B-problem
distress	I-problem
.	O

vital	O
signs	O
:	O

158/60	O
with	O
a	B-test
heart	I-test
rate	I-test
of	O
85	O
,	O
temperature	B-test
99.7	O
,	O
respirations	B-test
14	O
.	O

Her	O
neck	O
showed	O
no	O
JVD	B-problem
.	O

Lungs	O
clear	O
to	O
auscultation	B-test
.	O

Her	O
abdomen	O
was	O
obese	B-problem
and	O
distended	B-problem
with	O
good	O
bowel	O
sounds	O
,	O
large	B-problem
ventral	I-problem
hernia	I-problem
.	O

Colostomy	B-treatment
with	O
black	B-problem
stool	I-problem
.	O

She	O
had	O
some	B-problem
mid	I-problem
epigastric	I-problem
tenderness	I-problem
and	O
no	O
rebound	B-problem
.	O

Her	O
heart	O
showed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
an	O
S1-S2	O
,	O
no	O
murmur	B-problem
.	O

Her	B-test
neurological	I-test
exam	I-test
was	O
alert	O
and	O
oriented	O
.	O

She	O
had	O
5	O
out	O
of	O
5	O
strength	O
bilaterally	O
and	O
her	O
toes	O
were	O
downgoing	O
.	O

She	O
had	O
no	O
evidence	O
of	O
asterixis	B-problem
.	O

Her	O
skin	O
looked	O
very	O
bronze	O
and	O
tan	O
,	O
especially	O
in	O
the	O
sun	O
exposed	O
areas	O
.	O

She	O
had	O
no	O
spider	B-problem
angiomata	I-problem
,	O
no	O
palmar	B-problem
erythema	I-problem
,	O
no	O
xanthomas	B-problem
and	O
no	O
caput	B-problem
medusae	I-problem
.	O

She	O
did	O
not	O
look	O
teric	B-problem
(	O
???	O
)	O
.	O

LABORATORY	O
DATA	O
:	O

Notable	O
for	O
sodium	B-test
141	O
,	O
potassium	B-test
4.2	O
,	O
chloride	B-test
109	O
,	O
bicarb	B-test
19.8	O
,	O
BUN	B-test
38	O
,	O
creatinine	B-test
1.2	O
and	O
glucose	B-test
388	O
.	O

She	O
had	O
a	B-problem
pneumonia	I-problem
of	O
31	O
,	O
calcium	B-test
was	O
7.5	O
,	O
phosphorous	B-test
3.0	O
,	O
magnesium	B-test
1.3	O
.	O

Her	B-test
bilirubin	I-test
was	O
1.4	O
total	O
,	O
0.2	O
direct	B-test
.	O

alkaline	B-test
phosphatase	I-test
101	O
.	O

SGPT	B-test
22	O
,	O
SGOT	B-test
41	O
,	O
amylase	B-test
31	O
,	O
lipase	B-test
less	O
than	O
1	O
.	O

LDH	B-test
was	O
38.9	O
,	O
CK	B-test
was	O
66	O
,	O
her	B-test
hematocrit	I-test
was	O
27.4	O
,	O
white	B-test
count	I-test
was	O
8.0	O
and	O
her	B-test
platelets	I-test
were	O
55	O
.	O

PT	B-test
was	O
14.5	O
,	O
PTT	B-test
25.5	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

As	O
described	O
above	O
the	O
patient	O
was	O
transfused	O
an	B-treatment
additional	I-treatment
2	I-treatment
units	I-treatment
in	O
the	O
Intensive	O
Care	O
Unit	O
and	O
the	O
patient	O
also	O
received	O
an	B-test
upper	I-test
endoscopy	I-test
study	I-test
and	O
her	B-problem
varices	I-problem
were	O
banded	B-treatment
.	O

On	O
transfer	O
to	O
the	O
Lemgarson	O
Hospital	O
service	O
,	O
her	B-test
hematocrit	I-test
was	O
31.2	O
,	O
white	B-test
count	I-test
11.1	O
and	O
a	B-test
platelet	I-test
count	I-test
80	O
.	O

Her	B-test
PT	I-test
was	O
13.1	O
,	O
PTT	B-test
26.7	O
.	O

The	O
rest	O
of	O
her	B-test
labs	I-test
were	O
unremarkable	O
.	O

She	O
was	O
watched	O
very	O
closely	O
while	O
on	O
the	O
floor	O
.	O

She	O
was	O
on	O
GI	B-treatment
bleed	I-treatment
precautions	I-treatment
at	O
all	O
times	O
,	O
was	O
too	O
large	O
for	O
IV	B-treatment
.	O

She	O
had	O
a	B-problem
clot	I-problem
at	O
the	O
blood	O
bank	O
and	O
she	O
had	O
BID	B-test
hematocrits	I-test
checked	O
.	O

She	O
was	O
kept	O
NPO	B-treatment
until	O
January	O
26	O
when	O
she	O
began	O
to	O
feel	O
hungry	O
.	O

At	O
that	O
time	O
clear	B-treatment
liquids	I-treatment
were	O
started	O
.	O

All	O
of	O
her	O
stools	O
were	O
guaiaced	O
.	O

She	O
also	O
began	O
Nadolol	B-treatment
40	O
mg	O
QD	O
to	O
reduce	O
her	B-problem
portal	I-problem
hypertension	I-problem
.	O

The	O
GI	O
consult	O
team	O
continued	O
to	O
follow	O
her	O
.	O

We	O
also	O
tried	O
to	O
contact	O
her	O
physician	O
at	O
Va	O
Sit	O
Namar	O
Healthcare	O
and	O
was	O
unsuccessful	O
.	O

Therefore	O
we	O
decided	O
to	O
work	B-test
up	I-test
her	O
cirrhosis	B-problem
.	O

She	O
was	O
described	O
as	O
having	O
_______	O
cirrhosis	B-problem
and	O
we	O
decided	O
that	O
we	O
wanted	O
to	O
try	O
to	O
figure	O
out	O
the	O
etiology	O
.	O

Her	B-test
ferritin	I-test
and	O
iron	B-test
studies	I-test
did	O
not	O
reveal	O
any	O
evidence	O
of	O
hemochromatosis	B-problem
and	O
her	B-test
hep	I-test
serologies	I-test
were	O
all	O
negative	O
.	O

She	O
also	O
had	O
negative	O
antimitochondrial	O
antibody	O
and	O
she	O
also	O
had	O
no	O
evidence	O
of	O
ceruloplasmin	B-problem
.	O

Over	O
the	O
course	O
of	O
her	O
admission	O
were	O
also	O
sent	O
an	B-test
alpha-1-antitrypsin	I-test
,	O
which	O
was	O
negative	O
.	O

She	O
did	O
very	O
well	O
over	O
the	O
course	O
of	O
her	O
admission	O
with	O
no	O
evidence	O
of	O
further	B-problem
bleeding	I-problem
.	O

Her	B-test
hematocrit	I-test
stayed	O
stable	O
at	O
approximately	O
32	O
.	O

We	O
also	O
did	O
an	B-test
ultrasound	I-test
guided	I-test
paracentesis	I-test
.	O

The	B-test
peritoneal	I-test
fluid	I-test
showed	O
a	B-test
glucose	I-test
of	O
244	O
,	O
total	B-test
protein	I-test
0.8	O
and	O
a	B-test
albumin	I-test
of	O
0.5	O
,	O
globulin	B-test
0.3	O
,	O
amylase	B-test
16	O
,	O
LDH	B-test
of	O
51	O
.	O

The	B-test
serum	I-test
albumin	I-test
gradient	I-test
was	O
1.8	O
consistent	O
with	O
portal	B-problem
hypertension	I-problem
.	O

The	B-test
cell	I-test
count	I-test
showed	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
160	O
with	O
16%	B-test
polys	I-test
.	O

She	O
therefore	O
_________	O
criteria	O
for	O
a	B-problem
spontaneous	I-problem
bacterial	I-problem
peritonitis	I-problem
.	O

Her	B-test
platelet	I-test
count	I-test
stayed	O
persistently	B-problem
low	I-problem
and	O
we	O
decided	O
that	O
it	O
might	O
be	O
due	O
to	O
Cimetidine	B-treatment
.	O

Therefore	O
we	O
switched	O
her	O
Cimetidine	B-treatment
to	O
Prilosec	B-treatment
.	O

By	O
the	O
2th	O
the	O
patient	O
was	O
feeling	O
very	O
well	O
and	O
desired	O
to	O
transfer	O
or	O
discharge	O
to	O
home	O
.	O

She	O
wanted	O
to	O
be	O
closer	O
to	O
North	O
Dakota	O
.	O

After	O
discussion	O
with	O
her	O
private	O
physician	O
,	O
Dr.	O
Joasscchird	O
,	O
tel.	O
090-249-6079	O
,	O
at	O
Va	O
Sit	O
Namar	O
Healthcare	O
and	O
Dr.	O
Acrookesjo	O
at	O
Do	O
Of	O
Hospital	O
,	O
the	O
patient	O
was	O
judged	O
to	O
be	O
fit	O
for	O
discharge	O
and	O
she	O
was	O
sent	O
home	O
with	O
AH	B-treatment
and	O
physical	B-treatment
therapy	I-treatment
.	O

She	O
was	O
quite	O
able	O
to	O
climb	O
stairs	O
on	O
her	O
own	O
in	O
the	O
hospital	O
.	O

She	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Acrookesjo	O
in	O
one	O
week	O
and	O
Dr.	O
Work	O
the	O
gastrointestinal	O
fellow	O
here	O
at	O
PUOMC	O
in	O
2	O
weeks	O
.	O

She	O
may	O
require	O
a	B-test
repeat	I-test
upper	I-test
endoscopy	I-test
study	I-test
to	O
see	O
if	O
she	O
needs	O
any	B-treatment
rebanding	I-treatment
.	O

The	O
patient	O
however	O
complained	O
of	O
a	B-problem
persistent	I-problem
wheeze	I-problem
with	O
beta	B-treatment
blocker	I-treatment
,	O
therefore	O
it	O
was	O
agreed	O
that	O
we	O
would	O
stop	O
the	B-treatment
beta	I-treatment
blocker	I-treatment
until	O
the	O
patient	O
was	O
followed	O
up	O
as	O
an	O
outpatient	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Zoloft	B-treatment
50	O
mg	O
PO	O
QD	O
,	O
Lactulose	B-treatment
15	O
g	O
PO	O
BID	O
,	O
Synthroid	B-treatment
0.15	O
mg	O
PO	O
QD	O
,	O
Prilosec	B-treatment
20	O
mg	O
PO	O
BID	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

LENTNY	O
WORK	O
,	O
M.D.	O

TR	O
:	O

zs	O
PAD-WORD	O

DD	O
:	O

03/06/97	O
PAD-WORD	O

TD	O
:	O

03/10/97	O
2:14	O
P	O

cc	O
:	O

LENTNY	O
MAYLUTYNA	O
WORK	O
,	O
M.D.	O

991070824	O
SC	O

67707063	O
PAD-WORD	O

467502	O
PAD-WORD	O

9/26/2001	O
12:00:00	O
AM	O

FEVER	B-problem
PAD-WORD	O

Signed	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Admission	O
Date	O
:	O

09/26/2001	O
PAD-WORD	O

Report	O
Status	O
:	O

Signed	O
PAD-WORD	O

Discharge	O
Date	O
:	O

10/06/2001	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSES	O
:	O

1.	O
NEUTROPENIA	B-problem

2.	O
CELLULITIS	B-problem
.	O

3.	O
FEVER	B-problem
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
60-year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
notable	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
and	O
CABG	B-treatment
x2	O
in	O
2001	O
.	O

The	O
patient	O
has	O
felt	O
unwell	B-problem
since	O
7/21	O
after	O
his	B-problem
non-Q	I-problem
wave	I-problem
MI	I-problem
.	O

The	O
patient	O
,	O
at	O
this	O
time	O
,	O
was	O
started	O
on	O
Statin	B-treatment
and	O
developed	O
in	O
arthritis	B-problem
approximately	O
one	O
month	O
later	O
with	O
joint	B-problem
pain	I-problem
,	O
myalgia	B-problem
and	O
fatigue	B-problem
.	O

No	O
clear	O
diagnosis	O
was	O
made	O
.	O

The	O
patient	O
was	O
presumed	O
to	O
have	O
a	B-problem
rheumatoid	I-problem
factor	I-problem
negative	I-problem
,	I-problem
rheumatoid	I-problem
arthritis	I-problem
and	O
he	O
was	O
prescribed	O
Naprosyn	B-treatment
,	O
prednisone	B-treatment
and	O
sulfasalazine	B-treatment
.	O

He	O
had	O
a	B-test
CABG	I-test
review	I-test
in	O
2/21	O
.	O

His	B-treatment
first	I-treatment
CABG	I-treatment
was	O
in	O
02/89	O
.	O

Since	O
2/21	O
,	O
he	O
has	O
had	O
increasing	B-problem
weight	I-problem
loss	I-problem
of	O
30-49	O
pounds	O
,	O
night	B-problem
sweats	I-problem
which	O
he	O
attributed	O
to	O
the	B-treatment
prednisone	I-treatment
and	O
increased	B-problem
fatigue	I-problem
and	O
myalgias	B-problem
.	O

The	O
patient	O
has	O
gradually	O
taken	O
to	O
bed	O
with	O
decreasing	O
activity	O
.	O

In	O
late	O
7/22	O
,	O
sulfasalazine	B-treatment
was	O
started	O
at	O
one	O
tab	O
three	O
times	O
a	O
day	O
.	O

The	O
patient	O
subsequently	O
developed	O
diffuse	B-problem
abdominal	I-problem
pain	I-problem
,	O
nausea	B-problem
,	O
vomiting	B-problem
,	O
and	O
decreased	B-problem
p.o.	I-problem
intake	I-problem
.	O

A	B-problem
guaiac	I-problem
positive	I-problem
stool	I-problem
was	O
also	O
noted	O
in	O
the	O
month	O
of	O
July	O
.	O

10	O
days	O
prior	O
to	O
admission	O
,	O
the	O
patient	O
&apos;s	O
primary	O
care	O
physician	O
increased	O
his	B-treatment
sulfasalazine	I-treatment
dose	I-treatment
to	O
two	O
tabs	O
three	O
times	O
a	O
day	O
.	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
prednisone	I-treatment
was	O
increased	O
to	O
60	O
mg	O
q.d.	O
as	O
the	O
patient	O
was	O
diagnosed	O
with	O
an	B-problem
arthritis	I-problem
flare	I-problem
.	O

The	B-treatment
prednisone	I-treatment
dose	I-treatment
was	O
gradually	O
tapered	O
to	O
20	O
mg	O
q.d.	O

The	O
day	O
before	O
admission	O
,	O
the	O
patient	O
developed	O
a	B-problem
fever	I-problem
to	O
102	O
degrees	O
and	O
increasing	B-problem
abdominal	I-problem
pain	I-problem
.	O

He	O
presented	O
to	O
an	O
outside	O
hops	O
where	O
he	O
was	O
noted	O
to	O
be	O
leukopenic	B-problem
with	O
a	B-test
white	I-test
blood	I-test
cell	I-test
count	I-test
of	O
0.6	O
,	O
0	O
neutrophils	B-test
,	O
a	B-test
hematocrit	I-test
of	O
32	O
,	O
platelets	B-test
of	O
326	O
,	O
a	B-test
MCV	I-test
of	O
79	O
,	O
and	O
RDW	B-test
of	O
22	O
.	O

The	O
patient	O
was	O
given	O
IV	B-treatment
fluids	I-treatment
and	O
treated	O
with	O
imipenem	B-treatment
,	O
transferred	O
to	O
Ca	O
Valley	O
Hospital	O
ED	O
,	O
where	O
it	O
was	O
noted	O
that	O
the	O
patient	O
had	O
face	B-problem
and	I-problem
neck	I-problem
swelling	I-problem
,	O
as	O
well	O
as	O
erythema	B-problem
and	O
cervical	B-problem
lymphadenopathy	I-problem
.	O

The	O
patient	O
states	O
that	O
his	B-problem
swelling	I-problem
of	I-problem
his	I-problem
face	I-problem
began	O
two	O
days	O
prior	O
to	O
admission	O
and	O
has	O
doubled	O
since	O
then	O
.	O

In	O
the	O
emergency	O
department	O
,	O
CT	B-test
of	I-test
head	I-test
,	I-test
neck	I-test
and	I-test
abdomen	I-test
were	O
performed	O
.	O

The	B-test
CT	I-test
of	I-test
the	I-test
abdomen	I-test
was	O
without	O
lymphadenopathy	B-problem
,	O
revealed	O
a	B-problem
right	I-problem
renal	I-problem
cyst	I-problem
,	O
otherwise	O
unremarkable	O
.	O

The	B-test
CT	I-test
of	I-test
head	I-test
and	I-test
neck	I-test
was	O
likewise	O
unremarkable	O
showing	O
no	O
evidence	O
of	O
fasciitis	B-problem
or	O
deep	B-problem
tissue	I-problem
thread	I-problem
.	O

No	O
abscesses	B-problem
were	O
noted	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
patient	O
denies	O
shortness	B-problem
of	I-problem
breath	I-problem
,	O
chest	B-problem
pain	I-problem
,	O
orthopnea	B-problem
,	O
no	O
dysuria	B-problem
,	O
hematuria	B-problem
,	O
no	O
visual	B-problem
changes	I-problem
,	O
no	O
rashes	B-problem
,	O
no	O
blurry	B-problem
vision	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Coronary	B-problem
artery	I-problem
disease	I-problem
,	O
status	O
post	O
MI	B-problem
x2	O
,	O
CABG	B-treatment
x2	O
in	O
02/89	O
and	O
2/21	O
,	O
history	O
of	O
arthritis	B-problem
,	O
history	O
of	O
bilateral	B-problem
rotator	I-problem
cuff	I-problem
degeneration	I-problem
and	O
tears	B-problem
,	O
history	O
of	O
hypertension	B-problem
,	O
history	O
of	O
hyperlipidemia	B-problem
.	O

MEDICATIONS	O
:	O

Sulfasalazine	B-treatment
,	O
prednisone	B-treatment
20	O
mg	O
q.d.	O
,	O
Naprosyn	B-treatment
500	O
mg	O
t.i.d.	O
,	O
Zestril	B-treatment
10	O
mg	O
q.d.	O
,	O
Lopressor	B-treatment
50	O
mg	O
b.i.d.	O
and	O
iron	B-treatment
supplementation	I-treatment
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
wife	O
.	O

He	O
is	O
a	O
realtor	O
.	O

The	O
patient	O
has	O
history	O
of	O
heavy	O
cigar	O
smoking	O
,	O
no	O
cigarettes	O
.	O

Social	O
use	O
of	O
alcohol	O
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
coronary	B-problem
artery	I-problem
disease	I-problem
and	O
MI	B-problem
.	O

No	O
history	O
of	O
cancer	B-problem
.	O

PHYSICAL	O
EXAMINATION	O
:	O

VITAL	O
SIGNS	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
temperature	I-test
was	O
102	O
,	O
heart	B-test
rate	I-test
118	O
,	O
blood	B-test
pressure	I-test
111/56	O
,	O
respiratory	B-test
rate	I-test
28	O
,	O
satting	B-test
92%	O
on	O
room	O
air	O
.	O

HEENT	O
:	O

Pupils	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
,	O
extraocular	O
movements	O
,	O
fundi	O
bilaterally	O
without	O
exudate	B-problem
or	O
hemorrhage	B-problem
.	O

On	O
the	O
left	O
nasolabial	O
,	O
there	O
was	O
a	B-problem
boil	I-problem
with	O
pus	B-problem
and	O
surrounding	B-problem
erythema	I-problem
and	O
tenderness	B-problem
.	O

Left	O
eye	O
with	O
conjunctivae	B-problem
injected	I-problem
,	O
no	O
exudate	B-problem
or	O
pus	B-problem
.	O

Dentition	B-problem
very	I-problem
poor	I-problem
,	O
large	B-problem
bilateral	I-problem
neck	I-problem
and	I-problem
submandibular	I-problem
swelling	I-problem
very	B-problem
tender	I-problem
to	O
palpation	B-test
.	O

CHEST	O
:	O

Scattered	B-problem
bibasilar	I-problem
rales	I-problem
,	O
no	O
wheezes	B-problem
.	O

CARDIAC	O
:	O

Regular	O
rhythm	O
,	O
tachycardia	B-problem
,	O
no	O
murmurs	B-problem
,	O
no	O
JVD	B-problem
.	O

ABDOMEN	O
:	O

Obese	B-problem
,	O
non-distended	B-problem
,	O
positive	O
bowel	O
sounds	O
,	O
mild	B-problem
diffuse	I-problem
tenderness	I-problem
.	O

EXTREMITIES	O
:	O

No	O
edema	B-problem
,	O
positive	O
dorsalis	O
pedis	O
pulses	O
.	O

NEUROLOGICAL	O
:	O

Non-focal	O
,	O
alert	O
and	O
oriented	O
x3	O
,	O
5/5	O
motor	O
strength	O
in	O
the	O
upper	O
extremities	O
and	O
lower	O
extremities	O
,	O
Babinski	B-test
reflex	I-test
,	O
toes	O
are	O
downgoing	O
.	O

LABORATORY	O
DATA	O
:	O

Remarkable	O
for	O
a	B-test
white	I-test
cell	I-test
count	I-test
of	O
0.4	O
,	O
with	O
0	O
neutrophils	B-test
,	O
0	O
bands	B-test
,	O
19	O
lymphs	B-test
,	O
0	O
monos	B-test
,	O
hematocrit	B-test
28.8%	O
,	O
platelets	B-test
300,000	O
.	O

ALT	B-test
141	O
,	O
AST	B-test
40	O
,	O
alk	B-test
phos	I-test
108	O
,	O
and	O
a	B-test
total	I-test
bili	I-test
of	O
1.0.	O
Total	B-test
protein	I-test
was	O
5.7	O
,	O
albumin	B-test
2.5	O
and	O
globulin	B-test
3.2	O
.	O

His	B-test
electrolyte	I-test
panel	I-test
of	O
sodium	B-test
135	O
,	O
sodium	B-test
4.1	O
,	O
chloride	B-test
99	O
,	O
bicarb	B-test
30	O
,	O
BUN	B-test
15	O
,	O
creatinine	B-test
2.1	O
,	O
blood	B-test
glucose	I-test
of	O
196	O
.	O

Iron	B-test
studies	I-test
included	O
a	B-test
ferritin	I-test
of	O
607	O
,	O
an	B-test
iron	I-test
of	O
10	O
,	O
and	O
a	B-test
TIBC	I-test
of	O
239	O
.	O

EKG	B-test
showed	O
tachycardia	B-problem
with	O
a	O
sinus	O
rhythm	O
of	O
103	O
,	O
normal	O
axis	O
,	O
normal	O
intervals	O
,	O
no	O
Q-waves	B-problem
,	O
no	O
ST-T	B-problem
wave	I-problem
changes	I-problem
.	O

The	O
patient	O
had	O
a	O
history	O
from	O
7/12/01	O
of	O
a	O
normal	O
white	O
blood	O
cell	O
count	O
,	O
with	O
a	O
normal	O
absolute	O
neutrophil	O
count	O
.	O

The	B-test
patient	I-test
&apos;s	I-test
chest	I-test
x-ray	I-test
at	O
the	O
outside	O
hospital	O
was	O
unremarkable	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
started	O
on	O
ceftazidime	B-treatment
,	O
nafcillin	B-treatment
and	O
Flagyl	B-treatment
for	O
concern	O
of	O
a	B-problem
soft	I-problem
tissue	I-problem
infection	I-problem
.	O

Neutropenic	B-treatment
precautions	I-treatment
were	O
taken	O
.	O

The	O
patient	O
had	O
a	B-test
bone	I-test
marrow	I-test
biopsy	I-test
which	O
showed	O
myeloid	B-problem
arrest	I-problem
and	O
probable	O
neutropenia	B-problem
from	O
a	O
drug-related	O
cause	O
presumed	O
to	O
be	O
the	B-treatment
sulfasalazine	I-treatment
.	O

Over	O
the	O
course	O
of	O
the	O
hospitalization	O
,	O
the	B-test
patient	I-test
&apos;s	I-test
white	I-test
blood	I-test
cell	I-test
count	I-test
rose	O
from	O
0.4	O
to	O
6.3	O
after	O
he	O
was	O
given	O
G-CSF	B-treatment
,	O
a	O
course	O
lasting	O
from	O
9/28/01	O
until	O
9/30/01	O
.	O

After	O
the	B-treatment
G-CSF	I-treatment
,	O
the	B-test
absolute	I-test
neutrophil	I-test
count	I-test
was	O
greater	O
than	O
8000	O
.	O

On	O
10/3/01	O
,	O
the	O
patient	O
had	O
a	B-test
repeat	I-test
head	I-test
and	I-test
neck	I-test
CT	I-test
,	O
which	O
showed	O
a	B-problem
right	I-problem
parotitis	I-problem
and	O
left	B-problem
submandibular	I-problem
lymphadenopathy	I-problem
with	O
some	B-problem
necrosis	I-problem
.	O

No	O
frank	B-problem
abscesses	I-problem
.	O

The	B-treatment
patient	I-treatment
&apos;s	I-treatment
antibiotics	I-treatment
were	O
changed	O
to	O
clindamycin	B-treatment
300	O
mg	O
q.i.d.	O
and	O
patient	O
was	O
also	O
put	O
on	O
sialagogue	B-treatment
.	O

Over	O
the	O
course	O
of	O
the	O
hospitalization	O
,	O
the	B-problem
swelling	I-problem
and	O
tenderness	B-problem
and	O
erythema	B-problem
have	O
steadily	O
decreased	O
.	O

Recommendations	O
on	O
antibiotics	B-treatment
were	O
made	O
by	O
infectious	O
disease	O
team	O
,	O
who	O
was	O
consulted	O
.	O

Rheumatology	O
was	O
also	O
consulted	O
for	O
patient	O
and	O
after	O
workup	B-test
,	O
it	O
was	O
believed	O
that	O
arthritis	B-problem
may	O
be	O
a	O
rheumatoid	B-problem
factor	I-problem
negative	I-problem
,	I-problem
rheumatoid	I-problem
polyarthritis	I-problem
.	O

Rheumatology	O
recommended	O
a	B-treatment
taper	I-treatment
of	I-treatment
his	I-treatment
prednisone	I-treatment
to	O
20	O
mg	O
q.d.	O
and	O
the	O
patient	O
will	O
be	O
followed	O
by	O
the	O
rheumatology	O
service	O
.	O

The	O
oncology	O
service	O
was	O
also	O
consulted	O
for	O
patient	O
and	O
performed	O
a	B-test
bone	I-test
marrow	I-test
biopsy	I-test
.	O

Throughout	O
his	O
course	O
during	O
this	O
hospitalization	O
,	O
the	O
patient	O
was	O
also	O
followed	O
by	O
the	O
ENT	O
service	O
.	O

The	O
ENT	O
physicians	O
did	O
not	O
recommend	O
any	B-treatment
procedures	I-treatment
,	O
incision	B-treatment
and	O
drainage	B-treatment
for	O
his	B-problem
right	I-problem
parotitis	I-problem
or	O
left	B-problem
submandibular	I-problem
cervical	I-problem
lymph	I-problem
node	I-problem
necrosis	I-problem
.	O

The	O
ENT	O
team	O
recommended	O
watching	O
patient	O
in-house	O
for	O
two	O
days	O
after	O
his	B-test
repeat	I-test
imaging	I-test
on	O
10/3/01	O
,	O
and	O
to	O
continue	O
antibiotic	B-treatment
coverage	I-treatment
with	O
clindamycin	B-treatment
.	O

The	O
patient	O
had	O
no	O
positive	B-problem
blood	I-problem
cultures	I-problem
during	O
his	O
hospitalization	O
and	O
remained	O
afebrile	B-problem
after	O
the	O
second	O
day	O
of	O
admission	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Topical	B-treatment
Bactroban	I-treatment
to	O
be	O
applied	O
three	O
times	O
a	O
day	O
to	O
affected	O
naris	O
,	O
prednisone	B-treatment
5	O
mg	O
p.o.	O
q.a.m.	O
,	O
K-Dur	B-treatment
10	O
mEq	O
x2	O
p.o.	O
q.d.	O
,	O
OxyContin	B-treatment
10	O
mg	O
p.o.	O
q.12h.	O
,	O
clindamycin	B-treatment
300	O
mg	O
p.o.	O
q.i.d.	O
,	O
lisinopril	B-treatment
10	O
mg	O
p.o.	O
q.d.	O
,	O
atenolol	B-treatment
25	O
mg	O
p.o.	O
q.d.	O
,	O
trazodone	B-treatment
100	O
mg	O
p.o.	O
q.h.s.	O
,	O
Prilosec	B-treatment
40	O
mg	O
p.o.	O
q.d	O
,	O
clotrimazole	B-treatment
1%	I-treatment
cream	I-treatment
topical	I-treatment
to	O
be	O
applied	O
b.i.d.	O

DISCHARGE	O
FOLLOW-UP	O
:	O

The	O
patient	O
was	O
arranged	O
for	O
follow-up	O
appointment	O
with	O
Dr.	O
Scarvzine	O
of	O
rheumatology	O
on	O
10/11/01	O
.	O

Also	O
,	O
with	O
Dr.	O
Fyfe	O
of	O
ENT	O
scheduled	O
for	O
Halloween	O
.	O

Dr.	O
Twada	O
,	O
his	O
primary	O
care	O
physician	O
at	O
the	O
SBH	O
clinic	O
for	O
10/11/01	O
and	O
Dr.	O
Fyfechird	O
,	O
gastroenterologist	O
,	O
on	O
10/13/01	O
.	O

COMPLICATIONS	O
:	O

There	O
were	O
no	O
complications	B-problem
during	O
the	O
patient	O
&apos;s	O
hospitalization	O
and	O
he	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

Dictated	O
By	O
:	O

THRYNE	O
ANA	O
,	O
M.D.	O
GN628	O

Attending	O
:	O

DRIS	O
UPHKOTE	O
,	O
M.D.	O
IF67	O
TB150/196806	O

Batch	O
:	O

48373	O
PAD-WORD	O

Index	O
No.	O
RYZKWV6XG4	O

D	O
:	O

10/08/01	O
PAD-WORD	O

T	O
:	O

10/08/01	O
PAD-WORD	O

991193550	O
PAD-WORD	O

PUOMC	O
PAD-WORD	O

1585733	O
PAD-WORD	O

16900/0678	O
PAD-WORD	O

362005	O
PAD-WORD	O

11/30/1995	O
12:00:00	O
AM	O

GASTRIC	B-problem
ULCER	I-problem
AND	O
GASTRIC	B-problem
PERICARDIAL	I-problem
FISTULA	I-problem
,	O

Unsigned	O
PAD-WORD	O

DIS	O
PAD-WORD	O

Report	O
Status	O
:	O

Unsigned	O
PAD-WORD	O

ADMISSION	O
DATE	O
:	O

11-30-95	O
PAD-WORD	O

DISCHARGE	O
DATE	O
:	O

12-29-95	O
PAD-WORD	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Gastric	B-problem
ulcer	I-problem
and	O
gastric	B-problem
pericardial	I-problem
fistula	I-problem
,	O
constricting	B-problem
pericarditis	I-problem
,	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
,	O
status	O
post	O
gunshot	B-problem
wounds	I-problem
and	O
paraplegia	B-problem
since	O
1991	O
of	O
T4	O
on	O
down	O
.	O

The	O
patient	O
has	O
a	B-treatment
Greenfield	I-treatment
filter	I-treatment
in	O
.	O

He	O
has	O
multiple	B-problem
decubiti	I-problem
on	I-problem
his	I-problem
buttocks	I-problem
and	I-problem
penis	I-problem
.	O

He	O
had	O
a	B-treatment
gastric	I-treatment
pull	I-treatment
up	I-treatment
in	O
1992	O
of	O
the	O
stomach	O
into	O
the	O
left	O
thorax	O
and	O
he	O
has	O
a	B-treatment
transverse	I-treatment
colostomy	I-treatment
and	O
a	B-problem
sinus	I-problem
tract	I-problem
on	I-problem
the	I-problem
abdomen	I-problem
.	O

ALLERGIES	O
:	O

Bactrim	B-treatment
and	O
Vancomycin	B-treatment
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Albuterol	B-treatment
inhaler	I-treatment
.	O

Amphotericin	B-treatment
B	I-treatment
40	O
mg.	O
qday	O
.	O

Ceftazidime	B-treatment
1	O
gram	O
intravenous	O
q	O
8	O
.	O

Ciprofloxacin	B-treatment
500	O
mg.	O
po.	O
q12	O
.	O

Cisapride	B-treatment
10	O
mg.	O
po.	O
qid	O
.	O

Dakin	B-treatment
&apos;s	I-treatment
solution	I-treatment
1/4	O
strength	O
to	O
ulcer	O
of	O
penis	O
.	O

Benadryl	B-treatment
50	O
mg.	O
intravenous	O
tid	O
prn	O
.	O

______________	O
capsule	B-treatment
1	O
po.	O
tid	O
.	O

Lasix	B-treatment
prn	O
.	O

Nystatin	B-treatment
swish	I-treatment
and	I-treatment
swallow	I-treatment
tid	O
.	O

Percocet	B-treatment
po.	O
q4	O
to	O
6	O
prn	O
.	O

Trazodone	B-treatment
50	O
mg.	O
qhs.	O
multivitamins	B-treatment
1	O
po.	O
qd	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
25	O
year	O
old	O
who	O
has	O
a	O
history	O
of	O
a	B-problem
gunshot	I-problem
wound	I-problem
many	O
years	O
ago	O
and	O
has	O
had	O
multiple	B-treatment
surgical	I-treatment
procedures	I-treatment
since	O
then	O
.	O

Most	O
recently	O
he	O
was	O
admitted	O
to	O
an	O
outside	O
hospital	O
with	O
a	B-problem
drug	I-problem
overdose	I-problem
in	O
adult	B-problem
respiratory	I-problem
distress	I-problem
syndrome	I-problem
and	O
ultimately	O
found	O
to	O
have	O
Candidal	B-problem
pericarditis	I-problem
which	O
eventually	O
led	O
to	O
constrictive	B-problem
pericarditis	I-problem
.	O

He	O
had	O
a	B-treatment
pericardial	I-treatment
window	I-treatment
.	O

He	O
had	O
a	B-test
barium	I-test
swallow	I-test
and	O
endoscopy	B-test
and	O
was	O
said	O
not	O
to	O
have	O
gastric	B-problem
or	I-problem
pericardial	I-problem
ulcer	I-problem
.	O

He	O
had	O
previous	B-treatment
substernal	I-treatment
gastric	I-treatment
bypass	I-treatment
because	O
of	O
an	B-problem
interruption	I-problem
of	I-problem
his	I-problem
esophagus	I-problem
at	O
the	O
time	O
of	O
his	B-problem
gunshot	I-problem
wound	I-problem
.	O

He	O
had	O
been	O
noted	O
to	O
have	O
an	B-problem
ulcer	I-problem
and	O
ultimately	O
when	O
he	O
stabilized	O
it	O
was	O
our	O
feeling	O
that	O
he	O
most	O
likely	O
had	O
a	B-problem
gastric	I-problem
pericardial	I-problem
ulcer	I-problem
and	O
he	O
was	O
transferred	O
here	O
for	O
further	B-treatment
management	I-treatment
.	O

We	O
discussed	O
the	O
risks	O
with	O
his	O
family	O
.	O

It	O
was	O
a	O
very	O
high	O
risk	O
in	O
very	B-problem
poor	I-problem
condition	I-problem
and	O
a	O
cachectic	O
malnourished	O
edematous	O
individuals	O
who	O
have	O
very	B-problem
high	I-problem
venous	I-problem
pressures	I-problem
and	O
shortness	B-problem
of	I-problem
breath	I-problem
.	O

The	O
family	O
understood	O
that	O
this	O
was	O
a	B-treatment
life	I-treatment
saving	I-treatment
procedure	I-treatment
and	O
only	O
carried	O
with	O
it	O
approximately	O
50%	O
chance	O
of	O
success	O
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

esophagoscopy	B-test
,	O
bronchoscopy	B-test
,	O
pericardectomy	B-treatment
,	O
excision	B-treatment
of	O
gastric	B-problem
ulcer	I-problem
,	O
repair	B-treatment
of	O
gastric	B-problem
ulcer	I-problem
and	O
pectoralis	B-treatment
major	I-treatment
myocutaneous	I-treatment
flap	I-treatment
performed	O
on	O
December	O
4	O
,	O
1995	O
by	O
Dr.	O
Reg	O
Cranka	O
and	O
Dr.	O
Win	O
Shufffyfe	O
.	O

In	O
lieu	O
of	O
a	O
standard	O
discharge	O
summary	O
given	O
this	O
patient	O
&apos;s	O
complicated	O
hospital	O
course	O
and	O
associated	B-problem
illnesses	I-problem
I	O
feel	O
it	O
best	O
to	O
just	O
provide	O
a	O
system	O
summary	O
concerning	O
this	O
patient	O
&apos;s	O
current	O
status	O
.	O

1.	O
Neurologic	O
and	O
Psychologic	O
:	O

The	O
patient	O
is	O
on	O
Nortriptyline	B-treatment
for	O
depression	B-problem
.	O

He	O
is	O
a	B-problem
paraplegic	I-problem
from	I-problem
T4	I-problem
down	I-problem
.	O

Otherwise	O
he	O
is	O
awake	O
,	O
alert	O
and	O
appropriate	O
and	O
can	O
respond	O
to	O
questions	O
and	O
can	O
move	O
his	O
upper	O
extremities	O
.	O

The	O
patient	O
however	O
spends	O
most	O
of	O
his	O
time	O
at	O
bedrest	O
due	O
to	O
decubiti	B-problem
ulcer	I-problem
disease	I-problem
.	O

2.	O
Cardiac	O
:	O

The	O
patient	O
had	O
constrictive	B-problem
pericarditis	I-problem
that	O
was	O
relieved	O
by	O
his	B-treatment
surgical	I-treatment
procedure	I-treatment
.	O

He	O
had	O
a	B-test
cardiac	I-test
catheterization	I-test
on	O
December	O
1	O
,	O
1995	O
that	O
showed	O
no	O
complications	B-problem
,	O
elevated	B-problem
right	I-problem
atrial	I-problem
pressure	I-problem
and	O
moderate	B-problem
pulmonary	I-problem
hypertension	I-problem
.	O

The	B-test
cardiac	I-test
output	I-test
was	O
five	O
liters	O
per	O
minute	O
with	O
an	B-test
index	I-test
at	O
2.9	O
liters	O
per	O
minute	O
per	O
meter	O
2	O
which	O
is	O
normal	O
.	O

A	O
full	O
copy	O
of	O
the	O
cardiac	O
catheterization	O
report	O
is	O
enclosed	O
with	O
his	O
transfer	O
materials	O
.	O

The	O
patient	O
also	O
underwent	O
cardiac	B-test
ultrasound	I-test
on	O
December	O
11	O
,	O
1995	O
that	O
showed	O
abnormal	B-problem
right	I-problem
ventricle	I-problem
wall	I-problem
motion	I-problem
,	O
trace	B-problem
mitral	I-problem
regurgitation	I-problem
,	O
normal	O
left	O
ventricular	O
size	O
and	O
function	O
with	O
an	B-test
estimated	I-test
ejection	I-test
fraction	I-test
of	O
64%	O
.	O

There	O
is	O
Doppler	B-test
evidence	O
of	O
tricuspid	B-problem
insufficiency	I-problem
and	O
right	B-problem
atrial	I-problem
dilatation	I-problem
.	O

There	O
is	O
trace	B-problem
pulmonary	I-problem
insufficiency	I-problem
.	O

The	O
right	O
ventricle	O
is	O
dilated	B-problem
and	O
diffusely	B-problem
hypokinetic	I-problem
and	O
there	O
is	O
no	O
evidence	O
of	O
constrictive	B-problem
physiology	I-problem
which	O
was	O
seen	O
on	O
December	O
6	O
,	O
1995	O
.	O

A	O
copy	O
of	O
this	B-test
ultrasound	I-test
is	O
also	O
found	O
in	O
his	O
records	O
.	O

The	O
patient	O
is	O
on	O
no	O
specific	B-treatment
medications	I-treatment
for	O
his	B-problem
cardiac	I-problem
condition	I-problem
.	O

3.	O
Respiratory	O
:	O

the	O
patient	O
is	O
status	O
post	O
thoracotomy	B-treatment
and	O
has	O
staples	B-treatment
and	O
sutures	B-treatment
on	I-treatment
his	I-treatment
chest	I-treatment
.	O

These	O
may	O
be	O
removed	O
when	O
the	B-problem
incisions	I-problem
are	O
noted	O
to	O
be	O
well	O
healed	O
.	O

The	O
patient	O
is	O
approximately	O
three	O
weeks	O
following	O
his	B-treatment
procedure	I-treatment
and	O
several	O
of	O
these	B-treatment
stitches	I-treatment
will	O
be	O
removed	O
prior	O
to	O
discharge	O
.	O

The	O
patient	O
is	O
on	O
oxygen	B-treatment
by	O
face	B-treatment
mask	I-treatment
and	O
his	B-test
saturations	I-test
have	O
been	O
remaining	O
normal	O
.	O

His	B-treatment
medications	I-treatment
for	O
his	O
respiratory	O
system	O
are	O
Albuterol	B-treatment
nebulizer	I-treatment
0.5	O
mg.	O
2.5	O
cc.	O
q4hours	O
.	O

3.	O
GI	O
:	O

The	O
patient	O
has	O
had	O
gastric	B-treatment
ulcer	I-treatment
repair	I-treatment
and	O
also	O
has	O
a	B-treatment
colostomy	I-treatment
.	O

The	O
patient	O
has	O
a	B-problem
sinus	I-problem
tract	I-problem
that	O
was	O
studied	O
with	O
a	B-test
fistulogram	I-test
on	O
December	O
25	O
,	O
1995	O
.	O

This	O
showed	O
no	O
communication	B-problem
with	I-problem
the	I-problem
intestines	I-problem
and	O
was	O
simply	O
a	B-problem
sinus	I-problem
tract	I-problem
.	O

There	O
is	O
no	O
fistula	B-problem
seen	O
.	O

Dr.	O
Asha	O
Vengloan	O
of	O
General	O
Surgery	O
consulted	O
on	O
the	O
patient	O
and	O
concluded	O
the	O
patient	O
does	O
not	O
require	O
any	B-treatment
surgical	I-treatment
treatment	I-treatment
of	O
this	B-problem
problem	I-problem
at	O
the	O
current	O
time	O
and	O
the	B-treatment
best	I-treatment
treatment	I-treatment
for	O
this	O
situation	O
would	O
be	O
to	O
increase	O
the	O
patient	O
&apos;s	O
nutrition	O
.	O

The	O
patient	O
takes	O
poorly	O
his	O
po.	O
diet	O
.	O

However	O
he	O
is	O
able	O
to	O
swallow	O
and	O
tolerate	O
po&apos;s	O
.	O

He	O
just	O
claims	O
to	O
have	O
no	B-problem
appetite	I-problem
and	O
has	O
very	B-problem
poor	I-problem
effort	I-problem
with	O
feeding	O
.	O

The	O
patient	O
is	O
able	O
to	O
tolerate	O
po.	B-treatment
medicines	I-treatment
.	O

4.	O
GU	O
:	O

The	O
patient	O
has	O
an	B-problem
ulcer	I-problem
on	I-problem
his	I-problem
penis	I-problem
that	O
has	O
been	O
treated	O
with	O
dressing	B-treatment
changes	I-treatment
.	O

It	O
has	O
been	O
noted	O
to	O
be	O
improving	O
.	O

The	O
patient	O
has	O
a	B-treatment
Foley	I-treatment
catheter	I-treatment
in	O
and	O
when	O
the	O
penile	O
skin	O
is	O
very	O
well	O
healed	O
his	B-treatment
Foley	I-treatment
catheter	I-treatment
may	O
be	O
removed	O
.	O

Until	O
this	O
time	O
he	O
should	O
be	O
kept	O
on	O
three	O
times	O
daily	O
wet	B-treatment
to	I-treatment
dry	I-treatment
dressing	I-treatment
changes	I-treatment
.	O

5.	O
Skin	O
:	O

The	O
patient	O
has	O
multiple	B-problem
decubiti	I-problem
over	O
his	O
body	O
,	O
in	O
particular	O
his	O
perineum	O
and	O
buttocks	O
have	O
large	B-problem
decubiti	I-problem
.	O

Plastic	O
Surgery	O
was	O
consulted	O
Dr.	O
Ca	O
Shuff	O
who	O
saw	O
the	O
patient	O
and	O
decided	O
that	O
the	O
patient	O
is	O
not	O
a	O
surgical	O
candidate	O
at	O
this	O
point	O
.	O

These	B-problem
wounds	I-problem
should	O
be	O
treated	O
with	O
three	O
times	O
daily	O
wet	B-treatment
to	I-treatment
dry	I-treatment
dressings	I-treatment
.	O

The	O
patient	O
&apos;s	O
activity	O
should	O
be	O
limited	O
to	O
being	O
up	O
in	O
a	O
chair	O
only	O
for	O
several	O
minutes	O
per	O
day	O
and	O
sit	O
on	O
a	O
special	O
pad	O
that	O
the	O
family	O
has	O
purchased	O
.	O

6.	O
Infectious	O
Disease	O
:	O

The	B-test
patient	I-test
&apos;s	I-test
white	I-test
count	I-test
at	O
the	O
time	O
of	O
discharge	O
is	O
within	O
normal	O
limits	O
.	O

The	O
patient	O
remains	O
on	O
Fluconazole	B-treatment
.	O

His	B-treatment
other	I-treatment
antibiotics	I-treatment
were	O
discontinued	O
.	O

His	B-test
most	I-test
recent	I-test
cultures	I-test
are	O
negative	O
.	O

The	B-test
chest	I-test
X-ray	I-test
shows	O
no	O
evidence	O
of	O
pneumonia	B-problem
.	O

7.	O
Pain	B-problem
.	O

The	O
patient	O
has	O
been	O
very	O
closely	O
with	O
the	O
Pain	O
Service	O
here	O
while	O
admitted	O
.	O

He	O
has	O
been	O
placed	O
on	O
Oxycodone	B-treatment
10	O
mg.	O
po.	O
q3hours	O
as	O
needed	O
for	O
pain	B-problem
.	O

The	O
patient	O
had	O
a	B-treatment
PCA	I-treatment
and	O
several	B-treatment
other	I-treatment
medications	I-treatment
have	O
been	O
discontinued	O
.	O

The	O
patient	O
has	O
strong	O
narcotic	O
seeking	O
behavior	O
.	O

The	O
patient	O
for	O
sleep	O
was	O
given	O
Benadryl	B-treatment
25	O
to	O
50	O
mg.	O
qhs.	O
and	O
was	O
not	O
allowed	O
any	O
increases	O
in	O
his	B-treatment
narcotics	I-treatment
after	O
weaning	O
him	O
down	O
to	O
just	O
requiring	O
the	B-treatment
Oxycodone	I-treatment
.	O

A	O
complete	O
summary	O
of	O
the	B-treatment
patient	I-treatment
&apos;s	I-treatment
medications	I-treatment
are	O
as	O
follows	O
:	O

Cimetidine	B-treatment
300	O
mg.	O
intravenous	O
q6hours	O
.	O

Albuterol	B-treatment
nebulizer	I-treatment
0.5	O
mg.	O
2.5	O
cc.	O
q4hours	O
.	O

Senokot	B-treatment
two	O
tablets	O
po.	O
bid	O
or	O
Metamucil	B-treatment
one	O
tablespoon	O
po.	O
bid	O
.	O

Nortriptyline	B-treatment
25	O
mg.	O
po.	O
qhs	O
.	O

KCL	B-treatment
40	O
mEq.	O
po.	O
bid	O
.	O

Saline	B-treatment
wet	I-treatment
to	I-treatment
dry	I-treatment
dressing	I-treatment
changes	I-treatment
three	O
times	O
daily	O
to	O
penis	B-problem
and	I-problem
pelvis	I-problem
decubiti	I-problem
,	O
40%	B-treatment
humidified	I-treatment
oxygen	I-treatment
,	O
Fluconazole	B-treatment
200	O
mg.	O
po.	O
bid	O
.	O

Lasix	B-treatment
2.5	O
mg.	O
intravenous	O
qid	O
.	O

Prilosec	B-treatment
20	O
mg.	O
po.	O
qd	O
.	O

Benadryl	B-treatment
25	O
to	O
50	O
mg.	O
po.	O
qhs	O
prn	O
.	O

Oxycodone	B-treatment
10	O
mg.	O
po.	O
q3	O
hours	O
prn	O
.	O

Physicians	O
that	O
took	O
care	O
of	O
this	O
patient	O
while	O
at	O
the	O
Ph	O
University	O
Of	O
Medical	O
Center	O
are	O
as	O
follows	O
:	O

Admitting	O
Physician	O
and	O
Thoracic	O
Surgeon	O
:	O

Reg	O
Cranka	O
,	O
M.D.	O

Consulting	O
General	O
Surgeon	O
was	O
Asha	O
Vengloan	O
,	O
M.D.	O

Consulting	O
Urology	O
was	O
Ryna	O
Baker	O
,	O
M.D.	O

Consulting	O
Plastic	O
Surgeon	O
:	O

Ca	O
Shuff	O
,	O
M.D.	O

Consulting	O
Cardiologist	O
:	O

Cealme	O
Maressythe	O
,	O
M.D.	O

Consulting	O
Cardiac	O
Surgeon	O
:	O

Win	O
Shufffyfe	O
,	O
M.D.	O

Infectious	O
Disease	O
Consultant	O
:	O

Dr.	O
Jesc	O
.	O

Psychiatry	O
:	O

Dr.	O
Rencobe	O
and	O
Dr.	O
Saddbeem	O
.	O

Pain	O
Service	O
:	O

Dr.	O
Shuff	O
.	O

In	O
summary	O
this	O
is	O
a	O
25	O
year	O
old	O
male	O
with	O
a	O
very	O
complicated	O
history	O
and	O
a	O
patient	O
of	O
Dr.	O
Breunkays	O
&apos;s	O
.	O

The	O
patient	O
was	O
seen	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
for	O
problem	O
regarding	O
his	B-problem
constrictive	I-problem
pericarditis	I-problem
and	O
underwent	O
a	B-treatment
surgical	I-treatment
procedure	I-treatment
to	O
correct	O
this	O
.	O

Followup	B-test
cardiac	I-test
studies	I-test
showed	O
there	O
was	O
a	O
resolution	O
of	O
his	B-problem
constrictive	I-problem
pericarditis	I-problem
.	O

The	O
patient	O
also	O
had	O
a	B-problem
gastric	I-problem
ulcer	I-problem
repaired	O
at	O
the	O
same	O
time	O
.	O

Other	O
issues	O
of	O
the	O
patient	O
are	O
chronic	O
and	O
most	O
likely	O
will	O
be	O
followed	O
up	O
in	O
hospitals	O
closer	O
to	O
the	O
patient	O
&apos;s	O
home	O
.	O

If	O
there	O
are	O
any	O
questions	O
regarding	O
his	O
care	O
they	O
should	O
be	O
directed	O
to	O
Dr.	O
Cranka	O
&apos;s	O
office	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
and	O
we	O
will	O
be	O
happy	O
to	O
contact	O
any	O
or	O
all	O
of	O
the	O
consultations	O
concerned	O
with	O
Hauth	O
&apos;s	O
care	O
.	O

Hauth	O
is	O
a	O
very	O
complicated	O
patient	O
and	O
it	O
was	O
our	O
pleasure	O
to	O
provide	O
care	O
for	O
him	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
.	O

CA	O
SHUFF	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

REG	O
CRANKA	O
,	O
M.D.	O

TR	O
:	O

fp	O
/	O
bmot	O

DD	O
:	O

12-27-95	O
PAD-WORD	O

TD	O
:	O

12/27/95	O
PAD-WORD	O

CC	O
:	O

STAT	O
:	O

Goman	O
4	O

